##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PP2_HVAR=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=PP2_HDIV=Polyphen2 (HDIV) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=phylop_high=PhyloP value higher than 1.6 i.e. highly-conserved base and possibly pathognic.
##FILTER=pred_pathogenic_1=Variant predicted pathogenic by one of the prediction tools.
##FILTER=pred_pathogenic_2=Variant predicted pathogenic by two of the prediction tools.
##FILTER=pred_pathogenic_3=Variant predicted pathogenic by three of the prediction tools.
##FILTER=pred_pathogenic_4=Variant predicted pathogenic by four of the prediction tools.
##FILTER=trio_comp_f=Trio analyis:Variant is compound-heteroygous inherited from father.
##FILTER=trio_comp_m=Trio analyis: Variant is compound-heteroygous inherited from mother.
##FILTER=trio_denovo=Trio analyis: Variant is de-novo in child.
##FILTER=trio_hemizygous=Trio analyis: Variant is hemizygous.
##FILTER=trio_recessive=Trio analyis: Variant is recessively inherited from parents.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	Kaviar	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr1	977330	977330	T	C	hom	low_DP	QUAL=1743;DP=13;AF=1.00;MQM=60;TRIO=HOM,13,1.00,HOM,20,1.00,HOM,26,1.00	AGRN	splice_region&intron	AGRN:NM_001305275.1:splice_region&intron:LOW:exon6/37:c.1178-6T>C:,AGRN:NM_198576.3:splice_region&intron:LOW:exon6/35:c.1178-6T>C:		rs2799066	0.8852	0.9150	49652/26935/2511	0.8736						103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects];	RCV000116254.1 [benign]; 			913	168					AGRN (inh=n/a pLI=0.17)
chr1	981931	981931	A	G	hom		QUAL=6340;DP=55;AF=0.98;MQM=59;TRIO=HOM,55,0.98,HOM,73,1.00,HOM,96,1.00	AGRN	synonymous	AGRN:NM_001305275.1:synonymous:LOW:exon18/38:c.3066A>G:p.Ser1022Ser,AGRN:NM_198576.3:synonymous:LOW:exon18/36:c.3066A>G:p.Ser1022Ser		rs2465128	0.7977	0.8730	45286/25865/1210	0.8293						103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects];	RCV000116259.1 [benign]; 		COSM1126908	855	222				n/a (storniert, da VUS4 in SYNGAP1 SBW 2.03.2016)	AGRN (inh=n/a pLI=0.17)
chr1	982994	982994	T	C	hom		QUAL=15575;DP=143;AF=0.99;MQM=59;TRIO=HOM,143,0.99,HOM,143,1.00,HOM,208,1.00	AGRN	synonymous	AGRN:NM_001305275.1:synonymous:LOW:exon21/38:c.3558T>C:p.Phe1186Phe,AGRN:NM_198576.3:synonymous:LOW:exon21/36:c.3558T>C:p.Phe1186Phe		rs10267	0.8359	0.8980	49550/27787/1439	0.8697						103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects];	RCV000116264.1 [benign]; 		COSM4144271	903	180					AGRN (inh=n/a pLI=0.17)
chr1	984302	984302	T	C	het	low_DP	QUAL=572;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,WT,17,0.00,HOM,19,1.00	AGRN	synonymous	AGRN:NM_001305275.1:synonymous:LOW:exon24/38:c.4161T>C:p.Thr1387Thr,AGRN:NM_198576.3:synonymous:LOW:exon24/36:c.4161T>C:p.Thr1387Thr		rs9442391	0.5457	0.5010	6170/2886/108	0.4528						103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects];	RCV000116269.1 [benign]; 			310	536					AGRN (inh=n/a pLI=0.17)
chr1	987200	987200	C	T	hom		QUAL=11199;DP=65;AF=0.98;MQM=60;TRIO=HOM,65,0.98,HOM,144,1.00,HOM,160,0.99	AGRN	splice_region&intron	AGRN:NM_001305275.1:splice_region&intron:LOW:exon33/37:c.5660+5C>T:,AGRN:NM_198576.3:splice_region&intron:LOW:exon33/35:c.5651+5C>T:		rs9803031	0.7887	0.8750	47145/27015/1042	0.8466						103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects];	RCV000116279.1 [benign]; 			867	215					AGRN (inh=n/a pLI=0.17)
chr1	990380	990380	C	T	hom		QUAL=12528;DP=170;AF=0.96;MQM=60;TRIO=HOM,170,0.96,HET,332,0.44,HET,435,0.49	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*19C>T:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*19C>T:		rs3121561	0.3435	0.1950	938/271/224	0.1369										54	206					AGRN (inh=n/a pLI=0.17)
chr1	990417	990417	T	C	hom		QUAL=16882;DP=198;AF=0.99;MQM=59;TRIO=HOM,198,0.99,HET,389,0.46,HET,507,0.49	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*56T>C:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*56T>C:		rs2465136	0.3840	0.0000	0/0/0	0.0612										57	218					AGRN (inh=n/a pLI=0.17)
chr1	990517	990517	C	T	hom		QUAL=18598;DP=126;AF=0.99;MQM=59;TRIO=HOM,126,0.99,HET,285,0.48,HOM,376,1.00	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*156C>T:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*156C>T:		rs2710872	0.9179	0.0000	0/0/0	0.1403										244	62					AGRN (inh=n/a pLI=0.17)
chr1	990773	990773	C	T	hom		QUAL=22636;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HET,297,0.54,HOM,405,1.00	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*412C>T:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*412C>T:		rs2799072	0.8460	0.0000	0/0/0	0.1377										171	51					AGRN (inh=n/a pLI=0.17)
chr1	990806	990806	G	A	hom		QUAL=24719;DP=227;AF=0.98;MQM=59;TRIO=HOM,227,0.98,HET,312,0.54,HOM,451,1.00	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*445G>A:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*445G>A:		rs2799073	0.8462	0.0000	0/0/0	0.7988										171	51					AGRN (inh=n/a pLI=0.17)
chr1	990984	990984	G	A	hom		QUAL=16025;DP=154;AF=0.99;MQM=59;TRIO=HOM,154,0.99,HET,190,0.59,HOM,273,1.00	AGRN	3'UTR	AGRN:NM_001305275.1:3'UTR:MODIFIER:exon38/38:c.*623G>A:,AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*623G>A:		rs8014	0.9223	0.0000	0/0/0	0.8263										175	49					AGRN (inh=n/a pLI=0.17)
chr1	1957037	1957037	T	C	het		QUAL=6920;DP=173;AF=0.55;MQM=59;TRIO=HET,173,0.55,WT,342,0.00,HET,399,0.49	GABRD	synonymous	GABRD:NM_000815.4:synonymous:LOW:exon4/9:c.330T>C:p.Gly110Gly		rs2229110	0.5613	0.5920	22096/14241/2764	0.5736						137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to|Epilepsy,idiopathic generalized,10|Epilepsy,juvenile myoclonic,susceptibility to];			COSM424897	509	462					GABRD (inh=n/a pLI=0.92)
chr1	1960674	1960674	C	T	het		QUAL=4915;DP=126;AF=0.49;MQM=59;TRIO=HET,126,0.49,HET,266,0.56,WT,386,0.01	GABRD	synonymous	GABRD:NM_000815.4:synonymous:LOW:exon7/9:c.816C>T:p.Ser272Ser		rs28408173	0.1983	0.1570	1279/346/4	0.1500						137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to|Epilepsy,idiopathic generalized,10|Epilepsy,juvenile myoclonic,susceptibility to];				27	213					GABRD (inh=n/a pLI=0.92)
chr1	2337277	2337277	C	T	het		QUAL=119;DP=22;AF=0.41;MQM=60;TRIO=HET,22,0.41,WT,1,0.00,WT,1,0.00	PEX10	splice_region&intron	PEX10:NM_153818.1:splice_region&intron:LOW:exon5/5:c.973-4G>A:,PEX10:NM_002617.3:splice_region&intron:LOW:exon5/5:c.913-4G>A:		rs11586985	0.0809	0.0900	377/256/3	0.0874						602859 [PEX10 (confirmed) Peroxisome biogenesis disorder 6A (Zellweger)|Peroxisome biogenesis disorder 6B];				50	511					PEX10 (inh=AR pLI=0.01)
chr1	5926507	5926507	T	C	het		QUAL=8816;DP=279;AF=0.49;MQM=59;TRIO=HET,279,0.49,WT,156,0.00,HOM,182,0.99	NPHP4	synonymous,non_coding_exon	NPHP4:NM_015102.4:synonymous:LOW:exon26/30:c.3570A>G:p.Glu1190Glu,NPHP4:NM_001291593.1:synonymous:LOW:exon23/27:c.2031A>G:p.Glu677Glu,NPHP4:NM_001291594.1:synonymous:LOW:exon22/26:c.2034A>G:p.Glu678Glu,NPHP4:NR_111987.1:non_coding_exon:MODIFIER:exon29/33:n.4385A>G:		rs555164	0.3197	0.3750	7291/4640/147	0.3694						607215 [NPHP4 (provisional) Nephronophthisis 4|Senior-Loken syndrome 4];	RCV000081716.4 [benign]; 		COSM1126976	189	520					NPHP4 (inh=n/a pLI=0.00)
chr1	5935162	5935162	A	T	het	anno_high_impact	QUAL=4972;DP=90;AF=0.38;MQM=60;TRIO=HET,90,0.38,HOM,87,1.00,HET,128,0.52	NPHP4	splice_acceptor	NPHP4:NM_015102.4:splice_acceptor:HIGH:exon20/29:c.2818-2T>A:,NPHP4:NM_001291593.1:splice_acceptor:HIGH:exon17/26:c.1279-2T>A:,NPHP4:NM_001291594.1:splice_acceptor:HIGH:exon16/25:c.1282-2T>A:,NPHP4:NR_111987.1:splice_acceptor:HIGH:exon23/32:n.3633-2T>A:		rs1287637	0.8433	0.8250	35542/19394/3252	0.8135	0.4520					607215 [NPHP4 (provisional) Nephronophthisis 4|Senior-Loken syndrome 4];	RCV000153587.2 [benign]; 		COSM3751327	699	340	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			NPHP4 (inh=n/a pLI=0.00)
chr1	6526183	6526183	G	A	het	low_DP	QUAL=378;DP=16;AF=0.44;MQM=59;TRIO=HET,16,0.44,WT,5,0.00,HET,20,0.70	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-16C>T:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-16C>T:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-16C>T:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-16C>T:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1440C>T:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1468C>T:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1440C>T:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1440C>T:		rs3007417	0.2023	0.0820	440/67/329	0.0754										7	69					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=n/a pLI=0.00)
chr1	6526203	6526210	CGTGCTCT	-	het	low_DP	QUAL=389;DP=17;AF=0.53;MQM=59;TRIO=HET,17,0.53,WT,6,0.00,HET,21,0.67	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-43_-36delAGAGCACG:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-43_-36delAGAGCACG:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1441_*1448delAGAGCACG:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:		rs45616733	0.2027	0.0650	62/10/43	0.0586										0	36					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=n/a pLI=0.00)
chr1	6526241	6526244	CGCC	-	het	low_DP	QUAL=326;DP=11;AF=0.73;MQM=59;TRIO=HET,11,0.73,WT,3,0.00,HET,15,0.73	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-77_-74delGGCG:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-77_-74delGGCG:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-77_-74delGGCG:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-77_-74delGGCG:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-77_-74delGGCG:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-77_-74delGGCG:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1407_*1410delGGCG:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:		rs45542640	0.2025	0.0000	0/0/0	0.0856										0	14					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=n/a pLI=0.00)
chr1	6526319	6526319	C	T	het		QUAL=293;DP=31;AF=0.35;MQM=60;TRIO=HET,31,0.35,WT,30,0.00,HET,33,0.39	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1304G>A:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1332G>A:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1304G>A:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1304G>A:		rs45604837	0.0863	0.0000	0/0/0	0.0598										1	26					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6526465	6526465	C	G	het		QUAL=3463;DP=85;AF=0.48;MQM=60;TRIO=HET,85,0.48,WT,150,0.00,HET,199,0.54	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1158G>C:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1186G>C:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1158G>C:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1158G>C:	MIR3	rs2986754	0.2043	0.0000	0/0/0	0.0168										1	37					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6527333	6527333	A	G	het		QUAL=1629;DP=78;AF=0.51;MQM=59;TRIO=HET,78,0.51,WT,53,0.00,HET,59,0.47	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*318T>C:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*290T>C:		rs14708	0.2670	0.0000	0/0/0	0.0273										7	65					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6529443	6529443	A	G	het		QUAL=9849;DP=342;AF=0.47;MQM=59;TRIO=HET,342,0.47,WT,392,0.00,HET,488,0.48	PLEKHG5	synonymous	PLEKHG5:NM_001265592.1:synonymous:LOW:exon19/22:c.2238T>C:p.Ser746Ser,PLEKHG5:NM_001265593.1:synonymous:LOW:exon18/21:c.2208T>C:p.Ser736Ser,PLEKHG5:NM_001042665.1:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001042664.1:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001265594.1:synonymous:LOW:exon18/22:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_020631.4:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001042663.1:synonymous:LOW:exon19/22:c.2169T>C:p.Ser723Ser,PLEKHG5:NM_198681.3:synonymous:LOW:exon19/22:c.2232T>C:p.Ser744Ser		rs730600	0.2696	0.1720	2980/684/1843	0.1670						611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];	RCV000175354.1 [benign]; 			36	313					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6531589	6531589	C	T	het		QUAL=1721;DP=39;AF=0.69;MQM=59;TRIO=HET,39,0.69,WT,115,0.00,HET,115,0.44	PLEKHG5	missense	PLEKHG5:NM_001265592.1:missense:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr,PLEKHG5:NM_001265593.1:missense:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr,PLEKHG5:NM_001042665.1:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001042664.1:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001265594.1:missense:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_020631.4:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001042663.1:missense:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr,PLEKHG5:NM_198681.3:missense:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr		rs74809741	0.0553	0.0510	169/106/28	0.0493	0.6410	T	T,T,T,T,T,T,T,T,T,T,T,T,T	B,B,B,B,B	B,B,B,B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];			COSM4144152, COSM4144153	7	132					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6533393	6533393	G	C	het		QUAL=407;DP=23;AF=0.35;MQM=60;TRIO=HET,23,0.35,WT,19,0.00,HET,25,0.56	PLEKHG5	missense	PLEKHG5:NM_001265592.1:missense:MODERATE:exon9/22:c.950C>G:p.Thr317Ser,PLEKHG5:NM_001265593.1:missense:MODERATE:exon8/21:c.920C>G:p.Thr307Ser,PLEKHG5:NM_001042665.1:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001042664.1:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001265594.1:missense:MODERATE:exon8/22:c.713C>G:p.Thr238Ser,PLEKHG5:NM_020631.4:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001042663.1:missense:MODERATE:exon9/22:c.881C>G:p.Thr294Ser,PLEKHG5:NM_198681.3:missense:MODERATE:exon9/22:c.944C>G:p.Thr315Ser		rs61741379	0.2857	0.1280	796/120/537	0.1178	0.8480	T	T,T,T,T,T,T,T,T,T,T,T,T,T	B,B,B,B,B	B,B,B,B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];	RCV000180356.1 [benign]; 		COSM3751353, COSM3751354	35	306					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6579521	6579521	G	C	het		QUAL=3471;DP=124;AF=0.53;MQM=59;TRIO=HET,124,0.53,HET,78,0.46,HET,91,0.52	PLEKHG5	missense	PLEKHG5:NM_198681.3:missense:MODERATE:exon1/22:c.51C>G:p.Ser17Arg		rs17438786	0.0136	0.0250	51/36/0	0.0243	0.0870	T	T,T	B,B	B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];				0	54					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6579607	6579607	C	T	hom		QUAL=20275;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,206,1.00,HOM,271,1.00	PLEKHG5	5'UTR	PLEKHG5:NM_198681.3:5'UTR:MODIFIER:exon1/22:c.-36G>A:		rs1556035	0.7460	0.8510	44471/25994/1339	0.8284										164	64					PLEKHG5 (inh=n/a pLI=0.00)
chr1	6579843	6579843	C	T	hom		QUAL=41968;DP=296;AF=0.99;MQM=59;TRIO=HOM,296,0.99,HOM,454,1.00,HOM,585,1.00	PLEKHG5	5'UTR	PLEKHG5:NM_198681.3:5'UTR:MODIFIER:exon1/22:c.-272G>A:		rs1010584	0.7354	0.0000	0/0/0	0.1412										159	68					PLEKHG5 (inh=n/a pLI=0.00)
chr1	10435324	10435324	C	A	het		QUAL=7247;DP=299;AF=0.45;MQM=60;TRIO=HET,299,0.45,HET,116,0.57,HET,147,0.52	KIF1B	synonymous	KIF1B:NM_015074.3:synonymous:LOW:exon46/47:c.5163C>A:p.Thr1721Thr		rs11121552	0.2316	0.2720	4770/2846/50	0.2705						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];	RCV000117408.4 [other]; 		COSM146393	83	396					KIF1B (inh=n/a pLI=1.00)
chr1	10436892	10436892	-	AC	het		QUAL=4808;DP=130;AF=0.44;MQM=59;TRIO=HET,130,0.82,HET,110,0.32,WT,126,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*279_*280dupCA:		rs146112447;rs769994641	0.0000	0.0000	0/0/0	0.0182						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				0	16					KIF1B (inh=n/a pLI=1.00)
chr1	10436924	10436924	C	T	het		QUAL=4808;DP=130;AF=0.44;MQM=59;TRIO=HET,130,0.82,WT,110,0.32,HET,126,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*279C>T:	(AC)n	rs78490707	0.0403	0.0000	0/0/0	0.0118						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				0	5					KIF1B (inh=n/a pLI=1.00)
chr1	10438006	10438006	A	T	het		QUAL=1434;DP=82;AF=0.45;MQM=59;TRIO=HET,82,0.45,HET,59,0.53,WT,73,0.00	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*1361A>T:	AluSg	rs2847347	0.0182	0.0000	0/0/0	0.0388						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				2	26					KIF1B (inh=n/a pLI=1.00)
chr1	10438687	10438687	C	T	het		QUAL=12161;DP=255;AF=0.56;MQM=59;TRIO=HET,255,0.56,HET,281,0.51,HET,354,0.51	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*2042C>T:		rs1536262	0.5465	0.0000	0/0/0	0.0817										75	167					KIF1B (inh=n/a pLI=1.00)
chr1	10438892	10438892	G	A	het		QUAL=8905;DP=286;AF=0.54;MQM=59;TRIO=HET,286,0.54,HET,160,0.57,HET,193,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*2247G>A:		rs1002076	0.3337	0.0000	0/0/0	0.0557										26	104					KIF1B (inh=n/a pLI=1.00)
chr1	10440556	10440556	A	G	het		QUAL=8674;DP=321;AF=0.48;MQM=51;TRIO=HET,321,0.48,HET,181,0.49,HET,226,0.48	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*3911A>G:	AluSx	rs1138791	0.3488	0.0000	0/0/0	0.2200										29	82					KIF1B (inh=n/a pLI=1.00)
chr1	10441664	10441664	T	C	het		QUAL=13528;DP=457;AF=0.52;MQM=60;TRIO=HET,457,0.52,HET,272,0.44,HET,349,0.50	KIF1B-PGD	intergenic_region	KIF1B-PGD:KIF1B-PGD:intergenic_region:MODIFIER::n.10441664T>C:		rs3748581	0.5270	0.0000	0/0/0	0.4740										48	98					KIF1B-PGD (inh=n/a pLI=n/a)
chr1	11085004	11085004	-	TGTTT	het		QUAL=16980;DP=384;AF=0.49;MQM=59;TRIO=HET,384,0.49,HET,258,0.50,HOM,272,0.99	TARDBP	3'UTR	TARDBP:NM_007375.3:3'UTR:MODIFIER:exon6/6:c.*2294_*2295insGTTTT:		rs3059695;rs5772439	0.9151	0.0000	0/0/0	0.7595										163	92					TARDBP (inh=n/a pLI=0.98)
chr1	11846092	11846092	-	T	hom		QUAL=4482;DP=109;AF=0.79;MQM=59;TRIO=HOM,109,0.79,HOM,37,0.89,HOM,51,0.90	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4644dupA:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3567+757dupT:		rs397709443	0.9513	0.0000	0/0/0	0.6457										116	121					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846252	11846252	G	A	hom		QUAL=14879;DP=330;AF=1.00;MQM=59;TRIO=HOM,330,1.00,HET,159,0.50,HET,182,0.54	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4485C>T:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3567+906G>A:	Tigger15a	rs4846048	0.7065	0.0000	0/0/0	0.1252										119	116					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846447	11846447	G	A	hom		QUAL=25316;DP=383;AF=1.00;MQM=60;TRIO=HOM,383,1.00,HOM,182,1.00,HOM,216,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4290C>T:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-998G>A:		rs4845884	0.9333	0.0000	0/0/0	0.1465										268	0					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846660	11846663	TTTT	-	hom		QUAL=1919;DP=83;AF=0.64;MQM=57;TRIO=HOM,83,0.64,HOM,30,0.43,HOM,38,0.58	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4074_*4077delAAAA:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-770_3568-767delTTTT:	AluJr	rs55780505;rs796422158	0.7772	0.0000	0/0/0	0.4441										45	80					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11847334	11847334	-	GAA	hom		QUAL=9728;DP=231;AF=0.98;MQM=59;TRIO=HOM,231,0.98,HET,133,0.58,HET,222,0.41	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*3400_*3402dupTTC:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-108_3568-106dupAGA:		rs113394969;rs35134728;rs70983598	0.5701	0.0000	0/0/0	0.5640										114	163					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11847759	11847759	C	T	hom		QUAL=12117;DP=201;AF=0.98;MQM=59;TRIO=HOM,201,0.98,HET,245,0.50,HET,294,0.52	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*2978G>A:,C1orf167:NM_001010881.1:intron:MODIFIER:exon17/20:c.3674-171C>T:		rs3737966	0.5585	0.0000	0/0/0	0.6176										136	223					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11848879	11848879	A	G	hom		QUAL=19089;DP=250;AF=1.00;MQM=59;TRIO=HOM,250,1.00,HOM,151,1.00,HOM,217,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*1858T>C:,C1orf167:NM_001010881.1:intron:MODIFIER:exon20/20:c.4173+76A>G:		rs2077360	0.9305	0.0000	0/0/0	0.1471										475	3					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11849447	11849447	A	G	hom		QUAL=17848;DP=153;AF=1.00;MQM=59;TRIO=HOM,153,1.00,HOM,188,1.00,HOM,227,1.00	C1orf167,MTHFR	missense,3'UTR	C1orf167:NM_001010881.1:missense:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly,MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*1290T>C:		rs868014	0.9329	0.9760	7319/2565/292	0.2955	-4.9500	T,T	.,.,.,T	.,B	.,B				COSM4142235, COSM4142236	633	5					C1orf167 (inh=n/a pLI=0.16), MTHFR (inh=AR pLI=0.00)
chr1	11850365	11850365	T	G	hom		QUAL=18960;DP=314;AF=1.00;MQM=59;TRIO=HOM,314,1.00,HET,351,0.49,HET,383,0.48	MTHFR	3'UTR	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*372A>C:		rs4846049	0.6284	0.0000	0/0/0	0.1056								CR125703 [CLASS=DFP MUT=REF PHEN="Coronary heart disease increased risk association with" GENE=MTHFR]; 		112	121					MTHFR (inh=AR pLI=0.00)
chr1	11854457	11854457	G	A	hom		QUAL=18571;DP=121;AF=1.00;MQM=60;TRIO=HOM,121,1.00,HOM,205,1.00,HOM,264,1.00	MTHFR	synonymous	MTHFR:NM_005957.4:synonymous:LOW:exon8/12:c.1305C>T:p.Phe435Phe		rs4846051	0.9030	0.9700	57567/33195/2451	0.9399						607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency|Schizophrenia,susceptibility to|Vascular disease,susceptibility to|Neural tube defects,susceptibility to|Thromboembolism,susceptibility to];	RCV000153514.3 [benign]; 	CM044675 [CLASS=DP MUT=REF PHEN="Preeclampsia association with" GENE=MTHFR]; 		1142	12					MTHFR (inh=AR pLI=0.00)
chr1	12009955	12009955	C	T	het		QUAL=6861;DP=124;AF=0.46;MQM=59;TRIO=HET,124,0.46,HET,190,0.53,HET,248,0.49	PLOD1	synonymous	PLOD1:NM_001316320.1:synonymous:LOW:exon4/20:c.435C>T:p.Phe145Phe,PLOD1:NM_000302.3:synonymous:LOW:exon3/19:c.294C>T:p.Phe98Phe		rs7529452	0.2678	0.3280	7178/3488/33	0.3168						153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI];			COSM3996779, COSM3996782, COSM3996781, COSM3996780	112	480					PLOD1 (inh=AR pLI=0.00)
chr1	12024235	12024235	C	T	het	low_DP	QUAL=1188;DP=19;AF=0.58;MQM=59;TRIO=HET,19,0.58,HET,36,0.39,HET,54,0.54	PLOD1	synonymous	PLOD1:NM_001316320.1:synonymous:LOW:exon13/20:c.1347C>T:p.Asn449Asn,PLOD1:NM_000302.3:synonymous:LOW:exon12/19:c.1206C>T:p.Asn402Asn		rs1130529	0.3484	0.3630	8340/3773/429	0.3478						153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI];			COSM3996784, COSM3996785	111	496					PLOD1 (inh=AR pLI=0.00)
chr1	12040324	12040324	A	G	het		QUAL=4167;DP=34;AF=0.47;MQM=60;TRIO=HET,34,0.47,HOM,101,1.00,HET,123,0.36	MFN2	5'UTR	MFN2:NM_001127660.1:5'UTR:MODIFIER:exon1/18:c.-222A>G:,MFN2:NM_014874.3:5'UTR:MODIFIER:exon1/19:c.-367A>G:		rs2236054	0.5729	0.0000	0/0/0	0.4549										45	120					MFN2 (inh=AR+AD pLI=1.00)
chr1	12040479	12040479	T	C	het		QUAL=5233;DP=57;AF=0.51;MQM=60;TRIO=HET,57,0.51,HOM,112,1.00,HET,130,0.43	MFN2	5'UTR	MFN2:NM_001127660.1:5'UTR:MODIFIER:exon1/18:c.-67T>C:,MFN2:NM_014874.3:5'UTR:MODIFIER:exon1/19:c.-212T>C:		rs2180183	0.6100	0.0000	0/0/0	0.4980										46	120					MFN2 (inh=AR+AD pLI=1.00)
chr1	12071680	12071680	A	G	hom		QUAL=29308;DP=257;AF=0.99;MQM=59;TRIO=HOM,257,0.99,HOM,322,0.99,HOM,418,1.00	MFN2	3'UTR	MFN2:NM_001127660.1:3'UTR:MODIFIER:exon18/18:c.*58A>G:,MFN2:NM_014874.3:3'UTR:MODIFIER:exon19/19:c.*58A>G:		rs1042842	0.7324	0.0000	0/0/0	0.1320										167	173					MFN2 (inh=AR+AD pLI=1.00)
chr1	12072518	12072518	G	C	hom		QUAL=12885;DP=112;AF=0.98;MQM=59;TRIO=HOM,112,0.98,HOM,143,1.00,HOM,173,1.00	MFN2	3'UTR	MFN2:NM_001127660.1:3'UTR:MODIFIER:exon18/18:c.*896G>C:,MFN2:NM_014874.3:3'UTR:MODIFIER:exon19/19:c.*896G>C:		rs3088064	0.5441	0.0000	0/0/0	0.0960										101	130					MFN2 (inh=AR+AD pLI=1.00)
chr1	16371067	16371067	G	T	het	low_DP;pred_pathogenic_1	QUAL=234;DP=4;AF=0.75;MQM=60;TRIO=HET,4,0.75,HOM,1,1.00,HOM,5,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon2/20:c.80G>T:p.Arg27Leu		rs2015352	0.5555	0.6010	18450/10701/377	0.5711	-0.4670	T	D,D	P	B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM3750546	442	462					CLCNKB (inh=AR pLI=0.00)
chr1	16373124	16373124	A	G	hom		QUAL=23237;DP=186;AF=0.98;MQM=59;TRIO=HOM,186,0.98,HOM,249,1.00,HOM,312,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon4/20:c.324A>G:p.Ser108Ser		rs5257	0.7404	0.8020	40313/21921/836	0.7831						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				744	323					CLCNKB (inh=AR pLI=0.00)
chr1	16374533	16374533	G	C	hom	low_DP	QUAL=383;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,5,1.00,HOM,3,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon5/20:c.492G>C:p.Gly164Gly		rs2014562	0.8940	0.9290	52555/29576/3019	0.9087						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				938	134					CLCNKB (inh=AR pLI=0.00)
chr1	16374994	16374994	C	T	hom	low_MQM	QUAL=18061;DP=162;AF=0.99;MQM=46;TRIO=HOM,162,0.99,HOM,204,1.00,HOM,246,1.00	CLCNKB	splice_region&intron	CLCNKB:NM_000085.4:splice_region&intron:LOW:exon6/19:c.577-5C>T:		rs34666902	0.7386	0.8010	40086/21748/810	0.7275						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				739	325					CLCNKB (inh=AR pLI=0.00)
chr1	16375063	16375063	C	G	hom		QUAL=17380;DP=195;AF=0.99;MQM=52;TRIO=HOM,195,0.99,HOM,174,1.00,HOM,218,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon7/20:c.641C>G:p.Ala214Gly		rs45612832	0.8273	0.9000	49725/28393/1668	0.7830	-0.0370	T	T	B	B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				930	164					CLCNKB (inh=AR pLI=0.00)
chr1	16375064	16375064	A	C	hom		QUAL=17380;DP=195;AF=0.99;MQM=52;TRIO=HOM,195,0.99,HOM,174,1.00,HOM,218,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon7/20:c.642A>C:p.Ala214Ala		rs1889790;rs45575235	0.8273	0.9000	49718/28392/1667	0.7821						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				930	164					CLCNKB (inh=AR pLI=0.00)
chr1	16375354	16375354	C	T	hom		QUAL=19099;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,203,1.00,HOM,238,1.00	CLCNKB	5'UTR,intron	CLCNKB:NM_001165945.2:5'UTR:MODIFIER:exon1/13:c.-113C>T:,CLCNKB:NM_000085.4:intron:MODIFIER:exon7/19:c.656-261C>T:	MIR	rs9442227	0.7274	0.0000	0/0/0	0.1226						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				207	92					CLCNKB (inh=AR pLI=0.00)
chr1	16376191	16376191	C	T	hom	low_MQM	QUAL=25793;DP=188;AF=0.98;MQM=46;TRIO=HOM,188,0.98,HOM,314,1.00,HOM,406,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon9/20:c.860C>T:p.Ala287Val,CLCNKB:NM_001165945.2:missense:MODERATE:exon2/13:c.353C>T:p.Ala118Val		rs34188929	0.8299	0.9090	49342/28428/1594	0.7882	-0.3350	T	T,T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM4142953, COSM4142952	945	144					CLCNKB (inh=AR pLI=0.00)
chr1	16376319	16376319	T	C	hom		QUAL=33079;DP=194;AF=0.99;MQM=59;TRIO=HOM,194,0.99,HOM,362,1.00,HOM,486,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon10/20:c.876T>C:p.Cys292Cys,CLCNKB:NM_001165945.2:synonymous:LOW:exon3/13:c.369T>C:p.Cys123Cys		rs7368151	0.8301	0.9110	51203/29597/1694	0.8821						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM4142955, COSM4142954	950	146					CLCNKB (inh=AR pLI=0.00)
chr1	16380196	16380196	T	C	hom		QUAL=28369;DP=304;AF=1.00;MQM=51;TRIO=HOM,304,1.00,HOM,253,1.00,HOM,369,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon16/20:c.1685T>C:p.Met562Thr,CLCNKB:NM_001165945.2:missense:MODERATE:exon9/13:c.1178T>C:p.Met393Thr		rs5253	0.8383	0.9310	52942/31936/2492	0.9081	-0.9230	T	T,T,T,T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				1054	52					CLCNKB (inh=AR pLI=0.00)
chr1	16380243	16380243	A	G	hom	low_MQM;anno_pathogenic_hgmd	QUAL=15409;DP=132;AF=1.00;MQM=48;TRIO=HOM,132,1.00,HET,233,0.42,HOM,311,0.99	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu,CLCNKB:NM_001165945.2:missense:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu		rs2275166	0.7017	0.6580	26455/14211/3279	0.6456	0.8530	T	T,T,T,T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];		CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB]; 		476	482	1	[1] swoedl 28.06.2016			CLCNKB (inh=AR pLI=0.00)
chr1	16380252	16380252	C	T	hom	low_MQM	QUAL=14431;DP=124;AF=1.00;MQM=48;TRIO=HOM,124,1.00,HET,219,0.43,HOM,302,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon16/20:c.1741C>T:p.Leu581Leu,CLCNKB:NM_001165945.2:synonymous:LOW:exon9/13:c.1234C>T:p.Leu412Leu		rs2275167	0.6136	0.6210	23581/13624/1758	0.6095						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				450	491					CLCNKB (inh=AR pLI=0.00)
chr1	16383402	16383402	C	T	het	low_MQM	QUAL=650;DP=261;AF=0.26;MQM=34;TRIO=HET,261,0.26,WT,140,0.00,WT,143,0.07	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon20/20:c.2055C>T:p.Ala685Ala,CLCNKB:NM_001165945.2:synonymous:LOW:exon13/13:c.1545C>T:p.Ala515Ala		rs6698427	0.0000	0.0010	1/0/1	0.0003						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0	16					CLCNKB (inh=AR pLI=0.00)
chr1	16383448	16383448	A	C	het	low_MQM	QUAL=15861;DP=219;AF=0.69;MQM=40;TRIO=HET,219,0.69,HOM,241,1.00,HOM,290,0.89	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*37A>C:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*37A>C:		rs10803415	0.9010	0.9390	50420/29364/4051	0.8222										314	163					CLCNKB (inh=AR pLI=0.00)
chr1	16383574	16383574	A	T	het	low_MQM	QUAL=889;DP=247;AF=0.13;MQM=32;TRIO=HET,247,0.13,WT,381,0.00,HET,616,0.20	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*163A>T:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*163A>T:		rs1057841	0.0000	0.0000	0/0/0	0.0071										0	87					CLCNKB (inh=AR pLI=0.00)
chr1	16383581	16383581	G	T	het	low_MQM	QUAL=19835;DP=250;AF=0.84;MQM=37;TRIO=HET,250,0.84,HET,383,0.51,HET,618,0.80	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*170G>T:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*170G>T:		rs80126492	0.0000	0.0000	0/0/0	0.1624										69	300					CLCNKB (inh=AR pLI=0.00)
chr1	16383605	16383605	A	G	het	low_MQM	QUAL=19776;DP=200;AF=0.75;MQM=37;TRIO=HET,200,0.75,HET,403,0.53,HET,647,0.77	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*194A>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*194A>G:		rs1057845	0.0000	0.0000	0/0/0	0.1193										52	321					CLCNKB (inh=AR pLI=0.00)
chr1	16383668	16383668	T	G	hom	low_MQM	QUAL=32767;DP=174;AF=0.99;MQM=41;TRIO=HOM,174,0.99,HOM,360,1.00,HOM,661,1.00	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*257T>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*257T>G:		rs6660218	1.0000	0.9990	7654/2609/519	0.2301										639	0					CLCNKB (inh=AR pLI=0.00)
chr1	16383682	16383682	G	C	het	low_MQM;pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=4435;DP=223;AF=0.20;MQM=41;TRIO=HET,223,0.20,WT,322,0.00,HET,651,0.36	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*271G>C:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*271G>C:		rs1057854	0.0000	0.2240	10/0/8	0.0088	-3.2740	T	D					CR133355 [CLASS=DM? MUT=REF PHEN="Bartter syndrome 3" GENE=CLCNKB]; 		0	375	1	[1] Ute Grasshoff 13.08.2014			CLCNKB (inh=AR pLI=0.00)
chr1	16383742	16383742	C	G	het		QUAL=18366;DP=357;AF=0.54;MQM=57;TRIO=HET,357,0.54,HOM,224,1.00,HET,519,0.53	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*331C>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*331C>G:		rs1057857	0.0000	0.5850	2104/825/99	0.0503	-0.3020	T	T,T,T						COSM4142956	169	466					CLCNKB (inh=AR pLI=0.00)
chr1	17312743	17312743	C	T	het		QUAL=772;DP=23;AF=0.43;MQM=59;TRIO=HET,23,0.43,HOM,19,0.95,HET,25,0.44	ATP13A2	missense,synonymous	ATP13A2:NM_001141974.2:missense:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr,ATP13A2:NM_022089.3:synonymous:LOW:exon29/29:c.3516G>A:p.Pro1172Pro,ATP13A2:NM_001141973.2:synonymous:LOW:exon29/29:c.3501G>A:p.Pro1167Pro		rs3170740	0.3313	0.4550	12467/8266/189	0.4263	-2.5480	T	T,T	B	B	610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116444.1 [benign]; 		COSM3750607, COSM3750606	443	830					ATP13A2 (inh=AR pLI=0.00)
chr1	17313343	17313343	G	A	het		QUAL=10735;DP=99;AF=0.49;MQM=59;TRIO=HET,99,0.49,HOM,200,1.00,HET,283,0.49	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon27/29:c.3192C>T:p.Ala1064Ala,ATP13A2:NM_001141973.2:synonymous:LOW:exon27/29:c.3177C>T:p.Ala1059Ala,ATP13A2:NM_001141974.2:synonymous:LOW:exon26/27:c.3060C>T:p.Ala1020Ala		rs9435659	0.3385	0.4590	13360/8833/197	0.4508						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116442.1 [benign]; 		COSM3747591, COSM3747592	446	836					ATP13A2 (inh=AR pLI=0.00)
chr1	17313454	17313454	G	A	het		QUAL=2372;DP=64;AF=0.48;MQM=59;TRIO=HET,64,0.48,WT,138,0.00,HET,177,0.44	ATP13A2	splice_region&intron	ATP13A2:NM_022089.3:splice_region&intron:LOW:exon26/28:c.3084-3C>T:,ATP13A2:NM_001141973.2:splice_region&intron:LOW:exon26/28:c.3069-3C>T:,ATP13A2:NM_001141974.2:splice_region&intron:LOW:exon25/26:c.2952-3C>T:		rs7531163	0.3065	0.2730	5114/1978/157	0.2721						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116440.1 [benign]; 			98	650					ATP13A2 (inh=AR pLI=0.00)
chr1	17313654	17313654	C	T	het		QUAL=10630;DP=71;AF=0.48;MQM=60;TRIO=HET,71,0.48,HOM,245,1.00,HET,280,0.48	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon26/29:c.2970G>A:p.Val990Val,ATP13A2:NM_001141973.2:synonymous:LOW:exon26/29:c.2955G>A:p.Val985Val,ATP13A2:NM_001141974.2:synonymous:LOW:exon25/27:c.2838G>A:p.Val946Val		rs761421	0.3462	0.4600	13375/8738/258	0.4399						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116439.1 [benign]; 		COSM3750609, COSM3750608	445	836					ATP13A2 (inh=AR pLI=0.00)
chr1	17314702	17314702	C	T	het		QUAL=11025;DP=286;AF=0.48;MQM=60;TRIO=HET,286,0.48,WT,497,0.01,HET,583,0.51	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon25/29:c.2790G>A:p.Ser930Ser,ATP13A2:NM_001141973.2:synonymous:LOW:exon25/29:c.2775G>A:p.Ser925Ser,ATP13A2:NM_001141974.2:synonymous:LOW:exon24/27:c.2658G>A:p.Ser886Ser		rs3738815	0.2909	0.2410	4267/1325/125	0.2410						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116437.1 [benign]; 		COSM3750611, COSM3750610	75	548					ATP13A2 (inh=AR pLI=0.00)
chr1	17314942	17314942	G	A	het		QUAL=14158;DP=313;AF=0.50;MQM=59;TRIO=HET,313,0.50,HOM,263,0.99,HET,322,0.45	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon24/29:c.2637C>T:p.Gly879Gly,ATP13A2:NM_001141973.2:synonymous:LOW:exon24/29:c.2622C>T:p.Gly874Gly,ATP13A2:NM_001141974.2:synonymous:LOW:exon23/27:c.2505C>T:p.Gly835Gly		rs9435662	0.3387	0.4580	13485/8859/203	0.4503						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116435.1 [benign]; 		COSM3750613, COSM3750612	445	837					ATP13A2 (inh=AR pLI=0.00)
chr1	17319011	17319011	G	A	het		QUAL=6564;DP=83;AF=0.48;MQM=60;TRIO=HET,83,0.48,HOM,126,1.00,HET,152,0.48	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon17/29:c.1815C>T:p.Pro605Pro,ATP13A2:NM_001141973.2:synonymous:LOW:exon17/29:c.1800C>T:p.Pro600Pro,ATP13A2:NM_001141974.2:synonymous:LOW:exon17/27:c.1800C>T:p.Pro600Pro		rs2076603	0.4485	0.5540	19279/12838/984	0.5496						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116434.1 [benign]; 		COSM3997076, COSM3997075	618	784					ATP13A2 (inh=AR pLI=0.00)
chr1	19198064	19198064	T	G	het		QUAL=3432;DP=98;AF=0.51;MQM=59;TRIO=HET,98,0.51,WT,149,0.00,HET,185,0.47	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1275A>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1275A>C:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*1275A>C:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*262A>C:		rs1138333	0.1793	0.0000	0/0/0	0.0378										18	96					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198100	19198100	C	G	het		QUAL=3434;DP=99;AF=0.55;MQM=59;TRIO=HET,99,0.55,WT,144,0.00,HET,166,0.49	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1239G>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1239G>C:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*1239G>C:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*226G>C:		rs1138328	0.1651	0.0000	0/0/0	0.0366										18	94					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198141	19198141	T	C	het		QUAL=3367;DP=121;AF=0.51;MQM=60;TRIO=HET,121,0.51,WT,139,0.00,HET,146,0.48	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1198A>G:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1198A>G:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*1198A>G:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*185A>G:		rs7366541	0.1799	0.0000	0/0/0	0.0379										18	91					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198414	19198414	G	A	het		QUAL=4601;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,WT,168,0.00,HET,195,0.49	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*925C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-130C>T:		rs1140477	0.1935	0.0000	0/0/0	0.0384										13	63					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198418	19198418	C	T	het		QUAL=4601;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,WT,168,0.00,HET,195,0.49	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*921G>A:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-134G>A:		rs1138269	0.1933	0.0000	0/0/0	0.0383										13	63					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198576	19198576	A	G	hom		QUAL=29983;DP=378;AF=1.00;MQM=59;TRIO=HOM,378,1.00,HOM,239,1.00,HOM,313,0.99	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*763T>C:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-292T>C:		rs1138267	0.6751	0.0000	0/0/0	0.7021										81	55					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198627	19198627	G	A	het		QUAL=6409;DP=296;AF=0.49;MQM=60;TRIO=HET,296,0.49,WT,204,0.00,HET,264,0.45	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*712C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-343C>T:		rs14311	0.1935	0.0000	0/0/0	0.2258										13	63					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198637	19198637	G	A	het		QUAL=12517;DP=243;AF=0.49;MQM=59;TRIO=HET,243,0.49,HOM,206,1.00,HET,259,0.54	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*702C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-353C>T:		rs3202002	0.4744	0.0000	0/0/0	0.4715										29	70					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198682	19198682	C	-	het		QUAL=7969;DP=114;AF=0.46;MQM=59;TRIO=HET,114,0.46,HOM,176,0.99,HET,196,0.54	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*657delG:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-398delG:		rs11311839	0.4677	0.0000	0/0/0	0.4034										29	71					ALDH4A1 (inh=AR pLI=0.00)
chr1	19198895	19198895	A	G	het		QUAL=5086;DP=202;AF=0.48;MQM=59;TRIO=HET,202,0.48,WT,194,0.00,HET,246,0.45	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*444T>C:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*41+403T>C:		rs9117	0.1102	0.0000	0/0/0	0.0315										12	56					ALDH4A1 (inh=AR pLI=0.00)
chr1	19199221	19199221	C	T	het		QUAL=20955;DP=220;AF=0.44;MQM=60;TRIO=HET,220,0.44,HOM,404,1.00,HET,488,0.47	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:NM_001319218.1:3'UTR:MODIFIER:exon14/14:c.*118G>A:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*41+77G>A:		rs11740	0.4714	0.0000	0/0/0	0.0911										30	69					ALDH4A1 (inh=AR pLI=0.00)
chr1	19201956	19201956	A	G	hom		QUAL=18486;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,132,1.00,HOM,139,1.00	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon13/15:c.1380T>C:p.Asp460Asp,ALDH4A1:NM_001161504.1:synonymous:LOW:exon13/15:c.1200T>C:p.Asp400Asp,ALDH4A1:NM_001319218.1:synonymous:LOW:exon12/14:c.1227T>C:p.Asp409Asp,ALDH4A1:NM_170726.2:synonymous:LOW:exon13/16:c.1380T>C:p.Asp460Asp		rs2230708	0.7372	0.7300	32562/17258/2502	0.7237						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];				586	454					ALDH4A1 (inh=AR pLI=0.00)
chr1	19202896	19202896	G	A	hom		QUAL=7483;DP=139;AF=0.97;MQM=59;TRIO=HOM,139,0.97,HET,72,0.33,HOM,97,0.99	ALDH4A1	synonymous,intron	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1251C>T:p.Ala417Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1071C>T:p.Ala357Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1251C>T:p.Ala417Ala,ALDH4A1:NM_001319218.1:intron:MODIFIER:exon11/13:c.1185+806C>T:		rs2230707	0.5160	0.5020	15519/7243/1007	0.4927						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM4143135, COSM4143136	261	550					ALDH4A1 (inh=AR pLI=0.00)
chr1	19202917	19202917	T	C	hom		QUAL=7752;DP=108;AF=0.99;MQM=59;TRIO=HOM,108,0.99,HOM,73,0.97,HOM,87,0.99	ALDH4A1	synonymous,intron	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1230A>G:p.Ser410Ser,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1050A>G:p.Ser350Ser,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1230A>G:p.Ser410Ser,ALDH4A1:NM_001319218.1:intron:MODIFIER:exon11/13:c.1185+785A>G:		rs7550938	0.6609	0.6860	27774/14964/1171	0.6671						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM1337325, COSM1337326	534	478					ALDH4A1 (inh=AR pLI=0.00)
chr1	19202926	19202926	T	C	hom		QUAL=6368;DP=70;AF=0.99;MQM=59;TRIO=HOM,70,0.99,HOM,73,0.96,HOM,87,0.99	ALDH4A1	synonymous,intron	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1221A>G:p.Ala407Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1041A>G:p.Ala347Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1221A>G:p.Ala407Ala,ALDH4A1:NM_001319218.1:intron:MODIFIER:exon11/13:c.1185+776A>G:		rs2230706	0.6601	0.6840	26738/14365/1117	0.6465						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM1337327, COSM1337328	534	477					ALDH4A1 (inh=AR pLI=0.00)
chr1	19203997	19203997	C	G	hom		QUAL=7639;DP=87;AF=0.98;MQM=59;TRIO=HOM,87,0.98,HOM,56,1.00,HOM,107,1.00	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon10/15:c.1050G>C:p.Ala350Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon10/15:c.870G>C:p.Ala290Ala,ALDH4A1:NM_001319218.1:synonymous:LOW:exon10/14:c.1050G>C:p.Ala350Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon10/16:c.1050G>C:p.Ala350Ala		rs2230705	0.6416	0.6830	26078/15560/2381	0.6561						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM1473186, COSM424869	502	490					ALDH4A1 (inh=AR pLI=0.00)
chr1	21889635	21889635	T	C	hom		QUAL=4846;DP=33;AF=0.97;MQM=59;TRIO=HOM,33,0.97,HOM,90,1.00,HET,125,0.52	ALPL	synonymous	ALPL:NM_000478.5:synonymous:LOW:exon5/12:c.330T>C:p.Ser110Ser,ALPL:NM_001127501.3:synonymous:LOW:exon4/11:c.165T>C:p.Ser55Ser,ALPL:NM_001177520.2:synonymous:LOW:exon3/10:c.99T>C:p.Ser33Ser		rs1780316	0.9295	0.9450	54032/29655/3879	0.9141						171760 [ALPL (confirmed) Hypophosphatasia,infantile|Hypophosphatasia,childhood|Odontohypophosphatasia|Hypophosphatasia,adult];	RCV000178778.1 [benign]; 		COSM3746801	999	104					ALPL (inh=n/a pLI=0.00)
chr1	21904263	21904263	C	-	het		QUAL=5373;DP=210;AF=0.50;MQM=59;TRIO=HET,210,0.50,HET,243,0.53,WT,288,0.00	ALPL	3'UTR	ALPL:NM_000478.5:3'UTR:MODIFIER:exon12/12:c.*124delC:,ALPL:NM_001127501.3:3'UTR:MODIFIER:exon11/11:c.*124delC:,ALPL:NM_001177520.2:3'UTR:MODIFIER:exon10/10:c.*124delC:		rs140511985	0.0228	0.0000	0/0/0	0.0368										1	29					ALPL (inh=n/a pLI=0.00)
chr1	21904267	21904267	A	G	hom		QUAL=23868;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,245,0.98,HOM,296,1.00	ALPL	3'UTR	ALPL:NM_000478.5:3'UTR:MODIFIER:exon12/12:c.*126A>G:,ALPL:NM_001127501.3:3'UTR:MODIFIER:exon11/11:c.*126A>G:,ALPL:NM_001177520.2:3'UTR:MODIFIER:exon10/10:c.*126A>G:		rs1697406	0.8682	0.0000	0/0/0	0.1755										176	48					ALPL (inh=n/a pLI=0.00)
chr1	22149183	22149183	G	C	het		QUAL=1423;DP=27;AF=0.56;MQM=60;TRIO=HET,27,0.56,WT,28,0.00,HOM,42,1.00	LDLRAD2,HSPG2	3'UTR	LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*475G>C:,HSPG2:NM_001291860.1:3'UTR:MODIFIER:exon97/97:c.*626C>G:,HSPG2:NM_005529.6:3'UTR:MODIFIER:exon97/97:c.*626C>G:		rs1049644	0.3199	0.0000	0/0/0	0.0441										14	60					LDLRAD2 (inh=n/a pLI=0.00), HSPG2 (inh=AR pLI=0.00)
chr1	22149935	22149935	T	C	hom		QUAL=15305;DP=116;AF=1.00;MQM=59;TRIO=HOM,116,1.00,HOM,144,1.00,HOM,233,1.00	HSPG2,LDLRAD2	synonymous,3'UTR	HSPG2:NM_001291860.1:synonymous:LOW:exon97/97:c.13053A>G:p.Ser4351Ser,HSPG2:NM_005529.6:synonymous:LOW:exon97/97:c.13050A>G:p.Ser4350Ser,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1227T>C:		rs897467	0.7804	0.7970	29345/16802/1769	0.7612						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750884	747	270					HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22150120	22150120	C	T	het		QUAL=5840;DP=155;AF=0.46;MQM=59;TRIO=HET,155,0.46,WT,209,0.01,HET,317,0.55	HSPG2,LDLRAD2	missense,3'UTR	HSPG2:NM_001291860.1:missense:MODERATE:exon96/97:c.12995G>A:p.Ser4332Asn,HSPG2:NM_005529.6:missense:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1412C>T:		rs3736360	0.1761	0.1840	2248/1110/30	0.1787	0.0960	T	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750886	29	283					HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22150160	22150160	G	T	het		QUAL=8183;DP=304;AF=0.50;MQM=59;TRIO=HET,304,0.50,WT,206,0.01,HET,324,0.55	HSPG2,LDLRAD2	synonymous,3'UTR	HSPG2:NM_001291860.1:synonymous:LOW:exon96/97:c.12955C>A:p.Arg4319Arg,HSPG2:NM_005529.6:synonymous:LOW:exon96/97:c.12952C>A:p.Arg4318Arg,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1452G>T:		rs3736358	0.0000	0.1800	2228/1111/9	0.1696						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750887	29	281					HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22154845	22154845	A	G	het		QUAL=1286;DP=45;AF=0.33;MQM=60;TRIO=HET,45,0.33,WT,38,0.00,HOM,32,0.97	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon89/97:c.12315T>C:p.Asp4105Asp,HSPG2:NM_005529.6:synonymous:LOW:exon89/97:c.12312T>C:p.Asp4104Asp		rs2228347	0.2572	0.2970	5929/3255/98	0.2914						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3746805	99	461					HSPG2 (inh=AR pLI=0.00)
chr1	22159774	22159774	G	A	het		QUAL=4229;DP=147;AF=0.43;MQM=59;TRIO=HET,147,0.43,WT,207,0.00,HET,238,0.50	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon80/97:c.11085C>T:p.Pro3695Pro,HSPG2:NM_005529.6:synonymous:LOW:exon80/97:c.11082C>T:p.Pro3694Pro		rs2229486	0.0859	0.0790	484/201/147	0.0785						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				8	175					HSPG2 (inh=AR pLI=0.00)
chr1	22160043	22160043	C	T	het		QUAL=5275;DP=190;AF=0.42;MQM=60;TRIO=HET,190,0.42,WT,225,0.00,HET,287,0.48	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon79/97:c.10898G>A:p.Arg3633Gln,HSPG2:NM_005529.6:missense:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln		rs2229493	0.0859	0.0790	487/202/148	0.0786	-0.0650	T	T,T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				8	176					HSPG2 (inh=AR pLI=0.00)
chr1	22163390	22163390	G	A	het		QUAL=5476;DP=182;AF=0.50;MQM=60;TRIO=HET,182,0.50,WT,227,0.00,HET,353,0.40	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon75/97:c.10263C>T:p.His3421His,HSPG2:NM_005529.6:synonymous:LOW:exon75/97:c.10260C>T:p.His3420His		rs35444472	0.0861	0.0600	211/66/72	0.0598						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750889	7	172					HSPG2 (inh=AR pLI=0.00)
chr1	22165901	22165901	A	G	het		QUAL=2711;DP=85;AF=0.61;MQM=59;TRIO=HET,85,0.61,WT,39,0.00,HET,88,0.67	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon73/97:c.9855T>C:p.Ala3285Ala,HSPG2:NM_005529.6:synonymous:LOW:exon73/97:c.9852T>C:p.Ala3284Ala		rs2291826	0.3460	0.2870	5587/2297/1470	0.2821						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				77	415					HSPG2 (inh=AR pLI=0.00)
chr1	22167605	22167605	C	T	het		QUAL=2093;DP=53;AF=0.45;MQM=59;TRIO=HET,53,0.45,WT,164,0.00,HET,183,0.42	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon71/97:c.9505G>A:p.Ala3169Thr,HSPG2:NM_005529.6:missense:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr		rs2228349	0.0837	0.0750	377/153/103	0.0719	0.9110	T	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				8	173					HSPG2 (inh=AR pLI=0.00)
chr1	22168801	22168801	T	C	het		QUAL=1512;DP=69;AF=0.46;MQM=59;TRIO=HET,69,0.46,WT,76,0.00,HET,87,0.43	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon68/97:c.8986A>G:p.Ser2996Gly,HSPG2:NM_005529.6:missense:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly		rs2229491	0.0887	0.0800	498/194/166	0.0791	-0.0660	T	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				8	178					HSPG2 (inh=AR pLI=0.00)
chr1	22168845	22168845	A	T	het	phylop_high	QUAL=1052;DP=50;AF=0.56;MQM=59;TRIO=HET,50,0.56,WT,44,0.00,HET,57,0.39	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon68/97:c.8942T>A:p.Leu2981His,HSPG2:NM_005529.6:missense:MODERATE:exon68/97:c.8939T>A:p.Leu2980His		rs2229489	0.0343	0.0500	210/96/0	0.0487	1.8860	T	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM425370	3	138					HSPG2 (inh=AR pLI=0.00)
chr1	22173990	22173990	A	G	het		QUAL=7236;DP=164;AF=0.55;MQM=59;TRIO=HET,164,0.55,WT,327,0.00,HET,426,0.49	HSPG2	splice_region&intron	HSPG2:NM_001291860.1:splice_region&intron:LOW:exon61/96:c.8029-5T>C:,HSPG2:NM_005529.6:splice_region&intron:LOW:exon61/96:c.8026-5T>C:		rs35917892	0.0347	0.0500	223/104/0	0.0489						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				3	138					HSPG2 (inh=AR pLI=0.00)
chr1	22174518	22174518	G	T	het		QUAL=7681;DP=288;AF=0.44;MQM=59;TRIO=HET,288,0.44,WT,359,0.00,HET,362,0.51	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon60/97:c.7809C>A:p.Val2603Val,HSPG2:NM_005529.6:synonymous:LOW:exon60/97:c.7806C>A:p.Val2602Val		rs12737091	0.0347	0.0500	220/102/0	0.0498						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				3	138					HSPG2 (inh=AR pLI=0.00)
chr1	22179244	22179244	C	T	het		QUAL=3591;DP=92;AF=0.43;MQM=59;TRIO=HET,92,0.43,WT,152,0.00,HET,204,0.51	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon52/97:c.6676G>A:p.Gly2226Ser,HSPG2:NM_005529.6:missense:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser		rs35669711	0.0347	0.0500	222/103/0	0.0493	-0.1820	T	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				3	137					HSPG2 (inh=AR pLI=0.00)
chr1	22179451	22179451	C	T	het		QUAL=5828;DP=86;AF=0.48;MQM=59;TRIO=HET,86,0.48,WT,272,0.00,HET,434,0.46	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon51/97:c.6555G>A:p.Thr2185Thr,HSPG2:NM_005529.6:synonymous:LOW:exon51/97:c.6552G>A:p.Thr2184Thr		rs34443576	0.0345	0.0500	219/102/0	0.0488						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				3	137					HSPG2 (inh=AR pLI=0.00)
chr1	22180723	22180723	C	T	het		QUAL=3074;DP=84;AF=0.46;MQM=60;TRIO=HET,84,0.46,WT,144,0.00,HET,197,0.51	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon50/97:c.6405G>A:p.Val2135Val,HSPG2:NM_005529.6:synonymous:LOW:exon50/97:c.6402G>A:p.Val2134Val		rs12742444	0.0345	0.0430	149/60/0	0.0422						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1	135					HSPG2 (inh=AR pLI=0.00)
chr1	22181895	22181895	C	T	het	phylop_high;pred_pathogenic_2	QUAL=5770;DP=168;AF=0.49;MQM=59;TRIO=HET,168,0.49,WT,261,0.00,HET,311,0.53	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon47/97:c.5902G>A:p.Val1968Ile,HSPG2:NM_005529.6:missense:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile		rs2229475	0.0347	0.0500	207/95/0	0.0490	1.8290	T	T	D	D	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				3	137					HSPG2 (inh=AR pLI=0.00)
chr1	22191454	22191454	G	A	het	phylop_high;pred_pathogenic_2	QUAL=7192;DP=128;AF=0.40;MQM=59;TRIO=HET,128,0.40,HOM,210,1.00,WT,349,0.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon36/97:c.4511C>T:p.Ala1504Val,HSPG2:NM_005529.6:missense:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val		rs897471	0.6915	0.7060	25154/14147/1363	0.6776	2.2600	T	T	D	D	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750893	607	426					HSPG2 (inh=AR pLI=0.00)
chr1	22199245	22199245	C	T	het		QUAL=3097;DP=48;AF=0.58;MQM=60;TRIO=HET,48,0.58,HOM,81,1.00,WT,76,0.01	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon32/97:c.3900G>A:p.Val1300Val,HSPG2:NM_005529.6:synonymous:LOW:exon32/97:c.3897G>A:p.Val1299Val		rs2229482	0.4249	0.5430	17522/12414/386	0.5224						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM425375	432	507					HSPG2 (inh=AR pLI=0.00)
chr1	22206649	22206649	T	C	hom		QUAL=22322;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,239,1.00,HOM,255,1.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon17/97:c.2297A>G:p.Asn766Ser,HSPG2:NM_005529.6:missense:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser		rs989994	0.9299	0.9810	58602/33315/3265	0.9180	0.8030	T	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1118	5					HSPG2 (inh=AR pLI=0.00)
chr1	22206942	22206942	G	A	hom		QUAL=8248;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,61,1.00,HOM,74,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon16/97:c.2112C>T:p.Ala704Ala,HSPG2:NM_005529.6:synonymous:LOW:exon16/97:c.2109C>T:p.Ala703Ala		rs1874793	0.9299	0.9810	58461/33240/3259	0.9258						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM4143367	1118	5					HSPG2 (inh=AR pLI=0.00)
chr1	22207235	22207235	T	C	hom		QUAL=11349;DP=170;AF=0.99;MQM=59;TRIO=HOM,170,0.99,HOM,74,1.00,HOM,132,1.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon15/97:c.1915A>G:p.Met639Val,HSPG2:NM_005529.6:missense:MODERATE:exon15/97:c.1912A>G:p.Met638Val		rs1874792	0.9736	0.9920	47715/27169/3347	0.9216	1.5550	T	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1122	0					HSPG2 (inh=AR pLI=0.00)
chr1	22214127	22214127	A	G	hom	pred_pathogenic_1	QUAL=12838;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HET,183,0.50,HOM,214,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon8/97:c.744T>C:p.Leu248Leu,HSPG2:NM_005529.6:synonymous:LOW:exon8/97:c.744T>C:p.Leu248Leu		rs2229478	0.5363	0.4170	11513/3745/2116	0.4036	-0.2600	T	D,T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750895, COSM3750894	139	499					HSPG2 (inh=AR pLI=0.00)
chr1	22217108	22217108	G	A	hom		QUAL=25902;DP=224;AF=1.00;MQM=59;TRIO=HOM,224,1.00,HOM,277,1.00,HOM,332,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon4/97:c.324C>T:p.Phe108Phe,HSPG2:NM_005529.6:synonymous:LOW:exon4/97:c.324C>T:p.Phe108Phe		rs2501260	0.9481	0.9860	59156/33346/3754	0.9229						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1120	3					HSPG2 (inh=AR pLI=0.00)
chr1	22779159	22779159	T	C	hom		QUAL=28748;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,255,1.00,HOM,394,1.00	ZBTB40	5'UTR,intron	ZBTB40:NM_001083621.1:5'UTR:MODIFIER:exon2/19:c.-350T>C:,ZBTB40:NM_014870.3:intron:MODIFIER:exon1/17:c.-70+662T>C:	MER58B	rs10737466	0.9698	0.0000	0/0/0	0.8720										227	0					ZBTB40 (inh=n/a pLI=0.00)
chr1	22832743	22832743	A	T	hom		QUAL=15555;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HET,168,0.55,HOM,209,0.99	ZBTB40	splice_region&intron	ZBTB40:NM_001083621.1:splice_region&intron:LOW:exon7/18:c.1360+9A>T:,ZBTB40:NM_014870.3:splice_region&intron:LOW:exon6/17:c.1360+9A>T:		rs209732	0.7991	0.6930	29845/12471/4048	0.6696									COSM3746831	495	421					ZBTB40 (inh=n/a pLI=0.00)
chr1	22835677	22835677	A	G	hom		QUAL=24886;DP=342;AF=1.00;MQM=59;TRIO=HOM,342,1.00,HET,273,0.53,HOM,306,1.00	ZBTB40	missense	ZBTB40:NM_001083621.1:missense:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys,ZBTB40:NM_014870.3:missense:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys		rs209729	0.8225	0.7650	35937/17374/4314	0.7455	0.2230	T	T,T,T	B,B	B,B				COSM3746832	621	392					ZBTB40 (inh=n/a pLI=0.00)
chr1	22846709	22846709	G	A	hom	phylop_high	QUAL=12120;DP=169;AF=1.00;MQM=59;TRIO=HOM,169,1.00,HOM,93,1.00,HOM,135,1.00	ZBTB40	missense	ZBTB40:NM_001083621.1:missense:MODERATE:exon15/19:c.2989G>A:p.Val997Met,ZBTB40:NM_014870.3:missense:MODERATE:exon14/18:c.2989G>A:p.Val997Met		rs209720	0.9984	0.9970	60319/33052/5194	0.9674	2.3000	T	T,T,T	B,B	B,B					1106	2					ZBTB40 (inh=n/a pLI=0.00)
chr1	22852715	22852715	G	C	hom		QUAL=10923;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HET,108,0.46,HOM,140,0.99	ZBTB40	synonymous	ZBTB40:NM_001083621.1:synonymous:LOW:exon19/19:c.3546G>C:p.Pro1182Pro,ZBTB40:NM_014870.3:synonymous:LOW:exon18/18:c.3546G>C:p.Pro1182Pro		rs881646	0.3181	0.3420	7646/4486/132	0.3386									COSM3746849	162	480					ZBTB40 (inh=n/a pLI=0.00)
chr1	22853141	22853141	G	A	hom		QUAL=17671;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,234,0.50,HOM,316,1.00	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*252G>A:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*252G>A:		rs2281354	0.2378	0.0000	0/0/0	0.2992										18	105					ZBTB40 (inh=n/a pLI=0.00)
chr1	22855194	22855194	-	T	hom		QUAL=627;DP=49;AF=0.43;MQM=59;TRIO=HOM,49,0.43,WT,39,0.21,HOM,48,0.48	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*2320dupT:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*2320dupT:	AluJo	rs35637563;rs778707681	0.0000	0.0000	0/0/0	0.1538										0	40					ZBTB40 (inh=n/a pLI=0.00)
chr1	22856601	22856601	T	C	hom		QUAL=19089;DP=229;AF=0.99;MQM=59;TRIO=HOM,229,0.99,HET,218,0.48,HOM,284,1.00	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*3712T>C:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*3712T>C:		rs1062663	0.3295	0.0000	0/0/0	0.0605										27	106					ZBTB40 (inh=n/a pLI=0.00)
chr1	22965438	22965438	A	G	het	low_DP	QUAL=330;DP=14;AF=0.64;MQM=60;TRIO=HET,14,0.64,HOM,2,1.00,HET,5,0.60	C1QA	synonymous	C1QA:NM_015991.2:synonymous:LOW:exon3/3:c.276A>G:p.Gly92Gly		rs172378	0.6164	0.4680	11213/3757/1982	0.4598	-0.2960	T	T			120550 [C1QA (confirmed) C1q deficiency];		CM035950 [CLASS=DP MUT=REF PHEN="Subacute cutaneous lupus erythematosus association with" GENE=C1QA]; 	COSM3721050	172	486					C1QA (inh=n/a pLI=0.05)
chr1	22974534	22974534	T	-	het		QUAL=525;DP=54;AF=0.43;MQM=59;TRIO=HET,54,0.43,WT,39,0.21,HET,67,0.52	C1QC	3'UTR	C1QC:NM_001114101.1:3'UTR:MODIFIER:exon3/3:c.*273delT:,C1QC:NM_172369.3:3'UTR:MODIFIER:exon3/3:c.*273delT:	L2d2	rs71020441	0.0000	0.0000	0/0/0	0.0096										0	52					C1QC (inh=n/a pLI=0.02)
chr1	22974566	22974566	T	G	het		QUAL=76;DP=53;AF=0.40;MQM=57;TRIO=HET,53,0.40,WT,51,0.10,WT,65,0.11	C1QC	3'UTR	C1QC:NM_001114101.1:3'UTR:MODIFIER:exon3/3:c.*290T>G:,C1QC:NM_172369.3:3'UTR:MODIFIER:exon3/3:c.*290T>G:			0.0000	0.0000	0/0/0	0.0001										0	9					C1QC (inh=n/a pLI=0.02)
chr1	22987958	22987958	A	G	hom		QUAL=38139;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HOM,349,1.00,HOM,455,1.00	C1QB	3'UTR	C1QB:NM_000491.3:3'UTR:MODIFIER:exon3/3:c.*79A>G:		rs10580	0.9914	0.0000	0/0/0	0.1772										300	19					C1QB (inh=n/a pLI=0.09)
chr1	24128467	24128467	C	T	hom		QUAL=30088;DP=380;AF=0.99;MQM=59;TRIO=HOM,380,0.99,HET,345,0.50,HOM,430,1.00	HMGCL	3'UTR	HMGCL:NM_000191.2:3'UTR:MODIFIER:exon9/9:c.*486G>A:,HMGCL:NM_001166059.1:3'UTR:MODIFIER:exon7/7:c.*486G>A:		rs11714	0.8834	0.0000	0/0/0	0.1532										193	35					HMGCL (inh=n/a pLI=0.00)
chr1	24134721	24134721	T	C	hom		QUAL=21813;DP=293;AF=1.00;MQM=59;TRIO=HOM,293,1.00,HET,226,0.53,HOM,287,1.00	HMGCL	synonymous	HMGCL:NM_000191.2:synonymous:LOW:exon7/9:c.654A>G:p.Leu218Leu,HMGCL:NM_001166059.1:synonymous:LOW:exon5/7:c.441A>G:p.Leu147Leu		rs719400	0.8874	0.9040	49752/27714/4863	0.8959	0.8730	T				613898 [HMGCL (provisional) HMG-CoA lyase deficiency];	RCV000078343.5 [benign]; 			911	181					HMGCL (inh=n/a pLI=0.00)
chr1	24180962	24180962	T	C	het	pred_pathogenic_1	QUAL=9699;DP=254;AF=0.50;MQM=60;TRIO=HET,254,0.50,WT,210,0.00,HOM,202,1.00	FUCA1	missense	FUCA1:NM_000147.4:missense:MODERATE:exon5/8:c.857A>G:p.Gln286Arg		rs13551	0.2113	0.2790	5299/3906/125	0.2771	0.6520	T	D,D	B	B	612280 [FUCA1 (confirmed) Fucosidosis];	RCV000000726.2 [benign]; 		COSM3746875	87	442					FUCA1 (inh=AR pLI=0.00)
chr1	24194770	24194770	C	G	het		QUAL=2651;DP=160;AF=0.48;MQM=59;TRIO=HET,160,0.48,HET,107,0.45,WT,114,0.00	FUCA1	missense	FUCA1:NM_000147.4:missense:MODERATE:exon1/8:c.7G>C:p.Ala3Pro		rs61996282	0.0134	0.0067	4/0/0	0.0067	-2.4990	T	T	B	B	612280 [FUCA1 (confirmed) Fucosidosis];				0	17					FUCA1 (inh=AR pLI=0.00)
chr1	26131654	26131654	G	A	hom		QUAL=15817;DP=161;AF=0.99;MQM=59;TRIO=HOM,161,0.99,HOM,221,1.00,HET,333,0.52	SEPN1	missense	SEPN1:NM_020451.2:missense:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr,SEPN1:NM_206926.1:missense:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr		rs7349185	0.8419	0.8140	40353/20231/2986	0.7933	0.9620	T	T,T,T	B,B	B,B	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082016.6 [benign]; 			754	354					SEPN1 (inh=n/a pLI=0.00)
chr1	26138262	26138262	T	C	hom		QUAL=25217;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,352,1.00,HET,489,0.52	SEPN1	synonymous	SEPN1:NM_020451.2:synonymous:LOW:exon9/13:c.1173T>C:p.Pro391Pro,SEPN1:NM_206926.1:synonymous:LOW:exon8/12:c.1071T>C:p.Pro357Pro		rs760597	0.7919	0.7860	26670/14099/1304	0.7410						606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082009.6 [benign]; 		COSM1127046	746	356					SEPN1 (inh=n/a pLI=0.00)
chr1	26140573	26140573	C	A	hom	pred_pathogenic_1	QUAL=22048;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,326,1.00,HET,440,0.50	SEPN1	missense	SEPN1:NM_020451.2:missense:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys,SEPN1:NM_206926.1:missense:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys		rs2294228	0.6975	0.7730	37783/20184/467	0.7542	0.1580	T	T,T,D	B,B	B,B	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082012.6 [benign]; 		COSM4143697	731	369					SEPN1 (inh=n/a pLI=0.00)
chr1	26143704	26143704	-	TTTTG	hom		QUAL=13450;DP=154;AF=0.95;MQM=58;TRIO=HOM,154,0.95,HOM,192,1.00,HET,230,0.44	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1511_*1515dupTTTTG:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1511_*1515dupTTTTG:		rs397712756	0.0000	0.0000	0/0/0	0.5204										153	69					SEPN1 (inh=n/a pLI=0.00)
chr1	26143821	26143821	T	C	hom		QUAL=16548;DP=249;AF=0.99;MQM=54;TRIO=HOM,249,0.99,HOM,180,0.98,HET,268,0.46	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1612T>C:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1612T>C:	AluSx	rs3203750	0.7630	0.0000	0/0/0	0.7252										150	67					SEPN1 (inh=n/a pLI=0.00)
chr1	26143931	26143931	T	C	hom		QUAL=22045;DP=340;AF=0.99;MQM=53;TRIO=HOM,340,0.99,HOM,231,1.00,HET,349,0.45	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1722T>C:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1722T>C:	AluSx	rs4659383	0.8622	0.0000	0/0/0	0.7578										137	58					SEPN1 (inh=n/a pLI=0.00)
chr1	26144438	26144438	C	-	hom		QUAL=4305;DP=74;AF=0.99;MQM=59;TRIO=HOM,74,0.99,HOM,80,1.00,HET,108,0.60	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*2236delC:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*2236delC:		rs11319301;rs397752421;rs558875165	0.7666	0.0000	0/0/0	0.7264										154	68					SEPN1 (inh=n/a pLI=0.00)
chr1	33245802	33245802	C	G	het		QUAL=9423;DP=261;AF=0.52;MQM=60;TRIO=HET,261,0.52,HET,187,0.61,HET,252,0.46	YARS	synonymous	YARS:NM_003680.3:synonymous:LOW:exon11/13:c.1218G>C:p.Leu406Leu		rs699005	0.0875	0.0980	815/337/52	0.0950						603623 [YARS (confirmed) Charcot-Marie-Tooth disease,dominant intermediate C];				11	178					YARS (inh=n/a pLI=0.00)
chr1	33283528	33283528	G	A	het	low_DP	QUAL=44;DP=9;AF=0.56;MQM=60;TRIO=HET,9,0.56,WT,187,0.61,WT,1,0.00	YARS,S100PBP	5'UTR,intron	YARS:NM_003680.3:5'UTR:MODIFIER:exon1/13:c.-683C>T:,S100PBP:NM_001256121.1:intron:MODIFIER:exon1/6:c.-120+328G>A:,S100PBP:NM_022753.3:intron:MODIFIER:exon1/6:c.-120+238G>A:		rs72654022	0.0603	0.0000	0/0/0	0.0139										4	12					YARS (inh=n/a pLI=0.00), S100PBP (inh=n/a pLI=0.95)
chr1	33475639	33475639	G	A	het	low_MQM	QUAL=1234;DP=716;AF=0.14;MQM=33;TRIO=HET,716,0.14,HET,553,0.24,HET,541,0.12	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*791C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*791C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*840C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*791C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*791C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1691C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1478C>T:		rs138902451	0.0000	0.1070	0/0/0	0.0021										0	145					AK2 (inh=n/a pLI=0.01)
chr1	33475650	33475650	T	C	het	low_MQM	QUAL=1340;DP=668;AF=0.13;MQM=33;TRIO=HET,668,0.13,HET,550,0.24,HET,557,0.13	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*780A>G:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*780A>G:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*829A>G:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*780A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*780A>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1680A>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1467A>G:		rs141799861	0.0000	0.1240	0/0/0	0.0020										0	139					AK2 (inh=n/a pLI=0.01)
chr1	33475687	33475687	C	G	het	low_MQM	QUAL=2564;DP=384;AF=0.11;MQM=33;TRIO=HET,384,0.11,HET,606,0.29,HET,581,0.16	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*743G>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*743G>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*792G>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*743G>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*743G>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1643G>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1430G>C:		rs201444233	0.0000	0.0810	0/0/0	0.0009										0	99					AK2 (inh=n/a pLI=0.01)
chr1	33475721	33475721	G	C	het	low_MQM	QUAL=4116;DP=336;AF=0.11;MQM=34;TRIO=HET,336,0.11,HET,608,0.32,HET,552,0.20	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*709C>G:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*709C>G:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*758C>G:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*709C>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*709C>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1609C>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1396C>G:		rs139591926	0.0000	0.1300	0/0/0	0.0031										0	130					AK2 (inh=n/a pLI=0.01)
chr1	33475750	33475750	A	G	het	low_MQM	QUAL=4731;DP=438;AF=0.13;MQM=39;TRIO=HET,438,0.13,HET,577,0.32,HET,530,0.22	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*680T>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*680T>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*729T>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*680T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*680T>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1580T>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1367T>C:		rs142975905	0.0000	0.3490	0/0/0	0.0034										0	212					AK2 (inh=n/a pLI=0.01)
chr1	33475767	33475767	G	A	het	low_MQM	QUAL=4608;DP=520;AF=0.14;MQM=41;TRIO=HET,520,0.14,HET,548,0.34,HET,514,0.24	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*663C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*663C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*712C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*663C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*663C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1563C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1350C>T:		rs74066436	0.0000	0.3560	0/0/0	0.0035										0	216					AK2 (inh=n/a pLI=0.01)
chr1	33475791	33475791	A	G	het	low_MQM	QUAL=7358;DP=535;AF=0.21;MQM=42;TRIO=HET,535,0.21,HET,613,0.37,HET,526,0.27	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*639T>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*639T>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*688T>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*639T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*639T>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1539T>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1326T>C:		rs6884	0.0000	0.5050	554/81/22	0.0243										24	204					AK2 (inh=n/a pLI=0.01)
chr1	33475879	33475879	C	T	het		QUAL=9315;DP=581;AF=0.28;MQM=54;TRIO=HET,581,0.28,HET,398,0.41,HET,348,0.32	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*551G>A:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*551G>A:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*600G>A:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*551G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*551G>A:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1451G>A:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1238G>A:		rs61800917	0.0000	0.3740	0/0/0	0.0299										0	230					AK2 (inh=n/a pLI=0.01)
chr1	33475967	33475967	G	A	het	low_MQM	QUAL=2822;DP=417;AF=0.23;MQM=47;TRIO=HET,417,0.23,HET,173,0.29,HET,193,0.24	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*463C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*463C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*512C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*463C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*463C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1363C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1150C>T:		rs74066437	0.0000	0.3100	0/0/0	0.0036										0	205					AK2 (inh=n/a pLI=0.01)
chr1	33475977	33475977	G	A	het	low_MQM	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*453C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*453C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*502C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*453C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*453C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1353C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1140C>T:		rs115408325	0.0000	0.3080	0/0/0	0.0001										0	91					AK2 (inh=n/a pLI=0.01)
chr1	33475979	33475979	A	G	het	low_MQM	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*451T>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*451T>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*500T>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*451T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*451T>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1351T>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1138T>C:		rs4045165	0.0000	0.3060	0/0/0	0.0001										0	64					AK2 (inh=n/a pLI=0.01)
chr1	33475982	33475982	C	A	het	low_MQM	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*448G>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*448G>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*497G>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*448G>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*448G>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1348G>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1135G>T:		rs114902220	0.0000	0.3040	0/0/0	0.0003										0	64					AK2 (inh=n/a pLI=0.01)
chr1	33476032	33476032	T	C	het	low_MQM	QUAL=247;DP=231;AF=0.11;MQM=35;TRIO=HET,231,0.11,HET,129,0.22,HET,155,0.15	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*398A>G:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*398A>G:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*447A>G:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*398A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*398A>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1298A>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1085A>G:		rs142912817	0.0000	0.1170	0/0/0	0.0169										0	130					AK2 (inh=n/a pLI=0.01)
chr1	33476065	33476065	G	A	het	low_MQM	QUAL=1053;DP=324;AF=0.23;MQM=34;TRIO=HET,324,0.23,HET,114,0.20,HET,150,0.12	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*365C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*365C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*414C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*365C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*365C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1265C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1052C>T:		rs143947377	0.0000	0.3260	0/0/0	0.0088										0	158					AK2 (inh=n/a pLI=0.01)
chr1	33476074	33476074	A	T	het	low_MQM	QUAL=1142;DP=344;AF=0.23;MQM=34;TRIO=HET,344,0.23,HET,119,0.18,WT,156,0.10	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*356T>A:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*356T>A:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*405T>A:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*356T>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*356T>A:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1256T>A:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1043T>A:		rs199780633	0.0000	0.3240	0/0/0	0.0002										0	168					AK2 (inh=n/a pLI=0.01)
chr1	33476090	33476090	T	C	het	low_MQM	QUAL=1466;DP=395;AF=0.25;MQM=34;TRIO=HET,395,0.25,HET,119,0.16,HET,154,0.12	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*340A>G:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*340A>G:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*389A>G:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*340A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*340A>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1240A>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.1027A>G:		rs140167370	0.0000	0.2970	0/0/0	0.0100										0	164					AK2 (inh=n/a pLI=0.01)
chr1	33476143	33476143	G	A	het	low_MQM	QUAL=136;DP=259;AF=0.15;MQM=36;TRIO=HET,259,0.15,HET,86,0.14,HET,111,0.14	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*287C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*287C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*336C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*287C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*287C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1187C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.974C>T:		rs201412582	0.0000	0.0170	0/0/0	0.0049										0	156					AK2 (inh=n/a pLI=0.01)
chr1	33476224	33476225	AC	-	het	low_MQM	QUAL=1538;DP=219;AF=0.27;MQM=46;TRIO=HET,219,0.27,HET,71,0.27,HET,74,0.35	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*205_*206delGT:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*205_*206delGT:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*254_*255delGT:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*205_*206delGT:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*205_*206delGT:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1105_1106delGT:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.892_893delGT:		rs67829320	0.4665	0.1200	0/0/0	0.0352										0	184					AK2 (inh=n/a pLI=0.01)
chr1	33476239	33476239	T	C	het	low_MQM	QUAL=2629;DP=269;AF=0.30;MQM=48;TRIO=HET,269,0.30,HET,72,0.32,HET,81,0.38	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*191A>G:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*191A>G:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*240A>G:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*191A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*191A>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1091A>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.878A>G:		rs74066438	0.0000	0.1160	0/0/0	0.0136										0	193					AK2 (inh=n/a pLI=0.01)
chr1	33476292	33476292	A	G	het		QUAL=4626;DP=270;AF=0.30;MQM=50;TRIO=HET,270,0.30,HET,136,0.49,HET,119,0.46	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*138T>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*138T>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*187T>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*138T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*138T>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.1038T>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.825T>C:		rs74066439	0.0000	0.3270	1/1/0	0.0128									COSN163035	1	201					AK2 (inh=n/a pLI=0.01)
chr1	33476353	33476353	C	T	het	low_MQM	QUAL=2535;DP=235;AF=0.18;MQM=47;TRIO=HET,235,0.18,HET,155,0.41,HET,144,0.33	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*77G>A:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*77G>A:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*126G>A:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*77G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*77G>A:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.977G>A:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.764G>A:		rs66599471	0.0000	0.2850	0/0/0	0.0023										6	217					AK2 (inh=n/a pLI=0.01)
chr1	33476385	33476385	C	G	het	low_MQM	QUAL=1365;DP=228;AF=0.20;MQM=47;TRIO=HET,228,0.20,HET,137,0.36,HET,136,0.26	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*45G>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*45G>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*94G>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*45G>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*45G>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.945G>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.732G>C:		rs76881767	0.0000	0.1960	0/0/0	0.0001										8	235					AK2 (inh=n/a pLI=0.01)
chr1	33476387	33476387	C	T	het	low_MQM	QUAL=1365;DP=228;AF=0.20;MQM=47;TRIO=HET,228,0.20,HET,137,0.36,HET,136,0.26	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*43G>A:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*43G>A:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*92G>A:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*43G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*43G>A:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.943G>A:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.730G>A:		rs201842558	0.0000	0.1960	0/0/0	0.0001										8	234					AK2 (inh=n/a pLI=0.01)
chr1	33476396	33476396	G	A	het	low_MQM	QUAL=1717;DP=234;AF=0.20;MQM=47;TRIO=HET,234,0.20,HET,132,0.35,HET,137,0.23	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*34C>T:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*34C>T:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*83C>T:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*34C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*34C>T:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.934C>T:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.721C>T:		rs79824855	0.0000	0.1660	0/0/0	0.0005										7	287					AK2 (inh=n/a pLI=0.01)
chr1	33476404	33476404	T	G	het	low_MQM	QUAL=1360;DP=221;AF=0.20;MQM=47;TRIO=HET,221,0.20,HET,127,0.31,HET,132,0.23	AK2	3'UTR,non_coding_exon	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*26A>C:,AK2:NM_001319139.1:3'UTR:MODIFIER:exon8/8:c.*26A>C:,AK2:NM_001319141.1:3'UTR:MODIFIER:exon8/8:c.*75A>C:,AK2:NM_001319142.1:3'UTR:MODIFIER:exon6/6:c.*26A>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*26A>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon8/8:n.926A>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon6/6:n.713A>C:		rs76230073	0.0000	0.1650	0/0/0	0.0004										7	259					AK2 (inh=n/a pLI=0.01)
chr1	33478931	33478931	G	C	het	low_MQM;phylop_high;pred_pathogenic_2	QUAL=1074;DP=678;AF=0.19;MQM=37;TRIO=HET,678,0.19,WT,477,0.04,WT,594,0.02	AK2	missense,3'UTR,non_coding_exon	AK2:NM_001625.3:missense:MODERATE:exon6/6:c.571C>G:p.His191Asp,AK2:NM_001199199.1:missense:MODERATE:exon6/7:c.547C>G:p.His183Asp,AK2:NM_001319139.1:missense:MODERATE:exon7/8:c.427C>G:p.His143Asp,AK2:NM_001319141.1:missense:MODERATE:exon6/8:c.571C>G:p.His191Asp,AK2:NM_001319142.1:missense:MODERATE:exon5/6:c.445C>G:p.His149Asp,AK2:NM_013411.4:missense:MODERATE:exon6/7:c.571C>G:p.His191Asp,AK2:NM_001319140.1:missense:MODERATE:exon7/7:c.427C>G:p.His143Asp,AK2:NM_001319143.1:3'UTR:MODIFIER:exon5/5:c.*74C>G:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon7/8:n.772C>G:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon5/6:n.559C>G:,AK2:NR_037592.1:non_coding_exon:MODIFIER:exon7/7:n.772C>G:		rs80324279	0.0000	0.3200	0/0/0	0.0002	9.8270	T	D,D,D,D	P,D,P,P	B,P,P,B	103020 [AK2 (confirmed) Reticular dysgenesis];			COSM4143820, COSM4143819	1	401					AK2 (inh=n/a pLI=0.01)
chr1	33478959	33478959	C	G	het	low_MQM;pred_pathogenic_1	QUAL=1182;DP=650;AF=0.19;MQM=38;TRIO=HET,650,0.19,WT,425,0.04,WT,556,0.02	AK2	missense,3'UTR,non_coding_exon	AK2:NM_001625.3:missense:MODERATE:exon6/6:c.543G>C:p.Lys181Asn,AK2:NM_001199199.1:missense:MODERATE:exon6/7:c.519G>C:p.Lys173Asn,AK2:NM_001319139.1:missense:MODERATE:exon7/8:c.399G>C:p.Lys133Asn,AK2:NM_001319141.1:missense:MODERATE:exon6/8:c.543G>C:p.Lys181Asn,AK2:NM_001319142.1:missense:MODERATE:exon5/6:c.417G>C:p.Lys139Asn,AK2:NM_013411.4:missense:MODERATE:exon6/7:c.543G>C:p.Lys181Asn,AK2:NM_001319140.1:missense:MODERATE:exon7/7:c.399G>C:p.Lys133Asn,AK2:NM_001319143.1:3'UTR:MODIFIER:exon5/5:c.*46G>C:,AK2:NR_037591.1:non_coding_exon:MODIFIER:exon7/8:n.744G>C:,AK2:NR_134976.1:non_coding_exon:MODIFIER:exon5/6:n.531G>C:,AK2:NR_037592.1:non_coding_exon:MODIFIER:exon7/7:n.744G>C:		rs72884305	0.0000	0.3950	0/0/0	0.0001	-0.4040	T	D,D,D,D	B,B,B,B	B,B,B,B	103020 [AK2 (confirmed) Reticular dysgenesis];			COSM4143821, COSM4143822	0	391					AK2 (inh=n/a pLI=0.01)
chr1	39492080	39492080	G	T	het		QUAL=4687;DP=95;AF=0.52;MQM=60;TRIO=HET,95,0.52,HOM,91,1.00,HET,115,0.48	NDUFS5	splice_region&intron	NDUFS5:NM_001184979.1:splice_region&intron:LOW:exon1/2:c.-3+10G>T:,NDUFS5:NM_004552.2:splice_region&intron:LOW:exon1/2:c.-3+6G>T:		rs1122472	0.5377	0.0000	0/0/0	0.6956										133	80					NDUFS5 (inh=n/a pLI=0.10)
chr1	40539076	40539076	C	T	hom		QUAL=18386;DP=388;AF=1.00;MQM=59;TRIO=HOM,388,1.00,HET,208,0.39,HET,252,0.50	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*657G>A:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*657G>A:		rs1126973	0.6673	0.0000	0/0/0	0.7027										120	90					PPT1 (inh=n/a pLI=0.00)
chr1	40539203	40539203	-	TGAT	hom		QUAL=21578;DP=351;AF=0.99;MQM=59;TRIO=HOM,351,0.99,HET,365,0.45,HET,460,0.47	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*526_*529dupATCA:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*526_*529dupATCA:		rs3841663;rs397730033	0.6140	0.0000	0/0/0	0.6307										118	92					PPT1 (inh=n/a pLI=0.00)
chr1	40539228	40539228	G	C	hom		QUAL=29600;DP=535;AF=1.00;MQM=59;TRIO=HOM,535,1.00,HET,425,0.46,HET,539,0.48	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*505C>G:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*505C>G:		rs1126972	0.6607	0.0000	0/0/0	0.1107										120	90					PPT1 (inh=n/a pLI=0.00)
chr1	40539448	40539448	A	C	hom		QUAL=39256;DP=867;AF=1.00;MQM=59;TRIO=HOM,867,1.00,HET,416,0.53,HET,464,0.45	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*285T>G:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*285T>G:		rs1126970	0.6611	0.0000	0/0/0	0.7010										120	90					PPT1 (inh=n/a pLI=0.00)
chr1	40539572	40539572	A	G	het		QUAL=7546;DP=344;AF=0.46;MQM=60;TRIO=HET,344,0.46,WT,237,0.00,HET,267,0.48	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*161T>C:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*161T>C:		rs11552578	0.1514	0.0000	0/0/0	0.0189										2	43					PPT1 (inh=n/a pLI=0.00)
chr1	40557033	40557033	A	G	het		QUAL=9320;DP=434;AF=0.44;MQM=59;TRIO=HET,434,0.44,WT,345,0.00,HET,350,0.48	PPT1	missense,intron	PPT1:NM_000310.3:missense:MODERATE:exon4/9:c.401T>C:p.Ile134Thr,PPT1:NM_001142604.1:intron:MODIFIER:exon1/5:c.125-1849T>C:		rs1800205	0.0739	0.0660	410/111/0	0.0631	0.5740	T	T,T,T,T	B,B	B,B	600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1];	RCV000118047.3 [other]; 		COSM3751190	6	118					PPT1 (inh=n/a pLI=0.00)
chr1	40562993	40562993	T	C	hom		QUAL=5986;DP=36;AF=1.00;MQM=59;TRIO=HOM,36,1.00,HOM,62,1.00,HOM,101,1.00	PPT1	5'UTR	PPT1:NM_000310.3:5'UTR:MODIFIER:exon1/9:c.-83A>G:,PPT1:NM_001142604.1:5'UTR:MODIFIER:exon1/6:c.-83A>G:		rs6600313	0.8327	0.0000	0/0/0	0.1595										173	46					PPT1 (inh=n/a pLI=0.00)
chr1	40563019	40563019	G	T	het		QUAL=1556;DP=32;AF=0.59;MQM=60;TRIO=HET,32,0.59,WT,53,0.02,HET,87,0.51	PPT1	5'UTR	PPT1:NM_000310.3:5'UTR:MODIFIER:exon1/9:c.-109C>A:,PPT1:NM_001142604.1:5'UTR:MODIFIER:exon1/6:c.-109C>A:		rs41301070	0.1138	0.0000	0/0/0	0.0524										2	20					PPT1 (inh=n/a pLI=0.00)
chr1	43199024	43199024	C	T	het		QUAL=6613;DP=220;AF=0.50;MQM=59;TRIO=HET,220,0.50,WT,253,0.00,HET,338,0.51	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*1733G>A:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*2515G>A:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*2409G>A:	AluSx1	rs112310775	0.1254	0.0000	0/0/0	0.1126										5	44					CLDN19 (inh=n/a pLI=0.18)
chr1	43199115	43199115	A	G	het		QUAL=10924;DP=412;AF=0.49;MQM=60;TRIO=HET,412,0.49,WT,354,0.00,HET,441,0.50	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*1642T>C:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*2424T>C:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*2318T>C:		rs56345167	0.1907	0.0000	0/0/0	0.0288										8	58					CLDN19 (inh=n/a pLI=0.18)
chr1	43200526	43200526	T	C	het		QUAL=5078;DP=139;AF=0.49;MQM=59;TRIO=HET,139,0.49,HET,127,0.43,HET,142,0.51	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*231A>G:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*1013A>G:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*907A>G:		rs912075	0.6068	0.0000	0/0/0	0.1020										81	110					CLDN19 (inh=n/a pLI=0.18)
chr1	43200855	43200855	G	A	het		QUAL=7353;DP=130;AF=0.53;MQM=59;TRIO=HET,130,0.53,HET,212,0.54,HET,254,0.46	CLDN19	3'UTR,intron	CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*684C>T:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*578C>T:,CLDN19:NM_148960.2:intron:MODIFIER:exon4/4:c.627-50C>T:		rs74885359	0.0387	0.0960	677/577/2	0.0929						610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];				1	39					CLDN19 (inh=n/a pLI=0.18)
chr1	43201216	43201216	A	C	het		QUAL=10576;DP=197;AF=0.47;MQM=59;TRIO=HET,197,0.47,HET,286,0.49,HET,353,0.49	CLDN19	3'UTR,intron	CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*323T>G:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*217T>G:,CLDN19:NM_148960.2:intron:MODIFIER:exon4/4:c.626+333T>G:	L2b	rs12141833	0.5569	0.0000	0/0/0	0.0994						610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];				50	73					CLDN19 (inh=n/a pLI=0.18)
chr1	43201534	43201534	G	A	het	pred_pathogenic_1	QUAL=4072;DP=92;AF=0.47;MQM=59;TRIO=HET,92,0.47,WT,175,0.01,HET,243,0.56	CLDN19	missense,splice_region&intron,3'UTR	CLDN19:NM_001185117.1:missense:MODERATE:exon3/3:c.556C>T:p.Arg186Cys,CLDN19:NM_148960.2:splice_region&intron:LOW:exon4/4:c.626+15C>T:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*5C>T:		rs4660658	0.1905	0.1390	749/338/145	0.1378	-1.1650	T	D	B	B	610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];			COSM3746967	39	276					CLDN19 (inh=n/a pLI=0.18)
chr1	43212111	43212111	C	T	het		QUAL=9137;DP=306;AF=0.48;MQM=59;TRIO=HET,306,0.48,HET,181,0.54,HET,206,0.48	P3H1	3'UTR	P3H1:NM_001243246.1:3'UTR:MODIFIER:exon14/14:c.*472G>A:,P3H1:NM_001146289.1:3'UTR:MODIFIER:exon15/15:c.*393G>A:,P3H1:NM_022356.3:3'UTR:MODIFIER:exon15/15:c.*257G>A:		rs6882	0.6625	0.0000	0/0/0	0.1144										100	105					P3H1 (inh=n/a pLI=0.00)
chr1	43212431	43212431	A	G	hom		QUAL=23826;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,214,1.00,HOM,347,1.00	P3H1	synonymous,3'UTR	P3H1:NM_022356.3:synonymous:LOW:exon15/15:c.2148T>C:p.Gly716Gly,P3H1:NM_001243246.1:3'UTR:MODIFIER:exon14/14:c.*152T>C:,P3H1:NM_001146289.1:3'UTR:MODIFIER:exon15/15:c.*73T>C:		rs4660662	1.0000	0.9990	14842/7042/1411	0.8090							RCV000174947.1 [likely benign]; 			1106	0					P3H1 (inh=n/a pLI=0.00)
chr1	43212869	43212869	A	T	het	pred_pathogenic_1	QUAL=2982;DP=114;AF=0.47;MQM=60;TRIO=HET,114,0.47,WT,74,0.00,HET,126,0.50	P3H1	missense,intron	P3H1:NM_001243246.1:missense:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr,P3H1:NM_001146289.1:intron:MODIFIER:exon14/14:c.2074+55T>A:,P3H1:NM_022356.3:intron:MODIFIER:exon14/14:c.2055+74T>A:		rs3738496	0.1210	0.1230	1074/441/34	0.1224	-0.0100	T	D	B	B					22	213					P3H1 (inh=n/a pLI=0.00)
chr1	43408966	43408966	G	A	het		QUAL=7602;DP=303;AF=0.46;MQM=60;TRIO=HET,303,0.46,HET,350,0.53,WT,490,0.00	SLC2A1	synonymous	SLC2A1:NM_006516.2:synonymous:LOW:exon2/10:c.45C>T:p.Ala15Ala		rs1385129	0.2404	0.2390	3400/1609/153	0.2354						138140 [SLC2A1 (confirmed) GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|Epilepsy,idiopathic generalized,suscpetibility to,12|Dystonia 9];	RCV000081435.5 [benign]; 		COSM3751209, COSM3751207, COSM3751208	125	821					SLC2A1 (inh=n/a pLI=0.94)
chr1	44290530	44290530	A	G	het		QUAL=7859;DP=266;AF=0.46;MQM=60;TRIO=HET,266,0.46,HET,116,0.41,HOM,112,0.98	ST3GAL3	missense,intron	ST3GAL3:NM_174963.3:missense:MODERATE:exon5/13:c.382A>G:p.Thr128Ala,ST3GAL3:NM_174968.3:missense:MODERATE:exon5/13:c.337A>G:p.Thr113Ala,ST3GAL3:NM_174971.3:missense:MODERATE:exon4/12:c.289A>G:p.Thr97Ala,ST3GAL3:NM_001270459.1:intron:MODIFIER:exon4/11:c.209+9925A>G:,ST3GAL3:NM_001270460.1:intron:MODIFIER:exon4/10:c.209+9925A>G:,ST3GAL3:NM_001270461.1:intron:MODIFIER:exon3/8:c.161+9925A>G:,ST3GAL3:NM_001270462.1:intron:MODIFIER:exon3/7:c.161+9925A>G:,ST3GAL3:NM_001270463.1:intron:MODIFIER:exon3/7:c.206+9925A>G:,ST3GAL3:NM_001270464.1:intron:MODIFIER:exon3/7:c.161+9925A>G:,ST3GAL3:NM_001270465.1:intron:MODIFIER:exon3/7:c.206+9925A>G:,ST3GAL3:NM_001270466.1:intron:MODIFIER:exon3/4:c.161+9925A>G:,ST3GAL3:NM_006279.3:intron:MODIFIER:exon4/11:c.209+9925A>G:,ST3GAL3:NM_174964.2:intron:MODIFIER:exon4/11:c.254+9925A>G:,ST3GAL3:NM_174965.2:intron:MODIFIER:exon4/6:c.254+9925A>G:,ST3GAL3:NM_174966.2:intron:MODIFIER:exon4/9:c.209+9925A>G:,ST3GAL3:NM_174967.2:intron:MODIFIER:exon4/6:c.209+9925A>G:,ST3GAL3:NM_174969.2:intron:MODIFIER:exon3/10:c.161+9925A>G:,ST3GAL3:NM_174970.2:intron:MODIFIER:exon3/5:c.161+9925A>G:,ST3GAL3:NR_073016.1:intron:MODIFIER:exon4/11:n.400+9925A>G:,ST3GAL3:NR_073017.1:intron:MODIFIER:exon2/9:n.310-13361A>G:,ST3GAL3:NR_073018.1:intron:MODIFIER:exon4/10:n.400+9925A>G:,ST3GAL3:NR_073019.1:intron:MODIFIER:exon2/8:n.310-69525A>G:,ST3GAL3:NR_073020.1:intron:MODIFIER:exon3/9:n.352+9925A>G:,ST3GAL3:NR_073021.1:intron:MODIFIER:exon4/9:n.400+9925A>G:,ST3GAL3:NR_073023.1:intron:MODIFIER:exon4/8:n.400+9925A>G:	MER5B	rs37458	0.2364	0.2710	3717/2596/394	0.2577	-0.1510	T	T,T,T,T,T,T	B,B,B	B,B,B	606494 [ST3GAL3 (provisional) Mental retardation,autosomal recessive 12|Epileptic encephalopathy,early infantile,15];	RCV000118418.2 [likely benign]; 		COSM3751230	119	502					ST3GAL3 (inh=n/a pLI=0.57)
chr1	44396196	44396196	A	G	het		QUAL=3247;DP=160;AF=0.44;MQM=59;TRIO=HET,160,0.44,WT,78,0.00,HET,120,0.49	ST3GAL3	3'UTR,non_coding_exon	ST3GAL3:NM_174963.3:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:NM_001270459.1:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_001270460.1:3'UTR:MODIFIER:exon11/11:c.*303A>G:,ST3GAL3:NM_001270461.1:3'UTR:MODIFIER:exon9/9:c.*303A>G:,ST3GAL3:NM_001270462.1:3'UTR:MODIFIER:exon8/8:c.*303A>G:,ST3GAL3:NM_001270463.1:3'UTR:MODIFIER:exon8/8:c.*341A>G:,ST3GAL3:NM_001270464.1:3'UTR:MODIFIER:exon8/8:c.*341A>G:,ST3GAL3:NM_001270465.1:3'UTR:MODIFIER:exon8/8:c.*415A>G:,ST3GAL3:NM_001270466.1:3'UTR:MODIFIER:exon5/5:c.*341A>G:,ST3GAL3:NM_006279.3:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_174964.2:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_174965.2:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:NM_174966.2:3'UTR:MODIFIER:exon10/10:c.*303A>G:,ST3GAL3:NM_174967.2:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:NM_174968.3:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:NM_174969.2:3'UTR:MODIFIER:exon11/11:c.*303A>G:,ST3GAL3:NM_174970.2:3'UTR:MODIFIER:exon6/6:c.*322A>G:,ST3GAL3:NM_174971.3:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NR_073016.1:non_coding_exon:MODIFIER:exon12/12:n.1654A>G:,ST3GAL3:NR_073017.1:non_coding_exon:MODIFIER:exon10/10:n.1531A>G:,ST3GAL3:NR_073018.1:non_coding_exon:MODIFIER:exon11/11:n.1501A>G:,ST3GAL3:NR_073019.1:non_coding_exon:MODIFIER:exon9/9:n.1470A>G:,ST3GAL3:NR_073020.1:non_coding_exon:MODIFIER:exon10/10:n.1387A>G:,ST3GAL3:NR_073021.1:non_coding_exon:MODIFIER:exon10/10:n.1315A>G:,ST3GAL3:NR_073023.1:non_coding_exon:MODIFIER:exon9/9:n.1275A>G:		rs12561948	0.0507	0.0000	0/0/0	0.0090										0	21					ST3GAL3 (inh=n/a pLI=0.57)
chr1	44396646	44396646	C	G	het		QUAL=13577;DP=234;AF=0.49;MQM=59;TRIO=HET,234,0.49,HOM,222,1.00,HET,264,0.54	ST3GAL3	3'UTR,non_coding_exon	ST3GAL3:NM_174963.3:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:NM_001270459.1:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_001270460.1:3'UTR:MODIFIER:exon11/11:c.*753C>G:,ST3GAL3:NM_001270461.1:3'UTR:MODIFIER:exon9/9:c.*753C>G:,ST3GAL3:NM_001270462.1:3'UTR:MODIFIER:exon8/8:c.*753C>G:,ST3GAL3:NM_001270463.1:3'UTR:MODIFIER:exon8/8:c.*791C>G:,ST3GAL3:NM_001270464.1:3'UTR:MODIFIER:exon8/8:c.*791C>G:,ST3GAL3:NM_001270465.1:3'UTR:MODIFIER:exon8/8:c.*865C>G:,ST3GAL3:NM_001270466.1:3'UTR:MODIFIER:exon5/5:c.*791C>G:,ST3GAL3:NM_006279.3:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_174964.2:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_174965.2:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:NM_174966.2:3'UTR:MODIFIER:exon10/10:c.*753C>G:,ST3GAL3:NM_174967.2:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:NM_174968.3:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:NM_174969.2:3'UTR:MODIFIER:exon11/11:c.*753C>G:,ST3GAL3:NM_174970.2:3'UTR:MODIFIER:exon6/6:c.*772C>G:,ST3GAL3:NM_174971.3:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NR_073016.1:non_coding_exon:MODIFIER:exon12/12:n.2104C>G:,ST3GAL3:NR_073017.1:non_coding_exon:MODIFIER:exon10/10:n.1981C>G:,ST3GAL3:NR_073018.1:non_coding_exon:MODIFIER:exon11/11:n.1951C>G:,ST3GAL3:NR_073019.1:non_coding_exon:MODIFIER:exon9/9:n.1920C>G:,ST3GAL3:NR_073020.1:non_coding_exon:MODIFIER:exon10/10:n.1837C>G:,ST3GAL3:NR_073021.1:non_coding_exon:MODIFIER:exon10/10:n.1765C>G:,ST3GAL3:NR_073023.1:non_coding_exon:MODIFIER:exon9/9:n.1725C>G:		rs6801	0.5188	0.0000	0/0/0	0.1143										125	95					ST3GAL3 (inh=n/a pLI=0.57)
chr1	45285648	45285648	C	T	hom		QUAL=20148;DP=522;AF=0.99;MQM=59;TRIO=HOM,522,0.99,HET,168,0.54,HET,178,0.49	PTCH2	3'UTR	PTCH2:NM_001166292.1:3'UTR:MODIFIER:exon23/23:c.*713G>A:	U5	rs41269085	0.2290	0.0000	0/0/0	0.0328										8	40					PTCH2 (inh=n/a pLI=0.00)
chr1	45292866	45292866	G	A	hom		QUAL=9055;DP=168;AF=0.99;MQM=59;TRIO=HOM,168,0.99,HET,149,0.51,HET,208,0.50	PTCH2	synonymous	PTCH2:NM_003738.4:synonymous:LOW:exon16/22:c.2487C>T:p.Asp829Asp,PTCH2:NM_001166292.1:synonymous:LOW:exon16/23:c.2487C>T:p.Asp829Asp		rs2295996	0.1478	0.1610	1683/926/42	0.1606						603673 [PTCH2 (provisional) Medulloblastoma|Basal cell carcinoma,somatic|Basal cell nevus syndrome];			COSM3751243	32	296					PTCH2 (inh=n/a pLI=0.00)
chr1	45293518	45293518	A	G	hom		QUAL=13200;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HET,269,0.48,HET,323,0.48	PTCH2	synonymous	PTCH2:NM_003738.4:synonymous:LOW:exon14/22:c.2055T>C:p.Ala685Ala,PTCH2:NM_001166292.1:synonymous:LOW:exon14/23:c.2055T>C:p.Ala685Ala		rs7525308	0.4455	0.3830	9301/4018/1766	0.3798						603673 [PTCH2 (provisional) Medulloblastoma|Basal cell carcinoma,somatic|Basal cell nevus syndrome];			COSM3751244	133	497					PTCH2 (inh=n/a pLI=0.00)
chr1	45340282	45340282	C	T	hom		QUAL=20673;DP=403;AF=1.00;MQM=60;TRIO=HOM,403,1.00,HET,252,0.48,HET,315,0.48	EIF2B3	3'UTR,intron	EIF2B3:NM_001166588.2:3'UTR:MODIFIER:exon10/10:c.*31G>A:,EIF2B3:NM_020365.4:intron:MODIFIER:exon10/11:c.1202+68G>A:,EIF2B3:NM_001261418.1:intron:MODIFIER:exon10/10:c.1202+68G>A:	HAL1	rs9988451	0.4517	0.3950	9682/4009/1747	0.3862						606273 [EIF2B3 (provisional) Leukoencephalopathy with vanishing white matter];				31	91					EIF2B3 (inh=n/a pLI=0.39)
chr1	45452227	45452227	G	C	hom		QUAL=6946;DP=130;AF=1.00;MQM=59;TRIO=HOM,130,1.00,HET,108,0.43,HET,187,0.43	EIF2B3	5'UTR	EIF2B3:NM_020365.4:5'UTR:MODIFIER:exon1/12:c.-72C>G:,EIF2B3:NM_001261418.1:5'UTR:MODIFIER:exon1/11:c.-72C>G:,EIF2B3:NM_001166588.2:5'UTR:MODIFIER:exon1/10:c.-72C>G:		rs489676	0.4806	0.0000	0/0/0	0.4437										49	89					EIF2B3 (inh=n/a pLI=0.39)
chr1	46164846	46164846	A	T	hom		QUAL=21027;DP=306;AF=0.99;MQM=60;TRIO=HOM,306,0.99,HET,179,0.47,HOM,299,1.00	IPP	3'UTR,intron	IPP:NM_005897.2:3'UTR:MODIFIER:exon9/9:c.*792T>A:,IPP:NM_001145349.1:intron:MODIFIER:exon9/9:c.1651+896T>A:		rs10749856	0.3249	0.0000	0/0/0	0.0537										25	102					IPP (inh=n/a pLI=0.00)
chr1	46195375	46195375	T	C	hom	phylop_high	QUAL=10538;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HET,60,0.57,HOM,65,0.97	IPP	missense	IPP:NM_005897.2:missense:MODERATE:exon4/9:c.791A>G:p.Lys264Arg,IPP:NM_001145349.1:missense:MODERATE:exon4/10:c.791A>G:p.Lys264Arg		rs28375469	0.3149	0.3040	5748/2867/309	0.3012	7.6230	T	T,T	B,B	B,B				COSM146501, COSM3751253	83	284					IPP (inh=n/a pLI=0.00)
chr1	46655158	46655158	T	C	hom	phylop_high	QUAL=12742;DP=142;AF=0.99;MQM=59;TRIO=HOM,142,0.99,HOM,142,1.00,HOM,128,1.00	POMGNT1	missense&splice_region,missense	POMGNT1:NM_001243766.1:missense&splice_region:MODERATE:exon21/23:c.1867A>G:p.Met623Val,POMGNT1:NM_001290129.1:missense:MODERATE:exon20/22:c.1801A>G:p.Met601Val,POMGNT1:NM_001290130.1:missense:MODERATE:exon20/22:c.1438A>G:p.Met480Val,POMGNT1:NM_017739.3:missense:MODERATE:exon21/22:c.1867A>G:p.Met623Val		rs6659553	0.9425	0.9840	58446/33140/3478	0.9299	5.7560	T	T,T,T,T	B,B,B	B,B,B	606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3];	RCV000153758.3 [benign]; 			1107	0					POMGNT1 (inh=AR pLI=0.00)
chr1	46660295	46660295	T	C	hom	pred_pathogenic_1	QUAL=17633;DP=264;AF=1.00;MQM=59;TRIO=HOM,264,1.00,HOM,199,0.99,HET,302,0.44	POMGNT1	synonymous	POMGNT1:NM_001243766.1:synonymous:LOW:exon8/23:c.681A>G:p.Lys227Lys,POMGNT1:NM_001290129.1:synonymous:LOW:exon7/22:c.615A>G:p.Lys205Lys,POMGNT1:NM_001290130.1:synonymous:LOW:exon7/22:c.252A>G:p.Lys84Lys,POMGNT1:NM_017739.3:synonymous:LOW:exon8/22:c.681A>G:p.Lys227Lys		rs2292487	0.3335	0.3550	8093/4203/641	0.3477	0.5750	T	D			606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3];	RCV000081805.8 [other]; 		COSM3751255, COSM3751254	152	492					POMGNT1 (inh=AR pLI=0.00)
chr1	47716041	47716042	AA	-	het		QUAL=5398;DP=257;AF=0.51;MQM=56;TRIO=HET,257,0.51,HET,175,0.51,WT,176,0.00	STIL	3'UTR	STIL:NM_001048166.1:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:,STIL:NM_001282936.1:3'UTR:MODIFIER:exon18/18:c.*766_*767delTT:,STIL:NM_001282937.1:3'UTR:MODIFIER:exon18/18:c.*766_*767delTT:,STIL:NM_001282938.1:3'UTR:MODIFIER:exon19/19:c.*766_*767delTT:,STIL:NM_001282939.1:3'UTR:MODIFIER:exon19/19:c.*766_*767delTT:,STIL:NM_003035.2:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:		rs398089260	0.3926	0.0000	0/0/0	0.4191										73	116					STIL (inh=n/a pLI=0.20)
chr1	47717189	47717189	A	G	het		QUAL=8355;DP=443;AF=0.50;MQM=59;TRIO=HET,443,0.50,HET,230,0.40,WT,306,0.01	STIL	synonymous	STIL:NM_001048166.1:synonymous:LOW:exon17/17:c.3486T>C:p.Pro1162Pro,STIL:NM_001282936.1:synonymous:LOW:exon18/18:c.3483T>C:p.Pro1161Pro,STIL:NM_001282937.1:synonymous:LOW:exon18/18:c.3432T>C:p.Pro1144Pro,STIL:NM_001282938.1:synonymous:LOW:exon19/19:c.3345T>C:p.Pro1115Pro,STIL:NM_001282939.1:synonymous:LOW:exon19/19:c.3291T>C:p.Pro1097Pro,STIL:NM_003035.2:synonymous:LOW:exon17/17:c.3483T>C:p.Pro1161Pro		rs2758735	0.3934	0.4980	15897/9723/152	0.4882						181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000147697.1 [benign]; RCV000080044.6 [benign]; 			308	564					STIL (inh=n/a pLI=0.20)
chr1	47726087	47726087	T	C	het		QUAL=6435;DP=210;AF=0.51;MQM=60;TRIO=HET,210,0.51,HET,117,0.47,HET,176,0.47	STIL	missense	STIL:NM_001048166.1:missense:MODERATE:exon16/17:c.2954A>G:p.His985Arg,STIL:NM_001282936.1:missense:MODERATE:exon17/18:c.2951A>G:p.His984Arg,STIL:NM_001282937.1:missense:MODERATE:exon17/18:c.2900A>G:p.His967Arg,STIL:NM_001282938.1:missense:MODERATE:exon18/19:c.2813A>G:p.His938Arg,STIL:NM_001282939.1:missense:MODERATE:exon18/19:c.2759A>G:p.His920Arg,STIL:NM_003035.2:missense:MODERATE:exon16/17:c.2951A>G:p.His984Arg		rs13376679	0.1783	0.2420	4067/3002/232	0.2413	0.0410	T	T,T,T,T,T	B,B,B	B,B,B	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000080043.5 [benign]; 		COSM4144058	105	440					STIL (inh=n/a pLI=0.20)
chr1	47767914	47767914	G	A	het	phylop_high	QUAL=13793;DP=245;AF=0.51;MQM=60;TRIO=HET,245,0.51,HET,186,0.54,HOM,259,0.99	STIL	missense	STIL:NM_001048166.1:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val,STIL:NM_001282936.1:missense:MODERATE:exon5/18:c.257C>T:p.Ala86Val,STIL:NM_001282937.1:missense:MODERATE:exon5/18:c.257C>T:p.Ala86Val,STIL:NM_001282938.1:missense:MODERATE:exon5/19:c.257C>T:p.Ala86Val,STIL:NM_001282939.1:missense:MODERATE:exon5/19:c.257C>T:p.Ala86Val,STIL:NM_003035.2:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val		rs3125630	0.6064	0.5020	16139/7072/3680	0.5027	5.1820	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000020526.1 [benign]; RCV000147687.1 [likely benign]; 			238	558					STIL (inh=n/a pLI=0.20)
chr1	51066088	51066088	T	C	het		QUAL=3510;DP=166;AF=0.43;MQM=60;TRIO=HET,166,0.43,HET,136,0.48,WT,172,0.00	FAF1	intron	FAF1:NM_007051.2:intron:MODIFIER:exon8/18:c.745-4200A>G:	Charlie1a	rs6679854	0.1695	0.0000	0/0/0	0.2165										12	64					FAF1 (inh=n/a pLI=1.00)
chr1	53676448	53676448	G	A	het		QUAL=11045;DP=289;AF=0.53;MQM=59;TRIO=HET,289,0.53,WT,215,0.00,HOM,229,1.00	CPT2	missense	CPT2:NM_000098.2:missense:MODERATE:exon4/5:c.1102G>A:p.Val368Ile		rs1799821	0.4131	0.4830	15346/9849/451	0.4864	-0.0540	T	T	B	B	600650 [CPT2 (confirmed) Myopathy due to CPT II deficiency|CPT deficiency,hepatic,type II|CPT II deficiency,lethal neonatal|Encephalopathy,acute,infection-induced,4,susceptibility to];	RCV000023026.2 [other]; RCV000078116.5 [benign]; RCV000202483.1 [benign]; 	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2]; 	COSM3751293	302	507	2	[2] old entry - no details available			CPT2 (inh=n/a pLI=0.00)
chr1	53679229	53679229	A	G	het	phylop_high;pred_pathogenic_1	QUAL=6097;DP=270;AF=0.48;MQM=60;TRIO=HET,270,0.48,WT,179,0.00,HET,238,0.46	CPT2	missense	CPT2:NM_000098.2:missense:MODERATE:exon5/5:c.1939A>G:p.Met647Val		rs1799822	0.1004	0.1620	1862/1554/9	0.1630	7.4450	T	D	B	B	600650 [CPT2 (confirmed) Myopathy due to CPT II deficiency|CPT deficiency,hepatic,type II|CPT II deficiency,lethal neonatal|Encephalopathy,acute,infection-induced,4,susceptibility to];	RCV000078120.5 [benign]; RCV000202533.1 [benign]; 		COSM3751294	49	335					CPT2 (inh=n/a pLI=0.00)
chr1	55315351	55315351	T	C	hom		QUAL=17342;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,129,1.00,HOM,158,1.00	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*2555A>G:		rs657688	0.9998	0.0000	0/0/0	0.1799										230	0					DHCR24 (inh=n/a pLI=0.97)
chr1	55315941	55315941	G	T	het		QUAL=10507;DP=447;AF=0.47;MQM=60;TRIO=HET,447,0.47,WT,318,0.00,HET,386,0.50	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*1965C>A:		rs11555500	0.0102	0.0000	0/0/0	0.0046										0	11					DHCR24 (inh=n/a pLI=0.97)
chr1	55316082	55316082	A	C	hom		QUAL=25133;DP=320;AF=1.00;MQM=59;TRIO=HOM,320,1.00,HOM,190,1.00,HOM,258,1.00	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*1824T>G:		rs654561	0.9832	0.0000	0/0/0	0.1488										230	1					DHCR24 (inh=n/a pLI=0.97)
chr1	55319902	55319902	A	G	hom	low_DP	QUAL=600;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,3,1.00,HOM,9,1.00	DHCR24	synonymous	DHCR24:NM_014762.3:synonymous:LOW:exon7/9:c.1026T>C:p.Ile342Ile		rs718265	0.6276	0.6640	27364/15776/1954	0.6551						606418 [DHCR24 (confirmed) Desmosterolosis];			COSM4144102	470	482					DHCR24 (inh=n/a pLI=0.97)
chr1	55464743	55464743	T	C	hom		QUAL=35603;DP=348;AF=0.99;MQM=59;TRIO=HOM,348,0.99,HOM,531,1.00,HET,648,0.49	BSND	5'UTR	BSND:NM_057176.2:5'UTR:MODIFIER:exon1/4:c.-117T>C:		rs2500340	0.5941	0.0000	0/0/0	0.1345										130	82					BSND (inh=AR pLI=0.00)
chr1	55464790	55464790	C	G	hom		QUAL=37360;DP=331;AF=0.99;MQM=60;TRIO=HOM,331,0.99,HOM,567,1.00,HET,758,0.48	BSND	5'UTR_premature_start_codon_gain,5'UTR	BSND:NM_057176.2:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-70C>G:,BSND:NM_057176.2:5'UTR:MODIFIER:exon1/4:c.-70C>G:		rs2500341	0.5950	0.0000	0/0/0	0.1350										190	107					BSND (inh=AR pLI=0.00)
chr1	55474325	55474325	A	C	het		QUAL=18420;DP=304;AF=0.54;MQM=59;TRIO=HET,304,0.54,WT,322,0.01,HOM,452,1.00	BSND	3'UTR	BSND:NM_057176.2:3'UTR:MODIFIER:exon4/4:c.*24A>C:		rs6682884	0.3624	0.3750	9028/5896/1215	0.3730										88	207					BSND (inh=AR pLI=0.00)
chr1	57340727	57340727	C	A	het		QUAL=5784;DP=135;AF=0.44;MQM=60;TRIO=HET,135,0.44,HOM,141,0.99,WT,210,0.00	C8A	missense	C8A:NM_000562.2:missense:MODERATE:exon3/11:c.277C>A:p.Gln93Lys		rs652785	0.3437	0.3680	8692/4750/225	0.3641	0.1090	T	T	B	B	120950 [C8A (confirmed) C8 deficiency,type I];	RCV000018567.2 [benign]; 			202	532					C8A (inh=n/a pLI=0.00)
chr1	57395020	57395020	A	G	het		QUAL=14134;DP=543;AF=0.51;MQM=60;TRIO=HET,543,0.51,HET,531,0.49,WT,781,0.00	C8B	3'UTR	C8B:NM_000066.3:3'UTR:MODIFIER:exon12/12:c.*57T>C:,C8B:NM_001278543.1:3'UTR:MODIFIER:exon13/13:c.*57T>C:,C8B:NM_001278544.1:3'UTR:MODIFIER:exon13/13:c.*57T>C:		rs2795	0.3672	0.0000	0/0/0	0.0691										41	98					C8B (inh=n/a pLI=0.00)
chr1	57422484	57422484	C	T	hom		QUAL=26325;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,249,1.00,HOM,266,1.00	C8B	missense	C8B:NM_000066.3:missense:MODERATE:exon3/12:c.349G>A:p.Gly117Arg,C8B:NM_001278543.1:missense:MODERATE:exon4/13:c.193G>A:p.Gly65Arg,C8B:NM_001278544.1:missense:MODERATE:exon4/13:c.163G>A:p.Gly55Arg		rs1013579	0.9864	0.9770	58006/31300/5137	0.9214	0.5350	T	T,T,T	B,B	B,B	120960 [C8B (confirmed) C8 deficiency,type II];				1036	66					C8B (inh=n/a pLI=0.00)
chr1	63881552	63881552	C	T	het		QUAL=7428;DP=250;AF=0.57;MQM=60;TRIO=HET,250,0.57,HET,64,0.44,HOM,87,1.00	ALG6	missense	ALG6:NM_013339.3:missense:MODERATE:exon11/15:c.911C>T:p.Ser304Phe		rs4630153	0.8305	0.7500	34408/15616/3808	0.7375	0.9670	T	T,T	B	B	604566 [ALG6 (provisional) Congenital disorder of glycosylation,type Ic];	RCV000081560.7 [other]; 	CM001812 [CLASS=DFP MUT=REF PHEN="Congenital disorder of glycosylation 1c mild" GENE=ALG6]; 		1201	845	2	[2] Peter Bauer 25.08.2014			ALG6 (inh=AR pLI=0.06)
chr1	63903452	63903452	T	C	het		QUAL=2117;DP=96;AF=0.53;MQM=60;TRIO=HET,96,0.53,HET,14,0.57,HOM,21,1.00	ALG6	3'UTR	ALG6:NM_013339.3:3'UTR:MODIFIER:exon15/15:c.*761T>C:		rs3009572	0.6847	0.0000	0/0/0	0.0965										68	108					ALG6 (inh=AR pLI=0.06)
chr1	67520060	67520061	CA	-	het		QUAL=458;DP=26;AF=0.46;MQM=59;TRIO=HET,26,0.46,HET,8,0.50,HOM,12,1.00	SLC35D1	5'UTR	SLC35D1:NM_015139.2:5'UTR:MODIFIER:exon1/12:c.-365_-364delTG:		rs397707349;rs760658879	0.6562	0.0000	0/0/0	0.5830										85	88					SLC35D1 (inh=n/a pLI=0.00)
chr1	67520083	67520083	C	T	het	low_DP	QUAL=238;DP=17;AF=0.71;MQM=59;TRIO=HET,17,0.71,HET,6,0.50,WT,7,0.00	SLC35D1-C1orf141	intergenic_region	SLC35D1-C1orf141:SLC35D1-C1orf141:intergenic_region:MODIFIER::n.67520083C>T:		rs3806321	0.1567	0.0000	0/0/0	0.1649										10	39					SLC35D1-C1orf141 (inh=n/a pLI=n/a)
chr1	76190216	76190216	G	A	hom	low_DP	QUAL=2288;DP=17;AF=0.94;MQM=59;TRIO=HOM,17,0.94,HET,77,0.48,HET,108,0.45	ACADM	5'UTR	ACADM:NM_001286043.1:5'UTR:MODIFIER:exon1/13:c.-257G>A:,ACADM:NM_000016.5:5'UTR:MODIFIER:exon1/12:c.-257G>A:,ACADM:NM_001127328.2:5'UTR:MODIFIER:exon1/12:c.-257G>A:,ACADM:NM_001286042.1:5'UTR:MODIFIER:exon1/11:c.-277G>A:,ACADM:NM_001286044.1:5'UTR:MODIFIER:exon1/9:c.-554G>A:		rs17848068	0.2043	0.0000	0/0/0	0.0461										22	95					ACADM (inh=AR pLI=0.00)
chr1	92940411	92940411	C	T	het		QUAL=6192;DP=282;AF=0.55;MQM=60;TRIO=HET,282,0.55,WT,119,0.00,HET,164,0.49	GFI1	3'UTR	GFI1:NM_001127215.1:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:NM_001127216.1:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:NM_005263.3:3'UTR:MODIFIER:exon7/7:c.*1175G>A:		rs41313373	0.0673	0.0000	0/0/0	0.0173										1	60					GFI1 (inh=n/a pLI=0.03)
chr1	92944315	92944320	AGAGAG	-	hom		QUAL=4081;DP=59;AF=0.73;MQM=59;TRIO=HOM,59,0.73,HOM,98,0.46,HOM,149,0.42	GFI1	splice_region&intron	GFI1:NM_001127215.1:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:,GFI1:NM_001127216.1:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:,GFI1:NM_005263.3:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:	(AG)n	rs200902533	0.0000	0.1000	369/265/7	0.0872						600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant|Neutropenia,nonimmune chronic idiopathic,of adults];				40	57					GFI1 (inh=n/a pLI=0.03)
chr1	92948938	92948938	C	T	het	phylop_high	QUAL=3369;DP=105;AF=0.50;MQM=60;TRIO=HET,105,0.50,HET,267,0.45,WT,325,0.00	GFI1	missense	GFI1:NM_001127215.1:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:NM_001127216.1:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:NM_005263.3:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn		rs34631763	0.0194	0.0380	118/99/1	0.0380	4.3840	T	T,T,T	B	B	600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant|Neutropenia,nonimmune chronic idiopathic,of adults];			COSM3747114	3	89					GFI1 (inh=n/a pLI=0.03)
chr1	97543752	97543752	G	A	het		QUAL=15965;DP=471;AF=0.48;MQM=60;TRIO=HET,471,0.48,HET,323,0.50,HET,438,0.48	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*780C>T:		rs291593	0.3850	0.0000	0/0/0	0.0568							RCV000086445.1 [not provided]; 			15	89					DPYD (inh=AR pLI=0.00)
chr1	97543764	97543764	C	T	het		QUAL=15424;DP=403;AF=0.49;MQM=60;TRIO=HET,403,0.49,HET,340,0.50,HET,463,0.47	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*768G>A:		rs291592	0.5775	0.0000	0/0/0	0.0816							RCV000086446.1 [not provided]; 			40	110					DPYD (inh=AR pLI=0.00)
chr1	97543959	97543959	C	T	het		QUAL=7018;DP=325;AF=0.53;MQM=60;TRIO=HET,325,0.53,HET,214,0.44,WT,287,0.00	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*573G>A:		rs1042482	0.0895	0.0000	0/0/0	0.0145							RCV000086448.1 [not provided]; 			2	24					DPYD (inh=AR pLI=0.00)
chr1	97915624	97915624	A	G	het		QUAL=4765;DP=205;AF=0.44;MQM=60;TRIO=HET,205,0.44,WT,150,0.00,HET,187,0.52	DPYD	synonymous	DPYD:NM_000110.3:synonymous:LOW:exon14/23:c.1896T>C:p.Phe632Phe		rs17376848	0.0521	0.0470	204/58/2	0.0484						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];	RCV000086470.1 [not provided]; 			2	91					DPYD (inh=AR pLI=0.00)
chr1	98185527	98185527	A	G	hom		QUAL=15775;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,123,1.00,HOM,150,1.00	DPYD	3'UTR,intron	DPYD:NM_001160301.1:3'UTR:MODIFIER:exon6/6:c.*917T>C:,DPYD:NM_000110.3:intron:MODIFIER:exon5/22:c.483+1539T>C:		rs2151562	0.9978	0.0000	0/0/0	0.1495						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];				230	0					DPYD (inh=AR pLI=0.00)
chr1	98186077	98186077	T	C	hom		QUAL=20084;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,138,1.00,HOM,192,1.00	DPYD	3'UTR,intron	DPYD:NM_001160301.1:3'UTR:MODIFIER:exon6/6:c.*367A>G:,DPYD:NM_000110.3:intron:MODIFIER:exon5/22:c.483+989A>G:		rs1333718	0.9978	0.0000	0/0/0	0.1495						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];				230	0					DPYD (inh=AR pLI=0.00)
chr1	98348885	98348885	G	A	hom	phylop_high;pred_pathogenic_1;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=15099;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,163,1.00,HET,217,0.52	DPYD	missense	DPYD:NM_000110.3:missense:MODERATE:exon2/23:c.85C>T:p.Arg29Cys,DPYD:NM_001160301.1:missense:MODERATE:exon2/6:c.85C>T:p.Arg29Cys		rs1801265	0.7398	0.7650	35865/20266/1770	0.7480	2.2350	T	T,T	D	P	612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];	RCV000000464.2 [pathogenic]; RCV000086506.1 [not provided]; 	CM970421 [CLASS=DM? MUT=REF PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD]; 	COSM3735988, COSM3735989	640	427	2	[2] old entry - no details available			DPYD (inh=AR pLI=0.00)
chr1	98460060	98460060	A	C	het		QUAL=2938;DP=159;AF=0.48;MQM=60;TRIO=HET,159,0.48,WT,63,0.00,HET,88,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon4/4:n.899+412T>G:	AluSx		0.0000	0.0000	0/0/0	0.0000										0	1					MIR137HG (inh=n/a pLI=n/a)
chr1	98460106	98460106	G	A	hom		QUAL=9176;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HOM,87,1.00,HET,125,0.53	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon4/4:n.899+366C>T:	AluSx	rs9440288	0.8552	0.0000	0/0/0	0.7862										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98461132	98461132	G	C	hom		QUAL=22273;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,282,1.00,HET,368,0.47	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-576C>G:	L2a	rs9324380	0.9267	0.0000	0/0/0	0.8295										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98461257	98461257	-	TTGT	hom		QUAL=16857;DP=239;AF=0.96;MQM=59;TRIO=HOM,239,0.96,HOM,212,0.99,HET,275,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-702_815-701insACAA:		rs10655213	0.8936	0.0000	0/0/0	0.7612										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98461443	98461443	C	T	het		QUAL=4939;DP=163;AF=0.52;MQM=60;TRIO=HET,163,0.52,HET,96,0.47,HET,103,0.52	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-887G>A:		rs9662365	0.4657	0.0000	0/0/0	0.4819										32	85					MIR137HG (inh=n/a pLI=n/a)
chr1	98461954	98461954	T	C	hom		QUAL=5952;DP=151;AF=0.99;MQM=60;TRIO=HOM,151,0.99,HOM,26,1.00,HET,33,0.58	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-1398A>G:		rs1938570	0.8936	0.0000	0/0/0	0.7934										102	45					MIR137HG (inh=n/a pLI=n/a)
chr1	98462921	98462921	C	A	het		QUAL=5239;DP=253;AF=0.50;MQM=60;TRIO=HET,253,0.50,WT,157,0.00,HET,184,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-2365G>T:		rs146033831	0.0176	0.0000	0/0/0	0.0090										0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98465528	98465528	G	A	hom		QUAL=22761;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,253,1.00,HET,336,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-4972C>T:		rs2154403	0.9034	0.0000	0/0/0	0.8005										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98465840	98465840	G	A	het		QUAL=5673;DP=284;AF=0.48;MQM=60;TRIO=HET,284,0.48,HET,226,0.42,WT,308,0.00	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-5284C>T:	L2a	rs116319667	0.0046	0.0000	0/0/0	0.0104										0	6					MIR137HG (inh=n/a pLI=n/a)
chr1	98468539	98468540	TA	-	hom		QUAL=16913;DP=330;AF=0.99;MQM=59;TRIO=HOM,330,0.99,HOM,145,1.00,HET,207,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-7984_815-7983delTA:		rs775004417	0.8920	0.0000	0/0/0	0.7663										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98469687	98469687	A	-	het		QUAL=6817;DP=227;AF=0.47;MQM=59;TRIO=HET,227,0.47,WT,251,0.00,HET,318,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-9131delT:		rs564190891	0.0036	0.0000	0/0/0	0.0035										0	1					MIR137HG (inh=n/a pLI=n/a)
chr1	98470051	98470051	-	AT	hom		QUAL=23926;DP=520;AF=0.99;MQM=59;TRIO=HOM,520,0.99,HOM,129,0.99,HET,233,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-9496_815-9495insAT:		rs10655252;rs141251091	0.8636	0.0000	0/0/0	0.7729										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98470605	98470605	A	G	hom		QUAL=6798;DP=179;AF=1.00;MQM=59;TRIO=HOM,179,1.00,HOM,20,1.00,HET,25,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-10049T>C:		rs10747495	0.9022	0.0000	0/0/0	0.7966										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98472208	98472208	A	G	het		QUAL=2956;DP=167;AF=0.45;MQM=60;TRIO=HET,167,0.45,WT,75,0.00,HET,97,0.41	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-11652T>C:	(ATTAC)n	rs78878051	0.0633	0.0000	0/0/0	0.0389										0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98472879	98472879	C	T	hom		QUAL=20970;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,193,1.00,HET,254,0.56	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-12323G>A:		rs1938564	0.8137	0.0000	0/0/0	0.7712										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98472958	98472958	T	A	hom		QUAL=15823;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,170,1.00,HET,183,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-12402A>T:		rs1938563	0.9014	0.0000	0/0/0	0.7957										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98473716	98473716	T	A	hom		QUAL=18931;DP=397;AF=1.00;MQM=59;TRIO=HOM,397,1.00,HOM,117,1.00,HET,129,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-13160A>T:		rs1938562	0.9014	0.0000	0/0/0	0.7962										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98474767	98474767	C	T	hom		QUAL=15240;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,116,1.00,HET,162,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-14211G>A:		rs2391902	0.8247	0.0000	0/0/0	0.7712										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98475522	98475522	T	C	hom		QUAL=16468;DP=309;AF=1.00;MQM=60;TRIO=HOM,309,1.00,HOM,118,1.00,HET,172,0.52	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-14966A>G:		rs2154402	0.9255	0.0000	0/0/0	0.8296										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98475913	98475913	G	A	hom		QUAL=14309;DP=297;AF=1.00;MQM=60;TRIO=HOM,297,1.00,HOM,88,1.00,HET,127,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-15357C>T:		rs9324381	0.8606	0.0000	0/0/0	0.7821										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98476718	98476718	G	A	hom		QUAL=26022;DP=420;AF=1.00;MQM=60;TRIO=HOM,420,1.00,HOM,219,1.00,HET,280,0.59	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-16162C>T:		rs1938561	0.9022	0.0000	0/0/0	0.7998										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98476950	98476950	T	C	hom		QUAL=25133;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HOM,268,1.00,HET,329,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-16394A>G:	L2c	rs9440293	0.9024	0.0000	0/0/0	0.6403										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98476958	98476958	C	T	hom		QUAL=25465;DP=344;AF=1.00;MQM=59;TRIO=HOM,344,1.00,HOM,269,1.00,HET,338,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-16402G>A:	L2c	rs9727941	0.8614	0.0000	0/0/0	0.6352										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98476966	98476966	G	C	hom		QUAL=25209;DP=343;AF=1.00;MQM=59;TRIO=HOM,343,1.00,HOM,265,1.00,HET,342,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-16410C>G:	L2c	rs9724773	0.8614	0.0000	0/0/0	0.6354										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98478159	98478159	-	AC	hom		QUAL=10804;DP=248;AF=0.87;MQM=59;TRIO=HOM,248,0.87,HOM,119,0.91,HET,167,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-17605_815-17604dupGT:	MIRb	rs112555829;rs397754812;rs58879433	0.7742	0.0000	0/0/0	0.4118										6	142					MIR137HG (inh=n/a pLI=n/a)
chr1	98478544	98478544	A	T	hom		QUAL=29696;DP=410;AF=1.00;MQM=59;TRIO=HOM,410,1.00,HOM,333,1.00,HET,453,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-17988T>A:	L2c	rs1938565	0.9024	0.0000	0/0/0	0.7993										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98478981	98478981	C	T	hom		QUAL=5344;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,22,1.00,HET,28,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-18425G>A:		rs1938566	0.8247	0.0000	0/0/0	0.7323										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98480128	98480128	T	C	hom		QUAL=22156;DP=410;AF=0.99;MQM=60;TRIO=HOM,410,0.99,HOM,195,1.00,HET,222,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-19572A>G:	MER102b	rs1938567	0.8772	0.0000	0/0/0	0.7932										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98480212	98480212	C	T	het		QUAL=7964;DP=430;AF=0.53;MQM=59;TRIO=HET,430,0.53,HET,148,0.50,WT,203,0.00	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-19656G>A:	MER102b	rs11165944	0.3331	0.0000	0/0/0	0.3586										16	71					MIR137HG (inh=n/a pLI=n/a)
chr1	98480332	98480332	G	A	hom		QUAL=190;DP=171;AF=0.27;MQM=52;TRIO=HOM,171,0.27,HOM,48,0.19,HOM,72,0.14	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-19776C>T:	A-rich		0.0000	0.0000	0/0/0	0.0002										0	23					MIR137HG (inh=n/a pLI=n/a)
chr1	98480337	98480337	C	A	het		QUAL=423;DP=214;AF=0.30;MQM=52;TRIO=HET,214,0.30,WT,72,0.06,WT,113,0.10	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-19781G>T:	A-rich		0.0000	0.0000	0/0/0	0.0002										0	21					MIR137HG (inh=n/a pLI=n/a)
chr1	98481750	98481750	C	T	het		QUAL=6511;DP=333;AF=0.45;MQM=60;TRIO=HET,333,0.45,HET,216,0.47,WT,299,0.01	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-21194G>A:		rs6683447	0.3187	0.0000	0/0/0	0.3452										15	62					MIR137HG (inh=n/a pLI=n/a)
chr1	98482580	98482580	G	A	hom		QUAL=14223;DP=269;AF=1.00;MQM=59;TRIO=HOM,269,1.00,HOM,105,1.00,HET,171,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22024C>T:	L1MB1	rs2391903	0.9259	0.0000	0/0/0	0.8199										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98482693	98482693	A	G	hom		QUAL=16846;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,159,1.00,HET,246,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22137T>C:	L1MB1	rs1892549	0.8710	0.0000	0/0/0	0.7905										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98482828	98482828	A	G	hom		QUAL=15807;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HOM,122,1.00,HET,139,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22272T>C:	L1MB1	rs1892550	0.8710	0.0000	0/0/0	0.7905										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98482961	98482961	C	T	hom		QUAL=14130;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HOM,97,0.99,HET,134,0.45	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22405G>A:	L1MB1	rs1892551	0.8710	0.0000	0/0/0	0.7844										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98483035	98483035	G	A	hom		QUAL=9774;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,54,1.00,HET,75,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22479C>T:		rs1892552	0.8710	0.0000	0/0/0	0.7821										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98483150	98483150	A	G	hom		QUAL=6153;DP=147;AF=1.00;MQM=60;TRIO=HOM,147,1.00,HOM,19,1.00,HET,34,0.62	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22594T>C:		rs2391904	0.8710	0.0000	0/0/0	0.7714										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98483322	98483322	T	C	hom		QUAL=6597;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,33,1.00,HET,49,0.31	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-22766A>G:		rs9324382	0.8692	0.0000	0/0/0	0.7729										103	45					MIR137HG (inh=n/a pLI=n/a)
chr1	98484152	98484152	T	C	hom		QUAL=7933;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HOM,53,1.00,HET,91,0.35	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-23596A>G:		rs1938571	0.8157	0.0000	0/0/0	0.7732										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98484291	98484291	G	A	hom		QUAL=11171;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,97,1.00,HET,108,0.36	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-23735C>T:		rs4447033	0.8710	0.0000	0/0/0	0.7890										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98484474	98484474	T	C	hom		QUAL=3412;DP=60;AF=1.00;MQM=57;TRIO=HOM,60,1.00,HOM,40,1.00,HET,39,0.36	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-23918A>G:	AluSx1	rs1938572	0.8710	0.0000	0/0/0	0.7868										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98484617	98484617	C	T	hom		QUAL=3227;DP=80;AF=1.00;MQM=59;TRIO=HOM,80,1.00,HOM,12,1.00,HET,27,0.41	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-24061G>A:	AluSx1	rs1938573	0.8706	0.0000	0/0/0	0.7658										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98484954	98484954	G	T	hom		QUAL=19123;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,157,1.00,HET,223,0.47	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-24398C>A:		rs1938558	0.8708	0.0000	0/0/0	0.7888										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485102	98485102	G	A	hom		QUAL=13942;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,128,1.00,HET,154,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-24546C>T:	MIR	rs1938559	0.8710	0.0000	0/0/0	0.7887										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485192	98485192	C	T	hom		QUAL=22238;DP=509;AF=1.00;MQM=60;TRIO=HOM,509,1.00,HOM,106,1.00,HET,138,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-24636G>A:	MIR	rs1938560	0.8710	0.0000	0/0/0	0.7891										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485573	98485573	C	T	hom		QUAL=8871;DP=148;AF=1.00;MQM=60;TRIO=HOM,148,1.00,HOM,88,1.00,HET,74,0.64	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-25017G>A:		rs9324383	0.8710	0.0000	0/0/0	0.7911										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485698	98485698	-	TTT	hom		QUAL=470;DP=25;AF=0.40;MQM=58;TRIO=HOM,25,0.40,HOM,1,1.00,WT,2,0.00	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-25145_815-25143dupAAA:		rs10637296;rs10695922;rs34150565	0.8578	0.0000	0/0/0	0.4872										25	26					MIR137HG (inh=n/a pLI=n/a)
chr1	98485927	98485927	T	C	hom		QUAL=7083;DP=107;AF=1.00;MQM=57;TRIO=HOM,107,1.00,HOM,83,1.00,HET,108,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-25371A>G:	AluSx1	rs9725319	0.8710	0.0000	0/0/0	0.7903										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485991	98485991	C	T	het		QUAL=2548;DP=111;AF=0.38;MQM=59;TRIO=HET,111,0.38,WT,137,0.00,HET,160,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.815-25435G>A:	AluSx1	rs74829086	0.0527	0.0000	0/0/0	0.0194										0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98486162	98486162	T	C	hom		QUAL=7636;DP=152;AF=1.00;MQM=59;TRIO=HOM,152,1.00,HOM,66,1.00,HET,73,0.36	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+25402A>G:		rs4477335	0.8710	0.0000	0/0/0	0.7882										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98486242	98486242	-	A	hom		QUAL=4611;DP=129;AF=0.95;MQM=59;TRIO=HOM,129,0.95,HOM,19,0.95,HET,23,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+25321dupT:		rs397709296	0.8678	0.0000	0/0/0	0.7504										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98486370	98486370	G	A	hom		QUAL=4995;DP=101;AF=1.00;MQM=60;TRIO=HOM,101,1.00,HOM,32,1.00,HET,42,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+25194C>T:		rs4480407	0.8928	0.0000	0/0/0	0.7799										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487333	98487333	A	G	hom		QUAL=20750;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,220,1.00,HET,282,0.57	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+24231T>C:		rs9659624	0.8710	0.0000	0/0/0	0.7909										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487510	98487510	C	A	hom		QUAL=20809;DP=390;AF=1.00;MQM=60;TRIO=HOM,390,1.00,HOM,163,1.00,HET,204,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+24054G>T:		rs5005705	0.8690	0.0000	0/0/0	0.7895										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98487566	98487566	C	T	hom		QUAL=13847;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HOM,130,0.99,HET,144,0.53	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23998G>A:		rs9324384	0.8710	0.0000	0/0/0	0.7897										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487763	98487763	G	A	hom		QUAL=18171;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,165,0.99,HET,182,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23801C>T:		rs4634961	0.8710	0.0000	0/0/0	0.7913										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487899	98487899	C	A	hom		QUAL=19922;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,232,1.00,HET,262,0.52	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23665G>T:		rs9324385	0.8710	0.0000	0/0/0	0.7913										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487959	98487959	G	A	hom		QUAL=26008;DP=377;AF=0.99;MQM=60;TRIO=HOM,377,0.99,HOM,265,1.00,HET,326,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23605C>T:		rs9324386	0.8710	0.0000	0/0/0	0.7911										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98488030	98488030	G	A	hom		QUAL=22558;DP=331;AF=1.00;MQM=60;TRIO=HOM,331,1.00,HOM,214,1.00,HET,332,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23534C>T:		rs9324387	0.8712	0.0000	0/0/0	0.7899										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98488155	98488155	G	A	hom		QUAL=17795;DP=284;AF=1.00;MQM=60;TRIO=HOM,284,1.00,HOM,169,1.00,HET,197,0.46	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+23409C>T:		rs9324388	0.8710	0.0000	0/0/0	0.7905										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98488863	98488863	A	G	hom		QUAL=16835;DP=323;AF=1.00;MQM=60;TRIO=HOM,323,1.00,HOM,126,1.00,HET,131,0.64	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22701T>C:		rs9659996	0.8710	0.0000	0/0/0	0.7595										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98488895	98488895	C	T	hom		QUAL=10423;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,101,1.00,HET,92,0.58	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22669G>A:		rs9658841	0.8710	0.0000	0/0/0	0.7566										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98489080	98489080	G	A	hom		QUAL=7306;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,26,1.00,HET,38,0.61	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22484C>T:		rs9661157	0.8710	0.0000	0/0/0	0.7711										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489277	98489277	-	TACTT	het		QUAL=6221;DP=138;AF=0.86;MQM=59;TRIO=HET,138,0.86,HOM,56,0.96,HET,88,0.34	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22286_814+22287insAAGTA:		rs142603792;rs71071680	0.8708	0.0000	0/0/0	0.7380										89	59					MIR137HG (inh=n/a pLI=n/a)
chr1	98489330	98489330	C	T	hom		QUAL=9465;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HOM,52,1.00,HET,81,0.31	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22234G>A:		rs10747496	0.8710	0.0000	0/0/0	0.7704										105	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489478	98489478	A	G	hom		QUAL=19540;DP=402;AF=1.00;MQM=60;TRIO=HOM,402,1.00,HOM,125,1.00,HET,163,0.42	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+22086T>C:		rs4584446	0.8710	0.0000	0/0/0	0.7895										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489735	98489735	T	C	hom		QUAL=14574;DP=328;AF=1.00;MQM=60;TRIO=HOM,328,1.00,HOM,57,1.00,HET,130,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+21829A>G:		rs2391905	0.8710	0.0000	0/0/0	0.7857										107	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98490012	98490013	TT	-	hom		QUAL=10563;DP=299;AF=0.92;MQM=59;TRIO=HOM,299,0.92,HOM,78,0.95,HET,95,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+21551_814+21552delAA:	L2a	rs55633609;rs58960152	0.8706	0.0000	0/0/0	0.5632										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98490165	98490165	C	T	hom		QUAL=8589;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,46,1.00,HET,73,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+21399G>A:		rs4950117	0.8940	0.0000	0/0/0	0.7923										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98490358	98490358	G	T	hom		QUAL=16004;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,155,0.99,HET,168,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+21206C>A:		rs4950118	0.8710	0.0000	0/0/0	0.7832										105	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98490636	98490636	T	C	hom		QUAL=18224;DP=371;AF=0.99;MQM=59;TRIO=HOM,371,0.99,HOM,121,1.00,HET,172,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+20928A>G:		rs10783082	0.8710	0.0000	0/0/0	0.7864										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98490770	98490770	-	TTAAGTAT	hom		QUAL=16756;DP=229;AF=0.98;MQM=59;TRIO=HOM,229,0.98,HOM,155,0.99,HET,151,0.56	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+20786_814+20793dupATACTTAA:		rs397733292	0.8710	0.0000	0/0/0	0.6869										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98491248	98491248	A	C	hom		QUAL=18353;DP=339;AF=0.99;MQM=59;TRIO=HOM,339,0.99,HOM,140,1.00,HET,192,0.45	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+20316T>G:	MIR3	rs4950119	0.8682	0.0000	0/0/0	0.7714										96	51					MIR137HG (inh=n/a pLI=n/a)
chr1	98491382	98491382	G	A	hom		QUAL=14533;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,105,1.00,HET,175,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+20182C>T:	MIRb	rs4950120	0.8710	0.0000	0/0/0	0.7898										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98491473	98491473	A	C	hom		QUAL=17739;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,116,0.99,HET,173,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+20091T>G:	MIRb	rs4245673	0.8710	0.0000	0/0/0	0.7880										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98491732	98491732	T	C	hom		QUAL=18299;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,193,1.00,HET,287,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+19832A>G:		rs1938568	0.8710	0.0000	0/0/0	0.7908										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98492462	98492462	C	T	hom		QUAL=22574;DP=421;AF=1.00;MQM=60;TRIO=HOM,421,1.00,HOM,185,0.99,HET,198,0.46	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+19102G>A:		rs9440393	0.8710	0.0000	0/0/0	0.7908										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98492580	98492580	A	G	het		QUAL=13352;DP=471;AF=0.49;MQM=60;TRIO=HET,471,0.49,HET,263,0.48,HET,285,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+18984T>C:		rs9440302	0.4575	0.0000	0/0/0	0.4788										32	85					MIR137HG (inh=n/a pLI=n/a)
chr1	98492854	98492854	T	C	hom		QUAL=16862;DP=356;AF=1.00;MQM=60;TRIO=HOM,356,1.00,HOM,95,1.00,HET,113,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+18710A>G:		rs9324389	0.8710	0.0000	0/0/0	0.7912										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98493263	98493263	A	G	hom		QUAL=13426;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,124,1.00,HET,187,0.45	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+18301T>C:		rs1938569	0.8706	0.0000	0/0/0	0.7844										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98493785	98493785	G	A	hom		QUAL=3173;DP=63;AF=0.98;MQM=60;TRIO=HOM,63,0.98,HOM,11,1.00,HET,14,0.36	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+17779C>T:		rs2022864	0.8712	0.0000	0/0/0	0.6366										105	37					MIR137HG (inh=n/a pLI=n/a)
chr1	98493789	98493789	A	G	hom		QUAL=3173;DP=63;AF=0.98;MQM=60;TRIO=HOM,63,0.98,HOM,11,1.00,HET,14,0.36	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+17775T>C:		rs2022865	0.8712	0.0000	0/0/0	0.6393										105	38					MIR137HG (inh=n/a pLI=n/a)
chr1	98494185	98494185	G	A	hom		QUAL=12898;DP=217;AF=0.99;MQM=60;TRIO=HOM,217,0.99,HOM,104,0.99,HET,153,0.55	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+17379C>T:		rs10875124	0.8710	0.0000	0/0/0	0.7126										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98494200	98494200	A	C	hom		QUAL=12349;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,97,0.99,HET,140,0.53	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+17364T>G:		rs10875125	0.8710	0.0000	0/0/0	0.7278										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98494388	98494388	-	A	hom		QUAL=7544;DP=186;AF=0.92;MQM=60;TRIO=HOM,186,0.92,HOM,48,1.00,HET,83,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+17175dupT:		rs869272703	0.8700	0.0000	0/0/0	0.7178										78	69					MIR137HG (inh=n/a pLI=n/a)
chr1	98494606	98494606	A	G	hom		QUAL=14526;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,132,1.00,HET,151,0.44	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+16958T>C:		rs1198574	0.8712	0.0000	0/0/0	0.7876										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98495513	98495513	T	C	hom		QUAL=10041;DP=153;AF=1.00;MQM=60;TRIO=HOM,153,1.00,HOM,95,1.00,HET,129,0.54	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+16051A>G:		rs1198573	0.8708	0.0000	0/0/0	0.7762										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98496512	98496512	T	-	het		QUAL=3674;DP=218;AF=0.50;MQM=60;TRIO=HET,218,0.50,HET,105,0.60,WT,145,0.03	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+15052delA:		rs377025796	0.0000	0.0000	0/0/0	0.0028										0	5					MIR137HG (inh=n/a pLI=n/a)
chr1	98497176	98497176	A	C	hom		QUAL=6040;DP=157;AF=1.00;MQM=60;TRIO=HOM,157,1.00,HOM,16,1.00,HET,15,0.67	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+14388T>G:		rs1198572	0.8441	0.0000	0/0/0	0.7421										93	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98497355	98497355	A	G	het		QUAL=773;DP=54;AF=0.50;MQM=58;TRIO=HET,54,0.50,HET,14,0.57,WT,10,0.00	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+14209T>C:		rs188465986	0.0022	0.0000	0/0/0	0.0034										0	4					MIR137HG (inh=n/a pLI=n/a)
chr1	98497672	98497672	A	G	hom		QUAL=4984;DP=120;AF=1.00;MQM=60;TRIO=HOM,120,1.00,HOM,21,1.00,HET,35,0.37	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+13892T>C:		rs1198571	0.8706	0.0000	0/0/0	0.7711										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98498898	98498898	C	A	hom		QUAL=24030;DP=426;AF=1.00;MQM=60;TRIO=HOM,426,1.00,HOM,190,1.00,HET,268,0.47	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+12666G>T:		rs1782815	0.8686	0.0000	0/0/0	0.7872										104	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98499590	98499590	A	-	het		QUAL=1528;DP=84;AF=0.57;MQM=58;TRIO=HET,84,0.57,WT,30,0.00,HET,34,0.50	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11974delT:	(AGAA)n	rs143336786	0.0000	0.0000	0/0/0	0.0058										0	7					MIR137HG (inh=n/a pLI=n/a)
chr1	98499647	98499647	G	A	het		QUAL=359;DP=69;AF=0.26;MQM=53;TRIO=HET,69,0.26,HET,17,0.18,HET,14,0.21	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11917C>T:	(AGAA)n	rs12405733	0.0000	0.0000	0/0/0	0.0157										0	92					MIR137HG (inh=n/a pLI=n/a)
chr1	98499651	98499651	G	A	het		QUAL=495;DP=80;AF=0.25;MQM=52;TRIO=HET,80,0.25,HET,18,0.44,HET,14,0.21	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11913C>T:	(AGAA)n	rs1782814	0.0000	0.0000	0/0/0	0.0060										0	26					MIR137HG (inh=n/a pLI=n/a)
chr1	98499659	98499659	G	A	het		QUAL=1926;DP=64;AF=0.80;MQM=55;TRIO=HET,64,0.80,HET,16,0.63,HET,13,0.15	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11905C>T:	(AGAA)n	rs58126792	0.0000	0.0000	0/0/0	0.0409										0	139					MIR137HG (inh=n/a pLI=n/a)
chr1	98499663	98499663	A	G	het		QUAL=1926;DP=64;AF=0.80;MQM=55;TRIO=HET,64,0.80,HET,16,0.63,HET,13,0.15	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11901T>C:	(AGAA)n	rs60475427	0.0000	0.0000	0/0/0	0.0699										1	140					MIR137HG (inh=n/a pLI=n/a)
chr1	98499843	98499843	T	C	hom		QUAL=10102;DP=168;AF=0.99;MQM=60;TRIO=HOM,168,0.99,HOM,95,1.00,HET,159,0.47	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11721A>G:		rs1782813	0.8890	0.0000	0/0/0	0.7944										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98500045	98500045	G	C	het		QUAL=6848;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,HET,133,0.44,WT,168,0.01	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+11519C>G:	UCON1	rs7554283	0.3195	0.0000	0/0/0	0.3462										15	62					MIR137HG (inh=n/a pLI=n/a)
chr1	98501011	98501011	T	C	het		QUAL=7047;DP=317;AF=0.49;MQM=60;TRIO=HET,317,0.49,HET,201,0.53,WT,249,0.00	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+10553A>G:		rs4950101	0.2772	0.0000	0/0/0	0.3019										13	59					MIR137HG (inh=n/a pLI=n/a)
chr1	98501984	98501984	T	C	hom		QUAL=13773;DP=276;AF=0.99;MQM=60;TRIO=HOM,276,0.99,HOM,84,0.99,HET,106,0.59	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+9580A>G:		rs1702294	0.8401	0.0000	0/0/0	0.7529										95	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98502159	98502159	G	C	hom		QUAL=29026;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,361,1.00,HET,439,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+9405C>G:	Tigger3a	rs1702293	0.9257	0.0000	0/0/0	0.8287										120	30					MIR137HG (inh=n/a pLI=n/a)
chr1	98502340	98502340	G	A	hom		QUAL=18817;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,231,1.00,HET,244,0.48	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+9224C>T:	Tigger3a	rs1782810	0.7967	0.0000	0/0/0	0.7526										92	55					MIR137HG (inh=n/a pLI=n/a)
chr1	98502410	98502410	A	C	hom		QUAL=21509;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,249,1.00,HET,297,0.51	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+9154T>G:	Tigger3a	rs1782811	0.9026	0.0000	0/0/0	0.7998										106	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98502594	98502594	A	C	hom		QUAL=17993;DP=242;AF=1.00;MQM=59;TRIO=HOM,242,1.00,HOM,208,1.00,HET,271,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+8970T>G:		rs1628294	0.9257	0.0000	0/0/0	0.8274										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98502934	98502934	G	T	hom		QUAL=10727;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,73,1.00,HET,107,0.37	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+8630C>A:		rs1625579	0.7969	0.0000	0/0/0	0.7290										94	53					MIR137HG (inh=n/a pLI=n/a)
chr1	98506616	98506616	-	TTCATTCA	hom		QUAL=1348;DP=80;AF=0.45;MQM=59;TRIO=HOM,80,0.45,WT,20,0.60,HET,37,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+4940_814+4947dupTGAATGAA:		rs35835879	0.0000	0.0000	0/0/0	0.0212										2	28					MIR137HG (inh=n/a pLI=n/a)
chr1	98507696	98507696	A	G	hom		QUAL=6043;DP=154;AF=0.99;MQM=60;TRIO=HOM,154,0.99,HOM,15,1.00,HET,35,0.43	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+3868T>C:		rs4292998	0.8129	0.0000	0/0/0	0.7547										94	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98507718	98507718	C	A	hom		QUAL=7191;DP=184;AF=0.99;MQM=60;TRIO=HOM,184,0.99,HOM,18,1.00,HET,38,0.45	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+3846G>T:		rs4411173	0.8896	0.0000	0/0/0	0.7927										106	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98508258	98508258	C	T	hom		QUAL=39483;DP=578;AF=1.00;MQM=59;TRIO=HOM,578,1.00,HOM,412,1.00,HET,500,0.52	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+3306G>A:		rs2802535	0.8097	0.0000	0/0/0	0.7556										94	53					MIR137HG (inh=n/a pLI=n/a)
chr1	98508488	98508488	G	A	het		QUAL=8642;DP=419;AF=0.50;MQM=60;TRIO=HET,419,0.50,WT,173,0.00,HET,196,0.56	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon3/4:n.814+3076C>T:		rs78924727	0.0527	0.0000	0/0/0	0.0321										0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98512127	98512127	G	T	hom		QUAL=32994;DP=411;AF=1.00;MQM=59;TRIO=HOM,411,1.00,HOM,412,1.00,HET,497,0.47	MIR137HG	non_coding_exon	MIR137HG:NR_046105.1:non_coding_exon:MODIFIER:exon2/5:n.373C>A:		rs2660304	0.8468	0.0000	0/0/0	0.7675										95	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98513144	98513144	T	A	hom		QUAL=13152;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HOM,116,1.00,HET,133,0.53	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon1/4:n.317-961A>T:		rs2660303	0.9259	0.0000	0/0/0	0.7861										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98513676	98513676	-	CGCA	hom		QUAL=3176;DP=48;AF=0.06;MQM=57;TRIO=HOM,48,0.06,HOM,15,0.07,HOM,84,0.01	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon1/4:n.316+1257_316+1258insTGCG:		rs150117500	0.0000	0.0000	0/0/0	0.2080										0	1					MIR137HG (inh=n/a pLI=n/a)
chr1	98513712	98513712	-	CACACACC	hom		QUAL=3176;DP=48;AF=0.06;MQM=57;TRIO=HOM,48,0.06,HOM,15,0.07,HOM,84,0.01	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon1/4:n.316+1221_316+1222insGGTGTGTG:	(CA)n		0.0000	0.0000	0/0/0	0.0007										0	0					MIR137HG (inh=n/a pLI=n/a)
chr1	98513845	98513845	G	A	hom		QUAL=13347;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,186,0.99,HET,260,0.47	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon1/4:n.316+1089C>T:		rs61786696	0.9263	0.0000	0/0/0	0.8281										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98513959	98513959	A	G	hom		QUAL=18117;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,210,1.00,HET,277,0.49	MIR137HG	intron	MIR137HG:NR_046105.1:intron:MODIFIER:exon1/4:n.316+975T>C:		rs61786697	0.9261	0.0000	0/0/0	0.8280										119	31					MIR137HG (inh=n/a pLI=n/a)
chr1	100327026	100327026	C	T	het		QUAL=12699;DP=436;AF=0.53;MQM=60;TRIO=HET,436,0.53,HET,201,0.48,HET,300,0.46	AGL	5'UTR_premature_start_codon_gain,5'UTR,intron	AGL:NM_000645.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-2C>T:,AGL:NM_000645.2:5'UTR:MODIFIER:exon1/32:c.-2C>T:,AGL:NM_000028.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000642.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000643.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000644.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000646.2:intron:MODIFIER:exon2/33:c.35-33C>T:		rs2307129	0.2272	0.1890	2368/1011/766	0.1846						610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];				54	365					AGL (inh=n/a pLI=0.00)
chr1	100336361	100336361	C	T	het		QUAL=8597;DP=341;AF=0.43;MQM=60;TRIO=HET,341,0.43,HOM,98,1.00,HET,117,0.51	AGL	synonymous	AGL:NM_000028.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000642.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000643.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000644.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000646.2:synonymous:LOW:exon7/34:c.846C>T:p.Leu282Leu,AGL:NM_000645.2:synonymous:LOW:exon5/32:c.843C>T:p.Leu281Leu		rs2230306	0.7626	0.7220	31587/16316/4105	0.7110						610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];	RCV000179774.1 [benign]; 			576	454					AGL (inh=n/a pLI=0.00)
chr1	100358103	100358103	C	T	het	phylop_high;pred_pathogenic_1	QUAL=8351;DP=249;AF=0.49;MQM=60;TRIO=HET,249,0.49,HET,182,0.47,HET,223,0.51	AGL	missense	AGL:NM_000028.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000642.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000643.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000644.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000646.2:missense:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser,AGL:NM_000645.2:missense:MODERATE:exon22/32:c.3148C>T:p.Pro1050Ser		rs3753494	0.1106	0.1360	1249/817/71	0.1324	7.2300	T	D,D,D,D,D,D,D	B,B,B	B,B,B	610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];				34	310					AGL (inh=n/a pLI=0.00)
chr1	100387939	100387939	C	T	het		QUAL=4269;DP=172;AF=0.48;MQM=59;TRIO=HET,172,0.48,HOM,41,1.00,HET,53,0.45	AGL	3'UTR	AGL:NM_000028.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000642.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000643.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000644.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000646.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000645.2:3'UTR:MODIFIER:exon32/32:c.*732C>T:		rs3766600	0.5905	0.0000	0/0/0	0.1231										89	109					AGL (inh=n/a pLI=0.00)
chr1	100654908	100654908	A	-	het		QUAL=1042;DP=44;AF=0.27;MQM=56;TRIO=HET,44,0.80,WT,7,0.71,HOM,1,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6903delT:	AluSz	rs774983659	0.0000	0.0000	0/0/0	0.2479										9	93					DBT (inh=AR pLI=0.00)
chr1	100654908	100654908	A	T	het		QUAL=1042;DP=44;AF=0.27;MQM=59;TRIO=HET,44,0.80,HOM,7,0.71,WT,1,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6903T>A:	AluSz	rs10783125	0.9339	0.0000	0/0/0	0.1954										54	124					DBT (inh=AR pLI=0.00)
chr1	100654909	100654909	A	T	het		QUAL=1042;DP=44;AF=0.27;MQM=56;TRIO=HET,44,0.80,WT,7,0.71,HOM,1,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6902T>A:	AluSz	rs200943386	0.0000	0.0000	0/0/0	0.0172										9	93					DBT (inh=AR pLI=0.00)
chr1	100655583	100655583	T	A	hom		QUAL=4243;DP=101;AF=1.00;MQM=59;TRIO=HOM,101,1.00,HOM,15,1.00,HOM,13,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6228A>T:	MER3	rs4281338	0.7668	0.0000	0/0/0	0.7349										155	50					DBT (inh=AR pLI=0.00)
chr1	100655696	100655697	AA	-	het		QUAL=3391;DP=182;AF=0.48;MQM=59;TRIO=HET,182,0.48,WT,57,0.02,HET,89,0.65	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6114_*6115delTT:	MLT1J2	rs3081711	0.0000	0.0000	0/0/0	0.1587										12	70					DBT (inh=AR pLI=0.00)
chr1	100656265	100656265	C	T	hom		QUAL=13997;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HOM,106,1.00,HOM,140,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*5546G>A:		rs11166412	0.8007	0.0000	0/0/0	0.8565										174	52					DBT (inh=AR pLI=0.00)
chr1	100656661	100656661	T	C	hom		QUAL=24018;DP=361;AF=1.00;MQM=60;TRIO=HOM,361,1.00,HOM,156,1.00,HOM,208,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*5150A>G:		rs6701655	0.7696	0.0000	0/0/0	0.8410										166	59					DBT (inh=AR pLI=0.00)
chr1	100657305	100657305	T	C	hom	low_DP	QUAL=2968;DP=17;AF=0.06;MQM=51;TRIO=HOM,17,0.88,WT,39,0.97,WT,54,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*4506A>G:		rs112901689	0.7816	0.0000	0/0/0	0.1982										122	44					DBT (inh=AR pLI=0.00)
chr1	100658578	100658578	G	A	hom		QUAL=34963;DP=348;AF=0.98;MQM=59;TRIO=HOM,348,0.98,HOM,323,1.00,HOM,478,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*3233C>T:		rs2784174	0.7696	0.0000	0/0/0	0.8374										165	60					DBT (inh=AR pLI=0.00)
chr1	100672060	100672060	T	C	hom	phylop_high;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=28958;DP=345;AF=1.00;MQM=60;TRIO=HOM,345,1.00,HOM,246,1.00,HOM,301,1.00	DBT	missense	DBT:NM_001918.3:missense:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly		rs12021720	0.8918	0.9140	50877/27619/3051	0.8594	1.9050	T	T,T	B	B	248610 [DBT (confirmed) Maple syrup urine disease,type II];	RCV000012727.23 [pathogenic]; RCV000116865.5 [other]; 	CM983430 [CLASS=DM? MUT=REF PHEN="Maple syrup urine disease" GENE=DBT]; 		898	188	2	[2] old entry - no details available			DBT (inh=AR pLI=0.00)
chr1	109771063	109771063	T	C	hom		QUAL=21662;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,203,1.00,HOM,230,1.00	SARS	splice_region&intron	SARS:NM_006513.3:splice_region&intron:LOW:exon3/10:c.288+9T>C:		rs683182	0.6799	0.7570	35558/21327/1142	0.7545									COSM3747470, COSM3747471	420	227					SARS (inh=n/a pLI=1.00)
chr1	110709719	110709719	T	C	het		QUAL=18596;DP=267;AF=0.44;MQM=59;TRIO=HET,267,0.45,HET,333,0.54,HOM,387,1.00	SLC6A17	synonymous	SLC6A17:NM_001010898.2:synonymous:LOW:exon2/12:c.168T>C:p.Asp56Asp		rs7527375	0.3930	0.4570	12998/8876/1288	0.4280						610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48];				195	350					SLC6A17 (inh=n/a pLI=0.96)
chr1	110709720	110709720	G	A	het		QUAL=18596;DP=267;AF=0.44;MQM=59;TRIO=HET,267,0.45,WT,333,0.54,HOM,387,1.00	SLC6A17	missense	SLC6A17:NM_001010898.2:missense:MODERATE:exon2/12:c.169G>A:p.Ala57Thr		rs12737742	0.2502	0.3710	8912/6485/50	0.3483	0.5380	T	T,T	B	B	610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48];				147	345					SLC6A17 (inh=n/a pLI=0.96)
chr1	110738296	110738296	G	A	het		QUAL=16245;DP=299;AF=0.50;MQM=59;TRIO=HET,299,0.50,HET,383,0.53,HET,544,0.53	SLC6A17	synonymous	SLC6A17:NM_001010898.2:synonymous:LOW:exon10/12:c.1581G>A:p.Ser527Ser		rs2784140	0.2897	0.4140	11537/8339/52	0.4097						610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48];			COSM146574	131	321					SLC6A17 (inh=n/a pLI=0.96)
chr1	110741081	110741081	C	G	het		QUAL=2579;DP=145;AF=0.50;MQM=59;TRIO=HET,145,0.50,HET,120,0.35,WT,160,0.01	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*15C>G:		rs2761446	0.0170	0.0370	108/93/0	0.0354										3	33					SLC6A17 (inh=n/a pLI=0.96)
chr1	110741349	110741349	G	T	het		QUAL=17284;DP=384;AF=0.47;MQM=59;TRIO=HET,384,0.47,HOM,273,1.00,HET,332,0.57	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*283G>T:		rs2603580	0.5425	0.0000	0/0/0	0.0967										72	111					SLC6A17 (inh=n/a pLI=0.96)
chr1	110741583	110741583	C	G	het		QUAL=10073;DP=175;AF=0.38;MQM=59;TRIO=HET,175,0.38,HOM,177,1.00,HET,214,0.52	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*517C>G:		rs2784141	0.5447	0.0000	0/0/0	0.0967										72	111					SLC6A17 (inh=n/a pLI=0.96)
chr1	110742085	110742085	T	C	het		QUAL=27307;DP=287;AF=0.44;MQM=59;TRIO=HET,287,0.44,HOM,500,1.00,HET,681,0.49	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1019T>C:		rs2603579	0.5449	0.0000	0/0/0	0.5684										72	110					SLC6A17 (inh=n/a pLI=0.96)
chr1	110742502	110742502	A	G	het		QUAL=1540;DP=177;AF=0.31;MQM=58;TRIO=HET,177,0.31,HET,83,0.24,HET,104,0.26	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1436A>G:	(GATG)n	rs2361044	0.2883	0.0000	0/0/0	0.2934										42	87					SLC6A17 (inh=n/a pLI=0.96)
chr1	110742615	110742615	A	G	het		QUAL=2501;DP=127;AF=0.42;MQM=60;TRIO=HET,127,0.42,HET,70,0.34,HET,105,0.44	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1549A>G:	GA-rich	rs12133992	0.2867	0.0000	0/0/0	0.3792										37	92					SLC6A17 (inh=n/a pLI=0.96)
chr1	110742992	110742992	T	G	het		QUAL=7256;DP=180;AF=0.51;MQM=59;TRIO=HET,180,0.51,HET,182,0.52,HET,269,0.45	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1926T>G:		rs2784142	0.3079	0.0000	0/0/0	0.4179										43	108					SLC6A17 (inh=n/a pLI=0.96)
chr1	110743588	110743588	G	C	het		QUAL=8345;DP=167;AF=0.53;MQM=60;TRIO=HET,167,0.53,WT,389,0.00,HET,473,0.52	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*2522G>C:		rs151008748	0.0132	0.0000	0/0/0	0.0028										1	9					SLC6A17 (inh=n/a pLI=0.96)
chr1	115259401	115259401	C	T	het		QUAL=3853;DP=190;AF=0.60;MQM=59;TRIO=HET,190,0.60,WT,118,0.00,HET,138,0.38	NRAS	5'UTR	NRAS:NM_002524.4:5'UTR:MODIFIER:exon1/7:c.-140G>A:			0.0000	0.0000	0/0/0	0.0000										0	1					NRAS (inh=n/a pLI=0.91)
chr1	115576023	115576023	A	G	hom	anno_pathogenic_hgmd	QUAL=17910;DP=260;AF=1.00;MQM=59;TRIO=HOM,260,1.00,HOM,135,1.00,HOM,149,1.00	TSHB	missense	TSHB:NM_000549.4:missense:MODERATE:exon2/3:c.40A>G:p.Thr14Ala		rs10776792	0.9836	0.9710	57192/31035/5156	0.9401	0.2240	T	T,T	B	B	188540 [TSHB (confirmed) Hypothryoidism,congenital,nongoitrous 4];		CM991218 [CLASS=DM? MUT=REF PHEN="Hypothyroidism" GENE=TSHB]; 		1035	69	2	[2] Peter Bauer 25.08.2014			TSHB (inh=AR pLI=0.01)
chr1	115829313	115829313	G	A	hom	phylop_high;pred_pathogenic_1	QUAL=20368;DP=190;AF=0.99;MQM=60;TRIO=HOM,190,0.99,HET,277,0.51,HOM,390,0.99	NGF	missense	NGF:NM_002506.2:missense:MODERATE:exon3/3:c.104C>T:p.Ala35Val		rs6330	0.2474	0.3650	8859/6583/196	0.3653	2.2980	T	D	B	B	162030 [NGF (confirmed) Neuropathy,hereditary sensory and autonomic,type V];		CM086294 [CLASS=DFP MUT=REF PHEN="Anxiety-related traits gender-dependent association with" GENE=NGF]; 	COSM3735921	179	522					NGF (inh=n/a pLI=0.70)
chr1	119965519	119965519	C	T	het		QUAL=10741;DP=468;AF=0.54;MQM=59;TRIO=HET,468,0.54,WT,297,0.00,HET,354,0.41	HSD3B2	3'UTR	HSD3B2:NM_000198.3:3'UTR:MODIFIER:exon4/4:c.*276C>T:,HSD3B2:NM_001166120.1:3'UTR:MODIFIER:exon4/4:c.*276C>T:		rs1819698	0.3101	0.0000	0/0/0	0.0342						613890 [HSD3B2 (confirmed) 3-beta-hydroxysteroid dehydrogenase,type II,deficiency];				6	52					HSD3B2 (inh=n/a pLI=0.00)
chr1	119965564	119965564	C	G	het		QUAL=10623;DP=436;AF=0.55;MQM=60;TRIO=HET,436,0.55,WT,291,0.00,HET,356,0.42	HSD3B2	3'UTR	HSD3B2:NM_000198.3:3'UTR:MODIFIER:exon4/4:c.*321C>G:,HSD3B2:NM_001166120.1:3'UTR:MODIFIER:exon4/4:c.*321C>G:		rs1361530	0.2560	0.0000	0/0/0	0.0311						613890 [HSD3B2 (confirmed) 3-beta-hydroxysteroid dehydrogenase,type II,deficiency];				5	50					HSD3B2 (inh=n/a pLI=0.00)
chr1	147228874	147228874	C	T	het		QUAL=6217;DP=268;AF=0.51;MQM=60;TRIO=HET,268,0.51,HET,193,0.54,WT,301,0.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*1396G>A:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*1396G>A:		rs11240121	0.4073	0.0000	0/0/0	0.0510										19	88					GJA5 (inh=n/a pLI=0.10)
chr1	147229299	147229299	G	A	hom		QUAL=12825;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,133,1.00,HET,162,0.50	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*971C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*971C>T:		rs1043806	0.8662	0.0000	0/0/0	0.1397										151	69					GJA5 (inh=n/a pLI=0.10)
chr1	147229382	147229382	G	A	hom		QUAL=22626;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HOM,196,1.00,HOM,277,1.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*888C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*888C>T:		rs10900395	0.9886	0.0000	0/0/0	0.1492										230	0					GJA5 (inh=n/a pLI=0.10)
chr1	147229563	147229563	G	A	het		QUAL=7586;DP=356;AF=0.43;MQM=60;TRIO=HET,356,0.43,HET,317,0.48,WT,383,0.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*707C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*707C>T:		rs1043802	0.3191	0.0000	0/0/0	0.0410										16	85					GJA5 (inh=n/a pLI=0.10)
chr1	147229628	147229628	-	GGGCATTTGCCAGAGGTACATACCA	het		QUAL=11474;DP=217;AF=0.27;MQM=59;TRIO=HET,217,0.27,HET,287,0.45,HET,373,0.49	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*617_*641dupTGGTATGTACCTCTGGCAAATGCCC:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*617_*641dupTGGTATGTACCTCTGGCAAATGCCC:		rs371724095	0.4667	0.0000	0/0/0	0.2850										71	96					GJA5 (inh=n/a pLI=0.10)
chr1	147230217	147230217	T	C	hom		QUAL=19860;DP=325;AF=1.00;MQM=59;TRIO=HOM,325,1.00,HOM,192,0.99,HET,233,0.54	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*53A>G:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*53A>G:		rs1692141	0.8804	0.0000	0/0/0	0.1667										220	89					GJA5 (inh=n/a pLI=0.10)
chr1	147245474	147245474	G	C	hom		QUAL=20888;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,184,1.00,HOM,278,1.00	GJA5-GJA8	intergenic_region	GJA5-GJA8:GJA5-GJA8:intergenic_region:MODIFIER::n.147245474G>C:		rs791286	0.9748	0.0000	0/0/0	0.8714										229	1					GJA5-GJA8 (inh=n/a pLI=n/a)
chr1	150771703	150771703	T	C	hom		QUAL=35017;DP=355;AF=1.00;MQM=60;TRIO=HOM,355,1.00,HOM,341,1.00,HOM,363,1.00	CTSK	synonymous	CTSK:NM_000396.3:synonymous:LOW:exon7/8:c.831A>G:p.Ala277Ala		rs10788796	0.9633	0.9890	59361/33273/4455	0.9513						601105 [CTSK (provisional) Pycnodysostosis];				1099	8					CTSK (inh=n/a pLI=0.00)
chr1	151313774	151313774	A	G	het		QUAL=6544;DP=286;AF=0.48;MQM=59;TRIO=HET,286,0.48,HOM,90,1.00,WT,137,0.01	RFX5	3'UTR	RFX5:NM_000449.3:3'UTR:MODIFIER:exon11/11:c.*888T>C:,RFX5:NM_001025603.1:3'UTR:MODIFIER:exon11/11:c.*888T>C:		rs7552906	0.6280	0.0000	0/0/0	0.1066										96	114					RFX5 (inh=n/a pLI=0.00)
chr1	151314379	151314379	T	C	het		QUAL=8286;DP=200;AF=0.56;MQM=60;TRIO=HET,200,0.56,HOM,113,1.00,HET,157,0.47	RFX5	3'UTR	RFX5:NM_000449.3:3'UTR:MODIFIER:exon11/11:c.*283A>G:,RFX5:NM_001025603.1:3'UTR:MODIFIER:exon11/11:c.*283A>G:	MLT1K	rs1752387	0.7644	0.0000	0/0/0	0.0919										131	66					RFX5 (inh=n/a pLI=0.00)
chr1	151315287	151315287	G	C	het	phylop_high;pred_pathogenic_1	QUAL=3266;DP=123;AF=0.50;MQM=59;TRIO=HET,123,0.50,HET,139,0.50,WT,187,0.00	RFX5	missense	RFX5:NM_000449.3:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg,RFX5:NM_001025603.1:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg		rs2233854	0.0635	0.1190	1090/898/5	0.1190	1.7460	T	D,D,D,D,D	B,P	B,B	601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C|Bare lymphocyte syndrome,type II,complementation group E];			COSM3750354	29	274					RFX5 (inh=n/a pLI=0.00)
chr1	151316161	151316161	G	A	hom		QUAL=13269;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,93,1.00,HOM,132,1.00	RFX5	synonymous	RFX5:NM_000449.3:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu,RFX5:NM_001025603.1:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu		rs1752386	0.9780	0.9930	59713/33243/4434	0.9320						601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C|Bare lymphocyte syndrome,type II,complementation group E];				1106	1					RFX5 (inh=n/a pLI=0.00)
chr1	152274685	152274685	T	A	hom		QUAL=8578;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HOM,63,1.00,HOM,107,1.00	FLG	3'UTR	FLG:NM_002016.1:3'UTR:MODIFIER:exon3/3:c.*491A>T:		rs1933061	0.9994	0.0000	0/0/0	0.1761										227	2					FLG (inh=n/a pLI=n/a)
chr1	152276149	152276149	C	T	het		QUAL=45774;DP=518;AF=0.52;MQM=58;TRIO=HET,518,0.52,HET,1333,0.51,HET,1859,0.52	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.11213G>A:p.Arg3738His		rs77422831	0.2869	0.2290	4735/817/4	0.2111	-2.2530	T	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996928	33	221					FLG (inh=n/a pLI=n/a)
chr1	152276626	152276626	G	C	het	low_MQM	QUAL=9260;DP=471;AF=0.18;MQM=36;TRIO=HET,471,0.18,HET,823,0.22,HOM,338,0.98	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg		rs3126075	0.4778	0.0770	1683/83/1243	0.0751	-5.4480	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142671	47	111					FLG (inh=n/a pLI=n/a)
chr1	152276699	152276699	A	G	het	low_MQM	QUAL=13578;DP=561;AF=0.32;MQM=38;TRIO=HET,561,0.32,HET,979,0.21,HET,623,0.59	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg		rs12728605	0.0000	0.1900	11/3/0	0.0065	-1.1810	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142674	2	187					FLG (inh=n/a pLI=n/a)
chr1	152276772	152276772	C	A	het	pred_pathogenic_2	QUAL=31885;DP=429;AF=0.43;MQM=56;TRIO=HET,429,0.43,HET,1167,0.44,HET,725,0.80	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser		rs72697000	0.2905	0.2340	5402/1033/6	0.2047	-5.0060	T	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996929	27	230					FLG (inh=n/a pLI=n/a)
chr1	152276871	152276871	A	G	het		QUAL=38354;DP=539;AF=0.40;MQM=58;TRIO=HET,539,0.40,HET,1133,0.47,HOM,643,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10491T>C:p.Asp3497Asp		rs3126066	0.4471	0.2780	6890/1057/1209	0.2535						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996930	46	223					FLG (inh=n/a pLI=n/a)
chr1	152276889	152276889	A	G	het		QUAL=37876;DP=537;AF=0.40;MQM=58;TRIO=HET,537,0.40,HET,1146,0.46,HOM,633,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10473T>C:p.Asn3491Asn		rs3126067	0.5226	0.3010	8467/1093/2670	0.2726						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996931	52	225					FLG (inh=n/a pLI=n/a)
chr1	152277055	152277055	C	G	het		QUAL=26512;DP=469;AF=0.40;MQM=53;TRIO=HET,469,0.40,HET,892,0.44,HET,613,0.79	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala		rs2065955	0.5142	0.2990	8272/1051/2636	0.2665	-0.5970	T	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142675	32	245					FLG (inh=n/a pLI=n/a)
chr1	152277168	152277168	A	G	het		QUAL=46973;DP=514;AF=0.45;MQM=51;TRIO=HET,514,0.45,HET,1099,0.47,HOM,959,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10194T>C:p.Ser3398Ser		rs77811823	0.4736	0.2840	7123/1067/1406	0.2597						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996932	46	239					FLG (inh=n/a pLI=n/a)
chr1	152277345	152277345	C	T	het		QUAL=47107;DP=556;AF=0.46;MQM=58;TRIO=HET,556,0.46,HET,1341,0.48,HET,1992,0.48	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10017G>A:p.Gln3339Gln		rs2065956	0.2875	0.2290	4811/838/4	0.2121						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996933	34	219					FLG (inh=n/a pLI=n/a)
chr1	152277396	152277396	T	C	het		QUAL=80878;DP=522;AF=0.45;MQM=58;TRIO=HET,522,0.45,HET,1289,0.49,HOM,1872,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9966A>G:p.Gln3322Gln		rs6681433	0.3411	0.2610	5728/1092/77	0.2421						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				41	237					FLG (inh=n/a pLI=n/a)
chr1	152277717	152277717	C	A	het	low_MQM	QUAL=42828;DP=273;AF=0.31;MQM=48;TRIO=HET,273,0.31,HET,975,0.40,HOM,1117,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9645G>T:p.Val3215Val		rs9436066	0.4696	0.2990	7303/1113/1196	0.0247						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				47	213					FLG (inh=n/a pLI=n/a)
chr1	152277822	152277822	T	C	het	low_MQM	QUAL=11953;DP=325;AF=0.17;MQM=38;TRIO=HET,325,0.17,HET,814,0.19,HOM,400,0.98	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9540A>G:p.Ser3180Ser		rs3126069	0.2238	0.0970	2823/434/32	0.0902						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				31	87					FLG (inh=n/a pLI=n/a)
chr1	152277826	152277826	A	C	het	low_MQM	QUAL=11953;DP=325;AF=0.17;MQM=38;TRIO=HET,325,0.17,HET,814,0.19,HOM,400,0.98	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly		rs2065957	0.3936	0.1370	4141/444/1188	0.1313	-0.6040	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				38	95					FLG (inh=n/a pLI=n/a)
chr1	152278434	152278434	T	G	het	low_MQM	QUAL=2785;DP=449;AF=0.24;MQM=39;TRIO=HET,449,0.24,HET,492,0.25,WT,552,0.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp		rs61816760	0.2873	0.2880	129/24/98	0.0132	-1.3040	T	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3801882	12	319					FLG (inh=n/a pLI=n/a)
chr1	152278555	152278555	T	C	het	low_MQM	QUAL=26984;DP=450;AF=0.26;MQM=45;TRIO=HET,450,0.26,HET,1314,0.25,HET,1616,0.50	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly		rs80221306	0.0000	0.2080	4/0/3	0.0073	-0.3860	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM1317676	0	249					FLG (inh=n/a pLI=n/a)
chr1	152278689	152278689	C	A	het		QUAL=144558;DP=681;AF=0.55;MQM=50;TRIO=HET,681,0.55,HET,2485,0.54,HOM,3301,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.8673G>T:p.Val2891Val		rs57672167	0.3964	0.2690	6196/1077/556	0.2319						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				49	238					FLG (inh=n/a pLI=n/a)
chr1	152278856	152278856	T	G	het		QUAL=16438;DP=845;AF=0.22;MQM=50;TRIO=HET,845,0.22,HET,2636,0.21,HET,3913,0.18	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg		rs11582087	0.0000	0.1880	0/0/0	0.0053		T	T,T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	207					FLG (inh=n/a pLI=n/a)
chr1	152279019	152279019	G	A	het	low_MQM	QUAL=8430;DP=994;AF=0.16;MQM=35;TRIO=HET,994,0.16,HET,2438,0.19,HET,4119,0.17	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.8343C>T:p.Asp2781Asp		rs57670307	0.0000	0.1820	0/0/0	0.0037						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM1319976	0	161					FLG (inh=n/a pLI=n/a)
chr1	152279729	152279729	C	T	het		QUAL=70999;DP=577;AF=0.46;MQM=58;TRIO=HET,577,0.46,HET,1198,0.53,HOM,1550,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg		rs3126072	0.4748	0.2970	7255/1075/1480	0.2769	-0.2430	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996934	48	247					FLG (inh=n/a pLI=n/a)
chr1	152279841	152279841	G	C	het		QUAL=72444;DP=483;AF=0.47;MQM=58;TRIO=HET,483,0.47,HET,1197,0.52,HOM,1580,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7521C>G:p.His2507Gln		rs3126074	0.4623	0.2940	6970/1076/1209	0.2657	-7.9550	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				46	246					FLG (inh=n/a pLI=n/a)
chr1	152279920	152279920	A	G	het		QUAL=75412;DP=461;AF=0.49;MQM=59;TRIO=HET,461,0.49,HET,1216,0.53,HOM,1664,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser		rs55650366	0.3425	0.2610	5666/1064/88	0.2342	-1.3450	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996935	42	240					FLG (inh=n/a pLI=n/a)
chr1	152280032	152280032	T	C	het		QUAL=82464;DP=556;AF=0.47;MQM=58;TRIO=HET,556,0.47,HET,1332,0.51,HOM,1836,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu		rs71625200	0.3431	0.2610	5660/1063/88	0.2414	-0.8890	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996936	43	239					FLG (inh=n/a pLI=n/a)
chr1	152280170	152280170	C	G	het	low_MQM	QUAL=56531;DP=457;AF=0.45;MQM=47;TRIO=HET,457,0.45,HET,1167,0.44,HOM,1442,0.97	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln		rs71625201	0.3305	0.2580	5456/1036/72	0.2275	-1.3100	T	T,T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996937	27	249					FLG (inh=n/a pLI=n/a)
chr1	152280265	152280265	C	G	het	low_MQM;pred_pathogenic_3	QUAL=35095;DP=506;AF=0.39;MQM=38;TRIO=HET,506,0.39,HET,1102,0.31,HET,1088,0.86	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr		rs71625202	0.0000	0.2060	197/29/0	0.0158	0.0300	T	D,D	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3747555	7	225					FLG (inh=n/a pLI=n/a)
chr1	152280347	152280347	C	T	het	low_MQM;phylop_high;pred_pathogenic_3	QUAL=30219;DP=475;AF=0.35;MQM=37;TRIO=HET,475,0.35,HET,1162,0.29,HET,1021,0.79	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn		rs139476473	0.0000	0.1410	30/15/0	0.0083	1.6910	T	D,T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM146618	2	159					FLG (inh=n/a pLI=n/a)
chr1	152280372	152280372	G	A	het	low_MQM	QUAL=41242;DP=518;AF=0.49;MQM=36;TRIO=HET,518,0.49,HET,1128,0.35,HOM,1040,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6990C>T:p.His2330His		rs6664985	0.4535	0.2780	6451/965/1061	0.0258						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996938	43	171					FLG (inh=n/a pLI=n/a)
chr1	152280471	152280471	C	G	het	low_MQM	QUAL=10449;DP=683;AF=0.26;MQM=37;TRIO=HET,683,0.26,HET,1352,0.13,HET,1878,0.29	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp		rs78179835	0.0000	0.2080	23/0/23	0.0064	-0.9250	T	T,T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142679	1	246					FLG (inh=n/a pLI=n/a)
chr1	152280736	152280736	T	C	het		QUAL=22837;DP=802;AF=0.31;MQM=53;TRIO=HET,802,0.31,HET,1509,0.18,HET,2389,0.33	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6626A>G:p.His2209Arg		rs66977240	0.0000	0.2350	1/0/1	0.0039	-5.2630	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142690	0	254					FLG (inh=n/a pLI=n/a)
chr1	152280759	152280759	A	G	het		QUAL=35982;DP=882;AF=0.34;MQM=53;TRIO=HET,882,0.34,HET,1570,0.23,HET,2678,0.40	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6603T>C:p.Asp2201Asp		rs2338554	0.3672	0.2410	650/0/643	0.0189						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142691	1	279					FLG (inh=n/a pLI=n/a)
chr1	152280782	152280782	A	G	het		QUAL=131894;DP=889;AF=0.65;MQM=56;TRIO=HET,889,0.65,HET,1662,0.63,HOM,2800,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His		rs2184953	0.5397	0.3170	8529/1108/2650	0.3030	-2.7490	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3927615	54	247					FLG (inh=n/a pLI=n/a)
chr1	152280788	152280788	T	G	het		QUAL=71910;DP=898;AF=0.32;MQM=54;TRIO=HET,898,0.32,HET,1669,0.27,HET,2840,0.73	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln		rs66954353	0.0000	0.2370	61/14/1	0.0070	0.2450	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	283					FLG (inh=n/a pLI=n/a)
chr1	152280864	152280864	A	G	het		QUAL=112174;DP=520;AF=0.61;MQM=54;TRIO=HET,520,0.61,HET,1525,0.66,HOM,2569,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6498T>C:p.Ser2166Ser		rs75034106	0.4637	0.2940	6956/1068/1210	0.2781						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				47	245					FLG (inh=n/a pLI=n/a)
chr1	152280900	152280900	T	G	het		QUAL=31668;DP=707;AF=0.31;MQM=51;TRIO=HET,707,0.31,HET,1482,0.31,HET,2359,0.35	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6462A>C:p.Gln2154His		rs74129452	0.3439	0.2370	0/0/0	0.0172	-3.3340	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	280					FLG (inh=n/a pLI=n/a)
chr1	152281007	152281007	A	G	het		QUAL=28960;DP=826;AF=0.28;MQM=59;TRIO=HET,826,0.28,HET,1589,0.30,HET,2308,0.30	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His		rs7512553	0.3277	0.2210	0/0/0	0.0157	0.1210	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	264					FLG (inh=n/a pLI=n/a)
chr1	152281008	152281008	A	G	het		QUAL=28960;DP=826;AF=0.28;MQM=59;TRIO=HET,826,0.28,HET,1589,0.30,HET,2308,0.30	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6354T>C:p.His2118His		rs7512554	0.3277	0.2210	0/0/0	0.0158						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	263					FLG (inh=n/a pLI=n/a)
chr1	152281039	152281039	G	A	het		QUAL=33474;DP=956;AF=0.30;MQM=59;TRIO=HET,956,0.30,HET,1656,0.33,HET,2398,0.32	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val		rs7522925	0.0000	0.2210	0/0/0	0.0093	-3.7960	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142692	0	268					FLG (inh=n/a pLI=n/a)
chr1	152281228	152281228	C	G	het		QUAL=38205;DP=742;AF=0.26;MQM=53;TRIO=HET,742,0.26,HET,1969,0.35,HET,2615,0.33	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr		rs7546186	0.0000	0.2190	1/1/0	0.0067	1.5140	T	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	254					FLG (inh=n/a pLI=n/a)
chr1	152281290	152281290	A	G	het		QUAL=35643;DP=692;AF=0.23;MQM=50;TRIO=HET,692,0.23,HET,1998,0.34,HET,2597,0.33	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6072T>C:p.His2024His		rs80353812	0.3281	0.2200	0/0/0	0.0142						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142693	0	249					FLG (inh=n/a pLI=n/a)
chr1	152281304	152281304	A	C	het	pred_pathogenic_2	QUAL=37065;DP=691;AF=0.27;MQM=51;TRIO=HET,691,0.27,HET,1972,0.33,HET,2612,0.33	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala		rs7512857	0.0000	0.2180	0/0/0	0.0040	0.3910	T	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142694	0	260					FLG (inh=n/a pLI=n/a)
chr1	152281479	152281479	G	T	het		QUAL=106048;DP=894;AF=0.59;MQM=56;TRIO=HET,894,0.59,HET,1623,0.68,HOM,2002,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5883C>A:p.His1961Gln		rs3126079	0.5381	0.3170	8527/1116/2651	0.3045	-4.7080	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142695	54	251					FLG (inh=n/a pLI=n/a)
chr1	152281523	152281523	A	C	het	low_MQM	QUAL=20209;DP=835;AF=0.19;MQM=48;TRIO=HET,835,0.19,HET,1559,0.30,HET,1842,0.29	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly		rs80059102	0.0000	0.2200	0/0/0	0.0022	-0.5530	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	244					FLG (inh=n/a pLI=n/a)
chr1	152281534	152281534	A	T	het	low_MQM	QUAL=17162;DP=765;AF=0.18;MQM=48;TRIO=HET,765,0.18,HET,1518,0.28,HET,1786,0.28	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5828T>A:p.Leu1943His		rs113544881	0.3135	0.2150	1/0/0	0.0117	-2.7300	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	212					FLG (inh=n/a pLI=n/a)
chr1	152281690	152281690	C	T	het		QUAL=41373;DP=548;AF=0.48;MQM=59;TRIO=HET,548,0.48,HET,1176,0.51,HET,1373,0.53	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln		rs12407748	0.2875	0.2290	4730/821/4	0.2177	-4.0060	T	T,T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996939	29	228					FLG (inh=n/a pLI=n/a)
chr1	152281948	152281948	G	A	het	pred_pathogenic_2	QUAL=37411;DP=471;AF=0.48;MQM=58;TRIO=HET,471,0.48,HET,1123,0.51,HET,1995,0.38	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val		rs12405241	0.2875	0.2290	4747/824/4	0.2118	-5.6230	T	T,T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996940	34	220					FLG (inh=n/a pLI=n/a)
chr1	152282267	152282267	G	A	het	pred_pathogenic_3	QUAL=36513;DP=436;AF=0.46;MQM=59;TRIO=HET,436,0.46,HET,1239,0.48,HET,1533,0.49	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys		rs12405278	0.2877	0.2290	4748/823/4	0.2209	0.1370	T	D	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996941	34	219					FLG (inh=n/a pLI=n/a)
chr1	152282311	152282311	C	T	het	pred_pathogenic_2	QUAL=39336;DP=526;AF=0.46;MQM=59;TRIO=HET,526,0.46,HET,1241,0.48,HET,1517,0.51	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5051G>A:p.Arg1684His		rs12407807	0.2967	0.2320	4772/823/25	0.2241	-2.4830	T	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				34	223					FLG (inh=n/a pLI=n/a)
chr1	152282917	152282917	G	T	het	pred_pathogenic_1	QUAL=38140;DP=490;AF=0.50;MQM=59;TRIO=HET,490,0.50,HET,1078,0.49,HET,1524,0.50	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr		rs11204978	0.2871	0.2290	4739/822/4	0.2208	0.2470	T	D	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996942	33	220					FLG (inh=n/a pLI=n/a)
chr1	152283236	152283236	T	C	het		QUAL=75862;DP=528;AF=0.48;MQM=55;TRIO=HET,528,0.48,HET,1310,0.49,HOM,1682,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly		rs11581433	0.3431	0.2610	5670/1074/84	0.0395	-2.3740	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				42	243					FLG (inh=n/a pLI=n/a)
chr1	152283283	152283283	C	T	het		QUAL=39991;DP=525;AF=0.48;MQM=53;TRIO=HET,525,0.48,HET,1249,0.50,HET,1663,0.49	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4079G>A:p.Arg1360His		rs11586631	0.2877	0.2290	4733/821/5	0.2194	-6.3060	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142696	33	225					FLG (inh=n/a pLI=n/a)
chr1	152283862	152283862	G	C	het		QUAL=61859;DP=539;AF=0.49;MQM=54;TRIO=HET,539,0.49,HET,1071,0.48,HOM,1395,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly		rs58001094	0.5341	0.3060	7080/917/2165	0.2837		T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM1600315	36	264					FLG (inh=n/a pLI=n/a)
chr1	152283975	152283975	A	G	het		QUAL=72530;DP=573;AF=0.50;MQM=52;TRIO=HET,573,0.50,HET,1176,0.49,HOM,1637,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.3387T>C:p.Ser1129Ser		rs66831674	0.4631	0.2940	6959/1082/1208	0.2818						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996943	46	246					FLG (inh=n/a pLI=n/a)
chr1	152284377	152284377	G	A	het		QUAL=30395;DP=584;AF=0.53;MQM=55;TRIO=HET,584,0.53,WT,1297,0.00,HET,1614,0.55	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.2985C>T:p.His995His		rs373872833	0.0000	0.0001	0/0/0	0.0001						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	5					FLG (inh=n/a pLI=n/a)
chr1	152284854	152284854	A	G	het		QUAL=57077;DP=488;AF=0.47;MQM=58;TRIO=HET,488,0.47,HET,879,0.51,HOM,1248,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.2508T>C:p.Asp836Asp		rs3120653	0.4732	0.2980	7162/1091/1406	0.2741						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				46	249					FLG (inh=n/a pLI=n/a)
chr1	152285099	152285099	C	T	het		QUAL=86468;DP=493;AF=0.53;MQM=59;TRIO=HET,493,0.53,HET,1423,0.50,HOM,1887,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys		rs74129461	0.3277	0.2560	5584/1073/29	0.2420	-0.3080	T	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996944	39	240					FLG (inh=n/a pLI=n/a)
chr1	152285930	152285930	G	A	het		QUAL=70377;DP=522;AF=0.51;MQM=59;TRIO=HET,522,0.51,HET,1181,0.49,HOM,1576,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser		rs11584340	0.3446	0.2610	5646/1060/89	0.2526	-1.8930	T	T,T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];		CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG]; 		42	240					FLG (inh=n/a pLI=n/a)
chr1	152286002	152286002	T	C	het		QUAL=68436;DP=457;AF=0.48;MQM=59;TRIO=HET,457,0.48,HET,1157,0.49,HOM,1577,0.99	FLG,FLG-AS1	missense,non_coding_exon	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala,FLG-AS1:NR_103778.1:non_coding_exon:MODIFIER:exon1/7:n.68T>C:		rs2011331	0.4641	0.2950	6975/1079/1214	0.2817	-2.8550	T	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142699	46	246					FLG (inh=n/a pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286032	152286032	C	T	het		QUAL=40732;DP=577;AF=0.48;MQM=59;TRIO=HET,577,0.48,HET,1214,0.50,HET,1566,0.46	FLG,FLG-AS1	missense,non_coding_exon	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg,FLG-AS1:NR_103778.1:non_coding_exon:MODIFIER:exon1/7:n.98C>T:		rs11588170	0.2871	0.2290	4727/813/4	0.2210	-0.6390	T	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996946	33	221					FLG (inh=n/a pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286126	152286126	A	G	het		QUAL=20453;DP=473;AF=0.49;MQM=59;TRIO=HET,473,0.49,HET,1206,0.50,WT,1528,0.00	FLG,FLG-AS1	synonymous,non_coding_exon	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.1236T>C:p.Arg412Arg,FLG-AS1:NR_103778.1:non_coding_exon:MODIFIER:exon1/7:n.192A>G:		rs11582620	0.0861	0.1180	1007/442/1	0.1100						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM146620	16	140					FLG (inh=n/a pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286367	152286367	C	A	het	pred_pathogenic_2	QUAL=59549;DP=570;AF=0.51;MQM=59;TRIO=HET,570,0.51,HET,915,0.50,HOM,1284,1.00	FLG,FLG-AS1	missense,non_coding_exon	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.995G>T:p.Gly332Val,FLG-AS1:NR_103778.1:non_coding_exon:MODIFIER:exon1/7:n.433C>A:		rs41267154	0.3407	0.2600	5628/1059/75	0.2508	-1.0200	T	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				40	238					FLG (inh=n/a pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	154138283	154138283	G	A	hom		QUAL=446;DP=153;AF=0.25;MQM=53;TRIO=HOM,153,0.25,HOM,30,0.23,HOM,46,0.28	TPM3	3'UTR,intron	TPM3:NM_152263.3:3'UTR:MODIFIER:exon10/10:c.*2130C>T:,TPM3:NM_001278191.1:intron:MODIFIER:exon7/7:c.394+4593C>T:,TPM3:NM_001043351.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001043352.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001043353.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001278188.1:intron:MODIFIER:exon6/6:c.466+4593C>T:,TPM3:NM_001278189.1:intron:MODIFIER:exon8/8:c.743+3498C>T:,TPM3:NM_001278190.1:intron:MODIFIER:exon6/6:c.601+4593C>T:,TPM3:NM_153649.3:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NR_103461.1:intron:MODIFIER:exon7/7:n.790+4593C>T:	AluSq2	rs200411262	0.0000	0.0000	0/0/0	0.0002						191030 [TPM3 (confirmed) Nemaline myopathy 1,autosomal dominant or recessive|CAP myopathy 1|Myopathy,congenital,with fiber-type disproportion];				0	60					TPM3 (inh=n/a pLI=0.19)
chr1	154548721	154548721	T	C	hom		QUAL=8969;DP=115;AF=0.98;MQM=59;TRIO=HOM,115,0.98,HOM,126,1.00,HET,110,0.51	CHRNB2	3'UTR	CHRNB2:NM_000748.2:3'UTR:MODIFIER:exon6/6:c.*313T>C:		rs2072660	0.6927	0.0000	0/0/0	0.7343										141	77					CHRNB2 (inh=n/a pLI=0.72)
chr1	154552010	154552010	C	G	het		QUAL=8476;DP=299;AF=0.56;MQM=59;TRIO=HET,299,0.56,HET,337,0.48,WT,413,0.00	CHRNB2	3'UTR	CHRNB2:NM_000748.2:3'UTR:MODIFIER:exon6/6:c.*3602C>G:			0.0000	0.0000	0/0/0	0.0000										0	1					CHRNB2 (inh=n/a pLI=0.72)
chr1	156107534	156107534	C	T	het		QUAL=6821;DP=153;AF=0.60;MQM=59;TRIO=HET,153,0.60,WT,263,0.00,HET,353,0.54	LMNA	splice_region&synonymous,synonymous,intron	LMNA:NM_170707.3:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:NM_001282626.1:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:NM_001257374.2:splice_region&synonymous:LOW:exon10/13:c.1362C>T:p.His454His,LMNA:NM_001282625.1:synonymous:LOW:exon13/13:c.1698C>T:p.His566His,LMNA:NM_005572.3:synonymous:LOW:exon10/10:c.1698C>T:p.His566His,LMNA:NM_001282624.1:synonymous:LOW:exon11/11:c.1455C>T:p.His485His,LMNA:NM_170708.3:intron:MODIFIER:exon9/10:c.1608+511C>T:		rs4641	0.2202	0.1620	756/324/16	0.1137						150330 [LMNA (confirmed) Emery-Dreifuss muscular dystrophy 2,AD|Cardiomyopathy,dilated,1A|Lipodystrophy,familial partial,2|Emery-Dreifuss muscular dystrophy 3,AR|Charcot-Marie-Tooth disease,type 2B1|Muscular dystrophy,congenital|Muscular dystrophy,limb-girdle,type 1B|Mandibuloacral dysplasia|Hutchinson-Gilford progeria|Restrictive dermopathy,lethal|Heart-hand syndrome,Slovenian type|Malouf syndrome];	RCV000041327.7 [other]; RCV000057348.2 [benign]; 	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA]; 	COSM3750412, COSM3750413	83	437					LMNA (inh=AR+AD pLI=0.99)
chr1	156785617	156785617	G	A	hom		QUAL=22498;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,211,1.00,HOM,301,1.00	NTRK1,SH2D2A	5'UTR,intron	NTRK1:NM_001007792.1:5'UTR:MODIFIER:exon1/17:c.-5G>A:,SH2D2A:NM_001161441.1:intron:MODIFIER:exon2/8:c.123+181C>T:,SH2D2A:NM_001161443.1:intron:MODIFIER:exon1/7:c.39+181C>T:,SH2D2A:NM_001161442.1:intron:MODIFIER:exon2/8:c.69+181C>T:,SH2D2A:NM_003975.3:intron:MODIFIER:exon2/8:c.123+181C>T:,SH2D2A:NM_001161444.1:intron:MODIFIER:exon2/7:c.123+181C>T:		rs1800601	0.6370	0.6680	27406/15332/1316	0.6650										527	490					NTRK1 (inh=AR+AD pLI=0.00), SH2D2A (inh=n/a pLI=0.00)
chr1	156846233	156846233	G	A	het		QUAL=6482;DP=156;AF=0.49;MQM=60;TRIO=HET,156,0.49,HOM,150,1.00,WT,147,0.00	NTRK1	synonymous	NTRK1:NM_002529.3:synonymous:LOW:exon14/17:c.1674G>A:p.Gln558Gln,NTRK1:NM_001007792.1:synonymous:LOW:exon14/17:c.1566G>A:p.Gln522Gln,NTRK1:NM_001012331.1:synonymous:LOW:exon13/16:c.1656G>A:p.Gln552Gln		rs6334	0.2129	0.2190	3033/1498/102	0.2177						191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis|Medullary thyroid carcinoma,familial];			COSM3750439, COSM3750440	62	369					NTRK1 (inh=AR+AD pLI=0.00)
chr1	156848995	156848995	C	T	het		QUAL=3913;DP=53;AF=0.34;MQM=59;TRIO=HET,53,0.34,WT,104,0.01,HOM,128,0.97	NTRK1	synonymous	NTRK1:NM_002529.3:synonymous:LOW:exon15/17:c.1887C>T:p.Ala629Ala,NTRK1:NM_001007792.1:synonymous:LOW:exon15/17:c.1779C>T:p.Ala593Ala,NTRK1:NM_001012331.1:synonymous:LOW:exon14/16:c.1869C>T:p.Ala623Ala		rs6337	0.3341	0.5700	22665/17445/216	0.5593						191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis|Medullary thyroid carcinoma,familial];	RCV000127264.1 [benign]; 		COSM4142850, COSM4142851	534	482					NTRK1 (inh=AR+AD pLI=0.00)
chr1	160009121	160009121	A	C	het		QUAL=3032;DP=174;AF=0.50;MQM=59;TRIO=HET,174,0.50,HET,68,0.46,WT,81,0.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*2062T>G:		rs1053074	0.4810	0.0000	0/0/0	0.0662										37	107					KCNJ10 (inh=AR pLI=0.60)
chr1	160009143	160009143	G	C	hom		QUAL=8499;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,59,0.97,HOM,69,1.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*2040C>G:		rs2486254	0.9982	0.0000	0/0/0	0.8711										221	0					KCNJ10 (inh=AR pLI=0.60)
chr1	160009164	160009171	ACACACAC	-	hom	low_DP	QUAL=463;DP=9;AF=0.00;MQM=60;TRIO=HOM,9,0.56,WT,34,0.56,WT,42,0.05	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*2012_*2019delGTGTGTGT:	(AC)n	rs68110005;rs777546653	0.0000	0.0000	0/0/0	0.0684										2	6					KCNJ10 (inh=AR pLI=0.60)
chr1	160009419	160009419	A	C	hom		QUAL=31957;DP=369;AF=0.99;MQM=59;TRIO=HOM,369,0.99,HOM,263,1.00,HOM,346,1.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*1764T>G:		rs2486253	0.8628	0.0000	0/0/0	0.1419										157	66					KCNJ10 (inh=AR pLI=0.60)
chr1	160246990	160246990	T	-	het		QUAL=216;DP=292;AF=0.18;MQM=59;TRIO=HET,292,0.18,HET,137,0.21,WT,191,0.16	PEX19	3'UTR,non_coding_exon	PEX19:NM_002857.3:3'UTR:MODIFIER:exon8/8:c.*2351delA:,PEX19:NM_001193644.1:3'UTR:MODIFIER:exon8/8:c.*2359delA:,PEX19:NR_036492.1:non_coding_exon:MODIFIER:exon7/7:n.3168delA:,PEX19:NR_036493.1:non_coding_exon:MODIFIER:exon7/7:n.3192delA:	Charlie10	rs751979135	0.0000	0.2140	0/0/0	0.0189						615820 [DCAF8 (provisional) Giant axonal neuropathy 2,autosomal dominant];				0	11					PEX19 (inh=AR pLI=0.04)
chr1	160247185	160247185	G	C	het		QUAL=10232;DP=284;AF=0.44;MQM=60;TRIO=HET,284,0.44,WT,167,0.01,HOM,217,1.00	PEX19	3'UTR,non_coding_exon	PEX19:NM_002857.3:3'UTR:MODIFIER:exon8/8:c.*2156C>G:,PEX19:NM_001193644.1:3'UTR:MODIFIER:exon8/8:c.*2164C>G:,PEX19:NR_036492.1:non_coding_exon:MODIFIER:exon7/7:n.2973C>G:,PEX19:NR_036493.1:non_coding_exon:MODIFIER:exon7/7:n.2997C>G:	Charlie10	rs10594	0.4523	0.4960	1766/279/19	0.1258						615820 [DCAF8 (provisional) Giant axonal neuropathy 2,autosomal dominant];				293	478					PEX19 (inh=AR pLI=0.04)
chr1	161140278	161140278	A	-	het	anno_high_impact	QUAL=6153;DP=232;AF=0.45;MQM=59;TRIO=HET,232,0.45,WT,330,0.00,HET,376,0.45	PPOX	frameshift	PPOX:NM_000309.3:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs,PPOX:NM_001122764.1:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs			0.0000	0.0000	0/0/0	0.0000						600923 [PPOX (provisional) Porphyria variegata];				0	1					PPOX (inh=n/a pLI=0.33)
chr1	167399868	167399868	-	AG	hom		QUAL=15645;DP=191;AF=0.99;MQM=59;TRIO=HOM,191,0.99,HOM,147,0.99,HOM,177,0.99	POU2F1-CD247	intergenic_region	POU2F1-CD247:POU2F1-CD247:intergenic_region:MODIFIER::n.167399868_167399869insAG:		rs397750029	0.9870	0.0000	0/0/0	0.8746										228	1					POU2F1-CD247 (inh=n/a pLI=n/a)
chr1	167399962	167399962	T	C	hom		QUAL=39723;DP=389;AF=1.00;MQM=59;TRIO=HOM,389,1.00,HOM,381,1.00,HOM,464,1.00	CD247	3'UTR	CD247:NM_198053.2:3'UTR:MODIFIER:exon8/8:c.*956A>G:,CD247:NM_000734.3:3'UTR:MODIFIER:exon8/8:c.*956A>G:		rs947480	0.9874	0.0000	0/0/0	0.1492										229	1					CD247 (inh=n/a pLI=0.66)
chr1	167400074	167400074	T	A	hom		QUAL=45607;DP=406;AF=1.00;MQM=59;TRIO=HOM,406,1.00,HOM,433,1.00,HOM,593,1.00	CD247	3'UTR	CD247:NM_198053.2:3'UTR:MODIFIER:exon8/8:c.*844A>T:,CD247:NM_000734.3:3'UTR:MODIFIER:exon8/8:c.*844A>T:		rs1052231	0.8111	0.0000	0/0/0	0.1405										171	51					CD247 (inh=n/a pLI=0.66)
chr1	179519880	179519880	T	C	hom		QUAL=27918;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,272,1.00,HOM,330,1.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*428A>G:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*428A>G:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3767T>C:,AXDND1:NR_073544.1:intron:MODIFIER:exon25/25:n.3152-3767T>C:		rs1060775	0.9018	0.0000	0/0/0	0.1442							RCV000210058.1 [benign]; 			191	38					NPHS2 (inh=n/a pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520050	179520050	T	C	het		QUAL=7951;DP=330;AF=0.45;MQM=60;TRIO=HET,330,0.45,HOM,121,1.00,WT,177,0.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*258A>G:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*258A>G:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3597T>C:,AXDND1:NR_073544.1:intron:MODIFIER:exon25/25:n.3152-3597T>C:		rs2274622	0.2831	0.0000	0/0/0	0.0495							RCV000210053.1 [benign]; 			23	80					NPHS2 (inh=n/a pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520151	179520151	C	T	hom		QUAL=24234;DP=290;AF=1.00;MQM=59;TRIO=HOM,290,1.00,HOM,194,1.00,HOM,263,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*157G>A:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*157G>A:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3496C>T:,AXDND1:NR_073544.1:intron:MODIFIER:exon25/25:n.3152-3496C>T:		rs1410590	0.9052	0.0000	0/0/0	0.1444							RCV000210055.1 [benign]; 			191	38					NPHS2 (inh=n/a pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520254	179520254	C	G	hom		QUAL=22119;DP=393;AF=0.99;MQM=59;TRIO=HOM,393,0.99,HOM,131,0.99,HOM,174,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*54G>C:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*54G>C:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3393C>G:,AXDND1:NR_073544.1:intron:MODIFIER:exon25/25:n.3152-3393C>G:		rs1410591	0.5879	0.0000	0/0/0	0.1217										186	225					NPHS2 (inh=n/a pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520506	179520506	G	A	hom		QUAL=20741;DP=346;AF=0.99;MQM=60;TRIO=HOM,346,0.99,HOM,128,0.99,HOM,184,1.00	NPHS2,AXDND1	synonymous,intron	NPHS2:NM_014625.3:synonymous:LOW:exon8/8:c.954C>T:p.Ala318Ala,NPHS2:NM_001297575.1:synonymous:LOW:exon7/7:c.750C>T:p.Ala250Ala,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3141G>A:,AXDND1:NR_073544.1:intron:MODIFIER:exon25/25:n.3152-3141G>A:		rs1410592	0.5877	0.6190	23360/13445/1870	0.6111						604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2];			COSM146700	418	524					NPHS2 (inh=n/a pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179544898	179544898	T	C	hom	low_DP	QUAL=441;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,3,1.00,HOM,13,1.00	NPHS2	synonymous	NPHS2:NM_014625.3:synonymous:LOW:exon1/8:c.102A>G:p.Gly34Gly,NPHS2:NM_001297575.1:synonymous:LOW:exon1/7:c.102A>G:p.Gly34Gly		rs1079292	0.9309	0.9580	4890/1600/105	0.5163						604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2];			COSM3749013	954	32					NPHS2 (inh=n/a pLI=0.01)
chr1	180235728	180235728	C	T	het		QUAL=1870;DP=76;AF=0.51;MQM=59;TRIO=HET,76,0.51,WT,91,0.00,HET,108,0.42	LHX4	splice_region&synonymous	LHX4:NM_033343.3:splice_region&synonymous:LOW:exon3/6:c.450C>T:p.Asn150Asn		rs16855642	0.0427	0.0210	65/3/50	0.0194						602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];				0	23					LHX4 (inh=n/a pLI=0.40)
chr1	180240510	180240510	T	C	het		QUAL=1640;DP=69;AF=0.52;MQM=60;TRIO=HET,69,0.52,HET,77,0.47,WT,115,0.00	LHX4,LHX4-AS1	splice_region&intron,non_coding_exon	LHX4:NM_033343.3:splice_region&intron:LOW:exon3/5:c.452-5T>C:,LHX4-AS1:NR_037642.1:non_coding_exon:MODIFIER:exon5/5:n.945A>G:		rs2764449	0.0413	0.0660	352/213/2	0.0644						602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];			COSM3997105	8	155					LHX4 (inh=n/a pLI=0.40), LHX4-AS1 (inh=n/a pLI=n/a)
chr1	180243524	180243524	A	G	het	phylop_high	QUAL=7708;DP=211;AF=0.48;MQM=60;TRIO=HET,211,0.48,HET,155,0.48,HET,204,0.57	LHX4,LHX4-AS1	missense,intron	LHX4:NM_033343.3:missense:MODERATE:exon6/6:c.983A>G:p.Asn328Ser,LHX4-AS1:NR_037642.1:intron:MODIFIER:exon1/4:n.31+262T>C:		rs7536561	0.4263	0.4850	15435/9207/216	0.4810	2.5290	T	T	B	B	602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];			COSM3746684	317	509					LHX4 (inh=n/a pLI=0.40), LHX4-AS1 (inh=n/a pLI=n/a)
chr1	183155305	183155305	G	A	het		QUAL=20062;DP=281;AF=0.52;MQM=60;TRIO=HET,281,0.52,WT,367,0.00,HOM,522,1.00	LAMC2	5'UTR	LAMC2:NM_005562.2:5'UTR:MODIFIER:exon1/23:c.-183G>A:,LAMC2:NM_018891.2:5'UTR:MODIFIER:exon1/22:c.-183G>A:		rs2276543	0.2989	0.0000	0/0/0	0.0498										13	90					LAMC2 (inh=n/a pLI=0.00)
chr1	183524855	183524855	C	A	hom		QUAL=44594;DP=476;AF=1.00;MQM=59;TRIO=HOM,476,1.00,HOM,391,0.99,HOM,547,0.99	NCF2	3'UTR	NCF2:NM_000433.3:3'UTR:MODIFIER:exon15/15:c.*398G>T:,NCF2:NM_001190789.1:3'UTR:MODIFIER:exon13/13:c.*398G>T:,NCF2:NM_001190794.1:3'UTR:MODIFIER:exon14/14:c.*398G>T:,NCF2:NM_001127651.2:3'UTR:MODIFIER:exon16/16:c.*398G>T:		rs796860	0.9393	0.0000	0/0/0	0.5022										184	42					NCF2 (inh=n/a pLI=0.00)
chr1	183542387	183542387	T	C	hom		QUAL=18383;DP=259;AF=0.99;MQM=59;TRIO=HOM,259,0.99,HOM,191,1.00,HET,267,0.54	NCF2	missense,intron	NCF2:NM_000433.3:missense:MODERATE:exon5/15:c.542A>G:p.Lys181Arg,NCF2:NM_001190794.1:missense:MODERATE:exon4/14:c.407A>G:p.Lys136Arg,NCF2:NM_001127651.2:missense:MODERATE:exon6/16:c.542A>G:p.Lys181Arg,NCF2:NM_001190789.1:intron:MODIFIER:exon3/12:c.367-2413A>G:		rs2274064	0.4916	0.4890	15075/7092/687	0.4881	0.5830	T	T,T,T,T	B,B	B,B	608515 [NCF2 (confirmed) Chronic granulomatous disease due to deficiency of NCF-2];			COSM3750690	220	593					NCF2 (inh=n/a pLI=0.00)
chr1	196654324	196654324	A	C	het		QUAL=9439;DP=287;AF=0.49;MQM=60;TRIO=HET,287,0.49,HET,209,0.48,HET,266,0.47	CFH	synonymous	CFH:NM_000186.3:synonymous:LOW:exon7/22:c.921A>C:p.Ala307Ala,CFH:NM_001014975.2:synonymous:LOW:exon7/10:c.921A>C:p.Ala307Ala		rs1061147	0.7131	0.6670	27692/12666/1709	0.6631						134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];		CM057396 [CLASS=DP MUT=REF PHEN="Macular degeneration age-related association with" GENE=CFH]; 	COSM3750723	462	510					CFH (inh=n/a pLI=1.00)
chr1	196659237	196659237	C	T	het	anno_pathogenic_clinvar	QUAL=5463;DP=191;AF=0.57;MQM=56;TRIO=HET,191,0.57,HET,104,0.41,HET,108,0.49	CFH	missense	CFH:NM_000186.3:missense:MODERATE:exon9/22:c.1204C>T:p.His402Tyr,CFH:NM_001014975.2:missense:MODERATE:exon9/10:c.1204C>T:p.His402Tyr		rs1061170	0.7334	0.6710	27768/12485/2037	0.6661	-6.7150	T	T,T,T,T	B,B	B,B	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];	RCV000018015.4 [other]; RCV000018016.30 [pathogenic]; 	CM051020 [CLASS=DFP MUT=REF PHEN="Macular degeneration age-related association with" GENE=CFH]; 	COSM424915	464	506	2	[2] old entry - no details available			CFH (inh=n/a pLI=1.00)
chr1	196682947	196682947	G	A	het		QUAL=8619;DP=262;AF=0.42;MQM=60;TRIO=HET,262,0.42,HET,192,0.49,HET,257,0.48	CFH	synonymous	CFH:NM_000186.3:synonymous:LOW:exon10/22:c.1419G>A:p.Ala473Ala		rs2274700	0.4790	0.4420	12010/5836/1095	0.4374						134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];	RCV000018023.2 [other]; 	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH]; 	COSM3750724	238	527					CFH (inh=n/a pLI=1.00)
chr1	196709816	196709816	G	T	het	pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=6969;DP=285;AF=0.53;MQM=59;TRIO=HET,285,0.53,WT,187,0.00,HET,216,0.51	CFH	missense	CFH:NM_000186.3:missense:MODERATE:exon18/22:c.2850G>T:p.Gln950His		rs149474608	0.0016	0.0036	5/5/0	0.0038	-0.2730	T	D	P	B	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];		CM034428 [CLASS=DM MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH]; 		0	14	2	[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence			CFH (inh=n/a pLI=1.00)
chr1	197053373	197053373	G	A	hom		QUAL=19127;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,138,1.00,HOM,201,1.00	ASPM	3'UTR	ASPM:NM_018136.4:3'UTR:MODIFIER:exon28/28:c.*81C>T:,ASPM:NM_001206846.1:3'UTR:MODIFIER:exon27/27:c.*81C>T:		rs12677	0.7823	0.0000	0/0/0	0.1862										270	44					ASPM (inh=AR pLI=0.00)
chr1	197055925	197055925	T	C	hom		QUAL=13664;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,108,1.00,HOM,137,1.00	ASPM	splice_region&intron	ASPM:NM_018136.4:splice_region&intron:LOW:exon27/27:c.10331+8A>G:,ASPM:NM_001206846.1:splice_region&intron:LOW:exon26/26:c.5576+8A>G:		rs10754213	0.7827	0.8780	47902/27379/1065	0.8565						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000145076.2 [other]; 			896	187					ASPM (inh=AR pLI=0.00)
chr1	197070776	197070776	C	T	het		QUAL=8716;DP=228;AF=0.55;MQM=59;TRIO=HET,228,0.55,HET,190,0.46,HET,246,0.49	ASPM	synonymous,intron	ASPM:NM_018136.4:synonymous:LOW:exon18/28:c.7605G>A:p.Val2535Val,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5482G>A:		rs10922162	0.2949	0.2390	5351/822/16	0.2387						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020793.1 [benign]; RCV000145189.2 [benign]; 			48	289					ASPM (inh=AR pLI=0.00)
chr1	197070815	197070815	T	C	hom		QUAL=19710;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,155,1.00,HOM,198,1.00	ASPM	synonymous,intron	ASPM:NM_018136.4:synonymous:LOW:exon18/28:c.7566A>G:p.Leu2522Leu,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5521A>G:		rs1412640	0.8159	0.8870	48397/27386/1582	0.8660						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020792.1 [benign]; RCV000145187.5 [other]; 			898	191					ASPM (inh=AR pLI=0.00)
chr1	197070901	197070901	A	G	hom	phylop_high	QUAL=23221;DP=320;AF=1.00;MQM=60;TRIO=HOM,320,1.00,HOM,168,1.00,HOM,206,1.00	ASPM	missense,intron	ASPM:NM_018136.4:missense:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5607T>C:		rs964201	0.9974	0.9960	60051/32876/5182	0.9733	2.9990	T	T,T	B,B	B,B	605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020789.1 [benign]; RCV000145183.5 [benign]; 			1106	3					ASPM (inh=AR pLI=0.00)
chr1	197091537	197091537	A	T	hom		QUAL=24417;DP=311;AF=1.00;MQM=59;TRIO=HOM,311,1.00,HOM,203,1.00,HOM,251,1.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon14/28:c.3579T>A:p.Ser1193Ser,ASPM:NM_001206846.1:synonymous:LOW:exon14/27:c.3579T>A:p.Ser1193Ser		rs4915337	0.7825	0.8780	47849/27354/1075	0.8135						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020768.1 [benign]; RCV000145113.1 [likely benign]; 			895	189					ASPM (inh=AR pLI=0.00)
chr1	197094030	197094030	C	T	het		QUAL=9400;DP=394;AF=0.49;MQM=59;TRIO=HET,394,0.49,HET,152,0.48,HET,185,0.49	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon12/28:c.3138G>A:p.Arg1046Arg,ASPM:NM_001206846.1:synonymous:LOW:exon12/27:c.3138G>A:p.Arg1046Arg		rs6676084	0.2167	0.2800	5028/3284/147	0.2687						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020763.1 [benign]; RCV000145109.1 [benign]; 		COSM3750735	125	445					ASPM (inh=AR pLI=0.00)
chr1	197108946	197108946	A	G	het		QUAL=4087;DP=256;AF=0.41;MQM=60;TRIO=HET,256,0.41,HET,109,0.44,WT,143,0.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon4/28:c.1977T>C:p.Ile659Ile,ASPM:NM_001206846.1:synonymous:LOW:exon4/27:c.1977T>C:p.Ile659Ile		rs17550662	0.0192	0.0450	165/144/0	0.0431						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020751.1 [benign]; RCV000145092.1 [benign]; 			5	106					ASPM (inh=AR pLI=0.00)
chr1	197112533	197112533	G	A	hom		QUAL=7448;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HOM,61,0.98,HOM,52,1.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon3/28:c.849C>T:p.Ser283Ser,ASPM:NM_001206846.1:synonymous:LOW:exon3/27:c.849C>T:p.Ser283Ser		rs6677082	0.7556	0.8690	47376/27349/752	0.8055						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000081938.6 [other]; 			888	195					ASPM (inh=AR pLI=0.00)
chr1	198661668	198661668	G	A	het		QUAL=807;DP=56;AF=0.46;MQM=60;TRIO=HET,56,0.46,HET,7,0.86,WT,5,0.00	PTPRC	intron,non_coding_exon	PTPRC:NM_002838.4:intron:MODIFIER:exon3/32:c.100+166G>A:,PTPRC:NM_001267798.1:intron:MODIFIER:exon3/3:c.100+166G>A:,PTPRC:NM_080921.3:intron:MODIFIER:exon3/29:c.100+166G>A:,PTPRC:NR_052021.1:non_coding_exon:MODIFIER:exon3/3:n.479G>A:		rs115067628	0.0040	0.0000	0/0/0	0.0015						151460 [PTPRC (confirmed) Hepatitic C virus,susceptibility to|Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive];				0	6					PTPRC (inh=n/a pLI=1.00)
chr1	201012597	201012597	G	A	hom	low_DP	QUAL=366;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,WT,3,0.00,HOM,4,1.00	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon40/44:c.4860C>T:p.Pro1620Pro		rs41267497	0.0461	0.1070	954/852/5	0.1072						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				24	200					CACNA1S (inh=n/a pLI=0.00)
chr1	201038687	201038687	A	G	het		QUAL=8183;DP=223;AF=0.48;MQM=60;TRIO=HET,223,0.48,WT,344,0.00,HET,428,0.51	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon18/44:c.2403T>C:p.Phe801Phe		rs7415038	0.2941	0.3030	3683/2641/749	0.2790						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				146	451					CACNA1S (inh=n/a pLI=0.00)
chr1	201044748	201044748	A	G	het		QUAL=10600;DP=155;AF=0.51;MQM=59;TRIO=HET,155,0.51,WT,261,0.00,HOM,280,1.00	CACNA1S	splice_region&intron	CACNA1S:NM_000069.2:splice_region&intron:LOW:exon12/43:c.1828-5T>C:		rs1998721	0.7596	0.7810	37595/20198/1541	0.7622						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				657	378					CACNA1S (inh=n/a pLI=0.00)
chr1	201047062	201047062	G	A	hom		QUAL=14951;DP=142;AF=0.98;MQM=59;TRIO=HOM,142,0.98,HOM,261,1.00,HET,263,0.47	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon11/44:c.1564C>T:p.Leu522Leu		rs4915476	0.1909	0.2070	2934/1790/385	0.2032						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];		CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S]; 	COSM3750745	68	395					CACNA1S (inh=n/a pLI=0.00)
chr1	201047075	201047075	A	G	hom		QUAL=17599;DP=190;AF=0.99;MQM=59;TRIO=HOM,190,0.99,HOM,270,1.00,HET,286,0.50	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon11/44:c.1551T>C:p.Gly517Gly		rs4915477	0.5711	0.5840	22620/14306/4198	0.5821						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];		CM023569 [CLASS=DP MUT=REF PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S]; 	COSM4143154	442	484					CACNA1S (inh=n/a pLI=0.00)
chr1	209788213	209788213	T	C	hom		QUAL=5589;DP=150;AF=0.99;MQM=60;TRIO=HOM,150,0.99,HET,41,0.59,HET,72,0.46	CAMK1G-LAMB3	intergenic_region	CAMK1G-LAMB3:CAMK1G-LAMB3:intergenic_region:MODIFIER::n.209788213T>C:		rs926387	0.7748	0.0000	0/0/0	0.1206										96	104					CAMK1G-LAMB3 (inh=n/a pLI=n/a)
chr1	209788514	209788514	G	A	het		QUAL=5399;DP=185;AF=0.52;MQM=60;TRIO=HET,185,0.52,WT,241,0.00,HET,263,0.46	LAMB3	3'UTR	LAMB3:NM_000228.2:3'UTR:MODIFIER:exon23/23:c.*102C>T:,LAMB3:NM_001017402.1:3'UTR:MODIFIER:exon22/22:c.*102C>T:,LAMB3:NM_001127641.1:3'UTR:MODIFIER:exon23/23:c.*102C>T:		rs2566	0.2951	0.0000	0/0/0	0.0576								CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3]; 		25	114					LAMB3 (inh=n/a pLI=0.00)
chr1	209799253	209799253	A	G	het		QUAL=21322;DP=304;AF=0.39;MQM=59;TRIO=HET,304,0.39,HOM,383,1.00,HET,547,0.50	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys,LAMB3:NM_001017402.1:synonymous:LOW:exon13/22:c.1716T>C:p.Cys572Cys,LAMB3:NM_001127641.1:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys		rs2179402	0.7650	0.7540	34184/18267/3036	0.7444						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type|Amelogenesis imperfecta,type IA];			COSM3746765	639	387					LAMB3 (inh=n/a pLI=0.00)
chr1	209807972	209807972	G	A	hom		QUAL=5431;DP=37;AF=1.00;MQM=60;TRIO=HOM,37,1.00,HOM,58,1.00,HOM,91,1.00	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro,LAMB3:NM_001017402.1:synonymous:LOW:exon5/22:c.384C>T:p.Pro128Pro,LAMB3:NM_001127641.1:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro		rs1130667	0.2454	0.3440	7446/5200/99	0.3375						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type|Amelogenesis imperfecta,type IA];			COSM3746766	160	524					LAMB3 (inh=n/a pLI=0.00)
chr1	209811886	209811886	T	G	hom		QUAL=18952;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,137,1.00,HOM,211,1.00	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser,LAMB3:NM_001017402.1:synonymous:LOW:exon3/22:c.291A>C:p.Ser97Ser,LAMB3:NM_001127641.1:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser		rs2076356	0.4325	0.5700	20809/14492/881	0.5628						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type|Amelogenesis imperfecta,type IA];			COSM146753	461	498					LAMB3 (inh=n/a pLI=0.00)
chr1	209959614	209959614	G	T	het		QUAL=6941;DP=339;AF=0.54;MQM=57;TRIO=HET,339,0.54,WT,126,0.00,HET,185,0.50	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*2151C>A:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*2151C>A:		rs1044516	0.3099	0.0000	0/0/0	0.0443										7	36					IRF6 (inh=n/a pLI=0.98)
chr1	209959872	209959872	G	A	hom		QUAL=18993;DP=311;AF=1.00;MQM=56;TRIO=HOM,311,1.00,HOM,124,0.99,HOM,150,0.99	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*1893C>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*1893C>T:		rs680331	0.8081	0.0000	0/0/0	0.7942										99	42					IRF6 (inh=n/a pLI=0.98)
chr1	209960436	209960436	G	A	het		QUAL=6339;DP=256;AF=0.46;MQM=59;TRIO=HET,256,0.46,WT,202,0.00,HET,248,0.50	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*1329C>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*1329C>T:	AluJo	rs2235372	0.2991	0.0000	0/0/0	0.2137										7	36					IRF6 (inh=n/a pLI=0.98)
chr1	209960922	209960922	A	C	het		QUAL=2823;DP=125;AF=0.47;MQM=60;TRIO=HET,125,0.47,HOM,44,1.00,WT,126,0.00	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*843T>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*843T>G:		rs599021	0.3043	0.0000	0/0/0	0.3674										36	81					IRF6 (inh=n/a pLI=0.98)
chr1	209960925	209960925	T	C	het		QUAL=3095;DP=128;AF=0.53;MQM=59;TRIO=HET,128,0.53,WT,43,0.00,HET,125,0.46	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*840A>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*840A>G:		rs742214	0.2971	0.0000	0/0/0	0.2500										7	36					IRF6 (inh=n/a pLI=0.98)
chr1	209961023	209961023	T	A	het		QUAL=2200;DP=98;AF=0.50;MQM=60;TRIO=HET,98,0.50,WT,51,0.02,HET,82,0.49	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*742A>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*742A>T:		rs742215	0.3037	0.0000	0/0/0	0.0429										7	36					IRF6 (inh=n/a pLI=0.98)
chr1	209961314	209961314	T	C	het		QUAL=6575;DP=269;AF=0.50;MQM=60;TRIO=HET,269,0.50,WT,189,0.01,HET,241,0.47	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*451A>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*451A>G:		rs17317411	0.0875	0.0000	0/0/0	0.0199										6	34					IRF6 (inh=n/a pLI=0.98)
chr1	209968684	209968684	C	A	het		QUAL=18456;DP=339;AF=0.45;MQM=60;TRIO=HET,339,0.45,WT,326,0.00,HOM,458,1.00	IRF6	synonymous	IRF6:NM_006147.3:synonymous:LOW:exon5/9:c.459G>T:p.Ser153Ser,IRF6:NM_001206696.1:synonymous:LOW:exon3/7:c.174G>T:p.Ser58Ser		rs2013162	0.4038	0.4020	10291/4614/392	0.3976						607199 [IRF6 (confirmed) van der Woude syndrome|Popliteal pterygium syndrome 1|Orofacial cleft 6];			COSM3746770	138	490					IRF6 (inh=n/a pLI=0.98)
chr1	209969902	209969902	G	C	het		QUAL=4762;DP=210;AF=0.47;MQM=60;TRIO=HET,210,0.47,WT,51,0.02,HOM,86,0.99	IRF6	splice_region&intron	IRF6:NM_006147.3:splice_region&intron:LOW:exon3/8:c.175-5C>G:,IRF6:NM_001206696.1:splice_region&intron:LOW:exon1/6:c.-111-5C>G:		rs7552506	0.2710	0.3240	6527/4149/370	0.3161						607199 [IRF6 (confirmed) van der Woude syndrome|Popliteal pterygium syndrome 1|Orofacial cleft 6];				122	445					IRF6 (inh=n/a pLI=0.98)
chr1	209975386	209975386	A	G	het		QUAL=11915;DP=286;AF=0.49;MQM=60;TRIO=HET,286,0.49,HOM,263,1.00,WT,353,0.00	IRF6	splice_region,5'UTR,intron	IRF6:NM_006147.3:splice_region:LOW:exon2/9:c.-73T>C:,IRF6:NM_006147.3:5'UTR:MODIFIER:exon2/9:c.-73T>C:,IRF6:NM_001206696.1:intron:MODIFIER:exon1/6:c.-112+3906T>C:		rs861019	0.3864	0.0000	0/0/0	0.3907										49	119					IRF6 (inh=n/a pLI=0.98)
chr1	215796350	215796350	T	G	het		QUAL=13518;DP=354;AF=0.52;MQM=60;TRIO=HET,354,0.52,WT,178,0.00,HOM,266,1.00	USH2A	3'UTR	USH2A:NM_206933.2:3'UTR:MODIFIER:exon72/72:c.*2773A>C:		rs6667509	0.1030	0.0000	0/0/0	0.0167										5	39					USH2A (inh=n/a pLI=0.00)
chr1	215798014	215798014	G	A	hom		QUAL=33490;DP=447;AF=1.00;MQM=60;TRIO=HOM,447,1.00,HOM,227,1.00,HOM,326,1.00	USH2A	3'UTR	USH2A:NM_206933.2:3'UTR:MODIFIER:exon72/72:c.*1109C>T:		rs2797255	0.9912	0.0000	0/0/0	0.1493										229	0					USH2A (inh=n/a pLI=0.00)
chr1	215808007	215808007	G	A	het	phylop_high	QUAL=3650;DP=177;AF=0.47;MQM=60;TRIO=HET,177,0.47,HET,136,0.50,WT,196,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp		rs56038610	0.0060	0.0160	24/14/1	0.0153	3.0690	T	T,T	P	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041778.2 [benign]; RCV000087008.3 [not provided]; 			0	26					USH2A (inh=n/a pLI=0.00)
chr1	215848062	215848062	C	T	het		QUAL=8136;DP=379;AF=0.51;MQM=60;TRIO=HET,379,0.51,HET,246,0.50,WT,314,0.01	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon63/72:c.13191G>A:p.Glu4397Glu		rs2009923	0.2035	0.1990	2705/1107/12	0.1983						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041736.4 [benign]; 		COSM3746785, COSM3746784	40	337					USH2A (inh=n/a pLI=0.00)
chr1	215848641	215848641	T	C	het		QUAL=20824;DP=390;AF=0.48;MQM=60;TRIO=HET,390,0.48,HET,281,0.50,HOM,377,0.99	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon63/72:c.12612A>G:p.Thr4204Thr		rs2797235	0.6897	0.7650	35716/21979/2019	0.7585						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000152568.2 [benign]; RCV000154669.2 [benign]; 		COSM146765	721	339					USH2A (inh=n/a pLI=0.00)
chr1	215901492	215901492	C	T	hom		QUAL=39520;DP=412;AF=0.99;MQM=59;TRIO=HOM,412,0.99,HET,545,0.42,HOM,642,0.99	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon61/72:c.11946G>A:p.Leu3982Leu		rs2820718	0.1188	0.1560	1676/1148/143	0.1530						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041709.4 [benign]; 			30	341					USH2A (inh=n/a pLI=0.00)
chr1	215914751	215914751	G	T	het	phylop_high;pred_pathogenic_2	QUAL=5400;DP=209;AF=0.54;MQM=60;TRIO=HET,209,0.54,HET,194,0.51,WT,254,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr		rs41303285	0.0062	0.0170	29/22/0	0.0168	5.6550	T	T,T	D	D	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041701.3 [benign]; 			0	26					USH2A (inh=n/a pLI=0.00)
chr1	215960153	215960153	A	C	het	phylop_high;pred_pathogenic_3;anno_pathogenic_hgmd	QUAL=76;DP=237;AF=0.37;MQM=59;TRIO=HET,237,0.37,WT,232,0.01,WT,279,0.02	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon52/72:c.10246T>G:p.Cys3416Gly		rs527236140	0.0000	0.3120	0/0/0	0.0006	5.2280	T	D,D	D	D	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000132699.1 [likely benign]; 	CM135012 [CLASS=DM MUT=ALT PHEN="Usher syndrome" GENE=USH2A]; 	COSM130095, COSM4143327	0	58	2	[2] old entry - no details available			USH2A (inh=n/a pLI=0.00)
chr1	215960167	215960167	T	G	hom	phylop_high	QUAL=27367;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,288,1.00,HOM,369,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala		rs10864198	0.5887	0.5470	18352/9040/2437	0.5381	2.5980	T	T,T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000154357.1 [benign]; RCV000041665.7 [benign]; 		COSM3750864, COSM3750863	339	530					USH2A (inh=n/a pLI=0.00)
chr1	216166454	216166454	T	G	het	phylop_high;pred_pathogenic_2;anno_pathogenic_hgmd	QUAL=2793;DP=128;AF=0.48;MQM=60;TRIO=HET,128,0.48,HET,94,0.57,WT,98,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala		rs41277212	0.0076	0.0220	42/29/0	0.0217	4.8840	T	D,D	D	P	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041894.3 [benign]; RCV000087012.3 [not provided]; 	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A]; 	COSM3750866, COSM3750865	1	46					USH2A (inh=n/a pLI=0.00)
chr1	216172380	216172380	A	G	hom	phylop_high	QUAL=19062;DP=181;AF=0.99;MQM=60;TRIO=HOM,181,0.99,HOM,189,1.00,HOM,229,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr		rs10864219	0.5935	0.5560	19463/8401/992	0.5355	2.3950	T	T,T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041888.4 [benign]; 		COSM3750868, COSM3750867	327	470					USH2A (inh=n/a pLI=0.00)
chr1	216219781	216219781	A	G	het		QUAL=8795;DP=201;AF=0.49;MQM=60;TRIO=HET,201,0.49,HET,125,0.50,HOM,146,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr		rs6657250	0.5956	0.6060	23304/15047/3022	0.6040	0.9880	T	T,T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000154356.2 [benign]; RCV000154111.3 [benign]; 		COSM146769	469	496					USH2A (inh=n/a pLI=0.00)
chr1	216258194	216258194	G	T	het		QUAL=5971;DP=156;AF=0.49;MQM=60;TRIO=HET,156,0.49,HET,133,0.51,HET,177,0.51	USH2A,LOC102723833	synonymous,intron	USH2A:NM_206933.2:synonymous:LOW:exon25/72:c.5013C>A:p.Gly1671Gly,LOC102723833:NR_125992.1:intron:MODIFIER:exon2/2:n.266-1870G>T:,LOC102723833:NR_125993.1:intron:MODIFIER:exon1/1:n.137-1870G>T:		rs56110889	0.1058	0.1350	1316/977/195	0.1345						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041853.7 [benign]; 		COSM3746786, COSM3746787	25	278					USH2A (inh=n/a pLI=0.00), LOC102723833 (inh=n/a pLI=n/a)
chr1	216347452	216347452	C	A	het		QUAL=3567;DP=218;AF=0.42;MQM=60;TRIO=HET,218,0.42,HET,108,0.45,WT,121,0.00	USH2A	3'UTR,intron	USH2A:NM_007123.5:3'UTR:MODIFIER:exon21/21:c.*1128G>T:,USH2A:NM_206933.2:intron:MODIFIER:exon21/71:c.4627+1142G>T:		rs401269	0.1945	0.0000	0/0/0	0.0355						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];				9	81					USH2A (inh=n/a pLI=0.00)
chr1	216347556	216347556	A	G	het		QUAL=3710;DP=224;AF=0.48;MQM=60;TRIO=HET,224,0.48,HET,56,0.54,WT,55,0.00	USH2A	3'UTR,intron	USH2A:NM_007123.5:3'UTR:MODIFIER:exon21/21:c.*1024T>C:,USH2A:NM_206933.2:intron:MODIFIER:exon21/71:c.4627+1038T>C:		rs439940	0.1953	0.0000	0/0/0	0.0423						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];				9	80					USH2A (inh=n/a pLI=0.00)
chr1	216348764	216348764	C	T	het		QUAL=29533;DP=481;AF=0.53;MQM=60;TRIO=HET,481,0.53,HET,456,0.49,HOM,507,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys,USH2A:NM_007123.5:missense:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys		rs1805049	0.6623	0.6570	26453/12968/1738	0.6501	-1.6250	T	T,T,T	B,B	B,B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000154339.2 [benign]; RCV000154668.1 [benign]; 		COSM3746790, COSM3746789, COSM3746788	450	503					USH2A (inh=n/a pLI=0.00)
chr1	216371934	216371934	A	C	het		QUAL=4085;DP=223;AF=0.54;MQM=59;TRIO=HET,223,0.54,HET,82,0.55,WT,90,0.00	USH2A	splice_region&intron	USH2A:NM_206933.2:splice_region&intron:LOW:exon17/71:c.3812-8T>G:,USH2A:NM_007123.5:splice_region&intron:LOW:exon17/20:c.3812-8T>G:		rs646094	0.1977	0.2120	2706/1683/130	0.2097						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041834.3 [benign]; 			55	366					USH2A (inh=n/a pLI=0.00)
chr1	216592003	216592003	T	C	hom		QUAL=18945;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,190,0.99,HOM,254,1.00	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon3/72:c.504A>G:p.Thr168Thr,USH2A:NM_007123.5:synonymous:LOW:exon3/21:c.504A>G:p.Thr168Thr		rs4253963	0.6328	0.6480	25942/13990/1291	0.6464						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041854.3 [benign]; 			413	525					USH2A (inh=n/a pLI=0.00)
chr1	216595306	216595306	C	T	hom		QUAL=32981;DP=294;AF=0.99;MQM=60;TRIO=HOM,294,0.99,HOM,279,1.00,HOM,445,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon2/72:c.373G>A:p.Ala125Thr,USH2A:NM_007123.5:missense:MODERATE:exon2/21:c.373G>A:p.Ala125Thr		rs10779261	0.7612	0.7290	32387/16635/2945	0.7235	0.3550	T	T,T,T	B,B	B,B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041833.4 [benign]; 			512	467					USH2A (inh=n/a pLI=0.00)
chr1	220323449	220323449	T	-	het		QUAL=51;DP=149;AF=0.28;MQM=59;TRIO=HET,149,0.28,WT,44,0.34,WT,53,0.28	RAB3GAP2	3'UTR	RAB3GAP2:NM_012414.3:3'UTR:MODIFIER:exon35/35:c.*1144delA:	FLAM_C	rs11316594;rs778873874	0.0000	0.0000	0/0/0	0.1353										9	65					RAB3GAP2 (inh=AR pLI=1.00)
chr1	220324189	220324189	A	G	het		QUAL=9776;DP=417;AF=0.54;MQM=60;TRIO=HET,417,0.54,WT,218,0.00,HET,266,0.53	RAB3GAP2	3'UTR	RAB3GAP2:NM_012414.3:3'UTR:MODIFIER:exon35/35:c.*404T>C:		rs1059140	0.0627	0.0000	0/0/0	0.0139										4	41					RAB3GAP2 (inh=AR pLI=1.00)
chr1	220330672	220330672	C	T	het		QUAL=9349;DP=417;AF=0.54;MQM=60;TRIO=HET,417,0.54,WT,211,0.00,HET,288,0.48	RAB3GAP2	synonymous	RAB3GAP2:NM_012414.3:synonymous:LOW:exon31/35:c.3495G>A:p.Leu1165Leu		rs11547779	0.0605	0.0880	537/319/0	0.0856						609275 [RAB3GAP2 (provisional) Martsolf syndrome|Warburg micro syndrome 2];	RCV000118107.3 [other]; 		COSM3750881	15	235					RAB3GAP2 (inh=AR pLI=1.00)
chr1	220331205	220331205	C	G	het	phylop_high;pred_pathogenic_1	QUAL=6485;DP=291;AF=0.45;MQM=60;TRIO=HET,291,0.45,WT,182,0.00,HET,248,0.46	RAB3GAP2	missense	RAB3GAP2:NM_012414.3:missense:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr		rs2289189	0.0603	0.0870	513/299/0	0.0852	7.4300	T	T	D,D	P,P	609275 [RAB3GAP2 (provisional) Martsolf syndrome|Warburg micro syndrome 2];	RCV000118106.3 [other]; 		COSM3750882	15	235					RAB3GAP2 (inh=AR pLI=1.00)
chr1	223178561	223178561	A	C	hom		QUAL=20411;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HOM,287,1.00,HET,374,0.53	DISP1	synonymous	DISP1:NM_032890.3:synonymous:LOW:exon10/10:c.3822A>C:p.Pro1274Pro		rs9441941	0.4980	0.5440	18095/11104/998	0.5367									COSM146786	367	532					DISP1 (inh=n/a pLI=0.00)
chr1	225589473	225589473	C	T	het		QUAL=8375;DP=323;AF=0.50;MQM=59;TRIO=HET,323,0.50,WT,267,0.00,HET,352,0.44	LBR	3'UTR	LBR:NM_002296.3:3'UTR:MODIFIER:exon14/14:c.*1532G>A:,LBR:NM_194442.2:3'UTR:MODIFIER:exon14/14:c.*1532G>A:		rs7406	0.2726	0.0000	0/0/0	0.0295										3	58					LBR (inh=AR+AD pLI=1.00)
chr1	225590750	225590750	G	C	het		QUAL=4466;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,WT,47,0.00,HET,56,0.50	LBR	3'UTR	LBR:NM_002296.3:3'UTR:MODIFIER:exon14/14:c.*255C>G:,LBR:NM_194442.2:3'UTR:MODIFIER:exon14/14:c.*255C>G:		rs11551874	0.1020	0.0000	0/0/0	0.0174										3	44					LBR (inh=AR+AD pLI=1.00)
chr1	225607144	225607144	C	T	het		QUAL=1826;DP=75;AF=0.40;MQM=60;TRIO=HET,75,0.40,HOM,20,1.00,HET,47,0.45	LBR	missense	LBR:NM_002296.3:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn,LBR:NM_194442.2:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn		rs2230419	0.7123	0.7990	39850/23754/916	0.7769	-0.1880	T	T,T,T	B,B	B,B	600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				777	294					LBR (inh=AR+AD pLI=1.00)
chr1	225609884	225609884	A	G	het		QUAL=2398;DP=127;AF=0.57;MQM=59;TRIO=HET,127,0.57,HOM,16,1.00,HET,18,0.61	LBR	synonymous	LBR:NM_002296.3:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro,LBR:NM_194442.2:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro		rs1056608	0.6709	0.7500	35255/20940/767	0.7317						600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				693	364					LBR (inh=AR+AD pLI=1.00)
chr1	225611661	225611661	C	T	het		QUAL=17114;DP=367;AF=0.53;MQM=60;TRIO=HET,367,0.53,HET,210,0.49,HOM,283,1.00	LBR	synonymous	LBR:NM_002296.3:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val,LBR:NM_194442.2:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val		rs1056607	0.6571	0.7110	31217/18389/2091	0.6882						600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				607	422					LBR (inh=AR+AD pLI=1.00)
chr1	226555302	226555302	A	G	het	phylop_high	QUAL=5831;DP=200;AF=0.48;MQM=59;TRIO=HET,200,0.48,WT,220,0.00,HET,303,0.47	PARP1	missense	PARP1:NM_001618.3:missense:MODERATE:exon17/23:c.2285T>C:p.Val762Ala		rs1136410	0.1969	0.2020	3399/997/11	0.1990	8.9570	T	T	P	P			CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1]; 	COSM3997295	37	384					PARP1 (inh=n/a pLI=0.01)
chr1	226570840	226570840	T	C	het		QUAL=4927;DP=95;AF=0.57;MQM=59;TRIO=HET,95,0.57,HOM,73,1.00,HET,92,0.51	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon8/23:c.1056A>G:p.Lys352Lys		rs1805415	0.7893	0.7940	39108/22757/4192	0.7879									COSM3746819	878	378					PARP1 (inh=n/a pLI=0.01)
chr1	226573364	226573364	A	G	het		QUAL=4659;DP=152;AF=0.55;MQM=60;TRIO=HET,152,0.55,WT,208,0.00,HET,248,0.45	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon7/23:c.852T>C:p.Ala284Ala		rs1805414	0.5166	0.4230	12034/4017/1535	0.4146								CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1]; 	COSM4143411	160	588					PARP1 (inh=n/a pLI=0.01)
chr1	226589958	226589958	G	A	het		QUAL=9300;DP=303;AF=0.47;MQM=59;TRIO=HET,303,0.47,WT,299,0.00,HET,470,0.49	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon2/23:c.243C>T:p.Asp81Asp		rs1805404	0.2183	0.2080	3496/997/92	0.2046									COSM3997297, COSM3997296	38	387					PARP1 (inh=n/a pLI=0.01)
chr1	226595647	226595647	C	G	het		QUAL=2447;DP=43;AF=0.56;MQM=59;TRIO=HET,43,0.56,WT,147,0.00,HET,161,0.50	PARP1	5'UTR	PARP1:NM_001618.3:5'UTR:MODIFIER:exon1/23:c.-17G>C:		rs907187	0.1991	0.2010	3026/886/10	0.1974									COSN392383	23	184					PARP1 (inh=n/a pLI=0.01)
chr1	227172290	227172290	C	T	het		QUAL=15897;DP=342;AF=0.48;MQM=60;TRIO=HET,342,0.48,HOM,382,0.98,WT,506,0.00	ADCK3	synonymous	ADCK3:NM_020247.4:synonymous:LOW:exon12/15:c.1440C>T:p.Phe480Phe		rs12593	0.2386	0.3520	8437/6747/207	0.3538						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];	RCV000116235.2 [likely benign]; 		COSM146801, COSM146800	432	1048					ADCK3 (inh=AR pLI=0.00)
chr1	227174145	227174145	T	C	het		QUAL=4263;DP=115;AF=0.56;MQM=59;TRIO=HET,115,0.56,HOM,88,1.00,WT,169,0.00	ADCK3	splice_region&intron	ADCK3:NM_020247.4:splice_region&intron:LOW:exon14/14:c.1660-9T>C:		rs7552783	0.3516	0.4140	11096/8198/896	0.4116						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];				546	1086					ADCK3 (inh=AR pLI=0.00)
chr1	227174210	227174210	T	C	het		QUAL=5280;DP=160;AF=0.44;MQM=59;TRIO=HET,160,0.44,HOM,119,1.00,WT,185,0.00	ADCK3	synonymous	ADCK3:NM_020247.4:synonymous:LOW:exon15/15:c.1716T>C:p.Ser572Ser		rs3738725	0.3139	0.4050	10713/8223/489	0.4055						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];	RCV000116236.2 [likely benign]; 		COSM3997300, COSM3997301	534	1089					ADCK3 (inh=AR pLI=0.00)
chr1	227174823	227174823	-	T	het		QUAL=13660;DP=258;AF=0.46;MQM=59;TRIO=HET,258,0.46,HOM,381,0.98,WT,484,0.00	ADCK3	3'UTR	ADCK3:NM_020247.4:3'UTR:MODIFIER:exon15/15:c.*389dupT:		rs11420839	0.2927	0.0000	0/0/0	0.3878										43	121					ADCK3 (inh=AR pLI=0.00)
chr1	227175245	227175245	-	T	het		QUAL=8168;DP=167;AF=0.44;MQM=59;TRIO=HET,167,0.44,HOM,222,0.98,WT,333,0.00	ADCK3	3'UTR	ADCK3:NM_020247.4:3'UTR:MODIFIER:exon15/15:c.*797_*798insT:		rs397803535	0.2548	0.0000	0/0/0	0.3782										36	107					ADCK3 (inh=AR pLI=0.00)
chr1	227175253	227175253	C	T	het		QUAL=8741;DP=167;AF=0.47;MQM=59;TRIO=HET,167,0.47,HOM,218,1.00,WT,326,0.00	ADCK3-CDC42BPA	intergenic_region	ADCK3-CDC42BPA:ADCK3-CDC42BPA:intergenic_region:MODIFIER::n.227175253C>T:		rs10495274	0.4191	0.0000	0/0/0	0.3433										70	101					ADCK3-CDC42BPA (inh=n/a pLI=n/a)
chr1	228346936	228346936	G	A	het		QUAL=2306;DP=45;AF=0.60;MQM=59;TRIO=HET,45,0.60,WT,92,0.00,HET,131,0.53	GJC2	3'UTR	GJC2:NM_020435.3:3'UTR:MODIFIER:exon2/2:c.*157G>A:		rs45491398	0.0234	0.0000	0/0/0	0.0105										2	28					GJC2 (inh=AR+AD pLI=0.48)
chr1	228347352	228347352	A	G	hom		QUAL=1580;DP=33;AF=1.00;MQM=59;TRIO=HOM,33,1.00,HOM,8,1.00,HOM,13,1.00	GJC2	3'UTR	GJC2:NM_020435.3:3'UTR:MODIFIER:exon2/2:c.*573A>G:		rs6668719	0.8043	0.0000	0/0/0	0.1524										196	28					GJC2 (inh=AR+AD pLI=0.48)
chr1	228612838	228612838	G	T	het		QUAL=18647;DP=289;AF=0.52;MQM=60;TRIO=HET,289,0.52,HET,287,0.46,HOM,387,1.00	HIST3H3	synonymous	HIST3H3:NM_003493.2:synonymous:LOW:exon1/1:c.189C>A:p.Ile63Ile		rs2230656	0.6903	0.8210	42225/25958/845	0.8103									COSM4143485	811	266					HIST3H3 (inh=n/a pLI=0.00)
chr1	229569803	229569803	A	G	het		QUAL=3138;DP=68;AF=0.57;MQM=59;TRIO=HET,68,0.57,HET,74,0.49,HET,109,0.54	ACTA1	5'UTR	ACTA1:NM_001100.3:5'UTR:MODIFIER:exon1/7:c.-65T>C:		rs605430	0.6302	0.0000	0/0/0	0.3849										79	113					ACTA1 (inh=n/a pLI=0.01)
chr1	229569804	229569804	G	A	het		QUAL=3138;DP=68;AF=0.57;MQM=59;TRIO=HET,68,0.57,HET,74,0.49,HET,109,0.54	ACTA1	5'UTR	ACTA1:NM_001100.3:5'UTR:MODIFIER:exon1/7:c.-66C>T:		rs605428	0.6436	0.0000	0/0/0	0.3659										79	113					ACTA1 (inh=n/a pLI=0.01)
chr1	231377081	231377081	C	T	hom		QUAL=19215;DP=318;AF=0.95;MQM=59;TRIO=HOM,318,0.95,HOM,253,0.99,HET,318,0.55	GNPAT	5'UTR	GNPAT:NM_014236.3:5'UTR:MODIFIER:exon1/16:c.-44C>T:,GNPAT:NM_001316350.1:5'UTR:MODIFIER:exon1/15:c.-44C>T:		rs518686	0.5819	0.5490	18565/9146/1688	0.5463										128	236					GNPAT (inh=AR pLI=0.29)
chr1	231401902	231401902	G	A	hom		QUAL=17575;DP=348;AF=1.00;MQM=60;TRIO=HOM,348,1.00,HET,202,0.49,HET,258,0.50	GNPAT	synonymous	GNPAT:NM_014236.3:synonymous:LOW:exon7/16:c.915G>A:p.Glu305Glu,GNPAT:NM_001316350.1:synonymous:LOW:exon6/15:c.732G>A:p.Glu244Glu		rs574553	0.6286	0.5680	19885/9534/2503	0.5651						602744 [GNPAT (provisional) Chondrodysplasia punctata,rhizomelic,type 2];			COSM3750988	334	526					GNPAT (inh=AR pLI=0.29)
chr1	231500353	231500353	-	T	hom		QUAL=17746;DP=351;AF=0.96;MQM=59;TRIO=HOM,351,0.96,HET,164,0.44,HOM,185,0.98	EGLN1	3'UTR	EGLN1:NM_022051.2:3'UTR:MODIFIER:exon5/5:c.*1803dupA:		rs11386615;rs3215625;rs541569859	0.0000	0.0000	0/0/0	0.4445										101	99					EGLN1 (inh=n/a pLI=0.93)
chr1	231557255	231557255	C	G	het	low_DP	QUAL=206;DP=3;AF=0.67;MQM=60;TRIO=HET,3,0.67,HOM,9,1.00,WT,3,0.00	EGLN1	missense	EGLN1:NM_022051.2:missense:MODERATE:exon1/5:c.380G>C:p.Cys127Ser	(GCC)n	rs12097901	0.2604	0.0940	11/3/4	0.0290	-0.0310	T	T	B	B	606425 [EGLN1 (confirmed) Erythrocytosis,familial,3|Hemoglobin,high altitude adaptation];	RCV000144173.3 [other]; 	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1]; 	COSM4143508	20	129					EGLN1 (inh=n/a pLI=0.93)
chr1	231559226	231559226	A	G	het		QUAL=5115;DP=198;AF=0.52;MQM=60;TRIO=HET,198,0.52,HOM,70,1.00,WT,82,0.02	EGLN1	5'UTR	EGLN1:NM_022051.2:5'UTR:MODIFIER:exon1/5:c.-1592T>C:		rs12406290	0.2915	0.0000	0/0/0	0.0388										13	62					EGLN1 (inh=n/a pLI=0.93)
chr1	231560220	231560220	A	G	het		QUAL=15577;DP=596;AF=0.54;MQM=60;TRIO=HET,596,0.54,HOM,212,1.00,WT,206,0.00	EGLN1	5'UTR	EGLN1:NM_022051.2:5'UTR:MODIFIER:exon1/5:c.-2586T>C:		rs2153364	0.2939	0.0000	0/0/0	0.2292										13	62					EGLN1 (inh=n/a pLI=0.93)
chr1	235825643	235825643	G	A	het		QUAL=2726;DP=207;AF=0.46;MQM=60;TRIO=HET,207,0.46,HET,30,0.33,WT,66,0.00	LYST,MIR5096	3'UTR,intron	LYST:NM_000081.3:3'UTR:MODIFIER:exon53/53:c.*597C>T:,LYST:NM_001301365.1:3'UTR:MODIFIER:exon53/53:c.*597C>T:,MIR5096:NR_039973.1:intron:MODIFIER:exon1/1:n.52-55752G>A:			0.0000	0.0000	0/0/0	0.0000										0	1					LYST (inh=AR pLI=1.00), MIR5096 (inh=n/a pLI=n/a)
chr1	235826383	235826383	A	-	hom		QUAL=14828;DP=234;AF=0.92;MQM=59;TRIO=HOM,234,0.92,HET,194,0.50,HOM,276,0.90	LYST,MIR5096	splice_region&intron,intron	LYST:NM_000081.3:splice_region&intron:LOW:exon52/52:c.11268-5delT:,LYST:NM_001301365.1:splice_region&intron:LOW:exon52/52:c.11268-5delT:,MIR5096:NR_039973.1:intron:MODIFIER:exon1/1:n.52-55000delA:		rs36014994;rs796277765	0.4227	0.4810	8946/5649/2095	0.4303						606897 [LYST (confirmed) Chediak-Higashi syndrome];				188	607	1	[1] old entry - no details available			LYST (inh=AR pLI=1.00), MIR5096 (inh=n/a pLI=n/a)
chr1	235940450	235940450	C	T	hom		QUAL=17710;DP=241;AF=1.00;MQM=60;TRIO=HOM,241,1.00,HET,202,0.43,HOM,237,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon17/53:c.5373G>A:p.Lys1791Lys,LYST:NM_001301365.1:synonymous:LOW:exon17/53:c.5373G>A:p.Lys1791Lys		rs2273584	0.3009	0.3480	8275/5496/1288	0.3457						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746866	171	524					LYST (inh=AR pLI=1.00)
chr1	235945294	235945294	T	C	hom		QUAL=15537;DP=184;AF=0.99;MQM=60;TRIO=HOM,184,0.99,HET,151,0.50,HOM,234,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon15/53:c.4956A>G:p.Leu1652Leu,LYST:NM_001301365.1:synonymous:LOW:exon15/53:c.4956A>G:p.Leu1652Leu		rs6696123	0.3035	0.3490	8327/5510/1294	0.3472						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746867	175	524					LYST (inh=AR pLI=1.00)
chr1	235971763	235971763	A	G	het		QUAL=8439;DP=203;AF=0.53;MQM=60;TRIO=HET,203,0.53,HET,197,0.51,HET,267,0.51	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.2355T>C:p.Leu785Leu,LYST:NM_001301365.1:synonymous:LOW:exon5/53:c.2355T>C:p.Leu785Leu		rs3768066	0.0707	0.1030	758/615/24	0.1031						606897 [LYST (confirmed) Chediak-Higashi syndrome];				26	290					LYST (inh=AR pLI=1.00)
chr1	235972435	235972435	T	C	hom		QUAL=27834;DP=484;AF=0.99;MQM=60;TRIO=HOM,484,0.99,HET,197,0.51,HOM,286,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.1683A>G:p.Leu561Leu,LYST:NM_001301365.1:synonymous:LOW:exon5/53:c.1683A>G:p.Leu561Leu		rs3820553	0.3027	0.3500	8325/5507/1300	0.3466						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746868	175	524					LYST (inh=AR pLI=1.00)
chr1	235972867	235972867	T	C	hom		QUAL=27810;DP=456;AF=1.00;MQM=59;TRIO=HOM,456,1.00,HET,191,0.56,HOM,305,0.99	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.1251A>G:p.Gln417Gln,LYST:NM_001301365.1:synonymous:LOW:exon5/53:c.1251A>G:p.Gln417Gln		rs1063128	0.3033	0.3500	8312/5503/1292	0.3467						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746869	175	524					LYST (inh=AR pLI=1.00)
chr1	236557771	236557771	G	A	hom	pred_pathogenic_1	QUAL=24473;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,225,1.00,HOM,289,1.00	EDARADD	missense	EDARADD:NM_145861.2:missense:MODERATE:exon1/6:c.27G>A:p.Met9Ile		rs966365	0.7768	0.8310	42529/23173/1467	0.8123	-0.0830	T	D	B	B	606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant];			COSM3746871	786	293					EDARADD (inh=n/a pLI=0.10)
chr1	236647511	236647511	T	C	het		QUAL=13119;DP=280;AF=0.54;MQM=59;TRIO=HET,280,0.54,HET,142,0.49,HOM,225,1.00	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1562T>C:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1562T>C:		rs7513402	0.2540	0.0000	0/0/0	0.0566										34	100					EDARADD (inh=n/a pLI=0.10)
chr1	236647550	236647550	C	G	het		QUAL=13992;DP=335;AF=0.55;MQM=59;TRIO=HET,335,0.55,HET,127,0.53,HOM,224,1.00	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1601C>G:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1601C>G:		rs3916983	0.2033	0.0000	0/0/0	0.0388										20	90					EDARADD (inh=n/a pLI=0.10)
chr1	236647736	236647736	C	T	het		QUAL=7352;DP=163;AF=0.54;MQM=59;TRIO=HET,163,0.54,HET,74,0.54,HOM,131,0.99	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1787C>T:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1787C>T:		rs6428955	0.1378	0.0000	0/0/0	0.0328										14	82					EDARADD (inh=n/a pLI=0.10)
chr1	236648008	236648008	G	A	hom	low_DP	QUAL=869;DP=10;AF=0.60;MQM=57;TRIO=HOM,10,0.60,HOM,15,0.33,HOM,27,0.04	EDARADD	splice_region,3'UTR	EDARADD:NM_145861.2:splice_region:LOW:exon6/6:c.*2059G>A:,EDARADD:NM_080738.3:splice_region:LOW:exon6/6:c.*2059G>A:,EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*2059G>A:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*2059G>A:	AluSc	rs200288312	0.0000	0.0000	0/0/0	0.0002										1	25					EDARADD (inh=n/a pLI=0.10)
chr1	237054569	237054569	A	G	het		QUAL=7272;DP=103;AF=0.55;MQM=59;TRIO=HET,103,0.55,HET,101,0.50,HOM,145,1.00	MTR	synonymous	MTR:NM_000254.2:synonymous:LOW:exon29/33:c.3144A>G:p.Ala1048Ala,MTR:NM_001291939.1:synonymous:LOW:exon28/32:c.2991A>G:p.Ala997Ala,MTR:NM_001291940.1:synonymous:LOW:exon28/32:c.1923A>G:p.Ala641Ala		rs2229276	0.3233	0.3830	9367/5488/217	0.3826						156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126869.2 [benign]; 		COSM3751028	166	529					MTR (inh=AR pLI=0.00)
chr1	237058744	237058744	C	A	het		QUAL=14706;DP=218;AF=0.51;MQM=60;TRIO=HET,218,0.51,HET,223,0.46,HOM,310,1.00	MTR	synonymous	MTR:NM_000254.2:synonymous:LOW:exon31/33:c.3492C>A:p.Arg1164Arg,MTR:NM_001291939.1:synonymous:LOW:exon30/32:c.3339C>A:p.Arg1113Arg,MTR:NM_001291940.1:synonymous:LOW:exon30/32:c.2271C>A:p.Arg757Arg		rs12070777	0.3215	0.3630	6783/3972/162	0.3545						156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126862.2 [benign]; 		COSM3751029	164	530					MTR (inh=AR pLI=0.00)
chr1	237061056	237061056	A	C	het		QUAL=10754;DP=311;AF=0.55;MQM=59;TRIO=HET,311,0.55,HET,80,0.53,HOM,153,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*112A>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*112A>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*112A>C:		rs2853522	0.5401	0.0000	0/0/0	0.1182										139	172					MTR (inh=AR pLI=0.00)
chr1	237061705	237061705	T	-	het		QUAL=1748;DP=108;AF=0.47;MQM=57;TRIO=HET,108,0.47,HET,32,0.56,HOM,42,0.81	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*773delT:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*773delT:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*773delT:	AluY	rs796166778	0.4605	0.0000	0/0/0	0.1949										40	159					MTR (inh=AR pLI=0.00)
chr1	237061849	237061849	G	A	het		QUAL=1239;DP=81;AF=0.43;MQM=51;TRIO=HET,81,0.43,HET,34,0.59,WT,66,0.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*905G>A:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*905G>A:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*905G>A:	AluY	rs1131450	0.2460	0.0000	0/0/0	0.2902										25	86					MTR (inh=AR pLI=0.00)
chr1	237062198	237062198	A	C	het		QUAL=16868;DP=267;AF=0.54;MQM=60;TRIO=HET,267,0.54,HET,245,0.47,HOM,296,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*1254A>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*1254A>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*1254A>C:		rs2853523	0.7646	0.0000	0/0/0	0.1176										124	110					MTR (inh=AR pLI=0.00)
chr1	237062305	237062305	A	G	het		QUAL=21941;DP=415;AF=0.52;MQM=60;TRIO=HET,415,0.52,HET,296,0.52,HOM,370,0.99	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*1361A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*1361A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*1361A>G:		rs1050993	0.7644	0.0000	0/0/0	0.1177										123	110					MTR (inh=AR pLI=0.00)
chr1	237063335	237063335	G	C	het		QUAL=12927;DP=228;AF=0.50;MQM=60;TRIO=HET,228,0.50,HET,207,0.53,HOM,222,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2391G>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2391G>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2391G>C:	L1ME3F	rs1050996	0.7328	0.0000	0/0/0	0.1060										223	260					MTR (inh=AR pLI=0.00)
chr1	237063504	237063504	A	G	het		QUAL=11930;DP=380;AF=0.50;MQM=60;TRIO=HET,380,0.50,HET,106,0.54,HOM,148,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2560A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2560A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2560A>G:	L1ME3F	rs9779	0.3219	0.2910	440/132/8	0.0915										91	256					MTR (inh=AR pLI=0.00)
chr1	237063709	237063709	-	A	hom		QUAL=9455;DP=88;AF=0.88;MQM=59;TRIO=HOM,88,0.88,HOM,62,0.94,HOM,184,0.95	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2774dupA:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2774dupA:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2774dupA:	L1ME3F	rs537046483;rs757040639;rs796715143	0.6516	0.0000	0/0/0	0.4014										187	35					MTR (inh=AR pLI=0.00)
chr1	237064626	237064626	T	G	het		QUAL=33769;DP=424;AF=0.49;MQM=60;TRIO=HET,424,0.49,HET,514,0.48,HOM,672,0.99	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*3682T>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*3682T>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*3682T>G:		rs6676866	0.5397	0.0000	0/0/0	0.1004										105	119					MTR (inh=AR pLI=0.00)
chr1	237065326	237065326	C	T	het		QUAL=8093;DP=170;AF=0.55;MQM=60;TRIO=HET,170,0.55,HET,114,0.46,HOM,157,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4382C>T:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4382C>T:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4382C>T:		rs4659746	0.5447	0.0000	0/0/0	0.1009										109	115					MTR (inh=AR pLI=0.00)
chr1	237065583	237065583	G	T	het		QUAL=13268;DP=220;AF=0.52;MQM=59;TRIO=HET,220,0.52,HET,176,0.57,HOM,257,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4639G>T:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4639G>T:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4639G>T:		rs10925264	0.7646	0.0000	0/0/0	0.1174										124	110					MTR (inh=AR pLI=0.00)
chr1	237065810	237065810	T	G	het		QUAL=4783;DP=177;AF=0.52;MQM=60;TRIO=HET,177,0.52,WT,180,0.00,HET,171,0.55	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4866T>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4866T>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4866T>G:	L2c	rs45563435	0.0076	0.0000	0/0/0	0.0027										0	19					MTR (inh=AR pLI=0.00)
chr1	237066114	237066114	A	G	het		QUAL=3157;DP=158;AF=0.49;MQM=59;TRIO=HET,158,0.49,HET,86,0.59,WT,114,0.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*5170A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*5170A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*5170A>G:		rs6680753	0.0104	0.0000	0/0/0	0.0033										0	10					MTR (inh=AR pLI=0.00)
chr1	240939104	240939104	G	A	het		QUAL=9081;DP=345;AF=0.48;MQM=60;TRIO=HET,345,0.48,HOM,146,0.99,WT,165,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*359C>T:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*416C>T:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*416C>T:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*359C>T:		rs35557904	0.1727	0.0000	0/0/0	0.0229										2	42					RGS7 (inh=n/a pLI=0.78)
chr1	240939152	240939152	A	G	het		QUAL=9436;DP=319;AF=0.44;MQM=59;TRIO=HET,319,0.44,HOM,181,0.99,WT,209,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*311T>C:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*368T>C:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*368T>C:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*311T>C:		rs16840577	0.1727	0.0000	0/0/0	0.0229										2	41					RGS7 (inh=n/a pLI=0.78)
chr1	240939391	240939391	C	T	het		QUAL=12776;DP=503;AF=0.46;MQM=60;TRIO=HET,503,0.46,HET,553,0.47,WT,688,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*72G>A:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*129G>A:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*129G>A:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*72G>A:		rs12757054	0.0497	0.0000	0/0/0	0.0139										3	64					RGS7 (inh=n/a pLI=0.78)
chr1	240975213	240975213	T	C	het		QUAL=11065;DP=255;AF=0.55;MQM=60;TRIO=HET,255,0.55,WT,201,0.00,HOM,237,1.00	RGS7	splice_region&intron	RGS7:NM_002924.5:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:NM_001282773.1:splice_region&intron:LOW:exon12/15:c.923+5A>G:,RGS7:NM_001282775.1:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:NM_001282778.1:splice_region&intron:LOW:exon14/16:c.1082+5A>G:		rs2275742	0.4046	0.5050	16301/10968/360	0.5040									COSM146839	361	484					RGS7 (inh=n/a pLI=0.78)
chr1	241519098	241519098	T	A	hom		QUAL=35182;DP=434;AF=1.00;MQM=60;TRIO=HOM,434,1.00,HOM,287,1.00,HOM,423,1.00	RGS7	5'UTR	RGS7:NM_002924.5:5'UTR:MODIFIER:exon2/18:c.-22A>T:,RGS7:NM_001282773.1:5'UTR:MODIFIER:exon2/16:c.-22A>T:,RGS7:NM_001282775.1:5'UTR:MODIFIER:exon2/18:c.-22A>T:,RGS7:NM_001282778.1:5'UTR:MODIFIER:exon2/17:c.-22A>T:		rs4659599	0.9483	0.9780	57908/32328/3876	0.9442										465	16					RGS7 (inh=n/a pLI=0.78)
chr1	247581560	247581560	A	T	het		QUAL=12620;DP=502;AF=0.50;MQM=59;TRIO=HET,502,0.50,WT,357,0.00,HET,471,0.52	NLRP3	5'UTR	NLRP3:NM_001079821.2:5'UTR:MODIFIER:exon2/11:c.-71A>T:,NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-537A>T:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-537A>T:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-543A>T:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-537A>T:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-537A>T:		rs116502550	0.0030	0.0000	0/0/0	0.0032										0	12					NLRP3 (inh=n/a pLI=0.45)
chr1	247581692	247581692	T	C	hom		QUAL=17568;DP=264;AF=0.99;MQM=58;TRIO=HOM,264,0.99,HOM,161,1.00,HOM,169,1.00	NLRP3	5'UTR,intron	NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-405T>C:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-405T>C:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-411T>C:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-405T>C:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-405T>C:,NLRP3:NM_001079821.2:intron:MODIFIER:exon2/10:c.-39+100T>C:	AluSx1	rs7523422	0.9978	0.0000	0/0/0	0.8774										217	1					NLRP3 (inh=n/a pLI=0.45)
chr1	247581872	247581872	G	A	het		QUAL=5043;DP=217;AF=0.54;MQM=58;TRIO=HET,217,0.54,HET,67,0.55,HET,85,0.44	NLRP3	5'UTR,intron	NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-225G>A:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-225G>A:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-231G>A:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-225G>A:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-225G>A:,NLRP3:NM_001079821.2:intron:MODIFIER:exon2/10:c.-38-187G>A:	AluSx1	rs138900557	0.0158	0.0000	0/0/0	0.0301										1	27					NLRP3 (inh=n/a pLI=0.45)
chr1	247582063	247582063	G	T	het		QUAL=9894;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,232,0.41,HET,287,0.50	NLRP3	5'UTR	NLRP3:NM_001079821.2:5'UTR:MODIFIER:exon3/11:c.-34G>T:,NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-34G>T:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-34G>T:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-40G>T:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-34G>T:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-34G>T:		rs73136263	0.0270	0.0370	112/64/9	0.0357										1	29					NLRP3 (inh=n/a pLI=0.45)
chr1	247587477	247587477	G	A	het		QUAL=6296;DP=167;AF=0.47;MQM=60;TRIO=HET,167,0.47,HET,155,0.41,HET,192,0.58	NLRP3	synonymous	NLRP3:NM_001079821.2:synonymous:LOW:exon5/11:c.732G>A:p.Ala244Ala,NLRP3:NM_001127461.2:synonymous:LOW:exon4/9:c.732G>A:p.Ala244Ala,NLRP3:NM_001127462.2:synonymous:LOW:exon3/8:c.732G>A:p.Ala244Ala,NLRP3:NM_001243133.1:synonymous:LOW:exon3/9:c.726G>A:p.Ala242Ala,NLRP3:NM_004895.4:synonymous:LOW:exon3/9:c.732G>A:p.Ala244Ala,NLRP3:NM_183395.2:synonymous:LOW:exon3/7:c.732G>A:p.Ala244Ala		rs3806268	0.3874	0.4990	16070/10284/74	0.4990						606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1|Muckle-Wells syndrome|CINCA syndrome];	RCV000127218.1 [benign]; 		COSM146848	359	535					NLRP3 (inh=n/a pLI=0.45)
chr1	247587531	247587531	A	G	hom		QUAL=14196;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,120,1.00,HOM,162,1.00	NLRP3	synonymous	NLRP3:NM_001079821.2:synonymous:LOW:exon5/11:c.786A>G:p.Arg262Arg,NLRP3:NM_001127461.2:synonymous:LOW:exon4/9:c.786A>G:p.Arg262Arg,NLRP3:NM_001127462.2:synonymous:LOW:exon3/8:c.786A>G:p.Arg262Arg,NLRP3:NM_001243133.1:synonymous:LOW:exon3/9:c.780A>G:p.Arg260Arg,NLRP3:NM_004895.4:synonymous:LOW:exon3/9:c.786A>G:p.Arg262Arg,NLRP3:NM_183395.2:synonymous:LOW:exon3/7:c.786A>G:p.Arg262Arg		rs4925543	0.9199	0.9430	54053/30707/3740	0.9142						606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1|Muckle-Wells syndrome|CINCA syndrome];	RCV000127219.1 [benign]; 			1013	90					NLRP3 (inh=n/a pLI=0.45)
chr1	247612036	247612036	G	C	hom		QUAL=50300;DP=706;AF=1.00;MQM=59;TRIO=HOM,706,1.00,HOM,384,1.00,HOM,505,1.00	NLRP3	3'UTR	NLRP3:NM_001079821.2:3'UTR:MODIFIER:exon11/11:c.*230G>C:,NLRP3:NM_001127461.2:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_001127462.2:3'UTR:MODIFIER:exon8/8:c.*230G>C:,NLRP3:NM_001243133.1:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_004895.4:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_183395.2:3'UTR:MODIFIER:exon7/7:c.*230G>C:		rs10754558	0.6536	0.0000	0/0/0	0.1047								CR098789 [CLASS=DFP MUT=REF PHEN="Anaphylaxis food-induced association with" GENE=NLRP3]; 		66	103					NLRP3 (inh=n/a pLI=0.45)
chr2	1417244	1417244	A	G	het		QUAL=8243;DP=243;AF=0.54;MQM=60;TRIO=HET,243,0.54,WT,223,0.00,HET,355,0.52	TPO	5'UTR_premature_start_codon_gain,5'UTR	TPO:NM_000547.5:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-80A>G:,TPO:NM_001206744.1:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-75A>G:,TPO:NM_001206745.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-75A>G:,TPO:NM_175719.3:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-80A>G:,TPO:NM_000547.5:5'UTR:MODIFIER:exon1/17:c.-80A>G:,TPO:NM_001206744.1:5'UTR:MODIFIER:exon1/17:c.-75A>G:,TPO:NM_001206745.1:5'UTR:MODIFIER:exon1/16:c.-75A>G:,TPO:NM_175719.3:5'UTR:MODIFIER:exon1/16:c.-80A>G:		rs2071403	0.6324	0.0000	0/0/0	0.5693								CR146967 [CLASS=FP MUT=ALT PHEN="Decreased thyroid mRNA expression association with" GENE=TPO]; 		54	120					TPO (inh=n/a pLI=0.00)
chr2	1481155	1481155	G	T	het	low_DP	QUAL=693;DP=10;AF=0.50;MQM=60;TRIO=HET,10,0.50,HOM,22,1.00,WT,21,0.00	TPO	missense,intron	TPO:NM_000547.5:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:NM_001206744.1:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:NM_001206745.1:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:NM_175719.3:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:NM_175721.3:missense:MODERATE:exon7/15:c.1117G>T:p.Ala373Ser,TPO:NM_175722.3:intron:MODIFIER:exon6/14:c.820-7213G>T:		rs2280132	0.4081	0.3610	1258/473/48	0.2461	0.1730	T	T,T,T,T,T,T,T	B,B,B	B,B,B	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];		CM146545 [CLASS=DFP MUT=ALT PHEN="Thyroid dyshormonogenesis" GENE=TPO]; 	COSM3749597, COSM3749598	224	520					TPO (inh=n/a pLI=0.00)
chr2	1481231	1481231	G	C	hom	low_DP;pred_pathogenic_2	QUAL=287;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,8,1.00,WT,12,0.00	TPO	missense,intron	TPO:NM_000547.5:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:NM_001206744.1:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:NM_001206745.1:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:NM_175719.3:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:NM_175721.3:missense:MODERATE:exon7/15:c.1193G>C:p.Ser398Thr,TPO:NM_175722.3:intron:MODIFIER:exon6/14:c.820-7137G>C:		rs2175977	0.7103	0.4690	2234/500/70	0.2582	1.2970	T,T	T,T,T,T,T,T,T	.,D,D,D	.,D,D,D	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];			COSM1579950, COSM3749599	401	476					TPO (inh=n/a pLI=0.00)
chr2	1520676	1520676	T	C	het		QUAL=10050;DP=244;AF=0.52;MQM=59;TRIO=HET,244,0.52,WT,219,0.00,HOM,228,1.00	TPO	missense	TPO:NM_000547.5:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:NM_001206744.1:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:NM_001206745.1:missense:MODERATE:exon14/16:c.2369T>C:p.Val790Ala,TPO:NM_175719.3:missense:MODERATE:exon14/16:c.2369T>C:p.Val790Ala,TPO:NM_175721.3:missense:MODERATE:exon13/15:c.2408T>C:p.Val803Ala,TPO:NM_175722.3:missense:MODERATE:exon13/15:c.2021T>C:p.Val674Ala		rs1126799	0.6639	0.5890	21459/9540/3194	0.5800	0.6090	T,.	T,T,T,T,T,T,T,T,T,T,.	B,B,B,B,.	B,B,B,B,.	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];			COSM3927753, COSM148793	322	543					TPO (inh=n/a pLI=0.00)
chr2	1546327	1546327	C	G	het		QUAL=21208;DP=482;AF=0.45;MQM=60;TRIO=HET,482,0.45,HOM,501,1.00,WT,714,0.00	TPO	3'UTR	TPO:NM_000547.5:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:NM_001206744.1:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:NM_001206745.1:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:NM_175719.3:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:NM_175721.3:3'UTR:MODIFIER:exon15/15:c.*81C>G:,TPO:NM_175722.3:3'UTR:MODIFIER:exon15/15:c.*81C>G:		rs1042589	0.3526	0.3890	7417/4802/237	0.3892	-1.1970	T,T	T,.						COSM4001255	118	272					TPO (inh=n/a pLI=0.00)
chr2	11911761	11911761	C	T	het		QUAL=18152;DP=262;AF=0.59;MQM=59;TRIO=HET,262,0.59,HOM,445,1.00,WT,575,0.00	LPIN1	synonymous	LPIN1:NM_001261428.1:synonymous:LOW:exon5/22:c.699C>T:p.Ile233Ile,LPIN1:NM_001261429.1:synonymous:LOW:exon5/10:c.570C>T:p.Ile190Ile,LPIN1:NM_001261427.1:synonymous:LOW:exon5/21:c.570C>T:p.Ile190Ile,LPIN1:NM_145693.2:synonymous:LOW:exon4/20:c.552C>T:p.Ile184Ile		rs11538448	0.0507	0.0950	610/525/3	0.0957						605518 [LPIN1 (provisional) Myoglobinuria,acute recurrent,autosomal recessive];	RCV000082649.4 [benign]; 			31	264					LPIN1 (inh=n/a pLI=0.00)
chr2	26413917	26413917	C	T	hom		QUAL=37578;DP=558;AF=0.99;MQM=59;TRIO=HOM,558,0.99,HOM,258,1.00,HOM,360,1.00	HADHA	3'UTR	HADHA:NM_000182.4:3'UTR:MODIFIER:exon20/20:c.*202G>A:		rs7260	0.7875	0.0000	0/0/0	0.1366										150	72					HADHA (inh=n/a pLI=0.02)
chr2	26467666	26467666	G	A	hom		QUAL=5581;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,61,1.00,HOM,98,1.00	HADHB	5'UTR	HADHB:NM_000183.2:5'UTR:MODIFIER:exon1/16:c.-201G>A:,HADHB:NM_001281512.1:5'UTR:MODIFIER:exon1/15:c.-201G>A:,HADHB:NM_001281513.1:5'UTR:MODIFIER:exon1/17:c.-350G>A:		rs3806516	0.4573	0.0000	0/0/0	0.5540										111	96					HADHB (inh=n/a pLI=0.00)
chr2	26477125	26477125	-	ACT	hom		QUAL=18752;DP=277;AF=0.97;MQM=59;TRIO=HOM,277,0.97,HOM,115,1.00,HOM,181,1.00	HADHB	disruptive_inframe_insertion,5'UTR	HADHB:NM_000183.2:disruptive_inframe_insertion:MODERATE:exon2/16:c.5_7dupCTA:p.Thr2dup,HADHB:NM_001281512.1:disruptive_inframe_insertion:MODERATE:exon2/15:c.5_7dupCTA:p.Thr2dup,HADHB:NM_001281513.1:5'UTR:MODIFIER:exon2/17:c.-145_-143dupCTA:		rs147970487;rs59947000	0.7095	0.8320	44610/29087/3978	0.7772						143450 [HADHB (confirmed) Trifunctional protein deficiency];	RCV000078340.5 [benign]; RCV000144492.1,RCV000078340.5 [not provided,benign]; RCV000144492.1 [not provided]; 			907	169					HADHB (inh=n/a pLI=0.00)
chr2	26512957	26512957	G	C	hom		QUAL=38065;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,300,1.00,HOM,367,1.00	HADHB	3'UTR	HADHB:NM_000183.2:3'UTR:MODIFIER:exon16/16:c.*136G>C:,HADHB:NM_001281512.1:3'UTR:MODIFIER:exon15/15:c.*136G>C:,HADHB:NM_001281513.1:3'UTR:MODIFIER:exon17/17:c.*136G>C:		rs1056471	0.7111	0.0000	0/0/0	0.1581										181	45					HADHB (inh=n/a pLI=0.00)
chr2	27589810	27589810	T	C	het		QUAL=18564;DP=333;AF=0.55;MQM=60;TRIO=HET,333,0.55,WT,300,0.00,HOM,416,1.00	EIF2B4	splice_region&intron	EIF2B4:NM_001318965.1:splice_region&intron:LOW:exon9/11:c.1077-7A>G:,EIF2B4:NM_001318968.1:splice_region&intron:LOW:exon9/11:c.429-7A>G:,EIF2B4:NM_172195.3:splice_region&intron:LOW:exon9/11:c.1074-7A>G:,EIF2B4:NM_001318966.1:splice_region&intron:LOW:exon10/12:c.969-7A>G:,EIF2B4:NM_001034116.1:splice_region&intron:LOW:exon10/12:c.1014-7A>G:,EIF2B4:NM_001318967.1:splice_region&intron:LOW:exon10/12:c.921-7A>G:,EIF2B4:NM_001318969.1:splice_region&intron:LOW:exon10/12:c.396-7A>G:,EIF2B4:NM_015636.3:splice_region&intron:LOW:exon10/12:c.1011-7A>G:		rs2280737	0.3834	0.3980	10318/4965/1266	0.3789						606687 [EIF2B4 (provisional) Leukoencephaly with vanishing white matter|Ovarioleukodystrophy];	RCV000081778.4 [benign]; 			274	1017					EIF2B4 (inh=AR pLI=0.83)
chr2	31749714	31749714	C	T	het		QUAL=7042;DP=266;AF=0.49;MQM=60;TRIO=HET,266,0.49,WT,228,0.00,HET,259,0.54	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*1552G>A:	UCON44	rs1042578	0.1669	0.0000	0/0/0	0.1314							RCV000083670.1 [not provided]; 			8	65					SRD5A2 (inh=n/a pLI=n/a)
chr2	31749910	31749910	T	G	het		QUAL=11043;DP=521;AF=0.53;MQM=59;TRIO=HET,521,0.53,WT,217,0.00,HET,275,0.48	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*1356A>C:	UCON44	rs28383087	0.0046	0.0000	0/0/0	0.0074							RCV000083669.1 [not provided]; 			0	4					SRD5A2 (inh=n/a pLI=n/a)
chr2	31751223	31751223	C	T	het		QUAL=5049;DP=262;AF=0.52;MQM=60;TRIO=HET,262,0.52,WT,95,0.00,HET,113,0.48	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*43G>A:		rs28383082	0.0034	0.0042	1/1/0	0.0047										0	12					SRD5A2 (inh=n/a pLI=n/a)
chr2	31805706	31805706	G	C	het		QUAL=10914;DP=124;AF=0.52;MQM=59;TRIO=HET,124,0.52,HET,309,0.52,HET,411,0.50	SRD5A2	synonymous	SRD5A2:NM_000348.3:synonymous:LOW:exon1/5:c.264C>G:p.Ala88Ala		rs523349	0.6522	0.6370	17653/10654/1699	0.6070						607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias];	RCV000083650.1 [not provided]; 			535	491					SRD5A2 (inh=n/a pLI=n/a)
chr2	31805880	31805880	-	G	het	anno_high_impact	QUAL=13380;DP=60;AF=0.77;MQM=59;TRIO=HET,60,0.77,HOM,179,0.97,HOM,254,0.99	SRD5A2	frameshift	SRD5A2:NM_000348.3:frameshift:HIGH:exon1/5:c.89dupC:p.Pro31fs		rs142200057	1.0000	1.0000	58283/31916/4520	0.9316						607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias];				1118	36	1	[1] auto-classification 16.06.2016  21.04.2016 ahdoeha1: Artefakt ssHC			SRD5A2 (inh=n/a pLI=n/a)
chr2	31806031	31806031	C	G	het		QUAL=1678;DP=33;AF=0.48;MQM=59;TRIO=HET,33,0.48,HET,45,0.58,HET,51,0.59	SRD5A2	5'UTR	SRD5A2:NM_000348.3:5'UTR:MODIFIER:exon1/5:c.-62G>C:		rs632148	0.6404	0.0000	0/0/0	0.1124							RCV000083635.1 [not provided]; 			195	185					SRD5A2 (inh=n/a pLI=n/a)
chr2	32381110	32381110	T	G	het		QUAL=375;DP=37;AF=0.38;MQM=57;TRIO=HET,37,0.38,HOM,2,1.00,HET,9,0.44	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*1545T>G:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*1545T>G:	AluSp	rs9789593	0.3379	0.0000	0/0/0	0.1642										11	109					SPAST (inh=AD pLI=1.00)
chr2	32381727	32381727	-	AGG	het		QUAL=9988;DP=320;AF=0.47;MQM=60;TRIO=HET,320,0.47,HOM,118,0.99,HET,144,0.56	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*2164_*2165insGAG:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*2164_*2165insGAG:		rs141200833;rs3040810	0.9820	0.0000	0/0/0	0.9019										224	5					SPAST (inh=AD pLI=1.00)
chr2	32381829	32381829	G	A	het		QUAL=6327;DP=233;AF=0.47;MQM=60;TRIO=HET,233,0.47,HET,112,0.52,HET,128,0.53	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*2264G>A:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*2264G>A:		rs3769602	0.4800	0.0000	0/0/0	0.0687										50	116					SPAST (inh=AD pLI=1.00)
chr2	39209047	39209047	A	G	hom		QUAL=20388;DP=282;AF=1.00;MQM=59;TRIO=HOM,282,1.00,HOM,143,1.00,HOM,191,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*3918T>C:		rs1043793	0.7476	0.0000	0/0/0	0.1466										187	41					SOS1 (inh=AD pLI=1.00)
chr2	39209426	39209426	A	G	hom		QUAL=29135;DP=462;AF=1.00;MQM=60;TRIO=HOM,462,1.00,HOM,181,1.00,HOM,229,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*3539T>C:		rs1037495	0.7466	0.0000	0/0/0	0.1467										187	40					SOS1 (inh=AD pLI=1.00)
chr2	39210398	39210398	A	T	hom		QUAL=30095;DP=336;AF=1.00;MQM=60;TRIO=HOM,336,1.00,HOM,255,1.00,HOM,321,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*2567T>A:		rs6704656	0.8996	0.0000	0/0/0	0.1557										196	33					SOS1 (inh=AD pLI=1.00)
chr2	39210719	39210719	-	TA	hom		QUAL=21435;DP=344;AF=0.98;MQM=59;TRIO=HOM,344,0.98,HOM,139,0.99,HOM,176,0.98	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*2244_*2245dupTA:		rs35129186;rs397813136;rs55672510	0.7476	0.0000	0/0/0	0.7968							RCV000193464.1 [likely benign]; 			185	43					SOS1 (inh=AD pLI=1.00)
chr2	39211121	39211121	T	C	hom		QUAL=32493;DP=443;AF=1.00;MQM=59;TRIO=HOM,443,1.00,HOM,238,1.00,HOM,290,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*1844A>G:		rs10166395	0.7622	0.0000	0/0/0	0.1476										186	42					SOS1 (inh=AD pLI=1.00)
chr2	39211359	39211359	A	-	hom		QUAL=33377;DP=425;AF=1.00;MQM=59;TRIO=HOM,425,1.00,HOM,295,1.00,HOM,325,0.99	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*1606delT:		rs398080194	0.8976	0.0000	0/0/0	0.8462							RCV000192447.1 [likely benign]; 			194	35					SOS1 (inh=AD pLI=1.00)
chr2	39212565	39212565	-	TG	hom		QUAL=11581;DP=155;AF=0.96;MQM=59;TRIO=HOM,155,0.96,HOM,99,0.98,HOM,126,0.98	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*399_*400insCA:		rs58580760	0.9026	0.0000	0/0/0	0.8140										179	48					SOS1 (inh=AD pLI=1.00)
chr2	39212637	39212637	T	C	het		QUAL=11530;DP=498;AF=0.51;MQM=59;TRIO=HET,498,0.51,HOM,145,1.00,WT,178,0.01	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*328A>G:		rs1059310	0.5234	0.0000	0/0/0	0.1047										88	118					SOS1 (inh=AD pLI=1.00)
chr2	39262348	39262348	C	G	het		QUAL=3186;DP=161;AF=0.46;MQM=60;TRIO=HET,161,0.46,WT,93,0.00,HET,109,0.47	SOS1	splice_region&intron	SOS1:NM_005633.3:splice_region&intron:LOW:exon8/22:c.1074+5G>C:		rs145155424	0.0028	0.0078	4/3/0	0.0075						182530 [SOS1 (confirmed) Fibromatosis,gingival,1|Noonan syndrome 4];	RCV000038508.7 [benign]; RCV000128195.4 [benign]; RCV000157008.1 [benign]; 			0	11	2	[2] Stefanie Beck-Woedl 04.03.2015			SOS1 (inh=AD pLI=1.00)
chr2	44114074	44114074	G	A	hom		QUAL=16666;DP=212;AF=1.00;MQM=59;TRIO=HOM,212,1.00,HOM,131,1.00,HOM,188,1.00	LRPPRC	3'UTR	LRPPRC:NM_133259.3:3'UTR:MODIFIER:exon38/38:c.*1665C>T:	AluSz6	rs1139250	0.6006	0.0000	0/0/0	0.5634										86	104					LRPPRC (inh=AR pLI=0.00)
chr2	44115183	44115183	T	A	het		QUAL=2242;DP=116;AF=0.53;MQM=60;TRIO=HET,116,0.53,WT,40,0.00,HET,56,0.48	LRPPRC	3'UTR	LRPPRC:NM_133259.3:3'UTR:MODIFIER:exon38/38:c.*556A>T:		rs1136998	0.0603	0.0000	0/0/0	0.0132										2	44					LRPPRC (inh=AR pLI=0.00)
chr2	44209477	44209477	C	T	hom		QUAL=8924;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HET,60,0.55,HOM,82,1.00	LRPPRC	synonymous	LRPPRC:NM_133259.3:synonymous:LOW:exon2/38:c.246G>A:p.Gln82Gln		rs6741066	0.5040	0.6240	25833/17604/2539	0.6155						607544 [LRPPRC (confirmed) Leigh syndrome,French-Canadian type];	RCV000117556.2 [likely benign]; 		COSM1408165	523	457					LRPPRC (inh=AR pLI=0.00)
chr2	45171842	45171842	A	G	hom		QUAL=10931;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HOM,130,1.00,HOM,185,1.00	SIX3	synonymous	SIX3:NM_005413.3:synonymous:LOW:exon2/2:c.942A>G:p.Ala314Ala		rs338074	0.9375	0.9170	39340/21492/3257	0.8440						603714 [SIX3 (confirmed) Holoprosencephaly-2|Schizencephaly];	RCV000153953.3 [benign]; 			944	149					SIX3 (inh=AD pLI=0.35)
chr2	45172447	45172447	G	T	het	low_MQM	QUAL=32;DP=71;AF=0.20;MQM=48;TRIO=HET,71,0.20,WT,22,0.00,WT,36,0.08	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*548G>T:			0.0000	0.0000	0/0/0	0.0002										0	5					SIX3 (inh=AD pLI=0.35)
chr2	45172485	45172485	G	A	het		QUAL=595;DP=56;AF=0.45;MQM=53;TRIO=HET,56,0.45,HET,4,0.50,HET,9,0.44	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*586G>A:	A-rich	rs60528008	0.0000	0.0000	0/0/0	0.0209										4	98					SIX3 (inh=AD pLI=0.35)
chr2	45172557	45172557	T	-	het		QUAL=2095;DP=123;AF=0.48;MQM=59;TRIO=HET,123,0.48,HET,18,0.72,HET,26,0.54	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*666delT:	(CT)n	rs61475963;rs796089108	0.4643	0.0000	0/0/0	0.2521										18	88					SIX3 (inh=AD pLI=0.35)
chr2	45172925	45172925	G	A	het		QUAL=8928;DP=294;AF=0.50;MQM=60;TRIO=HET,294,0.50,HET,172,0.53,HET,246,0.50	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*1026G>A:	(TC)n	rs13022334	0.2384	0.0000	0/0/0	0.0394										11	81					SIX3 (inh=AD pLI=0.35)
chr2	46583281	46583281	C	T	het		QUAL=9404;DP=191;AF=0.50;MQM=59;TRIO=HET,191,0.50,HOM,246,1.00,WT,201,0.00	EPAS1	splice_region&intron	EPAS1:NM_001430.4:splice_region&intron:LOW:exon2/15:c.218-9C>T:		rs75984373	0.0663	0.3920	9868/3862/1591	0.3073						603349 [EPAS1 (confirmed) Erythrocytosis,familial,4];				191	240					EPAS1 (inh=n/a pLI=1.00)
chr2	46603671	46603671	C	G	het		QUAL=1014;DP=23;AF=0.52;MQM=60;TRIO=HET,23,0.52,WT,15,0.00,HOM,26,1.00	EPAS1	splice_region&intron	EPAS1:NM_001430.4:splice_region&intron:LOW:exon8/15:c.1035-7C>G:		rs7557402	0.3125	0.4100	11112/8162/371	0.3905						603349 [EPAS1 (confirmed) Erythrocytosis,familial,4];			COSM4001689	272	557					EPAS1 (inh=n/a pLI=1.00)
chr2	46612327	46612328	TT	-	het		QUAL=2523;DP=137;AF=0.51;MQM=59;TRIO=HET,137,0.51,WT,42,0.07,HOM,53,0.94	EPAS1	3'UTR	EPAS1:NM_001430.4:3'UTR:MODIFIER:exon16/16:c.*539_*540delTT:		rs397984477;rs759043045	0.8858	0.0000	0/0/0	0.5399										141	79					EPAS1 (inh=n/a pLI=1.00)
chr2	46613038	46613038	A	G	het		QUAL=10385;DP=337;AF=0.49;MQM=60;TRIO=HET,337,0.49,WT,345,0.00,HET,476,0.50	EPAS1	3'UTR	EPAS1:NM_001430.4:3'UTR:MODIFIER:exon16/16:c.*1239A>G:		rs11539645	0.0172	0.0000	0/0/0	0.0077										3	25					EPAS1 (inh=n/a pLI=1.00)
chr2	48914615	48914615	C	G	het		QUAL=3431;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HET,50,0.56,WT,85,0.00	LHCGR,STON1-GTF2A1L	3'UTR,intron	LHCGR:NM_000233.3:3'UTR:MODIFIER:exon11/11:c.*221G>C:,STON1-GTF2A1L:NM_001198593.1:intron:MODIFIER:exon10/10:c.3441+15796C>G:	MER5C	rs62137532	0.1627	0.0000	0/0/0	0.1851										8	56					LHCGR (inh=n/a pLI=0.00), STON1-GTF2A1L (inh=n/a pLI=0.00)
chr2	48925746	48925746	C	T	het		QUAL=8067;DP=103;AF=0.54;MQM=60;TRIO=HET,103,0.54,HOM,121,1.00,HET,218,0.50	LHCGR,STON1-GTF2A1L	splice_region&intron,intron	LHCGR:NM_000233.3:splice_region&intron:LOW:exon9/10:c.866+8G>A:,STON1-GTF2A1L:NM_001198593.1:intron:MODIFIER:exon10/10:c.3441+26927C>T:		rs6755901	0.7374	0.7650	36619/22916/3879	0.7622						152790 [LHCGR (provisional) Precocious puberty,male|Leydig cell hypoplasia with pseudohermaphroditism|Leydig cell hypoplasia with hypergonadotropic hypogonadism|Luteinizing hormone resistance,female|Leydig cell adenoma,somatic,with precocious puberty];			COSM4001691	768	317					LHCGR (inh=n/a pLI=0.00), STON1-GTF2A1L (inh=n/a pLI=0.00)
chr2	58388696	58388696	A	G	het		QUAL=10427;DP=317;AF=0.46;MQM=60;TRIO=HET,317,0.46,HET,198,0.53,HET,260,0.53	FANCL	synonymous	FANCL:NM_001114636.1:synonymous:LOW:exon12/14:c.996T>C:p.Ser332Ser,FANCL:NM_018062.3:synonymous:LOW:exon12/14:c.981T>C:p.Ser327Ser		rs848291	0.7065	0.6480	25916/12325/4274	0.6371						608111 [FANCL (provisional) Fanconi anemia,complementation group L];			COSM4001713	553	815					FANCL (inh=AR pLI=0.00)
chr2	61276263	61276263	G	A	hom		QUAL=13372;DP=233;AF=0.99;MQM=60;TRIO=HOM,233,0.99,HOM,72,1.00,HOM,106,1.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*358G>A:		rs1177230	0.9952	0.0000	0/0/0	0.9019										225	5					PEX13 (inh=AR pLI=0.02)
chr2	61276857	61276857	C	T	het		QUAL=1394;DP=58;AF=0.45;MQM=59;TRIO=HET,58,0.45,HET,62,0.58,WT,51,0.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*952C>T:	AluSp	rs56739127	0.3039	0.0000	0/0/0	0.2822										24	102					PEX13 (inh=AR pLI=0.02)
chr2	61277099	61277099	G	A	het		QUAL=1907;DP=121;AF=0.43;MQM=59;TRIO=HET,121,0.43,HET,46,0.54,WT,81,0.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*1194G>A:		rs75205376	0.0763	0.0000	0/0/0	0.1399										8	81					PEX13 (inh=AR pLI=0.02)
chr2	61278052	61278052	A	G	hom		QUAL=5954;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HET,71,0.58,HOM,63,0.98	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*2147A>G:	AluY	rs2564097	0.6160	0.0000	0/0/0	0.5281										88	111					PEX13 (inh=AR pLI=0.02)
chr2	69547236	69547236	G	C	het		QUAL=7606;DP=235;AF=0.50;MQM=55;TRIO=HET,235,0.50,WT,226,0.00,HET,325,0.54	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*6085C>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*6085C>G:		rs7642	0.6554	0.0000	0/0/0	0.5861										81	101					GFPT1 (inh=n/a pLI=0.97)
chr2	69548320	69548320	C	T	het		QUAL=7096;DP=374;AF=0.53;MQM=59;TRIO=HET,374,0.53,WT,111,0.00,HET,152,0.41	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*5001G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*5001G>A:		rs13396883	0.6587	0.0000	0/0/0	0.5884										82	100					GFPT1 (inh=n/a pLI=0.97)
chr2	69548591	69548591	C	T	het		QUAL=6701;DP=313;AF=0.54;MQM=60;TRIO=HET,313,0.54,WT,112,0.00,HET,132,0.53	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*4730G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*4730G>A:		rs28694003	0.6386	0.0000	0/0/0	0.5815										81	101					GFPT1 (inh=n/a pLI=0.97)
chr2	69549262	69549262	T	C	het		QUAL=5380;DP=252;AF=0.54;MQM=60;TRIO=HET,252,0.54,WT,107,0.00,HET,144,0.42	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*4059A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*4059A>G:		rs13751	0.6476	0.0000	0/0/0	0.5836										80	102					GFPT1 (inh=n/a pLI=0.97)
chr2	69550036	69550036	T	C	het		QUAL=15066;DP=572;AF=0.51;MQM=59;TRIO=HET,572,0.51,WT,409,0.00,HET,530,0.50	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3285A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3285A>G:		rs7579532	0.6587	0.0000	0/0/0	0.5878										82	100					GFPT1 (inh=n/a pLI=0.97)
chr2	69550230	69550230	T	G	het		QUAL=7740;DP=293;AF=0.53;MQM=59;TRIO=HET,293,0.53,WT,141,0.00,HET,209,0.61	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3091A>C:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3091A>C:		rs7582334	0.6476	0.0000	0/0/0	0.5834										81	101					GFPT1 (inh=n/a pLI=0.97)
chr2	69550256	69550256	C	T	het		QUAL=8184;DP=302;AF=0.56;MQM=60;TRIO=HET,302,0.56,WT,121,0.00,HET,201,0.61	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3065G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3065G>A:		rs7568296	0.6635	0.0000	0/0/0	0.5869										82	100					GFPT1 (inh=n/a pLI=0.97)
chr2	69550652	69550652	G	A	het		QUAL=7252;DP=313;AF=0.49;MQM=59;TRIO=HET,313,0.49,WT,173,0.00,HET,263,0.49	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2669C>T:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2669C>T:	AluJb	rs10185336	0.6384	0.0000	0/0/0	0.5447										81	101					GFPT1 (inh=n/a pLI=0.97)
chr2	69550811	69550811	T	-	het		QUAL=141;DP=110;AF=0.38;MQM=58;TRIO=HET,110,0.38,WT,15,0.13,WT,17,0.35	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2510delA:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2510delA:	AluJb:AluSc	rs370178312	0.0000	0.0000	0/0/0	0.0070										5	64					GFPT1 (inh=n/a pLI=0.97)
chr2	69551011	69551011	T	C	het	low_MQM	QUAL=396;DP=36;AF=0.53;MQM=45;TRIO=HET,36,0.53,WT,3,0.00,HET,5,0.20	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2310A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2310A>G:	AluSc	rs10198150	0.6384	0.0000	0/0/0	0.5451										74	62					GFPT1 (inh=n/a pLI=0.97)
chr2	69551052	69551052	T	C	het		QUAL=717;DP=55;AF=0.56;MQM=50;TRIO=HET,55,0.56,WT,2,0.00,HET,8,0.13	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2269A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2269A>G:	AluSc	rs10198171	0.6494	0.0000	0/0/0	0.5567										77	74					GFPT1 (inh=n/a pLI=0.97)
chr2	69552521	69552521	C	A	het		QUAL=9111;DP=470;AF=0.44;MQM=60;TRIO=HET,470,0.44,WT,183,0.00,HET,292,0.47	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*800G>T:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*800G>T:		rs2667	0.6382	0.0000	0/0/0	0.1131										82	100					GFPT1 (inh=n/a pLI=0.97)
chr2	69553376	69553376	A	-	het		QUAL=860;DP=93;AF=0.42;MQM=59;TRIO=HET,93,0.42,WT,58,0.16,HET,83,0.53	GFPT1	splice_region&intron	GFPT1:NM_001244710.1:splice_region&intron:LOW:exon19/19:c.2056-11delT:,GFPT1:NM_002056.3:splice_region&intron:LOW:exon18/18:c.2002-11delT:	(A)n	rs201330278	0.0000	0.4800	4291/2540/705	0.0447						138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates];				188	570					GFPT1 (inh=n/a pLI=0.97)
chr2	69573029	69573029	T	C	het		QUAL=4686;DP=184;AF=0.51;MQM=60;TRIO=HET,184,0.51,WT,129,0.00,HET,178,0.49	GFPT1	splice_region&intron	GFPT1:NM_001244710.1:splice_region&intron:LOW:exon12/19:c.1105+7A>G:,GFPT1:NM_002056.3:splice_region&intron:LOW:exon11/18:c.1051+7A>G:		rs6722492	0.6472	0.5950	22189/11621/3832	0.5887						138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates];	RCV000117140.2 [benign]; 			408	504					GFPT1 (inh=n/a pLI=0.97)
chr2	71680950	71680950	C	A	het		QUAL=2042;DP=79;AF=0.51;MQM=59;TRIO=HET,79,0.51,HET,107,0.57,WT,127,0.00	DYSF	5'UTR	DYSF:NM_001130976.1:5'UTR:MODIFIER:exon1/54:c.-179C>A:,DYSF:NM_001130977.1:5'UTR:MODIFIER:exon1/55:c.-179C>A:,DYSF:NM_001130978.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_001130979.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_001130980.1:5'UTR:MODIFIER:exon1/55:c.-179C>A:,DYSF:NM_001130981.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_003494.3:5'UTR:MODIFIER:exon1/55:c.-179C>A:		rs6741336	0.2049	0.0000	0/0/0	0.0251										2	40					DYSF (inh=n/a pLI=0.00)
chr2	71780215	71780215	T	C	het		QUAL=21671;DP=298;AF=0.44;MQM=60;TRIO=HET,298,0.44,HOM,372,0.99,HET,545,0.50	DYSF	synonymous	DYSF:NM_001130987.1:synonymous:LOW:exon20/56:c.1881T>C:p.Asp627Asp,DYSF:NM_001130976.1:synonymous:LOW:exon19/54:c.1785T>C:p.Asp595Asp,DYSF:NM_001130977.1:synonymous:LOW:exon19/55:c.1785T>C:p.Asp595Asp,DYSF:NM_001130978.1:synonymous:LOW:exon20/56:c.1827T>C:p.Asp609Asp,DYSF:NM_001130979.1:synonymous:LOW:exon21/56:c.1920T>C:p.Asp640Asp,DYSF:NM_001130980.1:synonymous:LOW:exon20/55:c.1878T>C:p.Asp626Asp,DYSF:NM_001130981.1:synonymous:LOW:exon20/56:c.1878T>C:p.Asp626Asp,DYSF:NM_003494.3:synonymous:LOW:exon20/55:c.1827T>C:p.Asp609Asp,DYSF:NM_001130455.1:synonymous:LOW:exon20/55:c.1830T>C:p.Asp610Asp,DYSF:NM_001130982.1:synonymous:LOW:exon21/56:c.1923T>C:p.Asp641Asp,DYSF:NM_001130983.1:synonymous:LOW:exon20/56:c.1830T>C:p.Asp610Asp,DYSF:NM_001130984.1:synonymous:LOW:exon19/55:c.1788T>C:p.Asp596Asp,DYSF:NM_001130985.1:synonymous:LOW:exon20/55:c.1881T>C:p.Asp627Asp,DYSF:NM_001130986.1:synonymous:LOW:exon19/54:c.1788T>C:p.Asp596Asp		rs2303596	0.5755	0.6430	26416/16845/3200	0.6379						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080244.8 [other]; 		COSM4001738, COSM4001739	523	473					DYSF (inh=n/a pLI=0.00)
chr2	71795152	71795152	A	T	het		QUAL=1121;DP=34;AF=0.38;MQM=60;TRIO=HET,34,0.38,HOM,21,1.00,HET,33,0.45	DYSF	synonymous	DYSF:NM_001130987.1:synonymous:LOW:exon25/56:c.2637A>T:p.Ser879Ser,DYSF:NM_001130976.1:synonymous:LOW:exon24/54:c.2541A>T:p.Ser847Ser,DYSF:NM_001130977.1:synonymous:LOW:exon24/55:c.2541A>T:p.Ser847Ser,DYSF:NM_001130978.1:synonymous:LOW:exon25/56:c.2583A>T:p.Ser861Ser,DYSF:NM_001130979.1:synonymous:LOW:exon26/56:c.2676A>T:p.Ser892Ser,DYSF:NM_001130980.1:synonymous:LOW:exon25/55:c.2634A>T:p.Ser878Ser,DYSF:NM_001130981.1:synonymous:LOW:exon25/56:c.2634A>T:p.Ser878Ser,DYSF:NM_003494.3:synonymous:LOW:exon25/55:c.2583A>T:p.Ser861Ser,DYSF:NM_001130455.1:synonymous:LOW:exon25/55:c.2586A>T:p.Ser862Ser,DYSF:NM_001130982.1:synonymous:LOW:exon26/56:c.2679A>T:p.Ser893Ser,DYSF:NM_001130983.1:synonymous:LOW:exon25/56:c.2586A>T:p.Ser862Ser,DYSF:NM_001130984.1:synonymous:LOW:exon24/55:c.2544A>T:p.Ser848Ser,DYSF:NM_001130985.1:synonymous:LOW:exon25/55:c.2637A>T:p.Ser879Ser,DYSF:NM_001130986.1:synonymous:LOW:exon24/54:c.2544A>T:p.Ser848Ser		rs2288355	0.5505	0.6040	23766/15206/3432	0.5991						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080254.8 [other]; 		COSM3766590, COSM3766591	442	517					DYSF (inh=n/a pLI=0.00)
chr2	71838597	71838597	C	A	het		QUAL=5805;DP=101;AF=0.50;MQM=60;TRIO=HET,101,0.50,HET,163,0.50,HET,271,0.44	DYSF	splice_region&synonymous	DYSF:NM_001130987.1:splice_region&synonymous:LOW:exon38/56:c.4062C>A:p.Ile1354Ile,DYSF:NM_001130976.1:splice_region&synonymous:LOW:exon37/54:c.3966C>A:p.Ile1322Ile,DYSF:NM_001130977.1:splice_region&synonymous:LOW:exon37/55:c.3966C>A:p.Ile1322Ile,DYSF:NM_001130978.1:splice_region&synonymous:LOW:exon38/56:c.4008C>A:p.Ile1336Ile,DYSF:NM_001130979.1:splice_region&synonymous:LOW:exon39/56:c.4101C>A:p.Ile1367Ile,DYSF:NM_001130980.1:splice_region&synonymous:LOW:exon38/55:c.4059C>A:p.Ile1353Ile,DYSF:NM_001130981.1:splice_region&synonymous:LOW:exon38/56:c.4059C>A:p.Ile1353Ile,DYSF:NM_003494.3:splice_region&synonymous:LOW:exon38/55:c.4008C>A:p.Ile1336Ile,DYSF:NM_001130455.1:splice_region&synonymous:LOW:exon38/55:c.4011C>A:p.Ile1337Ile,DYSF:NM_001130982.1:splice_region&synonymous:LOW:exon39/56:c.4104C>A:p.Ile1368Ile,DYSF:NM_001130983.1:splice_region&synonymous:LOW:exon38/56:c.4011C>A:p.Ile1337Ile,DYSF:NM_001130984.1:splice_region&synonymous:LOW:exon37/55:c.3969C>A:p.Ile1323Ile,DYSF:NM_001130985.1:splice_region&synonymous:LOW:exon38/55:c.4062C>A:p.Ile1354Ile,DYSF:NM_001130986.1:splice_region&synonymous:LOW:exon37/54:c.3969C>A:p.Ile1323Ile		rs2303606	0.4495	0.5010	15435/9359/839	0.4964						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080282.8 [other]; 			316	524					DYSF (inh=n/a pLI=0.00)
chr2	73613031	73613031	-	GGA	hom	low_DP	QUAL=352;DP=1;AF=0.00;MQM=59;TRIO=HOM,1,0.00,HOM,6,0.83,HOM,14,0.64	ALMS1	disruptive_inframe_insertion	ALMS1:NM_015120.4:disruptive_inframe_insertion:MODERATE:exon1/23:c.72_74dupGGA:p.Glu25dup		rs193922695;rs55889738;rs764804760;rs772724963;rs778948871	0.0000	0.0480	3/2/0	0.0383						606844 [ALMS1 (confirmed) Alstrom syndrome];	RCV000029331.1 [uncertain significance]; RCV000202933.1 [likely benign]; RCV000206303.1 [benign]; 			179	198	1	[1] old entry - no details available			ALMS1 (inh=AR pLI=0.00)
chr2	73651967	73651967	C	T	het		QUAL=7802;DP=310;AF=0.45;MQM=60;TRIO=HET,310,0.45,WT,272,0.00,HET,312,0.51	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon5/23:c.1174C>T:p.Arg392Cys		rs3813227	0.3636	0.2680	6226/1811/2992	0.2608	0.2600	T	T,T,T	B,B	B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				68	388					ALMS1 (inh=AR pLI=0.00)
chr2	73675227	73675227	-	CTC	het		QUAL=15046;DP=161;AF=0.46;MQM=59;TRIO=HET,161,0.46,HOM,299,1.00,HET,323,0.48	ALMS1	disruptive_inframe_insertion	ALMS1:NM_015120.4:disruptive_inframe_insertion:MODERATE:exon8/23:c.1571_1573dupCTC:p.Ser524_Leu525insPro		rs34628045;rs587621330	0.6004	0.6380	25241/13578/636	0.5967						606844 [ALMS1 (confirmed) Alstrom syndrome];	RCV000205185.1 [benign]; 			485	524	1	[1] old entry - no details available			ALMS1 (inh=AR pLI=0.00)
chr2	73675669	73675669	T	G	hom		QUAL=29406;DP=300;AF=1.00;MQM=59;TRIO=HOM,300,1.00,HOM,287,1.00,HOM,325,1.00	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.2012T>G:p.Val671Gly		rs2037814	0.8722	0.8630	45056/24926/3971	0.8512	-0.5500	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				849	282					ALMS1 (inh=AR pLI=0.00)
chr2	73675844	73675844	C	T	het		QUAL=14783;DP=254;AF=0.49;MQM=60;TRIO=HET,254,0.49,HOM,230,0.99,HET,325,0.50	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon8/23:c.2187C>T:p.Phe729Phe		rs7598901	0.5264	0.5990	22804/13264/187	0.5778						606844 [ALMS1 (confirmed) Alstrom syndrome];				464	525					ALMS1 (inh=AR pLI=0.00)
chr2	73677833	73677833	A	G	het		QUAL=8805;DP=175;AF=0.49;MQM=59;TRIO=HET,175,0.49,WT,359,0.01,HET,465,0.54	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon8/23:c.4176A>G:p.Gln1392Gln		rs6546836	0.3383	0.2610	5695/1808/2469	0.2542						606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM1409404	64	394					ALMS1 (inh=AR pLI=0.00)
chr2	73677898	73677898	G	C	het		QUAL=9043;DP=215;AF=0.44;MQM=59;TRIO=HET,215,0.44,WT,337,0.00,HET,451,0.55	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.4241G>C:p.Gly1414Ala		rs6546837	0.3636	0.2680	6259/1823/2999	0.2540	-2.3660	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				69	392					ALMS1 (inh=AR pLI=0.00)
chr2	73679280	73679280	A	G	het		QUAL=9602;DP=298;AF=0.51;MQM=60;TRIO=HET,298,0.51,WT,291,0.00,HET,380,0.54	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.5623A>G:p.Ile1875Val		rs6546838	0.3588	0.2670	6146/1827/2890	0.2604	-0.1850	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				69	392					ALMS1 (inh=AR pLI=0.00)
chr2	73679866	73679866	T	C	het		QUAL=6784;DP=277;AF=0.51;MQM=60;TRIO=HET,277,0.51,WT,198,0.00,HET,237,0.46	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6209T>C:p.Ile2070Thr		rs10496192	0.1036	0.1420	1355/899/31	0.1393	-0.1900	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				32	305					ALMS1 (inh=AR pLI=0.00)
chr2	73679990	73679990	T	A	het		QUAL=5300;DP=198;AF=0.47;MQM=60;TRIO=HET,198,0.47,WT,186,0.00,HET,220,0.49	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6333T>A:p.Ser2111Arg		rs6724782	0.3638	0.2690	6205/1830/2944	0.2619	-0.2040	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133927	68	393					ALMS1 (inh=AR pLI=0.00)
chr2	73680508	73680508	G	C	het	phylop_high	QUAL=9776;DP=418;AF=0.50;MQM=60;TRIO=HET,418,0.50,WT,286,0.00,HET,271,0.55	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6851G>C:p.Arg2284Pro		rs6546839	0.3644	0.2690	6267/1836/2991	0.2619	2.6600	T	T,T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				69	394					ALMS1 (inh=AR pLI=0.00)
chr2	73717567	73717567	G	T	het		QUAL=5821;DP=240;AF=0.51;MQM=60;TRIO=HET,240,0.51,WT,135,0.01,HET,221,0.50	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon10/23:c.8478G>T:p.Arg2826Ser		rs2056486	0.3582	0.2660	6089/1794/2866	0.2590	-0.0370	T	T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133929	69	388					ALMS1 (inh=AR pLI=0.00)
chr2	73717656	73717656	A	G	het		QUAL=8615;DP=321;AF=0.52;MQM=60;TRIO=HET,321,0.52,WT,235,0.00,HET,314,0.48	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon10/23:c.8567A>G:p.Asn2856Ser		rs10193972	0.3582	0.2660	6099/1798/2869	0.2592	-0.6910	T	T,T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				69	390					ALMS1 (inh=AR pLI=0.00)
chr2	73746923	73746923	C	T	het		QUAL=3520;DP=154;AF=0.48;MQM=60;TRIO=HET,154,0.48,WT,67,0.00,HET,101,0.60	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon11/23:c.9558C>T:p.Thr3186Thr		rs11884776	0.2568	0.2170	3536/1663/1229	0.2130						606844 [ALMS1 (confirmed) Alstrom syndrome];				59	377					ALMS1 (inh=AR pLI=0.00)
chr2	73828538	73828538	G	A	het		QUAL=12355;DP=204;AF=0.54;MQM=60;TRIO=HET,204,0.54,HOM,197,1.00,HET,279,0.50	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon19/23:c.12086G>A:p.Arg4029Lys		rs1052161	0.5823	0.6310	24870/13499/538	0.6260	-1.7990	T	T,T	B,B	B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133930	468	519					ALMS1 (inh=AR pLI=0.00)
chr2	73829372	73829372	C	T	het		QUAL=8135;DP=395;AF=0.49;MQM=59;TRIO=HET,395,0.49,WT,213,0.00,HET,274,0.50	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon20/23:c.12172C>T:p.Leu4058Leu		rs1052162	0.3417	0.2640	5895/1786/2706	0.2579						606844 [ALMS1 (confirmed) Alstrom syndrome];				68	384					ALMS1 (inh=AR pLI=0.00)
chr2	73837006	73837006	T	A	het		QUAL=9755;DP=211;AF=0.45;MQM=60;TRIO=HET,211,0.45,WT,177,0.00,HOM,229,1.00	ALMS1	3'UTR	ALMS1:NM_015120.4:3'UTR:MODIFIER:exon23/23:c.*267T>A:		rs62149804	0.1052	0.0000	0/0/0	0.0237										9	58					ALMS1 (inh=AR pLI=0.00)
chr2	74185876	74185876	A	T	hom		QUAL=10459;DP=108;AF=1.00;MQM=60;TRIO=HOM,108,1.00,HET,130,0.54,HOM,165,1.00	DGUOK,DGUOK-AS1	3'UTR,intron,non_coding_exon	DGUOK:NM_080916.2:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:NM_001318859.1:3'UTR:MODIFIER:exon5/5:c.*13A>T:,DGUOK:NM_001318860.1:3'UTR:MODIFIER:exon6/6:c.*13A>T:,DGUOK:NM_001318861.1:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:NM_001318862.1:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:NM_001318863.1:3'UTR:MODIFIER:exon6/6:c.*13A>T:,DGUOK:NM_080918.2:3'UTR:MODIFIER:exon5/5:c.*13A>T:,DGUOK-AS1:NR_104029.1:intron:MODIFIER:exon1/1:n.332-542T>A:,DGUOK-AS1:NR_104030.1:intron:MODIFIER:exon1/1:n.306-542T>A:,DGUOK:NR_134893.1:non_coding_exon:MODIFIER:exon4/4:n.555A>T:,DGUOK:NR_134894.1:non_coding_exon:MODIFIER:exon5/5:n.703A>T:,DGUOK:NR_134895.1:non_coding_exon:MODIFIER:exon3/3:n.367A>T:,DGUOK:NR_134896.1:non_coding_exon:MODIFIER:exon4/4:n.537A>T:,DGUOK:NR_134897.1:non_coding_exon:MODIFIER:exon6/6:n.747A>T:,DGUOK:NR_134898.1:non_coding_exon:MODIFIER:exon5/5:n.671A>T:		rs4777	0.5308	0.5860	21034/12311/1303	0.5778							RCV000124678.1 [benign]; 			163	265					DGUOK (inh=n/a pLI=0.37), DGUOK-AS1 (inh=n/a pLI=n/a)
chr2	84650707	84650707	A	G	hom		QUAL=17133;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,160,1.00,HOM,148,1.00	SUCLG1	3'UTR	SUCLG1:NM_003849.3:3'UTR:MODIFIER:exon9/9:c.*163T>C:		rs2832	0.8021	0.0000	0/0/0	0.1401										197	28					SUCLG1 (inh=AR pLI=0.06)
chr2	85894308	85894308	G	T	het		QUAL=4203;DP=168;AF=0.43;MQM=60;TRIO=HET,168,0.43,WT,115,0.00,HOM,87,1.00	SFTPB	splice_region&intron	SFTPB:NM_000542.3:splice_region&intron:LOW:exon3/11:c.232-8C>A:,SFTPB:NM_198843.2:splice_region&intron:LOW:exon3/11:c.232-8C>A:		rs3024798	0.2969	0.3560	7917/4570/53	0.3505						178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1];	RCV000151852.1 [benign]; 			179	526					SFTPB (inh=n/a pLI=0.04)
chr2	85895338	85895338	T	G	het		QUAL=5197;DP=123;AF=0.51;MQM=59;TRIO=HET,123,0.51,WT,105,0.01,HOM,120,1.00	SFTPB	missense	SFTPB:NM_000542.3:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro,SFTPB:NM_198843.2:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro		rs2077079	0.4185	0.3090	1818/709/187	0.1472	0.8210	T	T,T	B	B	178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1];	RCV000151854.1 [benign]; 	CR077669 [CLASS=FP MUT=ALT PHEN="Increased promoter activity" GENE=SFTPB]; 	COSM3766592	169	471					SFTPB (inh=n/a pLI=0.04)
chr2	86441303	86441303	A	C	hom		QUAL=24190;DP=399;AF=0.99;MQM=59;TRIO=HOM,399,0.99,HET,367,0.50,HET,500,0.46	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2920T>G:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2920T>G:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2859T>G:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2920T>G:		rs708600	0.3736	0.0000	0/0/0	0.0686										36	98					REEP1 (inh=n/a pLI=0.94)
chr2	86441334	86441334	-	TGTT	hom		QUAL=20520;DP=287;AF=0.98;MQM=59;TRIO=HOM,287,0.98,HET,352,0.51,HET,498,0.47	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2885_*2888dupAACA:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2824_*2827dupAACA:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:		rs397794472	0.3730	0.0000	0/0/0	0.3587										35	100					REEP1 (inh=n/a pLI=0.94)
chr2	86442112	86442112	-	A	het		QUAL=1569;DP=129;AF=0.61;MQM=59;TRIO=HET,129,0.61,HET,32,0.34,HET,69,0.36	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2110dupT:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2110dupT:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2049dupT:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2110dupT:		rs200132323	0.4267	0.0000	0/0/0	0.2568										2	109					REEP1 (inh=n/a pLI=0.94)
chr2	86481835	86481835	C	T	hom		QUAL=11637;DP=221;AF=0.99;MQM=60;TRIO=HOM,221,0.99,HET,159,0.56,HET,205,0.57	REEP1	synonymous,intron	REEP1:NM_001164730.1:synonymous:LOW:exon4/7:c.306G>A:p.Thr102Thr,REEP1:NM_001164731.1:synonymous:LOW:exon3/6:c.204G>A:p.Thr68Thr,REEP1:NM_022912.2:synonymous:LOW:exon4/7:c.285G>A:p.Thr95Thr,REEP1:NM_001164732.1:intron:MODIFIER:exon3/4:c.182+9253G>A:		rs2276625	0.4287	0.4670	13960/6927/274	0.4615						609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant|Neuronopathy,distal hereditary motor,type VB];	RCV000118136.3 [other]; 		COSM3758400	361	750					REEP1 (inh=n/a pLI=0.94)
chr2	87012073	87012073	A	G	het		QUAL=9929;DP=306;AF=0.54;MQM=59;TRIO=HET,306,0.54,HET,155,0.54,HET,231,0.55	CD8A	3'UTR,non_coding_exon	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*970T>C:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*970T>C:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*970T>C:,CD8A:NR_027353.1:non_coding_exon:MODIFIER:exon7/7:n.2153T>C:		rs1051386	0.1861	0.1200	115/24/5	0.0419										15	183					CD8A (inh=n/a pLI=0.02)
chr2	87012293	87012293	A	G	het		QUAL=3964;DP=217;AF=0.55;MQM=59;TRIO=HET,217,0.55,HET,31,0.45,HET,41,0.44	CD8A	3'UTR,non_coding_exon	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*750T>C:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*750T>C:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*750T>C:,CD8A:NR_027353.1:non_coding_exon:MODIFIER:exon7/7:n.1933T>C:		rs3020729	0.1861	0.1210	115/24/5	0.0412										15	183					CD8A (inh=n/a pLI=0.02)
chr2	87012399	87012399	-	AA	het		QUAL=579;DP=98;AF=0.35;MQM=59;TRIO=HET,98,0.35,HET,27,0.48,HET,21,0.24	CD8A	3'UTR,non_coding_exon	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*642_*643dupTT:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*642_*643dupTT:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*642_*643dupTT:,CD8A:NR_027353.1:non_coding_exon:MODIFIER:exon7/7:n.1825_1826dupTT:		rs10628397;rs538181811	0.1723	0.1080	1/1/0	0.0284										7	139					CD8A (inh=n/a pLI=0.02)
chr2	87016506	87016506	A	G	het		QUAL=7343;DP=125;AF=0.49;MQM=59;TRIO=HET,125,0.49,HET,212,0.45,HET,303,0.46	CD8A	synonymous,intron,non_coding_exon	CD8A:NM_001145873.1:synonymous:LOW:exon7/9:c.565T>C:p.Leu189Leu,CD8A:NM_001768.6:synonymous:LOW:exon4/6:c.565T>C:p.Leu189Leu,CD8A:NM_171827.3:intron:MODIFIER:exon3/4:c.514+257T>C:,CD8A:NR_027353.1:non_coding_exon:MODIFIER:exon5/7:n.1040T>C:		rs3020726	0.0821	0.1180	997/852/34	0.1199						186910 [CD8A (confirmed) CD8 deficiency,familial];			COSM4001774	28	285					CD8A (inh=n/a pLI=0.02)
chr2	87018452	87018452	A	G	hom		QUAL=39501;DP=524;AF=1.00;MQM=59;TRIO=HOM,524,1.00,HOM,316,1.00,HOM,405,1.00	CD8A	5'UTR,intron	CD8A:NM_001768.6:5'UTR:MODIFIER:exon1/6:c.-504T>C:,CD8A:NM_171827.3:5'UTR:MODIFIER:exon1/5:c.-504T>C:,CD8A:NM_001145873.1:intron:MODIFIER:exon3/8:c.-270-234T>C:,CD8A:NR_027353.1:intron:MODIFIER:exon1/6:n.205+181T>C:		rs6743139	0.6581	0.0000	0/0/0	0.1266										124	88					CD8A (inh=n/a pLI=0.02)
chr2	87018547	87018547	A	G	het		QUAL=16953;DP=322;AF=0.49;MQM=59;TRIO=HET,322,0.49,HOM,283,1.00,HET,327,0.53	CD8A	5'UTR,intron	CD8A:NM_001768.6:5'UTR:MODIFIER:exon1/6:c.-599T>C:,CD8A:NM_171827.3:5'UTR:MODIFIER:exon1/5:c.-599T>C:,CD8A:NM_001145873.1:intron:MODIFIER:exon3/8:c.-270-329T>C:,CD8A:NR_027353.1:intron:MODIFIER:exon1/6:n.205+86T>C:		rs3810831	0.1312	0.0000	0/0/0	0.1847										6	72					CD8A (inh=n/a pLI=0.02)
chr2	88874891	88874891	C	A	hom	phylop_high	QUAL=37058;DP=394;AF=1.00;MQM=60;TRIO=HOM,394,1.00,HOM,327,1.00,HOM,410,1.00	EIF2AK3,LOC101928371	missense,non_coding_exon	EIF2AK3:NM_004836.6:missense:MODERATE:exon13/17:c.2110G>T:p.Ala704Ser,EIF2AK3:NM_001313915.1:missense:MODERATE:exon13/17:c.1657G>T:p.Ala553Ser,LOC101928371:NR_110236.1:non_coding_exon:MODIFIER:exon3/3:n.1510C>A:		rs1805165	0.7206	0.7020	30514/17236/4704	0.6894	2.4940	T	T,T,T,T	B	B	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116968.2 [likely benign]; 			603	416					EIF2AK3 (inh=AR pLI=0.01), LOC101928371 (inh=n/a pLI=n/a)
chr2	88879131	88879131	T	C	het		QUAL=5031;DP=276;AF=0.47;MQM=60;TRIO=HET,276,0.47,WT,127,0.00,HET,115,0.50	EIF2AK3	synonymous	EIF2AK3:NM_004836.6:synonymous:LOW:exon11/17:c.1791A>G:p.Gln597Gln,EIF2AK3:NM_001313915.1:synonymous:LOW:exon11/17:c.1338A>G:p.Gln446Gln		rs1805164	0.2582	0.2840	5151/3017/242	0.2830						604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116967.2 [likely benign]; 		COSM3746552, COSM3746551	89	422					EIF2AK3 (inh=AR pLI=0.01)
chr2	88895123	88895123	T	C	hom	phylop_high	QUAL=24629;DP=365;AF=1.00;MQM=60;TRIO=HOM,365,1.00,HOM,171,1.00,HOM,211,1.00	EIF2AK3	missense	EIF2AK3:NM_004836.6:missense:MODERATE:exon3/17:c.497A>G:p.Gln166Arg,EIF2AK3:NM_001313915.1:missense:MODERATE:exon3/17:c.44A>G:p.Gln15Arg		rs13045	0.6490	0.6370	25325/14844/3911	0.6323	5.4970	T	T,T,T,T	B	B	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116970.3 [other]; 	CM138802 [CLASS=R MUT=ALT PHEN="Wolcott-Rallison syndrome" GENE=EIF2AK3]; 	COSM4001780, COSM4001781	525	461	2	[2] Peter Bauer 25.08.2014			EIF2AK3 (inh=AR pLI=0.01)
chr2	88926730	88926732	CAG	-	hom	low_DP	QUAL=550;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HET,14,0.21,HOM,15,1.00	EIF2AK3	conservative_inframe_deletion	EIF2AK3:NM_004836.6:conservative_inframe_deletion:MODERATE:exon1/17:c.61_63delCTG:p.Leu21del	(CAG)n	rs144052332;rs72416210	0.7965	0.4870	1883/442/59	0.1367						604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000173359.2 [benign]; 			472	362					EIF2AK3 (inh=AR pLI=0.01)
chr2	96778665	96778665	-	A	het		QUAL=1456;DP=130;AF=0.38;MQM=59;TRIO=HET,130,0.38,HOM,95,0.58,WT,115,0.08	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*1879dupT:		rs11464083;rs34790807	0.6280	0.0000	0/0/0	0.3956										1	198					ADRA2B (inh=n/a pLI=0.00)
chr2	96780122	96780122	G	T	het		QUAL=6477;DP=112;AF=0.51;MQM=59;TRIO=HET,112,0.51,WT,142,0.01,HOM,164,0.99	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*423C>A:		rs4907299	0.3335	0.0000	0/0/0	0.0683										19	101					ADRA2B (inh=n/a pLI=0.00)
chr2	96780185	96780185	G	T	het		QUAL=3806;DP=188;AF=0.47;MQM=59;TRIO=HET,188,0.47,HET,132,0.52,WT,147,0.00	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*360C>A:			0.0000	0.0000	0/0/0	0.0000										0	1					ADRA2B (inh=n/a pLI=0.00)
chr2	96780716	96780716	T	G	het		QUAL=14002;DP=369;AF=0.49;MQM=59;TRIO=HET,369,0.49,HOM,305,1.00,WT,452,0.01	ADRA2B	synonymous	ADRA2B:NM_000682.6:synonymous:LOW:exon1/1:c.1173A>C:p.Gly391Gly		rs2229169	0.7053	0.6730	26959/14687/2620	0.6634						104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2];				618	413					ADRA2B (inh=n/a pLI=0.00)
chr2	96780986	96780986	-	TCCTCCTCT	het		QUAL=7743;DP=173;AF=0.36;MQM=59;TRIO=HET,173,0.36,HOM,152,0.99,HET,234,0.44	ADRA2B	disruptive_inframe_insertion	ADRA2B:NM_000682.6:disruptive_inframe_insertion:MODERATE:exon1/1:c.894_902dupAGAGGAGGA:p.Glu299_Glu301dup	(CTC)n	rs28365031;rs29000568;rs34667759;rs4066772	0.4706	0.6040	7673/3576/1062	0.5353						104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2];			COSM1023814, COSM1023812	534	409					ADRA2B (inh=n/a pLI=0.00)
chr2	98330052	98330052	C	A	het		QUAL=3455;DP=158;AF=0.49;MQM=60;TRIO=HET,158,0.49,HET,58,0.45,HET,82,0.50	ZAP70	5'UTR	ZAP70:NM_001079.3:5'UTR:MODIFIER:exon1/14:c.-186C>A:		rs2276645	0.1935	0.0000	0/0/0	0.3252										41	101					ZAP70 (inh=n/a pLI=0.27)
chr2	98354511	98354511	G	A	het		QUAL=13319;DP=289;AF=0.57;MQM=59;TRIO=HET,289,0.57,HET,295,0.53,HET,381,0.51	ZAP70	synonymous	ZAP70:NM_001079.3:synonymous:LOW:exon13/14:c.1677G>A:p.Glu559Glu,ZAP70:NM_207519.1:synonymous:LOW:exon5/6:c.756G>A:p.Glu252Glu		rs3192177	0.1484	0.2700	5449/4154/79	0.2677						176947 [ZAP70 (confirmed) Selective T-cell defect];	RCV000126355.1 [benign]; 		COSM4134221	115	432					ZAP70 (inh=n/a pLI=0.27)
chr2	98355990	98355990	G	A	het		QUAL=2107;DP=37;AF=0.54;MQM=59;TRIO=HET,37,0.54,HET,47,0.55,HET,70,0.60	ZAP70	3'UTR	ZAP70:NM_001079.3:3'UTR:MODIFIER:exon14/14:c.*29G>A:,ZAP70:NM_207519.1:3'UTR:MODIFIER:exon6/6:c.*29G>A:		rs11678558	0.1486	0.2630	4892/3746/63	0.2482										26	95					ZAP70 (inh=n/a pLI=0.27)
chr2	98356250	98356250	G	C	het		QUAL=245;DP=21;AF=0.43;MQM=59;TRIO=HET,21,0.43,HET,17,0.35,WT,21,0.00	ZAP70	3'UTR	ZAP70:NM_001079.3:3'UTR:MODIFIER:exon14/14:c.*289G>C:,ZAP70:NM_207519.1:3'UTR:MODIFIER:exon6/6:c.*289G>C:		rs2278699	0.1488	0.0000	0/0/0	0.1265										4	59					ZAP70 (inh=n/a pLI=0.27)
chr2	99172243	99172243	C	T	het		QUAL=2986;DP=137;AF=0.46;MQM=60;TRIO=HET,137,0.46,WT,130,0.02,HET,173,0.42	INPP4A	synonymous,intron	INPP4A:NM_001134224.1:synonymous:LOW:exon17/26:c.1809C>T:p.Ser603Ser,INPP4A:NM_001134225.1:synonymous:LOW:exon16/25:c.1794C>T:p.Ser598Ser,INPP4A:NM_001566.2:intron:MODIFIER:exon17/25:c.1720+89C>T:,INPP4A:NM_004027.2:intron:MODIFIER:exon17/25:c.1720+89C>T:		rs41486345	0.0254	0.0560	202/133/0	0.0533										6	135					INPP4A (inh=n/a pLI=0.99)
chr2	105977776	105977776	G	A	het		QUAL=10160;DP=571;AF=0.50;MQM=60;TRIO=HET,571,0.50,HET,215,0.55,WT,339,0.00	FHL2	synonymous	FHL2:NM_001039492.2:synonymous:LOW:exon7/7:c.804C>T:p.Asp268Asp,FHL2:NM_001318896.1:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:NM_001318899.1:synonymous:LOW:exon8/8:c.480C>T:p.Asp160Asp,FHL2:NM_001318895.1:synonymous:LOW:exon7/7:c.804C>T:p.Asp268Asp,FHL2:NM_001318898.1:synonymous:LOW:exon6/6:c.462C>T:p.Asp154Asp,FHL2:NM_001450.3:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:NM_201555.1:synonymous:LOW:exon8/8:c.804C>T:p.Asp268Asp,FHL2:NM_001318894.1:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:NM_001318897.1:synonymous:LOW:exon5/5:c.462C>T:p.Asp154Asp,FHL2:NM_201557.3:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp		rs3087523	0.0517	0.0910	588/461/3	0.0907							RCV000041652.3 [benign]; 		COSM1398595	13	249					FHL2 (inh=n/a pLI=0.00)
chr2	106510191	106510191	-	AAAG	hom		QUAL=17434;DP=175;AF=0.98;MQM=59;TRIO=HOM,175,0.98,HOM,169,0.99,HOM,208,1.00	NCK2	3'UTR	NCK2:NM_001004720.2:3'UTR:MODIFIER:exon4/4:c.*562_*565dupAGAA:,NCK2:NM_001004722.3:3'UTR:MODIFIER:exon4/4:c.*731_*734dupAGAA:,NCK2:NM_003581.4:3'UTR:MODIFIER:exon5/5:c.*562_*565dupAGAA:		rs10645562	0.9591	0.0000	0/0/0	0.8405										199	30					NCK2 (inh=n/a pLI=0.70)
chr2	106510477	106510477	T	A	het		QUAL=142;DP=84;AF=0.15;MQM=56;TRIO=HET,84,0.15,HET,6,0.50,WT,74,0.03	NCK2	3'UTR	NCK2:NM_001004720.2:3'UTR:MODIFIER:exon4/4:c.*845T>A:,NCK2:NM_001004722.3:3'UTR:MODIFIER:exon4/4:c.*1014T>A:,NCK2:NM_003581.4:3'UTR:MODIFIER:exon5/5:c.*845T>A:	PRIMA4-int	rs73946608	0.0000	0.0000	0/0/0	0.0027										0	6					NCK2 (inh=n/a pLI=0.70)
chr2	106510478	106510478	A	C	het		QUAL=142;DP=84;AF=0.15;MQM=56;TRIO=HET,84,0.15,HET,6,0.50,WT,74,0.03	NCK2	3'UTR	NCK2:NM_001004720.2:3'UTR:MODIFIER:exon4/4:c.*846A>C:,NCK2:NM_001004722.3:3'UTR:MODIFIER:exon4/4:c.*1015A>C:,NCK2:NM_003581.4:3'UTR:MODIFIER:exon5/5:c.*846A>C:	PRIMA4-int	rs73946609	0.0000	0.0000	0/0/0	0.0027										0	6					NCK2 (inh=n/a pLI=0.70)
chr2	109389463	109389463	G	A	hom		QUAL=16314;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,173,1.00,HOM,167,1.00	RANBP2	synonymous	RANBP2:NM_006267.4:synonymous:LOW:exon23/29:c.8253G>A:p.Glu2751Glu		rs826580	0.9872	0.9960	59941/33182/4734	0.9418						601181 [RANBP2 (provisional) Encephalopathy,acute,infection-induced,3,susceptibility to];				1108	0					RANBP2 (inh=n/a pLI=1.00)
chr2	109510933	109510937	TAATG	-	het		QUAL=2911;DP=80;AF=0.68;MQM=59;TRIO=HET,80,1.00,WT,11,1.00,HET,17,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*2426_*2430delCATTA:		rs555061424	0.0026	0.0000	0/0/0	0.0044										0	3					EDAR (inh=n/a pLI=0.00)
chr2	109510937	109510937	G	A	het		QUAL=2911;DP=80;AF=0.68;MQM=60;TRIO=HET,80,1.00,HOM,11,1.00,HET,17,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*2426C>T:		rs1478517	0.5317	0.0000	0/0/0	0.1220										115	79					EDAR (inh=n/a pLI=0.00)
chr2	109511765	109511765	A	G	hom		QUAL=23775;DP=409;AF=1.00;MQM=60;TRIO=HOM,409,1.00,HOM,131,0.99,HOM,187,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*1598T>C:		rs10865025	0.6699	0.0000	0/0/0	0.1344										167	54					EDAR (inh=n/a pLI=0.00)
chr2	109512234	109512234	T	C	hom		QUAL=41846;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HOM,372,1.00,HOM,504,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*1129A>G:	MIR3	rs13001699	0.7208	0.0000	0/0/0	0.1380										173	48					EDAR (inh=n/a pLI=0.00)
chr2	109513321	109513321	C	A	hom		QUAL=20607;DP=250;AF=0.99;MQM=59;TRIO=HOM,250,0.99,HOM,163,1.00,HOM,240,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*42G>T:		rs7607563	0.8830	0.8960	34504/18960/2193	0.8647							RCV000143979.1 [not provided]; 			280	41					EDAR (inh=n/a pLI=0.00)
chr2	109513654	109513654	G	A	hom		QUAL=23709;DP=250;AF=1.00;MQM=59;TRIO=HOM,250,1.00,HOM,211,1.00,HOM,313,1.00	EDAR	synonymous	EDAR:NM_022336.3:synonymous:LOW:exon12/12:c.1056C>T:p.Cys352Cys		rs12623957	0.7119	0.8080	40324/23145/924	0.7975						604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive|Hair morphology 1,hair thickness];	RCV000143982.1 [uncertain significance]; RCV000150610.1 [benign]; 			773	288					EDAR (inh=n/a pLI=0.00)
chr2	109526969	109526969	G	A	hom		QUAL=24329;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,196,1.00,HOM,307,1.00	EDAR	synonymous	EDAR:NM_022336.3:synonymous:LOW:exon9/12:c.750C>T:p.Ser250Ser		rs260632	0.9213	0.9160	50929/27250/4027	0.8948						604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive|Hair morphology 1,hair thickness];	RCV000143987.1 [uncertain significance]; RCV000150611.1 [benign]; 		COSM3766486, COSM3766485	953	148					EDAR (inh=n/a pLI=0.00)
chr2	110922703	110922703	C	T	hom		QUAL=11612;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HET,145,0.52,HET,191,0.52	NPHP1	synonymous	NPHP1:NM_000272.3:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:NM_001128178.1:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:NM_001128179.1:synonymous:LOW:exon5/18:c.468G>A:p.Glu156Glu,NPHP1:NM_207181.2:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu		rs11675767	0.4744	0.3790	9426/3514/1250	0.3768						607100 [NPHP1 (confirmed) Nephronophthisis 1,juvenile|Senior-Loken syndrome-1|Joubert syndrome 4];	RCV000078490.7 [other]; 			285	962					NPHP1 (inh=AR pLI=0.00)
chr2	113820476	113820476	T	C	het		QUAL=4008;DP=169;AF=0.48;MQM=60;TRIO=HET,169,0.48,HET,78,0.41,HET,120,0.42	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*222T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*222T>C:		rs2515401	0.7153	0.0000	0/0/0	0.1115										91	108					IL36RN (inh=n/a pLI=0.00)
chr2	113820530	113820530	A	G	het		QUAL=4095;DP=174;AF=0.47;MQM=59;TRIO=HET,174,0.47,HET,85,0.32,HET,114,0.47	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*276A>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*276A>G:		rs1800930	0.7155	0.0000	0/0/0	0.6546										90	109					IL36RN (inh=n/a pLI=0.00)
chr2	113820580	113820580	C	A	het		QUAL=4316;DP=183;AF=0.40;MQM=60;TRIO=HET,183,0.40,HET,97,0.35,HET,152,0.48	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*326C>A:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*326C>A:		rs2515402	0.7155	0.0000	0/0/0	0.6544										91	106					IL36RN (inh=n/a pLI=0.00)
chr2	113820655	113820655	A	T	het		QUAL=7343;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HET,163,0.48,HET,249,0.53	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*401A>T:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*401A>T:		rs3180234	0.7151	0.0000	0/0/0	0.1110										91	108					IL36RN (inh=n/a pLI=0.00)
chr2	113820672	113820672	A	G	het		QUAL=8420;DP=218;AF=0.50;MQM=60;TRIO=HET,218,0.50,HET,176,0.48,HET,265,0.51	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*418A>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*418A>G:		rs3180235	0.7151	0.0000	0/0/0	0.1112										91	107					IL36RN (inh=n/a pLI=0.00)
chr2	113820732	113820732	T	C	het		QUAL=9904;DP=278;AF=0.43;MQM=59;TRIO=HET,278,0.43,HET,246,0.46,HET,311,0.53	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*478T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*478T>C:		rs2515403	0.7153	0.0000	0/0/0	0.6537										91	107					IL36RN (inh=n/a pLI=0.00)
chr2	113820814	113820814	C	G	het		QUAL=7791;DP=224;AF=0.46;MQM=60;TRIO=HET,224,0.46,HET,203,0.45,HET,232,0.51	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*560C>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*560C>G:		rs2472188	0.7153	0.0000	0/0/0	0.1113										91	108					IL36RN (inh=n/a pLI=0.00)
chr2	113821117	113821117	C	T	het		QUAL=6757;DP=330;AF=0.45;MQM=60;TRIO=HET,330,0.45,HET,108,0.43,HET,140,0.51	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*863C>T:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*863C>T:	L1ME4a	rs2515404	0.8698	0.0000	0/0/0	0.1293										110	84					IL36RN (inh=n/a pLI=0.00)
chr2	113821200	113821200	T	C	het		QUAL=5044;DP=163;AF=0.52;MQM=60;TRIO=HET,163,0.52,HET,107,0.40,HET,131,0.49	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*946T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*946T>C:		rs957201	0.7153	0.0000	0/0/0	0.1115										88	102					IL36RN (inh=n/a pLI=0.00)
chr2	113821653	113821653	T	C	het		QUAL=12895;DP=370;AF=0.50;MQM=59;TRIO=HET,370,0.50,HET,276,0.46,HET,408,0.45	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*1399T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*1399T>C:	MLT1C2	rs768627	0.7153	0.0000	0/0/0	0.1116										84	90					IL36RN (inh=n/a pLI=0.00)
chr2	113887207	113887207	T	C	het		QUAL=2257;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HOM,29,1.00,WT,46,0.00	IL1RN	synonymous	IL1RN:NM_173841.2:synonymous:LOW:exon4/6:c.180T>C:p.Ala60Ala,IL1RN:NM_000577.4:synonymous:LOW:exon3/5:c.117T>C:p.Ala39Ala,IL1RN:NM_001318914.1:synonymous:LOW:exon5/7:c.69T>C:p.Ala23Ala,IL1RN:NM_173843.2:synonymous:LOW:exon4/6:c.69T>C:p.Ala23Ala,IL1RN:NM_173842.2:synonymous:LOW:exon2/4:c.171T>C:p.Ala57Ala		rs419598	0.1917	0.2490	4299/2596/27	0.2452						147679 [IL1RN (confirmed) Gastric cancer risk after H. pylori infection|Microvascular complications of diabetes 4|Interleukin 1 receptor antagonist deficiency];		CM025329 [CLASS=DP MUT=ALT PHEN="Alopecia areata association with" GENE=IL1RN]; 	COSM3766494, COSM3766495, COSM3766493	82	397					IL1RN (inh=n/a pLI=0.34)
chr2	113891412	113891412	G	A	hom		QUAL=12529;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,169,0.99,HET,245,0.47	IL1RN	3'UTR	IL1RN:NM_173841.2:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:NM_000577.4:3'UTR:MODIFIER:exon5/5:c.*964G>A:,IL1RN:NM_001318914.1:3'UTR:MODIFIER:exon7/7:c.*964G>A:,IL1RN:NM_173843.2:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:NM_173842.2:3'UTR:MODIFIER:exon4/4:c.*964G>A:	L2b	rs9005	0.3199	0.0000	0/0/0	0.0539										28	105					IL1RN (inh=n/a pLI=0.34)
chr2	113975110	113975110	A	G	hom		QUAL=9499;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HET,136,0.50,HET,184,0.48	PAX8	3'UTR	PAX8:NM_003466.3:3'UTR:MODIFIER:exon12/12:c.*1000T>C:,PAX8:NM_013952.3:3'UTR:MODIFIER:exon12/12:c.*1077T>C:,PAX8:NM_013953.3:3'UTR:MODIFIER:exon10/10:c.*1077T>C:,PAX8:NM_013992.3:3'UTR:MODIFIER:exon9/9:c.*1077T>C:		rs1049137	0.1460	0.0000	0/0/0	0.0235										13	98					PAX8 (inh=n/a pLI=0.90)
chr2	114036436	114036436	G	C	hom	anno_pathogenic_hgmd	QUAL=11806;DP=82;AF=0.98;MQM=60;TRIO=HOM,82,0.98,HOM,137,1.00,HOM,168,1.00	PAX8	5'UTR	PAX8:NM_003466.3:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:NM_013952.3:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:NM_013953.3:5'UTR:MODIFIER:exon1/10:c.-104C>G:,PAX8:NM_013992.3:5'UTR:MODIFIER:exon1/9:c.-104C>G:		rs2084163	0.9764	0.0000	0/0/0	0.1495								CR161107 [CLASS=DM? MUT=REF PHEN="Thyroid dysgenesis" GENE=PAX8]; 		230	0					PAX8 (inh=n/a pLI=0.90)
chr2	121726447	121726447	G	A	hom		QUAL=9532;DP=83;AF=1.00;MQM=60;TRIO=HOM,83,1.00,HOM,108,1.00,HOM,148,1.00	GLI2	synonymous	GLI2:NM_005270.4:synonymous:LOW:exon5/13:c.801G>A:p.Ser267Ser		rs2592595	0.8273	0.9390	54822/32314/1206	0.9099	-5.5090	T	T,T	B	B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Culler-Jones syndrome];				1030	71					GLI2 (inh=n/a pLI=1.00)
chr2	121746956	121746956	G	T	hom		QUAL=16964;DP=89;AF=0.98;MQM=59;TRIO=HOM,89,0.98,HOM,178,1.00,HOM,296,1.00	GLI2	missense	GLI2:NM_005270.4:missense:MODERATE:exon13/13:c.3466G>T:p.Ala1156Ser		rs3738880	0.5090	0.6270	23928/16654/739	0.6228	-0.3680	T	T,T	B,B	B,B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Culler-Jones syndrome];	RCV000081284.4 [benign]; 			517	450					GLI2 (inh=n/a pLI=1.00)
chr2	121747406	121747406	G	A	hom	phylop_high	QUAL=21143;DP=189;AF=0.99;MQM=59;TRIO=HOM,189,0.99,HOM,213,1.00,HOM,270,1.00	GLI2	missense	GLI2:NM_005270.4:missense:MODERATE:exon13/13:c.3916G>A:p.Asp1306Asn		rs12711538	0.5671	0.6440	24934/16738/1632	0.6370	2.1560	T	T,T	B,B	B,B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Culler-Jones syndrome];	RCV000081285.4 [benign]; 		COSM3757603	526	454					GLI2 (inh=n/a pLI=1.00)
chr2	121747429	121747429	A	G	hom		QUAL=22752;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,233,1.00,HOM,307,1.00	GLI2	synonymous	GLI2:NM_005270.4:synonymous:LOW:exon13/13:c.3939A>G:p.Pro1313Pro		rs10167980	0.5124	0.6320	24344/16984/768	0.6008						165230 [GLI2 (confirmed) Holoprosencephaly-9|Culler-Jones syndrome];	RCV000081286.4 [benign]; 		COSM3721935	528	453					GLI2 (inh=n/a pLI=1.00)
chr2	121749067	121749067	G	C	hom		QUAL=20242;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,160,1.00,HOM,227,1.00	GLI2	3'UTR	GLI2:NM_005270.4:3'UTR:MODIFIER:exon13/13:c.*816G>C:		rs2278741	0.5078	0.0000	0/0/0	0.1090										114	96					GLI2 (inh=n/a pLI=1.00)
chr2	121749584	121749589	ACACAC	-	hom		QUAL=1688;DP=57;AF=0.00;MQM=59;TRIO=HOM,57,0.16,WT,28,0.50,HOM,89,0.51	GLI2	3'UTR	GLI2:NM_005270.4:3'UTR:MODIFIER:exon13/13:c.*1371_*1376delACACAC:	(AC)n		0.0000	0.0000	0/0/0	0.0001										0	1					GLI2 (inh=n/a pLI=1.00)
chr2	127819777	127819777	C	T	het		QUAL=5043;DP=161;AF=0.43;MQM=59;TRIO=HET,161,0.43,WT,236,0.00,HET,315,0.47	BIN1	splice_region&intron	BIN1:NM_139343.2:splice_region&intron:LOW:exon9/18:c.775-4G>A:,BIN1:NM_004305.3:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139344.2:splice_region&intron:LOW:exon9/17:c.775-4G>A:,BIN1:NM_139345.2:splice_region&intron:LOW:exon9/15:c.775-4G>A:,BIN1:NM_139346.2:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:NM_139347.2:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:NM_139348.2:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139349.2:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139350.2:splice_region&intron:LOW:exon8/13:c.682-4G>A:,BIN1:NM_139351.2:splice_region&intron:LOW:exon8/12:c.682-4G>A:		rs61748157	0.0972	0.1080	711/375/15	0.1055						601248 [BIN1 (provisional) Myopathy,centronuclear,autosomal recessive];	RCV000145347.2 [benign]; 			21	259					BIN1 (inh=AR pLI=0.47)
chr2	135677471	135677471	-	GTTT	het		QUAL=5897;DP=220;AF=0.45;MQM=59;TRIO=HET,220,0.45,HET,138,0.44,HET,206,0.46	CCNT2	splice_region&intron	CCNT2:NM_058241.2:splice_region&intron:LOW:exon2/8:c.240+13_240+14insTGTT:,CCNT2:NM_001241.3:splice_region&intron:LOW:exon2/9:c.240+13_240+14insTGTT:,CCNT2:NR_037649.1:splice_region&intron:LOW:exon2/10:n.273+13_273+14insTGTT:		rs3841862;rs45507394	0.4173	0.3330	7509/3221/1074	0.3099										132	315					CCNT2 (inh=n/a pLI=0.50)
chr2	135711516	135711516	C	T	het		QUAL=15482;DP=361;AF=0.49;MQM=60;TRIO=HET,361,0.49,HET,190,0.54,HOM,250,1.00	CCNT2	synonymous,non_coding_exon	CCNT2:NM_058241.2:synonymous:LOW:exon9/9:c.1491C>T:p.Asp497Asp,CCNT2:NM_001241.3:synonymous:LOW:exon9/10:c.1491C>T:p.Asp497Asp,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon10/11:n.1611C>T:		rs3814355	0.7328	0.5890	23022/9042/2736	0.5780										321	266					CCNT2 (inh=n/a pLI=0.50)
chr2	135711657	135711657	G	A	het		QUAL=25388;DP=414;AF=0.49;MQM=59;TRIO=HET,414,0.49,HET,365,0.53,HOM,469,1.00	CCNT2	synonymous,non_coding_exon	CCNT2:NM_058241.2:synonymous:LOW:exon9/9:c.1632G>A:p.Lys544Lys,CCNT2:NM_001241.3:synonymous:LOW:exon9/10:c.1632G>A:p.Lys544Lys,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon10/11:n.1752G>A:		rs3814354	0.7021	0.5800	22314/8992/2134	0.5691									COSM1399489, COSM1179790	310	271					CCNT2 (inh=n/a pLI=0.50)
chr2	135713386	135713389	AAAA	-	het		QUAL=7607;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,HET,110,0.60,HET,177,0.57	CCNT2	3'UTR,non_coding_exon	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*1170_*1173delAAAA:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*1270_*1273delAAAA:,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon11/11:n.3382_3385delAAAA:		rs397897552	0.0000	0.0000	0/0/0	0.1458										25	101					CCNT2 (inh=n/a pLI=0.50)
chr2	135713703	135713703	G	A	het		QUAL=9297;DP=261;AF=0.52;MQM=60;TRIO=HET,261,0.52,HET,70,0.46,HOM,146,1.00	CCNT2	3'UTR,non_coding_exon	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*1485G>A:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*1585G>A:,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon11/11:n.3697G>A:		rs3769023	0.7059	0.0000	0/0/0	0.0989										94	110					CCNT2 (inh=n/a pLI=0.50)
chr2	135715175	135715175	C	-	het		QUAL=13043;DP=325;AF=0.51;MQM=60;TRIO=HET,325,0.51,HET,169,0.50,HOM,208,1.00	CCNT2	3'UTR,non_coding_exon	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*2957delC:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3057delC:,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon11/11:n.5169delC:		rs869206358	0.0000	0.0000	0/0/0	0.3683										65	70					CCNT2 (inh=n/a pLI=0.50)
chr2	135715466	135715469	TAAT	-	het		QUAL=11143;DP=325;AF=0.51;MQM=59;TRIO=HET,325,0.51,HET,119,0.56,HOM,175,0.99	CCNT2	3'UTR,non_coding_exon	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*3252_*3255delTAAT:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3352_*3355delTAAT:,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon11/11:n.5464_5467delTAAT:		rs570752784	0.0000	0.0000	0/0/0	0.3652										64	71					CCNT2 (inh=n/a pLI=0.50)
chr2	135715957	135715957	A	G	het		QUAL=11406;DP=418;AF=0.44;MQM=59;TRIO=HET,418,0.44,HET,178,0.43,HOM,146,1.00	CCNT2	3'UTR,non_coding_exon	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*3739A>G:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3839A>G:,CCNT2:NR_037649.1:non_coding_exon:MODIFIER:exon11/11:n.5951A>G:		rs1947112	0.7055	0.0000	0/0/0	0.0980										65	70					CCNT2 (inh=n/a pLI=0.50)
chr2	145142173	145142173	T	-	het		QUAL=2205;DP=153;AF=0.50;MQM=59;TRIO=HET,153,0.50,WT,34,0.03,HET,73,0.48	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*4845delA:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*4845delA:		rs201661554	0.0885	0.0000	0/0/0	0.0230										0	14					ZEB2 (inh=AD pLI=1.00)
chr2	145143934	145143934	G	A	het		QUAL=3363;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,HOM,36,0.97,WT,49,0.00	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*3084C>T:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*3084C>T:		rs62169201	0.0397	0.0000	0/0/0	0.0937										6	32					ZEB2 (inh=AD pLI=1.00)
chr2	145144612	145144612	-	TA	hom		QUAL=546;DP=30;AF=0.67;MQM=59;TRIO=HOM,30,0.67,HET,28,0.21,HET,42,0.33	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*2404_*2405dupTA:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*2404_*2405dupTA:	(TG)n	rs143648355;rs767117745	0.0000	0.0000	0/0/0	0.1746										9	87					ZEB2 (inh=AD pLI=1.00)
chr2	145145034	145145034	A	G	hom		QUAL=17099;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HOM,113,1.00,HOM,142,0.99	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*1984T>C:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*1984T>C:		rs10179925	0.9958	0.0000	0/0/0	0.8648										187	0					ZEB2 (inh=AD pLI=1.00)
chr2	149270710	149270710	A	G	hom		QUAL=15036;DP=329;AF=0.99;MQM=60;TRIO=HOM,329,0.99,HET,157,0.50,HET,167,0.46	MBD5	3'UTR	MBD5:NM_018328.4:3'UTR:MODIFIER:exon15/15:c.*200A>G:		rs16828708	0.4491	0.0000	0/0/0	0.0657										21	96					MBD5 (inh=AD pLI=1.00)
chr2	149881076	149881076	A	G	hom		QUAL=4686;DP=95;AF=0.14;MQM=55;TRIO=HOM,95,0.14,HOM,45,0.02,HOM,84,0.07	KIF5C	3'UTR,non_coding_exon	KIF5C:NM_004522.2:3'UTR:MODIFIER:exon26/26:c.*1492A>G:,KIF5C:NR_111932.1:non_coding_exon:MODIFIER:exon20/20:n.3990A>G:	(GT)n	rs78917133	0.0000	0.0000	0/0/0	0.0008										0	6					KIF5C (inh=n/a pLI=1.00)
chr2	152346553	152346553	G	A	het	anno_high_impact;phylop_high;anno_pathogenic_hgmd	QUAL=4950;DP=279;AF=0.44;MQM=60;TRIO=HET,279,0.44,HET,145,0.48,WT,227,0.00	NEB	stop_gained	NEB:NM_001271208.1:stop_gained:HIGH:exon182/183:c.25441C>T:p.Arg8481*,NEB:NM_001164507.1:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:NM_001164508.1:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:NM_004543.4:stop_gained:HIGH:exon148/149:c.19732C>T:p.Arg6578*		rs200731870	0.0000	0.0001	0/0/0	0.0001	2.9000					161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];		CM1413908 [CLASS=DM MUT=ALT PHEN="Nemaline myopathy" GENE=NEB]; 	COSM1590777, COSM1007385, COSM1007383	0	1					NEB (inh=n/a pLI=0.00)
chr2	152346979	152346979	T	C	het		QUAL=10901;DP=291;AF=0.47;MQM=60;TRIO=HET,291,0.47,HET,240,0.49,HET,301,0.55	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon181/183:c.25309A>G:p.Ile8437Val,NEB:NM_001164507.1:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:NM_001164508.1:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:NM_004543.4:missense:MODERATE:exon147/149:c.19600A>G:p.Ile6534Val		rs1061305	0.3343	0.3640	7524/4880/826	0.3635	-0.6960	T	T,T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081132.8 [other]; 			179	504					NEB (inh=n/a pLI=0.00)
chr2	152352843	152352843	C	G	hom	phylop_high	QUAL=34171;DP=329;AF=1.00;MQM=59;TRIO=HOM,329,1.00,HOM,321,1.00,HOM,415,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon174/183:c.24538G>C:p.Ala8180Pro,NEB:NM_001164507.1:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:NM_001164508.1:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:NM_004543.4:missense:MODERATE:exon140/149:c.18829G>C:p.Ala6277Pro		rs7575451	0.6278	0.6390	24235/13117/1701	0.6285	3.0990	T,T,.	T,T,T,T,T,T,T,T,.,.	B,B,B,B,.,.	B,B,B,B,.,.	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081126.8 [other]; 		COSM4154530, COSM4154529, COSM4154531	482	493					NEB (inh=n/a pLI=0.00)
chr2	152354239	152354239	G	A	het		QUAL=4768;DP=187;AF=0.50;MQM=58;TRIO=HET,187,0.50,HET,221,0.43,WT,314,0.00	NEB	splice_region&intron,intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon171/182:c.24313-7C>T:,NEB:NM_001164507.1:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:NM_001164508.1:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:NM_004543.4:intron:MODIFIER:exon139/148:c.18790-1357C>T:		rs113048349	0.0050	0.0072	2/1/0	0.0072						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000223141.1 [benign]; 			0	13					NEB (inh=n/a pLI=0.00)
chr2	152387553	152387553	T	C	hom		QUAL=36292;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,311,0.99,HOM,450,1.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon146/183:c.21690A>G:p.Thr7230Thr,NEB:NM_001164507.1:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:NM_001164508.1:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:NM_004543.4:synonymous:LOW:exon117/149:c.16446A>G:p.Thr5482Thr		rs4664475	0.4916	0.5770	20606/12509/761	0.5728						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081120.8 [other]; 			429	520					NEB (inh=n/a pLI=0.00)
chr2	152388416	152388416	T	-	hom		QUAL=18751;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,153,1.00,HOM,259,1.00	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon144/182:c.21523-6delA:,NEB:NM_001164507.1:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:NM_001164508.1:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:NM_004543.4:splice_region&intron:LOW:exon115/148:c.16279-6delA:		rs398090759	0.4912	0.5590	14652/8850/622	0.5208						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081118.4 [benign]; 			428	520					NEB (inh=n/a pLI=0.00)
chr2	152422076	152422076	C	G	het	phylop_high	QUAL=20112;DP=415;AF=0.47;MQM=60;TRIO=HET,415,0.47,HET,275,0.55,HOM,328,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon116/183:c.18305G>C:p.Arg6102Thr,NEB:NM_001164507.1:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:NM_001164508.1:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:NM_004543.4:missense:MODERATE:exon88/149:c.13166G>C:p.Arg4389Thr		rs2288210	0.6532	0.6570	24879/13497/1824	0.6517	5.7170	T	T,T,T,T,T,T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081115.8 [other]; 		COSM4154536, COSM4154537, COSM4154535	507	480					NEB (inh=n/a pLI=0.00)
chr2	152424933	152424933	-	A	het		QUAL=2695;DP=139;AF=0.32;MQM=59;TRIO=HET,139,0.32,HET,77,0.44,HOM,84,0.83	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon111/182:c.17635-3dupT:,NEB:NM_001164507.1:splice_region&intron:LOW:exon111/181:c.17635-3dupT:,NEB:NM_001164508.1:splice_region&intron:LOW:exon111/181:c.17635-3dupT:,NEB:NM_004543.4:splice_region&intron:LOW:exon83/148:c.12496-3dupT:		rs3214503;rs397772995;rs539518038	0.5066	0.4700	2228/1284/229	0.0712						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];			COSM1613493, COSM1613494, COSM1613492	142	684					NEB (inh=n/a pLI=0.00)
chr2	152432311	152432311	T	C	het		QUAL=4116;DP=220;AF=0.46;MQM=60;TRIO=HET,220,0.46,HET,117,0.48,WT,160,0.00	NEB	splice_region&synonymous	NEB:NM_001271208.1:splice_region&synonymous:LOW:exon107/183:c.16911A>G:p.Pro5637Pro,NEB:NM_001164507.1:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:NM_001164508.1:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:NM_004543.4:splice_region&synonymous:LOW:exon79/149:c.11772A>G:p.Pro3924Pro		rs33988153	0.1102	0.1980	2894/2179/12	0.1876						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081112.8 [other]; 		COSM3757669, COSM3757668, COSM3757670	61	388					NEB (inh=n/a pLI=0.00)
chr2	152490458	152490458	A	G	hom	phylop_high	QUAL=45358;DP=402;AF=1.00;MQM=59;TRIO=HOM,402,1.00,HOM,434,1.00,HOM,605,1.00	NEB	missense,intron	NEB:NM_001271208.1:missense:MODERATE:exon65/183:c.9124T>C:p.Cys3042Arg,NEB:NM_001164507.1:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:NM_001164508.1:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:NM_004543.4:intron:MODIFIER:exon62/148:c.8854-3125T>C:		rs6710212	0.9720	0.9930	59546/33349/4133	0.9227	1.6720	T	T,T			161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000215771.1 [benign]; 			1103	1					NEB (inh=n/a pLI=0.00)
chr2	152496526	152496526	A	G	het	phylop_high	QUAL=7721;DP=181;AF=0.49;MQM=60;TRIO=HET,181,0.49,HET,204,0.47,HET,288,0.47	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon62/183:c.8734T>C:p.Ser2912Pro,NEB:NM_001164507.1:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:NM_001164508.1:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:NM_004543.4:missense:MODERATE:exon62/149:c.8734T>C:p.Ser2912Pro		rs6713162	0.4453	0.2540	5615/909/2004	0.2502	5.5460	T	T,T,T,T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117776.3 [other]; 		COSM148951, COSM3757671, COSM3757672	51	326					NEB (inh=n/a pLI=0.00)
chr2	152497088	152497088	G	A	het		QUAL=13542;DP=439;AF=0.47;MQM=53;TRIO=HET,439,0.47,HET,712,0.47,WT,902,0.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon61/183:c.8466C>T:p.His2822His,NEB:NM_001164507.1:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:NM_001164508.1:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:NM_004543.4:synonymous:LOW:exon61/149:c.8466C>T:p.His2822His		rs61730771	0.0323	0.0220	35/6/9	0.0202						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117774.3 [other]; 		COSM3694907, COSM3694906, COSM3694905	1	38					NEB (inh=n/a pLI=0.00)
chr2	152499143	152499143	C	T	het	phylop_high;pred_pathogenic_3	QUAL=7419;DP=245;AF=0.56;MQM=60;TRIO=HET,245,0.56,HET,275,0.50,WT,378,0.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon60/183:c.8318G>A:p.Arg2773Gln,NEB:NM_001164507.1:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:NM_001164508.1:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:NM_004543.4:missense:MODERATE:exon60/149:c.8318G>A:p.Arg2773Gln		rs35974308	0.0206	0.0230	37/16/0	0.0229	3.9180	T	T,D,D,T	D	D	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117773.3 [other]; 		COSM3757674, COSM3757673, COSM3757675	1	47					NEB (inh=n/a pLI=0.00)
chr2	152511778	152511778	A	C	het		QUAL=4466;DP=124;AF=0.58;MQM=60;TRIO=HET,124,0.58,HET,71,0.52,HET,86,0.62	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon51/182:c.6807+6T>G:,NEB:NM_001164507.1:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:NM_001164508.1:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:NM_004543.4:splice_region&intron:LOW:exon51/148:c.6807+6T>G:		rs10930723	0.4309	0.2480	5084/857/1656	0.2358						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117771.7 [other]; 			50	325					NEB (inh=n/a pLI=0.00)
chr2	152521096	152521096	C	T	het		QUAL=3490;DP=169;AF=0.44;MQM=60;TRIO=HET,169,0.44,HET,62,0.40,HET,85,0.46	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon44/183:c.5370G>A:p.Glu1790Glu,NEB:NM_001164507.1:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:NM_001164508.1:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:NM_004543.4:synonymous:LOW:exon44/149:c.5370G>A:p.Glu1790Glu		rs10170273	0.4349	0.2410	4373/710/1512	0.2420						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117761.3 [other]; 		COSM3757676, COSM148953, COSM3757677	51	332					NEB (inh=n/a pLI=0.00)
chr2	152527572	152527572	C	T	het	phylop_high;pred_pathogenic_1	QUAL=14815;DP=303;AF=0.51;MQM=59;TRIO=HET,303,0.51,HET,314,0.54,HET,432,0.56	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4471G>A:p.Val1491Met,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4471G>A:p.Val1491Met		rs7426114	0.5331	0.7370	34995/23317/423	0.7197	2.6960	T	D,T,T,D	P	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081137.8 [other]; 	CM1414605 [CLASS=DP MUT=ALT PHEN="Stress fracture association with" GENE=NEB]; 	COSM4001231, COSM4001233, COSM4001232	724	333					NEB (inh=n/a pLI=0.00)
chr2	152527608	152527608	C	T	het		QUAL=13856;DP=330;AF=0.49;MQM=60;TRIO=HET,330,0.49,HET,368,0.45,HET,515,0.43	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4435G>A:p.Val1479Ile,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4435G>A:p.Val1479Ile		rs34577613	0.3353	0.1900	3255/393/738	0.1888	0.0190	T	T,T,T,T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117759.3 [other]; 		COSM3757679, COSM3757678, COSM148955	28	251					NEB (inh=n/a pLI=0.00)
chr2	152527636	152527636	C	G	het	pred_pathogenic_2	QUAL=10215;DP=424;AF=0.48;MQM=60;TRIO=HET,424,0.48,HET,401,0.47,WT,545,0.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4407G>C:p.Glu1469Asp,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4407G>C:p.Glu1469Asp		rs34800215	0.0272	0.0200	37/6/20	0.0195	0.3640	T	T,T,T,T	D	D	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117758.3 [other]; 		COSM3694913, COSM3694911, COSM3694912	0	35					NEB (inh=n/a pLI=0.00)
chr2	152531077	152531077	A	G	het		QUAL=6951;DP=256;AF=0.49;MQM=60;TRIO=HET,256,0.49,HET,148,0.43,HET,206,0.41	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon36/183:c.3901T>C:p.Tyr1301His,NEB:NM_001164507.1:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:NM_001164508.1:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:NM_004543.4:missense:MODERATE:exon36/149:c.3901T>C:p.Tyr1301His		rs6711382	0.7161	0.8260	41970/26480/2028	0.8069	1.3400	T	T,T,T,T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000153548.3 [benign]; 		COSM4001236, COSM4001235, COSM4001234	840	246					NEB (inh=n/a pLI=0.00)
chr2	152536427	152536427	C	T	het		QUAL=8915;DP=293;AF=0.48;MQM=60;TRIO=HET,293,0.48,HET,398,0.52,WT,425,0.00	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon31/182:c.3147+5G>A:,NEB:NM_001164507.1:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:NM_001164508.1:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:NM_004543.4:splice_region&intron:LOW:exon31/148:c.3147+5G>A:		rs74859201	0.0114	0.0160	17/6/0	0.0152						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117754.2 [benign]; 			0	34					NEB (inh=n/a pLI=0.00)
chr2	152536498	152536498	T	A	het	pred_pathogenic_1	QUAL=23492;DP=396;AF=0.49;MQM=59;TRIO=HET,396,0.49,HET,373,0.48,HOM,420,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon31/183:c.3081A>T:p.Lys1027Asn,NEB:NM_001164507.1:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:NM_001164508.1:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:NM_004543.4:missense:MODERATE:exon31/149:c.3081A>T:p.Lys1027Asn		rs6735208	0.5835	0.7490	35419/23029/770	0.7362	-0.4180	T	T,T,T,T	D	P	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081134.8 [other]; 			727	323					NEB (inh=n/a pLI=0.00)
chr2	152573981	152573981	A	G	het		QUAL=14852;DP=354;AF=0.46;MQM=59;TRIO=HET,354,0.46,HET,182,0.48,HOM,252,1.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon10/183:c.771T>C:p.Ala257Ala,NEB:NM_001164507.1:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:NM_001164508.1:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:NM_004543.4:synonymous:LOW:exon10/149:c.771T>C:p.Ala257Ala		rs4611637	0.5693	0.7430	34969/22935/596	0.7248						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081142.8 [other]; 		COSM4001250, COSM4001251, COSM4001249	726	328					NEB (inh=n/a pLI=0.00)
chr2	152580766	152580766	A	G	het		QUAL=4603;DP=153;AF=0.42;MQM=60;TRIO=HET,153,0.42,HET,245,0.50,WT,388,0.00	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon8/182:c.612+8T>C:,NEB:NM_001164507.1:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:NM_001164508.1:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:NM_004543.4:splice_region&intron:LOW:exon8/148:c.612+8T>C:		rs113095802	0.0254	0.0190	26/4/13	0.0184						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117768.3 [other]; 			0	37					NEB (inh=n/a pLI=0.00)
chr2	152690248	152690248	G	A	hom		QUAL=16516;DP=304;AF=1.00;MQM=60;TRIO=HOM,304,1.00,HOM,82,1.00,HOM,111,1.00	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*5385C>T:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*5385C>T:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*5385C>T:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*5385C>T:		rs1568673	0.8784	0.0000	0/0/0	0.1566										216	13					CACNB4 (inh=AD pLI=0.01)
chr2	152691829	152691829	C	G	het		QUAL=6394;DP=340;AF=0.49;MQM=60;TRIO=HET,340,0.49,HET,123,0.55,WT,187,0.01	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*3804G>C:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*3804G>C:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*3804G>C:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*3804G>C:		rs2344734	0.4603	0.0000	0/0/0	0.0510										10	74					CACNB4 (inh=AD pLI=0.01)
chr2	152693977	152693977	A	G	het		QUAL=5973;DP=311;AF=0.49;MQM=60;TRIO=HET,311,0.49,HET,134,0.50,WT,237,0.00	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*1656T>C:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*1656T>C:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*1656T>C:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*1656T>C:		rs62174451	0.0236	0.0000	0/0/0	0.0041										0	11					CACNB4 (inh=AD pLI=0.01)
chr2	152695191	152695191	C	T	het		QUAL=2120;DP=135;AF=0.49;MQM=59;TRIO=HET,135,0.49,HET,21,0.48,WT,39,0.05	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*442G>A:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*442G>A:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*442G>A:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*442G>A:		rs7597215	0.4842	0.0000	0/0/0	0.0381										10	75					CACNB4 (inh=AD pLI=0.01)
chr2	152717331	152717331	A	T	het		QUAL=4631;DP=227;AF=0.49;MQM=60;TRIO=HET,227,0.49,HET,185,0.52,WT,267,0.00	CACNB4	synonymous	CACNB4:NM_000726.3:synonymous:LOW:exon10/14:c.762T>A:p.Ile254Ile,CACNB4:NM_001005747.2:synonymous:LOW:exon9/13:c.660T>A:p.Ile220Ile,CACNB4:NM_001005746.2:synonymous:LOW:exon10/14:c.708T>A:p.Ile236Ile,CACNB4:NM_001145798.1:synonymous:LOW:exon10/13:c.762T>A:p.Ile254Ile		rs61736804	0.0503	0.0330	111/21/74	0.0317						601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6|Epilepsy,idiopathic generalized,susceptibility to,9|Episodic ataxia,type 5];	RCV000116535.2 [likely benign]; 		COSM3757681, COSM3757680, COSM3757683, COSM3757682	2	100					CACNB4 (inh=AD pLI=0.01)
chr2	166170127	166170127	T	C	hom		QUAL=20756;DP=189;AF=0.99;MQM=60;TRIO=HOM,189,0.99,HOM,189,1.00,HOM,270,1.00	SCN2A	splice_region&intron	SCN2A:NM_001040142.1:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:NM_021007.2:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:NM_001040143.1:splice_region&intron:LOW:exon7/25:c.1035-3T>C:		rs2121371	0.7724	0.8020	39160/23066/3402	0.7900						182390 [SCN2A (confirmed) Seizures,benign familial infantile,3|Epileptic encephalopathy,early infantile,11];	RCV000118252.1 [benign]; 			722	333					SCN2A (inh=AD pLI=1.00)
chr2	166246710	166246710	A	C	het	trio_denovo	QUAL=660;DP=352;AF=0.50;MQM=59;TRIO=HET,352,0.50,WT,106,0.01,WT,187,0.01	SCN2A	3'UTR	SCN2A:NM_001040142.1:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:NM_021007.2:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:NM_001040143.1:3'UTR:MODIFIER:exon26/26:c.*376A>C:		rs376498111	0.0000	0.0000	0/0/0	0.0007										0	26					SCN2A (inh=AD pLI=1.00)
chr2	166248047	166248047	G	A	het		QUAL=8529;DP=360;AF=0.48;MQM=60;TRIO=HET,360,0.48,HET,122,0.44,HET,174,0.55	SCN2A	3'UTR	SCN2A:NM_001040142.1:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:NM_021007.2:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:NM_001040143.1:3'UTR:MODIFIER:exon26/26:c.*1713G>A:		rs1007722	0.3834	0.0000	0/0/0	0.0706										37	106					SCN2A (inh=AD pLI=1.00)
chr2	166847034	166847034	T	C	hom		QUAL=15770;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HOM,76,1.00,HOM,108,1.00	SCN1A,LOC102724058	3'UTR,intron	SCN1A:NM_001165963.1:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_001165964.1:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_006920.4:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_001202435.1:3'UTR:MODIFIER:exon28/28:c.*721A>G:,LOC102724058:NR_110598.1:intron:MODIFIER:exon1/3:n.176-25089T>C:		rs4667859	0.9972	0.0000	0/0/0	0.1511										230	0					SCN1A (inh=AD pLI=1.00), LOC102724058 (inh=n/a pLI=n/a)
chr2	166892788	166892788	C	T	hom		QUAL=17092;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HET,188,0.46,HOM,211,1.00	SCN1A,LOC102724058	missense,non_coding_exon	SCN1A:NM_001165963.1:missense:MODERATE:exon16/26:c.3199G>A:p.Ala1067Thr,SCN1A:NM_001165964.1:missense:MODERATE:exon16/26:c.3115G>A:p.Ala1039Thr,SCN1A:NM_006920.4:missense:MODERATE:exon16/26:c.3166G>A:p.Ala1056Thr,SCN1A:NM_001202435.1:missense:MODERATE:exon18/28:c.3199G>A:p.Ala1067Thr,LOC102724058:NR_110598.1:non_coding_exon:MODIFIER:exon4/4:n.618C>T:		rs2298771	0.7885	0.7250	32206/15293/3539	0.7198	-0.5650	T	T,T,T,T	B,B,B	B,B,B	182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030432.1 [benign]; RCV000079572.8 [other]; 	CM144700 [CLASS=DP MUT=ALT PHEN="Epilepsy symptomatic reduced risk" GENE=SCN1A]; 	COSM3757723, COSM3757724, COSM3757725	476	465					SCN1A (inh=AD pLI=1.00), LOC102724058 (inh=n/a pLI=n/a)
chr2	166897864	166897864	A	G	hom		QUAL=10229;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,79,0.62,HOM,119,0.99	SCN1A	synonymous	SCN1A:NM_001165963.1:synonymous:LOW:exon13/26:c.2292T>C:p.Val764Val,SCN1A:NM_001165964.1:synonymous:LOW:exon13/26:c.2208T>C:p.Val736Val,SCN1A:NM_006920.4:synonymous:LOW:exon13/26:c.2259T>C:p.Val753Val,SCN1A:NM_001202435.1:synonymous:LOW:exon15/28:c.2292T>C:p.Val764Val		rs6432860	0.7889	0.7260	32433/15442/3550	0.7205						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030431.1 [benign]; RCV000079565.7 [other]; RCV000127878.2 [benign]; 		COSM3757728, COSM3757726, COSM3757727	474	467					SCN1A (inh=AD pLI=1.00)
chr2	166897989	166897989	-	A	het		QUAL=543;DP=53;AF=0.47;MQM=60;TRIO=HET,53,0.47,HET,12,0.58,HOM,29,0.79	SCN1A	splice_region&intron	SCN1A:NM_001165963.1:splice_region&intron:LOW:exon12/25:c.2177-11dupT:,SCN1A:NM_001165964.1:splice_region&intron:LOW:exon12/25:c.2093-11dupT:,SCN1A:NM_006920.4:splice_region&intron:LOW:exon12/25:c.2144-11dupT:,SCN1A:NM_001202435.1:splice_region&intron:LOW:exon14/27:c.2177-11dupT:		rs11394960;rs397959165	0.4347	0.4200	1173/588/64	0.3555						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];				55	232					SCN1A (inh=AD pLI=1.00)
chr2	166903445	166903445	T	C	hom		QUAL=11324;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HET,144,0.53,HOM,161,0.99	SCN1A	synonymous	SCN1A:NM_001165963.1:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_001165964.1:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_006920.4:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_001202435.1:synonymous:LOW:exon11/28:c.1212A>G:p.Val404Val		rs7580482	0.7093	0.7030	30492/15443/1727	0.6985						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030430.1 [benign]; RCV000079554.7 [other]; 		COSM3757729, COSM3757730, COSM3757731	468	468					SCN1A (inh=AD pLI=1.00)
chr2	167054934	167054934	-	AATC	het		QUAL=4887;DP=188;AF=0.49;MQM=59;TRIO=HET,188,0.49,HET,79,0.44,HET,128,0.55	SCN9A,LOC101929680	3'UTR,intron	SCN9A:NM_002977.3:3'UTR:MODIFIER:exon27/27:c.*244_*247dupGATT:,LOC101929680:NR_110260.1:intron:MODIFIER:exon3/11:n.432-1213_432-1210dupATCA:		rs397744175	0.7458	0.0000	0/0/0	0.6779										133	80					SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167060981	167060984	AAAC	-	het	anno_pathogenic_hgmd	QUAL=4575;DP=81;AF=0.41;MQM=60;TRIO=HET,81,0.41,HET,64,0.56,HOM,100,1.00	SCN9A,LOC101929680	splice_region&intron,intron	SCN9A:NM_002977.3:splice_region&intron:LOW:exon24/26:c.4366-10_4366-7delGTTT:,LOC101929680:NR_110260.1:intron:MODIFIER:exon4/11:n.611+4660_611+4663delCAAA:		rs546230376	0.8988	0.8800	46221/24837/4352	0.8102						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000153913.3 [benign]; 	CD072486 [CLASS=DM? MUT=ALT PHEN="Congenital indifference to pain" GENE=SCN9A]; 		767	219	1	[1] old entry - no details available			SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167099158	167099158	A	G	het		QUAL=12011;DP=228;AF=0.53;MQM=60;TRIO=HET,228,0.53,HET,177,0.51,HOM,201,1.00	SCN9A,LOC101929680	missense,intron	SCN9A:NM_002977.3:missense:MODERATE:exon19/27:c.3448T>C:p.Trp1150Arg,LOC101929680:NR_110260.1:intron:MODIFIER:exon4/11:n.612-5547A>G:		rs6746030	0.8872	0.8520	9228/4075/1003	0.5988	0.9510	T	T,T,T,T	B	B	603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000020514.1 [benign]; 	CM051623 [CLASS=DFP MUT=REF PHEN="Erythermalgia primary" GENE=SCN9A]; 		839	247					SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167144974	167144974	A	T	het		QUAL=1668;DP=106;AF=0.51;MQM=60;TRIO=HET,106,0.51,HET,53,0.36,WT,83,0.00	SCN9A,LOC101929680	synonymous,intron	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1287T>A:p.Arg429Arg,LOC101929680:NR_110260.1:intron:MODIFIER:exon8/11:n.1030-6101A>T:		rs6747673	0.5467	0.4940	15287/7551/2822	0.4778						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000118293.3 [other]; 		COSM4001294, COSM4001293	264	507					SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167144995	167144995	T	C	het		QUAL=2355;DP=158;AF=0.48;MQM=60;TRIO=HET,158,0.48,HET,57,0.35,WT,96,0.01	SCN9A,LOC101929680	synonymous,intron	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1266A>G:p.Glu422Glu,LOC101929680:NR_110260.1:intron:MODIFIER:exon8/11:n.1030-6080T>C:		rs13402180	0.3544	0.3730	8581/5243/710	0.3640						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000118292.3 [other]; 		COSM3757732, COSM3757733	170	494					SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167145142	167145142	A	G	het		QUAL=1915;DP=116;AF=0.52;MQM=60;TRIO=HET,116,0.52,HET,41,0.46,WT,57,0.00	SCN9A,LOC101929680	synonymous,intron	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1119T>C:p.Ala373Ala,LOC101929680:NR_110260.1:intron:MODIFIER:exon8/11:n.1030-5933A>G:		rs13414203	0.3544	0.3730	8517/5205/702	0.3633						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000118290.3 [other]; 			169	492					SCN9A (inh=n/a pLI=0.00), LOC101929680 (inh=n/a pLI=n/a)
chr2	167163043	167163043	T	C	het		QUAL=6253;DP=243;AF=0.36;MQM=60;TRIO=HET,243,0.36,HET,137,0.55,HET,139,0.56	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon4/27:c.444A>G:p.Pro148Pro		rs9646771	0.6412	0.6050	14286/7626/2360	0.5923						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000118307.2 [likely benign]; 		COSM3933365, COSM3933366	468	499					SCN9A (inh=n/a pLI=0.00)
chr2	167168093	167168093	C	T	het		QUAL=11464;DP=296;AF=0.56;MQM=60;TRIO=HET,296,0.56,HET,256,0.53,HET,313,0.51	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon2/27:c.174G>A:p.Gln58Gln		rs6432901	0.5743	0.5870	21462/13126/2784	0.5803						603415 [SCN9A (confirmed) Erythermalgia,primary|Paroxysmal extreme pain disorder,|Insensitivity to pain,congenital|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of|HSAN2D,autosomal recessive];	RCV000118295.2 [likely benign]; 			414	517					SCN9A (inh=n/a pLI=0.00)
chr2	169828367	169828367	T	G	het	phylop_high	QUAL=69;DP=112;AF=0.47;MQM=60;TRIO=HET,112,0.47,WT,155,0.01,WT,208,0.00	ABCB11	missense	ABCB11:NM_003742.2:missense:MODERATE:exon14/28:c.1628A>C:p.Asp543Ala		rs200687717	0.0000	0.0910	0/0/0	0.0001	1.8360	T	T	B	B	603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2|Cholestasis,benign recurrent intrahepatic,2];			COSM3736641, COSM3736640	0	29					ABCB11 (inh=n/a pLI=0.00)
chr2	169830328	169830328	A	G	het	phylop_high	QUAL=19410;DP=454;AF=0.51;MQM=60;TRIO=HET,454,0.51,HET,277,0.47,HOM,305,1.00	ABCB11	missense	ABCB11:NM_003742.2:missense:MODERATE:exon13/28:c.1331T>C:p.Val444Ala		rs2287622	0.5887	0.5790	20582/11827/1670	0.5743	2.0330	T	T	B	B	603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2|Cholestasis,benign recurrent intrahepatic,2];	RCV000174528.1 [benign]; 	CM071525 [CLASS=DFP MUT=ALT PHEN="Cholestasis drug-induced association with" GENE=ABCB11]; 		416	510					ABCB11 (inh=n/a pLI=0.00)
chr2	169984262	169984262	-	T	hom		QUAL=9749;DP=202;AF=0.81;MQM=59;TRIO=HOM,202,0.81,HOM,120,0.89,HET,169,0.46	LRP2	3'UTR	LRP2:NM_004525.2:3'UTR:MODIFIER:exon79/79:c.*910dupA:		rs11411235;rs397941904	0.6619	0.0000	0/0/0	0.4423										14	203					LRP2 (inh=AR pLI=1.00)
chr2	170003432	170003432	T	G	hom	phylop_high;pred_pathogenic_3	QUAL=18211;DP=186;AF=1.00;MQM=60;TRIO=HOM,186,1.00,HOM,176,1.00,HOM,210,1.00	LRP2	missense	LRP2:NM_004525.2:missense:MODERATE:exon69/79:c.12628A>C:p.Ile4210Leu		rs4667591	0.5559	0.7110	32407/20298/321	0.7053	6.2840	T	D	D	D	600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117509.2 [likely benign]; 	CM065295 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=LRP2]; 	COSM1401028	678	378					LRP2 (inh=AR pLI=1.00)
chr2	170010985	170010985	T	C	hom	phylop_high	QUAL=23381;DP=340;AF=1.00;MQM=60;TRIO=HOM,340,1.00,HOM,153,1.00,HOM,211,0.99	LRP2	missense	LRP2:NM_004525.2:missense:MODERATE:exon66/79:c.12280A>G:p.Lys4094Glu		rs2075252	0.7780	0.7620	35867/18792/4168	0.7517	4.7880	T	T	B	B	600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117508.2 [likely benign]; 		COSM4001308	688	369					LRP2 (inh=AR pLI=1.00)
chr2	170025083	170025083	A	G	het	phylop_high	QUAL=10280;DP=426;AF=0.50;MQM=59;TRIO=HET,426,0.50,WT,251,0.00,HET,357,0.51	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon61/79:c.11601T>C:p.Cys3867Cys		rs2229268	0.1907	0.2020	2904/1434/12	0.2005	2.0780	T	T			600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117501.2 [likely benign]; 		COSM4133221	44	384					LRP2 (inh=AR pLI=1.00)
chr2	170032989	170032989	C	T	het		QUAL=18613;DP=392;AF=0.46;MQM=59;TRIO=HET,392,0.46,HOM,300,1.00,HET,417,0.45	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon54/79:c.10503G>A:p.Gln3501Gln		rs2229265	0.3796	0.4720	14603/8567/539	0.4678						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117498.2 [likely benign]; 		COSM4133222	314	532					LRP2 (inh=AR pLI=1.00)
chr2	170092395	170092395	A	G	het		QUAL=8650;DP=161;AF=0.52;MQM=60;TRIO=HET,161,0.52,WT,313,0.00,HET,448,0.55	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon29/79:c.4875T>C:p.Cys1625Cys		rs2229267	0.4613	0.3340	7934/2189/2243	0.3265						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117534.2 [likely benign]; 		COSM4133227	93	445					LRP2 (inh=AR pLI=1.00)
chr2	170099473	170099473	T	C	hom		QUAL=19832;DP=248;AF=0.99;MQM=60;TRIO=HOM,248,0.99,HOM,260,1.00,HET,293,0.51	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon24/79:c.3660A>G:p.Ala1220Ala		rs831042	0.5819	0.5230	17509/6874/1874	0.5123						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117527.2 [likely benign]; 			264	553					LRP2 (inh=AR pLI=1.00)
chr2	170103336	170103336	T	C	hom		QUAL=31117;DP=420;AF=1.00;MQM=60;TRIO=HOM,420,1.00,HOM,366,0.99,HET,515,0.49	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon21/79:c.3069A>G:p.Thr1023Thr		rs831043	0.6186	0.5380	18669/7113/2485	0.5267						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117524.2 [likely benign]; 			279	558					LRP2 (inh=AR pLI=1.00)
chr2	170103351	170103351	G	T	hom		QUAL=29733;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HOM,385,1.00,HET,517,0.48	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon21/79:c.3054C>A:p.Thr1018Thr		rs2075249	0.4565	0.4920	15497/7144/407	0.4819						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117523.2 [likely benign]; 			244	534					LRP2 (inh=AR pLI=1.00)
chr2	170115588	170115588	T	C	hom		QUAL=16616;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,177,1.00,HET,241,0.50	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon17/79:c.2460A>G:p.Thr820Thr		rs2241190	0.6224	0.5460	19120/7438/2458	0.5350						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117518.2 [likely benign]; 			296	555					LRP2 (inh=AR pLI=1.00)
chr2	170129528	170129528	G	A	het		QUAL=16200;DP=312;AF=0.49;MQM=60;TRIO=HET,312,0.49,WT,295,0.00,HOM,396,1.00	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon15/79:c.2025C>T:p.Val675Val		rs830994	0.6096	0.6240	24489/14495/1399	0.6243						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117515.2 [likely benign]; 			490	484					LRP2 (inh=AR pLI=1.00)
chr2	170150671	170150671	G	A	het		QUAL=11236;DP=267;AF=0.57;MQM=60;TRIO=HET,267,0.57,HOM,228,1.00,WT,304,0.00	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon6/79:c.639C>T:p.Asp213Asp		rs2229266	0.3702	0.3200	7064/2430/620	0.3166						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117541.2 [likely benign]; 		COSM3757758	106	395					LRP2 (inh=AR pLI=1.00)
chr2	170218847	170218847	C	G	hom		QUAL=6541;DP=55;AF=1.00;MQM=59;TRIO=HOM,55,1.00,HOM,67,1.00,HOM,108,0.99	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon1/79:c.63G>C:p.Ala21Ala		rs1559014	0.9846	0.9960	20105/10407/1277	0.8499						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117542.2 [likely benign]; 		COSM3749605	1098	0					LRP2 (inh=AR pLI=1.00)
chr2	172291616	172291616	C	T	het		QUAL=8524;DP=295;AF=0.53;MQM=60;TRIO=HET,295,0.53,WT,214,0.00,HET,283,0.57	DCAF17	synonymous,non_coding_exon	DCAF17:NM_025000.3:synonymous:LOW:exon2/14:c.150C>T:p.Val50Val,DCAF17:NM_001164821.1:synonymous:LOW:exon2/12:c.150C>T:p.Val50Val,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon2/13:n.477C>T:		rs6751956	0.3067	0.2720	4779/1780/705	0.2668						612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116869.2 [likely benign]; 			51	414					DCAF17 (inh=AR pLI=0.00)
chr2	172330393	172330393	A	G	het		QUAL=8211;DP=359;AF=0.43;MQM=60;TRIO=HET,359,0.43,WT,208,0.00,HET,310,0.50	DCAF17	synonymous,intron,non_coding_exon	DCAF17:NM_025000.3:synonymous:LOW:exon10/14:c.999A>G:p.Gln333Gln,DCAF17:NM_001164821.1:intron:MODIFIER:exon9/11:c.982-4104A>G:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon9/13:n.1220A>G:		rs3731983	0.2067	0.2240	3293/1285/171	0.2203	0.4960	T				612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116872.2 [likely benign]; 		COSM4001323	42	369					DCAF17 (inh=AR pLI=0.00)
chr2	172336541	172336541	C	T	het		QUAL=6522;DP=264;AF=0.51;MQM=60;TRIO=HET,264,0.51,WT,151,0.01,HET,243,0.49	DCAF17	splice_region&intron	DCAF17:NM_025000.3:splice_region&intron:LOW:exon12/13:c.1267-7C>T:,DCAF17:NM_001164821.1:splice_region&intron:LOW:exon10/11:c.1066-7C>T:,DCAF17:NR_028482.1:splice_region&intron:LOW:exon11/12:n.1488-7C>T:		rs3731981	0.2061	0.2240	3337/1318/169	0.2187						612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116867.2 [likely benign]; 		COSM4001324	42	367					DCAF17 (inh=AR pLI=0.00)
chr2	172338194	172338194	G	A	het		QUAL=7143;DP=344;AF=0.45;MQM=60;TRIO=HET,344,0.45,WT,132,0.00,HET,217,0.52	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*570G>A:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*570G>A:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.2354G>A:		rs3795998	0.2065	0.2260	405/80/1	0.0563										24	227					DCAF17 (inh=AR pLI=0.00)
chr2	172338300	172338300	T	G	het		QUAL=7519;DP=294;AF=0.49;MQM=60;TRIO=HET,294,0.49,WT,150,0.00,HET,231,0.56	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*676T>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*676T>G:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.2460T>G:		rs3821084	0.2061	0.2240	404/80/1	0.0565										24	226					DCAF17 (inh=AR pLI=0.00)
chr2	172339964	172339964	C	T	hom		QUAL=36717;DP=380;AF=1.00;MQM=59;TRIO=HOM,380,1.00,HOM,334,1.00,HOM,410,1.00	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2340C>T:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2340C>T:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.4124C>T:		rs888428	0.9774	0.9940	5382/1369/88	0.2297										651	1					DCAF17 (inh=AR pLI=0.00)
chr2	172340049	172340049	T	A	het		QUAL=9869;DP=454;AF=0.53;MQM=60;TRIO=HET,454,0.53,WT,300,0.01,HET,352,0.51	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2425T>A:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2425T>A:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.4209T>A:		rs12151641	0.2065	0.2280	408/80/1	0.0563										24	227					DCAF17 (inh=AR pLI=0.00)
chr2	172340419	172340419	T	C	het		QUAL=9731;DP=397;AF=0.47;MQM=60;TRIO=HET,397,0.47,WT,238,0.00,HET,320,0.55	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2795T>C:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2795T>C:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.4579T>C:		rs17221346	0.2718	0.2460	465/88/3	0.0651										28	247					DCAF17 (inh=AR pLI=0.00)
chr2	172340736	172340736	C	G	het		QUAL=5900;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,WT,150,0.00,HET,185,0.54	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*3112C>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*3112C>G:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.4896C>G:		rs17221367	0.2065	0.2270	400/80/1	0.0565										24	223					DCAF17 (inh=AR pLI=0.00)
chr2	172341327	172341327	A	G	het		QUAL=5046;DP=165;AF=0.52;MQM=60;TRIO=HET,165,0.52,WT,132,0.00,HET,196,0.53	DCAF17	3'UTR,non_coding_exon	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*3703A>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*3703A>G:,DCAF17:NR_028482.1:non_coding_exon:MODIFIER:exon13/13:n.5487A>G:	L1ME2z	rs9789572	0.2065	0.2230	407/80/1	0.0566										22	197					DCAF17 (inh=AR pLI=0.00)
chr2	173339808	173339808	G	A	het	phylop_high	QUAL=13435;DP=230;AF=0.52;MQM=59;TRIO=HET,230,0.52,WT,279,0.00,HOM,321,1.00	ITGA6	missense	ITGA6:NM_001079818.2:missense:MODERATE:exon7/25:c.1138G>A:p.Ala380Thr,ITGA6:NM_001316306.1:missense:MODERATE:exon7/26:c.781G>A:p.Ala261Thr,ITGA6:NM_000210.3:missense:MODERATE:exon7/26:c.1138G>A:p.Ala380Thr		rs11895564	0.2516	0.2810	5014/2867/580	0.2750	3.1200	T	T,T,T,T,T,T,T,T	P,B,P,P	B,B,P,P	147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis];			COSM3757774, COSM3757775, COSM3757773	97	471					ITGA6 (inh=n/a pLI=0.01)
chr2	173344474	173344474	A	G	het		QUAL=12733;DP=351;AF=0.46;MQM=59;TRIO=HET,351,0.46,WT,219,0.00,HOM,290,0.99	ITGA6	splice_region&intron	ITGA6:NM_001079818.2:splice_region&intron:LOW:exon10/24:c.1487+7A>G:,ITGA6:NM_001316306.1:splice_region&intron:LOW:exon10/25:c.1130+7A>G:,ITGA6:NM_000210.3:splice_region&intron:LOW:exon10/25:c.1487+7A>G:		rs1920979	0.4071	0.3710	8645/3834/1379	0.3634						147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis];			COSM4001327, COSM4001326, COSM4001325	140	509					ITGA6 (inh=n/a pLI=0.01)
chr2	173369231	173369231	A	G	het		QUAL=10124;DP=271;AF=0.45;MQM=59;TRIO=HET,271,0.45,WT,162,0.00,HOM,220,1.00	ITGA6	3'UTR	ITGA6:NM_001079818.2:3'UTR:MODIFIER:exon25/25:c.*251A>G:,ITGA6:NM_001316306.1:3'UTR:MODIFIER:exon26/26:c.*435A>G:,ITGA6:NM_000210.3:3'UTR:MODIFIER:exon26/26:c.*435A>G:		rs17664	0.6340	0.0000	0/0/0	0.0886										33	119					ITGA6 (inh=n/a pLI=0.01)
chr2	178404735	178404735	-	AAAG	hom		QUAL=1725;DP=48;AF=1.00;MQM=59;TRIO=HOM,48,1.00,HOM,6,1.00,HOM,9,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1814_*1815insAGAA:		rs139584283	0.8850	0.0000	0/0/0	0.6555										158	60					AGPS (inh=n/a pLI=1.00)
chr2	178404789	178404789	A	G	hom		QUAL=1364;DP=34;AF=1.00;MQM=59;TRIO=HOM,34,1.00,HOM,3,1.00,HOM,11,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1866A>G:	(TA)n	rs10930795	0.8944	0.0000	0/0/0	0.3260										172	47					AGPS (inh=n/a pLI=1.00)
chr2	178404802	178404805	TATA	-	hom		QUAL=1076;DP=40;AF=0.80;MQM=59;TRIO=HOM,40,0.80,HOM,5,1.00,HOM,14,0.64	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1896_*1899delATAT:	(TA)n	rs144293437;rs773223731	0.9101	0.0000	0/0/0	0.3978										139	57					AGPS (inh=n/a pLI=1.00)
chr2	178406481	178406481	C	T	hom		QUAL=14530;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HET,87,0.51,HOM,102,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*3558C>T:		rs8941	0.6967	0.0000	0/0/0	0.1426										131	86					AGPS (inh=n/a pLI=1.00)
chr2	178406769	178406769	-	T	hom		QUAL=11906;DP=205;AF=0.97;MQM=59;TRIO=HOM,205,0.97,HOM,73,0.99,HOM,104,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*3854dupT:		rs397783598	0.8902	0.0000	0/0/0	0.7601										175	50					AGPS (inh=n/a pLI=1.00)
chr2	178407176	178407176	C	A	hom		QUAL=15591;DP=267;AF=1.00;MQM=60;TRIO=HOM,267,1.00,HOM,87,1.00,HOM,133,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*4253C>A:		rs10803912	0.8770	0.0000	0/0/0	0.1334										173	52					AGPS (inh=n/a pLI=1.00)
chr2	178407897	178407897	T	C	hom		QUAL=22405;DP=266;AF=1.00;MQM=59;TRIO=HOM,266,1.00,HOM,180,1.00,HOM,279,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*4974T>C:		rs2293475	0.8764	0.0000	0/0/0	0.1283										173	52					AGPS (inh=n/a pLI=1.00)
chr2	179315444	179315444	T	G	het		QUAL=721;DP=42;AF=0.52;MQM=59;TRIO=HET,42,0.52,HET,16,0.50,HET,16,0.50	PRKRA,MIR548N	5'UTR,intron	PRKRA:NM_001139517.1:5'UTR:MODIFIER:exon1/7:c.-274A>C:,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.36+51746T>G:,PRKRA:NM_003690.4:intron:MODIFIER:exon1/7:c.65+249A>C:,PRKRA:NM_001316362.1:intron:MODIFIER:exon1/8:c.-385+249A>C:		rs184658426	0.0088	0.0000	0/0/0	0.0115						603424 [PRKRA (confirmed) Dystonia 16];				1	7					PRKRA (inh=AR pLI=0.15), MIR548N (inh=n/a pLI=n/a)
chr2	179395554	179395554	G	A	het	phylop_high	QUAL=4377;DP=312;AF=0.44;MQM=60;TRIO=HET,312,0.44,HET,98,0.43,WT,169,0.00	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105788C>T:p.Ala35263Val,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100865C>T:p.Ala33622Val,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79169C>T:p.Ala26390Val,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78593C>T:p.Ala26198Val,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98084C>T:p.Ala32695Val,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78968C>T:p.Ala26323Val,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-97961G>A:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon2/16:n.220-4905G>A:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon1/6:n.446+7191G>A:		rs66961115	0.0052	0.0110	20/18/0	0.0105	2.3280	T	T,T,T,T,T	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040971.7 [other]; 			0	30					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179395555	179395555	C	A	het	phylop_high	QUAL=4377;DP=312;AF=0.44;MQM=60;TRIO=HET,312,0.44,HET,98,0.43,WT,169,0.00	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105787G>T:p.Ala35263Ser,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100864G>T:p.Ala33622Ser,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79168G>T:p.Ala26390Ser,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78592G>T:p.Ala26198Ser,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98083G>T:p.Ala32695Ser,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78967G>T:p.Ala26323Ser,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-97960C>A:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon2/16:n.220-4904C>A:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon1/6:n.446+7192C>A:		rs67254537	0.0052	0.0110	20/18/0	0.0105	2.6440	T	T,T,T,T,T	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040970.7 [other]; 			0	30					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179395573	179395573	C	T	het	phylop_high;pred_pathogenic_3	QUAL=5161;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,95,0.45,WT,174,0.00	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105769G>A:p.Glu35257Lys,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100846G>A:p.Glu33616Lys,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79150G>A:p.Glu26384Lys,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78574G>A:p.Glu26192Lys,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98065G>A:p.Glu32689Lys,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78949G>A:p.Glu26317Lys,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-97942C>T:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon2/16:n.220-4886C>T:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon1/6:n.446+7210C>T:		rs56324595	0.0066	0.0140	27/23/0	0.0135	7.8180	T	D,D,D,D,D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040968.7 [other]; 			0	42					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179404498	179404498	G	C	het	phylop_high;pred_pathogenic_4	QUAL=15914;DP=509;AF=0.51;MQM=60;TRIO=HET,509,0.51,WT,526,0.00,HET,648,0.51	TTN,MIR548N,TTN-AS1	missense,intron,non_coding_exon	TTN:NM_001267550.2:missense:MODERATE:exon352/363:c.98294C>G:p.Ala32765Gly,TTN:NM_001256850.1:missense:MODERATE:exon302/313:c.93371C>G:p.Ala31124Gly,TTN:NM_133437.4:missense:MODERATE:exon181/192:c.71675C>G:p.Ala23892Gly,TTN:NM_003319.4:missense:MODERATE:exon180/191:c.71099C>G:p.Ala23700Gly,TTN:NM_133378.4:missense:MODERATE:exon301/312:c.90590C>G:p.Ala30197Gly,TTN:NM_133432.3:missense:MODERATE:exon181/192:c.71474C>G:p.Ala23825Gly,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-89017G>C:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon1/6:n.446+16135G>C:,TTN-AS1:NR_038272.1:non_coding_exon:MODIFIER:exon5/17:n.1721G>C:		rs72648273	0.0010	0.0028	0/0/0	0.0027	9.8690	D	D,D,D,D,D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040867.4 [likely benign]; RCV000118794.4 [likely benign]; 			1	14					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179432185	179432185	A	G	het	phylop_high;pred_pathogenic_1	QUAL=20892;DP=503;AF=0.53;MQM=60;TRIO=HET,503,0.53,HOM,416,1.00,WT,543,0.00	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon326/363:c.78674T>C:p.Ile26225Thr,TTN:NM_001256850.1:missense:MODERATE:exon276/313:c.73751T>C:p.Ile24584Thr,TTN:NM_133437.4:missense:MODERATE:exon155/192:c.52055T>C:p.Ile17352Thr,TTN:NM_003319.4:missense:MODERATE:exon154/191:c.51479T>C:p.Ile17160Thr,TTN:NM_133378.4:missense:MODERATE:exon275/312:c.70970T>C:p.Ile23657Thr,TTN:NM_133432.3:missense:MODERATE:exon155/192:c.51854T>C:p.Ile17285Thr,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-61330A>G:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon7/16:n.2044-15114A>G:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon1/6:n.447-3842A>G:		rs12463674	0.1300	0.2360	4109/3069/7	0.2337	5.9890	T	T,D,T,T,D	P,P,P,P	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040637.10 [benign]; 			91	453					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179440029	179440029	G	A	het		QUAL=13316;DP=381;AF=0.51;MQM=59;TRIO=HET,381,0.51,HOM,285,0.99,WT,396,0.00	TTN,MIR548N,TTN-AS1	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon326/363:c.70830C>T:p.Ser23610Ser,TTN:NM_001256850.1:synonymous:LOW:exon276/313:c.65907C>T:p.Ser21969Ser,TTN:NM_133437.4:synonymous:LOW:exon155/192:c.44211C>T:p.Ser14737Ser,TTN:NM_003319.4:synonymous:LOW:exon154/191:c.43635C>T:p.Ser14545Ser,TTN:NM_133378.4:synonymous:LOW:exon275/312:c.63126C>T:p.Ser21042Ser,TTN:NM_133432.3:synonymous:LOW:exon155/192:c.44010C>T:p.Ser14670Ser,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-53486G>A:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon7/16:n.2044-7270G>A:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon2/6:n.596+3853G>A:		rs12464787	0.1466	0.2390	4061/2996/58	0.2345						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040563.8 [benign]; 		COSM4133286, COSM4133285, COSM4133282, COSM4133284, COSM4133283	91	453					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179444768	179444768	C	G	hom		QUAL=59878;DP=523;AF=1.00;MQM=60;TRIO=HOM,523,1.00,HOM,561,1.00,HOM,773,1.00	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon318/363:c.67246G>C:p.Ala22416Pro,TTN:NM_001256850.1:missense:MODERATE:exon268/313:c.62323G>C:p.Ala20775Pro,TTN:NM_133437.4:missense:MODERATE:exon147/192:c.40627G>C:p.Ala13543Pro,TTN:NM_003319.4:missense:MODERATE:exon146/191:c.40051G>C:p.Ala13351Pro,TTN:NM_133378.4:missense:MODERATE:exon267/312:c.59542G>C:p.Ala19848Pro,TTN:NM_133432.3:missense:MODERATE:exon147/192:c.40426G>C:p.Ala13476Pro,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-48747C>G:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon7/16:n.2044-2531C>G:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon2/6:n.596+8592C>G:		rs4145333	0.9946	0.9990	60192/33352/4769	0.9353	0.6560	T	T,T,T,T,T	B,B,B	B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040520.6 [benign]; 			1206	1					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179453796	179453796	C	T	het	phylop_high;pred_pathogenic_3	QUAL=8369;DP=331;AF=0.56;MQM=59;TRIO=HET,331,0.56,WT,259,0.00,HET,298,0.44	TTN,MIR548N,TTN-AS1	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon304/363:c.62656G>A:p.Asp20886Asn,TTN:NM_001256850.1:missense:MODERATE:exon254/313:c.57733G>A:p.Asp19245Asn,TTN:NM_133437.4:missense:MODERATE:exon133/192:c.36037G>A:p.Asp12013Asn,TTN:NM_003319.4:missense:MODERATE:exon132/191:c.35461G>A:p.Asp11821Asn,TTN:NM_133378.4:missense:MODERATE:exon253/312:c.54952G>A:p.Asp18318Asn,TTN:NM_133432.3:missense:MODERATE:exon133/192:c.35836G>A:p.Asp11946Asn,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-39719C>T:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon11/16:n.3189-2070C>T:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon2/6:n.597-8527C>T:			0.0000	0.0000	0/0/0	0.0000	7.8180	T	T,D,D,D,D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];				0	1					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179462494	179462494	A	G	het		QUAL=22293;DP=578;AF=0.47;MQM=60;TRIO=HET,578,0.47,HOM,462,0.99,WT,664,0.00	TTN,MIR548N,TTN-AS1	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon294/363:c.57315T>C:p.His19105His,TTN:NM_001256850.1:synonymous:LOW:exon244/313:c.52392T>C:p.His17464His,TTN:NM_133437.4:synonymous:LOW:exon123/192:c.30696T>C:p.His10232His,TTN:NM_003319.4:synonymous:LOW:exon122/191:c.30120T>C:p.His10040His,TTN:NM_133378.4:synonymous:LOW:exon243/312:c.49611T>C:p.His16537His,TTN:NM_133432.3:synonymous:LOW:exon123/192:c.30495T>C:p.His10165His,MIR548N:NR_031666.1:intron:MODIFIER:exon3/4:n.37-31021A>G:,TTN-AS1:NR_038272.1:intron:MODIFIER:exon13/16:n.3450+86A>G:,TTN-AS1:NR_038271.1:intron:MODIFIER:exon3/6:n.682+86A>G:		rs35833641	0.1270	0.2340	4069/3055/8	0.2318						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040390.4 [benign]; 		COSM4001385, COSM4001388, COSM4001386, COSM4001387, COSM4001389	89	453					TTN (inh=AD pLI=0.00), MIR548N (inh=n/a pLI=n/a), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179542499	179542499	T	C	het	trio_denovo	QUAL=864;DP=293;AF=0.27;MQM=54;TRIO=HET,293,0.27,WT,658,0.00,WT,744,0.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon146/363:c.34140A>G:p.Glu11380Glu,TTN:NM_001256850.1:synonymous:LOW:exon144/313:c.33189A>G:p.Glu11063Glu,TTN:NM_133378.4:synonymous:LOW:exon143/312:c.30408A>G:p.Glu10136Glu,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-35455A>G:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-35455A>G:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-35455A>G:		rs147418835	0.0030	0.0001	0/0/0	0.0002						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];				0	2					TTN (inh=AD pLI=0.00)
chr2	179545859	179545859	C	T	het		QUAL=8789;DP=347;AF=0.49;MQM=60;TRIO=HET,347,0.49,HOM,131,0.98,WT,226,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon138/363:c.33287G>A:p.Arg11096His,TTN:NM_001256850.1:missense:MODERATE:exon136/313:c.32336G>A:p.Arg10779His,TTN:NM_133378.4:missense:MODERATE:exon135/312:c.29555G>A:p.Arg9852His,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-38815G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-38815G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-38815G>A:		rs36051007	0.1260	0.2330	3963/2974/7	0.2305	-0.5180	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040156.6 [benign]; 		COSM4001412, COSM4001413	92	445					TTN (inh=AD pLI=0.00)
chr2	179554305	179554305	C	T	het	phylop_high	QUAL=11498;DP=436;AF=0.45;MQM=60;TRIO=HET,436,0.45,HOM,199,1.00,WT,261,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon123/363:c.31864G>A:p.Gly10622Arg,TTN:NM_001256850.1:missense:MODERATE:exon121/313:c.30913G>A:p.Gly10305Arg,TTN:NM_133378.4:missense:MODERATE:exon120/312:c.28132G>A:p.Gly9378Arg,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-47261G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-47261G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-47261G>A:		rs2244492	0.4133	0.3780	8028/3459/1608	0.3705	3.2520	T	T,T			188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040129.5 [benign]; 			143	528					TTN (inh=AD pLI=0.00)
chr2	179569387	179569387	T	A	het	phylop_high	QUAL=7668;DP=324;AF=0.50;MQM=60;TRIO=HET,324,0.50,WT,162,0.00,HET,257,0.48	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon105/363:c.29812A>T:p.Thr9938Ser,TTN:NM_001256850.1:missense:MODERATE:exon103/313:c.28861A>T:p.Thr9621Ser,TTN:NM_133378.4:missense:MODERATE:exon102/312:c.26080A>T:p.Thr8694Ser,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+33422A>T:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+33422A>T:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+33422A>T:		rs72650006	0.0106	0.0190	22/18/0	0.0188	6.2960	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040096.5 [benign]; RCV000204308.1 [benign]; RCV000204308.1 [benign]; 			1	58					TTN (inh=AD pLI=0.00)
chr2	179585266	179585266	C	T	hom		QUAL=14818;DP=260;AF=1.00;MQM=60;TRIO=HOM,260,1.00,HOM,81,1.00,HOM,125,1.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon80/363:c.23223G>A:p.Gln7741Gln,TTN:NM_001256850.1:synonymous:LOW:exon78/313:c.22272G>A:p.Gln7424Gln,TTN:NM_133378.4:synonymous:LOW:exon77/312:c.19491G>A:p.Gln6497Gln,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+17543G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+17543G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+17543G>A:		rs2562831	0.9820	0.9950	59606/33233/4367	0.9314						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039984.8 [benign]; 			1208	1					TTN (inh=AD pLI=0.00)
chr2	179600563	179600563	G	A	hom		QUAL=21278;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,124,1.00,HOM,234,1.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon50/363:c.14610C>T:p.Ser4870Ser,TTN:NM_001256850.1:synonymous:LOW:exon48/313:c.13659C>T:p.Ser4553Ser,TTN:NM_133378.4:synonymous:LOW:exon47/312:c.10878C>T:p.Ser3626Ser,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+2246C>T:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+2246C>T:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+2246C>T:		rs2742348	0.9818	0.9950	59643/33284/4359	0.9314						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039860.8 [benign]; 			1209	1					TTN (inh=AD pLI=0.00)
chr2	179610967	179610967	C	T	het	phylop_high;pred_pathogenic_1	QUAL=8276;DP=394;AF=0.51;MQM=60;TRIO=HET,394,0.51,WT,172,0.01,HET,207,0.50	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.16160G>A:p.Cys5387Tyr,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11312-4319G>A:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10361-4319G>A:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10799-4319G>A:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10223-4319G>A:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+6884G>A:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10598-4319G>A:		rs72648913	0.0012	0.0029	1/1/0	0.0028	1.6850	T	D,D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041064.3 [likely benign]; RCV000172706.2 [likely benign]; 			0	13					TTN (inh=AD pLI=0.00)
chr2	179614952	179614952	A	G	hom		QUAL=49250;DP=587;AF=1.00;MQM=60;TRIO=HOM,587,1.00,HOM,395,1.00,HOM,510,1.00	TTN	synonymous,intron	TTN:NM_133379.4:synonymous:LOW:exon46/46:c.12175T>C:p.Leu4059Leu,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+2899T>C:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+2899T>C:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+2899T>C:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+2899T>C:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+2899T>C:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+2899T>C:		rs10803917	0.9750	0.9930	59714/33307/4396	0.9670						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041012.3 [benign]; 			1201	6					TTN (inh=AD pLI=0.00)
chr2	179615887	179615887	T	C	hom	phylop_high	QUAL=24534;DP=371;AF=1.00;MQM=60;TRIO=HOM,371,1.00,HOM,159,1.00,HOM,221,1.00	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.11240A>G:p.Asp3747Gly,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1964A>G:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1964A>G:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1964A>G:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1964A>G:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1964A>G:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1964A>G:		rs922984	0.7330	0.8260	42438/28413/1803	0.8284	1.9380	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041005.4 [benign]; 			1051	152					TTN (inh=AD pLI=0.00)
chr2	179615931	179615931	C	G	hom		QUAL=19566;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,136,1.00,HOM,182,1.00	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.11196G>C:p.Leu3732Phe,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1920G>C:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1920G>C:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1920G>C:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1920G>C:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1920G>C:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1920G>C:		rs922985	0.9750	0.9930	59376/33139/4336	0.9586	-0.1470	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041004.4 [benign]; 			1199	7					TTN (inh=AD pLI=0.00)
chr2	179615994	179615994	T	C	hom		QUAL=16792;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,119,0.99,HOM,164,1.00	TTN	synonymous,intron	TTN:NM_133379.4:synonymous:LOW:exon46/46:c.11133A>G:p.Thr3711Thr,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1857A>G:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1857A>G:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1857A>G:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1857A>G:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1857A>G:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1857A>G:		rs922986	0.9750	0.9930	59578/33255/4387	0.9668						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041002.3 [benign]; 			1206	6					TTN (inh=AD pLI=0.00)
chr2	179616771	179616771	A	-	hom		QUAL=3062;DP=140;AF=0.74;MQM=59;TRIO=HOM,140,0.74,HOM,25,0.64,HOM,44,0.41	TTN	splice_region&intron,intron	TTN:NM_133379.4:splice_region&intron:LOW:exon45/45:c.10361-5delT:,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1080delT:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1080delT:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1080delT:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1080delT:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1080delT:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1080delT:		rs397986815;rs577374633;rs58651353;rs770426988	0.5262	0.4780	1119/496/80	0.4346						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040993.2 [likely benign]; 			160	407	1	[1] old entry - no details available			TTN (inh=AD pLI=0.00)
chr2	179620951	179620951	C	T	hom	phylop_high	QUAL=12423;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,67,1.00,HOM,93,1.00	TTN	missense&splice_region,intron	TTN:NM_001267550.2:missense&splice_region:MODERATE:exon46/363:c.11252G>A:p.Gly3751Asp,TTN:NM_133437.4:missense&splice_region:MODERATE:exon44/192:c.10739G>A:p.Gly3580Asp,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2760G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2760G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2760G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+1318G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2760G>A:		rs7585334	0.8045	0.8490	44227/28583/3438	0.8449	3.7080	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041121.4 [benign]; 			1050	142					TTN (inh=AD pLI=0.00)
chr2	179621184	179621184	G	A	het		QUAL=10405;DP=475;AF=0.48;MQM=60;TRIO=HET,475,0.48,HET,355,0.50,WT,489,0.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon46/363:c.11019C>T:p.Cys3673Cys,TTN:NM_133437.4:synonymous:LOW:exon44/192:c.10506C>T:p.Cys3502Cys,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2527C>T:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2527C>T:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2527C>T:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+1085C>T:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2527C>T:		rs72955212	0.0052	0.0110	22/19/0	0.0112						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041119.3 [benign]; 			0	30					TTN (inh=AD pLI=0.00)
chr2	179621477	179621477	C	T	hom		QUAL=13190;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,83,1.00,HOM,115,1.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon46/363:c.10726G>A:p.Ala3576Thr,TTN:NM_133437.4:missense:MODERATE:exon44/192:c.10213G>A:p.Ala3405Thr,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2234G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2234G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2234G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+792G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2234G>A:		rs6433728	0.9990	1.0000	60261/33342/4863	0.9361	0.2260	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000155422.1 [likely benign]; RCV000152471.4 [other]; 			1214	0					TTN (inh=AD pLI=0.00)
chr2	179621503	179621503	C	T	het		QUAL=2979;DP=210;AF=0.48;MQM=60;TRIO=HET,210,0.48,HET,67,0.51,WT,102,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon46/363:c.10700G>A:p.Ser3567Asn,TTN:NM_133437.4:missense:MODERATE:exon44/192:c.10187G>A:p.Ser3396Asn,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2208G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2208G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2208G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+766G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2208G>A:		rs72955213	0.0064	0.0140	24/20/0	0.0138	1.3030	T	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041115.4 [benign]; 			0	41					TTN (inh=AD pLI=0.00)
chr2	179623758	179623758	C	T	hom		QUAL=16196;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,115,1.00,HOM,136,1.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon44/363:c.10256G>A:p.Ser3419Asn,TTN:NM_001256850.1:missense:MODERATE:exon44/313:c.10256G>A:p.Ser3419Asn,TTN:NM_133437.4:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:NM_003319.4:missense:MODERATE:exon43/191:c.10118G>A:p.Ser3373Asn,TTN:NM_133378.4:missense:MODERATE:exon44/312:c.10256G>A:p.Ser3419Asn,TTN:NM_133432.3:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:NM_133379.4:missense:MODERATE:exon44/46:c.10256G>A:p.Ser3419Asn		rs2291310	0.8089	0.8510	44905/28700/3721	0.8522	0.3980	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039852.9 [benign]; 			1056	149					TTN (inh=AD pLI=0.00)
chr2	179629363	179629363	T	C	hom		QUAL=44979;DP=501;AF=1.00;MQM=60;TRIO=HOM,501,1.00,HOM,401,1.00,HOM,509,1.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon42/363:c.9879A>G:p.Glu3293Glu,TTN:NM_001256850.1:synonymous:LOW:exon42/313:c.9879A>G:p.Glu3293Glu,TTN:NM_133437.4:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:NM_003319.4:synonymous:LOW:exon41/191:c.9741A>G:p.Glu3247Glu,TTN:NM_133378.4:synonymous:LOW:exon42/312:c.9879A>G:p.Glu3293Glu,TTN:NM_133432.3:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:NM_133379.4:synonymous:LOW:exon42/46:c.9879A>G:p.Glu3293Glu		rs4894043	0.9736	0.9920	59764/33351/4343	0.9588						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040976.8 [benign]; 			1209	6					TTN (inh=AD pLI=0.00)
chr2	179629461	179629461	C	T	hom	pred_pathogenic_1	QUAL=45091;DP=435;AF=1.00;MQM=59;TRIO=HOM,435,1.00,HOM,430,1.00,HOM,544,1.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon42/363:c.9781G>A:p.Val3261Met,TTN:NM_001256850.1:missense:MODERATE:exon42/313:c.9781G>A:p.Val3261Met,TTN:NM_133437.4:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:NM_003319.4:missense:MODERATE:exon41/191:c.9643G>A:p.Val3215Met,TTN:NM_133378.4:missense:MODERATE:exon42/312:c.9781G>A:p.Val3261Met,TTN:NM_133432.3:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:NM_133379.4:missense:MODERATE:exon42/46:c.9781G>A:p.Val3261Met		rs2291311	0.8049	0.8500	44778/28694/3593	0.8499	1.0930	T	T,T,T,T,T,T	D,D,D,D	P,P,P,P	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040961.9 [benign]; 			1062	149					TTN (inh=AD pLI=0.00)
chr2	179634421	179634421	T	G	het	phylop_high;pred_pathogenic_4	QUAL=425;DP=105;AF=0.66;MQM=58;TRIO=HET,105,0.66,WT,104,0.00,WT,137,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon37/363:c.8887A>C:p.Thr2963Pro,TTN:NM_001256850.1:missense:MODERATE:exon37/313:c.8887A>C:p.Thr2963Pro,TTN:NM_133437.4:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:NM_003319.4:missense:MODERATE:exon36/191:c.8749A>C:p.Thr2917Pro,TTN:NM_133378.4:missense:MODERATE:exon37/312:c.8887A>C:p.Thr2963Pro,TTN:NM_133432.3:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:NM_133379.4:missense:MODERATE:exon37/46:c.8887A>C:p.Thr2963Pro		rs200875815	0.2155	0.3550	5/5/0	0.0071	5.9120	D	T,T,T,T,T,D	D,D,D,D,D	D,D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000172804.2 [benign]; 		COSM146063, COSM146062, COSM146060, COSM146061	0	142					TTN (inh=AD pLI=0.00)
chr2	179642425	179642425	G	A	het		QUAL=5128;DP=174;AF=0.54;MQM=60;TRIO=HET,174,0.54,HOM,61,1.00,HET,65,0.46	TTN,LOC101927055	splice_region&intron,non_coding_exon	TTN:NM_001267550.2:splice_region&intron:LOW:exon25/362:c.4480+6C>T:,TTN:NM_001256850.1:splice_region&intron:LOW:exon25/312:c.4480+6C>T:,TTN:NM_133437.4:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:NM_003319.4:splice_region&intron:LOW:exon24/190:c.4342+6C>T:,TTN:NM_133378.4:splice_region&intron:LOW:exon25/311:c.4480+6C>T:,TTN:NM_133432.3:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:NM_133379.4:splice_region&intron:LOW:exon25/45:c.4480+6C>T:,LOC101927055:NR_120594.1:non_coding_exon:MODIFIER:exon1/2:n.773G>A:		rs719201	0.9115	0.9590	55886/32629/3762	0.9463						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040333.8 [benign]; 			1171	43					TTN (inh=AD pLI=0.00), LOC101927055 (inh=n/a pLI=n/a)
chr2	179644035	179644035	G	A	het	phylop_high	QUAL=13416;DP=289;AF=0.52;MQM=60;TRIO=HET,289,0.52,HOM,183,1.00,HET,194,0.58	TTN,LOC101927055	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon23/363:c.3884C>T:p.Ser1295Leu,TTN:NM_001256850.1:missense:MODERATE:exon23/313:c.3884C>T:p.Ser1295Leu,TTN:NM_133437.4:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:NM_003319.4:missense:MODERATE:exon22/191:c.3746C>T:p.Ser1249Leu,TTN:NM_133378.4:missense:MODERATE:exon23/312:c.3884C>T:p.Ser1295Leu,TTN:NM_133432.3:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:NM_133379.4:missense:MODERATE:exon23/46:c.3884C>T:p.Ser1295Leu,LOC101927055:NR_120594.1:intron:MODIFIER:exon1/1:n.1831-530G>A:		rs1552280	0.9201	0.9600	55941/32580/3872	0.9564	6.2480	T	T,T,T,T,T,T	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040271.8 [benign]; 			1167	41					TTN (inh=AD pLI=0.00), LOC101927055 (inh=n/a pLI=n/a)
chr2	179644855	179644855	T	C	het	phylop_high	QUAL=6197;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,65,1.00,HET,98,0.43	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon22/363:c.3601A>G:p.Lys1201Glu,TTN:NM_001256850.1:missense:MODERATE:exon22/313:c.3601A>G:p.Lys1201Glu,TTN:NM_133437.4:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:NM_003319.4:missense:MODERATE:exon21/191:c.3463A>G:p.Lys1155Glu,TTN:NM_133378.4:missense:MODERATE:exon22/312:c.3601A>G:p.Lys1201Glu,TTN:NM_133432.3:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:NM_133379.4:missense:MODERATE:exon22/46:c.3601A>G:p.Lys1201Glu		rs10497520	0.5002	0.6940	32542/24959/1082	0.6951	4.1160	T	T,T,T,T,T,T	B,B,B,B,P	B,B,B,B,P	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040243.8 [benign]; 		COSM4001424, COSM4001425, COSM4001423, COSM4001421, COSM4001422	876	297					TTN (inh=AD pLI=0.00)
chr2	179650701	179650701	C	T	het		QUAL=22536;DP=623;AF=0.56;MQM=60;TRIO=HET,623,0.56,HOM,488,1.00,WT,607,0.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon14/363:c.2244G>A:p.Glu748Glu,TTN:NM_001256850.1:synonymous:LOW:exon14/313:c.2244G>A:p.Glu748Glu,TTN:NM_133437.4:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:NM_003319.4:synonymous:LOW:exon13/191:c.2106G>A:p.Glu702Glu,TTN:NM_133378.4:synonymous:LOW:exon14/312:c.2244G>A:p.Glu748Glu,TTN:NM_133432.3:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:NM_133379.4:synonymous:LOW:exon14/46:c.2244G>A:p.Glu748Glu		rs6715406	0.2047	0.3190	7161/5389/191	0.3182						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040044.4 [benign]; 		COSM4001429, COSM4001431, COSM4001430, COSM4001426, COSM4001428, COSM4001427	182	541					TTN (inh=AD pLI=0.00)
chr2	190430177	190430177	A	G	hom		QUAL=30890;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,276,1.00,HOM,397,1.00	SLC40A1	synonymous	SLC40A1:NM_014585.5:synonymous:LOW:exon6/8:c.663T>C:p.Val221Val		rs2304704	0.5501	0.6140	24088/13127/244	0.6130						604653 [SLC40A1 (confirmed) Hemochromatosis,type 4];				430	510					SLC40A1 (inh=n/a pLI=0.98)
chr2	190445495	190445495	-	CCG	hom	low_DP	QUAL=1535;DP=15;AF=0.80;MQM=60;TRIO=HOM,15,0.80,HET,30,0.50,HOM,40,0.95	SLC40A1	5'UTR	SLC40A1:NM_014585.5:5'UTR:MODIFIER:exon1/8:c.-312_-310dupCGG:		rs16836041;rs3833570	0.5335	0.0000	0/0/0	0.3782										51	59					SLC40A1 (inh=n/a pLI=0.98)
chr2	191069434	191069434	G	A	het		QUAL=3249;DP=229;AF=0.45;MQM=60;TRIO=HET,229,0.45,WT,51,0.00,HET,69,0.49	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*409C>T:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*519C>T:		rs1058230	0.3632	0.0000	0/0/0	0.0515										19	84					HIBCH (inh=n/a pLI=0.00)
chr2	191069476	191069476	C	T	het		QUAL=5403;DP=328;AF=0.47;MQM=60;TRIO=HET,328,0.47,WT,96,0.00,HET,126,0.49	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*367G>A:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*477G>A:		rs1058227	0.3636	0.0000	0/0/0	0.0515										19	85					HIBCH (inh=n/a pLI=0.00)
chr2	191069689	191069689	T	A	het		QUAL=8108;DP=293;AF=0.46;MQM=59;TRIO=HET,293,0.46,WT,221,0.00,HET,329,0.51	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*154A>T:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*264A>T:	MER58B	rs11542	0.3480	0.0000	0/0/0	0.0508										20	73					HIBCH (inh=n/a pLI=0.00)
chr2	191110893	191110893	C	T	het	phylop_high	QUAL=3824;DP=217;AF=0.43;MQM=60;TRIO=HET,217,0.43,WT,47,0.00,HET,85,0.58	HIBCH	missense	HIBCH:NM_014362.3:missense:MODERATE:exon10/14:c.796G>A:p.Asp266Asn,HIBCH:NM_198047.2:missense:MODERATE:exon10/13:c.796G>A:p.Asp266Asn		rs144053672	0.0008	0.0025	1/1/0	0.0027	2.5220	T	T,T,T,T,T	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];				0	7					HIBCH (inh=n/a pLI=0.00)
chr2	191161622	191161622	T	C	het	phylop_high	QUAL=14883;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,HOM,229,1.00,HET,278,0.50	HIBCH	missense	HIBCH:NM_014362.3:missense:MODERATE:exon3/14:c.136A>G:p.Thr46Ala,HIBCH:NM_198047.2:missense:MODERATE:exon3/13:c.136A>G:p.Thr46Ala		rs1058180	0.6843	0.7390	33450/18999/2177	0.7279	2.9820	T	T,T,T	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];				554	447					HIBCH (inh=n/a pLI=0.00)
chr2	191184475	191184475	A	G	het	anno_high_impact;pred_pathogenic_1	QUAL=5024;DP=134;AF=0.46;MQM=60;TRIO=HET,134,0.46,HOM,86,1.00,HET,143,0.34	HIBCH	start_lost	HIBCH:NM_014362.3:start_lost:HIGH:exon1/14:c.2T>C:p.Met1?,HIBCH:NM_198047.2:start_lost:HIGH:exon1/13:c.2T>C:p.Met1?		rs291466	0.4317	0.5190	16666/11152/971	0.5117	1.2900	T	D,D	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];				387	523	1	[1] auto-classification 16.06.2016  			HIBCH (inh=n/a pLI=0.00)
chr2	191184524	191184524	C	T	hom		QUAL=15786;DP=250;AF=0.98;MQM=60;TRIO=HOM,250,0.98,HOM,119,1.00,HOM,190,0.98	HIBCH	5'UTR	HIBCH:NM_014362.3:5'UTR:MODIFIER:exon1/14:c.-48G>A:,HIBCH:NM_198047.2:5'UTR:MODIFIER:exon1/13:c.-48G>A:		rs3749022	0.5487	0.6640	19853/13606/545	0.6317									COSN166358	219	78					HIBCH (inh=n/a pLI=0.00)
chr2	191841759	191841759	G	A	het		QUAL=4966;DP=231;AF=0.45;MQM=60;TRIO=HET,231,0.45,WT,116,0.00,HET,172,0.53	STAT1	splice_region&intron	STAT1:NM_007315.3:splice_region&intron:LOW:exon21/24:c.1874-8C>T:,STAT1:NM_139266.2:splice_region&intron:LOW:exon21/22:c.1874-8C>T:		rs2066804	0.2266	0.2260	3440/1838/154	0.2283						600555 [STAT1 (provisional) Immunodeficiency 31A,mycobacteriosis,autosomal dominant|Immunodeficiency 31B,mycobacterial and viral infections,autosomal recessive|Immunodeficiency 31C,autosomal dominant];				68	483					STAT1 (inh=n/a pLI=1.00)
chr2	198362018	198362018	T	C	hom		QUAL=32193;DP=445;AF=1.00;MQM=59;TRIO=HOM,445,1.00,HOM,241,1.00,HOM,307,1.00	HSPD1	synonymous	HSPD1:NM_002156.4:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys,HSPD1:NM_199440.1:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys		rs8539	0.6546	0.6490	26123/15686/2679	0.6417						118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant|Leukodystrophy,hypomyelinating,4];	RCV000117240.3 [other]; 		COSM3757861, COSM3757863, COSM3757862	825	621					HSPD1 (inh=AR+AD pLI=0.99)
chr2	198363504	198363504	A	G	het		QUAL=2917;DP=207;AF=0.46;MQM=56;TRIO=HET,207,0.46,HET,60,0.45,WT,86,0.01	HSPD1	synonymous	HSPD1:NM_002156.4:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr,HSPD1:NM_199440.1:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr		rs1050347	0.1581	0.1650	506/311/29	0.1604						118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant|Leukodystrophy,hypomyelinating,4];	RCV000117242.3 [other]; 			64	461					HSPD1 (inh=AR+AD pLI=0.99)
chr2	198364518	198364518	G	A	het		QUAL=1295;DP=23;AF=0.87;MQM=60;TRIO=HET,23,0.87,HET,52,0.71,WT,63,0.00	HSPD1	5'UTR_premature_start_codon_gain,5'UTR,intron	HSPD1:NM_002156.4:5'UTR_premature_start_codon_gain:LOW:exon1/12:c.-15C>T:,HSPD1:NM_002156.4:5'UTR:MODIFIER:exon1/12:c.-15C>T:,HSPD1:NM_199440.1:intron:MODIFIER:exon1/11:c.-3+366C>T:		rs13165	0.2332	0.0000	0/0/0	0.2059							RCV000125394.1 [benign]; 			11	63					HSPD1 (inh=AR+AD pLI=0.99)
chr2	200134420	200134420	-	AA	hom		QUAL=2079;DP=99;AF=0.67;MQM=58;TRIO=HOM,99,0.67,HOM,9,0.33,HOM,6,0.50	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*2512_*2513dupTT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*2512_*2513dupTT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*2512_*2513dupTT:		rs367546534;rs386392269;rs58333872	0.0000	0.0000	0/0/0	0.3208										80	102					SATB2 (inh=AD pLI=1.00)
chr2	200135233	200135233	-	A	hom		QUAL=1948;DP=314;AF=0.42;MQM=59;TRIO=HOM,314,0.42,WT,126,0.26,HOM,169,0.49	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*1700dupT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*1700dupT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*1700dupT:		rs397987298	0.5377	0.0000	0/0/0	0.1536										4	156					SATB2 (inh=AD pLI=1.00)
chr2	200136284	200136284	A	-	het		QUAL=1798;DP=99;AF=0.47;MQM=59;TRIO=HET,99,0.47,HET,75,0.59,WT,66,0.14	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*650delT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*650delT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*650delT:		rs397987299	0.4403	0.0000	0/0/0	0.3245										50	123					SATB2 (inh=AD pLI=1.00)
chr2	200136583	200136583	T	A	hom		QUAL=16760;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HOM,121,1.00,HOM,199,1.00	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*351A>T:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*351A>T:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*351A>T:		rs6435006	0.9325	0.0000	0/0/0	0.1460										229	1					SATB2 (inh=AD pLI=1.00)
chr2	200173684	200173684	T	G	hom		QUAL=20796;DP=127;AF=1.00;MQM=60;TRIO=HOM,127,1.00,HOM,238,1.00,HOM,302,1.00	SATB2	splice_region&intron	SATB2:NM_001172509.1:splice_region&intron:LOW:exon9/10:c.1543-4A>C:,SATB2:NM_001172517.1:splice_region&intron:LOW:exon10/11:c.1543-4A>C:,SATB2:NM_015265.3:splice_region&intron:LOW:exon10/11:c.1543-4A>C:		rs10153730	0.9309	0.9810	58446/33219/3290	0.9524						608148 [SATB2 (confirmed) Glass syndrome];				1098	7					SATB2 (inh=AD pLI=1.00)
chr2	202565570	202565570	C	T	het		QUAL=4513;DP=243;AF=0.47;MQM=60;TRIO=HET,243,0.47,HET,138,0.45,WT,171,0.01	ALS2	3'UTR	ALS2:NM_020919.3:3'UTR:MODIFIER:exon34/34:c.*1004G>A:		rs11300	0.1024	0.0000	0/0/0	0.0172										2	39					ALS2 (inh=n/a pLI=0.00)
chr2	202565681	202565681	G	A	het		QUAL=4559;DP=280;AF=0.48;MQM=60;TRIO=HET,280,0.48,HET,102,0.44,WT,169,0.01	ALS2	3'UTR	ALS2:NM_020919.3:3'UTR:MODIFIER:exon34/34:c.*893C>T:		rs3219174	0.0897	0.0000	0/0/0	0.0800										1	30					ALS2 (inh=n/a pLI=0.00)
chr2	202575821	202575821	G	A	hom		QUAL=16533;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,149,1.00,HET,194,0.61	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon26/34:c.4015C>T:p.Leu1339Leu		rs3219168	0.9054	0.9230	51524/28358/3331	0.8971						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];				1375	208					ALS2 (inh=n/a pLI=0.00)
chr2	202593280	202593280	G	A	het		QUAL=7402;DP=337;AF=0.49;MQM=60;TRIO=HET,337,0.49,HET,242,0.50,WT,313,0.00	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon15/34:c.2796C>T:p.Ser932Ser		rs3219161	0.1150	0.0980	745/261/26	0.0973						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];			COSM3757885	22	262					ALS2 (inh=n/a pLI=0.00)
chr2	202598113	202598113	C	T	het		QUAL=5337;DP=190;AF=0.51;MQM=60;TRIO=HET,190,0.51,HET,90,0.52,HET,128,0.45	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon13/34:c.2466G>A:p.Val822Val		rs2276615	0.3724	0.5270	18156/12226/133	0.5216						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];			COSM149044	576	746					ALS2 (inh=n/a pLI=0.00)
chr2	202625615	202625615	C	T	hom		QUAL=24039;DP=492;AF=1.00;MQM=59;TRIO=HOM,492,1.00,HOM,165,1.00,HET,252,0.46	ALS2	missense	ALS2:NM_020919.3:missense:MODERATE:exon4/34:c.1102G>A:p.Val368Met,ALS2:NM_001135745.1:missense:MODERATE:exon4/4:c.1102G>A:p.Val368Met		rs3219156	0.8966	0.9100	50185/27117/3007	0.8768	-2.3570	T	T,T	B,B,B,B	B,B,B,B	606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];				1276	308					ALS2 (inh=n/a pLI=0.00)
chr2	206988751	206988751	A	G	het		QUAL=5405;DP=278;AF=0.52;MQM=60;TRIO=HET,278,0.52,HET,98,0.52,WT,131,0.00	NDUFS1	3'UTR	NDUFS1:NM_001199984.1:3'UTR:MODIFIER:exon19/19:c.*158T>C:,NDUFS1:NM_001199981.1:3'UTR:MODIFIER:exon18/18:c.*158T>C:,NDUFS1:NM_001199982.1:3'UTR:MODIFIER:exon16/16:c.*158T>C:,NDUFS1:NM_001199983.1:3'UTR:MODIFIER:exon18/18:c.*158T>C:,NDUFS1:NM_005006.6:3'UTR:MODIFIER:exon19/19:c.*158T>C:		rs3770989	0.0256	0.0000	0/0/0	0.0046										0	20					NDUFS1 (inh=AR pLI=0.00)
chr2	206992537	206992537	A	C	het	phylop_high;pred_pathogenic_4	QUAL=1524;DP=236;AF=0.53;MQM=60;TRIO=HET,236,0.53,WT,132,0.00,WT,161,0.00	NDUFS1	missense	NDUFS1:NM_001199984.1:missense:MODERATE:exon16/19:c.1910T>G:p.Ile637Arg,NDUFS1:NM_001199981.1:missense:MODERATE:exon15/18:c.1760T>G:p.Ile587Arg,NDUFS1:NM_001199982.1:missense:MODERATE:exon13/16:c.1535T>G:p.Ile512Arg,NDUFS1:NM_001199983.1:missense:MODERATE:exon15/18:c.1697T>G:p.Ile566Arg,NDUFS1:NM_005006.6:missense:MODERATE:exon16/19:c.1868T>G:p.Ile623Arg		rs201634181	0.0000	0.0046	0/0/0	0.0001	9.2840	D	D,D,D,D,D,D,D	D,P,P,P	D,P,P,P	157655 [NDUFS1 (provisional) Mitochondrial complex I deficiency];	RCV000197616.1 [uncertain significance]; 		COSM215852	0	58					NDUFS1 (inh=AR pLI=0.00)
chr2	207026131	207026131	G	A	het	phylop_high	QUAL=6049;DP=227;AF=0.45;MQM=55;TRIO=HET,227,0.45,HET,294,0.47,WT,379,0.00	EEF1B2	missense	EEF1B2:NM_001037663.1:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg,EEF1B2:NM_001959.3:missense:MODERATE:exon3/6:c.265G>A:p.Gly89Arg,EEF1B2:NM_021121.3:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg		rs11546386	0.0178	0.0130	25/3/0	0.0118	5.3110	T	T,T,T,T	B	B				COSM3695209	0	26					EEF1B2 (inh=n/a pLI=0.33)
chr2	207657706	207657706	G	C	het		QUAL=4824;DP=192;AF=0.52;MQM=59;TRIO=HET,192,0.52,WT,126,0.00,HET,177,0.53	FASTKD2	3'UTR	FASTKD2:NM_001136193.1:3'UTR:MODIFIER:exon12/12:c.*1180G>C:,FASTKD2:NM_001136194.1:3'UTR:MODIFIER:exon12/12:c.*1180G>C:,FASTKD2:NM_014929.3:3'UTR:MODIFIER:exon12/12:c.*1180G>C:	AluSc	rs114333222	0.0016	0.0000	0/0/0	0.0049										0	4					FASTKD2 (inh=AR pLI=0.00)
chr2	211421452	211421452	-	TCT	hom		QUAL=12769;DP=254;AF=0.95;MQM=59;TRIO=HOM,254,0.95,HET,166,0.49,HET,195,0.49	CPS1	conservative_inframe_insertion,5'UTR	CPS1:NM_001122633.2:conservative_inframe_insertion:MODERATE:exon2/39:c.15_16insTTC:p.Ile5_Lys6insPhe,CPS1:NM_001875.4:5'UTR:MODIFIER:exon1/38:c.-4_-3insTTC:		rs3835047;rs61509952	0.4770	0.4350	11669/5397/1790	0.4083						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000185816.1 [benign]; 			225	524	1	[1] old entry - no details available			CPS1 (inh=AR pLI=0.08)
chr2	211456637	211456637	A	G	hom		QUAL=15942;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,178,0.99,HET,254,0.51	CPS1	missense	CPS1:NM_001122633.2:missense:MODERATE:exon11/39:c.1048A>G:p.Thr350Ala,CPS1:NM_001875.4:missense:MODERATE:exon10/38:c.1030A>G:p.Thr344Ala		rs1047883	0.0000	0.5680	19535/10771/1924	0.5152	0.2530	T	T,T,T,T	B	B	608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116829.3 [other]; 		COSM4133424, COSM4133425	415	499					CPS1 (inh=AR pLI=0.08)
chr2	211456639	211456639	C	T	hom		QUAL=15942;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,178,0.99,HET,254,0.51	CPS1	synonymous	CPS1:NM_001122633.2:synonymous:LOW:exon11/39:c.1050C>T:p.Thr350Thr,CPS1:NM_001875.4:synonymous:LOW:exon10/38:c.1032C>T:p.Thr344Thr		rs2229589	0.5913	0.5720	19866/10782/2240	0.5436						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116830.3 [other]; 			417	497					CPS1 (inh=AR pLI=0.08)
chr2	211481257	211481257	C	G	hom		QUAL=15598;DP=142;AF=1.00;MQM=60;TRIO=HOM,142,1.00,HOM,254,1.00,HET,292,0.42	CPS1	synonymous	CPS1:NM_001122633.2:synonymous:LOW:exon22/39:c.2697C>G:p.Gly899Gly,CPS1:NM_001875.4:synonymous:LOW:exon21/38:c.2679C>G:p.Gly893Gly,CPS1:NM_001122634.3:synonymous:LOW:exon11/28:c.1326C>G:p.Gly442Gly		rs2287599	0.6492	0.5860	21467/10811/3868	0.5735						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116831.3 [other]; 			403	508					CPS1 (inh=AR pLI=0.08)
chr2	211543147	211543147	T	G	het		QUAL=7846;DP=273;AF=0.51;MQM=59;TRIO=HET,273,0.51,HET,93,0.63,HET,130,0.63	CPS1	3'UTR	CPS1:NM_001122633.2:3'UTR:MODIFIER:exon39/39:c.*438T>G:,CPS1:NM_001875.4:3'UTR:MODIFIER:exon38/38:c.*438T>G:,CPS1:NM_001122634.3:3'UTR:MODIFIER:exon28/28:c.*438T>G:		rs7684	0.2690	0.0000	0/0/0	0.0542										28	111					CPS1 (inh=AR pLI=0.08)
chr2	215796302	215796302	-	ACAA	het		QUAL=6985;DP=218;AF=0.49;MQM=59;TRIO=HET,218,0.49,HOM,156,0.97,WT,282,0.00	ABCA12,LOC101928103	3'UTR,intron,non_coding_exon	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*1052_*1055dupTTGT:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*1052_*1055dupTTGT:,LOC101928103:NR_110292.1:intron:MODIFIER:exon2/3:n.322-16243_322-16240dupAACA:,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon55/55:n.9140_9143dupTTGT:		rs57011945	0.3015	0.0000	0/0/0	0.3540										39	97					ABCA12 (inh=n/a pLI=0.00), LOC101928103 (inh=n/a pLI=n/a)
chr2	215796568	215796568	T	C	hom		QUAL=19207;DP=226;AF=1.00;MQM=59;TRIO=HOM,226,1.00,HOM,159,1.00,HOM,203,1.00	ABCA12,LOC101928103	3'UTR,intron,non_coding_exon	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*790A>G:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*790A>G:,LOC101928103:NR_110292.1:intron:MODIFIER:exon2/3:n.322-15981T>C:,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon55/55:n.8878A>G:		rs12694349	0.5939	0.0000	0/0/0	0.5229										64	104					ABCA12 (inh=n/a pLI=0.00), LOC101928103 (inh=n/a pLI=n/a)
chr2	215797332	215797332	C	T	hom		QUAL=15380;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,82,1.00,HET,127,0.55	ABCA12,LOC101928103	3'UTR,intron,non_coding_exon	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*26G>A:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*26G>A:,LOC101928103:NR_110292.1:intron:MODIFIER:exon2/3:n.322-15217C>T:,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon55/55:n.8114G>A:		rs17426207	0.3982	0.4190	10530/5449/641	0.4090										87	225					ABCA12 (inh=n/a pLI=0.00), LOC101928103 (inh=n/a pLI=n/a)
chr2	215820013	215820013	G	A	het		QUAL=13130;DP=328;AF=0.41;MQM=60;TRIO=HET,328,0.41,HOM,196,1.00,HET,265,0.49	ABCA12,LOC101928103	synonymous,intron,non_coding_exon	ABCA12:NM_173076.2:synonymous:LOW:exon43/53:c.6306C>T:p.Tyr2102Tyr,ABCA12:NM_015657.3:synonymous:LOW:exon35/45:c.5352C>T:p.Tyr1784Tyr,LOC101928103:NR_110292.1:intron:MODIFIER:exon3/3:n.445-6521G>A:,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon45/55:n.6606C>T:		rs10498027	0.3500	0.4050	10283/6091/513	0.3990						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];			COSM3757935	198	536					ABCA12 (inh=n/a pLI=0.00), LOC101928103 (inh=n/a pLI=n/a)
chr2	215839570	215839570	C	T	het		QUAL=8765;DP=334;AF=0.49;MQM=60;TRIO=HET,334,0.49,WT,246,0.00,HET,339,0.48	ABCA12	synonymous,non_coding_exon	ABCA12:NM_173076.2:synonymous:LOW:exon35/53:c.5400G>A:p.Thr1800Thr,ABCA12:NM_015657.3:synonymous:LOW:exon27/45:c.4446G>A:p.Thr1482Thr,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon37/55:n.5700G>A:		rs16853022	0.1196	0.0480	495/3/440	0.0467						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				2	83					ABCA12 (inh=n/a pLI=0.00)
chr2	215851303	215851303	A	G	hom		QUAL=15522;DP=180;AF=0.99;MQM=60;TRIO=HOM,180,0.99,HET,163,0.52,HOM,248,1.00	ABCA12	synonymous,non_coding_exon	ABCA12:NM_173076.2:synonymous:LOW:exon28/53:c.4126T>C:p.Leu1376Leu,ABCA12:NM_015657.3:synonymous:LOW:exon20/45:c.3172T>C:p.Leu1058Leu,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon30/55:n.4426T>C:		rs34351934	0.2071	0.1350	1703/316/769	0.1327						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				24	252					ABCA12 (inh=n/a pLI=0.00)
chr2	215854156	215854156	C	T	het		QUAL=14250;DP=345;AF=0.49;MQM=60;TRIO=HET,345,0.49,HET,348,0.49,HET,456,0.46	ABCA12	synonymous,non_coding_exon	ABCA12:NM_173076.2:synonymous:LOW:exon26/53:c.3726G>A:p.Pro1242Pro,ABCA12:NM_015657.3:synonymous:LOW:exon18/45:c.2772G>A:p.Pro924Pro,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon28/55:n.4026G>A:		rs71428357	0.0719	0.0650	427/98/43	0.0645						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				8	140					ABCA12 (inh=n/a pLI=0.00)
chr2	215876166	215876166	A	T	hom		QUAL=15166;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,127,1.00,HOM,162,1.00	ABCA12	missense,non_coding_exon	ABCA12:NM_173076.2:missense:MODERATE:exon17/53:c.2329T>A:p.Ser777Thr,ABCA12:NM_015657.3:missense:MODERATE:exon9/45:c.1375T>A:p.Ser459Thr,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon18/55:n.2573T>A:		rs7560008	0.9984	0.9990	60286/33210/5059	0.9375	-1.4110	T	T,T	B,B	B,B	607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				1102	2					ABCA12 (inh=n/a pLI=0.00)
chr2	215876371	215876371	T	C	hom		QUAL=10498;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HET,135,0.51,HET,211,0.51	ABCA12	splice_region&synonymous,splice_region&non_coding_exon	ABCA12:NM_173076.2:splice_region&synonymous:LOW:exon17/53:c.2124A>G:p.Ala708Ala,ABCA12:NM_015657.3:splice_region&synonymous:LOW:exon9/45:c.1170A>G:p.Ala390Ala,ABCA12:NR_103740.1:splice_region&non_coding_exon:LOW:exon18/55:n.2368A>G:		rs10198064	0.2794	0.1520	2861/266/1963	0.1490						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				24	247					ABCA12 (inh=n/a pLI=0.00)
chr2	215901774	215901774	C	T	het		QUAL=7551;DP=320;AF=0.52;MQM=60;TRIO=HET,320,0.52,WT,203,0.00,HET,236,0.52	ABCA12	synonymous,non_coding_exon	ABCA12:NM_173076.2:synonymous:LOW:exon8/53:c.888G>A:p.Val296Val,ABCA12:NR_103740.1:non_coding_exon:MODIFIER:exon9/55:n.1132G>A:		rs17501837	0.2234	0.2060	2859/1304/104	0.2082						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];			COSM50991	32	305					ABCA12 (inh=n/a pLI=0.00)
chr2	216176807	216176807	T	G	het		QUAL=2406;DP=41;AF=0.49;MQM=60;TRIO=HET,41,0.49,WT,130,0.00,HET,174,0.51	ATIC	5'UTR	ATIC:NM_004044.6:5'UTR:MODIFIER:exon1/16:c.-59T>G:		rs4535042	0.2448	0.0000	0/0/0	0.0471										64	199					ATIC (inh=AR pLI=0.00)
chr2	216214492	216214492	T	G	het		QUAL=10116;DP=210;AF=0.52;MQM=59;TRIO=HET,210,0.52,HOM,164,1.00,HET,206,0.42	ATIC	3'UTR	ATIC:NM_004044.6:3'UTR:MODIFIER:exon16/16:c.*114T>G:		rs10498036	0.5952	0.0000	0/0/0	0.1200										55	117					ATIC (inh=AR pLI=0.00)
chr2	217277249	217277249	C	T	het		QUAL=8659;DP=114;AF=0.48;MQM=60;TRIO=HET,114,0.48,WT,173,0.00,HOM,254,1.00	SMARCAL1	5'UTR	SMARCAL1:NM_014140.3:5'UTR:MODIFIER:exon1/18:c.-218C>T:		rs3755141	0.2079	0.0000	0/0/0	0.2680										18	84					SMARCAL1 (inh=n/a pLI=0.00)
chr2	219646547	219646547	-	C	hom		QUAL=4527;DP=52;AF=0.96;MQM=59;TRIO=HOM,52,0.96,HOM,56,0.98,HOM,59,1.00	CYP27A1	5'UTR	CYP27A1:NM_000784.3:5'UTR:MODIFIER:exon1/9:c.-357dupC:		rs397795841	0.9998	0.0000	0/0/0	0.9125										221	9					CYP27A1 (inh=AR pLI=0.00)
chr2	219940484	219940484	C	T	hom		QUAL=16790;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HOM,114,1.00,HOM,123,1.00	NHEJ1	3'UTR	NHEJ1:NM_024782.2:3'UTR:MODIFIER:exon8/8:c.*619G>A:		rs359960	0.9852	0.0000	0/0/0	0.1537										222	8					NHEJ1 (inh=n/a pLI=0.03)
chr2	219941063	219941063	G	A	hom		QUAL=20190;DP=326;AF=1.00;MQM=59;TRIO=HOM,326,1.00,HET,199,0.46,HOM,235,1.00	NHEJ1	3'UTR	NHEJ1:NM_024782.2:3'UTR:MODIFIER:exon8/8:c.*40C>T:		rs897477	0.6384	0.7100	31172/19666/2546	0.7014									COSM4001506	364	262					NHEJ1 (inh=n/a pLI=0.03)
chr2	220283259	220283259	A	G	het	low_DP	QUAL=4879;DP=6;AF=0.83;MQM=60;TRIO=HET,6,0.83,HOM,63,1.00,HOM,104,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon1/9:c.75A>G:p.Pro25Pro		rs1318299	0.8862	0.9580	49754/28119/1579	0.8660						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000154433.1 [benign]; RCV000029660.1 [benign]; RCV000037251.8 [benign]; 		COSM3757962	1109	32					DES (inh=n/a pLI=0.00)
chr2	220283277	220283277	T	C	hom	low_DP	QUAL=5311;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,67,1.00,HOM,102,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon1/9:c.93T>C:p.Ser31Ser		rs2017800	0.8660	0.9520	48951/27937/1280	0.8687						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000154434.1 [benign]; RCV000029661.1 [benign]; RCV000037256.8 [benign]; 		COSM3749630	1124	38					DES (inh=n/a pLI=0.00)
chr2	220285309	220285309	C	T	hom		QUAL=37665;DP=393;AF=0.98;MQM=59;TRIO=HOM,393,0.98,HOM,372,0.99,HOM,451,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon4/9:c.828C>T:p.Asp276Asp		rs1058261	0.3375	0.3360	6988/4285/1016	0.3349						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037254.7 [benign]; 			169	544					DES (inh=n/a pLI=0.00)
chr2	220285666	220285666	G	C	hom		QUAL=35360;DP=179;AF=0.99;MQM=59;TRIO=HOM,179,0.99,HOM,419,1.00,HOM,534,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon5/9:c.1014G>C:p.Leu338Leu		rs12920	0.3377	0.3350	6724/4097/1020	0.3317						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037222.7 [benign]; 		COSM4133480	169	544					DES (inh=n/a pLI=0.00)
chr2	220286142	220286142	G	A	hom		QUAL=29889;DP=207;AF=1.00;MQM=59;TRIO=HOM,207,1.00,HOM,317,1.00,HOM,467,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon6/9:c.1104G>A:p.Ala368Ala		rs1058284	0.3337	0.3360	7020/4314/1009	0.3356						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037225.7 [benign]; 		COSM4001515	169	543					DES (inh=n/a pLI=0.00)
chr2	223158653	223158653	T	-	hom		QUAL=17030;DP=166;AF=0.98;MQM=59;TRIO=HOM,166,0.98,HOM,194,1.00,HOM,235,1.00	PAX3	3'UTR,intron	PAX3:NM_000438.5:3'UTR:MODIFIER:exon4/4:c.*171delA:,PAX3:NM_181459.3:intron:MODIFIER:exon4/9:c.586+233delA:,PAX3:NM_001127366.2:intron:MODIFIER:exon4/8:c.583+233delA:,PAX3:NM_181458.3:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:NM_181460.3:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:NM_181461.3:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:NM_181457.3:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:NM_013942.4:intron:MODIFIER:exon4/4:c.587-177delA:		rs397987956	1.0000	0.0000	0/0/0	0.9164						606597 [PAX3 (confirmed) Waardenburg syndrome,type 1|Waardenburg syndrome,type 3|Craniofacial-deafness-hand syndrome|Rhabdomyosarcoma 2,alveolar];				150	0					PAX3 (inh=n/a pLI=0.90)
chr2	223161889	223161889	A	G	hom		QUAL=8521;DP=55;AF=1.00;MQM=59;TRIO=HOM,55,1.00,HOM,125,1.00,HOM,131,1.00	PAX3	synonymous	PAX3:NM_181459.3:synonymous:LOW:exon2/10:c.129T>C:p.Gly43Gly,PAX3:NM_001127366.2:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181458.3:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181460.3:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181461.3:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:NM_181457.3:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:NM_000438.5:synonymous:LOW:exon2/4:c.129T>C:p.Gly43Gly,PAX3:NM_013942.4:synonymous:LOW:exon2/5:c.129T>C:p.Gly43Gly		rs12623857	0.9044	0.8700	35371/17979/2524	0.8157						606597 [PAX3 (confirmed) Waardenburg syndrome,type 1|Waardenburg syndrome,type 3|Craniofacial-deafness-hand syndrome|Rhabdomyosarcoma 2,alveolar];	RCV000176002.2 [benign]; 			868	220					PAX3 (inh=n/a pLI=0.90)
chr2	227867719	227867719	G	A	het		QUAL=7022;DP=387;AF=0.47;MQM=59;TRIO=HET,387,0.47,HET,151,0.52,WT,199,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*4322C>T:		rs1054413	0.5399	0.0000	0/0/0	0.0769										34	123					COL4A4 (inh=n/a pLI=0.00)
chr2	227868854	227868854	C	T	het		QUAL=5734;DP=285;AF=0.51;MQM=59;TRIO=HET,285,0.51,HET,146,0.53,WT,173,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*3187G>A:	L2c	rs56324594	0.4683	0.0000	0/0/0	0.0729										33	111					COL4A4 (inh=n/a pLI=0.00)
chr2	227869921	227869921	T	-	het		QUAL=4323;DP=316;AF=0.52;MQM=59;TRIO=HET,316,0.52,HET,92,0.39,WT,117,0.08	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*2120delA:		rs71821803	0.2871	0.0000	0/0/0	0.2362										24	126					COL4A4 (inh=n/a pLI=0.00)
chr2	227871266	227871266	-	T	het		QUAL=4233;DP=255;AF=0.45;MQM=59;TRIO=HET,255,0.45,HET,180,0.46,WT,234,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*774dupA:		rs370368184;rs59918285	0.5154	0.0000	0/0/0	0.4069										33	124					COL4A4 (inh=n/a pLI=0.00)
chr2	227871475	227871475	T	-	het		QUAL=2965;DP=234;AF=0.48;MQM=59;TRIO=HET,234,0.48,HET,91,0.51,WT,101,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*566delA:		rs796331910	0.4806	0.0000	0/0/0	0.2780										30	127					COL4A4 (inh=n/a pLI=0.00)
chr2	227872182	227872182	G	A	het		QUAL=5371;DP=210;AF=0.55;MQM=60;TRIO=HET,210,0.55,HET,189,0.47,WT,200,0.02	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon48/48:c.4932C>T:p.Phe1644Phe		rs2228557	0.5144	0.4660	13498/5686/1763	0.4423						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757991	187	565					COL4A4 (inh=n/a pLI=0.00)
chr2	227872995	227872995	T	C	het		QUAL=4275;DP=110;AF=0.51;MQM=60;TRIO=HET,110,0.51,HET,230,0.55,WT,225,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon47/48:c.4548A>G:p.Val1516Val		rs2228555	0.6406	0.5600	19250/8400/2574	0.5480						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757992	288	570					COL4A4 (inh=n/a pLI=0.00)
chr2	227873028	227873028	A	G	het		QUAL=4395;DP=142;AF=0.56;MQM=59;TRIO=HET,142,0.56,HET,179,0.56,WT,176,0.00	COL4A4	splice_region&intron	COL4A4:NM_000092.4:splice_region&intron:LOW:exon46/47:c.4523-8T>C:		rs13419076	0.5156	0.4640	13136/5504/1736	0.4514						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];				189	563					COL4A4 (inh=n/a pLI=0.00)
chr2	227886773	227886773	A	G	het	phylop_high	QUAL=4776;DP=233;AF=0.49;MQM=60;TRIO=HET,233,0.49,HET,136,0.54,WT,203,0.00	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon44/48:c.4207T>C:p.Ser1403Pro		rs3752895	0.5262	0.4760	14088/6128/1982	0.4637	3.4190	T	T,T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757993	209	559					COL4A4 (inh=n/a pLI=0.00)
chr2	227892619	227892619	C	T	het		QUAL=4996;DP=256;AF=0.57;MQM=60;TRIO=HET,256,0.57,HET,69,0.71,WT,82,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon42/48:c.4080G>A:p.Pro1360Pro		rs2228556	0.4918	0.4690	13568/6287/1395	0.4581						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM1752390	210	560					COL4A4 (inh=n/a pLI=0.00)
chr2	227892720	227892720	C	T	het	anno_pathogenic_clinvar	QUAL=4077;DP=161;AF=0.57;MQM=60;TRIO=HET,161,0.57,HET,96,0.66,WT,91,0.00	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon42/48:c.3979G>A:p.Val1327Met		rs2229813	0.4930	0.4610	12092/5508/1240	0.4507	-0.1400	T	T,T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];	RCV000171504.1 [likely pathogenic]; 		COSM1752392	211	559					COL4A4 (inh=n/a pLI=0.00)
chr2	227896652	227896652	C	G	het		QUAL=6928;DP=322;AF=0.50;MQM=60;TRIO=HET,322,0.50,HET,185,0.60,WT,270,0.00	COL4A4	splice_region&intron	COL4A4:NM_000092.4:splice_region&intron:LOW:exon40/47:c.3817+9G>C:		rs13423714	0.4960	0.4700	13242/6080/1363	0.4545						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];				211	559					COL4A4 (inh=n/a pLI=0.00)
chr2	227896886	227896886	C	T	het		QUAL=3595;DP=210;AF=0.45;MQM=60;TRIO=HET,210,0.45,HET,97,0.46,WT,165,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon39/48:c.3684G>A:p.Lys1228Lys		rs2229812	0.4956	0.4710	13744/6323/1371	0.4591						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757994	210	559					COL4A4 (inh=n/a pLI=0.00)
chr2	227896976	227896976	C	T	het		QUAL=3707;DP=294;AF=0.49;MQM=59;TRIO=HET,294,0.49,HET,42,0.50,WT,72,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon39/48:c.3594G>A:p.Gly1198Gly		rs10203363	0.4950	0.4690	13401/6131/1351	0.4579						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757995	210	560					COL4A4 (inh=n/a pLI=0.00)
chr2	227915832	227915832	G	A	het	phylop_high;pred_pathogenic_1	QUAL=8110;DP=316;AF=0.51;MQM=60;TRIO=HET,316,0.51,HET,266,0.55,WT,384,0.01	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon33/48:c.3011C>T:p.Pro1004Leu		rs1800517	0.5473	0.5200	16667/7960/1561	0.5061	4.3580	T	D,D	P	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM4001525	276	560					COL4A4 (inh=n/a pLI=0.00)
chr2	227954599	227954599	G	A	het		QUAL=2729;DP=140;AF=0.47;MQM=60;TRIO=HET,140,0.47,HET,112,0.44,WT,152,0.01	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon21/48:c.1444C>T:p.Pro482Ser		rs2229814	0.5485	0.5340	17676/8236/1270	0.5246	0.6240	T	T,T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757996	289	547					COL4A4 (inh=n/a pLI=0.00)
chr2	228111435	228111435	T	C	het		QUAL=8339;DP=297;AF=0.52;MQM=60;TRIO=HET,297,0.52,HET,124,0.54,HET,180,0.50	COL4A3,LOC654841	missense,intron	COL4A3:NM_000091.4:missense:MODERATE:exon7/52:c.422T>C:p.Leu141Pro,LOC654841:NR_102371.1:intron:MODIFIER:exon9/13:n.1593-8545A>G:		rs10178458	0.7967	0.8300	41833/23030/1954	0.8190	0.3960	T	T,T,T,T,T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				727	328					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228113175	228113175	A	G	het		QUAL=8519;DP=342;AF=0.49;MQM=59;TRIO=HET,342,0.49,HET,115,0.52,HET,181,0.52	COL4A3,LOC654841	missense,intron	COL4A3:NM_000091.4:missense:MODERATE:exon9/52:c.485A>G:p.Glu162Gly,LOC654841:NR_102371.1:intron:MODIFIER:exon9/13:n.1593-10285T>C:		rs6436669	0.7963	0.8300	41904/23062/1956	0.8204	0.2100	T	T,T,T,T,T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				729	327					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228128540	228128540	C	T	hom		QUAL=9947;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,70,1.00,HOM,102,1.00	COL4A3,LOC654841	synonymous,intron	COL4A3:NM_000091.4:synonymous:LOW:exon21/52:c.1195C>T:p.Leu399Leu,LOC654841:NR_102371.1:intron:MODIFIER:exon8/13:n.1486+845G>A:		rs10205042	0.7676	0.7640	35528/17828/2160	0.7528						120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				565	427					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228135631	228135631	C	T	hom	phylop_high;pred_pathogenic_3	QUAL=9723;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,76,1.00,HET,103,0.52	COL4A3,LOC654841	missense,intron	COL4A3:NM_000091.4:missense:MODERATE:exon25/52:c.1721C>T:p.Pro574Leu,LOC654841:NR_102371.1:intron:MODIFIER:exon4/13:n.423-2146G>A:		rs28381984	0.4000	0.4690	13946/7735/189	0.4616	2.1930	T	D,D,D,D,D	D,D,D,D	D,D,D,D	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];			COSM3758002, COSM3758001	234	517					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228147093	228147093	A	G	het		QUAL=3605;DP=245;AF=0.47;MQM=60;TRIO=HET,245,0.47,WT,71,0.00,HET,77,0.52	COL4A3,LOC654841	missense,intron	COL4A3:NM_000091.4:missense:MODERATE:exon32/52:c.2501A>G:p.Lys834Arg,LOC654841:NR_102371.1:intron:MODIFIER:exon2/13:n.244-588T>C:		rs56226424	0.0056	0.0120	15/13/0	0.0122	-0.2720	T	T,T,T,T,T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				1	30					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228176901	228176901	A	C	hom		QUAL=38934;DP=587;AF=1.00;MQM=60;TRIO=HOM,587,1.00,HOM,241,1.00,HOM,346,1.00	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*315A>C:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-6530T>G:		rs2070735	0.7290	0.0000	0/0/0	0.1634										169	54					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228177479	228177479	C	T	hom		QUAL=27975;DP=416;AF=1.00;MQM=60;TRIO=HOM,416,1.00,HOM,179,1.00,HOM,254,1.00	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*893C>T:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-7108G>A:		rs7587228	0.8476	0.0000	0/0/0	0.1507										183	44					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228177751	228177751	G	A	hom		QUAL=24343;DP=462;AF=0.99;MQM=60;TRIO=HOM,462,0.99,HOM,195,1.00,HET,253,0.45	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*1165G>A:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-7380C>T:		rs28554165	0.2690	0.0000	0/0/0	0.0553										32	100					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228177825	228177825	C	G	hom		QUAL=28548;DP=414;AF=1.00;MQM=60;TRIO=HOM,414,1.00,HOM,189,1.00,HOM,253,1.00	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*1239C>G:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-7454G>C:	L2d	rs10188531	0.9161	0.0000	0/0/0	0.1569										190	34					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228178645	228178645	C	G	hom		QUAL=19235;DP=304;AF=0.99;MQM=59;TRIO=HOM,304,0.99,HOM,118,1.00,HOM,166,1.00	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*2059C>G:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-8274G>C:	MER5A	rs4290648	0.9161	0.0000	0/0/0	0.1807										164	32					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	228178780	228178780	A	C	hom		QUAL=18546;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,109,1.00,HOM,126,1.00	COL4A3,LOC654841	3'UTR,intron	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*2194A>C:,LOC654841:NR_102371.1:intron:MODIFIER:exon1/13:n.48-8409T>G:		rs7567291	1.0000	0.0000	0/0/0	0.1498										230	0					COL4A3 (inh=n/a pLI=0.00), LOC654841 (inh=n/a pLI=n/a)
chr2	231050715	231050715	A	G	hom		QUAL=23133;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,206,1.00,HOM,294,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon11/19:c.1274T>C:p.Leu425Ser,SP110:NM_004509.3:missense:MODERATE:exon11/18:c.1274T>C:p.Leu425Ser,SP110:NM_004510.3:missense:MODERATE:exon11/15:c.1274T>C:p.Leu425Ser,SP110:NM_001185015.1:missense:MODERATE:exon12/16:c.1292T>C:p.Leu431Ser		rs3948464	0.9040	0.8870	47894/25126/3764	0.8654	-0.3640	T	T,T,T,T,T,T	B,B,B,B,B	B,B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];	RCV000005877.5 [uncertain significance]; 	CM066604 [CLASS=DP MUT=REF PHEN="Tuberculosis reduced susceptibility association with" GENE=SP110]; 		859	225					SP110 (inh=n/a pLI=0.00)
chr2	231072709	231072709	C	T	hom		QUAL=20466;DP=315;AF=1.00;MQM=60;TRIO=HOM,315,1.00,HOM,137,0.99,HOM,163,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon8/19:c.895G>A:p.Gly299Arg,SP110:NM_004509.3:missense:MODERATE:exon8/18:c.895G>A:p.Gly299Arg,SP110:NM_004510.3:missense:MODERATE:exon8/15:c.895G>A:p.Gly299Arg,SP110:NM_001185015.1:missense:MODERATE:exon9/16:c.913G>A:p.Gly305Arg		rs1365776	0.8025	0.6650	24440/9224/3778	0.6518	-0.2260	T	T,T,T,T,T,T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				458	488					SP110 (inh=n/a pLI=0.00)
chr2	231077110	231077110	C	T	het		QUAL=7696;DP=295;AF=0.46;MQM=60;TRIO=HET,295,0.46,WT,346,0.00,HET,398,0.42	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon5/19:c.619G>A:p.Glu207Lys,SP110:NM_004509.3:missense:MODERATE:exon5/18:c.619G>A:p.Glu207Lys,SP110:NM_004510.3:missense:MODERATE:exon5/15:c.619G>A:p.Glu207Lys,SP110:NM_001185015.1:missense:MODERATE:exon6/16:c.637G>A:p.Glu213Lys		rs9061	0.1306	0.1140	1025/327/31	0.1102	-0.4510	T	T,T,T,T,T,T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];		CM131316 [CLASS=DP MUT=ALT PHEN="Pulmonary tuberculosis association with" GENE=SP110]; 	COSM149088, COSM3927760	16	239					SP110 (inh=n/a pLI=0.00)
chr2	231077112	231077112	G	A	het	pred_pathogenic_1	QUAL=14747;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,HOM,344,1.00,WT,399,0.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon5/19:c.617C>T:p.Ala206Val,SP110:NM_004509.3:missense:MODERATE:exon5/18:c.617C>T:p.Ala206Val,SP110:NM_004510.3:missense:MODERATE:exon5/15:c.617C>T:p.Ala206Val,SP110:NM_001185015.1:missense:MODERATE:exon6/16:c.635C>T:p.Ala212Val		rs28930679	0.1591	0.2110	2792/1894/113	0.2071	-0.0850	T	D,D,T,T,T,D,D	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				79	415					SP110 (inh=n/a pLI=0.00)
chr2	231077154	231077154	G	A	het		QUAL=11549;DP=203;AF=0.48;MQM=60;TRIO=HET,203,0.48,HOM,281,1.00,WT,335,0.00	SP110	splice_region&intron	SP110:NM_080424.2:splice_region&intron:LOW:exon4/18:c.584-9C>T:,SP110:NM_004509.3:splice_region&intron:LOW:exon4/17:c.584-9C>T:,SP110:NM_004510.3:splice_region&intron:LOW:exon4/14:c.584-9C>T:,SP110:NM_001185015.1:splice_region&intron:LOW:exon5/15:c.602-9C>T:		rs41309096	0.2288	0.2380	3534/2034/619	0.2367						604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				94	429					SP110 (inh=n/a pLI=0.00)
chr2	231077676	231077676	G	A	het	pred_pathogenic_3	QUAL=2165;DP=45;AF=0.51;MQM=60;TRIO=HET,45,0.51,WT,93,0.00,HET,125,0.54	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon4/19:c.383C>T:p.Ala128Val,SP110:NM_004509.3:missense:MODERATE:exon4/18:c.383C>T:p.Ala128Val,SP110:NM_004510.3:missense:MODERATE:exon4/15:c.383C>T:p.Ala128Val,SP110:NM_001185015.1:missense:MODERATE:exon5/16:c.401C>T:p.Ala134Val		rs11556887	0.0966	0.1040	924/350/5	0.1003	0.1220	T	T,T,D,D,D,D,D	P,P,D,D	B,B,P,D	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];			COSM149089, COSM3927761	15	234					SP110 (inh=n/a pLI=0.00)
chr2	231077725	231077725	A	G	hom		QUAL=7981;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,62,1.00,HOM,85,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon4/19:c.334T>C:p.Trp112Arg,SP110:NM_004509.3:missense:MODERATE:exon4/18:c.334T>C:p.Trp112Arg,SP110:NM_004510.3:missense:MODERATE:exon4/15:c.334T>C:p.Trp112Arg,SP110:NM_001185015.1:missense:MODERATE:exon5/16:c.352T>C:p.Trp118Arg		rs1129411	0.9511	0.9090	50293/25799/4991	0.8871	-0.1940	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				894	189					SP110 (inh=n/a pLI=0.00)
chr2	233390937	233390937	A	G	hom	low_DP	QUAL=473;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,6,0.67,HOM,11,0.91	CHRND	synonymous,5'UTR	CHRND:NM_000751.2:synonymous:LOW:exon1/12:c.12A>G:p.Pro4Pro,CHRND:NM_001256657.1:synonymous:LOW:exon1/11:c.12A>G:p.Pro4Pro,CHRND:NM_001311195.1:5'UTR:MODIFIER:exon1/10:c.-260A>G:,CHRND:NM_001311196.1:5'UTR:MODIFIER:exon1/12:c.-260A>G:		rs2245601	0.4834	0.4980	15364/7802/728	0.4877						100720 [CHRND (confirmed) Myasthenic syndrome,congenital,3A,slow-channel|Myasthenic syndrome,congenital,3B,fast-channel|Myasthenic syndrome,congenital,3C,associated with acetylcholine receptor deficiency|Multiple pterygium syndrome,lethal type];	RCV000116730.1 [benign]; 		COSM149097	246	541					CHRND (inh=n/a pLI=0.00)
chr2	233400074	233400074	A	G	het		QUAL=6324;DP=166;AF=0.44;MQM=60;TRIO=HET,166,0.44,HET,172,0.52,HET,185,0.48	CHRND	3'UTR	CHRND:NM_000751.2:3'UTR:MODIFIER:exon12/12:c.*52A>G:,CHRND:NM_001256657.1:3'UTR:MODIFIER:exon11/11:c.*52A>G:,CHRND:NM_001311195.1:3'UTR:MODIFIER:exon10/10:c.*52A>G:,CHRND:NM_001311196.1:3'UTR:MODIFIER:exon12/12:c.*52A>G:		rs2767	0.4159	0.4000	10267/4146/388	0.3937										135	417					CHRND (inh=n/a pLI=0.00)
chr2	233400907	233400907	T	C	het		QUAL=9011;DP=271;AF=0.48;MQM=59;TRIO=HET,271,0.48,HET,184,0.51,HET,238,0.53	CHRND	3'UTR	CHRND:NM_000751.2:3'UTR:MODIFIER:exon12/12:c.*885T>C:,CHRND:NM_001256657.1:3'UTR:MODIFIER:exon11/11:c.*885T>C:,CHRND:NM_001311195.1:3'UTR:MODIFIER:exon10/10:c.*885T>C:,CHRND:NM_001311196.1:3'UTR:MODIFIER:exon12/12:c.*885T>C:	MLT1F	rs1004175	0.4159	0.3500	941/173/11	0.1016										74	273					CHRND (inh=n/a pLI=0.00)
chr2	233411039	233411039	A	T	het	low_QUAL	QUAL=7;DP=158;AF=0.18;MQM=58;TRIO=HET,158,0.18,WT,61,0.07,WT,93,0.06	CHRNG-TIGD1	intergenic_region	CHRNG-TIGD1:CHRNG-TIGD1:intergenic_region:MODIFIER::n.233411039A>T:	(T)n		0.0000	0.0000	0/0/0	0.0021										0	4					CHRNG-TIGD1 (inh=n/a pLI=n/a)
chr2	238232752	238232752	C	A	het		QUAL=2699;DP=98;AF=0.48;MQM=59;TRIO=HET,98,0.48,HOM,41,0.85,HET,52,0.42	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*665G>T:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*665G>T:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*665G>T:		rs1050785	0.6879	0.0000	0/0/0	0.5273										69	115					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238232811	238232811	T	A	het		QUAL=4343;DP=273;AF=0.48;MQM=60;TRIO=HET,273,0.48,HET,92,0.41,WT,111,0.00	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*606A>T:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*606A>T:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*606A>T:		rs7436	0.1556	0.0000	0/0/0	0.0190										2	40					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238233410	238233410	C	G	het		QUAL=7207;DP=362;AF=0.46;MQM=60;TRIO=HET,362,0.46,HET,264,0.47,WT,541,0.00	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*7G>C:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*7G>C:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*7G>C:		rs4663722	0.2099	0.1410	1487/343/291	0.1389							RCV000080905.5 [benign]; 			16	223					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238243285	238243285	G	A	het		QUAL=3491;DP=173;AF=0.53;MQM=60;TRIO=HET,173,0.53,HET,106,0.48,WT,139,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon41/44:c.9213C>T:p.His3071His,COL6A3:NM_057166.4:synonymous:LOW:exon38/41:c.7392C>T:p.His2464His,COL6A3:NM_057167.3:synonymous:LOW:exon40/43:c.8595C>T:p.His2865His		rs2270671	0.1004	0.1050	706/372/43	0.1024						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000081024.7 [other]; 			20	248					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238243464	238243464	C	G	hom	phylop_high;anno_pathogenic_hgmd	QUAL=17044;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HOM,167,1.00,HOM,189,1.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon41/44:c.9034G>C:p.Ala3012Pro,COL6A3:NM_057166.4:missense:MODERATE:exon38/41:c.7213G>C:p.Ala2405Pro,COL6A3:NM_057167.3:missense:MODERATE:exon40/43:c.8416G>C:p.Ala2806Pro		rs2270669	0.7923	0.7730	36619/20313/4735	0.7657	5.5020	T	T,T,T,T,T,T	B,B,B	B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000081019.5 [benign]; 	CM151272 [CLASS=DM? MUT=ALT PHEN="Neuromuscular disorder" GENE=COL6A3]; 		679	373	2	[2] Ute Grasshoff 24.11.2015			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238244963	238244963	A	G	het	phylop_high;anno_pathogenic_hgmd	QUAL=7758;DP=200;AF=0.54;MQM=59;TRIO=HET,200,0.54,HET,185,0.44,HET,257,0.52	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon40/44:c.8780T>C:p.Met2927Thr,COL6A3:NM_057166.4:missense:MODERATE:exon37/41:c.6959T>C:p.Met2320Thr,COL6A3:NM_057167.3:missense:MODERATE:exon39/43:c.8162T>C:p.Met2721Thr		rs6728818	0.6366	0.6380	25150/14679/3160	0.6330	1.7470	T	T,T,T,T,T,T	B,B,B	B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000081013.5 [benign]; 	CM151271 [CLASS=DM? MUT=ALT PHEN="Neuromuscular disorder" GENE=COL6A3]; 		500	481	2	[2] Ute Grasshoff 24.11.2015			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238247734	238247734	C	G	het	phylop_high;pred_pathogenic_3	QUAL=2127;DP=166;AF=0.34;MQM=60;TRIO=HET,166,0.34,HET,64,0.27,HET,84,0.32	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon39/44:c.8491G>C:p.Asp2831His,COL6A3:NM_057166.4:missense:MODERATE:exon36/41:c.6670G>C:p.Asp2224His,COL6A3:NM_057167.3:missense:MODERATE:exon38/43:c.7873G>C:p.Asp2625His		rs36104025	0.0325	0.0670	354/278/6	0.0616	5.4160	T	D,D,D,D,D,D	D,D,D	D,D,D	120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000081011.5 [benign]; 			6	165					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238253065	238253065	C	T	het		QUAL=12004;DP=263;AF=0.48;MQM=60;TRIO=HET,263,0.48,HET,339,0.53,HET,467,0.48	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon36/44:c.7596G>A:p.Lys2532Lys,COL6A3:NM_057166.4:synonymous:LOW:exon33/41:c.5775G>A:p.Lys1925Lys,COL6A3:NM_057167.3:synonymous:LOW:exon35/43:c.6978G>A:p.Lys2326Lys		rs2291795	0.1548	0.1290	1110/416/144	0.1219						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080995.5 [benign]; 		COSM4001576	17	203					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238253149	238253149	G	A	het		QUAL=10631;DP=450;AF=0.44;MQM=59;TRIO=HET,450,0.44,HET,478,0.47,WT,664,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon36/44:c.7512C>T:p.Asn2504Asn,COL6A3:NM_057166.4:synonymous:LOW:exon33/41:c.5691C>T:p.Asn1897Asn,COL6A3:NM_057167.3:synonymous:LOW:exon35/43:c.6894C>T:p.Asn2298Asn		rs2646258	0.1084	0.1080	778/369/44	0.1064						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080994.7 [other]; 			18	256					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238257013	238257013	G	A	het		QUAL=7206;DP=440;AF=0.44;MQM=60;TRIO=HET,440,0.44,HET,166,0.49,WT,201,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon30/44:c.6945C>T:p.Phe2315Phe,COL6A3:NM_057166.4:synonymous:LOW:exon27/41:c.5124C>T:p.Phe1708Phe,COL6A3:NM_057167.3:synonymous:LOW:exon29/43:c.6327C>T:p.Phe2109Phe		rs2646265	0.1064	0.1100	800/393/37	0.1082						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080980.7 [other]; 			18	260					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238258814	238258814	C	G	het		QUAL=11478;DP=222;AF=0.47;MQM=60;TRIO=HET,222,0.47,HET,172,0.47,HOM,226,1.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon28/44:c.6855G>C:p.Gly2285Gly,COL6A3:NM_057166.4:synonymous:LOW:exon25/41:c.5034G>C:p.Gly1678Gly,COL6A3:NM_057167.3:synonymous:LOW:exon27/43:c.6237G>C:p.Gly2079Gly		rs3790993	0.5543	0.5490	18509/10030/1764	0.5441						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080973.5 [benign]; 			318	558					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238267717	238267717	C	T	het		QUAL=10617;DP=489;AF=0.47;MQM=59;TRIO=HET,489,0.47,HET,393,0.48,WT,540,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon20/44:c.6369G>A:p.Leu2123Leu,COL6A3:NM_057166.4:synonymous:LOW:exon17/41:c.4548G>A:p.Leu1516Leu,COL6A3:NM_057167.3:synonymous:LOW:exon19/43:c.5751G>A:p.Leu1917Leu		rs2646254	0.3309	0.2130	3532/644/1227	0.2077						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080967.5 [benign]; 			36	323					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238277573	238277573	C	A	het		QUAL=2279;DP=183;AF=0.46;MQM=59;TRIO=HET,183,0.46,HET,82,0.48,WT,98,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon10/44:c.4533G>T:p.Gly1511Gly,COL6A3:NM_057166.4:synonymous:LOW:exon7/41:c.2712G>T:p.Gly904Gly,COL6A3:NM_057167.3:synonymous:LOW:exon9/43:c.3915G>T:p.Gly1305Gly		rs2645774	0.2656	0.2350	3441/1524/409	0.2283						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080941.5 [benign]; 		COSM3758064	51	384					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238277795	238277795	A	G	het	low_DP	QUAL=41;DP=12;AF=0.25;MQM=60;TRIO=HET,12,0.25,HOM,1,1.00,WT,1,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon10/44:c.4311T>C:p.Ile1437Ile,COL6A3:NM_057166.4:synonymous:LOW:exon7/41:c.2490T>C:p.Ile830Ile,COL6A3:NM_057167.3:synonymous:LOW:exon9/43:c.3693T>C:p.Ile1231Ile		rs2646260	0.3884	0.2870	5612/1830/1780	0.2848						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000149961.1 [uncertain significance]; RCV000080938.5 [benign]; 		COSM3749639	67	382					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238283605	238283605	G	A	hom		QUAL=2378;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HET,43,0.53,HET,44,0.43	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon8/44:c.3129C>T:p.Gly1043Gly,COL6A3:NM_057166.4:synonymous:LOW:exon5/41:c.1308C>T:p.Gly436Gly,COL6A3:NM_057167.3:synonymous:LOW:exon7/43:c.2511C>T:p.Gly837Gly,COL6A3:NM_057164.4:synonymous:LOW:exon6/7:c.1908C>T:p.Gly636Gly,COL6A3:NM_057165.4:synonymous:LOW:exon7/8:c.2511C>T:p.Gly837Gly		rs12622093	0.2159	0.2310	3330/1920/92	0.2305						120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080926.5 [benign]; 		COSM1482931, COSM442555	66	399					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238289980	238289980	G	C	het		QUAL=8160;DP=270;AF=0.46;MQM=60;TRIO=HET,270,0.46,HET,291,0.52,WT,377,0.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon5/44:c.1475C>G:p.Thr492Ser,COL6A3:NM_057166.4:missense:MODERATE:exon3/41:c.254C>G:p.Thr85Ser,COL6A3:NM_057167.3:missense:MODERATE:exon4/43:c.857C>G:p.Thr286Ser,COL6A3:NM_057164.4:missense:MODERATE:exon3/7:c.254C>G:p.Thr85Ser,COL6A3:NM_057165.4:missense:MODERATE:exon4/8:c.857C>G:p.Thr286Ser		rs113897824	0.0036	0.0075	8/3/0	0.0071	0.2260	T	T,T,T,T,T,T,T,T,T	B,B,B,B,P,B	B,B,B,B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080913.5 [other]; 			1	20					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238289984	238289984	C	G	het	pred_pathogenic_1	QUAL=8160;DP=270;AF=0.46;MQM=60;TRIO=HET,270,0.46,HET,291,0.52,WT,377,0.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon5/44:c.1471G>C:p.Asp491His,COL6A3:NM_057166.4:missense:MODERATE:exon3/41:c.250G>C:p.Asp84His,COL6A3:NM_057167.3:missense:MODERATE:exon4/43:c.853G>C:p.Asp285His,COL6A3:NM_057164.4:missense:MODERATE:exon3/7:c.250G>C:p.Asp84His,COL6A3:NM_057165.4:missense:MODERATE:exon4/8:c.853G>C:p.Asp285His		rs112010940	0.0036	0.0075	8/3/0	0.0071	0.8220	T	D,D,D,D,D,D,D,D,D	B,P,B,B,P,B	B,P,B,B,P,B	120250 [COL6A3 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27];	RCV000080912.5 [other]; 			1	20					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238322712	238322712	C	T	het		QUAL=2579;DP=144;AF=0.48;MQM=60;TRIO=HET,144,0.48,HET,76,0.45,WT,92,0.00	COL6A3	5'UTR	COL6A3:NM_004369.3:5'UTR:MODIFIER:exon1/44:c.-147G>A:,COL6A3:NM_057166.4:5'UTR:MODIFIER:exon1/41:c.-147G>A:,COL6A3:NM_057167.3:5'UTR:MODIFIER:exon1/43:c.-147G>A:,COL6A3:NM_057164.4:5'UTR:MODIFIER:exon1/7:c.-147G>A:,COL6A3:NM_057165.4:5'UTR:MODIFIER:exon1/8:c.-147G>A:		rs113567254	0.0006	0.0000	0/0/0	0.0013										0	1					COL6A3 (inh=AR+AD pLI=0.00)
chr2	239969974	239969974	G	C	hom		QUAL=22615;DP=345;AF=0.99;MQM=59;TRIO=HOM,345,0.99,HET,359,0.53,HET,469,0.55	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4819C>G:		rs1055333	0.2346	0.0000	0/0/0	0.0424										12	76					HDAC4 (inh=AD pLI=1.00)
chr2	239970256	239970256	-	ATAGATAGATAG	hom		QUAL=8060;DP=111;AF=0.50;MQM=59;TRIO=HOM,111,0.90,HET,178,0.95,WT,216,0.98	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4525_*4536dupCTATCTATCTAT:		rs3841081	0.0491	0.0000	0/0/0	0.0240										2	21					HDAC4 (inh=AD pLI=1.00)
chr2	239970360	239970360	A	C	hom		QUAL=15265;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HET,207,0.50,HET,289,0.48	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4433T>G:		rs895808	0.3343	0.0000	0/0/0	0.0693										27	100					HDAC4 (inh=AD pLI=1.00)
chr2	239972883	239972883	C	T	het		QUAL=2788;DP=147;AF=0.52;MQM=60;TRIO=HET,147,0.52,HET,83,0.48,WT,143,0.01	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*1910G>A:		rs4852010	0.3361	0.0000	0/0/0	0.0605										13	107					HDAC4 (inh=AD pLI=1.00)
chr2	239974241	239974241	-	C	het		QUAL=3109;DP=110;AF=0.46;MQM=59;TRIO=HET,110,0.46,WT,88,0.00,HOM,109,0.87	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*551dupG:		rs397972964	0.0000	0.0000	0/0/0	0.0540										5	50					HDAC4 (inh=AD pLI=1.00)
chr2	240003870	240003870	G	A	hom		QUAL=6183;DP=81;AF=0.99;MQM=60;TRIO=HOM,81,0.99,HOM,51,1.00,HOM,73,1.00	HDAC4	synonymous	HDAC4:NM_006037.3:synonymous:LOW:exon21/27:c.2565C>T:p.Pro855Pro		rs1063639	0.5952	0.5330	17909/7374/1651	0.5226									COSM4133597	311	512					HDAC4 (inh=AD pLI=1.00)
chr2	240066417	240066417	A	G	hom		QUAL=8190;DP=68;AF=0.99;MQM=60;TRIO=HOM,68,0.99,HOM,93,0.99,HOM,103,1.00	HDAC4	splice_region&intron	HDAC4:NM_006037.3:splice_region&intron:LOW:exon7/26:c.734-7T>C:		rs2290087	0.8878	0.8610	45478/24708/4858	0.8534										843	240					HDAC4 (inh=AD pLI=1.00)
chr2	241531479	241531479	A	G	het		QUAL=1391;DP=40;AF=0.60;MQM=60;TRIO=HET,40,0.60,WT,27,0.00,HET,50,0.68	CAPN10	synonymous	CAPN10:NM_023083.3:synonymous:LOW:exon4/12:c.600A>G:p.Pro200Pro,CAPN10:NM_023085.3:synonymous:LOW:exon4/10:c.600A>G:p.Pro200Pro		rs3792269	0.1176	0.1430	1333/816/11	0.1361						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				26	272					CAPN10 (inh=n/a pLI=0.00)
chr2	241536126	241536126	A	G	het		QUAL=294;DP=26;AF=0.62;MQM=60;TRIO=HET,26,0.62,WT,6,0.00,HET,7,0.57	CAPN10	missense,intron	CAPN10:NM_023083.3:missense:MODERATE:exon9/12:c.1510A>G:p.Thr504Ala,CAPN10:NM_023085.3:intron:MODIFIER:exon7/9:c.1279-1179A>G:		rs7607759	0.1168	0.1400	1289/853/10	0.1325	-0.3280	T	T,T	B,B	B,B	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];		CM043260 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2 association with" GENE=CAPN10]; 		27	262					CAPN10 (inh=n/a pLI=0.00)
chr2	241537421	241537421	G	A	het		QUAL=2861;DP=122;AF=0.52;MQM=60;TRIO=HET,122,0.52,HOM,50,1.00,WT,63,0.00	CAPN10	synonymous	CAPN10:NM_023083.3:synonymous:LOW:exon10/12:c.1860G>A:p.Ala620Ala,CAPN10:NM_023085.3:synonymous:LOW:exon8/10:c.1395G>A:p.Ala465Ala		rs3749166	0.5118	0.5780	20691/12428/493	0.5758						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];			COSM4133667, COSM4133668	384	550					CAPN10 (inh=n/a pLI=0.00)
chr2	241538061	241538061	T	C	het		QUAL=2067;DP=83;AF=0.55;MQM=60;TRIO=HET,83,0.55,WT,40,0.00,HET,65,0.57	CAPN10	splice_region&intron	CAPN10:NM_023083.3:splice_region&intron:LOW:exon11/11:c.1990-7T>C:,CAPN10:NM_023085.3:splice_region&intron:LOW:exon9/9:c.1525-7T>C:		rs55878652	0.1204	0.1160	644/369/7	0.1131						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];			COSM3766550, COSM3766549	26	271					CAPN10 (inh=n/a pLI=0.00)
chr2	241538074	241538074	A	G	hom		QUAL=5183;DP=86;AF=0.99;MQM=59;TRIO=HOM,86,0.99,HOM,34,1.00,HOM,52,0.96	CAPN10	missense	CAPN10:NM_023083.3:missense:MODERATE:exon12/12:c.1996A>G:p.Ile666Val,CAPN10:NM_023085.3:missense:MODERATE:exon10/10:c.1531A>G:p.Ile511Val		rs2975766	0.9898	0.9740	29606/16386/3095	0.8886	-0.9330	T	T,T,T	B,B,B	B,B,B	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				1026	77					CAPN10 (inh=n/a pLI=0.00)
chr2	241538229	241538229	A	G	hom		QUAL=4391;DP=60;AF=0.97;MQM=60;TRIO=HOM,60,0.97,HOM,61,1.00,HET,82,0.51	CAPN10	3'UTR	CAPN10:NM_023083.3:3'UTR:MODIFIER:exon12/12:c.*132A>G:,CAPN10:NM_023085.3:3'UTR:MODIFIER:exon10/10:c.*132A>G:		rs2975767	0.7264	0.0000	0/0/0	0.1583						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				156	66					CAPN10 (inh=n/a pLI=0.00)
chr2	241538531	241538531	T	C	het		QUAL=876;DP=52;AF=0.48;MQM=60;TRIO=HET,52,0.48,WT,41,0.00,HET,54,0.39	CAPN10-GPR35	intergenic_region	CAPN10-GPR35:CAPN10-GPR35:intergenic_region:MODIFIER::n.241538531T>C:		rs17846983	0.0767	0.0000	0/0/0	0.0154						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				1	28					CAPN10-GPR35 (inh=n/a pLI=n/a)
chr3	3191388	3191388	T	A	hom		QUAL=35180;DP=465;AF=1.00;MQM=59;TRIO=HOM,465,1.00,HOM,265,1.00,HOM,326,1.00	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*1161A>T:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*1161A>T:		rs711628	0.9048	0.0000	0/0/0	0.8880										149	1					CRBN (inh=n/a pLI=0.04)
chr3	3191426	3191426	T	C	het		QUAL=13420;DP=377;AF=0.51;MQM=60;TRIO=HET,377,0.51,HET,253,0.51,HET,325,0.50	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*1123A>G:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*1123A>G:		rs1045433	0.1292	0.0000	0/0/0	0.1406										4	52					CRBN (inh=n/a pLI=0.04)
chr3	3191776	3191776	T	C	hom		QUAL=20079;DP=354;AF=0.99;MQM=60;TRIO=HOM,354,0.99,HOM,118,1.00,HOM,132,1.00	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*773A>G:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*773A>G:		rs711627	0.9048	0.0000	0/0/0	0.1514										227	3					CRBN (inh=n/a pLI=0.04)
chr3	3192524	3192524	-	TAAC	het		QUAL=7124;DP=196;AF=0.41;MQM=59;TRIO=HET,196,0.41,HET,156,0.46,HET,203,0.46	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:		rs3830315;rs397828468;rs4183	0.0000	0.5310	16578/12513/512	0.4891										70	120					CRBN (inh=n/a pLI=0.04)
chr3	3215954	3215954	A	G	hom		QUAL=21559;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HOM,130,1.00,HOM,208,1.00	CRBN	splice_region&intron	CRBN:NM_016302.3:splice_region&intron:LOW:exon2/10:c.175-9T>C:,CRBN:NM_001173482.1:splice_region&intron:LOW:exon2/10:c.172-9T>C:		rs1669321	0.8838	0.9670	57252/33213/2185	0.9362						609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2];	RCV000116835.1 [benign]; 			1094	14					CRBN (inh=n/a pLI=0.04)
chr3	4403357	4403357	A	C	hom		QUAL=16466;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,103,1.00,HOM,140,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*471T>G:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*471T>G:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*471T>G:		rs2259818	0.8802	0.0000	0/0/0	0.6096										216	13					SUMF1 (inh=AR pLI=0.04)
chr3	4403365	4403368	CTCA	-	hom		QUAL=13824;DP=239;AF=1.00;MQM=59;TRIO=HOM,239,1.00,HOM,90,1.00,HOM,128,1.00	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*460_*463delTGAG:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*460_*463delTGAG:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*460_*463delTGAG:		rs3835161;rs71873849	0.7047	0.0000	0/0/0	0.5351										72	114					SUMF1 (inh=AR pLI=0.04)
chr3	4403537	4403537	C	T	hom		QUAL=16273;DP=267;AF=0.99;MQM=59;TRIO=HOM,267,0.99,HOM,111,1.00,HOM,161,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*291G>A:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*291G>A:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*291G>A:	MIR3	rs4685744	0.4281	0.0000	0/0/0	0.0837										57	112					SUMF1 (inh=AR pLI=0.04)
chr3	4403767	4403767	A	G	hom		QUAL=19853;DP=292;AF=1.00;MQM=59;TRIO=HOM,292,1.00,HOM,153,1.00,HOM,172,1.00	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*61T>C:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*61T>C:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*61T>C:		rs2819561	0.7045	0.0000	0/0/0	0.1203										73	117					SUMF1 (inh=AR pLI=0.04)
chr3	4403817	4403817	T	A	hom		QUAL=18277;DP=185;AF=0.97;MQM=59;TRIO=HOM,185,0.97,HOM,196,0.99,HOM,234,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*11A>T:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*11A>T:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*11A>T:		rs2633851	0.7268	0.6330	24987/10216/3098	0.5679							RCV000082713.4 [benign]; 			164	218					SUMF1 (inh=AR pLI=0.04)
chr3	4403818	4403818	T	C	hom		QUAL=18277;DP=185;AF=0.97;MQM=59;TRIO=HOM,185,0.97,HOM,196,0.99,HOM,234,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*10A>G:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*10A>G:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*10A>G:		rs35083095	0.4321	0.4940	15396/8297/295	0.4387							RCV000082712.4 [benign]; 			225	238					SUMF1 (inh=AR pLI=0.04)
chr3	4403837	4403837	A	G	hom		QUAL=21313;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,223,1.00,HOM,269,1.00	SUMF1	synonymous	SUMF1:NM_182760.3:synonymous:LOW:exon9/9:c.1116T>C:p.Thr372Thr,SUMF1:NM_001164674.1:synonymous:LOW:exon8/8:c.1041T>C:p.Thr347Thr,SUMF1:NM_001164675.1:synonymous:LOW:exon8/8:c.1056T>C:p.Thr352Thr		rs2633852	0.7604	0.6440	26090/10370/3935	0.6169						607939 [SUMF1 (provisional) Multiple sulfatase deficiency];	RCV000082714.4 [benign]; 		COSM3760098	392	500					SUMF1 (inh=AR pLI=0.04)
chr3	4508742	4508742	C	T	het	pred_pathogenic_2	QUAL=834;DP=41;AF=0.56;MQM=60;TRIO=HET,41,0.56,HET,28,0.64,WT,27,0.00	SUMF1	missense	SUMF1:NM_182760.3:missense:MODERATE:exon1/9:c.188G>A:p.Ser63Asn,SUMF1:NM_001164674.1:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn,SUMF1:NM_001164675.1:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn		rs2819590	0.1166	0.1750	1161/941/1	0.1665	0.5130	T	T,T,T,T,D,T	D,P,P,P	P,P,P,B	607939 [SUMF1 (provisional) Multiple sulfatase deficiency];			COSM3760113, COSM3760112	76	397					SUMF1 (inh=AR pLI=0.04)
chr3	4712413	4712413	G	A	het		QUAL=6286;DP=122;AF=0.48;MQM=60;TRIO=HET,122,0.48,HOM,162,1.00,WT,165,0.01	ITPR1	splice_region&synonymous	ITPR1:NM_001168272.1:splice_region&synonymous:LOW:exon19/61:c.1962G>A:p.Lys654Lys,ITPR1:NM_001099952.2:splice_region&synonymous:LOW:exon20/59:c.2007G>A:p.Lys669Lys,ITPR1:NM_002222.5:splice_region&synonymous:LOW:exon19/58:c.1962G>A:p.Lys654Lys		rs2306875	0.6140	0.6190	14002/7958/1444	0.6073						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117299.2 [likely benign]; 			946	995					ITPR1 (inh=AD pLI=1.00)
chr3	4716811	4716811	A	C	het		QUAL=4917;DP=221;AF=0.50;MQM=59;TRIO=HET,221,0.50,HET,172,0.45,WT,239,0.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon22/61:c.2613A>C:p.Leu871Leu,ITPR1:NM_001099952.2:synonymous:LOW:exon23/59:c.2658A>C:p.Leu886Leu,ITPR1:NM_002222.5:synonymous:LOW:exon22/58:c.2613A>C:p.Leu871Leu		rs2306877	0.3329	0.2680	4898/1268/611	0.2582						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117300.2 [likely benign]; 			90	691					ITPR1 (inh=AD pLI=1.00)
chr3	4767262	4767262	T	C	hom		QUAL=21988;DP=319;AF=1.00;MQM=59;TRIO=HOM,319,1.00,HOM,153,0.99,HOM,264,1.00	ITPR1	synonymous,intron	ITPR1:NM_001168272.1:synonymous:LOW:exon40/61:c.5124T>C:p.Thr1708Thr,ITPR1:NM_001099952.2:intron:MODIFIER:exon39/58:c.5077-7510T>C:,ITPR1:NM_002222.5:intron:MODIFIER:exon38/57:c.5032-7510T>C:		rs7613447	0.5122	0.6870	29493/21347/1060	0.6702						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];				1336	714					ITPR1 (inh=AD pLI=1.00)
chr3	4817057	4817057	T	C	hom		QUAL=19477;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,133,1.00,HOM,205,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon46/61:c.6066T>C:p.Asn2022Asn,ITPR1:NM_001099952.2:synonymous:LOW:exon44/59:c.5967T>C:p.Asn1989Asn,ITPR1:NM_002222.5:synonymous:LOW:exon43/58:c.5922T>C:p.Asn1974Asn		rs6442905	0.9627	0.9700	56862/31392/4478	0.9422						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];				2087	143					ITPR1 (inh=AD pLI=1.00)
chr3	4842231	4842231	C	T	het		QUAL=6842;DP=304;AF=0.47;MQM=59;TRIO=HET,304,0.47,WT,188,0.00,HET,265,0.49	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:NM_001099952.2:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:NM_002222.5:synonymous:LOW:exon50/58:c.6865C>T:p.Leu2289Leu		rs2291862	0.2646	0.2870	5218/2657/88	0.2843						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117303.2 [likely benign]; 		COSM3760145, COSM3760144, COSM3760146	180	940					ITPR1 (inh=AD pLI=1.00)
chr3	4856180	4856180	T	C	hom		QUAL=11754;DP=141;AF=0.99;MQM=59;TRIO=HOM,141,0.99,HOM,111,1.00,HOM,121,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon57/61:c.7590T>C:p.Thr2530Thr,ITPR1:NM_001099952.2:synonymous:LOW:exon55/59:c.7491T>C:p.Thr2497Thr,ITPR1:NM_002222.5:synonymous:LOW:exon54/58:c.7446T>C:p.Thr2482Thr		rs711631	0.7909	0.8240	41384/23153/2400	0.8122						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117304.2 [likely benign]; 			1500	654					ITPR1 (inh=AD pLI=1.00)
chr3	4856234	4856234	G	A	het		QUAL=4181;DP=127;AF=0.45;MQM=60;TRIO=HET,127,0.45,HET,62,0.55,HOM,71,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon57/61:c.7644G>A:p.Lys2548Lys,ITPR1:NM_001099952.2:synonymous:LOW:exon55/59:c.7545G>A:p.Lys2515Lys,ITPR1:NM_002222.5:synonymous:LOW:exon54/58:c.7500G>A:p.Lys2500Lys		rs901854	0.5875	0.6040	22215/12504/1523	0.5815						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117305.2 [likely benign]; 			894	997					ITPR1 (inh=AD pLI=1.00)
chr3	4889079	4889079	-	AA	hom		QUAL=1232;DP=107;AF=0.14;MQM=59;TRIO=HOM,107,0.14,WT,21,0.57,HOM,19,0.11	ITPR1	3'UTR	ITPR1:NM_001168272.1:3'UTR:MODIFIER:exon61/61:c.*1183_*1184dupAA:,ITPR1:NM_001099952.2:3'UTR:MODIFIER:exon59/59:c.*1183_*1184dupAA:,ITPR1:NM_002222.5:3'UTR:MODIFIER:exon58/58:c.*1183_*1184dupAA:		rs3079679;rs36064013;rs71779262	0.0000	0.0000	0/0/0	0.0289										24	114					ITPR1 (inh=AD pLI=1.00)
chr3	8775589	8775589	C	T	hom		QUAL=20991;DP=272;AF=0.98;MQM=60;TRIO=HOM,272,0.98,HET,405,0.52,HET,529,0.53	CAV3	synonymous	CAV3:NM_001234.4:synonymous:LOW:exon1/3:c.27C>T:p.Leu9Leu,CAV3:NM_033337.2:synonymous:LOW:exon1/2:c.27C>T:p.Leu9Leu		rs1974763	0.0425	0.0860	639/570/3	0.0876						601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC|Rippling muscle disease|Creatine phosphokinase,elevated serum|Myopathy,distal,Tateyama type|Cardiomyopathy,familial hypertrophic|Long QT syndrome 9];	RCV000024400.1 [not provided]; RCV000039803.9 [other]; 			10	228					CAV3 (inh=n/a pLI=0.34)
chr3	8787220	8787220	T	C	het		QUAL=4850;DP=193;AF=0.45;MQM=59;TRIO=HET,193,0.45,HET,236,0.47,WT,308,0.00	CAV3	synonymous	CAV3:NM_001234.4:synonymous:LOW:exon2/3:c.123T>C:p.Phe41Phe,CAV3:NM_033337.2:synonymous:LOW:exon2/2:c.123T>C:p.Phe41Phe		rs13087941	0.1530	0.1880	2652/1897/430	0.1860						601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC|Rippling muscle disease|Creatine phosphokinase,elevated serum|Myopathy,distal,Tateyama type|Cardiomyopathy,familial hypertrophic|Long QT syndrome 9];	RCV000024401.3 [not provided]; RCV000039797.10 [other]; 		COSM1131343	42	344					CAV3 (inh=n/a pLI=0.34)
chr3	8788096	8788096	T	C	het		QUAL=8265;DP=411;AF=0.53;MQM=60;TRIO=HET,411,0.53,HET,195,0.55,WT,268,0.00	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*447T>C:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*543T>C:		rs13093809	0.0503	0.0000	0/0/0	0.0176							RCV000024402.1 [not provided]; 			7	61					CAV3 (inh=n/a pLI=0.34)
chr3	8788198	8788198	A	T	het		QUAL=9928;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HET,199,0.49,HET,268,0.53	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*549A>T:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*645A>T:		rs11476	0.3482	0.0000	0/0/0	0.0659							RCV000024384.1 [not provided]; 			39	122					CAV3 (inh=n/a pLI=0.34)
chr3	8788336	8788336	A	G	het		QUAL=10593;DP=318;AF=0.48;MQM=59;TRIO=HET,318,0.48,HET,238,0.48,HET,320,0.51	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*687A>G:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*783A>G:		rs7629329	0.2716	0.0000	0/0/0	0.0521							RCV000024404.1 [not provided]; 			26	124					CAV3 (inh=n/a pLI=0.34)
chr3	8788364	8788364	C	-	het		QUAL=12072;DP=402;AF=0.51;MQM=59;TRIO=HET,402,0.51,HET,252,0.51,WT,313,0.50	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*717delC:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*813delC:		rs66667169	0.0467	0.0000	0/0/0	0.0834										5	57					CAV3 (inh=n/a pLI=0.34)
chr3	10085536	10085536	A	G	het	low_MQM	QUAL=7196;DP=415;AF=0.31;MQM=43;TRIO=HET,415,0.31,HET,375,0.30,HET,490,0.30	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1220	37/0/37	0.0074						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM3759562, COSM3759563	0	737	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088266	10088266	G	T	het		QUAL=4244;DP=255;AF=0.18;MQM=50;TRIO=HET,255,0.18,HET,202,0.20,HET,363,0.41	FANCD2	splice_region&synonymous	FANCD2:NM_033084.3:splice_region&synonymous:LOW:exon15/43:c.1137G>T:p.Val379Val,FANCD2:NM_001018115.1:splice_region&synonymous:LOW:exon15/44:c.1137G>T:p.Val379Val		rs72492997	0.0000	0.3500	0/0/0	0.0030						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157095, COSM4157094	0	1000					FANCD2 (inh=AR pLI=0.00)
chr3	10088299	10088299	C	T	het	low_MQM	QUAL=5895;DP=332;AF=0.19;MQM=48;TRIO=HET,332,0.19,HET,244,0.23,HET,449,0.43	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon15/43:c.1170C>T:p.Ser390Ser,FANCD2:NM_001018115.1:synonymous:LOW:exon15/44:c.1170C>T:p.Ser390Ser		rs112887807	0.0000	0.4260	0/0/0	0.0032						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	1476	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088308	10088308	T	C	het	low_MQM	QUAL=6472;DP=302;AF=0.21;MQM=48;TRIO=HET,302,0.21,HET,249,0.23,HET,463,0.43	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon15/43:c.1179T>C:p.Thr393Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon15/44:c.1179T>C:p.Thr393Thr		rs72492998	0.0000	0.4290	0/0/0	0.0035						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4152592, COSM4152593	0	1562	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088343	10088343	A	G	het	low_MQM	QUAL=6096;DP=425;AF=0.15;MQM=45;TRIO=HET,425,0.15,HET,256,0.23,HET,472,0.43	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon15/43:c.1214A>G:p.Asn405Ser,FANCD2:NM_001018115.1:missense:MODERATE:exon15/44:c.1214A>G:p.Asn405Ser		rs73126218	0.0000	0.4120	0/0/0	0.0069	0.2110	T	T,T,T,T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4152595, COSM4152594	0	1606	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089723	10089723	G	A	het		QUAL=9610;DP=278;AF=0.29;MQM=58;TRIO=HET,278,0.29,HET,255,0.37,HET,430,0.50	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0.0000	0.4460	0/0/0	0.0059						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157098, COSM4157099	0	1852	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089738	10089738	A	G	het		QUAL=8689;DP=247;AF=0.27;MQM=57;TRIO=HET,247,0.27,HET,241,0.37,HET,410,0.51	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon16/42:c.1413+3A>G:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon16/43:c.1413+3A>G:		rs62245508	0.0000	0.4370	0/0/0	0.0019						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	1848	1	[1] old entry - no details available	n/a (1xTP, 0xFP)		FANCD2 (inh=AR pLI=0.00)
chr3	10091049	10091049	C	T	het	low_MQM	QUAL=1065;DP=159;AF=0.36;MQM=38;TRIO=HET,159,0.36,HET,108,0.10,WT,151,0.07	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon16/42:c.1414-9C>T:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon16/43:c.1414-9C>T:		rs35557429	0.0000	0.0740	212/81/45	0.0034						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				8	130	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10091153	10091153	C	T	het	low_MQM	QUAL=35;DP=310;AF=0.15;MQM=37;TRIO=HET,310,0.15,HET,185,0.15,HET,237,0.14	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:NM_001018115.1:synonymous:LOW:exon17/44:c.1509C>T:p.Asn503Asn		rs6785756	0.0000	0.0140	97/35/34	0.0158						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				19	367					FANCD2 (inh=AR pLI=0.00)
chr3	10106532	10106532	C	T	het	low_MQM	QUAL=6345;DP=212;AF=0.39;MQM=43;TRIO=HET,212,0.39,HET,171,0.48,HET,240,0.48	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0.0000	0.1550	988/525/211	0.0161	-0.1810	T	T,T,T,T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];	RCV000120989.1 [not provided]; 			53	672	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10138069	10138069	T	G	het		QUAL=5928;DP=281;AF=0.47;MQM=60;TRIO=HET,281,0.47,HET,78,0.59,HET,112,0.44	FANCD2,FANCD2OS	synonymous,intron	FANCD2:NM_033084.3:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.1870	2695/850/1177	0.1836						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];		CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	67	688	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140671	10140671	G	A	het		QUAL=13940;DP=474;AF=0.42;MQM=59;TRIO=HET,474,0.42,HET,311,0.43,HET,452,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+5211C>T:		rs7626117	0.3452	0.2280	4893/1088/2964	0.2213						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				9	92					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140696	10140696	A	G	het		QUAL=14993;DP=517;AF=0.46;MQM=60;TRIO=HET,517,0.46,HET,305,0.45,HET,428,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*62A>G:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+5186T>C:		rs7647987	0.2412	0.0000	0/0/0	0.0353						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				8	86					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10141065	10141065	T	G	het		QUAL=4667;DP=159;AF=0.55;MQM=60;TRIO=HET,159,0.55,HET,84,0.62,HET,67,0.57	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*431T>G:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+566T>G:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+4817A>C:	FLAM_C	rs3826	0.2420	0.0000	0/0/0	0.0302						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				5	60					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10141184	10141184	C	T	het		QUAL=738;DP=56;AF=0.48;MQM=58;TRIO=HET,56,0.48,HET,16,0.31,HET,14,0.36	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*550C>T:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+685C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+4698G>A:	AluSg	rs11716842	0.2061	0.0000	0/0/0	0.3041						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				47	97					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10142949	10142949	C	T	het		QUAL=6640;DP=168;AF=0.47;MQM=60;TRIO=HET,168,0.47,HET,189,0.45,HET,221,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*3C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2933G>A:		rs3172417	0.2147	0.3290	7582/6000/24	0.3246									COSN166813	414	1177	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10143274	10143274	C	T	het		QUAL=7537;DP=244;AF=0.50;MQM=59;TRIO=HET,244,0.50,HET,159,0.53,HET,216,0.47	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*328C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2608G>A:	AluSc8	rs58275763	0.1917	0.0000	0/0/0	0.1602										4	51					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10143328	10143328	A	T	het		QUAL=11469;DP=350;AF=0.52;MQM=58;TRIO=HET,350,0.52,HET,268,0.50,HET,314,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*382A>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2554T>A:	AluSc8	rs59318799	0.1925	0.0000	0/0/0	0.1603										3	54					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	12526006	12526006	G	A	het		QUAL=4839;DP=56;AF=0.41;MQM=60;TRIO=HET,56,0.41,HOM,190,0.98,WT,306,0.00	TSEN2	5'UTR	TSEN2:NM_001145393.1:5'UTR:MODIFIER:exon1/11:c.-28G>A:,TSEN2:NM_001145394.1:5'UTR:MODIFIER:exon1/13:c.-28G>A:		rs3806662	0.0791	0.0000	0/0/0	0.0571										5	22					TSEN2 (inh=AR pLI=0.00)
chr3	12526188	12526188	G	T	het		QUAL=7476;DP=215;AF=0.52;MQM=60;TRIO=HET,215,0.52,WT,301,0.00,HET,361,0.53	TSEN2	5'UTR,intron	TSEN2:NM_001145395.1:5'UTR:MODIFIER:exon1/9:c.-209G>T:,TSEN2:NM_025265.3:5'UTR:MODIFIER:exon1/12:c.-209G>T:,TSEN2:NM_001145392.1:intron:MODIFIER:exon1/11:c.-18+61G>T:,TSEN2:NM_001145393.1:intron:MODIFIER:exon1/10:c.-18+172G>T:,TSEN2:NM_001145394.1:intron:MODIFIER:exon1/12:c.-18+172G>T:		rs709161	0.4545	0.0000	0/0/0	0.4486										55	106					TSEN2 (inh=AR pLI=0.00)
chr3	12544829	12544829	G	A	het		QUAL=7396;DP=137;AF=0.60;MQM=60;TRIO=HET,137,0.60,HOM,183,0.99,WT,243,0.00	TSEN2	missense	TSEN2:NM_001145392.1:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His,TSEN2:NM_001145393.1:missense:MODERATE:exon5/11:c.377G>A:p.Arg126His,TSEN2:NM_001145394.1:missense:MODERATE:exon5/13:c.377G>A:p.Arg126His,TSEN2:NM_001145395.1:missense:MODERATE:exon5/9:c.377G>A:p.Arg126His,TSEN2:NM_025265.3:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His		rs33955793	0.0587	0.0780	827/113/21	0.0718	-0.3930	T	T,T,T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B];	RCV000082253.6 [benign]; 			12	227					TSEN2 (inh=AR pLI=0.00)
chr3	12571421	12571421	T	-	het		QUAL=4836;DP=244;AF=0.51;MQM=59;TRIO=HET,244,0.51,WT,156,0.05,HET,231,0.50	TSEN2	3'UTR,intron	TSEN2:NM_001145395.1:3'UTR:MODIFIER:exon9/9:c.*22delT:,TSEN2:NM_001145392.1:intron:MODIFIER:exon10/11:c.1248+61delT:,TSEN2:NM_001145393.1:intron:MODIFIER:exon9/10:c.1170+61delT:,TSEN2:NM_001145394.1:intron:MODIFIER:exon11/12:c.1071+61delT:,TSEN2:NM_025265.3:intron:MODIFIER:exon10/11:c.1248+61delT:		rs35445022	0.0000	0.1580	318/249/0	0.1378						608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B];				16	659					TSEN2 (inh=AR pLI=0.00)
chr3	12574512	12574512	G	T	het		QUAL=3570;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,WT,38,0.00,HET,42,0.40	TSEN2	3'UTR	TSEN2:NM_001145392.1:3'UTR:MODIFIER:exon12/12:c.*292G>T:,TSEN2:NM_001145393.1:3'UTR:MODIFIER:exon11/11:c.*292G>T:,TSEN2:NM_001145394.1:3'UTR:MODIFIER:exon13/13:c.*292G>T:,TSEN2:NM_025265.3:3'UTR:MODIFIER:exon12/12:c.*292G>T:		rs299643	0.4219	0.0000	0/0/0	0.0708										55	101					TSEN2 (inh=AR pLI=0.00)
chr3	12625747	12625747	G	A	het		QUAL=21864;DP=460;AF=0.52;MQM=59;TRIO=HET,460,0.52,HOM,514,0.99,WT,701,0.00	RAF1	3'UTR	RAF1:NM_002880.3:3'UTR:MODIFIER:exon17/17:c.*266C>T:		rs1051208	0.1739	0.0000	0/0/0	0.0266										8	65					RAF1 (inh=n/a pLI=1.00)
chr3	14183410	14183410	T	C	het		QUAL=17617;DP=296;AF=0.47;MQM=59;TRIO=HET,296,0.47,HOM,336,0.99,HET,375,0.42	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*115T>C:		rs1043943	0.6891	0.0000	0/0/0	0.1071										81	92					TMEM43 (inh=AD pLI=0.00)
chr3	14183758	14183758	A	G	het		QUAL=12675;DP=370;AF=0.52;MQM=60;TRIO=HET,370,0.52,HOM,254,0.99,WT,324,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*463A>G:		rs1043953	0.0927	0.0000	0/0/0	0.0311										7	71					TMEM43 (inh=AD pLI=0.00)
chr3	14184074	14184074	A	C	het		QUAL=11978;DP=399;AF=0.54;MQM=60;TRIO=HET,399,0.54,HOM,204,0.99,WT,286,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*779A>C:		rs13069	0.1300	0.0000	0/0/0	0.0306										10	82					TMEM43 (inh=AD pLI=0.00)
chr3	14184669	14184669	T	C	het		QUAL=10614;DP=303;AF=0.48;MQM=60;TRIO=HET,303,0.48,HOM,207,1.00,WT,229,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*1374T>C:		rs8516	0.1048	0.0000	0/0/0	0.0266										7	71					TMEM43 (inh=AD pLI=0.00)
chr3	14184719	14184719	T	C	het		QUAL=9704;DP=331;AF=0.46;MQM=60;TRIO=HET,331,0.46,HOM,171,1.00,WT,205,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*1424T>C:		rs10468	0.1306	0.0000	0/0/0	0.0302										10	82					TMEM43 (inh=AD pLI=0.00)
chr3	14186757	14186757	C	G	hom		QUAL=17949;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,130,1.00,HOM,157,1.00	XPC	3'UTR,non_coding_exon	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*684G>C:,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon15/15:n.3487G>C:		rs1126547	0.9189	0.8830	3487/770/66	0.2094										493	145					XPC (inh=AR pLI=0.00)
chr3	14186823	14186823	T	C	het		QUAL=12347;DP=302;AF=0.55;MQM=59;TRIO=HET,302,0.55,HOM,245,1.00,WT,301,0.00	XPC	3'UTR,non_coding_exon	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*618A>G:,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon15/15:n.3421A>G:		rs2470458	0.1078	0.1060	122/56/2	0.0251										30	204					XPC (inh=AR pLI=0.00)
chr3	14186830	14186830	A	T	het		QUAL=12742;DP=313;AF=0.55;MQM=59;TRIO=HET,313,0.55,HOM,251,1.00,WT,312,0.00	XPC	3'UTR,non_coding_exon	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*611T>A:,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon15/15:n.3414T>A:		rs2470352	0.1082	0.1040	121/55/2	0.0354										30	205					XPC (inh=AR pLI=0.00)
chr3	14187345	14187345	G	C	het		QUAL=6477;DP=216;AF=0.44;MQM=59;TRIO=HET,216,0.44,HOM,137,0.99,WT,223,0.00	XPC	3'UTR,non_coding_exon	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*96C>G:,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon15/15:n.2899C>G:		rs2229090	0.2550	0.2250	2507/1406/39	0.2237										48	228					XPC (inh=AR pLI=0.00)
chr3	14187449	14187449	G	T	het	phylop_high	QUAL=13423;DP=305;AF=0.47;MQM=59;TRIO=HET,305,0.47,HOM,198,1.00,HET,331,0.45	XPC	missense,non_coding_exon	XPC:NM_004628.4:missense:MODERATE:exon16/16:c.2815C>A:p.Gln939Lys,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon15/15:n.2795C>A:		rs2228001	0.6847	0.6310	24273/11654/2594	0.6119	2.9050	T	T,T	B,B	B,B	613208 [XPC (confirmed) Xeroderma pigmentosum,group C];	RCV000170436.1 [benign]; RCV000211268.1 [drug response]; 	CM070359 [CLASS=DFP MUT=REF PHEN="DNA repair rate association with" GENE=XPC]; 	COSM4002478	819	1147					XPC (inh=AR pLI=0.00)
chr3	14190237	14190237	T	G	het		QUAL=15305;DP=202;AF=0.50;MQM=59;TRIO=HET,202,0.50,HOM,266,1.00,HET,363,0.55	XPC	splice_region&intron	XPC:NM_004628.4:splice_region&intron:LOW:exon12/15:c.2251-6A>C:,XPC:NR_027299.1:splice_region&intron:LOW:exon11/14:n.2231-6A>C:		rs2279017	0.6797	0.6300	24122/11660/2445	0.6138						613208 [XPC (confirmed) Xeroderma pigmentosum,group C];	RCV000170435.1 [benign]; 			822	1151					XPC (inh=AR pLI=0.00)
chr3	14197987	14197987	A	T	hom		QUAL=26408;DP=155;AF=1.00;MQM=60;TRIO=HOM,155,1.00,HOM,290,1.00,HOM,394,1.00	XPC	synonymous,non_coding_exon	XPC:NM_004628.4:synonymous:LOW:exon10/16:c.1881T>A:p.Ala627Ala,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon9/15:n.1861T>A:		rs2958057	1.0000	1.0000	60391/33370/4907	0.9326						613208 [XPC (confirmed) Xeroderma pigmentosum,group C];	RCV000170433.1 [benign]; 			2472	0					XPC (inh=AR pLI=0.00)
chr3	14199887	14199887	G	A	het		QUAL=14092;DP=425;AF=0.50;MQM=60;TRIO=HET,425,0.50,HOM,303,0.99,WT,390,0.00	XPC	missense,non_coding_exon	XPC:NM_004628.4:missense:MODERATE:exon9/16:c.1496C>T:p.Ala499Val,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon8/15:n.1476C>T:		rs2228000	0.2330	0.2370	3688/2040/44	0.2362		T	T,T	B,B	B,B	613208 [XPC (confirmed) Xeroderma pigmentosum,group C];	RCV000122343.1 [not provided]; 	CM057944 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=XPC]; 		156	829					XPC (inh=AR pLI=0.00)
chr3	14220095	14220095	C	G	het		QUAL=9826;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HOM,195,1.00,HET,212,0.51	XPC	5'UTR,non_coding_exon	XPC:NM_004628.4:5'UTR:MODIFIER:exon1/16:c.-27G>C:,XPC:NR_027299.1:non_coding_exon:MODIFIER:exon1/15:n.78G>C:		rs2607775	0.3279	0.4140	11016/7269/639	0.4063										186	426					XPC (inh=AR pLI=0.00)
chr3	15677019	15677019	G	A	het	anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=8630;DP=263;AF=0.51;MQM=59;TRIO=HET,263,0.51,WT,309,0.00,HET,394,0.54	BTD	missense	BTD:NM_001281723.1:missense:MODERATE:exon2/4:c.139G>A:p.Gly47Arg,BTD:NM_001281726.1:missense:MODERATE:exon2/3:c.133G>A:p.Gly45Arg,BTD:NM_000060.3:missense:MODERATE:exon2/4:c.133G>A:p.Gly45Arg,BTD:NM_001281724.1:missense:MODERATE:exon4/6:c.139G>A:p.Gly47Arg,BTD:NM_001281725.1:missense:MODERATE:exon2/4:c.73G>A:p.Gly25Arg		rs34885143	0.0038	0.0100	11/9/0	0.0099	-0.0370	T	T,T,T,T,T,T	B,B,B	B,B,B	609019 [BTD (provisional) Biotinidase deficiency];	RCV000021888.2 [pathogenic]; RCV000021889.1 [pathogenic]; RCV000021890.1 [pathogenic]; RCV000175516.1 [uncertain significance]; RCV000185799.1 [likely benign]; 	CM993540 [CLASS=DM? MUT=ALT PHEN="Biotinidase deficiency" GENE=BTD]; 		0	49	2	[2] old entry - no details available			BTD (inh=AR pLI=0.00)
chr3	24159008	24159008	G	A	het		QUAL=9716;DP=343;AF=0.46;MQM=60;TRIO=HET,343,0.46,WT,278,0.00,HET,425,0.49	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*5367C>T:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*5367C>T:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*5367C>T:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*5367C>T:	MLT1K	rs2167116	0.2145	0.0000	0/0/0	0.1131										0	32					THRB (inh=n/a pLI=0.99)
chr3	24159023	24159023	G	A	het		QUAL=9377;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,WT,257,0.00,HET,384,0.51	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*5352C>T:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*5352C>T:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*5352C>T:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*5352C>T:	MLT1K	rs56204436	0.1160	0.0000	0/0/0	0.0776										1	25					THRB (inh=n/a pLI=0.99)
chr3	24159387	24159387	A	G	het		QUAL=17336;DP=236;AF=0.54;MQM=60;TRIO=HET,236,0.54,HOM,270,1.00,HET,355,0.52	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*4988T>C:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*4988T>C:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*4988T>C:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*4988T>C:		rs1349265	0.4802	0.0000	0/0/0	0.6206										102	100					THRB (inh=n/a pLI=0.99)
chr3	24168981	24168981	C	T	het		QUAL=336;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,HET,27,0.41,WT,57,0.00	THRB	splice_region&intron	THRB:NM_000461.4:splice_region&intron:LOW:exon9/9:c.1144+9G>A:,THRB:NM_001128176.2:splice_region&intron:LOW:exon10/10:c.1144+9G>A:,THRB:NM_001128177.1:splice_region&intron:LOW:exon10/10:c.1144+9G>A:,THRB:NM_001252634.1:splice_region&intron:LOW:exon11/11:c.1144+9G>A:		rs13063628	0.0629	0.1100	912/696/17	0.1049						190160 [THRB (confirmed) Thyroid hormone resistance|Thyroid hormone resistance,autosomal recessive|Thyroid hormone resistance,selective pituitary];				26	199					THRB (inh=n/a pLI=0.99)
chr3	24270500	24270500	-	A	hom		QUAL=6532;DP=138;AF=0.97;MQM=59;TRIO=HOM,138,0.97,HET,95,0.48,HET,107,0.48	THRB	splice_region&intron	THRB:NM_000461.4:splice_region&intron:LOW:exon2/9:c.-42-9dupT:,THRB:NM_001128176.2:splice_region&intron:LOW:exon3/10:c.-42-9dupT:,THRB:NM_001128177.1:splice_region&intron:LOW:exon3/10:c.-42-9dupT:,THRB:NM_001252634.1:splice_region&intron:LOW:exon4/11:c.-42-9dupT:		rs3836253;rs397841135	0.0000	0.3220	7102/2298/1738	0.2855										32	126					THRB (inh=n/a pLI=0.99)
chr3	30733402	30733403	TA	-	hom	low_DP	QUAL=84;DP=7;AF=0.71;MQM=60;TRIO=HOM,7,0.71,HOM,2,0.50,WT,107,0.48	TGFBR2	3'UTR	TGFBR2:NM_001024847.2:3'UTR:MODIFIER:exon8/8:c.*328_*329delAT:,TGFBR2:NM_003242.5:3'UTR:MODIFIER:exon7/7:c.*328_*329delAT:	(TA)n	rs750106981	0.0000	0.0000	0/0/0	0.1168										27	62					TGFBR2 (inh=AD pLI=0.04)
chr3	30735156	30735156	C	T	het		QUAL=9002;DP=397;AF=0.49;MQM=60;TRIO=HET,397,0.49,WT,223,0.00,HET,265,0.55	TGFBR2	3'UTR	TGFBR2:NM_001024847.2:3'UTR:MODIFIER:exon8/8:c.*2065C>T:,TGFBR2:NM_003242.5:3'UTR:MODIFIER:exon7/7:c.*2065C>T:		rs11466536	0.0232	0.0000	0/0/0	0.0080										1	19					TGFBR2 (inh=AD pLI=0.04)
chr3	30735330	30735330	-	T	het		QUAL=2196;DP=229;AF=0.32;MQM=59;TRIO=HET,229,0.32,WT,159,0.00,HET,206,0.45	TGFBR2	3'UTR	TGFBR2:NM_001024847.2:3'UTR:MODIFIER:exon8/8:c.*2248dupT:,TGFBR2:NM_003242.5:3'UTR:MODIFIER:exon7/7:c.*2248dupT:		rs542768261;rs71093922	0.2065	0.0000	0/0/0	0.1859										15	72					TGFBR2 (inh=AD pLI=0.04)
chr3	33055721	33055721	A	G	hom	anno_pathogenic_hgmd	QUAL=20080;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HOM,195,1.00,HOM,332,1.00	GLB1	missense	GLB1:NM_001317040.1:missense:MODERATE:exon16/17:c.1705T>C:p.Cys569Arg,GLB1:NM_001079811.2:missense:MODERATE:exon15/16:c.1471T>C:p.Cys491Arg,GLB1:NM_000404.3:missense:MODERATE:exon15/16:c.1561T>C:p.Cys521Arg,GLB1:NM_001135602.2:missense:MODERATE:exon12/13:c.1168T>C:p.Cys390Arg		rs4302331	0.9271	0.9800	58208/33273/2982	0.9289	0.3470	T	T,T,T,T	B	B	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000153326.2 [benign]; 	CM051080 [CLASS=DM? MUT=REF PHEN="Gangliosidosis GM1" GENE=GLB1]; 		2697	27	2	[2] Peter Bauer 25.08.2014			GLB1 (inh=AR pLI=0.00)
chr3	33138544	33138544	A	G	het	low_DP	QUAL=3476;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HOM,115,1.00,WT,204,0.01	GLB1	synonymous	GLB1:NM_001317040.1:synonymous:LOW:exon1/17:c.34T>C:p.Leu12Leu,GLB1:NM_000404.3:synonymous:LOW:exon1/16:c.34T>C:p.Leu12Leu,GLB1:NM_001135602.2:synonymous:LOW:exon1/13:c.34T>C:p.Leu12Leu		rs7614776	0.9277	0.9040	48924/25458/3600	0.8611						611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000078712.7 [other]; 		COSM4157974, COSM4157973	2178	427					GLB1 (inh=AR pLI=0.00)
chr3	33138549	33138549	G	A	het	low_DP;pred_pathogenic_1	QUAL=3131;DP=17;AF=0.41;MQM=60;TRIO=HET,17,0.41,HOM,114,0.97,WT,201,0.01	GLB1	missense	GLB1:NM_001317040.1:missense:MODERATE:exon1/17:c.29C>T:p.Pro10Leu,GLB1:NM_000404.3:missense:MODERATE:exon1/16:c.29C>T:p.Pro10Leu,GLB1:NM_001135602.2:missense:MODERATE:exon1/13:c.29C>T:p.Pro10Leu		rs7637099	0.4319	0.5600	19740/12821/102	0.5334	0.1970	T	T,T,T,D,T	B,B	B,B	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000078711.7 [other]; 	CM055955 [CLASS=R MUT=ALT PHEN="Gangliosidosis GM1" GENE=GLB1]; 	COSM4157976, COSM4157975	1067	1146					GLB1 (inh=AR pLI=0.00)
chr3	33174156	33174156	T	G	het		QUAL=10182;DP=208;AF=0.44;MQM=60;TRIO=HET,208,0.44,HOM,256,1.00,WT,339,0.00	CRTAP	synonymous	CRTAP:NM_006371.4:synonymous:LOW:exon5/7:c.1032T>G:p.Thr344Thr		rs1135127	0.2935	0.3750	9267/6573/378	0.3704						605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII];			COSM149349	219	527					CRTAP (inh=n/a pLI=0.00)
chr3	33174168	33174168	G	A	het		QUAL=9298;DP=174;AF=0.42;MQM=60;TRIO=HET,174,0.42,HOM,243,1.00,WT,322,0.00	CRTAP	synonymous	CRTAP:NM_006371.4:synonymous:LOW:exon5/7:c.1044G>A:p.Ser348Ser		rs1135128	0.2935	0.3750	9265/6572/378	0.3677						605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII];				219	526					CRTAP (inh=n/a pLI=0.00)
chr3	33185027	33185027	-	GAACTA	het		QUAL=7427;DP=306;AF=0.47;MQM=59;TRIO=HET,306,0.47,HOM,125,0.98,WT,159,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1090_*1095dupACTAGA:	L2a	rs5847775	0.3387	0.0000	0/0/0	0.4286										63	70					CRTAP (inh=n/a pLI=0.00)
chr3	33185407	33185407	G	A	het		QUAL=8951;DP=350;AF=0.49;MQM=59;TRIO=HET,350,0.49,WT,329,0.00,HET,426,0.50	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1467G>A:	L2a	rs4678475	0.3019	0.0000	0/0/0	0.2617										16	51					CRTAP (inh=n/a pLI=0.00)
chr3	33185798	33185798	T	A	hom		QUAL=19458;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,159,1.00,HOM,180,1.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1858T>A:	L2a	rs4678476	0.8960	0.0000	0/0/0	0.9465										173	2					CRTAP (inh=n/a pLI=0.00)
chr3	33186356	33186356	T	C	het		QUAL=5877;DP=216;AF=0.53;MQM=60;TRIO=HET,216,0.53,WT,141,0.01,HET,236,0.46	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*2416T>C:	L2a	rs1127898	0.3610	0.0000	0/0/0	0.3161										15	82					CRTAP (inh=n/a pLI=0.00)
chr3	33187425	33187425	G	A	het		QUAL=15652;DP=523;AF=0.50;MQM=60;TRIO=HET,523,0.50,HOM,283,0.99,WT,350,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*3485G>A:		rs1132392	0.3199	0.0000	0/0/0	0.4533										82	108					CRTAP (inh=n/a pLI=0.00)
chr3	33187831	33187831	C	T	het		QUAL=8142;DP=181;AF=0.48;MQM=60;TRIO=HET,181,0.48,WT,357,0.00,HET,461,0.51	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*3891C>T:		rs4678478	0.3037	0.0000	0/0/0	0.2979										15	82					CRTAP (inh=n/a pLI=0.00)
chr3	33189163	33189163	T	A	het		QUAL=3055;DP=175;AF=0.49;MQM=60;TRIO=HET,175,0.49,HET,71,0.51,WT,100,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*5223T>A:		rs192685869	0.0008	0.0000	0/0/0	0.0011										0	5					CRTAP (inh=n/a pLI=0.00)
chr3	41241154	41241154	C	G	het		QUAL=1790;DP=90;AF=0.49;MQM=59;TRIO=HET,90,0.49,HET,98,0.43,WT,107,0.00	CTNNB1	5'UTR_premature_start_codon_gain,5'UTR	CTNNB1:NM_001098209.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:NM_001098210.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:NM_001904.3:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-56C>G:,CTNNB1:NM_001098209.1:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:NM_001098210.1:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:NM_001904.3:5'UTR:MODIFIER:exon1/15:c.-56C>G:		rs11564435	0.0032	0.0000	0/0/0	0.0078										0	7					CTNNB1 (inh=AD pLI=1.00)
chr3	41281388	41281388	T	G	het		QUAL=2042;DP=76;AF=0.45;MQM=59;TRIO=HET,76,0.45,HET,46,0.59,HET,60,0.52	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*250T>G:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*91T>G:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*555T>G:		rs2953	0.3652	0.0000	0/0/0	0.0697										48	111					CTNNB1 (inh=AD pLI=1.00)
chr3	41281413	41281413	T	A	het		QUAL=931;DP=87;AF=0.25;MQM=60;TRIO=HET,87,0.25,HOM,17,0.47,HET,14,0.29	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*275T>A:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*116T>A:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*580T>A:	(T)n	rs4135387	0.2700	0.0000	0/0/0	0.2217										5	136					CTNNB1 (inh=AD pLI=1.00)
chr3	41281600	41281600	-	TAAT	het		QUAL=1812;DP=122;AF=0.46;MQM=60;TRIO=HET,122,0.46,HET,15,0.80,HET,14,0.36	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*464_*467dupAATT:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*305_*308dupAATT:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*769_*772dupAATT:		rs16339;rs3834205;rs71623294	0.3580	0.0000	0/0/0	0.3884										41	117					CTNNB1 (inh=AD pLI=1.00)
chr3	43761441	43761441	A	G	hom		QUAL=24205;DP=383;AF=1.00;MQM=60;TRIO=HOM,383,1.00,HET,221,0.44,HOM,263,1.00	ABHD5	3'UTR	ABHD5:NM_016006.4:3'UTR:MODIFIER:exon7/7:c.*1417A>G:		rs3733156	0.5487	0.0000	0/0/0	0.6881										108	103					ABHD5 (inh=AR pLI=0.00)
chr3	46944274	46944274	T	C	het		QUAL=22780;DP=363;AF=0.44;MQM=59;TRIO=HET,363,0.44,HOM,372,0.99,HET,473,0.54	PTH1R	synonymous	PTH1R:NM_000316.2:synonymous:LOW:exon15/16:c.1389T>C:p.Asn463Asn,PTH1R:NM_001184744.1:synonymous:LOW:exon14/15:c.1389T>C:p.Asn463Asn		rs1138518	0.6434	0.6140	22990/12787/3275	0.6084						168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type|Chondrodysplasia,Blomstrand type|Eiken syndrome|Failure of tooth eruption,primary];			COSM149372	441	472					PTH1R (inh=n/a pLI=0.74)
chr3	46945000	46945000	G	A	het	phylop_high	QUAL=3447;DP=148;AF=0.53;MQM=59;TRIO=HET,148,0.53,WT,106,0.00,HET,126,0.50	PTH1R	missense	PTH1R:NM_000316.2:missense:MODERATE:exon16/16:c.1636G>A:p.Glu546Lys,PTH1R:NM_001184744.1:missense:MODERATE:exon15/15:c.1636G>A:p.Glu546Lys		rs77048718	0.0086	0.0170	27/25/0	0.0171	1.8400	T	T,T,T,T,.,T	B	B	168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type|Chondrodysplasia,Blomstrand type|Eiken syndrome|Failure of tooth eruption,primary];				0	42					PTH1R (inh=n/a pLI=0.74)
chr3	46945263	46945263	-	A	het		QUAL=947;DP=81;AF=0.32;MQM=59;TRIO=HET,81,0.32,HOM,33,0.91,WT,56,0.00	PTH1R	3'UTR	PTH1R:NM_000316.2:3'UTR:MODIFIER:exon16/16:c.*127dupA:,PTH1R:NM_001184744.1:3'UTR:MODIFIER:exon15/15:c.*127dupA:	A-rich	rs552713678	0.1532	0.0000	0/0/0	0.1530										8	87					PTH1R (inh=n/a pLI=0.74)
chr3	48508585	48508585	C	T	het		QUAL=6156;DP=287;AF=0.47;MQM=59;TRIO=HET,287,0.47,WT,188,0.01,HET,246,0.48	TREX1	synonymous	TREX1:NM_016381.5:synonymous:LOW:exon1/1:c.696C>T:p.Tyr232Tyr,TREX1:NM_007248.3:synonymous:LOW:exon2/2:c.501C>T:p.Tyr167Tyr,TREX1:NM_033629.4:synonymous:LOW:exon2/2:c.531C>T:p.Tyr177Tyr		rs11797	0.3133	0.3700	8747/6279/391	0.3719						606609 [TREX1 (confirmed) Aicardi-Goutieres syndrome 1,dominant and recessive|Chilblain lupus|Vasculopathy,retinal,with cerebral leukodystrophy|Systemic lupus erythematosus,susceptibility to];	RCV000082324.4 [benign]; 		COSM4002723	255	597					TREX1 (inh=AR+AD pLI=0.09)
chr3	48605076	48605076	A	-	het		QUAL=2480;DP=64;AF=0.52;MQM=59;TRIO=HET,64,0.52,HET,199,0.47,WT,270,0.00	COL7A1	splice_region&intron	COL7A1:NM_000094.3:splice_region&intron:LOW:exon107/117:c.7984-7delT:		rs397989501	0.0697	0.0420	169/43/37	0.0397						120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD|Epidermolysis bullosa dystrophica,AR|Epidermolysis bullosa,pretibial|EBD,Bart type|EBD,localisata variant|Transient bullous of the newborn|Epidermolysis bullosa pruriginosa|Toenail dystrophy,isolated|EBD inversa];				1	86					COL7A1 (inh=n/a pLI=0.00)
chr3	48625266	48625266	T	C	hom		QUAL=11578;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HET,136,0.52,HET,161,0.53	COL7A1	synonymous	COL7A1:NM_000094.3:synonymous:LOW:exon21/118:c.2817A>G:p.Pro939Pro		rs1264194	0.6811	0.6780	28442/16228/4229	0.6683						120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD|Epidermolysis bullosa dystrophica,AR|Epidermolysis bullosa,pretibial|EBD,Bart type|EBD,localisata variant|Transient bullous of the newborn|Epidermolysis bullosa pruriginosa|Toenail dystrophy,isolated|EBD inversa];			COSM446657	525	444					COL7A1 (inh=n/a pLI=0.00)
chr3	49162040	49162040	T	G	het	phylop_high;pred_pathogenic_1	QUAL=2496;DP=108;AF=0.43;MQM=60;TRIO=HET,108,0.43,HET,82,0.62,WT,102,0.00	LAMB2	missense	LAMB2:NM_002292.3:missense:MODERATE:exon22/32:c.3115A>C:p.Thr1039Pro		rs747604203	0.0000	0.0001	0/0/0	0.0001	1.8160	T	D,D	P	B	150325 [LAMB2 (confirmed) Nephrotic syndrome,type 5,with or without ocular abnormalities|Pierson syndrome];				0	1					LAMB2 (inh=n/a pLI=0.00)
chr3	49506273	49506273	-	T	het		QUAL=1277;DP=46;AF=0.76;MQM=58;TRIO=HET,46,0.76,HOM,14,0.71,HOM,9,1.00	DAG1	5'UTR	DAG1:NM_001177643.2:5'UTR:MODIFIER:exon1/3:c.-320dupT:	AluJb	rs71080520	0.6699	0.0000	0/0/0	0.4375										10	106					DAG1 (inh=AR pLI=0.94)
chr3	49506299	49506299	C	T	hom		QUAL=1799;DP=40;AF=1.00;MQM=59;TRIO=HOM,40,1.00,HOM,15,1.00,HOM,14,1.00	DAG1	5'UTR	DAG1:NM_001177643.2:5'UTR:MODIFIER:exon1/3:c.-306C>T:	AluJb	rs6797164	0.9659	0.0000	0/0/0	0.7671										147	0					DAG1 (inh=AR pLI=0.94)
chr3	49507847	49507847	G	A	hom	low_DP	QUAL=184;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,6,0.50,HET,5,0.60	DAG1	5'UTR,intron	DAG1:NM_001165928.3:5'UTR:MODIFIER:exon1/6:c.-497G>A:,DAG1:NM_001177634.2:5'UTR:MODIFIER:exon1/6:c.-440G>A:,DAG1:NM_001177636.2:5'UTR:MODIFIER:exon1/5:c.-418G>A:,DAG1:NM_001177637.2:5'UTR:MODIFIER:exon1/4:c.-256G>A:,DAG1:NM_001177638.2:5'UTR:MODIFIER:exon1/4:c.-287G>A:,DAG1:NM_001177640.2:5'UTR:MODIFIER:exon1/4:c.-193G>A:,DAG1:NM_001177641.2:5'UTR:MODIFIER:exon1/4:c.-283G>A:,DAG1:NM_001177642.2:5'UTR:MODIFIER:exon1/4:c.-188G>A:,DAG1:NM_001177644.2:5'UTR:MODIFIER:exon1/3:c.-276G>A:,DAG1:NM_004393.5:5'UTR:MODIFIER:exon1/3:c.-136G>A:,DAG1:NM_001177643.2:intron:MODIFIER:exon1/2:c.-117+1359G>A:,DAG1:NM_001177635.2:intron:MODIFIER:exon1/3:c.-169+140G>A:,DAG1:NM_001177639.2:intron:MODIFIER:exon1/2:c.-117+140G>A:		rs4855839	0.5829	0.0000	0/0/0	0.4355										29	74					DAG1 (inh=AR pLI=0.94)
chr3	49548008	49548008	C	G	hom	phylop_high	QUAL=35044;DP=312;AF=1.00;MQM=60;TRIO=HOM,312,1.00,HOM,341,1.00,HOM,448,1.00	DAG1	missense	DAG1:NM_001165928.3:missense:MODERATE:exon5/6:c.41C>G:p.Ser14Trp,DAG1:NM_001177643.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_001177634.2:missense:MODERATE:exon5/6:c.41C>G:p.Ser14Trp,DAG1:NM_001177635.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177636.2:missense:MODERATE:exon4/5:c.41C>G:p.Ser14Trp,DAG1:NM_001177637.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177638.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177639.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_001177640.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177641.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177642.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177644.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_004393.5:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp		rs2131107	0.9659	0.9920	59800/33354/4367	0.9479	2.0690	T	T,T,T,T,T,T,T,T,T,T,T,T,T,.	B	B	128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9];	RCV000024443.1 [not provided]; RCV000214409.1 [benign]; 			1107	2					DAG1 (inh=AR pLI=0.94)
chr3	49570882	49570882	T	C	hom		QUAL=6774;DP=174;AF=1.00;MQM=59;TRIO=HOM,174,1.00,HET,50,0.42,HET,61,0.52	DAG1	3'UTR	DAG1:NM_001165928.3:3'UTR:MODIFIER:exon6/6:c.*250T>C:,DAG1:NM_001177643.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_001177634.2:3'UTR:MODIFIER:exon6/6:c.*250T>C:,DAG1:NM_001177635.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177636.2:3'UTR:MODIFIER:exon5/5:c.*250T>C:,DAG1:NM_001177637.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177638.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177639.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_001177640.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177641.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177642.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177644.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_004393.5:3'UTR:MODIFIER:exon3/3:c.*250T>C:		rs1050088	0.5541	0.4360	2135/268/24	0.1458							RCV000024448.1 [not provided]; 			123	288					DAG1 (inh=AR pLI=0.94)
chr3	49572894	49572894	T	C	hom		QUAL=13192;DP=163;AF=1.00;MQM=59;TRIO=HOM,163,1.00,HOM,120,1.00,HOM,141,1.00	DAG1	3'UTR	DAG1:NM_001165928.3:3'UTR:MODIFIER:exon6/6:c.*2262T>C:,DAG1:NM_001177643.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_001177634.2:3'UTR:MODIFIER:exon6/6:c.*2262T>C:,DAG1:NM_001177635.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177636.2:3'UTR:MODIFIER:exon5/5:c.*2262T>C:,DAG1:NM_001177637.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177638.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177639.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_001177640.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177641.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177642.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177644.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_004393.5:3'UTR:MODIFIER:exon3/3:c.*2262T>C:		rs6446283	0.9758	0.0000	0/0/0	0.1502							RCV000024451.1 [not provided]; 			276	0					DAG1 (inh=AR pLI=0.94)
chr3	52017423	52017423	G	C	het	low_DP	QUAL=264;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,HET,18,0.39,WT,36,0.00	ACY1,ABHD14A-ACY1	5'UTR,intron	ACY1:NM_000666.2:5'UTR:MODIFIER:exon1/15:c.-201G>C:,ACY1:NM_001198895.1:5'UTR:MODIFIER:exon1/15:c.-196G>C:,ACY1:NM_001198896.1:5'UTR:MODIFIER:exon1/13:c.-201G>C:,ACY1:NM_001198897.1:5'UTR:MODIFIER:exon1/13:c.-201G>C:,ACY1:NM_001198898.1:5'UTR:MODIFIER:exon1/14:c.-201G>C:,ABHD14A-ACY1:NM_001316331.1:intron:MODIFIER:exon3/16:c.253-640G>C:		rs554462231	0.0018	0.0000	0/0/0	0.0015										0	2					ACY1 (inh=AR pLI=0.00), ABHD14A-ACY1 (inh=n/a pLI=0.00)
chr3	53122969	53122969	G	A	het	low_MQM	QUAL=972;DP=78;AF=0.46;MQM=45;TRIO=HET,78,0.46,HET,19,0.42,WT,24,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2950C>T:	AluSx4	rs2082093	0.4904	0.0000	0/0/0	0.4983										43	77					RFT1 (inh=AR pLI=0.00)
chr3	53123032	53123032	C	T	hom	low_MQM	QUAL=3186;DP=95;AF=0.94;MQM=47;TRIO=HOM,95,0.94,HET,37,0.49,HET,34,0.56	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2887G>A:	AluSx4	rs2099162	0.7185	0.0000	0/0/0	0.6347										81	66					RFT1 (inh=AR pLI=0.00)
chr3	53123079	53123079	A	T	het		QUAL=2056;DP=126;AF=0.48;MQM=57;TRIO=HET,126,0.48,WT,57,0.00,HET,65,0.54	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2840T>A:	AluSx4	rs9875573	0.1699	0.0000	0/0/0	0.1083										0	43					RFT1 (inh=AR pLI=0.00)
chr3	53123273	53123273	A	G	het		QUAL=6809;DP=283;AF=0.53;MQM=59;TRIO=HET,283,0.53,HET,219,0.52,WT,315,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2646T>C:		rs891368	0.4904	0.0000	0/0/0	0.0967										67	110					RFT1 (inh=AR pLI=0.00)
chr3	53123486	53123486	G	A	het		QUAL=6342;DP=271;AF=0.48;MQM=59;TRIO=HET,271,0.48,HET,234,0.59,WT,328,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2433C>T:		rs1078968	0.4904	0.0000	0/0/0	0.0969										67	111					RFT1 (inh=AR pLI=0.00)
chr3	53125297	53125297	G	C	het		QUAL=5271;DP=292;AF=0.46;MQM=60;TRIO=HET,292,0.46,WT,124,0.00,HET,138,0.52	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*622C>G:	L2a	rs7645611	0.1669	0.0000	0/0/0	0.0194										2	55					RFT1 (inh=AR pLI=0.00)
chr3	53125469	53125469	G	A	hom		QUAL=15301;DP=311;AF=1.00;MQM=60;TRIO=HOM,311,1.00,HET,199,0.43,HET,234,0.48	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*450C>T:		rs2564922	0.6508	0.0000	0/0/0	0.6820										103	97					RFT1 (inh=AR pLI=0.00)
chr3	53125585	53125585	T	C	het		QUAL=5035;DP=302;AF=0.46;MQM=60;TRIO=HET,302,0.46,HET,104,0.50,WT,137,0.01	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*334A>G:		rs2564921	0.4904	0.0000	0/0/0	0.0971										67	111					RFT1 (inh=AR pLI=0.00)
chr3	53125922	53125922	T	C	het		QUAL=6838;DP=304;AF=0.45;MQM=59;TRIO=HET,304,0.45,HET,234,0.55,WT,261,0.00	RFT1	synonymous	RFT1:NM_052859.3:synonymous:LOW:exon13/13:c.1623A>G:p.Thr541Thr		rs11242	0.4904	0.5500	19154/10709/334	0.5492						611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In];	RCV000082329.4 [benign]; 			341	533					RFT1 (inh=AR pLI=0.00)
chr3	55499781	55499781	T	C	hom		QUAL=7361;DP=119;AF=0.99;MQM=60;TRIO=HOM,119,0.99,HET,116,0.58,HET,131,0.51	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*4339A>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*4339A>G:		rs1047898	0.4840	0.0000	0/0/0	0.0846										43	116					WNT5A (inh=n/a pLI=0.97)
chr3	55500408	55500408	T	A	hom		QUAL=8051;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HET,101,0.51,HET,143,0.49	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*3712A>T:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*3712A>T:		rs10865994	0.4595	0.0000	0/0/0	0.0829										42	116					WNT5A (inh=n/a pLI=0.97)
chr3	55501002	55501002	G	C	hom		QUAL=16748;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HET,132,0.54,HOM,177,1.00	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*3118C>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*3118C>G:		rs669889	0.8095	0.0000	0/0/0	0.1314										125	89					WNT5A (inh=n/a pLI=0.97)
chr3	55501175	55501175	T	C	hom		QUAL=13138;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HET,166,0.45,HET,201,0.53	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*2945A>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*2945A>G:		rs1829556	0.4655	0.0000	0/0/0	0.0842										42	116					WNT5A (inh=n/a pLI=0.97)
chr3	55501393	55501393	T	-	hom		QUAL=1574;DP=114;AF=0.61;MQM=59;TRIO=HOM,114,0.61,HET,51,0.43,WT,56,0.32	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*2727delA:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*2727delA:	(T)n	rs34280613;rs397873965	0.0000	0.0000	0/0/0	0.1971										1	74					WNT5A (inh=n/a pLI=0.97)
chr3	55502167	55502168	AA	-	hom		QUAL=635;DP=44;AF=0.00;MQM=59;TRIO=HOM,44,0.00,HOM,19,0.00,HOM,23,0.22	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*1952_*1953delTT:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*1952_*1953delTT:	(A)n	rs796958500	0.0000	0.0000	0/0/0	0.0365										3	23					WNT5A (inh=n/a pLI=0.97)
chr3	58080583	58080583	A	G	het	phylop_high	QUAL=5362;DP=250;AF=0.45;MQM=60;TRIO=HET,250,0.45,HET,219,0.48,WT,291,0.00	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon5/47:c.808A>G:p.Met270Val,FLNB:NM_001164318.1:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val,FLNB:NM_001164319.1:missense:MODERATE:exon5/45:c.808A>G:p.Met270Val,FLNB:NM_001457.3:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val		rs145036794	0.0002	0.0006	0/0/0	0.0006	2.5940	T	T,T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM1485422, COSM1485423	0	3	3	[3] Stephan Waldm?ller 12.08.2014			FLNB (inh=AR+AD pLI=0.00)
chr3	58081888	58081888	T	C	het		QUAL=8922;DP=298;AF=0.45;MQM=59;TRIO=HET,298,0.45,WT,353,0.00,HET,453,0.47	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon6/47:c.927T>C:p.Ser309Ser,FLNB:NM_001164318.1:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser,FLNB:NM_001164319.1:synonymous:LOW:exon6/45:c.927T>C:p.Ser309Ser,FLNB:NM_001457.3:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser		rs1522384	0.6420	0.4640	15585/3520/1517	0.4466						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];				140	486					FLNB (inh=AR+AD pLI=0.00)
chr3	58109162	58109162	G	A	het	phylop_high;pred_pathogenic_2	QUAL=6801;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,WT,253,0.01,HET,363,0.51	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon21/47:c.3469G>A:p.Asp1157Asn,FLNB:NM_001164318.1:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn,FLNB:NM_001164319.1:missense:MODERATE:exon21/45:c.3469G>A:p.Asp1157Asn,FLNB:NM_001457.3:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn		rs1131356	0.5461	0.3720	10732/2038/923	0.3699	9.8690	T	T,T,T,T,T,T,T,T	D,D,D,D,D,D	D,D,D,P,D,D	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158258, COSM4158257, COSM4158256	92	394					FLNB (inh=AR+AD pLI=0.00)
chr3	58112440	58112440	A	G	het		QUAL=12449;DP=251;AF=0.53;MQM=60;TRIO=HET,251,0.53,HET,171,0.46,HOM,227,1.00	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon24/47:c.4173A>G:p.Ala1391Ala,FLNB:NM_001164318.1:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala,FLNB:NM_001164319.1:synonymous:LOW:exon24/45:c.4173A>G:p.Ala1391Ala,FLNB:NM_001457.3:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala		rs2362903	0.8333	0.7080	31452/13071/4263	0.6893						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158260, COSM4158259, COSM4158261	478	507					FLNB (inh=AR+AD pLI=0.00)
chr3	58112488	58112488	C	T	het		QUAL=4167;DP=168;AF=0.49;MQM=59;TRIO=HET,168,0.49,WT,123,0.00,HET,167,0.49	FLNB	splice_region&synonymous	FLNB:NM_001164317.1:splice_region&synonymous:LOW:exon24/47:c.4221C>T:p.Pro1407Pro,FLNB:NM_001164318.1:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro,FLNB:NM_001164319.1:splice_region&synonymous:LOW:exon24/45:c.4221C>T:p.Pro1407Pro,FLNB:NM_001457.3:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro		rs2362904	0.6486	0.4080	13314/2047/2719	0.3910						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158262, COSM4158264, COSM4158263	102	399					FLNB (inh=AR+AD pLI=0.00)
chr3	58118555	58118555	G	A	het	phylop_high	QUAL=9295;DP=268;AF=0.46;MQM=60;TRIO=HET,268,0.46,WT,343,0.00,HET,484,0.48	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon27/47:c.4504G>A:p.Val1502Met,FLNB:NM_001164318.1:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met,FLNB:NM_001164319.1:missense:MODERATE:exon26/45:c.4411G>A:p.Val1471Met,FLNB:NM_001457.3:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met		rs12632456	0.6082	0.3950	12348/2052/1840	0.3793	2.9510	T	T,T,T,T,T,T,T,T	P,P,B,B,P,P	B,B,B,B,B,B	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158266, COSM4158267, COSM4158265	98	402					FLNB (inh=AR+AD pLI=0.00)
chr3	58145363	58145363	A	C	het	phylop_high;pred_pathogenic_1	QUAL=56;DP=154;AF=0.26;MQM=59;TRIO=HET,154,0.26,WT,162,0.00,WT,190,0.00	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon43/47:c.7064A>C:p.His2355Pro,FLNB:NM_001164318.1:missense:MODERATE:exon42/46:c.6938A>C:p.His2313Pro,FLNB:NM_001164319.1:missense:MODERATE:exon41/45:c.6899A>C:p.His2300Pro,FLNB:NM_001457.3:missense:MODERATE:exon42/46:c.6971A>C:p.His2324Pro		rs202222289	0.0000	0.0031	0/0/0	0.0001	9.3390	D	T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM304726	0	50					FLNB (inh=AR+AD pLI=0.00)
chr3	58154327	58154327	C	T	het		QUAL=7770;DP=297;AF=0.48;MQM=59;TRIO=HET,297,0.48,WT,296,0.00,HET,377,0.48	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon45/47:c.7452C>T:p.Ser2484Ser,FLNB:NM_001164318.1:synonymous:LOW:exon44/46:c.7326C>T:p.Ser2442Ser,FLNB:NM_001164319.1:synonymous:LOW:exon43/45:c.7287C>T:p.Ser2429Ser,FLNB:NM_001457.3:synonymous:LOW:exon44/46:c.7359C>T:p.Ser2453Ser		rs8640	0.5713	0.3850	11362/2159/1400	0.3837						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];				100	410					FLNB (inh=AR+AD pLI=0.00)
chr3	58157519	58157519	G	C	het		QUAL=20302;DP=379;AF=0.49;MQM=60;TRIO=HET,379,0.49,HET,288,0.52,HOM,369,1.00	FLNB	3'UTR	FLNB:NM_001164317.1:3'UTR:MODIFIER:exon47/47:c.*1030G>C:,FLNB:NM_001164318.1:3'UTR:MODIFIER:exon46/46:c.*1030G>C:,FLNB:NM_001164319.1:3'UTR:MODIFIER:exon45/45:c.*1030G>C:,FLNB:NM_001457.3:3'UTR:MODIFIER:exon46/46:c.*1030G>C:		rs1131264	0.6931	0.0000	0/0/0	0.0855										46	112					FLNB (inh=AR+AD pLI=0.00)
chr3	58157799	58157799	T	G	het		QUAL=46;DP=193;AF=0.27;MQM=58;TRIO=HET,193,0.27,WT,188,0.01,WT,196,0.03	FLNB	3'UTR	FLNB:NM_001164317.1:3'UTR:MODIFIER:exon47/47:c.*1310T>G:,FLNB:NM_001164318.1:3'UTR:MODIFIER:exon46/46:c.*1310T>G:,FLNB:NM_001164319.1:3'UTR:MODIFIER:exon45/45:c.*1310T>G:,FLNB:NM_001457.3:3'UTR:MODIFIER:exon46/46:c.*1310T>G:		rs761905985	0.0000	0.0000	0/0/0	0.0008										0	37					FLNB (inh=AR+AD pLI=0.00)
chr3	58413405	58413405	T	C	het		QUAL=2000;DP=132;AF=0.41;MQM=60;TRIO=HET,132,0.41,WT,58,0.00,HET,75,0.51	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*356A>G:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*356A>G:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*356A>G:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1549A>G:		rs1126737	0.3674	0.2660	418/38/0	0.0791										56	248					PDHB (inh=n/a pLI=0.36)
chr3	58413408	58413408	A	G	het		QUAL=3603;DP=137;AF=0.59;MQM=59;TRIO=HET,137,0.59,HOM,61,1.00,WT,77,0.00	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*353T>C:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*353T>C:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*353T>C:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1546T>C:		rs1126735	0.1847	0.2410	332/185/0	0.0676										65	307					PDHB (inh=n/a pLI=0.36)
chr3	58413465	58413465	G	C	hom		QUAL=16218;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HOM,160,1.00,HET,192,0.53	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*296C>G:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*296C>G:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*296C>G:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1489C>G:		rs7231	0.7418	0.7260	3406/888/41	0.2006										413	211					PDHB (inh=n/a pLI=0.36)
chr3	58413518	58413518	T	G	het		QUAL=10454;DP=207;AF=0.56;MQM=60;TRIO=HET,207,0.56,HOM,231,1.00,WT,277,0.00	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*243A>C:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*243A>C:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*243A>C:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1436A>C:		rs1126722	0.2005	0.2120	544/289/8	0.0765										68	305					PDHB (inh=n/a pLI=0.36)
chr3	58413662	58413662	G	A	het		QUAL=8186;DP=248;AF=0.42;MQM=60;TRIO=HET,248,0.42,WT,288,0.00,HET,378,0.55	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*99C>T:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*99C>T:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*99C>T:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1292C>T:		rs7230	0.3672	0.2720	2235/587/10	0.2594										56	254					PDHB (inh=n/a pLI=0.36)
chr3	58413669	58413669	G	T	het		QUAL=13150;DP=274;AF=0.57;MQM=60;TRIO=HET,274,0.57,HOM,276,1.00,WT,375,0.01	PDHB	3'UTR,non_coding_exon	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*92C>A:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*92C>A:,PDHB:NM_001315536.1:3'UTR:MODIFIER:exon9/9:c.*92C>A:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon9/9:n.1285C>A:		rs4228	0.2047	0.2450	2180/1608/100	0.2387										68	305					PDHB (inh=n/a pLI=0.36)
chr3	58416535	58416535	C	T	het		QUAL=30480;DP=283;AF=0.47;MQM=60;TRIO=HET,283,1.00,HOM,311,0.99,WT,410,1.00	PDHB	splice_region&intron,synonymous,non_coding_exon	PDHB:NM_001173468.1:splice_region&intron:LOW:exon6/10:c.404-20G>A:,PDHB:NM_000925.3:synonymous:LOW:exon6/10:c.438G>A:p.Gly146Gly,PDHB:NM_001315536.1:synonymous:LOW:exon5/9:c.384G>A:p.Gly128Gly,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon5/9:n.551G>A:		rs1126551	0.2047	0.2830	5680/4480/230	0.2755						179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency];	RCV000117898.2 [likely benign]; 		COSM3760211	139	524					PDHB (inh=n/a pLI=0.36)
chr3	58416538	58416538	T	C	hom		QUAL=30480;DP=283;AF=0.47;MQM=60;TRIO=HOM,283,1.00,HOM,311,0.99,HOM,410,1.00	PDHB	synonymous,intron,non_coding_exon	PDHB:NM_000925.3:synonymous:LOW:exon6/10:c.435A>G:p.Arg145Arg,PDHB:NM_001315536.1:synonymous:LOW:exon5/9:c.381A>G:p.Arg127Arg,PDHB:NM_001173468.1:intron:MODIFIER:exon6/10:c.404-23A>G:,PDHB:NR_033384.1:non_coding_exon:MODIFIER:exon5/9:n.548A>G:		rs4264746	0.9848	0.9950	60093/33348/4655	0.9540						179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency];	RCV000127406.1 [benign]; 			1105	3					PDHB (inh=n/a pLI=0.36)
chr3	63850298	63850298	T	G	het		QUAL=12280;DP=300;AF=0.45;MQM=59;TRIO=HET,300,0.45,HET,167,0.47,HOM,251,1.00	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-488T>G:		rs6779372	0.7492	0.0000	0/0/0	0.5121										134	85					ATXN7 (inh=n/a pLI=0.93)
chr3	63850299	63850299	G	C	het		QUAL=12280;DP=300;AF=0.45;MQM=59;TRIO=HET,300,0.45,HET,167,0.47,HOM,251,1.00	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-487G>C:		rs3733120	0.7490	0.0000	0/0/0	0.5005										134	85					ATXN7 (inh=n/a pLI=0.93)
chr3	63850660	63850660	C	G	het		QUAL=6045;DP=266;AF=0.52;MQM=59;TRIO=HET,266,0.52,WT,173,0.00,HET,225,0.50	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-126C>G:		rs3733121	0.1088	0.0000	0/0/0	0.1239										4	59					ATXN7 (inh=n/a pLI=0.93)
chr3	63967900	63967900	A	G	het	phylop_high;pred_pathogenic_2	QUAL=4861;DP=176;AF=0.48;MQM=60;TRIO=HET,176,0.48,WT,140,0.00,HET,202,0.53	ATXN7	missense	ATXN7:NM_001177387.1:missense:MODERATE:exon6/13:c.791A>G:p.Lys264Arg,ATXN7:NM_000333.3:missense:MODERATE:exon7/13:c.791A>G:p.Lys264Arg,ATXN7:NM_001128149.2:missense:MODERATE:exon3/9:c.356A>G:p.Lys119Arg		rs1053338	0.1146	0.1340	1256/660/9	0.1321	4.0620	T	T,T,T,T,T	D,P,P	D,B,B	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116489.2 [likely benign]; 	CM1413188 [CLASS=DP MUT=ALT PHEN="Breast cancer susceptibility to" GENE=ATXN7]; 		31	258					ATXN7 (inh=n/a pLI=0.93)
chr3	63981635	63981635	C	T	het		QUAL=7048;DP=278;AF=0.51;MQM=59;TRIO=HET,278,0.51,HET,260,0.56,WT,327,0.00	ATXN7	synonymous	ATXN7:NM_001177387.1:synonymous:LOW:exon11/13:c.2137C>T:p.Leu713Leu,ATXN7:NM_000333.3:synonymous:LOW:exon12/13:c.2137C>T:p.Leu713Leu,ATXN7:NM_001128149.2:synonymous:LOW:exon8/9:c.1702C>T:p.Leu568Leu		rs3733125	0.0905	0.0960	739/381/2	0.0980						607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116486.2 [likely benign]; 		COSM149408	15	198					ATXN7 (inh=n/a pLI=0.93)
chr3	63982082	63982082	G	A	hom		QUAL=21351;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HET,209,0.55,HOM,316,1.00	ATXN7	missense	ATXN7:NM_001177387.1:missense:MODERATE:exon11/13:c.2584G>A:p.Val862Met,ATXN7:NM_000333.3:missense:MODERATE:exon12/13:c.2584G>A:p.Val862Met,ATXN7:NM_001128149.2:missense:MODERATE:exon8/9:c.2149G>A:p.Val717Met		rs3774729	0.4377	0.3470	7726/3392/1615	0.3443	-0.2650	T	T,T,T,T,T,T	B,B,B	B,B,B	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116488.2 [likely benign]; 		COSM1567155, COSM1567156	142	469					ATXN7 (inh=n/a pLI=0.93)
chr3	63986047	63986047	T	-	het		QUAL=5586;DP=199;AF=0.46;MQM=59;TRIO=HET,199,0.46,WT,66,0.00,HOM,113,0.97	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*815delT:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*907delT:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*907delT:		rs397841163	0.1999	0.0000	0/0/0	0.1606										4	72					ATXN7 (inh=n/a pLI=0.93)
chr3	63986170	63986170	A	G	hom		QUAL=23462;DP=394;AF=1.00;MQM=59;TRIO=HOM,394,1.00,HET,208,0.48,HOM,256,1.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*935A>G:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*1027A>G:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*1027A>G:		rs13272	0.5104	0.0000	0/0/0	0.0669										26	114					ATXN7 (inh=n/a pLI=0.93)
chr3	63988171	63988171	C	T	het		QUAL=11836;DP=355;AF=0.47;MQM=59;TRIO=HET,355,0.47,WT,171,0.00,HOM,245,1.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*2936C>T:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*3028C>T:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*3028C>T:	(TG)n	rs3733126	0.1861	0.0000	0/0/0	0.1565										4	73					ATXN7 (inh=n/a pLI=0.93)
chr3	63988174	63988174	C	T	het		QUAL=6462;DP=354;AF=0.51;MQM=59;TRIO=HET,354,0.51,HET,164,0.42,WT,240,0.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*2939C>T:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*3031C>T:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*3031C>T:	(TG)n	rs3733127	0.2634	0.0000	0/0/0	0.1641										4	65					ATXN7 (inh=n/a pLI=0.93)
chr3	81643167	81643167	T	C	hom	phylop_high	QUAL=27307;DP=330;AF=1.00;MQM=60;TRIO=HOM,330,1.00,HOM,223,1.00,HOM,281,1.00	GBE1	missense	GBE1:NM_000158.3:missense:MODERATE:exon8/16:c.1000A>G:p.Ile334Val		rs2172397	0.9836	0.9690	26318/13594/2692	0.9120	5.5970	T	T,T,T,T	B,B	B,B	607839 [GBE1 (provisional) Glycogen storage disease IV|Polyglucosan body disease,adult form];				2088	141					GBE1 (inh=AR pLI=0.00)
chr3	81698130	81698130	T	C	het	phylop_high;pred_pathogenic_1	QUAL=4841;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,WT,103,0.00,HET,156,0.52	GBE1	missense	GBE1:NM_000158.3:missense:MODERATE:exon5/16:c.568A>G:p.Arg190Gly		rs2229519	0.3215	0.3070	5135/2559/322	0.3028	3.4770	T	D,D,D	B,B	B,B	607839 [GBE1 (provisional) Glycogen storage disease IV|Polyglucosan body disease,adult form];	RCV000178721.1 [benign]; 			187	877	1	[1] auto-classification 16.06.2016  [2] harmuth 13.04.2016; in-house frequency: 156x hom/ 700x het and is also too frequent in open databases			GBE1 (inh=AR pLI=0.00)
chr3	81810702	81810702	-	G	hom		QUAL=1354;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HOM,14,1.00,HOM,14,1.00	GBE1	5'UTR	GBE1:NM_000158.3:5'UTR:MODIFIER:exon1/16:c.-35dupC:		rs11391701;rs55840733	0.9968	0.9990	38368/21124/2671	0.9100										1314	46					GBE1 (inh=AR pLI=0.00)
chr3	81810725	81810725	C	T	het	low_DP	QUAL=161;DP=14;AF=0.64;MQM=58;TRIO=HET,14,0.64,WT,10,0.00,HET,11,0.27	GBE1	5'UTR	GBE1:NM_000158.3:5'UTR:MODIFIER:exon1/16:c.-57G>A:		rs2290081	0.4209	0.3290	2523/1143/280	0.2923										162	603					GBE1 (inh=AR pLI=0.00)
chr3	87308831	87308831	C	T	hom		QUAL=2157;DP=46;AF=1.00;MQM=60;TRIO=HOM,46,1.00,HOM,9,1.00,HOM,16,1.00	POU1F1	3'UTR	POU1F1:NM_001122757.2:3'UTR:MODIFIER:exon6/6:c.*213G>A:,POU1F1:NM_000306.3:3'UTR:MODIFIER:exon6/6:c.*213G>A:		rs6792500	1.0000	0.0000	0/0/0	0.1492										230	0					POU1F1 (inh=AR+AD pLI=0.62)
chr3	87308904	87308904	T	A	het		QUAL=3569;DP=151;AF=0.57;MQM=60;TRIO=HET,151,0.57,HOM,43,1.00,WT,62,0.00	POU1F1	3'UTR	POU1F1:NM_001122757.2:3'UTR:MODIFIER:exon6/6:c.*140A>T:,POU1F1:NM_000306.3:3'UTR:MODIFIER:exon6/6:c.*140A>T:		rs33936108	0.2508	0.0000	0/0/0	0.2863										42	112					POU1F1 (inh=AR+AD pLI=0.62)
chr3	101370530	101370531	AA	-	hom		QUAL=429;DP=88;AF=0.30;MQM=59;TRIO=HOM,88,0.30,WT,38,0.13,HOM,64,0.27	ZBTB11	splice_region&intron	ZBTB11:NM_014415.3:splice_region&intron:LOW:exon10/10:c.2645-4_2645-3delTT:	(A)n	rs796206524	0.0000	0.1530	9/1/8	0.1188										1	14					ZBTB11 (inh=n/a pLI=0.27)
chr3	101383562	101383562	G	A	het		QUAL=5784;DP=267;AF=0.50;MQM=60;TRIO=HET,267,0.50,WT,163,0.00,HET,203,0.42	ZBTB11	splice_region&intron	ZBTB11:NM_014415.3:splice_region&intron:LOW:exon4/10:c.1624-4C>T:		rs11712748	0.3307	0.3230	6673/4027/969	0.3235									COSM4002354	66	263					ZBTB11 (inh=n/a pLI=0.27)
chr3	121488995	121488995	C	G	hom		QUAL=16903;DP=307;AF=1.00;MQM=59;TRIO=HOM,307,1.00,HET,124,0.56,HOM,166,1.00	IQCB1	3'UTR,non_coding_exon	IQCB1:NM_001023570.3:3'UTR:MODIFIER:exon15/15:c.*197G>C:,IQCB1:NM_001023571.3:3'UTR:MODIFIER:exon12/12:c.*197G>C:,IQCB1:NM_001319107.1:3'UTR:MODIFIER:exon15/15:c.*197G>C:,IQCB1:NR_134968.1:non_coding_exon:MODIFIER:exon14/14:n.2098G>C:		rs1135750	0.6212	0.0000	0/0/0	0.0988										79	107					IQCB1 (inh=n/a pLI=0.00)
chr3	121500699	121500699	C	T	het	phylop_high;pred_pathogenic_1	QUAL=3175;DP=194;AF=0.51;MQM=60;TRIO=HET,194,0.51,WT,57,0.00,HET,76,0.43	IQCB1	missense,non_coding_exon	IQCB1:NM_001023570.3:missense:MODERATE:exon13/15:c.1301G>A:p.Cys434Tyr,IQCB1:NM_001023571.3:missense:MODERATE:exon10/12:c.902G>A:p.Cys301Tyr,IQCB1:NM_001319107.1:missense:MODERATE:exon13/15:c.1301G>A:p.Cys434Tyr,IQCB1:NR_134968.1:non_coding_exon:MODIFIER:exon12/14:n.1405G>A:		rs17849995	0.3027	0.2890	6050/1960/301	0.2815	2.8010	T	T,T	P,D	B,P	609237 [IQCB1 (provisional) Senior-Loken syndrome 5];				75	421					IQCB1 (inh=n/a pLI=0.00)
chr3	121526204	121526204	G	A	hom		QUAL=17764;DP=308;AF=1.00;MQM=59;TRIO=HOM,308,1.00,HET,119,0.50,HOM,187,0.99	IQCB1	synonymous,non_coding_exon	IQCB1:NM_001023570.3:synonymous:LOW:exon7/15:c.574C>T:p.Leu192Leu,IQCB1:NM_001023571.3:synonymous:LOW:exon7/12:c.574C>T:p.Leu192Leu,IQCB1:NM_001319107.1:synonymous:LOW:exon7/15:c.574C>T:p.Leu192Leu,IQCB1:NR_134968.1:non_coding_exon:MODIFIER:exon7/14:n.788C>T:		rs4543051	0.6200	0.6270	24452/12877/2663	0.6162						609237 [IQCB1 (provisional) Senior-Loken syndrome 5];	RCV000179799.1 [benign]; 			398	496					IQCB1 (inh=n/a pLI=0.00)
chr3	121553853	121553858	CTCCCA	-	hom		QUAL=9992;DP=199;AF=0.99;MQM=59;TRIO=HOM,199,0.99,HET,140,0.45,HOM,153,1.00	IQCB1	5'UTR,non_coding_exon	IQCB1:NM_001023570.3:5'UTR:MODIFIER:exon1/15:c.-147_-142delTGGGAG:,IQCB1:NM_001023571.3:5'UTR:MODIFIER:exon1/12:c.-147_-142delTGGGAG:,IQCB1:NM_001319107.1:5'UTR:MODIFIER:exon1/15:c.-146_-141delTGGGAG:,IQCB1:NR_134968.1:non_coding_exon:MODIFIER:exon1/14:n.69_74delTGGGAG:		rs72421117	0.6218	0.0000	0/0/0	0.5761										80	108					IQCB1 (inh=n/a pLI=0.00)
chr3	121903266	121903266	G	A	hom	low_DP	QUAL=3024;DP=12;AF=1.00;MQM=60;TRIO=HOM,12,1.00,HET,44,0.50,HOM,76,0.97	CASR	5'UTR,intron	CASR:NM_001178065.1:5'UTR:MODIFIER:exon1/7:c.-353G>A:,CASR:NM_000388.3:intron:MODIFIER:exon1/6:c.-243+607G>A:		rs9883981	0.2179	0.0000	0/0/0	0.2521										9	52					CASR (inh=n/a pLI=0.37)
chr3	122003045	122003045	G	C	hom		QUAL=35494;DP=330;AF=1.00;MQM=59;TRIO=HOM,330,1.00,HOM,362,1.00,HOM,413,1.00	CASR	synonymous	CASR:NM_001178065.1:synonymous:LOW:exon7/7:c.2274G>C:p.Pro758Pro,CASR:NM_000388.3:synonymous:LOW:exon7/7:c.2244G>C:p.Pro748Pro		rs2036400	0.9728	0.9920	59427/33130/4241	0.9374						601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I|Hyperparathyroidism,neonatal|Hypocalcemia,autosomal dominant|Hypocalcemia,autosomal dominant,with Bartter syndrome|Epilepsy idiopathic generalized,susceptibility to,8|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000152932.2 [benign]; 			1102	3					CASR (inh=n/a pLI=0.37)
chr3	122003832	122003832	G	C	het		QUAL=20480;DP=276;AF=0.49;MQM=59;TRIO=HET,276,0.49,HET,309,0.56,HOM,391,1.00	CASR	missense	CASR:NM_001178065.1:missense:MODERATE:exon7/7:c.3061G>C:p.Glu1021Gln,CASR:NM_000388.3:missense:MODERATE:exon7/7:c.3031G>C:p.Glu1011Gln		rs1801726	0.9241	0.9450	54228/30247/3532	0.9161	1.1740	T	T,T,T	B	B	601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I|Hyperparathyroidism,neonatal|Hypocalcemia,autosomal dominant|Hypocalcemia,autosomal dominant,with Bartter syndrome|Epilepsy idiopathic generalized,susceptibility to,8|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000152934.3 [benign]; 	CM045983 [CLASS=FP MUT=REF PHEN="Increased blood ionised calcium level" GENE=CASR]; 		1020	87					CASR (inh=n/a pLI=0.37)
chr3	122004098	122004098	A	T	het		QUAL=16926;DP=339;AF=0.48;MQM=60;TRIO=HET,339,0.48,HET,221,0.48,HOM,325,1.00	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*60A>T:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*60A>T:		rs4677948	0.9201	0.0000	0/0/0	0.1737										293	27					CASR (inh=n/a pLI=0.37)
chr3	122004612	122004612	C	G	hom		QUAL=40168;DP=445;AF=1.00;MQM=59;TRIO=HOM,445,1.00,HOM,358,1.00,HOM,425,1.00	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*574C>G:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*574C>G:		rs6438718	0.9687	0.0000	0/0/0	0.1498										229	1					CASR (inh=n/a pLI=0.37)
chr3	122005053	122005053	A	G	het		QUAL=6478;DP=231;AF=0.49;MQM=60;TRIO=HET,231,0.49,WT,219,0.00,HET,270,0.51	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*1015A>G:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*1015A>G:		rs9740	0.1815	0.0000	0/0/0	0.0437										22	95					CASR (inh=n/a pLI=0.37)
chr3	122005236	122005236	T	C	het		QUAL=6045;DP=321;AF=0.45;MQM=59;TRIO=HET,321,0.45,WT,106,0.01,HET,151,0.55	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*1198T>C:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*1198T>C:	MIRb	rs10190	0.5331	0.0000	0/0/0	0.1053										97	72					CASR (inh=n/a pLI=0.37)
chr3	128622922	128622922	G	A	het	phylop_high;pred_pathogenic_4;anno_pathogenic_clinvar	QUAL=11119;DP=423;AF=0.46;MQM=60;TRIO=HET,423,0.46,WT,363,0.00,HET,526,0.48	ACAD9	missense,non_coding_exon	ACAD9:NM_014049.4:missense:MODERATE:exon10/18:c.976G>A:p.Ala326Thr,ACAD9:NR_033426.1:non_coding_exon:MODIFIER:exon10/18:n.1354G>A:		rs115532916	0.0078	0.0180	35/29/0	0.0171	6.9770	D	D,D	D,D	D,D	611103 [ACAD9 (confirmed) Mitochondrial complex I deficiency due to ACAD9 deficiency];	RCV000123467.1 [benign]; RCV000201693.1 [pathogenic]; RCV000023868.2 [pathogenic]; RCV000198883.2 [pathogenic]; 			1	67	2	[2] Peter Bauer 28.01.2015			ACAD9 (inh=n/a pLI=0.00)
chr3	128887147	128887147	C	T	hom		QUAL=28052;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,232,1.00,HOM,315,1.00	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*2149G>A:		rs9880375	0.9780	0.0000	0/0/0	0.8918										216	11					CNBP (inh=n/a pLI=0.92)
chr3	128887527	128887527	A	G	hom		QUAL=7096;DP=139;AF=0.99;MQM=60;TRIO=HOM,139,0.99,HOM,44,1.00,HOM,37,1.00	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1769T>C:	AluSq2	rs12633752	0.8764	0.0000	0/0/0	0.8507										157	11					CNBP (inh=n/a pLI=0.92)
chr3	128887783	128887783	-	A	het	low_DP	QUAL=140;DP=9;AF=0.78;MQM=54;TRIO=HET,9,0.78,WT,1,0.00,HET,5,0.80	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1512dupT:	AluY	rs11401192	0.8157	0.0000	0/0/0	0.5365										38	36					CNBP (inh=n/a pLI=0.92)
chr3	128887862	128887862	A	G	hom	low_DP;low_MQM	QUAL=323;DP=11;AF=1.00;MQM=43;TRIO=HOM,11,1.00,WT,1,0.00,WT,5,0.80	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1434T>C:	AluY	rs6792159	0.9687	0.0000	0/0/0	0.7929										88	8					CNBP (inh=n/a pLI=0.92)
chr3	128890350	128890350	G	A	hom		QUAL=37084;DP=385;AF=1.00;MQM=59;TRIO=HOM,385,1.00,HOM,338,1.00,HOM,409,1.00	CNBP	synonymous	CNBP:NM_001127192.1:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:NM_001127193.1:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:NM_001127194.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_001127195.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_001127196.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_003418.4:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp		rs4303883	0.7572	0.8900	49449/31266/983	0.8873						116955 [CNBP (confirmed) Myotonic dystrophy 2];				974	122					CNBP (inh=n/a pLI=0.92)
chr3	142168331	142168331	C	T	het		QUAL=23422;DP=520;AF=0.43;MQM=60;TRIO=HET,520,0.43,HET,318,0.50,HOM,404,1.00	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln		rs1802904	0.9163	0.8650	45665/23944/4913	0.8579						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079601.6 [other]; 			1811	582	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142178144	142178144	C	T	het		QUAL=10045;DP=396;AF=0.44;MQM=60;TRIO=HET,396,0.44,HET,178,0.48,HET,272,0.44	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.1320	1212/874/28	0.1324	0.0440	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145330.2 [benign]; 		COSM149485	58	623	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142277575	142277575	A	T	het		QUAL=7934;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,172,0.52,HET,220,0.55	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.5980	0.5530	19239/11031/3356	0.5329						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145291.5 [other]; 		COSM149486	848	1159	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142281612	142281612	A	G	het		QUAL=8138;DP=255;AF=0.49;MQM=60;TRIO=HET,255,0.49,HET,163,0.49,HET,202,0.51	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.5520	19098/10972/3300	0.5505	1.2730	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079600.6 [other]; 		COSM149487	847	1157	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	150644247	150644247	C	T	het		QUAL=8586;DP=297;AF=0.52;MQM=59;TRIO=HET,297,0.52,HOM,154,1.00,WT,161,0.01	CLRN1	3'UTR	CLRN1:NM_052995.2:3'UTR:MODIFIER:exon4/4:c.*392G>A:		rs3796239	0.6408	0.0000	0/0/0	0.1015						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				94	103					CLRN1 (inh=n/a pLI=0.00)
chr3	150645351	150645351	G	A	het		QUAL=5156;DP=252;AF=0.43;MQM=60;TRIO=HET,252,0.43,HOM,71,1.00,WT,148,0.00	CLRN1	3'UTR,intron,non_coding_exon	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*372C>T:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*685C>T:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*372C>T:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+501C>T:,CLRN1:NR_046380.2:non_coding_exon:MODIFIER:exon5/5:n.1552C>T:		rs4680058	0.7778	0.5780	2011/520/79	0.1625						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				336	252					CLRN1 (inh=n/a pLI=0.00)
chr3	150645408	150645408	G	A	het		QUAL=5632;DP=241;AF=0.50;MQM=59;TRIO=HET,241,0.50,HOM,77,1.00,WT,125,0.00	CLRN1	3'UTR,intron,non_coding_exon	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*315C>T:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*628C>T:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*315C>T:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+444C>T:,CLRN1:NR_046380.2:non_coding_exon:MODIFIER:exon5/5:n.1495C>T:		rs1456138	0.7768	0.5500	2081/568/90	0.1723						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				337	251					CLRN1 (inh=n/a pLI=0.00)
chr3	150645419	150645420	AC	-	het		QUAL=3375;DP=208;AF=0.50;MQM=59;TRIO=HET,208,0.50,HOM,62,0.94,WT,97,0.07	CLRN1	3'UTR,intron,non_coding_exon	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*303_*304delGT:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*616_*617delGT:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*303_*304delGT:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+432_342+433delGT:,CLRN1:NR_046380.2:non_coding_exon:MODIFIER:exon5/5:n.1483_1484delGT:	(AC)n	rs34027634;rs397897647	0.6300	0.3420	299/94/6	0.0854						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				93	148					CLRN1 (inh=n/a pLI=0.00)
chr3	150661842	150661842	T	G	het		QUAL=9913;DP=419;AF=0.49;MQM=59;TRIO=HET,419,0.49,WT,338,0.00,HET,439,0.42	CLRN1	5'UTR,intron	CLRN1:NM_052995.2:5'UTR:MODIFIER:exon1/4:c.-211A>C:,CLRN1:NM_001195794.1:intron:MODIFIER:exon1/3:c.254-2294A>C:,CLRN1:NM_001256819.1:intron:MODIFIER:exon1/3:c.254-64A>C:,CLRN1:NM_174878.2:intron:MODIFIER:exon1/2:c.254-2294A>C:,CLRN1:NR_046380.2:intron:MODIFIER:exon2/4:n.695+1474A>C:	L2a	rs11914988	0.2720	0.0000	0/0/0	0.0455						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				12	78					CLRN1 (inh=n/a pLI=0.00)
chr3	150690566	150690566	T	C	het		QUAL=28019;DP=422;AF=0.52;MQM=59;TRIO=HET,422,0.52,HOM,471,1.00,HET,601,0.51	CLRN1,CLRN1-AS1	5'UTR,non_coding_exon	CLRN1:NM_001195794.1:5'UTR:MODIFIER:exon1/4:c.-71A>G:,CLRN1:NM_001256819.1:5'UTR:MODIFIER:exon1/4:c.-71A>G:,CLRN1:NM_174878.2:5'UTR:MODIFIER:exon1/3:c.-71A>G:,CLRN1-AS1:NR_024066.1:non_coding_exon:MODIFIER:exon1/6:n.102T>C:,CLRN1:NR_046380.2:non_coding_exon:MODIFIER:exon1/5:n.221A>G:		rs3796240	0.4692	0.5120	15307/9075/649	0.4760										186	269					CLRN1 (inh=n/a pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a)
chr3	155572067	155572067	G	A	het		QUAL=2580;DP=61;AF=0.57;MQM=60;TRIO=HET,61,0.57,HET,136,0.52,WT,175,0.00	SLC33A1	5'UTR	SLC33A1:NM_001190992.1:5'UTR:MODIFIER:exon1/7:c.-281C>T:,SLC33A1:NM_004733.3:5'UTR:MODIFIER:exon1/6:c.-281C>T:		rs560777515	0.0000	0.0000	0/0/0	0.0020										0	3					SLC33A1 (inh=AR+AD pLI=0.10)
chr3	158362391	158362391	C	T	hom		QUAL=10101;DP=156;AF=0.99;MQM=59;TRIO=HOM,156,0.99,HOM,127,1.00,HET,213,0.46	GFM1	5'UTR	GFM1:NM_001308164.1:5'UTR:MODIFIER:exon1/19:c.-33C>T:,GFM1:NM_001308166.1:5'UTR:MODIFIER:exon1/14:c.-33C>T:,GFM1:NM_024996.5:5'UTR:MODIFIER:exon1/18:c.-33C>T:		rs28372852	0.1474	0.1100	379/223/14	0.1041										12	98					GFM1 (inh=n/a pLI=0.00)
chr3	158362441	158362441	T	C	hom		QUAL=11953;DP=230;AF=1.00;MQM=59;TRIO=HOM,230,1.00,HOM,116,1.00,HET,220,0.44	GFM1	synonymous	GFM1:NM_001308164.1:synonymous:LOW:exon1/19:c.18T>C:p.Ala6Ala,GFM1:NM_001308166.1:synonymous:LOW:exon1/14:c.18T>C:p.Ala6Ala,GFM1:NM_024996.5:synonymous:LOW:exon1/18:c.18T>C:p.Ala6Ala		rs1864507	0.5831	0.4940	7683/3873/1112	0.4546						606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1];			COSM3721924	370	518					GFM1 (inh=n/a pLI=0.00)
chr3	158366900	158366900	G	A	hom	phylop_high	QUAL=12890;DP=239;AF=0.99;MQM=60;TRIO=HOM,239,0.99,HOM,115,1.00,HET,140,0.36	GFM1	missense	GFM1:NM_001308164.1:missense:MODERATE:exon5/19:c.643G>A:p.Val215Ile,GFM1:NM_001308166.1:missense:MODERATE:exon5/14:c.643G>A:p.Val215Ile,GFM1:NM_024996.5:missense:MODERATE:exon5/18:c.643G>A:p.Val215Ile		rs2303909	0.5833	0.5470	18614/9501/2707	0.5396	3.3150	T	T,T,T	B,B,B	B,B,B	606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1];			COSM4002505	370	520					GFM1 (inh=n/a pLI=0.00)
chr3	158409262	158409262	C	T	hom		QUAL=17169;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,142,1.00,HET,236,0.48	GFM1	3'UTR	GFM1:NM_001308164.1:3'UTR:MODIFIER:exon19/19:c.*6C>T:,GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*6C>T:		rs1047355	0.4091	0.3660	8751/4710/1822	0.3599										181	513					GFM1 (inh=n/a pLI=0.00)
chr3	158409482	158409482	C	T	hom		QUAL=3311;DP=89;AF=1.00;MQM=60;TRIO=HOM,89,1.00,HOM,7,1.00,HET,6,0.50	GFM1	3'UTR	GFM1:NM_001308164.1:3'UTR:MODIFIER:exon19/19:c.*226C>T:,GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*226C>T:		rs1047366	0.5833	0.0000	0/0/0	0.0903										74	114					GFM1 (inh=n/a pLI=0.00)
chr3	158409708	158409710	TTG	-	hom		QUAL=8403;DP=164;AF=0.99;MQM=59;TRIO=HOM,164,0.99,HOM,78,1.00,HET,90,0.41	GFM1	3'UTR	GFM1:NM_001308164.1:3'UTR:MODIFIER:exon19/19:c.*454_*456delGTT:,GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*454_*456delGTT:		rs367730845	0.1472	0.0000	0/0/0	0.1726										9	78					GFM1 (inh=n/a pLI=0.00)
chr3	158409947	158409947	T	A	hom		QUAL=9752;DP=152;AF=0.99;MQM=60;TRIO=HOM,152,0.99,HOM,96,1.00,HET,134,0.53	GFM1	3'UTR	GFM1:NM_001308164.1:3'UTR:MODIFIER:exon19/19:c.*691T>A:,GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*691T>A:		rs8650	0.4091	0.0000	0/0/0	0.0614										36	107					GFM1 (inh=n/a pLI=0.00)
chr3	182755209	182755209	T	G	hom		QUAL=11069;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HET,202,0.50,HET,245,0.47	MCCC1	missense,intron,non_coding_exon	MCCC1:NM_020166.4:missense:MODERATE:exon13/19:c.1391A>C:p.His464Pro,MCCC1:NM_001293273.1:missense:MODERATE:exon11/17:c.1040A>C:p.His347Pro,MCCC1:NR_120640.1:intron:MODIFIER:exon12/18:n.2044+1605A>C:,MCCC1:NR_120639.1:non_coding_exon:MODIFIER:exon11/16:n.1305A>C:		rs2270968	0.4649	0.6230	25068/17346/404	0.6185	1.1180	T	T,T,T,T,T,T	B,B,B	B,B,B	609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency];	RCV000081992.4 [benign]; 		COSM4002526	653	555					MCCC1 (inh=AR pLI=0.00)
chr3	182790249	182790249	G	A	hom		QUAL=16280;DP=188;AF=1.00;MQM=60;TRIO=HOM,188,1.00,HOM,116,1.00,HOM,201,1.00	MCCC1	synonymous,intron,non_coding_exon	MCCC1:NM_020166.4:synonymous:LOW:exon5/19:c.396C>T:p.Leu132Leu,MCCC1:NM_001293273.1:intron:MODIFIER:exon3/16:c.141-1104C>T:,MCCC1:NR_120640.1:non_coding_exon:MODIFIER:exon5/19:n.1063C>T:,MCCC1:NR_120639.1:non_coding_exon:MODIFIER:exon3/16:n.310C>T:		rs7622479	0.9155	0.9290	52539/28967/3232	0.9073						609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency];	RCV000081994.4 [benign]; 			1156	188					MCCC1 (inh=AR pLI=0.00)
chr3	182817328	182817328	C	G	hom		QUAL=16483;DP=74;AF=0.99;MQM=59;TRIO=HOM,74,0.99,HOM,207,1.00,HOM,268,1.00	MCCC1	5'UTR,non_coding_exon	MCCC1:NM_020166.4:5'UTR:MODIFIER:exon1/19:c.-100G>C:,MCCC1:NM_001293273.1:5'UTR:MODIFIER:exon1/17:c.-192G>C:,MCCC1:NR_120639.1:non_coding_exon:MODIFIER:exon1/16:n.48G>C:		rs937652	0.5449	0.0000	0/0/0	0.1172										175	120					MCCC1 (inh=AR pLI=0.00)
chr3	190023552	190023552	T	C	hom		QUAL=12141;DP=226;AF=0.98;MQM=59;TRIO=HOM,226,0.98,HOM,87,1.00,HET,140,0.52	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2514A>G:		rs8298	0.7212	0.0000	0/0/0	0.1279										83	100					CLDN1 (inh=n/a pLI=0.06)
chr3	190023837	190023837	A	G	hom		QUAL=21492;DP=390;AF=0.99;MQM=60;TRIO=HOM,390,0.99,HOM,177,0.99,HET,249,0.46	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2229T>C:		rs8798	0.7143	0.0000	0/0/0	0.1108										86	100					CLDN1 (inh=n/a pLI=0.06)
chr3	190024057	190024057	C	T	hom		QUAL=34483;DP=644;AF=0.99;MQM=60;TRIO=HOM,644,0.99,HOM,263,0.99,HET,333,0.50	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2009G>A:		rs1364722	0.7005	0.0000	0/0/0	0.1101										86	101					CLDN1 (inh=n/a pLI=0.06)
chr3	190024103	190024103	T	C	hom		QUAL=30764;DP=551;AF=1.00;MQM=59;TRIO=HOM,551,1.00,HOM,249,1.00,HET,296,0.50	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1963A>G:		rs1895708	0.7021	0.0000	0/0/0	0.1101										86	101					CLDN1 (inh=n/a pLI=0.06)
chr3	190024188	190024188	G	A	hom		QUAL=25001;DP=476;AF=1.00;MQM=60;TRIO=HOM,476,1.00,HOM,192,1.00,HET,243,0.47	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1878C>T:		rs2204226	0.6969	0.0000	0/0/0	0.1256										86	101					CLDN1 (inh=n/a pLI=0.06)
chr3	190024457	190024457	A	G	hom		QUAL=37159;DP=555;AF=0.99;MQM=60;TRIO=HOM,555,0.99,HOM,400,1.00,HET,538,0.45	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1609T>C:	MIRc	rs9290928	0.7011	0.0000	0/0/0	0.1107										85	101					CLDN1 (inh=n/a pLI=0.06)
chr3	190024643	190024643	G	T	hom		QUAL=55820;DP=714;AF=0.99;MQM=59;TRIO=HOM,714,0.99,HOM,727,1.00,HET,1010,0.47	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1423C>A:		rs1060680	0.1166	0.0000	0/0/0	0.1515										8	72					CLDN1 (inh=n/a pLI=0.06)
chr3	190025617	190025617	T	A	hom		QUAL=15939;DP=236;AF=0.99;MQM=60;TRIO=HOM,236,0.99,HOM,163,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*449A>T:		rs9825098	0.6975	0.0000	0/0/0	0.0705										85	102					CLDN1 (inh=n/a pLI=0.06)
chr3	190025618	190025618	A	G	hom		QUAL=15939;DP=236;AF=0.99;MQM=60;TRIO=HOM,236,0.99,HOM,163,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*448T>C:		rs9842576	0.6969	0.0000	0/0/0	0.0705										85	102					CLDN1 (inh=n/a pLI=0.06)
chr3	190025805	190025805	G	T	hom		QUAL=9946;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HOM,59,1.00,HET,83,0.51	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*261C>A:		rs1043747	0.7007	0.0000	0/0/0	0.1088										86	101					CLDN1 (inh=n/a pLI=0.06)
chr3	190030680	190030680	A	G	hom		QUAL=16519;DP=131;AF=1.00;MQM=60;TRIO=HOM,131,1.00,HOM,173,1.00,HOM,236,1.00	CLDN1	synonymous	CLDN1:NM_021101.4:synonymous:LOW:exon2/4:c.369T>C:p.Gly123Gly		rs9869263	0.8111	0.8330	42235/24128/3079	0.8177						603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis];	RCV000175932.1 [benign]; 			806	277					CLDN1 (inh=n/a pLI=0.06)
chr3	190040008	190040008	C	G	het		QUAL=4694;DP=196;AF=0.45;MQM=59;TRIO=HET,196,0.45,HET,222,0.54,WT,290,0.00	CLDN1	5'UTR	CLDN1:NM_021101.4:5'UTR:MODIFIER:exon1/4:c.-13G>C:		rs17429833	0.0509	0.0650	311/223/7	0.0644										3	64					CLDN1 (inh=n/a pLI=0.06)
chr3	190040207	190040207	C	A	het		QUAL=5053;DP=283;AF=0.55;MQM=60;TRIO=HET,283,0.55,HOM,38,1.00,HET,61,0.52	CLDN1	5'UTR	CLDN1:NM_021101.4:5'UTR:MODIFIER:exon1/4:c.-212G>T:		rs12696600	0.6625	0.0000	0/0/0	0.0900										48	113					CLDN1 (inh=n/a pLI=0.06)
chr3	193355074	193355074	T	C	hom		QUAL=10928;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HET,105,0.42,HOM,149,0.99	OPA1	splice_region&intron	OPA1:NM_130837.2:splice_region&intron:LOW:exon10/30:c.1035+4T>C:,OPA1:NM_015560.2:splice_region&intron:LOW:exon8/28:c.870+4T>C:,OPA1:NM_130831.2:splice_region&intron:LOW:exon7/27:c.762+4T>C:,OPA1:NM_130832.2:splice_region&intron:LOW:exon8/28:c.816+4T>C:,OPA1:NM_130833.2:splice_region&intron:LOW:exon8/28:c.873+4T>C:,OPA1:NM_130834.2:splice_region&intron:LOW:exon9/29:c.924+4T>C:,OPA1:NM_130835.2:splice_region&intron:LOW:exon9/29:c.927+4T>C:,OPA1:NM_130836.2:splice_region&intron:LOW:exon9/29:c.981+4T>C:		rs166850	0.9229	0.8720	46256/23201/4866	0.8351						605290 [OPA1 (confirmed) Optic atrophy 1|Glaucoma,normal tension,susceptibility to|Optic atrophy plus syndrome];	RCV000081773.6 [benign]; 			1928	727					OPA1 (inh=AR+AD pLI=0.99)
chr3	193412672	193412672	A	G	het		QUAL=12970;DP=327;AF=0.54;MQM=60;TRIO=HET,327,0.54,WT,233,0.01,HOM,252,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*283A>G:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*283A>G:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:		rs1061648	0.6412	0.0000	0/0/0	0.6289										96	100					OPA1 (inh=AR+AD pLI=0.99)
chr3	193412949	193412949	T	C	hom		QUAL=20036;DP=335;AF=0.99;MQM=60;TRIO=HOM,335,0.99,HET,187,0.50,HOM,192,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*560T>C:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*560T>C:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:		rs7643844	0.9137	0.0000	0/0/0	0.8036										166	58					OPA1 (inh=AR+AD pLI=0.99)
chr3	193413502	193413502	C	T	het		QUAL=8562;DP=277;AF=0.53;MQM=60;TRIO=HET,277,0.53,WT,127,0.00,HOM,135,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*1113C>T:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*1113C>T:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:		rs12630	0.5958	0.0000	0/0/0	0.5632										71	99					OPA1 (inh=AR+AD pLI=0.99)
chr3	193413732	193413732	A	G	het		QUAL=13276;DP=339;AF=0.51;MQM=60;TRIO=HET,339,0.51,WT,215,0.00,HOM,263,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*1343A>G:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*1343A>G:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:		rs1056366	0.6963	0.0000	0/0/0	0.6478										97	99					OPA1 (inh=AR+AD pLI=0.99)
chr3	196769762	196769762	-	T	hom		QUAL=13796;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HOM,116,1.00,HOM,100,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1731dupA:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1731dupA:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1731dupA:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1731dupA:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1731dupA:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1731dupA:		rs386399009	0.0000	0.0000	0/0/0	0.5299										125	93					DLG1 (inh=n/a pLI=1.00)
chr3	196769797	196769797	A	G	hom		QUAL=15370;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,103,1.00,HOM,103,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1697T>C:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1697T>C:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1697T>C:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1697T>C:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1697T>C:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1697T>C:		rs7753	0.6174	0.0000	0/0/0	0.1279										89	107					DLG1 (inh=n/a pLI=1.00)
chr3	196769982	196769982	C	G	het		QUAL=11418;DP=366;AF=0.48;MQM=60;TRIO=HET,366,0.48,HOM,131,1.00,HET,178,0.50	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1512G>C:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1512G>C:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1512G>C:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1512G>C:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1512G>C:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1512G>C:		rs7641	0.3636	0.0000	0/0/0	0.0708										37	108					DLG1 (inh=n/a pLI=1.00)
chr3	196770356	196770359	AAGG	-	hom		QUAL=9507;DP=165;AF=0.99;MQM=59;TRIO=HOM,165,0.99,HOM,69,1.00,HOM,103,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1135_*1138delCCTT:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1135_*1138delCCTT:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1135_*1138delCCTT:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:		rs569151903	0.7562	0.0000	0/0/0	0.6613										117	96					DLG1 (inh=n/a pLI=1.00)
chr3	196771245	196771245	G	A	hom		QUAL=34015;DP=501;AF=1.00;MQM=59;TRIO=HOM,501,1.00,HOM,257,1.00,HOM,280,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*249C>T:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*249C>T:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*249C>T:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*249C>T:		rs4916600	0.7478	0.0000	0/0/0	0.1279										124	93					DLG1 (inh=n/a pLI=1.00)
chr3	196865242	196865242	C	T	het	phylop_high;pred_pathogenic_2;anno_pathogenic_hgmd	QUAL=2528;DP=146;AF=0.46;MQM=60;TRIO=HET,146,0.46,WT,55,0.00,HET,72,0.54	DLG1	missense	DLG1:NM_004087.2:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:NM_001204387.1:missense:MODERATE:exon5/22:c.485G>A:p.Arg162Gln,DLG1:NM_001204388.1:missense:MODERATE:exon5/21:c.485G>A:p.Arg162Gln,DLG1:NM_001098424.1:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:NM_001204386.1:missense:MODERATE:exon9/25:c.734G>A:p.Arg245Gln,DLG1:NM_001290983.1:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln		rs1134986	0.1280	0.1550	1948/737/4	0.1493	7.4450	T	T,T,T,T,T,T,T,T,T,T,T,T,T	P,P,D,D,D,P,D	B,B,D,D,D,P,D			CM146495 [CLASS=DM? MUT=ALT PHEN="Crohn's disease susceptibility to" GENE=DLG1]; 		23	198					DLG1 (inh=n/a pLI=1.00)
chr4	1807894	1807894	G	A	hom		QUAL=33835;DP=132;AF=0.99;MQM=59;TRIO=HOM,132,0.99,HOM,410,1.00,HOM,568,1.00	FGFR3	synonymous	FGFR3:NM_001163213.1:synonymous:LOW:exon14/18:c.1959G>A:p.Thr653Thr,FGFR3:NM_000142.4:synonymous:LOW:exon14/18:c.1953G>A:p.Thr651Thr,FGFR3:NM_022965.3:synonymous:LOW:exon12/16:c.1617G>A:p.Thr539Thr		rs7688609	0.9561	0.9870	58288/32669/3762	0.9484						134934 [FGFR3 (confirmed) Achondroplasia|Hypochondroplasia|Thanatophoric dysplasia,type I|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Bladder cancer,somatic|Colorectal cancer,somatic|Cervical cancer,somatic|LADD syndrome|CATSHL syndrome|Nevus,epidermal,somatic|Thanatophoric dysplasia,type II|Spermatocytic seminoma,somatic|SADDAN];				1165	5					FGFR3 (inh=AR+AD pLI=0.00)
chr4	1809128	1809129	GT	-	hom		QUAL=6769;DP=61;AF=0.87;MQM=59;TRIO=HOM,61,0.87,HOM,87,0.99,HOM,108,0.96	FGFR3	3'UTR	FGFR3:NM_001163213.1:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:NM_000142.4:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:NM_022965.3:3'UTR:MODIFIER:exon16/16:c.*156_*157delTG:	(TG)n	rs34562534;rs796200908	0.0000	0.7530	1890/694/149	0.2460									COSN504966, COSN504965	407	18					FGFR3 (inh=AR+AD pLI=0.00)
chr4	1809787	1809787	C	T	hom		QUAL=9298;DP=166;AF=0.99;MQM=59;TRIO=HOM,166,0.99,HOM,70,0.99,HOM,85,1.00	FGFR3	3'UTR	FGFR3:NM_001163213.1:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:NM_000142.4:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:NM_022965.3:3'UTR:MODIFIER:exon16/16:c.*798C>T:		rs3135904	0.8982	0.0000	0/0/0	0.1480										299	5					FGFR3 (inh=AR+AD pLI=0.00)
chr4	1981229	1981229	G	T	het		QUAL=6389;DP=262;AF=0.52;MQM=59;TRIO=HET,262,0.52,HET,237,0.48,WT,288,0.00	WHSC1	3'UTR	WHSC1:NM_001042424.2:3'UTR:MODIFIER:exon22/22:c.*593G>T:,WHSC1:NM_133330.2:3'UTR:MODIFIER:exon24/24:c.*593G>T:,WHSC1:NM_133331.2:3'UTR:MODIFIER:exon23/23:c.*593G>T:,WHSC1:NM_133335.3:3'UTR:MODIFIER:exon22/22:c.*593G>T:		rs73202837	0.0443	0.0000	0/0/0	0.0088										0	21					WHSC1 (inh=n/a pLI=1.00)
chr4	3475252	3475252	T	C	hom		QUAL=7670;DP=62;AF=1.00;MQM=60;TRIO=HOM,62,1.00,HOM,60,1.00,HOM,134,1.00	DOK7	synonymous	DOK7:NM_001301071.1:synonymous:LOW:exon3/10:c.220T>C:p.Leu74Leu,DOK7:NM_001164673.1:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu,DOK7:NM_173660.4:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu		rs4325970	1.0000	1.0000	59627/32806/4807	0.9315						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];	RCV000177424.1 [benign]; 			1108	0					DOK7 (inh=n/a pLI=0.00)
chr4	3494600	3494600	A	G	hom	phylop_high	QUAL=6715;DP=89;AF=0.99;MQM=60;TRIO=HOM,89,0.99,HET,157,0.52,HET,206,0.47	DOK7	missense,5'UTR,3'UTR	DOK7:NM_001301071.1:missense:MODERATE:exon7/10:c.887A>G:p.Gln296Arg,DOK7:NM_173660.4:missense:MODERATE:exon7/7:c.887A>G:p.Gln296Arg,DOK7:NM_001256896.1:5'UTR:MODIFIER:exon4/4:c.-44A>G:,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*108A>G:		rs6811423	0.2181	0.2180	2920/1258/10	0.2118	1.6510	T	T,T	P,B	B,B	610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];	RCV000116896.2 [benign]; 		COSM4159034, COSM447809	54	327					DOK7 (inh=n/a pLI=0.00)
chr4	3494826	3494826	A	C	hom		QUAL=1332;DP=23;AF=1.00;MQM=59;TRIO=HOM,23,1.00,HET,35,0.40,HET,41,0.46	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1113A>C:p.Ser371Ser,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1113A>C:p.Ser371Ser,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.183A>C:p.Ser61Ser,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*334A>C:		rs6811856	0.2169	0.1980	1576/709/9	0.1929						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];	RCV000116884.2 [benign]; 		COSM3760590, COSM3760589	53	315					DOK7 (inh=n/a pLI=0.00)
chr4	3494847	3494847	G	A	hom		QUAL=1186;DP=28;AF=0.89;MQM=59;TRIO=HOM,28,0.89,HET,28,0.54,HET,36,0.44	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1134G>A:p.Ala378Ala,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1134G>A:p.Ala378Ala,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.204G>A:p.Ala68Ala,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*355G>A:		rs6831659	0.2149	0.1980	1923/822/10	0.1844						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];	RCV000116885.2 [benign]; 		COSM3749873, COSM3749874	51	307					DOK7 (inh=n/a pLI=0.00)
chr4	3494898	3494898	C	T	hom		QUAL=2130;DP=53;AF=0.98;MQM=59;TRIO=HOM,53,0.98,HET,25,0.56,HET,36,0.44	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1185C>T:p.Tyr395Tyr,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1185C>T:p.Tyr395Tyr,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.255C>T:p.Tyr85Tyr,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*406C>T:		rs6850908	0.2196	0.2180	2979/1280/14	0.2119						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];	RCV000116887.2 [benign]; 		COSM3760591, COSM447810	52	321					DOK7 (inh=n/a pLI=0.00)
chr4	3495446	3495446	C	T	hom		QUAL=10481;DP=114;AF=0.97;MQM=59;TRIO=HOM,114,0.97,HET,153,0.42,HOM,186,0.99	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*954C>T:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*218C>T:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*218C>T:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+236C>T:		rs10022432	0.6342	0.0000	0/0/0	0.1053						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];				85	108					DOK7 (inh=n/a pLI=0.00)
chr4	3495477	3495477	T	C	hom		QUAL=16894;DP=139;AF=0.99;MQM=59;TRIO=HOM,139,0.99,HOM,178,1.00,HOM,228,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*985T>C:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*249T>C:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*249T>C:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+267T>C:		rs2858030	0.7406	0.0000	0/0/0	0.1244						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];				125	89					DOK7 (inh=n/a pLI=0.00)
chr4	3495941	3495941	T	C	hom		QUAL=5213;DP=91;AF=0.99;MQM=59;TRIO=HOM,91,0.99,HET,93,0.43,HET,116,0.51	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1449T>C:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*713T>C:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*713T>C:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+731T>C:		rs1054661	0.4367	0.0000	0/0/0	0.0737						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];				42	105					DOK7 (inh=n/a pLI=0.00)
chr4	3496150	3496150	A	G	hom		QUAL=23183;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HET,291,0.44,HOM,378,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1658A>G:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*922A>G:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*922A>G:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+940A>G:		rs1054662	0.6554	0.0000	0/0/0	0.1072						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];				85	108					DOK7 (inh=n/a pLI=0.00)
chr4	3496205	3496205	C	T	hom		QUAL=23217;DP=160;AF=0.99;MQM=60;TRIO=HOM,160,0.99,HOM,263,1.00,HOM,329,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1713C>T:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*977C>T:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*977C>T:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+995C>T:		rs2105849	0.7390	0.0000	0/0/0	0.1248						610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10|Fetal akinesia deformation sequence];				124	89					DOK7 (inh=n/a pLI=0.00)
chr4	5564191	5564191	A	T	hom		QUAL=15522;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,105,1.00,HOM,126,1.00	EVC2	3'UTR	EVC2:NM_147127.4:3'UTR:MODIFIER:exon22/22:c.*384T>A:,EVC2:NM_001166136.1:3'UTR:MODIFIER:exon22/22:c.*384T>A:		rs2287576	0.5409	0.0000	0/0/0	0.1243										119	76					EVC2 (inh=AR+AD pLI=0.00)
chr4	5570221	5570221	G	A	het		QUAL=4952;DP=86;AF=0.50;MQM=60;TRIO=HET,86,0.50,HET,62,0.48,HOM,106,1.00	EVC2	synonymous	EVC2:NM_147127.4:synonymous:LOW:exon20/22:c.3507C>T:p.His1169His,EVC2:NM_001166136.1:synonymous:LOW:exon20/22:c.3267C>T:p.His1089His		rs12511039	0.4409	0.3620	7484/2238/122	0.3517						607261 [EVC2 (confirmed) Ellis-van Creveld syndrome|Weyers acrofacial dysostosis];	RCV000176126.1 [benign]; 		COSM3760662, COSM330193	145	469					EVC2 (inh=AR+AD pLI=0.00)
chr4	5710647	5710647	A	G	het		QUAL=4383;DP=113;AF=0.50;MQM=60;TRIO=HET,113,0.50,WT,193,0.02,HET,244,0.49	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-104T>C:		rs2013183	0.3800	0.0000	0/0/0	0.4226										51	106					EVC2 (inh=AR+AD pLI=0.00)
chr4	5710856	5710856	G	A	het		QUAL=740;DP=52;AF=0.50;MQM=60;TRIO=HET,52,0.50,HET,17,0.59,WT,40,0.00	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-313C>T:		rs3755842	0.2133	0.0000	0/0/0	0.2197										17	81					EVC2 (inh=AR+AD pLI=0.00)
chr4	5710988	5710990	AGG	-	het		QUAL=562;DP=70;AF=0.41;MQM=59;TRIO=HET,70,0.41,HET,21,0.38,WT,31,0.00	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-447_-445delCCT:	(AGG)n	rs772310935	0.2274	0.0000	0/0/0	0.2273										19	83					EVC2 (inh=AR+AD pLI=0.00)
chr4	5711095	5711095	G	A	het		QUAL=3299;DP=109;AF=0.50;MQM=59;TRIO=HET,109,0.50,HET,97,0.46,HET,107,0.49	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-552C>T:		rs10000314	0.4625	0.0000	0/0/0	0.4627										58	93					EVC2 (inh=AR+AD pLI=0.00)
chr4	5721049	5721049	A	G	het		QUAL=9743;DP=307;AF=0.45;MQM=60;TRIO=HET,307,0.45,WT,404,0.00,HET,469,0.50	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon2/21:c.249A>G:p.Ser83Ser,EVC:NM_001306092.1:synonymous:LOW:exon2/12:c.249A>G:p.Ser83Ser,EVC:NM_001306090.1:synonymous:LOW:exon2/21:c.249A>G:p.Ser83Ser		rs35870680	0.0695	0.1150	1009/753/5	0.1136						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];			COSM3760673	32	293					EVC (inh=AR+AD pLI=0.00)
chr4	5743509	5743509	C	T	hom		QUAL=14833;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HOM,83,1.00,HOM,130,1.00	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon6/21:c.769C>T:p.Leu257Leu,EVC:NM_001306092.1:synonymous:LOW:exon6/12:c.769C>T:p.Leu257Leu,EVC:NM_001306090.1:synonymous:LOW:exon6/21:c.769C>T:p.Leu257Leu		rs6446393	0.9667	0.9450	54081/29003/5020	0.9106						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];	RCV000179557.1 [benign]; 			953	150					EVC (inh=AR+AD pLI=0.00)
chr4	5743512	5743512	T	C	hom	phylop_high	QUAL=14833;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HET,83,1.00,HET,130,1.00	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon6/21:c.772T>C:p.Tyr258His,EVC:NM_001306092.1:missense:MODERATE:exon6/12:c.772T>C:p.Tyr258His,EVC:NM_001306090.1:missense:MODERATE:exon6/21:c.772T>C:p.Tyr258His		rs6414624	0.7448	0.7940	38535/21387/1423	0.7752	1.9260	T	T,T,T	B	B	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];	RCV000179558.1 [benign]; 			649	394					EVC (inh=AR+AD pLI=0.00)
chr4	5747072	5747072	C	T	het		QUAL=1445;DP=35;AF=0.60;MQM=60;TRIO=HET,35,0.60,HOM,24,0.96,HET,32,0.34	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon7/20:c.939+4C>T:,EVC:NM_001306092.1:splice_region&intron:LOW:exon7/11:c.939+4C>T:,EVC:NM_001306090.1:splice_region&intron:LOW:exon7/20:c.939+4C>T:		rs2286343	0.4093	0.3730	9048/3301/402	0.3654						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				144	474					EVC (inh=AR+AD pLI=0.00)
chr4	5747078	5747078	A	G	het		QUAL=755;DP=33;AF=0.39;MQM=60;TRIO=HET,33,0.39,WT,22,0.05,HET,30,0.67	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon7/20:c.939+10A>G:,EVC:NM_001306092.1:splice_region&intron:LOW:exon7/11:c.939+10A>G:,EVC:NM_001306090.1:splice_region&intron:LOW:exon7/20:c.939+10A>G:		rs2286342	0.5931	0.6290	24638/15565/2662	0.6164						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				491	473					EVC (inh=AR+AD pLI=0.00)
chr4	5750003	5750003	A	G	het		QUAL=6951;DP=251;AF=0.54;MQM=60;TRIO=HET,251,0.54,WT,175,0.00,HET,217,0.59	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon8/21:c.1068A>G:p.Leu356Leu,EVC:NM_001306092.1:synonymous:LOW:exon8/12:c.1068A>G:p.Leu356Leu,EVC:NM_001306090.1:synonymous:LOW:exon8/21:c.1068A>G:p.Leu356Leu		rs33929747	0.2175	0.2920	5696/4231/69	0.2904						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				141	471					EVC (inh=AR+AD pLI=0.00)
chr4	5755542	5755542	C	A	het		QUAL=18364;DP=164;AF=0.55;MQM=60;TRIO=HET,164,0.55,HET,287,0.54,HOM,383,1.00	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon10/21:c.1346C>A:p.Thr449Lys,EVC:NM_001306092.1:missense:MODERATE:exon10/12:c.1346C>A:p.Thr449Lys,EVC:NM_001306090.1:missense:MODERATE:exon10/21:c.1346C>A:p.Thr449Lys		rs2302075	0.8446	0.7960	38777/20992/4783	0.7919	0.3130	T	T,T,T	B	B	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];	RCV000153204.3 [benign]; 			681	363					EVC (inh=AR+AD pLI=0.00)
chr4	5785442	5785442	G	A	hom	phylop_high;pred_pathogenic_2	QUAL=9497;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HET,198,0.48,HET,226,0.54	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon12/21:c.1727G>A:p.Arg576Gln,EVC:NM_001306090.1:missense:MODERATE:exon12/21:c.1727G>A:p.Arg576Gln		rs1383180	0.3015	0.3390	7250/4461/210	0.3393	4.5440	T	T,T	D	D	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];			COSM3760684	155	525					EVC (inh=AR+AD pLI=0.00)
chr4	5803669	5803669	T	C	het		QUAL=2986;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,HOM,45,1.00,HET,53,0.47	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon15/20:c.2305-8T>C:,EVC:NM_001306090.1:splice_region&intron:LOW:exon15/20:c.2305-8T>C:		rs1031919	0.6905	0.7230	31597/17587/2630	0.7074						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				565	449					EVC (inh=AR+AD pLI=0.00)
chr4	5812778	5812778	G	A	het		QUAL=15841;DP=250;AF=0.47;MQM=60;TRIO=HET,250,0.47,HOM,275,1.00,HET,341,0.48	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*14G>A:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*14G>A:		rs2291151	0.5337	0.5750	18375/10766/1831	0.5634									COSN167150	171	276					EVC (inh=AR+AD pLI=0.00)
chr4	5812974	5812974	C	A	het		QUAL=6853;DP=374;AF=0.48;MQM=60;TRIO=HET,374,0.48,HET,204,0.42,WT,339,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*210C>A:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*210C>A:		rs16837692	0.0885	0.0000	0/0/0	0.0187										2	47					EVC (inh=AR+AD pLI=0.00)
chr4	5813695	5813695	T	C	het		QUAL=36965;DP=492;AF=0.54;MQM=59;TRIO=HET,492,0.54,HOM,672,1.00,HET,792,0.51	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*931T>C:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*931T>C:		rs6840435	0.4369	0.0000	0/0/0	0.4527										51	122					EVC (inh=AR+AD pLI=0.00)
chr4	5813824	5813824	A	C	het		QUAL=6300;DP=385;AF=0.23;MQM=53;TRIO=HET,385,0.23,HET,656,0.42,WT,1032,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1060A>C:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*1060A>C:		rs71599848	0.1168	0.0000	0/0/0	0.0786										1	53					EVC (inh=AR+AD pLI=0.00)
chr4	5813876	5813876	T	C	het		QUAL=5959;DP=330;AF=0.14;MQM=53;TRIO=HET,330,0.14,HET,515,0.51,WT,741,0.03	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1112T>C:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*1112T>C:		rs28460555	0.0000	0.0000	0/0/0	0.0320										4	78					EVC (inh=AR+AD pLI=0.00)
chr4	5813887	5813887	A	G	het		QUAL=7656;DP=424;AF=0.23;MQM=53;TRIO=HET,424,0.23,HET,575,0.50,WT,814,0.03	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1123A>G:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*1123A>G:		rs112378896	0.0000	0.0000	0/0/0	0.0178										1	53					EVC (inh=AR+AD pLI=0.00)
chr4	5814608	5814608	T	-	het		QUAL=20065;DP=401;AF=0.47;MQM=59;TRIO=HET,401,0.47,HOM,344,1.00,HET,462,0.47	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1845delT:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*1845delT:		rs397690241	0.3748	0.0000	0/0/0	0.3828										35	117					EVC (inh=AR+AD pLI=0.00)
chr4	5815181	5815181	T	C	het		QUAL=4595;DP=213;AF=0.46;MQM=59;TRIO=HET,213,0.46,HOM,42,0.90,HET,59,0.37	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2417T>C:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*2417T>C:	AluSx3	rs6848370	0.7230	0.0000	0/0/0	0.6730										110	105					EVC (inh=AR+AD pLI=0.00)
chr4	5815381	5815381	G	A	het		QUAL=9630;DP=213;AF=0.39;MQM=60;TRIO=HET,213,0.39,HOM,147,1.00,HET,239,0.49	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2617G>A:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*2617G>A:	L3	rs3733186	0.3876	0.0000	0/0/0	0.0698										35	121					EVC (inh=AR+AD pLI=0.00)
chr4	5815444	5815444	G	A	het		QUAL=2988;DP=191;AF=0.46;MQM=59;TRIO=HET,191,0.46,HET,118,0.47,WT,200,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2680G>A:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*2680G>A:		rs3733187	0.0745	0.0000	0/0/0	0.1104										2	52					EVC (inh=AR+AD pLI=0.00)
chr4	5815477	5815477	C	T	het		QUAL=9549;DP=200;AF=0.51;MQM=59;TRIO=HET,200,0.51,HOM,136,1.00,HET,193,0.52	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2713C>T:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*2713C>T:		rs3733188	0.3852	0.0000	0/0/0	0.4090										35	120					EVC (inh=AR+AD pLI=0.00)
chr4	5815635	5815635	C	T	het		QUAL=6422;DP=282;AF=0.47;MQM=59;TRIO=HET,282,0.47,HET,289,0.46,WT,321,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2871C>T:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*2871C>T:		rs3733189	0.0731	0.0000	0/0/0	0.0189										2	52					EVC (inh=AR+AD pLI=0.00)
chr4	5815929	5815929	T	C	het		QUAL=7936;DP=250;AF=0.48;MQM=60;TRIO=HET,250,0.48,HET,401,0.48,WT,495,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*3165T>C:,EVC:NM_001306090.1:3'UTR:MODIFIER:exon21/21:c.*3165T>C:	LTR89	rs3755847	0.0815	0.0000	0/0/0	0.0194										2	52					EVC (inh=AR+AD pLI=0.00)
chr4	6292915	6292915	A	G	het		QUAL=3047;DP=68;AF=0.43;MQM=59;TRIO=HET,68,0.43,HET,204,0.50,WT,246,0.00	WFS1	splice_region&intron	WFS1:NM_001145853.1:splice_region&intron:LOW:exon4/7:c.461-9A>G:,WFS1:NM_006005.3:splice_region&intron:LOW:exon4/7:c.461-9A>G:		rs10010131	0.7288	0.6550	26281/11622/2223	0.6374						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000004785.4 [other]; RCV000038664.6 [other]; 			917	1098					WFS1 (inh=AR+AD pLI=n/a)
chr4	6293696	6293696	C	G	het		QUAL=2363;DP=58;AF=0.50;MQM=59;TRIO=HET,58,0.50,HOM,52,1.00,WT,67,0.04	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg,WFS1:NM_006005.3:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg		rs1801213	0.7564	0.7030	28093/13548/2082	0.6613	-0.0970	T				606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038665.6 [other]; 		COSM448012	1157	983					WFS1 (inh=AR+AD pLI=n/a)
chr4	6302519	6302519	G	A	het	phylop_high	QUAL=21813;DP=394;AF=0.51;MQM=60;TRIO=HET,394,0.51,HOM,524,0.99,WT,661,0.00	WFS1	missense	WFS1:NM_001145853.1:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile,WFS1:NM_006005.3:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile		rs1801212	0.8844	0.7820	37650/17117/4752	0.7624	3.7380	T	T,T	B	B	606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038668.7 [benign]; RCV000155337.1 [benign]; 	CM115388 [CLASS=DFP MUT=ALT PHEN="Wolframin variant" GENE=WFS1]; 		1343	890					WFS1 (inh=AR+AD pLI=n/a)
chr4	6302707	6302707	C	T	het		QUAL=9445;DP=280;AF=0.51;MQM=60;TRIO=HET,280,0.51,HET,442,0.53,WT,561,0.00	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val		rs1801206	0.6416	0.6240	24439/11648/1139	0.6086						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038635.9 [other]; 	CM021362 [CLASS=DP MUT=REF PHEN="Diabetes type 1 association with" GENE=WFS1]; 		861	1119					WFS1 (inh=AR+AD pLI=n/a)
chr4	6303022	6303022	C	T	het		QUAL=7238;DP=225;AF=0.49;MQM=60;TRIO=HET,225,0.49,HET,321,0.53,WT,344,0.01	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn		rs1801214	0.7294	0.6590	26970/12016/2381	0.6406						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038641.9 [other]; 			912	1105					WFS1 (inh=AR+AD pLI=n/a)
chr4	6303354	6303354	G	A	het	phylop_high	QUAL=4679;DP=265;AF=0.48;MQM=60;TRIO=HET,265,0.48,HET,143,0.50,WT,201,0.00	WFS1	missense	WFS1:NM_001145853.1:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His,WFS1:NM_006005.3:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His		rs734312	0.4692	0.5360	18996/9719/74	0.5341	4.7040	T	T,T	B	B	606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038646.9 [other]; 	CM000447 [CLASS=DP MUT=REF PHEN="Diabetes type 1 association with" GENE=WFS1]; 	COSM149634	690	1150					WFS1 (inh=AR+AD pLI=n/a)
chr4	6303955	6303955	G	A	het		QUAL=5440;DP=196;AF=0.49;MQM=59;TRIO=HET,196,0.49,HET,251,0.50,WT,319,0.00	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys		rs1046314	0.6532	0.6260	24206/11393/1309	0.6091						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038659.9 [other]; 	CM021365 [CLASS=DP MUT=REF PHEN="Diabetes type 1 association with" GENE=WFS1]; 	COSM3760688	860	1133					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304087	6304087	A	G	het		QUAL=9970;DP=210;AF=0.50;MQM=60;TRIO=HET,210,0.50,HOM,247,1.00,WT,292,0.01	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser		rs1046316	0.7800	0.7210	31745/15023/2981	0.6852						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038660.9 [other]; 	CM021366 [CLASS=DP MUT=REF PHEN="Diabetes type 1 association with" GENE=WFS1]; 	COSM448013	1181	980					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304242	6304242	T	C	het		QUAL=13842;DP=179;AF=0.59;MQM=59;TRIO=HET,179,0.59,HOM,359,1.00,WT,477,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*47T>C:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*47T>C:		rs1046317	0.7837	0.7200	30808/14412/2933	0.6888								CR1510534 [CLASS=DP MUT=REF PHEN="Diabetes type 2 association with" GENE=WFS1]; 		155	127					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304286	6304286	C	T	het		QUAL=13815;DP=224;AF=0.60;MQM=60;TRIO=HET,224,0.60,HOM,388,1.00,WT,525,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*91C>T:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*91C>T:		rs1046319	0.8480	0.0000	0/0/0	0.1621										118	81					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304344	6304344	G	A	het		QUAL=10458;DP=251;AF=0.54;MQM=60;TRIO=HET,251,0.54,HET,521,0.51,WT,678,0.00	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*149G>A:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*149G>A:		rs1046320	0.6066	0.0000	0/0/0	0.5593										76	97					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304762	6304762	C	G	het		QUAL=4725;DP=191;AF=0.49;MQM=60;TRIO=HET,191,0.49,WT,141,0.00,HET,159,0.57	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*567C>G:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*567C>G:		rs12508118	0.0114	0.0000	0/0/0	0.0257										2	16					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304799	6304799	G	C	het		QUAL=4113;DP=192;AF=0.47;MQM=59;TRIO=HET,192,0.47,HET,126,0.53,WT,148,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*604G>C:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*604G>C:		rs9457	0.6262	0.0000	0/0/0	0.5428										77	93					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304878	6304878	C	T	het		QUAL=3660;DP=187;AF=0.55;MQM=60;TRIO=HET,187,0.55,HET,134,0.47,WT,179,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*683C>T:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*683C>T:		rs3200	0.6476	0.0000	0/0/0	0.5333										78	96					WFS1 (inh=AR+AD pLI=n/a)
chr4	15568992	15568992	T	C	hom		QUAL=19703;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HOM,232,1.00,HET,327,0.53	CC2D2A	splice_region&intron	CC2D2A:NM_001080522.2:splice_region&intron:LOW:exon25/37:c.3183-8T>C:		rs13121363	0.6625	0.7060	30227/17461/1967	0.6940						612013 [CC2D2A (confirmed) Joubert syndrome 9|Meckel syndrome 6|COACH syndrome];	RCV000114172.2 [likely benign]; 			1163	870					CC2D2A (inh=AR pLI=0.00)
chr4	15603069	15603069	G	C	hom		QUAL=21251;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,229,1.00,HET,296,0.46	CC2D2A	3'UTR	CC2D2A:NM_001080522.2:3'UTR:MODIFIER:exon38/38:c.*21G>C:		rs1134634	0.5669	0.5250	7077/4110/793	0.4890										484	594					CC2D2A (inh=AR pLI=0.00)
chr4	17488064	17488064	T	C	hom		QUAL=31275;DP=285;AF=1.00;MQM=60;TRIO=HOM,285,1.00,HOM,305,1.00,HOM,362,0.99	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*690A>G:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*690A>G:		rs1031326	0.6260	0.0000	0/0/0	0.6319										89	98					QDPR (inh=n/a pLI=0.07)
chr4	17488072	17488072	T	C	hom		QUAL=33779;DP=341;AF=1.00;MQM=59;TRIO=HOM,341,1.00,HOM,313,0.99,HOM,374,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*682A>G:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*682A>G:		rs699459	0.6595	0.0000	0/0/0	0.6743										104	91					QDPR (inh=n/a pLI=0.07)
chr4	17488132	17488132	A	G	hom		QUAL=19115;DP=355;AF=0.99;MQM=60;TRIO=HOM,355,0.99,HET,272,0.46,HET,355,0.45	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*622T>C:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*622T>C:		rs10604	0.2324	0.0000	0/0/0	0.0550										30	93					QDPR (inh=n/a pLI=0.07)
chr4	17488244	17488244	G	A	hom		QUAL=20107;DP=300;AF=1.00;MQM=60;TRIO=HOM,300,1.00,HOM,147,0.99,HOM,174,0.99	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*510C>T:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*510C>T:		rs1031327	0.6585	0.0000	0/0/0	0.1147										104	92					QDPR (inh=n/a pLI=0.07)
chr4	17488286	17488286	T	G	hom		QUAL=17438;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,135,0.99,HOM,154,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*468A>C:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*468A>C:		rs699460	0.6591	0.0000	0/0/0	0.1148										104	92					QDPR (inh=n/a pLI=0.07)
chr4	17488508	17488508	C	-	hom		QUAL=23517;DP=455;AF=0.98;MQM=59;TRIO=HOM,455,0.98,HET,356,0.51,HET,461,0.46	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*246delG:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*246delG:		rs71810044	0.1877	0.0000	0/0/0	0.2355										22	92					QDPR (inh=n/a pLI=0.07)
chr4	17488533	17488533	C	T	hom		QUAL=38687;DP=436;AF=1.00;MQM=59;TRIO=HOM,436,1.00,HOM,328,1.00,HOM,428,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*221G>A:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*221G>A:		rs1049582	0.6589	0.0000	0/0/0	0.5265										103	93					QDPR (inh=n/a pLI=0.07)
chr4	17488534	17488534	A	G	hom		QUAL=38687;DP=436;AF=1.00;MQM=59;TRIO=HOM,436,1.00,HOM,328,1.00,HOM,428,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*220T>C:,QDPR:NM_001306140.1:3'UTR:MODIFIER:exon6/6:c.*220T>C:		rs1049581	0.6593	0.0000	0/0/0	0.0896										103	93					QDPR (inh=n/a pLI=0.07)
chr4	17503382	17503382	C	T	hom		QUAL=13171;DP=317;AF=0.99;MQM=60;TRIO=HOM,317,0.99,HET,117,0.55,HET,201,0.43	QDPR	synonymous	QDPR:NM_000320.2:synonymous:LOW:exon4/7:c.396G>A:p.Leu132Leu,QDPR:NM_001306140.1:synonymous:LOW:exon3/6:c.303G>A:p.Leu101Leu		rs2597775	0.2324	0.2880	5710/3657/299	0.2835						612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C];				149	471					QDPR (inh=n/a pLI=0.07)
chr4	52888026	52888026	A	C	hom		QUAL=10103;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,61,1.00,HOM,87,0.99	SGCB	3'UTR	SGCB:NM_000232.4:3'UTR:MODIFIER:exon6/6:c.*2097T>G:		rs170424	0.4786	0.0000	0/0/0	0.1032										127	88					SGCB (inh=n/a pLI=0.00)
chr4	56236328	56236328	C	T	het		QUAL=8042;DP=406;AF=0.49;MQM=59;TRIO=HET,406,0.49,HET,268,0.44,WT,326,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*70C>T:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-2998G>A:		rs2538	0.2676	0.0000	0/0/0	0.0528										26	85					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236568	56236575	AACCGAAA	-	het		QUAL=7858;DP=219;AF=0.53;MQM=59;TRIO=HET,219,0.99,HET,88,0.66,WT,82,0.60	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*319_*326delACCGAAAA:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-3245_364-3238delTTTCGGTT:		rs767292453	0.2678	0.0000	0/0/0	0.2092										26	82					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236579	56236579	C	T	het		QUAL=7858;DP=219;AF=0.53;MQM=59;TRIO=HET,219,0.99,WT,88,0.66,HET,82,0.60	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*321C>T:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-3249G>A:		rs13149568	0.3592	0.0000	0/0/0	0.1999										20	101					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236599	56236610	CACACACACACA	-	hom		QUAL=3519;DP=105;AF=0.69;MQM=59;TRIO=HOM,105,0.88,HOM,67,0.66,WT,72,0.49	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*371_*382delCACACACACACA:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-3280_364-3269delTGTGTGTGTGTG:	(CA)n	rs148010163;rs57961190	0.0000	0.0000	0/0/0	0.0818										29	30					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236804	56236804	G	A	het		QUAL=3488;DP=173;AF=0.50;MQM=59;TRIO=HET,173,0.50,HET,93,0.54,WT,111,0.00	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*546G>A:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-3474C>T:	AluJb	rs573960	0.2676	0.0000	0/0/0	0.0430										23	57					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56237137	56237137	C	T	het		QUAL=2071;DP=122;AF=0.57;MQM=59;TRIO=HET,122,0.57,HET,23,0.43,WT,29,0.00	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*879C>T:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.364-3807G>A:		rs576732	0.2674	0.0000	0/0/0	0.0454										26	85					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56237327	56237327	G	A	hom		QUAL=10324;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HET,78,0.41,HET,128,0.48	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*1069G>A:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+3711C>T:		rs501679	0.6887	0.0000	0/0/0	0.1137										84	112					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238263	56238263	T	C	het		QUAL=4155;DP=210;AF=0.54;MQM=60;TRIO=HET,210,0.54,HET,102,0.38,WT,148,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2005T>C:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+2775A>G:		rs819269	0.2692	0.0000	0/0/0	0.0459										14	52					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238321	56238321	G	A	het		QUAL=5156;DP=315;AF=0.49;MQM=60;TRIO=HET,315,0.49,HET,97,0.43,WT,149,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2063G>A:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+2717C>T:		rs73236134	0.0162	0.0000	0/0/0	0.0052										0	20					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238626	56238626	G	A	het		QUAL=10173;DP=465;AF=0.48;MQM=60;TRIO=HET,465,0.48,HET,318,0.49,WT,467,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2368G>A:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+2412C>T:		rs819270	0.2676	0.0000	0/0/0	0.0455										14	52					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238847	56238847	G	A	hom		QUAL=16006;DP=337;AF=0.99;MQM=60;TRIO=HOM,337,0.99,HET,174,0.46,HET,242,0.51	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2589G>A:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+2191C>T:		rs819271	0.7500	0.0000	0/0/0	0.1170										51	73					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56239103	56239103	A	-	hom		QUAL=1680;DP=97;AF=0.71;MQM=59;TRIO=HOM,97,0.71,HET,25,0.36,HET,27,0.48	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2858delA:,SRD5A3-AS1:NR_037969.1:intron:MODIFIER:exon3/3:n.363+1935delT:		rs750107327	0.0000	0.0000	0/0/0	0.2567										5	115					SRD5A3 (inh=n/a pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	68603535	68603535	C	A	het		QUAL=6105;DP=244;AF=0.39;MQM=60;TRIO=HET,244,0.39,HET,84,0.52,HET,134,0.63	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2663G>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2772G>T:		rs1038426	0.3452	0.0000	0/0/0	0.3623								CR113071 [CLASS=DFP MUT=ALT PHEN="Polycystic ovary syndrome association with" GENE=GNRHR]; 		49	109					GNRHR (inh=n/a pLI=0.01)
chr4	68603702	68603702	C	T	het		QUAL=2107;DP=134;AF=0.40;MQM=59;TRIO=HET,134,0.40,HET,32,0.38,HET,32,0.50	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2496G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2605G>A:		rs1038427	0.3452	0.0000	0/0/0	0.3261										47	99					GNRHR (inh=n/a pLI=0.01)
chr4	68603757	68603757	A	G	het		QUAL=2454;DP=112;AF=0.55;MQM=60;TRIO=HET,112,0.55,WT,23,0.00,HET,46,0.65	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2441T>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2550T>C:	(AATTAT)n	rs2319657	0.0421	0.0000	0/0/0	0.0376										3	22					GNRHR (inh=n/a pLI=0.01)
chr4	68604032	68604032	C	T	het		QUAL=2272;DP=158;AF=0.42;MQM=60;TRIO=HET,158,0.42,HET,20,0.40,HET,37,0.43	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2166G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2275G>A:	Charlie4a	rs7666201	0.3492	0.0000	0/0/0	0.3493										49	108					GNRHR (inh=n/a pLI=0.01)
chr4	68604143	68604143	C	T	het		QUAL=4228;DP=180;AF=0.46;MQM=60;TRIO=HET,180,0.46,HET,78,0.47,HET,101,0.44	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2055G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2164G>A:		rs17635749	0.1773	0.0000	0/0/0	0.2249										20	91					GNRHR (inh=n/a pLI=0.01)
chr4	68604307	68604307	A	C	het		QUAL=6432;DP=233;AF=0.52;MQM=60;TRIO=HET,233,0.52,HET,106,0.42,HET,137,0.52	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*1891T>G:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2000T>G:		rs12508464	0.1855	0.0000	0/0/0	0.2280										20	92					GNRHR (inh=n/a pLI=0.01)
chr4	68604938	68604938	C	A	het		QUAL=10082;DP=284;AF=0.52;MQM=60;TRIO=HET,284,0.52,HET,199,0.48,HET,252,0.54	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*1260G>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*1369G>T:		rs13150734	0.1855	0.0000	0/0/0	0.2284										20	93					GNRHR (inh=n/a pLI=0.01)
chr4	68605369	68605369	A	G	het		QUAL=7668;DP=365;AF=0.51;MQM=60;TRIO=HET,365,0.51,HET,94,0.44,HET,128,0.45	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*829T>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*938T>C:		rs17635850	0.3492	0.0000	0/0/0	0.0642										49	111					GNRHR (inh=n/a pLI=0.01)
chr4	68605389	68605389	G	A	het		QUAL=7201;DP=331;AF=0.50;MQM=60;TRIO=HET,331,0.50,HET,100,0.44,HET,123,0.46	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*809C>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*918C>T:		rs35683646	0.1859	0.0000	0/0/0	0.0309										20	93					GNRHR (inh=n/a pLI=0.01)
chr4	68605396	68605396	C	G	het		QUAL=7398;DP=334;AF=0.49;MQM=60;TRIO=HET,334,0.49,HET,109,0.47,HET,124,0.46	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*802G>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*911G>C:		rs35610027	0.1859	0.0000	0/0/0	0.2187										20	92					GNRHR (inh=n/a pLI=0.01)
chr4	68605615	68605615	T	C	het		QUAL=7429;DP=277;AF=0.51;MQM=59;TRIO=HET,277,0.51,HET,156,0.53,HET,187,0.41	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*583A>G:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*692A>G:		rs35845954	0.1855	0.0000	0/0/0	0.2279										20	93					GNRHR (inh=n/a pLI=0.01)
chr4	68620277	68620277	T	C	hom		QUAL=15725;DP=278;AF=1.00;MQM=60;TRIO=HOM,278,1.00,HOM,84,1.00,HOM,114,1.00	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-224A>G:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-224A>G:		rs2627260	0.9810	0.0000	0/0/0	0.9113										227	3					GNRHR (inh=n/a pLI=0.01)
chr4	68620957	68620957	T	C	het		QUAL=5435;DP=198;AF=0.66;MQM=59;TRIO=HET,198,0.66,WT,87,0.00,HET,137,0.49	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-904A>G:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-904A>G:		rs6552113	0.4663	0.0000	0/0/0	0.4882										64	112					GNRHR (inh=n/a pLI=0.01)
chr4	68621197	68621197	A	G	het		QUAL=4216;DP=162;AF=0.61;MQM=60;TRIO=HET,162,0.61,WT,49,0.00,HET,76,0.71	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1144T>C:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1144T>C:	L2a	rs2062303	0.4417	0.0000	0/0/0	0.4272										64	110					GNRHR (inh=n/a pLI=0.01)
chr4	68621308	68621308	A	G	het		QUAL=4739;DP=202;AF=0.50;MQM=60;TRIO=HET,202,0.50,WT,123,0.01,HET,150,0.52	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1255T>C:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1255T>C:		rs2062302	0.4669	0.0000	0/0/0	0.4747										64	110					GNRHR (inh=n/a pLI=0.01)
chr4	68621332	68621332	C	T	het		QUAL=6840;DP=249;AF=0.59;MQM=60;TRIO=HET,249,0.59,WT,149,0.01,HET,194,0.54	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1279G>A:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1279G>A:	LTR16D	rs2062301	0.4659	0.0000	0/0/0	0.4748										64	110					GNRHR (inh=n/a pLI=0.01)
chr4	68621550	68621550	G	A	het		QUAL=4756;DP=229;AF=0.55;MQM=60;TRIO=HET,229,0.55,WT,56,0.00,HET,92,0.51	GNRHR	5'UTR_premature_start_codon_gain,5'UTR	GNRHR:NM_000406.2:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-1497C>T:,GNRHR:NM_001012763.1:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-1497C>T:,GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1497C>T:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1497C>T:		rs13138607	0.4661	0.0000	0/0/0	0.5008										65	111					GNRHR (inh=n/a pLI=0.01)
chr4	68621586	68621586	A	-	het		QUAL=4478;DP=245;AF=0.52;MQM=60;TRIO=HET,245,0.52,WT,49,0.04,HET,84,0.57	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1533delT:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1533delT:		rs34993359	0.4675	0.0000	0/0/0	0.3285										64	110					GNRHR (inh=n/a pLI=0.01)
chr4	72425863	72425863	C	T	hom		QUAL=27049;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,256,1.00,HOM,333,1.00	SLC4A4	synonymous	SLC4A4:NM_001134742.1:synonymous:LOW:exon23/25:c.2991C>T:p.His997His,SLC4A4:NM_001098484.2:synonymous:LOW:exon23/26:c.2991C>T:p.His997His,SLC4A4:NM_003759.3:synonymous:LOW:exon20/23:c.2859C>T:p.His953His		rs1453458	0.7823	0.8890	48487/30393/2232	0.8830						603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities];				933	165					SLC4A4 (inh=AR pLI=1.00)
chr4	72433759	72433759	C	T	hom		QUAL=21945;DP=299;AF=1.00;MQM=60;TRIO=HOM,299,1.00,HOM,148,1.00,HOM,217,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*149C>T:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*291C>T:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*291C>T:		rs1453453	0.9115	0.0000	0/0/0	0.1524										222	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72433879	72433879	G	C	hom		QUAL=35339;DP=501;AF=1.00;MQM=59;TRIO=HOM,501,1.00,HOM,250,1.00,HOM,313,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*269G>C:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*411G>C:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*411G>C:		rs1453452	0.8882	0.0000	0/0/0	0.8822										222	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72434457	72434457	T	A	het		QUAL=6533;DP=258;AF=0.46;MQM=60;TRIO=HET,258,0.46,WT,182,0.00,HET,245,0.51	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*847T>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*989T>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*989T>A:		rs34921070	0.0286	0.0000	0/0/0	0.0105										3	26					SLC4A4 (inh=AR pLI=1.00)
chr4	72435944	72435973	TAACTCATCATTTCAGCCTCTGAGTAGAGG	-	hom		QUAL=15889;DP=263;AF=1.00;MQM=59;TRIO=HOM,263,1.00,HOM,145,1.00,HOM,198,0.99	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2337_*2366delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*2479_*2508delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*2479_*2508delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:		rs71822971	0.3185	0.0000	0/0/0	0.3697										49	106					SLC4A4 (inh=AR pLI=1.00)
chr4	72436235	72436235	A	G	hom		QUAL=31106;DP=427;AF=1.00;MQM=60;TRIO=HOM,427,1.00,HOM,216,1.00,HOM,289,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2625A>G:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*2767A>G:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*2767A>G:		rs1043218	0.6206	0.0000	0/0/0	0.1202										124	85					SLC4A4 (inh=AR pLI=1.00)
chr4	72436498	72436498	G	A	hom		QUAL=29711;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,252,1.00,HOM,338,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2888G>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*3030G>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*3030G>A:		rs9997127	0.9191	0.0000	0/0/0	0.8887										222	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72436804	72436804	G	A	hom		QUAL=27566;DP=426;AF=1.00;MQM=60;TRIO=HOM,426,1.00,HOM,168,1.00,HOM,231,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*3194G>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*3336G>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*3336G>A:		rs9997398	0.9191	0.0000	0/0/0	0.1526										222	8					SLC4A4 (inh=AR pLI=1.00)
chr4	79186171	79186171	G	A	hom		QUAL=26911;DP=357;AF=1.00;MQM=60;TRIO=HOM,357,1.00,HOM,209,1.00,HOM,278,1.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon6/73:c.604-8G>A:,FRAS1:NM_001166133.1:splice_region&intron:LOW:exon6/41:c.604-8G>A:		rs2867014	0.9221	0.9730	56632/32848/3056	0.9399						607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003160, COSM4003159, COSM4003158, COSM4003161	1087	20					FRAS1 (inh=AR pLI=0.00)
chr4	79188595	79188595	C	T	het		QUAL=6576;DP=176;AF=0.51;MQM=59;TRIO=HET,176,0.51,WT,319,0.00,HET,411,0.46	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon9/73:c.981+9C>T:,FRAS1:NM_001166133.1:splice_region&intron:LOW:exon9/41:c.981+9C>T:		rs112081709	0.0092	0.0190	27/23/0	0.0190						607830 [FRAS1 (provisional) Fraser syndrome];				0	47					FRAS1 (inh=AR pLI=0.00)
chr4	79205699	79205699	T	A	het	pred_pathogenic_2	QUAL=10843;DP=209;AF=0.46;MQM=60;TRIO=HET,209,0.46,HET,292,0.47,HET,410,0.48	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon13/74:c.1396T>A:p.Leu466Ile,FRAS1:NM_001166133.1:missense:MODERATE:exon13/42:c.1396T>A:p.Leu466Ile		rs12504081	0.3211	0.3490	7558/4179/160	0.3430	0.9550	T,T	.,T,T,T,T	.,P,P,D,D	.,P,P,D,D	607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003163, COSM4003162, COSM4003164, COSM4003165	133	524					FRAS1 (inh=AR pLI=0.00)
chr4	79238649	79238649	T	C	het		QUAL=9255;DP=192;AF=0.43;MQM=60;TRIO=HET,192,0.43,HET,147,0.41,HOM,194,1.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon17/74:c.1947T>C:p.His649His,FRAS1:NM_001166133.1:synonymous:LOW:exon17/42:c.1947T>C:p.His649His		rs345514	0.0000	0.7420	33581/19735/3516	0.7103	-2.4890	T,T				607830 [FRAS1 (provisional) Fraser syndrome];	RCV000175235.1 [benign]; 		COSM4159211, COSM4159212, COSM4159210, COSM4159209	567	452					FRAS1 (inh=AR pLI=0.00)
chr4	79240063	79240063	A	G	het		QUAL=8809;DP=263;AF=0.56;MQM=59;TRIO=HET,263,0.56,HET,175,0.45,HET,216,0.53	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon18/74:c.2060A>G:p.Asp687Gly,FRAS1:NM_001166133.1:missense:MODERATE:exon18/42:c.2060A>G:p.Asp687Gly		rs345513	0.4343	0.4100	10166/5124/1170	0.3998	0.4320	T,T,.	T,T,T,.,.	B,B,B,.,.	B,B,B,.,.	607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003168, COSM4003166, COSM4003167, COSM4003169	192	524					FRAS1 (inh=AR pLI=0.00)
chr4	79372930	79372930	C	T	hom		QUAL=18800;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,171,1.00,HOM,241,1.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon46/74:c.6468C>T:p.His2156His		rs753752	0.5795	0.6720	27638/18398/1428	0.6645	-2.3510	T				607830 [FRAS1 (provisional) Fraser syndrome];	RCV000178609.1 [benign]; 		COSM1131036, COSM1131035	536	442					FRAS1 (inh=AR pLI=0.00)
chr4	79385632	79385632	C	T	het	phylop_high	QUAL=10054;DP=353;AF=0.55;MQM=60;TRIO=HET,353,0.55,WT,254,0.00,HET,344,0.54	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon49/74:c.6924C>T:p.Val2308Val		rs13123710	0.0244	0.0580	286/239/1	0.0576	2.6800					607830 [FRAS1 (provisional) Fraser syndrome];				5	133					FRAS1 (inh=AR pLI=0.00)
chr4	79385719	79385719	G	A	het		QUAL=11143;DP=284;AF=0.56;MQM=60;TRIO=HET,284,0.56,HET,232,0.46,HET,323,0.52	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon49/74:c.7011G>A:p.Ala2337Ala		rs6851427	0.2975	0.3650	8459/5063/140	0.3563	-2.2490	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM3760769, COSM3760770	149	514					FRAS1 (inh=AR pLI=0.00)
chr4	79387442	79387442	C	T	het		QUAL=13885;DP=359;AF=0.46;MQM=59;TRIO=HET,359,0.46,HET,351,0.46,HET,538,0.44	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon50/74:c.7110C>T:p.His2370His		rs7660664	0.3221	0.3170	6533/4256/1175	0.3142	-0.0540	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM1131033, COSM1131032	103	502					FRAS1 (inh=AR pLI=0.00)
chr4	79387464	79387464	A	G	hom	phylop_high	QUAL=42740;DP=437;AF=1.00;MQM=60;TRIO=HOM,437,1.00,HOM,353,1.00,HOM,540,1.00	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon50/74:c.7132A>G:p.Lys2378Glu		rs7684722	0.9677	0.9900	59254/33229/4018	0.9567	7.6740	T,T	.,T	.,B	.,B	607830 [FRAS1 (provisional) Fraser syndrome];				1100	6					FRAS1 (inh=AR pLI=0.00)
chr4	79400868	79400868	C	T	het		QUAL=7615;DP=308;AF=0.49;MQM=59;TRIO=HET,308,0.49,HET,171,0.44,HET,221,0.48	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon56/74:c.8439C>T:p.Asp2813Asp		rs11098194	0.2913	0.3580	7770/4810/133	0.3499	1.3810	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM3760774, COSM3760773	147	472					FRAS1 (inh=AR pLI=0.00)
chr4	79420869	79420869	C	T	het		QUAL=2918;DP=169;AF=0.41;MQM=60;TRIO=HET,169,0.41,HET,95,0.56,WT,144,0.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon60/73:c.9116-6C>T:		rs76630865	0.1725	0.1790	2016/1223/146	0.1581						607830 [FRAS1 (provisional) Fraser syndrome];				48	311					FRAS1 (inh=AR pLI=0.00)
chr4	79420870	79420870	C	G	het		QUAL=2918;DP=169;AF=0.41;MQM=60;TRIO=HET,169,0.41,HET,95,0.56,WT,144,0.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon60/73:c.9116-5C>G:		rs7695038	0.5917	0.5070	16318/6527/2057	0.4655						607830 [FRAS1 (provisional) Fraser syndrome];				285	520					FRAS1 (inh=AR pLI=0.00)
chr4	79437155	79437155	C	T	het		QUAL=4201;DP=204;AF=0.43;MQM=60;TRIO=HET,204,0.43,HET,222,0.44,WT,306,0.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon66/74:c.10377C>T:p.Thr3459Thr		rs3749487	0.1765	0.1800	2009/1201/163	0.1775	-1.6450	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM1131030, COSM1131029	48	319					FRAS1 (inh=AR pLI=0.00)
chr4	79447763	79447763	T	C	het		QUAL=7261;DP=397;AF=0.46;MQM=60;TRIO=HET,397,0.46,HET,170,0.55,WT,240,0.00	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon70/74:c.10877T>C:p.Val3626Ala		rs34670941	0.1454	0.1160	773/305/110	0.1151	0.3720	T	T	B	B	607830 [FRAS1 (provisional) Fraser syndrome];				13	188					FRAS1 (inh=AR pLI=0.00)
chr4	79455714	79455714	C	G	het		QUAL=8830;DP=468;AF=0.47;MQM=60;TRIO=HET,468,0.47,HET,269,0.45,WT,366,0.01	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon71/74:c.11037C>G:p.Pro3679Pro		rs4975070	0.5150	0.4880	15351/6473/591	0.4768	0.4930	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM4005806, COSM4005805	260	527					FRAS1 (inh=AR pLI=0.00)
chr4	79455733	79455733	C	T	het		QUAL=7620;DP=412;AF=0.47;MQM=60;TRIO=HET,412,0.47,HET,250,0.43,WT,337,0.01	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon71/74:c.11056C>T:p.Leu3686Leu		rs4975139	0.5150	0.4880	15331/6469/590	0.4767	1.1260	T				607830 [FRAS1 (provisional) Fraser syndrome];			COSM4005807, COSM4005808	259	527					FRAS1 (inh=AR pLI=0.00)
chr4	79462311	79462311	T	A	het		QUAL=5826;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,95,0.44,HET,143,0.45	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*33T>A:		rs72659058	0.1056	0.1540	1095/948/27	0.1488										17	98					FRAS1 (inh=AR pLI=0.00)
chr4	79462560	79462560	A	T	het		QUAL=14676;DP=479;AF=0.50;MQM=60;TRIO=HET,479,0.50,HET,263,0.50,HET,346,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*282A>T:		rs3749485	0.2023	0.0000	0/0/0	0.0451										20	101					FRAS1 (inh=AR pLI=0.00)
chr4	79464432	79464432	C	T	het		QUAL=15437;DP=372;AF=0.50;MQM=60;TRIO=HET,372,0.50,HET,353,0.47,HET,449,0.52	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2154C>T:		rs3811747	0.6617	0.0000	0/0/0	0.1144										105	96					FRAS1 (inh=AR pLI=0.00)
chr4	79464767	79464767	T	C	het		QUAL=18066;DP=420;AF=0.54;MQM=60;TRIO=HET,420,0.54,HET,390,0.57,HET,413,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2489T>C:		rs11098227	0.6617	0.0000	0/0/0	0.1340										106	97					FRAS1 (inh=AR pLI=0.00)
chr4	79464978	79464978	G	A	het		QUAL=10586;DP=314;AF=0.45;MQM=59;TRIO=HET,314,0.45,HET,211,0.54,HET,267,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2700G>A:		rs11098228	0.6404	0.0000	0/0/0	0.6461										92	103					FRAS1 (inh=AR pLI=0.00)
chr4	79465100	79465100	-	TTTT	het		QUAL=12525;DP=454;AF=0.48;MQM=59;TRIO=HET,454,0.48,HET,231,0.50,HET,336,0.49	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2824_*2825insTTTT:		rs10667708;rs397724155	0.6406	0.0000	0/0/0	0.5787										92	103					FRAS1 (inh=AR pLI=0.00)
chr4	80823880	80823880	-	T	hom		QUAL=4998;DP=185;AF=0.73;MQM=59;TRIO=HOM,185,0.73,HET,69,0.36,HOM,83,0.76	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4702dupA:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4702dupA:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4702dupA:		rs34821632;rs397702828	0.5996	0.0000	0/0/0	0.4044										3	211					ANTXR2 (inh=n/a pLI=0.41)
chr4	80824302	80824302	-	A	het		QUAL=9376;DP=165;AF=0.65;MQM=58;TRIO=HET,165,0.87,WT,112,0.94,HET,165,0.94	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4280dupT:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4280dupT:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4280dupT:	AluSz6	rs373264816	0.0000	0.0000	0/0/0	0.1016										0	38					ANTXR2 (inh=n/a pLI=0.41)
chr4	80824311	80824311	G	A	hom		QUAL=9376;DP=165;AF=0.65;MQM=58;TRIO=HOM,165,0.87,HOM,112,0.94,HOM,165,0.94	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4272C>T:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4272C>T:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4272C>T:	AluSz6	rs56708107	0.4858	0.0000	0/0/0	0.1701										67	117					ANTXR2 (inh=n/a pLI=0.41)
chr4	80824527	80824527	A	T	hom		QUAL=14991;DP=312;AF=0.78;MQM=59;TRIO=HOM,312,0.78,HET,137,0.40,HOM,188,0.78	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4056T>A:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4056T>A:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4056T>A:		rs11946205	0.2516	0.0000	0/0/0	0.2827										7	141					ANTXR2 (inh=n/a pLI=0.41)
chr4	80824888	80824888	A	G	hom		QUAL=19263;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,125,1.00,HOM,162,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*3695T>C:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*3695T>C:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*3695T>C:		rs4611863	0.9798	0.0000	0/0/0	0.8733										230	0					ANTXR2 (inh=n/a pLI=0.41)
chr4	80825271	80825271	A	-	hom		QUAL=9431;DP=197;AF=0.99;MQM=60;TRIO=HOM,197,0.99,HOM,41,1.00,HOM,53,0.98	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*3312delT:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*3312delT:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*3312delT:		rs796643476	0.4858	0.0000	0/0/0	0.5031										74	111					ANTXR2 (inh=n/a pLI=0.41)
chr4	80826920	80826920	C	T	het		QUAL=5010;DP=325;AF=0.44;MQM=60;TRIO=HET,325,0.44,HET,117,0.45,WT,147,0.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*1663G>A:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*1663G>A:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*1663G>A:		rs113322831	0.0200	0.0000	0/0/0	0.0339										1	26					ANTXR2 (inh=n/a pLI=0.41)
chr4	80827062	80827062	T	C	hom		QUAL=23516;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,194,1.00,HOM,281,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*1521A>G:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*1521A>G:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*1521A>G:		rs7747	0.8516	0.0000	0/0/0	0.1310										148	72					ANTXR2 (inh=n/a pLI=0.41)
chr4	80827798	80827798	A	G	hom		QUAL=34009;DP=456;AF=1.00;MQM=60;TRIO=HOM,456,1.00,HOM,251,1.00,HOM,328,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*785T>C:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*785T>C:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*785T>C:		rs63539261	0.8492	0.0000	0/0/0	0.0977										148	72					ANTXR2 (inh=n/a pLI=0.41)
chr4	80827799	80827799	A	C	hom		QUAL=34009;DP=456;AF=1.00;MQM=60;TRIO=HOM,456,1.00,HOM,251,1.00,HOM,328,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*784T>G:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*784T>G:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*784T>G:		rs1139638	0.8494	0.0000	0/0/0	0.0975										148	72					ANTXR2 (inh=n/a pLI=0.41)
chr4	80905990	80905990	C	G	hom	phylop_high	QUAL=4954;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,52,0.44,HOM,49,1.00	ANTXR2	missense	ANTXR2:NM_001145794.1:missense:MODERATE:exon13/16:c.1069G>C:p.Ala357Pro,ANTXR2:NM_001286781.1:missense:MODERATE:exon13/17:c.838G>C:p.Ala280Pro,ANTXR2:NM_058172.5:missense:MODERATE:exon13/17:c.1069G>C:p.Ala357Pro,ANTXR2:NM_001286780.1:missense:MODERATE:exon13/17:c.838G>C:p.Ala280Pro		rs12647691	0.8027	0.7670	32664/15944/2320	0.7124	2.2410	T	T,T,T,T	B,B,B	B,B,B	608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome];		CM121492 [CLASS=DFP MUT=ALT PHEN="Anthrax toxin sensitivity association with" GENE=ANTXR2]; 	COSM3760783, COSM3760782	614	410					ANTXR2 (inh=n/a pLI=0.41)
chr4	80977078	80977078	T	G	hom		QUAL=9673;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HET,80,0.51,HOM,84,1.00	ANTXR2	splice_region&intron	ANTXR2:NM_001145794.1:splice_region&intron:LOW:exon4/15:c.378+8A>C:,ANTXR2:NM_001286781.1:splice_region&intron:LOW:exon4/16:c.147+8A>C:,ANTXR2:NM_058172.5:splice_region&intron:LOW:exon4/16:c.378+8A>C:,ANTXR2:NM_001286780.1:splice_region&intron:LOW:exon4/16:c.147+8A>C:		rs4594664	0.6973	0.6260	9612/3853/571	0.5720						608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome];				421	494					ANTXR2 (inh=n/a pLI=0.41)
chr4	84188850	84188850	G	A	het		QUAL=2678;DP=143;AF=0.45;MQM=59;TRIO=HET,143,0.45,WT,116,0.00,HET,111,0.46	COQ2	synonymous	COQ2:NM_015697.7:synonymous:LOW:exon6/7:c.990C>T:p.Ser330Ser		rs1129617	0.2103	0.1690	1012/529/24	0.1615						609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116809.3 [other]; 			149	746					COQ2 (inh=AR pLI=0.00)
chr4	84191031	84191031	A	G	het		QUAL=10873;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,174,1.00,HET,208,0.50	COQ2	synonymous	COQ2:NM_015697.7:synonymous:LOW:exon5/7:c.894T>C:p.Asp298Asp		rs6535454	0.7782	0.7340	32565/16698/3262	0.7229						609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116808.3 [other]; 			973	789					COQ2 (inh=AR pLI=0.00)
chr4	84205872	84205872	C	A	hom	low_DP	QUAL=682;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,10,1.00,HOM,9,1.00	COQ2	missense	COQ2:NM_015697.7:missense:MODERATE:exon1/7:c.196G>T:p.Val66Leu		rs6818847	0.6498	0.6140	3350/959/47	0.4124	-1.9210	T	T,T,T	B	B	609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116807.3 [other]; 			852	637					COQ2 (inh=AR pLI=0.00)
chr4	87684031	87684031	A	G	het		QUAL=11295;DP=340;AF=0.44;MQM=60;TRIO=HET,340,0.44,HOM,245,1.00,WT,388,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:NM_006264.2:synonymous:LOW:exon23/47:c.3648A>G:p.Pro1216Pro,PTPN13:NM_080683.2:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:NM_080684.2:synonymous:LOW:exon21/45:c.3132A>G:p.Pro1044Pro		rs710832	0.7109	0.7110	30965/18126/3402	0.7044										542	472					PTPN13 (inh=n/a pLI=0.00)
chr4	87685796	87685796	T	G	het	phylop_high	QUAL=6322;DP=262;AF=0.48;MQM=60;TRIO=HET,262,0.48,HET,178,0.62,WT,196,0.01	PTPN13	missense	PTPN13:NM_080685.2:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:NM_006264.2:missense:MODERATE:exon24/47:c.4011T>G:p.Phe1337Leu,PTPN13:NM_080683.2:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:NM_080684.2:missense:MODERATE:exon22/45:c.3495T>G:p.Phe1165Leu		rs10033029	0.0521	0.0760	379/323/12	0.0767	2.6660	T	T,T,T,T,T,T	B,B,B,B	B,B,B,B					6	193					PTPN13 (inh=n/a pLI=0.00)
chr4	87692393	87692393	G	A	het	phylop_high	QUAL=9875;DP=478;AF=0.49;MQM=60;TRIO=HET,478,0.49,HET,312,0.50,WT,413,0.00	PTPN13	missense	PTPN13:NM_080685.2:missense:MODERATE:exon31/48:c.4888G>A:p.Glu1630Lys,PTPN13:NM_006264.2:missense:MODERATE:exon30/47:c.4816G>A:p.Glu1606Lys,PTPN13:NM_080683.2:missense:MODERATE:exon31/48:c.4873G>A:p.Glu1625Lys,PTPN13:NM_080684.2:missense:MODERATE:exon28/45:c.4300G>A:p.Glu1434Lys		rs12500797	0.0443	0.0780	441/376/4	0.0782	5.2760	T	T,T,T,T,T,T	P,B,B,B	B,B,B,B			CM067710 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=PTPN13]; 		5	200					PTPN13 (inh=n/a pLI=0.00)
chr4	87696470	87696470	A	G	het		QUAL=4625;DP=269;AF=0.49;MQM=60;TRIO=HET,269,0.49,HET,82,0.50,WT,114,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon34/48:c.5670A>G:p.Thr1890Thr,PTPN13:NM_006264.2:synonymous:LOW:exon33/47:c.5598A>G:p.Thr1866Thr,PTPN13:NM_080683.2:synonymous:LOW:exon34/48:c.5655A>G:p.Thr1885Thr,PTPN13:NM_080684.2:synonymous:LOW:exon31/45:c.5082A>G:p.Thr1694Thr		rs12507034	0.0705	0.0850	519/404/51	0.0850										7	203					PTPN13 (inh=n/a pLI=0.00)
chr4	87696476	87696476	G	A	het		QUAL=4425;DP=260;AF=0.48;MQM=60;TRIO=HET,260,0.48,HET,84,0.51,WT,116,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon34/48:c.5676G>A:p.Thr1892Thr,PTPN13:NM_006264.2:synonymous:LOW:exon33/47:c.5604G>A:p.Thr1868Thr,PTPN13:NM_080683.2:synonymous:LOW:exon34/48:c.5661G>A:p.Thr1887Thr,PTPN13:NM_080684.2:synonymous:LOW:exon31/45:c.5088G>A:p.Thr1696Thr		rs12499471	0.0705	0.0850	520/404/52	0.0852										7	204					PTPN13 (inh=n/a pLI=0.00)
chr4	87736307	87736307	A	C	het		QUAL=4562;DP=249;AF=0.41;MQM=60;TRIO=HET,249,0.41,HET,147,0.48,WT,178,0.00	PTPN13	3'UTR	PTPN13:NM_080685.2:3'UTR:MODIFIER:exon48/48:c.*603A>C:,PTPN13:NM_006264.2:3'UTR:MODIFIER:exon47/47:c.*603A>C:,PTPN13:NM_080683.2:3'UTR:MODIFIER:exon48/48:c.*603A>C:,PTPN13:NM_080684.2:3'UTR:MODIFIER:exon45/45:c.*603A>C:		rs17750575	0.0657	0.0000	0/0/0	0.0147										0	38					PTPN13 (inh=n/a pLI=0.00)
chr4	88584148	88584148	C	T	het		QUAL=7638;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,WT,301,0.01,HET,382,0.46	DMP1	synonymous	DMP1:NM_004407.3:synonymous:LOW:exon6/6:c.1218C>T:p.Ser406Ser,DMP1:NM_001079911.2:synonymous:LOW:exon5/5:c.1170C>T:p.Ser390Ser		rs2615498	0.1757	0.1910	2452/1239/25	0.1900						600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR];			COSM3760817	62	358					DMP1 (inh=n/a pLI=0.00)
chr4	88584160	88584160	G	A	het		QUAL=8226;DP=285;AF=0.49;MQM=60;TRIO=HET,285,0.49,WT,281,0.01,HET,369,0.46	DMP1	synonymous	DMP1:NM_004407.3:synonymous:LOW:exon6/6:c.1230G>A:p.Glu410Glu,DMP1:NM_001079911.2:synonymous:LOW:exon5/5:c.1182G>A:p.Glu394Glu		rs2615497	0.3213	0.2590	4358/1760/849	0.2545						600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR];			COSM3760818	99	419					DMP1 (inh=n/a pLI=0.00)
chr4	88584507	88584507	G	A	het		QUAL=8482;DP=304;AF=0.50;MQM=60;TRIO=HET,304,0.50,WT,263,0.00,HET,321,0.49	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*35G>A:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*35G>A:		rs2627724	0.3213	0.2590	4346/1761/832	0.2529										29	121					DMP1 (inh=n/a pLI=0.00)
chr4	88585079	88585079	A	G	het		QUAL=8169;DP=438;AF=0.53;MQM=60;TRIO=HET,438,0.53,WT,123,0.01,HET,138,0.49	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*607A>G:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*607A>G:	L2c	rs2627725	0.6661	0.0000	0/0/0	0.1023										61	112					DMP1 (inh=n/a pLI=0.00)
chr4	88585218	88585218	T	-	het		QUAL=11094;DP=222;AF=0.43;MQM=59;TRIO=HET,222,0.43,HET,151,0.37,HET,174,0.40	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*758delT:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*758delT:		rs35239689;rs398083277;rs545768168	0.4824	0.0000	0/0/0	0.2974										24	126					DMP1 (inh=n/a pLI=0.00)
chr4	88585218	88585219	TT	-	het		QUAL=11094;DP=222;AF=0.50;MQM=59;TRIO=HET,222,0.50,HET,151,0.52,HET,174,0.49	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*757_*758delTT:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*757_*758delTT:		rs35239689;rs60181711	0.3486	0.0000	0/0/0	0.1939										22	96					DMP1 (inh=n/a pLI=0.00)
chr4	103611845	103611845	C	T	hom		QUAL=8499;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HET,135,0.50,HET,164,0.50	MANBA	missense	MANBA:NM_005908.3:missense:MODERATE:exon6/17:c.757G>A:p.Val253Ile		rs227368	0.3766	0.4420	12586/7817/184	0.4206	-0.2430	T	T,T	B,B	B,B	609489 [MANBA (confirmed) Mannosidosis,beta];			COSM4155100	286	505					MANBA (inh=AR pLI=0.00)
chr4	107270027	107270027	G	A	het		QUAL=8735;DP=363;AF=0.48;MQM=60;TRIO=HET,363,0.48,WT,228,0.00,HET,263,0.56	AIMP1	3'UTR	AIMP1:NM_001142416.1:3'UTR:MODIFIER:exon7/7:c.*1178G>A:,AIMP1:NM_001142415.1:3'UTR:MODIFIER:exon7/7:c.*1178G>A:,AIMP1:NM_004757.3:3'UTR:MODIFIER:exon7/7:c.*1178G>A:		rs13534	0.1785	0.0000	0/0/0	0.0376										15	84					AIMP1 (inh=n/a pLI=0.00)
chr4	108931039	108931039	T	C	hom	phylop_high	QUAL=21968;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,151,0.99,HOM,187,1.00	HADH	missense	HADH:NM_001184705.2:missense:MODERATE:exon2/9:c.257T>C:p.Leu86Pro,HADH:NM_005327.4:missense:MODERATE:exon2/8:c.257T>C:p.Leu86Pro		rs4956145	0.8690	0.9150	51193/28932/2554	0.8942	4.8010	T	T,T,T,T	B,B,B	B,B,B	601609 [HADH (confirmed) 3-hydroxyacyl-CoA dehydrogenase deficiency|Hyperinsulinemic hypoglycemia,familial,4];	RCV000153344.2 [benign]; 			947	149					HADH (inh=AR pLI=0.00)
chr4	110661937	110661937	G	A	hom		QUAL=13180;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,75,1.00,HOM,86,1.00	CFI	3'UTR	CFI:NM_001318057.1:3'UTR:MODIFIER:exon14/14:c.*112C>T:,CFI:NM_000204.4:3'UTR:MODIFIER:exon13/13:c.*112C>T:		rs551	0.9537	0.9830	27997/14744/1528	0.8710										478	4					CFI (inh=n/a pLI=0.00)
chr4	110678925	110678925	T	C	hom		QUAL=8991;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,44,1.00,HOM,61,1.00	CFI	missense	CFI:NM_001318057.1:missense:MODERATE:exon8/14:c.922A>G:p.Thr308Ala,CFI:NM_000204.4:missense:MODERATE:exon7/13:c.898A>G:p.Thr300Ala		rs11098044	0.9669	0.9890	54184/29997/3457	0.9263	-0.2530	T	T,T,T	B,B	B,B	217030 [CFI (confirmed) Complement factor I deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,3|Macular degeneration,age-related,13,susceptibility to];				1093	9					CFI (inh=n/a pLI=0.00)
chr4	113565887	113565889	AAG	-	het		QUAL=2516;DP=107;AF=0.52;MQM=59;TRIO=HET,107,0.52,HET,102,0.50,WT,121,0.00	LARP7	disruptive_inframe_deletion,non_coding_exon	LARP7:NM_001267039.1:disruptive_inframe_deletion:MODERATE:exon4/15:c.86_88delAAG:p.Glu29del,LARP7:NM_016648.3:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del,LARP7:NM_015454.2:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del,LARP7:NR_049768.1:non_coding_exon:MODIFIER:exon2/13:n.343_345delAAG:		rs570445594	0.0012	0.0026	1/0/0	0.0024						612026 [LARP7 (provisional) Alazami syndrome];				0	6					LARP7 (inh=n/a pLI=0.02)
chr4	119201532	119201533	TT	-	het		QUAL=7817;DP=307;AF=0.54;MQM=59;TRIO=HET,307,0.54,HOM,128,0.99,WT,161,0.00	PRSS12	3'UTR	PRSS12:NM_003619.3:3'UTR:MODIFIER:exon13/13:c.*1558_*1559delAA:		rs397839202	0.2312	0.0000	0/0/0	0.3204										15	59					PRSS12 (inh=AR pLI=0.00)
chr4	119201587	119201587	C	T	het		QUAL=7535;DP=364;AF=0.45;MQM=60;TRIO=HET,364,0.45,WT,183,0.00,HET,238,0.49	PRSS12	3'UTR	PRSS12:NM_003619.3:3'UTR:MODIFIER:exon13/13:c.*1504G>A:		rs1045817	0.0958	0.0000	0/0/0	0.0217										9	46					PRSS12 (inh=AR pLI=0.00)
chr4	119219909	119219909	C	A	het		QUAL=8295;DP=248;AF=0.55;MQM=60;TRIO=HET,248,0.55,WT,269,0.00,HET,362,0.53	PRSS12	missense	PRSS12:NM_003619.3:missense:MODERATE:exon9/13:c.1816G>T:p.Ala606Ser		rs28661939	0.1246	0.1480	1534/739/83	0.1441	0.8120	T	T	B	B	606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1];	RCV000118070.2 [likely benign]; 			29	289					PRSS12 (inh=AR pLI=0.00)
chr4	119237348	119237348	T	C	het		QUAL=10549;DP=223;AF=0.53;MQM=60;TRIO=HET,223,0.53,WT,170,0.01,HOM,232,1.00	PRSS12	synonymous	PRSS12:NM_003619.3:synonymous:LOW:exon6/13:c.1281A>G:p.Gln427Gln		rs2292597	0.5453	0.5540	18794/9996/1198	0.5486						606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1];	RCV000118068.2 [likely benign]; 		COSM149728	351	517					PRSS12 (inh=AR pLI=0.00)
chr4	122742217	122742217	T	C	hom		QUAL=18127;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,103,1.00,HOM,199,1.00	CCNA2	missense	CCNA2:NM_001237.3:missense:MODERATE:exon3/8:c.487A>G:p.Ile163Val		rs769242	0.9687	0.9630	56293/30604/5095	0.9415	1.1430	T	T	B	B					1053	51					CCNA2 (inh=n/a pLI=0.99)
chr4	122744942	122744942	G	A	hom		QUAL=10408;DP=61;AF=0.98;MQM=60;TRIO=HOM,61,0.98,HOM,186,1.00,HET,214,0.54	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:NM_001237.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-159C>T:,CCNA2:NM_001237.3:5'UTR:MODIFIER:exon1/8:c.-159C>T:	(CAGCC)n	rs769238	0.2494	0.0000	0/0/0	0.0475										32	95					CCNA2 (inh=n/a pLI=0.99)
chr4	122744979	122744979	G	A	het		QUAL=2234;DP=52;AF=0.46;MQM=60;TRIO=HET,52,0.46,HET,141,0.53,WT,191,0.00	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:NM_001237.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-196C>T:,CCNA2:NM_001237.3:5'UTR:MODIFIER:exon1/8:c.-196C>T:		rs769237	0.0208	0.0000	0/0/0	0.0029										0	16					CCNA2 (inh=n/a pLI=0.99)
chr4	122745729	122745729	C	T	hom		QUAL=11636;DP=199;AF=1.00;MQM=60;TRIO=HOM,199,1.00,HOM,114,1.00,HET,137,0.43	BBS7	3'UTR	BBS7:NM_176824.2:3'UTR:MODIFIER:exon19/19:c.*1286G>A:		rs1507996	0.1723	0.0000	0/0/0	0.0338										25	77					BBS7 (inh=AR pLI=0.00)
chr4	122746325	122746325	A	G	hom		QUAL=22203;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,160,0.99,HET,217,0.54	BBS7	3'UTR	BBS7:NM_176824.2:3'UTR:MODIFIER:exon19/19:c.*690T>C:	MamSINE1	rs3217753	0.2494	0.0000	0/0/0	0.0477										32	96					BBS7 (inh=AR pLI=0.00)
chr4	145701128	145701128	T	G	hom		QUAL=25863;DP=364;AF=1.00;MQM=60;TRIO=HOM,364,1.00,HOM,174,1.00,HOM,240,1.00	HHIP-ANAPC10	intergenic_region	HHIP-ANAPC10:HHIP-ANAPC10:intergenic_region:MODIFIER::n.145701128T>G:		rs4835188	0.9589	0.0000	0/0/0	0.8686										150	0					HHIP-ANAPC10 (inh=n/a pLI=n/a)
chr4	146579194	146579194	T	C	het		QUAL=5920;DP=286;AF=0.47;MQM=60;TRIO=HET,286,0.47,HET,77,0.45,HET,132,0.45	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2608T>C:	MSTB	rs7699187	0.5657	0.0000	0/0/0	0.0819										33	76					MMAA (inh=n/a pLI=0.00)
chr4	146579354	146579354	A	T	het		QUAL=4150;DP=147;AF=0.43;MQM=60;TRIO=HET,147,0.43,HET,86,0.49,HET,127,0.44	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2768A>T:	MSTB	rs7699166	0.5657	0.0000	0/0/0	0.0825										41	88					MMAA (inh=n/a pLI=0.00)
chr4	146579452	146579452	A	G	het		QUAL=7531;DP=422;AF=0.45;MQM=60;TRIO=HET,422,0.45,WT,103,0.00,HET,180,0.50	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2866A>G:	MIR:MIR	rs17020500	0.2742	0.0000	0/0/0	0.0473										12	85					MMAA (inh=n/a pLI=0.00)
chr4	146579844	146579844	A	-	het		QUAL=253;DP=266;AF=0.30;MQM=59;TRIO=HET,266,0.30,WT,81,0.41,WT,99,0.17	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*3274delA:	(A)n	rs33978754	0.2766	0.0000	0/0/0	0.0653										0	113					MMAA (inh=n/a pLI=0.00)
chr4	149000024	149000024	C	T	hom		QUAL=21264;DP=399;AF=0.99;MQM=60;TRIO=HOM,399,0.99,HOM,115,1.00,HOM,161,0.99	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*2471G>A:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*2471G>A:		rs2871	0.7163	0.0000	0/0/0	0.1228										118	117					NR3C2 (inh=n/a pLI=0.93)
chr4	149001085	149001085	T	C	hom		QUAL=19988;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HOM,172,1.00,HET,259,0.54	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*1410A>G:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*1410A>G:		rs5534	0.5535	0.0000	0/0/0	0.1027								CR1111313 [CLASS=DFP MUT=REF PHEN="Myocardial infarction increased risk association with" GENE=NR3C2]; 		85	123					NR3C2 (inh=n/a pLI=0.93)
chr4	149002017	149002017	T	-	hom		QUAL=5959;DP=121;AF=0.99;MQM=59;TRIO=HOM,121,0.99,HOM,31,1.00,HOM,37,1.00	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*478delA:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*478delA:	(T)n	rs397779293;rs63748994	0.0000	0.6730	2874/771/34	0.1391										265	274					NR3C2 (inh=n/a pLI=0.93)
chr4	149356516	149356516	A	G	hom		QUAL=33543;DP=397;AF=0.99;MQM=59;TRIO=HOM,397,0.99,HOM,265,1.00,HOM,371,1.00	NR3C2	synonymous	NR3C2:NM_000901.4:synonymous:LOW:exon2/9:c.1497T>C:p.Asp499Asp,NR3C2:NM_001166104.1:synonymous:LOW:exon2/8:c.1497T>C:p.Asp499Asp		rs5525	0.8920	0.8820	47268/26588/4307	0.8722						600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy];				935	165					NR3C2 (inh=n/a pLI=0.93)
chr4	149357475	149357475	C	T	hom		QUAL=27706;DP=370;AF=1.00;MQM=60;TRIO=HOM,370,1.00,HOM,236,1.00,HOM,247,1.00	NR3C2	missense	NR3C2:NM_000901.4:missense:MODERATE:exon2/9:c.538G>A:p.Val180Ile,NR3C2:NM_001166104.1:missense:MODERATE:exon2/8:c.538G>A:p.Val180Ile		rs5522	0.8920	0.8810	47201/26545/4300	0.8729	-0.3800	T	T,T,T,T,T,T,T	B,B	B,B	600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy];		CM030066 [CLASS=DFP MUT=REF PHEN="Reduced expression" GENE=NR3C2]; 		932	166					NR3C2 (inh=n/a pLI=0.93)
chr4	149358014	149358014	G	C	hom		QUAL=17721;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HET,251,0.54,HET,318,0.50	NR3C2	splice_region,5'UTR	NR3C2:NM_000901.4:splice_region:LOW:exon2/9:c.-2C>G:,NR3C2:NM_001166104.1:splice_region:LOW:exon2/8:c.-2C>G:,NR3C2:NM_000901.4:5'UTR:MODIFIER:exon2/9:c.-2C>G:,NR3C2:NM_001166104.1:5'UTR:MODIFIER:exon2/8:c.-2C>G:		rs2070951	0.5008	0.5180	16376/7303/255	0.5127								CR030126 [CLASS=DFP MUT=REF PHEN="Increased blood pressure association with" GENE=NR3C2]; 		280	490					NR3C2 (inh=n/a pLI=0.93)
chr4	159601676	159601676	C	T	hom		QUAL=25364;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,228,1.00,HOM,272,1.00	ETFDH	missense,intron	ETFDH:NM_004453.3:missense:MODERATE:exon2/13:c.92C>T:p.Thr31Ile,ETFDH:NM_001281737.1:intron:MODIFIER:exon1/11:c.35-1671C>T:		rs11559290	0.6727	0.8120	42011/25002/287	0.8056	1.1210	T	T	B	B	231675 [ETFDH (confirmed) Glutaric acidemia IIC];	RCV000081080.4 [benign]; 		COSM4158888	1119	333					ETFDH (inh=AR pLI=0.00)
chr4	178352679	178352679	T	G	hom		QUAL=11591;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,45,1.00,HOM,77,1.00	AGA	3'UTR,non_coding_exon	AGA:NM_000027.3:3'UTR:MODIFIER:exon9/9:c.*183A>C:,AGA:NM_001171988.1:3'UTR:MODIFIER:exon9/9:c.*183A>C:,AGA:NR_033655.1:non_coding_exon:MODIFIER:exon8/8:n.1276A>C:		rs1061814	0.4569	0.4750	2634/1161/36	0.1840										262	303					AGA (inh=AR pLI=0.00)
chr4	178359960	178359960	G	C	hom		QUAL=19377;DP=243;AF=1.00;MQM=60;TRIO=HOM,243,1.00,HOM,154,1.00,HOM,203,1.00	AGA	missense,non_coding_exon	AGA:NM_000027.3:missense:MODERATE:exon4/9:c.446C>G:p.Thr149Ser,AGA:NM_001171988.1:missense:MODERATE:exon4/9:c.446C>G:p.Thr149Ser,AGA:NR_033655.1:non_coding_exon:MODIFIER:exon4/8:n.574C>G:		rs2228119	0.9209	0.9780	58324/33314/3038	0.9310	-0.1550	T,T	.,T,T	.,B	.,B	613228 [AGA (confirmed) Aspartylglucosaminuria];	RCV000077944.4 [benign]; 			1097	8					AGA (inh=AR pLI=0.00)
chr4	184369040	184369040	G	A	hom		QUAL=12196;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HET,99,0.56,HET,141,0.42	CDKN2AIP	3'UTR	CDKN2AIP:NM_017632.3:3'UTR:MODIFIER:exon3/3:c.*460G>A:,CDKN2AIP:NM_001317343.1:3'UTR:MODIFIER:exon3/3:c.*1791G>A:		rs3187025	0.0719	0.0000	0/0/0	0.0136										6	39					CDKN2AIP (inh=n/a pLI=0.99)
chr4	186068637	186068637	A	G	hom		QUAL=14520;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HOM,123,1.00,HOM,119,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*512A>G:		rs7660552	0.9365	0.0000	0/0/0	0.9016										187	37					SLC25A4 (inh=n/a pLI=0.48)
chr4	186069178	186069178	T	C	hom		QUAL=10524;DP=154;AF=1.00;MQM=59;TRIO=HOM,154,1.00,HET,101,0.49,HOM,139,0.99	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*1053T>C:	MLT1A0	rs55905558	0.4399	0.0000	0/0/0	0.5046										50	63					SLC25A4 (inh=n/a pLI=0.48)
chr4	186070432	186070432	T	C	hom		QUAL=38759;DP=462;AF=1.00;MQM=59;TRIO=HOM,462,1.00,HET,450,0.50,HOM,565,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*2307T>C:		rs2046535	0.4687	0.0000	0/0/0	0.5228										60	97					SLC25A4 (inh=n/a pLI=0.48)
chr4	186071068	186071068	G	A	hom		QUAL=22208;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HET,195,0.46,HOM,260,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*2943G>A:		rs7675110	0.4305	0.0000	0/0/0	0.5058										57	98					SLC25A4 (inh=n/a pLI=0.48)
chr4	186997767	186997767	C	A	het		QUAL=9373;DP=259;AF=0.48;MQM=60;TRIO=HET,259,0.48,HET,139,0.49,HOM,161,0.99	TLR3	splice_region,5'UTR	TLR3:NM_003265.2:splice_region:LOW:exon2/5:c.-7C>A:,TLR3:NM_003265.2:5'UTR:MODIFIER:exon2/5:c.-7C>A:		rs3775296	0.1817	0.1820	2017/1125/125	0.1819										42	309					TLR3 (inh=n/a pLI=0.00)
chr4	187004074	187004074	C	T	het	phylop_high;pred_pathogenic_3	QUAL=7682;DP=360;AF=0.49;MQM=59;TRIO=HET,360,0.49,HET,232,0.48,WT,299,0.01	TLR3	missense	TLR3:NM_003265.2:missense:MODERATE:exon4/5:c.1234C>T:p.Leu412Phe		rs3775291	0.2318	0.2710	4813/2945/20	0.2704	4.0310	T	D,D,D,D	D	D	603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to];	RCV000034357.3 [other]; 	CM073380 [CLASS=DFP MUT=ALT PHEN="Altered activity association with" GENE=TLR3]; 	COSM149771	79	456	1	[1] Ute Grasshoff 13.08.2014			TLR3 (inh=n/a pLI=0.00)
chr4	187004217	187004217	C	T	het		QUAL=18798;DP=458;AF=0.51;MQM=60;TRIO=HET,458,0.51,HET,239,0.49,HOM,290,1.00	TLR3	synonymous	TLR3:NM_003265.2:synonymous:LOW:exon4/5:c.1377C>T:p.Phe459Phe		rs3775290	0.2722	0.3000	5608/3033/193	0.2988						603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to];			COSM1428947	93	435					TLR3 (inh=n/a pLI=0.00)
chr4	187158034	187158034	G	A	het	phylop_high;anno_pathogenic_clinvar	QUAL=18120;DP=372;AF=0.49;MQM=59;TRIO=HET,372,0.49,HOM,280,1.00,HET,382,0.44	KLKB1	missense,5'UTR	KLKB1:NM_000892.4:missense:MODERATE:exon5/15:c.428G>A:p.Ser143Asn,KLKB1:NM_001318394.1:missense:MODERATE:exon6/15:c.314G>A:p.Ser105Asn,KLKB1:NM_001318396.1:5'UTR:MODIFIER:exon5/15:c.-210G>A:		rs3733402	0.6046	0.5360	18108/8547/2824	0.5331	3.7480	T,T	T,T,T,T,T,T,.	B,.	B,.	229000 [KLKB1 (provisional) Fletcher factor (prekallikrein) deficiency];	RCV000012817.25 [pathogenic]; 	CM073166 [CLASS=DFP MUT=REF PHEN="Prekallikrein deficiency" GENE=KLKB1]; 	COSM3760537, COSM149774	280	551	2	[2] old entry - no details available			KLKB1 (inh=n/a pLI=0.00)
chr4	187179210	187179210	T	C	het		QUAL=13107;DP=184;AF=0.48;MQM=60;TRIO=HET,184,0.48,HOM,238,0.98,HET,295,0.50	KLKB1	missense,synonymous	KLKB1:NM_001318394.1:missense:MODERATE:exon15/15:c.1507T>C:p.Trp503Arg,KLKB1:NM_000892.4:synonymous:LOW:exon15/15:c.1761T>C:p.Asn587Asn,KLKB1:NM_001318396.1:synonymous:LOW:exon15/15:c.1155T>C:p.Asn385Asn		rs925453	0.6581	0.6680	27709/15526/2259	0.6668	-3.8940	T,T	.,T,T	.,B	.,B	229000 [KLKB1 (provisional) Fletcher factor (prekallikrein) deficiency];				495	469					KLKB1 (inh=n/a pLI=0.00)
chr4	187179486	187179486	A	G	het		QUAL=14781;DP=313;AF=0.49;MQM=60;TRIO=HET,313,0.49,HOM,228,1.00,HET,293,0.53	KLKB1	3'UTR	KLKB1:NM_000892.4:3'UTR:MODIFIER:exon15/15:c.*120A>G:,KLKB1:NM_001318394.1:3'UTR:MODIFIER:exon15/15:c.*238A>G:,KLKB1:NM_001318396.1:3'UTR:MODIFIER:exon15/15:c.*120A>G:	MIRb	rs3087505	0.9185	0.0000	0/0/0	0.1633										180	47					KLKB1 (inh=n/a pLI=0.00)
chr4	190874234	190874234	C	T	het	low_MQM;phylop_high;pred_pathogenic_4	QUAL=2910;DP=199;AF=0.16;MQM=41;TRIO=HET,199,0.16,HET,169,0.33,HET,239,0.36	FRG1	missense	FRG1:NM_004477.2:missense:MODERATE:exon4/9:c.271C>T:p.Pro91Ser		rs200620299	0.0000	0.3140	0/0/0	0.0001	7.0600	D	D,D	D	D					0	683					FRG1 (inh=n/a pLI=0.00)
chr4	190878597	190878597	C	T	het	low_MQM	QUAL=13138;DP=536;AF=0.44;MQM=34;TRIO=HET,536,0.44,HET,473,0.45,HET,637,0.51	FRG1	synonymous	FRG1:NM_004477.2:synonymous:LOW:exon6/9:c.477C>T:p.Cys159Cys		rs73598383	0.0000	0.4620	0/0/0	0.0107									COSM4158962	0	1080					FRG1 (inh=n/a pLI=0.00)
chr4	190878654	190878654	C	G	het	low_MQM;pred_pathogenic_1	QUAL=3798;DP=485;AF=0.21;MQM=33;TRIO=HET,485,0.21,HET,475,0.26,HET,637,0.26	FRG1	missense	FRG1:NM_004477.2:missense:MODERATE:exon6/9:c.534C>G:p.Ile178Met		rs78653319	0.0000	0.4460	1/0/0	0.0024	0.0290	T	D,D,D	B	P				COSM4158963	0	910					FRG1 (inh=n/a pLI=0.00)
chr4	190878661	190878661	A	T	het	low_MQM	QUAL=11975;DP=473;AF=0.41;MQM=34;TRIO=HET,473,0.41,HET,478,0.42,HET,633,0.48	FRG1	splice_region&intron	FRG1:NM_004477.2:splice_region&intron:LOW:exon6/8:c.537+4A>T:		rs62345291	0.0000	0.4910	2/1/1	0.0026										0	1048					FRG1 (inh=n/a pLI=0.00)
chr5	231111	231111	T	C	hom		QUAL=11160;DP=109;AF=1.00;MQM=56;TRIO=HOM,109,1.00,HOM,118,1.00,HOM,144,1.00	SDHA	synonymous	SDHA:NM_004168.3:synonymous:LOW:exon7/15:c.891T>C:p.Pro297Pro,SDHA:NM_001294332.1:synonymous:LOW:exon6/14:c.747T>C:p.Pro249Pro		rs1126417	0.6534	0.7070	31200/19114/3161	0.6868						600857 [SDHA (confirmed) Leigh syndrome|Mitochondrial respiratory chain complex II deficiency|Cardiomyopathy,dilated,1GG|Paragangliomas 5];	RCV000118321.2 [likely benign]; RCV000162482.1 [benign]; 		COSM4159838	582	524					SDHA (inh=AR+AD pLI=0.00)
chr5	1393588	1393590	TGT	-	het		QUAL=6481;DP=331;AF=0.47;MQM=59;TRIO=HET,331,0.47,HET,265,0.52,WT,350,0.00	SLC6A3	3'UTR	SLC6A3:NM_001044.4:3'UTR:MODIFIER:exon15/15:c.*1260_*1262delACA:			0.0000	0.0000	0/0/0	0.0003										0	2					SLC6A3 (inh=AR pLI=1.00)
chr5	6599493	6599493	G	-	het		QUAL=3527;DP=127;AF=0.49;MQM=58;TRIO=HET,127,0.49,HET,51,0.47,HET,114,0.51	NSUN2	3'UTR,non_coding_exon	NSUN2:NM_017755.5:3'UTR:MODIFIER:exon19/19:c.*546delC:,NSUN2:NM_001193455.1:3'UTR:MODIFIER:exon18/18:c.*546delC:,NSUN2:NR_037947.1:non_coding_exon:MODIFIER:exon18/18:n.3146delC:		rs200230801	0.0248	0.0000	0/0/0	0.0409										0	31					NSUN2 (inh=AR pLI=0.96)
chr5	6599940	6599940	C	T	het		QUAL=8656;DP=361;AF=0.47;MQM=59;TRIO=HET,361,0.47,HET,299,0.56,WT,470,0.00	NSUN2	3'UTR,non_coding_exon	NSUN2:NM_017755.5:3'UTR:MODIFIER:exon19/19:c.*99G>A:,NSUN2:NM_001193455.1:3'UTR:MODIFIER:exon18/18:c.*99G>A:,NSUN2:NR_037947.1:non_coding_exon:MODIFIER:exon18/18:n.2699G>A:		rs3776448	0.1462	0.0000	0/0/0	0.0276										3	49					NSUN2 (inh=AR pLI=0.96)
chr5	6600064	6600064	G	T	het		QUAL=16863;DP=407;AF=0.52;MQM=59;TRIO=HET,407,0.52,HET,371,0.49,HET,574,0.53	NSUN2	missense,non_coding_exon	NSUN2:NM_017755.5:missense:MODERATE:exon19/19:c.2279C>A:p.Pro760Gln,NSUN2:NM_001193455.1:missense:MODERATE:exon18/18:c.2174C>A:p.Pro725Gln,NSUN2:NR_037947.1:non_coding_exon:MODIFIER:exon18/18:n.2575C>A:		rs61744358	0.0551	0.0590	230/152/17	0.0578	0.6020	T	T,T,T	B,B,B	B,B,B	610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117858.2 [likely benign]; 			21	177					NSUN2 (inh=AR pLI=0.96)
chr5	6600150	6600150	G	A	het		QUAL=12581;DP=444;AF=0.47;MQM=59;TRIO=HET,444,0.47,HET,600,0.49,WT,851,0.00	NSUN2	synonymous,non_coding_exon	NSUN2:NM_017755.5:synonymous:LOW:exon19/19:c.2193C>T:p.Asp731Asp,NSUN2:NM_001193455.1:synonymous:LOW:exon18/18:c.2088C>T:p.Asp696Asp,NSUN2:NR_037947.1:non_coding_exon:MODIFIER:exon18/18:n.2489C>T:		rs3822434	0.1735	0.1740	2085/729/46	0.1703						610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117856.2 [likely benign]; 		COSM1438254	28	250					NSUN2 (inh=AR pLI=0.96)
chr5	6622122	6622122	T	A	het		QUAL=9717;DP=252;AF=0.47;MQM=60;TRIO=HET,252,0.47,HET,246,0.48,HET,300,0.47	NSUN2	splice_region&intron,intron	NSUN2:NM_017755.5:splice_region&intron:LOW:exon6/18:c.622+7A>T:,NSUN2:NM_001193455.1:splice_region&intron:LOW:exon5/17:c.517+7A>T:,NSUN2:NR_037947.1:intron:MODIFIER:exon5/17:n.918+1205A>T:		rs16877704	0.0160	0.0380	130/109/1	0.0397						610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117861.2 [likely benign]; 			6	106					NSUN2 (inh=AR pLI=0.96)
chr5	7869235	7869235	T	C	het		QUAL=4611;DP=51;AF=0.35;MQM=60;TRIO=HET,51,0.35,HET,132,0.52,HET,228,0.47	MTRR	5'UTR,non_coding_exon	MTRR:NM_024010.2:5'UTR:MODIFIER:exon1/15:c.-12T>C:,MTRR:NM_002454.2:5'UTR:MODIFIER:exon1/15:c.-119T>C:,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon1/15:n.19T>C:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon1/14:n.19T>C:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon1/14:n.19T>C:		rs72716536	0.2290	0.1580	2132/387/521	0.1553							RCV000126883.2 [benign]; 			16	148					MTRR (inh=AR pLI=0.00)
chr5	7878192	7878192	T	C	het		QUAL=12145;DP=510;AF=0.47;MQM=59;TRIO=HET,510,0.47,HET,427,0.49,WT,614,0.00	MTRR	synonymous,non_coding_exon	MTRR:NM_024010.2:synonymous:LOW:exon5/15:c.618T>C:p.Leu206Leu,MTRR:NM_002454.2:synonymous:LOW:exon5/15:c.537T>C:p.Leu179Leu,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon5/15:n.660T>C:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon5/14:n.674T>C:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon4/14:n.520T>C:		rs161870	0.2530	0.1710	2515/475/787	0.1677	-3.7990	T				602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126885.2 [benign]; 			39	286					MTRR (inh=AR pLI=0.00)
chr5	7885959	7885959	A	G	het		QUAL=4987;DP=139;AF=0.55;MQM=60;TRIO=HET,139,0.55,HET,239,0.50,WT,344,0.00	MTRR	missense,non_coding_exon	MTRR:NM_024010.2:missense:MODERATE:exon7/15:c.1130A>G:p.Lys377Arg,MTRR:NM_002454.2:missense:MODERATE:exon7/15:c.1049A>G:p.Lys350Arg,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon7/15:n.1172A>G:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon7/14:n.1186A>G:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon6/14:n.1032A>G:		rs162036	0.2532	0.1710	2514/474/785	0.1677	1.2300	T	T,T	B	B	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126870.2 [benign]; RCV000144925.1 [uncertain significance]; 			39	286					MTRR (inh=AR pLI=0.00)
chr5	7897191	7897191	C	T	het		QUAL=6665;DP=260;AF=0.51;MQM=59;TRIO=HET,260,0.51,HET,223,0.51,WT,255,0.00	MTRR	missense,non_coding_exon	MTRR:NM_024010.2:missense:MODERATE:exon14/15:c.1864C>T:p.His622Tyr,MTRR:NM_002454.2:missense:MODERATE:exon14/15:c.1783C>T:p.His595Tyr,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon14/15:n.1906C>T:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon13/14:n.1831C>T:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon13/14:n.1766C>T:		rs10380	0.2194	0.1510	2003/337/542	0.1475	0.5320	T	T,T	B	B	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126880.2 [benign]; RCV000144924.1 [uncertain significance]; 	CM083724 [CLASS=DFP MUT=ALT PHEN="Pancreatic cancer increased risk association with" GENE=MTRR]; 		28	249	1	[1] auto-classification 16.06.2016  [2] harmuth 06.04.2016; ih-frequency homo: 21, het: 177			MTRR (inh=AR pLI=0.00)
chr5	7897283	7897283	G	A	het		QUAL=8325;DP=366;AF=0.48;MQM=60;TRIO=HET,366,0.48,HET,298,0.51,WT,325,0.00	MTRR	synonymous,non_coding_exon	MTRR:NM_024010.2:synonymous:LOW:exon14/15:c.1956G>A:p.Val652Val,MTRR:NM_002454.2:synonymous:LOW:exon14/15:c.1875G>A:p.Val625Val,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon14/15:n.1998G>A:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon13/14:n.1923G>A:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon13/14:n.1858G>A:		rs12347	0.2438	0.1680	2431/470/756	0.1643						602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126881.2 [benign]; 			39	279					MTRR (inh=AR pLI=0.00)
chr5	7900712	7900712	G	A	het		QUAL=2506;DP=214;AF=0.40;MQM=60;TRIO=HET,214,0.40,HET,27,0.44,WT,35,0.03	MTRR	3'UTR,non_coding_exon	MTRR:NM_024010.2:3'UTR:MODIFIER:exon15/15:c.*541G>A:,MTRR:NM_002454.2:3'UTR:MODIFIER:exon15/15:c.*541G>A:,MTRR:NR_134480.1:non_coding_exon:MODIFIER:exon15/15:n.2761G>A:,MTRR:NR_134481.1:non_coding_exon:MODIFIER:exon14/14:n.2686G>A:,MTRR:NR_134482.1:non_coding_exon:MODIFIER:exon14/14:n.2621G>A:		rs9332	0.2472	0.0000	0/0/0	0.0282										7	42					MTRR (inh=AR pLI=0.00)
chr5	10250430	10250430	G	A	hom		QUAL=4950;DP=51;AF=1.00;MQM=60;TRIO=HOM,51,1.00,HOM,51,1.00,HOM,68,1.00	CCT5	5'UTR,intron	CCT5:NM_012073.4:5'UTR:MODIFIER:exon1/11:c.-23G>A:,CCT5:NM_001306154.1:5'UTR:MODIFIER:exon1/10:c.-23G>A:,CCT5:NM_001306153.1:intron:MODIFIER:exon1/10:c.42+273G>A:		rs2548546	0.6853	0.7890	38433/24216/1013	0.7843										648	287					CCT5 (inh=AR pLI=1.00)
chr5	10250443	10250443	T	C	hom		QUAL=4797;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,51,1.00,HOM,64,1.00	CCT5	5'UTR_premature_start_codon_gain,5'UTR,intron	CCT5:NM_012073.4:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-10T>C:,CCT5:NM_001306154.1:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-10T>C:,CCT5:NM_012073.4:5'UTR:MODIFIER:exon1/11:c.-10T>C:,CCT5:NM_001306154.1:5'UTR:MODIFIER:exon1/10:c.-10T>C:,CCT5:NM_001306153.1:intron:MODIFIER:exon1/10:c.42+286T>C:		rs2578618	0.6853	0.7890	38594/24311/1021	0.7858										1080	455					CCT5 (inh=AR pLI=1.00)
chr5	10254817	10254817	A	G	hom		QUAL=16305;DP=156;AF=1.00;MQM=59;TRIO=HOM,156,1.00,HOM,165,1.00,HOM,194,1.00	CCT5	synonymous,intron	CCT5:NM_012073.4:synonymous:LOW:exon3/11:c.198A>G:p.Gly66Gly,CCT5:NM_001306153.1:synonymous:LOW:exon3/11:c.135A>G:p.Gly45Gly,CCT5:NM_001306156.1:synonymous:LOW:exon3/11:c.84A>G:p.Gly28Gly,CCT5:NM_001306154.1:intron:MODIFIER:exon2/9:c.166+500A>G:,CCT5:NM_001306155.1:intron:MODIFIER:exon2/9:c.52+500A>G:		rs2578617	0.6859	0.7890	38838/24492/1032	0.7875						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				1084	453					CCT5 (inh=AR pLI=1.00)
chr5	10256161	10256161	T	C	hom		QUAL=16114;DP=276;AF=1.00;MQM=60;TRIO=HOM,276,1.00,HOM,105,1.00,HOM,123,1.00	CCT5	synonymous	CCT5:NM_012073.4:synonymous:LOW:exon4/11:c.426T>C:p.Arg142Arg,CCT5:NM_001306153.1:synonymous:LOW:exon4/11:c.363T>C:p.Arg121Arg,CCT5:NM_001306154.1:synonymous:LOW:exon3/10:c.261T>C:p.Arg87Arg,CCT5:NM_001306155.1:synonymous:LOW:exon3/10:c.147T>C:p.Arg49Arg,CCT5:NM_001306156.1:synonymous:LOW:exon4/11:c.312T>C:p.Arg104Arg		rs1042392	0.6925	0.7940	39246/24749/1097	0.7936						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				1096	446					CCT5 (inh=AR pLI=1.00)
chr5	10262740	10262740	C	A	hom		QUAL=11823;DP=85;AF=0.99;MQM=60;TRIO=HOM,85,0.99,HOM,114,1.00,HOM,188,1.00	CCT5	splice_region&intron	CCT5:NM_012073.4:splice_region&intron:LOW:exon9/10:c.1317+10C>A:,CCT5:NM_001306153.1:splice_region&intron:LOW:exon9/10:c.1254+10C>A:,CCT5:NM_001306154.1:splice_region&intron:LOW:exon8/9:c.1152+10C>A:,CCT5:NM_001306155.1:splice_region&intron:LOW:exon8/9:c.1038+10C>A:,CCT5:NM_001306156.1:splice_region&intron:LOW:exon9/10:c.1203+10C>A:		rs2578642	0.6859	0.7890	38834/24488/1033	0.7885						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				1080	454					CCT5 (inh=AR pLI=1.00)
chr5	10264962	10264962	A	G	hom		QUAL=18719;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,134,1.00,HOM,176,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*67A>G:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*67A>G:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*67A>G:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*67A>G:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*67A>G:		rs544	0.6857	0.0000	0/0/0	0.1614										151	70					CCT5 (inh=AR pLI=1.00)
chr5	10265076	10265076	C	T	hom		QUAL=13475;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HOM,83,1.00,HOM,110,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*181C>T:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*181C>T:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*181C>T:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*181C>T:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*181C>T:		rs699113	0.6859	0.0000	0/0/0	0.1373										150	71					CCT5 (inh=AR pLI=1.00)
chr5	10265278	10265278	A	G	hom		QUAL=21680;DP=375;AF=1.00;MQM=60;TRIO=HOM,375,1.00,HOM,143,1.00,HOM,167,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*383A>G:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*383A>G:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*383A>G:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*383A>G:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*383A>G:		rs2662533	0.6859	0.0000	0/0/0	0.1505										151	70					CCT5 (inh=AR pLI=1.00)
chr5	10265462	10265462	G	A	hom		QUAL=24262;DP=225;AF=1.00;MQM=59;TRIO=HOM,225,1.00,HOM,245,1.00,HOM,312,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*567G>A:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*567G>A:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*567G>A:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*567G>A:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*567G>A:		rs2607286	0.0000	0.0000	0/0/0	0.1150										150	70					CCT5 (inh=AR pLI=1.00)
chr5	10265488	10265488	A	G	hom		QUAL=22612;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,219,1.00,HOM,268,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*593A>G:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*593A>G:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*593A>G:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*593A>G:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*593A>G:		rs2578640	0.6861	0.0000	0/0/0	0.8063										150	70					CCT5 (inh=AR pLI=1.00)
chr5	10265719	10265719	C	G	hom		QUAL=31559;DP=547;AF=1.00;MQM=59;TRIO=HOM,547,1.00,HOM,200,1.00,HOM,229,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*824C>G:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*824C>G:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*824C>G:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*824C>G:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*824C>G:		rs2578639	0.6631	0.0000	0/0/0	0.1362										151	70					CCT5 (inh=AR pLI=1.00)
chr5	10265886	10265886	-	TCTAT	hom		QUAL=16103;DP=251;AF=0.98;MQM=59;TRIO=HOM,251,0.98,HOM,134,0.99,HOM,144,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*994_*995insATTCT:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*994_*995insATTCT:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*994_*995insATTCT:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*994_*995insATTCT:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*994_*995insATTCT:	MIR	rs112586209;rs70943997	0.6809	0.0000	0/0/0	0.6957										147	68					CCT5 (inh=AR pLI=1.00)
chr5	10266067	10266067	G	T	hom		QUAL=36470;DP=437;AF=1.00;MQM=60;TRIO=HOM,437,1.00,HOM,296,1.00,HOM,378,1.00	CCT5	3'UTR	CCT5:NM_012073.4:3'UTR:MODIFIER:exon11/11:c.*1172G>T:,CCT5:NM_001306153.1:3'UTR:MODIFIER:exon11/11:c.*1172G>T:,CCT5:NM_001306154.1:3'UTR:MODIFIER:exon10/10:c.*1172G>T:,CCT5:NM_001306155.1:3'UTR:MODIFIER:exon10/10:c.*1172G>T:,CCT5:NM_001306156.1:3'UTR:MODIFIER:exon11/11:c.*1172G>T:		rs2578638	0.8880	0.0000	0/0/0	0.8985										182	43					CCT5 (inh=AR pLI=1.00)
chr5	11117583	11117583	C	T	het		QUAL=9316;DP=395;AF=0.52;MQM=60;TRIO=HET,395,0.52,WT,207,0.00,HET,342,0.51	CTNND2	synonymous,non_coding_exon	CTNND2:NM_001332.3:synonymous:LOW:exon13/22:c.2256G>A:p.Gly752Gly,CTNND2:NM_001288715.1:synonymous:LOW:exon12/21:c.1983G>A:p.Gly661Gly,CTNND2:NM_001288716.1:synonymous:LOW:exon10/19:c.1245G>A:p.Gly415Gly,CTNND2:NM_001288717.1:synonymous:LOW:exon12/21:c.957G>A:p.Gly319Gly,CTNND2:NR_109988.1:non_coding_exon:MODIFIER:exon11/22:n.1708G>A:		rs2285975	0.2236	0.1180	1649/108/182	0.1177									COSM4003253	8	79					CTNND2 (inh=n/a pLI=1.00)
chr5	16474795	16474795	C	T	hom		QUAL=333;DP=159;AF=0.38;MQM=57;TRIO=HOM,159,0.38,HOM,36,0.17,WT,41,0.02	FAM134B	3'UTR	FAM134B:NM_001034850.2:3'UTR:MODIFIER:exon9/9:c.*55G>A:,FAM134B:NM_019000.4:3'UTR:MODIFIER:exon7/7:c.*55G>A:	(TTTTTC)n		0.0000	0.0000	0/0/0	0.0002										0	32					FAM134B (inh=AR pLI=0.01)
chr5	16478200	16478200	G	A	hom		QUAL=12416;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,74,1.00,HOM,103,1.00	FAM134B	synonymous	FAM134B:NM_001034850.2:synonymous:LOW:exon7/9:c.816C>T:p.Asp272Asp,FAM134B:NM_019000.4:synonymous:LOW:exon5/7:c.393C>T:p.Asp131Asp		rs162848	0.6775	0.6590	25890/15604/3106	0.6521						613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB];				613	479					FAM134B (inh=AR pLI=0.01)
chr5	16508898	16508898	T	C	het		QUAL=5947;DP=257;AF=0.46;MQM=60;TRIO=HET,257,0.46,HET,226,0.50,WT,307,0.00	FAM134B	5'UTR,intron	FAM134B:NM_019000.4:5'UTR:MODIFIER:exon1/7:c.-177A>G:,FAM134B:NM_001034850.2:intron:MODIFIER:exon3/8:c.459-25317A>G:		rs33684	0.5431	0.0000	0/0/0	0.6291						613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB];				135	142					FAM134B (inh=AR pLI=0.01)
chr5	33988581	33988581	C	A	het		QUAL=7274;DP=321;AF=0.44;MQM=60;TRIO=HET,321,0.44,WT,223,0.00,HET,247,0.55	AMACR,C1QTNF3-AMACR	3'UTR,intron,non_coding_exon	AMACR:NM_014324.5:3'UTR:MODIFIER:exon5/5:c.*617G>T:,AMACR:NM_203382.2:3'UTR:MODIFIER:exon4/4:c.*1008G>T:,AMACR:NM_001167595.1:intron:MODIFIER:exon5/5:c.1132-115G>T:,C1QTNF3-AMACR:NR_037951.1:non_coding_exon:MODIFIER:exon9/9:n.2122G>T:		rs12659370	0.0749	0.0000	0/0/0	0.0108						604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];				2	24					AMACR (inh=AR pLI=0.13), C1QTNF3-AMACR (inh=n/a pLI=n/a)
chr5	33989518	33989518	C	T	hom	phylop_high	QUAL=26504;DP=333;AF=0.99;MQM=60;TRIO=HOM,333,0.99,HET,255,0.49,HOM,384,1.00	AMACR,C1QTNF3-AMACR	missense,3'UTR,non_coding_exon	AMACR:NM_001167595.1:missense:MODERATE:exon5/6:c.829G>A:p.Glu277Lys,AMACR:NM_014324.5:missense:MODERATE:exon5/5:c.829G>A:p.Glu277Lys,AMACR:NM_203382.2:3'UTR:MODIFIER:exon4/4:c.*71G>A:,C1QTNF3-AMACR:NR_037951.1:non_coding_exon:MODIFIER:exon9/9:n.1185G>A:		rs2278008	0.6961	0.7010	30827/18374/3205	0.7023	2.0460	T	T,T,T	B,B,B	B,B,B	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116324.2 [likely benign]; 	CM078460 [CLASS=DP MUT=REF PHEN="Advanced distal colorectal adenoma increased risk association" GENE=AMACR]; 	COSM3761202	1166	872					AMACR (inh=AR pLI=0.13), C1QTNF3-AMACR (inh=n/a pLI=n/a)
chr5	33998768	33998768	C	A	het	phylop_high;pred_pathogenic_3	QUAL=6587;DP=204;AF=0.49;MQM=60;TRIO=HET,204,0.49,HET,138,0.50,HET,167,0.57	AMACR,C1QTNF3-AMACR	missense,non_coding_exon	AMACR:NM_001167595.1:missense:MODERATE:exon4/6:c.717G>T:p.Gln239His,AMACR:NM_014324.5:missense:MODERATE:exon4/5:c.717G>T:p.Gln239His,AMACR:NM_203382.2:missense:MODERATE:exon3/4:c.556G>T:p.Val186Phe,C1QTNF3-AMACR:NR_037951.1:non_coding_exon:MODIFIER:exon8/9:n.1073G>T:		rs34677	0.1144	0.1260	1051/604/17	0.1246	1.8670	T,T	D,D,D,T,T	P,P,P,P,D,D	B,B,B,B,D,P	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116323.2 [likely benign]; 		COSM149809	26	521					AMACR (inh=AR pLI=0.13), C1QTNF3-AMACR (inh=n/a pLI=n/a)
chr5	33998883	33998883	A	G	hom		QUAL=15948;DP=239;AF=0.99;MQM=60;TRIO=HOM,239,0.99,HET,151,0.59,HOM,177,1.00	AMACR,C1QTNF3-AMACR	missense,synonymous,non_coding_exon	AMACR:NM_001167595.1:missense:MODERATE:exon4/6:c.602T>C:p.Leu201Ser,AMACR:NM_014324.5:missense:MODERATE:exon4/5:c.602T>C:p.Leu201Ser,AMACR:NM_203382.2:synonymous:LOW:exon3/4:c.441T>C:p.Ile147Ile,C1QTNF3-AMACR:NR_037951.1:non_coding_exon:MODIFIER:exon8/9:n.958T>C:		rs2287939	0.7149	0.6990	30273/16686/3479	0.6984	-0.7150	T	T,T,T	B,B,B	B,B,B	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116322.2 [likely benign]; 	CM078459 [CLASS=DP MUT=REF PHEN="Advanced distal colorectal adenoma increased risk association" GENE=AMACR]; 		1072	940					AMACR (inh=AR pLI=0.13), C1QTNF3-AMACR (inh=n/a pLI=n/a)
chr5	38475507	38475507	G	A	het		QUAL=4792;DP=119;AF=0.50;MQM=60;TRIO=HET,119,0.50,HET,93,0.60,HET,130,0.51	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*6190C>T:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*6190C>T:		rs1046224	0.3728	0.0000	0/0/0	0.0658										27	100					LIFR (inh=n/a pLI=0.00)
chr5	38476027	38476027	T	C	het		QUAL=9811;DP=309;AF=0.50;MQM=59;TRIO=HET,309,0.50,HET,145,0.57,HET,228,0.54	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*5670A>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*5670A>G:		rs3822425	0.3255	0.0000	0/0/0	0.0598										29	99					LIFR (inh=n/a pLI=0.00)
chr5	38476624	38476624	-	T	het		QUAL=3600;DP=279;AF=0.38;MQM=59;TRIO=HET,279,0.38,HET,96,0.44,HET,136,0.41	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*5072dupA:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*5072dupA:		rs397997444	0.3107	0.0000	0/0/0	0.2070										4	122					LIFR (inh=n/a pLI=0.00)
chr5	38477863	38477863	G	C	het		QUAL=8891;DP=294;AF=0.49;MQM=60;TRIO=HET,294,0.49,HET,162,0.51,HET,196,0.53	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*3834C>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*3834C>G:		rs34130318	0.3223	0.0000	0/0/0	0.3506										27	98					LIFR (inh=n/a pLI=0.00)
chr5	38480227	38480227	A	C	het		QUAL=6130;DP=259;AF=0.52;MQM=60;TRIO=HET,259,0.52,HET,66,0.55,HET,111,0.50	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*1470T>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*1470T>G:	(AACA)n	rs13156520	0.3181	0.0000	0/0/0	0.3458										27	100					LIFR (inh=n/a pLI=0.00)
chr5	38481271	38481271	C	T	het		QUAL=7323;DP=429;AF=0.44;MQM=60;TRIO=HET,429,0.44,HET,200,0.49,WT,247,0.00	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*426G>A:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*426G>A:		rs116625329	0.0048	0.0000	0/0/0	0.0024										0	10					LIFR (inh=n/a pLI=0.00)
chr5	38481335	38481335	C	T	het		QUAL=13609;DP=469;AF=0.48;MQM=60;TRIO=HET,469,0.48,HET,261,0.49,HET,323,0.50	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*362G>A:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*362G>A:		rs1005017	0.7290	0.0000	0/0/0	0.1141										102	100					LIFR (inh=n/a pLI=0.00)
chr5	38482731	38482731	T	C	het	phylop_high;pred_pathogenic_2	QUAL=1475;DP=95;AF=0.54;MQM=60;TRIO=HET,95,0.54,HET,13,0.38,WT,16,0.00	LIFR	missense	LIFR:NM_001127671.1:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly,LIFR:NM_002310.5:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly			0.0000	0.0000	0/0/0	0.0000	3.9330	T	T,T	D	D	151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome];				0	1					LIFR (inh=n/a pLI=0.00)
chr5	38528952	38528953	AC	-	hom		QUAL=2915;DP=21;AF=0.67;MQM=59;TRIO=HOM,21,0.86,HET,54,0.98,HET,77,0.94	LIFR	splice_region&intron	LIFR:NM_001127671.1:splice_region&intron:LOW:exon2/19:c.143-11_143-10delGT:,LIFR:NM_002310.5:splice_region&intron:LOW:exon2/19:c.143-11_143-10delGT:	(AC)n	rs34759137;rs760641742	0.0000	0.1740	80/56/1	0.1152						151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome];				214	181					LIFR (inh=n/a pLI=0.00)
chr5	38919158	38919158	G	A	het	phylop_high;pred_pathogenic_1	QUAL=4304;DP=153;AF=0.52;MQM=60;TRIO=HET,153,0.52,WT,150,0.00,HET,176,0.51	OSMR	missense	OSMR:NM_003999.2:missense:MODERATE:exon11/18:c.1579G>A:p.Glu527Lys		rs10941412	0.1464	0.1540	1607/957/306	0.1518	2.3480	T	T,T	D	P	601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1];				29	271					OSMR (inh=n/a pLI=0.00)
chr5	38933749	38933749	C	T	hom		QUAL=17042;DP=300;AF=0.99;MQM=60;TRIO=HOM,300,0.99,HET,313,0.49,HET,306,0.45	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*203C>T:		rs1239344	0.4491	0.0000	0/0/0	0.0771										35	117					OSMR (inh=n/a pLI=0.00)
chr5	38935101	38935101	G	C	hom		QUAL=10822;DP=178;AF=0.99;MQM=54;TRIO=HOM,178,0.99,HET,187,0.52,HET,229,0.50	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*1555G>C:	AluSp	rs357252	0.6404	0.0000	0/0/0	0.5581										55	70					OSMR (inh=n/a pLI=0.00)
chr5	38935412	38935414	CAA	-	hom		QUAL=23560;DP=367;AF=0.99;MQM=59;TRIO=HOM,367,0.99,HET,491,0.49,HET,624,0.48	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*1870_*1872delAAC:		rs16351	0.6432	0.0000	0/0/0	0.5550										55	70					OSMR (inh=n/a pLI=0.00)
chr5	38935682	38935682	C	T	hom		QUAL=6228;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HET,27,0.63,HET,51,0.25	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*2136C>T:		rs7318	0.3620	0.0000	0/0/0	0.0682										21	76					OSMR (inh=n/a pLI=0.00)
chr5	39285139	39285139	T	A	hom		QUAL=24140;DP=391;AF=0.99;MQM=59;TRIO=HOM,391,0.99,HOM,154,0.98,HOM,205,0.98	C9	3'UTR	C9:NM_001737.3:3'UTR:MODIFIER:exon11/11:c.*162A>T:		rs261738	0.8067	0.0000	0/0/0	0.1363										184	44					C9 (inh=n/a pLI=0.00)
chr5	39342308	39342308	C	T	het		QUAL=8217;DP=269;AF=0.49;MQM=60;TRIO=HET,269,0.49,HOM,150,1.00,WT,200,0.00	C9	splice_region&intron	C9:NM_001737.3:splice_region&intron:LOW:exon1/10:c.78-10G>A:		rs476569	0.6278	0.5350	18011/8200/3495	0.5255						120940 [C9 (confirmed) C9 deficiency|Macular degeneration,age-related,15,susceptibility to];				334	511					C9 (inh=n/a pLI=0.00)
chr5	40949997	40949997	C	T	hom		QUAL=17688;DP=147;AF=1.00;MQM=60;TRIO=HOM,147,1.00,HOM,191,1.00,HOM,213,1.00	C7	splice_region&intron	C7:NM_000587.2:splice_region&intron:LOW:exon8/17:c.983-9C>T:		rs1450656	0.6585	0.6050	12563/6452/1565	0.5809						217070 [C7 (confirmed) C7 deficiency];				460	488					C7 (inh=n/a pLI=0.00)
chr5	40955561	40955561	G	C	hom		QUAL=32233;DP=360;AF=1.00;MQM=60;TRIO=HOM,360,1.00,HOM,280,1.00,HOM,359,1.00	C7	missense	C7:NM_000587.2:missense:MODERATE:exon10/18:c.1166G>C:p.Ser389Thr		rs1063499	0.4812	0.5700	20093/12300/512	0.5549	1.3790	T	T,T	P	P	217070 [C7 (confirmed) C7 deficiency];			COSM3761227	389	536					C7 (inh=n/a pLI=0.00)
chr5	40981769	40981771	CTT	-	het		QUAL=8742;DP=364;AF=0.45;MQM=59;TRIO=HET,364,0.45,HET,438,0.52,WT,545,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*99_*101delTCT:		rs35249475	0.3009	0.0000	0/0/0	0.2178										12	87					C7 (inh=n/a pLI=0.00)
chr5	40982175	40982175	T	C	het		QUAL=5668;DP=243;AF=0.51;MQM=60;TRIO=HET,243,0.51,HET,190,0.51,WT,243,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*500T>C:		rs16870568	0.3015	0.0000	0/0/0	0.0404										11	76					C7 (inh=n/a pLI=0.00)
chr5	40982460	40982460	C	T	het		QUAL=1102;DP=93;AF=0.48;MQM=54;TRIO=HET,93,0.48,HET,11,0.36,WT,15,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*785C>T:	AluSx1	rs12153342	0.2240	0.0000	0/0/0	0.1947										13	83					C7 (inh=n/a pLI=0.00)
chr5	40982620	40982620	G	T	het		QUAL=2194;DP=151;AF=0.44;MQM=60;TRIO=HET,151,0.44,HET,61,0.46,WT,88,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*945G>T:		rs1061442	0.2238	0.0000	0/0/0	0.0279										12	87					C7 (inh=n/a pLI=0.00)
chr5	40982622	40982622	G	T	het		QUAL=2194;DP=151;AF=0.44;MQM=60;TRIO=HET,151,0.44,HET,61,0.46,WT,88,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*947G>T:		rs1061443	0.2113	0.0000	0/0/0	0.0276										12	87					C7 (inh=n/a pLI=0.00)
chr5	40982977	40982977	A	G	het		QUAL=1829;DP=162;AF=0.38;MQM=60;TRIO=HET,162,0.38,HET,26,0.46,WT,23,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*1302A>G:		rs14190	0.2115	0.0000	0/0/0	0.2113										12	84					C7 (inh=n/a pLI=0.00)
chr5	41142573	41142573	G	T	het		QUAL=4933;DP=300;AF=0.45;MQM=60;TRIO=HET,300,0.45,HET,112,0.45,WT,150,0.00	C6	3'UTR	C6:NM_000065.3:3'UTR:MODIFIER:exon18/18:c.*354C>A:,C6:NM_001115131.2:3'UTR:MODIFIER:exon18/18:c.*354C>A:		rs10067242	0.0172	0.0000	0/0/0	0.0033										0	21					C6 (inh=n/a pLI=0.00)
chr5	41142606	41142606	C	T	het		QUAL=6067;DP=377;AF=0.47;MQM=60;TRIO=HET,377,0.47,HET,134,0.44,WT,201,0.00	C6	3'UTR	C6:NM_000065.3:3'UTR:MODIFIER:exon18/18:c.*321G>A:,C6:NM_001115131.2:3'UTR:MODIFIER:exon18/18:c.*321G>A:		rs9200	0.6707	0.0000	0/0/0	0.0978										67	111					C6 (inh=n/a pLI=0.00)
chr5	41158863	41158863	G	A	hom		QUAL=25822;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,248,1.00,HOM,297,1.00	C6	synonymous	C6:NM_000065.3:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp,C6:NM_001115131.2:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp		rs6866352	0.9982	1.0000	60472/33296/5202	0.9448						217050 [C6 (confirmed) C6 deficiency|Combined C6/C7 deficiency];				1123	0					C6 (inh=n/a pLI=0.00)
chr5	41199959	41199959	G	T	het	phylop_high	QUAL=10556;DP=252;AF=0.52;MQM=60;TRIO=HET,252,0.52,HET,261,0.48,HET,314,0.47	C6	missense	C6:NM_000065.3:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu,C6:NM_001115131.2:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu		rs1801033	0.5539	0.5930	21755/13246/1588	0.5828	2.5510	T	T,T,T	B	B	217050 [C6 (confirmed) C6 deficiency|Combined C6/C7 deficiency];			COSM4159876	459	503					C6 (inh=n/a pLI=0.00)
chr5	52394019	52394019	C	-	het		QUAL=1192;DP=70;AF=0.49;MQM=60;TRIO=HET,70,0.49,HET,21,0.52,HET,24,0.46	MOCS2	3'UTR	MOCS2:NM_004531.4:3'UTR:MODIFIER:exon7/7:c.*413delG:,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon7/7:c.*900delG:		rs3839261	0.1520	0.0000	0/0/0	0.1247										3	57					MOCS2 (inh=AR pLI=0.04)
chr5	52397311	52397311	T	C	het		QUAL=3770;DP=187;AF=0.51;MQM=60;TRIO=HET,187,0.51,HET,83,0.57,WT,114,0.00	MOCS2	synonymous,3'UTR	MOCS2:NM_004531.4:synonymous:LOW:exon5/7:c.255A>G:p.Lys85Lys,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon5/7:c.*175A>G:		rs2233216	0.0363	0.0380	120/49/3	0.0376						603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				2	88					MOCS2 (inh=AR pLI=0.04)
chr5	52398005	52398005	T	C	het	phylop_high;pred_pathogenic_1	QUAL=6455;DP=306;AF=0.44;MQM=60;TRIO=HET,306,0.44,HET,178,0.60,WT,276,0.00	MOCS2	missense,3'UTR	MOCS2:NM_004531.4:missense:MODERATE:exon4/7:c.148A>G:p.Thr50Ala,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon4/7:c.*68A>G:		rs2233213	0.0363	0.0380	116/47/3	0.0385	4.5420	T	T,D	P	B	603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				2	92	1	[1] ahbuchr1 18.04.2016 MAF>5%			MOCS2 (inh=AR pLI=0.04)
chr5	52405174	52405174	C	A	het		QUAL=6401;DP=121;AF=0.58;MQM=60;TRIO=HET,121,0.58,HET,119,0.60,HET,204,0.51	MOCS2	5'UTR_premature_start_codon_gain,5'UTR,intron	MOCS2:NM_004531.4:5'UTR_premature_start_codon_gain:LOW:exon1/7:c.-263G>T:,MOCS2:NM_004531.4:5'UTR:MODIFIER:exon1/7:c.-263G>T:,MOCS2:NM_176806.3:intron:MODIFIER:exon1/6:c.18+368G>T:		rs77585010	0.0000	0.0000	0/0/0	0.1085						603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				3	57					MOCS2 (inh=AR pLI=0.04)
chr5	52942083	52942083	A	C	hom		QUAL=17221;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,126,1.00,HOM,209,1.00	NDUFS4	synonymous,non_coding_exon	NDUFS4:NM_002495.3:synonymous:LOW:exon3/5:c.198A>C:p.Gly66Gly,NDUFS4:NM_001318051.1:synonymous:LOW:exon3/4:c.198A>C:p.Gly66Gly,NDUFS4:NR_134473.1:non_coding_exon:MODIFIER:exon4/6:n.400A>C:,NDUFS4:NR_134474.1:non_coding_exon:MODIFIER:exon4/6:n.317A>C:,NDUFS4:NR_134475.1:non_coding_exon:MODIFIER:exon4/6:n.352A>C:		rs31304	0.9435	0.9550	54795/30657/4900	0.9383						602694 [NDUFS4 (provisional) Leigh syndrome|Mitochondrial complex I deficiency];	RCV000117714.2 [likely benign]; 			1011	91					NDUFS4 (inh=AR pLI=0.00)
chr5	52942197	52942197	A	G	het		QUAL=7848;DP=400;AF=0.52;MQM=60;TRIO=HET,400,0.52,HET,189,0.48,WT,294,0.00	NDUFS4	synonymous,non_coding_exon	NDUFS4:NM_002495.3:synonymous:LOW:exon3/5:c.312A>G:p.Arg104Arg,NDUFS4:NM_001318051.1:synonymous:LOW:exon3/4:c.312A>G:p.Arg104Arg,NDUFS4:NR_134473.1:non_coding_exon:MODIFIER:exon4/6:n.514A>G:,NDUFS4:NR_134474.1:non_coding_exon:MODIFIER:exon4/6:n.431A>G:,NDUFS4:NR_134475.1:non_coding_exon:MODIFIER:exon4/6:n.466A>G:		rs31303	0.8001	0.7730	36419/19269/3799	0.7649						602694 [NDUFS4 (provisional) Leigh syndrome|Mitochondrial complex I deficiency];	RCV000117715.2 [likely benign]; 		COSM4159887	602	419					NDUFS4 (inh=AR pLI=0.00)
chr5	52979097	52979097	G	A	het		QUAL=5923;DP=294;AF=0.51;MQM=60;TRIO=HET,294,0.51,HET,138,0.50,WT,175,0.01	NDUFS4	3'UTR,non_coding_exon	NDUFS4:NM_002495.3:3'UTR:MODIFIER:exon5/5:c.*46G>A:,NDUFS4:NM_001318051.1:3'UTR:MODIFIER:exon4/4:c.*137G>A:,NDUFS4:NR_134473.1:non_coding_exon:MODIFIER:exon6/6:n.776G>A:,NDUFS4:NR_134474.1:non_coding_exon:MODIFIER:exon6/6:n.693G>A:,NDUFS4:NR_134475.1:non_coding_exon:MODIFIER:exon6/6:n.728G>A:		rs567	0.3786	0.4460	12338/7266/394	0.4356										48	114					NDUFS4 (inh=AR pLI=0.00)
chr5	55660603	55660603	T	G	het		QUAL=8189;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,HET,155,0.50,HET,210,0.47	ANKRD55-LOC102467147	intergenic_region	ANKRD55-LOC102467147:ANKRD55-LOC102467147:intergenic_region:MODIFIER::n.55660603T>G:	L2c	rs1900155	0.3728	0.0000	0/0/0	0.3621										24	80					ANKRD55-LOC102467147 (inh=n/a pLI=n/a)
chr5	60170337	60170337	A	G	het		QUAL=5724;DP=204;AF=0.52;MQM=60;TRIO=HET,204,0.52,HOM,52,0.98,HET,79,0.53	ERCC8	3'UTR	ERCC8:NM_000082.3:3'UTR:MODIFIER:exon12/12:c.*105T>C:,ERCC8:NM_001007233.2:3'UTR:MODIFIER:exon13/13:c.*105T>C:,ERCC8:NM_001290285.1:3'UTR:MODIFIER:exon11/11:c.*105T>C:		rs3117	0.3067	0.0000	0/0/0	0.0640										48	146					ERCC8 (inh=AR pLI=0.00)
chr5	60240986	60240986	A	G	het		QUAL=7404;DP=282;AF=0.47;MQM=59;TRIO=HET,282,0.47,WT,273,0.00,HET,372,0.47	NDUFAF2	5'UTR	NDUFAF2:NM_174889.4:5'UTR:MODIFIER:exon1/4:c.-97A>G:		rs158922	0.7242	0.0000	0/0/0	0.6317										96	109					NDUFAF2 (inh=n/a pLI=0.00)
chr5	60241142	60241142	G	A	het		QUAL=7788;DP=238;AF=0.51;MQM=54;TRIO=HET,238,0.51,WT,334,0.00,HET,414,0.48	NDUFAF2	synonymous	NDUFAF2:NM_174889.4:synonymous:LOW:exon1/4:c.60G>A:p.Lys20Lys		rs158921	0.6929	0.6420	23562/10617/1815	0.6318						609653 [NDUFAF2 (provisional) Mitochondrial complex I deficiency|Leigh syndrome];	RCV000117705.2 [likely benign]; 		COSM3761271	342	618					NDUFAF2 (inh=n/a pLI=0.00)
chr5	68788261	68788261	G	A	hom		QUAL=10225;DP=51;AF=1.00;MQM=59;TRIO=HOM,51,1.00,HOM,130,1.00,HOM,162,0.99	OCLN	5'UTR	OCLN:NM_002538.3:5'UTR:MODIFIER:exon1/9:c.-294G>A:		rs3733742	0.8516	0.0000	0/0/0	0.8277										172	54					OCLN (inh=AR pLI=0.49)
chr5	68850922	68850922	G	C	het	low_MQM	QUAL=215;DP=45;AF=0.38;MQM=28;TRIO=HET,45,0.38,HOM,6,1.00,WT,11,0.00	OCLN	3'UTR	OCLN:NM_001205254.1:3'UTR:MODIFIER:exon9/9:c.*1424G>C:,OCLN:NM_002538.3:3'UTR:MODIFIER:exon9/9:c.*1424G>C:,OCLN:NM_001205255.1:3'UTR:MODIFIER:exon7/7:c.*1424G>C:	AluSx4	rs76123058	0.5627	0.0000	0/0/0	0.1248										73	45					OCLN (inh=AR pLI=0.49)
chr5	68853877	68853877	C	T	het	low_MQM	QUAL=6382;DP=341;AF=0.33;MQM=28;TRIO=HET,341,0.33,WT,198,0.01,HET,385,0.65	OCLN	3'UTR	OCLN:NM_001205254.1:3'UTR:MODIFIER:exon9/9:c.*4379C>T:,OCLN:NM_002538.3:3'UTR:MODIFIER:exon9/9:c.*4379C>T:,OCLN:NM_001205255.1:3'UTR:MODIFIER:exon7/7:c.*4379C>T:		rs200773462	0.0000	0.0000	0/0/0	0.0264										2	41					OCLN (inh=AR pLI=0.49)
chr5	70883136	70883136	A	G	het	low_DP	QUAL=1130;DP=6;AF=0.67;MQM=59;TRIO=HET,6,0.67,HOM,28,1.00,HET,34,0.35	MCCC2	5'UTR	MCCC2:NM_022132.4:5'UTR:MODIFIER:exon1/17:c.-117A>G:		rs11746722	0.0000	0.0000	0/0/0	0.1160										218	78					MCCC2 (inh=n/a pLI=0.00)
chr5	70945075	70945075	A	G	hom		QUAL=24705;DP=223;AF=0.99;MQM=59;TRIO=HOM,223,0.99,HOM,252,1.00,HOM,305,1.00	MCCC2	synonymous	MCCC2:NM_022132.4:synonymous:LOW:exon14/17:c.1368A>G:p.Ala456Ala		rs10064079	0.8514	0.8780	47117/25267/2558	0.8559						609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency];	RCV000082093.4 [benign]; 			856	228					MCCC2 (inh=n/a pLI=0.00)
chr5	70952934	70952934	C	T	hom		QUAL=21922;DP=377;AF=1.00;MQM=59;TRIO=HOM,377,1.00,HOM,124,1.00,HOM,150,1.00	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*247C>T:	MIR	rs1135667	0.8111	0.0000	0/0/0	0.1339										163	44					MCCC2 (inh=n/a pLI=0.00)
chr5	70953280	70953280	G	T	het		QUAL=4434;DP=200;AF=0.53;MQM=59;TRIO=HET,200,0.53,WT,138,0.00,HET,245,0.36	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*593G>T:	AluSz	rs60069076	0.1154	0.0000	0/0/0	0.0836										1	26					MCCC2 (inh=n/a pLI=0.00)
chr5	70953930	70953930	G	C	hom		QUAL=38850;DP=419;AF=1.00;MQM=59;TRIO=HOM,419,1.00,HOM,292,1.00,HOM,482,1.00	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*1243G>C:	L2c	rs7731970	0.0000	0.0000	0/0/0	0.1078										127	35					MCCC2 (inh=n/a pLI=0.00)
chr5	73981270	73981270	T	C	hom	low_DP;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=4412;DP=17;AF=0.94;MQM=59;TRIO=HOM,17,0.94,HOM,86,1.00,HET,144,0.40	HEXB	missense,intron	HEXB:NM_000521.3:missense:MODERATE:exon1/14:c.185T>C:p.Leu62Ser,HEXB:NM_001292004.1:intron:MODIFIER:exon1/13:c.-376-3883T>C:		rs820878	0.9814	0.9700	53506/28644/4303	0.9328	0.9630	T	T			606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000004086.2 [pathogenic]; RCV000153357.2 [benign]; 	CM952225 [CLASS=DM? MUT=REF PHEN="Sandhoff disease" GENE=HEXB]; 	COSM450042	2095	140	2	[2] old entry - no details available [import GPD] Julia Bickmann 2014-04-01 14:28:01 -type: mutation details L62S wurde bisher nur einmal im Zusammenhang mit einer infantilen Sandhoff-Erkrankung beschrieben (Zhang et al., 1995); das Kind trug eine 50kb-Deletion auf dem anderen HEXB-Allel; die Hexosaminidase-Aktivit?t war nicht bestimmt worden. In Abh?ngigkeit von der Restaktivit?t der HEX kann bei HEXB-Mutationen ein breites Symptomenspektrum bis hin zur Symptomfreiheit bestehen.  Die HEX-Akt. Bestimmung ist daher obligat.			HEXB (inh=AR pLI=0.00)
chr5	73985215	73985215	A	G	het		QUAL=9391;DP=365;AF=0.48;MQM=60;TRIO=HET,365,0.48,WT,301,0.00,HET,344,0.51	HEXB	missense,5'UTR	HEXB:NM_000521.3:missense:MODERATE:exon2/14:c.362A>G:p.Lys121Arg,HEXB:NM_001292004.1:5'UTR:MODIFIER:exon2/14:c.-314A>G:		rs11556045	0.2226	0.1990	2615/1053/383	0.1948	-0.9130	T	T	B	B	606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000004078.2 [benign]; RCV000079063.4 [benign]; 		COSM149850	93	623					HEXB (inh=AR pLI=0.00)
chr5	74009327	74009327	A	G	het		QUAL=5289;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,HET,203,0.58,WT,248,0.00	HEXB	splice_region&intron	HEXB:NM_000521.3:splice_region&intron:LOW:exon6/13:c.772-4A>G:,HEXB:NM_001292004.1:splice_region&intron:LOW:exon6/13:c.97-4A>G:		rs17561000	0.0395	0.0730	502/386/2	0.0719						606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000079066.4 [benign]; 			19	341					HEXB (inh=AR pLI=0.00)
chr5	76704849	76704849	T	C	hom		QUAL=23492;DP=244;AF=1.00;MQM=59;TRIO=HOM,244,1.00,HOM,211,1.00,HOM,284,1.00	PDE8B	synonymous,intron	PDE8B:NM_003719.3:synonymous:LOW:exon14/22:c.1497T>C:p.Pro499Pro,PDE8B:NM_001029851.2:synonymous:LOW:exon11/19:c.1206T>C:p.Pro402Pro,PDE8B:NM_001029853.2:synonymous:LOW:exon13/21:c.1437T>C:p.Pro479Pro,PDE8B:NM_001029854.2:synonymous:LOW:exon13/21:c.1356T>C:p.Pro452Pro,PDE8B:NM_001029852.2:intron:MODIFIER:exon13/20:c.1365+1567T>C:		rs186753	0.0000	1.0000	60699/33367/5201	0.9123						603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3|Striatal degeneration,autosomal dominant];				1107	0					PDE8B (inh=n/a pLI=0.99)
chr5	76722442	76722442	C	T	het		QUAL=7617;DP=347;AF=0.54;MQM=60;TRIO=HET,347,0.54,HET,150,0.61,WT,179,0.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*63C>T:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*63C>T:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:		rs62362531	0.1098	0.0000	0/0/0	0.0281										7	81					PDE8B (inh=n/a pLI=0.99)
chr5	76722443	76722443	G	A	het		QUAL=11334;DP=346;AF=0.45;MQM=59;TRIO=HET,346,0.45,HET,150,0.39,HOM,177,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*64G>A:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*64G>A:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:		rs40594	0.6611	0.0000	0/0/0	0.1113										93	161					PDE8B (inh=n/a pLI=0.99)
chr5	76722877	76722877	C	-	het		QUAL=7042;DP=294;AF=0.37;MQM=59;TRIO=HET,294,0.48,WT,93,0.55,HET,126,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*498delC:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*498delC:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*498delC:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*498delC:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*498delC:		rs567378113	0.0000	0.0000	0/0/0	0.0422										1	9					PDE8B (inh=n/a pLI=0.99)
chr5	76722891	76722891	T	C	het		QUAL=9578;DP=304;AF=0.49;MQM=59;TRIO=HET,304,0.49,HET,96,0.51,HOM,143,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*512T>C:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*512T>C:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:		rs460267	0.4455	0.0000	0/0/0	0.4044										48	116					PDE8B (inh=n/a pLI=0.99)
chr5	76723227	76723228	AA	-	hom		QUAL=1218;DP=35;AF=0.80;MQM=59;TRIO=HOM,35,0.80,HOM,3,1.00,HOM,17,0.71	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*863_*864delAA:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*863_*864delAA:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:	(A)n	rs771815865	0.6236	0.0000	0/0/0	0.2811										35	93					PDE8B (inh=n/a pLI=0.99)
chr5	77425028	77425028	A	T	hom	phylop_high	QUAL=12409;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,97,1.00,HET,158,0.45	AP3B1	missense	AP3B1:NM_003664.4:missense:MODERATE:exon16/27:c.1754T>A:p.Val585Glu,AP3B1:NM_001271769.1:missense:MODERATE:exon16/27:c.1607T>A:p.Val536Glu		rs6453373	0.0000	0.8630	46196/28358/4696	0.8285	6.3070	T	T,T,T,T	B	B	603401 [AP3B1 (provisional) Hermansky-Pudlak syndrome 2];	RCV000150163.1 [benign]; 			925	168					AP3B1 (inh=AR pLI=1.00)
chr5	78073245	78073245	C	A	hom		QUAL=8578;DP=105;AF=1.00;MQM=60;TRIO=HOM,105,1.00,HOM,70,1.00,HOM,87,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*2975G>T:	L1MB5	rs3088247	0.7374	0.0000	0/0/0	0.1248										100	55					ARSB (inh=n/a pLI=0.00)
chr5	78074198	78074198	A	C	het		QUAL=18779;DP=419;AF=0.48;MQM=60;TRIO=HET,419,0.48,WT,300,0.00,HOM,407,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*2022T>G:		rs7704939	0.4467	0.0000	0/0/0	0.0705										45	105					ARSB (inh=n/a pLI=0.00)
chr5	78074751	78074751	G	A	het		QUAL=2370;DP=166;AF=0.50;MQM=59;TRIO=HET,166,0.50,WT,24,0.00,HET,26,0.50	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*1469C>T:	AluJr	rs55710452	0.0427	0.0000	0/0/0	0.0635										4	36					ARSB (inh=n/a pLI=0.00)
chr5	78074918	78074918	C	A	het		QUAL=4624;DP=148;AF=0.53;MQM=60;TRIO=HET,148,0.53,HET,48,0.60,HOM,62,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*1302G>T:		rs754566	0.5026	0.0000	0/0/0	0.0872										73	107					ARSB (inh=n/a pLI=0.00)
chr5	78135201	78135201	C	T	het		QUAL=2336;DP=158;AF=0.38;MQM=60;TRIO=HET,158,0.38,HET,70,0.51,WT,123,0.00	ARSB	synonymous	ARSB:NM_000046.3:synonymous:LOW:exon6/8:c.1191G>A:p.Pro397Pro,ARSB:NM_198709.2:synonymous:LOW:exon7/8:c.1191G>A:p.Pro397Pro		rs25413	0.2592	0.2010	3295/1263/1388	0.1971						611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000078001.4 [benign]; 		COSM3761329, COSM3761330	71	371					ARSB (inh=n/a pLI=0.00)
chr5	78181477	78181477	C	T	het	phylop_high;pred_pathogenic_2	QUAL=10429;DP=288;AF=0.54;MQM=59;TRIO=HET,288,0.54,HET,211,0.52,HET,300,0.49	ARSB	missense	ARSB:NM_000046.3:missense:MODERATE:exon5/8:c.1072G>A:p.Val358Met,ARSB:NM_198709.2:missense:MODERATE:exon6/8:c.1072G>A:p.Val358Met		rs1065757	0.2855	0.3910	10273/6619/62	0.3851	3.9850	T	T,T	D,D	D,D	611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000077997.4 [benign]; 	CM088428 [CLASS=FP MUT=ALT PHEN="Reduced activity" GENE=ARSB]; 		175	517					ARSB (inh=n/a pLI=0.00)
chr5	78181577	78181577	T	C	het		QUAL=4922;DP=160;AF=0.49;MQM=60;TRIO=HET,160,0.49,WT,192,0.00,HET,253,0.51	ARSB	synonymous	ARSB:NM_000046.3:synonymous:LOW:exon5/8:c.972A>G:p.Gly324Gly,ARSB:NM_198709.2:synonymous:LOW:exon6/8:c.972A>G:p.Gly324Gly		rs72762973	0.0266	0.0530	221/173/3	0.0521						611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000078006.4 [benign]; 			5	91					ARSB (inh=n/a pLI=0.00)
chr5	78281373	78281373	T	C	hom		QUAL=13240;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,79,1.00,HOM,96,1.00	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-302A>G:,ARSB:NM_198709.2:5'UTR:MODIFIER:exon2/8:c.-302A>G:		rs163127	0.9052	0.0000	0/0/0	0.9516										226	4					ARSB (inh=n/a pLI=0.00)
chr5	78281635	78281635	T	C	het		QUAL=7383;DP=363;AF=0.52;MQM=60;TRIO=HET,363,0.52,HET,230,0.50,WT,258,0.00	ARSB	5'UTR,intron	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-564A>G:,ARSB:NM_198709.2:intron:MODIFIER:exon1/7:c.-311+87A>G:		rs59558132	0.1719	0.0000	0/0/0	0.1694										14	68					ARSB (inh=n/a pLI=0.00)
chr5	78281909	78281909	-	TG	hom		QUAL=30786;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HOM,266,1.00,HOM,375,0.99	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-840_-839dupCA:		rs397805372	0.9519	0.0000	0/0/0	0.8971										225	4					ARSB (inh=n/a pLI=0.00)
chr5	78281977	78281977	G	C	het		QUAL=11600;DP=530;AF=0.50;MQM=59;TRIO=HET,530,0.50,HET,307,0.54,WT,402,0.00	ARSB	5'UTR_premature_start_codon_gain,5'UTR	ARSB:NM_000046.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-906C>G:,ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-906C>G:		rs62377914	0.1456	0.0000	0/0/0	0.1627										13	65					ARSB (inh=n/a pLI=0.00)
chr5	78282029	78282029	T	C	het		QUAL=10920;DP=554;AF=0.48;MQM=59;TRIO=HET,554,0.48,HET,260,0.54,WT,362,0.00	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-958A>G:		rs57586329	0.1629	0.0000	0/0/0	0.1676										12	59					ARSB (inh=n/a pLI=0.00)
chr5	78282249	78282249	T	C	het		QUAL=11762;DP=291;AF=0.55;MQM=60;TRIO=HET,291,0.55,HET,130,0.54,HOM,171,1.00	ARSB	5'UTR_premature_start_codon_gain,5'UTR	ARSB:NM_000046.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-1178A>G:,ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-1178A>G:	LTR37A	rs163126	0.8163	0.0000	0/0/0	0.8080										108	48					ARSB (inh=n/a pLI=0.00)
chr5	88015545	88015545	A	C	hom		QUAL=15078;DP=317;AF=0.00;MQM=60;TRIO=HOM,317,0.00,HET,98,0.39,HET,115,0.00	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2876T>G:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2876T>G:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2876T>G:,MEF2C:NM_001308002.1:3'UTR:MODIFIER:exon9/9:c.*2876T>G:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2876T>G:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2876T>G:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2876T>G:		rs34316	0.4824	0.0000	0/0/0	0.0907										61	123					MEF2C (inh=n/a pLI=0.00)
chr5	88016008	88016008	A	G	hom		QUAL=30854;DP=452;AF=1.00;MQM=59;TRIO=HOM,452,1.00,HOM,311,1.00,HET,454,0.48	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2413T>C:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2413T>C:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2413T>C:,MEF2C:NM_001308002.1:3'UTR:MODIFIER:exon9/9:c.*2413T>C:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2413T>C:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2413T>C:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2413T>C:		rs34317	0.7013	0.0000	0/0/0	0.1247										114	98					MEF2C (inh=n/a pLI=0.00)
chr5	88016153	88016153	-	T	hom		QUAL=6856;DP=213;AF=0.82;MQM=59;TRIO=HOM,213,0.82,HOM,57,0.86,HET,89,0.40	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2267dupA:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2267dupA:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2267dupA:,MEF2C:NM_001308002.1:3'UTR:MODIFIER:exon9/9:c.*2267dupA:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2267dupA:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2267dupA:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2267dupA:		rs3841444;rs398109145	0.6384	0.0000	0/0/0	0.3821										14	156					MEF2C (inh=n/a pLI=0.00)
chr5	88016605	88016605	T	-	hom		QUAL=9887;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HOM,29,1.00,HET,35,0.63	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*1816delA:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*1816delA:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*1816delA:,MEF2C:NM_001308002.1:3'UTR:MODIFIER:exon9/9:c.*1816delA:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*1816delA:		rs397780880	0.4828	0.0000	0/0/0	0.4628										66	117					MEF2C (inh=n/a pLI=0.00)
chr5	88179070	88179070	A	G	het	low_DP	QUAL=111;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,17,0.00,HET,16,0.44	MEF2C	5'UTR,intron	MEF2C:NM_001193350.1:5'UTR:MODIFIER:exon1/11:c.-438T>C:,MEF2C:NM_002397.4:5'UTR:MODIFIER:exon1/11:c.-441T>C:,MEF2C:NM_001193347.1:intron:MODIFIER:exon2/11:c.-143+4249T>C:,MEF2C:NM_001131005.2:intron:MODIFIER:exon2/10:c.-143+4249T>C:	(GC)n		0.0000	0.0000	0/0/0	0.0003										2	26					MEF2C (inh=n/a pLI=0.00)
chr5	90107108	90107108	A	G	hom		QUAL=14045;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HOM,101,1.00,HOM,153,1.00	ADGRV1	missense,non_coding_exon	ADGRV1:NM_032119.3:missense:MODERATE:exon74/90:c.16031A>G:p.Glu5344Gly,ADGRV1:NR_003149.1:non_coding_exon:MODIFIER:exon74/90:n.16044A>G:		rs2438374	0.9461	0.9680	56122/31251/3507	0.9401	1.3490	T	T,T,T	B,B,B	B,B,B		RCV000039538.8 [other]; 			1032	69					ADGRV1 (inh=n/a pLI=0.00)
chr5	90119324	90119324	G	A	hom		QUAL=34744;DP=393;AF=1.00;MQM=60;TRIO=HOM,393,1.00,HOM,298,1.00,HOM,380,1.00	ADGRV1	missense,non_coding_exon	ADGRV1:NM_032119.3:missense:MODERATE:exon76/90:c.16279G>A:p.Val5427Met,ADGRV1:NR_003149.1:non_coding_exon:MODIFIER:exon76/90:n.16292G>A:		rs2438378	0.9722	0.9920	59457/33328/4077	0.9247	-0.0070	T	T,T,T	B,B,B	B,B,B		RCV000039541.5 [other]; 			1105	5					ADGRV1 (inh=n/a pLI=0.00)
chr5	90151589	90151589	G	A	het	phylop_high	QUAL=6450;DP=244;AF=0.46;MQM=60;TRIO=HET,244,0.46,HOM,121,0.99,WT,156,0.00	ADGRV1	missense,non_coding_exon	ADGRV1:NM_032119.3:missense:MODERATE:exon82/90:c.17626G>A:p.Val5876Ile,ADGRV1:NR_003149.1:non_coding_exon:MODIFIER:exon82/90:n.17639G>A:		rs2247870	0.4591	0.5360	18353/9977/172	0.5294	2.8990	T	T,T,T	B,P,B	B,B,B		RCV000039547.4 [other]; 		COSM149886	313	525					ADGRV1 (inh=n/a pLI=0.00)
chr5	90449031	90449031	T	C	hom		QUAL=14009;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,115,1.00,HOM,151,1.00	ADGRV1	splice_region&intron	ADGRV1:NM_032119.3:splice_region&intron:LOW:exon88/89:c.18625-7T>C:,ADGRV1:NR_003149.1:splice_region&intron:LOW:exon88/89:n.18638-7T>C:		rs7726023	0.8984	0.9180	41170/23329/2844	0.9024							RCV000154372.1 [benign]; RCV000039555.4 [other]; 			969	128					ADGRV1 (inh=n/a pLI=0.00)
chr5	118788196	118788196	C	G	het		QUAL=9595;DP=183;AF=0.57;MQM=59;TRIO=HET,183,0.57,WT,164,0.01,HOM,243,1.00	HSD17B4	5'UTR	HSD17B4:NM_001199291.2:5'UTR:MODIFIER:exon1/25:c.-253C>G:,HSD17B4:NM_000414.3:5'UTR:MODIFIER:exon1/24:c.-75C>G:,HSD17B4:NM_001199292.1:5'UTR:MODIFIER:exon1/23:c.-75C>G:,HSD17B4:NM_001292027.1:5'UTR:MODIFIER:exon1/25:c.-212C>G:,HSD17B4:NM_001292028.1:5'UTR:MODIFIER:exon1/24:c.-674C>G:		rs26180	0.4064	0.0000	0/0/0	0.0852										65	114					HSD17B4 (inh=AR pLI=0.00)
chr5	118811533	118811533	G	A	het	phylop_high;pred_pathogenic_2;anno_pathogenic_clinvar	QUAL=11627;DP=385;AF=0.51;MQM=59;TRIO=HET,385,0.51,WT,139,0.00,HOM,191,1.00	HSD17B4	missense,5'UTR	HSD17B4:NM_001199291.2:missense:MODERATE:exon7/25:c.392G>A:p.Arg131His,HSD17B4:NM_000414.3:missense:MODERATE:exon6/24:c.317G>A:p.Arg106His,HSD17B4:NM_001199292.1:missense:MODERATE:exon5/23:c.263G>A:p.Arg88His,HSD17B4:NM_001292027.1:missense:MODERATE:exon7/25:c.245G>A:p.Arg82His,HSD17B4:NM_001292028.1:5'UTR:MODIFIER:exon6/24:c.-95G>A:		rs25640	0.3626	0.4400	12496/7227/164	0.4357	7.6330	T	D,D,D,D	D,D,D,D	P,B,P,B	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency|Perrault syndrome 1];	RCV000179310.2 [benign]; RCV000008096.2 [pathogenic]; 		COSM1432658	361	740	2	[2] Ute Grasshoff 08.07.2014			HSD17B4 (inh=AR pLI=0.00)
chr5	118861713	118861713	A	G	het	phylop_high	QUAL=12673;DP=284;AF=0.45;MQM=60;TRIO=HET,284,0.45,WT,229,0.00,HOM,283,1.00	HSD17B4	missense	HSD17B4:NM_001199291.2:missense:MODERATE:exon20/25:c.1750A>G:p.Ile584Val,HSD17B4:NM_000414.3:missense:MODERATE:exon19/24:c.1675A>G:p.Ile559Val,HSD17B4:NM_001199292.1:missense:MODERATE:exon18/23:c.1621A>G:p.Ile541Val,HSD17B4:NM_001292027.1:missense:MODERATE:exon20/25:c.1603A>G:p.Ile535Val,HSD17B4:NM_001292028.1:missense:MODERATE:exon19/24:c.1255A>G:p.Ile419Val		rs11205	0.4002	0.4110	10654/5794/812	0.4033	3.8360	T	T,T,T,T,T,T,T	P,B,B,B,B	B,B,B,B,B	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency|Perrault syndrome 1];	RCV000221678.1 [benign]; 		COSM1130959	340	876					HSD17B4 (inh=AR pLI=0.00)
chr5	118877933	118877933	-	A	het		QUAL=5117;DP=270;AF=0.45;MQM=59;TRIO=HET,270,0.45,WT,76,0.01,HOM,88,0.97	HSD17B4	3'UTR	HSD17B4:NM_001199291.2:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:NM_000414.3:3'UTR:MODIFIER:exon24/24:c.*250dupA:,HSD17B4:NM_001199292.1:3'UTR:MODIFIER:exon23/23:c.*250dupA:,HSD17B4:NM_001292027.1:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:NM_001292028.1:3'UTR:MODIFIER:exon24/24:c.*250dupA:		rs149778406;rs34381335	0.5639	0.0000	0/0/0	0.4964										84	104					HSD17B4 (inh=AR pLI=0.00)
chr5	125877635	125877635	A	G	hom		QUAL=3793;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HET,32,0.59,HOM,30,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*3022T>C:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*3022T>C:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*3022T>C:		rs2035471	0.4718	0.0000	0/0/0	0.0867										44	69					ALDH7A1 (inh=AR pLI=0.00)
chr5	125877659	125877659	-	A	hom		QUAL=2938;DP=48;AF=0.81;MQM=60;TRIO=HOM,48,0.81,HOM,26,0.81,HOM,31,0.90	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*2997dupT:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*2997dupT:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*2997dupT:		rs397760043	0.9625	0.0000	0/0/0	0.3297										44	106					ALDH7A1 (inh=AR pLI=0.00)
chr5	125877838	125877838	G	A	hom		QUAL=1231;DP=47;AF=0.32;MQM=57;TRIO=HOM,47,0.32,HOM,12,0.33,HOM,19,0.11	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*2819C>T:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*2819C>T:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*2819C>T:			0.0000	0.0000	0/0/0	0.0005										0	11					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878158	125878158	C	T	hom		QUAL=18498;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HET,176,0.47,HOM,230,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*2499G>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*2499G>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*2499G>A:	AluJr	rs7715516	0.4856	0.0000	0/0/0	0.0849										44	70					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878908	125878908	C	A	hom		QUAL=19970;DP=390;AF=0.99;MQM=59;TRIO=HOM,390,0.99,HET,226,0.54,HET,328,0.49	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1749G>T:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1749G>T:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1749G>T:		rs744722	0.3732	0.0000	0/0/0	0.2795										34	107					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878909	125878909	A	T	hom		QUAL=19970;DP=390;AF=0.99;MQM=59;TRIO=HOM,390,0.99,HET,226,0.54,HET,328,0.49	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1748T>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1748T>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1748T>A:		rs744721	0.3732	0.0000	0/0/0	0.2767										34	107					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878955	125878955	A	-	hom		QUAL=22583;DP=397;AF=0.99;MQM=59;TRIO=HOM,397,0.99,HET,153,0.55,HOM,232,0.99	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1702delT:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1702delT:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1702delT:		rs796838466	0.5705	0.0000	0/0/0	0.5105										66	107					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879549	125879549	C	T	hom		QUAL=12141;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HET,94,0.47,HOM,103,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1108G>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1108G>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1108G>A:		rs1483780	0.4916	0.0000	0/0/0	0.0900										65	111					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879677	125879677	G	T	het		QUAL=71;DP=136;AF=0.14;MQM=60;TRIO=HET,136,0.14,HET,41,0.12,HET,58,0.26	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*980C>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*980C>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*980C>A:	AluSx1	rs74892068	0.0000	0.0000	0/0/0	0.0003										0	18					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879850	125879850	G	C	hom		QUAL=2106;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HET,3,0.33,HOM,6,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*807C>G:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*807C>G:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*807C>G:	AluSx1	rs1807	0.5759	0.0000	0/0/0	0.5148										63	84					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879981	125879981	G	A	hom		QUAL=4828;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HOM,32,1.00,HOM,35,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*676C>T:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*676C>T:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*676C>T:		rs7447380	0.9974	0.0000	0/0/0	0.1496										230	0					ALDH7A1 (inh=AR pLI=0.00)
chr5	125880589	125880589	T	C	hom		QUAL=10830;DP=209;AF=1.00;MQM=58;TRIO=HOM,209,1.00,HET,128,0.45,HET,161,0.57	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*68A>G:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*68A>G:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*68A>G:		rs2775	0.3606	0.0000	0/0/0	0.0868										35	109					ALDH7A1 (inh=AR pLI=0.00)
chr5	125931022	125931022	T	G	hom		QUAL=1293;DP=24;AF=1.00;MQM=59;TRIO=HOM,24,1.00,HET,30,0.40,HET,33,0.52	ALDH7A1	5'UTR	ALDH7A1:NM_001182.4:5'UTR:MODIFIER:exon1/18:c.-132A>C:,ALDH7A1:NM_001201377.1:5'UTR:MODIFIER:exon1/18:c.-216A>C:,ALDH7A1:NM_001202404.1:5'UTR:MODIFIER:exon1/16:c.-132A>C:		rs900641	0.2464	0.0000	0/0/0	0.0210										0	66					ALDH7A1 (inh=AR pLI=0.00)
chr5	126112580	126112580	T	C	het		QUAL=462;DP=35;AF=0.40;MQM=60;TRIO=HET,35,0.40,HET,33,0.36,WT,43,0.00	LMNB1	5'UTR,non_coding_exon	LMNB1:NM_005573.3:5'UTR:MODIFIER:exon1/11:c.-621T>C:,LMNB1:NR_134488.1:non_coding_exon:MODIFIER:exon1/12:n.266T>C:		rs35091677	0.2324	0.0000	0/0/0	0.2185										7	47					LMNB1 (inh=AD pLI=0.95)
chr5	126171999	126171999	T	C	hom		QUAL=17467;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,116,1.00,HOM,198,1.00	LMNB1	3'UTR,non_coding_exon	LMNB1:NM_005573.3:3'UTR:MODIFIER:exon11/11:c.*43T>C:,LMNB1:NM_001198557.1:3'UTR:MODIFIER:exon11/11:c.*43T>C:,LMNB1:NR_134488.1:non_coding_exon:MODIFIER:exon12/12:n.2768T>C:		rs1051643	0.6727	0.6750	27655/14739/2303	0.6616										221	188					LMNB1 (inh=AD pLI=0.95)
chr5	126172195	126172195	C	T	het		QUAL=3724;DP=125;AF=0.50;MQM=60;TRIO=HET,125,0.50,HOM,45,1.00,HET,54,0.44	LMNB1	3'UTR,non_coding_exon	LMNB1:NM_005573.3:3'UTR:MODIFIER:exon11/11:c.*239C>T:,LMNB1:NM_001198557.1:3'UTR:MODIFIER:exon11/11:c.*239C>T:,LMNB1:NR_134488.1:non_coding_exon:MODIFIER:exon12/12:n.2964C>T:		rs1051644	0.4479	0.0000	0/0/0	0.0793										50	114					LMNB1 (inh=AD pLI=0.95)
chr5	127594512	127594512	T	C	hom		QUAL=18597;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,135,1.00,HOM,185,1.00	FBN2	3'UTR	FBN2:NM_001999.3:3'UTR:MODIFIER:exon65/65:c.*635A>G:		rs27858	0.9856	0.0000	0/0/0	0.1519										214	15					FBN2 (inh=AD pLI=1.00)
chr5	127638759	127638759	A	G	het		QUAL=3966;DP=268;AF=0.45;MQM=60;TRIO=HET,268,0.45,HET,68,0.54,WT,128,0.00	FBN2	synonymous	FBN2:NM_001999.3:synonymous:LOW:exon46/65:c.5823T>C:p.His1941His		rs11955288	0.0929	0.0950	584/328/52	0.0937						612570 [FBN2 (provisional) Contractural arachnodactyly,congenital|Macular degeneration,early-onset];	RCV000117025.3 [benign]; 		COSM4159390, COSM4159389	25	192					FBN2 (inh=AD pLI=1.00)
chr5	127640783	127640783	G	A	het		QUAL=7403;DP=180;AF=0.47;MQM=60;TRIO=HET,180,0.47,HET,147,0.50,HET,246,0.53	FBN2	splice_region&intron	FBN2:NM_001999.3:splice_region&intron:LOW:exon44/64:c.5675-9C>T:		rs27713	0.7344	0.7110	26406/14136/1341	0.6731						612570 [FBN2 (provisional) Contractural arachnodactyly,congenital|Macular degeneration,early-onset];	RCV000117024.4 [other]; 			603	435					FBN2 (inh=AD pLI=1.00)
chr5	127685135	127685135	C	T	hom	phylop_high	QUAL=15309;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HET,206,0.42,HET,275,0.48	FBN2	missense	FBN2:NM_001999.3:missense:MODERATE:exon23/65:c.2893G>A:p.Val965Ile		rs154001	0.7310	0.7230	32094/15903/1986	0.7148	3.8840	T	T,T,T	B,B	B,B	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital|Macular degeneration,early-onset];	RCV000117020.3 [benign]; 	CM1413000 [CLASS=DP MUT=REF PHEN="Macular degeneration age related association with" GENE=FBN2]; 		583	437					FBN2 (inh=AD pLI=1.00)
chr5	127873094	127873094	G	A	het	phylop_high	QUAL=2017;DP=53;AF=0.62;MQM=59;TRIO=HET,53,0.62,HET,134,0.49,WT,192,0.01	FBN2	missense	FBN2:NM_001999.3:missense:MODERATE:exon1/65:c.203C>T:p.Ala68Val		rs62390671	0.0148	0.0300	68/61/0	0.0292	1.9370	T	T,T,T,T	B,B,B,B	B,B,B,B	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital|Macular degeneration,early-onset];	RCV000079963.9 [other]; 			1	85					FBN2 (inh=AD pLI=1.00)
chr5	127873605	127873605	T	C	het		QUAL=2624;DP=76;AF=0.41;MQM=59;TRIO=HET,76,0.41,HET,59,0.61,HET,69,0.57	FBN2	5'UTR	FBN2:NM_001999.3:5'UTR:MODIFIER:exon1/65:c.-309A>G:		rs7732639	0.4375	0.0000	0/0/0	0.0554										16	86					FBN2 (inh=AD pLI=1.00)
chr5	131705458	131705458	C	G	het	low_DP	QUAL=134;DP=6;AF=0.83;MQM=60;TRIO=HET,6,0.83,WT,4,0.00,HET,8,0.38	SLC22A5,LOC553103	5'UTR,intron	SLC22A5:NM_001308122.1:5'UTR:MODIFIER:exon1/11:c.-207C>G:,SLC22A5:NM_003060.3:5'UTR:MODIFIER:exon1/10:c.-207C>G:,LOC553103:NR_110997.1:intron:MODIFIER:exon1/7:n.73+78G>C:		rs2631367	0.7330	0.0000	0/0/0	0.0936							RCV000022284.2 [not provided]; 	CR041140 [CLASS=DFP MUT=REF PHEN="Crohn's disease susceptibility association with" GENE=SLC22A5]; 		56	95					SLC22A5 (inh=n/a pLI=0.00), LOC553103 (inh=n/a pLI=n/a)
chr5	131705949	131705949	T	C	het		QUAL=3123;DP=39;AF=0.31;MQM=57;TRIO=HET,39,0.31,WT,217,0.00,HET,311,0.44	SLC22A5	synonymous	SLC22A5:NM_001308122.1:synonymous:LOW:exon1/11:c.285T>C:p.Leu95Leu,SLC22A5:NM_003060.3:synonymous:LOW:exon1/10:c.285T>C:p.Leu95Leu	(GGAGCT)n	rs61742215	0.4862	0.3880	6001/2365/201	0.3654						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022310.2 [not provided]; RCV000080053.4,RCV000022310.2 [benign,not provided]; RCV000080053.4 [benign]; 		COSM4005841, COSM4005840	204	497					SLC22A5 (inh=n/a pLI=0.00)
chr5	131706028	131706028	G	T	het	phylop_high;pred_pathogenic_4;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=7123;DP=178;AF=0.39;MQM=59;TRIO=HET,178,0.39,WT,355,0.00,HET,467,0.50	SLC22A5	missense	SLC22A5:NM_001308122.1:missense:MODERATE:exon1/11:c.364G>T:p.Asp122Tyr,SLC22A5:NM_003060.3:missense:MODERATE:exon1/10:c.364G>T:p.Asp122Tyr		rs201082652	0.0000	0.0003	0/0/0	0.0004	6.0270	D	D,D,D	D,D	D,D	603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022318.3 [pathogenic]; RCV000186160.2 [pathogenic]; 	CM104584 [CLASS=DM MUT=ALT PHEN="Carnitine deficiency systemic primary" GENE=SLC22A5]; 		0	3					SLC22A5 (inh=n/a pLI=0.00)
chr5	131719999	131719999	A	G	hom		QUAL=28847;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,290,1.00,HOM,408,1.00	SLC22A5	splice_region&intron	SLC22A5:NM_001308122.1:splice_region&intron:LOW:exon4/10:c.724+6A>G:,SLC22A5:NM_003060.3:splice_region&intron:LOW:exon3/9:c.652+6A>G:		rs4551059	1.0000	1.0000	60705/33370/5203	0.9363						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022335.2 [not provided]; RCV000080057.5 [benign]; 			1108	0					SLC22A5 (inh=n/a pLI=0.00)
chr5	131721174	131721174	A	G	het		QUAL=9108;DP=430;AF=0.51;MQM=60;TRIO=HET,430,0.51,WT,239,0.00,HET,315,0.50	SLC22A5	synonymous	SLC22A5:NM_001308122.1:synonymous:LOW:exon5/11:c.879A>G:p.Leu293Leu,SLC22A5:NM_003060.3:synonymous:LOW:exon4/10:c.807A>G:p.Leu269Leu		rs274558	0.4862	0.4390	12476/5231/669	0.4317						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022346.2 [not provided]; RCV000080060.4 [benign]; 		COSM3760912, COSM3760913	204	515					SLC22A5 (inh=n/a pLI=0.00)
chr5	131730011	131730011	C	T	het		QUAL=11989;DP=478;AF=0.47;MQM=59;TRIO=HET,478,0.47,WT,329,0.00,HET,441,0.52	SLC22A5	3'UTR	SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*47C>T:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*47C>T:		rs1045020	0.0517	0.1030	909/622/3	0.1000							RCV000022391.2 [not provided]; 			3	92					SLC22A5 (inh=n/a pLI=0.00)
chr5	131730053	131730053	A	-	hom		QUAL=30418;DP=319;AF=0.97;MQM=59;TRIO=HOM,319,0.97,HOM,294,0.98,HOM,391,0.97	SLC22A5	3'UTR	SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*92delA:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*92delA:		rs397999277	0.7552	0.0000	0/0/0	0.1669										302	156					SLC22A5 (inh=n/a pLI=0.00)
chr5	131730807	131730807	T	C	hom		QUAL=20582;DP=404;AF=1.00;MQM=59;TRIO=HOM,404,1.00,HOM,100,0.99,HOM,116,1.00	SLC22A5	3'UTR	SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*843T>C:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*843T>C:	(TTTG)n	rs274548	0.7442	0.0000	0/0/0	0.1265										156	66					SLC22A5 (inh=n/a pLI=0.00)
chr5	131730920	131730920	T	A	het		QUAL=2071;DP=88;AF=0.50;MQM=59;TRIO=HET,88,0.50,HET,31,0.58,HET,40,0.53	SLC22A5	3'UTR	SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*956T>A:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*956T>A:	(T)n	rs72795171	0.0000	0.0000	0/0/0	0.0025										8	41					SLC22A5 (inh=n/a pLI=0.00)
chr5	131730923	131730923	A	C	het		QUAL=2071;DP=88;AF=0.50;MQM=59;TRIO=HET,88,0.50,HET,31,0.58,HET,40,0.53	SLC22A5	3'UTR	SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*959A>C:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*959A>C:		rs14701	0.0000	0.0000	0/0/0	0.0055										8	127					SLC22A5 (inh=n/a pLI=0.00)
chr5	131731304	131731304	A	T	hom		QUAL=10677;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,41,1.00,HOM,66,1.00	SLC22A5	splice_region,3'UTR	SLC22A5:NM_001308122.1:splice_region:LOW:exon11/11:c.*1340A>T:,SLC22A5:NM_003060.3:splice_region:LOW:exon10/10:c.*1340A>T:,SLC22A5:NM_001308122.1:3'UTR:MODIFIER:exon11/11:c.*1340A>T:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*1340A>T:		rs274547	0.7442	0.0000	0/0/0	0.7418										156	64					SLC22A5 (inh=n/a pLI=0.00)
chr5	131892979	131892979	G	A	hom		QUAL=13652;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,103,1.00,HOM,159,1.00	RAD50	5'UTR	RAD50:NM_005732.3:5'UTR:MODIFIER:exon1/25:c.-38G>A:		rs4526098	0.9249	0.9750	57988/33161/2994	0.9411							RCV000160912.1 [benign]; 			316	5					RAD50 (inh=n/a pLI=0.00)
chr5	132203997	132203997	A	G	het		QUAL=19542;DP=406;AF=0.48;MQM=59;TRIO=HET,406,0.48,WT,326,0.00,HOM,435,1.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*723A>G:	MIR	rs17166297	0.1707	0.0000	0/0/0	0.1820										10	48					UQCRQ (inh=n/a pLI=0.09)
chr5	132204031	132204031	G	A	het		QUAL=16599;DP=377;AF=0.49;MQM=59;TRIO=HET,377,0.49,WT,301,0.00,HOM,368,0.99	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*757G>A:	MIR	rs17624157	0.0479	0.0000	0/0/0	0.1134										9	42					UQCRQ (inh=n/a pLI=0.09)
chr5	132204448	132204448	G	-	het		QUAL=13741;DP=412;AF=0.47;MQM=59;TRIO=HET,412,0.47,HOM,293,1.00,WT,363,0.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*1175delG:		rs67367845	0.4253	0.0000	0/0/0	0.4455										39	77					UQCRQ (inh=n/a pLI=0.09)
chr5	132204467	132204467	A	G	het		QUAL=15584;DP=491;AF=0.49;MQM=59;TRIO=HET,491,0.49,HOM,294,1.00,WT,368,0.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*1193A>G:		rs254284	0.0000	0.0000	0/0/0	0.3917										40	78					UQCRQ (inh=n/a pLI=0.09)
chr5	137206560	137206560	A	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=21668;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,242,1.00,HOM,261,1.00	MYOT	missense,splice_region&intron,intron	MYOT:NM_006790.2:missense:MODERATE:exon2/10:c.220A>C:p.Lys74Gln,MYOT:NM_001300911.1:splice_region&intron:LOW:exon2/10:c.-120-6A>C:,MYOT:NM_001135940.1:intron:MODIFIER:exon2/9:c.-197+346A>C:		rs6890689	0.0000	0.9960	60215/33356/4749	0.8996	2.8090	T	T	B	B	604103 [MYOT (confirmed) Muscular dystrophy,limb-girdle,type 1A|Myopathy,myofibrillar,3|Myopathy,spheroid body];	RCV000153527.3 [benign]; 	CM056011 [CLASS=DM MUT=REF PHEN="Myotilinopathy" GENE=MYOT]; 		1024	2	2	[2] old entry - no details available			MYOT (inh=n/a pLI=0.00)
chr5	138456815	138456815	T	C	het		QUAL=16336;DP=246;AF=0.52;MQM=59;TRIO=HET,246,0.52,WT,298,0.00,HOM,406,1.00	SIL1	synonymous	SIL1:NM_001037633.1:synonymous:LOW:exon4/11:c.153A>G:p.Thr51Thr,SIL1:NM_022464.4:synonymous:LOW:exon3/10:c.153A>G:p.Thr51Thr		rs3088052	0.4269	0.4350	12233/6708/2342	0.4277						608005 [SIL1 (confirmed) Marinesco-Sjogren syndrome];	RCV000082151.7 [other]; 			561	1332	1	[1] Florian Harmuth 23.11.2015 [n/a] comment imported from detected variant: frequency is almost 50% in different databases			SIL1 (inh=AR pLI=0.00)
chr5	138609609	138609609	C	G	het		QUAL=5213;DP=232;AF=0.50;MQM=60;TRIO=HET,232,0.50,WT,195,0.00,HET,245,0.45	MATR3,SNHG4	5'UTR,non_coding_exon	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon1/17:c.-528C>G:,MATR3:NM_001282278.1:5'UTR:MODIFIER:exon1/17:c.-535C>G:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon1/18:c.-610C>G:,SNHG4:NR_003141.3:non_coding_exon:MODIFIER:exon1/4:n.169C>G:,SNHG4:NR_036536.1:non_coding_exon:MODIFIER:exon1/5:n.169C>G:		rs11242456	0.4203	0.5590	2230/568/10	0.1454										243	260					MATR3 (inh=n/a pLI=1.00), SNHG4 (inh=n/a pLI=n/a)
chr5	138614072	138614072	T	G	het	trio_denovo	QUAL=363;DP=266;AF=0.45;MQM=60;TRIO=HET,266,0.45,WT,166,0.01,WT,203,0.00	MATR3,SNHG4	5'UTR,intron,non_coding_exon	MATR3:NM_001282278.1:5'UTR:MODIFIER:exon3/17:c.-207T>G:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon3/18:c.-282T>G:,MATR3:NM_001194954.1:intron:MODIFIER:exon2/16:c.-256-668T>G:,SNHG4:NR_003141.3:non_coding_exon:MODIFIER:exon3/4:n.497T>G:,SNHG4:NR_036536.1:non_coding_exon:MODIFIER:exon3/5:n.497T>G:		rs776067427	0.0000	0.0001	0/0/0	0.0001										0	8					MATR3 (inh=n/a pLI=1.00), SNHG4 (inh=n/a pLI=n/a)
chr5	138642997	138642997	-	T	het		QUAL=6447;DP=239;AF=0.47;MQM=59;TRIO=HET,239,0.47,WT,72,0.00,HOM,117,0.99	MATR3	5'UTR,intron	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon4/17:c.-103dupT:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon5/18:c.-103dupT:,MATR3:NM_018834.5:5'UTR:MODIFIER:exon2/15:c.-103dupT:,MATR3:NM_001194955.1:5'UTR:MODIFIER:exon2/15:c.-103dupT:,MATR3:NM_001282278.1:intron:MODIFIER:exon4/16:c.-102-7362dupT:,MATR3:NM_001194956.1:intron:MODIFIER:exon1/13:c.49-7362dupT:		rs112107315;rs59150359	0.4317	0.0000	0/0/0	0.5447						164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21];				80	83					MATR3 (inh=n/a pLI=1.00)
chr5	138643062	138643062	T	A	het		QUAL=6225;DP=182;AF=0.55;MQM=59;TRIO=HET,182,0.55,WT,85,0.00,HOM,120,1.00	MATR3	5'UTR,intron	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon4/17:c.-43T>A:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon5/18:c.-43T>A:,MATR3:NM_018834.5:5'UTR:MODIFIER:exon2/15:c.-43T>A:,MATR3:NM_001194955.1:5'UTR:MODIFIER:exon2/15:c.-43T>A:,MATR3:NM_001282278.1:intron:MODIFIER:exon4/16:c.-102-7302T>A:,MATR3:NM_001194956.1:intron:MODIFIER:exon1/13:c.49-7302T>A:		rs12153162	0.4465	0.6260	19481/12762/240	0.5511						164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21];				138	110					MATR3 (inh=n/a pLI=1.00)
chr5	138665756	138665756	G	A	het		QUAL=7146;DP=293;AF=0.50;MQM=59;TRIO=HET,293,0.50,WT,71,0.00,HOM,95,1.00	MATR3	3'UTR	MATR3:NM_001194954.1:3'UTR:MODIFIER:exon17/17:c.*672G>A:,MATR3:NM_001282278.1:3'UTR:MODIFIER:exon17/17:c.*672G>A:,MATR3:NM_199189.2:3'UTR:MODIFIER:exon18/18:c.*672G>A:,MATR3:NM_018834.5:3'UTR:MODIFIER:exon15/15:c.*672G>A:,MATR3:NM_001194955.1:3'UTR:MODIFIER:exon15/15:c.*672G>A:,MATR3:NM_001194956.1:3'UTR:MODIFIER:exon14/14:c.*672G>A:		rs7305	0.0000	0.5890	2459/799/9	0.1367										282	299					MATR3 (inh=n/a pLI=1.00)
chr5	138666372	138666372	T	G	het		QUAL=5329;DP=257;AF=0.44;MQM=60;TRIO=HET,257,0.44,WT,42,0.00,HOM,73,1.00	MATR3	3'UTR	MATR3:NM_001194954.1:3'UTR:MODIFIER:exon17/17:c.*1288T>G:,MATR3:NM_001282278.1:3'UTR:MODIFIER:exon17/17:c.*1288T>G:,MATR3:NM_199189.2:3'UTR:MODIFIER:exon18/18:c.*1288T>G:,MATR3:NM_018834.5:3'UTR:MODIFIER:exon15/15:c.*1288T>G:,MATR3:NM_001194955.1:3'UTR:MODIFIER:exon15/15:c.*1288T>G:,MATR3:NM_001194956.1:3'UTR:MODIFIER:exon14/14:c.*1288T>G:		rs10515507	0.4000	0.6150	2424/680/5	0.1469										258	255					MATR3 (inh=n/a pLI=1.00)
chr5	140027216	140027216	T	C	het		QUAL=4824;DP=169;AF=0.49;MQM=60;TRIO=HET,169,0.49,WT,241,0.00,HET,259,0.45	NDUFA2	5'UTR,non_coding_exon	NDUFA2:NM_002488.4:5'UTR:MODIFIER:exon1/3:c.-48A>G:,NDUFA2:NM_001185012.1:5'UTR:MODIFIER:exon1/3:c.-48A>G:,NDUFA2:NR_033697.1:non_coding_exon:MODIFIER:exon1/2:n.155A>G:		rs778593	0.3778	0.3980	7804/4470/296	0.3896										124	350					NDUFA2 (inh=n/a pLI=0.34)
chr5	140027304	140027304	T	C	het		QUAL=3283;DP=189;AF=0.44;MQM=60;TRIO=HET,189,0.44,WT,134,0.00,HET,152,0.43	NDUFA2	5'UTR_premature_start_codon_gain,5'UTR,non_coding_exon	NDUFA2:NM_002488.4:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-136A>G:,NDUFA2:NM_001185012.1:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-136A>G:,NDUFA2:NM_002488.4:5'UTR:MODIFIER:exon1/3:c.-136A>G:,NDUFA2:NM_001185012.1:5'UTR:MODIFIER:exon1/3:c.-136A>G:,NDUFA2:NR_033697.1:non_coding_exon:MODIFIER:exon1/2:n.67A>G:		rs778594	0.3776	0.3640	4137/2347/159	0.3324										94	274					NDUFA2 (inh=n/a pLI=0.34)
chr5	146435580	146435580	A	G	het		QUAL=10513;DP=286;AF=0.42;MQM=60;TRIO=HET,286,0.42,HET,156,0.53,HOM,187,1.00	PPP2R2B	5'UTR,intron	PPP2R2B:NM_181674.2:5'UTR:MODIFIER:exon1/10:c.-279T>C:,PPP2R2B:NM_181676.2:5'UTR:MODIFIER:exon1/9:c.-274T>C:,PPP2R2B:NM_001271899.1:intron:MODIFIER:exon2/9:c.88+25042T>C:,PPP2R2B:NM_001271900.1:intron:MODIFIER:exon2/10:c.50+25042T>C:,PPP2R2B:NM_181677.2:intron:MODIFIER:exon2/10:c.-62-20777T>C:,PPP2R2B:NM_181678.2:intron:MODIFIER:exon2/10:c.-49+25042T>C:		rs1480153	0.6585	0.0000	0/0/0	0.1125						604325 [PPP2R2B (provisional) Spinocerebellar ataxia 12];				99	118					PPP2R2B (inh=n/a pLI=0.90)
chr5	147469113	147469113	G	A	het		QUAL=10471;DP=388;AF=0.46;MQM=60;TRIO=HET,388,0.46,HET,487,0.47,WT,635,0.00	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon7/34:c.531G>A:p.Arg177Arg,SPINK5:NM_001127699.1:synonymous:LOW:exon7/28:c.531G>A:p.Arg177Arg,SPINK5:NM_006846.3:synonymous:LOW:exon7/33:c.531G>A:p.Arg177Arg		rs35121983	0.0469	0.0340	107/14/12	0.0312						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128216.1 [benign]; 		COSM149969	1	51					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147475386	147475386	A	G	het		QUAL=7594;DP=246;AF=0.51;MQM=60;TRIO=HET,246,0.51,HET,139,0.47,HET,207,0.46	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon10/34:c.800A>G:p.Gln267Arg,SPINK5:NM_001127699.1:missense:MODERATE:exon10/28:c.800A>G:p.Gln267Arg,SPINK5:NM_006846.3:missense:MODERATE:exon10/33:c.800A>G:p.Gln267Arg		rs6892205	0.5090	0.5210	16635/8528/1026	0.5139	-4.0170	T	T,T,T,T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128217.1 [benign]; 		COSM4003377, COSM4003378	323	504					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147477551	147477551	C	T	het		QUAL=7329;DP=198;AF=0.49;MQM=60;TRIO=HET,198,0.49,HET,172,0.53,HET,202,0.48	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon11/34:c.1004C>T:p.Ala335Val,SPINK5:NM_001127699.1:missense:MODERATE:exon11/28:c.1004C>T:p.Ala335Val,SPINK5:NM_006846.3:missense:MODERATE:exon11/33:c.1004C>T:p.Ala335Val		rs34482796	0.4465	0.5070	15959/8512/445	0.4999	0.0650	T	T,T,T,T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128218.1 [benign]; 			314	504					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480027	147480027	G	A	het		QUAL=12361;DP=199;AF=0.52;MQM=59;TRIO=HET,199,0.52,HET,265,0.57,HET,377,0.56	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon13/34:c.1103G>A:p.Ser368Asn,SPINK5:NM_001127699.1:missense:MODERATE:exon13/28:c.1103G>A:p.Ser368Asn,SPINK5:NM_006846.3:missense:MODERATE:exon13/33:c.1103G>A:p.Ser368Asn		rs2303063	0.4315	0.5060	16068/8742/304	0.4944	0.0360	T	T,T,T,T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];		CM013814 [CLASS=DP MUT=ALT PHEN="Atopy maternally inherited association with" GENE=SPINK5]; 	COSM4003379, COSM4003380	319	499					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480080	147480080	G	A	het	phylop_high	QUAL=12983;DP=389;AF=0.47;MQM=60;TRIO=HET,389,0.47,HET,313,0.45,HET,430,0.43	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon13/34:c.1156G>A:p.Asp386Asn,SPINK5:NM_001127699.1:missense:MODERATE:exon13/28:c.1156G>A:p.Asp386Asn,SPINK5:NM_006846.3:missense:MODERATE:exon13/33:c.1156G>A:p.Asp386Asn		rs2303064	0.3482	0.2120	3871/550/1206	0.2058	1.8960	T	T,T,T,T	P,P,P,B	B,B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128219.1 [benign]; 			46	246					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480112	147480112	T	C	het		QUAL=14746;DP=297;AF=0.53;MQM=60;TRIO=HET,297,0.53,HET,307,0.55,HET,400,0.58	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon13/34:c.1188T>C:p.His396His,SPINK5:NM_001127699.1:synonymous:LOW:exon13/28:c.1188T>C:p.His396His,SPINK5:NM_006846.3:synonymous:LOW:exon13/33:c.1188T>C:p.His396His		rs2303065	0.4329	0.5070	16217/8832/309	0.4926						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128220.1 [benign]; 		COSM149970, COSM4003381	318	501					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480955	147480955	A	G	het		QUAL=9090;DP=207;AF=0.49;MQM=60;TRIO=HET,207,0.49,HET,240,0.52,HET,291,0.47	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon14/34:c.1258A>G:p.Lys420Glu,SPINK5:NM_001127699.1:missense:MODERATE:exon14/28:c.1258A>G:p.Lys420Glu,SPINK5:NM_006846.3:missense:MODERATE:exon14/33:c.1258A>G:p.Lys420Glu		rs2303067	0.4331	0.5070	16138/8797/306	0.5007	0.1530	T	T,T,T,T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000005585.2 [other]; RCV000005586.2 [other]; RCV000005587.2 [other]; 	CM013815 [CLASS=DFP MUT=REF PHEN="Atopy maternally inherited association with" GENE=SPINK5]; 	COSM4003382, COSM4003383	319	498					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147481430	147481430	A	G	het		QUAL=12030;DP=315;AF=0.50;MQM=59;TRIO=HET,315,0.50,HET,287,0.49,HET,337,0.49	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon15/34:c.1389A>G:p.Gly463Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon15/28:c.1389A>G:p.Gly463Gly,SPINK5:NM_006846.3:synonymous:LOW:exon15/33:c.1389A>G:p.Gly463Gly		rs6896303	0.4329	0.5070	16230/8836/309	0.5003						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003384, COSM149971	320	497					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147486677	147486677	C	A	het		QUAL=14922;DP=334;AF=0.51;MQM=59;TRIO=HET,334,0.51,HET,348,0.46,HET,511,0.48	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon17/34:c.1557C>A:p.Gly519Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon17/28:c.1557C>A:p.Gly519Gly,SPINK5:NM_006846.3:synonymous:LOW:exon17/33:c.1557C>A:p.Gly519Gly		rs880687	0.4293	0.5050	16185/8818/288	0.4996						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003385, COSM149972	316	503					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147488367	147488367	C	T	het		QUAL=8238;DP=291;AF=0.40;MQM=60;TRIO=HET,291,0.40,HET,202,0.47,HET,235,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon18/34:c.1659C>T:p.Val553Val,SPINK5:NM_001127699.1:synonymous:LOW:exon18/28:c.1659C>T:p.Val553Val,SPINK5:NM_006846.3:synonymous:LOW:exon18/33:c.1659C>T:p.Val553Val	GA-rich	rs2303071	0.6020	0.5520	18995/8871/2833	0.5372						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000175321.1 [benign]; 		COSM149973, COSM449063	301	479					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147498019	147498019	G	A	het		QUAL=11689;DP=291;AF=0.52;MQM=60;TRIO=HET,291,0.52,HET,236,0.47,HET,392,0.47	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon23/34:c.2132G>A:p.Arg711Gln,SPINK5:NM_001127699.1:missense:MODERATE:exon23/28:c.2132G>A:p.Arg711Gln,SPINK5:NM_006846.3:missense:MODERATE:exon23/33:c.2132G>A:p.Arg711Gln		rs3777134	0.4884	0.5830	21117/12616/603	0.5758	0.4400	T	T,T,T,T	P,B,P	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003386, COSM149974	421	484					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499616	147499616	C	T	het		QUAL=11668;DP=348;AF=0.50;MQM=60;TRIO=HET,348,0.50,HET,226,0.52,HET,313,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon25/34:c.2358C>T:p.Leu786Leu,SPINK5:NM_001127699.1:synonymous:LOW:exon25/28:c.2358C>T:p.Leu786Leu,SPINK5:NM_006846.3:synonymous:LOW:exon25/33:c.2358C>T:p.Leu786Leu		rs17704908	0.4874	0.5820	20947/12512/601	0.5753						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003388, COSM4003387	421	482					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499670	147499670	C	T	het		QUAL=11194;DP=354;AF=0.48;MQM=60;TRIO=HET,354,0.48,HET,247,0.48,HET,340,0.46	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon25/34:c.2412C>T:p.Gly804Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon25/28:c.2412C>T:p.Gly804Gly,SPINK5:NM_006846.3:synonymous:LOW:exon25/33:c.2412C>T:p.Gly804Gly		rs33920397	0.4884	0.5820	21043/12566/601	0.5756						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003389, COSM149975	421	483					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499891	147499891	G	T	het		QUAL=8411;DP=326;AF=0.47;MQM=60;TRIO=HET,326,0.47,HET,358,0.51,WT,418,0.00	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon26/34:c.2475G>T:p.Glu825Asp,SPINK5:NM_001127699.1:missense:MODERATE:exon26/28:c.2475G>T:p.Glu825Asp,SPINK5:NM_006846.3:missense:MODERATE:exon26/33:c.2475G>T:p.Glu825Asp		rs2303070	0.1745	0.1280	1229/249/42	0.1238	-0.6140	T	T,T,T,T	B,B,B,B	B,B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128223.1 [benign]; 			30	201					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147505116	147505116	G	A	het		QUAL=16075;DP=471;AF=0.45;MQM=59;TRIO=HET,471,0.45,HET,325,0.49,HET,459,0.51	SPINK5	synonymous,intron	SPINK5:NM_001127698.1:synonymous:LOW:exon29/34:c.2769G>A:p.Ala923Ala,SPINK5:NM_006846.3:intron:MODIFIER:exon28/32:c.2740-170G>A:		rs3764930	0.4533	0.5720	20523/12421/306	0.5601						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003390	417	485					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147510866	147510866	T	C	het		QUAL=9858;DP=266;AF=0.47;MQM=60;TRIO=HET,266,0.47,HET,237,0.48,HET,290,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon32/34:c.3099T>C:p.Gly1033Gly,SPINK5:NM_006846.3:synonymous:LOW:exon31/33:c.3009T>C:p.Gly1003Gly		rs2400478	0.5092	0.5890	21404/12623/854	0.5597						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149978, COSM149977	423	481					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516598	147516598	T	C	het		QUAL=8313;DP=212;AF=0.53;MQM=60;TRIO=HET,212,0.53,HET,160,0.57,HET,227,0.48	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*44T>C:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*44T>C:		rs4349706	0.4910	0.4110	10657/4872/1635	0.4059										100	218					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516762	147516762	C	G	het		QUAL=16228;DP=543;AF=0.43;MQM=59;TRIO=HET,543,0.43,HET,295,0.55,HET,422,0.50	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*208C>G:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*208C>G:		rs3088193	0.4910	0.0000	0/0/0	0.4163										36	102					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516884	147516884	T	C	het		QUAL=5063;DP=251;AF=0.45;MQM=59;TRIO=HET,251,0.45,HET,165,0.54,WT,202,0.00	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*330T>C:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*330T>C:		rs72660265	0.1743	0.0000	0/0/0	0.0210										6	41					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516914	147516914	-	CTC	het		QUAL=4328;DP=189;AF=0.39;MQM=59;TRIO=HET,189,0.39,HET,89,0.44,HET,136,0.51	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*361_*363dupCTC:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*361_*363dupCTC:		rs35952402;rs397704765	0.4910	0.0000	0/0/0	0.3680										36	101					SPINK5 (inh=AR+AD pLI=0.00)
chr5	148361720	148361720	-	T	hom		QUAL=8848;DP=108;AF=0.87;MQM=59;TRIO=HOM,108,0.87,HOM,94,0.95,HOM,137,0.91	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*22553dupA:		rs397725504	0.4810	0.0000	0/0/0	0.3594										48	107					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364355	148364355	A	G	hom		QUAL=34928;DP=459;AF=1.00;MQM=59;TRIO=HOM,459,1.00,HOM,265,0.99,HOM,332,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19919T>C:		rs2217638	0.8023	0.0000	0/0/0	0.8132										173	75					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364701	148364701	C	T	hom		QUAL=14297;DP=233;AF=1.00;MQM=59;TRIO=HOM,233,1.00,HOM,105,1.00,HOM,148,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19573G>A:		rs4560536	0.4716	0.0000	0/0/0	0.5094										97	109					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364709	148364709	-	A	het		QUAL=7135;DP=219;AF=0.71;MQM=59;TRIO=HET,219,0.71,HOM,76,0.80,HOM,98,0.81	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19564dupT:		rs398109536	0.6817	0.0000	0/0/0	0.4156										31	197					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148365234	148365234	T	C	hom		QUAL=27137;DP=444;AF=0.99;MQM=60;TRIO=HOM,444,0.99,HOM,176,1.00,HOM,200,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19040A>G:	L1ME1	rs930205	0.5092	0.0000	0/0/0	0.5525										89	93					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148365720	148365720	C	A	hom		QUAL=30772;DP=377;AF=1.00;MQM=60;TRIO=HOM,377,1.00,HOM,234,1.00,HOM,315,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*18554G>T:	MIR	rs10040598	0.7973	0.0000	0/0/0	0.8113										170	74					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148366571	148366571	T	C	hom		QUAL=19443;DP=374;AF=1.00;MQM=60;TRIO=HOM,374,1.00,HOM,93,1.00,HOM,131,0.99	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*17703A>G:		rs4235739	0.6234	0.0000	0/0/0	0.6211										106	114					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367324	148367324	A	G	hom		QUAL=22978;DP=418;AF=1.00;MQM=59;TRIO=HOM,418,1.00,HOM,98,1.00,HOM,188,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16950T>C:		rs10040798	0.7881	0.0000	0/0/0	0.1383										170	76					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367373	148367376	TGTG	-	hom		QUAL=1515;DP=49;AF=0.47;MQM=59;TRIO=HOM,49,0.47,HOM,45,0.44,HOM,62,0.44	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16898_*16901delCACA:	(TG)n		0.0000	0.0000	0/0/0	0.0003										1	12					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367643	148367643	C	T	hom		QUAL=19934;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,183,1.00,HET,257,0.46	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16631G>A:		rs4705303	0.4613	0.0000	0/0/0	0.5174										91	116					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148368254	148368254	T	G	hom		QUAL=19402;DP=268;AF=0.99;MQM=60;TRIO=HOM,268,0.99,HOM,148,0.99,HOM,211,0.99	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16020A>C:	MLT1F	rs4543254	0.6180	0.0000	0/0/0	0.6203										97	89					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148368451	148368451	A	G	hom		QUAL=26442;DP=492;AF=1.00;MQM=60;TRIO=HOM,492,1.00,HOM,141,1.00,HOM,183,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*15823T>C:		rs4562031	0.7981	0.0000	0/0/0	0.8114										168	73					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148372163	148372163	G	TT	hom		QUAL=4406;DP=40;AF=0.30;MQM=53;TRIO=HOM,40,0.30,HOM,8,0.00,HOM,28,0.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*12111delCinsAA:			0.0000	0.0000	0/0/0	0.0000										0	0					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148373306	148373306	C	T	het		QUAL=6556;DP=201;AF=0.55;MQM=60;TRIO=HET,201,0.55,HOM,117,1.00,WT,148,0.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*10968G>A:		rs13166730	0.0723	0.0000	0/0/0	0.1210										5	74					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148374164	148374167	TGGT	-	hom		QUAL=4373;DP=37;AF=0.92;MQM=59;TRIO=HOM,37,0.92,HOM,126,0.98,HET,163,0.48	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*10107_*10110delACCA:	(TGGT)n	rs72253703	0.0000	0.0000	0/0/0	0.0041										39	15					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148381138	148381138	C	T	hom		QUAL=24849;DP=509;AF=0.99;MQM=60;TRIO=HOM,509,0.99,HOM,183,1.00,HET,192,0.51	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*3136G>A:		rs1019927	0.9904	0.0000	0/0/0	0.8948										250	14					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148407708	148407708	A	C	hom		QUAL=19009;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,277,1.00,HET,364,0.45	SH3TC2	synonymous	SH3TC2:NM_024577.3:synonymous:LOW:exon11/17:c.1587T>G:p.Arg529Arg		rs1432794	0.9906	0.9780	58110/31287/5147	0.9472						608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C|Mononeuropathy of the median nerve,mild];	RCV000118336.3 [other]; 			1051	55					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	149360877	149360877	T	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=31042;DP=373;AF=1.00;MQM=59;TRIO=HOM,373,1.00,HOM,257,1.00,HOM,324,1.00	SLC26A2	missense	SLC26A2:NM_000112.3:missense:MODERATE:exon3/3:c.1721T>C:p.Ile574Thr		rs30832	0.0000	0.9930	59817/32644/5173	0.9291	1.6390	T	T	B	B	606718 [SLC26A2 (confirmed) Diastrophic dysplasia|Atelosteogenesis II|Achondrogenesis Ib|Epiphyseal dysplasia,multiple,4|Diastrophic dysplasia,broad bone-platyspondylic variant|De la Chapelle dysplasia];	RCV000176982.1 [benign]; 	CM016008 [CLASS=DM? MUT=REF PHEN="Diastrophic dysplasia" GENE=SLC26A2]; 		1096	12	2	[2] old entry - no details available			SLC26A2 (inh=n/a pLI=0.00)
chr5	149362400	149362400	T	G	het		QUAL=13143;DP=395;AF=0.48;MQM=59;TRIO=HET,395,0.48,WT,198,0.01,HOM,243,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*1024T>G:		rs8073	0.2740	0.0000	0/0/0	0.0411										13	88					SLC26A2 (inh=n/a pLI=0.00)
chr5	149364780	149364780	C	T	hom		QUAL=34230;DP=509;AF=0.99;MQM=59;TRIO=HOM,509,0.99,HET,300,0.55,HOM,435,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*3404C>T:		rs30833	0.9920	0.0000	0/0/0	0.1543										223	7					SLC26A2 (inh=n/a pLI=0.00)
chr5	149365837	149365837	T	-	het		QUAL=1791;DP=97;AF=0.54;MQM=60;TRIO=HET,97,0.54,WT,21,0.00,HOM,24,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*4469delT:		rs869166489	0.4681	0.0000	0/0/0	0.1719										33	109					SLC26A2 (inh=n/a pLI=0.00)
chr5	149907533	149907533	T	G	hom		QUAL=28917;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HET,558,0.52,HET,769,0.48	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon3/15:c.681T>G:p.Val227Val,NDST1:NM_001301063.1:synonymous:LOW:exon3/14:c.681T>G:p.Val227Val		rs2273235	0.3658	0.4500	12745/7315/426	0.4422						600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46];			COSM4159647	187	537					NDST1 (inh=AR pLI=1.00)
chr5	149907602	149907602	A	G	hom		QUAL=23691;DP=290;AF=0.99;MQM=59;TRIO=HOM,290,0.99,HET,553,0.51,HET,724,0.48	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon3/15:c.750A>G:p.Pro250Pro,NDST1:NM_001301063.1:synonymous:LOW:exon3/14:c.750A>G:p.Pro250Pro		rs2273234	0.2995	0.4180	11292/6936/139	0.4099						600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46];				179	538					NDST1 (inh=AR pLI=1.00)
chr5	149919739	149919739	G	C	hom		QUAL=19358;DP=287;AF=0.99;MQM=59;TRIO=HOM,287,0.99,HET,205,0.54,HOM,249,1.00	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon8/15:c.1662G>C:p.Thr554Thr,NDST1:NM_001301063.1:synonymous:LOW:exon8/14:c.1662G>C:p.Thr554Thr		rs1290147	0.8069	0.7150	31517/14234/4433	0.7075						600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46];				453	505					NDST1 (inh=AR pLI=1.00)
chr5	149933899	149933899	A	T	het	low_DP	QUAL=148;DP=18;AF=0.50;MQM=60;TRIO=HET,18,0.50,HET,6,0.17,WT,6,0.00	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*1005A>T:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*1005A>T:	(TA)n		0.0000	0.0000	0/0/0	0.0000										0	1					NDST1 (inh=AR pLI=1.00)
chr5	149935171	149935171	T	C	hom		QUAL=26579;DP=253;AF=1.00;MQM=59;TRIO=HOM,253,1.00,HOM,378,1.00,HET,498,0.52	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*2277T>C:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*2277T>C:		rs13181064	0.5735	0.0000	0/0/0	0.6789										140	79					NDST1 (inh=AR pLI=1.00)
chr5	149935680	149935680	A	G	hom		QUAL=23359;DP=447;AF=0.99;MQM=59;TRIO=HOM,447,0.99,HET,282,0.47,HET,414,0.51	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*2786A>G:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*2786A>G:	MamRep137	rs11542921	0.2430	0.0000	0/0/0	0.0563										27	121					NDST1 (inh=AR pLI=1.00)
chr5	149937496	149937496	A	-	hom		QUAL=11897;DP=224;AF=0.98;MQM=59;TRIO=HOM,224,0.98,HET,195,0.49,HET,300,0.46	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*4602delA:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*4602delA:		rs36071594	0.2426	0.0000	0/0/0	0.3185										26	121					NDST1 (inh=AR pLI=1.00)
chr5	149937739	149937739	G	A	hom		QUAL=12713;DP=227;AF=1.00;MQM=60;TRIO=HOM,227,1.00,HET,214,0.50,HET,256,0.46	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*4845G>A:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*4845G>A:		rs11994	0.3131	0.0000	0/0/0	0.0757										28	121					NDST1 (inh=AR pLI=1.00)
chr5	155754192	155754192	C	G	het		QUAL=13161;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HOM,233,1.00,HET,286,0.55	SGCD	5'UTR	SGCD:NM_000337.5:5'UTR:MODIFIER:exon1/9:c.-94C>G:,SGCD:NM_172244.2:5'UTR:MODIFIER:exon1/8:c.-94C>G:,SGCD:NM_001128209.1:5'UTR:MODIFIER:exon1/8:c.-51C>G:		rs13170573	0.4605	0.0000	0/0/0	0.4694							RCV000041400.2 [benign]; 			64	133					SGCD (inh=n/a pLI=0.00)
chr5	155771579	155771579	T	C	het		QUAL=7855;DP=194;AF=0.53;MQM=59;TRIO=HET,194,0.53,HOM,105,1.00,HET,139,0.49	SGCD	synonymous	SGCD:NM_000337.5:synonymous:LOW:exon3/9:c.84T>C:p.Tyr28Tyr,SGCD:NM_172244.2:synonymous:LOW:exon3/8:c.84T>C:p.Tyr28Tyr,SGCD:NM_001128209.1:synonymous:LOW:exon2/8:c.81T>C:p.Tyr27Tyr		rs1801193	0.4854	0.4660	13829/6317/346	0.4589						601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F|Cardiomyopathy,dilated,1L];	RCV000041413.8 [benign]; 		COSM4159670, COSM4159671	280	567					SGCD (inh=n/a pLI=0.00)
chr5	156187928	156187928	C	T	het		QUAL=13867;DP=516;AF=0.47;MQM=60;TRIO=HET,516,0.47,HET,253,0.51,HET,322,0.49	SGCD	3'UTR	SGCD:NM_000337.5:3'UTR:MODIFIER:exon9/9:c.*1527C>T:,SGCD:NM_001128209.1:3'UTR:MODIFIER:exon8/8:c.*1527C>T:		rs284445	0.2073	0.0000	0/0/0	0.0511										30	80					SGCD (inh=n/a pLI=0.00)
chr5	156193118	156193118	G	A	hom		QUAL=22806;DP=369;AF=1.00;MQM=59;TRIO=HOM,369,1.00,HOM,124,1.00,HOM,195,1.00	SGCD	3'UTR	SGCD:NM_000337.5:3'UTR:MODIFIER:exon9/9:c.*6717G>A:,SGCD:NM_001128209.1:3'UTR:MODIFIER:exon8/8:c.*6717G>A:		rs1827368	0.9271	0.0000	0/0/0	0.1496										182	43					SGCD (inh=n/a pLI=0.00)
chr5	156680685	156680685	A	G	hom		QUAL=29098;DP=353;AF=0.99;MQM=59;TRIO=HOM,353,0.99,HOM,230,1.00,HOM,324,1.00	ITK	3'UTR	ITK:NM_005546.3:3'UTR:MODIFIER:exon17/17:c.*997A>G:		rs27988	0.8335	0.0000	0/0/0	0.1441										180	46					ITK (inh=n/a pLI=0.00)
chr5	158742014	158742014	G	T	hom		QUAL=24041;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,275,1.00,HOM,343,1.00	IL12B	3'UTR	IL12B:NM_002187.2:3'UTR:MODIFIER:exon8/8:c.*1095C>A:		rs1368439	0.9203	0.0000	0/0/0	0.7603										164	59					IL12B (inh=n/a pLI=0.00)
chr5	161324898	161324898	A	G	hom		QUAL=9342;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HOM,52,1.00,HET,70,0.63	GABRA1	3'UTR	GABRA1:NM_000806.5:3'UTR:MODIFIER:exon11/11:c.*470A>G:,GABRA1:NM_001127643.1:3'UTR:MODIFIER:exon11/11:c.*470A>G:,GABRA1:NM_001127644.1:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:NM_001127645.1:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:NM_001127648.1:3'UTR:MODIFIER:exon9/9:c.*470A>G:		rs2290732	0.5811	0.0000	0/0/0	0.1040										78	117					GABRA1 (inh=n/a pLI=0.96)
chr5	161325934	161325934	A	C	hom		QUAL=16323;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HOM,102,1.00,HET,168,0.63	GABRA1	3'UTR	GABRA1:NM_000806.5:3'UTR:MODIFIER:exon11/11:c.*1506A>C:,GABRA1:NM_001127643.1:3'UTR:MODIFIER:exon11/11:c.*1506A>C:,GABRA1:NM_001127644.1:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:NM_001127645.1:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:NM_001127648.1:3'UTR:MODIFIER:exon9/9:c.*1506A>C:		rs998754	0.5805	0.0000	0/0/0	0.1044										80	116					GABRA1 (inh=n/a pLI=0.96)
chr5	161494852	161494852	C	T	het		QUAL=7294;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,WT,278,0.00,HET,381,0.44	GABRG2	5'UTR	GABRG2:NM_198903.2:5'UTR:MODIFIER:exon1/11:c.-154C>T:,GABRG2:NM_000816.3:5'UTR:MODIFIER:exon1/9:c.-154C>T:,GABRG2:NM_198904.2:5'UTR:MODIFIER:exon1/10:c.-154C>T:		rs3219203	0.0361	0.0000	0/0/0	0.0088										0	41					GABRG2 (inh=AD pLI=0.96)
chr5	161529571	161529571	A	G	hom		QUAL=2378;DP=31;AF=1.00;MQM=60;TRIO=HOM,31,1.00,HOM,20,1.00,HOM,26,1.00	GABRG2	missense,intron	GABRG2:NM_198903.2:missense:MODERATE:exon6/11:c.643A>G:p.Ile215Val,GABRG2:NM_000816.3:intron:MODIFIER:exon5/8:c.631+1248A>G:,GABRG2:NM_198904.2:intron:MODIFIER:exon5/9:c.631+1248A>G:	AluJb	rs211035	0.8213	0.7930	3639/835/70	0.1967		T	T	B	B	137164 [GABRG2 (confirmed) Epilepsy,generalized,with febrile seizures plus,type 3|Epilepsy,childhood absence,susceptibility to,2|Febrile seizures,familial,8];				578	282					GABRG2 (inh=AD pLI=0.96)
chr5	172659511	172659511	C	A	hom		QUAL=5397;DP=37;AF=0.92;MQM=60;TRIO=HOM,37,0.92,HOM,113,0.99,HET,96,0.53	NKX2-5	3'UTR	NKX2-5:NM_004387.3:3'UTR:MODIFIER:exon2/2:c.*61G>T:,NKX2-5:NM_001166175.1:3'UTR:MODIFIER:exon2/2:c.*989G>T:,NKX2-5:NM_001166176.1:3'UTR:MODIFIER:exon2/2:c.*835G>T:		rs703752	0.2556	0.0000	0/0/0	0.0606							RCV000192692.1 [benign]; 			30	96					NKX2-5 (inh=AR+AD pLI=0.86)
chr5	176636882	176636882	C	T	het		QUAL=6352;DP=214;AF=0.51;MQM=60;TRIO=HET,214,0.51,HOM,108,0.99,WT,119,0.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon5/23:c.1482C>T:p.Cys494Cys,NSD1:NM_172349.2:synonymous:LOW:exon6/24:c.675C>T:p.Cys225Cys		rs1363405	0.4681	0.3000	6927/1374/2480	0.2926						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082100.5 [benign]; 			79	425					NSD1 (inh=AD pLI=1.00)
chr5	176637149	176637149	G	A	het		QUAL=8454;DP=304;AF=0.44;MQM=60;TRIO=HET,304,0.44,HOM,165,0.98,WT,235,0.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon5/23:c.1749G>A:p.Glu583Glu,NSD1:NM_172349.2:synonymous:LOW:exon6/24:c.942G>A:p.Glu314Glu		rs3733874	0.0000	0.1750	2686/572/21	0.1645						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082103.5 [benign]; 			29	257					NSD1 (inh=AD pLI=1.00)
chr5	176637240	176637240	G	T	het		QUAL=12381;DP=517;AF=0.44;MQM=59;TRIO=HET,517,0.44,HOM,205,0.99,WT,306,0.00	NSD1	missense	NSD1:NM_022455.4:missense:MODERATE:exon5/23:c.1840G>T:p.Val614Leu,NSD1:NM_172349.2:missense:MODERATE:exon6/24:c.1033G>T:p.Val345Leu		rs3733875	0.2286	0.1740	2633/566/20	0.1710	-0.3010	T	T,T,T,T,T	B,B,B	B,B,B	606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082107.5 [benign]; 			29	256					NSD1 (inh=AD pLI=1.00)
chr5	176637576	176637576	T	C	het	pred_pathogenic_3	QUAL=12405;DP=605;AF=0.47;MQM=60;TRIO=HET,605,0.47,HOM,151,1.00,WT,268,0.00	NSD1	missense	NSD1:NM_022455.4:missense:MODERATE:exon5/23:c.2176T>C:p.Ser726Pro,NSD1:NM_172349.2:missense:MODERATE:exon6/24:c.1369T>C:p.Ser457Pro		rs28932178	0.2496	0.1990	3137/808/47	0.1949	0.3970	T	D,D,D,D,D	D,D,D	D,P,P	606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082108.5 [benign]; 			37	323					NSD1 (inh=AD pLI=1.00)
chr5	176721198	176721198	T	C	het		QUAL=11521;DP=380;AF=0.51;MQM=59;TRIO=HET,380,0.51,WT,150,0.00,HOM,213,1.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon23/23:c.6829T>C:p.Leu2277Leu,NSD1:NM_172349.2:synonymous:LOW:exon24/24:c.6022T>C:p.Leu2008Leu		rs28580074	0.7714	0.8240	42011/25695/4422	0.8081						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082138.6 [other]; RCV000127260.1 [benign]; 		COSM4003461, COSM150019	907	259					NSD1 (inh=AD pLI=1.00)
chr5	176726002	176726002	T	C	het		QUAL=13743;DP=458;AF=0.48;MQM=60;TRIO=HET,458,0.48,WT,254,0.00,HOM,250,1.00	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*3542T>C:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*3542T>C:		rs4976682	0.7640	0.0000	0/0/0	0.1364										185	41					NSD1 (inh=AD pLI=1.00)
chr5	176727058	176727058	G	C	hom		QUAL=1467;DP=28;AF=0.39;MQM=54;TRIO=HOM,28,0.39,HOM,9,0.00,HOM,33,0.00	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*4598G>C:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*4598G>C:			0.0000	0.0000	0/0/0	0.0000										0	8					NSD1 (inh=AD pLI=1.00)
chr5	176727072	176727072	G	C	hom		QUAL=1467;DP=28;AF=0.39;MQM=54;TRIO=HOM,28,0.39,HOM,9,0.00,HOM,33,0.00	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*4612G>C:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*4612G>C:	(C)n	rs867075292	0.0000	0.0000	0/0/0	0.0015										0	60					NSD1 (inh=AD pLI=1.00)
chr5	177031348	177031348	T	C	het		QUAL=4589;DP=50;AF=0.42;MQM=59;TRIO=HET,50,0.42,HOM,115,0.99,HET,113,0.38	B4GALT7	synonymous	B4GALT7:NM_007255.2:synonymous:LOW:exon2/6:c.219T>C:p.Arg73Arg		rs11537644	0.6613	0.6490	23835/12353/1963	0.6396						604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome,progeroid type,1];			COSM3761139	436	514					B4GALT7 (inh=n/a pLI=0.00)
chr5	177035964	177035964	T	C	het		QUAL=12525;DP=191;AF=0.50;MQM=59;TRIO=HET,191,0.50,HOM,214,1.00,HET,263,0.52	B4GALT7	synonymous	B4GALT7:NM_007255.2:synonymous:LOW:exon5/6:c.777T>C:p.His259His		rs729459	0.6050	0.5900	21537/10771/1974	0.5831						604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome,progeroid type,1];			COSM3761140	347	550					B4GALT7 (inh=n/a pLI=0.00)
chr5	177422876	177422876	T	C	hom		QUAL=17249;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HOM,177,1.00,HOM,249,1.00	PROP1	missense	PROP1:NM_006261.4:missense:MODERATE:exon1/3:c.59A>G:p.Asn20Ser		rs7445271	0.9994	1.0000	60692/33365/5194	0.9333	-0.4890	T	T	B	B	601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2];				1107	0					PROP1 (inh=AR pLI=0.30)
chr5	177422908	177422908	A	G	hom		QUAL=15860;DP=149;AF=0.99;MQM=60;TRIO=HOM,149,0.99,HET,232,0.48,HOM,304,1.00	PROP1	synonymous	PROP1:NM_006261.4:synonymous:LOW:exon1/3:c.27T>C:p.Ala9Ala		rs1135320	0.4477	0.4760	14261/6913/404	0.4643						601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2];			COSM4159781	299	506					PROP1 (inh=AR pLI=0.30)
chr5	177423144	177423144	T	G	hom		QUAL=32074;DP=354;AF=0.99;MQM=59;TRIO=HOM,354,0.99,HET,408,0.46,HOM,531,1.00	PROP1	5'UTR	PROP1:NM_006261.4:5'UTR:MODIFIER:exon1/3:c.-210A>C:		rs13187293	0.3303	0.0000	0/0/0	0.0580										50	138					PROP1 (inh=AR pLI=0.30)
chr6	3224825	3224825	A	-	hom		QUAL=42698;DP=395;AF=0.99;MQM=59;TRIO=HOM,395,0.99,HOM,422,1.00,HOM,551,0.99	TUBB2B	3'UTR	TUBB2B:NM_178012.4:3'UTR:MODIFIER:exon4/4:c.*160delT:		rs398000197	0.0000	0.0000	0/0/0	0.5135										195	33					TUBB2B (inh=AD pLI=n/a)
chr6	7542148	7542148	-	A	het	anno_high_impact	QUAL=1795;DP=60;AF=0.52;MQM=59;TRIO=HET,60,0.52,HET,115,0.43,WT,121,0.01	DSP	frameshift&start_lost	DSP:NM_004415.3:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs,DSP:NM_001008844.2:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs,DSP:NM_001319034.1:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs		rs17133512;rs606231377	0.1997	0.1580	1480/549/173	0.1474							RCV000029674.1 [uncertain significance]; RCV000037982.6,RCV000029674.1 [other,uncertain significance]; RCV000037982.6 [other]; 			28	272	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			DSP (inh=AR+AD pLI=1.00)
chr6	7542274	7542274	T	C	het		QUAL=1094;DP=20;AF=0.25;MQM=60;TRIO=HET,20,0.25,WT,63,0.00,HET,71,0.61	DSP	synonymous	DSP:NM_004415.3:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr,DSP:NM_001008844.2:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr,DSP:NM_001319034.1:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr		rs36087964	0.0609	0.0450	95/49/18	0.0417						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000037988.2 [benign]; 		COSM451787	5	139					DSP (inh=AR+AD pLI=1.00)
chr6	7563983	7563983	T	G	hom		QUAL=32492;DP=451;AF=1.00;MQM=59;TRIO=HOM,451,1.00,HOM,231,1.00,HOM,314,1.00	DSP	synonymous	DSP:NM_004415.3:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala,DSP:NM_001008844.2:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala,DSP:NM_001319034.1:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala		rs2806234	1.0000	0.9990	60601/33273/5200	0.9624						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000154388.1 [likely benign]; RCV000038087.3 [other]; RCV000038088.2 [likely benign]; 			1218	3					DSP (inh=AR+AD pLI=1.00)
chr6	7565727	7565727	A	T	het	phylop_high;pred_pathogenic_3;anno_pathogenic_hgmd	QUAL=7274;DP=228;AF=0.50;MQM=60;TRIO=HET,228,0.50,WT,281,0.00,HET,404,0.47	DSP	missense	DSP:NM_004415.3:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe,DSP:NM_001008844.2:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe,DSP:NM_001319034.1:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe		rs17604693	0.0184	0.0300	85/59/0	0.0300	9.2100	D	D,D,D	D,D	P,P	125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000029686.1 [benign]; RCV000038119.4 [other]; RCV000143884.1 [uncertain significance]; RCV000202852.1 [benign]; 	CM150219 [CLASS=DM? MUT=ALT PHEN="Arrhythmogenic right ventricular cardiomyopathy" GENE=DSP]; 	COSM1685467	3	109	3	[3] Stephan Waldm?ller 09.11.2015 [n/a] comment imported from detected variant: HGMD: DM? f?r ARVC, VUS3, swal 151109			DSP (inh=AR+AD pLI=1.00)
chr6	7572262	7572262	A	G	hom		QUAL=14095;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,98,1.00,HOM,146,1.00	DSP	synonymous	DSP:NM_004415.3:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly,DSP:NM_001008844.2:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly,DSP:NM_001319034.1:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly		rs2076304	0.7744	0.7610	35334/19903/3342	0.7531						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000154389.1 [benign]; RCV000206052.1 [benign]; RCV000206052.1 [benign]; RCV000038004.2 [benign]; 			749	425					DSP (inh=AR+AD pLI=1.00)
chr6	7576527	7576527	G	A	hom		QUAL=10117;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HOM,56,1.00,HOM,89,1.00	DSP	splice_region&synonymous	DSP:NM_004415.3:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg,DSP:NM_001008844.2:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg,DSP:NM_001319034.1:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg		rs1016835	0.7354	0.7710	36242/21321/2142	0.7704						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000154390.1 [benign]; RCV000038011.2 [benign]; 			795	375					DSP (inh=AR+AD pLI=1.00)
chr6	7584617	7584617	C	T	hom		QUAL=23047;DP=442;AF=1.00;MQM=59;TRIO=HOM,442,1.00,HET,161,0.51,HOM,222,0.99	DSP	synonymous	DSP:NM_004415.3:synonymous:LOW:exon24/24:c.7122C>T:p.Thr2374Thr,DSP:NM_001008844.2:synonymous:LOW:exon24/24:c.5325C>T:p.Thr1775Thr,DSP:NM_001319034.1:synonymous:LOW:exon24/24:c.5793C>T:p.Thr1931Thr		rs2076300	0.2117	0.2880	5622/4248/152	0.2873						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000038083.2 [benign]; 		COSM150043	170	556					DSP (inh=AR+AD pLI=1.00)
chr6	7585967	7585967	G	C	hom		QUAL=18002;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HET,178,0.49,HOM,260,0.99	DSP	synonymous	DSP:NM_004415.3:synonymous:LOW:exon24/24:c.8472G>C:p.Gly2824Gly,DSP:NM_001008844.2:synonymous:LOW:exon24/24:c.6675G>C:p.Gly2225Gly,DSP:NM_001319034.1:synonymous:LOW:exon24/24:c.7143G>C:p.Gly2381Gly		rs2744380	0.7095	0.7100	30649/16753/2060	0.6999						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Cardiomyopathy,dilated,with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis];	RCV000154391.1 [benign]; RCV000038104.3 [benign]; 			640	461					DSP (inh=AR+AD pLI=1.00)
chr6	16305506	16305506	A	-	het		QUAL=69;DP=146;AF=0.20;MQM=59;TRIO=HET,146,0.20,HET,76,0.22,WT,98,0.13	ATXN1	3'UTR	ATXN1:NM_000332.3:3'UTR:MODIFIER:exon9/9:c.*1054delT:,ATXN1:NM_001128164.1:3'UTR:MODIFIER:exon8/8:c.*1054delT:			0.0000	0.0000	0/0/0	0.0014										0	15					ATXN1 (inh=AD pLI=0.40)
chr6	16327615	16327615	A	G	het		QUAL=4440;DP=107;AF=0.42;MQM=59;TRIO=HET,107,0.42,HET,146,0.40,HET,186,0.45	ATXN1	synonymous	ATXN1:NM_000332.3:synonymous:LOW:exon8/9:c.927T>C:p.Ala309Ala,ATXN1:NM_001128164.1:synonymous:LOW:exon7/8:c.927T>C:p.Ala309Ala		rs179990	0.7802	0.7320	32824/15394/3257	0.7221						601556 [ATXN1 (confirmed) Spinocerebellar ataxia 1];	RCV000116476.2 [likely benign]; RCV000116475.2 [likely benign]; 		COSM3761638	493	482					ATXN1 (inh=AD pLI=0.40)
chr6	18122506	18122506	G	A	het	pred_pathogenic_2;anno_pathogenic_hgmd	QUAL=2093;DP=56;AF=0.57;MQM=59;TRIO=HET,56,0.57,WT,90,0.00,HET,108,0.62	NHLRC1	missense	NHLRC1:NM_198586.2:missense:MODERATE:exon1/1:c.332C>T:p.Pro111Leu		rs10949483	0.3429	0.3860	8525/4596/226	0.3755	1.4920	D	D	B	B	608072 [NHLRC1 (confirmed) Epilepsy,progressive myoclonic 2B (Lafora)];	RCV000117782.5 [benign]; 	CM065338 [CLASS=DM? MUT=ALT PHEN="Myoclonic epilepsy of Lafora" GENE=NHLRC1]; 	COSM3749962	291	1113	2	[2] old entry - no details available [n/a] comment imported from detected variant: GS140155; too often in 1000g and esp6500 and in house; 18.06.2014; FH 			NHLRC1 (inh=AR pLI=0.04)
chr6	24532392	24532392	T	C	het		QUAL=5964;DP=268;AF=0.46;MQM=60;TRIO=HET,268,0.46,HET,198,0.53,WT,304,0.00	ALDH5A1	synonymous	ALDH5A1:NM_170740.1:synonymous:LOW:exon10/11:c.1428T>C:p.Asp476Asp,ALDH5A1:NM_001080.3:synonymous:LOW:exon9/10:c.1389T>C:p.Asp463Asp		rs58747567	0.0026	0.0062	7/7/0	0.0066						610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency];				0	14	2	[2] swoedl 19.10.2016			ALDH5A1 (inh=AR pLI=0.00)
chr6	24532412	24532412	G	A	het		QUAL=4652;DP=203;AF=0.43;MQM=60;TRIO=HET,203,0.43,HET,192,0.52,WT,289,0.00	ALDH5A1	splice_region&intron	ALDH5A1:NM_170740.1:splice_region&intron:LOW:exon10/10:c.1441+7G>A:,ALDH5A1:NM_001080.3:splice_region&intron:LOW:exon9/9:c.1402+7G>A:		rs12211574	0.0507	0.0810	506/363/2	0.0803						610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency];				10	141					ALDH5A1 (inh=AR pLI=0.00)
chr6	24535179	24535179	T	G	het		QUAL=8505;DP=392;AF=0.48;MQM=60;TRIO=HET,392,0.48,HET,235,0.58,WT,272,0.00	ALDH5A1	3'UTR	ALDH5A1:NM_170740.1:3'UTR:MODIFIER:exon11/11:c.*1239T>G:,ALDH5A1:NM_001080.3:3'UTR:MODIFIER:exon10/10:c.*1239T>G:		rs191960134	0.0026	0.0000	0/0/0	0.0012										0	3					ALDH5A1 (inh=AR pLI=0.00)
chr6	24535817	24535817	A	G	het		QUAL=3074;DP=216;AF=0.40;MQM=56;TRIO=HET,216,0.40,HET,117,0.37,WT,140,0.01	ALDH5A1	3'UTR	ALDH5A1:NM_170740.1:3'UTR:MODIFIER:exon11/11:c.*1877A>G:,ALDH5A1:NM_001080.3:3'UTR:MODIFIER:exon10/10:c.*1877A>G:	AluY	rs41271787	0.0026	0.0000	0/0/0	0.0072										0	2					ALDH5A1 (inh=AR pLI=0.00)
chr6	26027135	26027135	G	A	het		QUAL=3021;DP=148;AF=0.48;MQM=60;TRIO=HET,148,0.48,HET,125,0.52,WT,168,0.01	HIST1H4B	3'UTR	HIST1H4B:NM_003544.2:3'UTR:MODIFIER:exon1/1:c.*34C>T:		rs3752420	0.3918	0.3950	9809/4918/151	0.3922										73	208					HIST1H4B (inh=n/a pLI=0.01)
chr6	26027433	26027433	G	A	het		QUAL=3851;DP=174;AF=0.47;MQM=60;TRIO=HET,174,0.47,HET,194,0.48,WT,233,0.00	HIST1H4B	synonymous	HIST1H4B:NM_003544.2:synonymous:LOW:exon1/1:c.48C>T:p.Ala16Ala		rs3752419	0.3944	0.4040	10715/5188/165	0.4046									COSM4160437	97	298					HIST1H4B (inh=n/a pLI=0.01)
chr6	31830593	31830593	A	C	het		QUAL=8056;DP=413;AF=0.50;MQM=59;TRIO=HET,413,0.50,HET,298,0.46,WT,453,0.00	NEU1	5'UTR	NEU1:NM_000434.3.8:5'UTR:MODIFIER:exon1/6:c.-40T>G:		rs41267082	0.0511	0.0440	197/63/2	0.0415										0	25					NEU1 (inh=n/a pLI=0.00)
chr6	31964621	31964621	-	CT	het	low_MQM;anno_high_impact;anno_pathogenic_hgmd	QUAL=163;DP=21;AF=0.57;MQM=36;TRIO=HET,21,0.57,HET,14,0.14,WT,2,0.00	C4A,C4B,C4B_2	frameshift	C4A:NM_007293.2.2:frameshift:HIGH:exon29/41:c.3694_3695dupTC:p.Val1233fs,C4B:NM_001002029.3.2:frameshift:HIGH:exon29/41:c.3694_3695dupTC:p.Val1233fs,C4B_2:NM_001242823.2.7:frameshift:HIGH:exon29/41:c.3694_3695dupTC:p.Val1233fs,C4A:NM_001252204.1.3:frameshift:HIGH:exon29/40:c.3694_3695dupTC:p.Val1233fs		rs760602547	0.0000	0.0013	0/0/0	0.0002						120810 [C4A (confirmed) C4a deficiency|Blood group,Rodgers];		CI931069 [CLASS=DM MUT=ALT PHEN="Complement C4a deficiency" GENE=C4A]; 		1	11					C4A (inh=n/a pLI=n/a), C4B (inh=n/a pLI=n/a), C4B_2 (inh=n/a pLI=n/a)
chr6	31973863	31973863	C	T	het	low_MQM	QUAL=7831;DP=151;AF=0.50;MQM=48;TRIO=HET,151,0.50,WT,213,0.00,HOM,222,0.99	CYP21A2,CYP21A1P	splice_region&intron,intron,non_coding_exon	CYP21A2:NM_000500.7.9:splice_region&intron:LOW:exon2/10:c.292+9C>T:,CYP21A2:NM_001128590.3.6:intron:MODIFIER:exon1/9:c.202+196C>T:,CYP21A1P:NR_040090.1:non_coding_exon:MODIFIER:exon1/8:n.451C>T:		rs28361033	0.4123	0.4620	12668/7204/514	0.3890						120810 [C4A (confirmed) C4a deficiency|Blood group,Rodgers]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency];			COSN167727	355	393					CYP21A2 (inh=n/a pLI=0.67), CYP21A1P (inh=n/a pLI=n/a)
chr6	31975463	31975463	T	C	het	low_MQM;anno_high_impact	QUAL=703;DP=78;AF=0.14;MQM=37;TRIO=HET,78,0.14,WT,236,0.00,HOM,35,0.97	CYP21A2,CYP21A1P	stop_lost,non_coding_exon	CYP21A2:NM_000500.7.9:stop_lost:HIGH:exon9/11:c.946T>C:p.Ter316Glnext*?,CYP21A2:NM_001128590.3.6:stop_lost:HIGH:exon8/10:c.856T>C:p.Ter286Glnext*?,CYP21A1P:NR_040090.1:non_coding_exon:MODIFIER:exon6/8:n.1386T>C:		rs370433041	0.0541	0.0056	19/1/3	0.0055						120810 [C4A (confirmed) C4a deficiency|Blood group,Rodgers]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency];				16	25	2	[2] Ute Grasshoff 24.11.2015			CYP21A2 (inh=n/a pLI=0.67), CYP21A1P (inh=n/a pLI=n/a)
chr6	31975577	31975577	T	C	hom	low_MQM	QUAL=359;DP=20;AF=1.00;MQM=34;TRIO=HOM,20,1.00,WT,248,0.08,HOM,5,1.00	CYP21A2,CYP21A1P	missense,non_coding_exon	CYP21A2:NM_000500.7.9:missense:MODERATE:exon9/11:c.1060T>C:p.Trp354Arg,CYP21A2:NM_001128590.3.6:missense:MODERATE:exon8/10:c.970T>C:p.Trp324Arg,CYP21A1P:NR_040090.1:non_coding_exon:MODIFIER:exon6/8:n.1500T>C:		rs147390813	0.2943	0.0095	6/3/0	0.0274						120810 [C4A (confirmed) C4a deficiency|Blood group,Rodgers]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency];				203	55					CYP21A2 (inh=n/a pLI=0.67), CYP21A1P (inh=n/a pLI=n/a)
chr6	31976228	31976228	C	T	hom	low_MQM	QUAL=6263;DP=114;AF=0.89;MQM=44;TRIO=HOM,114,0.89,HET,370,0.48,WT,258,0.03	CYP21A2,TNXB,CYP21A1P,TNXA	3'UTR,non_coding_exon	CYP21A2:NM_000500.7.9:3'UTR:MODIFIER:exon11/11:c.*52C>T:,TNXB:NM_032470.3.10:3'UTR:MODIFIER:exon13/13:c.*163G>A:,CYP21A2:NM_001128590.3.6:3'UTR:MODIFIER:exon10/10:c.*52C>T:,CYP21A1P:NR_040090.1:non_coding_exon:MODIFIER:exon8/8:n.1971C>T:,TNXA:NR_001284.2.4:non_coding_exon:MODIFIER:exon13/13:n.2752G>A:		rs182239097	0.2656	0.0000	0/0/0	0.1020						120810 [C4A (confirmed) C4a deficiency|Blood group,Rodgers]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency];				12	87					CYP21A2 (inh=n/a pLI=0.67), TNXB (inh=n/a pLI=0.77), CYP21A1P (inh=n/a pLI=n/a), TNXA (inh=n/a pLI=n/a)
chr6	31994782	31994782	C	T	het	low_DP;low_MQM	QUAL=2728;DP=5;AF=0.20;MQM=29;TRIO=HET,5,0.20,HOM,77,1.00,HET,141,0.45	C4B,C4B_2	synonymous	C4B:NM_001002029.3:synonymous:LOW:exon20/41:c.2475C>T:p.Val825Val,C4B_2:NM_001242823.2.4:synonymous:LOW:exon20/41:c.2475C>T:p.Val825Val		rs451637	0.1028	0.1790	2087/1733/15	0.1363						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];			COSM4160886, COSM4160885	84	177					C4B (inh=n/a pLI=n/a), C4B_2 (inh=n/a pLI=n/a)
chr6	31997401	31997401	G	A	het	low_MQM	QUAL=455;DP=39;AF=0.51;MQM=31;TRIO=HET,39,0.51,WT,63,0.00,HET,67,0.22	C4B,C4B_2	synonymous	C4B:NM_001002029.3:synonymous:LOW:exon29/41:c.3735G>A:p.Pro1245Pro,C4B_2:NM_001242823.2.4:synonymous:LOW:exon29/41:c.3735G>A:p.Pro1245Pro		rs12526327	0.0000	0.2060	11/3/0	0.0030						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];				1	381					C4B (inh=n/a pLI=n/a), C4B_2 (inh=n/a pLI=n/a)
chr6	32006119	32006119	A	C	het		QUAL=3871;DP=159;AF=0.53;MQM=52;TRIO=HET,159,0.53,HET,165,0.49,WT,225,0.00	CYP21A2	5'UTR	CYP21A2:NM_000500.7.10:5'UTR:MODIFIER:exon1/10:c.-81A>C:,CYP21A2:NM_001128590.3.10:5'UTR:MODIFIER:exon1/9:c.-81A>C:		rs554941446	0.0026	0.0000	0/0/0	0.0044						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];				0	5					CYP21A2 (inh=n/a pLI=0.67)
chr6	32006215	32006217	CTG	-	het	low_MQM	QUAL=2805;DP=138;AF=0.48;MQM=45;TRIO=HET,138,0.48,WT,241,0.00,HET,335,0.39	CYP21A2	disruptive_inframe_deletion	CYP21A2:NM_000500.7.10:disruptive_inframe_deletion:MODERATE:exon1/10:c.29_31delTGC:p.Leu10del,CYP21A2:NM_001128590.3.10:disruptive_inframe_deletion:MODERATE:exon1/9:c.29_31delTGC:p.Leu10del	(TGC)n	rs754295868	0.2169	0.1730	787/441/4	0.1466						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];	RCV000079017.4 [benign]; 		COSM1077762	136	392					CYP21A2 (inh=n/a pLI=0.67)
chr6	32006317	32006317	C	T	hom	low_MQM	QUAL=20502;DP=205;AF=1.00;MQM=40;TRIO=HOM,205,1.00,HET,292,0.51,HOM,419,1.00	CYP21A2	synonymous	CYP21A2:NM_000500.7.10:synonymous:LOW:exon1/10:c.118C>T:p.Leu40Leu,CYP21A2:NM_001128590.3.10:synonymous:LOW:exon1/9:c.118C>T:p.Leu40Leu		rs6468	0.0000	0.7880	29981/15454/3159	0.0998						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];			COSM4160891	600	358					CYP21A2 (inh=n/a pLI=0.67)
chr6	32006337	32006337	C	A	hom	low_MQM	QUAL=18897;DP=187;AF=1.00;MQM=37;TRIO=HOM,187,1.00,HET,272,0.52,HOM,389,0.99	CYP21A2	synonymous	CYP21A2:NM_000500.7.10:synonymous:LOW:exon1/10:c.138C>A:p.Pro46Pro,CYP21A2:NM_001128590.3.10:synonymous:LOW:exon1/9:c.138C>A:p.Pro46Pro		rs6464	0.0000	0.6670	15896/8501/1149	0.0448						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];			COSM4160892	476	436					CYP21A2 (inh=n/a pLI=0.67)
chr6	32006597	32006597	C	T	het	low_MQM	QUAL=9594;DP=93;AF=0.53;MQM=49;TRIO=HET,93,0.53,WT,172,0.01,HOM,289,1.00	CYP21A2	splice_region&intron,intron	CYP21A2:NM_000500.7.10:splice_region&intron:LOW:exon2/9:c.292+9C>T:,CYP21A2:NM_001128590.3.10:intron:MODIFIER:exon1/8:c.202+196C>T:		rs6462	0.7115	0.7150	21254/11276/1484	0.6273						613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];				564	455					CYP21A2 (inh=n/a pLI=0.67)
chr6	32006886	32006886	G	A	het		QUAL=2289;DP=78;AF=0.46;MQM=59;TRIO=HET,78,0.46,WT,210,0.02,HET,146,0.47	CYP21A2	missense	CYP21A2:NM_000500.7.10:missense:MODERATE:exon3/10:c.308G>A:p.Arg103Lys,CYP21A2:NM_001128590.3.10:missense:MODERATE:exon2/9:c.218G>A:p.Arg73Lys		rs6474	0.2149	0.3000	5625/3562/20	0.2871	-1.0340	T	T,T,T,T	B,B	B,B	613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];	RCV000055817.1 [benign]; 		COSM1319109	160	457					CYP21A2 (inh=n/a pLI=0.67)
chr6	32008963	32008963	C	T	het	low_MQM	QUAL=15751;DP=113;AF=0.57;MQM=48;TRIO=HET,113,0.57,HET,288,0.47,HOM,416,0.98	CYP21A2,TNXB	3'UTR	CYP21A2:NM_000500.7.10:3'UTR:MODIFIER:exon10/10:c.*52C>T:,TNXB:NM_019105.6.6:3'UTR:MODIFIER:exon44/44:c.*163G>A:,CYP21A2:NM_001128590.3.10:3'UTR:MODIFIER:exon9/9:c.*52C>T:,TNXB:NM_032470.3.9:3'UTR:MODIFIER:exon13/13:c.*163G>A:		rs1058152	0.4996	0.5490	12122/6662/301	0.4481						600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];				8	106					CYP21A2 (inh=n/a pLI=0.67), TNXB (inh=n/a pLI=0.77)
chr6	32009456	32009456	A	G	het	low_MQM	QUAL=4803;DP=169;AF=0.27;MQM=46;TRIO=HET,169,0.27,WT,342,0.00,HET,434,0.44	TNXB	intron	TNXB:NM_019105.6.6:intron:MODIFIER:exon43/43:c.12627+92T>C:,TNXB:NM_032470.3.9:intron:MODIFIER:exon12/12:c.1920+92T>C:		rs3128757	0.0000	0.0000	0/0/0	0.0601						600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency|Vesicoureteral reflux 8];				13	50					TNXB (inh=n/a pLI=0.77)
chr6	32793981	32793981	A	C	het		QUAL=11037;DP=308;AF=0.51;MQM=59;TRIO=HET,308,0.51,HET,118,0.53,HOM,162,1.00	TAP2	3'UTR,intron	TAP2:NM_000544.3.8:3'UTR:MODIFIER:exon12/12:c.*2651T>G:,TAP2:NM_001290043.1.8:3'UTR:MODIFIER:exon12/12:c.*2702T>G:,TAP2:NM_018833.2.2:intron:MODIFIER:exon11/11:c.1932+3196T>G:		rs1044043	0.8211	0.0000	0/0/0	0.1342						170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency|Wegener-like granulomatosis];				161	88					TAP2 (inh=n/a pLI=0.00)
chr6	32795032	32795032	G	A	het		QUAL=7880;DP=363;AF=0.52;MQM=60;TRIO=HET,363,0.52,WT,209,0.00,HET,280,0.42	TAP2	3'UTR,intron	TAP2:NM_000544.3.8:3'UTR:MODIFIER:exon12/12:c.*1600C>T:,TAP2:NM_001290043.1.8:3'UTR:MODIFIER:exon12/12:c.*1651C>T:,TAP2:NM_018833.2.2:intron:MODIFIER:exon11/11:c.1932+2145C>T:		rs10484565	0.0511	0.0000	0/0/0	0.0123						170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency|Wegener-like granulomatosis];				1	33					TAP2 (inh=n/a pLI=0.00)
chr6	32796451	32796451	A	C	het		QUAL=1644;DP=102;AF=0.38;MQM=59;TRIO=HET,102,0.38,WT,45,0.00,HET,79,0.44	TAP2	3'UTR,intron	TAP2:NM_000544.3.8:3'UTR:MODIFIER:exon12/12:c.*181T>G:,TAP2:NM_001290043.1.8:3'UTR:MODIFIER:exon12/12:c.*232T>G:,TAP2:NM_018833.2.2:intron:MODIFIER:exon11/11:c.1932+726T>G:		rs141809764	0.0038	0.0000	0/0/0	0.0028						170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency|Wegener-like granulomatosis];				0	4					TAP2 (inh=n/a pLI=0.00)
chr6	32796793	32796793	G	A	het	pred_pathogenic_1	QUAL=4028;DP=187;AF=0.47;MQM=59;TRIO=HET,187,0.47,HET,168,0.48,WT,252,0.00	TAP2	missense,intron	TAP2:NM_000544.3.8:missense:MODERATE:exon12/12:c.1951C>T:p.Arg651Cys,TAP2:NM_001290043.1.8:missense:MODERATE:exon12/12:c.1951C>T:p.Arg651Cys,TAP2:NM_018833.2.2:intron:MODIFIER:exon11/11:c.1932+384C>T:		rs4148876	0.0585	0.0350	66/42/0	0.0354	0.0370	T	T	D,D	P,P	170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency|Wegener-like granulomatosis];		CM077979 [CLASS=DP MUT=ALT PHEN="Diabetes type 1 association with" GENE=TAP2]; 		4	122					TAP2 (inh=n/a pLI=0.00)
chr6	32800224	32800224	C	A	het		QUAL=2818;DP=165;AF=0.52;MQM=60;TRIO=HET,165,0.52,HET,81,0.43,WT,99,0.00	TAP2	synonymous	TAP2:NM_000544.3.8:synonymous:LOW:exon7/12:c.1158G>T:p.Gly386Gly,TAP2:NM_018833.2.2:synonymous:LOW:exon7/12:c.1158G>T:p.Gly386Gly,TAP2:NM_001290043.1.8:synonymous:LOW:exon7/12:c.1158G>T:p.Gly386Gly		rs2228397	0.2442	0.2520	3643/1674/239	0.2435						170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency|Wegener-like granulomatosis];				87	416					TAP2 (inh=n/a pLI=0.00)
chr6	32806530	32806530	C	G	het		QUAL=2080;DP=66;AF=0.64;MQM=60;TRIO=HET,66,0.64,WT,47,0.00,HET,85,0.56	TAP2	5'UTR	TAP2:NM_000544.3.8:5'UTR:MODIFIER:exon1/12:c.-105G>C:,TAP2:NM_018833.2.2:5'UTR:MODIFIER:exon1/12:c.-105G>C:,TAP2:NM_001290043.1.8:5'UTR:MODIFIER:exon1/12:c.-105G>C:		rs146973617	0.0032	0.0000	0/0/0	0.0058										0	6					TAP2 (inh=n/a pLI=0.00)
chr6	32813279	32813279	C	A	hom		QUAL=26004;DP=438;AF=0.99;MQM=59;TRIO=HOM,438,0.99,HET,412,0.48,HET,605,0.52	TAP1,PSMB8-AS1	3'UTR,non_coding_exon	TAP1:NM_000593.5:3'UTR:MODIFIER:exon11/11:c.*77G>T:,TAP1:NM_001292022.1.8:3'UTR:MODIFIER:exon11/11:c.*77G>T:,PSMB8-AS1:NR_037173.1.6:non_coding_exon:MODIFIER:exon3/3:n.500C>A:,PSMB8-AS1:NR_037174.1:non_coding_exon:MODIFIER:exon2/2:n.362C>A:,PSMB8-AS1:NR_037175.1:non_coding_exon:MODIFIER:exon3/3:n.335C>A:,PSMB8-AS1:NR_037176.1:non_coding_exon:MODIFIER:exon2/2:n.274C>A:		rs1057373	0.0909	0.0000	0/0/0	0.0191										4	65					TAP1 (inh=n/a pLI=0.29), PSMB8-AS1 (inh=n/a pLI=n/a)
chr6	32814909	32814909	C	T	het	phylop_high;pred_pathogenic_3;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=4880;DP=272;AF=0.46;MQM=60;TRIO=HET,272,0.46,WT,172,0.00,HET,189,0.40	TAP1	missense	TAP1:NM_000593.5:missense:MODERATE:exon10/11:c.2156G>A:p.Arg719Gln,TAP1:NM_001292022.1.8:missense:MODERATE:exon10/11:c.1373G>A:p.Arg458Gln		rs121917702	0.0008	0.0016	1/1/0	0.0015	3.0610	D	D,D	D	P	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I];	RCV000014734.4 [pathogenic]; 	CM963078 [CLASS=DM MUT=ALT PHEN="HLA class I deficiency" GENE=TAP1]; 		0	2					TAP1 (inh=n/a pLI=0.29)
chr6	32814975	32814975	T	C	hom	phylop_high	QUAL=9508;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HET,141,0.55,HET,161,0.38	TAP1	missense	TAP1:NM_000593.5:missense:MODERATE:exon10/11:c.2090A>G:p.Asp697Gly,TAP1:NM_001292022.1.8:missense:MODERATE:exon10/11:c.1307A>G:p.Asp436Gly		rs1135216	0.1915	0.1710	1823/753/239	0.1629	4.9980	T	T,T	B	B	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I];	RCV000014733.2 [benign]; 	CM920657 [CLASS=DP MUT=ALT PHEN="Nasopharyngeal carcinoma reduced risk association with" GENE=TAP1]; 	COSM4161045	21	280					TAP1 (inh=n/a pLI=0.29)
chr6	32818774	32818774	T	C	hom		QUAL=15037;DP=231;AF=0.99;MQM=59;TRIO=HOM,231,0.99,HET,263,0.54,HET,332,0.55	TAP1	missense	TAP1:NM_000593.5:missense:MODERATE:exon4/11:c.1177A>G:p.Ile393Val,TAP1:NM_001292022.1.8:missense:MODERATE:exon4/11:c.394A>G:p.Ile132Val		rs1057141	0.2282	0.2030	2584/1032/318	0.1917	-0.5640	T	T,T	B	B	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I];	RCV000014732.2 [benign]; 	CM920656 [CLASS=DP MUT=ALT PHEN="Nasopharyngeal carcinoma reduced risk association with" GENE=TAP1]; 		35	292					TAP1 (inh=n/a pLI=0.29)
chr6	33267672	33267672	A	G	hom		QUAL=35312;DP=496;AF=0.99;MQM=59;TRIO=HOM,496,0.99,HOM,471,1.00,HET,565,0.44	TAPBP	3'UTR	TAPBP:NM_003190.4:3'UTR:MODIFIER:exon8/8:c.*1865T>C:,TAPBP:NM_172209.2:3'UTR:MODIFIER:exon7/7:c.*1865T>C:	L2b	rs1059288	0.5905	0.0000	0/0/0	0.1041										81	102					TAPBP (inh=n/a pLI=0.00)
chr6	33267908	33267908	G	A	het		QUAL=9073;DP=363;AF=0.48;MQM=59;TRIO=HET,363,0.48,WT,332,0.00,HET,414,0.47	TAPBP	3'UTR	TAPBP:NM_003190.4:3'UTR:MODIFIER:exon8/8:c.*1629C>T:,TAPBP:NM_172209.2:3'UTR:MODIFIER:exon7/7:c.*1629C>T:		rs147996331	0.0020	0.0000	0/0/0	0.0081										1	6					TAPBP (inh=n/a pLI=0.00)
chr6	33268437	33268437	-	AGAAAAAA	hom		QUAL=2536;DP=80;AF=0.99;MQM=53;TRIO=HOM,80,0.99,HOM,15,1.00,HET,18,0.50	TAPBP	3'UTR	TAPBP:NM_003190.4:3'UTR:MODIFIER:exon8/8:c.*1092_*1099dupTTTTTTCT:,TAPBP:NM_172209.2:3'UTR:MODIFIER:exon7/7:c.*1092_*1099dupTTTTTTCT:	AluY	rs71536179;rs9282488	0.0000	0.0000	0/0/0	0.1252										48	65					TAPBP (inh=n/a pLI=0.00)
chr6	33268737	33268737	C	A	het	low_MQM	QUAL=704;DP=69;AF=0.48;MQM=45;TRIO=HET,69,0.48,WT,2,0.00,HET,2,0.50	TAPBP	3'UTR	TAPBP:NM_003190.4:3'UTR:MODIFIER:exon8/8:c.*800G>T:,TAPBP:NM_172209.2:3'UTR:MODIFIER:exon7/7:c.*800G>T:	AluY	rs3130259	0.2210	0.0000	0/0/0	0.1386										24	27					TAPBP (inh=n/a pLI=0.00)
chr6	33272813	33272813	T	G	het	low_QUAL;phylop_high;pred_pathogenic_3	QUAL=17;DP=134;AF=0.43;MQM=59;TRIO=HET,134,0.43,WT,238,0.02,WT,315,0.02	TAPBP	missense	TAPBP:NM_172208.2:missense:MODERATE:exon4/7:c.821A>C:p.His274Pro,TAPBP:NM_003190.4:missense:MODERATE:exon4/8:c.821A>C:p.His274Pro,TAPBP:NM_172209.2:missense:MODERATE:exon3/7:c.560A>C:p.His187Pro		rs201276892	0.0000	0.0220	0/0/0	0.0001	2.2540	T	D,D,T,D,D,.,.	D,D,D,D,D,D	D,D,D,D,D,D	601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I];				0	24					TAPBP (inh=n/a pLI=0.00)
chr6	33272855	33272855	G	C	hom		QUAL=24421;DP=265;AF=0.99;MQM=59;TRIO=HOM,265,0.99,HOM,339,1.00,HET,462,0.51	TAPBP	missense	TAPBP:NM_172208.2:missense:MODERATE:exon4/7:c.779C>G:p.Thr260Arg,TAPBP:NM_003190.4:missense:MODERATE:exon4/8:c.779C>G:p.Thr260Arg,TAPBP:NM_172209.2:missense:MODERATE:exon3/7:c.518C>G:p.Thr173Arg		rs2071888	0.5913	0.5680	20032/10182/2907	0.5494	0.9400	T	T,T,T,T,T,.,.	B,B,B,P	B,B,B,B	601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I];		CM056992 [CLASS=DP MUT=ALT PHEN="Rheumatoid arthritis juvenile association with" GENE=TAPBP]; 	COSM1180607, COSM1180608	358	537					TAPBP (inh=n/a pLI=0.00)
chr6	33281842	33281842	G	T	het		QUAL=7103;DP=126;AF=0.44;MQM=59;TRIO=HET,126,0.44,HET,206,0.43,HET,280,0.52	TAPBP	5'UTR	TAPBP:NM_172208.2:5'UTR:MODIFIER:exon1/7:c.-24C>A:,TAPBP:NM_003190.4:5'UTR:MODIFIER:exon1/8:c.-24C>A:,TAPBP:NM_172209.2:5'UTR:MODIFIER:exon1/7:c.-24C>A:		rs2239841	0.2206	0.2950	5751/3310/15	0.2723										60	182					TAPBP (inh=n/a pLI=0.00)
chr6	33281843	33281843	A	T	het		QUAL=7103;DP=126;AF=0.44;MQM=59;TRIO=HET,126,0.44,HET,206,0.43,HET,280,0.52	TAPBP	5'UTR	TAPBP:NM_172208.2:5'UTR:MODIFIER:exon1/7:c.-25T>A:,TAPBP:NM_003190.4:5'UTR:MODIFIER:exon1/8:c.-25T>A:,TAPBP:NM_172209.2:5'UTR:MODIFIER:exon1/7:c.-25T>A:		rs2239840	0.2206	0.2950	5749/3309/15	0.2723										60	182					TAPBP (inh=n/a pLI=0.00)
chr6	33282002	33282002	C	T	hom		QUAL=8695;DP=100;AF=0.98;MQM=60;TRIO=HOM,100,0.98,HOM,152,0.99,HET,196,0.55	TAPBP	5'UTR	TAPBP:NM_172208.2:5'UTR:MODIFIER:exon1/7:c.-184G>A:,TAPBP:NM_003190.4:5'UTR:MODIFIER:exon1/8:c.-184G>A:,TAPBP:NM_172209.2:5'UTR:MODIFIER:exon1/7:c.-184G>A:		rs3106189	0.5186	0.0000	0/0/0	0.0760										48	65					TAPBP (inh=n/a pLI=0.00)
chr6	33408542	33408542	G	A	het		QUAL=2341;DP=66;AF=0.47;MQM=59;TRIO=HET,66,0.47,HET,72,0.49,HET,59,0.56	SYNGAP1	synonymous	SYNGAP1:NM_006772.2:synonymous:LOW:exon11/19:c.1713G>A:p.Ser571Ser		rs411136	0.4377	0.3890	8796/4235/338	0.3767						603384 [SYNGAP1 (confirmed) Mental retardation,autosomal dominant 5];	RCV000118564.2 [likely benign]; 		COSM150074, COSM150073	162	540					SYNGAP1 (inh=AD pLI=1.00)
chr6	35423662	35423662	A	C	het		QUAL=2462;DP=63;AF=0.52;MQM=60;TRIO=HET,63,0.52,HET,72,0.44,HET,70,0.53	FANCE	synonymous	FANCE:NM_021922.2:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7210	31791/15371/3918	0.7107						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				1128	1047	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCE (inh=AR pLI=0.00)
chr6	42931628	42931631	TTTA	-	het	low_DP	QUAL=525;DP=7;AF=0.29;MQM=58;TRIO=HET,7,0.29,WT,16,0.00,HOM,19,1.00	PEX6	3'UTR,non_coding_exon	PEX6:NM_000287.3:3'UTR:MODIFIER:exon17/17:c.*442_*445delTAAA:,PEX6:NM_001316313.1:3'UTR:MODIFIER:exon17/17:c.*442_*445delTAAA:,PEX6:NR_133009.1:non_coding_exon:MODIFIER:exon15/15:n.3231_3234delTAAA:		rs144286892	0.6474	0.0000	0/0/0	0.5488										80	66					PEX6 (inh=n/a pLI=0.00)
chr6	42932200	42932200	G	T	het		QUAL=2505;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,69,0.00,HET,71,0.97	PEX6	missense,non_coding_exon	PEX6:NM_000287.3:missense:MODERATE:exon17/17:c.2816C>A:p.Pro939Gln,PEX6:NM_001316313.1:missense:MODERATE:exon17/17:c.2552C>A:p.Pro851Gln,PEX6:NR_133009.1:non_coding_exon:MODIFIER:exon15/15:n.2662C>A:		rs1129187	0.3315	0.3900	9823/6476/723	0.3714	0.2320	T	T	B	B	601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078574.4 [benign]; 		COSM1444600	239	515					PEX6 (inh=n/a pLI=0.00)
chr6	42932202	42932202	C	T	het		QUAL=2505;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,69,0.00,HOM,71,0.97	PEX6	synonymous,non_coding_exon	PEX6:NM_000287.3:synonymous:LOW:exon17/17:c.2814G>A:p.Glu938Glu,PEX6:NM_001316313.1:synonymous:LOW:exon17/17:c.2550G>A:p.Glu850Glu,PEX6:NR_133009.1:non_coding_exon:MODIFIER:exon15/15:n.2660G>A:		rs1129186	0.4936	0.4900	15519/8954/2749	0.4659						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078573.4 [benign]; 		COSM1444601	337	499					PEX6 (inh=n/a pLI=0.00)
chr6	42942779	42942779	A	G	het		QUAL=7160;DP=188;AF=0.51;MQM=60;TRIO=HET,188,0.51,WT,242,0.00,HET,339,0.54	PEX6	splice_region&intron	PEX6:NM_000287.3:splice_region&intron:LOW:exon1/16:c.883-3T>C:,PEX6:NM_001316313.1:splice_region&intron:LOW:exon1/16:c.619-3T>C:,PEX6:NR_133009.1:splice_region&intron:LOW:exon1/14:n.976-3T>C:		rs9986447	0.2897	0.3770	9493/6582/266	0.3720						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078578.4 [benign]; 			241	521					PEX6 (inh=n/a pLI=0.00)
chr6	42946490	42946490	C	A	het		QUAL=1692;DP=75;AF=0.44;MQM=59;TRIO=HET,75,0.44,WT,68,0.01,HET,88,0.57	PEX6	synonymous,non_coding_exon	PEX6:NM_000287.3:synonymous:LOW:exon1/17:c.399G>T:p.Val133Val,PEX6:NM_001316313.1:synonymous:LOW:exon1/17:c.399G>T:p.Val133Val,PEX6:NR_133009.1:non_coding_exon:MODIFIER:exon1/15:n.492G>T:		rs9462858	0.3319	0.2850	1242/436/36	0.2284						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078576.4 [benign]; 		COSM3749975	246	501					PEX6 (inh=n/a pLI=0.00)
chr6	42946943	42946943	G	A	het		QUAL=5954;DP=212;AF=0.41;MQM=60;TRIO=HET,212,0.41,WT,225,0.00,HET,348,0.48	PEX6	5'UTR,non_coding_exon	PEX6:NM_000287.3:5'UTR:MODIFIER:exon1/17:c.-55C>T:,PEX6:NM_001316313.1:5'UTR:MODIFIER:exon1/17:c.-55C>T:,PEX6:NR_133009.1:non_coding_exon:MODIFIER:exon1/15:n.39C>T:		rs9462859	0.3339	0.0000	0/0/0	0.3783										65	149					PEX6 (inh=n/a pLI=0.00)
chr6	43584323	43584323	-	A	het		QUAL=2288;DP=187;AF=0.29;MQM=59;TRIO=HET,187,0.29,WT,108,0.09,HOM,138,0.57	POLH	3'UTR	POLH:NM_006502.2:3'UTR:MODIFIER:exon11/11:c.*2043dupA:,POLH:NM_001291969.1:3'UTR:MODIFIER:exon9/9:c.*2043dupA:,POLH:NM_001291970.1:3'UTR:MODIFIER:exon11/11:c.*2869dupA:	AluSg4	rs368089629	0.1971	0.0000	0/0/0	0.0574										3	65					POLH (inh=AR pLI=0.00)
chr6	49398861	49398861	T	C	hom		QUAL=15901;DP=227;AF=1.00;MQM=60;TRIO=HOM,227,1.00,HOM,174,0.99,HET,192,0.51	MUT	3'UTR	MUT:NM_000255.3:3'UTR:MODIFIER:exon13/13:c.*580A>G:		rs11757098	0.1136	0.0000	0/0/0	0.0216										6	50					MUT (inh=AR pLI=0.00)
chr6	49399315	49399315	T	C	het		QUAL=3475;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HET,87,0.39,WT,104,0.00	MUT	3'UTR	MUT:NM_000255.3:3'UTR:MODIFIER:exon13/13:c.*126A>G:		rs192605776	0.0014	0.0000	0/0/0	0.0006										0	3					MUT (inh=AR pLI=0.00)
chr6	49403282	49403282	T	C	hom	phylop_high	QUAL=18083;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HOM,173,1.00,HET,233,0.44	MUT	missense	MUT:NM_000255.3:missense:MODERATE:exon12/13:c.2011A>G:p.Ile671Val		rs8589	0.5495	0.5740	20583/12465/1819	0.5664	3.8290	T	T,T	B	B	609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type];	RCV000203350.1 [benign]; RCV000078444.4 [benign]; 	CM0911477 [CLASS=R MUT=ALT PHEN="Methylmalonic aciduria" GENE=MUT]; 	COSM4004063	392	516	2	[2] Ute Grasshoff 28.10.2015			MUT (inh=AR pLI=0.00)
chr6	49425521	49425521	C	T	hom		QUAL=28703;DP=570;AF=0.99;MQM=60;TRIO=HOM,570,0.99,HOM,235,1.00,HET,323,0.46	MUT	synonymous	MUT:NM_000255.3:synonymous:LOW:exon3/13:c.636G>A:p.Lys212Lys		rs2229384	0.5515	0.5730	20580/12475/1731	0.5691						609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type];	RCV000203353.1 [benign]; RCV000078447.5 [benign]; 			399	519					MUT (inh=AR pLI=0.00)
chr6	51480486	51480486	G	T	hom		QUAL=15885;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HET,172,0.55,HOM,213,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*3393C>A:		rs2784198	0.6867	0.0000	0/0/0	0.6489										81	109					PKHD1 (inh=n/a pLI=0.00)
chr6	51480853	51480853	T	C	hom		QUAL=10185;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HET,56,0.48,HOM,91,0.98	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*3026A>G:		rs2784199	0.7548	0.0000	0/0/0	0.1317										97	100					PKHD1 (inh=n/a pLI=0.00)
chr6	51481315	51481315	T	C	hom		QUAL=15904;DP=299;AF=1.00;MQM=59;TRIO=HOM,299,1.00,HET,127,0.51,HOM,156,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*2564A>G:		rs1414504	0.8834	0.0000	0/0/0	0.8505										169	52					PKHD1 (inh=n/a pLI=0.00)
chr6	51481671	51481671	T	C	het		QUAL=6272;DP=349;AF=0.48;MQM=60;TRIO=HET,349,0.48,WT,106,0.00,HET,151,0.47	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*2208A>G:	L2	rs2784200	0.1316	0.0000	0/0/0	0.0201										5	39					PKHD1 (inh=n/a pLI=0.00)
chr6	51483505	51483505	A	G	hom		QUAL=63772;DP=859;AF=1.00;MQM=60;TRIO=HOM,859,1.00,HOM,469,1.00,HOM,585,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*374T>C:		rs2784201	0.9968	0.0000	0/0/0	0.9115										229	1					PKHD1 (inh=n/a pLI=0.00)
chr6	51483961	51483961	T	C	het	anno_pathogenic_hgmd	QUAL=11232;DP=436;AF=0.50;MQM=59;TRIO=HET,436,0.50,HET,169,0.54,HET,237,0.50	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon67/67:c.12143A>G:p.Gln4048Arg		rs9381994	0.5657	0.5630	19326/9873/1178	0.5570	0.4300	T	T	B	B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082526.4 [benign]; 	CM1513513 [CLASS=DM MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 	COSM1445058	333	572					PKHD1 (inh=n/a pLI=0.00)
chr6	51491884	51491884	T	C	het	phylop_high;pred_pathogenic_1	QUAL=7382;DP=219;AF=0.47;MQM=60;TRIO=HET,219,0.47,HET,171,0.54,HET,214,0.46	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon66/67:c.11696A>G:p.Gln3899Arg		rs4715227	0.5533	0.5550	18800/9647/1205	0.5493	1.9650	T	D	B	B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082522.4 [benign]; 		COSM4004068	312	580					PKHD1 (inh=n/a pLI=0.00)
chr6	51586771	51586771	G	A	hom		QUAL=15803;DP=307;AF=0.47;MQM=60;TRIO=HOM,307,0.99,HET,218,0.53,HET,297,0.51	PKHD1	3'UTR,intron	PKHD1:NM_170724.2:3'UTR:MODIFIER:exon61/61:c.*13C>T:,PKHD1:NM_138694.3:intron:MODIFIER:exon60/66:c.10156+22412C>T:		rs9349593	0.7660	0.6500	26722/9600/3178	0.6145						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];				187	264					PKHD1 (inh=n/a pLI=0.00)
chr6	51586772	51586772	C	T	het		QUAL=15803;DP=307;AF=0.47;MQM=59;TRIO=HET,307,0.99,HET,218,0.53,WT,297,0.51	PKHD1	3'UTR,intron	PKHD1:NM_170724.2:3'UTR:MODIFIER:exon61/61:c.*12G>A:,PKHD1:NM_138694.3:intron:MODIFIER:exon60/66:c.10156+22411G>A:		rs45451196	0.2194	0.1690	1988/724/757	0.1559						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];			COSN167788	17	165					PKHD1 (inh=n/a pLI=0.00)
chr6	51613177	51613177	C	T	het		QUAL=7691;DP=222;AF=0.54;MQM=59;TRIO=HET,222,0.54,WT,264,0.00,HET,330,0.53	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon58/67:c.9237G>A:p.Ala3079Ala,PKHD1:NM_170724.2:synonymous:LOW:exon58/61:c.9237G>A:p.Ala3079Ala		rs765525	0.3860	0.4040	11292/4413/49	0.3992						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082591.4 [benign]; 			149	516					PKHD1 (inh=n/a pLI=0.00)
chr6	51732807	51732807	C	T	hom		QUAL=21165;DP=269;AF=1.00;MQM=60;TRIO=HOM,269,1.00,HOM,158,0.99,HOM,228,1.00	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon48/67:c.7587G>A:p.Gly2529Gly,PKHD1:NM_170724.2:synonymous:LOW:exon48/61:c.7587G>A:p.Gly2529Gly		rs12210295	0.3676	0.5060	17299/13446/613	0.5039						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082571.4 [benign]; 		COSM1179828, COSM1179827	446	542					PKHD1 (inh=n/a pLI=0.00)
chr6	51875250	51875250	A	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=24114;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HOM,232,1.00,HOM,334,1.00	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon35/67:c.5608T>G:p.Leu1870Val,PKHD1:NM_170724.2:missense:MODERATE:exon35/61:c.5608T>G:p.Leu1870Val		rs2435322	0.9559	0.9870	59245/33342/3858	0.9240	5.0500	T	T,T,T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082560.4 [benign]; 	CM1513512 [CLASS=DM MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 		1145	6					PKHD1 (inh=n/a pLI=0.00)
chr6	51890823	51890823	G	A	hom		QUAL=16326;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HET,159,0.55,HOM,229,0.99	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon32/67:c.3785C>T:p.Ala1262Val,PKHD1:NM_170724.2:missense:MODERATE:exon32/61:c.3785C>T:p.Ala1262Val		rs9296669	0.3546	0.4680	14368/9136/109	0.4652	0.2650	T	T,T,T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082549.4 [benign]; 		COSM4004073, COSM4004072	309	531					PKHD1 (inh=n/a pLI=0.00)
chr6	51890852	51890852	C	G	het		QUAL=6389;DP=213;AF=0.52;MQM=59;TRIO=HET,213,0.52,WT,174,0.00,HET,288,0.50	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon32/67:c.3756G>C:p.Leu1252Leu,PKHD1:NM_170724.2:synonymous:LOW:exon32/61:c.3756G>C:p.Leu1252Leu		rs9689306	0.0186	0.0380	144/123/0	0.0388						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000153717.3 [benign]; 		COSM3762128, COSM3762127	3	79					PKHD1 (inh=n/a pLI=0.00)
chr6	51893107	51893107	T	C	het	pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=5549;DP=290;AF=0.49;MQM=60;TRIO=HET,290,0.49,HET,154,0.53,WT,188,0.00	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon30/67:c.3407A>G:p.Tyr1136Cys,PKHD1:NM_170724.2:missense:MODERATE:exon30/61:c.3407A>G:p.Tyr1136Cys		rs41273726	0.0026	0.0079	14/12/0	0.0076	-0.0620	T	T,T,T	D,D	P,P	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000153718.3 [benign]; RCV000168029.3 [other]; 	CM051142 [CLASS=DM? MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 		0	38					PKHD1 (inh=n/a pLI=0.00)
chr6	51914956	51914956	G	A	hom		QUAL=5159;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HET,51,0.43,HOM,59,1.00	PKHD1	missense&splice_region	PKHD1:NM_138694.3:missense&splice_region:MODERATE:exon22/67:c.2278C>T:p.Arg760Cys,PKHD1:NM_170724.2:missense&splice_region:MODERATE:exon22/61:c.2278C>T:p.Arg760Cys		rs9370096	0.3558	0.4650	14183/8985/110	0.4591	-0.4870	T	T,T,T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082536.4 [benign]; 			303	533					PKHD1 (inh=n/a pLI=0.00)
chr6	51924774	51924774	A	G	hom		QUAL=25599;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,188,1.00,HOM,270,1.00	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon15/67:c.1185T>C:p.Asp395Asp,PKHD1:NM_170724.2:synonymous:LOW:exon15/61:c.1185T>C:p.Asp395Asp		rs1896976	0.9583	0.9880	59343/33329/3980	0.9250						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082524.4 [benign]; RCV000169626.1 [benign]; 			1144	7					PKHD1 (inh=n/a pLI=0.00)
chr6	52357260	52357260	C	A	hom		QUAL=14733;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,128,1.00,HOM,139,1.00	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*121C>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*121C>A:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.3516C>A:		rs7757370	0.9000	0.8620	11217/4932/959	0.6960						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				493	141					EFHC1 (inh=n/a pLI=0.00)
chr6	52358010	52358010	C	G	het		QUAL=5830;DP=142;AF=0.45;MQM=59;TRIO=HET,142,0.45,HOM,137,1.00,WT,169,0.00	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*871C>G:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*871C>G:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.4266C>G:	MLT2B4	rs78956562	0.1721	0.1440	180/30/0	0.0382						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				13	122					EFHC1 (inh=n/a pLI=0.00)
chr6	52358020	52358020	A	T	hom		QUAL=13286;DP=134;AF=1.00;MQM=59;TRIO=HOM,134,1.00,HOM,137,1.00,HOM,159,1.00	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*881A>T:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*881A>T:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.4276A>T:	MLT2B4	rs6926242	0.9331	0.8850	4405/1019/76	0.2220						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				447	124					EFHC1 (inh=n/a pLI=0.00)
chr6	52358319	52358319	G	A	hom		QUAL=5762;DP=103;AF=0.98;MQM=59;TRIO=HOM,103,0.98,HOM,46,1.00,HOM,50,1.00	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1180G>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1180G>A:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.4575G>A:	AluSx	rs4455668	0.9000	0.8790	3309/807/57	0.2036						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				457	130					EFHC1 (inh=n/a pLI=0.00)
chr6	52358453	52358453	-	A	het		QUAL=4445;DP=213;AF=0.41;MQM=59;TRIO=HET,213,0.41,HOM,116,0.84,WT,170,0.01	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1325dupA:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1325dupA:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.4720dupA:	AluSx	rs35994917;rs539728759	0.2278	0.2450	4/0/0	0.0328						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				1	161					EFHC1 (inh=n/a pLI=0.00)
chr6	52358887	52358887	-	CA	hom		QUAL=18566;DP=269;AF=0.95;MQM=59;TRIO=HOM,269,0.95,HOM,156,0.99,HOM,206,0.97	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1749_*1750insAC:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1749_*1750insAC:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.5144_5145insAC:		rs58779695;rs77236493	0.8996	0.8790	4372/1014/65	0.2083						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				457	172					EFHC1 (inh=n/a pLI=0.00)
chr6	52360283	52360283	T	A	hom		QUAL=20852;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,214,1.00,HET,287,0.47	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*3144T>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*3144T>A:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.6539T>A:	LTR78	rs3789772	0.6991	0.6210	2355/587/46	0.1662						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				282	248					EFHC1 (inh=n/a pLI=0.00)
chr6	52360545	52360545	T	C	het		QUAL=10124;DP=439;AF=0.49;MQM=59;TRIO=HET,439,0.49,WT,263,0.00,HET,366,0.47	EFHC1	3'UTR,non_coding_exon	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*3406T>C:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*3406T>C:,EFHC1:NR_033327.1:non_coding_exon:MODIFIER:exon10/10:n.6801T>C:		rs6919266	0.2794	0.2310	16/7/1	0.0779						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				110	265					EFHC1 (inh=n/a pLI=0.00)
chr6	81053642	81053642	G	A	hom		QUAL=28010;DP=455;AF=1.00;MQM=60;TRIO=HOM,455,1.00,HOM,279,1.00,HET,342,0.46	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*121G>A:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*121G>A:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+113G>A:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1478G>A:		rs926733	0.7151	0.0000	0/0/0	0.1780										150	54					BCKDHB (inh=AR pLI=0.00)
chr6	81053717	81053719	TTG	-	hom		QUAL=8662;DP=210;AF=0.98;MQM=59;TRIO=HOM,210,0.98,HOM,78,1.00,HET,93,0.43	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*210_*212delGTT:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*210_*212delGTT:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+202_*8+204delGTT:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1567_1569delGTT:	AluSx1	rs869224641	0.0000	0.0000	0/0/0	0.5775										152	51					BCKDHB (inh=AR pLI=0.00)
chr6	81053814	81053814	T	C	hom		QUAL=4791;DP=92;AF=0.98;MQM=56;TRIO=HOM,92,0.98,HOM,52,1.00,HET,56,0.41	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*293T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*293T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+285T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1650T>C:	AluSx1	rs926732	0.7155	0.0000	0/0/0	0.6874										130	37					BCKDHB (inh=AR pLI=0.00)
chr6	81053825	81053825	G	A	hom		QUAL=4332;DP=77;AF=0.99;MQM=54;TRIO=HOM,77,0.99,HOM,50,1.00,HET,50,0.46	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*304G>A:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*304G>A:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+296G>A:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1661G>A:	AluSx1	rs926731	0.7159	0.0000	0/0/0	0.6928										130	38					BCKDHB (inh=AR pLI=0.00)
chr6	81053866	81053866	C	T	hom		QUAL=5283;DP=139;AF=0.99;MQM=55;TRIO=HOM,139,0.99,HOM,34,1.00,HET,29,0.38	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*345C>T:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*345C>T:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+337C>T:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1702C>T:	AluSx1	rs1811844	0.5899	0.0000	0/0/0	0.6874										128	43					BCKDHB (inh=AR pLI=0.00)
chr6	81053916	81053916	G	T	hom		QUAL=4782;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,12,1.00,HET,15,0.33	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*395G>T:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*395G>T:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+387G>T:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1752G>T:	AluSx1	rs4706116	0.9585	0.0000	0/0/0	0.8727										163	17					BCKDHB (inh=AR pLI=0.00)
chr6	81054066	81054067	TT	-	hom	low_DP	QUAL=139;DP=12;AF=0.83;MQM=58;TRIO=HOM,12,0.83,WT,12,1.00,HET,2,1.00	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*559_*560delTT:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*559_*560delTT:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+551_*8+552delTT:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1916_1917delTT:	AluSc	rs869223033	0.8930	0.0000	0/0/0	0.5400										64	25					BCKDHB (inh=AR pLI=0.00)
chr6	81054148	81054148	T	C	hom		QUAL=2388;DP=71;AF=1.00;MQM=57;TRIO=HOM,71,1.00,HOM,5,1.00,HET,19,0.53	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*627T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*627T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+619T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.1984T>C:	AluSc	rs4706838	0.7153	0.0000	0/0/0	0.7183										131	38					BCKDHB (inh=AR pLI=0.00)
chr6	81054252	81054252	C	T	hom		QUAL=4916;DP=92;AF=1.00;MQM=51;TRIO=HOM,92,1.00,HOM,58,1.00,HET,66,0.44	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*731C>T:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*731C>T:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+723C>T:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2088C>T:	AluSc	rs4706117	0.3998	0.0000	0/0/0	0.4442										53	85					BCKDHB (inh=AR pLI=0.00)
chr6	81054310	81054310	C	T	hom		QUAL=7972;DP=125;AF=0.99;MQM=56;TRIO=HOM,125,0.99,HOM,98,1.00,HET,138,0.43	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*789C>T:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*789C>T:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+781C>T:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2146C>T:	AluSc	rs4706118	0.7155	0.0000	0/0/0	0.6925										153	52					BCKDHB (inh=AR pLI=0.00)
chr6	81054326	81054326	T	C	hom		QUAL=8497;DP=114;AF=0.99;MQM=59;TRIO=HOM,114,0.99,HOM,113,1.00,HET,158,0.46	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*805T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*805T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+797T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2162T>C:	AluSc	rs4706839	0.7155	0.0000	0/0/0	0.6922										157	51					BCKDHB (inh=AR pLI=0.00)
chr6	81054515	81054515	G	A	hom		QUAL=19876;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,170,0.99,HET,255,0.46	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*994G>A:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*994G>A:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*8+986G>A:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2351G>A:		rs4502885	0.7153	0.0000	0/0/0	0.1334										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	81054663	81054663	C	G	hom		QUAL=14710;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,138,1.00,HET,178,0.53	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1142C>G:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1142C>G:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-1029C>G:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2499C>G:		rs1042367	0.6887	0.0000	0/0/0	0.1323										158	59					BCKDHB (inh=AR pLI=0.00)
chr6	81054762	81054762	A	G	hom		QUAL=15976;DP=267;AF=1.00;MQM=60;TRIO=HOM,267,1.00,HOM,134,1.00,HET,187,0.53	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1241A>G:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1241A>G:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-930A>G:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2598A>G:		rs1042368	0.7153	0.0000	0/0/0	0.1555										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	81054965	81054965	T	C	hom		QUAL=12762;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HOM,43,1.00,HET,79,0.57	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1444T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1444T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-727T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.2801T>C:		rs3805848	0.7153	0.0000	0/0/0	0.1337										157	61					BCKDHB (inh=AR pLI=0.00)
chr6	81055299	81055299	A	G	hom		QUAL=22313;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HOM,234,1.00,HET,309,0.51	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1778A>G:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1778A>G:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-393A>G:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3135A>G:		rs7758761	0.7149	0.0000	0/0/0	0.1568										157	61					BCKDHB (inh=AR pLI=0.00)
chr6	81055331	81055331	T	C	hom		QUAL=23186;DP=352;AF=1.00;MQM=60;TRIO=HOM,352,1.00,HOM,230,1.00,HET,322,0.46	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1810T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1810T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-361T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3167T>C:		rs7740932	0.7153	0.0000	0/0/0	0.1339										156	62					BCKDHB (inh=AR pLI=0.00)
chr6	81055396	81055396	G	A	hom		QUAL=25947;DP=387;AF=1.00;MQM=59;TRIO=HOM,387,1.00,HOM,275,1.00,HET,409,0.49	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1875G>A:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1875G>A:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-296G>A:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3232G>A:		rs7759304	0.7153	0.0000	0/0/0	0.1338										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	81055413	81055413	T	C	hom		QUAL=27888;DP=420;AF=1.00;MQM=59;TRIO=HOM,420,1.00,HOM,286,1.00,HET,416,0.49	BCKDHB	3'UTR,intron,non_coding_exon	BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*1892T>C:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*1892T>C:,BCKDHB:NM_000056.4:intron:MODIFIER:exon10/10:c.*9-279T>C:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3249T>C:		rs7740958	0.7153	0.0000	0/0/0	0.1332										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	81055792	81055792	G	A	hom		QUAL=8195;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HOM,46,0.98,HET,50,0.44	BCKDHB	3'UTR,non_coding_exon	BCKDHB:NM_000056.4:3'UTR:MODIFIER:exon11/11:c.*109G>A:,BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*2271G>A:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*2271G>A:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3628G>A:		rs15062	0.7159	0.0000	0/0/0	0.1287										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	81055803	81055803	C	T	hom		QUAL=8089;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,51,0.98,HET,49,0.41	BCKDHB	3'UTR,non_coding_exon	BCKDHB:NM_000056.4:3'UTR:MODIFIER:exon11/11:c.*120C>T:,BCKDHB:NM_001318975.1:3'UTR:MODIFIER:exon10/10:c.*2282C>T:,BCKDHB:NM_183050.3:3'UTR:MODIFIER:exon10/10:c.*2282C>T:,BCKDHB:NR_134945.1:non_coding_exon:MODIFIER:exon11/11:n.3639C>T:		rs10864	0.7157	0.0000	0/0/0	0.1288										158	60					BCKDHB (inh=AR pLI=0.00)
chr6	88221391	88221391	C	T	het		QUAL=11721;DP=536;AF=0.49;MQM=60;TRIO=HET,536,0.49,HET,354,0.50,WT,459,0.00	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*147C>T:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*147C>T:		rs55960393	0.0230	0.0000	0/0/0	0.0073										0	11					SLC35A1 (inh=n/a pLI=0.21)
chr6	88221546	88221546	A	G	hom		QUAL=21539;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HET,174,0.51,HET,244,0.52	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*302A>G:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*302A>G:		rs1051131	0.6392	0.0000	0/0/0	0.0992										58	108					SLC35A1 (inh=n/a pLI=0.21)
chr6	88221763	88221763	-	TGAA	hom		QUAL=15837;DP=328;AF=0.96;MQM=59;TRIO=HOM,328,0.96,HET,185,0.53,HET,317,0.49	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*521_*522insAATG:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*521_*522insAATG:		rs10681831;rs10694624	0.6556	0.0000	0/0/0	0.4164										57	107					SLC35A1 (inh=n/a pLI=0.21)
chr6	88221767	88221767	-	TAAC	het		QUAL=8042;DP=304;AF=0.54;MQM=59;TRIO=HET,304,0.54,WT,179,0.00,HET,305,0.50	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*525_*528dupAACT:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*525_*528dupAACT:		rs376325658	0.0000	0.0000	0/0/0	0.0197										16	79					SLC35A1 (inh=n/a pLI=0.21)
chr6	88221892	88221892	T	G	hom		QUAL=12811;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HET,83,0.55,HET,109,0.47	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*648T>G:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*648T>G:		rs1051148	0.6386	0.0000	0/0/0	0.0991										58	107					SLC35A1 (inh=n/a pLI=0.21)
chr6	88240570	88240570	C	T	het		QUAL=7833;DP=336;AF=0.49;MQM=59;TRIO=HET,336,0.49,WT,199,0.00,HET,271,0.48	RARS2	missense,non_coding_exon	RARS2:NM_020320.4:missense:MODERATE:exon9/20:c.703G>A:p.Val235Met,RARS2:NM_001318785.1:missense:MODERATE:exon8/19:c.178G>A:p.Val60Met,RARS2:NR_134857.1:non_coding_exon:MODIFIER:exon9/20:n.778G>A:		rs35862137	0.0206	0.0320	89/52/1	0.0322	-1.0730	T	T	B	B	611524 [RARS2 (confirmed) Pontocerebellar hypoplasia,type 6];	RCV000118126.2 [benign]; 			3	120					RARS2 (inh=AR pLI=0.00)
chr6	89883013	89883013	A	T	het		QUAL=9035;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,91,0.45,HOM,178,0.99	PM20D2-GABRR1	intergenic_region	PM20D2-GABRR1:PM20D2-GABRR1:intergenic_region:MODIFIER::n.89883013A>T:		rs9353650	0.1625	0.0000	0/0/0	0.1823										10	54					PM20D2-GABRR1 (inh=n/a pLI=n/a)
chr6	97337537	97337537	C	T	hom		QUAL=24361;DP=446;AF=1.00;MQM=59;TRIO=HOM,446,1.00,HET,322,0.46,HET,432,0.50	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*1443G>A:		rs7758762	0.2748	0.0000	0/0/0	0.2540										22	79					NDUFAF4 (inh=n/a pLI=0.38)
chr6	97338598	97338598	A	T	hom		QUAL=38394;DP=460;AF=1.00;MQM=59;TRIO=HOM,460,1.00,HOM,308,1.00,HOM,426,1.00	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*382T>A:		rs1971475	0.9341	0.0000	0/0/0	0.8211										177	51					NDUFAF4 (inh=n/a pLI=0.38)
chr6	97338679	97338679	A	T	hom		QUAL=17675;DP=330;AF=0.99;MQM=60;TRIO=HOM,330,0.99,HET,198,0.50,HET,281,0.48	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*301T>A:		rs1854268	0.2750	0.0000	0/0/0	0.0429										22	79					NDUFAF4 (inh=n/a pLI=0.38)
chr6	97339078	97339078	A	G	hom		QUAL=13233;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HET,99,0.59,HOM,109,0.99	NDUFAF4	synonymous	NDUFAF4:NM_014165.3:synonymous:LOW:exon3/3:c.430T>C:p.Leu144Leu		rs6684	0.5150	0.5180	16639/8429/792	0.5066						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];	RCV000117707.2 [likely benign]; 		COSM3762230	294	544					NDUFAF4 (inh=n/a pLI=0.38)
chr6	97339088	97339088	C	T	hom		QUAL=15509;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,101,1.00,HOM,114,1.00	NDUFAF4	synonymous	NDUFAF4:NM_014165.3:synonymous:LOW:exon3/3:c.420G>A:p.Gln140Gln		rs11402	0.9339	0.8940	48572/24796/4675	0.8621						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];	RCV000117706.2 [likely benign]; 			842	248					NDUFAF4 (inh=n/a pLI=0.38)
chr6	97339275	97339275	-	A	hom		QUAL=4493;DP=119;AF=0.85;MQM=59;TRIO=HOM,119,0.85,HOM,52,0.87,HOM,52,0.81	NDUFAF4	splice_region&intron	NDUFAF4:NM_014165.3:splice_region&intron:LOW:exon2/2:c.241-9dupT:		rs34213186;rs397799265	0.6701	0.6290	10741/5817/962	0.0946						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];				321	707					NDUFAF4 (inh=n/a pLI=0.38)
chr6	100837889	100837889	T	A	het		QUAL=14543;DP=413;AF=0.48;MQM=60;TRIO=HET,413,0.48,HET,267,0.53,HET,352,0.52	SIM1	3'UTR	SIM1:NM_005068.2:3'UTR:MODIFIER:exon11/11:c.*348A>T:		rs1395119	0.3988	0.0000	0/0/0	0.0683										37	111					SIM1 (inh=n/a pLI=1.00)
chr6	100988267	100988267	A	-	het	low_QUAL	QUAL=9;DP=188;AF=0.18;MQM=59;TRIO=HET,188,0.18,WT,67,0.22,WT,105,0.10	ASCC3	splice_region&intron	ASCC3:NM_006828.3:splice_region&intron:LOW:exon36/41:c.5551-4delT:		rs760353390	0.0000	0.3200	13/1/12	0.0028									COSM1620704	0	69					ASCC3 (inh=n/a pLI=0.00)
chr6	101094554	101094554	A	G	hom		QUAL=19828;DP=309;AF=0.99;MQM=60;TRIO=HOM,309,0.99,HET,209,0.53,HOM,210,1.00	ASCC3	synonymous	ASCC3:NM_006828.3:synonymous:LOW:exon22/42:c.3570T>C:p.Pro1190Pro		rs239239	0.5713	0.5420	18410/9136/1860	0.5409									COSM3761400	332	534					ASCC3 (inh=n/a pLI=0.00)
chr6	101215224	101215224	A	-	hom		QUAL=12587;DP=196;AF=0.95;MQM=59;TRIO=HOM,196,0.95,HOM,117,0.97,HOM,131,0.95	ASCC3	splice_region&intron	ASCC3:NM_006828.3:splice_region&intron:LOW:exon8/41:c.1396-3delT:,ASCC3:NM_001284271.1:splice_region&intron:LOW:exon8/12:c.1396-3delT:		rs397888735;rs869050069	0.9696	0.9880	58759/32771/4206	0.8873										1096	20					ASCC3 (inh=n/a pLI=0.00)
chr6	101296389	101296389	G	A	het	phylop_high	QUAL=12038;DP=424;AF=0.49;MQM=60;TRIO=HET,424,0.49,WT,170,0.01,HOM,188,1.00	ASCC3	missense	ASCC3:NM_006828.3:missense:MODERATE:exon4/42:c.436C>T:p.Leu146Phe,ASCC3:NM_001284271.1:missense:MODERATE:exon4/13:c.436C>T:p.Leu146Phe		rs9390698	0.2454	0.3650	8953/6620/77	0.3678	2.5230	T	T,T,T	B,B,B	B,B,B				COSM150148	188	535					ASCC3 (inh=n/a pLI=0.00)
chr6	101304332	101304332	T	C	het		QUAL=6830;DP=286;AF=0.53;MQM=60;TRIO=HET,286,0.53,WT,120,0.01,HET,201,0.48	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2652A>G:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7608A>G:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7608A>G:		rs78942177	0.0395	0.0000	0/0/0	0.0096										0	26					ASCC3 (inh=n/a pLI=0.00)
chr6	101304644	101304644	C	T	het		QUAL=7234;DP=336;AF=0.51;MQM=60;TRIO=HET,336,0.51,WT,173,0.00,HET,205,0.48	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2340G>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7296G>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7296G>A:	L1ME3	rs80004866	0.0058	0.0000	0/0/0	0.0019										0	2					ASCC3 (inh=n/a pLI=0.00)
chr6	101304829	101304829	C	T	het		QUAL=9062;DP=319;AF=0.43;MQM=60;TRIO=HET,319,0.43,WT,146,0.01,HOM,171,1.00	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2155G>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7111G>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7111G>A:	L1ME3	rs705599	0.6667	0.0000	0/0/0	0.1198										83	61					ASCC3 (inh=n/a pLI=0.00)
chr6	101305983	101305983	A	T	hom		QUAL=5702;DP=141;AF=1.00;MQM=60;TRIO=HOM,141,1.00,HOM,8,1.00,HOM,18,1.00	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*1001T>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+5957T>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+5957T>A:	L1ME3	rs846793	0.9471	0.0000	0/0/0	0.1461										139	20					ASCC3 (inh=n/a pLI=0.00)
chr6	101306006	101306010	TAAAT	-	het		QUAL=1568;DP=124;AF=0.47;MQM=60;TRIO=HET,124,0.47,WT,8,0.00,HET,17,0.47	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*974_*978delATTTA:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+5930_241+5934delATTTA:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+5930_241+5934delATTTA:	L1ME3	rs67936868	0.1601	0.0000	0/0/0	0.2060										10	63					ASCC3 (inh=n/a pLI=0.00)
chr6	101312097	101312097	C	T	hom		QUAL=12444;DP=164;AF=1.00;MQM=60;TRIO=HOM,164,1.00,HOM,82,1.00,HOM,136,1.00	ASCC3	splice_region&intron	ASCC3:NM_006828.3:splice_region&intron:LOW:exon2/41:c.91-7G>A:,ASCC3:NM_001284271.1:splice_region&intron:LOW:exon2/12:c.91-7G>A:,ASCC3:NM_022091.4:splice_region&intron:LOW:exon2/3:c.91-7G>A:		rs846791	0.9800	0.9600	55882/30230/5020	0.9015										1010	92					ASCC3 (inh=n/a pLI=0.00)
chr6	101329173	101329173	A	C	het		QUAL=22120;DP=184;AF=0.52;MQM=59;TRIO=HET,184,0.52,WT,502,0.00,HOM,659,0.99	ASCC3	5'UTR_premature_start_codon_gain,5'UTR	ASCC3:NM_006828.3:5'UTR_premature_start_codon_gain:LOW:exon1/42:c.-278T>G:,ASCC3:NM_001284271.1:5'UTR_premature_start_codon_gain:LOW:exon1/13:c.-278T>G:,ASCC3:NM_022091.4:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-278T>G:,ASCC3:NM_006828.3:5'UTR:MODIFIER:exon1/42:c.-278T>G:,ASCC3:NM_001284271.1:5'UTR:MODIFIER:exon1/13:c.-278T>G:,ASCC3:NM_022091.4:5'UTR:MODIFIER:exon1/4:c.-278T>G:	(CAGA)n	rs12530388	0.5194	0.0000	0/0/0	0.4806										64	109					ASCC3 (inh=n/a pLI=0.00)
chr6	102376517	102376517	G	A	het		QUAL=5101;DP=196;AF=0.53;MQM=60;TRIO=HET,196,0.53,WT,172,0.00,HET,193,0.52	GRIK2	splice_region&intron	GRIK2:NM_021956.4:splice_region&intron:LOW:exon13/15:c.2085+10G>A:,GRIK2:NM_001166247.1:splice_region&intron:LOW:exon13/16:c.2085+10G>A:,GRIK2:NM_175768.3:splice_region&intron:LOW:exon13/16:c.2085+10G>A:		rs2243355	0.1705	0.2740	5091/3711/20	0.2652						138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6];	RCV000117160.2 [likely benign]; 			126	472					GRIK2 (inh=AR pLI=0.99)
chr6	102503317	102503317	G	A	het		QUAL=1679;DP=53;AF=0.51;MQM=60;TRIO=HET,53,0.51,HOM,17,1.00,HET,34,0.56	GRIK2	synonymous	GRIK2:NM_021956.4:synonymous:LOW:exon15/16:c.2424G>A:p.Glu808Glu,GRIK2:NM_001166247.1:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu,GRIK2:NM_175768.3:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu		rs2227283	0.3275	0.3910	9631/6345/417	0.3868						138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6];	RCV000117164.2 [likely benign]; 		COSM3761402, COSM3761401, COSM3761403	192	534					GRIK2 (inh=AR pLI=0.99)
chr6	107475278	107475278	-	A	het		QUAL=2037;DP=204;AF=0.39;MQM=59;TRIO=HET,204,0.39,HET,97,0.46,WT,132,0.02	PDSS2	3'UTR	PDSS2:NM_020381.3:3'UTR:MODIFIER:exon8/8:c.*544dupT:	AluSq2	rs35619837;rs397807908	0.1815	0.0000	0/0/0	0.1710										5	102					PDSS2 (inh=AR pLI=0.00)
chr6	107475512	107475512	C	T	het		QUAL=6426;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,WT,204,0.00,HET,269,0.51	PDSS2	3'UTR	PDSS2:NM_020381.3:3'UTR:MODIFIER:exon8/8:c.*311G>A:		rs41292442	0.0333	0.0000	0/0/0	0.0095										0	33					PDSS2 (inh=AR pLI=0.00)
chr6	108363645	108363645	G	C	het		QUAL=1821;DP=83;AF=0.66;MQM=58;TRIO=HET,83,0.66,WT,30,0.00,HET,39,0.67	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2344C>G:	AluJb	rs113263335	0.1392	0.0000	0/0/0	0.0569										1	14					OSTM1 (inh=n/a pLI=0.06)
chr6	108363660	108363660	C	A	het		QUAL=1748;DP=79;AF=0.66;MQM=59;TRIO=HET,79,0.66,WT,37,0.00,HET,52,0.60	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2329G>T:	AluJb	rs112792700	0.1392	0.0000	0/0/0	0.0671										0	14					OSTM1 (inh=n/a pLI=0.06)
chr6	108363688	108363688	T	C	het		QUAL=2544;DP=117;AF=0.56;MQM=59;TRIO=HET,117,0.56,WT,47,0.00,HET,63,0.56	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2301A>G:	AluJb	rs9386700	0.3441	0.0000	0/0/0	0.2720										13	72					OSTM1 (inh=n/a pLI=0.06)
chr6	108363706	108363706	A	G	het		QUAL=2907;DP=142;AF=0.55;MQM=59;TRIO=HET,142,0.55,WT,53,0.02,HET,66,0.59	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2283T>C:	AluJb	rs112283202	0.1392	0.0000	0/0/0	0.0654										1	15					OSTM1 (inh=n/a pLI=0.06)
chr6	108363936	108363936	G	A	het		QUAL=10544;DP=459;AF=0.52;MQM=60;TRIO=HET,459,0.52,WT,232,0.00,HET,280,0.53	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2053C>T:		rs17069215	0.0757	0.0000	0/0/0	0.0106										0	25					OSTM1 (inh=n/a pLI=0.06)
chr6	108364106	108364106	A	G	het		QUAL=8915;DP=432;AF=0.56;MQM=60;TRIO=HET,432,0.56,WT,127,0.00,HET,168,0.47	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1883T>C:		rs7662	0.3441	0.0000	0/0/0	0.0525										16	99					OSTM1 (inh=n/a pLI=0.06)
chr6	108364548	108364548	T	-	het		QUAL=7042;DP=313;AF=0.46;MQM=59;TRIO=HET,313,0.46,WT,184,0.00,HET,286,0.50	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1441delA:		rs140320992	0.1256	0.0000	0/0/0	0.0709										0	26					OSTM1 (inh=n/a pLI=0.06)
chr6	108364637	108364637	T	C	het		QUAL=6267;DP=318;AF=0.55;MQM=60;TRIO=HET,318,0.55,WT,79,0.00,HET,125,0.54	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1352A>G:		rs9372179	0.0757	0.0000	0/0/0	0.0106										0	25					OSTM1 (inh=n/a pLI=0.06)
chr6	108364655	108364655	A	G	het		QUAL=5211;DP=251;AF=0.57;MQM=60;TRIO=HET,251,0.57,WT,59,0.00,HET,108,0.49	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1334T>C:		rs9374008	0.0757	0.0000	0/0/0	0.0106										0	25					OSTM1 (inh=n/a pLI=0.06)
chr6	108365658	108365658	T	C	het		QUAL=2929;DP=144;AF=0.55;MQM=60;TRIO=HET,144,0.55,WT,50,0.00,HET,55,0.53	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*331A>G:		rs9320250	0.4764	0.0000	0/0/0	0.0649										21	102					OSTM1 (inh=n/a pLI=0.06)
chr6	110106234	110106234	A	G	hom		QUAL=21830;DP=318;AF=0.99;MQM=60;TRIO=HOM,318,0.99,HOM,133,1.00,HOM,230,0.98	FIG4	splice_region&intron	FIG4:NM_014845.5:splice_region&intron:LOW:exon17/22:c.1948+3A>G:		rs10499054	0.3588	0.5260	18582/14556/244	0.5282						609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J|Amyotrophic lateral sclerosis 11|Yunis-Varon syndrome|Polymicrogyria,bilateral temporooccipital];				648	733					FIG4 (inh=AR+AD pLI=0.00)
chr6	110146303	110146303	G	A	hom		QUAL=20286;DP=276;AF=0.99;MQM=60;TRIO=HOM,276,0.99,HOM,226,1.00,HET,332,0.53	FIG4	synonymous	FIG4:NM_014845.5:synonymous:LOW:exon23/23:c.2559G>A:p.Ser853Ser		rs1127771	0.3958	0.4290	11975/5732/114	0.4259						609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J|Amyotrophic lateral sclerosis 11|Yunis-Varon syndrome|Polymicrogyria,bilateral temporooccipital];				300	813					FIG4 (inh=AR+AD pLI=0.00)
chr6	110146588	110146588	C	T	hom		QUAL=22876;DP=275;AF=0.99;MQM=59;TRIO=HOM,275,0.99,HOM,297,1.00,HET,385,0.49	FIG4	3'UTR	FIG4:NM_014845.5:3'UTR:MODIFIER:exon23/23:c.*120C>T:		rs1127775	0.4483	0.0000	0/0/0	0.0898										47	114					FIG4 (inh=AR+AD pLI=0.00)
chr6	129381026	129381026	C	A	hom		QUAL=20222;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,194,1.00,HOM,219,1.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon3/65:c.381C>A:p.Thr127Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon3/64:c.381C>A:p.Thr127Thr		rs4404787	0.9367	0.9580	55756/31416/4252	0.9363						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078766.5 [benign]; 			1107	61					LAMA2 (inh=AR pLI=0.00)
chr6	129571330	129571330	G	A	het		QUAL=8124;DP=348;AF=0.46;MQM=60;TRIO=HET,348,0.46,WT,248,0.00,HET,330,0.45	LAMA2	missense	LAMA2:NM_000426.3:missense:MODERATE:exon13/65:c.1856G>A:p.Arg619His,LAMA2:NM_001079823.1:missense:MODERATE:exon13/64:c.1856G>A:p.Arg619His		rs3816665	0.2710	0.1830	2946/585/1562	0.1772	-1.5750	T	T,T,T	B,B	B,B	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078752.5 [benign]; 			34	318					LAMA2 (inh=AR pLI=0.00)
chr6	129612808	129612808	A	G	het		QUAL=7216;DP=285;AF=0.54;MQM=60;TRIO=HET,285,0.54,WT,131,0.00,HET,199,0.57	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon20/65:c.2799A>G:p.Gln933Gln,LAMA2:NM_001079823.1:synonymous:LOW:exon20/64:c.2799A>G:p.Gln933Gln		rs1027199	0.3139	0.2680	4524/1657/543	0.2647						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078759.5 [benign]; 		COSM3761478	77	425					LAMA2 (inh=AR pLI=0.00)
chr6	129691132	129691132	C	G	hom		QUAL=14999;DP=303;AF=0.99;MQM=60;TRIO=HOM,303,0.99,HET,189,0.46,HET,258,0.47	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon34/65:c.4956C>G:p.Thr1652Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon34/64:c.4956C>G:p.Thr1652Thr		rs17057184	0.0966	0.0850	614/154/69	0.0816						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078774.5 [benign]; 			15	170					LAMA2 (inh=AR pLI=0.00)
chr6	129722389	129722389	A	G	het		QUAL=14678;DP=322;AF=0.51;MQM=59;TRIO=HET,322,0.51,HOM,328,1.00,WT,431,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon38/65:c.5466A>G:p.Glu1822Glu,LAMA2:NM_001079823.1:synonymous:LOW:exon38/64:c.5466A>G:p.Glu1822Glu		rs3749877	0.5445	0.4980	15361/7378/2018	0.4910						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078777.5 [benign]; 			284	561					LAMA2 (inh=AR pLI=0.00)
chr6	129722425	129722425	G	A	het		QUAL=18733;DP=531;AF=0.47;MQM=59;TRIO=HET,531,0.47,HOM,375,1.00,WT,484,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon38/65:c.5502G>A:p.Glu1834Glu,LAMA2:NM_001079823.1:synonymous:LOW:exon38/64:c.5502G>A:p.Glu1834Glu		rs3749878	0.5433	0.4960	15250/7305/2017	0.4884						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078778.5 [benign]; 		COSM4160174	284	560					LAMA2 (inh=AR pLI=0.00)
chr6	129762112	129762112	G	A	het		QUAL=7817;DP=289;AF=0.50;MQM=59;TRIO=HET,289,0.50,WT,284,0.00,HET,321,0.50	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon43/65:c.6237G>A:p.Thr2079Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon43/64:c.6237G>A:p.Thr2079Thr		rs2297738	0.1825	0.1680	1867/800/105	0.1662						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078786.5 [benign]; 		COSM3761479	34	313					LAMA2 (inh=AR pLI=0.00)
chr6	129807629	129807629	C	T	het	phylop_high;pred_pathogenic_3	QUAL=3996;DP=202;AF=0.49;MQM=60;TRIO=HET,202,0.49,HET,143,0.45,WT,199,0.00	LAMA2	missense	LAMA2:NM_000426.3:missense:MODERATE:exon56/65:c.7760C>T:p.Ala2587Val,LAMA2:NM_001079823.1:missense:MODERATE:exon55/64:c.7748C>T:p.Ala2583Val		rs2229848	0.5839	0.6670	27343/16984/1093	0.6645	4.4990	D	T,T,T,T	D,D	D,D	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000153440.2 [benign]; 	CM023406 [CLASS=DP MUT=REF PHEN="Tuberculoid leprosy association with" GENE=LAMA2]; 	COSM1440401	575	478					LAMA2 (inh=AR pLI=0.00)
chr6	129807699	129807699	G	C	het		QUAL=6298;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,HET,181,0.44,WT,249,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon56/65:c.7830G>C:p.Val2610Val,LAMA2:NM_001079823.1:synonymous:LOW:exon55/64:c.7818G>C:p.Val2606Val		rs2229849	0.5843	0.6680	27409/17019/1102	0.6656						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078800.5 [benign]; 			575	479					LAMA2 (inh=AR pLI=0.00)
chr6	129807714	129807714	G	A	het		QUAL=15812;DP=332;AF=0.55;MQM=60;TRIO=HET,332,0.55,HET,181,0.56,HOM,249,1.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon56/65:c.7845G>A:p.Pro2615Pro,LAMA2:NM_001079823.1:synonymous:LOW:exon55/64:c.7833G>A:p.Pro2611Pro		rs2229850	0.4038	0.3080	6146/2190/1514	0.3031						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078801.5 [benign]; 			98	443					LAMA2 (inh=AR pLI=0.00)
chr6	129837681	129837683	AAT	-	hom		QUAL=9285;DP=243;AF=1.00;MQM=59;TRIO=HOM,243,1.00,HET,36,0.69,HOM,55,1.00	LAMA2	3'UTR	LAMA2:NM_000426.3:3'UTR:MODIFIER:exon65/65:c.*193_*195delATA:,LAMA2:NM_001079823.1:3'UTR:MODIFIER:exon64/64:c.*193_*195delATA:		rs371188338	0.7051	0.0000	0/0/0	0.7281										147	76					LAMA2 (inh=AR pLI=0.00)
chr6	132212889	132212890	TT	-	hom		QUAL=166;DP=42;AF=0.31;MQM=60;TRIO=HOM,42,0.31,WT,12,0.08,WT,17,0.29	ENPP1	3'UTR	ENPP1:NM_006208.2:3'UTR:MODIFIER:exon25/25:c.*1255_*1256delTT:		rs769107294	0.0000	0.0000	0/0/0	0.0368										0	0					ENPP1 (inh=n/a pLI=0.00)
chr6	135715915	135715915	G	A	het		QUAL=261;DP=23;AF=0.57;MQM=60;TRIO=HET,23,0.57,WT,2,0.00,WT,12,0.00	AHI1	splice_region&synonymous	AHI1:NM_001134830.1:splice_region&synonymous:LOW:exon21/27:c.3108C>T:p.Thr1036Thr,AHI1:NM_001134831.1:splice_region&synonymous:LOW:exon23/29:c.3108C>T:p.Thr1036Thr,AHI1:NM_017651.4:splice_region&synonymous:LOW:exon22/28:c.3108C>T:p.Thr1036Thr,AHI1:NM_001134832.1:splice_region&synonymous:LOW:exon22/23:c.3108C>T:p.Thr1036Thr		rs761976492	0.0000	0.0001	0/0/0	0.0001	-3.5700	T				608894 [AHI1 (confirmed) Joubert syndrome-3];				0	0					AHI1 (inh=AR pLI=0.00)
chr6	135818897	135818897	C	A	het	low_DP	QUAL=4655;DP=10;AF=0.50;MQM=59;TRIO=HET,10,0.50,HOM,113,1.00,HET,163,0.47	AHI1	5'UTR	AHI1:NM_001134830.1:5'UTR:MODIFIER:exon1/27:c.-231G>T:,AHI1:NM_001134831.1:5'UTR:MODIFIER:exon1/29:c.-378G>T:,AHI1:NM_017651.4:5'UTR:MODIFIER:exon1/28:c.-293G>T:,AHI1:NM_001134832.1:5'UTR:MODIFIER:exon1/23:c.-293G>T:		rs13197384	0.3011	0.1570	5/2/0	0.0611										21	101					AHI1 (inh=AR pLI=0.00)
chr6	137166790	137166790	A	C	het	phylop_high	QUAL=8128;DP=364;AF=0.49;MQM=60;TRIO=HET,364,0.49,WT,203,0.00,HET,268,0.46	PEX7	missense	PEX7:NM_000288.3:missense:MODERATE:exon4/10:c.377A>C:p.Gln126Pro		rs113268723	0.0014	0.0038	0/0/0	0.0036	5.5310	T	T,T	P	P	601757 [PEX7 (provisional) Chondrodysplasia punctata,rhizomelic,type 1|Peroxisome biogenesis disorder 9B];				0	13	3	[3] Julia Bickmann 19.11.2014			PEX7 (inh=n/a pLI=0.00)
chr6	137234919	137234919	-	GTA	het		QUAL=6226;DP=277;AF=0.51;MQM=59;TRIO=HET,277,0.51,HOM,93,1.00,WT,110,0.00	PEX7	3'UTR	PEX7:NM_000288.3:3'UTR:MODIFIER:exon10/10:c.*257_*258insAGT:		rs141139220;rs1801001	0.5230	0.0000	0/0/0	0.4473										60	120					PEX7 (inh=n/a pLI=0.00)
chr6	137234970	137234970	T	G	het		QUAL=3823;DP=186;AF=0.48;MQM=60;TRIO=HET,186,0.48,HOM,56,1.00,WT,61,0.00	PEX7	3'UTR	PEX7:NM_000288.3:3'UTR:MODIFIER:exon10/10:c.*306T>G:		rs1050803	0.5206	0.0000	0/0/0	0.0854										61	117					PEX7 (inh=n/a pLI=0.00)
chr6	143810682	143810682	A	T	het	low_DP	QUAL=129;DP=12;AF=0.50;MQM=60;TRIO=HET,12,0.50,HOM,2,1.00,WT,3,0.00	PEX3	3'UTR	PEX3:NM_003630.2:3'UTR:MODIFIER:exon12/12:c.*319A>T:	(AT)n	rs223234	0.7927	0.0000	0/0/0	0.1002										102	49					PEX3 (inh=AR pLI=0.00)
chr6	143810909	143810909	A	G	het		QUAL=982;DP=62;AF=0.48;MQM=59;TRIO=HET,62,0.48,HET,15,0.53,WT,18,0.00	PEX3	3'UTR	PEX3:NM_003630.2:3'UTR:MODIFIER:exon12/12:c.*546A>G:		rs10809	0.1290	0.0000	0/0/0	0.0295										8	90					PEX3 (inh=AR pLI=0.00)
chr6	144509845	144509845	-	A	hom		QUAL=894;DP=36;AF=0.64;MQM=59;TRIO=HOM,36,0.64,HOM,12,0.83,HET,22,0.36	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1221dupA:		rs397725572	0.5583	0.0000	0/0/0	0.3712										6	118					STX11 (inh=n/a pLI=0.02)
chr6	144509855	144509855	C	T	het	low_MQM	QUAL=36;DP=52;AF=0.35;MQM=48;TRIO=HET,52,0.35,WT,9,0.00,WT,14,0.00	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1227C>T:	AluSc8	rs148087652	0.0000	0.0000	0/0/0	0.0005										3	75					STX11 (inh=n/a pLI=0.02)
chr6	144510421	144510421	A	C	het		QUAL=5810;DP=178;AF=0.49;MQM=59;TRIO=HET,178,0.49,HET,100,0.57,HET,146,0.53	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1793A>C:	AluJo	rs4896705	0.2730	0.0000	0/0/0	0.2854										26	91					STX11 (inh=n/a pLI=0.02)
chr6	144510926	144510926	C	T	het		QUAL=8979;DP=352;AF=0.49;MQM=60;TRIO=HET,352,0.49,HET,179,0.50,HET,189,0.40	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*2298C>T:		rs3734227	0.2670	0.0000	0/0/0	0.0524										23	107					STX11 (inh=n/a pLI=0.02)
chr6	144512671	144512671	-	A	hom		QUAL=10671;DP=259;AF=0.88;MQM=59;TRIO=HOM,259,0.88,HOM,66,0.88,HOM,65,0.85	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*4054dupA:		rs11397393;rs397795966	0.9277	0.0000	0/0/0	0.6539										81	149					STX11 (inh=n/a pLI=0.02)
chr6	145947080	145947080	C	T	hom		QUAL=29676;DP=388;AF=1.00;MQM=60;TRIO=HOM,388,1.00,HOM,205,0.99,HOM,308,0.99	EPM2A	3'UTR,intron	EPM2A:NM_005670.3:3'UTR:MODIFIER:exon4/4:c.*1472G>A:,EPM2A:NM_001018041.1:intron:MODIFIER:exon4/4:c.925-220G>A:	MIRb	rs1045820	0.4471	0.0000	0/0/0	0.4167						607566 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2A (Lafora)];				84	166					EPM2A (inh=AR pLI=0.00)
chr6	146056848	146056848	T	C	het	low_DP	QUAL=90;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,205,0.99,HOM,2,1.00	EPM2A,LOC100507557	5'UTR_premature_start_codon_gain,5'UTR,intron	EPM2A:NM_005670.3:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-214A>G:,EPM2A:NM_001018041.1:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-214A>G:,EPM2A:NM_005670.3:5'UTR:MODIFIER:exon1/4:c.-214A>G:,EPM2A:NM_001018041.1:5'UTR:MODIFIER:exon1/5:c.-214A>G:,LOC100507557:NR_038246.1:intron:MODIFIER:exon1/2:n.52+792T>C:		rs2235481	0.7352	0.0000	0/0/0	0.1182										51	32					EPM2A (inh=AR pLI=0.00), LOC100507557 (inh=n/a pLI=n/a)
chr6	152443468	152443468	G	T	het		QUAL=13547;DP=539;AF=0.49;MQM=59;TRIO=HET,539,0.49,HET,484,0.54,WT,732,0.00	SYNE1	3'UTR	SYNE1:NM_182961.3:3'UTR:MODIFIER:exon146/146:c.*103C>A:,SYNE1:NM_033071.3:3'UTR:MODIFIER:exon146/146:c.*103C>A:		rs2250122	0.2452	0.0000	0/0/0	0.0486										19	118					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152464839	152464839	A	G	het		QUAL=15246;DP=432;AF=0.52;MQM=60;TRIO=HET,432,0.52,HOM,292,1.00,WT,387,0.01	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon138/146:c.25038T>C:p.Arg8346Arg,SYNE1:NM_033071.3:synonymous:LOW:exon138/146:c.24894T>C:p.Arg8298Arg		rs2256135	0.6897	0.6110	23222/10072/3002	0.6054						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118470.2 [likely benign]; 			777	1174					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152466674	152466674	T	C	het		QUAL=7249;DP=316;AF=0.49;MQM=60;TRIO=HET,316,0.49,HET,245,0.52,WT,295,0.00	SYNE1	synonymous,intron	SYNE1:NM_033071.3:synonymous:LOW:exon137/146:c.24780A>G:p.Glu8260Glu,SYNE1:NM_182961.3:intron:MODIFIER:exon137/145:c.24977-1774A>G:		rs2747662	0.3662	0.3450	7689/3414/609	0.3417						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118469.1 [benign]; 		COSM3761563, COSM3761562	280	1082					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469188	152469188	C	G	het	phylop_high	QUAL=3713;DP=171;AF=0.47;MQM=60;TRIO=HET,171,0.47,HET,135,0.55,WT,209,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon137/146:c.24968G>C:p.Gly8323Ala,SYNE1:NM_033071.3:missense:MODERATE:exon136/146:c.24755G>C:p.Gly8252Ala		rs2252755	0.3994	0.3580	8245/3497/1029	0.3546	2.6650	T	T,T,T,T,T,T,T,T,.,T,T,T	P,P,B,B,B	B,B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118468.2 [likely benign]; 			295	1086					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469204	152469204	G	A	het	phylop_high;pred_pathogenic_1	QUAL=3829;DP=183;AF=0.44;MQM=60;TRIO=HET,183,0.44,HET,157,0.54,WT,230,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon137/146:c.24952C>T:p.Leu8318Phe,SYNE1:NM_033071.3:missense:MODERATE:exon136/146:c.24739C>T:p.Leu8247Phe		rs141716975	0.0022	0.0053	2/2/0	0.0050	6.9680	T	D,D,D,T,D,T,D,D,.,T,T,T	P,P,P,P,P	B,B,P,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000174640.1 [benign]; 			1	28	2	VUS2, MR, 14.07.2016, ExAC >0,5% [3] Julia Bickmann 29.01.2015 [2] ahrautm1 14.07.2016			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469331	152469331	C	T	het		QUAL=5708;DP=231;AF=0.48;MQM=60;TRIO=HET,231,0.48,HET,259,0.48,WT,375,0.00	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon137/146:c.24825G>A:p.Pro8275Pro,SYNE1:NM_033071.3:synonymous:LOW:exon136/146:c.24612G>A:p.Pro8204Pro		rs2252748	0.3395	0.3130	6398/2580/499	0.3098						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118467.2 [likely benign]; 		COSM3761568, COSM3761564, COSM3761567, COSM3761566, COSM3761565	222	1018	1	[1] old entry - no details available			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152532702	152532702	T	C	het	phylop_high;pred_pathogenic_2	QUAL=7134;DP=340;AF=0.50;MQM=60;TRIO=HET,340,0.50,WT,146,0.00,HET,235,0.42	SYNE1,MIR3163	missense,intron	SYNE1:NM_182961.3:missense:MODERATE:exon124/146:c.22516A>G:p.Ser7506Gly,SYNE1:NM_033071.3:missense:MODERATE:exon123/146:c.22303A>G:p.Ser7435Gly,MIR3163:NR_036121.1.2:intron:MODIFIER:exon5/5:n.53-13545T>C:		rs35763277	0.0046	0.0140	24/22/0	0.0133	7.9410	T	T,T,T,T,T,T,T,T	D,D,D,D	D,D,D,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118462.2 [likely benign]; 			0	76					SYNE1 (inh=AR+AD pLI=0.00), MIR3163 (inh=n/a pLI=n/a)
chr6	152534768	152534768	C	T	het		QUAL=7394;DP=293;AF=0.48;MQM=60;TRIO=HET,293,0.48,WT,213,0.00,HET,275,0.50	SYNE1,MIR3163	synonymous,intron	SYNE1:NM_182961.3:synonymous:LOW:exon123/146:c.22473G>A:p.Leu7491Leu,SYNE1:NM_033071.3:synonymous:LOW:exon122/146:c.22260G>A:p.Leu7420Leu,MIR3163:NR_036121.1.2:intron:MODIFIER:exon5/5:n.53-11479C>T:		rs34891041	0.0206	0.0260	60/47/7	0.0246						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118461.2 [likely benign]; 			2	125					SYNE1 (inh=AR+AD pLI=0.00), MIR3163 (inh=n/a pLI=n/a)
chr6	152540278	152540278	A	C	hom		QUAL=26106;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,215,1.00,HOM,278,1.00	SYNE1,MIR3163	missense,intron	SYNE1:NM_182961.3:missense:MODERATE:exon120/146:c.21904T>G:p.Phe7302Val,SYNE1:NM_033071.3:missense:MODERATE:exon119/146:c.21691T>G:p.Phe7231Val,MIR3163:NR_036121.1.2:intron:MODIFIER:exon5/5:n.53-5969A>C:		rs2147377	0.9956	0.9920	59771/32617/5183	0.9696	1.3490	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118459.2 [likely benign]; 			2416	40	1	[1] old entry - no details available	n/a (11xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00), MIR3163 (inh=n/a pLI=n/a)
chr6	152615200	152615200	G	A	hom		QUAL=18883;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HET,245,0.57,HET,296,0.48	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon94/146:c.17745C>T:p.His5915His,SYNE1:NM_033071.3:synonymous:LOW:exon93/146:c.17532C>T:p.His5844His		rs12664753	0.1478	0.1870	2359/1241/12	0.1843						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118454.2 [likely benign]; 			112	719	1	[1] Julia Bickmann 18.09.2014	n/a (2xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00)
chr6	152629773	152629773	A	-	het		QUAL=484;DP=155;AF=0.17;MQM=59;TRIO=HET,155,0.17,HET,70,0.51,WT,86,0.16	SYNE1	splice_region&intron	SYNE1:NM_182961.3:splice_region&intron:LOW:exon90/145:c.17203-6delT:,SYNE1:NM_033071.3:splice_region&intron:LOW:exon89/145:c.16994-10delT:		rs535229755;rs55633181;rs796838050	0.4265	0.4090	1972/899/64	0.0455						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000203031.1 [benign]; 			91	1325					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152647681	152647681	A	T	het	phylop_high	QUAL=16374;DP=488;AF=0.50;MQM=60;TRIO=HET,488,0.50,HET,323,0.53,HET,425,0.51	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon79/146:c.15043T>A:p.Leu5015Met,SYNE1:NM_033071.3:missense:MODERATE:exon78/146:c.14830T>A:p.Leu4944Met		rs2306916	0.8147	0.7790	37372/19174/4518	0.7737	2.9340	T	T,T,T,T,T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118448.2 [likely benign]; 			1346	937					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152652034	152652034	A	T	het		QUAL=9480;DP=189;AF=0.58;MQM=60;TRIO=HET,189,0.58,HET,189,0.56,HET,257,0.57	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon78/146:c.13786T>A:p.Ser4596Thr,SYNE1:NM_033071.3:missense:MODERATE:exon77/146:c.13573T>A:p.Ser4525Thr		rs6911096	0.8033	0.7760	36980/19174/4081	0.7705	-2.5130	T	T,T,T,T,T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118444.2 [likely benign]; 		COSM450728, COSM450729, COSM1487365	1344	942					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152658062	152658062	C	G	het	phylop_high;pred_pathogenic_3	QUAL=7816;DP=318;AF=0.44;MQM=60;TRIO=HET,318,0.44,WT,173,0.01,HET,310,0.50	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon76/146:c.12442G>C:p.Asp4148His,SYNE1:NM_033071.3:missense:MODERATE:exon75/146:c.12229G>C:p.Asp4077His		rs117501809	0.0124	0.0270	70/46/0	0.0262	7.8150	T	D,D,D,D,D	D,D,D,D	D,D,D,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118441.2 [likely benign]; 			8	155					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152658142	152658142	T	C	het		QUAL=7102;DP=155;AF=0.51;MQM=60;TRIO=HET,155,0.51,HET,133,0.50,HET,247,0.53	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon76/146:c.12362A>G:p.Lys4121Arg,SYNE1:NM_033071.3:missense:MODERATE:exon75/146:c.12149A>G:p.Lys4050Arg		rs9479297	0.7931	0.7510	34481/18325/4464	0.7260	1.4310	T	T,T,T,T,T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118439.2 [likely benign]; 			1306	956					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152697675	152697675	G	T	het		QUAL=4423;DP=228;AF=0.49;MQM=60;TRIO=HET,228,0.49,HET,133,0.44,WT,220,0.00	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon58/146:c.9165C>A:p.Ser3055Ser,SYNE1:NM_033071.3:synonymous:LOW:exon58/146:c.9186C>A:p.Ser3062Ser		rs117020413	0.0068	0.0130	23/10/0	0.0125	1.2490	T				608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];				0	67					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152772264	152772264	A	G	hom	phylop_high;pred_pathogenic_2	QUAL=18097;DP=347;AF=1.00;MQM=59;TRIO=HOM,347,1.00,HET,199,0.47,HET,278,0.54	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon26/146:c.3104T>C:p.Val1035Ala,SYNE1:NM_033071.3:missense:MODERATE:exon26/146:c.3125T>C:p.Val1042Ala		rs214976	0.6072	0.4810	15138/6165/2930	0.4769	8.6440	D	D,D,D,D,D,D,D,D	B,B,B,B,B,P	B,B,B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118478.2 [likely benign]; 			504	1177	1	[1] old entry - no details available			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152774753	152774753	C	T	het	phylop_high;pred_pathogenic_3	QUAL=4906;DP=244;AF=0.50;MQM=59;TRIO=HET,244,0.50,HET,123,0.59,WT,142,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:NM_033071.3:missense:MODERATE:exon25/146:c.3016G>A:p.Glu1006Lys		rs148346599	0.0020	0.0034	2/0/0	0.0029	7.3880	T	D,D,D,D,D,D,T,D,T	D,D,D,D,D,D,D	P,P,P,D,D,P,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];			COSM231095, COSM231094	0	8					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152809527	152809527	A	T	hom		QUAL=8860;DP=181;AF=1.00;MQM=59;TRIO=HOM,181,1.00,HET,88,0.56,HET,136,0.45	SYNE1	splice_region&intron	SYNE1:NM_182961.3:splice_region&intron:LOW:exon12/145:c.1047+4T>A:,SYNE1:NM_033071.3:splice_region&intron:LOW:exon12/145:c.1068+4T>A:		rs9397106	0.5893	0.4760	14464/6127/2331	0.4715						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118432.3 [other]; 			512	1151	1	[1] Julia Bickmann 18.09.2014	n/a (4xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00)
chr6	152958461	152958461	G	A	het		QUAL=1282;DP=52;AF=0.52;MQM=60;TRIO=HET,52,0.52,WT,86,0.00,HET,104,0.38	SYNE1	5'UTR	SYNE1:NM_182961.3:5'UTR:MODIFIER:exon1/146:c.-529C>T:		rs9478345	0.3301	0.0000	0/0/0	0.4113										22	111					SYNE1 (inh=AR+AD pLI=0.00)
chr6	157522360	157522360	G	A	het		QUAL=6665;DP=203;AF=0.56;MQM=59;TRIO=HET,203,0.56,HET,311,0.50,WT,419,0.00	ARID1B	synonymous	ARID1B:NM_020732.3:synonymous:LOW:exon18/20:c.4632G>A:p.Pro1544Pro,ARID1B:NM_017519.2:synonymous:LOW:exon17/19:c.4593G>A:p.Pro1531Pro		rs61738955	0.0184	0.0270	52/40/0	0.0270						614556 [ARID1B (confirmed) Mental retardation,autosomal dominant 12];	RCV000114277.1 [benign]; 			5	67					ARID1B (inh=AD pLI=1.00)
chr6	157529844	157529844	C	T	het		QUAL=393;DP=105;AF=0.37;MQM=55;TRIO=HET,105,0.37,WT,37,0.11,HET,39,0.15	ARID1B	3'UTR	ARID1B:NM_020732.3:3'UTR:MODIFIER:exon20/20:c.*819C>T:,ARID1B:NM_017519.2:3'UTR:MODIFIER:exon19/19:c.*819C>T:	(T)n		0.0000	0.0000	0/0/0	0.0007										1	91					ARID1B (inh=AD pLI=1.00)
chr6	157529849	157529849	C	T	hom		QUAL=878;DP=73;AF=0.52;MQM=54;TRIO=HOM,73,0.52,HOM,6,0.50,HOM,9,0.56	ARID1B	3'UTR	ARID1B:NM_020732.3:3'UTR:MODIFIER:exon20/20:c.*824C>T:,ARID1B:NM_017519.2:3'UTR:MODIFIER:exon19/19:c.*824C>T:	(T)n	rs139366986	0.0000	0.0000	0/0/0	0.0014										5	129					ARID1B (inh=AD pLI=1.00)
chr6	158613375	158613375	A	-	het		QUAL=1051;DP=224;AF=0.21;MQM=59;TRIO=HET,224,0.21,HET,68,0.56,WT,87,0.09	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*198delA:		rs3841147	0.3193	0.0000	0/0/0	0.1269										6	86					GTF2H5 (inh=n/a pLI=0.05)
chr6	158613603	158613603	A	C	het		QUAL=12177;DP=328;AF=0.49;MQM=60;TRIO=HET,328,0.49,HET,273,0.45,HET,316,0.56	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*414A>C:		rs4425618	0.4239	0.0000	0/0/0	0.0606										24	101					GTF2H5 (inh=n/a pLI=0.05)
chr6	158613910	158613910	G	A	het		QUAL=3157;DP=132;AF=0.54;MQM=60;TRIO=HET,132,0.54,HET,47,0.66,HET,59,0.46	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*721G>A:	FRAM	rs9457163	0.4239	0.0000	0/0/0	0.0610										22	79					GTF2H5 (inh=n/a pLI=0.05)
chr6	158614236	158614236	-	AGGAGGATGGCTTAAGCCC	het		QUAL=5018;DP=125;AF=0.26;MQM=59;TRIO=HET,125,0.26,HET,121,0.45,HET,161,0.53	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*1053_*1054insATGGCTTAAGCCCAGGAGG:	AluJo	rs6149883	0.3786	0.0000	0/0/0	0.2559										16	85					GTF2H5 (inh=n/a pLI=0.05)
chr6	158614528	158614528	G	A	het		QUAL=7503;DP=338;AF=0.49;MQM=59;TRIO=HET,338,0.49,WT,181,0.00,HET,239,0.48	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*1339G>A:		rs35508045	0.0935	0.0000	0/0/0	0.0180										7	62					GTF2H5 (inh=n/a pLI=0.05)
chr6	158615926	158615926	A	T	het		QUAL=11204;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,HET,202,0.47,HET,249,0.49	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*2737A>T:		rs1019682	0.7798	0.0000	0/0/0	0.6672										117	96					GTF2H5 (inh=n/a pLI=0.05)
chr6	158616335	158616335	A	C	het		QUAL=4427;DP=204;AF=0.58;MQM=60;TRIO=HET,204,0.58,HET,35,0.46,HET,50,0.52	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3146A>C:		rs10946159	0.3722	0.0000	0/0/0	0.3409										21	104					GTF2H5 (inh=n/a pLI=0.05)
chr6	158616727	158616727	C	T	het		QUAL=11223;DP=443;AF=0.51;MQM=58;TRIO=HET,443,0.51,HET,152,0.54,HET,232,0.47	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3538C>T:		rs1047876	0.4233	0.0000	0/0/0	0.3550										25	100					GTF2H5 (inh=n/a pLI=0.05)
chr6	158616876	158616876	A	C	het		QUAL=7032;DP=312;AF=0.54;MQM=55;TRIO=HET,312,0.54,WT,133,0.00,HET,221,0.43	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3687A>C:		rs4354181	0.0986	0.0000	0/0/0	0.1076										7	64					GTF2H5 (inh=n/a pLI=0.05)
chr6	158617694	158617694	A	T	het		QUAL=5262;DP=300;AF=0.49;MQM=60;TRIO=HET,300,0.49,WT,103,0.00,HET,136,0.43	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*4505A>T:	HSMAR2	rs144679213	0.0126	0.0000	0/0/0	0.0257										1	13					GTF2H5 (inh=n/a pLI=0.05)
chr6	158619409	158619409	G	A	hom		QUAL=32038;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,214,1.00,HOM,285,1.00	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6220G>A:		rs599345	0.8912	0.0000	0/0/0	0.7328										128	86					GTF2H5 (inh=n/a pLI=0.05)
chr6	158619713	158619713	C	G	hom		QUAL=13106;DP=269;AF=0.99;MQM=59;TRIO=HOM,269,0.99,HOM,100,1.00,HET,149,0.37	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6524C>G:	AluSz	rs615107	0.5677	0.0000	0/0/0	0.5252										83	105					GTF2H5 (inh=n/a pLI=0.05)
chr6	158619948	158619948	G	C	het		QUAL=4640;DP=301;AF=0.48;MQM=60;TRIO=HET,301,0.48,WT,91,0.01,HET,96,0.34	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6759G>C:		rs71563797	0.1032	0.0000	0/0/0	0.1082										7	61					GTF2H5 (inh=n/a pLI=0.05)
chr6	161132146	161132146	C	T	het		QUAL=6046;DP=229;AF=0.47;MQM=55;TRIO=HET,229,0.47,HET,310,0.48,WT,369,0.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon4/19:c.330C>T:p.Asn110Asn,PLG:NM_001168338.1:synonymous:LOW:exon4/4:c.330C>T:p.Asn110Asn		rs4757	0.2494	0.2630	5054/3267/1239	0.2487						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				144	490					PLG (inh=n/a pLI=0.00)
chr6	161132417	161132417	T	G	het	low_MQM	QUAL=6350;DP=322;AF=0.48;MQM=48;TRIO=HET,322,0.48,HET,209,0.47,WT,281,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*190T>G:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+194T>G:	MER2	rs4252082	0.2486	0.0000	0/0/0	0.1593						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				17	72					PLG (inh=n/a pLI=0.00)
chr6	161132725	161132725	T	C	het		QUAL=6300;DP=257;AF=0.53;MQM=57;TRIO=HET,257,0.53,HET,162,0.57,WT,198,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*498T>C:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+502T>C:		rs4252086	0.2486	0.0000	0/0/0	0.2239						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				29	115					PLG (inh=n/a pLI=0.00)
chr6	161132804	161132804	T	C	het		QUAL=7321;DP=284;AF=0.53;MQM=56;TRIO=HET,284,0.53,HET,213,0.56,WT,317,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*577T>C:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+581T>C:		rs1853018	0.2486	0.0000	0/0/0	0.1989						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				17	71					PLG (inh=n/a pLI=0.00)
chr6	161132830	161132830	G	A	hom		QUAL=30607;DP=347;AF=1.00;MQM=58;TRIO=HOM,347,1.00,HOM,243,1.00,HOM,332,1.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*603G>A:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+607G>A:		rs1830519	0.6066	0.0000	0/0/0	0.5591						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				90	53					PLG (inh=n/a pLI=0.00)
chr6	161137779	161137779	T	C	het		QUAL=5663;DP=133;AF=0.57;MQM=60;TRIO=HET,133,0.57,HET,55,0.58,HOM,97,0.99	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon7/19:c.771T>C:p.Cys257Cys		rs14224	0.4499	0.4220	10982/5880/1443	0.4175						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				229	552					PLG (inh=n/a pLI=0.00)
chr6	161137790	161137790	G	A	het	phylop_high;pred_pathogenic_2	QUAL=1394;DP=112;AF=0.41;MQM=60;TRIO=HET,112,0.41,HET,51,0.41,WT,84,0.00	PLG	missense	PLG:NM_000301.3:missense:MODERATE:exon7/19:c.782G>A:p.Arg261His		rs4252187	0.0008	0.0031	1/1/0	0.0031	4.4140	T	D	D	P	173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				0	10					PLG (inh=n/a pLI=0.00)
chr6	161139480	161139480	C	T	het		QUAL=11006;DP=325;AF=0.54;MQM=60;TRIO=HET,325,0.54,HET,114,0.49,HOM,185,1.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon8/19:c.942C>T:p.Phe314Phe		rs1130656	0.3498	0.3780	8956/5424/342	0.3757						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];			COSM1131985	175	505					PLG (inh=n/a pLI=0.00)
chr6	161139857	161139857	A	G	het		QUAL=5035;DP=219;AF=0.42;MQM=59;TRIO=HET,219,0.42,HET,186,0.58,WT,260,0.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon9/19:c.1083A>G:p.Gln361Gln		rs13231	0.1364	0.2150	3405/2875/155	0.2157						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				89	454					PLG (inh=n/a pLI=0.00)
chr6	161143608	161143608	T	C	het		QUAL=3780;DP=192;AF=0.43;MQM=60;TRIO=HET,192,0.43,HET,153,0.48,WT,189,0.01	PLG	splice_region&intron	PLG:NM_000301.3:splice_region&intron:LOW:exon10/18:c.1256+9T>C:		rs4252120	0.1400	0.2170	3457/2904/170	0.2057						173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];				87	457					PLG (inh=n/a pLI=0.00)
chr6	161152240	161152240	G	A	het		QUAL=4322;DP=217;AF=0.48;MQM=60;TRIO=HET,217,0.48,HET,153,0.51,WT,199,0.00	PLG	missense	PLG:NM_000301.3:missense:MODERATE:exon11/19:c.1414G>A:p.Asp472Asn		rs4252125	0.1398	0.2170	3455/2903/170	0.2179	0.0580	T	T	B	B	173350 [PLG (confirmed) Dysplasminogenemia|Plasminogen deficiency,type I];		CM043559 [CLASS=DFP MUT=ALT PHEN="Invasive aspergillosis susceptibility" GENE=PLG]; 		86	459					PLG (inh=n/a pLI=0.00)
chr6	161174658	161174658	G	A	het	low_MQM	QUAL=11403;DP=243;AF=0.52;MQM=46;TRIO=HET,243,0.52,HOM,180,1.00,HET,198,0.50	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*565G>A:		rs80294183	0.8738	0.0000	0/0/0	0.5201										102	46					PLG (inh=n/a pLI=0.00)
chr6	161174933	161174933	C	T	het		QUAL=14184;DP=456;AF=0.47;MQM=60;TRIO=HET,456,0.47,WT,539,0.00,HET,656,0.49	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*840C>T:		rs4252199	0.0110	0.0000	0/0/0	0.0156										1	7					PLG (inh=n/a pLI=0.00)
chr6	161175004	161175004	C	T	het		QUAL=13966;DP=537;AF=0.51;MQM=55;TRIO=HET,537,0.51,HET,541,0.48,WT,653,0.00	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*911C>T:		rs4252181	0.1126	0.0000	0/0/0	0.1956										11	67					PLG (inh=n/a pLI=0.00)
chr6	161768651	161768651	G	T	het		QUAL=238;DP=37;AF=0.35;MQM=54;TRIO=HET,37,0.35,WT,541,0.48,HOM,2,1.00	PARK2	3'UTR	PARK2:NM_004562.2:3'UTR:MODIFIER:exon12/12:c.*2480C>A:,PARK2:NM_013987.2:3'UTR:MODIFIER:exon11/11:c.*2480C>A:,PARK2:NM_013988.2:3'UTR:MODIFIER:exon9/9:c.*2480C>A:	AluSg4	rs68121389	0.4990	0.0000	0/0/0	0.1519										22	54					PARK2 (inh=AR pLI=0.02)
chr6	161769835	161769835	T	C	het		QUAL=11219;DP=420;AF=0.53;MQM=59;TRIO=HET,420,0.53,WT,359,0.00,HET,444,0.48	PARK2	3'UTR	PARK2:NM_004562.2:3'UTR:MODIFIER:exon12/12:c.*1296A>G:,PARK2:NM_013987.2:3'UTR:MODIFIER:exon11/11:c.*1296A>G:,PARK2:NM_013988.2:3'UTR:MODIFIER:exon9/9:c.*1296A>G:		rs3734464	0.0577	0.0000	0/0/0	0.0132										1	46					PARK2 (inh=AR pLI=0.02)
chr6	167369897	167369897	C	A	het	low_DP	QUAL=1197;DP=18;AF=0.56;MQM=59;TRIO=HET,18,0.56,WT,60,0.02,HET,86,0.52	RNASET2	5'UTR	RNASET2:NM_003730.4:5'UTR:MODIFIER:exon1/9:c.-227G>T:		rs1044059	0.6737	0.0000	0/0/0	0.5184										65	100					RNASET2 (inh=AR pLI=0.01)
chr6	167369992	167369992	A	G	het	low_DP	QUAL=598;DP=11;AF=0.64;MQM=60;TRIO=HET,11,0.64,WT,26,0.00,HET,38,0.58	RNASET2	5'UTR	RNASET2:NM_003730.4:5'UTR:MODIFIER:exon1/9:c.-322T>C:		rs2247325	0.6396	0.0000	0/0/0	0.0817										35	86					RNASET2 (inh=AR pLI=0.01)
chr6	170871040	170871040	A	G	het	low_DP	QUAL=7078;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon3/8:c.216A>G:p.Gln72Gln,TBP:NM_001172085.1:synonymous:LOW:exon2/7:c.156A>G:p.Gln52Gln	(GCA)n	rs55736770	0.0000	0.0074	3/2/0	0.0024						600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];	RCV000118598.2 [likely benign]; 		COSM3723811	67	647					TBP (inh=AD pLI=0.49)
chr6	170871043	170871043	G	A	het	low_DP	QUAL=7078;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon3/8:c.219G>A:p.Gln73Gln,TBP:NM_001172085.1:synonymous:LOW:exon2/7:c.159G>A:p.Gln53Gln	(GCA)n	rs764035011	0.0000	0.0001	0/0/0	0.0007						600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];			COSM1076231	37	420	1	[1] Tanja Benkert 20.04.2015 [n/a] comment imported from detected variant: 20.04.2015, TCB: Poly-Q, auch in Kontrolle (SCA-V4)			TBP (inh=AD pLI=0.49)
chr6	170871046	170871046	A	G	het	low_DP	QUAL=7078;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.29,HET,379,0.00	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon3/8:c.222A>G:p.Gln74Gln,TBP:NM_001172085.1:synonymous:LOW:exon2/7:c.162A>G:p.Gln54Gln	(GCA)n	rs62430309	0.0000	0.0057	4/3/0	0.0003						600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];			COSM2156799	90	573					TBP (inh=AD pLI=0.49)
chr6	170871049	170871049	G	A	het	low_DP	QUAL=7078;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon3/8:c.225G>A:p.Gln75Gln,TBP:NM_001172085.1:synonymous:LOW:exon2/7:c.165G>A:p.Gln55Gln	(GCA)n	rs56241301	0.0000	0.0037	3/2/0	0.0002						600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];			COSM595316	78	536	1	[1] Tanja Benkert 20.04.2015 [n/a] comment imported from detected variant: 20.04.2015, TCB: Poly-Q, auch in Kontrolle (SCA-V4)			TBP (inh=AD pLI=0.49)
chr6	170878793	170878793	T	C	hom		QUAL=17626;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HET,250,0.49,HET,338,0.47	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon6/8:c.771T>C:p.Asn257Asn,TBP:NM_001172085.1:synonymous:LOW:exon5/7:c.711T>C:p.Asn237Asn		rs1042327	0.6146	0.5310	17709/8802/2320	0.5301	0.3870	T				600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];	RCV000118601.2 [likely benign]; 			315	583					TBP (inh=AD pLI=0.49)
chr7	286402	286402	A	G	het		QUAL=5419;DP=165;AF=0.36;MQM=59;TRIO=HET,165,0.36,HOM,147,0.99,WT,325,0.00	FAM20C	synonymous	FAM20C:NM_020223.3:synonymous:LOW:exon4/10:c.885A>G:p.Thr295Thr		rs141256626	0.2883	0.2340	691/195/228	0.0719						611061 [FAM20C (confirmed) Raine syndrome];			COSM4162129	47	358					FAM20C (inh=AR pLI=0.59)
chr7	4831675	4831675	G	A	het		QUAL=1962;DP=63;AF=0.49;MQM=60;TRIO=HET,63,0.49,HET,116,0.47,WT,150,0.00	AP5Z1	3'UTR	AP5Z1:NM_014855.2:3'UTR:MODIFIER:exon17/17:c.*659G>A:		rs140612456	0.0136	0.0000	0/0/0	0.0348										0	19					AP5Z1 (inh=AR pLI=n/a)
chr7	6026775	6026775	T	C	hom	anno_pathogenic_hgmd	QUAL=31806;DP=190;AF=0.99;MQM=56;TRIO=HOM,190,0.99,HOM,324,1.00,HOM,487,1.00	PMS2	missense,non_coding_exon	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon11/15:n.1703A>G:		rs2228006	0.8832	0.8510	44055/24216/4305	0.8176	1.4430	T	T,T,T,T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030365.3 [benign]; RCV000034619.3 [benign]; RCV000121840.3 [benign]; 	BM1497492 [CLASS=DM? MUT=REF PHEN="Colorectal cancer non-polyposis" GENE=PMS2]; 	COSM4162329	1978	674	1	[1] Tanja Benkert 16.04.2015			PMS2 (inh=n/a pLI=0.00)
chr7	6026959	6026959	G	C	het	low_MQM	QUAL=3707;DP=175;AF=0.38;MQM=47;TRIO=HET,175,0.38,WT,120,0.00,HET,198,0.51	PMS2	missense,non_coding_exon	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1437C>G:p.His479Gln,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon11/15:n.1519C>G:		rs63750685	0.0028	0.0045	3/2/0	0.0005	0.1820	T	T,T,T,T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000166894.1 [likely benign]; RCV000034615.3 [benign]; RCV000076809.5 [uncertain significance]; RCV000121844.1 [benign]; RCV000162366.1 [benign]; 			0	19	3	[3] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=n/a pLI=0.00)
chr7	6026988	6026988	G	A	hom		QUAL=9619;DP=217;AF=1.00;MQM=52;TRIO=HOM,217,1.00,HET,102,0.48,HET,165,0.48	PMS2	missense,non_coding_exon	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1408C>T:p.Pro470Ser,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon11/15:n.1490C>T:		rs1805321	0.3582	0.3850	9186/5718/417	0.3781	0.2650	T	T,T,T,T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030364.3 [benign]; RCV000034614.1 [benign]; RCV000079103.5 [benign]; RCV000130721.2 [benign]; RCV000144645.1 [benign]; 		COSM3736445	496	1310	1	[1] old entry - no details available			PMS2 (inh=n/a pLI=0.00)
chr7	6036980	6036980	G	C	hom		QUAL=7014;DP=124;AF=1.00;MQM=60;TRIO=HOM,124,1.00,HOM,47,1.00,HOM,40,1.00	PMS2	synonymous,non_coding_exon	PMS2:NM_000535.5:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon7/15:n.862C>G:		rs1805319	0.8313	0.8090	39906/22309/3695	0.7970						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000162392.1 [benign]; RCV000030372.3 [benign]; RCV000079112.5 [benign]; RCV000131484.2 [benign]; 		COSM4162330	1823	792	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=n/a pLI=0.00)
chr7	6037058	6037058	A	-	hom	low_DP	QUAL=344;DP=17;AF=0.47;MQM=59;TRIO=HOM,17,0.47,HET,32,0.50,HET,29,0.34	PMS2	splice_region&intron	PMS2:NM_000535.5:splice_region&intron:LOW:exon6/14:c.706-4delT:,PMS2:NR_003085.2:splice_region&intron:LOW:exon6/14:n.788-4delT:	(A)n	rs549498051;rs549793612;rs60794673;rs796382014	0.4531	0.3700	321/196/10	0.3329						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000203188.1,RCV000203188.1 [benign,benign]; 			131	1744					PMS2 (inh=n/a pLI=0.00)
chr7	22980929	22980929	-	AC	het		QUAL=4808;DP=127;AF=0.48;MQM=59;TRIO=HET,127,0.48,WT,66,0.00,HOM,100,1.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*4278_*4279insGT:		rs35708583;rs55691833	0.4275	0.0000	0/0/0	0.3715										34	105					FAM126A (inh=AR pLI=0.80)
chr7	22981404	22981404	T	G	het		QUAL=4841;DP=150;AF=0.41;MQM=59;TRIO=HET,150,0.41,HOM,102,1.00,WT,128,0.01	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3804A>C:		rs34683819	0.2250	0.0000	0/0/0	0.2726										33	87					FAM126A (inh=AR pLI=0.80)
chr7	22981528	22981528	T	C	het		QUAL=8018;DP=203;AF=0.50;MQM=59;TRIO=HET,203,0.50,WT,86,0.00,HOM,167,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3680A>G:		rs3815348	0.4275	0.0000	0/0/0	0.0703										34	104					FAM126A (inh=AR pLI=0.80)
chr7	22982207	22982207	T	C	het		QUAL=8371;DP=261;AF=0.56;MQM=60;TRIO=HET,261,0.56,WT,94,0.00,HOM,139,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3001A>G:		rs2286495	0.4277	0.0000	0/0/0	0.0708										34	106					FAM126A (inh=AR pLI=0.80)
chr7	22982547	22982547	G	A	het		QUAL=5820;DP=276;AF=0.46;MQM=60;TRIO=HET,276,0.46,HOM,80,0.96,WT,152,0.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*2661C>T:		rs13222017	0.2206	0.0000	0/0/0	0.0455										31	88					FAM126A (inh=AR pLI=0.80)
chr7	22982826	22982827	AT	-	het		QUAL=7427;DP=298;AF=0.50;MQM=59;TRIO=HET,298,0.50,WT,99,0.00,HOM,114,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*2381_*2382delAT:		rs143367578	0.1086	0.0000	0/0/0	0.1113										5	64					FAM126A (inh=AR pLI=0.80)
chr7	22983600	22983600	T	C	het		QUAL=10760;DP=428;AF=0.48;MQM=60;TRIO=HET,428,0.48,HOM,158,1.00,WT,215,0.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1608A>G:		rs10488277	0.2250	0.0000	0/0/0	0.0468										31	90					FAM126A (inh=AR pLI=0.80)
chr7	22983702	22983702	A	T	hom		QUAL=32399;DP=490;AF=1.00;MQM=59;TRIO=HOM,490,1.00,HOM,239,1.00,HOM,308,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1506T>A:		rs4607514	0.6671	0.0000	0/0/0	0.1183										116	92					FAM126A (inh=AR pLI=0.80)
chr7	22983890	22983890	T	C	hom		QUAL=30281;DP=340;AF=1.00;MQM=60;TRIO=HOM,340,1.00,HOM,226,1.00,HOM,350,1.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1318A>G:		rs1583511	0.6721	0.0000	0/0/0	0.1193										117	92					FAM126A (inh=AR pLI=0.80)
chr7	22984772	22984772	A	C	het		QUAL=17653;DP=505;AF=0.46;MQM=59;TRIO=HET,505,0.46,WT,265,0.00,HOM,347,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*436T>G:		rs10085448	0.4301	0.0000	0/0/0	0.0461										34	105					FAM126A (inh=AR pLI=0.80)
chr7	22984773	22984773	G	A	het		QUAL=17653;DP=505;AF=0.46;MQM=59;TRIO=HET,505,0.46,WT,265,0.00,HOM,347,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*435C>T:		rs10085739	0.4273	0.0000	0/0/0	0.0454										34	105					FAM126A (inh=AR pLI=0.80)
chr7	22984824	22984824	T	C	hom		QUAL=37253;DP=592;AF=1.00;MQM=60;TRIO=HOM,592,1.00,HOM,246,1.00,HOM,303,1.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*384A>G:		rs2286494	0.6530	0.0000	0/0/0	0.1175										116	92					FAM126A (inh=AR pLI=0.80)
chr7	22984967	22984967	A	G	het		QUAL=7369;DP=286;AF=0.47;MQM=60;TRIO=HET,286,0.47,HOM,116,0.99,WT,156,0.02	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*241T>C:		rs2286493	0.2025	0.0000	0/0/0	0.0457										30	89					FAM126A (inh=AR pLI=0.80)
chr7	23015831	23015831	T	C	het	phylop_high	QUAL=11183;DP=269;AF=0.52;MQM=60;TRIO=HET,269,0.52,WT,203,0.00,HOM,225,1.00	FAM126A	splice_region&synonymous	FAM126A:NM_032581.3:splice_region&synonymous:LOW:exon7/11:c.624A>G:p.Ser208Ser		rs3735231	0.3748	0.3720	8519/4256/634	0.3676	1.6430	T				610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5];	RCV000020929.2 [benign]; 			180	698	1	[1] old entry - no details available			FAM126A (inh=AR pLI=0.80)
chr7	30634661	30634661	C	G	hom	low_DP	QUAL=3762;DP=19;AF=1.00;MQM=59;TRIO=HOM,19,1.00,HOM,44,1.00,HOM,71,1.00	GARS	missense,5'UTR	GARS:NM_002047.3:missense:MODERATE:exon1/17:c.124C>G:p.Pro42Ala,GARS:NM_001316772.1:5'UTR:MODIFIER:exon1/17:c.-39C>G:		rs1049402	0.6494	0.6590	10805/6788/464	0.6091	-0.6710	T	T	B	B	600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D|Neuropathy,distal hereditary motor,type VA];			COSM3762627	910	546					GARS (inh=AD pLI=0.79)
chr7	30673345	30673345	C	T	hom		QUAL=20047;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,185,1.00,HOM,241,1.00	GARS	splice_region&intron	GARS:NM_002047.3:splice_region&intron:LOW:exon16/16:c.2095-6C>T:,GARS:NM_001316772.1:splice_region&intron:LOW:exon16/16:c.1933-6C>T:		rs2240401	0.4042	0.5520	19754/13801/124	0.5485						600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D|Neuropathy,distal hereditary motor,type VA];			COSM4004448	597	728					GARS (inh=AD pLI=0.79)
chr7	30673513	30673513	A	-	hom		QUAL=9245;DP=277;AF=0.63;MQM=59;TRIO=HOM,277,0.63,HOM,189,0.73,HOM,238,0.72	GARS	3'UTR	GARS:NM_002047.3:3'UTR:MODIFIER:exon17/17:c.*51delA:,GARS:NM_001316772.1:3'UTR:MODIFIER:exon17/17:c.*51delA:		rs70983380;rs755441530	0.0000	0.3990	1411/1015/47	0.3560										70	239					GARS (inh=AD pLI=0.79)
chr7	44184403	44184403	C	T	het		QUAL=2265;DP=118;AF=0.51;MQM=59;TRIO=HET,118,0.51,HET,79,0.51,WT,119,0.00	GCK	3'UTR	GCK:NM_033507.1:3'UTR:MODIFIER:exon10/10:c.*332G>A:,GCK:NM_033508.1:3'UTR:MODIFIER:exon11/11:c.*332G>A:,GCK:NM_000162.3:3'UTR:MODIFIER:exon10/10:c.*332G>A:		rs13306388	0.1520	0.0000	0/0/0	0.0376										14	88					GCK (inh=AD pLI=0.20)
chr7	47865325	47865325	C	A	hom		QUAL=19261;DP=316;AF=1.00;MQM=60;TRIO=HOM,316,1.00,HOM,142,1.00,HOM,150,1.00	PKD1L1	intron	PKD1L1:NM_138295.3:intron:MODIFIER:exon45/56:c.6854+1623G>T:		rs4720618	0.9802	0.0000	0/0/0	0.8727										150	0					PKD1L1 (inh=n/a pLI=0.00)
chr7	50560382	50560382	A	T	het		QUAL=7059;DP=287;AF=0.57;MQM=59;TRIO=HET,287,0.57,HOM,140,0.99,WT,227,0.00	DDC	3'UTR,intron	DDC:NM_001242890.1:3'UTR:MODIFIER:exon10/10:c.*249T>A:,DDC:NM_000790.3:intron:MODIFIER:exon9/14:c.944+2666T>A:,DDC:NM_001242886.1:intron:MODIFIER:exon8/13:c.830+2666T>A:,DDC:NM_001242887.1:intron:MODIFIER:exon8/13:c.800+2666T>A:,DDC:NM_001242888.1:intron:MODIFIER:exon7/12:c.710+2666T>A:,DDC:NM_001242889.1:intron:MODIFIER:exon7/12:c.665+2666T>A:,DDC:NM_001082971.1:intron:MODIFIER:exon9/14:c.944+2666T>A:		rs866666526	0.0000	0.0000	0/0/0	0.0011						107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				62	77					DDC (inh=AR pLI=0.00)
chr7	50560384	50560388	TTTCC	-	het		QUAL=7059;DP=287;AF=0.57;MQM=59;TRIO=HET,287,0.57,HOM,140,0.99,WT,227,0.00	DDC	3'UTR,intron	DDC:NM_001242890.1:3'UTR:MODIFIER:exon10/10:c.*243_*247delGGAAA:,DDC:NM_000790.3:intron:MODIFIER:exon9/14:c.944+2660_944+2664delGGAAA:,DDC:NM_001242886.1:intron:MODIFIER:exon8/13:c.830+2660_830+2664delGGAAA:,DDC:NM_001242887.1:intron:MODIFIER:exon8/13:c.800+2660_800+2664delGGAAA:,DDC:NM_001242888.1:intron:MODIFIER:exon7/12:c.710+2660_710+2664delGGAAA:,DDC:NM_001242889.1:intron:MODIFIER:exon7/12:c.665+2660_665+2664delGGAAA:,DDC:NM_001082971.1:intron:MODIFIER:exon9/14:c.944+2660_944+2664delGGAAA:			0.0000	0.0000	0/0/0	0.0000						107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				62	77					DDC (inh=AR pLI=0.00)
chr7	50560391	50560391	-	CTC	het		QUAL=8282;DP=301;AF=0.55;MQM=59;TRIO=HET,301,0.55,HOM,156,1.00,WT,246,0.00	DDC	3'UTR,intron	DDC:NM_001242890.1:3'UTR:MODIFIER:exon10/10:c.*239_*240insGAG:,DDC:NM_000790.3:intron:MODIFIER:exon9/14:c.944+2656_944+2657insGAG:,DDC:NM_001242886.1:intron:MODIFIER:exon8/13:c.830+2656_830+2657insGAG:,DDC:NM_001242887.1:intron:MODIFIER:exon8/13:c.800+2656_800+2657insGAG:,DDC:NM_001242888.1:intron:MODIFIER:exon7/12:c.710+2656_710+2657insGAG:,DDC:NM_001242889.1:intron:MODIFIER:exon7/12:c.665+2656_665+2657insGAG:,DDC:NM_001082971.1:intron:MODIFIER:exon9/14:c.944+2656_944+2657insGAG:		rs774393354	0.0000	0.0000	0/0/0	0.0001						107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				62	77					DDC (inh=AR pLI=0.00)
chr7	50560394	50560394	G	TCCTCTCTC	het		QUAL=8376;DP=287;AF=0.55;MQM=59;TRIO=HET,287,0.55,HOM,159,1.00,WT,243,0.00	DDC	3'UTR,intron	DDC:NM_001242890.1:3'UTR:MODIFIER:exon10/10:c.*237delCinsGAGAGAGGA:,DDC:NM_000790.3:intron:MODIFIER:exon9/14:c.944+2654delCinsGAGAGAGGA:,DDC:NM_001242886.1:intron:MODIFIER:exon8/13:c.830+2654delCinsGAGAGAGGA:,DDC:NM_001242887.1:intron:MODIFIER:exon8/13:c.800+2654delCinsGAGAGAGGA:,DDC:NM_001242888.1:intron:MODIFIER:exon7/12:c.710+2654delCinsGAGAGAGGA:,DDC:NM_001242889.1:intron:MODIFIER:exon7/12:c.665+2654delCinsGAGAGAGGA:,DDC:NM_001082971.1:intron:MODIFIER:exon9/14:c.944+2654delCinsGAGAGAGGA:			0.0000	0.0000	0/0/0	0.0000						107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				61	76					DDC (inh=AR pLI=0.00)
chr7	50611735	50611735	T	C	hom		QUAL=33279;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,343,1.00,HOM,466,1.00	DDC	missense	DDC:NM_000790.3:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:NM_001242886.1:missense:MODERATE:exon2/14:c.49A>G:p.Met17Val,DDC:NM_001242887.1:missense:MODERATE:exon2/14:c.49A>G:p.Met17Val,DDC:NM_001242888.1:missense:MODERATE:exon2/13:c.49A>G:p.Met17Val,DDC:NM_001242889.1:missense:MODERATE:exon2/13:c.49A>G:p.Met17Val,DDC:NM_001082971.1:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:NM_001242890.1:missense:MODERATE:exon2/10:c.49A>G:p.Met17Val		rs6264	0.9932	0.9980	60489/33368/5000	0.9346	-0.6030	T	T,T,T,T,T,T	B	B	107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				1303	0					DDC (inh=AR pLI=0.00)
chr7	50628740	50628743	CTCT	-	het		QUAL=7905;DP=256;AF=0.46;MQM=59;TRIO=HET,256,0.46,WT,218,0.00,HOM,185,0.99	DDC	5'UTR,intron	DDC:NM_000790.3:5'UTR:MODIFIER:exon1/15:c.-61_-58delAGAG:,DDC:NM_001242886.1:5'UTR:MODIFIER:exon1/14:c.-61_-58delAGAG:,DDC:NM_001242887.1:5'UTR:MODIFIER:exon1/14:c.-61_-58delAGAG:,DDC:NM_001242888.1:5'UTR:MODIFIER:exon1/13:c.-61_-58delAGAG:,DDC:NM_001242889.1:5'UTR:MODIFIER:exon1/13:c.-61_-58delAGAG:,DDC:NM_001242890.1:5'UTR:MODIFIER:exon1/10:c.-61_-58delAGAG:,DDC:NM_001082971.1:intron:MODIFIER:exon1/14:c.-29+4239_-29+4242delAGAG:	(CT)n	rs10600316;rs3837091	0.2929	0.0000	0/0/0	0.2399										30	148					DDC (inh=AR pLI=0.00)
chr7	65425894	65425894	A	G	hom		QUAL=31959;DP=465;AF=0.99;MQM=59;TRIO=HOM,465,0.99,HET,593,0.50,HET,757,0.48	GUSB	missense,non_coding_exon	GUSB:NM_000181.3:missense:MODERATE:exon12/12:c.1946T>C:p.Leu649Pro,GUSB:NM_001284290.1:missense:MODERATE:exon10/10:c.1508T>C:p.Leu503Pro,GUSB:NM_001293104.1:missense:MODERATE:exon11/11:c.1376T>C:p.Leu459Pro,GUSB:NM_001293105.1:missense:MODERATE:exon10/10:c.1289T>C:p.Leu430Pro,GUSB:NR_120531.1:non_coding_exon:MODIFIER:exon11/11:n.1992T>C:		rs9530	0.5807	0.5800	21049/10611/711	0.5757	-0.0470	T	T,T,T	B,B	B,B	611499 [GUSB (confirmed) Mucopolysaccharidosis VII];	RCV000078327.4 [benign]; 			373	520					GUSB (inh=AR pLI=0.00)
chr7	65447242	65447242	C	A	het		QUAL=439;DP=24;AF=0.54;MQM=59;TRIO=HET,24,0.54,HET,15,0.73,WT,22,0.00	GUSB	5'UTR,non_coding_exon	GUSB:NM_000181.3:5'UTR:MODIFIER:exon1/12:c.-72G>T:,GUSB:NM_001284290.1:5'UTR:MODIFIER:exon1/10:c.-72G>T:,GUSB:NM_001293104.1:5'UTR:MODIFIER:exon1/11:c.-457G>T:,GUSB:NM_001293105.1:5'UTR:MODIFIER:exon1/10:c.-401G>T:,GUSB:NR_120531.1:non_coding_exon:MODIFIER:exon1/11:n.60G>T:		rs2279904	0.0377	0.0000	0/0/0	0.0523										1	29					GUSB (inh=AR pLI=0.00)
chr7	66104909	66104909	G	C	het		QUAL=5392;DP=248;AF=0.50;MQM=59;TRIO=HET,248,0.50,HET,185,0.50,WT,218,0.00	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*690G>C:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-472G>C:		rs4718382	0.0407	0.0000	0/0/0	0.0092						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				0	26					KCTD7 (inh=AR pLI=0.50)
chr7	66105163	66105163	C	G	het		QUAL=18258;DP=344;AF=0.50;MQM=59;TRIO=HET,344,0.50,HOM,273,1.00,HET,335,0.56	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*944C>G:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-218C>G:		rs9791712	0.6238	0.0000	0/0/0	0.6275						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				78	124					KCTD7 (inh=AR pLI=0.50)
chr7	66105198	66105198	C	A	het		QUAL=14975;DP=247;AF=0.51;MQM=60;TRIO=HET,247,0.51,HOM,238,1.00,HET,292,0.55	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*979C>A:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-183C>A:		rs9791713	0.6236	0.0000	0/0/0	0.1070						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				78	124					KCTD7 (inh=AR pLI=0.50)
chr7	66105946	66105946	G	C	het		QUAL=6332;DP=306;AF=0.44;MQM=60;TRIO=HET,306,0.44,HET,250,0.48,WT,318,0.00	KCTD7	3'UTR	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*1727G>C:,KCTD7:NM_001167961.2:3'UTR:MODIFIER:exon5/5:c.*565G>C:		rs17229513	0.0371	0.0000	0/0/0	0.0090										0	26					KCTD7 (inh=AR pLI=0.50)
chr7	66106875	66106875	A	G	het		QUAL=21078;DP=379;AF=0.53;MQM=60;TRIO=HET,379,0.53,HOM,334,1.00,HET,352,0.54	KCTD7	3'UTR	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*2656A>G:,KCTD7:NM_001167961.2:3'UTR:MODIFIER:exon5/5:c.*1494A>G:		rs1860469	0.6234	0.0000	0/0/0	0.1067										78	124					KCTD7 (inh=AR pLI=0.50)
chr7	73442480	73442480	C	T	het	low_DP	QUAL=129;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,8,0.00,HET,11,0.45	ELN	5'UTR_premature_start_codon_gain,5'UTR	ELN:NM_001278939.1:5'UTR_premature_start_codon_gain:LOW:exon1/34:c.-38C>T:,ELN:NM_000501.3:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:NM_001081752.2:5'UTR_premature_start_codon_gain:LOW:exon1/30:c.-38C>T:,ELN:NM_001081753.2:5'UTR_premature_start_codon_gain:LOW:exon1/31:c.-38C>T:,ELN:NM_001081754.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001081755.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278912.1:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278913.1:5'UTR_premature_start_codon_gain:LOW:exon1/29:c.-38C>T:,ELN:NM_001278914.1:5'UTR_premature_start_codon_gain:LOW:exon1/31:c.-38C>T:,ELN:NM_001278915.1:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:NM_001278916.1:5'UTR_premature_start_codon_gain:LOW:exon1/29:c.-38C>T:,ELN:NM_001278917.1:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278918.1:5'UTR_premature_start_codon_gain:LOW:exon1/28:c.-38C>T:,ELN:NM_001278939.1:5'UTR:MODIFIER:exon1/34:c.-38C>T:,ELN:NM_000501.3:5'UTR:MODIFIER:exon1/33:c.-38C>T:,ELN:NM_001081752.2:5'UTR:MODIFIER:exon1/30:c.-38C>T:,ELN:NM_001081753.2:5'UTR:MODIFIER:exon1/31:c.-38C>T:,ELN:NM_001081754.2:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001081755.2:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278912.1:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278913.1:5'UTR:MODIFIER:exon1/29:c.-38C>T:,ELN:NM_001278914.1:5'UTR:MODIFIER:exon1/31:c.-38C>T:,ELN:NM_001278915.1:5'UTR:MODIFIER:exon1/33:c.-38C>T:,ELN:NM_001278916.1:5'UTR:MODIFIER:exon1/29:c.-38C>T:,ELN:NM_001278917.1:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278918.1:5'UTR:MODIFIER:exon1/28:c.-38C>T:		rs41410045	0.0260	0.0190	54/3/0	0.0168							RCV000195554.1 [benign]; 			1	18					ELN (inh=n/a pLI=0.00)
chr7	73483531	73483531	-	A	het		QUAL=4590;DP=145;AF=0.48;MQM=59;TRIO=HET,145,0.48,WT,181,0.00,HET,246,0.50	ELN	3'UTR	ELN:NM_001278939.1:3'UTR:MODIFIER:exon34/34:c.*501_*502insA:,ELN:NM_000501.3:3'UTR:MODIFIER:exon33/33:c.*501_*502insA:,ELN:NM_001081752.2:3'UTR:MODIFIER:exon30/30:c.*501_*502insA:,ELN:NM_001081753.2:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:NM_001081754.2:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001081755.2:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278912.1:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278913.1:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:NM_001278914.1:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:NM_001278915.1:3'UTR:MODIFIER:exon33/33:c.*501_*502insA:,ELN:NM_001278916.1:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:NM_001278917.1:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278918.1:3'UTR:MODIFIER:exon28/28:c.*501_*502insA:		rs34208922	0.2901	0.0000	0/0/0	0.2328										8	97					ELN (inh=n/a pLI=0.00)
chr7	74193668	74193668	G	A	het	low_DP;low_MQM	QUAL=11518;DP=14;AF=0.71;MQM=36;TRIO=HET,14,0.71,HET,275,0.80,HET,542,0.59	NCF1	missense	NCF1:NM_000265.5:missense:MODERATE:exon4/11:c.295G>A:p.Gly99Ser		rs10614	0.6312	0.5350	7339/4021/264	0.0573	0.5180	T	T,T,T,.	B,B	B,B	608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1];			COSM4162428	441	615					NCF1 (inh=n/a pLI=0.92)
chr7	75163169	75163169	A	G	hom		QUAL=28291;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,282,1.00,HOM,348,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*4324T>C:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*4324T>C:		rs1167827	0.5280	0.0000	0/0/0	0.4847										49	78					HIP1 (inh=n/a pLI=1.00)
chr7	75166401	75166401	C	T	hom		QUAL=31149;DP=310;AF=0.99;MQM=59;TRIO=HOM,310,0.99,HOM,317,0.99,HOM,382,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*1092G>A:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*1092G>A:		rs1167830	0.3758	0.0000	0/0/0	0.3046										36	98					HIP1 (inh=n/a pLI=1.00)
chr7	75166426	75166426	C	T	hom		QUAL=21458;DP=220;AF=0.99;MQM=59;TRIO=HOM,220,0.99,HET,284,0.50,HOM,347,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*1067G>A:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*1067G>A:		rs55859405	0.0940	0.0000	0/0/0	0.0079										2	22					HIP1 (inh=n/a pLI=1.00)
chr7	75183403	75183403	A	G	hom		QUAL=14789;DP=174;AF=1.00;MQM=59;TRIO=HOM,174,1.00,HOM,131,0.98,HOM,178,1.00	HIP1	splice_region&intron	HIP1:NM_005338.6:splice_region&intron:LOW:exon21/30:c.2158+9T>C:,HIP1:NM_001243198.2:splice_region&intron:LOW:exon21/28:c.2158+9T>C:		rs1167807	0.6759	0.6120	22903/10533/3491	0.5960						601767 [HIP1 (confirmed) Prostate cancer,progression of];			COSM3950799	373	510					HIP1 (inh=n/a pLI=1.00)
chr7	75513062	75513062	A	G	hom		QUAL=26003;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,262,1.00,HOM,332,1.00	RHBDD2	synonymous	RHBDD2:NM_001040456.1:synonymous:LOW:exon3/4:c.633A>G:p.Ala211Ala,RHBDD2:NM_001040457.1:synonymous:LOW:exon4/5:c.210A>G:p.Ala70Ala		rs42183	0.9866	0.9680	56605/30549/4852	0.9432	-2.5140	T	T							655	41					RHBDD2 (inh=n/a pLI=0.65)
chr7	75544455	75544455	A	C	hom	low_DP	QUAL=354;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,26,0.38,HET,31,0.19	POR	5'UTR	POR:NM_000941.2:5'UTR:MODIFIER:exon1/16:c.-47A>C:		rs3823884	0.4836	0.0000	0/0/0	0.0580										47	206					POR (inh=n/a pLI=0.00)
chr7	75583325	75583325	A	G	het	anno_pathogenic_clinvar	QUAL=4004;DP=122;AF=0.47;MQM=60;TRIO=HET,122,0.47,HET,248,0.46,WT,323,0.00	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon2/16:c.15A>G:p.Gly5Gly		rs10262966	0.1046	0.0350	315/2/265	0.0326						124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];	RCV000018413.28 [pathogenic]; 			2	40					POR (inh=n/a pLI=0.00)
chr7	75609677	75609677	A	G	het		QUAL=8006;DP=136;AF=0.53;MQM=59;TRIO=HET,136,0.53,HET,207,0.47,HET,295,0.51	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon5/16:c.387A>G:p.Pro129Pro		rs1135612	0.2494	0.2640	4863/2221/20	0.2624	-5.4830	T				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];			COSM453393	78	430					POR (inh=n/a pLI=0.00)
chr7	75614953	75614953	T	C	hom		QUAL=5471;DP=65;AF=1.00;MQM=59;TRIO=HOM,65,1.00,HOM,63,1.00,HOM,58,1.00	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon13/16:c.1455T>C:p.Ala485Ala		rs2228104	0.8353	0.9110	39379/24462/1441	0.8517	-6.5840	T				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];	RCV000127583.2 [benign]; 		COSM4162446, COSM4162445	1027	86					POR (inh=n/a pLI=0.00)
chr7	75615287	75615287	G	A	het		QUAL=6043;DP=200;AF=0.49;MQM=59;TRIO=HET,200,0.49,HET,285,0.55,WT,385,0.01	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon14/16:c.1716G>A:p.Ser572Ser		rs1057870	0.1953	0.2470	2930/2239/46	0.2344	-2.3900	T				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];			COSM3762835, COSM3762836	132	485					POR (inh=n/a pLI=0.00)
chr7	75615875	75615875	G	A	het		QUAL=3664;DP=153;AF=0.50;MQM=60;TRIO=HET,153,0.50,HET,127,0.59,WT,143,0.00	POR	3'UTR	POR:NM_000941.2:3'UTR:MODIFIER:exon16/16:c.*76G>A:		rs55909219	0.0000	0.0000	0/0/0	0.0005										1	6					POR (inh=n/a pLI=0.00)
chr7	82993252	82993252	G	A	het	low_MQM	QUAL=379;DP=20;AF=0.65;MQM=40;TRIO=HET,20,0.65,WT,10,0.00,HOM,9,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3650C>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3650C>T:	AluYb8	rs111864994	0.0747	0.0000	0/0/0	0.0590										2	26					SEMA3E (inh=AD pLI=0.03)
chr7	82993432	82993432	G	A	het	low_MQM	QUAL=3568;DP=185;AF=0.49;MQM=43;TRIO=HET,185,0.49,WT,107,0.00,HET,151,0.50	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3470C>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3470C>T:	AluYb8	rs181922588	0.0096	0.0000	0/0/0	0.0123										0	19					SEMA3E (inh=AD pLI=0.03)
chr7	82993568	82993568	T	C	het		QUAL=13643;DP=383;AF=0.52;MQM=59;TRIO=HET,383,0.52,WT,245,0.00,HOM,266,0.98	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3334A>G:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3334A>G:		rs112935076	0.1008	0.0000	0/0/0	0.0189										4	48					SEMA3E (inh=AD pLI=0.03)
chr7	82994067	82994067	C	G	het		QUAL=12135;DP=344;AF=0.46;MQM=59;TRIO=HET,344,0.46,WT,205,0.00,HOM,242,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*2835G>C:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*2835G>C:		rs73709849	0.1008	0.0000	0/0/0	0.0189										4	48					SEMA3E (inh=AD pLI=0.03)
chr7	82995006	82995006	T	A	het		QUAL=5405;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,HOM,100,1.00,WT,141,0.02	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1896A>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1896A>T:		rs2723017	0.6384	0.0000	0/0/0	0.1401										121	96					SEMA3E (inh=AD pLI=0.03)
chr7	82995443	82995443	A	G	het		QUAL=2714;DP=170;AF=0.41;MQM=60;TRIO=HET,170,0.41,HET,51,0.63,WT,65,0.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1459T>C:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1459T>C:		rs571661220	0.0000	0.0000	0/0/0	0.0023										0	6					SEMA3E (inh=AD pLI=0.03)
chr7	82995774	82995774	A	-	het		QUAL=4635;DP=196;AF=0.53;MQM=60;TRIO=HET,196,0.53,WT,48,0.02,HOM,60,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1128delT:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1128delT:		rs146062755	0.1010	0.0000	0/0/0	0.0925										3	47					SEMA3E (inh=AD pLI=0.03)
chr7	82996706	82996706	A	T	het		QUAL=7934;DP=361;AF=0.53;MQM=60;TRIO=HET,361,0.53,WT,69,0.00,HOM,80,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*196T>A:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*196T>A:		rs3801661	0.0907	0.0000	0/0/0	0.0148										4	48					SEMA3E (inh=AD pLI=0.03)
chr7	82996831	82996831	A	T	het		QUAL=2850;DP=201;AF=0.46;MQM=59;TRIO=HET,201,0.46,HET,38,0.58,WT,38,0.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*71T>A:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*71T>A:		rs75164403	0.1046	0.0000	0/0/0	0.0210										6	80					SEMA3E (inh=AD pLI=0.03)
chr7	83029438	83029438	C	T	het		QUAL=9443;DP=236;AF=0.55;MQM=60;TRIO=HET,236,0.55,HOM,187,0.99,WT,284,0.00	SEMA3E	synonymous	SEMA3E:NM_012431.2:synonymous:LOW:exon11/17:c.1272G>A:p.Leu424Leu,SEMA3E:NM_001178129.1:synonymous:LOW:exon11/17:c.1092G>A:p.Leu364Leu		rs2722974	0.3395	0.4220	11543/6819/84	0.4181						608166 [SEMA3E (provisional) CHARGE syndrome];				207	532					SEMA3E (inh=AD pLI=0.03)
chr7	83037731	83037731	C	G	het		QUAL=8461;DP=230;AF=0.49;MQM=60;TRIO=HET,230,0.49,WT,127,0.00,HOM,181,1.00	SEMA3E	missense	SEMA3E:NM_012431.2:missense:MODERATE:exon6/17:c.623G>C:p.Arg208Pro,SEMA3E:NM_001178129.1:missense:MODERATE:exon6/17:c.443G>C:p.Arg148Pro		rs61729612	0.0976	0.1130	885/621/34	0.1138	1.1470	T	T,T,T,T	B	B	608166 [SEMA3E (provisional) CHARGE syndrome];			COSM4162479	16	229					SEMA3E (inh=AD pLI=0.03)
chr7	83037751	83037751	C	A	het		QUAL=7069;DP=201;AF=0.52;MQM=60;TRIO=HET,201,0.52,HOM,139,1.00,WT,191,0.00	SEMA3E	synonymous	SEMA3E:NM_012431.2:synonymous:LOW:exon6/17:c.603G>T:p.Ala201Ala,SEMA3E:NM_001178129.1:synonymous:LOW:exon6/17:c.423G>T:p.Ala141Ala		rs2722985	0.5563	0.6070	23793/11809/245	0.6004						608166 [SEMA3E (provisional) CHARGE syndrome];			COSM3762861	375	533					SEMA3E (inh=AD pLI=0.03)
chr7	83278198	83278198	G	A	hom	trio_denovo	QUAL=84;DP=107;AF=0.26;MQM=59;TRIO=HOM,107,0.26,WT,30,0.03,WT,111,0.02	SEMA3E	5'UTR_premature_start_codon_gain,5'UTR	SEMA3E:NM_012431.2:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-340C>T:,SEMA3E:NM_012431.2:5'UTR:MODIFIER:exon1/17:c.-340C>T:		rs200070960	0.0000	0.0000	0/0/0	0.0001										0	16					SEMA3E (inh=AD pLI=0.03)
chr7	83278227	83278227	C	A	het		QUAL=3505;DP=238;AF=0.38;MQM=58;TRIO=HET,238,0.38,HOM,52,1.00,WT,158,0.01	SEMA3E	5'UTR	SEMA3E:NM_012431.2:5'UTR:MODIFIER:exon1/17:c.-369G>T:	(A)n	rs302114	0.7534	0.0000	0/0/0	0.2857										111	98					SEMA3E (inh=AD pLI=0.03)
chr7	87079406	87079406	T	A	het		QUAL=5897;DP=254;AF=0.51;MQM=60;TRIO=HET,254,0.51,WT,189,0.00,HET,212,0.48	ABCB4	splice_region&synonymous	ABCB4:NM_018849.2:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:NM_000443.3:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:NM_018850.2:splice_region&synonymous:LOW:exon8/27:c.711A>T:p.Ile237Ile		rs2109505	0.2614	0.2100	2748/1022/514	0.2062						171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3|Cholestasis,intrahepatic,of pregnancy,3|Gallbladder disease 1];		CM031116 [CLASS=DP MUT=ALT PHEN="Intrahepatic cholestasis of pregnancy association" GENE=ABCB4]; 	COSM3982275	45	339					ABCB4 (inh=n/a pLI=0.00)
chr7	87092185	87092185	G	A	het		QUAL=1542;DP=87;AF=0.48;MQM=60;TRIO=HET,87,0.48,WT,38,0.00,HET,48,0.46	ABCB4	synonymous	ABCB4:NM_018849.2:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:NM_000443.3:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:NM_018850.2:synonymous:LOW:exon4/27:c.175C>T:p.Leu59Leu		rs2302387	0.2524	0.1750	2299/650/1032	0.1728						171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3|Cholestasis,intrahepatic,of pregnancy,3|Gallbladder disease 1];				32	289					ABCB4 (inh=n/a pLI=0.00)
chr7	92129162	92129162	A	-	hom		QUAL=10069;DP=167;AF=0.89;MQM=60;TRIO=HOM,167,0.89,HOM,115,0.84,HOM,158,0.86	PEX1	splice_region&intron	PEX1:NM_000466.2:splice_region&intron:LOW:exon15/23:c.2584-10delT:,PEX1:NM_001282677.1:splice_region&intron:LOW:exon14/22:c.2413-10delT:,PEX1:NM_001282678.1:splice_region&intron:LOW:exon15/23:c.1960-10delT:		rs5885806;rs796789699	0.0000	0.6410	14857/9143/874	0.5697						602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B (NALD/IRD)];				514	449	2	[2] Ute Grasshoff 09.04.2015			PEX1 (inh=AR pLI=0.00)
chr7	92131289	92131289	G	T	hom		QUAL=23261;DP=421;AF=1.00;MQM=60;TRIO=HOM,421,1.00,HOM,113,1.00,HOM,201,1.00	PEX1	synonymous	PEX1:NM_000466.2:synonymous:LOW:exon14/24:c.2331C>A:p.Gly777Gly,PEX1:NM_001282677.1:synonymous:LOW:exon13/23:c.2160C>A:p.Gly720Gly,PEX1:NM_001282678.1:synonymous:LOW:exon14/24:c.1707C>A:p.Gly569Gly		rs10278857	0.9499	0.9220	51668/27598/4958	0.8698						602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B (NALD/IRD)];	RCV000078920.7 [other]; 			951	145					PEX1 (inh=AR pLI=0.00)
chr7	94039032	94039032	C	T	het		QUAL=13081;DP=336;AF=0.56;MQM=60;TRIO=HET,336,0.56,HET,299,0.46,HET,351,0.50	COL1A2	splice_region&intron	COL1A2:NM_000089.3:splice_region&intron:LOW:exon18/51:c.937-3C>T:		rs42519	0.8243	0.7740	36721/19160/4223	0.7588						120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];		CS151749 [CLASS=R MUT=ALT PHEN="Osteogenesis imperfecta" GENE=COL1A2]; 		598	410	2	[2] Ute Grasshoff 24.11.2015			COL1A2 (inh=n/a pLI=1.00)
chr7	94041937	94041937	A	C	het		QUAL=8906;DP=239;AF=0.51;MQM=59;TRIO=HET,239,0.51,HET,183,0.49,HET,234,0.57	COL1A2	synonymous	COL1A2:NM_000089.3:synonymous:LOW:exon25/52:c.1446A>C:p.Pro482Pro		rs412777	0.3273	0.3440	7333/4586/646	0.3424						120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];			COSM1452968	154	492					COL1A2 (inh=n/a pLI=1.00)
chr7	94043239	94043239	C	G	het		QUAL=19066;DP=626;AF=0.47;MQM=60;TRIO=HET,626,0.47,HET,394,0.49,HET,499,0.49	COL1A2	missense	COL1A2:NM_000089.3:missense:MODERATE:exon28/52:c.1645C>G:p.Pro549Ala		rs42524	0.8217	0.7690	36256/18737/4121	0.7519	1.2480	T	T,T	B	B	120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];		CM040403 [CLASS=DP MUT=REF PHEN="Intracranial aneurysm susceptibility association with" GENE=COL1A2]; 	COSM3762900	590	414					COL1A2 (inh=n/a pLI=1.00)
chr7	99699169	99699169	A	T	het		QUAL=438;DP=20;AF=0.45;MQM=60;TRIO=HET,20,0.45,WT,26,0.04,HET,30,0.53	MCM7,AP4M1	5'UTR	MCM7:NM_005916.4:5'UTR:MODIFIER:exon1/15:c.-252T>A:,AP4M1:NM_004722.3:5'UTR:MODIFIER:exon1/15:c.-169A>T:,MCM7:NM_001278595.1:5'UTR:MODIFIER:exon1/14:c.-855T>A:		rs1534310	0.2772	0.0000	0/0/0	0.0453										11	54					MCM7 (inh=n/a pLI=0.00), AP4M1 (inh=n/a pLI=0.00)
chr7	99704796	99704796	A	T	hom		QUAL=6416;DP=128;AF=1.00;MQM=59;TRIO=HOM,128,1.00,HOM,48,0.98,HOM,54,1.00	AP4M1,TAF6	3'UTR,non_coding_exon	AP4M1:NM_004722.3:3'UTR:MODIFIER:exon15/15:c.*291A>T:,TAF6:NM_001190415.1:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:NM_005641.3:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:NM_139315.2:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:NR_033792.1:non_coding_exon:MODIFIER:exon15/15:n.2210T>A:		rs13309	0.6352	0.0000	0/0/0	0.1226										71	125					AP4M1 (inh=n/a pLI=0.00), TAF6 (inh=n/a pLI=0.00)
chr7	103112862	103112862	C	T	hom		QUAL=19845;DP=379;AF=1.00;MQM=60;TRIO=HOM,379,1.00,HOM,87,1.00,HOM,118,1.00	RELN,LOC101927870	3'UTR,intron	RELN:NM_005045.3:3'UTR:MODIFIER:exon65/65:c.*397G>A:,RELN:NM_173054.2:3'UTR:MODIFIER:exon64/64:c.*397G>A:,LOC101927870:NR_110141.1:intron:MODIFIER:exon2/3:n.1365+25747C>T:		rs7811262	0.9984	0.0000	0/0/0	0.1566										230	0					RELN (inh=AR+AD pLI=1.00), LOC101927870 (inh=n/a pLI=n/a)
chr7	103138517	103138517	C	G	hom		QUAL=23510;DP=207;AF=1.00;MQM=59;TRIO=HOM,207,1.00,HOM,217,1.00,HOM,300,1.00	RELN,LOC101927870	splice_region&intron,intron	RELN:NM_005045.3:splice_region&intron:LOW:exon54/64:c.8843+7G>C:,RELN:NM_173054.2:splice_region&intron:LOW:exon54/63:c.8843+7G>C:,LOC101927870:NR_110141.1:intron:MODIFIER:exon2/3:n.1366-6334C>G:		rs2711885	0.9956	0.9870	59119/32274/5179	0.9650						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];	RCV000081246.7 [other]; 			2193	56					RELN (inh=AR+AD pLI=1.00), LOC101927870 (inh=n/a pLI=n/a)
chr7	103155705	103155705	A	G	het		QUAL=3825;DP=132;AF=0.49;MQM=59;TRIO=HET,132,0.49,HOM,78,0.97,WT,64,0.00	RELN	synonymous	RELN:NM_005045.3:synonymous:LOW:exon50/65:c.8046T>C:p.His2682His,RELN:NM_173054.2:synonymous:LOW:exon50/64:c.8046T>C:p.His2682His		rs2229864	0.6484	0.4710	15217/4311/3118	0.4642						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];	RCV000081242.7 [other]; 			386	1060					RELN (inh=AR+AD pLI=1.00)
chr7	103155864	103155864	A	G	het		QUAL=1904;DP=78;AF=0.33;MQM=59;TRIO=HET,78,0.33,HOM,50,0.96,WT,42,0.00	RELN	synonymous	RELN:NM_005045.3:synonymous:LOW:exon50/65:c.7887T>C:p.Pro2629Pro,RELN:NM_173054.2:synonymous:LOW:exon50/64:c.7887T>C:p.Pro2629Pro		rs56345626	0.1749	0.1810	2079/1124/72	0.1797						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];	RCV000118171.2 [likely benign]; 		COSM3762300	94	704					RELN (inh=AR+AD pLI=1.00)
chr7	103202406	103202406	C	A	hom		QUAL=3463;DP=90;AF=0.02;MQM=57;TRIO=HOM,90,0.02,HOM,24,0.13,HOM,28,0.07	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon34/64:c.5211-6G>T:,RELN:NM_173054.2:splice_region&intron:LOW:exon34/63:c.5211-6G>T:			0.0000	0.0000	0/0/0	0.0001						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];			COSM1622159	1	36					RELN (inh=AR+AD pLI=1.00)
chr7	103206001	103206001	-	A	het		QUAL=4072;DP=147;AF=0.75;MQM=59;TRIO=HET,147,0.75,HET,123,0.44,HET,148,0.41	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon33/64:c.4937-4dupT:,RELN:NM_173054.2:splice_region&intron:LOW:exon33/63:c.4937-4dupT:		rs35268159;rs397763920	0.2508	0.2480	367/232/42	0.2239						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];	RCV000177788.1 [benign]; 			38	969					RELN (inh=AR+AD pLI=1.00)
chr7	103389954	103389954	A	G	het		QUAL=8034;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,WT,215,0.00,HET,288,0.50	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon5/64:c.578-3T>C:,RELN:NM_173054.2:splice_region&intron:LOW:exon5/63:c.578-3T>C:		rs607755	0.4655	0.4960	15270/9719/1029	0.4925						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)|Epilepsy,familial temporal lobe,7];	RCV000081236.7 [other]; 			637	1096					RELN (inh=AR+AD pLI=1.00)
chr7	107545799	107545799	T	C	het		QUAL=10834;DP=245;AF=0.53;MQM=60;TRIO=HET,245,0.53,HET,118,0.53,HOM,178,0.99	DLD	splice_region&intron,intron	DLD:NM_000108.4:splice_region&intron:LOW:exon6/13:c.439-7T>C:,DLD:NM_001289750.1:splice_region&intron:LOW:exon4/11:c.142-7T>C:,DLD:NM_001289751.1:splice_region&intron:LOW:exon5/12:c.370-7T>C:,DLD:NM_001289752.1:intron:MODIFIER:exon6/12:c.438+296T>C:		rs10263341	0.7161	0.6160	23373/11110/3206	0.6106						238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency];	RCV000179713.2 [benign]; 			459	455					DLD (inh=n/a pLI=0.37)
chr7	107559502	107559502	A	C	het		QUAL=8505;DP=361;AF=0.50;MQM=59;TRIO=HET,361,0.50,WT,202,0.00,HET,292,0.48	DLD	synonymous	DLD:NM_000108.4:synonymous:LOW:exon13/14:c.1422A>C:p.Gly474Gly,DLD:NM_001289750.1:synonymous:LOW:exon11/12:c.1125A>C:p.Gly375Gly,DLD:NM_001289751.1:synonymous:LOW:exon12/13:c.1353A>C:p.Gly451Gly,DLD:NM_001289752.1:synonymous:LOW:exon12/13:c.1278A>C:p.Gly426Gly		rs34453495	0.0048	0.0088	7/4/0	0.0087						238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency];	RCV000124696.2 [benign]; 			0	24					DLD (inh=n/a pLI=0.37)
chr7	107559722	107559722	A	T	het		QUAL=3693;DP=197;AF=0.50;MQM=60;TRIO=HET,197,0.50,HET,15,0.33,HET,46,0.67	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*18A>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*18A>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*18A>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*18A>T:		rs8721	0.2758	0.3560	7987/5250/71	0.3353							RCV000124697.2 [benign]; 			98	213					DLD (inh=n/a pLI=0.37)
chr7	107559911	107559911	G	A	het		QUAL=7556;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,HET,55,0.62,HOM,94,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*207G>A:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*207G>A:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*207G>A:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*207G>A:		rs4564	0.7107	0.0000	0/0/0	0.1101										102	95					DLD (inh=n/a pLI=0.37)
chr7	107560191	107560191	C	T	het		QUAL=12956;DP=255;AF=0.53;MQM=60;TRIO=HET,255,0.53,HET,159,0.41,HOM,223,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*487C>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*487C>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*487C>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*487C>T:		rs4518	0.7145	0.0000	0/0/0	0.1116										104	96					DLD (inh=n/a pLI=0.37)
chr7	107560651	107560651	G	T	het		QUAL=10513;DP=345;AF=0.45;MQM=60;TRIO=HET,345,0.45,HET,219,0.49,HET,306,0.45	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*947G>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*947G>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*947G>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*947G>T:		rs7777259	0.2724	0.0000	0/0/0	0.3618										49	108					DLD (inh=n/a pLI=0.37)
chr7	107560682	107560682	T	C	het		QUAL=19296;DP=478;AF=0.47;MQM=59;TRIO=HET,478,0.47,HET,263,0.42,HOM,325,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*978T>C:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*978T>C:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*978T>C:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*978T>C:		rs2158835	0.7147	0.0000	0/0/0	0.6488										103	94					DLD (inh=n/a pLI=0.37)
chr7	107561155	107561155	T	C	het		QUAL=13231;DP=364;AF=0.49;MQM=60;TRIO=HET,364,0.49,HET,140,0.54,HOM,201,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*1451T>C:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*1451T>C:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*1451T>C:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*1451T>C:	L1MEb	rs2108223	0.7153	0.0000	0/0/0	0.6519										101	72					DLD (inh=n/a pLI=0.37)
chr7	107561392	107561392	G	A	het		QUAL=12412;DP=443;AF=0.47;MQM=60;TRIO=HET,443,0.47,HET,169,0.56,HET,269,0.55	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*1688G>A:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*1688G>A:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*1688G>A:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*1688G>A:	L1MEb	rs8440	0.2722	0.0000	0/0/0	0.3616										49	107					DLD (inh=n/a pLI=0.37)
chr7	112092211	112092211	T	-	hom		QUAL=15061;DP=306;AF=0.82;MQM=59;TRIO=HOM,306,0.82,HET,225,0.49,HOM,307,0.82	IFRD1	5'UTR,intron	IFRD1:NM_001197079.1:5'UTR:MODIFIER:exon1/12:c.-400delT:,IFRD1:NM_001007245.2:intron:MODIFIER:exon2/12:c.94+1386delT:,IFRD1:NM_001197080.1:intron:MODIFIER:exon1/11:c.-56-3595delT:,IFRD1:NM_001550.3:intron:MODIFIER:exon1/11:c.94+1386delT:,IFRD1:NR_120333.1:intron:MODIFIER:exon1/11:n.275+1386delT:	AluJr	rs796411555	0.8345	0.0000	0/0/0	0.5266										13	127					IFRD1 (inh=n/a pLI=0.11)
chr7	112092347	112092347	C	T	het		QUAL=6059;DP=249;AF=0.51;MQM=60;TRIO=HET,249,0.51,WT,199,0.00,HET,231,0.47	IFRD1	5'UTR,intron	IFRD1:NM_001197079.1:5'UTR:MODIFIER:exon1/12:c.-276C>T:,IFRD1:NM_001007245.2:intron:MODIFIER:exon2/12:c.94+1510C>T:,IFRD1:NM_001197080.1:intron:MODIFIER:exon1/11:c.-56-3471C>T:,IFRD1:NM_001550.3:intron:MODIFIER:exon1/11:c.94+1510C>T:,IFRD1:NR_120333.1:intron:MODIFIER:exon1/11:n.275+1510C>T:	AluJr	rs4727771	0.2087	0.0000	0/0/0	0.1507										4	27					IFRD1 (inh=n/a pLI=0.11)
chr7	112112892	112112892	G	A	het		QUAL=6121;DP=253;AF=0.50;MQM=60;TRIO=HET,253,0.50,HET,225,0.47,WT,306,0.00	IFRD1	synonymous,non_coding_exon	IFRD1:NM_001007245.2:synonymous:LOW:exon12/13:c.1242G>A:p.Thr414Thr,IFRD1:NM_001197080.1:synonymous:LOW:exon11/12:c.1092G>A:p.Thr364Thr,IFRD1:NM_001550.3:synonymous:LOW:exon11/12:c.1242G>A:p.Thr414Thr,IFRD1:NM_001197079.1:synonymous:LOW:exon11/12:c.1092G>A:p.Thr364Thr,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon10/12:n.1265G>A:		rs11542468	0.0453	0.0650	345/210/9	0.0647									COSM3762331	2	169					IFRD1 (inh=n/a pLI=0.11)
chr7	112115658	112115658	C	T	het		QUAL=3823;DP=236;AF=0.47;MQM=60;TRIO=HET,236,0.47,WT,69,0.00,HET,65,0.49	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*84C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.1557C>T:		rs7817	0.3930	0.0000	0/0/0	0.0867								CR092300 [CLASS=DFP MUT=ALT PHEN="Severity in cystic fibrosis association with" GENE=IFRD1]; 		49	121					IFRD1 (inh=n/a pLI=0.11)
chr7	112116198	112116198	G	A	het		QUAL=16936;DP=410;AF=0.57;MQM=60;TRIO=HET,410,0.57,HOM,311,1.00,WT,435,0.00	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*624G>A:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*624G>A:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*624G>A:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*624G>A:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.2097G>A:		rs7467	0.2851	0.0000	0/0/0	0.0569										21	98					IFRD1 (inh=n/a pLI=0.11)
chr7	112116537	112116537	A	C	het		QUAL=7686;DP=318;AF=0.47;MQM=59;TRIO=HET,318,0.47,WT,307,0.00,HET,413,0.44	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*963A>C:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*963A>C:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*963A>C:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*963A>C:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.2436A>C:	AluJo	rs2190587	0.3990	0.0000	0/0/0	0.4249										31	74					IFRD1 (inh=n/a pLI=0.11)
chr7	112116659	112116659	T	C	hom		QUAL=25247;DP=369;AF=0.99;MQM=59;TRIO=HOM,369,0.99,HOM,263,1.00,HET,429,0.48	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1085T>C:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1085T>C:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1085T>C:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1085T>C:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.2558T>C:	AluJo	rs2190588	0.7049	0.0000	0/0/0	0.7068										88	55					IFRD1 (inh=n/a pLI=0.11)
chr7	112116685	112116685	C	T	het		QUAL=8613;DP=360;AF=0.46;MQM=59;TRIO=HET,360,0.46,WT,239,0.00,HET,382,0.47	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1111C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1111C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1111C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1111C>T:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.2584C>T:	AluJo	rs12532656	0.1034	0.0000	0/0/0	0.0755										1	18					IFRD1 (inh=n/a pLI=0.11)
chr7	112116980	112116980	C	T	het		QUAL=6888;DP=305;AF=0.48;MQM=60;TRIO=HET,305,0.48,WT,175,0.00,HET,248,0.48	IFRD1	3'UTR,non_coding_exon	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1406C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1406C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1406C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1406C>T:,IFRD1:NR_120333.1:non_coding_exon:MODIFIER:exon12/12:n.2879C>T:		rs1054043	0.3994	0.0000	0/0/0	0.4321										31	74					IFRD1 (inh=n/a pLI=0.11)
chr7	114330185	114330186	TT	-	hom		QUAL=326;DP=67;AF=0.48;MQM=59;TRIO=HOM,67,0.48,HOM,16,0.38,HOM,23,0.57	FOXP2	3'UTR,non_coding_exon	FOXP2:NM_148898.3:3'UTR:MODIFIER:exon18/18:c.*219_*220delTT:,FOXP2:NM_001172766.2:3'UTR:MODIFIER:exon17/17:c.*219_*220delTT:,FOXP2:NM_014491.3:3'UTR:MODIFIER:exon17/17:c.*219_*220delTT:,FOXP2:NM_148900.3:3'UTR:MODIFIER:exon18/18:c.*219_*220delTT:,FOXP2:NR_033766.1:non_coding_exon:MODIFIER:exon20/20:n.2752_2753delTT:,FOXP2:NR_033767.1:non_coding_exon:MODIFIER:exon18/18:n.2799_2800delTT:	(T)n	rs58777789;rs796306184	0.0000	0.1270	27/18/0	0.0508										73	175					FOXP2 (inh=AD pLI=1.00)
chr7	114331999	114331999	A	-	het		QUAL=1920;DP=253;AF=0.27;MQM=58;TRIO=HET,253,0.27,HET,68,0.38,HET,121,0.27	FOXP2	3'UTR,non_coding_exon	FOXP2:NM_148898.3:3'UTR:MODIFIER:exon18/18:c.*2030delA:,FOXP2:NM_001172766.2:3'UTR:MODIFIER:exon17/17:c.*2030delA:,FOXP2:NM_014491.3:3'UTR:MODIFIER:exon17/17:c.*2030delA:,FOXP2:NM_148900.3:3'UTR:MODIFIER:exon18/18:c.*2030delA:,FOXP2:NR_033766.1:non_coding_exon:MODIFIER:exon20/20:n.4563delA:,FOXP2:NR_033767.1:non_coding_exon:MODIFIER:exon18/18:n.4610delA:	(A)n	rs58804519;rs796214969	0.2430	0.3170	90/62/2	0.0149										0	174					FOXP2 (inh=AD pLI=1.00)
chr7	114332246	114332246	G	T	het		QUAL=11061;DP=435;AF=0.51;MQM=60;TRIO=HET,435,0.51,HET,189,0.48,HET,194,0.52	FOXP2	3'UTR,non_coding_exon	FOXP2:NM_148898.3:3'UTR:MODIFIER:exon18/18:c.*2265G>T:,FOXP2:NM_001172766.2:3'UTR:MODIFIER:exon17/17:c.*2265G>T:,FOXP2:NM_014491.3:3'UTR:MODIFIER:exon17/17:c.*2265G>T:,FOXP2:NM_148900.3:3'UTR:MODIFIER:exon18/18:c.*2265G>T:,FOXP2:NR_033766.1:non_coding_exon:MODIFIER:exon20/20:n.4798G>T:,FOXP2:NR_033767.1:non_coding_exon:MODIFIER:exon18/18:n.4845G>T:		rs12705977	0.2230	0.2890	589/160/3	0.0847										85	268					FOXP2 (inh=AD pLI=1.00)
chr7	117188736	117188736	C	A	het	low_MQM	QUAL=818;DP=176;AF=0.32;MQM=32;TRIO=HET,176,0.32,HET,95,0.16,WT,146,0.07	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon10/27:c.1251C>A:p.Asn417Lys	(AAAAC)n	rs4727853	0.0000	0.0190	0/0/0	0.0023	-0.0310	T	T,T	B	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000173697.1 [benign]; 		COSM4161731	0	493					CFTR (inh=n/a pLI=0.00)
chr7	117188750	117188750	C	T	het	low_MQM;phylop_high;pred_pathogenic_1	QUAL=255;DP=192;AF=0.20;MQM=33;TRIO=HET,192,0.20,WT,113,0.10,WT,154,0.05	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon10/27:c.1265C>T:p.Ser422Phe		rs201880593	0.0000	0.0032	0/0/0	0.0001	3.1910	D	T,T	P	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];			COSM1284105	0	141					CFTR (inh=n/a pLI=0.00)
chr7	117188797	117188797	A	G	het	low_MQM	QUAL=516;DP=260;AF=0.20;MQM=34;TRIO=HET,260,0.20,WT,138,0.08,WT,187,0.04	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon10/27:c.1312A>G:p.Thr438Ala		rs201434579	0.0000	0.0025	0/0/0	0.0002	0.1610	T	T,T	B	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000173699.1 [uncertain significance]; 		COSM3734028	0	151					CFTR (inh=n/a pLI=0.00)
chr7	117188850	117188850	G	T	het	low_MQM	QUAL=580;DP=391;AF=0.21;MQM=34;TRIO=HET,391,0.21,WT,159,0.06,WT,203,0.03	CFTR	synonymous	CFTR:NM_000492.3:synonymous:LOW:exon10/27:c.1365G>T:p.Ala455Ala		rs79074685	0.0000	0.0007	0/0/0	0.0019						602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000029473.1 [likely benign]; RCV000173698.1 [uncertain significance]; 		COSM3774275	0	193					CFTR (inh=n/a pLI=0.00)
chr7	117199533	117199533	G	A	het	phylop_high	QUAL=8169;DP=227;AF=0.50;MQM=60;TRIO=HET,227,0.50,HOM,105,1.00,HET,157,0.55	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon11/27:c.1408G>A:p.Val470Met		rs213950	0.5821	0.4830	15242/5854/3908	0.4711	2.6080	T	T,T,T	B	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000152994.2 [benign]; RCV000007550.2 [benign]; RCV000036517.9 [other]; 	CM034388 [CLASS=DFP MUT=REF PHEN="Respiratory/pancreatic disease association with" GENE=CFTR]; 	COSM3762337	164	549					CFTR (inh=n/a pLI=0.00)
chr7	121714653	121714653	C	T	het		QUAL=5006;DP=159;AF=0.49;MQM=60;TRIO=HET,159,0.49,WT,88,0.00,HOM,85,1.00	AASS	3'UTR	AASS:NM_005763.3:3'UTR:MODIFIER:exon24/24:c.*1890G>A:	L1MB8	rs12217	0.6697	0.0000	0/0/0	0.5708										58	66					AASS (inh=AR pLI=0.00)
chr7	121715965	121715965	C	T	het		QUAL=4067;DP=148;AF=0.51;MQM=60;TRIO=HET,148,0.51,WT,46,0.00,HOM,65,1.00	AASS	3'UTR	AASS:NM_005763.3:3'UTR:MODIFIER:exon24/24:c.*578G>A:		rs1206380	0.6673	0.0000	0/0/0	0.5626										75	100					AASS (inh=AR pLI=0.00)
chr7	121738926	121738926	T	A	hom	low_DP;low_MQM	QUAL=45;DP=18;AF=0.50;MQM=48;TRIO=HOM,18,0.50,WT,4,0.00,HOM,3,0.33	AASS	splice_region&intron	AASS:NM_005763.3:splice_region&intron:LOW:exon13/23:c.1407-6A>T:			0.0000	0.0000	0/0/0	0.0001						605113 [AASS (provisional) Hyperlysinemia|Saccharopinuria];				0	7	2	[2] Stefanie Beck-Woedl 07.10.2015		n/a (in GS150233_01 vermutl. Artefakt, swal 150921)	AASS (inh=AR pLI=0.00)
chr7	127950724	127950724	C	T	het		QUAL=9569;DP=364;AF=0.47;MQM=59;TRIO=HET,364,0.47,WT,330,0.00,HET,443,0.47	RBM28	3'UTR	RBM28:NM_018077.2:3'UTR:MODIFIER:exon19/19:c.*126G>A:,RBM28:NM_001166135.1:3'UTR:MODIFIER:exon15/15:c.*126G>A:		rs141043380	0.0126	0.0000	0/0/0	0.0072										1	22					RBM28 (inh=AR pLI=0.00)
chr7	127950725	127950725	G	A	het		QUAL=21590;DP=364;AF=0.51;MQM=60;TRIO=HET,364,0.51,HOM,330,1.00,HET,447,0.53	RBM28	3'UTR	RBM28:NM_018077.2:3'UTR:MODIFIER:exon19/19:c.*125C>T:,RBM28:NM_001166135.1:3'UTR:MODIFIER:exon15/15:c.*125C>T:		rs12850	0.3399	0.0000	0/0/0	0.0839										33	104					RBM28 (inh=AR pLI=0.00)
chr7	128470482	128470482	G	A	hom	low_DP	QUAL=1058;DP=2;AF=1.00;MQM=59;TRIO=HOM,2,1.00,HOM,18,1.00,HOM,26,1.00	CCDC136-FLNC	intergenic_region	CCDC136-FLNC:CCDC136-FLNC:intergenic_region:MODIFIER::n.128470482G>A:	(CCCGG)n	rs2639138	1.0000	0.0000	0/0/0	0.7584										197	1					CCDC136-FLNC (inh=n/a pLI=n/a)
chr7	128487866	128487866	T	C	hom		QUAL=6140;DP=49;AF=1.00;MQM=60;TRIO=HOM,49,1.00,HOM,69,1.00,HOM,81,1.00	FLNC	synonymous	FLNC:NM_001458.4:synonymous:LOW:exon25/48:c.4404T>C:p.Asp1468Asp,FLNC:NM_001127487.1:synonymous:LOW:exon25/47:c.4404T>C:p.Asp1468Asp		rs2249128	0.9906	0.9970	59996/33309/4599	0.9298						102565 [FLNC (confirmed) Myopathy,myofibrillar,5|Myopathy,distal,4];	RCV000221141.1 [benign]; 			1107	0					FLNC (inh=n/a pLI=1.00)
chr7	128489228	128489228	T	C	het		QUAL=3312;DP=165;AF=0.50;MQM=59;TRIO=HET,165,0.50,WT,92,0.01,HET,138,0.48	FLNC	splice_region&intron	FLNC:NM_001458.4:splice_region&intron:LOW:exon28/47:c.4928-7T>C:,FLNC:NM_001127487.1:splice_region&intron:LOW:exon28/46:c.4928-7T>C:		rs201957008	0.0040	0.0046	3/2/0	0.0044						102565 [FLNC (confirmed) Myopathy,myofibrillar,5|Myopathy,distal,4];	RCV000176925.1 [benign]; 			0	9					FLNC (inh=n/a pLI=1.00)
chr7	139784641	139784641	A	G	hom		QUAL=1483;DP=38;AF=1.00;MQM=60;TRIO=HOM,38,1.00,HOM,5,1.00,HOM,7,1.00	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*6253T>C:		rs12703525	0.9960	0.0000	0/0/0	0.1804										225	3					KDM7A (inh=n/a pLI=1.00)
chr7	139785024	139785024	C	A	het		QUAL=8610;DP=313;AF=0.51;MQM=60;TRIO=HET,313,0.51,HET,180,0.49,HET,246,0.51	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*5870G>T:		rs10984	0.3596	0.0000	0/0/0	0.2366										57	95					KDM7A (inh=n/a pLI=1.00)
chr7	139785028	139785030	AAG	-	het		QUAL=8610;DP=313;AF=0.51;MQM=59;TRIO=HET,313,0.51,WT,180,0.49,HET,246,0.51	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*5864_*5866delCTT:		rs371560827	0.1991	0.0000	0/0/0	0.1692										17	64					KDM7A (inh=n/a pLI=1.00)
chr7	139786186	139786186	G	A	het		QUAL=3119;DP=166;AF=0.51;MQM=60;TRIO=HET,166,0.51,HET,26,0.42,HET,53,0.40	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*4708C>T:		rs11972958	0.3712	0.0000	0/0/0	0.0650										57	95					KDM7A (inh=n/a pLI=1.00)
chr7	139787189	139787189	G	A	het		QUAL=9686;DP=529;AF=0.46;MQM=60;TRIO=HET,529,0.46,WT,191,0.02,HET,225,0.50	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*3705C>T:		rs1476619	0.1687	0.0000	0/0/0	0.0390										32	81					KDM7A (inh=n/a pLI=1.00)
chr7	139787853	139787853	A	-	het		QUAL=8099;DP=260;AF=0.52;MQM=59;TRIO=HET,260,0.52,HET,163,0.52,HET,178,0.51	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*3041delT:		rs398006590	0.3598	0.0000	0/0/0	0.3615										56	95					KDM7A (inh=n/a pLI=1.00)
chr7	139797431	139797431	G	T	het	phylop_high	QUAL=5884;DP=294;AF=0.50;MQM=60;TRIO=HET,294,0.50,WT,172,0.00,HET,192,0.44	KDM7A	missense	KDM7A:NM_030647.1:missense:MODERATE:exon15/20:c.1930C>A:p.Arg644Ser		rs6950119	0.3275	0.3200	6322/3998/730	0.3114	2.4720	T	T,T	B	B				COSM321080	114	295					KDM7A (inh=n/a pLI=1.00)
chr7	139801777	139801777	T	G	het		QUAL=6373;DP=194;AF=0.52;MQM=60;TRIO=HET,194,0.52,WT,222,0.00,HET,299,0.48	KDM7A	synonymous	KDM7A:NM_030647.1:synonymous:LOW:exon12/20:c.1612A>C:p.Arg538Arg		rs1062277	0.3335	0.3220	6492/4085/766	0.3184									COSM3762429	114	294					KDM7A (inh=n/a pLI=1.00)
chr7	143016928	143016928	C	T	het		QUAL=6089;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,HET,247,0.47,WT,324,0.00	CLCN1	synonymous,non_coding_exon	CLCN1:NM_000083.2:synonymous:LOW:exon2/23:c.261C>T:p.Thr87Thr,CLCN1:NR_046453.1:non_coding_exon:MODIFIER:exon2/22:n.348C>T:		rs6962852	0.3229	0.2970	6310/3421/1707	0.2929						118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM3762451	168	495					CLCN1 (inh=n/a pLI=0.00)
chr7	143017807	143017807	G	T	hom	phylop_high;anno_pathogenic_hgmd	QUAL=23061;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,180,1.00,HOM,307,1.00	CLCN1	missense,non_coding_exon	CLCN1:NM_000083.2:missense:MODERATE:exon3/23:c.352G>T:p.Gly118Trp,CLCN1:NR_046453.1:non_coding_exon:MODIFIER:exon3/22:n.439G>T:		rs10282312	0.9936	0.9860	59039/31948/5160	0.9617	5.9710	T	T	B	B	118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];		CM127929 [CLASS=DM? MUT=REF PHEN="Myotonia" GENE=CLCN1]; 		1080	25	2	[2] old entry - no details available			CLCN1 (inh=n/a pLI=0.00)
chr7	143036337	143036337	C	T	het		QUAL=7301;DP=328;AF=0.41;MQM=60;TRIO=HET,328,0.41,HET,130,0.52,HET,195,0.47	CLCN1	splice_region&intron	CLCN1:NM_000083.2:splice_region&intron:LOW:exon12/22:c.1402-9C>T:,CLCN1:NR_046453.1:splice_region&intron:LOW:exon11/21:n.1342-9C>T:		rs2272252	0.4143	0.4110	10743/6061/1715	0.3951						118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM4004350	215	523					CLCN1 (inh=n/a pLI=0.00)
chr7	143043240	143043240	C	T	het		QUAL=9069;DP=121;AF=0.47;MQM=60;TRIO=HET,121,0.47,HET,271,0.47,HET,367,0.47	CLCN1	missense,non_coding_exon	CLCN1:NM_000083.2:missense:MODERATE:exon18/23:c.2180C>T:p.Pro727Leu,CLCN1:NR_046453.1:non_coding_exon:MODIFIER:exon17/22:n.2120C>T:		rs13438232	0.3694	0.3970	9877/6021/928	0.3881	0.8500	T	T	P	B	118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM3737851	213	527					CLCN1 (inh=n/a pLI=0.00)
chr7	145813854	145813854	G	A	hom		QUAL=1103;DP=25;AF=1.00;MQM=60;TRIO=HOM,25,1.00,HET,16,0.38,HET,24,0.58	CNTNAP2	5'UTR	CNTNAP2:NM_014141.5:5'UTR:MODIFIER:exon1/24:c.-115G>A:		rs2462603	0.5120	0.0000	0/0/0	0.5126										73	106					CNTNAP2 (inh=AR pLI=0.00)
chr7	145814006	145814006	T	A	het	low_QUAL;low_DP;phylop_high;pred_pathogenic_1	QUAL=21;DP=7;AF=0.43;MQM=50;TRIO=HET,7,0.43,WT,2,0.00,WT,1,0.00	CNTNAP2	missense	CNTNAP2:NM_014141.5:missense:MODERATE:exon1/24:c.38T>A:p.Leu13His			0.0000	0.0000	0/0/0	0.0000	4.1240	T	D	P	B	604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];				0	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	145814017	145814017	A	C	het	low_QUAL;low_DP	QUAL=21;DP=8;AF=0.50;MQM=50;TRIO=HET,8,0.50,WT,2,0.00,WT,1,0.00	CNTNAP2	missense	CNTNAP2:NM_014141.5:missense:MODERATE:exon1/24:c.49A>C:p.Ile17Leu			0.0000	0.0000	0/0/0	0.0000	0.7260	T	T	B	B	604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];				0	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	147092861	147092861	G	A	het		QUAL=5843;DP=188;AF=0.53;MQM=59;TRIO=HET,188,0.53,HET,253,0.50,WT,311,0.00	CNTNAP2,MIR548I4	synonymous,intron	CNTNAP2:NM_014141.5:synonymous:LOW:exon10/24:c.1659G>A:p.Ala553Ala,MIR548I4:NR_031690.1:intron:MODIFIER:exon2/2:n.40+5971C>T:		rs34592169	0.0937	0.1870	2610/1938/14	0.1845						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081587.7 [other]; 		COSM3762462	35	336					CNTNAP2 (inh=AR pLI=0.00), MIR548I4 (inh=n/a pLI=n/a)
chr7	148106477	148106477	C	G	het		QUAL=12290;DP=248;AF=0.50;MQM=59;TRIO=HET,248,0.50,HOM,192,0.99,HET,239,0.47	CNTNAP2	splice_region&intron	CNTNAP2:NM_014141.5:splice_region&intron:LOW:exon22/23:c.3716-6C>G:		rs77025884	0.0000	0.0062	10/7/0	0.0163						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081603.6 [benign]; 		COSM3785030	338	508					CNTNAP2 (inh=AR pLI=0.00)
chr7	148106490	148106490	G	A	het		QUAL=13121;DP=267;AF=0.47;MQM=59;TRIO=HET,267,0.47,HOM,211,1.00,HET,267,0.46	CNTNAP2	synonymous	CNTNAP2:NM_014141.5:synonymous:LOW:exon23/24:c.3723G>A:p.Ala1241Ala		rs9648691	0.5491	0.5360	18239/10331/2268	0.5019						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081604.7 [other]; 		COSM3762466	339	509					CNTNAP2 (inh=AR pLI=0.00)
chr7	148112872	148112872	-	A	hom		QUAL=3834;DP=154;AF=0.76;MQM=59;TRIO=HOM,154,0.76,HET,42,0.31,HOM,56,0.86	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*175dupA:		rs397763623;rs61125105	0.5226	0.0000	0/0/0	0.3827										16	169					CNTNAP2 (inh=AR pLI=0.00)
chr7	148112987	148112987	C	A	het		QUAL=5955;DP=232;AF=0.52;MQM=60;TRIO=HET,232,0.52,HET,86,0.53,HET,128,0.48	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*279C>A:		rs987456	0.6607	0.0000	0/0/0	0.1308										151	72					CNTNAP2 (inh=AR pLI=0.00)
chr7	148113624	148113628	TAGTT	-	hom		QUAL=20916;DP=344;AF=0.99;MQM=59;TRIO=HOM,344,0.99,HOM,156,1.00,HOM,172,1.00	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*921_*925delTAGTT:		rs569195865	0.9844	0.0000	0/0/0	0.8975										230	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	148113895	148113895	G	A	het		QUAL=9303;DP=356;AF=0.51;MQM=60;TRIO=HET,356,0.51,WT,264,0.00,HET,339,0.49	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*1187G>A:		rs2530312	0.3746	0.0000	0/0/0	0.0752										48	102					CNTNAP2 (inh=AR pLI=0.00)
chr7	148114265	148114265	A	C	het		QUAL=8183;DP=335;AF=0.48;MQM=60;TRIO=HET,335,0.48,WT,188,0.01,HET,300,0.48	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*1557A>C:		rs3194	0.3944	0.0000	0/0/0	0.0801										52	102					CNTNAP2 (inh=AR pLI=0.00)
chr7	148114865	148114865	A	G	het		QUAL=6559;DP=368;AF=0.49;MQM=60;TRIO=HET,368,0.49,WT,113,0.00,HET,156,0.44	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*2157A>G:		rs1062072	0.5371	0.0000	0/0/0	0.0884										59	100					CNTNAP2 (inh=AR pLI=0.00)
chr7	148115639	148115640	AA	-	het		QUAL=10090;DP=291;AF=0.57;MQM=59;TRIO=HET,291,0.57,HET,231,0.47,HET,263,0.48	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*2935_*2936delAA:		rs869179688	0.7817	0.0000	0/0/0	0.7450										156	66					CNTNAP2 (inh=AR pLI=0.00)
chr7	148116450	148116450	A	G	het		QUAL=8144;DP=313;AF=0.56;MQM=60;TRIO=HET,313,0.56,WT,190,0.00,HET,245,0.53	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*3742A>G:		rs2530311	0.5210	0.0000	0/0/0	0.0871										56	102					CNTNAP2 (inh=AR pLI=0.00)
chr7	148117505	148117505	G	C	het		QUAL=12304;DP=349;AF=0.45;MQM=60;TRIO=HET,349,0.45,HET,258,0.50,HET,346,0.53	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*4797G>C:		rs2717829	0.7935	0.0000	0/0/0	0.1383										157	65					CNTNAP2 (inh=AR pLI=0.00)
chr7	148117642	148117642	C	T	het		QUAL=6567;DP=297;AF=0.47;MQM=60;TRIO=HET,297,0.47,WT,158,0.01,HET,230,0.47	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*4934C>T:		rs2530310	0.3860	0.0000	0/0/0	0.0669										47	106					CNTNAP2 (inh=AR pLI=0.00)
chr8	1729217	1729217	C	T	hom		QUAL=20979;DP=268;AF=1.00;MQM=59;TRIO=HOM,268,1.00,HOM,168,0.99,HOM,238,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*484C>T:		rs11778824	0.8097	0.0000	0/0/0	0.1362										170	47					CLN8 (inh=n/a pLI=0.00)
chr8	1729514	1729514	A	G	hom		QUAL=8939;DP=116;AF=1.00;MQM=56;TRIO=HOM,116,1.00,HOM,71,1.00,HOM,105,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*781A>G:	AluSz	rs1137514	0.6220	0.0000	0/0/0	0.5738										88	77					CLN8 (inh=n/a pLI=0.00)
chr8	1729582	1729582	-	TGG	hom		QUAL=12720;DP=155;AF=0.97;MQM=59;TRIO=HOM,155,0.97,HOM,105,1.00,HOM,169,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*853_*855dupTGG:		rs397698661	0.6190	0.0000	0/0/0	0.3769										98	93					CLN8 (inh=n/a pLI=0.00)
chr8	1730119	1730119	-	TG	hom		QUAL=9835;DP=112;AF=0.81;MQM=59;TRIO=HOM,112,0.81,HOM,112,0.89,HOM,188,0.87	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*1413_*1414dupTG:		rs10638018;rs398006927	0.5948	0.0000	0/0/0	0.3357										5	125					CLN8 (inh=n/a pLI=0.00)
chr8	1732224	1732224	G	C	hom		QUAL=17435;DP=229;AF=1.00;MQM=55;TRIO=HOM,229,1.00,HOM,165,0.99,HOM,172,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*3491G>C:	AluSz	rs10089222	0.7123	0.0000	0/0/0	0.6544										102	60					CLN8 (inh=n/a pLI=0.00)
chr8	1732580	1732580	C	G	hom		QUAL=29394;DP=318;AF=1.00;MQM=59;TRIO=HOM,318,1.00,HOM,283,1.00,HOM,317,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*3847C>G:	MLT1A1	rs7827009	0.8079	0.0000	0/0/0	0.1359										144	38					CLN8 (inh=n/a pLI=0.00)
chr8	1732756	1732756	C	A	hom		QUAL=32013;DP=288;AF=0.99;MQM=59;TRIO=HOM,288,0.99,HOM,287,1.00,HOM,432,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*4023C>A:		rs7827285	0.8057	0.0000	0/0/0	0.1356										159	44					CLN8 (inh=n/a pLI=0.00)
chr8	1734452	1734452	C	G	hom		QUAL=6686;DP=131;AF=1.00;MQM=60;TRIO=HOM,131,1.00,HOM,32,1.00,HOM,53,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*5719C>G:		rs3812477	0.6983	0.0000	0/0/0	0.1212										132	88					CLN8 (inh=n/a pLI=0.00)
chr8	1857548	1857548	T	C	het		QUAL=4354;DP=179;AF=0.51;MQM=59;TRIO=HET,179,0.51,HET,51,0.63,HET,123,0.41	ARHGEF10	synonymous	ARHGEF10:NM_001308153.1:synonymous:LOW:exon19/30:c.2127T>C:p.Tyr709Tyr,ARHGEF10:NM_001308152.1:synonymous:LOW:exon17/28:c.1941T>C:p.Tyr647Tyr,ARHGEF10:NM_014629.3:synonymous:LOW:exon18/29:c.2055T>C:p.Tyr685Tyr		rs2294038	0.1569	0.1530	1464/753/76	0.1520						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM3982453, COSM3982452	30	266					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1876631	1876631	C	T	het		QUAL=3055;DP=147;AF=0.54;MQM=60;TRIO=HET,147,0.54,HET,107,0.42,WT,162,0.00	ARHGEF10	synonymous	ARHGEF10:NM_001308153.1:synonymous:LOW:exon25/30:c.2808C>T:p.Ile936Ile,ARHGEF10:NM_001308152.1:synonymous:LOW:exon23/28:c.2622C>T:p.Ile874Ile,ARHGEF10:NM_014629.3:synonymous:LOW:exon24/29:c.2736C>T:p.Ile912Ile		rs2272611	0.1444	0.1560	1592/690/85	0.1536						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM1455922, COSM1455921	32	264					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1900911	1900911	C	T	het		QUAL=3105;DP=137;AF=0.53;MQM=59;TRIO=HET,137,0.53,HET,123,0.50,WT,150,0.00	ARHGEF10	synonymous	ARHGEF10:NM_001308153.1:synonymous:LOW:exon29/30:c.3510C>T:p.His1170His,ARHGEF10:NM_001308152.1:synonymous:LOW:exon27/28:c.3324C>T:p.His1108His,ARHGEF10:NM_014629.3:synonymous:LOW:exon28/29:c.3438C>T:p.His1146His		rs2272608	0.2151	0.1610	1853/514/530	0.1583						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM3982456, COSM3982455	31	236					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1905615	1905615	G	A	het		QUAL=8863;DP=350;AF=0.47;MQM=60;TRIO=HET,350,0.47,WT,284,0.00,HET,357,0.49	ARHGEF10	3'UTR	ARHGEF10:NM_001308153.1:3'UTR:MODIFIER:exon30/30:c.*186G>A:,ARHGEF10:NM_001308152.1:3'UTR:MODIFIER:exon28/28:c.*186G>A:,ARHGEF10:NM_014629.3:3'UTR:MODIFIER:exon29/29:c.*186G>A:			0.0000	0.0000	0/0/0	0.0000										0	1					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1905728	1905728	G	A	hom		QUAL=16176;DP=192;AF=1.00;MQM=59;TRIO=HOM,192,1.00,HOM,148,1.00,HOM,158,1.00	ARHGEF10	3'UTR	ARHGEF10:NM_001308153.1:3'UTR:MODIFIER:exon30/30:c.*299G>A:,ARHGEF10:NM_001308152.1:3'UTR:MODIFIER:exon28/28:c.*299G>A:,ARHGEF10:NM_014629.3:3'UTR:MODIFIER:exon29/29:c.*299G>A:		rs6558566	0.9453	0.0000	0/0/0	0.1457										211	19					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1905823	1905823	A	G	het		QUAL=2822;DP=164;AF=0.48;MQM=60;TRIO=HET,164,0.48,HET,54,0.48,WT,53,0.02	ARHGEF10	3'UTR	ARHGEF10:NM_001308153.1:3'UTR:MODIFIER:exon30/30:c.*394A>G:,ARHGEF10:NM_001308152.1:3'UTR:MODIFIER:exon28/28:c.*394A>G:,ARHGEF10:NM_014629.3:3'UTR:MODIFIER:exon29/29:c.*394A>G:		rs6991392	0.3970	0.0000	0/0/0	0.0672										42	113					ARHGEF10 (inh=n/a pLI=0.00)
chr8	1906630	1906630	G	T	hom		QUAL=52487;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HOM,559,1.00,HOM,667,1.00	ARHGEF10	3'UTR	ARHGEF10:NM_001308153.1:3'UTR:MODIFIER:exon30/30:c.*1201G>T:,ARHGEF10:NM_001308152.1:3'UTR:MODIFIER:exon28/28:c.*1201G>T:,ARHGEF10:NM_014629.3:3'UTR:MODIFIER:exon29/29:c.*1201G>T:		rs14375	0.9519	0.0000	0/0/0	0.1470										211	19					ARHGEF10 (inh=n/a pLI=0.00)
chr8	6264130	6264130	G	C	het	low_DP	QUAL=2173;DP=11;AF=0.27;MQM=60;TRIO=HET,11,0.27,HOM,48,1.00,HET,54,0.59	MCPH1	5'UTR	MCPH1:NM_024596.3:5'UTR:MODIFIER:exon1/14:c.-59G>C:,MCPH1:NM_001172574.1:5'UTR:MODIFIER:exon1/8:c.-59G>C:,MCPH1:NM_001172575.1:5'UTR:MODIFIER:exon1/7:c.-59G>C:		rs2305023	0.5387	0.0000	0/0/0	0.1118										169	124					MCPH1 (inh=AR pLI=0.00)
chr8	6272399	6272399	G	T	het		QUAL=5864;DP=204;AF=0.48;MQM=60;TRIO=HET,204,0.48,HOM,70,1.00,HET,81,0.51	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon3/14:c.228G>T:p.Val76Val,MCPH1:NM_001172574.1:synonymous:LOW:exon3/8:c.228G>T:p.Val76Val,MCPH1:NM_001172575.1:synonymous:LOW:exon3/7:c.228G>T:p.Val76Val		rs2305022	0.6781	0.7720	36743/21237/956	0.7606						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146307.1 [likely benign]; 			635	415					MCPH1 (inh=AR pLI=0.00)
chr8	6296550	6296550	G	T	hom		QUAL=24334;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,200,1.00,HOM,269,1.00	MCPH1	missense,intron	MCPH1:NM_024596.3:missense:MODERATE:exon6/14:c.513G>T:p.Arg171Ser,MCPH1:NM_001172574.1:missense:MODERATE:exon6/8:c.513G>T:p.Arg171Ser,MCPH1:NM_001172575.1:intron:MODIFIER:exon5/6:c.436+2867G>T:		rs2442513	0.9169	0.9660	56549/32517/2976	0.9410	-0.2920	T	T,T	B,B	B,B	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000194980.2 [benign]; 			1070	37					MCPH1 (inh=AR pLI=0.00)
chr8	6302106	6302106	C	A	het	phylop_high;pred_pathogenic_3	QUAL=10134;DP=369;AF=0.54;MQM=60;TRIO=HET,369,0.54,WT,230,0.00,HET,351,0.50	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.863C>A:p.Pro288His,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.863C>A:p.Pro288His,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.719C>A:p.Pro240His		rs35590577	0.0693	0.0290	215/6/199	0.0273	2.1950	T	D,D,D	D,D,D	D,D,D	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146333.1 [benign]; 			1	52					MCPH1 (inh=AR pLI=0.00)
chr8	6302183	6302183	G	C	het	pred_pathogenic_3	QUAL=20871;DP=440;AF=0.50;MQM=60;TRIO=HET,440,0.50,HOM,289,1.00,HET,394,0.55	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.940G>C:p.Asp314His,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.940G>C:p.Asp314His,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.796G>C:p.Asp266His		rs930557	0.6448	0.7700	36968/21790/538	0.7592	0.3110	T	T,D,D	D,D,D	D,D,D	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000020903.1 [benign]; RCV000146337.1 [likely benign]; 			674	371					MCPH1 (inh=AR pLI=0.00)
chr8	6302418	6302418	A	G	hom		QUAL=29954;DP=275;AF=1.00;MQM=59;TRIO=HOM,275,1.00,HOM,310,1.00,HOM,358,1.00	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.1175A>G:p.Asp392Gly,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.1175A>G:p.Asp392Gly,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.1031A>G:p.Asp344Gly		rs2515569	0.9944	0.9980	60074/33307/4660	0.9307	-3.5300	T	T,T,T	B,B,B	B,B,B	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000082198.6 [other]; 			1105	2					MCPH1 (inh=AR pLI=0.00)
chr8	6302671	6302671	C	T	het		QUAL=8317;DP=282;AF=0.54;MQM=60;TRIO=HET,282,0.54,WT,211,0.00,HET,279,0.56	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon8/14:c.1428C>T:p.Phe476Phe,MCPH1:NM_001172574.1:synonymous:LOW:exon8/8:c.1428C>T:p.Phe476Phe,MCPH1:NM_001172575.1:synonymous:LOW:exon7/7:c.1284C>T:p.Phe428Phe		rs2920676	0.2081	0.0850	1241/14/880	0.0823						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000082200.5 [benign]; 			1	80					MCPH1 (inh=AR pLI=0.00)
chr8	6303025	6303025	G	A	het		QUAL=20055;DP=466;AF=0.51;MQM=59;TRIO=HET,466,0.51,HOM,297,1.00,HET,318,0.49	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon8/14:c.1782G>A:p.Thr594Thr,MCPH1:NM_001172574.1:synonymous:LOW:exon8/8:c.1782G>A:p.Thr594Thr,MCPH1:NM_001172575.1:synonymous:LOW:exon7/7:c.1638G>A:p.Thr546Thr		rs2584	0.1322	0.2570	4880/3762/25	0.2548						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146282.1 [benign]; 			89	422					MCPH1 (inh=AR pLI=0.00)
chr8	6303409	6303409	T	G	het		QUAL=6240;DP=336;AF=0.47;MQM=60;TRIO=HET,336,0.47,WT,169,0.00,HET,211,0.40	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*333T>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*333T>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+341T>G:		rs2916750	0.2935	0.0000	0/0/0	0.0359						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				5	51					MCPH1 (inh=AR pLI=0.00)
chr8	6303434	6303434	T	A	het		QUAL=10273;DP=234;AF=0.50;MQM=60;TRIO=HET,234,0.50,HOM,143,1.00,HET,168,0.61	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*358T>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*358T>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+366T>A:		rs2515570	0.6536	0.0000	0/0/0	0.1296						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	50					MCPH1 (inh=AR pLI=0.00)
chr8	6303511	6303511	T	A	het		QUAL=6086;DP=187;AF=0.52;MQM=60;TRIO=HET,187,0.52,HOM,67,1.00,HET,77,0.61	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*435T>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*435T>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+443T>A:		rs1054073	0.6691	0.0000	0/0/0	0.1304						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	50					MCPH1 (inh=AR pLI=0.00)
chr8	6303614	6303614	A	C	het		QUAL=3503;DP=150;AF=0.54;MQM=59;TRIO=HET,150,0.54,HOM,20,1.00,HET,44,0.50	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*538A>C:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*538A>C:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+546A>C:		rs1054074	0.6609	0.0000	0/0/0	0.1538						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				93	51					MCPH1 (inh=AR pLI=0.00)
chr8	6303846	6303846	A	G	het		QUAL=4298;DP=132;AF=0.49;MQM=60;TRIO=HET,132,0.49,WT,125,0.01,HET,206,0.49	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*770A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*770A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+778A>G:		rs79010412	0.0705	0.0000	0/0/0	0.0046						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0	4					MCPH1 (inh=AR pLI=0.00)
chr8	6303859	6303859	C	T	het		QUAL=9093;DP=121;AF=0.50;MQM=60;TRIO=HET,121,0.50,HOM,135,0.99,HET,237,0.52	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*783C>T:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*783C>T:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+791C>T:		rs2440415	0.6442	0.0000	0/0/0	0.1288						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	50					MCPH1 (inh=AR pLI=0.00)
chr8	6304259	6304259	G	A	het		QUAL=5365;DP=154;AF=0.44;MQM=60;TRIO=HET,154,0.44,HOM,79,1.00,HET,89,0.53	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1183G>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1183G>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1191G>A:		rs2515571	0.6534	0.0000	0/0/0	0.7595						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	50					MCPH1 (inh=AR pLI=0.00)
chr8	6304348	6304348	C	T	het		QUAL=7549;DP=186;AF=0.49;MQM=60;TRIO=HET,186,0.49,HOM,110,1.00,HET,139,0.50	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1272C>T:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1272C>T:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1280C>T:		rs2166006	0.6725	0.0000	0/0/0	0.7773						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304522	6304535	CAGGCAGGGGTGTC	-	het		QUAL=8119;DP=212;AF=0.56;MQM=59;TRIO=HET,212,0.56,HOM,149,1.00,HET,245,0.41	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1455_*1468delGTGTCCAGGCAGGG:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1455_*1468delGTGTCCAGGCAGGG:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1463_1825+1476delGTGTCCAGGCAGGG:		rs370636933	0.6482	0.0000	0/0/0	0.6422						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304694	6304694	A	G	het		QUAL=13738;DP=249;AF=0.51;MQM=60;TRIO=HET,249,0.51,HOM,204,1.00,HET,282,0.51	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1618A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1618A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1626A>G:		rs1129703	0.6573	0.0000	0/0/0	0.7732						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304730	6304730	A	C	het		QUAL=12580;DP=278;AF=0.49;MQM=60;TRIO=HET,278,0.49,HOM,172,1.00,HET,252,0.51	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1654A>C:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1654A>C:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1662A>C:		rs1129704	0.6492	0.0000	0/0/0	0.7712						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304814	6304814	A	G	het		QUAL=14667;DP=247;AF=0.49;MQM=60;TRIO=HET,247,0.49,HOM,227,1.00,HET,289,0.52	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1738A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1738A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1746A>G:		rs1129706	0.6573	0.0000	0/0/0	0.7726						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				94	51					MCPH1 (inh=AR pLI=0.00)
chr8	8559832	8559832	G	A	het		QUAL=1679;DP=39;AF=0.54;MQM=59;TRIO=HET,39,0.54,HOM,47,1.00,WT,79,0.00	CLDN23	5'UTR	CLDN23:NM_194284.2:5'UTR:MODIFIER:exon1/1:c.-77G>A:		rs9644774	0.2163	0.0000	0/0/0	0.0504										27	105					CLDN23 (inh=n/a pLI=0.00)
chr8	10581882	10581882	A	C	hom		QUAL=21014;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,159,1.00,HOM,207,1.00	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*1366T>G:		rs11250064	0.6781	0.0000	0/0/0	0.1109										103	99					SOX7 (inh=n/a pLI=0.13)
chr8	10582523	10582523	T	G	het		QUAL=1023;DP=77;AF=0.48;MQM=58;TRIO=HET,77,0.48,WT,11,0.00,HET,15,0.47	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*725A>C:	AluSq2	rs145522498	0.0296	0.0000	0/0/0	0.0094										1	24					SOX7 (inh=n/a pLI=0.13)
chr8	10583203	10583203	A	G	hom		QUAL=26903;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,295,1.00,HOM,341,1.00	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*45T>C:		rs10110624	0.6500	0.6460	24815/14571/3315	0.6158										103	97					SOX7 (inh=n/a pLI=0.13)
chr8	10583506	10583506	A	G	het		QUAL=2777;DP=74;AF=0.51;MQM=59;TRIO=HET,74,0.51,HOM,64,1.00,WT,73,0.00	SOX7	synonymous	SOX7:NM_031439.3:synonymous:LOW:exon2/2:c.909T>C:p.Leu303Leu		rs4841432	0.4327	0.3620	8812/4334/2921	0.3602										93	332					SOX7 (inh=n/a pLI=0.13)
chr8	22021933	22021933	C	T	het	pred_pathogenic_1	QUAL=2513;DP=172;AF=0.54;MQM=59;TRIO=HET,172,0.54,WT,66,0.00,HET,66,0.64	SFTPC	3'UTR	SFTPC:NM_001172410.1:3'UTR:MODIFIER:exon6/6:c.*165C>T:,SFTPC:NM_001172357.1:3'UTR:MODIFIER:exon5/5:c.*379C>T:,SFTPC:NM_001317778.1:3'UTR:MODIFIER:exon6/6:c.*173C>T:,SFTPC:NM_001317779.1:3'UTR:MODIFIER:exon5/5:c.*173C>T:,SFTPC:NM_001317780.1:3'UTR:MODIFIER:exon6/6:c.*165C>T:,SFTPC:NM_003018.3:3'UTR:MODIFIER:exon6/6:c.*173C>T:		rs1126931	0.1044	0.1350	175/41/1	0.0373	-1.7130	T	D			178620 [SFTPC (confirmed) Surfactant metabolism dysfunction,pulmonary,2];				16	158					SFTPC (inh=n/a pLI=0.07)
chr8	24809067	24809067	C	T	hom		QUAL=29216;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HOM,215,1.00,HOM,283,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*1256G>A:		rs2979704	0.7196	0.0000	0/0/0	0.8063										175	80					NEFL (inh=n/a pLI=n/a)
chr8	24809636	24809636	C	G	hom		QUAL=19101;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,147,1.00,HOM,201,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*687G>C:		rs2976439	0.5427	0.0000	0/0/0	0.6238										93	124					NEFL (inh=n/a pLI=n/a)
chr8	24810088	24810088	T	A	hom		QUAL=33012;DP=382;AF=1.00;MQM=59;TRIO=HOM,382,1.00,HOM,299,1.00,HOM,344,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*235A>T:		rs1059111	0.7208	0.0000	0/0/0	0.8084										215	86					NEFL (inh=n/a pLI=n/a)
chr8	24811065	24811065	G	-	hom	anno_high_impact	QUAL=33485;DP=197;AF=0.99;MQM=59;TRIO=HOM,197,0.99,HOM,377,1.00,HOM,558,1.00	NEFL	splice_acceptor&splice_donor	NEFL:NM_006158.4:splice_acceptor&splice_donor:HIGH:exon3/4:c.1413+1delC:		rs397788090	1.0000	1.0000	59987/33132/4877	0.9316						162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E|Charcot-Marie-Tooth disease,type 1F];				1105	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			NEFL (inh=n/a pLI=n/a)
chr8	27317337	27317337	A	G	hom		QUAL=41620;DP=281;AF=1.00;MQM=59;TRIO=HOM,281,1.00,HOM,416,0.99,HOM,600,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1809T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1809T>C:		rs2280375	0.8057	0.0000	0/0/0	0.8149										170	54					CHRNA2 (inh=n/a pLI=0.00)
chr8	27317445	27317445	G	T	het		QUAL=20525;DP=187;AF=0.57;MQM=60;TRIO=HET,187,0.57,HOM,374,1.00,HET,582,0.52	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1701C>A:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1701C>A:		rs1057137	0.4052	0.0000	0/0/0	0.3634										30	116					CHRNA2 (inh=n/a pLI=0.00)
chr8	27317762	27317762	G	A	het		QUAL=4911;DP=185;AF=0.52;MQM=59;TRIO=HET,185,0.52,WT,166,0.00,HET,234,0.48	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1384C>T:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1384C>T:		rs2280376	0.2218	0.0000	0/0/0	0.2632										18	94					CHRNA2 (inh=n/a pLI=0.00)
chr8	27317987	27317987	A	G	het		QUAL=7647;DP=289;AF=0.49;MQM=59;TRIO=HET,289,0.49,WT,280,0.00,HET,387,0.45	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1159T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1159T>C:		rs1560344	0.3654	0.0000	0/0/0	0.4341										48	122					CHRNA2 (inh=n/a pLI=0.00)
chr8	27318391	27318391	C	T	het		QUAL=6893;DP=277;AF=0.48;MQM=59;TRIO=HET,277,0.48,WT,221,0.00,HET,303,0.48	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*755G>A:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*755G>A:		rs2292974	0.3614	0.0000	0/0/0	0.4282										47	121					CHRNA2 (inh=n/a pLI=0.00)
chr8	27318425	27318425	C	A	het		QUAL=7218;DP=289;AF=0.51;MQM=59;TRIO=HET,289,0.51,WT,206,0.00,HET,265,0.49	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*721G>T:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*721G>T:		rs2292975	0.3590	0.0000	0/0/0	0.4263										47	121					CHRNA2 (inh=n/a pLI=0.00)
chr8	27318544	27318544	A	G	hom		QUAL=26622;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,275,1.00,HOM,332,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*602T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*602T>C:		rs2292976	0.7867	0.0000	0/0/0	0.8046										170	54					CHRNA2 (inh=n/a pLI=0.00)
chr8	27318635	27318635	C	G	hom		QUAL=27758;DP=296;AF=0.99;MQM=59;TRIO=HOM,296,0.99,HOM,264,1.00,HOM,330,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*511G>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*511G>C:		rs2292977	0.7819	0.0000	0/0/0	0.7954										162	62					CHRNA2 (inh=n/a pLI=0.00)
chr8	27324822	27324822	T	C	hom		QUAL=14302;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HET,236,0.50,HET,317,0.50	CHRNA2	missense	CHRNA2:NM_000742.3:missense:MODERATE:exon5/7:c.373A>G:p.Thr125Ala,CHRNA2:NM_001282455.1:missense:MODERATE:exon5/7:c.328A>G:p.Thr110Ala		rs891398	0.6102	0.5310	17658/8288/3096	0.5286	0.6030	T	T,T,T	B	B	118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4];	RCV000116712.4 [other]; 	CM144682 [CLASS=DP MUT=ALT PHEN="Nicotine dependence association with" GENE=CHRNA2]; 		288	536					CHRNA2 (inh=n/a pLI=0.00)
chr8	27336446	27336446	T	G	het		QUAL=207;DP=117;AF=0.34;MQM=58;TRIO=HET,117,0.34,WT,121,0.02,WT,187,0.03	CHRNA2	5'UTR	CHRNA2:NM_000742.3:5'UTR:MODIFIER:exon1/7:c.-242A>C:,CHRNA2:NM_001282455.1:5'UTR:MODIFIER:exon1/7:c.-242A>C:		rs368160505	0.0000	0.0000	0/0/0	0.0005										0	68					CHRNA2 (inh=n/a pLI=0.00)
chr8	27661066	27661066	-	AC	het		QUAL=9079;DP=220;AF=0.48;MQM=59;TRIO=HET,220,0.48,HET,79,0.42,HOM,128,0.87	ESCO2	3'UTR	ESCO2:NM_001017420.2:3'UTR:MODIFIER:exon11/11:c.*128_*129dupAC:	(AC)n	rs144484866;rs56062620	0.0000	0.0000	0/0/0	0.1961										17	119					ESCO2 (inh=AR pLI=0.18)
chr8	27661066	27661066	-	ACAC	het		QUAL=9079;DP=220;AF=0.27;MQM=57;TRIO=HET,220,0.27,HET,79,0.42,WT,128,0.00	ESCO2	3'UTR	ESCO2:NM_001017420.2:3'UTR:MODIFIER:exon11/11:c.*126_*129dupACAC:	(AC)n	rs144484866	0.0000	0.0000	0/0/0	0.1015										19	75					ESCO2 (inh=AR pLI=0.18)
chr8	27661085	27661085	G	A	het		QUAL=9079;DP=220;AF=0.48;MQM=57;TRIO=HET,220,0.75,HET,79,0.84,WT,128,0.87	ESCO2	3'UTR	ESCO2:NM_001017420.2:3'UTR:MODIFIER:exon11/11:c.*130G>A:	(AC)n	rs62498042	0.4970	0.0000	0/0/0	0.1875										48	103					ESCO2 (inh=AR pLI=0.18)
chr8	33356562	33356562	G	-	het		QUAL=12249;DP=331;AF=0.44;MQM=60;TRIO=HET,331,0.44,HOM,177,1.00,HET,221,0.49	MAK16,TTI2	3'UTR	MAK16:NM_032509.3:3'UTR:MODIFIER:exon10/10:c.*416delG:,TTI2:NM_001102401.2:3'UTR:MODIFIER:exon8/8:c.*129delC:,TTI2:NM_001265581.1:3'UTR:MODIFIER:exon8/8:c.*129delC:,TTI2:NM_025115.3:3'UTR:MODIFIER:exon7/7:c.*129delC:		rs397698667	0.5815	0.0000	0/0/0	0.5547										61	71					MAK16 (inh=n/a pLI=0.99), TTI2 (inh=AR pLI=0.00)
chr8	33369944	33369944	T	C	het	pred_pathogenic_1	QUAL=13859;DP=288;AF=0.49;MQM=59;TRIO=HET,288,0.49,HOM,188,1.00,HET,304,0.52	TTI2	missense	TTI2:NM_001102401.2:missense:MODERATE:exon2/8:c.188A>G:p.Glu63Gly,TTI2:NM_001265581.1:missense:MODERATE:exon2/8:c.188A>G:p.Glu63Gly,TTI2:NM_025115.3:missense:MODERATE:exon1/7:c.188A>G:p.Glu63Gly		rs2304748	0.5068	0.5610	19675/12776/1112	0.5583	0.7680	T	D,D,D,D,T,T	P,B,B	B,B,B	614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39];				381	525					TTI2 (inh=AR pLI=0.00)
chr8	33369994	33369994	A	G	het		QUAL=15371;DP=416;AF=0.48;MQM=59;TRIO=HET,416,0.48,HOM,190,0.99,HET,321,0.52	TTI2	synonymous	TTI2:NM_001102401.2:synonymous:LOW:exon2/8:c.138T>C:p.Asn46Asn,TTI2:NM_001265581.1:synonymous:LOW:exon2/8:c.138T>C:p.Asn46Asn,TTI2:NM_025115.3:synonymous:LOW:exon1/7:c.138T>C:p.Asn46Asn		rs3098657	0.5789	0.6010	22504/14012/2332	0.5966						614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39];				419	528					TTI2 (inh=AR pLI=0.00)
chr8	33370261	33370261	G	A	het		QUAL=1767;DP=113;AF=0.43;MQM=60;TRIO=HET,113,0.43,HOM,15,1.00,HET,31,0.35	TTI2	5'UTR,intron	TTI2:NM_025115.3:5'UTR:MODIFIER:exon1/7:c.-130C>T:,TTI2:NM_001102401.2:intron:MODIFIER:exon1/7:c.-99-31C>T:,TTI2:NM_001265581.1:intron:MODIFIER:exon1/7:c.-99-31C>T:		rs34226219	0.2206	0.0000	0/0/0	0.0685										33	122					TTI2 (inh=AR pLI=0.00)
chr8	38000267	38000267	T	C	hom		QUAL=27669;DP=285;AF=1.00;MQM=59;TRIO=HOM,285,1.00,HOM,255,1.00,HOM,344,1.00	STAR	3'UTR	STAR:NM_000349.2:3'UTR:MODIFIER:exon7/7:c.*1524A>G:	AluSx	rs3990403	0.5505	0.0000	0/0/0	0.6766										165	61					STAR (inh=n/a pLI=0.00)
chr8	38000824	38000827	TTTT	-	hom		QUAL=1482;DP=64;AF=0.05;MQM=60;TRIO=HOM,64,0.05,WT,27,0.11,WT,58,0.00	STAR	3'UTR	STAR:NM_000349.2:3'UTR:MODIFIER:exon7/7:c.*964_*967delAAAA:	AluSc8		0.0000	0.0000	0/0/0	0.0000										0	0					STAR (inh=n/a pLI=0.00)
chr8	38005835	38005835	T	C	hom		QUAL=13399;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HOM,138,1.00,HOM,156,1.00	STAR	synonymous	STAR:NM_000349.2:synonymous:LOW:exon3/7:c.189A>G:p.Leu63Leu		rs2229620	0.9954	0.9990	60504/33353/5041	0.9349						600617 [STAR (provisional) Lipoid adrenal hyperplasia];			COSM4162974	1106	1					STAR (inh=n/a pLI=0.00)
chr8	38326046	38326046	G	A	het	low_DP	QUAL=653;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,HET,11,0.27,HOM,21,1.00	FGFR1	5'UTR_premature_start_codon_gain,5'UTR	FGFR1:NM_001174063.1:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_001174064.1:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-728C>T:,FGFR1:NM_015850.3:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_023105.2:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:NM_023106.2:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:NM_023110.2:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_001174063.1:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:NM_001174064.1:5'UTR:MODIFIER:exon1/19:c.-728C>T:,FGFR1:NM_015850.3:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:NM_023105.2:5'UTR:MODIFIER:exon1/17:c.-636C>T:,FGFR1:NM_023106.2:5'UTR:MODIFIER:exon1/17:c.-636C>T:,FGFR1:NM_023110.2:5'UTR:MODIFIER:exon1/18:c.-636C>T:	(GCCGCCC)n	rs3213849	0.3407	0.0000	0/0/0	0.3611										32	78					FGFR1 (inh=AD pLI=0.99)
chr8	38326161	38326161	G	A	hom		QUAL=2238;DP=49;AF=1.00;MQM=60;TRIO=HOM,49,1.00,HOM,23,1.00,HOM,25,1.00	FGFR1	5'UTR	FGFR1:NM_001174063.1:5'UTR:MODIFIER:exon1/18:c.-751C>T:,FGFR1:NM_001174064.1:5'UTR:MODIFIER:exon1/19:c.-843C>T:,FGFR1:NM_015850.3:5'UTR:MODIFIER:exon1/18:c.-751C>T:,FGFR1:NM_023105.2:5'UTR:MODIFIER:exon1/17:c.-751C>T:,FGFR1:NM_023106.2:5'UTR:MODIFIER:exon1/17:c.-751C>T:,FGFR1:NM_023110.2:5'UTR:MODIFIER:exon1/18:c.-751C>T:		rs2445003	0.9569	0.0000	0/0/0	0.8478										209	0					FGFR1 (inh=AD pLI=0.99)
chr8	43054553	43054553	T	C	hom		QUAL=30540;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,231,1.00,HOM,302,1.00	HGSNAT	synonymous	HGSNAT:NM_152419.2:synonymous:LOW:exon18/18:c.1749T>C:p.Tyr583Tyr		rs1126058	0.9916	0.9960	52329/29275/4110	0.9369						610453 [HGSNAT (confirmed) Mucopolysaccharidosis type IIIC (Sanfilippo C)|Retinitis pigmentosa 73];	RCV000082655.4 [benign]; 			1102	4					HGSNAT (inh=AR pLI=0.00)
chr8	43056513	43056513	T	C	hom		QUAL=33068;DP=217;AF=1.00;MQM=59;TRIO=HOM,217,1.00,HOM,428,1.00,HOM,438,1.00	HGSNAT	3'UTR	HGSNAT:NM_152419.2:3'UTR:MODIFIER:exon18/18:c.*1801T>C:	L2d2	rs3739431	0.8219	0.0000	0/0/0	0.8981										208	21					HGSNAT (inh=AR pLI=0.00)
chr8	48805816	48805816	-	G	hom	anno_high_impact	QUAL=16843;DP=177;AF=0.97;MQM=59;TRIO=HOM,177,0.97,HOM,176,1.00,HOM,212,1.00	PRKDC	frameshift	PRKDC:NM_006904.6:frameshift:HIGH:exon31/86:c.3729dupC:p.Phe1244fs,PRKDC:NM_001081640.1:frameshift:HIGH:exon31/85:c.3729dupC:p.Phe1244fs		rs11411516;rs397814002	1.0000	1.0000	58497/32352/4644	0.9346						600899 [PRKDC (confirmed) Immunodeficiency 26,with or without neurologic abnormalities];				1365	0	1	[1] old entry - no details available			PRKDC (inh=n/a pLI=1.00)
chr8	48846519	48846519	T	C	hom		QUAL=17742;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HOM,191,1.00,HET,242,0.55	PRKDC	splice_region&intron	PRKDC:NM_006904.6:splice_region&intron:LOW:exon15/85:c.1623+6A>G:,PRKDC:NM_001081640.1:splice_region&intron:LOW:exon15/84:c.1623+6A>G:		rs1231202	0.9836	0.9600	55684/29495/4825	0.9316						600899 [PRKDC (confirmed) Immunodeficiency 26,with or without neurologic abnormalities];				1214	136					PRKDC (inh=n/a pLI=1.00)
chr8	61178574	61178574	T	C	hom		QUAL=18635;DP=280;AF=1.00;MQM=59;TRIO=HOM,280,1.00,HOM,189,1.00,HET,233,0.50	CA8	synonymous	CA8:NM_004056.4:synonymous:LOW:exon3/9:c.327A>G:p.Glu109Glu		rs7464181	0.5010	0.4270	11930/5706/3069	0.4206						114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3];	RCV000116510.2 [likely benign]; 		COSM3763364	376	1110					CA8 (inh=AR pLI=0.78)
chr8	61193760	61193760	T	G	hom		QUAL=12585;DP=51;AF=0.98;MQM=59;TRIO=HOM,51,0.98,HOM,267,1.00,HET,400,0.36	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-54A>C:		rs10101374	0.6266	0.0000	0/0/0	0.4764										77	99					CA8 (inh=AR pLI=0.78)
chr8	61193809	61193809	A	G	hom		QUAL=14485;DP=90;AF=1.00;MQM=59;TRIO=HOM,90,1.00,HOM,282,1.00,HET,412,0.37	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-103T>C:		rs10086341	0.6258	0.0000	0/0/0	0.0868										77	94					CA8 (inh=AR pLI=0.78)
chr8	61193828	61193828	A	G	hom		QUAL=14962;DP=95;AF=0.99;MQM=59;TRIO=HOM,95,0.99,HOM,293,1.00,HET,425,0.37	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-122T>C:		rs10086352	0.4329	0.0000	0/0/0	0.0517										44	86					CA8 (inh=AR pLI=0.78)
chr8	61193843	61193843	C	G	hom		QUAL=15298;DP=91;AF=1.00;MQM=59;TRIO=HOM,91,1.00,HOM,286,1.00,HET,425,0.38	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-137G>C:		rs10086449	0.4329	0.0000	0/0/0	0.0605										40	85					CA8 (inh=AR pLI=0.78)
chr8	61779681	61779681	A	C	het		QUAL=15277;DP=505;AF=0.51;MQM=60;TRIO=HET,505,0.51,HOM,164,1.00,HET,224,0.49	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1189A>C:,CHD7:NM_001316690.1:3'UTR:MODIFIER:exon5/5:c.*1189A>C:		rs4738834	0.5004	0.0000	0/0/0	0.5740										56	63					CHD7 (inh=AD pLI=1.00)
chr8	61779936	61779936	T	G	het		QUAL=15991;DP=539;AF=0.51;MQM=60;TRIO=HET,539,0.51,HOM,188,0.99,HET,291,0.43	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1444T>G:,CHD7:NM_001316690.1:3'UTR:MODIFIER:exon5/5:c.*1444T>G:		rs4237040	0.4958	0.0000	0/0/0	0.5710										56	62					CHD7 (inh=AD pLI=1.00)
chr8	61780220	61780220	T	C	het		QUAL=13092;DP=419;AF=0.53;MQM=60;TRIO=HET,419,0.53,HOM,141,1.00,HET,233,0.50	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1728T>C:,CHD7:NM_001316690.1:3'UTR:MODIFIER:exon5/5:c.*1728T>C:		rs2280917	0.7376	0.0000	0/0/0	0.6715										72	56					CHD7 (inh=AD pLI=1.00)
chr8	61780289	61780289	C	T	het		QUAL=12048;DP=361;AF=0.47;MQM=60;TRIO=HET,361,0.47,HOM,155,1.00,HET,219,0.49	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1797C>T:,CHD7:NM_001316690.1:3'UTR:MODIFIER:exon5/5:c.*1797C>T:		rs6985168	0.4962	0.0000	0/0/0	0.5729										57	62					CHD7 (inh=AD pLI=1.00)
chr8	62562872	62562872	C	T	het		QUAL=22750;DP=431;AF=0.52;MQM=60;TRIO=HET,431,0.52,HET,304,0.51,HOM,384,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon5/24:c.490+737G>A:,ASPH:NM_001164750.1:intron:MODIFIER:exon5/24:c.403+737G>A:,ASPH:NM_001164751.1:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:NM_001164752.1:intron:MODIFIER:exon6/13:c.448+737G>A:,ASPH:NM_001164753.1:intron:MODIFIER:exon6/13:c.448+737G>A:,ASPH:NM_032468.4:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:NM_001164754.1:intron:MODIFIER:exon5/12:c.490+737G>A:,ASPH:NM_001164755.1:intron:MODIFIER:exon5/12:c.490+737G>A:,ASPH:NM_032466.3:intron:MODIFIER:exon5/13:c.490+737G>A:		rs2350590	0.8045	0.0000	0/0/0	0.8198						600582 [ASPH (confirmed) Traboulsi syndrome];				105	40					ASPH (inh=n/a pLI=0.00)
chr8	62563764	62563764	A	G	het		QUAL=12109;DP=262;AF=0.53;MQM=60;TRIO=HET,262,0.53,HET,154,0.46,HOM,205,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon4/24:c.416-81T>C:,ASPH:NM_001164750.1:intron:MODIFIER:exon4/24:c.329-81T>C:,ASPH:NM_001164751.1:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:NM_001164752.1:intron:MODIFIER:exon5/13:c.374-81T>C:,ASPH:NM_001164753.1:intron:MODIFIER:exon5/13:c.374-81T>C:,ASPH:NM_032468.4:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:NM_001164754.1:intron:MODIFIER:exon4/12:c.416-81T>C:,ASPH:NM_001164755.1:intron:MODIFIER:exon4/12:c.416-81T>C:,ASPH:NM_032466.3:intron:MODIFIER:exon4/13:c.416-81T>C:		rs7016141	0.8051	0.0000	0/0/0	0.1837						600582 [ASPH (confirmed) Traboulsi syndrome];				171	61					ASPH (inh=n/a pLI=0.00)
chr8	62565897	62565897	G	A	het		QUAL=19385;DP=585;AF=0.47;MQM=60;TRIO=HET,585,0.47,WT,244,0.00,HOM,360,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon4/24:c.415+230C>T:,ASPH:NM_001164750.1:intron:MODIFIER:exon4/24:c.328+230C>T:,ASPH:NM_001164751.1:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:NM_001164752.1:intron:MODIFIER:exon5/13:c.373+230C>T:,ASPH:NM_001164753.1:intron:MODIFIER:exon5/13:c.373+230C>T:,ASPH:NM_032468.4:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:NM_001164754.1:intron:MODIFIER:exon4/12:c.415+230C>T:,ASPH:NM_001164755.1:intron:MODIFIER:exon4/12:c.415+230C>T:,ASPH:NM_032466.3:intron:MODIFIER:exon4/13:c.415+230C>T:	MIRc	rs949761	0.1034	0.0000	0/0/0	0.1171						600582 [ASPH (confirmed) Traboulsi syndrome];				2	33					ASPH (inh=n/a pLI=0.00)
chr8	62567097	62567097	C	T	het		QUAL=19342;DP=678;AF=0.45;MQM=60;TRIO=HET,678,0.45,WT,243,0.00,HOM,344,0.99	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon3/24:c.323-878G>A:,ASPH:NM_001164750.1:intron:MODIFIER:exon3/24:c.236-878G>A:,ASPH:NM_001164751.1:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:NM_001164752.1:intron:MODIFIER:exon4/13:c.281-878G>A:,ASPH:NM_001164753.1:intron:MODIFIER:exon4/13:c.281-878G>A:,ASPH:NM_032468.4:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:NM_001164754.1:intron:MODIFIER:exon3/12:c.323-878G>A:,ASPH:NM_001164755.1:intron:MODIFIER:exon3/12:c.323-878G>A:,ASPH:NM_032466.3:intron:MODIFIER:exon3/13:c.323-878G>A:		rs10504331	0.1034	0.0000	0/0/0	0.1171						600582 [ASPH (confirmed) Traboulsi syndrome];				2	33					ASPH (inh=n/a pLI=0.00)
chr8	62567214	62567214	G	C	het		QUAL=19950;DP=387;AF=0.52;MQM=60;TRIO=HET,387,0.52,HET,252,0.46,HOM,349,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon3/24:c.323-995C>G:,ASPH:NM_001164750.1:intron:MODIFIER:exon3/24:c.236-995C>G:,ASPH:NM_001164751.1:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:NM_001164752.1:intron:MODIFIER:exon4/13:c.281-995C>G:,ASPH:NM_001164753.1:intron:MODIFIER:exon4/13:c.281-995C>G:,ASPH:NM_032468.4:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:NM_001164754.1:intron:MODIFIER:exon3/12:c.323-995C>G:,ASPH:NM_001164755.1:intron:MODIFIER:exon3/12:c.323-995C>G:,ASPH:NM_032466.3:intron:MODIFIER:exon3/13:c.323-995C>G:		rs9283975	0.7829	0.0000	0/0/0	0.8070						600582 [ASPH (confirmed) Traboulsi syndrome];				104	41					ASPH (inh=n/a pLI=0.00)
chr8	63972324	63972324	C	T	het		QUAL=304;DP=20;AF=0.55;MQM=60;TRIO=HET,20,0.55,HET,4,0.50,HOM,2,1.00	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*1487G>A:		rs6472068	0.5284	0.0000	0/0/0	0.3766										35	46					TTPA (inh=n/a pLI=0.01)
chr8	63972718	63972718	C	T	het		QUAL=14550;DP=364;AF=0.47;MQM=60;TRIO=HET,364,0.47,HOM,184,0.99,HET,303,0.50	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*1093G>A:		rs4587328	0.6755	0.0000	0/0/0	0.0935										43	66					TTPA (inh=n/a pLI=0.01)
chr8	63973233	63973235	AAA	-	het		QUAL=3355;DP=146;AF=0.43;MQM=59;TRIO=HET,146,0.43,HOM,81,0.83,HET,70,0.54	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*576_*578delTTT:	AluSz6	rs35504965;rs759014557	0.6747	0.0000	0/0/0	0.3481										41	68					TTPA (inh=n/a pLI=0.01)
chr8	63978659	63978659	A	-	hom		QUAL=14908;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,123,0.99,HOM,171,0.99	TTPA	splice_region&intron	TTPA:NM_000370.3:splice_region&intron:LOW:exon2/4:c.359-3delT:		rs869234227	1.0000	1.0000	59537/32668/5107	0.9379						600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency];	RCV000078673.4,RCV000078673.4 [benign,benign]; 			2234	0					TTPA (inh=n/a pLI=0.01)
chr8	75262798	75262798	G	C	hom		QUAL=36496;DP=272;AF=1.00;MQM=59;TRIO=HOM,272,1.00,HOM,361,1.00,HOM,501,1.00	GDAP1	synonymous,intron,non_coding_exon	GDAP1:NM_018972.2:synonymous:LOW:exon1/6:c.102G>C:p.Ser34Ser,GDAP1:NM_001040875.2:intron:MODIFIER:exon1/5:c.-64+91G>C:,GDAP1:NR_046346.1:non_coding_exon:MODIFIER:exon1/6:n.181G>C:		rs7828201	0.9956	0.9970	60381/33363/5201	0.9339						606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis|Charcot-Marie-Tooth disease,axonal,type 2K|Charcot-Marie-Tooth disease,recessive intermediate,A];			COSM4163063	1108	0					GDAP1 (inh=n/a pLI=0.00)
chr8	75274141	75274141	T	G	het		QUAL=13573;DP=293;AF=0.47;MQM=59;TRIO=HET,293,0.47,WT,249,0.01,HOM,318,0.99	GDAP1	synonymous,non_coding_exon	GDAP1:NM_018972.2:synonymous:LOW:exon4/6:c.507T>G:p.Ser169Ser,GDAP1:NM_001040875.2:synonymous:LOW:exon4/6:c.303T>G:p.Ser101Ser,GDAP1:NR_046346.1:non_coding_exon:MODIFIER:exon4/6:n.441T>G:		rs11554166	0.2192	0.2770	5106/3653/70	0.2780						606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis|Charcot-Marie-Tooth disease,axonal,type 2K|Charcot-Marie-Tooth disease,recessive intermediate,A];			COSM3763403	126	434					GDAP1 (inh=n/a pLI=0.00)
chr8	75277399	75277399	A	G	hom		QUAL=20051;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,155,1.00,HOM,190,1.00	GDAP1	3'UTR,non_coding_exon	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*797A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*797A>G:,GDAP1:NR_046346.1:non_coding_exon:MODIFIER:exon6/6:n.1808A>G:		rs7007283	0.9898	0.9880	5259/1363/93	0.2308										651	2					GDAP1 (inh=n/a pLI=0.00)
chr8	75278457	75278457	A	G	het		QUAL=18609;DP=768;AF=0.53;MQM=60;TRIO=HET,768,0.53,WT,161,0.00,HOM,235,1.00	GDAP1	3'UTR,non_coding_exon	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*1855A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*1855A>G:,GDAP1:NR_046346.1:non_coding_exon:MODIFIER:exon6/6:n.2866A>G:		rs6472842	0.2668	0.2260	414/180/17	0.0719										75	267					GDAP1 (inh=n/a pLI=0.00)
chr8	75278816	75278816	A	G	het		QUAL=12804;DP=404;AF=0.51;MQM=60;TRIO=HET,404,0.51,WT,139,0.00,HOM,214,1.00	GDAP1	3'UTR,non_coding_exon	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*2214A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*2214A>G:,GDAP1:NR_046346.1:non_coding_exon:MODIFIER:exon6/6:n.3225A>G:		rs10504580	0.2294	0.2090	343/132/2	0.0672										75	266					GDAP1 (inh=n/a pLI=0.00)
chr8	75279333	75279333	C	AAA	hom		QUAL=1637;DP=71;AF=0.11;MQM=54;TRIO=HOM,71,0.11,HOM,85,0.04,HOM,99,0.00	GDAP1	splice_region,splice_region&non_coding_exon,3'UTR	GDAP1:NM_018972.2:splice_region:LOW:exon6/6:c.*2731delCinsAAA:,GDAP1:NM_001040875.2:splice_region:LOW:exon6/6:c.*2731delCinsAAA:,GDAP1:NR_046346.1:splice_region&non_coding_exon:LOW:exon6/6:n.3742delCinsAAA:,GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*2731delCinsAAA:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*2731delCinsAAA:			0.0000	0.0000	0/0/0	0.0000										0	0					GDAP1 (inh=n/a pLI=0.00)
chr8	77892834	77892834	A	T	het		QUAL=8995;DP=238;AF=0.56;MQM=60;TRIO=HET,238,0.56,HET,190,0.43,HET,252,0.50	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*2663T>A:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*2663T>A:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*2663T>A:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*2663T>A:	MLT1K	rs28435921	0.5180	0.0000	0/0/0	0.5682										76	83					PEX2 (inh=AR pLI=0.06)
chr8	77893120	77893120	T	C	hom		QUAL=29461;DP=430;AF=1.00;MQM=60;TRIO=HOM,430,1.00,HOM,211,1.00,HOM,238,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*2377A>G:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*2377A>G:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*2377A>G:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*2377A>G:		rs4388434	0.9543	0.0000	0/0/0	0.1520										220	10					PEX2 (inh=AR pLI=0.06)
chr8	77894303	77894303	T	C	hom		QUAL=15691;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,112,1.00,HOM,113,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*1194A>G:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*1194A>G:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*1194A>G:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*1194A>G:		rs4311633	0.9858	0.0000	0/0/0	0.1529										220	10					PEX2 (inh=AR pLI=0.06)
chr8	77894770	77894770	A	G	hom		QUAL=19738;DP=336;AF=0.99;MQM=59;TRIO=HOM,336,0.99,HOM,110,1.00,HOM,172,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*727T>C:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*727T>C:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*727T>C:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*727T>C:	AluSc8	rs4610720	0.9543	0.0000	0/0/0	0.1520										219	9					PEX2 (inh=AR pLI=0.06)
chr8	77895865	77895865	A	G	hom	phylop_high	QUAL=21972;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,159,1.00,HOM,216,1.00	PEX2	missense	PEX2:NM_000318.2:missense:MODERATE:exon4/4:c.550T>C:p.Cys184Arg,PEX2:NM_001079867.1:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg,PEX2:NM_001172086.1:missense:MODERATE:exon5/5:c.550T>C:p.Cys184Arg,PEX2:NM_001172087.1:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg		rs10087163	0.9962	0.9880	59201/32347/5149	0.9661	6.1730	T	T,T,T,T	B	B	170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger)|Peroxisome biogenesis disorder 5B];	RCV000153682.2 [benign]; 			2173	62					PEX2 (inh=AR pLI=0.06)
chr8	77912230	77912230	G	T	het		QUAL=4444;DP=147;AF=0.51;MQM=60;TRIO=HET,147,0.51,WT,155,0.00,HET,203,0.50	PEX2	5'UTR	PEX2:NM_000318.2:5'UTR:MODIFIER:exon1/4:c.-164C>A:,PEX2:NM_001079867.1:5'UTR:MODIFIER:exon1/3:c.-132C>A:,PEX2:NM_001172086.1:5'UTR:MODIFIER:exon2/5:c.-164C>A:,PEX2:NM_001172087.1:5'UTR:MODIFIER:exon2/3:c.-22C>A:		rs12718	0.2778	0.2140	428/84/24	0.0645										24	192					PEX2 (inh=AR pLI=0.06)
chr8	77912424	77912424	T	G	hom		QUAL=35393;DP=432;AF=1.00;MQM=59;TRIO=HOM,432,1.00,HOM,296,1.00,HOM,390,1.00	PEX2	5'UTR,intron	PEX2:NM_000318.2:5'UTR:MODIFIER:exon1/4:c.-358A>C:,PEX2:NM_001079867.1:5'UTR:MODIFIER:exon1/3:c.-326A>C:,PEX2:NM_001172086.1:intron:MODIFIER:exon1/4:c.-302-56A>C:,PEX2:NM_001172087.1:intron:MODIFIER:exon1/2:c.-160-56A>C:		rs10081480	0.9655	0.0000	0/0/0	0.8956										290	12					PEX2 (inh=AR pLI=0.06)
chr8	86376130	86376130	A	T	hom	low_DP	QUAL=1235;DP=15;AF=1.00;MQM=59;TRIO=HOM,15,1.00,HOM,17,1.00,HOM,15,0.93	CA3-AS1	intron	CA3-AS1:NR_121630.1:intron:MODIFIER:exon1/2:n.334+681T>A:,CA3-AS1:NR_121631.1:intron:MODIFIER:exon1/2:n.106+327T>A:		rs11261477	0.9988	0.0000	0/0/0	0.0882										207	5					CA3-AS1 (inh=n/a pLI=n/a)
chr8	86389403	86389403	T	C	hom		QUAL=36634;DP=405;AF=1.00;MQM=60;TRIO=HOM,405,1.00,HOM,329,0.99,HOM,402,1.00	CA2	synonymous	CA2:NM_000067.2:synonymous:LOW:exon6/7:c.562T>C:p.Leu188Leu,CA2:NM_001293675.1:synonymous:LOW:exon5/6:c.259T>C:p.Leu87Leu		rs703	0.5777	0.5890	21573/12965/2655	0.5664						611492 [CA2 (confirmed) Osteopetrosis,autosomal recessive 3,with renal tubular acidosis];			COSM3982612	461	477	1	Prima vista kein Anhalt f?r Splice Defekt, swal, 160405 [1] ahwalds1 05.04.2016			CA2 (inh=AR pLI=0.10)
chr8	90946056	90946056	A	G	het		QUAL=5398;DP=212;AF=0.52;MQM=60;TRIO=HET,212,0.52,WT,48,0.00,HOM,71,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*1754T>C:,NBN:NM_001024688.2:3'UTR:MODIFIER:exon17/17:c.*1754T>C:	L1MEf	rs9995	0.3355	0.0000	0/0/0	0.0572										17	63					NBN (inh=AR pLI=0.00)
chr8	90946601	90946601	T	G	het		QUAL=20538;DP=534;AF=0.49;MQM=60;TRIO=HET,534,0.49,WT,328,0.00,HOM,406,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*1209A>C:,NBN:NM_001024688.2:3'UTR:MODIFIER:exon17/17:c.*1209A>C:	LTR67B	rs1063054	0.3353	0.0000	0/0/0	0.0572										18	93					NBN (inh=AR pLI=0.00)
chr8	90947269	90947269	C	G	het		QUAL=6151;DP=224;AF=0.52;MQM=60;TRIO=HET,224,0.52,WT,68,0.00,HOM,99,0.98	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*541G>C:,NBN:NM_001024688.2:3'UTR:MODIFIER:exon17/17:c.*541G>C:		rs2735383	0.3303	0.0000	0/0/0	0.0570								CR121123 [CLASS=DFP MUT=ALT PHEN="Lung cancer increased risk association with" GENE=NBN]; 		18	93					NBN (inh=AR pLI=0.00)
chr8	90947409	90947409	G	C	het		QUAL=3852;DP=199;AF=0.51;MQM=60;TRIO=HET,199,0.51,HET,60,0.63,WT,90,0.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*401C>G:,NBN:NM_001024688.2:3'UTR:MODIFIER:exon17/17:c.*401C>G:	L1ME4b	rs104895030	0.0012	0.0000	0/0/0	0.0042							RCV000114873.1 [not provided]; 			0	3					NBN (inh=AR pLI=0.00)
chr8	90947537	90947537	C	T	het		QUAL=6771;DP=200;AF=0.48;MQM=60;TRIO=HET,200,0.48,WT,105,0.00,HOM,130,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*273G>A:,NBN:NM_001024688.2:3'UTR:MODIFIER:exon17/17:c.*273G>A:	L1ME4b	rs1063053	0.3219	0.0000	0/0/0	0.0559										18	92					NBN (inh=AR pLI=0.00)
chr8	90958422	90958422	T	C	het		QUAL=8837;DP=281;AF=0.48;MQM=60;TRIO=HET,281,0.48,WT,96,0.01,HOM,163,1.00	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:NM_001024688.2:synonymous:LOW:exon14/17:c.1770A>G:p.Pro590Pro		rs1061302	0.3528	0.3450	7411/3552/277	0.3422						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162357.1 [benign]; 		COSM3763441	290	1222	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90958530	90958530	T	C	het		QUAL=8109;DP=286;AF=0.50;MQM=60;TRIO=HET,286,0.50,WT,104,0.01,HOM,137,0.99	NBN	splice_region&intron	NBN:NM_002485.4:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:NM_001024688.2:splice_region&intron:LOW:exon13/16:c.1669-7A>G:		rs2308962	0.3790	0.3530	7684/3567/522	0.3497						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				291	1226	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90967711	90967711	A	G	het		QUAL=5887;DP=177;AF=0.50;MQM=60;TRIO=HET,177,0.50,WT,100,0.00,HOM,116,0.98	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:NM_001024688.2:synonymous:LOW:exon11/17:c.951T>C:p.Asp317Asp		rs709816	0.6086	0.4670	14308/4457/3067	0.4608						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162376.1 [benign]; RCV000173761.1 [benign]; 		COSM3763442	368	1284	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90990479	90990479	C	G	het	phylop_high	QUAL=10500;DP=286;AF=0.45;MQM=60;TRIO=HET,286,0.45,WT,138,0.00,HOM,217,1.00	NBN	missense	NBN:NM_002485.4:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:NM_001024688.2:missense:MODERATE:exon6/17:c.307G>C:p.Glu103Gln		rs1805794	0.3570	0.3450	7417/3546/292	0.3425	2.1330	T	T,T,T,T	B	B	602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000121620.2 [benign]; RCV000162358.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	286	1228	1	[1] Christopher Schroeder 27.04.2015			NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het		QUAL=13525;DP=408;AF=0.43;MQM=60;TRIO=HET,408,0.43,WT,210,0.00,HOM,269,1.00	NBN	synonymous,5'UTR	NBN:NM_002485.4:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:NM_001024688.2:5'UTR:MODIFIER:exon2/17:c.-195G>A:		rs1063045	0.3792	0.3530	7704/3573/531	0.3497						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162359.1 [benign]; 		COSM3763444	293	1206	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	94794620	94794620	C	T	het		QUAL=5438;DP=134;AF=0.49;MQM=60;TRIO=HET,134,0.49,HOM,116,1.00,WT,142,0.01	TMEM67	splice_region&intron	TMEM67:NM_153704.5:splice_region&intron:LOW:exon10/27:c.1066-3C>T:,TMEM67:NM_001142301.1:splice_region&intron:LOW:exon11/28:c.823-3C>T:,TMEM67:NR_024522.1:splice_region&intron:LOW:exon10/28:n.1137-3C>T:		rs3097427	0.7151	0.6310	24646/11127/3055	0.6253						609884 [TMEM67 (confirmed) Meckel syndrome 3|Joubert syndrome 6|Bardet-Biedl syndrome 14,modifier of|COACH syndrome|Nephronophthisis 11];	RCV000082681.7 [other]; 			739	909					TMEM67 (inh=AR pLI=0.00)
chr8	94808165	94808165	A	G	het		QUAL=4452;DP=220;AF=0.45;MQM=60;TRIO=HET,220,0.45,HOM,58,1.00,WT,93,0.00	TMEM67	missense,non_coding_exon	TMEM67:NM_153704.5:missense:MODERATE:exon18/28:c.1810A>G:p.Ile604Val,TMEM67:NM_001142301.1:missense:MODERATE:exon19/29:c.1567A>G:p.Ile523Val,TMEM67:NR_024522.1:non_coding_exon:MODIFIER:exon18/29:n.1881A>G:		rs3134031	0.6929	0.6370	25016/12052/2777	0.6307	0.3570	T	T,T	B,B	B,B	609884 [TMEM67 (confirmed) Meckel syndrome 3|Joubert syndrome 6|Bardet-Biedl syndrome 14,modifier of|COACH syndrome|Nephronophthisis 11];	RCV000114244.2 [likely benign]; 		COSM3763454, COSM3763455, COSM3763456	813	1054					TMEM67 (inh=AR pLI=0.00)
chr8	94929079	94929079	T	A	hom	low_DP	QUAL=364;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,7,1.00,HET,11,0.55	MIR378D2-PDP1	intergenic_region	MIR378D2-PDP1:MIR378D2-PDP1:intergenic_region:MODIFIER::n.94929079T>A:		rs4469422	0.4966	0.0000	0/0/0	0.3476										64	99					MIR378D2-PDP1 (inh=n/a pLI=n/a)
chr8	94935937	94935937	T	C	het		QUAL=16765;DP=558;AF=0.45;MQM=60;TRIO=HET,558,0.45,HOM,203,1.00,HET,280,0.48	PDP1	3'UTR	PDP1:NM_001161779.1:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:NM_018444.3:3'UTR:MODIFIER:exon2/2:c.*36T>C:,PDP1:NM_001161780.1:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:NM_001161781.1:3'UTR:MODIFIER:exon2/2:c.*36T>C:		rs4735258	0.4952	0.4660	13945/5556/805	0.4548										40	109					PDP1 (inh=AR pLI=0.34)
chr8	94936532	94936532	G	C	het		QUAL=10112;DP=301;AF=0.52;MQM=60;TRIO=HET,301,0.52,HOM,110,1.00,HET,167,0.49	PDP1	3'UTR	PDP1:NM_001161779.1:3'UTR:MODIFIER:exon3/3:c.*631G>C:,PDP1:NM_018444.3:3'UTR:MODIFIER:exon2/2:c.*631G>C:,PDP1:NM_001161780.1:3'UTR:MODIFIER:exon3/3:c.*631G>C:,PDP1:NM_001161781.1:3'UTR:MODIFIER:exon2/2:c.*631G>C:		rs911	0.5939	0.0000	0/0/0	0.0871										40	109					PDP1 (inh=AR pLI=0.34)
chr8	96047806	96047806	-	A	hom	anno_pathogenic_clinvar	QUAL=2743;DP=91;AF=0.79;MQM=59;TRIO=HOM,91,0.79,HET,36,0.81,HOM,34,0.88	NDUFAF6	splice_region&intron	NDUFAF6:NM_152416.3:splice_region&intron:LOW:exon3/8:c.420+15dupA:		rs34960210;rs397749867	0.6376	0.5350	1933/1128/159	0.0898						612392 [NDUFAF6 (provisional) Leigh syndrome due to mitochondrial complex I deficiency];	RCV000198813.1 [pathogenic]; 			235	760	1	[1] old entry - no details available			NDUFAF6 (inh=AR pLI=0.00)
chr8	96070181	96070181	T	C	hom		QUAL=8781;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HOM,83,1.00,HOM,95,1.00	NDUFAF6	3'UTR	NDUFAF6:NM_152416.3:3'UTR:MODIFIER:exon9/9:c.*16T>C:		rs2678832	0.9265	0.9410	49924/26745/3260	0.9138										434	48					NDUFAF6 (inh=AR pLI=0.00)
chr8	97239126	97239126	T	C	hom		QUAL=10876;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,61,1.00,HET,82,0.60	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*4207A>G:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*4157A>G:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*4157A>G:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.4887A>G:		rs7827095	0.5100	0.4510	1259/303/51	0.1150										153	266					UQCRB (inh=n/a pLI=0.21)
chr8	97239613	97239613	A	C	hom		QUAL=16670;DP=181;AF=1.00;MQM=57;TRIO=HOM,181,1.00,HOM,232,1.00,HET,283,0.52	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*3720T>G:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*3670T>G:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*3670T>G:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.4400T>G:		rs2292836	0.3664	0.3760	981/298/21	0.1029										160	308					UQCRB (inh=n/a pLI=0.21)
chr8	97240129	97240129	C	T	hom		QUAL=14559;DP=312;AF=0.99;MQM=51;TRIO=HOM,312,0.99,HOM,88,0.99,HET,124,0.58	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*3204G>A:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*3154G>A:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*3154G>A:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.3884G>A:		rs10504961	0.3664	0.3810	981/299/20	0.1013										161	310					UQCRB (inh=n/a pLI=0.21)
chr8	97240847	97240847	A	G	hom		QUAL=27248;DP=346;AF=1.00;MQM=59;TRIO=HOM,346,1.00,HOM,303,1.00,HET,409,0.53	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*2486T>C:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*2436T>C:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*2436T>C:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.3166T>C:	MIR	rs13253635	0.3666	0.3870	982/299/21	0.1038										161	303					UQCRB (inh=n/a pLI=0.21)
chr8	97242124	97242124	G	A	hom		QUAL=19159;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,186,0.99,HET,229,0.53	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*1209C>T:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*1159C>T:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*1159C>T:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.1889C>T:		rs7002575	0.3658	0.3830	978/296/20	0.1014										161	308					UQCRB (inh=n/a pLI=0.21)
chr8	97242134	97242135	CT	-	hom		QUAL=18731;DP=316;AF=1.00;MQM=59;TRIO=HOM,316,1.00,HOM,200,0.98,HET,247,0.53	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*1198_*1199delAG:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*1148_*1149delAG:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*1148_*1149delAG:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.1878_1879delAG:		rs35954659	0.2330	0.3010	659/174/4	0.0772										106	298					UQCRB (inh=n/a pLI=0.21)
chr8	97242849	97242849	C	T	hom		QUAL=13068;DP=245;AF=1.00;MQM=59;TRIO=HOM,245,1.00,HOM,88,1.00,HET,141,0.49	UQCRB	3'UTR,non_coding_exon	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*484G>A:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*434G>A:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*434G>A:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon5/5:n.1164G>A:		rs7836698	0.2336	0.2830	660/175/4	0.0800										106	299					UQCRB (inh=n/a pLI=0.21)
chr8	97243720	97243720	G	A	hom		QUAL=18858;DP=284;AF=0.99;MQM=60;TRIO=HOM,284,0.99,HOM,175,1.00,HET,281,0.54	UQCRB	synonymous,intron,non_coding_exon	UQCRB:NM_001254752.1:synonymous:LOW:exon4/5:c.282C>T:p.His94His,UQCRB:NM_001199975.2:intron:MODIFIER:exon4/4:c.162+282C>T:,UQCRB:NM_006294.4:intron:MODIFIER:exon3/3:c.258+282C>T:,UQCRB:NR_045639.1:non_coding_exon:MODIFIER:exon4/5:n.386C>T:	MIR3	rs2292835	0.2334	0.2040	724/233/5	0.0946						191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3];				161	452					UQCRB (inh=n/a pLI=0.21)
chr8	100133706	100133706	T	G	het	anno_high_impact	QUAL=19339;DP=360;AF=0.49;MQM=60;TRIO=HET,360,0.49,HOM,282,1.00,HET,369,0.53	VPS13B	stop_gained,intron,non_coding_exon	VPS13B:NM_181661.2:stop_gained:HIGH:exon8/8:c.1239T>G:p.Tyr413*,VPS13B:NM_017890.4:intron:MODIFIER:exon8/61:c.1206+33T>G:,VPS13B:NM_015243.2:intron:MODIFIER:exon8/17:c.1206+33T>G:,VPS13B:NM_152564.4:intron:MODIFIER:exon8/61:c.1206+33T>G:,VPS13B:NR_047582.1:non_coding_exon:MODIFIER:exon9/9:n.1465T>G:		rs7460625	0.7051	0.7490	34863/21188/2427	0.7356	0.0410					607817 [VPS13B (confirmed) Cohen syndrome];				709	352	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			VPS13B (inh=AR pLI=0.00)
chr8	100844595	100844595	A	T	het	anno_high_impact;phylop_high	QUAL=81;DP=103;AF=0.20;MQM=54;TRIO=HET,103,0.20,WT,85,0.01,HET,99,0.12	VPS13B	splice_acceptor	VPS13B:NM_017890.4:splice_acceptor:HIGH:exon51/61:c.9406-2A>T:,VPS13B:NM_152564.4:splice_acceptor:HIGH:exon51/61:c.9331-2A>T:		rs74485751	0.3738	0.0045	0/0/0	0.0121	6.2810					607817 [VPS13B (confirmed) Cohen syndrome];				0	20	2	[2] kehrer 22.04.2016 H?ufigkeit			VPS13B (inh=AR pLI=0.00)
chr8	100844758	100844758	T	C	het		QUAL=9409;DP=344;AF=0.51;MQM=60;TRIO=HET,344,0.51,WT,287,0.00,HET,385,0.49	VPS13B	synonymous	VPS13B:NM_017890.4:synonymous:LOW:exon52/62:c.9567T>C:p.Ser3189Ser,VPS13B:NM_152564.4:synonymous:LOW:exon52/62:c.9492T>C:p.Ser3164Ser		rs36074608	0.1971	0.1920	2869/959/32	0.1914						607817 [VPS13B (confirmed) Cohen syndrome];	RCV000081923.7 [other]; 		COSM3982312, COSM3982313	29	289					VPS13B (inh=AR pLI=0.00)
chr8	100888323	100888325	TAT	-	hom		QUAL=10226;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HET,135,0.55,HET,142,0.61	VPS13B	3'UTR	VPS13B:NM_017890.4:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:,VPS13B:NM_152564.4:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:		rs10542428	0.5519	0.0000	0/0/0	0.4135										38	122					VPS13B (inh=AR pLI=0.00)
chr8	103218466	103218466	-	A	het		QUAL=2979;DP=165;AF=0.45;MQM=59;TRIO=HET,165,0.45,WT,83,0.00,HET,124,0.48	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*1894dupT:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*1894dupT:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*1894dupT:		rs150629554	0.0853	0.0000	0/0/0	0.0742										2	42					RRM2B (inh=AR+AD pLI=0.16)
chr8	103218873	103218873	C	G	het		QUAL=5313;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,WT,127,0.00,HET,139,0.42	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*1488G>C:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*1488G>C:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*1488G>C:		rs1265116	0.0777	0.0000	0/0/0	0.0136										3	31					RRM2B (inh=AR+AD pLI=0.16)
chr8	103220351	103220351	A	G	hom		QUAL=18458;DP=305;AF=1.00;MQM=60;TRIO=HOM,305,1.00,HOM,108,1.00,HOM,149,1.00	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*10T>C:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*10T>C:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*10T>C:		rs1265117	1.0000	1.0000	60515/33321/5108	0.9353										2338	0					RRM2B (inh=AR+AD pLI=0.16)
chr8	105440271	105440271	G	C	het		QUAL=4536;DP=230;AF=0.55;MQM=60;TRIO=HET,230,0.55,HET,68,0.65,WT,87,0.00	DPYS	synonymous	DPYS:NM_001385.2:synonymous:LOW:exon6/10:c.1029C>G:p.Thr343Thr		rs117104587	0.0046	0.0110	6/4/0	0.0102						613326 [DPYS (provisional) Dihydropyrimidinuria];	RCV000086522.1 [not provided]; 			0	19					DPYS (inh=AR pLI=0.00)
chr8	105479149	105479149	A	G	het	low_DP	QUAL=941;DP=6;AF=0.50;MQM=60;TRIO=HET,6,0.50,WT,37,0.00,HOM,35,1.00	DPYS	5'UTR	DPYS:NM_001385.2:5'UTR:MODIFIER:exon1/10:c.-1T>C:		rs2959023	0.6362	0.4870	1301/322/107	0.2415							RCV000086534.1 [not provided]; 			395	465					DPYS (inh=AR pLI=0.00)
chr8	119936246	119936246	C	T	het		QUAL=4759;DP=300;AF=0.52;MQM=59;TRIO=HET,300,0.52,WT,55,0.00,HET,63,0.41	TNFRSF11B	3'UTR	TNFRSF11B:NM_002546.3:3'UTR:MODIFIER:exon5/5:c.*367G>A:		rs7815884	0.0887	0.0000	0/0/0	0.0256										0	3					TNFRSF11B (inh=n/a pLI=0.27)
chr8	119936330	119936330	-	T	het		QUAL=2112;DP=194;AF=0.38;MQM=59;TRIO=HET,194,0.38,WT,86,0.05,HET,111,0.39	TNFRSF11B	3'UTR	TNFRSF11B:NM_002546.3:3'UTR:MODIFIER:exon5/5:c.*282dupA:		rs112977670	0.0000	0.0000	0/0/0	0.0022										0	4					TNFRSF11B (inh=n/a pLI=0.27)
chr8	119936669	119936669	A	G	het		QUAL=9350;DP=362;AF=0.51;MQM=59;TRIO=HET,362,0.51,WT,268,0.01,HET,380,0.45	TNFRSF11B	synonymous	TNFRSF11B:NM_002546.3:synonymous:LOW:exon5/5:c.1150T>C:p.Leu384Leu		rs1804854	0.0881	0.0260	451/0/450	0.0248						602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset];				0	9					TNFRSF11B (inh=n/a pLI=0.27)
chr8	119941173	119941173	A	G	hom		QUAL=16709;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HET,182,0.44,HOM,222,1.00	TNFRSF11B	splice_region&intron	TNFRSF11B:NM_002546.3:splice_region&intron:LOW:exon2/4:c.401-5T>C:		rs3134046	0.9237	0.9340	52979/29951/4361	0.9167						602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset];	RCV000177160.1 [benign]; 			971	126					TNFRSF11B (inh=n/a pLI=0.27)
chr8	119964052	119964052	G	C	hom		QUAL=2850;DP=30;AF=1.00;MQM=60;TRIO=HOM,30,1.00,HOM,47,0.98,HET,79,0.42	TNFRSF11B	missense	TNFRSF11B:NM_002546.3:missense:MODERATE:exon1/5:c.9C>G:p.Asn3Lys		rs2073618	0.6667	0.4970	11044/4287/2280	0.4782	0.6450	T	T	B	B	602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset];		CM045665 [CLASS=DP MUT=ALT PHEN="Osteoporotic fractures association with" GENE=TNFRSF11B]; 	COSM453917, COSM1488949	305	547					TNFRSF11B (inh=n/a pLI=0.27)
chr8	119964283	119964283	G	A	hom		QUAL=2636;DP=56;AF=0.98;MQM=60;TRIO=HOM,56,0.98,HET,51,0.43,HET,68,0.44	TNFRSF11B	5'UTR	TNFRSF11B:NM_002546.3:5'UTR:MODIFIER:exon1/5:c.-223C>T:		rs2073617	0.6216	0.0000	0/0/0	0.0904								CR021403 [CLASS=DFP MUT=REF PHEN="Increased intima-media thickness association" GENE=TNFRSF11B]; 		59	116					TNFRSF11B (inh=n/a pLI=0.27)
chr8	120803637	120803637	C	G	het	phylop_high	QUAL=11597;DP=341;AF=0.43;MQM=60;TRIO=HET,341,0.43,HET,239,0.50,HET,294,0.56	TAF2	missense	TAF2:NM_003184.3:missense:MODERATE:exon11/26:c.1340G>C:p.Ser447Thr		rs9297605	0.6583	0.6850	28820/16734/3013	0.6757	4.7700	T,T	T,.	B,.	B,.	604912 [TAF2 (provisional) Mental retardation,autosomal recessive 40];			COSM3982377, COSM150523	565	440					TAF2 (inh=n/a pLI=0.57)
chr8	133133361	133133361	C	T	het		QUAL=11887;DP=360;AF=0.47;MQM=60;TRIO=HET,360,0.47,HOM,146,0.99,HET,219,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*8148G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*8148G>A:		rs1437822	0.1352	0.0000	0/0/0	0.1985										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134003	133134003	G	A	het		QUAL=2036;DP=77;AF=0.57;MQM=60;TRIO=HET,77,0.57,WT,48,0.00,HET,66,0.58	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7506C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7506C>T:		rs11785257	0.1222	0.0000	0/0/0	0.1429										2	54					KCNQ3 (inh=AD pLI=0.99)
chr8	133134288	133134288	G	A	het		QUAL=15554;DP=285;AF=0.44;MQM=60;TRIO=HET,285,0.44,HOM,266,1.00,HET,343,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7221C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7221C>T:		rs2436124	0.1352	0.0000	0/0/0	0.1986										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134366	133134366	T	C	het		QUAL=13891;DP=397;AF=0.46;MQM=60;TRIO=HET,397,0.46,HOM,192,1.00,HET,266,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7143A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7143A>G:	MIRb	rs2436125	0.1352	0.0000	0/0/0	0.1982										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134390	133134390	G	A	het		QUAL=14876;DP=386;AF=0.46;MQM=60;TRIO=HET,386,0.46,HOM,209,1.00,HET,301,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7119C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7119C>T:	MIRb	rs2436126	0.1352	0.0000	0/0/0	0.1982										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134434	133134434	T	C	het		QUAL=15946;DP=423;AF=0.48;MQM=60;TRIO=HET,423,0.48,HOM,226,1.00,HET,323,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7075A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7075A>G:	MIRb	rs2436127	0.1348	0.0000	0/0/0	0.1969										11	72					KCNQ3 (inh=AD pLI=0.99)
chr8	133134476	133134476	A	G	het		QUAL=18323;DP=520;AF=0.45;MQM=60;TRIO=HET,520,0.45,HOM,239,1.00,HET,365,0.48	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7033T>C:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7033T>C:	MIRb	rs2436128	0.1348	0.0000	0/0/0	0.1971										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134553	133134553	T	C	het		QUAL=14369;DP=373;AF=0.45;MQM=60;TRIO=HET,373,0.45,HOM,202,1.00,HET,319,0.47	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6956A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6956A>G:		rs2469630	0.1360	0.0000	0/0/0	0.1978										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134635	133134635	G	C	het		QUAL=12070;DP=378;AF=0.44;MQM=60;TRIO=HET,378,0.44,HOM,157,1.00,HET,217,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6874C>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6874C>G:	L4_C_Mam	rs2436129	0.1348	0.0000	0/0/0	0.1975										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133135169	133135169	C	T	het		QUAL=10936;DP=308;AF=0.50;MQM=60;TRIO=HET,308,0.50,HOM,128,0.99,HET,185,0.51	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6340G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6340G>A:		rs2469629	0.1392	0.0000	0/0/0	0.1986										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133135577	133135577	T	G	het		QUAL=15381;DP=321;AF=0.51;MQM=59;TRIO=HET,321,0.51,HOM,245,1.00,HET,290,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*5932A>C:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*5932A>C:		rs2436130	0.1352	0.0000	0/0/0	0.1984										11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133135790	133135790	G	A	het		QUAL=7835;DP=314;AF=0.47;MQM=60;TRIO=HET,314,0.47,WT,207,0.01,HET,299,0.48	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*5719C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*5719C>T:		rs11786417	0.1222	0.0000	0/0/0	0.1433										2	54					KCNQ3 (inh=AD pLI=0.99)
chr8	133136551	133136551	T	C	hom		QUAL=20848;DP=262;AF=1.00;MQM=59;TRIO=HOM,262,1.00,HOM,146,1.00,HOM,223,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4958A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4958A>G:		rs1437824	0.7228	0.0000	0/0/0	0.7947										105	44					KCNQ3 (inh=AD pLI=0.99)
chr8	133136762	133136762	-	CTGT	hom		QUAL=22274;DP=190;AF=0.98;MQM=59;TRIO=HOM,190,0.98,HOM,218,1.00,HOM,303,0.99	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4746_*4747insACAG:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4746_*4747insACAG:		rs112550767	0.2863	0.0000	0/0/0	0.3801										43	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137266	133137266	T	A	hom		QUAL=26613;DP=381;AF=0.99;MQM=60;TRIO=HOM,381,0.99,HOM,205,1.00,HOM,221,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4243A>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4243A>T:		rs2436131	0.2863	0.0000	0/0/0	0.3957										43	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137532	133137532	C	T	hom		QUAL=16213;DP=288;AF=0.99;MQM=59;TRIO=HOM,288,0.99,HOM,92,1.00,HOM,119,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3977G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3977G>A:		rs2469628	0.3109	0.0000	0/0/0	0.4023										43	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137912	133137912	C	T	hom		QUAL=15931;DP=303;AF=1.00;MQM=60;TRIO=HOM,303,1.00,HOM,77,1.00,HOM,87,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3597G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3597G>A:		rs1025436	0.7208	0.0000	0/0/0	0.7924										103	46					KCNQ3 (inh=AD pLI=0.99)
chr8	133138474	133138474	T	C	het		QUAL=16747;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.99,HOM,136,1.00,HET,179,0.99	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3035A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3035A>G:		rs2469627	0.1432	0.0000	0/0/0	0.2117										14	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133138477	133138477	T	C	hom		QUAL=16747;DP=243;AF=0.48;MQM=60;TRIO=HOM,243,0.99,HOM,136,1.00,HOM,179,0.99	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3032A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3032A>G:		rs2469626	0.2931	0.0000	0/0/0	0.4086										47	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133139755	133139755	G	A	hom		QUAL=43706;DP=579;AF=0.99;MQM=60;TRIO=HOM,579,0.99,HOM,344,0.99,HOM,419,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*1754C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*1754C>T:		rs977939	0.2686	0.0000	0/0/0	0.0605										40	79					KCNQ3 (inh=AD pLI=0.99)
chr8	133140755	133140760	TGTGTG	-	hom		QUAL=3782;DP=104;AF=0.56;MQM=59;TRIO=HOM,104,0.56,WT,58,0.47,HOM,115,0.54	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*749_*754delCACACA:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*749_*754delCACACA:	(TG)n	rs201964249	0.0000	0.0000	0/0/0	0.0507										6	37					KCNQ3 (inh=AD pLI=0.99)
chr8	133883671	133883671	C	T	het	phylop_high;pred_pathogenic_3	QUAL=10247;DP=332;AF=0.43;MQM=59;TRIO=HET,332,0.43,WT,320,0.00,HET,514,0.52	TG	missense	TG:NM_003235.4:missense:MODERATE:exon4/48:c.353C>T:p.Pro118Leu		rs114322847	0.0058	0.0150	19/15/0	0.0151	5.2540	D	T,T,.	D	D	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];				1	46					TG (inh=AR pLI=0.00)
chr8	133900252	133900252	T	G	het	phylop_high	QUAL=1826;DP=103;AF=0.45;MQM=59;TRIO=HET,103,0.45,HET,71,0.55,WT,70,0.00	TG	missense	TG:NM_003235.4:missense:MODERATE:exon10/48:c.2200T>G:p.Ser734Ala		rs180223	0.6763	0.5830	20870/9287/2702	0.5724	6.0760	T	T,T,.	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013534.2 [other]; 		COSM4162675	353	530					TG (inh=AR pLI=0.00)
chr8	133900386	133900386	T	C	het		QUAL=6312;DP=283;AF=0.56;MQM=59;TRIO=HET,283,0.56,HET,209,0.46,WT,285,0.00	TG	synonymous	TG:NM_003235.4:synonymous:LOW:exon10/48:c.2334T>C:p.Pro778Pro		rs2069550	0.6727	0.5820	20815/9308/2601	0.5768						188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];				356	530					TG (inh=AR pLI=0.00)
chr8	133909974	133909974	A	G	het		QUAL=8746;DP=436;AF=0.50;MQM=59;TRIO=HET,436,0.50,HET,247,0.50,WT,343,0.01	TG	missense	TG:NM_003235.4:missense:MODERATE:exon12/48:c.3082A>G:p.Met1028Val		rs853326	0.6749	0.5840	21191/9469/2712	0.5782	-0.4530	T	T,T	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013535.2 [other]; 		COSM4162676	356	533					TG (inh=AR pLI=0.00)
chr8	133920518	133920518	A	G	hom	phylop_high	QUAL=15198;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,161,1.00,HET,199,0.50	TG	missense	TG:NM_003235.4:missense:MODERATE:exon18/48:c.3935A>G:p.Asp1312Gly		rs2069556	0.3988	0.5690	21204/13133/123	0.5544	4.2890	T	T,T,T	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM1454960	411	507					TG (inh=AR pLI=0.00)
chr8	133931748	133931748	T	C	hom		QUAL=18648;DP=358;AF=0.99;MQM=60;TRIO=HOM,358,0.99,HOM,154,0.99,HET,218,0.49	TG	synonymous	TG:NM_003235.4:synonymous:LOW:exon21/48:c.4506T>C:p.Ala1502Ala		rs853304	0.4738	0.5910	21933/13093/804	0.5820	-0.6180	T				188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM150549	414	498					TG (inh=AR pLI=0.00)
chr8	133975283	133975283	G	A	hom	pred_pathogenic_1	QUAL=14137;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,139,1.00,HET,202,0.52	TG	missense	TG:NM_003235.4:missense:MODERATE:exon29/48:c.5512G>A:p.Asp1838Asn		rs2069561	0.3468	0.4850	15551/9018/67	0.4654	0.5280	T,T	T,T,D,T,.	B,B,.	B,B,.	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM150550	291	507					TG (inh=AR pLI=0.00)
chr8	133984058	133984058	C	T	het		QUAL=8440;DP=310;AF=0.49;MQM=59;TRIO=HET,310,0.49,WT,294,0.00,HET,322,0.55	TG	missense	TG:NM_003235.4:missense:MODERATE:exon33/48:c.5995C>T:p.Arg1999Trp		rs2076740	0.3325	0.3230	6808/4063/1350	0.3198	0.0500	T,T	T,T,T,T,T,.	B,B,B,.	B,B,B,.	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013533.2 [other]; 	CM035973 [CLASS=DP MUT=ALT PHEN="Autoimmune thyroid disease association with" GENE=TG]; 	COSM3982409	155	504					TG (inh=AR pLI=0.00)
chr8	134250165	134250165	A	G	het		QUAL=4828;DP=215;AF=0.47;MQM=59;TRIO=HET,215,0.47,HET,175,0.53,WT,236,0.00	NDRG1	3'UTR	NDRG1:NM_001135242.1:3'UTR:MODIFIER:exon16/16:c.*956T>C:,NDRG1:NM_001258432.1:3'UTR:MODIFIER:exon14/14:c.*956T>C:,NDRG1:NM_001258433.1:3'UTR:MODIFIER:exon15/15:c.*956T>C:,NDRG1:NM_006096.3:3'UTR:MODIFIER:exon16/16:c.*956T>C:		rs1049697	0.8303	0.0000	0/0/0	0.8020										147	74					NDRG1 (inh=n/a pLI=0.05)
chr8	134250430	134250430	C	T	het		QUAL=7645;DP=342;AF=0.51;MQM=59;TRIO=HET,342,0.51,HET,256,0.49,WT,366,0.00	NDRG1	3'UTR	NDRG1:NM_001135242.1:3'UTR:MODIFIER:exon16/16:c.*691G>A:,NDRG1:NM_001258432.1:3'UTR:MODIFIER:exon14/14:c.*691G>A:,NDRG1:NM_001258433.1:3'UTR:MODIFIER:exon15/15:c.*691G>A:,NDRG1:NM_006096.3:3'UTR:MODIFIER:exon16/16:c.*691G>A:		rs1049694	0.2718	0.0000	0/0/0	0.2940										24	98					NDRG1 (inh=n/a pLI=0.05)
chr8	134292516	134292516	A	G	hom		QUAL=23790;DP=298;AF=1.00;MQM=59;TRIO=HOM,298,1.00,HET,246,0.56,HOM,328,0.99	NDRG1	splice_region&intron,intron	NDRG1:NM_001135242.1:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:NM_001258433.1:splice_region&intron:LOW:exon2/14:c.-74-6T>C:,NDRG1:NM_006096.3:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:NM_001258432.1:intron:MODIFIER:exon1/13:c.-99-15621T>C:		rs2272653	0.6134	0.5630	20102/11176/3883	0.5584						605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D];				378	517					NDRG1 (inh=n/a pLI=0.05)
chr8	134309134	134309134	G	A	het		QUAL=1462;DP=59;AF=0.53;MQM=60;TRIO=HET,59,0.53,HET,62,0.60,WT,98,0.00	NDRG1	5'UTR,intron	NDRG1:NM_001135242.1:5'UTR:MODIFIER:exon1/16:c.-173C>T:,NDRG1:NM_001258432.1:intron:MODIFIER:exon1/13:c.-100+243C>T:,NDRG1:NM_001258433.1:intron:MODIFIER:exon1/14:c.-156+243C>T:,NDRG1:NM_006096.3:intron:MODIFIER:exon1/15:c.-19+243C>T:		rs10108354	0.0847	0.0000	0/0/0	0.0757										6	44					NDRG1 (inh=n/a pLI=0.05)
chr8	140624798	140624798	-	G	hom		QUAL=27195;DP=228;AF=0.99;MQM=59;TRIO=HOM,228,0.99,HOM,283,1.00,HOM,363,1.00	KCNK9	non_coding_exon	KCNK9:NR_104210.1:non_coding_exon:MODIFIER:exon3/4:n.1308dupC:		rs386414214;rs79186831	1.0000	0.0000	0/0/0	0.9145										230	0					KCNK9 (inh=n/a pLI=0.13)
chr8	140743200	140743200	G	A	hom		QUAL=6554;DP=91;AF=1.00;MQM=59;TRIO=HOM,91,1.00,HET,132,0.55,HET,174,0.60	TRAPPC9	3'UTR	TRAPPC9:NM_031466.6:3'UTR:MODIFIER:exon23/23:c.*104C>T:,TRAPPC9:NM_001160372.2:3'UTR:MODIFIER:exon23/23:c.*104C>T:	GA-rich	rs199226	0.2007	0.0000	0/0/0	0.0277										4	62					TRAPPC9 (inh=AR pLI=0.00)
chr8	141310644	141310644	G	A	het		QUAL=10928;DP=364;AF=0.48;MQM=60;TRIO=HET,364,0.48,HET,540,0.47,WT,677,0.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon11/23:c.1986C>T:p.Asn662Asn,TRAPPC9:NM_001160372.2:synonymous:LOW:exon11/23:c.1692C>T:p.Asn564Asn		rs12549048	0.3558	0.2680	5520/1066/285	0.2629	0.2020	T				611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118668.2 [likely benign]; 			45	299					TRAPPC9 (inh=AR pLI=0.00)
chr8	141445350	141445370	AGAAAACAAAAAACAAAAACC	-	het		QUAL=10485;DP=184;AF=0.98;MQM=59;TRIO=HET,184,0.98,HET,168,0.97,HET,185,0.97	TRAPPC9	splice_region&intron	TRAPPC9:NM_031466.6:splice_region&intron:LOW:exon3/22:c.1025-31_1025-11delGGTTTTTGTTTTTTGTTTTCT:,TRAPPC9:NM_001160372.2:splice_region&intron:LOW:exon3/22:c.731-31_731-11delGGTTTTTGTTTTTTGTTTTCT:	(AAAACAA)n	rs11267571	0.7768	0.7400	27026/12824/1535	0.6880						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];				178	710					TRAPPC9 (inh=AR pLI=0.00)
chr8	141461062	141461062	G	A	het		QUAL=16667;DP=332;AF=0.46;MQM=60;TRIO=HET,332,0.46,HET,241,0.55,HOM,303,1.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.705C>T:p.Asn235Asn,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.411C>T:p.Asn137Asn		rs3735803	0.4667	0.4680	13536/7670/893	0.4644						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118685.2 [likely benign]; 			261	545					TRAPPC9 (inh=AR pLI=0.00)
chr8	141461185	141461185	A	G	het		QUAL=13227;DP=182;AF=0.48;MQM=60;TRIO=HET,182,0.48,HET,217,0.47,HOM,271,0.99	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.582T>C:p.Phe194Phe,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.288T>C:p.Phe96Phe		rs3735802	0.5389	0.5440	18260/10740/1545	0.5388						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118681.2 [likely benign]; 			373	522					TRAPPC9 (inh=AR pLI=0.00)
chr8	141461266	141461266	A	G	het		QUAL=10353;DP=239;AF=0.44;MQM=59;TRIO=HET,239,0.44,HET,178,0.43,HOM,206,1.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.501T>C:p.Gly167Gly,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.207T>C:p.Gly69Gly		rs3735801	0.5379	0.5440	18207/10738/1546	0.5239						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118680.2 [likely benign]; 			373	522					TRAPPC9 (inh=AR pLI=0.00)
chr8	143953937	143953937	A	C	het		QUAL=12017;DP=429;AF=0.53;MQM=60;TRIO=HET,429,0.53,HET,193,0.47,HET,273,0.48	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1852T>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1852T>G:	MLT1A0-int	rs4736312	0.6963	0.0000	0/0/0	0.1073										69	71					CYP11B1 (inh=n/a pLI=0.00)
chr8	143954223	143954223	C	A	het		QUAL=12749;DP=412;AF=0.53;MQM=60;TRIO=HET,412,0.53,HET,240,0.60,HET,270,0.47	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1566G>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1566G>T:	MLT1A0	rs1134096	0.6961	0.0000	0/0/0	0.1073										74	73					CYP11B1 (inh=n/a pLI=0.00)
chr8	143954290	143954290	G	A	het		QUAL=14300;DP=443;AF=0.48;MQM=59;TRIO=HET,443,0.48,HET,307,0.56,HET,340,0.46	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1499C>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1499C>T:	MLT1A0	rs1134095	0.6941	0.0000	0/0/0	0.1068										74	75					CYP11B1 (inh=n/a pLI=0.00)
chr8	143954747	143954747	T	C	het		QUAL=12770;DP=390;AF=0.51;MQM=59;TRIO=HET,390,0.51,HET,263,0.49,HET,308,0.52	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1042A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1042A>G:		rs7003319	0.6957	0.0000	0/0/0	0.1072										94	105					CYP11B1 (inh=n/a pLI=0.00)
chr8	143954769	143954769	G	A	het		QUAL=12168;DP=391;AF=0.47;MQM=57;TRIO=HET,391,0.47,HET,270,0.49,HET,316,0.52	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1020C>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1020C>T:		rs5017238	0.6957	0.0000	0/0/0	0.6276										94	105					CYP11B1 (inh=n/a pLI=0.00)
chr8	143955051	143955051	C	T	het		QUAL=21317;DP=311;AF=0.44;MQM=59;TRIO=HET,311,0.44,HET,628,0.50,HET,781,0.50	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*738G>A:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*738G>A:		rs5304	0.6957	0.0000	0/0/0	0.6221										95	106					CYP11B1 (inh=n/a pLI=0.00)
chr8	143955095	143955095	A	G	het		QUAL=18874;DP=393;AF=0.45;MQM=59;TRIO=HET,393,0.45,HET,551,0.49,HET,672,0.48	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*694T>C:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*694T>C:		rs5303	0.7462	0.0000	0/0/0	0.1090										95	106					CYP11B1 (inh=n/a pLI=0.00)
chr8	143955273	143955273	T	C	het		QUAL=20125;DP=453;AF=0.51;MQM=59;TRIO=HET,453,0.51,HET,525,0.51,HET,655,0.45	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*516A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*516A>G:		rs5301	0.5745	0.0000	0/0/0	0.0907										67	114					CYP11B1 (inh=n/a pLI=0.00)
chr8	143955318	143955318	T	G	het		QUAL=17586;DP=388;AF=0.42;MQM=59;TRIO=HET,388,0.42,HET,508,0.52,HET,603,0.45	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*471A>C:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*471A>C:		rs12543598	0.7512	0.0000	0/0/0	0.6429										95	106					CYP11B1 (inh=n/a pLI=0.00)
chr8	143955471	143955471	T	C	het		QUAL=12469;DP=304;AF=0.49;MQM=59;TRIO=HET,304,0.49,HET,292,0.49,HET,378,0.52	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*318A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*318A>G:		rs5299	0.6957	0.0000	0/0/0	0.1066										95	106					CYP11B1 (inh=n/a pLI=0.00)
chr8	143960597	143960597	G	A	het		QUAL=10335;DP=127;AF=0.56;MQM=59;TRIO=HET,127,0.56,HET,302,0.53,HET,410,0.50	CYP11B1	synonymous	CYP11B1:NM_000497.3:synonymous:LOW:exon2/9:c.246C>T:p.Asp82Asp,CYP11B1:NM_001026213.1:synonymous:LOW:exon2/8:c.246C>T:p.Asp82Asp		rs5283	0.3027	0.3980	10240/6426/64	0.3935						610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency|Aldosteronism,glucocorticoid-remediable];			COSM4162721	234	531					CYP11B1 (inh=n/a pLI=0.00)
chr8	143961005	143961005	T	C	het		QUAL=7892;DP=182;AF=0.49;MQM=59;TRIO=HET,182,0.49,HET,239,0.51,HET,242,0.45	CYP11B1	synonymous	CYP11B1:NM_000497.3:synonymous:LOW:exon1/9:c.225A>G:p.Leu75Leu,CYP11B1:NM_001026213.1:synonymous:LOW:exon1/8:c.225A>G:p.Leu75Leu		rs6410	0.5841	0.5720	20338/9825/996	0.5663						610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency|Aldosteronism,glucocorticoid-remediable];				384	531					CYP11B1 (inh=n/a pLI=0.00)
chr8	143992218	143992218	A	G	het		QUAL=16719;DP=404;AF=0.51;MQM=59;TRIO=HET,404,0.51,HET,400,0.52,HET,476,0.47	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*1178T>C:		rs3802228	0.5988	0.0000	0/0/0	0.5367										86	108					CYP11B2 (inh=n/a pLI=0.00)
chr8	143992661	143992661	C	T	het		QUAL=20623;DP=363;AF=0.47;MQM=59;TRIO=HET,363,0.47,HET,698,0.47,HET,763,0.43	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*735G>A:		rs28491316	0.3099	0.0000	0/0/0	0.3790										50	119					CYP11B2 (inh=n/a pLI=0.00)
chr8	143992864	143992864	C	A	het		QUAL=20981;DP=463;AF=0.41;MQM=59;TRIO=HET,463,0.41,HET,572,0.50,HET,694,0.50	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*532G>T:		rs3802230	0.5958	0.0000	0/0/0	0.0857										86	108					CYP11B2 (inh=n/a pLI=0.00)
chr8	143993101	143993101	-	GGA	het		QUAL=8624;DP=261;AF=0.44;MQM=59;TRIO=HET,261,0.44,HET,232,0.49,HET,269,0.53	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*292_*294dupTCC:		rs377036717;rs3839864	0.7748	0.0000	0/0/0	0.5847										97	104					CYP11B2 (inh=n/a pLI=0.00)
chr8	143993157	143993157	A	G	hom		QUAL=22709;DP=217;AF=1.00;MQM=59;TRIO=HOM,217,1.00,HOM,264,1.00,HOM,250,1.00	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*239T>C:		rs9297975	0.9990	0.0000	0/0/0	0.1496										230	0					CYP11B2 (inh=n/a pLI=0.00)
chr8	143994702	143994702	G	T	het		QUAL=4466;DP=62;AF=0.53;MQM=50;TRIO=HET,62,0.53,HET,138,0.52,HET,166,0.51	CYP11B2	splice_region&synonymous	CYP11B2:NM_000498.3:splice_region&synonymous:LOW:exon6/9:c.1120C>A:p.Arg374Arg		rs4538	0.6076	0.5890	21108/10299/1112	0.5363						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];			COSM454129	416	508					CYP11B2 (inh=n/a pLI=0.00)
chr8	143995761	143995761	C	T	hom		QUAL=34663;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,347,1.00,HOM,491,1.00	CYP11B2	synonymous	CYP11B2:NM_000498.3:synonymous:LOW:exon5/9:c.873G>A:p.Ala291Ala		rs4536	0.8235	0.9090	51128/31890/4646	0.8896						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];				1037	65					CYP11B2 (inh=n/a pLI=0.00)
chr8	143996539	143996539	T	C	het		QUAL=10762;DP=166;AF=0.48;MQM=54;TRIO=HET,166,0.48,HET,320,0.48,HET,422,0.49	CYP11B2	missense	CYP11B2:NM_000498.3:missense:MODERATE:exon3/9:c.518A>G:p.Lys173Arg		rs4539	0.3464	0.4170	10586/6607/276	0.3638	-0.6680	T	T	B	B	124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];		CM962423 [CLASS=DP MUT=ALT PHEN="Low renin hypertension association with" GENE=CYP11B2]; 	COSM4006860	254	530					CYP11B2 (inh=n/a pLI=0.00)
chr8	143996553	143996553	G	A	het		QUAL=11254;DP=196;AF=0.47;MQM=55;TRIO=HET,196,0.47,HET,315,0.48,HET,424,0.50	CYP11B2	synonymous	CYP11B2:NM_000498.3:synonymous:LOW:exon3/9:c.504C>T:p.Phe168Phe		rs72552275	0.3454	0.4160	10689/6665/273	0.3680						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];			COSM1569160	255	528					CYP11B2 (inh=n/a pLI=0.00)
chr8	144989452	144989452	T	C	het		QUAL=1198;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,WT,53,0.00,HET,66,0.56	PLEC	3'UTR	PLEC:NM_201380.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201384.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201383.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201382.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201381.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201379.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201378.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_000445.4:3'UTR:MODIFIER:exon33/33:c.*893A>G:		rs189205952	0.0006	0.0000	0/0/0	0.0008										0	1					PLEC (inh=n/a pLI=0.02)
chr8	144995964	144995964	G	A	het		QUAL=4193;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,WT,210,0.00,HET,265,0.44	PLEC	synonymous	PLEC:NM_201380.3:synonymous:LOW:exon32/32:c.8436C>T:p.Gly2812Gly,PLEC:NM_201384.2:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:NM_201383.2:synonymous:LOW:exon32/32:c.8037C>T:p.Gly2679Gly,PLEC:NM_201382.3:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:NM_201381.2:synonymous:LOW:exon32/32:c.7929C>T:p.Gly2643Gly,PLEC:NM_201379.2:synonymous:LOW:exon32/32:c.7959C>T:p.Gly2653Gly,PLEC:NM_201378.3:synonymous:LOW:exon32/32:c.7983C>T:p.Gly2661Gly,PLEC:NM_000445.4:synonymous:LOW:exon33/33:c.8106C>T:p.Gly2702Gly		rs35139934	0.0276	0.0570	288/244/1	0.0556						601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q|Epidermolysis bullosa simplex with nail dystrophy];	RCV000117978.4 [other]; 		COSM4162792, COSM4162791, COSM4162789, COSM4162790, COSM4162793, COSM4162788	19	172					PLEC (inh=n/a pLI=0.02)
chr8	144997503	144997503	G	A	het		QUAL=3304;DP=102;AF=0.40;MQM=60;TRIO=HET,102,0.40,HET,210,0.48,WT,259,0.00	PLEC	synonymous	PLEC:NM_201380.3:synonymous:LOW:exon31/32:c.7005C>T:p.Thr2335Thr,PLEC:NM_201384.2:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:NM_201383.2:synonymous:LOW:exon31/32:c.6606C>T:p.Thr2202Thr,PLEC:NM_201382.3:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:NM_201381.2:synonymous:LOW:exon31/32:c.6498C>T:p.Thr2166Thr,PLEC:NM_201379.2:synonymous:LOW:exon31/32:c.6528C>T:p.Thr2176Thr,PLEC:NM_201378.3:synonymous:LOW:exon31/32:c.6552C>T:p.Thr2184Thr,PLEC:NM_000445.4:synonymous:LOW:exon32/33:c.6675C>T:p.Thr2225Thr		rs144242254	0.0016	0.0012	1/0/0	0.0012						601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q|Epidermolysis bullosa simplex with nail dystrophy];	RCV000177614.1 [uncertain significance]; 			0	10					PLEC (inh=n/a pLI=0.02)
chr8	145004546	145004546	G	A	hom	low_DP	QUAL=1003;DP=14;AF=1.00;MQM=60;TRIO=HOM,14,1.00,HOM,11,1.00,HOM,12,1.00	PLEC	splice_region&intron	PLEC:NM_201380.3:splice_region&intron:LOW:exon20/31:c.2868+6C>T:,PLEC:NM_201384.2:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:NM_201383.2:splice_region&intron:LOW:exon20/31:c.2469+6C>T:,PLEC:NM_201382.3:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:NM_201381.2:splice_region&intron:LOW:exon20/31:c.2361+6C>T:,PLEC:NM_201379.2:splice_region&intron:LOW:exon20/31:c.2391+6C>T:,PLEC:NM_201378.3:splice_region&intron:LOW:exon20/31:c.2415+6C>T:,PLEC:NM_000445.4:splice_region&intron:LOW:exon21/32:c.2538+6C>T:		rs11780911	0.5719	0.6800	15015/10543/338	0.5965						601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q|Epidermolysis bullosa simplex with nail dystrophy];	RCV000117959.6 [other]; 			705	339					PLEC (inh=n/a pLI=0.02)
chr8	145024450	145024450	C	T	het	phylop_high;pred_pathogenic_1	QUAL=4700;DP=106;AF=0.53;MQM=59;TRIO=HET,106,0.53,HET,261,0.54,WT,329,0.00	PLEC	missense,intron	PLEC:NM_201380.3:missense:MODERATE:exon1/32:c.425G>A:p.Arg142Gln,PLEC:NM_201379.2:intron:MODIFIER:exon1/31:c.46+3444G>A:,PLEC:NM_201378.3:intron:MODIFIER:exon1/31:c.71-11590G>A:,PLEC:NM_000445.4:intron:MODIFIER:exon2/32:c.194-11590G>A:		rs558227477	0.0000	0.0000	0/0/0	0.0001	2.5110	T	D	B	B	601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q|Epidermolysis bullosa simplex with nail dystrophy];				0	1					PLEC (inh=n/a pLI=0.02)
chr8	145699382	145699384	CTC	-	het		QUAL=7327;DP=276;AF=0.52;MQM=58;TRIO=HET,276,0.52,HET,369,0.51,WT,459,0.00	KIFC2,FOXH1	3'UTR	KIFC2:NM_145754.3:3'UTR:MODIFIER:exon17/17:c.*551_*553delCCT:,FOXH1:NM_003923.2:3'UTR:MODIFIER:exon3/3:c.*237_*239delGAG:		rs550365735	0.0012	0.0000	0/0/0	0.0006										0	1					KIFC2 (inh=n/a pLI=0.00), FOXH1 (inh=n/a pLI=0.01)
chr8	145699601	145699601	T	C	hom		QUAL=17184;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HOM,185,0.99,HOM,217,1.00	FOXH1	3'UTR	FOXH1:NM_003923.2:3'UTR:MODIFIER:exon3/3:c.*20A>G:		rs2721176	0.9457	0.9700	42177/25590/3618	0.8869										473	8					FOXH1 (inh=n/a pLI=0.01)
chr8	145700346	145700346	T	A	het	phylop_high;pred_pathogenic_2	QUAL=1709;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,WT,122,0.00,HET,116,0.51	FOXH1	missense	FOXH1:NM_003923.2:missense:MODERATE:exon3/3:c.373A>T:p.Thr125Ser		rs112028242	0.0266	0.0068	30/0/30	0.0066	2.3370	T	T,T	D	D		RCV000177182.1 [benign]; 			0	7					FOXH1 (inh=n/a pLI=0.01)
chr8	145701453	145701453	A	C	hom		QUAL=2881;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,17,0.94,HOM,34,1.00	FOXH1	5'UTR_premature_start_codon_gain,5'UTR	FOXH1:NM_003923.2:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-314T>G:,FOXH1:NM_003923.2:5'UTR:MODIFIER:exon1/3:c.-314T>G:		rs750472	0.4443	0.0000	0/0/0	0.4519										65	108					FOXH1 (inh=n/a pLI=0.01)
chr9	271638	271638	C	T	het	pred_pathogenic_1	QUAL=14394;DP=356;AF=0.53;MQM=60;TRIO=HET,356,0.53,HOM,301,1.00,WT,322,0.00	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon2/48:c.65C>T:p.Ala22Val		rs506121	0.3077	0.3090	1198/518/103	0.1090	1.4180	T	D,D	B	B	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150504.2 [benign]; RCV000210052.1 [benign]; 		COSM3982814	118	482					DOCK8 (inh=n/a pLI=0.00)
chr9	286491	286491	G	A	het	phylop_high;pred_pathogenic_3	QUAL=7367;DP=188;AF=0.48;MQM=60;TRIO=HET,188,0.48,HET,192,0.46,HET,275,0.48	DOCK8	missense,5'UTR	DOCK8:NM_203447.3:missense:MODERATE:exon3/48:c.187G>A:p.Asp63Asn,DOCK8:NM_001190458.1:5'UTR:MODIFIER:exon2/46:c.-18G>A:,DOCK8:NM_001193536.1:5'UTR:MODIFIER:exon2/47:c.-18G>A:		rs3209441	0.0701	0.1230	1179/957/7	0.1237	9.4790	T	D,T	D	D	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150505.2 [benign]; 			44	264					DOCK8 (inh=n/a pLI=0.00)
chr9	286593	286593	C	A	het	phylop_high;pred_pathogenic_3	QUAL=11803;DP=277;AF=0.49;MQM=60;TRIO=HET,277,0.49,HET,228,0.58,HET,321,0.59	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon3/48:c.289C>A:p.Pro97Thr,DOCK8:NM_001190458.1:missense:MODERATE:exon2/46:c.85C>A:p.Pro29Thr,DOCK8:NM_001193536.1:missense:MODERATE:exon2/47:c.85C>A:p.Pro29Thr		rs529208	0.5298	0.5200	16792/8156/852	0.5158	3.1490	T	D,D,D,T,T,D	D,D,P	D,P,P	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155526.1 [benign]; RCV000210057.1 [benign]; 		COSM3763875, COSM3763874	282	515					DOCK8 (inh=n/a pLI=0.00)
chr9	312124	312124	T	C	het		QUAL=8963;DP=142;AF=0.53;MQM=59;TRIO=HET,142,0.53,HET,267,0.51,HET,282,0.52	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon6/48:c.699T>C:p.Asn233Asn,DOCK8:NM_001190458.1:synonymous:LOW:exon5/46:c.495T>C:p.Asn165Asn,DOCK8:NM_001193536.1:synonymous:LOW:exon5/47:c.495T>C:p.Asn165Asn		rs2039045	0.1643	0.1680	1905/1074/344	0.1667						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150506.2 [benign]; 			36	324					DOCK8 (inh=n/a pLI=0.00)
chr9	334337	334337	A	G	het		QUAL=9217;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,HOM,148,1.00,HET,188,0.46	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon11/48:c.1238A>G:p.Asn413Ser,DOCK8:NM_001190458.1:missense:MODERATE:exon10/46:c.1034A>G:p.Asn345Ser,DOCK8:NM_001193536.1:missense:MODERATE:exon10/47:c.1034A>G:p.Asn345Ser		rs10970979	0.1997	0.2490	4204/3002/270	0.2316	0.4170	T	T,T,T,T	B,B	B,B	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150508.1 [benign]; 		COSM3765452, COSM3765451	105	452					DOCK8 (inh=n/a pLI=0.00)
chr9	370244	370244	A	G	het		QUAL=20135;DP=406;AF=0.44;MQM=60;TRIO=HET,406,0.44,HOM,301,0.99,HET,408,0.51	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon16/48:c.1812A>G:p.Lys604Lys,DOCK8:NM_001190458.1:synonymous:LOW:exon15/46:c.1608A>G:p.Lys536Lys,DOCK8:NM_001193536.1:synonymous:LOW:exon15/47:c.1608A>G:p.Lys536Lys		rs913703	0.2159	0.2230	3228/1843/421	0.2196						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155528.2 [benign]; 		COSM3763926, COSM3763925	67	399					DOCK8 (inh=n/a pLI=0.00)
chr9	377111	377111	G	C	het		QUAL=5599;DP=167;AF=0.43;MQM=59;TRIO=HET,167,0.43,HOM,97,0.99,HET,135,0.42	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon20/48:c.2340G>C:p.Leu780Leu,DOCK8:NM_001190458.1:synonymous:LOW:exon19/46:c.2136G>C:p.Leu712Leu,DOCK8:NM_001193536.1:synonymous:LOW:exon19/47:c.2136G>C:p.Leu712Leu		rs10814431	0.2286	0.2290	3272/1891/414	0.2273						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150510.2 [benign]; 		COSM3763936, COSM3763935	75	396					DOCK8 (inh=n/a pLI=0.00)
chr9	390512	390512	C	T	het		QUAL=20055;DP=324;AF=0.53;MQM=59;TRIO=HET,324,0.53,HOM,321,1.00,HET,372,0.50	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon24/48:c.2916C>T:p.Thr972Thr,DOCK8:NM_001190458.1:synonymous:LOW:exon22/46:c.2616C>T:p.Thr872Thr,DOCK8:NM_001193536.1:synonymous:LOW:exon23/47:c.2712C>T:p.Thr904Thr		rs2297075	0.2550	0.2340	3600/1858/730	0.2318						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155529.2 [benign]; 		COSM1179612, COSM1179613	72	391					DOCK8 (inh=n/a pLI=0.00)
chr9	429719	429719	T	C	hom		QUAL=26415;DP=294;AF=1.00;MQM=60;TRIO=HOM,294,1.00,HOM,219,1.00,HOM,306,1.00	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon36/48:c.4491T>C:p.Phe1497Phe,DOCK8:NM_001190458.1:synonymous:LOW:exon34/46:c.4191T>C:p.Phe1397Phe,DOCK8:NM_001193536.1:synonymous:LOW:exon35/47:c.4287T>C:p.Phe1429Phe		rs7854035	0.9994	0.9980	60443/33169/5196	0.9661						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155534.1 [benign]; 			1102	5					DOCK8 (inh=n/a pLI=0.00)
chr9	432330	432330	C	G	hom		QUAL=17048;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,192,0.49,HOM,255,1.00	DOCK8	splice_region&intron	DOCK8:NM_203447.3:splice_region&intron:LOW:exon37/47:c.4785+6C>G:,DOCK8:NM_001190458.1:splice_region&intron:LOW:exon35/45:c.4485+6C>G:,DOCK8:NM_001193536.1:splice_region&intron:LOW:exon36/46:c.4581+6C>G:		rs7036567	0.7143	0.7580	35655/19625/1209	0.7405						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150514.1 [benign]; 			632	394					DOCK8 (inh=n/a pLI=0.00)
chr9	433978	433978	A	G	hom		QUAL=20539;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HET,216,0.52,HOM,299,1.00	DOCK8	splice_region&intron	DOCK8:NM_203447.3:splice_region&intron:LOW:exon38/47:c.4886+3A>G:,DOCK8:NM_001190458.1:splice_region&intron:LOW:exon36/45:c.4586+3A>G:,DOCK8:NM_001193536.1:splice_region&intron:LOW:exon37/46:c.4682+3A>G:		rs2360712	0.7210	0.7590	35664/19535/1311	0.7420						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150515.1 [benign]; 			626	400					DOCK8 (inh=n/a pLI=0.00)
chr9	441952	441952	G	A	het		QUAL=9539;DP=276;AF=0.44;MQM=60;TRIO=HET,276,0.44,WT,161,0.01,HOM,199,1.00	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon42/48:c.5433G>A:p.Glu1811Glu,DOCK8:NM_001190458.1:synonymous:LOW:exon40/46:c.5133G>A:p.Glu1711Glu,DOCK8:NM_001193536.1:synonymous:LOW:exon41/47:c.5229G>A:p.Glu1743Glu		rs1887957	0.8039	0.8200	41298/22413/1852	0.8018						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155535.1 [benign]; RCV000210054.1 [benign]; 		COSM4163900, COSM4163899	729	332					DOCK8 (inh=n/a pLI=0.00)
chr9	449798	449798	G	A	het		QUAL=4306;DP=159;AF=0.48;MQM=60;TRIO=HET,159,0.48,WT,125,0.00,HET,213,0.44	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon45/48:c.5832G>A:p.Pro1944Pro,DOCK8:NM_001190458.1:synonymous:LOW:exon43/46:c.5532G>A:p.Pro1844Pro,DOCK8:NM_001193536.1:synonymous:LOW:exon44/47:c.5628G>A:p.Pro1876Pro		rs10491684	0.0717	0.0700	370/202/106	0.0687						611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150517.2 [benign]; 			6	122					DOCK8 (inh=n/a pLI=0.00)
chr9	464920	464920	G	A	het		QUAL=12175;DP=442;AF=0.45;MQM=59;TRIO=HET,442,0.45,WT,164,0.00,HOM,211,1.00	DOCK8	3'UTR	DOCK8:NM_203447.3:3'UTR:MODIFIER:exon48/48:c.*701G>A:,DOCK8:NM_001190458.1:3'UTR:MODIFIER:exon46/46:c.*701G>A:,DOCK8:NM_001193536.1:3'UTR:MODIFIER:exon47/47:c.*701G>A:		rs3780338	0.8560	0.0000	0/0/0	0.1482										139	82					DOCK8 (inh=n/a pLI=0.00)
chr9	470302	470302	T	C	het		QUAL=4169;DP=254;AF=0.56;MQM=59;TRIO=HET,254,0.56,WT,84,0.01,HET,114,0.45	KANK1	5'UTR	KANK1:NM_001256876.1:5'UTR:MODIFIER:exon1/16:c.-641T>C:		rs151242444	0.0130	0.0000	0/0/0	0.0045										0	3					KANK1 (inh=n/a pLI=n/a)
chr9	707077	707077	C	T	hom		QUAL=15751;DP=178;AF=0.99;MQM=60;TRIO=HOM,178,0.99,HOM,221,0.99,HET,331,0.51	KANK1	5'UTR_premature_start_codon_gain,5'UTR,intron	KANK1:NM_153186.4:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-608C>T:,KANK1:NM_153186.4:5'UTR:MODIFIER:exon1/11:c.-608C>T:,KANK1:NM_001256876.1:intron:MODIFIER:exon6/15:c.38-3727C>T:,KANK1:NM_001256877.1:intron:MODIFIER:exon3/12:c.38-3727C>T:,KANK1:NM_015158.3:intron:MODIFIER:exon2/11:c.38-3727C>T:		rs7871551	0.3676	0.0000	0/0/0	0.4134						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];				55	116					KANK1 (inh=n/a pLI=n/a)
chr9	712060	712060	G	C	hom	phylop_high	QUAL=18655;DP=308;AF=0.99;MQM=59;TRIO=HOM,308,0.99,HET,290,0.44,HET,451,0.48	KANK1	missense	KANK1:NM_001256876.1:missense:MODERATE:exon7/16:c.1294G>C:p.Glu432Gln,KANK1:NM_001256877.1:missense:MODERATE:exon4/13:c.1294G>C:p.Glu432Gln,KANK1:NM_015158.3:missense:MODERATE:exon3/12:c.1294G>C:p.Glu432Gln,KANK1:NM_153186.4:missense:MODERATE:exon2/11:c.820G>C:p.Glu274Gln		rs4465020	0.2352	0.3390	8021/5294/32	0.3316	2.0530	T	T,T,T,T	B,B	B,B	607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM1132467, COSM1132465	202	473					KANK1 (inh=n/a pLI=n/a)
chr9	712599	712599	C	T	hom		QUAL=36999;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HET,592,0.52,HET,815,0.54	KANK1	synonymous	KANK1:NM_001256876.1:synonymous:LOW:exon7/16:c.1833C>T:p.Asn611Asn,KANK1:NM_001256877.1:synonymous:LOW:exon4/13:c.1833C>T:p.Asn611Asn,KANK1:NM_015158.3:synonymous:LOW:exon3/12:c.1833C>T:p.Asn611Asn,KANK1:NM_153186.4:synonymous:LOW:exon2/11:c.1359C>T:p.Asn453Asn		rs11789987	0.2530	0.3480	8269/5478/89	0.3406						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM1462713, COSM3750179, COSM1462714	204	483					KANK1 (inh=n/a pLI=n/a)
chr9	742342	742342	A	G	hom		QUAL=2904;DP=40;AF=1.00;MQM=60;TRIO=HOM,40,1.00,HOM,17,1.00,HOM,40,1.00	KANK1	synonymous	KANK1:NM_001256876.1:synonymous:LOW:exon14/16:c.3834A>G:p.Gly1278Gly,KANK1:NM_001256877.1:synonymous:LOW:exon11/13:c.3834A>G:p.Gly1278Gly,KANK1:NM_015158.3:synonymous:LOW:exon10/12:c.3834A>G:p.Gly1278Gly,KANK1:NM_153186.4:synonymous:LOW:exon9/11:c.3360A>G:p.Gly1120Gly		rs10733535	0.9976	0.9950	60119/32897/5192	0.9632						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM3763986, COSM3763984, COSM3763985	1099	9					KANK1 (inh=n/a pLI=n/a)
chr9	2039793	2039793	A	C	hom		QUAL=5241;DP=60;AF=0.98;MQM=59;TRIO=HOM,60,0.98,HET,131,0.53,HET,156,0.53	SMARCA2	missense	SMARCA2:NM_001289396.1:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:NM_001289397.1:missense:MODERATE:exon4/33:c.683A>C:p.Gln228Pro,SMARCA2:NM_003070.4:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:NM_139045.3:missense:MODERATE:exon4/33:c.683A>C:p.Gln228Pro	(GCA)n	rs62534884	0.0292	0.0350	82/70/0	0.0311	0.7910	T	T,T,T,T,T	B,B	B,B	600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome];	RCV000114294.1 [benign]; 		COSM1461691, COSM1461690	10	120					SMARCA2 (inh=AD pLI=1.00)
chr9	2116037	2116037	G	A	het		QUAL=2800;DP=69;AF=0.52;MQM=60;TRIO=HET,69,0.52,WT,116,0.00,HET,164,0.47	SMARCA2	synonymous	SMARCA2:NM_001289396.1:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:NM_001289397.1:synonymous:LOW:exon25/33:c.3498G>A:p.Glu1166Glu,SMARCA2:NM_003070.4:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:NM_139045.3:synonymous:LOW:exon25/33:c.3672G>A:p.Glu1224Glu		rs6601	0.2354	0.1320	2349/355/1832	0.1293						600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome];	RCV000114289.2 [likely benign]; 		COSM3763857, COSM3763856	12	215					SMARCA2 (inh=AD pLI=1.00)
chr9	2622121	2622121	A	G	hom	low_DP	QUAL=2093;DP=4;AF=1.00;MQM=59;TRIO=HOM,4,1.00,HOM,33,1.00,HOM,36,1.00	VLDLR,VLDLR-AS1	5'UTR,non_coding_exon	VLDLR:NM_003383.3:5'UTR:MODIFIER:exon1/19:c.-69A>G:,VLDLR:NM_001018056.1:5'UTR:MODIFIER:exon1/18:c.-69A>G:,VLDLR-AS1:NR_015375.2:non_coding_exon:MODIFIER:exon1/4:n.253T>C:		rs12379259	0.8123	0.0000	0/0/0	0.1402										307	182					VLDLR (inh=AR pLI=0.00), VLDLR-AS1 (inh=n/a pLI=n/a)
chr9	2622146	2622146	-	CGG	hom	low_DP	QUAL=181;DP=1;AF=1.00;MQM=59;TRIO=HOM,1,1.00,HET,26,0.27,HET,25,0.44	VLDLR,VLDLR-AS1	5'UTR,non_coding_exon	VLDLR:NM_003383.3:5'UTR:MODIFIER:exon1/19:c.-21_-19dupGGC:,VLDLR:NM_001018056.1:5'UTR:MODIFIER:exon1/18:c.-21_-19dupGGC:,VLDLR-AS1:NR_015375.2:non_coding_exon:MODIFIER:exon1/4:n.225_227dupCCG:		rs555425887;rs770767853	0.0000	0.1080	178/42/2	0.0574										56	153					VLDLR (inh=AR pLI=0.00), VLDLR-AS1 (inh=n/a pLI=n/a)
chr9	6532477	6532477	G	A	het		QUAL=1928;DP=76;AF=0.51;MQM=58;TRIO=HET,76,0.51,HOM,21,1.00,HET,24,0.63	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*540C>T:		rs7848919	0.7712	0.0000	0/0/0	0.1121										108	97					GLDC (inh=AR pLI=0.00)
chr9	6532511	6532512	AA	-	het		QUAL=850;DP=82;AF=0.13;MQM=50;TRIO=HET,82,0.13,HET,26,0.00,WT,34,0.47	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*505_*506delTT:		rs145481724	0.0000	0.0000	0/0/0	0.0452										4	41					GLDC (inh=AR pLI=0.00)
chr9	6532544	6532544	G	A	het	low_MQM	QUAL=3512;DP=129;AF=0.48;MQM=41;TRIO=HET,129,0.48,HOM,50,1.00,HET,61,0.54	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*473C>T:		rs1061407	0.7516	0.0000	0/0/0	0.6240										97	106					GLDC (inh=AR pLI=0.00)
chr9	6533010	6533010	C	G	het		QUAL=16809;DP=270;AF=0.50;MQM=56;TRIO=HET,270,0.50,HOM,292,1.00,HET,363,0.48	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*7G>C:		rs2228098	0.7552	0.6860	29234/12907/2674	0.6565										618	653					GLDC (inh=AR pLI=0.00)
chr9	33112715	33112718	TTCT	-	het		QUAL=5376;DP=310;AF=0.50;MQM=59;TRIO=HET,310,0.50,WT,110,0.00,HET,162,0.51	B4GALT1	3'UTR	B4GALT1:NM_001497.3:3'UTR:MODIFIER:exon6/6:c.*734_*737delAGAA:		rs537888935	0.0046	0.0000	0/0/0	0.0113										0	6					B4GALT1 (inh=AR pLI=0.49)
chr9	33113196	33113196	G	T	hom		QUAL=15493;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,114,0.98,HOM,125,1.00	B4GALT1	3'UTR	B4GALT1:NM_001497.3:3'UTR:MODIFIER:exon6/6:c.*256C>A:		rs7019896	0.9485	0.0000	0/0/0	0.8646										211	19					B4GALT1 (inh=AR pLI=0.49)
chr9	35060302	35060302	T	C	het		QUAL=3715;DP=154;AF=0.51;MQM=60;TRIO=HET,154,0.51,HET,53,0.47,HET,67,0.64	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon13/16:c.1695+8A>G:		rs684562	0.4087	0.5850	22983/16416/378	0.5798						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];				504	560					VCP (inh=n/a pLI=1.00)
chr9	35061693	35061693	-	ACAGTACACAA	het		QUAL=6691;DP=138;AF=0.46;MQM=59;TRIO=HET,138,0.46,HET,188,0.51,HET,239,0.52	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon9/16:c.1082-18_1082-8dupTTGTGTACTGT:		rs11272867;rs6150985	0.4083	0.5810	22507/16066/365	0.0927						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];				484	534					VCP (inh=n/a pLI=1.00)
chr9	35062972	35062972	C	T	het		QUAL=13221;DP=310;AF=0.49;MQM=60;TRIO=HET,310,0.49,HET,312,0.47,HET,394,0.53	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon7/16:c.811+3G>A:		rs514492	0.7011	0.7440	34218/20040/2862	0.7371						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];			COSM150600	686	461					VCP (inh=n/a pLI=1.00)
chr9	35074917	35074917	T	C	het		QUAL=7576;DP=208;AF=0.51;MQM=59;TRIO=HET,208,0.51,HET,141,0.58,HET,223,0.48	FANCG	splice_region&intron	FANCG:NM_004629.1:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.3960	11389/8269/33	0.3923						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];				587	1193	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCG (inh=n/a pLI=0.00)
chr9	35657741	35657741	A	G	het		QUAL=1252;DP=55;AF=0.49;MQM=60;TRIO=HET,55,0.49,HET,70,0.49,WT,74,0.00	SIT1-RMRP	intergenic_region	SIT1-RMRP:SIT1-RMRP:intergenic_region:MODIFIER::n.35657741A>G:		rs71521283	0.1558	0.1750	225/69/0	0.0524										48	243					SIT1-RMRP (inh=n/a pLI=n/a)
chr9	71650752	71650752	A	G	hom		QUAL=4451;DP=23;AF=1.00;MQM=60;TRIO=HOM,23,1.00,HOM,57,1.00,HOM,78,1.00	FXN	synonymous	FXN:NM_000144.4:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:NM_181425.2:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:NM_001161706.1:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro	(ACCCAG)n	rs2481598	0.9848	0.9890	5328/1350/99	0.2654						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];	RCV000117105.3 [other]; 			2699	3					FXN (inh=AR pLI=0.82)
chr9	71688476	71688476	T	G	het		QUAL=21108;DP=781;AF=0.51;MQM=59;TRIO=HET,781,0.51,HET,334,0.56,HET,413,0.50	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*798T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*848T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+8525T>G:		rs11145043	0.3281	0.0000	0/0/0	0.0685						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];		CR132641 [CLASS=FP MUT=REF PHEN="Altered expression" GENE=FXN]; 		49	114					FXN (inh=AR pLI=0.82)
chr9	71689436	71689436	A	-	het		QUAL=617;DP=107;AF=0.50;MQM=59;TRIO=HET,107,0.50,HET,53,0.64,WT,65,0.18	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*1771delA:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*1821delA:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+9498delA:	AluSx	rs34933249	0.0000	0.0000	0/0/0	0.0035						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				6	11					FXN (inh=AR pLI=0.82)
chr9	71690150	71690150	T	G	hom		QUAL=13268;DP=213;AF=1.00;MQM=52;TRIO=HOM,213,1.00,HOM,76,1.00,HOM,132,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2472T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2522T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10199T>G:	AluSx	rs7875272	0.9916	0.0000	0/0/0	0.7322						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				162	0					FXN (inh=AR pLI=0.82)
chr9	71690452	71690452	T	A	het		QUAL=12163;DP=395;AF=0.49;MQM=60;TRIO=HET,395,0.49,HET,255,0.44,HET,352,0.46	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2774T>A:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2824T>A:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10501T>A:		rs7875693	0.6617	0.0000	0/0/0	0.5608						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				54	69					FXN (inh=AR pLI=0.82)
chr9	71690482	71690482	T	G	het		QUAL=11468;DP=344;AF=0.49;MQM=60;TRIO=HET,344,0.49,HET,277,0.43,HET,386,0.47	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2804T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2854T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10531T>G:		rs7849347	0.6643	0.0000	0/0/0	0.5629						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				55	69					FXN (inh=AR pLI=0.82)
chr9	71690684	71690684	G	T	hom		QUAL=24918;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,216,1.00,HOM,274,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3006G>T:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3056G>T:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10733G>T:	AluJb	rs6560541	0.9898	0.0000	0/0/0	0.8768						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				175	0					FXN (inh=AR pLI=0.82)
chr9	71690872	71690872	C	T	het		QUAL=5322;DP=290;AF=0.52;MQM=59;TRIO=HET,290,0.52,HET,97,0.49,WT,125,0.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3194C>T:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3244C>T:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10921C>T:	AluJb	rs188391059	0.0010	0.0000	0/0/0	0.0030						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0	1					FXN (inh=AR pLI=0.82)
chr9	71691134	71691134	T	-	het		QUAL=1520;DP=135;AF=0.50;MQM=59;TRIO=HET,135,0.50,HET,55,0.45,HET,73,0.55	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3469delT:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3519delT:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+11196delT:	MIRb	rs11310316;rs11327946	0.7163	0.0000	0/0/0	0.3357						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				9	95					FXN (inh=AR pLI=0.82)
chr9	71692705	71692705	C	G	hom		QUAL=8777;DP=118;AF=1.00;MQM=54;TRIO=HOM,118,1.00,HOM,69,1.00,HOM,104,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*5027C>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*5077C>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+12754C>G:	AluSx	rs7848466	0.9898	0.0000	0/0/0	0.8759						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				225	0					FXN (inh=AR pLI=0.82)
chr9	71693128	71693128	G	C	hom		QUAL=35198;DP=424;AF=1.00;MQM=60;TRIO=HOM,424,1.00,HOM,279,1.00,HOM,361,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*5450G>C:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*5500G>C:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+13177G>C:	MER91C	rs7866579	0.9920	0.0000	0/0/0	0.8778						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				224	0					FXN (inh=AR pLI=0.82)
chr9	79792440	79792440	G	A	het	low_DP	QUAL=186;DP=11;AF=0.36;MQM=60;TRIO=HET,11,0.36,WT,10,0.00,HET,15,0.60	VPS13A,VPS13A-AS1	5'UTR,intron	VPS13A:NM_033305.2:5'UTR:MODIFIER:exon1/72:c.-181G>A:,VPS13A:NM_001018038.2:5'UTR:MODIFIER:exon1/69:c.-181G>A:,VPS13A:NM_015186.3:5'UTR:MODIFIER:exon1/69:c.-181G>A:,VPS13A:NM_001018037.1:5'UTR:MODIFIER:exon1/71:c.-181G>A:,VPS13A-AS1:NR_026668.2:intron:MODIFIER:exon1/1:n.291+103C>T:		rs117488726	0.0759	0.0000	0/0/0	0.0234										7	40					VPS13A (inh=AR pLI=0.00), VPS13A-AS1 (inh=n/a pLI=n/a)
chr9	79936415	79936415	A	G	het		QUAL=5102;DP=230;AF=0.53;MQM=60;TRIO=HET,230,0.53,WT,117,0.00,HET,134,0.54	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon44/72:c.5583A>G:p.Thr1861Thr,VPS13A:NM_001018038.2:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr,VPS13A:NM_015186.3:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr,VPS13A:NM_001018037.1:synonymous:LOW:exon43/71:c.5466A>G:p.Thr1822Thr		rs17423984	0.0487	0.0750	422/243/3	0.0735	0.1070	T				605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764012, COSM3764011, COSM3764010	19	384					VPS13A (inh=AR pLI=0.00)
chr9	79954425	79954425	A	T	het		QUAL=112;DP=112;AF=0.24;MQM=54;TRIO=HET,112,0.24,WT,36,0.00,WT,37,0.00	VPS13A	splice_region&intron	VPS13A:NM_033305.2:splice_region&intron:LOW:exon47/71:c.6379-7A>T:,VPS13A:NM_001018038.2:splice_region&intron:LOW:exon47/68:c.6379-7A>T:,VPS13A:NM_015186.3:splice_region&intron:LOW:exon47/68:c.6379-7A>T:,VPS13A:NM_001018037.1:splice_region&intron:LOW:exon46/70:c.6262-7A>T:	(T)n	rs759586753	0.0000	0.0210	0/0/0	0.0121						605978 [VPS13A (confirmed) Choreoacanthocytosis];				5	48					VPS13A (inh=AR pLI=0.00)
chr9	79954545	79954545	T	C	het		QUAL=9943;DP=321;AF=0.44;MQM=60;TRIO=HET,321,0.44,HET,229,0.48,HET,285,0.49	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon48/72:c.6492T>C:p.Asp2164Asp,VPS13A:NM_001018038.2:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp,VPS13A:NM_015186.3:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp,VPS13A:NM_001018037.1:synonymous:LOW:exon47/71:c.6375T>C:p.Asp2125Asp		rs7025532	0.1627	0.1750	2013/1205/238	0.1718						605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764013, COSM3764014, COSM3764015	118	741					VPS13A (inh=AR pLI=0.00)
chr9	79984232	79984232	T	C	het		QUAL=8863;DP=342;AF=0.49;MQM=60;TRIO=HET,342,0.49,WT,163,0.00,HET,281,0.56	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon63/72:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_001018038.2:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_015186.3:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_001018037.1:synonymous:LOW:exon62/71:c.8454T>C:p.Tyr2818Tyr		rs17340192	0.0517	0.0760	426/250/3	0.0741						605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764016, COSM3764017, COSM3764018	17	339					VPS13A (inh=AR pLI=0.00)
chr9	79986057	79986057	A	G	het		QUAL=15260;DP=408;AF=0.52;MQM=59;TRIO=HET,408,0.52,HET,297,0.55,HET,416,0.50	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon67/72:c.9069A>G:p.Gly3023Gly,VPS13A:NM_001018038.2:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly,VPS13A:NM_015186.3:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly,VPS13A:NM_001018037.1:synonymous:LOW:exon66/71:c.8952A>G:p.Gly2984Gly		rs3737289	0.4151	0.4490	12564/6158/517	0.4403						605978 [VPS13A (confirmed) Choreoacanthocytosis];				443	1098					VPS13A (inh=AR pLI=0.00)
chr9	79997881	79997881	T	C	het		QUAL=11452;DP=368;AF=0.46;MQM=60;TRIO=HET,368,0.46,HET,197,0.51,HET,277,0.53	VPS13A	3'UTR,intron	VPS13A:NM_001018038.2:3'UTR:MODIFIER:exon69/69:c.*666T>C:,VPS13A:NM_033305.2:intron:MODIFIER:exon68/71:c.9189+878T>C:,VPS13A:NM_015186.3:intron:MODIFIER:exon68/68:c.9189+878T>C:,VPS13A:NM_001018037.1:intron:MODIFIER:exon67/70:c.9072+878T>C:		rs10869921	0.3844	0.0000	0/0/0	0.4088						605978 [VPS13A (confirmed) Choreoacanthocytosis];				46	131					VPS13A (inh=AR pLI=0.00)
chr9	79999824	79999824	T	C	het		QUAL=4925;DP=215;AF=0.50;MQM=60;TRIO=HET,215,0.50,WT,105,0.00,HET,162,0.45	VPS13A	3'UTR,intron	VPS13A:NM_015186.3:3'UTR:MODIFIER:exon69/69:c.*225T>C:,VPS13A:NM_033305.2:intron:MODIFIER:exon68/71:c.9189+2821T>C:,VPS13A:NM_001018037.1:intron:MODIFIER:exon67/70:c.9072+2821T>C:		rs7872010	0.0731	0.0000	0/0/0	0.0130						605978 [VPS13A (confirmed) Choreoacanthocytosis];				2	39					VPS13A (inh=AR pLI=0.00)
chr9	80031144	80031144	G	A	het		QUAL=4179;DP=168;AF=0.51;MQM=60;TRIO=HET,168,0.51,HET,58,0.50,HET,68,0.56	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*222G>A:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*222G>A:		rs12343797	0.1653	0.0000	0/0/0	0.0290										16	110					VPS13A (inh=AR pLI=0.00)
chr9	80031946	80031946	C	T	het		QUAL=7991;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.48,HET,151,0.50,HET,194,0.53	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*1024C>T:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*1024C>T:		rs9186	0.5757	0.0000	0/0/0	0.0922										60	145					VPS13A (inh=AR pLI=0.00)
chr9	80032300	80032300	C	A	het		QUAL=11116;DP=379;AF=0.47;MQM=59;TRIO=HET,379,0.47,HET,203,0.44,HET,294,0.49	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*1378C>A:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*1378C>A:		rs13286867	0.2494	0.0000	0/0/0	0.0500										37	120					VPS13A (inh=AR pLI=0.00)
chr9	94087622	94087622	T	G	het		QUAL=7005;DP=329;AF=0.56;MQM=60;TRIO=HET,329,0.56,WT,126,0.00,HET,154,0.47	AUH	synonymous,intron	AUH:NM_001698.2:synonymous:LOW:exon4/10:c.483A>C:p.Ile161Ile,AUH:NM_001306190.1:intron:MODIFIER:exon3/8:c.419-27264A>C:		rs7874056	0.0895	0.0870	593/331/183	0.0856						600529 [AUH (provisional) 3-methylglutaconic aciduria,type I];	RCV000116490.2 [likely benign]; 		COSM3764058	12	265					AUH (inh=AR pLI=0.01)
chr9	94830356	94830356	C	A	het	phylop_high;pred_pathogenic_1	QUAL=6680;DP=323;AF=0.51;MQM=60;TRIO=HET,323,0.51,WT,112,0.00,HET,186,0.51	SPTLC1	missense	SPTLC1:NM_001281303.1:missense:MODERATE:exon6/15:c.452G>T:p.Arg151Leu,SPTLC1:NM_006415.3:missense:MODERATE:exon6/15:c.452G>T:p.Arg151Leu		rs45461899	0.0116	0.0220	51/42/0	0.0214	3.9190	T	D	B,B	B,B	605712 [SPTLC1 (provisional) Neuropathy,hereditary sensory and autonomic,type IA];				1	46					SPTLC1 (inh=n/a pLI=0.00)
chr9	97862118	97862118	C	T	het		QUAL=12662;DP=292;AF=0.48;MQM=60;TRIO=HET,292,0.48,HET,365,0.47,HET,413,0.49	FANCC	3'UTR	FANCC:NM_000136.2:3'UTR:MODIFIER:exon15/15:c.*1871G>A:,FANCC:NM_001243743.1:3'UTR:MODIFIER:exon15/15:c.*1871G>A:		rs4647558	0.4135	0.0000	0/0/0	0.4334										31	120					FANCC (inh=AR pLI=0.00)
chr9	97862701	97862701	A	G	het		QUAL=12121;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,HET,244,0.53,HET,259,0.54	FANCC	3'UTR	FANCC:NM_000136.2:3'UTR:MODIFIER:exon15/15:c.*1288T>C:,FANCC:NM_001243743.1:3'UTR:MODIFIER:exon15/15:c.*1288T>C:		rs4647554	0.5028	0.0000	0/0/0	0.0786										32	124					FANCC (inh=AR pLI=0.00)
chr9	97872712	97872712	C	T	hom		QUAL=10896;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,55,1.00,HOM,64,1.00	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*766G>A:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+1033G>A:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+1033G>A:		rs10429619	0.9980	0.0000	0/0/0	0.9128						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				149	1					FANCC (inh=AR pLI=0.00)
chr9	97873004	97873007	TAAC	-	het		QUAL=4053;DP=182;AF=0.47;MQM=59;TRIO=HET,182,0.47,WT,129,0.01,HET,194,0.46	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*471_*474delGTTA:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:		rs71934724	0.1350	0.0000	0/0/0	0.1392						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				9	46					FANCC (inh=AR pLI=0.00)
chr9	97873339	97873339	G	A	het		QUAL=7688;DP=162;AF=0.48;MQM=59;TRIO=HET,162,0.48,HET,200,0.53,HET,258,0.52	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*139C>T:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+406C>T:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+406C>T:		rs879492	0.4167	0.0000	0/0/0	0.4342						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				20	77					FANCC (inh=AR pLI=0.00)
chr9	97873435	97873435	G	A	het		QUAL=6382;DP=169;AF=0.51;MQM=60;TRIO=HET,169,0.51,HET,134,0.56,HET,171,0.53	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*43C>T:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+310C>T:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+310C>T:		rs2404457	0.4111	0.2090	994/244/20	0.1157						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				34	112					FANCC (inh=AR pLI=0.00)
chr9	98229389	98229389	C	G	hom		QUAL=8503;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,58,1.00,HOM,72,1.00	PTCH1,LOC100507346	splice_region&intron,non_coding_exon	PTCH1:NM_000264.3:splice_region&intron:LOW:exon15/23:c.2560+9G>C:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon15/23:c.2362+9G>C:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon15/23:c.2557+9G>C:,LOC100507346:NR_038982.1:non_coding_exon:MODIFIER:exon2/4:n.368C>G:		rs2066829	0.3906	0.3580	8491/4561/2155	0.3507						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				335	1118	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00), LOC100507346 (inh=n/a pLI=n/a)
chr9	98238358	98238358	G	A	hom		QUAL=14352;DP=213;AF=0.99;MQM=59;TRIO=HOM,213,0.99,HOM,87,0.99,HOM,171,0.99	PTCH1	synonymous	PTCH1:NM_000264.3:synonymous:LOW:exon12/24:c.1686C>T:p.Ala562Ala,PTCH1:NM_001083607.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083606.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083604.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083605.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083602.1:synonymous:LOW:exon12/24:c.1488C>T:p.Ala496Ala,PTCH1:NM_001083603.1:synonymous:LOW:exon12/24:c.1683C>T:p.Ala561Ala		rs2066836	0.0919	0.1710	2070/1597/9	0.1698						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];			COSM1756288, COSM1756290, COSM1756289, COSM1756287	130	823	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00)
chr9	98269419	98269419	G	-	hom		QUAL=19876;DP=173;AF=1.00;MQM=59;TRIO=HOM,173,1.00,HOM,218,0.99,HOM,304,1.00	PTCH1	5'UTR,intron	PTCH1:NM_001083607.1:5'UTR:MODIFIER:exon1/24:c.-453delC:,PTCH1:NM_000264.3:intron:MODIFIER:exon1/23:c.202-538delC:,PTCH1:NM_001083606.1:intron:MODIFIER:exon1/23:c.-253+92delC:,PTCH1:NM_001083604.1:intron:MODIFIER:exon1/23:c.-252-538delC:,PTCH1:NM_001083605.1:intron:MODIFIER:exon1/23:c.-252-538delC:,PTCH1:NM_001083602.1:intron:MODIFIER:exon1/23:c.4-538delC:,PTCH1:NM_001083603.1:intron:MODIFIER:exon1/23:c.199-538delC:		rs397728992	0.2228	0.0000	0/0/0	0.2045						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				13	75					PTCH1 (inh=AD pLI=1.00)
chr9	98270321	98270328	GTGAGTGT	-	hom		QUAL=17651;DP=78;AF=1.00;MQM=59;TRIO=HOM,78,1.00,HOM,254,1.00,HOM,373,0.98	PTCH1	5'UTR,intron,non_coding_transcript	PTCH1:NM_001083604.1:5'UTR:MODIFIER:exon1/24:c.-22231_-358delACACTCAC:,PTCH1:NM_001083605.1:5'UTR:MODIFIER:exon1/24:c.-22231_-341delACACTCAC:,PTCH1:NM_000264.3:intron:MODIFIER:exon1/23:c.201+115_201+122delACACTCAC:,PTCH1:NM_001083602.1:intron:MODIFIER:exon1/23:c.4-1447_4-1440delACACTCAC:,PTCH1:NM_001083603.1:intron:MODIFIER:exon1/23:c.199-1447_199-1440delACACTCAC:,PTCH1:NM_001083604.1:non_coding_transcript:MODIFIER:exon19/24:c.-22231_-358delACACTCAC:,PTCH1:NM_001083605.1:non_coding_transcript:MODIFIER:exon17/24:c.-22231_-341delACACTCAC:	(GT)n	rs148507954	0.0000	0.0000	0/0/0	0.1499						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				15	91					PTCH1 (inh=AD pLI=1.00)
chr9	100459578	100459578	T	C	hom		QUAL=6735;DP=63;AF=0.98;MQM=59;TRIO=HOM,63,0.98,HET,104,0.28,HOM,150,1.00	XPA	5'UTR,non_coding_exon	XPA:NM_000380.3:5'UTR:MODIFIER:exon1/6:c.-4A>G:,XPA:NR_027302.1:non_coding_exon:MODIFIER:exon1/7:n.114A>G:		rs1800975	0.6464	0.6280	22195/12832/2430	0.5829							RCV000170427.1 [benign]; 	CR044772 [CLASS=DP MUT=ALT PHEN="Lung adenocarcinoma risk association with" GENE=XPA]; 		1129	1008					XPA (inh=n/a pLI=0.00)
chr9	100615553	100615553	A	G	het	low_DP	QUAL=903;DP=4;AF=0.75;MQM=59;TRIO=HET,4,0.75,WT,48,0.00,HET,86,0.51	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-644A>G:		rs13302470	0.6859	0.0000	0/0/0	0.1116										73	79					FOXE1 (inh=n/a pLI=n/a)
chr9	100615572	100615572	G	A	het	low_DP	QUAL=1078;DP=7;AF=0.43;MQM=59;TRIO=HET,7,0.43,WT,62,0.00,HET,105,0.52	FOXE1	5'UTR_premature_start_codon_gain,5'UTR	FOXE1:NM_004473.3:5'UTR_premature_start_codon_gain:LOW:exon1/1:c.-625G>A:,FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-625G>A:			0.0000	0.0000	0/0/0	0.0000										0	1					FOXE1 (inh=n/a pLI=n/a)
chr9	100615660	100615660	G	C	hom		QUAL=5019;DP=31;AF=1.00;MQM=59;TRIO=HOM,31,1.00,HET,152,0.53,HET,194,0.49	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-537G>C:		rs7849497	0.8830	0.0000	0/0/0	0.1196										135	75					FOXE1 (inh=n/a pLI=n/a)
chr9	100615914	100615914	A	G	het		QUAL=662;DP=22;AF=0.45;MQM=60;TRIO=HET,22,0.45,WT,26,0.00,HET,51,0.45	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-283A>G:		rs1867277	0.6859	0.0000	0/0/0	0.0969								CR095675 [CLASS=DFP MUT=REF PHEN="Thyroid cancer susceptibility association with" GENE=FOXE1]; 		82	106					FOXE1 (inh=n/a pLI=n/a)
chr9	100615949	100615949	C	A	het		QUAL=1434;DP=28;AF=0.46;MQM=60;TRIO=HET,28,0.46,WT,113,0.00,HET,157,0.45	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-248C>A:		rs1867278	0.6859	0.0000	0/0/0	0.1096										81	110					FOXE1 (inh=n/a pLI=n/a)
chr9	100616041	100616041	T	C	hom	low_DP	QUAL=1277;DP=12;AF=0.92;MQM=60;TRIO=HOM,12,0.92,HET,42,0.48,HET,56,0.52	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-156T>C:		rs1867279	0.8830	0.0000	0/0/0	0.7029										159	78					FOXE1 (inh=n/a pLI=n/a)
chr9	100616066	100616066	G	C	het	low_DP	QUAL=403;DP=12;AF=0.50;MQM=60;TRIO=HET,12,0.50,WT,25,0.00,HET,30,0.53	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-131G>C:		rs1867280	0.6861	0.0000	0/0/0	0.1272										95	107					FOXE1 (inh=n/a pLI=n/a)
chr9	100616583	100616583	T	C	hom		QUAL=2544;DP=41;AF=1.00;MQM=60;TRIO=HOM,41,1.00,HET,59,0.59,HET,78,0.53	FOXE1	synonymous	FOXE1:NM_004473.3:synonymous:LOW:exon1/1:c.387T>C:p.Leu129Leu		rs3021523	0.8828	0.7990	38874/18153/4531	0.7715						602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome|Thyroid cancer,nonmedullary,4];	RCV000081101.4 [benign]; 		COSM4163149	632	393					FOXE1 (inh=n/a pLI=n/a)
chr9	100616692	100616692	G	C	het	low_QUAL;low_DP;pred_pathogenic_3	QUAL=10;DP=10;AF=0.30;MQM=55;TRIO=HET,10,0.30,WT,4,0.00,WT,13,0.00	FOXE1	missense	FOXE1:NM_004473.3:missense:MODERATE:exon1/1:c.496G>C:p.Ala166Pro			0.0000	0.0000	0/0/0	0.0000	1.2530	D	D	D	P	602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome|Thyroid cancer,nonmedullary,4];				0	0					FOXE1 (inh=n/a pLI=n/a)
chr9	100617375	100617375	T	C	hom		QUAL=18056;DP=258;AF=0.99;MQM=59;TRIO=HOM,258,0.99,HET,416,0.49,HET,514,0.45	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*57T>C:		rs7046645	0.8828	0.0000	0/0/0	0.1432										134	77					FOXE1 (inh=n/a pLI=n/a)
chr9	100617433	100617433	A	C	het		QUAL=6611;DP=156;AF=0.54;MQM=59;TRIO=HET,156,0.54,HET,387,0.49,WT,461,0.00	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*115A>C:		rs7043516	0.1813	0.0000	0/0/0	0.0233										4	61					FOXE1 (inh=n/a pLI=n/a)
chr9	100617479	100617479	G	T	het		QUAL=6396;DP=173;AF=0.51;MQM=59;TRIO=HET,173,0.51,WT,306,0.00,HET,424,0.43	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*161G>T:		rs1443434	0.6861	0.0000	0/0/0	0.1128										83	111					FOXE1 (inh=n/a pLI=n/a)
chr9	100617583	100617583	T	C	het		QUAL=8372;DP=295;AF=0.47;MQM=60;TRIO=HET,295,0.47,WT,316,0.01,HET,427,0.46	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*265T>C:		rs1443435	0.6861	0.0000	0/0/0	0.1118										84	110					FOXE1 (inh=n/a pLI=n/a)
chr9	100617649	100617649	A	G	het		QUAL=9064;DP=373;AF=0.50;MQM=60;TRIO=HET,373,0.50,WT,280,0.00,HET,363,0.48	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*331A>G:		rs41274258	0.0152	0.0000	0/0/0	0.0057										0	19					FOXE1 (inh=n/a pLI=n/a)
chr9	100618660	100618660	G	A	het		QUAL=4027;DP=225;AF=0.46;MQM=60;TRIO=HET,225,0.46,HET,78,0.62,WT,147,0.00	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*1342G>A:		rs10984009	0.0956	0.0000	0/0/0	0.0160										1	45					FOXE1 (inh=n/a pLI=n/a)
chr9	101913690	101913690	T	G	het		QUAL=1636;DP=117;AF=0.53;MQM=59;TRIO=HET,117,0.53,HET,3,0.33,HOM,12,1.00	TGFBR1	3'UTR	TGFBR1:NM_001306210.1:3'UTR:MODIFIER:exon9/9:c.*2103T>G:,TGFBR1:NM_001130916.2:3'UTR:MODIFIER:exon8/8:c.*2103T>G:,TGFBR1:NM_004612.3:3'UTR:MODIFIER:exon9/9:c.*2103T>G:	(T)n	rs7871490	0.0000	0.0000	0/0/0	0.0967										6	73					TGFBR1 (inh=AD pLI=0.95)
chr9	103015184	103015184	T	C	het		QUAL=4818;DP=123;AF=0.56;MQM=60;TRIO=HET,123,0.56,HOM,100,1.00,WT,142,0.00	INVS	splice_region&intron	INVS:NM_014425.4:splice_region&intron:LOW:exon9/16:c.1235-5T>C:,INVS:NM_001318381.1:splice_region&intron:LOW:exon10/17:c.947-5T>C:,INVS:NM_001318382.1:splice_region&intron:LOW:exon9/16:c.257-5T>C:,INVS:NR_134606.1:splice_region&intron:LOW:exon9/16:n.1491-5T>C:		rs2245216	0.2105	0.3120	6743/5428/109	0.3121						243305 [INVS (confirmed) Nephronophthisis 2,infantile];	RCV000081626.4 [benign]; 		COSM150650	180	519					INVS (inh=n/a pLI=0.00)
chr9	103054951	103054951	T	C	het		QUAL=15678;DP=232;AF=0.47;MQM=60;TRIO=HET,232,0.47,HOM,290,1.00,HET,341,0.47	INVS	synonymous,non_coding_exon	INVS:NM_014425.4:synonymous:LOW:exon14/17:c.2412T>C:p.Ser804Ser,INVS:NM_001318381.1:synonymous:LOW:exon15/18:c.2124T>C:p.Ser708Ser,INVS:NM_001318382.1:synonymous:LOW:exon14/17:c.1434T>C:p.Ser478Ser,INVS:NR_134606.1:non_coding_exon:MODIFIER:exon14/17:n.2619T>C:		rs2787374	0.4073	0.4670	14861/10875/1792	0.4645						243305 [INVS (confirmed) Nephronophthisis 2,infantile];	RCV000081629.4 [benign]; 		COSM3763489, COSM3763490	310	515					INVS (inh=n/a pLI=0.00)
chr9	103063422	103063425	CACA	-	hom		QUAL=525;DP=29;AF=0.90;MQM=58;TRIO=HOM,29,0.90,HOM,16,0.44,HOM,5,0.00	INVS	3'UTR,non_coding_exon	INVS:NM_014425.4:3'UTR:MODIFIER:exon17/17:c.*502_*505delCACA:,INVS:NM_001318381.1:3'UTR:MODIFIER:exon18/18:c.*502_*505delCACA:,INVS:NM_001318382.1:3'UTR:MODIFIER:exon17/17:c.*502_*505delCACA:,INVS:NR_134606.1:non_coding_exon:MODIFIER:exon17/17:n.3907_3910delCACA:	(CA)n		0.0000	0.0000	0/0/0	0.0000										1	4					INVS (inh=n/a pLI=0.00)
chr9	104183194	104183194	C	T	het		QUAL=12616;DP=425;AF=0.48;MQM=60;TRIO=HET,425,0.48,HOM,225,0.99,WT,360,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*897G>A:	HAL1ME	rs17772839	0.0625	0.0000	0/0/0	0.0147										6	34					ALDOB (inh=n/a pLI=0.00)
chr9	104183479	104183479	T	C	het		QUAL=7857;DP=237;AF=0.52;MQM=60;TRIO=HET,237,0.52,HOM,144,0.98,WT,130,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*612A>G:	MER5B	rs41296049	0.0625	0.0000	0/0/0	0.0147										6	33					ALDOB (inh=n/a pLI=0.00)
chr9	104183539	104183539	A	T	het		QUAL=11018;DP=425;AF=0.48;MQM=59;TRIO=HET,425,0.48,HOM,193,0.98,WT,232,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*552T>A:	MER5B	rs41308902	0.0627	0.0000	0/0/0	0.0861										6	34					ALDOB (inh=n/a pLI=0.00)
chr9	104183586	104183586	G	T	het		QUAL=11867;DP=466;AF=0.46;MQM=60;TRIO=HET,466,0.46,HOM,194,0.98,WT,255,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*505C>A:		rs17772845	0.0625	0.0000	0/0/0	0.0147										6	34					ALDOB (inh=n/a pLI=0.00)
chr9	104183885	104183885	G	T	het		QUAL=8417;DP=362;AF=0.45;MQM=60;TRIO=HET,362,0.45,HOM,127,1.00,WT,162,0.01	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*206C>A:		rs17772869	0.0561	0.0000	0/0/0	0.0144										7	57					ALDOB (inh=n/a pLI=0.00)
chr9	104183969	104183969	C	T	het		QUAL=5481;DP=192;AF=0.47;MQM=60;TRIO=HET,192,0.47,HOM,98,1.00,WT,119,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*122G>A:		rs41310087	0.0397	0.0000	0/0/0	0.0610										4	46					ALDOB (inh=n/a pLI=0.00)
chr9	108398678	108398678	A	G	het		QUAL=13681;DP=248;AF=0.53;MQM=60;TRIO=HET,248,0.53,HET,327,0.55,HET,398,0.52	FKTN	3'UTR,intron	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*1133A>G:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*1133A>G:,FKTN:NM_001198963.1:intron:MODIFIER:exon11/11:c.1270+1249A>G:		rs2768282	0.1354	0.0000	0/0/0	0.0264						607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4|Cardiomyopathy,dilated,1X|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4];				10	91					FKTN (inh=AR pLI=0.00)
chr9	108399825	108399825	T	C	het		QUAL=17626;DP=580;AF=0.53;MQM=60;TRIO=HET,580,0.53,HET,311,0.41,HET,425,0.50	FKTN	3'UTR,intron	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*2280T>C:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*2280T>C:,FKTN:NM_001198963.1:intron:MODIFIER:exon11/11:c.1270+2396T>C:		rs1024366	0.1342	0.0000	0/0/0	0.0264						607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4|Cardiomyopathy,dilated,1X|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4];				10	90					FKTN (inh=AR pLI=0.00)
chr9	108402805	108402805	G	T	het		QUAL=1511;DP=87;AF=0.48;MQM=58;TRIO=HET,87,0.48,HET,16,0.38,HET,25,0.64	FKTN	3'UTR	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*5260G>T:,FKTN:NM_001198963.1:3'UTR:MODIFIER:exon12/12:c.*401G>T:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*5260G>T:	AluSz	rs2010861	0.1318	0.0000	0/0/0	0.1363										10	88					FKTN (inh=AR pLI=0.00)
chr9	108402836	108402836	A	-	het		QUAL=131;DP=86;AF=0.21;MQM=58;TRIO=HET,86,0.21,WT,23,0.04,WT,41,0.12	FKTN	3'UTR	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*5303delA:,FKTN:NM_001198963.1:3'UTR:MODIFIER:exon12/12:c.*444delA:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*5303delA:	AluSz		0.0000	0.0000	0/0/0	0.0014										0	10					FKTN (inh=AR pLI=0.00)
chr9	111653574	111653574	C	G	hom		QUAL=13554;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HET,202,0.40,HET,282,0.47	IKBKAP	synonymous	IKBKAP:NM_003640.4:synonymous:LOW:exon28/37:c.3069G>C:p.Leu1023Leu,IKBKAP:NM_001318360.1:synonymous:LOW:exon28/37:c.2727G>C:p.Leu909Leu		rs1063110	0.3155	0.3910	10015/6650/72	0.3869						603722 [IKBKAP (confirmed) Dysautonomia,familial];			COSM3763506	207	555					IKBKAP (inh=n/a pLI=0.00)
chr9	111696389	111696389	G	C	het		QUAL=1620;DP=41;AF=0.49;MQM=59;TRIO=HET,41,0.49,HET,105,0.48,WT,166,0.00	IKBKAP	5'UTR	IKBKAP:NM_003640.4:5'UTR:MODIFIER:exon1/37:c.-301C>G:,IKBKAP:NM_001318360.1:5'UTR:MODIFIER:exon1/37:c.-498C>G:		rs2275641	0.3520	0.0000	0/0/0	0.3696										29	100					IKBKAP (inh=n/a pLI=0.00)
chr9	113457726	113457726	G	A	het		QUAL=8213;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,HET,170,0.49,HET,233,0.52	MUSK	synonymous	MUSK:NM_005592.3:synonymous:LOW:exon4/14:c.402G>A:p.Glu134Glu,MUSK:NM_001166280.1:synonymous:LOW:exon4/13:c.402G>A:p.Glu134Glu,MUSK:NM_001166281.1:synonymous:LOW:exon4/12:c.402G>A:p.Glu134Glu		rs10980531	0.1701	0.1330	717/380/41	0.1380						601296 [MUSK (confirmed) Myasthenic syndrome,congenital,9,associated with acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000117647.1 [benign]; 			37	319					MUSK (inh=n/a pLI=0.00)
chr9	116023498	116023498	C	T	het		QUAL=5709;DP=226;AF=0.52;MQM=53;TRIO=HET,226,0.52,WT,174,0.00,HET,238,0.52	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*745C>T:	AluSq2	rs139028783	0.0096	0.0000	0/0/0	0.0108										0	5					SLC31A1 (inh=n/a pLI=0.52)
chr9	116023979	116023979	A	C	het		QUAL=8036;DP=263;AF=0.56;MQM=59;TRIO=HET,263,0.56,WT,188,0.01,HET,282,0.53	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*1226A>C:	MER5A	rs41280225	0.1384	0.0000	0/0/0	0.0227										3	41					SLC31A1 (inh=n/a pLI=0.52)
chr9	116025024	116025024	A	C	het		QUAL=8842;DP=433;AF=0.50;MQM=59;TRIO=HET,433,0.50,HET,234,0.50,WT,267,0.00	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*2271A>C:		rs10759637	0.5092	0.0000	0/0/0	0.0804										48	109					SLC31A1 (inh=n/a pLI=0.52)
chr9	116026255	116026255	G	C	het		QUAL=7780;DP=355;AF=0.54;MQM=59;TRIO=HET,355,0.54,HET,189,0.53,WT,250,0.00	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*3502G>C:		rs1143245	0.3185	0.0000	0/0/0	0.0404										11	74					SLC31A1 (inh=n/a pLI=0.52)
chr9	119462112	119462112	C	T	hom		QUAL=27330;DP=359;AF=1.00;MQM=60;TRIO=HOM,359,1.00,HOM,216,1.00,HOM,254,1.00	TRIM32,ASTN2	3'UTR,intron	TRIM32:NM_001099679.1:3'UTR:MODIFIER:exon2/2:c.*129C>T:,TRIM32:NM_012210.3:3'UTR:MODIFIER:exon2/2:c.*129C>T:,ASTN2:NM_014010.4:intron:MODIFIER:exon15/21:c.2653+25938G>A:		rs3019	0.9491	0.0000	0/0/0	0.1686										203	26					TRIM32 (inh=AR pLI=0.10), ASTN2 (inh=n/a pLI=0.99)
chr9	119463189	119463189	T	C	het		QUAL=9991;DP=356;AF=0.54;MQM=60;TRIO=HET,356,0.54,WT,326,0.00,HET,327,0.54	TRIM32,ASTN2	3'UTR,intron	TRIM32:NM_001099679.1:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,TRIM32:NM_012210.3:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,ASTN2:NM_014010.4:intron:MODIFIER:exon15/21:c.2653+24861A>G:		rs2281627	0.2680	0.0000	0/0/0	0.0565										27	122					TRIM32 (inh=AR pLI=0.10), ASTN2 (inh=n/a pLI=0.99)
chr9	123170733	123170733	C	G	hom		QUAL=29763;DP=361;AF=0.99;MQM=59;TRIO=HOM,361,0.99,HOM,275,1.00,HOM,338,1.00	CDK5RAP2	missense,non_coding_exon	CDK5RAP2:NM_018249.5:missense:MODERATE:exon31/38:c.4618G>C:p.Val1540Leu,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon31/37:c.4618G>C:p.Val1540Leu,CDK5RAP2:NM_001272039.1:missense:MODERATE:exon28/35:c.3928G>C:p.Val1310Leu,CDK5RAP2:NR_073554.1:non_coding_exon:MODIFIER:exon31/38:n.4887G>C:,CDK5RAP2:NR_073555.1:non_coding_exon:MODIFIER:exon31/38:n.4810G>C:,CDK5RAP2:NR_073556.1:non_coding_exon:MODIFIER:exon32/39:n.5017G>C:,CDK5RAP2:NR_073557.1:non_coding_exon:MODIFIER:exon31/38:n.4890G>C:,CDK5RAP2:NR_073558.1:non_coding_exon:MODIFIER:exon31/38:n.4887G>C:		rs4837768	0.7532	0.7690	36224/18864/1789	0.7620	-0.0830	T	T,T,T,T,T,T,T	B,B,B,B,B	B,B,B,B,B	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];	RCV000020841.1 [benign]; RCV000145488.1 [likely benign]; 			645	401					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123215872	123215872	G	C	het		QUAL=9842;DP=386;AF=0.48;MQM=60;TRIO=HET,386,0.48,WT,325,0.00,HET,408,0.50	CDK5RAP2	missense,intron,non_coding_exon	CDK5RAP2:NM_018249.5:missense:MODERATE:exon21/38:c.2655C>G:p.Phe885Leu,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon21/37:c.2655C>G:p.Phe885Leu,CDK5RAP2:NM_001272039.1:intron:MODIFIER:exon18/34:c.2104-5468C>G:,CDK5RAP2:NR_073554.1:non_coding_exon:MODIFIER:exon21/38:n.2924C>G:,CDK5RAP2:NR_073555.1:non_coding_exon:MODIFIER:exon21/38:n.2847C>G:,CDK5RAP2:NR_073556.1:non_coding_exon:MODIFIER:exon22/39:n.3054C>G:,CDK5RAP2:NR_073557.1:non_coding_exon:MODIFIER:exon21/38:n.2927C>G:,CDK5RAP2:NR_073558.1:non_coding_exon:MODIFIER:exon21/38:n.2924C>G:		rs112600265	0.0014	0.0040	0/0/0	0.0037	0.5100	T	T,T,T,T,T	B,B,B,B	B,B,B,B	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];				1	7	3	[3] Stephan Waldm?ller 12.08.2014			CDK5RAP2 (inh=AR pLI=0.00)
chr9	123291036	123291036	C	G	hom	phylop_high	QUAL=34573;DP=329;AF=1.00;MQM=60;TRIO=HOM,329,1.00,HOM,332,1.00,HOM,385,1.00	CDK5RAP2	missense,non_coding_exon	CDK5RAP2:NM_018249.5:missense:MODERATE:exon9/38:c.865G>C:p.Glu289Gln,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon9/37:c.865G>C:p.Glu289Gln,CDK5RAP2:NM_001272039.1:missense:MODERATE:exon9/35:c.865G>C:p.Glu289Gln,CDK5RAP2:NR_073554.1:non_coding_exon:MODIFIER:exon9/38:n.1057G>C:,CDK5RAP2:NR_073555.1:non_coding_exon:MODIFIER:exon9/38:n.1057G>C:,CDK5RAP2:NR_073556.1:non_coding_exon:MODIFIER:exon9/39:n.1054G>C:,CDK5RAP2:NR_073557.1:non_coding_exon:MODIFIER:exon9/38:n.1057G>C:,CDK5RAP2:NR_073558.1:non_coding_exon:MODIFIER:exon9/38:n.1054G>C:		rs4836822	0.8011	0.8770	47115/28550/2381	0.8694	2.5270	T	T,T,T,T,T,T	P,B,P	P,B,P	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];	RCV000020847.1 [benign]; RCV000145507.1 [likely benign]; 			915	182					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123342259	123342259	C	A	hom		QUAL=6138;DP=91;AF=1.00;MQM=60;TRIO=HOM,91,1.00,HOM,41,1.00,HOM,69,1.00	CDK5RAP2	5'UTR,non_coding_exon	CDK5RAP2:NM_018249.5:5'UTR:MODIFIER:exon1/38:c.-3G>T:,CDK5RAP2:NM_001011649.2:5'UTR:MODIFIER:exon1/37:c.-3G>T:,CDK5RAP2:NM_001272039.1:5'UTR:MODIFIER:exon1/35:c.-3G>T:,CDK5RAP2:NR_073554.1:non_coding_exon:MODIFIER:exon1/38:n.190G>T:,CDK5RAP2:NR_073555.1:non_coding_exon:MODIFIER:exon1/38:n.190G>T:,CDK5RAP2:NR_073556.1:non_coding_exon:MODIFIER:exon1/39:n.190G>T:,CDK5RAP2:NR_073557.1:non_coding_exon:MODIFIER:exon1/38:n.190G>T:,CDK5RAP2:NR_073558.1:non_coding_exon:MODIFIER:exon1/38:n.190G>T:		rs932975	0.9804	0.9920	58644/32739/4293	0.9285							RCV000081944.5 [benign]; 			1099	8					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123342275	123342275	A	G	hom		QUAL=5221;DP=79;AF=1.00;MQM=60;TRIO=HOM,79,1.00,HOM,41,1.00,HOM,62,1.00	CDK5RAP2	5'UTR,non_coding_exon	CDK5RAP2:NM_018249.5:5'UTR:MODIFIER:exon1/38:c.-19T>C:,CDK5RAP2:NM_001011649.2:5'UTR:MODIFIER:exon1/37:c.-19T>C:,CDK5RAP2:NM_001272039.1:5'UTR:MODIFIER:exon1/35:c.-19T>C:,CDK5RAP2:NR_073554.1:non_coding_exon:MODIFIER:exon1/38:n.174T>C:,CDK5RAP2:NR_073555.1:non_coding_exon:MODIFIER:exon1/38:n.174T>C:,CDK5RAP2:NR_073556.1:non_coding_exon:MODIFIER:exon1/39:n.174T>C:,CDK5RAP2:NR_073557.1:non_coding_exon:MODIFIER:exon1/38:n.174T>C:,CDK5RAP2:NR_073558.1:non_coding_exon:MODIFIER:exon1/38:n.174T>C:		rs932974	0.9655	0.9870	56249/31622/3699	0.9215							RCV000081943.4 [benign]; 			526	3					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123714876	123714876	C	T	het		QUAL=7325;DP=310;AF=0.48;MQM=60;TRIO=HET,310,0.48,HET,235,0.57,WT,333,0.00	C5	3'UTR	C5:NM_001317163.1:3'UTR:MODIFIER:exon41/41:c.*141G>A:,C5:NM_001735.2:3'UTR:MODIFIER:exon41/41:c.*141G>A:			0.0000	0.0000	0/0/0	0.0000										0	1					C5 (inh=n/a pLI=0.00)
chr9	123769200	123769200	C	T	hom		QUAL=23907;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,187,1.00,HOM,250,1.00	C5	missense	C5:NM_001317163.1:missense:MODERATE:exon19/41:c.2422G>A:p.Val808Ile,C5:NM_001735.2:missense:MODERATE:exon19/41:c.2404G>A:p.Val802Ile,C5:NM_001317164.1:missense:MODERATE:exon19/21:c.2404G>A:p.Val802Ile		rs17611	0.4048	0.4590	13996/6618/45	0.4511	0.1000	T	T,T	B	B	120900 [C5 (confirmed) C5 deficiency|Eculizumab,poor response to];		CM093430 [CLASS=DP MUT=ALT PHEN="Ischemic stroke association with" GENE=C5]; 		239	551					C5 (inh=n/a pLI=0.00)
chr9	123780005	123780005	G	A	hom		QUAL=28153;DP=396;AF=0.99;MQM=60;TRIO=HOM,396,0.99,HOM,202,1.00,HOM,246,1.00	C5	synonymous	C5:NM_001317163.1:synonymous:LOW:exon13/41:c.1650C>T:p.Tyr550Tyr,C5:NM_001735.2:synonymous:LOW:exon13/41:c.1632C>T:p.Tyr544Tyr,C5:NM_001317164.1:synonymous:LOW:exon13/21:c.1632C>T:p.Tyr544Tyr		rs25681	0.4058	0.4570	13895/6570/43	0.4496						120900 [C5 (confirmed) C5 deficiency|Eculizumab,poor response to];			COSM1459729	235	552					C5 (inh=n/a pLI=0.00)
chr9	124083614	124083614	C	T	het		QUAL=5903;DP=262;AF=0.46;MQM=59;TRIO=HET,262,0.46,HET,311,0.47,WT,418,0.00	GSN	synonymous	GSN:NM_000177.4:synonymous:LOW:exon10/17:c.1413C>T:p.Gly471Gly,GSN:NM_001127662.1:synonymous:LOW:exon10/17:c.1260C>T:p.Gly420Gly,GSN:NM_001127663.1:synonymous:LOW:exon12/19:c.1368C>T:p.Gly456Gly,GSN:NM_001127664.1:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:NM_001127665.1:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:NM_001127666.1:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:NM_001127667.1:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:NM_198252.2:synonymous:LOW:exon11/18:c.1260C>T:p.Gly420Gly,GSN:NM_001258029.1:synonymous:LOW:exon10/17:c.1311C>T:p.Gly437Gly,GSN:NM_001258030.1:synonymous:LOW:exon10/17:c.1284C>T:p.Gly428Gly		rs2304393	0.0855	0.0620	355/103/37	0.0600						137350 [GSN (provisional) Amyloidosis,Finnish type];				5	162					GSN (inh=n/a pLI=0.00)
chr9	129453229	129453229	A	G	hom		QUAL=8960;DP=110;AF=1.00;MQM=59;TRIO=HOM,110,1.00,HET,105,0.55,HOM,131,0.99	LMX1B	synonymous	LMX1B:NM_001174146.1:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:NM_001174147.1:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:NM_002316.3:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu		rs2277158	0.4800	0.4450	11975/5956/1445	0.4382						602575 [LMX1B (confirmed) Nail-patella syndrome];			COSM3763642, COSM3763643, COSM3763641	216	536					LMX1B (inh=n/a pLI=0.82)
chr9	129455587	129455587	G	C	hom		QUAL=9114;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HET,128,0.40,HOM,172,0.99	LMX1B	synonymous	LMX1B:NM_001174146.1:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:NM_001174147.1:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:NM_002316.3:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser		rs13295990	0.4393	0.4160	8617/4539/644	0.4110						602575 [LMX1B (confirmed) Nail-patella syndrome];				219	529					LMX1B (inh=n/a pLI=0.82)
chr9	129459181	129459181	C	T	het		QUAL=4899;DP=117;AF=0.49;MQM=59;TRIO=HET,117,0.49,WT,254,0.00,HET,304,0.48	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*451C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*451C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*451C>T:		rs71497630	0.1516	0.0000	0/0/0	0.1362										2	51					LMX1B (inh=n/a pLI=0.82)
chr9	129459314	129459314	C	T	het		QUAL=13134;DP=326;AF=0.45;MQM=59;TRIO=HET,326,0.45,HET,378,0.47,HET,494,0.44	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*584C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*584C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*584C>T:		rs34200683	0.2181	0.0000	0/0/0	0.2694										20	124					LMX1B (inh=n/a pLI=0.82)
chr9	129459438	129459438	G	A	het		QUAL=8308;DP=161;AF=0.45;MQM=60;TRIO=HET,161,0.45,HET,278,0.46,HET,363,0.40	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*708G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*708G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*708G>A:		rs10987413	0.2057	0.0000	0/0/0	0.2636										17	122					LMX1B (inh=n/a pLI=0.82)
chr9	129459478	129459478	C	T	het		QUAL=7256;DP=197;AF=0.46;MQM=59;TRIO=HET,197,0.46,HET,219,0.46,HET,322,0.40	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*748C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*748C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*748C>T:		rs10987414	0.2340	0.0000	0/0/0	0.2662										20	125					LMX1B (inh=n/a pLI=0.82)
chr9	129459662	129459662	G	T	het		QUAL=9261;DP=458;AF=0.47;MQM=59;TRIO=HET,458,0.47,WT,229,0.00,HET,266,0.56	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*932G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*932G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*932G>T:		rs28687510	0.2298	0.0000	0/0/0	0.1616										2	52					LMX1B (inh=n/a pLI=0.82)
chr9	129459985	129459985	A	G	het		QUAL=5786;DP=226;AF=0.50;MQM=60;TRIO=HET,226,0.50,WT,244,0.00,HET,250,0.49	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1255A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1255A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1255A>G:	L3b	rs16929236	0.2302	0.0000	0/0/0	0.1628										2	40					LMX1B (inh=n/a pLI=0.82)
chr9	129460119	129460119	T	G	hom		QUAL=4189;DP=34;AF=0.35;MQM=56;TRIO=HOM,34,1.00,WT,95,0.43,HET,68,0.94	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1389T>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1389T>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1389T>G:	(TGTTT)n	rs13300385	0.1641	0.0000	0/0/0	0.0774										3	32					LMX1B (inh=n/a pLI=0.82)
chr9	129460123	129460123	G	T	hom		QUAL=4189;DP=34;AF=0.35;MQM=56;TRIO=HOM,34,1.00,WT,95,0.43,HET,68,0.94	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1393G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1393G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1393G>T:	(TGTTT)n	rs13299451	0.1613	0.0000	0/0/0	0.0517										3	32					LMX1B (inh=n/a pLI=0.82)
chr9	129460203	129460203	G	A	het	low_MQM	QUAL=2120;DP=133;AF=0.44;MQM=48;TRIO=HET,133,0.44,WT,133,0.00,HET,99,0.35	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1473G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1473G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1473G>A:	AluSp	rs13299609	0.1508	0.0000	0/0/0	0.1136										2	36					LMX1B (inh=n/a pLI=0.82)
chr9	129460312	129460312	A	G	hom		QUAL=11431;DP=164;AF=0.99;MQM=56;TRIO=HOM,164,0.99,HET,143,0.44,HOM,166,0.99	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1582A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1582A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1582A>G:	AluSp	rs10987415	0.4103	0.0000	0/0/0	0.3790										36	77					LMX1B (inh=n/a pLI=0.82)
chr9	129460396	129460396	C	T	het		QUAL=11244;DP=248;AF=0.53;MQM=56;TRIO=HET,248,0.53,HET,288,0.46,HET,370,0.54	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1666C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1666C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1666C>T:	AluSp	rs10987416	0.2169	0.0000	0/0/0	0.2512										11	81					LMX1B (inh=n/a pLI=0.82)
chr9	129460722	129460722	T	C	hom		QUAL=21495;DP=419;AF=1.00;MQM=59;TRIO=HOM,419,1.00,HET,247,0.49,HET,356,0.52	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1992T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1992T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1992T>C:	L3	rs34776870	0.1955	0.0000	0/0/0	0.1508										2	43					LMX1B (inh=n/a pLI=0.82)
chr9	129460727	129460727	G	A	hom		QUAL=20742;DP=419;AF=0.99;MQM=59;TRIO=HOM,419,0.99,HET,253,0.48,HET,352,0.53	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1997G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1997G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1997G>A:	L3	rs35632228	0.1953	0.0000	0/0/0	0.1507										2	42					LMX1B (inh=n/a pLI=0.82)
chr9	129461123	129461123	T	C	hom		QUAL=8085;DP=157;AF=0.57;MQM=59;TRIO=HOM,157,1.00,HOM,60,1.00,HOM,61,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2393T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2393T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2393T>C:		rs10120414	0.8714	0.0000	0/0/0	0.7389										202	28					LMX1B (inh=n/a pLI=0.82)
chr9	129461124	129461124	G	C	het		QUAL=8085;DP=157;AF=0.57;MQM=59;TRIO=HET,157,1.00,WT,60,1.00,HET,61,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2394G>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2394G>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2394G>C:		rs10760451	0.4089	0.0000	0/0/0	0.2877										31	111					LMX1B (inh=n/a pLI=0.82)
chr9	129461319	129461320	TT	-	het		QUAL=3786;DP=181;AF=0.46;MQM=59;TRIO=HET,181,0.46,HET,147,0.27,HET,172,0.37	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:		rs560251761	0.3754	0.0000	0/0/0	0.3813										35	103					LMX1B (inh=n/a pLI=0.82)
chr9	129462501	129462501	G	T	het		QUAL=12151;DP=317;AF=0.53;MQM=60;TRIO=HET,317,0.53,HET,272,0.46,HET,375,0.50	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3771G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3771G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3771G>T:		rs10987417	0.5407	0.0000	0/0/0	0.4961										51	113					LMX1B (inh=n/a pLI=0.82)
chr9	129462563	129462563	A	G	het		QUAL=13475;DP=321;AF=0.48;MQM=60;TRIO=HET,321,0.48,HET,347,0.45,HET,462,0.50	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3833A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3833A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3833A>G:		rs10987418	0.5481	0.0000	0/0/0	0.4962										53	114					LMX1B (inh=n/a pLI=0.82)
chr9	129462594	129462594	T	C	het		QUAL=14410;DP=284;AF=0.49;MQM=59;TRIO=HET,284,0.49,HET,399,0.46,HET,533,0.51	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3864T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3864T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3864T>C:		rs10987419	0.5483	0.0000	0/0/0	0.3616										53	114					LMX1B (inh=n/a pLI=0.82)
chr9	129462687	129462687	C	A	het		QUAL=17614;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,477,0.49,HET,637,0.50	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3957C>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3957C>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3957C>A:		rs10987422	0.5323	0.0000	0/0/0	0.5041										53	114					LMX1B (inh=n/a pLI=0.82)
chr9	129462901	129462901	T	C	hom		QUAL=21460;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HET,280,0.46,HOM,362,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*4171T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*4171T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*4171T>C:	(CACGCA)n	rs3814119	0.5511	0.0000	0/0/0	0.5273										54	117					LMX1B (inh=n/a pLI=0.82)
chr9	130629139	130629139	T	G	hom		QUAL=5420;DP=60;AF=1.00;MQM=60;TRIO=HOM,60,1.00,HOM,35,1.00,HOM,74,1.00	AK1	3'UTR	AK1:NM_001318122.1:3'UTR:MODIFIER:exon6/6:c.*1148A>C:,AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*1148A>C:,AK1:NM_001318121.1:3'UTR:MODIFIER:exon7/7:c.*1148A>C:	LFSINE_Vert	rs913987	0.7087	0.0000	0/0/0	0.7214										152	70					AK1 (inh=n/a pLI=0.65)
chr9	130629527	130629527	G	T	hom		QUAL=7876;DP=91;AF=0.98;MQM=57;TRIO=HOM,91,0.98,HOM,79,1.00,HOM,103,0.99	AK1	3'UTR	AK1:NM_001318122.1:3'UTR:MODIFIER:exon6/6:c.*760C>A:,AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*760C>A:,AK1:NM_001318121.1:3'UTR:MODIFIER:exon7/7:c.*760C>A:	AluSx	rs2249308	0.9181	0.0000	0/0/0	0.8322										191	38					AK1 (inh=n/a pLI=0.65)
chr9	130630233	130630233	G	T	hom		QUAL=39405;DP=187;AF=1.00;MQM=59;TRIO=HOM,187,1.00,HOM,482,1.00,HOM,614,1.00	AK1	3'UTR	AK1:NM_001318122.1:3'UTR:MODIFIER:exon6/6:c.*54C>A:,AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*54C>A:,AK1:NM_001318121.1:3'UTR:MODIFIER:exon7/7:c.*54C>A:		rs4226	0.6817	0.0000	0/0/0	0.1600										305	156					AK1 (inh=n/a pLI=0.65)
chr9	130630639	130630639	A	G	hom		QUAL=24473;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,250,1.00,HOM,273,1.00	AK1	synonymous	AK1:NM_001318122.1:synonymous:LOW:exon5/6:c.525T>C:p.Pro175Pro,AK1:NM_000476.2:synonymous:LOW:exon6/7:c.477T>C:p.Pro159Pro,AK1:NM_001318121.1:synonymous:LOW:exon6/7:c.477T>C:p.Pro159Pro		rs913986	0.9982	0.9990	56343/31274/4781	0.9439	-4.9500	T				103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency];				1108	0					AK1 (inh=n/a pLI=0.65)
chr9	130698029	130698029	G	C	hom		QUAL=35788;DP=368;AF=1.00;MQM=59;TRIO=HOM,368,1.00,HOM,307,1.00,HOM,420,1.00	DPM2	missense	DPM2:NM_003863.3:missense:MODERATE:exon4/4:c.227C>G:p.Thr76Ser		rs7997	0.6835	0.7870	38367/24522/2292	0.7750	0.1410	T	T	B	B	603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu];	RCV000116901.1 [benign]; 		COSM3982740	485	173					DPM2 (inh=n/a pLI=0.02)
chr9	130698043	130698043	A	G	hom		QUAL=33736;DP=334;AF=1.00;MQM=60;TRIO=HOM,334,1.00,HOM,309,1.00,HOM,392,1.00	DPM2	synonymous	DPM2:NM_003863.3:synonymous:LOW:exon4/4:c.213T>C:p.Tyr71Tyr		rs6781	0.7310	0.8140	40571/24672/2304	0.8057						603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu];	RCV000116900.4 [benign]; 			497	166					DPM2 (inh=n/a pLI=0.02)
chr9	130700251	130700251	T	C	hom		QUAL=36008;DP=430;AF=1.00;MQM=59;TRIO=HOM,430,1.00,HOM,330,1.00,HOM,409,1.00	DPM2	5'UTR	DPM2:NM_003863.3:5'UTR:MODIFIER:exon1/4:c.-152A>G:		rs6478802	0.6839	0.0000	0/0/0	0.1310										179	44					DPM2 (inh=n/a pLI=0.02)
chr9	130700727	130700727	T	C	hom		QUAL=23385;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,212,1.00,HOM,269,1.00	DPM2	5'UTR	DPM2:NM_003863.3:5'UTR:MODIFIER:exon1/4:c.-628A>G:		rs3758327	0.6839	0.0000	0/0/0	0.1301										178	45					DPM2 (inh=n/a pLI=0.02)
chr9	131285955	131285955	A	G	het	phylop_high;anno_pathogenic_hgmd	QUAL=758;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,HET,24,0.33,WT,60,0.00	GLE1,MIR1268A	missense,intron	GLE1:NM_001003722.1:missense:MODERATE:exon6/16:c.727A>G:p.Ile243Val,GLE1:NM_001499.2:missense:MODERATE:exon6/14:c.727A>G:p.Ile243Val,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-138438A>G:		rs2275260	0.3474	0.2670	4751/1439/746	0.2638	1.7440	T	T,T	B,B	B,B	603371 [GLE1 (confirmed) Lethal congenital contracture syndrome 1|Arthrogryposis,lethal,with anterior horn cell disease];	RCV000179351.1 [benign]; 	CM1310812 [CLASS=DM? MUT=ALT PHEN="Arthrogryposis & hypoplasia" GENE=GLE1]; 		75	412	2	[2] old entry - no details available			GLE1 (inh=n/a pLI=0.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131303522	131303522	G	A	het		QUAL=4448;DP=191;AF=0.49;MQM=60;TRIO=HET,191,0.49,HET,155,0.49,WT,163,0.01	GLE1,MIR1268A	3'UTR,intron	GLE1:NM_001003722.1:3'UTR:MODIFIER:exon16/16:c.*73G>A:,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-120871G>A:		rs10760563	0.2660	0.0000	0/0/0	0.0457										28	174					GLE1 (inh=n/a pLI=0.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131346218	131346218	A	C	hom		QUAL=37049;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,398,1.00,HOM,532,1.00	SPTAN1,MIR1268A	synonymous,intron	SPTAN1:NM_001130438.2:synonymous:LOW:exon16/57:c.2163A>C:p.Ala721Ala,SPTAN1:NM_001195532.1:synonymous:LOW:exon16/55:c.2163A>C:p.Ala721Ala,SPTAN1:NM_003127.3:synonymous:LOW:exon16/56:c.2163A>C:p.Ala721Ala,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-78175A>C:		rs10760566	0.9698	0.9910	59701/33359/4277	0.9361						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000128236.2 [benign]; 			1105	3					SPTAN1 (inh=AD pLI=1.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131360750	131360750	C	T	hom		QUAL=16616;DP=225;AF=1.00;MQM=59;TRIO=HOM,225,1.00,HOM,133,1.00,HOM,160,1.00	SPTAN1,MIR1268A	synonymous,intron	SPTAN1:NM_001130438.2:synonymous:LOW:exon25/57:c.3486C>T:p.Leu1162Leu,SPTAN1:NM_001195532.1:synonymous:LOW:exon24/55:c.3426C>T:p.Leu1142Leu,SPTAN1:NM_003127.3:synonymous:LOW:exon25/56:c.3486C>T:p.Leu1162Leu,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-63643C>T:		rs2227864	0.6428	0.7970	39037/26231/1134	0.7913						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000147625.1 [benign]; RCV000147626.1 [benign]; 			876	206					SPTAN1 (inh=AD pLI=1.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131375701	131375701	A	G	hom		QUAL=27141;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HOM,234,1.00,HOM,332,1.00	SPTAN1,MIR1268A	synonymous,intron	SPTAN1:NM_001130438.2:synonymous:LOW:exon40/57:c.5085A>G:p.Leu1695Leu,SPTAN1:NM_001195532.1:synonymous:LOW:exon38/55:c.5010A>G:p.Leu1670Leu,SPTAN1:NM_003127.3:synonymous:LOW:exon39/56:c.5070A>G:p.Leu1690Leu,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-48692A>G:		rs1415568	0.9848	0.9960	60218/33367/4754	0.9314						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000128256.2 [benign]; 			1107	2					SPTAN1 (inh=AD pLI=1.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131379967	131379967	C	T	hom		QUAL=28391;DP=283;AF=1.00;MQM=59;TRIO=HOM,283,1.00,HOM,252,1.00,HOM,377,1.00	SPTAN1,MIR1268A	synonymous,intron	SPTAN1:NM_001130438.2:synonymous:LOW:exon42/57:c.5406C>T:p.Thr1802Thr,SPTAN1:NM_001195532.1:synonymous:LOW:exon40/55:c.5331C>T:p.Thr1777Thr,SPTAN1:NM_003127.3:synonymous:LOW:exon41/56:c.5391C>T:p.Thr1797Thr,MIR1268A:NR_031672.1.4:intron:MODIFIER:exon2/2:n.30-44426C>T:		rs2227862	0.6170	0.7910	39713/26898/787	0.7850						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000147635.1 [benign]; RCV000147636.2 [benign]; 		COSM4163385, COSM4163386	868	217					SPTAN1 (inh=AD pLI=1.00), MIR1268A (inh=n/a pLI=n/a)
chr9	131670919	131670919	T	C	hom		QUAL=23089;DP=249;AF=1.00;MQM=59;TRIO=HOM,249,1.00,HOM,314,0.99,HET,416,0.55	LRRC8A	synonymous	LRRC8A:NM_001127244.1:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg,LRRC8A:NM_001127245.1:synonymous:LOW:exon2/3:c.1476T>C:p.Arg492Arg,LRRC8A:NM_019594.3:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg		rs3750319	0.5711	0.6880	28974/16911/487	0.6811						608360 [LRRC8A (confirmed) Agammaglobulinemia 5];				578	429					LRRC8A (inh=n/a pLI=0.92)
chr9	131679892	131679892	C	T	hom		QUAL=11683;DP=129;AF=0.99;MQM=60;TRIO=HOM,129,0.99,HOM,171,1.00,HET,179,0.55	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1242C>T:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1242C>T:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1242C>T:		rs9031	0.5118	0.0000	0/0/0	0.1102										112	98					LRRC8A (inh=n/a pLI=0.92)
chr9	131679897	131679897	A	G	hom		QUAL=15058;DP=130;AF=1.00;MQM=60;TRIO=HOM,130,1.00,HOM,171,1.00,HOM,182,1.00	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1247A>G:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1247A>G:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1247A>G:		rs10819453	0.9974	0.0000	0/0/0	0.1493										230	0					LRRC8A (inh=n/a pLI=0.92)
chr9	131680177	131680177	G	T	het		QUAL=8052;DP=296;AF=0.49;MQM=59;TRIO=HET,296,0.49,HET,335,0.49,WT,429,0.00	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1527G>T:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1527G>T:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1527G>T:		rs11542344	0.0262	0.0000	0/0/0	0.0079										4	21					LRRC8A (inh=n/a pLI=0.92)
chr9	132575797	132575797	A	T	het		QUAL=5659;DP=258;AF=0.47;MQM=60;TRIO=HET,258,0.47,WT,167,0.00,HET,211,0.47	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*454T>A:		rs1045441	0.0681	0.0000	0/0/0	0.0128										5	53					TOR1A (inh=AD pLI=0.17)
chr9	132575828	132575828	A	-	het		QUAL=4153;DP=256;AF=0.50;MQM=59;TRIO=HET,256,0.50,HET,132,0.49,WT,162,0.01	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*423delT:		rs573629050	0.0136	0.0000	0/0/0	0.0065										4	18					TOR1A (inh=AD pLI=0.17)
chr9	132576037	132576037	G	C	het		QUAL=2975;DP=136;AF=0.49;MQM=60;TRIO=HET,136,0.49,WT,62,0.00,HET,104,0.49	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*214C>G:		rs1183	0.0681	0.0000	0/0/0	0.0128										5	52					TOR1A (inh=AD pLI=0.17)
chr9	132585058	132585058	G	A	het		QUAL=5796;DP=260;AF=0.48;MQM=60;TRIO=HET,260,0.48,HET,289,0.41,WT,367,0.00	TOR1A	synonymous	TOR1A:NM_000113.2:synonymous:LOW:exon2/5:c.246C>T:p.Ala82Ala		rs2296793	0.2262	0.2270	3176/1911/254	0.2275						605204 [TOR1A (confirmed) Dystonia-1,torsion|Dystonia,early-onset atypical,with myoclonic features|Dystonia-1,modifier of];			COSM150726	90	488					TOR1A (inh=AD pLI=0.17)
chr9	133364757	133364757	T	C	het		QUAL=5532;DP=137;AF=0.49;MQM=57;TRIO=HET,137,0.49,WT,230,0.00,HET,269,0.57	ASS1	synonymous	ASS1:NM_000050.4:synonymous:LOW:exon13/16:c.876T>C:p.His292His,ASS1:NM_054012.3:synonymous:LOW:exon12/15:c.876T>C:p.His292His		rs1057484	0.0767	0.0940	630/394/65	0.0902						603470 [ASS1 (confirmed) Citrullinemia];	RCV000078028.5 [benign]; 			16	198					ASS1 (inh=n/a pLI=0.00)
chr9	133376666	133376681	GTGTGTGTGTGTGTGT	-	hom		QUAL=831;DP=21;AF=0.14;MQM=60;TRIO=HOM,21,0.19,WT,24,0.63,WT,21,0.62	ASS1-LOC100272217	intergenic_region	ASS1-LOC100272217:ASS1-LOC100272217:intergenic_region:MODIFIER::n.133376666_133376681delGTGTGTGTGTGTGTGT:	(GT)n		0.0000	0.0000	0/0/0	0.0010										0	3					ASS1-LOC100272217 (inh=n/a pLI=n/a)
chr9	134385436	134385436	A	G	hom		QUAL=21086;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HET,312,0.47,HOM,382,1.00	POMT1	missense,intron	POMT1:NM_007171.3:missense:MODERATE:exon8/20:c.752A>G:p.Gln251Arg,POMT1:NM_001077365.1:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:NM_001077366.1:intron:MODIFIER:exon7/18:c.537+53A>G:,POMT1:NM_001136113.1:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:NM_001136114.1:intron:MODIFIER:exon6/17:c.348+53A>G:		rs2296949	0.8706	0.9230	52010/30185/2838	0.9034	1.3280	T	T,T,T	B	B	607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000081493.4 [benign]; RCV000216907.1 [benign]; 			938	85					POMT1 (inh=AR pLI=0.00)
chr9	134386744	134386744	T	C	hom	pred_pathogenic_1	QUAL=10758;DP=131;AF=1.00;MQM=59;TRIO=HOM,131,1.00,HET,102,0.49,HOM,166,1.00	POMT1	synonymous	POMT1:NM_007171.3:synonymous:LOW:exon10/20:c.942T>C:p.Thr314Thr,POMT1:NM_001077365.1:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:NM_001077366.1:synonymous:LOW:exon9/19:c.714T>C:p.Thr238Thr,POMT1:NM_001136113.1:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:NM_001136114.1:synonymous:LOW:exon8/18:c.525T>C:p.Thr175Thr		rs10901065	0.8708	0.9230	52033/30195/2847	0.9071	-1.7260	T	D,D			607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000153752.3 [benign]; 			1007	93					POMT1 (inh=AR pLI=0.00)
chr9	134387488	134387488	T	C	hom		QUAL=22363;DP=287;AF=0.99;MQM=60;TRIO=HOM,287,0.99,HET,260,0.53,HOM,298,1.00	POMT1	synonymous	POMT1:NM_007171.3:synonymous:LOW:exon11/20:c.1113T>C:p.Asp371Asp,POMT1:NM_001077365.1:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:NM_001077366.1:synonymous:LOW:exon10/19:c.885T>C:p.Asp295Asp,POMT1:NM_001136113.1:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:NM_001136114.1:synonymous:LOW:exon9/18:c.696T>C:p.Asp232Asp		rs3739494	0.8708	0.9230	51995/30184/2844	0.9156						607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000153753.4 [benign]; 			1008	93					POMT1 (inh=AR pLI=0.00)
chr9	134398534	134398534	T	C	hom		QUAL=21150;DP=151;AF=0.99;MQM=59;TRIO=HOM,151,0.99,HET,298,0.55,HOM,401,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*41T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*41T>C:		rs3739495	0.8704	0.9200	47097/27263/2415	0.9013										433	50					POMT1 (inh=AR pLI=0.00)
chr9	134398719	134398719	T	C	hom		QUAL=28648;DP=365;AF=1.00;MQM=59;TRIO=HOM,365,1.00,HET,310,0.52,HOM,418,0.99	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*226T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*226T>C:		rs3824395	0.8708	0.0000	0/0/0	0.1834										199	26					POMT1 (inh=AR pLI=0.00)
chr9	134398771	134398771	T	C	hom		QUAL=28031;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HET,334,0.53,HOM,444,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*278T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*278T>C:		rs10793885	0.8712	0.0000	0/0/0	0.1504										201	25					POMT1 (inh=AR pLI=0.00)
chr9	134398778	134398778	A	G	hom		QUAL=33140;DP=261;AF=0.99;MQM=59;TRIO=HOM,261,0.99,HOM,332,1.00,HOM,440,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*285A>G:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*285A>G:		rs4740259	0.9812	0.0000	0/0/0	0.8392										229	1					POMT1 (inh=AR pLI=0.00)
chr9	134398841	134398841	C	T	hom		QUAL=20370;DP=178;AF=0.99;MQM=59;TRIO=HOM,178,0.99,HET,261,0.50,HOM,366,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*348C>T:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*348C>T:		rs7857419	0.8664	0.0000	0/0/0	0.1549										190	35					POMT1 (inh=AR pLI=0.00)
chr9	134398946	134398946	T	C	hom		QUAL=11520;DP=164;AF=1.00;MQM=59;TRIO=HOM,164,1.00,HET,200,0.56,HET,268,0.51	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*453T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*453T>C:		rs11005	0.7490	0.0000	0/0/0	0.1352										136	86					POMT1 (inh=AR pLI=0.00)
chr9	135202829	135202829	T	C	hom		QUAL=23269;DP=326;AF=1.00;MQM=60;TRIO=HOM,326,1.00,HOM,171,1.00,HOM,205,1.00	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val		rs543573	0.5561	0.7250	33935/23205/761	0.7203	-0.6580	T	T,T,T	B,B,B	B,B,B	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile|Spinocerebellar ataxia,autosomal recessive 1];	RCV000081696.7 [other]; 		COSM3982759, COSM150732	1875	788					SETX (inh=AR+AD pLI=0.20)
chr9	135203231	135203231	C	T	hom		QUAL=14736;DP=201;AF=0.99;MQM=59;TRIO=HOM,201,0.99,HOM,96,0.98,HOM,164,1.00	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg		rs1183768	0.5561	0.7250	33914/23192/758	0.6938	0.4900	T	T,T,T	P,P,P	B,B,B	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile|Spinocerebellar ataxia,autosomal recessive 1];	RCV000081695.7 [other]; 		COSM3982760, COSM150733	1886	782					SETX (inh=AR+AD pLI=0.20)
chr9	135203409	135203409	A	C	hom		QUAL=15430;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,62,1.00,HOM,83,0.99	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu		rs1185193	0.6406	0.7630	36812/24117/2182	0.7563	-0.9950	T	T,T,T	B,B,B	B,B,B	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile|Spinocerebellar ataxia,autosomal recessive 1];	RCV000081694.7 [other]; 			1966	714					SETX (inh=AR+AD pLI=0.20)
chr9	135206460	135206460	A	G	hom		QUAL=29150;DP=516;AF=1.00;MQM=60;TRIO=HOM,516,1.00,HOM,171,0.99,HOM,190,1.00	SETX	synonymous	SETX:NM_015046.5:synonymous:LOW:exon9/26:c.1077T>C:p.Tyr359Tyr		rs9411449	0.6266	0.7470	35321/23221/2007	0.7420						608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile|Spinocerebellar ataxia,autosomal recessive 1];	RCV000081691.7 [other]; 		COSM150734, COSM4163458	1894	779					SETX (inh=AR+AD pLI=0.20)
chr9	135767185	135767185	C	T	het		QUAL=8687;DP=411;AF=0.45;MQM=60;TRIO=HET,411,0.45,WT,312,0.00,HET,375,0.42	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*4437G>A:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*4437G>A:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*4437G>A:		rs11553763	0.1034	0.0000	0/0/0	0.0144										1	27					TSC1 (inh=AD pLI=1.00)
chr9	135770115	135770115	C	T	hom		QUAL=14553;DP=257;AF=1.00;MQM=59;TRIO=HOM,257,1.00,HOM,93,1.00,HOM,106,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1507G>A:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1507G>A:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1507G>A:		rs739441	0.7734	0.0000	0/0/0	0.7171										116	72					TSC1 (inh=AD pLI=1.00)
chr9	135770134	135770134	G	A	het		QUAL=7494;DP=299;AF=0.48;MQM=59;TRIO=HET,299,0.48,WT,107,0.00,HOM,126,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1488C>T:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1488C>T:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1488C>T:		rs739442	0.4507	0.0000	0/0/0	0.0889										54	103					TSC1 (inh=AD pLI=1.00)
chr9	135770250	135770250	A	C	het		QUAL=10462;DP=268;AF=0.44;MQM=59;TRIO=HET,268,0.44,HET,231,0.55,HET,325,0.52	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1372T>G:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1372T>G:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1372T>G:		rs58612431	0.2196	0.0000	0/0/0	0.0308										7	60					TSC1 (inh=AD pLI=1.00)
chr9	135770300	135770300	G	A	het		QUAL=19647;DP=399;AF=0.45;MQM=60;TRIO=HET,399,0.45,HET,265,0.52,HOM,357,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1322C>T:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1322C>T:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1322C>T:		rs2809243	0.5521	0.0000	0/0/0	0.1021										66	122					TSC1 (inh=AD pLI=1.00)
chr9	135770347	135770347	A	C	hom		QUAL=32149;DP=351;AF=1.00;MQM=59;TRIO=HOM,351,1.00,HOM,276,0.99,HOM,373,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1275T>G:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1275T>G:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1275T>G:		rs2809244	0.7482	0.0000	0/0/0	0.7349										116	89					TSC1 (inh=AD pLI=1.00)
chr9	135772717	135772717	G	A	het		QUAL=11310;DP=295;AF=0.49;MQM=59;TRIO=HET,295,0.49,HET,246,0.58,HET,270,0.52	TSC1	synonymous	TSC1:NM_000368.4:synonymous:LOW:exon22/23:c.2829C>T:p.Ala943Ala,TSC1:NM_001162426.1:synonymous:LOW:exon22/23:c.2826C>T:p.Ala942Ala,TSC1:NM_001162427.1:synonymous:LOW:exon21/22:c.2676C>T:p.Ala892Ala		rs4962081	0.0621	0.0760	457/224/37	0.0752						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042257.2 [not provided]; RCV000054906.1 [not provided]; RCV000055028.1 [not provided]; RCV000055028.1 [not provided]; RCV000118693.7 [other]; RCV000162946.1 [benign]; 			4	142					TSC1 (inh=AD pLI=1.00)
chr9	135773001	135773001	A	-	hom		QUAL=1122;DP=45;AF=0.38;MQM=59;TRIO=HOM,45,0.38,WT,21,0.33,WT,26,0.12	TSC1	splice_region&intron	TSC1:NM_000368.4:splice_region&intron:LOW:exon20/22:c.2626-4delT:,TSC1:NM_001162426.1:splice_region&intron:LOW:exon20/22:c.2623-4delT:,TSC1:NM_001162427.1:splice_region&intron:LOW:exon19/21:c.2473-4delT:	(A)n	rs118203716	0.3427	0.2400	1/1/0	0.1961						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042234.2 [not provided]; 			8	84					TSC1 (inh=AD pLI=1.00)
chr9	135782221	135782221	T	C	het		QUAL=3635;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,HET,99,0.47,WT,140,0.00	TSC1	splice_region&synonymous	TSC1:NM_000368.4:splice_region&synonymous:LOW:exon14/23:c.1335A>G:p.Glu445Glu,TSC1:NM_001162426.1:splice_region&synonymous:LOW:exon14/23:c.1332A>G:p.Glu444Glu,TSC1:NM_001162427.1:splice_region&synonymous:LOW:exon13/22:c.1182A>G:p.Glu394Glu		rs7862221	0.1386	0.1360	1225/741/254	0.1350						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042015.2 [not provided]; RCV000118690.6 [other]; RCV000162953.1 [benign]; 		COSM3763712	28	308					TSC1 (inh=AD pLI=1.00)
chr9	135786904	135786904	A	G	het		QUAL=6103;DP=322;AF=0.44;MQM=60;TRIO=HET,322,0.44,HET,192,0.51,WT,215,0.00	TSC1	missense	TSC1:NM_000368.4:missense:MODERATE:exon10/23:c.965T>C:p.Met322Thr,TSC1:NM_001162426.1:missense:MODERATE:exon10/23:c.965T>C:p.Met322Thr,TSC1:NM_001162427.1:missense:MODERATE:exon9/22:c.812T>C:p.Met271Thr		rs1073123	0.1352	0.1290	1104/639/250	0.1273	1.3780	T	T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000034613.5 [benign]; RCV000054853.1 [not provided]; RCV000054992.1 [not provided]; RCV000054997.1 [not provided]; RCV000054997.1 [not provided]; RCV000118695.7 [other]; RCV000162954.1 [benign]; 	CM131323 [CLASS=DP MUT=ALT PHEN="Respiratory disease aspirin-exacerbated association with" GENE=TSC1]; 	COSM3763713	27	296					TSC1 (inh=AD pLI=1.00)
chr9	135974079	135974079	G	C	het		QUAL=12689;DP=236;AF=0.42;MQM=59;TRIO=HET,236,0.42,HOM,201,1.00,HET,323,0.46	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon18/18:c.2640C>G:p.Leu880Leu,RALGDS:NM_001271776.1:synonymous:LOW:exon18/18:c.2604C>G:p.Leu868Leu,RALGDS:NM_001271775.1:synonymous:LOW:exon18/18:c.2637C>G:p.Leu879Leu,RALGDS:NM_001271774.1:synonymous:LOW:exon18/18:c.2553C>G:p.Leu851Leu,RALGDS:NM_001042368.2:synonymous:LOW:exon18/18:c.2475C>G:p.Leu825Leu		rs1062356	0.8275	0.8410	43048/24211/3818	0.8337										807	275					RALGDS (inh=n/a pLI=0.30)
chr9	135974100	135974100	G	A	het		QUAL=4947;DP=221;AF=0.41;MQM=60;TRIO=HET,221,0.41,HET,215,0.51,WT,337,0.00	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon18/18:c.2619C>T:p.Thr873Thr,RALGDS:NM_001271776.1:synonymous:LOW:exon18/18:c.2583C>T:p.Thr861Thr,RALGDS:NM_001271775.1:synonymous:LOW:exon18/18:c.2616C>T:p.Thr872Thr,RALGDS:NM_001271774.1:synonymous:LOW:exon18/18:c.2532C>T:p.Thr844Thr,RALGDS:NM_001042368.2:synonymous:LOW:exon18/18:c.2454C>T:p.Thr818Thr		rs886017	0.4916	0.5420	18396/9569/464	0.5337										325	547					RALGDS (inh=n/a pLI=0.30)
chr9	135985796	135985796	C	T	het		QUAL=3891;DP=157;AF=0.51;MQM=60;TRIO=HET,157,0.51,HET,201,0.47,WT,272,0.00	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:NM_001271776.1:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:NM_001271775.1:synonymous:LOW:exon3/18:c.372G>A:p.Val124Val,RALGDS:NM_001271774.1:synonymous:LOW:exon3/18:c.324G>A:p.Val108Val,RALGDS:NM_001042368.2:synonymous:LOW:exon3/18:c.210G>A:p.Val70Val		rs3761824	0.2486	0.2840	5054/3159/113	0.2817									COSM4163476, COSM4163477, COSM4163475, COSM4163478	92	464					RALGDS (inh=n/a pLI=0.30)
chr9	136223366	136223366	G	A	hom	low_DP	QUAL=175;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,1,1.00,HOM,2,1.00	SURF1-SURF2	intergenic_region	SURF1-SURF2:SURF1-SURF2:intergenic_region:MODIFIER::n.136223366G>A:		rs523304	0.5120	0.3790	992/273/15	0.1182							RCV000128344.1 [benign]; 			69	121					SURF1-SURF2 (inh=n/a pLI=n/a)
chr9	136291063	136291063	C	T	hom		QUAL=32083;DP=343;AF=0.99;MQM=59;TRIO=HOM,343,0.99,HOM,326,0.99,HOM,388,1.00	ADAMTS13	synonymous,non_coding_exon	ADAMTS13:NM_139025.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:NM_139026.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:NM_139027.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:NR_024514.2:non_coding_exon:MODIFIER:exon5/18:n.621C>T:		rs3118667	0.5819	0.5500	18927/9627/1196	0.5450						604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial];			COSM1460807	364	502					ADAMTS13 (inh=n/a pLI=0.00)
chr9	136304497	136304497	A	G	hom		QUAL=31669;DP=268;AF=1.00;MQM=59;TRIO=HOM,268,1.00,HOM,333,1.00,HOM,390,1.00	ADAMTS13	synonymous,non_coding_exon	ADAMTS13:NM_139025.4:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr,ADAMTS13:NM_139026.4:synonymous:LOW:exon15/29:c.1623A>G:p.Thr541Thr,ADAMTS13:NM_139027.4:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr,ADAMTS13:NR_024514.2:non_coding_exon:MODIFIER:exon8/18:n.1003A>G:		rs3124768	0.5160	0.4720	14527/6664/695	0.4702						604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial];		CM1213383 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=ADAMTS13]; 	COSM4163494	256	519					ADAMTS13 (inh=n/a pLI=0.00)
chr9	136412170	136412170	C	T	hom		QUAL=23599;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HET,372,0.54,HOM,479,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp		rs2073874	0.7240	0.8190	41810/27676/3235	0.8052						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				855	227					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136412236	136412236	A	T	hom		QUAL=37057;DP=328;AF=0.99;MQM=59;TRIO=HOM,328,0.99,HET,514,0.50,HOM,641,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala		rs2073875	0.7246	0.8190	41848/27706/3236	0.7824						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				858	227					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136412255	136412255	A	C	hom		QUAL=36693;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HET,520,0.52,HOM,639,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg		rs2073876	0.7246	0.8190	41848/27707/3236	0.7823						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				858	227					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136440144	136440144	G	A	hom	low_MQM	QUAL=5138;DP=66;AF=1.00;MQM=46;TRIO=HOM,66,1.00,HET,76,0.38,HOM,95,0.99	ADAMTSL2	3'UTR	ADAMTSL2:NM_001145320.1:3'UTR:MODIFIER:exon19/19:c.*158G>A:,ADAMTSL2:NM_014694.3:3'UTR:MODIFIER:exon19/19:c.*158G>A:		rs1105952	0.4637	0.0000	0/0/0	0.0543										66	108					ADAMTSL2 (inh=AR pLI=0.07)
chr9	139323201	139323201	A	G	het		QUAL=5771;DP=252;AF=0.57;MQM=60;TRIO=HET,252,0.57,HET,138,0.57,WT,161,0.00	INPP5E	3'UTR	INPP5E:NM_019892.5:3'UTR:MODIFIER:exon10/10:c.*926T>C:,INPP5E:NM_001318502.1:3'UTR:MODIFIER:exon10/10:c.*926T>C:		rs1128877	0.1278	0.0000	0/0/0	0.0242										4	59					INPP5E (inh=AR pLI=0.39)
chr9	139323311	139323311	T	C	het		QUAL=11105;DP=186;AF=0.60;MQM=59;TRIO=HET,186,0.60,HOM,188,0.99,HET,233,0.48	INPP5E	3'UTR	INPP5E:NM_019892.5:3'UTR:MODIFIER:exon10/10:c.*816A>G:,INPP5E:NM_001318502.1:3'UTR:MODIFIER:exon10/10:c.*816A>G:		rs8413	0.3658	0.0000	0/0/0	0.0671										48	110					INPP5E (inh=AR pLI=0.39)
chr9	139323424	139323424	T	C	het		QUAL=8631;DP=159;AF=0.55;MQM=59;TRIO=HET,159,0.55,HOM,140,0.98,HET,146,0.51	INPP5E	3'UTR	INPP5E:NM_019892.5:3'UTR:MODIFIER:exon10/10:c.*703A>G:,INPP5E:NM_001318502.1:3'UTR:MODIFIER:exon10/10:c.*703A>G:		rs1128874	0.3776	0.0000	0/0/0	0.0717										51	112					INPP5E (inh=AR pLI=0.39)
chr9	139323497	139323497	C	T	het		QUAL=3322;DP=135;AF=0.49;MQM=59;TRIO=HET,135,0.49,HET,127,0.57,WT,141,0.00	INPP5E	3'UTR	INPP5E:NM_019892.5:3'UTR:MODIFIER:exon10/10:c.*630G>A:,INPP5E:NM_001318502.1:3'UTR:MODIFIER:exon10/10:c.*630G>A:		rs539039743	0.0004	0.0000	0/0/0	0.0002										0	1					INPP5E (inh=AR pLI=0.39)
chr9	139323799	139323799	A	G	het		QUAL=9671;DP=134;AF=0.57;MQM=59;TRIO=HET,134,0.57,HOM,186,0.99,HET,229,0.43	INPP5E	3'UTR	INPP5E:NM_019892.5:3'UTR:MODIFIER:exon10/10:c.*328T>C:,INPP5E:NM_001318502.1:3'UTR:MODIFIER:exon10/10:c.*328T>C:		rs35763810	0.3828	0.0000	0/0/0	0.0686										49	114					INPP5E (inh=AR pLI=0.39)
chr9	139324740	139324740	C	T	het		QUAL=3799;DP=110;AF=0.57;MQM=60;TRIO=HET,110,0.57,HET,196,0.51,WT,276,0.00	INPP5E	synonymous	INPP5E:NM_019892.5:synonymous:LOW:exon9/10:c.1791G>A:p.Pro597Pro,INPP5E:NM_001318502.1:synonymous:LOW:exon9/10:c.1788G>A:p.Pro596Pro		rs10870182	0.1284	0.0750	229/71/4	0.0592						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117270.1 [benign]; RCV000117269.3 [other]; 			42	486					INPP5E (inh=AR pLI=0.39)
chr9	139326304	139326304	G	A	het		QUAL=807;DP=40;AF=0.38;MQM=59;TRIO=HET,40,0.38,HET,56,0.54,WT,57,0.00	INPP5E	synonymous	INPP5E:NM_019892.5:synonymous:LOW:exon7/10:c.1521C>T:p.His507His,INPP5E:NM_001318502.1:synonymous:LOW:exon7/10:c.1518C>T:p.His506His		rs10870188	0.1214	0.1350	1288/510/7	0.1292						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117267.3 [other]; 		COSM1162712	43	478					INPP5E (inh=AR pLI=0.39)
chr9	139327034	139327034	A	G	het		QUAL=7739;DP=114;AF=0.54;MQM=59;TRIO=HET,114,0.54,HOM,132,1.00,HET,143,0.61	INPP5E	splice_region&synonymous,synonymous	INPP5E:NM_001318502.1:splice_region&synonymous:LOW:exon6/10:c.1281T>C:p.Cys427Cys,INPP5E:NM_019892.5:synonymous:LOW:exon6/10:c.1284T>C:p.Gly428Gly		rs10870194	0.3778	0.2580	1662/879/204	0.1718						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117265.2 [likely benign]; 		COSM3722170	399	1051					INPP5E (inh=AR pLI=0.39)
chr9	139327439	139327439	A	G	het		QUAL=32677;DP=287;AF=0.52;MQM=59;TRIO=HET,287,0.52,HOM,660,0.99,HET,835,0.42	INPP5E	synonymous	INPP5E:NM_019892.5:synonymous:LOW:exon5/10:c.1248T>C:p.Thr416Thr,INPP5E:NM_001318502.1:synonymous:LOW:exon5/10:c.1248T>C:p.Thr416Thr		rs10781542	0.3784	0.4140	10634/6412/754	0.4120						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117264.2 [likely benign]; 			415	1097					INPP5E (inh=AR pLI=0.39)
chr9	139328551	139328551	T	C	het		QUAL=2305;DP=97;AF=0.46;MQM=60;TRIO=HET,97,0.46,HET,129,0.40,WT,165,0.00	INPP5E	synonymous	INPP5E:NM_019892.5:synonymous:LOW:exon3/10:c.972A>G:p.Pro324Pro,INPP5E:NM_001318502.1:synonymous:LOW:exon3/10:c.972A>G:p.Pro324Pro		rs10870199	0.1238	0.1370	1213/502/4	0.1319						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117276.3 [other]; 		COSM3763772	42	493					INPP5E (inh=AR pLI=0.39)
chr9	139726239	139726239	A	G	hom		QUAL=26466;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HOM,275,1.00,HOM,357,1.00	RABL6	synonymous	RABL6:NM_001173988.1:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly,RABL6:NM_001173989.2:synonymous:LOW:exon6/8:c.525A>G:p.Gly175Gly,RABL6:NM_024718.4:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly		rs2811748	0.8167	0.8470	43413/25653/3796	0.8240	-1.1310	T							COSM4163585, COSM4163586, COSM4163584	813	261					RABL6 (inh=n/a pLI=0.97)
chr9	139731969	139731969	C	T	hom	low_DP	QUAL=856;DP=7;AF=1.00;MQM=56;TRIO=HOM,7,1.00,HOM,12,1.00,HOM,13,1.00	RABL6	synonymous	RABL6:NM_001173988.1:synonymous:LOW:exon9/15:c.984C>T:p.Ala328Ala,RABL6:NM_024718.4:synonymous:LOW:exon9/15:c.981C>T:p.Ala327Ala		rs2811742	0.7666	0.7270	6608/2900/359	0.5700									COSM3763796, COSM455622, COSM455621	672	304					RABL6 (inh=n/a pLI=0.97)
chr9	139732331	139732331	G	C	hom	phylop_high;pred_pathogenic_2	QUAL=12927;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HOM,159,1.00,HOM,183,1.00	RABL6	missense	RABL6:NM_001173988.1:missense:MODERATE:exon10/15:c.1147G>C:p.Glu383Gln,RABL6:NM_024718.4:missense:MODERATE:exon10/15:c.1144G>C:p.Glu382Gln		rs2811741	0.8055	0.7270	7251/3259/722	0.5115	3.6890	T	T,T,T,T,T	D,D,D	D,D,P					719	340					RABL6 (inh=n/a pLI=0.97)
chr9	139981627	139981627	A	G	hom		QUAL=18102;DP=58;AF=1.00;MQM=60;TRIO=HOM,58,1.00,HOM,231,1.00,HOM,315,1.00	MAN1B1	missense,non_coding_exon	MAN1B1:NM_016219.4:missense:MODERATE:exon1/13:c.176A>G:p.Asn59Ser,MAN1B1:NR_045720.1:non_coding_exon:MODIFIER:exon1/13:n.249A>G:,MAN1B1:NR_045721.1:non_coding_exon:MODIFIER:exon1/14:n.249A>G:		rs968733	0.9054	0.9700	38578/22191/1633	0.8893	0.9110	T	T	B	B	604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15];	RCV000117582.2 [likely benign]; 		COSM4163617	1088	21					MAN1B1 (inh=AR pLI=0.00)
chr9	140002989	140002989	T	C	hom		QUAL=20124;DP=155;AF=0.99;MQM=59;TRIO=HOM,155,0.99,HOM,341,1.00,HET,441,0.44	MAN1B1	synonymous,non_coding_exon	MAN1B1:NM_016219.4:synonymous:LOW:exon13/13:c.2046T>C:p.Asp682Asp,MAN1B1:NR_045720.1:non_coding_exon:MODIFIER:exon13/13:n.2094T>C:,MAN1B1:NR_045721.1:non_coding_exon:MODIFIER:exon14/14:n.2250T>C:		rs4880091	0.8099	0.7660	35940/18905/4714	0.7513	1.0730	T,T				604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15];	RCV000117585.2 [likely benign]; 		COSM4138895	641	404					MAN1B1 (inh=AR pLI=0.00)
chr9	140003427	140003427	A	G	hom		QUAL=8896;DP=141;AF=0.99;MQM=59;TRIO=HOM,141,0.99,HOM,102,1.00,HET,107,0.49	MAN1B1	3'UTR,non_coding_exon	MAN1B1:NM_016219.4:3'UTR:MODIFIER:exon13/13:c.*384A>G:,MAN1B1:NR_045720.1:non_coding_exon:MODIFIER:exon13/13:n.2532A>G:,MAN1B1:NR_045721.1:non_coding_exon:MODIFIER:exon14/14:n.2688A>G:		rs4567	0.5519	0.4300	1497/416/73	0.1329	-3.1640	T						CR094058 [CLASS=DFP MUT=REF PHEN="End-stage liver disease early onset association with" GENE=MAN1B1]; 		207	446					MAN1B1 (inh=AR pLI=0.00)
chr9	140003640	140003640	G	A	hom		QUAL=15398;DP=196;AF=0.98;MQM=60;TRIO=HOM,196,0.98,HOM,211,1.00,HET,248,0.53	MAN1B1-DPP7	intergenic_region	MAN1B1-DPP7:MAN1B1-DPP7:intergenic_region:MODIFIER::n.140003640G>A:		rs7853336	0.4040	0.2520	529/191/48	0.0858										53	266					MAN1B1-DPP7 (inh=n/a pLI=n/a)
chr9	140729844	140729844	G	C	het		QUAL=4269;DP=196;AF=0.46;MQM=59;TRIO=HET,196,0.46,HET,162,0.52,WT,238,0.00	EHMT1	3'UTR	EHMT1:NM_024757.4:3'UTR:MODIFIER:exon27/27:c.*439G>C:			0.0000	0.0000	0/0/0	0.0000										0	1					EHMT1 (inh=AD pLI=1.00)
chr10	6053374	6053374	A	G	het		QUAL=26947;DP=574;AF=0.50;MQM=59;TRIO=HET,574,0.50,HOM,624,0.99,WT,820,0.00	IL2RA	3'UTR	IL2RA:NM_000417.2:3'UTR:MODIFIER:exon8/8:c.*1461T>C:,IL2RA:NM_001308242.1:3'UTR:MODIFIER:exon7/7:c.*1461T>C:,IL2RA:NM_001308243.1:3'UTR:MODIFIER:exon6/6:c.*1461T>C:	MER5A	rs12244380	0.3548	0.0000	0/0/0	0.0657										24	76					IL2RA (inh=n/a pLI=0.88)
chr10	6053568	6053568	C	T	hom		QUAL=30049;DP=322;AF=0.99;MQM=59;TRIO=HOM,322,0.99,HET,392,0.46,HOM,497,1.00	IL2RA	3'UTR	IL2RA:NM_000417.2:3'UTR:MODIFIER:exon8/8:c.*1267G>A:,IL2RA:NM_001308242.1:3'UTR:MODIFIER:exon7/7:c.*1267G>A:,IL2RA:NM_001308243.1:3'UTR:MODIFIER:exon6/6:c.*1267G>A:	AluJr	rs1570538	0.3760	0.0000	0/0/0	0.4195										42	84					IL2RA (inh=n/a pLI=0.88)
chr10	6066200	6066200	C	G	hom		QUAL=12161;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HET,314,0.50,HET,399,0.50	IL2RA	splice_region&intron	IL2RA:NM_000417.2:splice_region&intron:LOW:exon3/7:c.367+7G>C:,IL2RA:NM_001308242.1:splice_region&intron:LOW:exon3/6:c.367+7G>C:,IL2RA:NM_001308243.1:splice_region&intron:LOW:exon3/5:c.367+7G>C:		rs11256369	0.1793	0.2120	3019/1778/41	0.2066						147730 [IL2RA (confirmed) Immunodeficiency 41 with lymphoproliferation and autoimmunity|Diabetes,mellitus,insulin-dependent,susceptibility to,10];				59	377					IL2RA (inh=n/a pLI=0.88)
chr10	14949856	14949856	C	T	het	low_MQM	QUAL=640;DP=70;AF=0.57;MQM=44;TRIO=HET,70,0.57,HET,39,0.15,HET,62,0.31	DCLRE1C	3'UTR,non_coding_exon	DCLRE1C:NM_001033855.2:3'UTR:MODIFIER:exon14/14:c.*551G>A:,DCLRE1C:NM_001033857.2:3'UTR:MODIFIER:exon15/15:c.*551G>A:,DCLRE1C:NM_001033858.2:3'UTR:MODIFIER:exon16/16:c.*551G>A:,DCLRE1C:NM_001289076.1:3'UTR:MODIFIER:exon12/12:c.*551G>A:,DCLRE1C:NM_001289077.1:3'UTR:MODIFIER:exon15/15:c.*551G>A:,DCLRE1C:NM_001289078.1:3'UTR:MODIFIER:exon12/12:c.*551G>A:,DCLRE1C:NM_001289079.1:3'UTR:MODIFIER:exon16/16:c.*551G>A:,DCLRE1C:NM_022487.3:3'UTR:MODIFIER:exon13/13:c.*551G>A:,DCLRE1C:NR_110297.1:non_coding_exon:MODIFIER:exon17/17:n.3405G>A:	AluSp	rs373280996	0.0000	0.0000	0/0/0	0.0030						605988 [DCLRE1C (confirmed) Severe combined immunodeficiency,Athabascan type|Omenn syndrome];				0	127					DCLRE1C (inh=n/a pLI=0.00)
chr10	26993598	26993598	T	-	het		QUAL=2622;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,HOM,31,1.00,HET,43,0.58	PDSS1	splice_region&intron	PDSS1:NM_014317.3:splice_region&intron:LOW:exon2/11:c.163-5delT:		rs863224161	0.2374	0.3040	5907/3779/51	0.2831						607429 [PDSS1 (provisional) Coenzyme Q10 deficiency,primary,2];	RCV000199022.1,RCV000199022.1 [benign,benign]; 			270	1008					PDSS1 (inh=AR pLI=0.26)
chr10	38344700	38344700	C	G	het	phylop_high	QUAL=15695;DP=373;AF=0.49;MQM=57;TRIO=HET,373,0.49,HET,350,0.50,HET,422,0.55	ZNF33A	missense	ZNF33A:NM_001278177.1:missense:MODERATE:exon5/5:c.1711C>G:p.Gln571Glu,ZNF33A:NM_001278170.1:missense:MODERATE:exon4/4:c.1666C>G:p.Gln556Glu,ZNF33A:NM_001278171.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278173.1:missense:MODERATE:exon6/6:c.1702C>G:p.Gln568Glu,ZNF33A:NM_001278174.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278175.1:missense:MODERATE:exon6/6:c.1414C>G:p.Gln472Glu,ZNF33A:NM_001278176.1:missense:MODERATE:exon6/6:c.1519C>G:p.Gln507Glu,ZNF33A:NM_001278178.1:missense:MODERATE:exon5/5:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278179.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_006954.1:missense:MODERATE:exon5/5:c.1648C>G:p.Gln550Glu,ZNF33A:NM_006974.2:missense:MODERATE:exon5/5:c.1645C>G:p.Gln549Glu		rs2505232	0.4770	0.4460	12613/7105/1354	0.4448	4.3420	T	T,T,T,T	B,B,B	B,B,B					158	342					ZNF33A (inh=n/a pLI=0.00)
chr10	38346092	38346092	C	T	het		QUAL=6228;DP=300;AF=0.50;MQM=60;TRIO=HET,300,0.50,HET,153,0.52,WT,213,0.00	ZNF33A	3'UTR	ZNF33A:NM_001278177.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_001278170.1:3'UTR:MODIFIER:exon4/4:c.*604C>T:,ZNF33A:NM_001278171.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278173.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278174.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278175.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278176.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278178.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_001278179.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_006954.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_006974.2:3'UTR:MODIFIER:exon5/5:c.*604C>T:	L1MD2	rs2142349	0.0128	0.0000	0/0/0	0.0037										0	9					ZNF33A (inh=n/a pLI=0.00)
chr10	43595968	43595968	A	G	het		QUAL=1504;DP=31;AF=0.52;MQM=59;TRIO=HET,31,0.52,HET,71,0.68,WT,98,0.00	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:NM_020630.4:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.7360	33200/17899/4676	0.7262						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000014967.2 [other]; RCV000127776.1 [benign]; RCV000205827.1 [benign]; RCV000216697.1 [not provided]; RCV000153833.3 [benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	COSM4144677, COSM4144678	1366	949	1	[1] old entry - no details available			RET (inh=n/a pLI=1.00)
chr10	43606687	43606687	A	G	hom		QUAL=9839;DP=67;AF=1.00;MQM=60;TRIO=HOM,67,1.00,HOM,131,0.98,HOM,128,1.00	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon7/20:c.1296A>G:p.Ala432Ala,RET:NM_020630.4:synonymous:LOW:exon7/19:c.1296A>G:p.Ala432Ala		rs1800860	0.7752	0.7060	30695/15829/3890	0.6998						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000082048.5 [benign]; RCV000131068.2 [benign]; 	CM033447 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		1197	1056	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=n/a pLI=1.00)
chr10	43613843	43613843	G	T	het		QUAL=6292;DP=191;AF=0.48;MQM=60;TRIO=HET,191,0.48,HOM,94,1.00,HET,111,0.46	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7420	33769/19608/4074	0.7333						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1 [benign]; RCV000203706.1 [benign]; RCV000153835.3 [benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		1430	902	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=n/a pLI=1.00)
chr10	43622217	43622217	T	C	het		QUAL=11261;DP=205;AF=0.57;MQM=59;TRIO=HET,205,0.57,HOM,158,1.00,HET,258,0.49	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.7550	0.7870	33460/19436/3910	0.7666						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000151742.1 [benign]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		440	194					RET (inh=n/a pLI=1.00)
chr10	43622368	43622368	T	A	het		QUAL=4430;DP=165;AF=0.51;MQM=59;TRIO=HET,165,0.51,HOM,52,1.00,HET,60,0.40	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*166T>A:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3187+198T>A:		rs2075913	0.6607	0.0000	0/0/0	0.1183						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				84	52					RET (inh=n/a pLI=1.00)
chr10	43622933	43622933	T	C	het		QUAL=26813;DP=414;AF=0.50;MQM=60;TRIO=HET,414,0.50,HOM,439,1.00,HET,533,0.51	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*731T>C:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3188-627T>C:		rs2565200	0.7654	0.0000	0/0/0	0.1531						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				99	44					RET (inh=n/a pLI=1.00)
chr10	43623812	43623812	C	T	het		QUAL=13119;DP=303;AF=0.51;MQM=60;TRIO=HET,303,0.51,HOM,194,1.00,HET,232,0.47	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*95C>T:		rs17028	0.1366	0.0000	0/0/0	0.0376										8	80					RET (inh=n/a pLI=1.00)
chr10	43624317	43624317	A	T	het		QUAL=6319;DP=182;AF=0.47;MQM=59;TRIO=HET,182,0.47,HOM,81,1.00,HET,114,0.50	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*600A>T:		rs2742240	0.7524	0.0000	0/0/0	0.1241										154	66					RET (inh=n/a pLI=1.00)
chr10	43624833	43624833	T	C	het		QUAL=19762;DP=364;AF=0.48;MQM=60;TRIO=HET,364,0.48,HOM,346,0.99,HET,341,0.46	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*1116T>C:		rs2435355	0.1899	0.0000	0/0/0	0.0369										13	87					RET (inh=n/a pLI=1.00)
chr10	43625223	43625223	G	A	het		QUAL=18009;DP=420;AF=0.54;MQM=59;TRIO=HET,420,0.54,HOM,226,1.00,HET,391,0.46	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*1506G>A:		rs2742241	0.7472	0.0000	0/0/0	0.1302								CR032442 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		153	67					RET (inh=n/a pLI=1.00)
chr10	50664895	50664897	AAT	-	het		QUAL=7558;DP=341;AF=0.55;MQM=59;TRIO=HET,341,0.55,HET,286,0.48,WT,339,0.00	ERCC6	3'UTR	ERCC6:NM_000124.3:3'UTR:MODIFIER:exon21/21:c.*1964_*1966delATT:		rs147228327	0.0349	0.0000	0/0/0	0.0601										5	29					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50667105	50667105	T	C	het		QUAL=15915;DP=247;AF=0.50;MQM=59;TRIO=HET,247,0.50,HET,231,0.50,HOM,303,1.00	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon21/21:c.4238A>G:p.Gln1413Arg		rs2228529	0.1789	0.2180	3279/1699/83	0.2092	0.1010	T	T,T,T	B	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000117001.4 [other]; 		COSM427630	66	489					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50678369	50678369	T	C	het	phylop_high	QUAL=12517;DP=230;AF=0.57;MQM=59;TRIO=HET,230,0.57,HET,203,0.49,HOM,209,0.99	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon18/21:c.3637A>G:p.Arg1213Gly		rs2228527	0.1847	0.2200	3325/1708/118	0.2041	1.7160	T	T,T,T	P	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116998.5 [other]; 	CM980633 [CLASS=DP MUT=ALT PHEN="Colorectal cancer increased risk association with" GENE=ERCC6]; 	COSM3751836	71	490					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50678717	50678717	T	C	het		QUAL=29118;DP=472;AF=0.49;MQM=60;TRIO=HET,472,0.49,HET,356,0.59,HOM,521,1.00	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon18/21:c.3289A>G:p.Met1097Val		rs2228526	0.1825	0.2190	3293/1702/93	0.2098	-0.2110	T	T,T,T	B	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116997.5 [other]; 	CM076169 [CLASS=DP MUT=ALT PHEN="Reduced chromosomal damage in coke oven workers association with" GENE=ERCC6]; 	COSM3751837	68	488					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50701156	50701156	G	A	het		QUAL=10492;DP=205;AF=0.49;MQM=60;TRIO=HET,205,0.49,HET,146,0.49,HOM,190,1.00	ERCC6	splice_region&intron	ERCC6:NM_000124.3:splice_region&intron:LOW:exon8/20:c.1821+7C>T:		rs4253132	0.8770	0.8880	48044/25622/2737	0.8680						609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000170371.1 [benign]; 			1019	257					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50740876	50740876	G	C	het		QUAL=13156;DP=175;AF=0.49;MQM=59;TRIO=HET,175,0.49,HET,228,0.47,HOM,280,1.00	ERCC6,ERCC6-PGBD3	synonymous	ERCC6:NM_000124.3:synonymous:LOW:exon2/21:c.135C>G:p.Leu45Leu,ERCC6-PGBD3:NM_001277058.1:synonymous:LOW:exon2/6:c.135C>G:p.Leu45Leu,ERCC6-PGBD3:NM_001277059.1:synonymous:LOW:exon2/6:c.135C>G:p.Leu45Leu		rs2228524	0.5909	0.6940	30180/18280/767	0.6793						609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116995.4 [other]; 			722	482					ERCC6 (inh=AR+AD pLI=0.00), ERCC6-PGBD3 (inh=n/a pLI=0.00)
chr10	50821191	50821191	G	T	het		QUAL=10865;DP=252;AF=0.48;MQM=59;TRIO=HET,252,0.48,HET,282,0.53,HET,326,0.48	CHAT	5'UTR,intron	CHAT:NM_020985.3:5'UTR:MODIFIER:exon1/16:c.-298G>T:,CHAT:NM_020986.3:5'UTR:MODIFIER:exon1/15:c.-126G>T:,CHAT:NM_020984.3:intron:MODIFIER:exon1/14:c.-68-3357G>T:		rs3729496	0.4307	0.0000	0/0/0	0.6145										116	96					CHAT (inh=n/a pLI=0.01)
chr10	50863147	50863147	T	C	hom		QUAL=14486;DP=229;AF=1.00;MQM=59;TRIO=HOM,229,1.00,HOM,118,1.00,HOM,129,1.00	CHAT	synonymous	CHAT:NM_020549.4:synonymous:LOW:exon12/15:c.1641T>C:p.His547His,CHAT:NM_020984.3:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_020985.3:synonymous:LOW:exon13/16:c.1287T>C:p.His429His,CHAT:NM_020986.3:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_001142929.1:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_001142933.1:synonymous:LOW:exon13/16:c.1395T>C:p.His465His,CHAT:NM_001142934.1:synonymous:LOW:exon13/16:c.1287T>C:p.His429His		rs8178992	0.7935	0.8490	44227/27257/2476	0.8437						118490 [CHAT (confirmed) Myasthenic syndrome,congenital,6,presynaptic];	RCV000116692.2 [benign]; 		COSM4144745, COSM4144746	861	222					CHAT (inh=n/a pLI=0.01)
chr10	64572038	64572038	T	-	hom		QUAL=18614;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,170,0.99,HOM,181,1.00	EGR2	3'UTR	EGR2:NM_000399.3:3'UTR:MODIFIER:exon2/2:c.*929delA:,EGR2:NM_001136177.1:3'UTR:MODIFIER:exon3/3:c.*929delA:,EGR2:NM_001136179.1:3'UTR:MODIFIER:exon3/3:c.*929delA:,EGR2:NM_001136178.1:3'UTR:MODIFIER:exon4/4:c.*929delA:		rs398013782	0.9944	0.0000	0/0/0	0.9094										230	0					EGR2 (inh=n/a pLI=0.62)
chr10	64573771	64573771	C	T	hom		QUAL=36295;DP=175;AF=1.00;MQM=59;TRIO=HOM,175,1.00,HOM,475,1.00,HOM,568,1.00	EGR2	synonymous	EGR2:NM_000399.3:synonymous:LOW:exon2/2:c.627G>A:p.Pro209Pro,EGR2:NM_001136177.1:synonymous:LOW:exon3/3:c.627G>A:p.Pro209Pro,EGR2:NM_001136179.1:synonymous:LOW:exon3/3:c.477G>A:p.Pro159Pro,EGR2:NM_001136178.1:synonymous:LOW:exon4/4:c.627G>A:p.Pro209Pro		rs224083	0.9860	0.9950	60144/33365/4686	0.9251						129010 [EGR2 (provisional) Neuropathy,congenital hypomyelinating,1|Charcot-Marie-Tooth disease,type 1D|Dejerine-Sottas disease];				1107	0					EGR2 (inh=n/a pLI=0.62)
chr10	70748784	70748784	G	A	het		QUAL=6877;DP=190;AF=0.51;MQM=59;TRIO=HET,190,0.51,HET,186,0.49,HET,251,0.49	KIAA1279	missense	KIAA1279:NM_015634.3:missense:MODERATE:exon1/7:c.196G>A:p.Gly66Ser		rs2255607	0.3538	0.4100	10594/7462/598	0.4102	0.2110	T	T	B	B		RCV000146132.1 [benign]; 		COSM3751905	229	536					KIF1BP (inh=AR pLI=0.05)
chr10	70776594	70776594	A	C	het		QUAL=4926;DP=203;AF=0.54;MQM=60;TRIO=HET,203,0.54,HET,39,0.56,HET,77,0.60	KIAA1279	3'UTR	KIAA1279:NM_015634.3:3'UTR:MODIFIER:exon7/7:c.*422A>C:		rs6864	0.3638	0.0000	0/0/0	0.4304										40	115					KIF1BP (inh=AR pLI=0.05)
chr10	71332204	71332204	A	G	hom		QUAL=10824;DP=105;AF=1.00;MQM=59;TRIO=HOM,105,1.00,HOM,100,1.00,HOM,143,1.00	NEUROG3	missense	NEUROG3:NM_020999.3:missense:MODERATE:exon2/2:c.596T>C:p.Phe199Ser		rs4536103	0.4299	0.5340	11362/7860/197	0.5069	1.4960	T	T	B	B	604882 [NEUROG3 (provisional) Diarrhea 4,malabsorptive,congenital];	RCV000117780.2 [likely benign]; 	CM068025 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=NEUROG3]; 	COSM3749111	423	459					NEUROG3 (inh=n/a pLI=0.00)
chr10	72357713	72357713	C	T	hom		QUAL=38260;DP=545;AF=0.99;MQM=59;TRIO=HOM,545,0.99,HOM,300,0.99,HOM,408,1.00	PRF1	3'UTR	PRF1:NM_001083116.1:3'UTR:MODIFIER:exon3/3:c.*96G>A:,PRF1:NM_005041.4:3'UTR:MODIFIER:exon3/3:c.*96G>A:	MER30	rs1889490	0.5779	0.0000	0/0/0	0.0904										31	107					PRF1 (inh=n/a pLI=0.00)
chr10	72358577	72358577	G	A	hom		QUAL=27545;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,311,1.00,HOM,401,1.00	PRF1	synonymous	PRF1:NM_001083116.1:synonymous:LOW:exon3/3:c.900C>T:p.His300His,PRF1:NM_005041.4:synonymous:LOW:exon3/3:c.900C>T:p.His300His		rs885822	0.6959	0.6350	24936/11530/3341	0.6280						170280 [PRF1 (confirmed) Hemophagocytic lymphohistiocytosis,familial,2|Lymphoma,non-Hodgkin|Aplastic anemia];			COSM3765513	412	515					PRF1 (inh=n/a pLI=0.00)
chr10	73270906	73270906	T	C	hom		QUAL=40725;DP=329;AF=0.99;MQM=59;TRIO=HOM,329,0.99,HOM,419,1.00,HOM,547,1.00	CDH23,LOC102723377	synonymous,intron	CDH23:NM_022124.5:synonymous:LOW:exon6/68:c.366T>C:p.Val122Val,CDH23:NM_001171932.1:synonymous:LOW:exon6/11:c.366T>C:p.Val122Val,CDH23:NM_052836.3:synonymous:LOW:exon6/13:c.366T>C:p.Val122Val,CDH23:NM_001171931.1:synonymous:LOW:exon6/25:c.366T>C:p.Val122Val,CDH23:NM_001171930.1:synonymous:LOW:exon6/31:c.366T>C:p.Val122Val,LOC102723377:NR_120672.1:intron:MODIFIER:exon1/2:n.143+629A>G:		rs3802720	0.7346	0.6720	28139/14978/4298	0.6606						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000150270.1 [benign]; RCV000039162.2 [benign]; 		COSM4144828, COSM4144829, COSM4144830, COSM4144827	490	492					CDH23 (inh=n/a pLI=0.05), LOC102723377 (inh=n/a pLI=n/a)
chr10	73377314	73377314	C	G	hom		QUAL=25262;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,248,1.00,HOM,344,0.99	CDH23	3'UTR,intron	CDH23:NM_001171932.1:3'UTR:MODIFIER:exon11/11:c.*77C>G:,CDH23:NM_022124.5:intron:MODIFIER:exon11/67:c.1134+164C>G:,CDH23:NM_052836.3:intron:MODIFIER:exon11/12:c.1134+164C>G:,CDH23:NM_001171931.1:intron:MODIFIER:exon11/24:c.1134+164C>G:,CDH23:NM_001171930.1:intron:MODIFIER:exon11/30:c.1134+164C>G:	Charlie7a	rs7903772	0.5495	0.0000	0/0/0	0.6312						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				119	103					CDH23 (inh=n/a pLI=0.05)
chr10	73406599	73406599	G	A	het		QUAL=10677;DP=210;AF=0.54;MQM=60;TRIO=HET,210,0.54,HET,242,0.50,HET,358,0.51	CDH23	3'UTR,intron	CDH23:NM_052836.3:3'UTR:MODIFIER:exon13/13:c.*81G>A:,CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+225G>A:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+225G>A:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+225G>A:		rs2305210	0.2592	0.0000	0/0/0	0.0478						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				10	48					CDH23 (inh=n/a pLI=0.05)
chr10	73406636	73406636	C	T	het		QUAL=7816;DP=221;AF=0.43;MQM=60;TRIO=HET,221,0.43,HET,194,0.48,HET,272,0.46	CDH23	3'UTR,intron	CDH23:NM_052836.3:3'UTR:MODIFIER:exon13/13:c.*118C>T:,CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+262C>T:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+262C>T:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+262C>T:		rs11598249	0.2368	0.0000	0/0/0	0.2760						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				17	66					CDH23 (inh=n/a pLI=0.05)
chr10	73407220	73407220	A	-	hom	low_DP	QUAL=279;DP=13;AF=0.92;MQM=56;TRIO=HOM,13,0.92,HOM,1,1.00,WT,272,0.46	CDH23	intron	CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+858delA:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+858delA:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+858delA:	AluSz	rs113373333;rs56367143	0.8317	0.0000	0/0/0	0.5641						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				35	22					CDH23 (inh=n/a pLI=0.05)
chr10	73434906	73434906	G	A	hom		QUAL=25363;DP=401;AF=1.00;MQM=59;TRIO=HOM,401,1.00,HOM,258,0.99,HET,383,0.48	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon14/68:c.1487G>A:p.Ser496Asn,CDH23:NM_001171931.1:missense:MODERATE:exon14/25:c.1487G>A:p.Ser496Asn,CDH23:NM_001171930.1:missense:MODERATE:exon14/31:c.1487G>A:p.Ser496Asn		rs10999947	0.2524	0.2720	4500/2314/301	0.2673	0.4000	T	T,T,T,T,T,T	B,B,B	B,B,B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039108.2 [benign]; 			81	421					CDH23 (inh=n/a pLI=0.05)
chr10	73492079	73492079	A	G	het	phylop_high	QUAL=19200;DP=203;AF=0.40;MQM=59;TRIO=HET,203,0.40,HET,349,0.54,HOM,399,1.00	CDH23,C10orf105	missense,intron	CDH23:NM_022124.5:missense:MODERATE:exon31/68:c.4051A>G:p.Asn1351Asp,CDH23:NM_001171930.1:missense:MODERATE:exon31/31:c.4051A>G:p.Asn1351Asp,C10orf105:NM_001168390.1:intron:MODIFIER:exon1/1:c.-6+5406T>C:		rs1227065	0.7821	0.7940	31531/18061/2288	0.7833	7.6660	T	T,T,T,T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000154336.1 [benign]; RCV000039171.6 [benign]; 			761	302					CDH23 (inh=n/a pLI=0.05), C10orf105 (inh=n/a pLI=n/a)
chr10	73501556	73501556	G	A	het	phylop_high	QUAL=25178;DP=353;AF=0.52;MQM=60;TRIO=HET,353,0.52,HET,402,0.53,HOM,539,1.00	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon36/68:c.4723G>A:p.Ala1575Thr		rs1227051	0.7288	0.7670	34657/19701/1730	0.7579	6.2020	T	T,T,T,T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000154337.1 [benign]; RCV000039189.2 [benign]; 			699	351					CDH23 (inh=n/a pLI=0.05)
chr10	73537614	73537614	G	A	het		QUAL=932;DP=47;AF=0.51;MQM=60;TRIO=HET,47,0.51,HET,42,0.43,WT,56,0.00	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon37/68:c.5023G>A:p.Val1675Ile		rs17712523	0.1322	0.1780	2098/1315/9	0.1758	0.1020	T	T,T,T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039194.2 [benign]; RCV000086975.1 [not provided]; 		COSM146951	40	338					CDH23 (inh=n/a pLI=0.05)
chr10	73550117	73550117	C	G	het	phylop_high	QUAL=7302;DP=153;AF=0.42;MQM=60;TRIO=HET,153,0.42,HET,232,0.42,HET,313,0.44	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon44/68:c.5996C>G:p.Thr1999Ser		rs11592462	0.3452	0.4260	11548/7665/379	0.4188	1.6610	T	T,T,T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039232.6 [benign]; 		COSM3751946	255	528					CDH23 (inh=n/a pLI=0.05)
chr10	73569749	73569749	C	T	het		QUAL=9699;DP=253;AF=0.51;MQM=60;TRIO=HET,253,0.51,WT,461,0.00,HET,583,0.46	CDH23	synonymous	CDH23:NM_022124.5:synonymous:LOW:exon59/68:c.8895C>T:p.Pro2965Pro,CDH23:NM_001171933.1:synonymous:LOW:exon14/23:c.2175C>T:p.Pro725Pro,CDH23:NM_001171934.1:synonymous:LOW:exon14/22:c.2175C>T:p.Pro725Pro		rs11000009	0.0809	0.1130	924/627/48	0.1089						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039294.5 [benign]; 			31	299					CDH23 (inh=n/a pLI=0.05)
chr10	73575384	73575384	A	G	het		QUAL=12043;DP=186;AF=0.46;MQM=60;TRIO=HET,186,0.46,HOM,225,1.00,HET,242,0.54	CDH23	3'UTR	CDH23:NM_022124.5:3'UTR:MODIFIER:exon68/68:c.*349A>G:,CDH23:NM_001171933.1:3'UTR:MODIFIER:exon23/23:c.*349A>G:,CDH23:NM_001171934.1:3'UTR:MODIFIER:exon22/22:c.*349A>G:,CDH23:NM_001171935.1:3'UTR:MODIFIER:exon5/5:c.*349A>G:,CDH23:NM_001171936.1:3'UTR:MODIFIER:exon4/4:c.*349A>G:		rs1867978	0.7893	0.0000	0/0/0	0.1289										115	100					CDH23 (inh=n/a pLI=0.05)
chr10	75009977	75009977	A	-	het		QUAL=120;DP=31;AF=0.35;MQM=54;TRIO=HET,31,0.35,HOM,4,1.00,HET,6,0.50	MRPS16,DNAJC9-AS1	3'UTR,intron	MRPS16:NM_016065.3:3'UTR:MODIFIER:exon3/3:c.*633delT:,DNAJC9-AS1:NR_038373.1:intron:MODIFIER:exon2/3:n.175+1784delA:	AluY	rs555061429	0.0000	0.0000	0/0/0	0.0109										2	49					MRPS16 (inh=n/a pLI=0.08), DNAJC9-AS1 (inh=n/a pLI=n/a)
chr10	75936611	75936611	C	T	hom		QUAL=5205;DP=26;AF=0.96;MQM=59;TRIO=HOM,26,0.96,HET,106,0.51,HOM,114,0.99	ADK	5'UTR_premature_start_codon_gain,5'UTR,intron	ADK:NM_001123.3:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-20C>T:,ADK:NM_001202449.1:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-20C>T:,ADK:NM_001123.3:5'UTR:MODIFIER:exon1/11:c.-20C>T:,ADK:NM_001202449.1:5'UTR:MODIFIER:exon1/10:c.-20C>T:,ADK:NM_006721.3:intron:MODIFIER:exon1/10:c.66-23911C>T:,ADK:NM_001202450.1:intron:MODIFIER:exon1/9:c.66-23911C>T:		rs10824095	0.6302	0.6780	27735/18112/3019	0.6523						102750 [ADK (confirmed) Hypermethioninemia due to adenosine kinase deficiency];				322	177					ADK (inh=n/a pLI=0.32)
chr10	76468851	76468851	C	T	het		QUAL=3986;DP=181;AF=0.52;MQM=60;TRIO=HET,181,0.52,HOM,46,0.98,WT,96,0.00	ADK	3'UTR	ADK:NM_006721.3:3'UTR:MODIFIER:exon11/11:c.*648C>T:,ADK:NM_001202450.1:3'UTR:MODIFIER:exon10/10:c.*648C>T:,ADK:NM_001123.3:3'UTR:MODIFIER:exon11/11:c.*648C>T:,ADK:NM_001202449.1:3'UTR:MODIFIER:exon10/10:c.*648C>T:		rs1189553	0.8500	0.0000	0/0/0	0.7920										145	74					ADK (inh=n/a pLI=0.32)
chr10	82031937	82031937	-	CCAGCCTGAA	het		QUAL=5057;DP=244;AF=0.46;MQM=59;TRIO=HET,244,0.46,HET,204,0.49,WT,319,0.00	MAT1A	3'UTR	MAT1A:NM_000429.2:3'UTR:MODIFIER:exon9/9:c.*1599_*1600insTTCAGGCTGG:		rs145159688	0.4900	0.0000	0/0/0	0.3440										32	104					MAT1A (inh=n/a pLI=0.75)
chr10	82032240	82032240	A	G	het		QUAL=9759;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,HOM,247,0.99,WT,284,0.00	MAT1A	3'UTR	MAT1A:NM_000429.2:3'UTR:MODIFIER:exon9/9:c.*1297T>C:		rs1985908	0.4982	0.0000	0/0/0	0.0693										33	91					MAT1A (inh=n/a pLI=0.75)
chr10	82033594	82033594	G	A	het		QUAL=18954;DP=486;AF=0.48;MQM=59;TRIO=HET,486,0.48,HET,419,0.51,HET,544,0.50	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon9/9:c.1131C>T:p.Tyr377Tyr		rs2993763	0.5869	0.5120	16539/6889/2909	0.5024						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM3751998	255	538					MAT1A (inh=n/a pLI=0.75)
chr10	82034842	82034842	A	G	het		QUAL=3648;DP=177;AF=0.48;MQM=59;TRIO=HET,177,0.48,HOM,30,1.00,HET,80,0.35	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon7/9:c.882T>C:p.Ala294Ala		rs10887711	0.8405	0.7030	20007/7937/2472	0.6787						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM428025	508	445					MAT1A (inh=n/a pLI=0.75)
chr10	82034854	82034854	T	C	het		QUAL=3402;DP=152;AF=0.50;MQM=59;TRIO=HET,152,0.50,HOM,31,1.00,HET,78,0.38	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon7/9:c.870A>G:p.Val290Val		rs10788546	0.8409	0.7120	26294/10521/3162	0.6868						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];				510	448					MAT1A (inh=n/a pLI=0.75)
chr10	82040052	82040052	A	G	hom		QUAL=21601;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,241,1.00,HOM,297,0.99	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon5/9:c.426T>C:p.Ala142Ala		rs1143694	0.8634	0.7540	35357/14968/4554	0.7439						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM4144914	573	424					MAT1A (inh=n/a pLI=0.75)
chr10	82049251	82049251	-	TTCTTC	hom		QUAL=12518;DP=125;AF=0.90;MQM=59;TRIO=HOM,125,0.90,HOM,176,0.91,HET,216,0.50	MAT1A	5'UTR	MAT1A:NM_000429.2:5'UTR:MODIFIER:exon1/9:c.-78_-73dupGAAGAA:	(TTC)n	rs10694757;rs145126070	0.7696	0.0000	0/0/0	0.3409										76	104					MAT1A (inh=n/a pLI=0.75)
chr10	83637775	83637775	C	G	het	pred_pathogenic_1	QUAL=8421;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,136,0.00,HOM,166,0.99	NRG3	missense&splice_region,intron	NRG3:NM_001165973.1:missense&splice_region:MODERATE:exon1/11:c.59C>G:p.Thr20Arg,NRG3:NM_001010848.3:intron:MODIFIER:exon1/8:c.823+1856C>G:,NRG3:NM_001165972.1:intron:MODIFIER:exon1/8:c.823+1856C>G:		rs1884282	0.1394	0.1260	244/48/39	0.0405	-0.8040	T	D,T,D	B	B				COSM146979	18	191					NRG3 (inh=n/a pLI=0.21)
chr10	84746576	84746576	C	T	hom		QUAL=24632;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,208,1.00,HOM,253,1.00	NRG3	3'UTR	NRG3:NM_001010848.3:3'UTR:MODIFIER:exon9/9:c.*1215C>T:,NRG3:NM_001165972.1:3'UTR:MODIFIER:exon9/9:c.*1215C>T:,NRG3:NM_001165973.1:3'UTR:MODIFIER:exon11/11:c.*1215C>T:		rs3763704	0.9307	0.0000	0/0/0	0.1456										203	26					NRG3 (inh=n/a pLI=0.21)
chr10	84746621	84746621	A	G	hom		QUAL=23542;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,222,1.00,HET,265,0.51	NRG3	3'UTR	NRG3:NM_001010848.3:3'UTR:MODIFIER:exon9/9:c.*1260A>G:,NRG3:NM_001165972.1:3'UTR:MODIFIER:exon9/9:c.*1260A>G:,NRG3:NM_001165973.1:3'UTR:MODIFIER:exon11/11:c.*1260A>G:		rs8421	0.3464	0.0000	0/0/0	0.0776										71	115					NRG3 (inh=n/a pLI=0.21)
chr10	87359561	87359561	T	A	hom	low_DP	QUAL=107;DP=6;AF=0.17;MQM=60;TRIO=HOM,6,0.83,WT,222,1.00,HET,8,0.50	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2469A>T:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-5591T>A:	(AT)n	rs200266031	0.0000	0.0000	0/0/0	0.0017										0	24					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87359563	87359563	T	A	het	low_DP	QUAL=107;DP=6;AF=0.17;MQM=60;TRIO=HET,6,0.83,WT,222,1.00,WT,8,0.50	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2467A>T:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-5589T>A:	(AT)n	rs866354599	0.0000	0.0000	0/0/0	0.0002										0	5					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87359676	87359676	T	A	het		QUAL=227;DP=70;AF=0.20;MQM=53;TRIO=HET,70,0.31,HOM,13,0.77,HET,31,0.23	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2354A>T:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-5476T>A:	(TC)n	rs12253218	0.0000	0.0000	0/0/0	0.0056										6	97					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87359697	87359697	A	C	het		QUAL=61;DP=70;AF=0.24;MQM=51;TRIO=HET,70,0.24,WT,49,0.10,WT,72,0.08	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2333T>G:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-5455A>C:	(CA)n	rs201962779	0.0000	0.0000	0/0/0	0.0033										0	54					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87359826	87359826	A	G	hom		QUAL=12310;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HOM,121,1.00,HET,177,0.59	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2204T>C:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-5326A>G:		rs2664405	0.6500	0.0000	0/0/0	0.1015										82	116					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87360712	87360712	G	C	hom		QUAL=20210;DP=279;AF=0.99;MQM=59;TRIO=HOM,279,0.99,HOM,225,0.99,HET,352,0.51	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*1318C>G:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-4440G>C:		rs2616672	0.6506	0.0000	0/0/0	0.5870										82	116					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87360723	87360723	A	G	hom		QUAL=20900;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HOM,241,1.00,HET,355,0.52	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*1307T>C:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-4429A>G:		rs2664404	0.6506	0.0000	0/0/0	0.5926										82	116					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87361961	87361961	G	A	hom		QUAL=1983;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HET,31,0.48,HET,41,0.51	GRID1,GRID1-AS1	3'UTR,intron	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*69C>T:,GRID1-AS1:NR_038986.1:intron:MODIFIER:exon2/2:n.282-3191G>A:	(TG)n	rs1054979	0.3618	0.0000	0/0/0	0.0588										23	89					GRID1 (inh=n/a pLI=0.95), GRID1-AS1 (inh=n/a pLI=n/a)
chr10	87898729	87898729	G	A	hom		QUAL=15879;DP=208;AF=0.98;MQM=59;TRIO=HOM,208,0.98,HET,364,0.49,HET,458,0.48	GRID1	synonymous	GRID1:NM_017551.2:synonymous:LOW:exon4/16:c.573C>T:p.Asp191Asp		rs17106320	0.1809	0.1480	1594/765/326	0.1456										29	333					GRID1 (inh=n/a pLI=0.95)
chr10	88428303	88428303	G	A	het		QUAL=7589;DP=240;AF=0.54;MQM=59;TRIO=HET,240,0.54,WT,271,0.00,HET,360,0.53	LDB3	5'UTR	LDB3:NM_001171610.1:5'UTR:MODIFIER:exon1/14:c.-48G>A:		rs2803556	0.0597	0.0000	0/0/0	0.0966							RCV000126610.3 [benign]; 			1	31					LDB3 (inh=n/a pLI=0.00)
chr10	88428335	88428335	T	C	hom		QUAL=25960;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HOM,322,1.00,HOM,388,0.99	LDB3	splice_region&intron,5'UTR	LDB3:NM_001171610.1:splice_region&intron:LOW:exon1/13:c.-24+8T>C:,LDB3:NM_001080116.1:5'UTR:MODIFIER:exon1/8:c.-114T>C:		rs2803558	0.7522	0.0000	0/0/0	0.6847							RCV000126612.2 [benign]; 			152	129					LDB3 (inh=n/a pLI=0.00)
chr10	88494752	88494752	A	-	hom		QUAL=2860;DP=102;AF=0.67;MQM=59;TRIO=HOM,102,0.67,HOM,28,0.79,HOM,45,0.76	LDB3	3'UTR	LDB3:NM_001171610.1:3'UTR:MODIFIER:exon14/14:c.*2033delA:,LDB3:NM_001080114.1:3'UTR:MODIFIER:exon13/13:c.*2033delA:,LDB3:NM_007078.2:3'UTR:MODIFIER:exon13/13:c.*2033delA:		rs11314847;rs753169910;rs869199516	0.8584	0.0000	0/0/0	0.4180										17	193					LDB3 (inh=n/a pLI=0.00)
chr10	88494809	88494809	-	AC	hom		QUAL=396;DP=21;AF=0.43;MQM=57;TRIO=HOM,21,0.43,HOM,3,1.00,HOM,7,0.29	LDB3	3'UTR	LDB3:NM_001171610.1:3'UTR:MODIFIER:exon14/14:c.*2123_*2124dupAC:,LDB3:NM_001080114.1:3'UTR:MODIFIER:exon13/13:c.*2123_*2124dupAC:,LDB3:NM_007078.2:3'UTR:MODIFIER:exon13/13:c.*2123_*2124dupAC:			0.0000	0.0000	0/0/0	0.0001										0	2					LDB3 (inh=n/a pLI=0.00)
chr10	89623716	89623716	G	A	het	low_DP	QUAL=125;DP=3;AF=0.33;MQM=60;TRIO=HET,3,0.33,WT,10,0.00,HET,11,0.64	PTEN	missense,5'UTR	PTEN:NM_001304717.2:missense:MODERATE:exon1/10:c.10G>A:p.Gly4Arg,PTEN:NM_000314.6:5'UTR:MODIFIER:exon1/9:c.-511G>A:,PTEN:NM_001304718.1:5'UTR:MODIFIER:exon1/9:c.-1216G>A:	(GGC)n	rs12573787	0.1603	0.0000	0/0/0	0.1632										2	27					PTEN (inh=AD pLI=0.98)
chr10	89623861	89623861	T	-	hom	low_DP;anno_high_impact	QUAL=1192;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,16,0.94,HOM,22,1.00	PTEN	splice_acceptor&splice_donor,5'UTR	PTEN:NM_001304717.2:splice_acceptor&splice_donor:HIGH:exon1/9:c.154+1delT:,PTEN:NM_000314.6:5'UTR:MODIFIER:exon1/9:c.-366delT:,PTEN:NM_001304718.1:5'UTR:MODIFIER:exon1/9:c.-1071delT:	(CGG)n	rs71022512	1.0000	0.0000	0/0/0	0.4537										211	7	1	[1] auto-classification 16.06.2016  			PTEN (inh=AD pLI=0.98)
chr10	89623901	89623901	G	C	hom		QUAL=1757;DP=25;AF=1.00;MQM=50;TRIO=HOM,25,1.00,HOM,16,1.00,HOM,22,1.00	PTEN	missense,5'UTR	PTEN:NM_001304717.2:missense:MODERATE:exon2/10:c.194G>C:p.Cys65Ser,PTEN:NM_000314.6:5'UTR:MODIFIER:exon1/9:c.-326G>C:,PTEN:NM_001304718.1:5'UTR:MODIFIER:exon1/9:c.-1031G>C:		rs2943772	1.0000	0.0000	0/0/0	0.5228										234	2					PTEN (inh=AD pLI=0.98)
chr10	90771829	90771829	T	C	het		QUAL=9521;DP=300;AF=0.55;MQM=60;TRIO=HET,300,0.55,HOM,154,0.98,WT,234,0.01	FAS	synonymous,non_coding_exon	FAS:NM_000043.4:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:NM_152871.2:synonymous:LOW:exon6/8:c.579T>C:p.Thr193Thr,FAS:NM_152872.2:synonymous:LOW:exon7/8:c.642T>C:p.Thr214Thr,FAS:NR_028033.2:non_coding_exon:MODIFIER:exon5/7:n.816T>C:,FAS:NR_028034.2:non_coding_exon:MODIFIER:exon4/6:n.678T>C:,FAS:NR_028035.2:non_coding_exon:MODIFIER:exon5/7:n.741T>C:,FAS:NR_028036.2:non_coding_exon:MODIFIER:exon6/8:n.879T>C:		rs2234978	0.7754	0.7560	35133/16231/2363	0.7408						134637 [FAS (confirmed) Autoimmune lymphoproliferative syndrome|Squamous cell carcinoma,burn scar-related,somatic|Autoimmune lymphoproliferative syndrome,type IA];		CM045201 [CLASS=DP MUT=REF PHEN="Thyroid carcinoma association with" GENE=FAS]; 		571	438					FAS (inh=n/a pLI=0.73)
chr10	95552653	95552653	T	C	hom		QUAL=20561;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HOM,165,1.00,HOM,212,1.00	LGI1	synonymous,non_coding_exon	LGI1:NM_005097.3:synonymous:LOW:exon6/8:c.657T>C:p.Phe219Phe,LGI1:NM_001308275.1:synonymous:LOW:exon6/8:c.657T>C:p.Phe219Phe,LGI1:NM_001308276.1:synonymous:LOW:exon4/6:c.513T>C:p.Phe171Phe,LGI1:NR_131777.1:non_coding_exon:MODIFIER:exon4/6:n.921T>C:		rs1111820	0.9774	0.9930	59851/33261/4529	0.9551						604619 [LGI1 (confirmed) Epilepsy,familial temporal lobe,1];				1102	5					LGI1 (inh=n/a pLI=1.00)
chr10	95892129	95892129	T	A	het	phylop_high;pred_pathogenic_1	QUAL=15012;DP=609;AF=0.48;MQM=60;TRIO=HET,609,0.48,HET,658,0.50,WT,768,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon3/33:c.1405T>A:p.Ser469Thr,PLCE1:NM_001288989.1:missense:MODERATE:exon3/33:c.1405T>A:p.Ser469Thr,PLCE1:NM_001165979.2:missense:MODERATE:exon2/32:c.481T>A:p.Ser161Thr		rs17508082	0.0172	0.0310	85/74/0	0.0309	3.4920	T	D,D,D,D	P,P,P	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];				4	120					PLCE1 (inh=n/a pLI=0.20)
chr10	96039597	96039597	G	C	het		QUAL=7484;DP=306;AF=0.50;MQM=59;TRIO=HET,306,0.50,HET,336,0.46,WT,490,0.00	PLCE1,PLCE1-AS1	missense,non_coding_exon	PLCE1:NM_016341.3:missense:MODERATE:exon20/33:c.4724G>C:p.Arg1575Pro,PLCE1:NM_001288989.1:missense:MODERATE:exon20/33:c.4676G>C:p.Arg1559Pro,PLCE1:NM_001165979.2:missense:MODERATE:exon19/32:c.3800G>C:p.Arg1267Pro,PLCE1-AS1:NR_033969.1:non_coding_exon:MODIFIER:exon4/4:n.858C>G:		rs2274224	0.4862	0.4370	11866/6347/1515	0.4156	0.7950	T	T,T,T,T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM1314035 [CLASS=DP MUT=REF PHEN="Oesophageal squamous cell carcinoma reduced risk" GENE=PLCE1]; 		269	544					PLCE1 (inh=n/a pLI=0.20), PLCE1-AS1 (inh=n/a pLI=n/a)
chr10	96058298	96058298	C	T	het	phylop_high	QUAL=8558;DP=408;AF=0.49;MQM=60;TRIO=HET,408,0.49,HET,306,0.54,WT,398,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon24/33:c.5330C>T:p.Thr1777Ile,PLCE1:NM_001288989.1:missense:MODERATE:exon24/33:c.5282C>T:p.Thr1761Ile,PLCE1:NM_001165979.2:missense:MODERATE:exon23/32:c.4406C>T:p.Thr1469Ile		rs3765524	0.3079	0.2710	4911/2783/909	0.2686	5.1480	T	T,T,T,T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM105437 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC association with" GENE=PLCE1]; 		134	477					PLCE1 (inh=n/a pLI=0.20)
chr10	96058433	96058433	G	A	het		QUAL=5680;DP=231;AF=0.48;MQM=60;TRIO=HET,231,0.48,HET,239,0.52,WT,300,0.00	PLCE1	splice_region&intron	PLCE1:NM_016341.3:splice_region&intron:LOW:exon24/32:c.5458+7G>A:,PLCE1:NM_001288989.1:splice_region&intron:LOW:exon24/32:c.5410+7G>A:,PLCE1:NM_001165979.2:splice_region&intron:LOW:exon23/31:c.4534+7G>A:		rs17516758	0.1068	0.1370	1360/876/45	0.1332						608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];				39	330					PLCE1 (inh=n/a pLI=0.20)
chr10	96066341	96066341	A	G	het	phylop_high	QUAL=8447;DP=355;AF=0.53;MQM=60;TRIO=HET,355,0.53,HET,281,0.49,WT,366,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon26/33:c.5780A>G:p.His1927Arg,PLCE1:NM_001288989.1:missense:MODERATE:exon26/33:c.5732A>G:p.His1911Arg,PLCE1:NM_001165979.2:missense:MODERATE:exon25/32:c.4856A>G:p.His1619Arg		rs2274223	0.2985	0.2840	5213/3247/609	0.2829	3.0200	T	T,T,T,T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM105436 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC association with" GENE=PLCE1]; 		148	495					PLCE1 (inh=n/a pLI=0.20)
chr10	96087728	96087728	A	G	het	phylop_high	QUAL=3905;DP=247;AF=0.51;MQM=60;TRIO=HET,247,0.51,HET,78,0.51,WT,95,0.00	PLCE1	3'UTR	PLCE1:NM_016341.3:3'UTR:MODIFIER:exon33/33:c.*28A>G:,PLCE1:NM_001288989.1:3'UTR:MODIFIER:exon33/33:c.*28A>G:,PLCE1:NM_001165979.2:3'UTR:MODIFIER:exon32/32:c.*28A>G:		rs3203713	0.1054	0.1340	1214/780/45	0.1273	2.1340	T	T							21	202					PLCE1 (inh=n/a pLI=0.20)
chr10	97365820	97365820	G	A	het		QUAL=5482;DP=219;AF=0.53;MQM=60;TRIO=HET,219,0.53,HET,75,0.53,HET,109,0.50	ALDH18A1	3'UTR	ALDH18A1:NM_002860.3:3'UTR:MODIFIER:exon18/18:c.*699C>T:,ALDH18A1:NM_001017423.1:3'UTR:MODIFIER:exon18/18:c.*699C>T:		rs4037	0.2005	0.0000	0/0/0	0.0498										24	107					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97366364	97366364	C	T	het		QUAL=6119;DP=208;AF=0.50;MQM=60;TRIO=HET,208,0.50,HET,63,0.54,HOM,86,1.00	ALDH18A1	3'UTR	ALDH18A1:NM_002860.3:3'UTR:MODIFIER:exon18/18:c.*155G>A:,ALDH18A1:NM_001017423.1:3'UTR:MODIFIER:exon18/18:c.*155G>A:		rs1053905	0.2979	0.0000	0/0/0	0.0874										64	123					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97388162	97388162	G	A	het	phylop_high;pred_pathogenic_1	QUAL=11993;DP=284;AF=0.49;MQM=60;TRIO=HET,284,0.49,WT,227,0.00,HOM,265,1.00	ALDH18A1	missense	ALDH18A1:NM_002860.3:missense:MODERATE:exon8/18:c.896C>T:p.Thr299Ile,ALDH18A1:NM_001017423.1:missense:MODERATE:exon8/18:c.890C>T:p.Thr297Ile		rs2275272	0.0717	0.1030	782/603/10	0.1021	6.1520	T	T,D	B,B	B,B	138250 [ALDH18A1 (confirmed) Cutis laxa,autosomal recessive,type IIIA|Spastic paraplegia 9A,autosomal dominant|Spastic paraplegia 9B,autosomal recessive];				25	292					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97515949	97515949	G	T	het		QUAL=7343;DP=357;AF=0.49;MQM=60;TRIO=HET,357,0.49,WT,208,0.00,HET,242,0.51	ENTPD1,ENTPD1-AS1	5'UTR_premature_start_codon_gain,5'UTR,intron,non_coding_exon	ENTPD1:NM_001164179.1:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-48G>T:,ENTPD1:NM_001164182.1:5'UTR_premature_start_codon_gain:LOW:exon1/9:c.-311G>T:,ENTPD1:NM_001164183.1:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-193G>T:,ENTPD1:NM_001776.5:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-48G>T:,ENTPD1:NM_001164179.1:5'UTR:MODIFIER:exon1/10:c.-48G>T:,ENTPD1:NM_001164182.1:5'UTR:MODIFIER:exon1/9:c.-311G>T:,ENTPD1:NM_001164183.1:5'UTR:MODIFIER:exon1/8:c.-193G>T:,ENTPD1:NM_001776.5:5'UTR:MODIFIER:exon1/10:c.-48G>T:,ENTPD1:NM_001164178.1:intron:MODIFIER:exon1/9:c.52+426G>T:,ENTPD1:NM_001098175.1:intron:MODIFIER:exon1/9:c.37+44199G>T:,ENTPD1:NM_001164181.1:intron:MODIFIER:exon1/8:c.-181+426G>T:,ENTPD1:NM_001312654.1:intron:MODIFIER:exon1/9:c.-355+426G>T:,ENTPD1-AS1:NR_038444.1:non_coding_exon:MODIFIER:exon6/6:n.1276C>A:		rs200451742	0.0004	0.0005	0/0/0	0.0005						601752 [ENTPD1 (provisional) Spastic paraplegia 64];				0	2					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97628170	97628170	T	C	het		QUAL=18965;DP=469;AF=0.50;MQM=59;TRIO=HET,469,0.50,WT,287,0.00,HOM,385,1.00	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*2030T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+8105A>G:		rs3181115	0.0499	0.0000	0/0/0	0.0133										4	53					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97630523	97630523	C	T	het		QUAL=18962;DP=400;AF=0.47;MQM=60;TRIO=HET,400,0.47,HET,250,0.49,HOM,336,1.00	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*4383C>T:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+5752G>A:		rs10736094	0.5841	0.0000	0/0/0	0.6183										98	99					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97631051	97631051	T	C	het		QUAL=12960;DP=411;AF=0.48;MQM=59;TRIO=HET,411,0.48,HET,131,0.57,HOM,171,0.98	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*4911T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+5224A>G:		rs2153914	0.5865	0.0000	0/0/0	0.6182										98	100					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97631172	97631172	A	C	het		QUAL=11223;DP=361;AF=0.48;MQM=60;TRIO=HET,361,0.48,WT,150,0.00,HOM,208,0.99	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*5032A>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+5103T>G:		rs34630379	0.0541	0.0000	0/0/0	0.0829										4	53					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97633021	97633021	C	T	het		QUAL=18297;DP=328;AF=0.50;MQM=59;TRIO=HET,328,0.50,HET,260,0.40,HOM,345,1.00	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*6881C>T:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+3254G>A:	L3	rs11188513	0.5839	0.0000	0/0/0	0.6176										96	100					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97633470	97633470	T	C	het		QUAL=12915;DP=310;AF=0.53;MQM=59;TRIO=HET,310,0.53,WT,239,0.00,HOM,263,1.00	ENTPD1,ENTPD1-AS1	3'UTR,intron	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:NM_001312654.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*7330T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1-AS1:NR_038444.1:intron:MODIFIER:exon3/5:n.439+2805A>G:	THE1A	rs11592937	0.0497	0.0000	0/0/0	0.0790										5	35					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97990583	97990583	A	G	hom		QUAL=14500;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,158,1.00,HET,198,0.55	BLNK	synonymous,non_coding_exon	BLNK:NM_013314.3:synonymous:LOW:exon4/17:c.171T>C:p.Pro57Pro,BLNK:NM_001258440.1:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro,BLNK:NM_001258441.1:synonymous:LOW:exon4/15:c.171T>C:p.Pro57Pro,BLNK:NM_001258442.1:synonymous:LOW:exon4/14:c.171T>C:p.Pro57Pro,BLNK:NM_001114094.1:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro,BLNK:NR_047680.1:non_coding_exon:MODIFIER:exon4/16:n.289T>C:,BLNK:NR_047681.1:non_coding_exon:MODIFIER:exon4/15:n.294T>C:,BLNK:NR_047682.1:non_coding_exon:MODIFIER:exon4/15:n.289T>C:,BLNK:NR_047683.1:non_coding_exon:MODIFIER:exon4/14:n.289T>C:		rs727852	0.4613	0.6210	23363/15833/277	0.6135						604515 [BLNK (provisional) Agammaglobulinemia 4];			COSM147002	546	440					BLNK (inh=n/a pLI=0.99)
chr10	101469605	101469605	G	A	hom		QUAL=38982;DP=520;AF=1.00;MQM=60;TRIO=HOM,520,1.00,HET,402,0.44,HOM,508,1.00	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*5165G>A:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*4739C>T:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*3566C>T:		rs2300983	0.8263	0.0000	0/0/0	0.8566										111	35					ENTPD7 (inh=n/a pLI=0.00), COX15 (inh=AR pLI=0.00)
chr10	101470858	101470858	-	A	hom		QUAL=10597;DP=243;AF=0.96;MQM=59;TRIO=HOM,243,0.96,HET,54,0.43,HOM,78,1.00	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*6426dupA:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*3485dupT:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*2312dupT:		rs11405417;rs397764905	0.8227	0.0000	0/0/0	0.7346										110	36					ENTPD7 (inh=n/a pLI=0.00), COX15 (inh=AR pLI=0.00)
chr10	101470927	101470927	A	G	hom		QUAL=10632;DP=266;AF=1.00;MQM=59;TRIO=HOM,266,1.00,HET,77,0.49,HET,92,0.42	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*6487A>G:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*3417T>C:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*2244T>C:		rs10883407	0.1264	0.0000	0/0/0	0.1325										2	25					ENTPD7 (inh=n/a pLI=0.00), COX15 (inh=AR pLI=0.00)
chr10	101473218	101473218	A	G	hom		QUAL=18289;DP=250;AF=0.99;MQM=60;TRIO=HOM,250,0.99,HET,183,0.49,HOM,231,1.00	COX15	missense,3'UTR	COX15:NM_004376.5:missense:MODERATE:exon9/9:c.1120T>C:p.Phe374Leu,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*1126T>C:	L3	rs2231687	0.8271	0.8600	44825/25308/2970	0.8438	0.2480	T	T	B	B	603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2];	RCV000116814.2 [other]; 			847	226					COX15 (inh=AR pLI=0.00)
chr10	101473535	101473535	C	T	hom		QUAL=17617;DP=296;AF=1.00;MQM=56;TRIO=HOM,296,1.00,HET,141,0.52,HOM,195,1.00	COX15	3'UTR,intron	COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*809G>A:,COX15:NM_004376.5:intron:MODIFIER:exon8/8:c.1102-299G>A:	AluSq2	rs7073616	0.8518	0.0000	0/0/0	0.7976						603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2];				111	35					COX15 (inh=AR pLI=0.00)
chr10	102747363	102747363	G	T	het		QUAL=16033;DP=534;AF=0.51;MQM=60;TRIO=HET,534,0.51,HET,370,0.50,HET,487,0.49	C10orf2	5'UTR	C10orf2:NM_021830.4:5'UTR:MODIFIER:exon1/5:c.-605G>T:,C10orf2:NM_001163812.1:5'UTR:MODIFIER:exon1/5:c.-605G>T:,C10orf2:NM_001163813.1:5'UTR:MODIFIER:exon1/5:c.-127G>T:,C10orf2:NM_001163814.1:5'UTR:MODIFIER:exon1/5:c.-127G>T:		rs3740484	0.4121	0.0000	0/0/0	0.3752							RCV000124045.1 [benign]; 			23	112					C10orf2 (inh=AR+AD pLI=0.99)
chr10	102750621	102750621	C	T	het		QUAL=5407;DP=282;AF=0.47;MQM=60;TRIO=HET,282,0.47,HET,220,0.45,WT,298,0.00	C10orf2	splice_region&intron	C10orf2:NM_021830.4:splice_region&intron:LOW:exon3/4:c.1593-5C>T:,C10orf2:NM_001163812.1:splice_region&intron:LOW:exon3/4:c.1593-5C>T:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon3/4:c.231-5C>T:,C10orf2:NM_001163814.1:splice_region&intron:LOW:exon3/4:c.231-5C>T:		rs3740485	0.3760	0.2750	5495/1347/1029	0.0402						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|Perrault syndrome 5];	RCV000124041.1 [benign]; 			89	701					C10orf2 (inh=AR+AD pLI=0.99)
chr10	102750623	102750623	T	C	het		QUAL=5407;DP=282;AF=0.47;MQM=60;TRIO=HET,282,0.47,HET,220,0.45,WT,298,0.00	C10orf2	splice_region&intron	C10orf2:NM_021830.4:splice_region&intron:LOW:exon3/4:c.1593-3T>C:,C10orf2:NM_001163812.1:splice_region&intron:LOW:exon3/4:c.1593-3T>C:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon3/4:c.231-3T>C:,C10orf2:NM_001163814.1:splice_region&intron:LOW:exon3/4:c.231-3T>C:		rs3740486	0.3760	0.2750	5496/1346/1029	0.2532						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|Perrault syndrome 5];	RCV000124042.1 [benign]; 			89	701					C10orf2 (inh=AR+AD pLI=0.99)
chr10	102750783	102750783	C	A	het		QUAL=6242;DP=217;AF=0.53;MQM=60;TRIO=HET,217,0.53,HET,276,0.49,WT,340,0.00	C10orf2	splice_region&intron,3'UTR	C10orf2:NM_021830.4:splice_region&intron:LOW:exon4/4:c.1734+16C>A:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon4/4:c.372+16C>A:,C10orf2:NM_001163812.1:3'UTR:MODIFIER:exon4/5:c.*1C>A:,C10orf2:NM_001163814.1:3'UTR:MODIFIER:exon4/5:c.*1C>A:		rs3740487	0.3758	0.2750	5487/1344/1027	0.2720						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|Perrault syndrome 5];	RCV000124043.1 [benign]; 			90	685					C10orf2 (inh=AR+AD pLI=0.99)
chr10	102754033	102754033	A	T	het		QUAL=8136;DP=342;AF=0.54;MQM=60;TRIO=HET,342,0.54,HET,270,0.53,WT,387,0.00	C10orf2	3'UTR	C10orf2:NM_021830.4:3'UTR:MODIFIER:exon5/5:c.*766A>T:,C10orf2:NM_001163812.1:3'UTR:MODIFIER:exon5/5:c.*1116A>T:,C10orf2:NM_001163813.1:3'UTR:MODIFIER:exon5/5:c.*766A>T:,C10orf2:NM_001163814.1:3'UTR:MODIFIER:exon5/5:c.*1116A>T:		rs3740488	0.3748	0.0000	0/0/0	0.0502										11	80					C10orf2 (inh=AR+AD pLI=0.99)
chr10	104596924	104596924	C	A	hom		QUAL=4722;DP=94;AF=1.00;MQM=59;TRIO=HOM,94,1.00,HET,61,0.49,HOM,54,1.00	CYP17A1	synonymous	CYP17A1:NM_000102.3:synonymous:LOW:exon1/8:c.195G>T:p.Ser65Ser		rs6163	0.4103	0.3970	9728/5086/683	0.3951						609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency|17,20-lyase deficiency,isolated];			COSM3751499	204	514					CYP17A1 (inh=n/a pLI=0.04)
chr10	104596981	104596981	G	A	hom		QUAL=8546;DP=152;AF=0.99;MQM=59;TRIO=HOM,152,0.99,HET,103,0.44,HOM,111,1.00	CYP17A1	synonymous	CYP17A1:NM_000102.3:synonymous:LOW:exon1/8:c.138C>T:p.His46His		rs6162	0.4425	0.4250	11081/5549/693	0.4204						609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency|17,20-lyase deficiency,isolated];			COSM3751500	238	519					CYP17A1 (inh=n/a pLI=0.04)
chr10	104597152	104597152	A	G	hom		QUAL=18487;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HET,213,0.52,HOM,242,1.00	CYP17A1	5'UTR	CYP17A1:NM_000102.3:5'UTR:MODIFIER:exon1/8:c.-34T>C:		rs743572	0.4105	0.3960	9368/4905/624	0.3883								CR942079 [CLASS=DP MUT=ALT PHEN="Polycystic ovaries association with" GENE=CYP17A1]; 		58	138					CYP17A1 (inh=n/a pLI=0.04)
chr10	105791355	105791355	C	T	het		QUAL=9980;DP=370;AF=0.48;MQM=60;TRIO=HET,370,0.48,HET,157,0.47,HET,232,0.50	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*638G>A:		rs9425	0.1885	0.0000	0/0/0	0.1694										7	63					COL17A1 (inh=n/a pLI=0.00)
chr10	105791630	105791630	A	-	het		QUAL=13642;DP=345;AF=0.51;MQM=59;TRIO=HET,345,0.51,HET,330,0.49,HET,429,0.49	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*363delT:		rs113786874	0.2466	0.0000	0/0/0	0.1849										12	64					COL17A1 (inh=n/a pLI=0.00)
chr10	105791929	105791929	C	G	het		QUAL=12027;DP=364;AF=0.52;MQM=59;TRIO=HET,364,0.52,HET,239,0.51,HET,358,0.42	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*64G>C:		rs805687	0.2288	0.0000	0/0/0	0.0357										7	64					COL17A1 (inh=n/a pLI=0.00)
chr10	105796399	105796399	G	C	het		QUAL=3985;DP=69;AF=0.42;MQM=60;TRIO=HET,69,0.42,HET,93,0.55,HET,140,0.59	COL17A1	splice_region&intron	COL17A1:NM_000494.3:splice_region&intron:LOW:exon47/55:c.3278-9C>G:		rs2274098	0.6915	0.7790	37104/22537/1286	0.7642						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];				731	313					COL17A1 (inh=n/a pLI=0.00)
chr10	105796819	105796819	A	G	hom		QUAL=32186;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,338,1.00,HOM,435,1.00	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon47/56:c.3261T>C:p.Ile1087Ile		rs2476958	0.9860	0.9960	55550/31287/4211	0.9409						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];				1101	0					COL17A1 (inh=n/a pLI=0.00)
chr10	105798872	105798872	T	C	het		QUAL=12251;DP=396;AF=0.45;MQM=60;TRIO=HET,396,0.45,HET,329,0.34,HET,406,0.48	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon44/56:c.2904A>G:p.Pro968Pro		rs2274100	0.6815	0.7770	37240/22857/1302	0.7728						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];			COSM3751514	731	319					COL17A1 (inh=n/a pLI=0.00)
chr10	105799216	105799216	G	T	het		QUAL=9298;DP=244;AF=0.52;MQM=59;TRIO=HET,244,0.52,HET,199,0.49,HET,265,0.52	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon43/56:c.2883C>A:p.Pro961Pro		rs2296219	0.6835	0.7770	37320/22756/1206	0.7568						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];			COSM3751515	733	311					COL17A1 (inh=n/a pLI=0.00)
chr10	105801253	105801253	G	A	het		QUAL=4997;DP=151;AF=0.45;MQM=59;TRIO=HET,151,0.45,HET,113,0.49,HET,137,0.63	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon37/56:c.2595C>T:p.Arg865Arg		rs4918079	0.6739	0.7690	36341/22479/1244	0.7573						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];		CM144867 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament association with" GENE=COL17A1]; 	COSM3751516	725	322					COL17A1 (inh=n/a pLI=0.00)
chr10	105810400	105810400	T	C	het		QUAL=28202;DP=426;AF=0.50;MQM=60;TRIO=HET,426,0.50,HOM,456,1.00,HET,586,0.50	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon27/56:c.2107A>G:p.Met703Val		rs805722	0.6937	0.7800	37505/22415/1454	0.7754	-0.2220	T	T,T	B	B	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];			COSM1178415	713	352					COL17A1 (inh=n/a pLI=0.00)
chr10	105816916	105816916	C	T	hom		QUAL=25000;DP=117;AF=0.99;MQM=59;TRIO=HOM,117,0.99,HOM,292,1.00,HOM,370,1.00	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon17/56:c.1282G>A:p.Gly428Ser		rs805698	0.8185	0.9340	53798/32795/1593	0.9252	0.8810	T	T,T,T	B,B	B,B	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];		CM144866 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament association with" GENE=COL17A1]; 		1062	38					COL17A1 (inh=n/a pLI=0.00)
chr10	105819956	105819956	G	A	het		QUAL=27562;DP=420;AF=0.52;MQM=59;TRIO=HET,420,0.52,HOM,465,1.00,HET,572,0.47	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon14/56:c.1062C>T:p.Ala354Ala		rs805701	0.5525	0.6470	26225/15108/512	0.6435						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];				491	499					COL17A1 (inh=n/a pLI=0.00)
chr10	105824333	105824333	G	A	het	phylop_high;pred_pathogenic_2	QUAL=1983;DP=50;AF=0.48;MQM=60;TRIO=HET,50,0.48,HOM,39,0.97,HET,23,0.48	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon10/56:c.629C>T:p.Thr210Met		rs805708	0.5649	0.6660	27226/16148/617	0.6626	6.8340	T	T,T,T,T	D,D,D	D,D,P	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa,junctional,localisata variant|Epithelial recurrent erosion dystrophy];				519	479					COL17A1 (inh=n/a pLI=0.00)
chr10	112361870	112361870	A	G	hom		QUAL=17448;DP=230;AF=1.00;MQM=58;TRIO=HOM,230,1.00,HOM,129,1.00,HOM,170,1.00	SMC3	synonymous	SMC3:NM_005445.3:synonymous:LOW:exon25/29:c.3039A>G:p.Ser1013Ser		rs2419565	0.9868	0.9960	60202/33298/4794	0.9645						606062 [SMC3 (provisional) Cornelia de Lange syndrome 3];	RCV000147595.1 [benign]; 			1104	3					SMC3 (inh=AD pLI=1.00)
chr10	112773063	112773063	G	-	het		QUAL=1928;DP=201;AF=0.40;MQM=59;TRIO=HET,201,0.40,WT,47,0.00,HET,80,0.29	SHOC2	3'UTR	SHOC2:NM_007373.3:3'UTR:MODIFIER:exon9/9:c.*1487delG:,SHOC2:NM_001269039.1:3'UTR:MODIFIER:exon7/7:c.*1487delG:		rs143768227	0.0525	0.0000	0/0/0	0.0348										0	20					SHOC2 (inh=AD pLI=0.99)
chr10	119302341	119302341	-	T	hom		QUAL=2081;DP=66;AF=0.45;MQM=59;TRIO=HOM,66,0.45,HOM,71,0.68,HOM,123,0.58	EMX2,EMX2OS	5'UTR,intron	EMX2:NM_004098.3:5'UTR:MODIFIER:exon1/3:c.-424dupT:,EMX2:NM_001165924.1:5'UTR:MODIFIER:exon1/2:c.-424dupT:,EMX2OS:NR_002791.2:intron:MODIFIER:exon2/3:n.574+1475dupA:		rs534695537	0.5284	0.0000	0/0/0	0.3523										3	134					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119302449	119302449	G	A	het		QUAL=411;DP=76;AF=0.34;MQM=52;TRIO=HET,76,0.34,HET,17,0.35,HET,21,0.10	EMX2,EMX2OS	5'UTR,intron	EMX2:NM_004098.3:5'UTR:MODIFIER:exon1/3:c.-330G>A:,EMX2:NM_001165924.1:5'UTR:MODIFIER:exon1/2:c.-330G>A:,EMX2OS:NR_002791.2:intron:MODIFIER:exon2/3:n.574+1368C>T:	(A)n		0.0000	0.0000	0/0/0	0.0008										1	132					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119302459	119302459	G	A	het	low_QUAL;low_MQM	QUAL=19;DP=68;AF=0.21;MQM=44;TRIO=HET,68,0.21,HET,13,0.23,WT,23,0.04	EMX2,EMX2OS	5'UTR,intron	EMX2:NM_004098.3:5'UTR:MODIFIER:exon1/3:c.-320G>A:,EMX2:NM_001165924.1:5'UTR:MODIFIER:exon1/2:c.-320G>A:,EMX2OS:NR_002791.2:intron:MODIFIER:exon2/3:n.574+1358C>T:	(A)n		0.0000	0.0000	0/0/0	0.0004										0	107					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119308060	119308063	AGAG	-	hom		QUAL=11167;DP=94;AF=0.95;MQM=59;TRIO=HOM,94,0.95,HOM,143,0.92,HOM,187,0.97	EMX2	3'UTR	EMX2:NM_004098.3:3'UTR:MODIFIER:exon3/3:c.*338_*341delGAGA:,EMX2:NM_001165924.1:3'UTR:MODIFIER:exon2/2:c.*402_*405delGAGA:	(GAGA)n	rs34929200;rs66710107	0.9497	0.0000	0/0/0	0.6184										199	29					EMX2 (inh=n/a pLI=0.94)
chr10	121436362	121436362	A	G	het		QUAL=10002;DP=385;AF=0.53;MQM=59;TRIO=HET,385,0.53,HET,153,0.54,HET,234,0.49	BAG3	synonymous	BAG3:NM_004281.3:synonymous:LOW:exon4/4:c.1296A>G:p.Val432Val		rs196295	0.7065	0.7410	33720/20379/2977	0.7374						603883 [BAG3 (provisional) Myopathy,myofibrillar,6|Cardiomyopathy,dilated,1HH];	RCV000037886.7 [benign]; 			751	362					BAG3 (inh=n/a pLI=0.53)
chr10	121437032	121437034	TTG	-	het		QUAL=9345;DP=390;AF=0.50;MQM=59;TRIO=HET,390,0.50,WT,276,0.00,HET,386,0.51	BAG3	3'UTR	BAG3:NM_004281.3:3'UTR:MODIFIER:exon4/4:c.*243_*245delGTT:		rs71758126	0.4585	0.0000	0/0/0	0.5259										87	101					BAG3 (inh=n/a pLI=0.53)
chr10	123239112	123239112	G	A	het		QUAL=12951;DP=198;AF=0.48;MQM=59;TRIO=HET,198,0.48,HOM,238,1.00,HET,288,0.42	FGFR2	synonymous,3'UTR,non_coding_exon	FGFR2:NM_001144915.1:synonymous:LOW:exon17/17:c.2107C>T:p.Leu703Leu,FGFR2:NM_022970.3:3'UTR:MODIFIER:exon18/18:c.*259C>T:,FGFR2:NM_001144914.1:3'UTR:MODIFIER:exon15/15:c.*259C>T:,FGFR2:NM_023029.2:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:NM_001144916.1:3'UTR:MODIFIER:exon15/15:c.*259C>T:,FGFR2:NM_000141.4:3'UTR:MODIFIER:exon18/18:c.*259C>T:,FGFR2:NM_001144917.1:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:NM_001144918.1:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:NR_073009.1:non_coding_exon:MODIFIER:exon17/17:n.3175C>T:		rs1047057	0.4143	0.3650	3140/1421/27	0.1985						176943 [FGFR2 (confirmed) Crouzon syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Apert syndrome|Saethre-Chotzen syndrome|Craniosynostosis,nonspecific|Gastric cancer,somatic|Craniofacial-skeletal-dermatologic dysplasia|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome|Scaphocephaly,maxillary retrusion,and mental retardation|Bent bone dysplasia syndrome];			COSM147070	365	567					FGFR2 (inh=AR+AD pLI=1.00)
chr10	123298158	123298158	T	C	hom		QUAL=40379;DP=412;AF=1.00;MQM=59;TRIO=HOM,412,1.00,HET,469,0.55,HOM,618,1.00	FGFR2	synonymous,non_coding_exon	FGFR2:NM_022970.3:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:NM_001144914.1:synonymous:LOW:exon5/15:c.696A>G:p.Val232Val,FGFR2:NM_023029.2:synonymous:LOW:exon4/16:c.429A>G:p.Val143Val,FGFR2:NM_001144916.1:synonymous:LOW:exon3/15:c.351A>G:p.Val117Val,FGFR2:NM_001144915.1:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val,FGFR2:NM_000141.4:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:NM_001144917.1:synonymous:LOW:exon6/16:c.696A>G:p.Val232Val,FGFR2:NM_001144918.1:synonymous:LOW:exon4/16:c.351A>G:p.Val117Val,FGFR2:NM_001144913.1:synonymous:LOW:exon5/17:c.696A>G:p.Val232Val,FGFR2:NM_001144919.1:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val,FGFR2:NR_073009.1:non_coding_exon:MODIFIER:exon4/17:n.998A>G:		rs1047100	0.7953	0.7800	37171/19910/2915	0.7745						176943 [FGFR2 (confirmed) Crouzon syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Apert syndrome|Saethre-Chotzen syndrome|Craniosynostosis,nonspecific|Gastric cancer,somatic|Craniofacial-skeletal-dermatologic dysplasia|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome|Scaphocephaly,maxillary retrusion,and mental retardation|Bent bone dysplasia syndrome];				721	390					FGFR2 (inh=AR+AD pLI=1.00)
chr10	123357561	123357561	C	T	hom	low_DP	QUAL=1869;DP=12;AF=0.92;MQM=60;TRIO=HOM,12,0.92,HET,29,0.55,HOM,52,1.00	FGFR2	5'UTR,non_coding_exon	FGFR2:NM_022970.3:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:NM_000141.4:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:NM_001144917.1:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:NM_001144918.1:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:NM_001144919.1:5'UTR:MODIFIER:exon1/17:c.-236G>A:,FGFR2:NR_073009.1:non_coding_exon:MODIFIER:exon1/17:n.412G>A:		rs1047111	0.7103	0.0000	0/0/0	0.6842										152	62					FGFR2 (inh=AR+AD pLI=1.00)
chr10	126107506	126107506	A	C	het		QUAL=8062;DP=148;AF=0.59;MQM=60;TRIO=HET,148,0.59,HOM,126,1.00,HET,186,0.49	OAT	5'UTR	OAT:NM_000274.3:5'UTR:MODIFIER:exon1/10:c.-94T>G:,OAT:NM_001171814.1:5'UTR:MODIFIER:exon1/9:c.-280T>G:		rs4144117	0.8630	0.0000	0/0/0	0.7491										155	70					OAT (inh=n/a pLI=0.00)
chr11	791462	791462	G	A	het		QUAL=4079;DP=132;AF=0.48;MQM=60;TRIO=HET,132,0.48,WT,117,0.00,HET,208,0.51	SLC25A22	3'UTR	SLC25A22:NM_001191060.1:3'UTR:MODIFIER:exon10/10:c.*453C>T:,SLC25A22:NM_024698.5:3'UTR:MODIFIER:exon10/10:c.*453C>T:,SLC25A22:NM_001191061.1:3'UTR:MODIFIER:exon10/10:c.*453C>T:		rs4963153	0.2993	0.0000	0/0/0	0.0706										47	111					SLC25A22 (inh=AR pLI=0.57)
chr11	1861760	1861760	T	C	hom		QUAL=21630;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HOM,227,1.00,HOM,329,1.00	TNNI2	splice_region&synonymous	TNNI2:NM_001145829.1:splice_region&synonymous:LOW:exon4/7:c.60T>C:p.Ser20Ser,TNNI2:NM_003282.3:splice_region&synonymous:LOW:exon4/7:c.60T>C:p.Ser20Ser,TNNI2:NM_001145841.1:splice_region&synonymous:LOW:exon3/6:c.60T>C:p.Ser20Ser		rs907610	0.8277	0.8710	44552/24284/2076	0.8203						191043 [TNNI2 (confirmed) Arthrogryposis multiplex congenita,distal,type 2B];	RCV000080081.7 [other]; RCV000128669.1 [not provided]; 		COSM4145619	868	224					TNNI2 (inh=n/a pLI=0.09)
chr11	1959707	1959707	C	T	het		QUAL=836;DP=32;AF=0.47;MQM=59;TRIO=HET,32,0.47,HET,26,0.50,HET,41,0.37	TNNT3	synonymous	TNNT3:NM_006757.3:synonymous:LOW:exon16/16:c.762C>T:p.Gly254Gly,TNNT3:NM_001042780.2:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:NM_001042781.2:synonymous:LOW:exon16/16:c.756C>T:p.Gly252Gly,TNNT3:NM_001042782.2:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:NM_001297646.1:synonymous:LOW:exon16/16:c.738C>T:p.Gly246Gly		rs4727	0.1370	0.1440	1645/842/7	0.1441						600692 [TNNT3 (confirmed) Arthyrgryposis,distal,type 2B];	RCV000024568.1 [not provided]; RCV000118647.1 [benign]; 		COSM3752283, COSM3752285, COSM3752284	41	295					TNNT3 (inh=n/a pLI=0.00)
chr11	2187855	2187855	G	C	het	low_DP	QUAL=2184;DP=16;AF=0.63;MQM=60;TRIO=HET,16,0.63,WT,127,0.00,HET,158,0.53	TH	splice_region&intron	TH:NM_199292.2:splice_region&intron:LOW:exon9/13:c.1070+8C>G:,TH:NM_000360.3:splice_region&intron:LOW:exon8/12:c.977+8C>G:,TH:NM_199293.2:splice_region&intron:LOW:exon9/13:c.1058+8C>G:		rs12419447	0.1799	0.2430	2558/2162/34	0.2279						191290 [TH (confirmed) Segawa syndrome,recessive];				190	728					TH (inh=AR pLI=0.00)
chr11	2188238	2188238	C	T	het		QUAL=1472;DP=35;AF=0.43;MQM=60;TRIO=HET,35,0.43,WT,72,0.00,HET,94,0.51	TH	synonymous	TH:NM_199292.2:synonymous:LOW:exon8/14:c.813G>A:p.Lys271Lys,TH:NM_000360.3:synonymous:LOW:exon7/13:c.720G>A:p.Lys240Lys,TH:NM_199293.2:synonymous:LOW:exon8/14:c.801G>A:p.Lys267Lys		rs6357	0.1546	0.2070	2044/1694/44	0.2007						191290 [TH (confirmed) Segawa syndrome,recessive];			COSM3752293	147	749					TH (inh=AR pLI=0.00)
chr11	3877114	3877118	TCTCT	-	het		QUAL=2916;DP=78;AF=0.40;MQM=59;TRIO=HET,78,0.40,HET,78,0.33,HOM,79,0.99	STIM1	5'UTR	STIM1:NM_001277961.1:5'UTR:MODIFIER:exon1/12:c.-370_-366delTCTTC:,STIM1:NM_001277962.1:5'UTR:MODIFIER:exon1/13:c.-370_-366delTCTTC:,STIM1:NM_003156.3:5'UTR:MODIFIER:exon1/12:c.-370_-366delTCTTC:	(TCTCT)n	rs147711952	0.2688	0.0000	0/0/0	0.3058										28	106					STIM1 (inh=n/a pLI=0.93)
chr11	4103524	4103524	A	G	hom	phylop_high	QUAL=16507;DP=217;AF=0.99;MQM=60;TRIO=HOM,217,0.99,HET,179,0.43,HOM,244,1.00	STIM1	synonymous	STIM1:NM_001277961.1:synonymous:LOW:exon8/12:c.1080A>G:p.Gln360Gln,STIM1:NM_001277962.1:synonymous:LOW:exon8/13:c.1080A>G:p.Gln360Gln,STIM1:NM_003156.3:synonymous:LOW:exon8/12:c.1080A>G:p.Gln360Gln		rs2304891	0.3890	0.4960	15744/10562/190	0.4993	1.7940	T				605921 [STIM1 (provisional) Immunodeficiency 10|Myopathy,tubular aggregate,1 160565|Stormorken syndrome];			COSM428967	327	526					STIM1 (inh=n/a pLI=0.93)
chr11	4113395	4113395	G	A	hom		QUAL=22561;DP=311;AF=1.00;MQM=59;TRIO=HOM,311,1.00,HET,252,0.51,HOM,293,1.00	STIM1	3'UTR	STIM1:NM_001277961.1:3'UTR:MODIFIER:exon12/12:c.*367G>A:,STIM1:NM_001277962.1:3'UTR:MODIFIER:exon13/13:c.*839G>A:,STIM1:NM_003156.3:3'UTR:MODIFIER:exon12/12:c.*367G>A:		rs1561876	0.6941	0.0000	0/0/0	0.1389										171	49					STIM1 (inh=n/a pLI=0.93)
chr11	4113471	4113471	G	A	het		QUAL=13495;DP=361;AF=0.52;MQM=59;TRIO=HET,361,0.52,HET,305,0.52,HET,358,0.48	STIM1	3'UTR	STIM1:NM_001277961.1:3'UTR:MODIFIER:exon12/12:c.*443G>A:,STIM1:NM_001277962.1:3'UTR:MODIFIER:exon13/13:c.*915G>A:,STIM1:NM_003156.3:3'UTR:MODIFIER:exon12/12:c.*443G>A:		rs76833585	0.0397	0.0000	0/0/0	0.0117										3	22					STIM1 (inh=n/a pLI=0.93)
chr11	5248243	5248243	A	G	het		QUAL=23335;DP=418;AF=0.49;MQM=59;TRIO=HET,418,0.49,HET,367,0.47,HOM,425,1.00	HBB	synonymous	HBB:NM_000518.4:synonymous:LOW:exon1/3:c.9T>C:p.His3His		rs713040	0.7143	0.7670	36531/23436/3939	0.7564						141900 [HBB (confirmed) Sickle cell anemia|Thalassemias,beta-|Erythremias,beta-|Methemoglobinemias,beta-|Heinz body anemias,beta-|Thalassemia-beta,dominant inclusion-body|Hereditary persistence of fetal hemoglobin|Delta-beta thalassemia|Malaria,resistance to];	RCV000173144.1 [benign]; RCV000016529.1 [other]; 			760	318					HBB (inh=n/a pLI=0.00)
chr11	6411935	6411935	T	C	het		QUAL=3986;DP=53;AF=0.74;MQM=60;TRIO=HET,53,0.91,WT,36,1.00,HOM,47,1.00	SMPD1	missense,5'UTR,non_coding_exon	SMPD1:NM_000543.4:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:NM_001007593.2:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:NM_001318087.1:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:NM_001318088.1:5'UTR:MODIFIER:exon1/6:c.-855T>C:,SMPD1:NR_027400.2:non_coding_exon:MODIFIER:exon1/5:n.292T>C:,SMPD1:NR_134502.1:non_coding_exon:MODIFIER:exon1/6:n.292T>C:	(CTGGCG)n	rs1050228	0.5613	0.5420	18416/8580/254	0.4869	0.5000	T	T,T,T,T	B,B	B,B	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];	RCV000079189.4 [benign]; 	CM154141 [CLASS=R MUT=ALT PHEN="Niemann-Pick disease" GENE=SMPD1]; 	COSM1561696, COSM1561695	336	535	2	[2] Ute Grasshoff 28.10.2015			SMPD1 (inh=AR pLI=0.00)
chr11	6411936	6411941	GCTGGC	-	het		QUAL=3986;DP=53;AF=0.74;MQM=59;TRIO=HET,53,0.91,HOM,36,1.00,WT,47,1.00	SMPD1	disruptive_inframe_deletion,5'UTR,non_coding_exon	SMPD1:NM_000543.4:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:NM_001007593.2:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:NM_001318087.1:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:NM_001318088.1:5'UTR:MODIFIER:exon1/6:c.-824_-819delGCTGGC:,SMPD1:NR_027400.2:non_coding_exon:MODIFIER:exon1/5:n.323_328delGCTGGC:,SMPD1:NR_134502.1:non_coding_exon:MODIFIER:exon1/6:n.323_328delGCTGGC:	(CTGGCG)n	rs558809956	0.0000	0.2340	6066/4023/610	0.1941						607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];			COSM930080, COSM930081	171	502					SMPD1 (inh=AR pLI=0.00)
chr11	6415463	6415463	G	A	het	phylop_high;pred_pathogenic_1	QUAL=13168;DP=363;AF=0.51;MQM=59;TRIO=HET,363,0.51,HOM,265,0.99,WT,342,0.00	SMPD1	missense,3'UTR,non_coding_exon	SMPD1:NM_000543.4:missense:MODERATE:exon6/6:c.1522G>A:p.Gly508Arg,SMPD1:NM_001007593.2:missense:MODERATE:exon6/6:c.1519G>A:p.Gly507Arg,SMPD1:NM_001318088.1:missense:MODERATE:exon6/6:c.601G>A:p.Gly201Arg,SMPD1:NM_001318087.1:3'UTR:MODIFIER:exon6/6:c.*15G>A:,SMPD1:NR_027400.2:non_coding_exon:MODIFIER:exon5/5:n.1535G>A:,SMPD1:NR_134502.1:non_coding_exon:MODIFIER:exon6/6:n.1074G>A:		rs1050239	0.1500	0.1920	2401/1754/95	0.1927	6.2260	T	T,T,T,T	D,D,D	P,P,P	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];	RCV000079195.4 [benign]; RCV000192218.1 [benign]; 		COSM3752608, COSM3752609	38	376					SMPD1 (inh=AR pLI=0.00)
chr11	6634149	6634149	C	T	het		QUAL=19952;DP=358;AF=0.49;MQM=59;TRIO=HET,358,0.49,HOM,313,1.00,HET,395,0.52	TPP1	3'UTR	TPP1:NM_000391.3:3'UTR:MODIFIER:exon13/13:c.*1628G>A:	L2c	rs7488	0.8103	0.0000	0/0/0	0.1332										124	71					TPP1 (inh=AR pLI=0.03)
chr11	6634189	6634189	G	A	het		QUAL=14138;DP=437;AF=0.49;MQM=59;TRIO=HET,437,0.49,HET,289,0.52,HET,340,0.51	TPP1	3'UTR	TPP1:NM_000391.3:3'UTR:MODIFIER:exon13/13:c.*1588C>T:	L2c	rs7487	0.4489	0.0000	0/0/0	0.0893										73	95					TPP1 (inh=AR pLI=0.03)
chr11	6637740	6637743	TTTT	-	hom		QUAL=1108;DP=49;AF=0.16;MQM=59;TRIO=HOM,49,0.16,HOM,44,0.05,HOM,53,0.06	TPP1	splice_region&intron	TPP1:NM_000391.3:splice_region&intron:LOW:exon7/12:c.887-9_887-6delAAAA:	(T)n	rs769864650	0.0000	0.0078	0/0/0	0.0057						607998 [TPP1 (confirmed) Ceroid lipofuscinosis,neuronal,2|Spinocerebellar ataxia,autosomal recessive 7];				25	7					TPP1 (inh=AR pLI=0.03)
chr11	9800601	9800601	G	A	het		QUAL=6576;DP=189;AF=0.50;MQM=60;TRIO=HET,189,0.50,HET,66,0.61,HOM,88,1.00	SBF2,SBF2-AS1	3'UTR,intron	SBF2:NM_030962.3:3'UTR:MODIFIER:exon40/40:c.*1364C>T:,SBF2-AS1:NR_036485.1:intron:MODIFIER:exon1/2:n.211+20551G>A:		rs10118	0.6108	0.0000	0/0/0	0.1228										98	110					SBF2 (inh=n/a pLI=0.38), SBF2-AS1 (inh=n/a pLI=n/a)
chr11	9801925	9801925	T	G	het		QUAL=20468;DP=272;AF=0.47;MQM=60;TRIO=HET,272,0.47,HET,304,0.46,HOM,414,1.00	SBF2,SBF2-AS1	3'UTR,intron	SBF2:NM_030962.3:3'UTR:MODIFIER:exon40/40:c.*40A>C:,SBF2-AS1:NR_036485.1:intron:MODIFIER:exon1/2:n.211+21875T>G:		rs3751000	0.3275	0.3010	5548/2156/529	0.2912										20	102					SBF2 (inh=n/a pLI=0.38), SBF2-AS1 (inh=n/a pLI=n/a)
chr11	9812236	9812236	G	A	hom		QUAL=9387;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,58,1.00,HOM,82,1.00	SBF2,SBF2-AS1	splice_region&intron,intron	SBF2:NM_030962.3:splice_region&intron:LOW:exon33/39:c.4571-6C>T:,SBF2-AS1:NR_036485.1:intron:MODIFIER:exon1/2:n.212-17159G>A:		rs2645029	0.8027	0.8580	44419/26489/3513	0.8256						607697 [SBF2 (confirmed) Charcot-Marie-Tooth disease,type 4B2];				829	223					SBF2 (inh=n/a pLI=0.38), SBF2-AS1 (inh=n/a pLI=n/a)
chr11	13514417	13514417	C	T	het		QUAL=9272;DP=233;AF=0.50;MQM=60;TRIO=HET,233,0.50,HET,133,0.49,HOM,139,1.00	PTH	splice_region&intron	PTH:NM_001316352.1:splice_region&intron:LOW:exon1/2:c.92-10G>A:,PTH:NM_000315.3:splice_region&intron:LOW:exon1/2:c.-5-10G>A:		rs694	0.4177	0.5490	19191/13468/337	0.5370										215	233					PTH (inh=n/a pLI=0.27)
chr11	17408025	17408025	A	G	het		QUAL=4454;DP=177;AF=0.51;MQM=60;TRIO=HET,177,0.51,HET,231,0.42,WT,267,0.00	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*441T>C:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*441T>C:		rs2285676	0.4689	0.0000	0/0/0	0.0709										20	117					KCNJ11 (inh=n/a pLI=0.31)
chr11	17408251	17408251	G	A	het		QUAL=5891;DP=260;AF=0.48;MQM=59;TRIO=HET,260,0.48,HET,299,0.44,WT,422,0.00	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*215C>T:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*215C>T:		rs5210	0.4677	0.0000	0/0/0	0.0708								CS035715 [CLASS=DFP MUT=ALT PHEN="Diabetes type 2 association with" GENE=KCNJ11]; 		20	117					KCNJ11 (inh=n/a pLI=0.31)
chr11	17408404	17408404	C	T	hom		QUAL=27272;DP=218;AF=0.99;MQM=59;TRIO=HOM,218,0.99,HOM,450,0.99,HET,620,0.50	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*62G>A:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*62G>A:		rs5213	0.7358	0.0000	0/0/0	0.1333										130	159					KCNJ11 (inh=n/a pLI=0.31)
chr11	17408630	17408630	C	T	hom		QUAL=39002;DP=337;AF=0.99;MQM=59;TRIO=HOM,337,0.99,HOM,617,1.00,HET,763,0.48	KCNJ11	missense	KCNJ11:NM_000525.3:missense:MODERATE:exon1/1:c.1009G>A:p.Val337Ile,KCNJ11:NM_001166290.1:missense:MODERATE:exon2/2:c.748G>A:p.Val250Ile		rs5215	0.7306	0.6450	25728/13093/4355	0.6426	-0.1400	T	T,T	B	B	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3|Maturity-onset diabetes of the young,type 13];	RCV000146099.1 [benign]; 	CM078157 [CLASS=DP MUT=REF PHEN="Diabetes mellitus 2 association with" GENE=KCNJ11]; 		470	535					KCNJ11 (inh=n/a pLI=0.31)
chr11	17408838	17408838	G	C	het		QUAL=9816;DP=276;AF=0.47;MQM=59;TRIO=HET,276,0.47,WT,413,0.00,HET,495,0.51	KCNJ11	synonymous	KCNJ11:NM_000525.3:synonymous:LOW:exon1/1:c.801C>G:p.Leu267Leu,KCNJ11:NM_001166290.1:synonymous:LOW:exon2/2:c.540C>G:p.Leu180Leu		rs5216	0.0134	0.0170	26/12/0	0.0178						600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3|Maturity-onset diabetes of the young,type 13];	RCV000146118.1 [benign]; 	CM156016 [CLASS=R MUT=ALT PHEN="Hyperinsulinaemic hypoglycaemia" GENE=KCNJ11]; 		1	48					KCNJ11 (inh=n/a pLI=0.31)
chr11	17409069	17409069	G	A	het		QUAL=6285;DP=215;AF=0.49;MQM=60;TRIO=HET,215,0.49,HET,313,0.50,WT,384,0.00	KCNJ11	synonymous	KCNJ11:NM_000525.3:synonymous:LOW:exon1/1:c.570C>T:p.Ala190Ala,KCNJ11:NM_001166290.1:synonymous:LOW:exon2/2:c.309C>T:p.Ala103Ala		rs5218	0.2274	0.2560	4538/2773/34	0.2600						600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3|Maturity-onset diabetes of the young,type 13];	RCV000146111.1 [benign]; 	CM035697 [CLASS=DFP MUT=REF PHEN="Diabetes type 2 association with" GENE=KCNJ11]; 	COSM3752262	75	404					KCNJ11 (inh=n/a pLI=0.31)
chr11	17409572	17409572	T	C	hom	phylop_high	QUAL=22496;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,377,0.99,HET,439,0.49	KCNJ11	missense,intron	KCNJ11:NM_000525.3:missense:MODERATE:exon1/1:c.67A>G:p.Lys23Glu,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-16-179A>G:		rs5219	0.7370	0.6470	25897/13054/4555	0.6432	2.0650	T	T	B	B	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3|Maturity-onset diabetes of the young,type 13];	RCV000009214.3 [other]; RCV000009215.3 [drug response]; RCV000020356.1 [benign]; RCV000146116.2 [benign]; 	CM981121 [CLASS=DFP MUT=REF PHEN="Diabetes mellitus 2 association with" GENE=KCNJ11]; 	COSM3765554	470	535					KCNJ11 (inh=n/a pLI=0.31)
chr11	17410136	17410136	A	G	het		QUAL=619;DP=57;AF=0.51;MQM=55;TRIO=HET,57,0.51,WT,24,0.00,HET,39,0.18	KCNJ11	5'UTR,intron	KCNJ11:NM_000525.3:5'UTR:MODIFIER:exon1/1:c.-498T>C:,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-17+585T>C:	AluSg	rs529946415	0.0030	0.0000	0/0/0	0.0027										0	0					KCNJ11 (inh=n/a pLI=0.31)
chr11	17410145	17410145	A	-	het		QUAL=752;DP=46;AF=0.50;MQM=57;TRIO=HET,46,0.50,HET,19,0.63,WT,31,0.00	KCNJ11	5'UTR,intron	KCNJ11:NM_000525.3:5'UTR:MODIFIER:exon1/1:c.-507delT:,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-17+576delT:	AluSg	rs397808534	0.0000	0.0000	0/0/0	0.2678										31	115					KCNJ11 (inh=n/a pLI=0.31)
chr11	17418477	17418477	C	A	hom		QUAL=12018;DP=118;AF=0.97;MQM=60;TRIO=HOM,118,0.97,HOM,198,0.99,HET,331,0.46	ABCC8	missense	ABCC8:NM_001287174.1:missense:MODERATE:exon33/39:c.4108G>T:p.Ala1370Ser,ABCC8:NM_000352.4:missense:MODERATE:exon33/39:c.4105G>T:p.Ala1369Ser		rs757110	0.7264	0.6430	25565/12982/4579	0.6402	0.1700	T,T	T,T,.	B,.	B,.	600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144996.1 [likely benign]; 	CM004821 [CLASS=DFP MUT=REF PHEN="Enhanced insulin secretion in pregnancy association" GENE=ABCC8]; 		453	532					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17419279	17419279	C	T	het		QUAL=5196;DP=126;AF=0.58;MQM=59;TRIO=HET,126,0.58,WT,131,0.00,HET,218,0.61	ABCC8	synonymous	ABCC8:NM_001287174.1:synonymous:LOW:exon31/39:c.3822G>A:p.Arg1274Arg,ABCC8:NM_000352.4:synonymous:LOW:exon31/39:c.3819G>A:p.Arg1273Arg		rs1799859	0.3910	0.2950	6572/2174/2599	0.2933	0.3110	T				600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144994.2 [other]; 	CM981881 [CLASS=DP MUT=ALT PHEN="Hyperinsulinaemia association with" GENE=ABCC8]; 	COSM3752264	101	464					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17448704	17448704	G	A	het		QUAL=3423;DP=141;AF=0.44;MQM=60;TRIO=HET,141,0.44,HET,225,0.44,WT,340,0.00	ABCC8	splice_region&intron	ABCC8:NM_001287174.1:splice_region&intron:LOW:exon15/38:c.2117-3C>T:,ABCC8:NM_000352.4:splice_region&intron:LOW:exon15/38:c.2117-3C>T:		rs1799854	0.3684	0.4280	11790/6320/135	0.4215						600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144983.2 [other]; 	CS991507 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2 association with" GENE=ABCC8]; 		227	506					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17496516	17496516	A	G	het		QUAL=8988;DP=331;AF=0.50;MQM=59;TRIO=HET,331,0.50,HET,407,0.45,WT,532,0.00	ABCC8	synonymous	ABCC8:NM_001287174.1:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro,ABCC8:NM_000352.4:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro		rs1048099	0.4393	0.4740	13970/8522/818	0.4705						600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144982.2 [other]; 	CM129527 [CLASS=DFP MUT=ALT PHEN="Diabetes mellitus protection against" GENE=ABCC8]; 	COSM3752266	296	551					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17515459	17515459	-	TGTT	hom		QUAL=8861;DP=150;AF=0.94;MQM=59;TRIO=HOM,150,0.94,HOM,71,1.00,HET,81,0.48	USH1C	3'UTR,non_coding_exon	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*419_*420insAACA:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*451_*452insAACA:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*451_*452insAACA:,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon20/20:n.2145_2146insAACA:		rs10649542	0.9453	0.0000	0/0/0	0.8462										219	11					USH1C (inh=AR pLI=0.00)
chr11	17515668	17515668	T	C	het		QUAL=8900;DP=324;AF=0.48;MQM=59;TRIO=HET,324,0.48,HET,430,0.47,WT,575,0.00	USH1C	3'UTR,non_coding_exon	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*211A>G:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*243A>G:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*243A>G:,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon20/20:n.1937A>G:		rs1055581	0.3826	0.0000	0/0/0	0.0713										54	112					USH1C (inh=AR pLI=0.00)
chr11	17515693	17515693	G	A	het		QUAL=9016;DP=324;AF=0.47;MQM=59;TRIO=HET,324,0.47,HET,434,0.48,WT,584,0.00	USH1C	3'UTR,non_coding_exon	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*186C>T:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*218C>T:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*218C>T:,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon20/20:n.1912C>T:		rs1055577	0.3666	0.0000	0/0/0	0.0705										53	112					USH1C (inh=AR pLI=0.00)
chr11	17515833	17515833	A	G	het		QUAL=7290;DP=284;AF=0.52;MQM=59;TRIO=HET,284,0.52,HET,308,0.49,WT,441,0.00	USH1C	3'UTR,non_coding_exon	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*46T>C:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*78T>C:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*78T>C:,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon20/20:n.1772T>C:		rs1055574	0.3704	0.4070	8142/5336/674	0.4005										110	229					USH1C (inh=AR pLI=0.00)
chr11	17519742	17519742	C	G	het	pred_pathogenic_1	QUAL=8770;DP=370;AF=0.48;MQM=59;TRIO=HET,370,0.48,HET,365,0.49,WT,584,0.00	USH1C	missense,non_coding_exon	USH1C:NM_153676.3:missense:MODERATE:exon24/27:c.2457G>C:p.Glu819Asp,USH1C:NM_001297764.1:missense:MODERATE:exon18/20:c.1500G>C:p.Glu500Asp,USH1C:NM_005709.3:missense:MODERATE:exon19/21:c.1557G>C:p.Glu519Asp,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon18/20:n.1592G>C:		rs1064074	0.4209	0.4870	14857/10035/925	0.4840	0.6000	T	T,T,D,D	B,B,B	B,B,B	605242 [USH1C (confirmed) Usher syndrome,type 1C|Deafness,autosomal recessive 18A];	RCV000041279.2 [benign]; 		COSM3736036, COSM3736035	325	519					USH1C (inh=AR pLI=0.00)
chr11	17542439	17542439	T	C	hom		QUAL=20959;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HET,255,0.51,HOM,348,0.99	USH1C	synonymous,non_coding_exon	USH1C:NM_153676.3:synonymous:LOW:exon14/27:c.1188A>G:p.Pro396Pro,USH1C:NM_001297764.1:synonymous:LOW:exon13/20:c.1131A>G:p.Pro377Pro,USH1C:NM_005709.3:synonymous:LOW:exon14/21:c.1188A>G:p.Pro396Pro,USH1C:NR_123738.1:non_coding_exon:MODIFIER:exon14/20:n.1297A>G:		rs2240487	0.5164	0.5690	20210/11477/602	0.5607						605242 [USH1C (confirmed) Usher syndrome,type 1C|Deafness,autosomal recessive 18A];	RCV000041251.2 [benign]; 		COSM4145600, COSM4145599	347	551					USH1C (inh=AR pLI=0.00)
chr11	22214877	22214877	-	AGGAGGAGGGGAATGAGGAGGAGG	het		QUAL=6989;DP=78;AF=0.28;MQM=59;TRIO=HET,78,0.28,WT,296,0.00,HOM,251,0.96	ANO5	5'UTR	ANO5:NM_213599.2:5'UTR:MODIFIER:exon1/22:c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG:,ANO5:NM_001142649.1:5'UTR:MODIFIER:exon1/22:c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG:	GA-rich	rs139514865;rs71034576	0.7814	0.0000	0/0/0	0.3097										183	111					ANO5 (inh=n/a pLI=0.00)
chr11	22214903	22214903	G	C	het		QUAL=9448;DP=67;AF=0.45;MQM=59;TRIO=HET,67,0.45,WT,289,0.00,HOM,299,1.00	ANO5	5'UTR	ANO5:NM_213599.2:5'UTR:MODIFIER:exon1/22:c.-136G>C:,ANO5:NM_001142649.1:5'UTR:MODIFIER:exon1/22:c.-136G>C:	GA-rich	rs12792259	0.7899	0.0000	0/0/0	0.0890							RCV000128763.1 [not provided]; 			223	81					ANO5 (inh=n/a pLI=0.00)
chr11	22242729	22242729	T	C	het		QUAL=13430;DP=368;AF=0.57;MQM=60;TRIO=HET,368,0.57,WT,203,0.01,HOM,230,1.00	ANO5	synonymous	ANO5:NM_213599.2:synonymous:LOW:exon5/22:c.267T>C:p.Asp89Asp,ANO5:NM_001142649.1:synonymous:LOW:exon5/22:c.264T>C:p.Asp88Asp		rs4312063	0.7899	0.7760	37046/21355/4526	0.7670						608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia|Muscular dystrophy,limb-girdle,type 2L|Miyoshi muscular dystrophy 3];	RCV000082848.6 [benign]; RCV000128783.1 [not provided]; 		COSM3998372	722	343					ANO5 (inh=n/a pLI=0.00)
chr11	22271870	22271870	A	T	het		QUAL=7567;DP=188;AF=0.46;MQM=60;TRIO=HET,188,0.46,WT,146,0.00,HOM,161,0.99	ANO5	missense	ANO5:NM_213599.2:missense:MODERATE:exon10/22:c.966A>T:p.Leu322Phe,ANO5:NM_001142649.1:missense:MODERATE:exon10/22:c.963A>T:p.Leu321Phe		rs7481951	0.0000	0.4800	15551/11314/142	0.4645	-0.0010	T	T	B	B	608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia|Muscular dystrophy,limb-girdle,type 2L|Miyoshi muscular dystrophy 3];	RCV000082855.6 [benign]; RCV000128791.1 [not provided]; 		COSM3998373	378	512					ANO5 (inh=n/a pLI=0.00)
chr11	22301411	22301412	TT	-	hom		QUAL=3247;DP=131;AF=0.37;MQM=59;TRIO=HOM,131,0.37,WT,33,0.88,HOM,51,0.02	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*112_*113delTT:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*112_*113delTT:	(T)n	rs398015551;rs67178076	0.0000	0.0000	0/0/0	0.2375										117	106					ANO5 (inh=n/a pLI=0.00)
chr11	22301807	22301807	A	G	het		QUAL=11079;DP=321;AF=0.55;MQM=60;TRIO=HET,321,0.55,WT,136,0.00,HOM,182,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*496A>G:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*496A>G:		rs10766930	0.4441	0.0000	0/0/0	0.0929										90	113					ANO5 (inh=n/a pLI=0.00)
chr11	22302597	22302597	G	T	het		QUAL=7443;DP=223;AF=0.47;MQM=60;TRIO=HET,223,0.47,WT,116,0.01,HOM,144,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1286G>T:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1286G>T:		rs7925081	0.5675	0.0000	0/0/0	0.0982										93	108					ANO5 (inh=n/a pLI=0.00)
chr11	22303068	22303068	A	-	het		QUAL=12520;DP=245;AF=0.49;MQM=60;TRIO=HET,245,0.49,WT,226,0.00,HOM,303,0.99	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1762delA:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1762delA:		rs398015552	0.4702	0.0000	0/0/0	0.5224										89	113					ANO5 (inh=n/a pLI=0.00)
chr11	22303201	22303204	AAGA	-	het		QUAL=13829;DP=277;AF=0.55;MQM=59;TRIO=HET,277,0.55,WT,226,0.00,HOM,322,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1894_*1897delAAGA:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1894_*1897delAAGA:		rs397786204	0.4527	0.0000	0/0/0	0.5201										89	113					ANO5 (inh=n/a pLI=0.00)
chr11	22303406	22303406	G	A	het		QUAL=8189;DP=398;AF=0.51;MQM=60;TRIO=HET,398,0.51,HOM,76,1.00,WT,119,0.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*2095G>A:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*2095G>A:		rs142192440	0.0052	0.0000	0/0/0	0.0021										1	8					ANO5 (inh=n/a pLI=0.00)
chr11	22304489	22304489	C	G	het		QUAL=7759;DP=219;AF=0.49;MQM=60;TRIO=HET,219,0.49,WT,94,0.00,HOM,148,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*3178C>G:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*3178C>G:		rs6483841	0.6929	0.0000	0/0/0	0.1099										104	101					ANO5 (inh=n/a pLI=0.00)
chr11	22644893	22644893	-	T	hom		QUAL=7748;DP=181;AF=0.99;MQM=59;TRIO=HOM,181,0.99,HOM,31,1.00,HOM,28,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*1338dupA:		rs397727091;rs45554234	0.0000	0.0000	0/0/0	0.6714										227	3					FANCF (inh=n/a pLI=0.00)
chr11	22645413	22645413	G	A	hom		QUAL=5736;DP=101;AF=0.92;MQM=59;TRIO=HOM,101,0.92,HOM,55,1.00,HOM,64,0.98	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*819C>T:	AluSx3	rs450946	0.9491	0.0000	0/0/0	0.8624										191	2					FANCF (inh=n/a pLI=0.00)
chr11	22645600	22645600	C	T	hom		QUAL=9065;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,46,1.00,HOM,63,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*632G>A:		rs444923	0.9714	0.0000	0/0/0	0.1482										230	0					FANCF (inh=n/a pLI=0.00)
chr11	22646025	22646025	G	A	hom		QUAL=26262;DP=383;AF=0.99;MQM=59;TRIO=HOM,383,0.99,HOM,194,1.00,HOM,215,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*207C>T:		rs4447177	0.7037	0.0000	0/0/0	0.1364										153	63					FANCF (inh=n/a pLI=0.00)
chr11	30352473	30352473	-	AG	hom		QUAL=13795;DP=217;AF=0.99;MQM=59;TRIO=HOM,217,0.99,HOM,105,0.99,HOM,131,0.99	ARL14EP	5'UTR	ARL14EP:NM_152316.2:5'UTR:MODIFIER:exon2/4:c.-23_-22insAG:		rs35824273	0.0000	0.6860	28383/13960/3255	0.6156										209	217					ARL14EP (inh=n/a pLI=0.15)
chr11	30358475	30358475	A	T	hom		QUAL=19051;DP=316;AF=1.00;MQM=59;TRIO=HOM,316,1.00,HOM,128,1.00,HOM,135,1.00	ARL14EP	3'UTR	ARL14EP:NM_152316.2:3'UTR:MODIFIER:exon4/4:c.*133A>T:		rs1222206	1.0000	0.0000	0/0/0	0.1496										227	3					ARL14EP (inh=n/a pLI=0.15)
chr11	31807524	31807524	C	T	hom		QUAL=19723;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,133,1.00,HOM,182,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*3958G>A:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*3958G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3958G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3958G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3958G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3958G>A:		rs3026401	0.6432	0.0000	0/0/0	0.1198										152	94					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808235	31808235	-	AAAA	hom		QUAL=16640;DP=196;AF=0.98;MQM=59;TRIO=HOM,196,0.98,HOM,141,0.98,HOM,183,0.99	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*3246_*3247insTTTT:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*3246_*3247insTTTT:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3246_*3247insTTTT:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:		rs34919147;rs397768344	0.4946	0.0000	0/0/0	0.6047										143	101					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808280	31808280	C	T	hom		QUAL=18260;DP=226;AF=1.00;MQM=59;TRIO=HOM,226,1.00,HOM,150,1.00,HOM,184,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*3202G>A:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*3202G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3202G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3202G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3202G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3202G>A:		rs608293	0.8498	0.0000	0/0/0	0.1407										191	66					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808585	31808585	-	AAAT	hom		QUAL=15487;DP=224;AF=1.00;MQM=59;TRIO=HOM,224,1.00,HOM,108,1.00,HOM,151,0.99	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*2893_*2896dupATTT:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*2893_*2896dupATTT:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2893_*2896dupATTT:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:	(ATAA)n	rs10623053;rs397795797	0.8478	0.0000	0/0/0	0.7499										187	64					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808775	31808775	G	A	het		QUAL=11224;DP=299;AF=0.50;MQM=59;TRIO=HET,299,0.50,HOM,246,0.99,WT,285,0.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*2707C>T:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*2707C>T:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2707C>T:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2707C>T:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2707C>T:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2707C>T:		rs3026398	0.1540	0.0000	0/0/0	0.2145										18	98					PAX6 (inh=AR+AD pLI=1.00)
chr11	31809322	31809322	C	T	het		QUAL=10656;DP=276;AF=0.53;MQM=60;TRIO=HET,276,0.53,WT,166,0.01,HOM,208,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*2160G>A:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*2160G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2160G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2160G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2160G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2160G>A:		rs12421026	0.4479	0.0000	0/0/0	0.0806										63	133					PAX6 (inh=AR+AD pLI=1.00)
chr11	31810298	31810298	T	A	hom		QUAL=28875;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HOM,201,1.00,HOM,281,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001310160.1:3'UTR:MODIFIER:exon10/10:c.*1184A>T:,PAX6:NM_001310161.1:3'UTR:MODIFIER:exon11/11:c.*1184A>T:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*1184A>T:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*1184A>T:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*1184A>T:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001310158.1:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*1184A>T:		rs1506	0.6609	0.0000	0/0/0	0.1493										153	91					PAX6 (inh=AR+AD pLI=1.00)
chr11	32456298	32456298	G	A	het		QUAL=2439;DP=75;AF=0.36;MQM=60;TRIO=HET,75,0.36,HET,170,0.49,WT,234,0.00	WT1	synonymous	WT1:NM_024426.4:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn,WT1:NM_000378.4:synonymous:LOW:exon1/9:c.594C>T:p.Asn198Asn,WT1:NM_024424.3:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn		rs2234583	0.1212	0.0780	598/148/366	0.0765						607102 [WT1 (confirmed) Wilms tumor,type 1|Denys-Drash syndrome|Nephrotic syndrome,type 4|Frasier syndrome|Meacham syndrome|Mesothelioma,somatic];				13	198					WT1 (inh=n/a pLI=n/a)
chr11	32456694	32456694	C	A	het	low_DP	QUAL=193;DP=9;AF=0.67;MQM=60;TRIO=HET,9,0.67,HET,11,0.55,WT,11,0.00	WT1	synonymous	WT1:NM_024426.4:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro,WT1:NM_000378.4:synonymous:LOW:exon1/9:c.198G>T:p.Pro66Pro,WT1:NM_024424.3:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro		rs2234582	0.3017	0.1270	520/108/51	0.1000						607102 [WT1 (confirmed) Wilms tumor,type 1|Denys-Drash syndrome|Nephrotic syndrome,type 4|Frasier syndrome|Meacham syndrome|Mesothelioma,somatic];			COSM4145655	82	345					WT1 (inh=n/a pLI=n/a)
chr11	33724780	33724780	T	C	hom		QUAL=18464;DP=359;AF=0.99;MQM=59;TRIO=HOM,359,0.99,HET,218,0.50,HET,293,0.51	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*6892A>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*6892A>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*6892A>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*6892A>G:		rs704697	0.5096	0.0000	0/0/0	0.5102										65	120					CD59 (inh=n/a pLI=0.07)
chr11	33724992	33724992	T	C	hom		QUAL=16971;DP=334;AF=0.98;MQM=59;TRIO=HOM,334,0.98,HET,222,0.50,HET,290,0.48	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*6680A>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*6680A>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*6680A>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*6680A>G:		rs1047581	0.2103	0.0000	0/0/0	0.2332										22	100					CD59 (inh=n/a pLI=0.07)
chr11	33726222	33726222	G	A	hom		QUAL=18874;DP=381;AF=0.99;MQM=60;TRIO=HOM,381,0.99,HET,248,0.49,HET,312,0.52	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5450C>T:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5450C>T:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5450C>T:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5450C>T:	MIR	rs1546727	0.1589	0.0000	0/0/0	0.2172										23	93					CD59 (inh=n/a pLI=0.07)
chr11	33726290	33726290	C	A	hom		QUAL=12935;DP=241;AF=0.98;MQM=59;TRIO=HOM,241,0.98,HET,209,0.50,HET,266,0.51	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5382G>T:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5382G>T:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5382G>T:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5382G>T:		rs36093484	0.1863	0.0000	0/0/0	0.0386										23	97					CD59 (inh=n/a pLI=0.07)
chr11	33726544	33726544	C	G	hom		QUAL=12829;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HET,144,0.49,HET,177,0.53	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5128G>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5128G>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5128G>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5128G>C:		rs12364970	0.1571	0.0000	0/0/0	0.2167										23	97					CD59 (inh=n/a pLI=0.07)
chr11	33726980	33726980	A	G	hom		QUAL=22961;DP=345;AF=0.99;MQM=59;TRIO=HOM,345,0.99,HOM,233,0.99,HET,337,0.51	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*4692T>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*4692T>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*4692T>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*4692T>C:		rs7046	0.6410	0.0000	0/0/0	0.5832										82	110					CD59 (inh=n/a pLI=0.07)
chr11	33728614	33728614	T	G	hom		QUAL=15620;DP=358;AF=0.99;MQM=60;TRIO=HOM,358,0.99,HET,146,0.48,HET,199,0.44	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*3058A>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*3058A>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*3058A>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*3058A>C:		rs831618	0.5092	0.0000	0/0/0	0.5107										66	119					CD59 (inh=n/a pLI=0.07)
chr11	33730060	33730060	A	C	hom		QUAL=4099;DP=95;AF=0.98;MQM=60;TRIO=HOM,95,0.98,HET,46,0.70,HET,50,0.50	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*1612T>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*1612T>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*1612T>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*1612T>G:		rs11032350	0.1583	0.0000	0/0/0	0.2163										23	92					CD59 (inh=n/a pLI=0.07)
chr11	33730261	33730261	G	T	hom		QUAL=13859;DP=198;AF=0.98;MQM=59;TRIO=HOM,198,0.98,HET,243,0.58,HET,318,0.47	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*1411C>A:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*1411C>A:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*1411C>A:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*1411C>A:		rs7357	0.1867	0.0000	0/0/0	0.2249										23	98					CD59 (inh=n/a pLI=0.07)
chr11	33731406	33731406	C	T	hom		QUAL=13732;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HET,169,0.47,HET,215,0.48	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*266G>A:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*266G>A:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*266G>A:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*266G>A:		rs842	0.1863	0.0000	0/0/0	0.0382										23	99					CD59 (inh=n/a pLI=0.07)
chr11	33757941	33757941	A	G	hom		QUAL=4502;DP=33;AF=0.97;MQM=60;TRIO=HOM,33,0.97,HOM,77,1.00,HET,106,0.53	CD59	5'UTR_premature_start_codon_gain,5'UTR	CD59:NM_000611.5:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-32T>C:,CD59:NM_203329.2:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-148T>C:,CD59:NM_203330.2:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-193T>C:,CD59:NM_203331.2:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-77T>C:,CD59:NM_000611.5:5'UTR:MODIFIER:exon1/4:c.-32T>C:,CD59:NM_203329.2:5'UTR:MODIFIER:exon1/5:c.-148T>C:,CD59:NM_203330.2:5'UTR:MODIFIER:exon1/6:c.-193T>C:,CD59:NM_203331.2:5'UTR:MODIFIER:exon1/5:c.-77T>C:		rs13614	0.6468	0.0000	0/0/0	0.5768										93	112					CD59 (inh=n/a pLI=0.07)
chr11	34937697	34937697	T	C	hom		QUAL=2015;DP=29;AF=0.38;MQM=59;TRIO=HOM,29,0.93,HET,41,0.56,HOM,35,1.00	PDHX,APIP	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-506T>C:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-222T>C:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-506T>C:,APIP:NM_015957.3:intron:MODIFIER:exon1/6:c.57+78A>G:		rs2016814	0.7722	0.0000	0/0/0	0.1449										133	79					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34937698	34937698	G	A	het		QUAL=2015;DP=29;AF=0.38;MQM=59;TRIO=HET,29,0.93,WT,41,0.56,HOM,35,1.00	PDHX,APIP	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-505G>A:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-221G>A:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-505G>A:,APIP:NM_015957.3:intron:MODIFIER:exon1/6:c.57+77C>T:		rs16926448	0.1927	0.0000	0/0/0	0.0157										9	37					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34937901	34937901	A	G	hom		QUAL=3895;DP=46;AF=0.96;MQM=59;TRIO=HOM,46,0.96,HET,56,0.52,HOM,65,1.00	PDHX,APIP	5'UTR_premature_start_codon_gain,5'UTR	PDHX:NM_003477.2:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-302A>G:,PDHX:NM_001135024.1:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-18A>G:,PDHX:NM_001166158.1:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-302A>G:,APIP:NM_015957.3:5'UTR:MODIFIER:exon1/7:c.-70T>C:,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-302A>G:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-18A>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-302A>G:		rs2956112	0.7626	0.7510	20446/11997/1396	0.6960										944	461					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34938001	34938001	A	G	het	low_DP	QUAL=1138;DP=19;AF=0.58;MQM=59;TRIO=HET,19,0.58,WT,17,0.00,HOM,30,1.00	PDHX	missense,5'UTR	PDHX:NM_001135024.1:missense:MODERATE:exon1/11:c.83A>G:p.Glu28Gly,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-202A>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-202A>G:		rs113073242	0.1927	0.0410	33/1/30	0.0397	0.1540	T	T	B	B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM3749158	48	460					PDHX (inh=AR pLI=0.00)
chr11	34938072	34938074	GGC	-	het		QUAL=1634;DP=23;AF=0.43;MQM=59;TRIO=HET,23,1.00,WT,19,0.37,HOM,46,1.00	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-129_-127delCGG:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-129_-127delCGG:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+41_115+43delCGG:		rs371074122	0.0000	0.0480	57/6/43	0.0409						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				15	97					PDHX (inh=AR pLI=0.00)
chr11	34938074	34938074	C	T	het		QUAL=1634;DP=23;AF=0.43;MQM=60;TRIO=HET,23,1.00,HET,19,0.37,WT,46,1.00	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-129C>T:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-129C>T:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+41C>T:		rs112032820	0.1206	0.0980	74/62/4	0.0777						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				44	173					PDHX (inh=AR pLI=0.00)
chr11	34938079	34938079	G	C	het		QUAL=1246;DP=37;AF=0.46;MQM=59;TRIO=HET,37,0.46,WT,27,0.00,HOM,44,0.98	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-124G>C:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-124G>C:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+46G>C:		rs375130125	0.1925	0.0420	66/9/49	0.0388						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				14	94					PDHX (inh=AR pLI=0.00)
chr11	34938115	34938115	C	A	het		QUAL=1929;DP=131;AF=0.47;MQM=60;TRIO=HET,131,0.47,HET,65,0.49,WT,87,0.02	PDHX	5'UTR_premature_start_codon_gain,5'UTR,intron	PDHX:NM_003477.2:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-88C>A:,PDHX:NM_001166158.1:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-88C>A:,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-88C>A:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-88C>A:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+82C>A:		rs2956110	0.5719	0.0000	0/0/0	0.6381						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				125	154					PDHX (inh=AR pLI=0.00)
chr11	34938199	34938199	C	G	het		QUAL=6751;DP=108;AF=0.66;MQM=59;TRIO=HET,108,0.66,WT,124,0.00,HOM,175,0.99	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-4C>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-4C>G:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+166C>G:		rs3818401	0.1925	0.1350	1459/449/764	0.1303						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				48	498					PDHX (inh=AR pLI=0.00)
chr11	34938265	34938265	C	T	hom		QUAL=9483;DP=77;AF=0.48;MQM=59;TRIO=HOM,77,0.99,HET,132,0.51,HOM,199,0.99	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon1/11:c.63C>T:p.Pro21Pro,PDHX:NM_001166158.1:synonymous:LOW:exon1/6:c.63C>T:p.Pro21Pro,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+232C>T:		rs2956109	0.7646	0.7710	35869/21045/3058	0.7574						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				1423	706					PDHX (inh=AR pLI=0.00)
chr11	34938269	34938269	C	T	het		QUAL=9483;DP=77;AF=0.48;MQM=60;TRIO=HET,77,0.99,WT,132,0.51,HOM,199,0.99	PDHX	missense,intron	PDHX:NM_003477.2:missense:MODERATE:exon1/11:c.67C>T:p.Arg23Cys,PDHX:NM_001166158.1:missense:MODERATE:exon1/6:c.67C>T:p.Arg23Cys,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+236C>T:		rs1049306	0.1925	0.1340	1438/445/743	0.1285	-0.0800	T	T,T,T	B,B	B,B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				47	502					PDHX (inh=AR pLI=0.00)
chr11	34938310	34938310	T	C	het		QUAL=8801;DP=139;AF=0.52;MQM=59;TRIO=HET,139,0.52,WT,158,0.01,HOM,230,1.00	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon1/11:c.108T>C:p.Ser36Ser,PDHX:NM_001166158.1:synonymous:LOW:exon1/6:c.108T>C:p.Ser36Ser,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+277T>C:		rs1049307	0.1927	0.1300	1207/357/631	0.1257						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				47	503					PDHX (inh=AR pLI=0.00)
chr11	34969112	34969112	A	G	het	phylop_high;pred_pathogenic_2	QUAL=5287;DP=233;AF=0.48;MQM=60;TRIO=HET,233,0.48,HET,163,0.53,WT,244,0.00	PDHX	missense	PDHX:NM_003477.2:missense:MODERATE:exon3/11:c.301A>G:p.Thr101Ala,PDHX:NM_001135024.1:missense:MODERATE:exon3/11:c.256A>G:p.Thr86Ala,PDHX:NM_001166158.1:missense:MODERATE:exon3/6:c.301A>G:p.Thr101Ala		rs11539202	0.1088	0.2200	3654/3176/27	0.2211	8.1290	T	T,T,T,T,T	D,P,B	D,B,B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM3752346	188	896					PDHX (inh=AR pLI=0.00)
chr11	34991727	34991727	T	C	het		QUAL=5750;DP=248;AF=0.50;MQM=60;TRIO=HET,248,0.50,HET,187,0.52,WT,199,0.00	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon7/11:c.858T>C:p.Val286Val,PDHX:NM_001135024.1:synonymous:LOW:exon7/11:c.813T>C:p.Val271Val,PDHX:NM_001166158.1:intron:MODIFIER:exon3/5:c.343-14390T>C:		rs497582	0.5705	0.6430	25844/16343/746	0.6417						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM4145675, COSM4145674	1015	966					PDHX (inh=AR pLI=0.00)
chr11	35017205	35017205	G	T	het		QUAL=7911;DP=357;AF=0.53;MQM=59;TRIO=HET,357,0.53,HET,200,0.49,WT,238,0.00	PDHX	3'UTR	PDHX:NM_003477.2:3'UTR:MODIFIER:exon11/11:c.*486G>T:,PDHX:NM_001135024.1:3'UTR:MODIFIER:exon11/11:c.*486G>T:,PDHX:NM_001166158.1:3'UTR:MODIFIER:exon6/6:c.*486G>T:		rs9326	0.6248	0.0000	0/0/0	0.1338										97	104					PDHX (inh=AR pLI=0.00)
chr11	35017363	35017363	C	A	hom		QUAL=22371;DP=439;AF=1.00;MQM=59;TRIO=HOM,439,1.00,HET,176,0.40,HOM,180,0.99	PDHX	3'UTR	PDHX:NM_003477.2:3'UTR:MODIFIER:exon11/11:c.*644C>A:,PDHX:NM_001135024.1:3'UTR:MODIFIER:exon11/11:c.*644C>A:,PDHX:NM_001166158.1:3'UTR:MODIFIER:exon6/6:c.*644C>A:		rs7808	0.7816	0.0000	0/0/0	0.1556										136	79					PDHX (inh=AR pLI=0.00)
chr11	36595600	36595600	A	G	het	anno_pathogenic_hgmd	QUAL=7408;DP=283;AF=0.51;MQM=59;TRIO=HET,283,0.51,WT,262,0.00,HET,313,0.45	RAG1	missense	RAG1:NM_000448.2:missense:MODERATE:exon2/2:c.746A>G:p.His249Arg		rs3740955	0.6134	0.4470	13935/3540/2722	0.4424	0.1690	T	T,T	B	B	179615 [RAG1 (confirmed) Severe combined immunodeficiency,B cell-negative|Omenn syndrome, 603554|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion,severe cytomegalovirus infection,and autoimmunity|Combined cellular and humoral immune defects with granulomas];	RCV000127709.1 [benign]; 	CM122460 [CLASS=DM? MUT=ALT PHEN="Immunodeficiency severe combined" GENE=RAG1]; 		171	509	2	[2] old entry - no details available			RAG1 (inh=n/a pLI=0.00)
chr11	36601170	36601170	G	A	het		QUAL=2486;DP=171;AF=0.44;MQM=59;TRIO=HET,171,0.44,WT,30,0.00,HET,51,0.49	RAG1	3'UTR	RAG1:NM_000448.2:3'UTR:MODIFIER:exon2/2:c.*3184G>A:		rs1056403	0.6126	0.0000	0/0/0	0.0800										35	108					RAG1 (inh=n/a pLI=0.00)
chr11	36613807	36613807	T	C	het		QUAL=4907;DP=211;AF=0.52;MQM=60;TRIO=HET,211,0.52,WT,115,0.00,HET,130,0.55	RAG2	3'UTR	RAG2:NM_000536.3:3'UTR:MODIFIER:exon2/2:c.*328A>G:,RAG2:NM_001243785.1:3'UTR:MODIFIER:exon3/3:c.*328A>G:,RAG2:NM_001243786.1:3'UTR:MODIFIER:exon3/3:c.*328A>G:		rs10836573	0.6132	0.0000	0/0/0	0.0765										33	110					RAG2 (inh=n/a pLI=0.01)
chr11	44117102	44117102	T	C	het		QUAL=12731;DP=443;AF=0.57;MQM=60;TRIO=HET,443,0.57,HOM,206,0.99,WT,291,0.00	EXT2	5'UTR	EXT2:NM_001178083.1:5'UTR:MODIFIER:exon1/15:c.-331T>C:,EXT2:NM_207122.1:5'UTR:MODIFIER:exon1/14:c.-331T>C:		rs10458911	0.3061	0.0000	0/0/0	0.3302						608210 [EXT2 (confirmed) Exostoses,multiple,type 2];				18	77					EXT2 (inh=AD pLI=0.00)
chr11	44117122	44117122	G	A	hom		QUAL=20974;DP=400;AF=0.99;MQM=59;TRIO=HOM,400,0.99,HOM,202,1.00,HET,292,0.51	EXT2	5'UTR	EXT2:NM_001178083.1:5'UTR:MODIFIER:exon1/15:c.-311G>A:,EXT2:NM_207122.1:5'UTR:MODIFIER:exon1/14:c.-311G>A:		rs3923808	0.5208	0.0000	0/0/0	0.5873						608210 [EXT2 (confirmed) Exostoses,multiple,type 2];				69	104					EXT2 (inh=AD pLI=0.00)
chr11	44283297	44283297	T	C	hom		QUAL=43895;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,450,1.00,HOM,605,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*3107A>G:		rs4755239	0.9073	0.0000	0/0/0	0.8343										181	44					ALX4 (inh=n/a pLI=0.23)
chr11	44283722	44283722	G	A	het		QUAL=20423;DP=295;AF=0.52;MQM=59;TRIO=HET,295,0.52,HOM,353,1.00,HET,435,0.48	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*2682C>T:		rs897005	0.7326	0.0000	0/0/0	0.7134										98	108					ALX4 (inh=n/a pLI=0.23)
chr11	44284294	44284294	T	C	hom		QUAL=17791;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,115,1.00,HOM,148,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*2110A>G:		rs7105993	0.9918	0.0000	0/0/0	0.1493										230	0					ALX4 (inh=n/a pLI=0.23)
chr11	44285857	44285857	T	C	hom		QUAL=21833;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,258,1.00,HOM,315,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*547A>G:		rs4755796	0.8848	0.0000	0/0/0	0.1409										149	73					ALX4 (inh=n/a pLI=0.23)
chr11	44285887	44285887	G	A	hom		QUAL=23222;DP=159;AF=0.99;MQM=59;TRIO=HOM,159,0.99,HOM,263,1.00,HOM,324,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*517C>T:		rs4755797	0.7560	0.0000	0/0/0	0.1285										116	93					ALX4 (inh=n/a pLI=0.23)
chr11	44286176	44286176	G	A	hom		QUAL=6206;DP=80;AF=0.99;MQM=59;TRIO=HOM,80,0.99,HET,142,0.46,HET,177,0.56	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*228C>T:		rs4755798	0.1991	0.0000	0/0/0	0.0388										14	92					ALX4 (inh=n/a pLI=0.23)
chr11	44289071	44289071	G	A	hom		QUAL=8111;DP=125;AF=0.99;MQM=60;TRIO=HOM,125,0.99,HET,135,0.50,HET,195,0.55	ALX4	synonymous	ALX4:NM_021926.3:synonymous:LOW:exon3/4:c.879C>T:p.Leu293Leu		rs12419361	0.1036	0.1100	752/394/17	0.1091						605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];				24	227					ALX4 (inh=n/a pLI=0.23)
chr11	44297054	44297054	T	C	hom		QUAL=8585;DP=59;AF=1.00;MQM=60;TRIO=HOM,59,1.00,HOM,107,1.00,HOM,110,1.00	ALX4	synonymous	ALX4:NM_021926.3:synonymous:LOW:exon2/4:c.621A>G:p.Ser207Ser		rs10769028	0.9916	0.9980	60402/33362/4920	0.9690						605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM4145711	1106	1					ALX4 (inh=n/a pLI=0.23)
chr11	44331309	44331309	G	A	het	low_DP;pred_pathogenic_1	QUAL=1705;DP=5;AF=0.40;MQM=60;TRIO=HET,5,0.40,HET,63,0.44,HET,90,0.56	ALX4	missense	ALX4:NM_021926.3:missense:MODERATE:exon1/4:c.304C>T:p.Pro102Ser	(GCGGCT)n	rs12421995	0.3720	0.4000	2981/913/8	0.2672		T	D	B	B	605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM3749161	224	506					ALX4 (inh=n/a pLI=0.23)
chr11	44331509	44331509	C	G	het	phylop_high;pred_pathogenic_1	QUAL=5741;DP=58;AF=0.50;MQM=60;TRIO=HET,58,0.50,HET,185,0.53,HET,239,0.45	ALX4	missense	ALX4:NM_021926.3:missense:MODERATE:exon1/4:c.104G>C:p.Arg35Thr		rs3824915	0.4726	0.4820	11196/5385/291	0.4588	5.2690	T	D	B	B	605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM3752366	286	547					ALX4 (inh=n/a pLI=0.23)
chr11	45832935	45832935	G	A	hom		QUAL=15267;DP=186;AF=0.99;MQM=59;TRIO=HOM,186,0.99,HET,292,0.55,HET,427,0.56	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*49G>A:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*49G>A:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*49G>A:		rs1139266	0.4513	0.5570	2211/1758/25	0.4493										183	133					SLC35C1 (inh=AR pLI=0.15)
chr11	45834044	45834044	C	T	hom		QUAL=18675;DP=206;AF=0.98;MQM=60;TRIO=HOM,206,0.98,HOM,188,1.00,HOM,220,1.00	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*1158C>T:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*1158C>T:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*1158C>T:	MLT1A0	rs4756027	0.7206	0.0000	0/0/0	0.1347										283	92					SLC35C1 (inh=AR pLI=0.15)
chr11	45834198	45834198	T	C	hom		QUAL=18808;DP=235;AF=0.99;MQM=59;TRIO=HOM,235,0.99,HOM,157,1.00,HOM,210,1.00	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*1312T>C:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*1312T>C:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*1312T>C:	MLT1A0	rs7943306	0.6538	0.7480	3296/1095/39	0.1954										440	159					SLC35C1 (inh=AR pLI=0.15)
chr11	45931502	45931502	G	A	hom		QUAL=19327;DP=177;AF=0.98;MQM=60;TRIO=HOM,177,0.98,HET,248,0.48,HOM,361,1.00	PEX16	3'UTR	PEX16:NM_057174.2:3'UTR:MODIFIER:exon11/11:c.*138C>T:,PEX16:NM_004813.2:3'UTR:MODIFIER:exon11/11:c.*303C>T:		rs10838529	0.3936	0.0000	0/0/0	0.0961										117	83					PEX16 (inh=n/a pLI=0.00)
chr11	45935384	45935384	A	G	hom		QUAL=21005;DP=184;AF=1.00;MQM=59;TRIO=HOM,184,1.00,HET,255,0.46,HOM,393,1.00	PEX16	synonymous	PEX16:NM_057174.2:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr,PEX16:NM_004813.2:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr		rs1132349	0.6891	0.8150	42019/27922/1802	0.8018						603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A,(Zellweger)|Peroxisome biogenesis disorder 8B];			COSM4145722, COSM4145721	862	223					PEX16 (inh=n/a pLI=0.00)
chr11	45937267	45937267	C	T	hom	phylop_high	QUAL=30239;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,304,1.00,HOM,451,1.00	PEX16	missense	PEX16:NM_057174.2:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile,PEX16:NM_004813.2:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile		rs10742772	1.0000	1.0000	60695/33362/5202	0.9362	3.7850	T	T,T,T,T	B,B	B,B	603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A,(Zellweger)|Peroxisome biogenesis disorder 8B];				1107	0					PEX16 (inh=n/a pLI=0.00)
chr11	47238522	47238522	T	C	hom		QUAL=1242;DP=20;AF=1.00;MQM=60;TRIO=HOM,20,1.00,HOM,10,1.00,HOM,10,1.00	DDB2	synonymous	DDB2:NM_000107.2:synonymous:LOW:exon3/10:c.378T>C:p.Thr126Thr,DDB2:NM_001300734.1:synonymous:LOW:exon3/6:c.378T>C:p.Thr126Thr		rs326212	0.9942	0.9990	60550/33369/5055	0.9443						600811 [DDB2 (provisional) Xeroderma pigmentosum,group E,DDB-negative subtype];				2464	1					DDB2 (inh=n/a pLI=0.01)
chr11	47460306	47460306	A	G	hom	low_DP	QUAL=1604;DP=17;AF=1.00;MQM=60;TRIO=HOM,17,1.00,HET,21,0.57,HOM,28,1.00	RAPSN	synonymous	RAPSN:NM_005055.4:synonymous:LOW:exon7/8:c.1143T>C:p.Pro381Pro,RAPSN:NM_032645.4:synonymous:LOW:exon5/6:c.966T>C:p.Pro322Pro		rs7126210	0.6248	0.6110	10399/5850/425	0.5710						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000118117.2 [likely benign]; 		COSM3931321	596	421					RAPSN (inh=n/a pLI=0.03)
chr11	47463484	47463484	G	-	hom		QUAL=2246;DP=23;AF=1.00;MQM=59;TRIO=HOM,23,1.00,HET,49,0.29,HOM,53,1.00	RAPSN	splice_region&intron	RAPSN:NM_005055.4:splice_region&intron:LOW:exon3/7:c.691-11delC:,RAPSN:NM_032645.4:splice_region&intron:LOW:exon3/5:c.691-11delC:		rs397825047	0.6108	0.6280	10475/5999/322	0.5567						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000178237.1 [benign]; 			549	350					RAPSN (inh=n/a pLI=0.03)
chr11	47469439	47469439	A	G	hom		QUAL=29279;DP=289;AF=1.00;MQM=59;TRIO=HOM,289,1.00,HET,422,0.45,HOM,522,1.00	RAPSN	synonymous	RAPSN:NM_005055.4:synonymous:LOW:exon2/8:c.456T>C:p.Tyr152Tyr,RAPSN:NM_032645.4:synonymous:LOW:exon2/6:c.456T>C:p.Tyr152Tyr		rs7111873	0.6256	0.6790	27963/16859/899	0.6731						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000118119.2 [likely benign]; 			601	422					RAPSN (inh=n/a pLI=0.03)
chr11	60236272	60236272	A	G	het		QUAL=13559;DP=347;AF=0.54;MQM=60;TRIO=HET,347,0.54,HOM,268,1.00,WT,327,0.01	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*331A>G:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*331A>G:		rs1051756	0.6380	0.0000	0/0/0	0.0994										81	109					MS4A1 (inh=n/a pLI=0.02)
chr11	60237234	60237234	T	C	het		QUAL=4996;DP=239;AF=0.51;MQM=60;TRIO=HET,239,0.51,HET,141,0.50,WT,187,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*1293T>C:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*1293T>C:		rs1051461	0.2228	0.0000	0/0/0	0.0512										26	104					MS4A1 (inh=n/a pLI=0.02)
chr11	60237991	60237991	T	C	het		QUAL=7828;DP=351;AF=0.52;MQM=60;TRIO=HET,351,0.52,HOM,81,1.00,WT,105,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*2050T>C:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*2050T>C:		rs1051593	0.4756	0.0000	0/0/0	0.0783										56	119					MS4A1 (inh=n/a pLI=0.02)
chr11	60238054	60238054	C	T	het		QUAL=6663;DP=272;AF=0.49;MQM=60;TRIO=HET,272,0.49,HOM,94,1.00,WT,123,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*2113C>T:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*2113C>T:		rs1051594	0.4742	0.0000	0/0/0	0.4566										56	119					MS4A1 (inh=n/a pLI=0.02)
chr11	61165280	61165280	G	A	het		QUAL=4496;DP=136;AF=0.45;MQM=59;TRIO=HET,136,0.45,HET,65,0.43,HOM,82,1.00	TMEM216	synonymous	TMEM216:NM_001173991.2:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:NM_001173990.2:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:NM_016499.5:synonymous:LOW:exon4/5:c.81G>A:p.Pro27Pro		rs3741265	0.8558	0.8650	45445/24981/2828	0.8337						613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];	RCV000114238.2 [likely benign]; 			1732	467					TMEM216 (inh=AR pLI=0.00)
chr11	61165731	61165731	-	A	het	anno_high_impact	QUAL=7846;DP=189;AF=0.54;MQM=59;TRIO=HET,189,0.54,HET,103,0.55,HOM,126,0.99	TMEM216	splice_acceptor,splice_region&intron	TMEM216:NM_001173991.2:splice_acceptor:HIGH:exon4/4:c.432-2_432-1insA:,TMEM216:NM_016499.5:splice_acceptor:HIGH:exon4/4:c.249-2_249-1insA:,TMEM216:NM_001173990.2:splice_region&intron:LOW:exon4/4:c.432-11_432-10insA:		rs11382548	0.8558	0.8580	43189/23691/2710	0.8032						613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];	RCV000154006.3 [benign]; 			1549	421	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			TMEM216 (inh=AR pLI=0.00)
chr11	61165741	61165741	G	C	het	anno_high_impact	QUAL=8618;DP=187;AF=0.55;MQM=59;TRIO=HET,187,0.55,HET,121,0.54,HOM,143,0.99	TMEM216	splice_acceptor,missense	TMEM216:NM_001173990.2:splice_acceptor:HIGH:exon4/4:c.432-1G>C:,TMEM216:NM_001173991.2:missense:MODERATE:exon5/5:c.440G>C:p.Arg147Thr,TMEM216:NM_016499.5:missense:MODERATE:exon5/5:c.257G>C:p.Arg86Thr		rs10897158	0.7196	0.8130	40102/23265/640	0.7371	0.7930	.,T	.,.,T			613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];	RCV000114239.4 [benign]; RCV000200066.2 [benign]; 		COSM1582850	1669	523	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			TMEM216 (inh=AR pLI=0.00)
chr11	61166306	61166306	G	A	het		QUAL=919;DP=112;AF=0.34;MQM=60;TRIO=HET,112,0.34,WT,4,0.00,HOM,7,1.00	TMEM216	3'UTR	TMEM216:NM_001173991.2:3'UTR:MODIFIER:exon5/5:c.*558G>A:,TMEM216:NM_001173990.2:3'UTR:MODIFIER:exon5/5:c.*558G>A:,TMEM216:NM_016499.5:3'UTR:MODIFIER:exon5/5:c.*558G>A:		rs7607	0.7196	0.0000	0/0/0	0.1181										174	48					TMEM216 (inh=AR pLI=0.00)
chr11	61717607	61717607	C	T	het		QUAL=7597;DP=297;AF=0.48;MQM=60;TRIO=HET,297,0.48,WT,349,0.00,HET,395,0.47	BEST1	5'UTR,non_coding_exon	BEST1:NM_001139443.1:5'UTR:MODIFIER:exon1/9:c.-321C>T:,BEST1:NM_001300786.1:5'UTR:MODIFIER:exon1/9:c.-321C>T:,BEST1:NM_001300787.1:5'UTR:MODIFIER:exon1/10:c.-321C>T:,BEST1:NM_004183.3:5'UTR:MODIFIER:exon1/11:c.-329C>T:,BEST1:NR_134580.1:non_coding_exon:MODIFIER:exon1/11:n.252C>T:		rs972354	0.3490	0.0000	0/0/0	0.2440										5	47					BEST1 (inh=n/a pLI=0.00)
chr11	61717715	61717715	T	C	het		QUAL=12101;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,HET,285,0.51,HET,313,0.47	BEST1	5'UTR,non_coding_exon	BEST1:NM_001139443.1:5'UTR:MODIFIER:exon1/9:c.-213T>C:,BEST1:NM_001300786.1:5'UTR:MODIFIER:exon1/9:c.-213T>C:,BEST1:NM_001300787.1:5'UTR:MODIFIER:exon1/10:c.-213T>C:,BEST1:NM_004183.3:5'UTR:MODIFIER:exon1/11:c.-221T>C:,BEST1:NR_134580.1:non_coding_exon:MODIFIER:exon1/11:n.360T>C:		rs972353	0.6793	0.0000	0/0/0	0.4136										31	106					BEST1 (inh=n/a pLI=0.00)
chr11	61719387	61719387	T	C	het		QUAL=462;DP=34;AF=0.50;MQM=60;TRIO=HET,34,0.50,HET,8,0.13,HET,12,0.50	BEST1	synonymous,intron,non_coding_exon	BEST1:NM_004183.3:synonymous:LOW:exon2/11:c.109T>C:p.Leu37Leu,BEST1:NM_001139443.1:intron:MODIFIER:exon1/8:c.-29+1488T>C:,BEST1:NM_001300786.1:intron:MODIFIER:exon1/8:c.-29+1488T>C:,BEST1:NM_001300787.1:intron:MODIFIER:exon1/9:c.-29+1488T>C:,BEST1:NR_134580.1:non_coding_exon:MODIFIER:exon2/11:n.689T>C:		rs1800007	0.6805	0.4850	17100/3272/2778	0.4613						607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2|Bestrophinopathy,autosomal recessive|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];	RCV000086084.1 [not provided]; RCV000152861.3 [benign]; 		COSM3752558	127	482					BEST1 (inh=n/a pLI=0.00)
chr11	61727438	61727438	C	T	het	pred_pathogenic_2	QUAL=6090;DP=244;AF=0.50;MQM=60;TRIO=HET,244,0.50,WT,163,0.01,HET,246,0.50	BEST1	synonymous,non_coding_exon	BEST1:NM_001139443.1:synonymous:LOW:exon8/9:c.843C>T:p.Pro281Pro,BEST1:NM_001300786.1:synonymous:LOW:exon7/9:c.762C>T:p.Pro254Pro,BEST1:NM_001300787.1:synonymous:LOW:exon8/10:c.843C>T:p.Pro281Pro,BEST1:NM_004183.3:synonymous:LOW:exon9/11:c.1023C>T:p.Pro341Pro,BEST1:NR_134580.1:non_coding_exon:MODIFIER:exon9/11:n.1806C>T:		rs1801390	0.0140	0.0220	40/22/7	0.0213	-3.4650	D	D	B,B	B,B	607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2|Bestrophinopathy,autosomal recessive|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];	RCV000086082.1 [not provided]; 			1	52					BEST1 (inh=n/a pLI=0.00)
chr11	61730036	61730036	G	A	het		QUAL=8556;DP=293;AF=0.55;MQM=59;TRIO=HET,293,0.55,HET,213,0.52,HET,252,0.45	BEST1	synonymous,non_coding_exon	BEST1:NM_001139443.1:synonymous:LOW:exon9/9:c.1230G>A:p.Thr410Thr,BEST1:NM_001300786.1:synonymous:LOW:exon8/9:c.1149G>A:p.Thr383Thr,BEST1:NM_001300787.1:synonymous:LOW:exon9/10:c.1230G>A:p.Thr410Thr,BEST1:NM_004183.3:synonymous:LOW:exon10/11:c.1410G>A:p.Thr470Thr,BEST1:NR_134580.1:non_coding_exon:MODIFIER:exon10/11:n.2193G>A:		rs149698	0.1122	0.2270	3986/3382/31	0.2275						607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2|Bestrophinopathy,autosomal recessive|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];	RCV000173795.1 [benign]; 		COSM3752559, COSM3752560	99	448					BEST1 (inh=n/a pLI=0.00)
chr11	63990997	63990997	C	-	het		QUAL=5728;DP=157;AF=0.45;MQM=59;TRIO=HET,157,0.45,HET,172,0.52,HET,240,0.48	FERMT3	3'UTR	FERMT3:NM_178443.2:3'UTR:MODIFIER:exon15/15:c.*35delC:,FERMT3:NM_031471.5:3'UTR:MODIFIER:exon15/15:c.*35delC:		rs5792315	0.0000	0.4440	9066/3303/1610	0.3899										36	111					FERMT3 (inh=n/a pLI=0.26)
chr11	65485727	65485727	T	G	hom		QUAL=30748;DP=387;AF=0.99;MQM=59;TRIO=HOM,387,0.99,HET,348,0.49,HOM,445,0.99	RNASEH2C,KAT5	3'UTR,intron	RNASEH2C:NM_032193.3:3'UTR:MODIFIER:exon4/4:c.*1527A>C:,KAT5:NM_182710.2:intron:MODIFIER:exon10/12:c.1265-334T>G:,KAT5:NM_001206833.1:intron:MODIFIER:exon9/11:c.1109-334T>G:,KAT5:NM_006388.3:intron:MODIFIER:exon11/13:c.1166-334T>G:,KAT5:NM_182709.2:intron:MODIFIER:exon10/12:c.1010-334T>G:		rs521678	0.8249	0.0000	0/0/0	0.1501										194	34					RNASEH2C (inh=n/a pLI=0.51), KAT5 (inh=n/a pLI=0.47)
chr11	65636053	65636053	T	C	hom		QUAL=27488;DP=338;AF=1.00;MQM=59;TRIO=HOM,338,1.00,HOM,245,1.00,HOM,308,1.00	EFEMP2	missense,non_coding_exon	EFEMP2:NM_016938.4:missense:MODERATE:exon8/11:c.775A>G:p.Ile259Val,EFEMP2:NR_037718.1:non_coding_exon:MODIFIER:exon8/12:n.1034A>G:		rs601314	0.8946	0.9690	57465/33186/2374	0.9323	0.5430	T	T,T	B,B	B,B	604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB];	RCV000032273.1 [benign]; RCV000155538.1 [benign]; 			1133	22					EFEMP2 (inh=n/a pLI=0.03)
chr11	65638719	65638719	G	A	hom		QUAL=15870;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HET,266,0.52,HOM,327,1.00	EFEMP2	synonymous,non_coding_exon	EFEMP2:NM_016938.4:synonymous:LOW:exon4/11:c.276C>T:p.His92His,EFEMP2:NR_037718.1:non_coding_exon:MODIFIER:exon4/12:n.535C>T:		rs633800	0.3211	0.4500	13690/8944/130	0.4423						604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB];	RCV000150612.1 [benign]; 		COSM3752644	323	554					EFEMP2 (inh=n/a pLI=0.03)
chr11	66282095	66282095	G	A	het		QUAL=6493;DP=140;AF=0.49;MQM=60;TRIO=HET,140,0.49,WT,96,0.00,HOM,169,1.00	BBS1	synonymous	BBS1:NM_024649.4:synonymous:LOW:exon4/17:c.378G>A:p.Leu126Leu		rs2298806	0.2117	0.2230	3285/1868/79	0.2212	1.1130	T	T			209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];			COSM147274, COSM3998544	49	392					BBS1 (inh=AR pLI=0.00)
chr11	66288733	66288733	G	C	het		QUAL=4205;DP=105;AF=0.52;MQM=60;TRIO=HET,105,0.52,WT,69,0.00,HOM,99,0.98	BBS1	splice_region&intron	BBS1:NM_024649.4:splice_region&intron:LOW:exon8/16:c.724-8G>C:		rs10896125	0.2426	0.2320	3458/1862/251	0.2297						209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];	RCV000082204.4 [benign]; 		COSM3998545, COSM147275	50	394					BBS1 (inh=AR pLI=0.00)
chr11	66297363	66297363	C	T	het		QUAL=11063;DP=206;AF=0.50;MQM=59;TRIO=HET,206,0.50,WT,189,0.00,HOM,274,1.00	BBS1	synonymous	BBS1:NM_024649.4:synonymous:LOW:exon14/17:c.1413C>T:p.Leu471Leu		rs3816492	0.1434	0.2030	2812/1803/11	0.1982						209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];			COSM3752663, COSM3752662	48	386					BBS1 (inh=AR pLI=0.00)
chr11	66299515	66299515	A	G	hom		QUAL=11302;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HET,104,0.54,HOM,155,1.00	BBS1	3'UTR	BBS1:NM_024649.4:3'UTR:MODIFIER:exon17/17:c.*7A>G:		rs8432	0.6128	0.5400	13682/8183/2600	0.5219										377	512					BBS1 (inh=AR pLI=0.00)
chr11	66300348	66300348	A	G	het		QUAL=1902;DP=57;AF=0.49;MQM=60;TRIO=HET,57,0.49,WT,33,0.00,HOM,42,0.98	BBS1	3'UTR	BBS1:NM_024649.4:3'UTR:MODIFIER:exon17/17:c.*840A>G:		rs3741360	0.2358	0.0000	0/0/0	0.2283										9	83					BBS1 (inh=AR pLI=0.00)
chr11	66458980	66458980	G	A	het		QUAL=7340;DP=96;AF=0.57;MQM=59;TRIO=HET,96,0.57,WT,117,0.00,HOM,205,1.00	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon26/37:c.5340C>T:p.Asn1780Asn		rs623022	0.0631	0.0650	366/173/1	0.0627						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];				8	217					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66460527	66460527	C	T	het		QUAL=4377;DP=97;AF=0.60;MQM=59;TRIO=HET,97,0.60,WT,74,0.01,HOM,98,0.98	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon24/37:c.4899G>A:p.Leu1633Leu		rs639938	0.0777	0.0690	378/171/13	0.0666						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];			COSM3998546, COSM3998547	9	219					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66468469	66468469	A	G	het		QUAL=4644;DP=97;AF=0.46;MQM=60;TRIO=HET,97,0.46,WT,128,0.01,HOM,118,0.98	SPTBN2	missense	SPTBN2:NM_006946.2:missense:MODERATE:exon16/37:c.3101T>C:p.Val1034Ala		rs506028	0.2057	0.1310	1312/375/379	0.1284	-0.1020	T	T,T,T	B	B	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];	RCV000118411.2 [likely benign]; 		COSM3752672, COSM3752673	25	432					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66472274	66472274	T	C	hom	phylop_high	QUAL=5420;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,74,1.00,HOM,72,1.00	SPTBN2	missense	SPTBN2:NM_006946.2:missense:MODERATE:exon14/37:c.2473A>G:p.Ser825Gly		rs4930388	0.9878	0.9960	56199/30704/4050	0.9306	2.0170	T	T,T,T	B	B	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];			COSM3752675, COSM3752674	2230	5					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66481633	66481633	G	A	het		QUAL=12361;DP=418;AF=0.53;MQM=60;TRIO=HET,418,0.53,HET,528,0.48,WT,634,0.00	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon6/37:c.585C>T:p.Asn195Asn		rs34775878	0.0407	0.0820	586/514/2	0.0832						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];	RCV000118412.2 [likely benign]; 			33	466					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	67758895	67758895	G	C	het	low_DP;low_MQM	QUAL=247;DP=14;AF=0.71;MQM=43;TRIO=HET,14,0.71,HOM,7,1.00,WT,14,0.00	UNC93B1	3'UTR	UNC93B1:NM_030930.3:3'UTR:MODIFIER:exon11/11:c.*122C>G:		rs7932	0.2302	0.0000	0/0/0	0.1751										17	78					UNC93B1 (inh=n/a pLI=0.51)
chr11	67759254	67759254	G	C	het	low_MQM	QUAL=2164;DP=22;AF=0.27;MQM=35;TRIO=HET,22,0.27,HOM,78,0.99,HET,97,0.24	UNC93B1	synonymous	UNC93B1:NM_030930.3:synonymous:LOW:exon11/11:c.1554C>G:p.Arg518Arg		rs7149	0.2566	0.0130	32/9/6	0.0147						608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1];			COSM1288831	47	258					UNC93B1 (inh=n/a pLI=0.51)
chr11	67765163	67765163	-	G	hom	anno_high_impact	QUAL=14494;DP=74;AF=0.97;MQM=59;TRIO=HOM,74,0.97,HOM,175,1.00,HOM,251,1.00	UNC93B1	frameshift	UNC93B1:NM_030930.3:frameshift:HIGH:exon7/11:c.887dupC:p.Ser297fs		rs11428176;rs5792426	1.0000	1.0000	60061/33107/4866	0.9364						608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1];			COSM1356479	1115	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			UNC93B1 (inh=n/a pLI=0.51)
chr11	67804074	67804074	C	T	het		QUAL=12374;DP=195;AF=0.52;MQM=59;TRIO=HET,195,0.52,HOM,337,1.00,WT,384,0.00	NDUFS8	3'UTR	NDUFS8:NM_002496.3:3'UTR:MODIFIER:exon7/7:c.*14C>T:		rs1051806	0.1699	0.1530	1549/1008/286	0.1557										25	131					NDUFS8 (inh=n/a pLI=0.01)
chr11	67814979	67814979	G	C	hom		QUAL=18974;DP=146;AF=1.00;MQM=59;TRIO=HOM,146,1.00,HOM,199,1.00,HOM,264,1.00	TCIRG1	synonymous	TCIRG1:NM_006019.3:synonymous:LOW:exon11/20:c.1245G>C:p.Leu415Leu,TCIRG1:NM_006053.3:synonymous:LOW:exon6/15:c.597G>C:p.Leu199Leu		rs2471829	0.9698	0.9930	59623/33159/4404	0.9290	0.4660	T				604592 [TCIRG1 (confirmed) Osteopetrosis,autosomal recessive 1];				1101	6					TCIRG1 (inh=n/a pLI=0.00)
chr11	68133035	68133035	T	C	het		QUAL=2030;DP=59;AF=0.58;MQM=57;TRIO=HET,59,0.58,HET,133,0.44,WT,200,0.00	LRP5	splice_region&intron	LRP5:NM_002335.3:splice_region&intron:LOW:exon4/22:c.884-4T>C:,LRP5:NM_001291902.1:splice_region&intron:LOW:exon4/22:c.-882-4T>C:		rs314776	0.4032	0.3760	10142/5257/2532	0.3691						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM3765595	181	552					LRP5 (inh=n/a pLI=1.00)
chr11	68171013	68171013	T	C	hom		QUAL=7263;DP=66;AF=1.00;MQM=59;TRIO=HOM,66,1.00,HOM,76,1.00,HOM,91,1.00	LRP5	synonymous,5'UTR	LRP5:NM_002335.3:synonymous:LOW:exon8/23:c.1647T>C:p.Phe549Phe,LRP5:NM_001291902.1:5'UTR:MODIFIER:exon7/23:c.-291T>C:		rs545382	0.8415	0.9000	49650/27709/2102	0.8789						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM4146219	892	200					LRP5 (inh=n/a pLI=1.00)
chr11	68174122	68174122	G	A	het		QUAL=9828;DP=293;AF=0.51;MQM=59;TRIO=HET,293,0.51,HET,443,0.55,WT,544,0.00	LRP5	synonymous	LRP5:NM_002335.3:synonymous:LOW:exon9/23:c.1932G>A:p.Glu644Glu,LRP5:NM_001291902.1:synonymous:LOW:exon9/23:c.189G>A:p.Glu63Glu		rs2277268	0.0559	0.0600	227/155/20	0.0597						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];				3	147					LRP5 (inh=n/a pLI=1.00)
chr11	68177614	68177614	T	C	het		QUAL=3358;DP=146;AF=0.45;MQM=59;TRIO=HET,146,0.45,HET,188,0.45,WT,228,0.00	LRP5	splice_region&intron	LRP5:NM_002335.3:splice_region&intron:LOW:exon10/22:c.2318+6T>C:,LRP5:NM_001291902.1:splice_region&intron:LOW:exon10/22:c.575+6T>C:		rs4988322	0.0559	0.0600	219/152/18	0.0583						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];				3	150					LRP5 (inh=n/a pLI=1.00)
chr11	68192690	68192690	G	A	het		QUAL=8939;DP=192;AF=0.51;MQM=60;TRIO=HET,192,0.51,WT,170,0.00,HOM,218,1.00	LRP5	synonymous	LRP5:NM_002335.3:synonymous:LOW:exon15/23:c.3357G>A:p.Val1119Val,LRP5:NM_001291902.1:synonymous:LOW:exon15/23:c.1614G>A:p.Val538Val		rs556442	0.5793	0.6750	29005/15721/282	0.6631						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM3752692	479	491					LRP5 (inh=n/a pLI=1.00)
chr11	68522216	68522216	T	C	het		QUAL=10787;DP=490;AF=0.50;MQM=60;TRIO=HET,490,0.50,HET,312,0.50,WT,392,0.00	CPT1A	3'UTR	CPT1A:NM_001031847.2:3'UTR:MODIFIER:exon19/19:c.*68A>G:		rs75022915	0.0104	0.0000	0/0/0	0.0049										0	43					CPT1A (inh=n/a pLI=0.94)
chr11	68523910	68523910	T	C	het		QUAL=10879;DP=292;AF=0.54;MQM=59;TRIO=HET,292,0.54,HET,135,0.60,HOM,139,0.99	CPT1A	3'UTR,intron	CPT1A:NM_001876.3:3'UTR:MODIFIER:exon19/19:c.*1202A>G:,CPT1A:NM_001031847.2:intron:MODIFIER:exon18/18:c.2236-1591A>G:		rs2278908	0.6488	0.0000	0/0/0	0.6562						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];				122	114					CPT1A (inh=n/a pLI=0.94)
chr11	68524053	68524053	G	A	het		QUAL=4188;DP=148;AF=0.52;MQM=59;TRIO=HET,148,0.52,HET,53,0.49,HOM,59,1.00	CPT1A	3'UTR,intron	CPT1A:NM_001876.3:3'UTR:MODIFIER:exon19/19:c.*1059C>T:,CPT1A:NM_001031847.2:intron:MODIFIER:exon18/18:c.2236-1734C>T:		rs2278907	0.5625	0.0000	0/0/0	0.5606						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];				92	139					CPT1A (inh=n/a pLI=0.94)
chr11	68549340	68549340	A	G	hom		QUAL=37439;DP=324;AF=1.00;MQM=60;TRIO=HOM,324,1.00,HOM,341,1.00,HOM,492,1.00	CPT1A	synonymous	CPT1A:NM_001876.3:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe,CPT1A:NM_001031847.2:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe	L3	rs2228502	0.8926	0.9310	52771/30243/3693	0.9236						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000124600.2 [benign]; RCV000153103.3 [benign]; 			944	143					CPT1A (inh=n/a pLI=0.94)
chr11	68560787	68560787	C	T	het		QUAL=3290;DP=140;AF=0.54;MQM=60;TRIO=HET,140,0.54,HET,93,0.60,WT,111,0.00	CPT1A	synonymous	CPT1A:NM_001876.3:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu,CPT1A:NM_001031847.2:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu		rs2229737	0.0509	0.0890	557/444/11	0.0868						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000079919.5 [benign]; 		COSM3752694, COSM3752695	13	199					CPT1A (inh=n/a pLI=0.94)
chr11	68562328	68562328	C	T	het	anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=9826;DP=418;AF=0.49;MQM=60;TRIO=HET,418,0.49,WT,338,0.00,HET,401,0.52	CPT1A	missense	CPT1A:NM_001876.3:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr,CPT1A:NM_001031847.2:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr		rs2229738	0.0238	0.0650	388/297/2	0.0619	0.2480	T	T,T,T,T,T	B,B,B	B,B,B	600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000055868.1 [pathogenic]; RCV000180224.2 [benign]; 	CM033597 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 1 deficiency" GENE=CPT1A]; 		8	147	2	[2] Peter Bauer 05.08.2014			CPT1A (inh=n/a pLI=0.94)
chr11	68671419	68671419	C	T	het		QUAL=1697;DP=65;AF=0.48;MQM=60;TRIO=HET,65,0.48,HOM,50,0.96,WT,105,0.00	IGHMBP2	5'UTR	IGHMBP2:NM_002180.2:5'UTR:MODIFIER:exon1/15:c.-2C>T:		rs4930624	0.1160	0.1570	1037/900/20	0.1465										56	412					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68671477	68671477	T	C	het	low_DP	QUAL=2470;DP=17;AF=0.47;MQM=60;TRIO=HET,17,0.47,HOM,55,1.00,HET,91,0.42	IGHMBP2	synonymous	IGHMBP2:NM_002180.2:synonymous:LOW:exon1/15:c.57T>C:p.Leu19Leu		rs1249463	0.6751	0.6740	5684/2673/466	0.4110						600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI|Charcot-Marie-Tooth disease,axonal,type 2S];				754	315					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68678962	68678962	T	C	het		QUAL=18544;DP=273;AF=0.49;MQM=60;TRIO=HET,273,0.49,HOM,316,1.00,HET,457,0.45	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon5/15:c.602T>C:p.Leu201Ser		rs560096	0.6805	0.7710	36809/23109/2139	0.7681	-0.0700	T	T	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI|Charcot-Marie-Tooth disease,axonal,type 2S];			COSM4146225	757	318					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68682402	68682402	A	G	het		QUAL=4997;DP=166;AF=0.51;MQM=60;TRIO=HET,166,0.51,HOM,96,0.99,WT,113,0.00	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon6/15:c.823A>G:p.Ile275Val		rs10896380	0.1198	0.1820	2378/1979/70	0.1837	1.5760	T	T	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI|Charcot-Marie-Tooth disease,axonal,type 2S];			COSM1178425	60	411					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68701948	68701948	C	T	het		QUAL=12471;DP=202;AF=0.51;MQM=60;TRIO=HET,202,0.51,HOM,325,0.99,WT,451,0.00	IGHMBP2	synonymous	IGHMBP2:NM_002180.2:synonymous:LOW:exon11/15:c.1554C>T:p.Val518Val		rs11228413	0.1328	0.1840	2103/1685/134	0.1861						600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI|Charcot-Marie-Tooth disease,axonal,type 2S];			COSM429749	59	413					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68704028	68704028	C	T	het	pred_pathogenic_1	QUAL=5643;DP=117;AF=0.40;MQM=59;TRIO=HET,117,0.40,HOM,152,0.99,WT,170,0.01	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon13/15:c.2080C>T:p.Arg694Trp		rs2236654	0.1330	0.1870	2409/1934/147	0.1889	0.1980	T	D	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI|Charcot-Marie-Tooth disease,axonal,type 2S];			COSM3722147	59	414					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68707454	68707454	T	C	het		QUAL=3523;DP=115;AF=0.50;MQM=59;TRIO=HET,115,0.50,HOM,45,1.00,HET,73,0.51	IGHMBP2	3'UTR	IGHMBP2:NM_002180.2:3'UTR:MODIFIER:exon15/15:c.*255T>C:		rs564244	0.6709	0.0000	0/0/0	0.7581										150	73					IGHMBP2 (inh=n/a pLI=0.00)
chr11	68707880	68707880	T	C	het		QUAL=4916;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,HOM,103,0.99,WT,119,0.00	IGHMBP2	3'UTR	IGHMBP2:NM_002180.2:3'UTR:MODIFIER:exon15/15:c.*681T>C:		rs9095	0.1536	0.0000	0/0/0	0.1949										13	99					IGHMBP2 (inh=n/a pLI=0.00)
chr11	70049523	70049523	A	G	het	low_DP	QUAL=1236;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HOM,39,1.00,WT,57,0.02	FADD	5'UTR	FADD:NM_003824.3:5'UTR:MODIFIER:exon1/2:c.-43A>G:		rs1131677	0.5327	0.3870	2231/1103/134	0.3280										76	104					FADD (inh=n/a pLI=0.67)
chr11	70053123	70053123	-	TGT	het		QUAL=2575;DP=80;AF=0.51;MQM=59;TRIO=HET,80,0.51,HOM,63,1.00,WT,102,0.00	FADD	3'UTR	FADD:NM_003824.3:3'UTR:MODIFIER:exon2/2:c.*545_*547dupTGT:	G-rich	rs397720848	0.4653	0.0000	0/0/0	0.4657										65	117					FADD (inh=n/a pLI=0.67)
chr11	70053487	70053487	C	T	het		QUAL=10131;DP=325;AF=0.42;MQM=60;TRIO=HET,325,0.42,HOM,204,1.00,WT,280,0.00	FADD	3'UTR	FADD:NM_003824.3:3'UTR:MODIFIER:exon2/2:c.*908C>T:		rs1131715	0.5405	0.0000	0/0/0	0.5594										72	112					FADD (inh=n/a pLI=0.67)
chr11	70314597	70314597	T	A	hom		QUAL=29450;DP=385;AF=1.00;MQM=60;TRIO=HOM,385,1.00,HOM,216,1.00,HOM,301,1.00	SHANK2	3'UTR,non_coding_exon	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*4377A>T:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*4377A>T:,SHANK2:NR_110766.1:non_coding_exon:MODIFIER:exon9/9:n.5781A>T:		rs513996	0.9635	0.0000	0/0/0	0.8695										264	2					SHANK2 (inh=AD pLI=1.00)
chr11	70316391	70316391	A	G	het		QUAL=17026;DP=399;AF=0.47;MQM=59;TRIO=HET,399,0.47,HET,280,0.48,HOM,272,1.00	SHANK2	3'UTR,non_coding_exon	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*2583T>C:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*2583T>C:,SHANK2:NR_110766.1:non_coding_exon:MODIFIER:exon9/9:n.3987T>C:		rs55678639	0.2173	0.0000	0/0/0	0.0508										21	133					SHANK2 (inh=AD pLI=1.00)
chr11	70318714	70318714	A	G	hom		QUAL=25930;DP=249;AF=1.00;MQM=59;TRIO=HOM,249,1.00,HOM,260,1.00,HOM,306,1.00	SHANK2	3'UTR,non_coding_exon	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*260T>C:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*260T>C:,SHANK2:NR_110766.1:non_coding_exon:MODIFIER:exon9/9:n.1664T>C:		rs578657	0.9683	0.0000	0/0/0	0.8705										309	2					SHANK2 (inh=AD pLI=1.00)
chr11	70666765	70666765	C	T	het		QUAL=471;DP=20;AF=0.40;MQM=60;TRIO=HET,20,0.40,HET,32,0.53,WT,54,0.00	SHANK2	synonymous	SHANK2:NM_012309.4:synonymous:LOW:exon9/23:c.1005G>A:p.Ala335Ala		rs11237599	0.0931	0.0830	89/71/0	0.0401						603290 [SHANK2 (provisional) Autism susceptibility 17];				32	305					SHANK2 (inh=AD pLI=1.00)
chr11	70935766	70935766	T	C	het		QUAL=15957;DP=315;AF=0.46;MQM=60;TRIO=HET,315,0.46,HOM,263,1.00,HET,373,0.43	SHANK2	5'UTR	SHANK2:NM_012309.4:5'UTR:MODIFIER:exon1/23:c.-36A>G:		rs3020047	0.7468	0.0000	0/0/0	0.5742										56	103					SHANK2 (inh=AD pLI=1.00)
chr11	71145687	71145687	T	C	hom		QUAL=18606;DP=214;AF=1.00;MQM=59;TRIO=HOM,214,1.00,HOM,164,1.00,HOM,201,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*734A>G:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*734A>G:	LTR41B	rs7690	0.7736	0.0000	0/0/0	0.8822										216	20					DHCR7 (inh=AR pLI=0.00)
chr11	71145778	71145778	G	A	hom		QUAL=22902;DP=200;AF=0.99;MQM=59;TRIO=HOM,200,0.99,HOM,234,1.00,HOM,299,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*643C>T:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*643C>T:		rs1044535	0.7436	0.0000	0/0/0	0.1472										211	22					DHCR7 (inh=AR pLI=0.00)
chr11	71145941	71145941	G	A	het		QUAL=17450;DP=209;AF=0.44;MQM=60;TRIO=HET,209,0.44,HET,290,0.49,HOM,388,0.99	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*480C>T:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*480C>T:	LTR41B	rs1790345	0.3594	0.0000	0/0/0	0.0468										20	108					DHCR7 (inh=AR pLI=0.00)
chr11	71146249	71146260	AGCAAGGAACAG	-	het		QUAL=19666;DP=236;AF=0.47;MQM=59;TRIO=HET,236,0.47,HET,372,0.51,HOM,480,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:		rs368755383	0.3544	0.2250	1513/287/69	0.0393										36	217					DHCR7 (inh=AR pLI=0.00)
chr11	71146577	71146577	G	A	het		QUAL=3677;DP=116;AF=0.46;MQM=59;TRIO=HET,116,0.46,HET,299,0.46,WT,428,0.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly,DHCR7:NM_001360.2:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly		rs909217	0.3820	0.5470	19688/15390/493	0.5202						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079641.4 [benign]; 		COSM329305	510	453					DHCR7 (inh=AR pLI=0.00)
chr11	71146691	71146691	A	G	hom	pred_pathogenic_1	QUAL=13139;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HOM,172,1.00,HOM,172,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp,DHCR7:NM_001360.2:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp		rs760241	0.7564	0.8530	44219/28936/2543	0.8492	-0.7980	T	D			602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079639.4 [benign]; 		COSM429787, COSM1475860	922	174					DHCR7 (inh=AR pLI=0.00)
chr11	71152461	71152461	A	G	hom		QUAL=31128;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,307,1.00,HOM,436,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn,DHCR7:NM_001360.2:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn		rs949177	0.8073	0.8720	46425/29488/3574	0.8706						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079654.4 [benign]; 			930	156					DHCR7 (inh=AR pLI=0.00)
chr11	71155153	71155153	A	G	hom		QUAL=28422;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,270,1.00,HOM,371,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr,DHCR7:NM_001360.2:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr		rs1790334	0.8101	0.8710	45276/28900/3465	0.8693						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079649.4 [benign]; 		COSM4146259, COSM4146260	934	160					DHCR7 (inh=AR pLI=0.00)
chr11	71155171	71155171	C	T	het		QUAL=6706;DP=256;AF=0.55;MQM=59;TRIO=HET,256,0.55,HET,285,0.46,WT,374,0.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln,DHCR7:NM_001360.2:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln		rs1044482	0.4010	0.5500	19162/15003/756	0.5574						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079647.4 [benign]; 		COSM3931425, COSM3931426	515	440					DHCR7 (inh=AR pLI=0.00)
chr11	71159429	71159429	G	A	hom		QUAL=3481;DP=37;AF=0.97;MQM=59;TRIO=HOM,37,0.97,HET,81,0.56,HET,97,0.60	DHCR7	5'UTR	DHCR7:NM_001163817.1:5'UTR:MODIFIER:exon1/9:c.-202C>T:,DHCR7:NM_001360.2:5'UTR:MODIFIER:exon1/9:c.-225C>T:		rs4944946	0.3534	0.0000	0/0/0	0.5805										120	91					DHCR7 (inh=AR pLI=0.00)
chr11	74165954	74165954	G	C	het		QUAL=10086;DP=410;AF=0.45;MQM=60;TRIO=HET,410,0.45,HET,407,0.48,WT,503,0.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*2343C>G:		rs34315739	0.1677	0.0000	0/0/0	0.0223										3	55					KCNE3 (inh=n/a pLI=0.44)
chr11	74166278	74166278	G	A	hom		QUAL=19111;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,113,1.00,HOM,145,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*2019C>T:		rs9516	0.5960	0.0000	0/0/0	0.0960										59	127					KCNE3 (inh=n/a pLI=0.44)
chr11	74166320	74166320	T	G	hom		QUAL=20899;DP=285;AF=0.99;MQM=59;TRIO=HOM,285,0.99,HOM,153,1.00,HOM,201,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1977A>C:		rs7789	0.4247	0.0000	0/0/0	0.0787										44	117					KCNE3 (inh=n/a pLI=0.44)
chr11	74166781	74166781	-	T	het		QUAL=2040;DP=193;AF=0.40;MQM=56;TRIO=HET,193,0.40,HET,94,0.41,WT,140,0.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1515dupA:	AluSx1	rs141878274	0.2863	0.0000	0/0/0	0.1167										2	47					KCNE3 (inh=n/a pLI=0.44)
chr11	74166859	74166859	A	G	hom		QUAL=11391;DP=167;AF=0.99;MQM=51;TRIO=HOM,167,0.99,HOM,86,0.99,HOM,126,0.99	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1438T>C:	AluSx1	rs35833816	0.5956	0.0000	0/0/0	0.4085										33	83					KCNE3 (inh=n/a pLI=0.44)
chr11	74166866	74166866	G	A	hom		QUAL=11466;DP=162;AF=0.99;MQM=52;TRIO=HOM,162,0.99,HOM,87,0.99,HOM,124,0.99	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1431C>T:	AluSx1	rs28705219	0.5671	0.0000	0/0/0	0.4238										33	80					KCNE3 (inh=n/a pLI=0.44)
chr11	74167201	74167206	ATATAT	-	hom	low_DP	QUAL=173;DP=6;AF=1.00;MQM=60;TRIO=HOM,6,1.00,WT,29,0.00,WT,32,0.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1091_*1096delATATAT:	AluSx1:(AT)n	rs113583236;rs56871652;rs773139324	0.0000	0.0000	0/0/0	0.2817										14	1					KCNE3 (inh=n/a pLI=0.44)
chr11	74167388	74167388	G	A	het		QUAL=5424;DP=175;AF=0.39;MQM=55;TRIO=HET,175,0.56,HET,99,0.57,HET,155,0.79	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*909C>T:	AluSx1	rs41258394	0.0000	0.0000	0/0/0	0.0073										0	48					KCNE3 (inh=n/a pLI=0.44)
chr11	74167409	74167409	T	C	hom		QUAL=15881;DP=193;AF=1.00;MQM=59;TRIO=HOM,193,1.00,HOM,129,0.99,HOM,213,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*888A>G:		rs12272502	0.5667	0.0000	0/0/0	0.3470										40	78					KCNE3 (inh=n/a pLI=0.44)
chr11	74167630	74167630	A	G	hom		QUAL=22404;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,193,1.00,HOM,246,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*667T>C:	Arthur1B	rs12271177	0.5733	0.0000	0/0/0	0.0849										51	115					KCNE3 (inh=n/a pLI=0.44)
chr11	74168411	74168411	A	G	het		QUAL=4218;DP=162;AF=0.47;MQM=60;TRIO=HET,162,0.47,HET,166,0.57,WT,267,0.00	KCNE3	synonymous	KCNE3:NM_005472.4:synonymous:LOW:exon3/3:c.198T>C:p.Phe66Phe		rs2270676	0.1412	0.1330	1245/458/90	0.1289						604433 [KCNE3 (provisional) Brugada syndrome 6];		CM057459 [CLASS=DP MUT=ALT PHEN="Meniere's disease association with" GENE=KCNE3]; 		14	210					KCNE3 (inh=n/a pLI=0.44)
chr11	76853783	76853783	T	C	het	phylop_high	QUAL=9836;DP=139;AF=0.51;MQM=59;TRIO=HET,139,0.51,WT,136,0.01,HOM,263,1.00	MYO7A	missense	MYO7A:NM_000260.3:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser,MYO7A:NM_001127179.2:missense:MODERATE:exon3/27:c.47T>C:p.Leu16Ser,MYO7A:NM_001127180.1:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser		rs1052030	0.5136	0.3990	9797/3817/2689	0.3901	4.4690	T	T,T,T,T,T,T,T,T	B,B,B	B,B,B	276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];	RCV000036163.3 [benign]; RCV000132571.1 [likely benign]; 		COSM4146342	183	502					MYO7A (inh=n/a pLI=0.00)
chr11	76868392	76868392	A	G	het	pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=8814;DP=272;AF=0.50;MQM=60;TRIO=HET,272,0.50,WT,284,0.00,HET,367,0.53	MYO7A	missense	MYO7A:NM_000260.3:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg,MYO7A:NM_001127179.2:missense:MODERATE:exon8/27:c.803A>G:p.Lys268Arg,MYO7A:NM_001127180.1:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg		rs184866544	0.0006	0.0009	0/0/0	0.0010	0.6210	D	T,T,T,T,T,T,T,T	B,B,B	B,B,B	276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];	RCV000155225.2 [likely benign]; RCV000180118.1 [uncertain significance]; 	CM112920 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=MYO7A]; 		0	2					MYO7A (inh=n/a pLI=0.00)
chr11	76895855	76895855	C	G	het	pred_pathogenic_1	QUAL=10477;DP=348;AF=0.53;MQM=60;TRIO=HET,348,0.53,HET,472,0.47,WT,558,0.00	MYO7A	3'UTR,intron	MYO7A:NM_001127179.2:3'UTR:MODIFIER:exon27/27:c.*61C>G:,MYO7A:NM_000260.3:intron:MODIFIER:exon27/48:c.3503+95C>G:,MYO7A:NM_001127180.1:intron:MODIFIER:exon27/48:c.3503+95C>G:	MIRb	rs576982361	0.0010	0.0014	0/0/0	0.0012	-0.0160	T	D			276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];				0	5					MYO7A (inh=n/a pLI=0.00)
chr11	76926245	76926245	C	T	het		QUAL=6869;DP=268;AF=0.53;MQM=60;TRIO=HET,268,0.53,HET,134,0.50,HET,174,0.52	MYO7A	3'UTR	MYO7A:NM_000260.3:3'UTR:MODIFIER:exon49/49:c.*504C>T:,MYO7A:NM_001127180.1:3'UTR:MODIFIER:exon49/49:c.*504C>T:		rs34765389	0.0339	0.0000	0/0/0	0.0131										0	37					MYO7A (inh=n/a pLI=0.00)
chr11	77811990	77811990	T	C	hom		QUAL=14759;DP=121;AF=1.00;MQM=59;TRIO=HOM,121,1.00,HOM,154,1.00,HOM,187,1.00	ALG8	splice_region,3'UTR	ALG8:NM_024079.4:splice_region:LOW:exon13/13:c.*20A>G:,ALG8:NM_001007027.2:splice_region:LOW:exon14/14:c.*272A>G:,ALG8:NM_024079.4:3'UTR:MODIFIER:exon13/13:c.*20A>G:,ALG8:NM_001007027.2:3'UTR:MODIFIER:exon14/14:c.*272A>G:		rs1263505	0.8327	0.8320	42282/24157/4541	0.8202							RCV000082154.4 [benign]; 			359	107					ALG8 (inh=n/a pLI=0.00)
chr11	77825320	77825320	T	C	hom		QUAL=19441;DP=248;AF=0.99;MQM=60;TRIO=HOM,248,0.99,HOM,223,1.00,HET,351,0.46	ALG8	missense	ALG8:NM_024079.4:missense:MODERATE:exon6/13:c.665A>G:p.Asn222Ser,ALG8:NM_001007027.2:missense:MODERATE:exon6/14:c.665A>G:p.Asn222Ser		rs665278	0.1464	0.1990	2626/1804/18	0.1968	0.5410	T,T	.,.,T,T,T,T,T,T,T	.,B,B,B	.,B,B,B	608103 [ALG8 (provisional) Congenital disorder of glycosylation,type Ih];	RCV000082158.4 [benign]; 		COSM3752755	75	385					ALG8 (inh=n/a pLI=0.00)
chr11	87013438	87013438	G	A	hom	phylop_high	QUAL=19888;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,146,1.00,HOM,233,1.00	TMEM135	missense,non_coding_exon	TMEM135:NM_022918.3:missense:MODERATE:exon8/15:c.652G>A:p.Gly218Arg,TMEM135:NM_001168724.1:missense:MODERATE:exon7/14:c.586G>A:p.Gly196Arg,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon7/14:n.820G>A:		rs2276102	0.5829	0.6240	24141/14924/1951	0.6211	2.4950	T	T,T,T,T,T	B,B	B,B					490	495					TMEM135 (inh=n/a pLI=0.88)
chr11	87036784	87036784	T	C	hom		QUAL=23599;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,167,0.99,HOM,202,0.99	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4409T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4409T>C:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.5954T>C:		rs10898669	0.2306	0.2930	627/245/3	0.0759										70	279					TMEM135 (inh=n/a pLI=0.88)
chr11	87037139	87037139	T	A	het		QUAL=6485;DP=262;AF=0.56;MQM=60;TRIO=HET,262,0.66,WT,117,0.22,HET,179,0.63	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4764T>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4764T>A:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.6309T>A:		rs551809652	0.0006	0.0000	0/0/0	0.0001										0	1					TMEM135 (inh=n/a pLI=0.88)
chr11	87037202	87037202	T	C	hom		QUAL=24302;DP=301;AF=0.99;MQM=59;TRIO=HOM,301,0.99,HOM,181,1.00,HOM,289,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4827T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4827T>C:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.6372T>C:		rs12276145	0.2151	0.2730	626/249/3	0.0759										70	278					TMEM135 (inh=n/a pLI=0.88)
chr11	87037565	87037565	T	C	hom		QUAL=35015;DP=482;AF=1.00;MQM=60;TRIO=HOM,482,1.00,HOM,228,0.99,HOM,348,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5190T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5190T>C:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.6735T>C:		rs7926724	0.4461	0.5310	1775/570/19	0.1351										214	278					TMEM135 (inh=n/a pLI=0.88)
chr11	87037680	87037680	A	G	hom		QUAL=14545;DP=216;AF=1.00;MQM=59;TRIO=HOM,216,1.00,HOM,113,1.00,HOM,167,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5305A>G:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5305A>G:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.6850A>G:	(TCCTT)n	rs12282551	0.3502	0.4230	1222/401/16	0.1057										149	289					TMEM135 (inh=n/a pLI=0.88)
chr11	87037743	87037743	G	A	hom		QUAL=13879;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,105,1.00,HOM,123,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5368G>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5368G>A:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.6913G>A:		rs10898670	0.3385	0.4300	1220/402/13	0.1078										150	288					TMEM135 (inh=n/a pLI=0.88)
chr11	87037954	87037955	TT	-	hom		QUAL=2248;DP=88;AF=0.42;MQM=59;TRIO=HOM,88,0.42,HOM,43,0.58,WT,42,0.36	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5596_*5597delTT:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5596_*5597delTT:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.7141_7142delTT:	(T)n	rs202144692;rs756445728	0.0000	0.2510	5/1/0	0.0621										14	137					TMEM135 (inh=n/a pLI=0.88)
chr11	87039402	87039402	G	A	hom		QUAL=19340;DP=277;AF=1.00;MQM=59;TRIO=HOM,277,1.00,HOM,136,0.99,HOM,188,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7027G>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7027G>A:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.8572G>A:		rs4480563	0.3411	0.4220	1171/399/12	0.1068										149	289					TMEM135 (inh=n/a pLI=0.88)
chr11	87039467	87039467	T	G	hom		QUAL=20642;DP=299;AF=1.00;MQM=58;TRIO=HOM,299,1.00,HOM,143,1.00,HOM,175,0.99	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7092T>G:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7092T>G:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.8637T>G:	L1PB3	rs4644661	0.3413	0.4180	1163/397/12	0.1071										149	289					TMEM135 (inh=n/a pLI=0.88)
chr11	87039532	87039532	C	T	hom		QUAL=21042;DP=295;AF=1.00;MQM=60;TRIO=HOM,295,1.00,HOM,148,0.99,HOM,196,1.00	TMEM135	3'UTR,non_coding_exon	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7157C>T:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7157C>T:,TMEM135:NR_033149.1:non_coding_exon:MODIFIER:exon14/14:n.8702C>T:	L1PB3	rs4318005	0.3411	0.4180	1168/397/12	0.1069										149	289					TMEM135 (inh=n/a pLI=0.88)
chr11	88045583	88045583	A	G	het	anno_pathogenic_hgmd	QUAL=12386;DP=249;AF=0.49;MQM=60;TRIO=HET,249,0.49,HOM,212,1.00,HET,255,0.40	CTSC	missense	CTSC:NM_001814.5:missense:MODERATE:exon3/7:c.458T>C:p.Ile153Thr		rs217086	0.9309	0.8860	47848/23928/4334	0.8631	-0.6170	T,.	T,T,.	B,.	B,.	602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];		CM002936 [CLASS=DM? MUT=REF PHEN="Papillon-Lefevre syndrome" GENE=CTSC]; 	COSM3752799	802	281	2	[2] old entry - no details available			CTSC (inh=n/a pLI=0.00)
chr11	88053979	88053979	T	C	het		QUAL=5870;DP=130;AF=0.58;MQM=60;TRIO=HET,130,0.58,HOM,77,1.00,HET,106,0.55	CTSC	splice_region,3'UTR,intron	CTSC:NM_001114173.2:splice_region:LOW:exon4/4:c.*5566A>G:,CTSC:NM_148170.4:splice_region:LOW:exon4/4:c.*5622A>G:,CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*5566A>G:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*5622A>G:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-8257A>G:		rs217053	0.8239	0.0000	0/0/0	0.1411						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				107	53					CTSC (inh=n/a pLI=0.00)
chr11	88054346	88054346	G	C	het		QUAL=959;DP=59;AF=0.49;MQM=60;TRIO=HET,59,0.49,HOM,7,1.00,HET,9,0.44	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*5199C>G:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*5255C>G:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-8624C>G:	L1PA10	rs217054	0.8516	0.0000	0/0/0	0.7118						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				98	54					CTSC (inh=n/a pLI=0.00)
chr11	88054571	88054571	G	A	het		QUAL=819;DP=46;AF=0.43;MQM=59;TRIO=HET,46,0.43,HOM,7,1.00,HET,12,0.50	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*4974C>T:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*5030C>T:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-8849C>T:	L1PA10	rs10830669	0.1861	0.0000	0/0/0	0.0517						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				36	69					CTSC (inh=n/a pLI=0.00)
chr11	88055089	88055089	C	T	het		QUAL=6241;DP=207;AF=0.49;MQM=60;TRIO=HET,207,0.49,HOM,76,1.00,HET,78,0.53	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*4456G>A:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*4512G>A:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-9367G>A:	L1PA10	rs217055	0.9311	0.0000	0/0/0	0.8034						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				111	45					CTSC (inh=n/a pLI=0.00)
chr11	88055170	88055170	G	A	het		QUAL=4462;DP=110;AF=0.52;MQM=60;TRIO=HET,110,0.52,HOM,68,1.00,HET,55,0.49	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*4375C>T:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*4431C>T:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-9448C>T:	L1PA10	rs596261	0.3456	0.0000	0/0/0	0.0763						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				48	76					CTSC (inh=n/a pLI=0.00)
chr11	88055291	88055291	T	C	het		QUAL=2904;DP=141;AF=0.48;MQM=60;TRIO=HET,141,0.48,HOM,27,1.00,HET,30,0.50	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*4254A>G:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*4310A>G:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-9569A>G:	L1PA10	rs12288615	0.2037	0.0000	0/0/0	0.3112						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				35	72					CTSC (inh=n/a pLI=0.00)
chr11	88055789	88055789	A	T	het		QUAL=1617;DP=70;AF=0.56;MQM=54;TRIO=HET,70,0.56,HOM,12,1.00,HET,14,0.71	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*3756T>A:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*3812T>A:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-10067T>A:	L1P3	rs452648	0.8650	0.0000	0/0/0	0.7296						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				99	51					CTSC (inh=n/a pLI=0.00)
chr11	88055794	88055794	A	G	het		QUAL=1714;DP=69;AF=0.55;MQM=53;TRIO=HET,69,0.55,HOM,12,1.00,HET,15,0.67	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*3751T>C:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*3807T>C:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-10072T>C:	L1P3	rs442528	0.8650	0.0000	0/0/0	0.7295						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				99	50					CTSC (inh=n/a pLI=0.00)
chr11	88056130	88056130	A	G	het		QUAL=1830;DP=71;AF=0.51;MQM=58;TRIO=HET,71,0.51,HOM,17,1.00,HET,27,0.59	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*3415T>C:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*3471T>C:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-10408T>C:	L1P3	rs217056	0.7899	0.0000	0/0/0	0.7428						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				90	61					CTSC (inh=n/a pLI=0.00)
chr11	88056396	88056396	T	G	het		QUAL=1376;DP=47;AF=0.62;MQM=59;TRIO=HET,47,0.62,HOM,15,1.00,HET,12,0.33	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*3149A>C:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*3205A>C:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.319-10674A>C:	L1P3	rs217057	0.7895	0.0000	0/0/0	0.7405						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				91	60					CTSC (inh=n/a pLI=0.00)
chr11	88056942	88056942	G	A	het	low_DP	QUAL=312;DP=19;AF=0.37;MQM=59;TRIO=HET,19,0.37,HOM,5,1.00,HET,7,0.29	CTSC	3'UTR,intron	CTSC:NM_001114173.2:3'UTR:MODIFIER:exon4/4:c.*2603C>T:,CTSC:NM_148170.4:3'UTR:MODIFIER:exon4/4:c.*2659C>T:,CTSC:NM_001814.5:intron:MODIFIER:exon2/6:c.318+11163C>T:	L1P3	rs217058	0.9083	0.0000	0/0/0	0.7966						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				99	19					CTSC (inh=n/a pLI=0.00)
chr11	94151547	94151547	-	T	het		QUAL=3341;DP=244;AF=0.40;MQM=59;TRIO=HET,244,0.40,HET,188,0.41,WT,268,0.06	MRE11A	3'UTR	MRE11A:NM_005591.3:3'UTR:MODIFIER:exon20/20:c.*1743dupA:,MRE11A:NM_005590.3:3'UTR:MODIFIER:exon19/19:c.*1743dupA:		rs200848216	0.1270	0.0000	0/0/0	0.1080										1	79					MRE11A (inh=AR+AD pLI=0.00)
chr11	94152631	94152631	-	GGGAGAGAGAGAGA	hom		QUAL=1523;DP=74;AF=0.00;MQM=60;TRIO=HOM,74,0.49,HOM,15,0.40,WT,36,0.58	MRE11A	3'UTR	MRE11A:NM_005591.3:3'UTR:MODIFIER:exon20/20:c.*659_*660insTCTCTCTCTCTCCC:,MRE11A:NM_005590.3:3'UTR:MODIFIER:exon19/19:c.*659_*660insTCTCTCTCTCTCCC:	(GA)n		0.0000	0.0000	0/0/0	0.0006										1	2					MRE11A (inh=AR+AD pLI=0.00)
chr11	94212048	94212048	C	T	het		QUAL=7179;DP=156;AF=0.46;MQM=60;TRIO=HET,156,0.46,WT,149,0.00,HOM,173,0.99	MRE11A	splice_region&intron	MRE11A:NM_005591.3:splice_region&intron:LOW:exon5/19:c.403-6G>A:,MRE11A:NM_005590.3:splice_region&intron:LOW:exon5/18:c.403-6G>A:		rs535801	0.3131	0.3250	6588/3086/210	0.3209						600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];	RCV000117634.2 [likely benign]; 			411	1672	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MRE11A (inh=AR+AD pLI=0.00)
chr11	95566048	95566048	G	A	het		QUAL=2941;DP=146;AF=0.54;MQM=60;TRIO=HET,146,0.54,HET,72,0.57,WT,136,0.00	MTMR2	3'UTR	MTMR2:NM_016156.5:3'UTR:MODIFIER:exon15/15:c.*2406C>T:,MTMR2:NM_001243571.1:3'UTR:MODIFIER:exon18/18:c.*2406C>T:,MTMR2:NM_201278.2:3'UTR:MODIFIER:exon17/17:c.*2406C>T:,MTMR2:NM_201281.2:3'UTR:MODIFIER:exon16/16:c.*2406C>T:		rs16922613	0.0298	0.0000	0/0/0	0.0232										0	10					MTMR2 (inh=n/a pLI=0.21)
chr11	102980324	102980324	C	T	hom		QUAL=12477;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HET,234,0.44,HET,352,0.47	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon1/90:c.21C>T:p.Asp7Asp,DYNC2H1:NM_001377.2:synonymous:LOW:exon1/89:c.21C>T:p.Asp7Asp		rs17301028	0.0411	0.0740	407/302/3	0.0719						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				14	194					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103029516	103029516	A	G	hom	phylop_high	QUAL=9808;DP=171;AF=1.00;MQM=60;TRIO=HOM,171,1.00,HOM,48,1.00,HOM,73,1.00	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon27/90:c.4238A>G:p.Lys1413Arg,DYNC2H1:NM_001377.2:missense:MODERATE:exon27/89:c.4238A>G:p.Lys1413Arg		rs688906	0.6683	0.6550	5704/2722/293	0.4542	4.1300	T	T,T	B,P	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000176721.1 [benign]; 			626	389					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103047007	103047007	C	A	hom		QUAL=12900;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,76,1.00,HOM,127,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon37/90:c.5718C>A:p.Thr1906Thr,DYNC2H1:NM_001377.2:synonymous:LOW:exon37/89:c.5718C>A:p.Thr1906Thr		rs585692	0.9313	0.9050	10622/4998/1304	0.7405						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000153168.3 [benign]; 			928	163	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	103057048	103057048	A	G	hom		QUAL=20027;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,183,1.00,HOM,223,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon42/90:c.6711A>G:p.Arg2237Arg,DYNC2H1:NM_001377.2:synonymous:LOW:exon42/89:c.6711A>G:p.Arg2237Arg		rs658804	0.5715	0.6200	23424/13354/1323	0.6067						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				475	483					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103058126	103058126	C	T	hom		QUAL=14047;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,103,1.00,HOM,138,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon43/90:c.6951C>T:p.His2317His,DYNC2H1:NM_001377.2:synonymous:LOW:exon43/89:c.6951C>T:p.His2317His		rs586592	0.6170	0.6320	24445/13441/2150	0.6203						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000079444.4 [benign]; 			482	480					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103082590	103082590	G	A	hom	phylop_high	QUAL=13998;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,83,1.00,HOM,105,1.00	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon54/90:c.8612G>A:p.Arg2871Gln,DYNC2H1:NM_001377.2:missense:MODERATE:exon54/89:c.8612G>A:p.Arg2871Gln		rs589623	0.7384	0.7410	8800/4453/565	0.6169	4.3360	T	T,T	P,B	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];			COSM147316	741	317					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103153788	103153788	C	A	het		QUAL=5176;DP=322;AF=0.46;MQM=60;TRIO=HET,322,0.46,HET,93,0.52,WT,163,0.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon74/90:c.10885C>A:p.Arg3629Arg,DYNC2H1:NM_001377.2:synonymous:LOW:exon73/89:c.10864C>A:p.Arg3622Arg		rs117178504	0.0042	0.0069	3/3/0	0.0074						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000205607.1 [benign]; 			0	13					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103158278	103158278	C	T	het	phylop_high	QUAL=6218;DP=285;AF=0.46;MQM=60;TRIO=HET,285,0.46,WT,159,0.00,HET,230,0.50	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon76/90:c.11060C>T:p.Ala3687Val,DYNC2H1:NM_001377.2:missense:MODERATE:exon75/89:c.11039C>T:p.Ala3680Val		rs10895391	0.2863	0.3250	6544/3984/170	0.3221	6.1230	T	T,T	P,P	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				124	481	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	103229027	103229027	T	C	het		QUAL=10430;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HOM,141,1.00,HET,168,0.48	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon84/90:c.12117T>C:p.Asp4039Asp,DYNC2H1:NM_001377.2:synonymous:LOW:exon83/89:c.12096T>C:p.Asp4032Asp		rs2566913	0.4950	0.5910	16885/10514/341	0.5820						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				475	495					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103270607	103270607	G	A	het		QUAL=5738;DP=158;AF=0.46;MQM=60;TRIO=HET,158,0.46,WT,76,0.00,HOM,124,1.00	DYNC2H1	splice_region&intron	DYNC2H1:NM_001080463.1:splice_region&intron:LOW:exon85/89:c.12387+7G>A:,DYNC2H1:NM_001377.2:splice_region&intron:LOW:exon84/88:c.12366+7G>A:		rs10895417	0.5377	0.4890	14633/6500/1858	0.4807						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				230	540	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	107992312	107992312	C	G	het		QUAL=2502;DP=81;AF=0.63;MQM=59;TRIO=HET,81,0.63,HET,103,0.48,WT,110,0.00	ACAT1	5'UTR	ACAT1:NM_000019.3:5'UTR:MODIFIER:exon1/12:c.-22C>G:		rs3741054	0.0954	0.0950	240/93/10	0.0749										3	133					ACAT1 (inh=AR pLI=0.00)
chr11	107992325	107992325	T	A	het		QUAL=4348;DP=136;AF=0.38;MQM=59;TRIO=HET,136,0.38,WT,95,0.00,HOM,110,1.00	ACAT1	5'UTR	ACAT1:NM_000019.3:5'UTR:MODIFIER:exon1/12:c.-9T>A:		rs3741055	0.3137	0.1860	1348/357/8	0.1634							RCV000077928.4 [benign]; 			173	480					ACAT1 (inh=AR pLI=0.00)
chr11	107992346	107992346	G	C	het	pred_pathogenic_1	QUAL=3958;DP=127;AF=0.35;MQM=59;TRIO=HET,127,0.35,WT,86,0.00,HOM,100,1.00	ACAT1	missense	ACAT1:NM_000019.3:missense:MODERATE:exon1/12:c.13G>C:p.Ala5Pro		rs3741056	0.3319	0.1970	1372/362/18	0.1727	-0.1180	T	D,T	P,P	B,B	607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria];	RCV000077929.4 [benign]; 		COSM3752118	174	478					ACAT1 (inh=AR pLI=0.00)
chr11	108009660	108009660	C	A	het		QUAL=5557;DP=202;AF=0.42;MQM=60;TRIO=HET,202,0.42,HET,308,0.45,WT,395,0.00	ACAT1	synonymous	ACAT1:NM_000019.3:synonymous:LOW:exon6/12:c.471C>A:p.Ser157Ser		rs35188041	0.1270	0.1560	1659/997/206	0.1525	0.1580	T				607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria];	RCV000077930.4 [benign]; 		COSM1350699	17	266					ACAT1 (inh=AR pLI=0.00)
chr11	108018894	108018897	AATT	-	het		QUAL=5426;DP=271;AF=0.49;MQM=59;TRIO=HET,271,0.49,HET,211,0.58,WT,270,0.00	ACAT1-NPAT	intergenic_region	ACAT1-NPAT:ACAT1-NPAT:intergenic_region:MODIFIER::n.108018894_108018897delAATT:		rs112801981;rs577109182	0.2039	0.0000	0/0/0	0.2592										30	83					ACAT1-NPAT (inh=n/a pLI=n/a)
chr11	108093833	108093833	G	A	het		QUAL=17303;DP=341;AF=0.45;MQM=60;TRIO=HET,341,0.45,WT,397,0.00,HOM,501,0.99	ATM	5'UTR	ATM:NM_000051.3:5'UTR:MODIFIER:exon1/63:c.-111G>A:		rs189037	0.4760	0.0000	0/0/0	0.5334								CR109394 [CLASS=DFP MUT=ALT PHEN="Longevity association with" GENE=ATM]; 		95	93					ATM (inh=AR+AD pLI=0.00)
chr11	108183167	108183167	A	G	hom		QUAL=14951;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,92,1.00,HOM,142,1.00	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1.0000	1.0000	60654/33353/5170	0.9355	-1.0580	T	T,T	B,B	B,B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1 [benign]; RCV000120149.2 [benign]; 			4039	0	1	[3] Ilnaz Sepahi 29-03-2016 batch import [1] ahdoeha1 31.03.2016: GC-HBOC class 1 [n/a] harmuth 02.09.2016; observed base G is the wildtype base (hg38) which means that we sequenced the wildtype 			ATM (inh=AR+AD pLI=0.00)
chr11	108236783	108236783	G	T	het		QUAL=1517;DP=72;AF=0.49;MQM=58;TRIO=HET,72,0.49,WT,19,0.00,HOM,25,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*548G>T:		rs227092	0.5184	0.0000	0/0/0	0.4976										77	62					ATM (inh=AR+AD pLI=0.00)
chr11	108237839	108237839	C	T	het		QUAL=1686;DP=93;AF=0.33;MQM=52;TRIO=HET,93,0.33,WT,37,0.03,HOM,34,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*1604C>T:	AluSc8	rs227091	0.5182	0.0000	0/0/0	0.5093										77	70					ATM (inh=AR+AD pLI=0.00)
chr11	108239628	108239628	G	T	het		QUAL=7099;DP=332;AF=0.52;MQM=60;TRIO=HET,332,0.52,WT,88,0.01,HOM,83,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*3393G>T:		rs4585	0.5345	0.0000	0/0/0	0.1098										99	97					ATM (inh=AR+AD pLI=0.00)
chr11	111654621	111654625	TATAT	-	het		QUAL=2854;DP=196;AF=0.56;MQM=59;TRIO=HET,196,0.56,HET,83,0.46,WT,125,0.00	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2496_*2500delATATA:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2496_*2500delATATA:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2496_*2500delATATA:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2496_*2500delATATA:		rs66517706	0.2372	0.0000	0/0/0	0.2440										23	101					ALG9 (inh=n/a pLI=0.00)
chr11	111654647	111654647	-	A	het		QUAL=6246;DP=215;AF=0.62;MQM=59;TRIO=HET,215,0.75,HET,56,0.71,WT,72,0.43	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2473_*2474insT:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2473_*2474insT:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2473_*2474insT:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2473_*2474insT:			0.0000	0.0000	0/0/0	0.0102										0	52					ALG9 (inh=n/a pLI=0.00)
chr11	111654648	111654648	T	A	hom		QUAL=6246;DP=215;AF=0.62;MQM=59;TRIO=HOM,215,0.75,HOM,56,0.71,HET,72,0.43	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2473A>T:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2473A>T:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2473A>T:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2473A>T:		rs2554994	0.0000	0.0000	0/0/0	0.0760										70	157					ALG9 (inh=n/a pLI=0.00)
chr11	111654670	111654678	GACAAAACA	-	het		QUAL=2623;DP=200;AF=0.46;MQM=58;TRIO=HET,200,0.46,HET,62,0.56,WT,69,0.00	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2443_*2451delTGTTTTGTC:	GA-rich	rs72428193	0.0000	0.0000	0/0/0	0.0838										27	102					ALG9 (inh=n/a pLI=0.00)
chr11	111724133	111724133	C	T	het	phylop_high;pred_pathogenic_1	QUAL=9187;DP=316;AF=0.47;MQM=60;TRIO=HET,316,0.47,HET,224,0.49,HET,251,0.39	ALG9	missense	ALG9:NM_024740.2:missense:MODERATE:exon9/16:c.865G>A:p.Val289Ile,ALG9:NM_001077691.1:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:NM_001077692.1:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:NM_001077690.1:missense:MODERATE:exon9/16:c.865G>A:p.Val289Ile		rs10502151	0.3265	0.3500	7918/3581/92	0.3448	6.0710	T	T,T,T	D,B,D	P,B,P	606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il];			COSM3998221, COSM3998222, COSM3998223	133	481					ALG9 (inh=n/a pLI=0.00)
chr11	111742146	111742146	G	-	hom	anno_high_impact	QUAL=10671;DP=28;AF=1.00;MQM=59;TRIO=HOM,28,1.00,HOM,125,1.00,HOM,221,1.00	ALG9	splice_acceptor&splice_donor	ALG9:NM_024740.2:splice_acceptor&splice_donor:HIGH:exon1/15:c.60+1delC:,ALG9:NM_001077690.1:splice_acceptor&splice_donor:HIGH:exon1/15:c.60+1delC:		rs869187252	1.0000	1.0000	6194/1836/287	0.2542						606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il];				1073	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			ALG9 (inh=n/a pLI=0.00)
chr11	111781047	111781047	A	C	het		QUAL=4806;DP=213;AF=0.48;MQM=60;TRIO=HET,213,0.48,HET,182,0.47,WT,267,0.00	CRYAB	splice_region&intron	CRYAB:NM_001289807.1:splice_region&intron:LOW:exon3/3:c.324+4T>G:,CRYAB:NM_001289808.1:splice_region&intron:LOW:exon2/2:c.324+4T>G:,CRYAB:NM_001885.2:splice_region&intron:LOW:exon3/3:c.324+4T>G:		rs11603779	0.2398	0.2690	4615/2908/218	0.2692		T	T	B	B	123590 [CRYAB (confirmed) Myopathy,myofibrillar,2|Cataract 16,multiple types|Myopathy,myofibrillar,fatal infantile hypertrophy,alpha-B crystallin-related|Cardiomyopathy,dilated,1II];	RCV000037213.3 [benign]; 		COSM3998232	119	500					CRYAB (inh=n/a pLI=0.01)
chr11	118175439	118175439	G	A	het		QUAL=3974;DP=213;AF=0.42;MQM=60;TRIO=HET,213,0.42,HET,62,0.47,HET,85,0.52	CD3E	5'UTR	CD3E:NM_000733.3:5'UTR:MODIFIER:exon1/9:c.-112G>A:		rs2231440	0.2290	0.0000	0/0/0	0.3006										20	104					CD3E (inh=n/a pLI=0.30)
chr11	118178007	118178007	C	T	het		QUAL=4651;DP=153;AF=0.48;MQM=60;TRIO=HET,153,0.48,HET,107,0.48,HET,125,0.56	CD3E	synonymous	CD3E:NM_000733.3:synonymous:LOW:exon3/9:c.54C>T:p.Gly18Gly		rs1126924	0.2254	0.3060	6374/3322/39	0.3032						186830 [CD3E (provisional) Immunodeficiency 18|Immunodeficiency 18,SCID variant];			COSM147335	107	492					CD3E (inh=n/a pLI=0.30)
chr11	118215076	118215079	GGCT	-	het		QUAL=3500;DP=158;AF=0.51;MQM=59;TRIO=HET,158,0.51,HET,193,0.55,WT,240,0.00	CD3G	5'UTR	CD3G:NM_000073.2:5'UTR:MODIFIER:exon1/7:c.-46_-43delGCTG:	(CTGG)n	rs68070310	0.4026	0.0000	0/0/0	0.2976										18	105					CD3G (inh=n/a pLI=0.03)
chr11	118221349	118221349	T	C	het		QUAL=752;DP=70;AF=0.33;MQM=60;TRIO=HET,70,0.33,HET,24,0.50,WT,47,0.00	CD3G	synonymous	CD3G:NM_000073.2:synonymous:LOW:exon4/7:c.390T>C:p.Ala130Ala		rs3753059	0.2963	0.2190	3926/848/115	0.1923						186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient];			COSM3998253	57	351					CD3G (inh=n/a pLI=0.03)
chr11	118221350	118221350	G	T	het	pred_pathogenic_2	QUAL=752;DP=70;AF=0.33;MQM=60;TRIO=HET,70,0.33,HET,24,0.50,WT,47,0.00	CD3G	missense	CD3G:NM_000073.2:missense:MODERATE:exon4/7:c.391G>T:p.Val131Phe		rs3753058	0.2975	0.2190	3923/846/115	0.2003	0.3220	T	D	D	P	186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient];			COSM3931231	57	351					CD3G (inh=n/a pLI=0.03)
chr11	118224059	118224059	A	G	het		QUAL=4090;DP=252;AF=0.52;MQM=60;TRIO=HET,252,0.52,WT,20,0.00,HET,48,0.54	CD3G	3'UTR	CD3G:NM_000073.2:3'UTR:MODIFIER:exon7/7:c.*244A>G:		rs45508093	0.0721	0.0000	0/0/0	0.1323										7	63					CD3G (inh=n/a pLI=0.03)
chr11	118224268	118224268	G	T	het		QUAL=1147;DP=116;AF=0.39;MQM=54;TRIO=HET,116,0.39,HET,21,0.67,WT,25,0.08	CD3G	3'UTR	CD3G:NM_000073.2:3'UTR:MODIFIER:exon7/7:c.*453G>T:	AluSz	rs45477194	0.2977	0.0000	0/0/0	0.1264										9	56					CD3G (inh=n/a pLI=0.03)
chr11	118898436	118898436	C	-	hom	anno_high_impact	QUAL=54851;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,679,1.00,HOM,852,1.00	SLC37A4	splice_acceptor&splice_donor	SLC37A4:NM_001164278.1:splice_acceptor&splice_donor:HIGH:exon5/11:c.527+1delG:,SLC37A4:NM_001164280.1:splice_acceptor&splice_donor:HIGH:exon3/8:c.527+1delG:,SLC37A4:NM_001164277.1:splice_acceptor&splice_donor:HIGH:exon5/10:c.527+1delG:,SLC37A4:NM_001164279.1:splice_acceptor&splice_donor:HIGH:exon5/10:c.308+1delG:,SLC37A4:NM_001467.5:splice_acceptor&splice_donor:HIGH:exon4/9:c.527+1delG:		rs869034262	1.0000	1.0000	60059/33162/4885	0.9338						602671 [SLC37A4 (confirmed) Glycogen storage disease Ib|Glycogen storage disease Ic];				1107	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			SLC37A4 (inh=n/a pLI=0.00)
chr11	118901166	118901166	C	G	het		QUAL=7627;DP=89;AF=0.38;MQM=59;TRIO=HET,89,0.38,HET,126,0.54,HOM,178,0.99	SLC37A4	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC37A4:NM_001164277.1:5'UTR_premature_start_codon_gain:LOW:exon2/11:c.-420G>C:,SLC37A4:NM_001164277.1:5'UTR:MODIFIER:exon2/11:c.-420G>C:,SLC37A4:NM_001164278.1:intron:MODIFIER:exon2/11:c.-196+92G>C:,SLC37A4:NM_001164279.1:intron:MODIFIER:exon1/10:c.-345+393G>C:,SLC37A4:NM_001467.5:intron:MODIFIER:exon1/9:c.-196+393G>C:		rs2846281	0.8496	0.0000	0/0/0	0.7904										152	70					SLC37A4 (inh=n/a pLI=0.00)
chr11	118967524	118967524	C	T	het		QUAL=17357;DP=251;AF=0.47;MQM=60;TRIO=HET,251,0.47,HET,272,0.50,HOM,338,1.00	DPAGT1	3'UTR	DPAGT1:NM_001382.3:3'UTR:MODIFIER:exon9/9:c.*184G>A:		rs8551	0.4367	0.0000	0/0/0	0.0744										44	104					DPAGT1 (inh=AR pLI=0.00)
chr11	118967758	118967758	T	C	het		QUAL=20347;DP=372;AF=0.52;MQM=59;TRIO=HET,372,0.52,HET,276,0.53,HOM,352,1.00	DPAGT1	missense	DPAGT1:NM_001382.3:missense:MODERATE:exon9/9:c.1177A>G:p.Ile393Val		rs643788	0.4333	0.4210	11492/6311/443	0.4211	-0.3200	T	T,T,T	B,B	B,B	191350 [DPAGT1 (confirmed) Congenital disorder of glycosylation,type Ij|Myasthenic syndrome,congenital,13,with tubular aggregates];	RCV000079665.5 [benign]; 			216	515					DPAGT1 (inh=AR pLI=0.00)
chr11	119209979	119209979	T	A	het		QUAL=2849;DP=124;AF=0.48;MQM=60;TRIO=HET,124,0.48,HET,162,0.44,WT,243,0.00	C1QTNF5,MFRP	3'UTR	C1QTNF5:NM_001278431.1:3'UTR:MODIFIER:exon3/3:c.*62A>T:,MFRP:NM_031433.3:3'UTR:MODIFIER:exon15/15:c.*1690A>T:,C1QTNF5:NM_015645.4:3'UTR:MODIFIER:exon15/15:c.*62A>T:		rs9640	0.1378	0.0000	0/0/0	0.0255								CR080754 [CLASS=DP MUT=REF PHEN="Increased BMI association with" GENE=C1QTNF5]; 		2	48					C1QTNF5 (inh=n/a pLI=0.83), MFRP (inh=n/a pLI=0.00)
chr11	119216231	119216231	A	G	hom		QUAL=6365;DP=100;AF=1.00;MQM=60;TRIO=HOM,100,1.00,HOM,43,1.00,HOM,55,1.00	MFRP,C1QTNF5	synonymous,5'UTR	MFRP:NM_031433.3:synonymous:LOW:exon5/15:c.540T>C:p.His180His,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon5/15:c.-2097T>C:		rs2510143	0.9020	0.9360	53245/30591/4010	0.9276						606227 [MFRP (provisional) Microphthalmia,isolated 5|Nanophthalmos 2];	RCV000153496.2 [benign]; 		COSM4145393	947	77					MFRP (inh=n/a pLI=0.00), C1QTNF5 (inh=n/a pLI=0.83)
chr11	119216504	119216504	C	T	het		QUAL=1596;DP=86;AF=0.44;MQM=59;TRIO=HET,86,0.44,HOM,24,1.00,WT,38,0.03	MFRP,C1QTNF5	missense,5'UTR_premature_start_codon_gain,5'UTR	MFRP:NM_031433.3:missense:MODERATE:exon4/15:c.406G>A:p.Val136Met,C1QTNF5:NM_015645.4:5'UTR_premature_start_codon_gain:LOW:exon4/15:c.-2231G>A:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon4/15:c.-2231G>A:		rs3814762	0.1821	0.2650	4745/3585/43	0.2651	-1.8680	T	T,T,T	B,B	B,B	606227 [MFRP (provisional) Microphthalmia,isolated 5|Nanophthalmos 2];	RCV000153499.3 [benign]; 			119	432					MFRP (inh=n/a pLI=0.00), C1QTNF5 (inh=n/a pLI=0.83)
chr11	119217254	119217254	C	T	het		QUAL=9480;DP=259;AF=0.49;MQM=59;TRIO=HET,259,0.49,HOM,207,1.00,WT,323,0.00	MFRP,C1QTNF5	5'UTR	MFRP:NM_031433.3:5'UTR:MODIFIER:exon1/15:c.-31G>A:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon1/15:c.-2667G>A:		rs883247	0.6356	0.5940	21471/11104/1496	0.5865										125	131					MFRP (inh=n/a pLI=0.00), C1QTNF5 (inh=n/a pLI=0.83)
chr11	119217311	119217311	G	A	het		QUAL=7836;DP=208;AF=0.53;MQM=60;TRIO=HET,208,0.53,HOM,171,1.00,WT,276,0.01	MFRP,C1QTNF5	5'UTR_premature_start_codon_gain,5'UTR	MFRP:NM_031433.3:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-88C>T:,C1QTNF5:NM_015645.4:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-2724C>T:,MFRP:NM_031433.3:5'UTR:MODIFIER:exon1/15:c.-88C>T:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon1/15:c.-2724C>T:		rs883245	0.5839	0.0000	0/0/0	0.0938										56	65					MFRP (inh=n/a pLI=0.00), C1QTNF5 (inh=n/a pLI=0.83)
chr11	119510644	119510644	A	C	hom		QUAL=23199;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HOM,196,1.00,HOM,313,1.00	PVRL1	missense	PVRL1:NM_203285.1:missense:MODERATE:exon6/8:c.1082T>G:p.Val361Gly		rs7940667	0.8728	0.9160	51183/28172/2686	0.9070	0.0680	T	T	B	B	600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7];		CM066206 [CLASS=DP MUT=ALT PHEN="Cleft lip / palate association with" GENE=PVRL1]; 		972	132					PVRL1 (inh=n/a pLI=0.50)
chr11	119545224	119545224	-	G	het		QUAL=3997;DP=112;AF=0.47;MQM=59;TRIO=HET,112,0.47,HOM,114,0.98,WT,156,0.00	PVRL1	3'UTR,intron	PVRL1:NM_203286.1:3'UTR:MODIFIER:exon6/6:c.*77dupC:,PVRL1:NM_002855.4:intron:MODIFIER:exon5/5:c.1003+644dupC:,PVRL1:NM_203285.1:intron:MODIFIER:exon5/7:c.1003+644dupC:		rs113705862;rs534319501;rs763447380	0.1040	0.0000	0/0/0	0.0354						600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7];				1	37					PVRL1 (inh=n/a pLI=0.50)
chr11	121178302	121178302	A	C	het		QUAL=14865;DP=274;AF=0.54;MQM=60;TRIO=HET,274,0.54,HET,195,0.45,HOM,273,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*81A>C:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*81A>C:		rs1061332	0.7246	0.0000	0/0/0	0.1395										110	95					SC5D (inh=n/a pLI=0.10)
chr11	121179847	121179847	A	T	het		QUAL=18253;DP=325;AF=0.54;MQM=60;TRIO=HET,325,0.54,HET,234,0.51,HOM,323,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*1626A>T:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*1626A>T:	MLT1J2	rs2060008	0.4221	0.0000	0/0/0	0.4887										60	108					SC5D (inh=n/a pLI=0.10)
chr11	121181184	121181184	G	T	hom		QUAL=3699;DP=110;AF=0.00;MQM=60;TRIO=HOM,110,0.00,HOM,28,0.14,HOM,64,0.03	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*2963G>T:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*2963G>T:	AluY		0.0000	0.0000	0/0/0	0.0001										0	0					SC5D (inh=n/a pLI=0.10)
chr11	121183145	121183145	T	C	het		QUAL=6409;DP=192;AF=0.49;MQM=59;TRIO=HET,192,0.49,HET,69,0.61,HOM,80,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*4924T>C:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*4924T>C:		rs35288685	0.3934	0.0000	0/0/0	0.4671										60	111					SC5D (inh=n/a pLI=0.10)
chr11	126139100	126139100	T	C	hom		QUAL=24943;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,285,1.00,HOM,347,1.00	FOXRED1	5'UTR,non_coding_exon	FOXRED1:NM_017547.3:5'UTR:MODIFIER:exon1/11:c.-2T>C:,FOXRED1:NR_037647.1:non_coding_exon:MODIFIER:exon1/10:n.166T>C:,FOXRED1:NR_037648.1:non_coding_exon:MODIFIER:exon1/11:n.61T>C:		rs1786702	0.7861	0.7880	38033/19007/1620	0.7422										654	372					FOXRED1 (inh=AR pLI=0.00)
chr11	126146290	126146290	T	G	het	phylop_high;pred_pathogenic_3	QUAL=281;DP=48;AF=0.67;MQM=59;TRIO=HET,48,0.67,WT,62,0.13,WT,82,0.16	FOXRED1	missense&splice_region,splice_region&non_coding_exon	FOXRED1:NM_017547.3:missense&splice_region:MODERATE:exon9/11:c.973T>G:p.Tyr325Asp,FOXRED1:NR_037647.1:splice_region&non_coding_exon:LOW:exon8/10:n.919T>G:,FOXRED1:NR_037648.1:splice_region&non_coding_exon:LOW:exon9/11:n.1159T>G:		rs201062084	0.2644	0.3600	0/0/0	0.0086	7.1660	D	D,D,D	B,D,B	B,P,B	613622 [FOXRED1 (provisional) Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial complex I deficiency];			COSM3746238	0	82					FOXRED1 (inh=AR pLI=0.00)
chr11	126147697	126147697	G	A	het		QUAL=6022;DP=196;AF=0.40;MQM=60;TRIO=HET,196,0.40,HET,157,0.45,HET,225,0.47	FOXRED1	3'UTR,non_coding_exon	FOXRED1:NM_017547.3:3'UTR:MODIFIER:exon11/11:c.*113G>A:,FOXRED1:NR_037647.1:non_coding_exon:MODIFIER:exon10/10:n.1520G>A:,FOXRED1:NR_037648.1:non_coding_exon:MODIFIER:exon11/11:n.1760G>A:		rs667627	0.1314	0.1790	1917/1466/51	0.1760										29	224					FOXRED1 (inh=AR pLI=0.00)
chr11	126293799	126293799	C	G	het		QUAL=2156;DP=78;AF=0.45;MQM=59;TRIO=HET,78,0.45,HOM,50,0.98,WT,61,0.00	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*676G>C:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*676G>C:		rs948053	0.5783	0.0000	0/0/0	0.0935										69	111					KIRREL3 (inh=n/a pLI=0.98)
chr11	126294080	126294080	C	G	hom		QUAL=12747;DP=135;AF=0.99;MQM=59;TRIO=HOM,135,0.99,HOM,125,0.98,HOM,147,0.99	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*395G>C:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*395G>C:		rs7113456	0.7179	0.0000	0/0/0	0.6457										84	122					KIRREL3 (inh=n/a pLI=0.98)
chr11	126294237	126294237	G	A	het		QUAL=3821;DP=138;AF=0.47;MQM=59;TRIO=HET,138,0.47,WT,159,0.01,HET,200,0.50	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*238C>T:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*238C>T:		rs34642230	0.1190	0.0000	0/0/0	0.0195										2	51					KIRREL3 (inh=n/a pLI=0.98)
chr11	126294261	126294261	T	C	het		QUAL=8927;DP=172;AF=0.48;MQM=60;TRIO=HET,172,0.48,WT,180,0.00,HOM,230,0.99	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*214A>G:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*214A>G:		rs3802815	0.3874	0.0000	0/0/0	0.0634										40	95					KIRREL3 (inh=n/a pLI=0.98)
chr11	126294817	126294817	G	A	hom		QUAL=10398;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HOM,146,0.99,HOM,189,1.00	KIRREL3	synonymous	KIRREL3:NM_032531.3:synonymous:LOW:exon17/17:c.1995C>T:p.Gly665Gly,KIRREL3:NM_001301097.1:synonymous:LOW:exon16/16:c.1959C>T:p.Gly653Gly		rs948052	0.7037	0.6640	26534/13761/2444	0.6536						607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4];	RCV000117432.2 [likely benign]; 			521	468					KIRREL3 (inh=n/a pLI=0.98)
chr11	128708423	128708423	G	A	het		QUAL=8161;DP=420;AF=0.49;MQM=60;TRIO=HET,420,0.49,HET,231,0.45,WT,268,0.00	KCNJ1	3'UTR	KCNJ1:NM_000220.4:3'UTR:MODIFIER:exon2/2:c.*597C>T:,KCNJ1:NM_153764.2:3'UTR:MODIFIER:exon2/2:c.*597C>T:,KCNJ1:NM_153765.2:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:NM_153766.2:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:NM_153767.3:3'UTR:MODIFIER:exon4/4:c.*597C>T:		rs117189807	0.0108	0.0000	0/0/0	0.0031										0	7					KCNJ1 (inh=AR pLI=0.00)
chr11	128737188	128737188	A	G	hom		QUAL=30920;DP=378;AF=1.00;MQM=59;TRIO=HOM,378,1.00,HOM,222,1.00,HOM,338,1.00	KCNJ1	5'UTR	KCNJ1:NM_153764.2:5'UTR:MODIFIER:exon1/2:c.-142T>C:,KCNJ1:NM_153765.2:5'UTR:MODIFIER:exon1/3:c.-224T>C:,KCNJ1:NM_153766.2:5'UTR:MODIFIER:exon1/3:c.-312T>C:,KCNJ1:NM_153767.3:5'UTR:MODIFIER:exon1/4:c.-445T>C:		rs2855790	0.8185	0.0000	0/0/0	0.8297										171	54					KCNJ1 (inh=AR pLI=0.00)
chr12	431586	431586	T	A	het	phylop_high	QUAL=3006;DP=105;AF=0.56;MQM=60;TRIO=HET,105,0.56,WT,110,0.00,HET,154,0.44	KDM5A	missense	KDM5A:NM_001042603.2:missense:MODERATE:exon17/28:c.2423A>T:p.His808Leu		rs74894801	0.0084	0.0160	22/17/0	0.0169	5.8510	T	T,T,T,T,T	B,B,B	B,B,B					1	40					KDM5A (inh=n/a pLI=1.00)
chr12	498282	498283	GT	-	hom	low_DP	QUAL=1201;DP=5;AF=0.00;MQM=51;TRIO=HOM,5,0.00,WT,15,0.00,HOM,71,0.11	KDM5A	5'UTR	KDM5A:NM_001042603.2:5'UTR:MODIFIER:exon1/28:c.-26_-25delAC:		rs796202342	0.0000	0.0063	0/0/0	0.0002										2	4					KDM5A (inh=n/a pLI=1.00)
chr12	862641	862641	T	G	het		QUAL=1290;DP=36;AF=0.64;MQM=59;TRIO=HET,36,0.64,WT,68,0.00,HET,79,0.47	WNK1	5'UTR	WNK1:NM_001184985.1:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:NM_014823.2:5'UTR:MODIFIER:exon1/26:c.-91T>G:,WNK1:NM_018979.3:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:NM_213655.4:5'UTR:MODIFIER:exon1/28:c.-91T>G:		rs3088353	0.3399	0.0000	0/0/0	0.0689										45	112					WNK1 (inh=n/a pLI=1.00)
chr12	862989	862989	T	C	hom		QUAL=10318;DP=118;AF=1.00;MQM=59;TRIO=HOM,118,1.00,HOM,98,1.00,HOM,116,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:NM_014823.2:synonymous:LOW:exon1/26:c.258T>C:p.Cys86Cys,WNK1:NM_018979.3:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:NM_213655.4:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys		rs3168640	0.9756	0.9920	58554/32517/4124	0.9257						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				1107	0					WNK1 (inh=n/a pLI=1.00)
chr12	863152	863152	G	A	het	phylop_high;pred_pathogenic_1	QUAL=3792;DP=153;AF=0.53;MQM=59;TRIO=HET,153,0.53,WT,112,0.00,HET,207,0.46	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:NM_014823.2:missense:MODERATE:exon1/26:c.421G>A:p.Ala141Thr,WNK1:NM_018979.3:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:NM_213655.4:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr		rs11554421	0.0745	0.1070	689/375/6	0.0989	2.0540	T	D,D,D,D,D	B,B,B	B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126341.1 [benign]; 		COSM3753517, COSM3753516	29	232					WNK1 (inh=n/a pLI=1.00)
chr12	939302	939302	A	G	hom		QUAL=33876;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,395,1.00,HOM,412,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:NM_014823.2:synonymous:LOW:exon4/26:c.1287A>G:p.Ala429Ala,WNK1:NM_018979.3:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:NM_213655.4:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala		rs10774466	0.6935	0.7450	34121/19376/1544	0.7283						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM3753538	592	437					WNK1 (inh=n/a pLI=1.00)
chr12	968489	968489	T	C	het		QUAL=4595;DP=250;AF=0.38;MQM=60;TRIO=HET,250,0.38,WT,172,0.00,HET,210,0.45	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:NM_014823.2:synonymous:LOW:exon6/26:c.1479T>C:p.Asp493Asp,WNK1:NM_018979.3:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:NM_213655.4:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp		rs2286006	0.0935	0.1480	1643/1002/17	0.1418						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126337.1 [benign]; 		COSM3753547, COSM3753546	37	300					WNK1 (inh=n/a pLI=1.00)
chr12	974355	974355	-	C	hom	anno_high_impact	QUAL=11265;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HET,135,0.50,HOM,199,0.99	WNK1	frameshift,intron	WNK1:NM_213655.4:frameshift:HIGH:exon9/28:c.2220dupC:p.Phe741fs,WNK1:NM_001184985.1:intron:MODIFIER:exon8/27:c.2140-2676dupC:,WNK1:NM_014823.2:intron:MODIFIER:exon8/25:c.2139+2920dupC:,WNK1:NM_018979.3:intron:MODIFIER:exon8/27:c.2139+2920dupC:		rs397768556	0.5184	0.4810	1852/575/64	0.1412						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				360	446	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			WNK1 (inh=n/a pLI=1.00)
chr12	974404	974404	T	C	hom		QUAL=17910;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HOM,227,0.99,HET,363,0.43	WNK1	synonymous,intron	WNK1:NM_213655.4:synonymous:LOW:exon9/28:c.2268T>C:p.Pro756Pro,WNK1:NM_001184985.1:intron:MODIFIER:exon8/27:c.2140-2628T>C:,WNK1:NM_014823.2:intron:MODIFIER:exon8/25:c.2139+2968T>C:,WNK1:NM_018979.3:intron:MODIFIER:exon8/27:c.2139+2968T>C:		rs7300829	0.6540	0.5540	2301/609/144	0.1660						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				306	466					WNK1 (inh=n/a pLI=1.00)
chr12	987482	987482	G	A	hom		QUAL=10681;DP=172;AF=0.99;MQM=59;TRIO=HOM,172,0.99,HOM,66,1.00,HOM,101,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon11/28:c.3567G>A:p.Gln1189Gln,WNK1:NM_014823.2:synonymous:LOW:exon10/26:c.2325G>A:p.Gln775Gln,WNK1:NM_018979.3:synonymous:LOW:exon10/28:c.2328G>A:p.Gln776Gln,WNK1:NM_213655.4:synonymous:LOW:exon12/28:c.3822G>A:p.Gln1274Gln		rs1012729	0.6795	0.7340	33053/19022/1583	0.7206	-0.8680	T				605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM3753549, COSM3753548	570	456					WNK1 (inh=n/a pLI=1.00)
chr12	987533	987533	-	T	het		QUAL=1393;DP=111;AF=0.59;MQM=59;TRIO=HET,111,0.59,HOM,25,0.72,HOM,42,0.64	WNK1	intron	WNK1:NM_001184985.1:intron:MODIFIER:exon11/27:c.3612+21dupT:,WNK1:NM_014823.2:intron:MODIFIER:exon10/25:c.2370+21dupT:,WNK1:NM_018979.3:intron:MODIFIER:exon10/27:c.2373+21dupT:,WNK1:NM_213655.4:intron:MODIFIER:exon12/27:c.3867+21dupT:		rs398116010;rs570861980;rs5795952	0.4421	0.4440	481/279/35	0.0640						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000202746.1,RCV000202746.1 [benign,benign]; 			103	626					WNK1 (inh=n/a pLI=1.00)
chr12	990912	990912	A	C	het		QUAL=19731;DP=400;AF=0.50;MQM=60;TRIO=HET,400,0.50,HOM,286,1.00,HET,374,0.53	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon13/28:c.3946A>C:p.Thr1316Pro,WNK1:NM_014823.2:missense:MODERATE:exon11/26:c.2425A>C:p.Thr809Pro,WNK1:NM_018979.3:missense:MODERATE:exon13/28:c.3166A>C:p.Thr1056Pro,WNK1:NM_213655.4:missense:MODERATE:exon13/28:c.3922A>C:p.Thr1308Pro		rs956868	0.8528	0.8310	42059/23307/3857	0.8287	0.0100	T,T	.,T,T,T,T,T,T	.,B,B,B	.,B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];		CM065520 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=WNK1]; 		764	301					WNK1 (inh=n/a pLI=1.00)
chr12	993930	993930	C	T	het		QUAL=14198;DP=317;AF=0.51;MQM=60;TRIO=HET,317,0.51,HOM,215,1.00,HET,262,0.47	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon19/28:c.4740C>T:p.Asn1580Asn,WNK1:NM_014823.2:synonymous:LOW:exon17/26:c.3219C>T:p.Asn1073Asn,WNK1:NM_018979.3:synonymous:LOW:exon19/28:c.3960C>T:p.Asn1320Asn,WNK1:NM_213655.4:synonymous:LOW:exon19/28:c.4716C>T:p.Asn1572Asn		rs7300444	0.3990	0.4190	10950/6561/457	0.4188						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126339.1 [benign]; 		COSM3753553, COSM3753554	208	492					WNK1 (inh=n/a pLI=1.00)
chr12	994014	994014	C	T	het		QUAL=6000;DP=257;AF=0.53;MQM=59;TRIO=HET,257,0.53,WT,180,0.00,HET,223,0.47	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon19/28:c.4824C>T:p.Thr1608Thr,WNK1:NM_014823.2:synonymous:LOW:exon17/26:c.3303C>T:p.Thr1101Thr,WNK1:NM_018979.3:synonymous:LOW:exon19/28:c.4044C>T:p.Thr1348Thr,WNK1:NM_213655.4:synonymous:LOW:exon19/28:c.4800C>T:p.Thr1600Thr		rs10849577	0.1158	0.1550	1649/900/14	0.1486						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126340.1 [benign]; 		COSM3998995, COSM3998996	36	291					WNK1 (inh=n/a pLI=1.00)
chr12	994487	994487	G	C	hom		QUAL=30159;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,190,1.00,HOM,255,1.00	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon19/28:c.5297G>C:p.Cys1766Ser,WNK1:NM_014823.2:missense:MODERATE:exon17/26:c.3776G>C:p.Cys1259Ser,WNK1:NM_018979.3:missense:MODERATE:exon19/28:c.4517G>C:p.Cys1506Ser,WNK1:NM_213655.4:missense:MODERATE:exon19/28:c.5273G>C:p.Cys1758Ser		rs7955371	0.9868	0.9960	60269/33358/4809	0.9326	0.1530	T	T,T,T,T,T,T	B,B,B	B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				1106	2					WNK1 (inh=n/a pLI=1.00)
chr12	1017197	1017197	C	T	hom		QUAL=26695;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,274,1.00,HOM,373,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon27/28:c.7608C>T:p.Tyr2536Tyr,WNK1:NM_014823.2:synonymous:LOW:exon25/26:c.6084C>T:p.Tyr2028Tyr,WNK1:NM_018979.3:synonymous:LOW:exon27/28:c.6828C>T:p.Tyr2276Tyr,WNK1:NM_213655.4:synonymous:LOW:exon27/28:c.7584C>T:p.Tyr2528Tyr		rs4766334	0.9870	0.9960	59903/33156/4714	0.9392						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM4146468, COSM4146469	1104	3					WNK1 (inh=n/a pLI=1.00)
chr12	1019453	1019453	-	ATC	het		QUAL=12313;DP=353;AF=0.44;MQM=59;TRIO=HET,353,0.44,HOM,150,1.00,HET,239,0.53	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*1496_*1498dupATC:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:		rs3072752;rs397783428	0.0000	0.0000	0/0/0	0.2928										24	98					WNK1 (inh=n/a pLI=1.00)
chr12	1019944	1019944	G	A	hom		QUAL=25808;DP=339;AF=1.00;MQM=60;TRIO=HOM,339,1.00,HOM,203,1.00,HOM,244,1.00	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*1986G>A:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*1986G>A:		rs2023944	0.9872	0.0000	0/0/0	0.1488										230	0					WNK1 (inh=n/a pLI=1.00)
chr12	1020266	1020266	T	C	het		QUAL=8066;DP=391;AF=0.47;MQM=60;TRIO=HET,391,0.47,WT,149,0.00,HET,213,0.56	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*2308T>C:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*2308T>C:		rs1060499	0.1192	0.0000	0/0/0	0.0233										9	68					WNK1 (inh=n/a pLI=1.00)
chr12	5020435	5020435	G	A	het		QUAL=1067;DP=59;AF=0.47;MQM=60;TRIO=HET,59,0.47,HET,49,0.51,WT,86,0.00	KCNA1	5'UTR	KCNA1:NM_000217.2:5'UTR:MODIFIER:exon2/2:c.-110G>A:		rs35678382	0.1583	0.0000	0/0/0	0.1309										6	49					KCNA1 (inh=n/a pLI=0.05)
chr12	5021984	5021984	T	A	het		QUAL=14967;DP=262;AF=0.56;MQM=60;TRIO=HET,262,0.56,HOM,360,1.00,WT,427,0.00	KCNA1	synonymous	KCNA1:NM_000217.2:synonymous:LOW:exon2/2:c.1440T>A:p.Thr480Thr		rs4766309	0.8205	0.7380	33542/15798/3831	0.7071						176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome];	RCV000117314.3 [other]; 			1037	977	1	[1] Julia Bickmann 23.09.2014	n/a (1xTP, 0xFP)		KCNA1 (inh=n/a pLI=0.05)
chr12	5026471	5026471	C	T	het		QUAL=13343;DP=356;AF=0.49;MQM=60;TRIO=HET,356,0.49,HOM,269,0.99,WT,339,0.00	KCNA1	3'UTR	KCNA1:NM_000217.2:3'UTR:MODIFIER:exon2/2:c.*4439C>T:		rs12424292	0.2438	0.0000	0/0/0	0.2186										11	73					KCNA1 (inh=n/a pLI=0.05)
chr12	6457062	6457062	T	C	hom		QUAL=8153;DP=107;AF=1.00;MQM=59;TRIO=HOM,107,1.00,HOM,113,1.00,HET,131,0.46	SCNN1A	missense	SCNN1A:NM_001159576.1:missense:MODERATE:exon12/12:c.2164A>G:p.Thr722Ala,SCNN1A:NM_001038.5:missense:MODERATE:exon13/13:c.1987A>G:p.Thr663Ala,SCNN1A:NM_001159575.1:missense:MODERATE:exon13/13:c.2056A>G:p.Thr686Ala		rs2228576	0.7406	0.6800	22085/10769/2783	0.6427	-0.5860	T	T,T,T,T,T	B,B,B	B,B,B	600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 2];	RCV000151811.2 [benign]; 	CM994637 [CLASS=DFP MUT=ALT PHEN="Hypertension reduced risk association with" GENE=SCNN1A]; 	COSM1747194	546	411					SCNN1A (inh=n/a pLI=0.00)
chr12	6484709	6484709	T	C	het		QUAL=1098;DP=22;AF=0.55;MQM=60;TRIO=HET,22,0.55,WT,30,0.00,HOM,29,1.00	SCNN1A,LTBR	5'UTR,intron	SCNN1A:NM_001038.5:5'UTR:MODIFIER:exon1/13:c.-93A>G:,LTBR:NM_001270987.1:5'UTR:MODIFIER:exon1/10:c.-13T>C:,SCNN1A:NM_001159575.1:intron:MODIFIER:exon1/12:c.16-706A>G:		rs10849447	0.7568	0.4560	1920/204/73	0.1404						600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 2];				116	239					SCNN1A (inh=n/a pLI=0.00), LTBR (inh=n/a pLI=0.43)
chr12	7045178	7045178	G	A	het	phylop_high;pred_pathogenic_1	QUAL=918;DP=29;AF=0.66;MQM=60;TRIO=HET,29,0.66,HET,55,0.38,WT,69,0.00	ATN1	missense	ATN1:NM_001007026.1:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser,ATN1:NM_001940.3:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser		rs148694613	0.0030	0.0062	5/5/0	0.0065	2.6350	T	D,D,D	B,B	B,B	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy];				0	16					ATN1 (inh=n/a pLI=1.00)
chr12	7048292	7048292	C	T	het	phylop_high;pred_pathogenic_2;trio_denovo	QUAL=2234;DP=215;AF=0.46;MQM=60;TRIO=HET,215,0.46,WT,303,0.00,WT,420,0.00	ATN1	missense	ATN1:NM_001007026.1:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr,ATN1:NM_001940.3:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr	(CACCAG)n		0.0000	0.0000	0/0/0	0.0000	7.6510	D	D,D,D,D	P	P	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy];				0	0					ATN1 (inh=n/a pLI=1.00)
chr12	7242204	7242204	C	T	het		QUAL=3000;DP=121;AF=0.40;MQM=60;TRIO=HET,121,0.40,HOM,69,0.96,WT,94,0.00	C1R	missense	C1R:NM_001733.4:missense:MODERATE:exon4/9:c.550G>A:p.Glu184Lys		rs1126605	0.1749	0.1170	1215/265/109	0.1168	-0.4440	T	T,T,T,T,T,T	B,B,B	B,B,B	613785 [C1R (confirmed) C1r/C1s deficiency,combined];				16	182					C1R (inh=n/a pLI=n/a)
chr12	7242299	7242299	G	A	het		QUAL=2242;DP=125;AF=0.53;MQM=59;TRIO=HET,125,0.53,WT,61,0.02,HET,74,0.39	C1R	missense	C1R:NM_001733.4:missense:MODERATE:exon4/9:c.455C>T:p.Ser152Leu		rs1801046	0.2392	0.2320	3593/1941/159	0.2303	0.0160	T	T,T,T,T,T,T,T,T,T	B,B,B	B,B,B	613785 [C1R (confirmed) C1r/C1s deficiency,combined];				54	394					C1R (inh=n/a pLI=n/a)
chr12	7363574	7363574	C	G	het		QUAL=11760;DP=280;AF=0.50;MQM=59;TRIO=HET,280,0.50,HOM,261,1.00,WT,270,0.00	PEX5	3'UTR,intron	PEX5:NM_001300789.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_001131023.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_001131024.1:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:NM_001131025.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_000319.4:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:NM_001131026.1:intron:MODIFIER:exon17/17:c.*19+736C>G:		rs1057225	0.4321	0.0000	0/0/0	0.4912										39	69					PEX5 (inh=AR pLI=0.40)
chr12	8755737	8755737	C	T	hom		QUAL=3179;DP=24;AF=0.00;MQM=60;TRIO=HOM,24,0.00,HOM,15,0.07,HOM,27,0.15	AICDA	3'UTR	AICDA:NM_020661.2:3'UTR:MODIFIER:exon5/5:c.*1143G>A:	(TTCTCT)n		0.0000	0.0000	0/0/0	0.0001										0	0					AICDA (inh=n/a pLI=0.00)
chr12	8757481	8757481	G	A	het		QUAL=2804;DP=195;AF=0.42;MQM=59;TRIO=HET,195,0.42,HET,31,0.48,HET,70,0.31	AICDA	synonymous	AICDA:NM_020661.2:synonymous:LOW:exon4/5:c.465C>T:p.His155His		rs2028373	0.4842	0.5890	21560/13501/541	0.5602	-0.1680	T				605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2];				426	488					AICDA (inh=n/a pLI=0.00)
chr12	8757522	8757522	-	A	hom		QUAL=911;DP=36;AF=0.56;MQM=59;TRIO=HOM,36,0.56,HOM,11,0.91,HOM,30,0.83	AICDA	splice_region&intron	AICDA:NM_020661.2:splice_region&intron:LOW:exon3/4:c.428-5dupT:		rs397718057;rs5796316	0.6424	0.5740	6110/3495/306	0.0883						605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2];				173	580	1	[1] old entry - no details available			AICDA (inh=n/a pLI=0.00)
chr12	8765447	8765447	T	C	hom		QUAL=34885;DP=384;AF=1.00;MQM=60;TRIO=HOM,384,1.00,HOM,284,1.00,HOM,413,1.00	AICDA-MFAP5	intergenic_region	AICDA-MFAP5:AICDA-MFAP5:intergenic_region:MODIFIER::n.8765447T>C:		rs1345004	0.9954	0.0000	0/0/0	0.1526										479	2					AICDA-MFAP5 (inh=n/a pLI=n/a)
chr12	13714729	13714729	T	C	hom		QUAL=28867;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HOM,205,1.00,HOM,270,1.00	GRIN2B	3'UTR	GRIN2B:NM_000834.3:3'UTR:MODIFIER:exon13/13:c.*988A>G:		rs1805477	0.8914	0.0000	0/0/0	0.1446										423	3					GRIN2B (inh=AD pLI=1.00)
chr12	13715308	13715308	A	C	het		QUAL=8140;DP=414;AF=0.49;MQM=60;TRIO=HET,414,0.49,HET,203,0.50,WT,308,0.01	GRIN2B	3'UTR	GRIN2B:NM_000834.3:3'UTR:MODIFIER:exon13/13:c.*409T>G:		rs890	0.2750	0.0000	0/0/0	0.0719										98	222					GRIN2B (inh=AD pLI=1.00)
chr12	13716638	13716638	G	A	het		QUAL=6448;DP=238;AF=0.39;MQM=59;TRIO=HET,238,0.39,WT,306,0.00,HET,350,0.48	GRIN2B	synonymous	GRIN2B:NM_000834.3:synonymous:LOW:exon13/13:c.3534C>T:p.His1178His		rs1806191	0.2476	0.3910	10739/8298/201	0.3914						138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6|Epileptic encephalopathy,early infantile,27];	RCV000117197.2 [likely benign]; 		COSM4146926	315	639					GRIN2B (inh=AD pLI=1.00)
chr12	14019157	14019157	C	T	het		QUAL=1380;DP=79;AF=0.43;MQM=59;TRIO=HET,79,0.43,WT,47,0.00,HET,54,0.54	GRIN2B	5'UTR	GRIN2B:NM_000834.3:5'UTR:MODIFIER:exon2/13:c.-15G>A:		rs12818068	0.0379	0.0790	509/440/1	0.0792							RCV000125318.2 [benign]; 			9	124					GRIN2B (inh=AD pLI=1.00)
chr12	25358650	25358650	A	T	hom		QUAL=10937;DP=265;AF=1.00;MQM=57;TRIO=HOM,265,1.00,HOM,47,1.00,HET,64,0.50	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4200T>A:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*4079T>A:		rs12245	0.5483	0.0000	0/0/0	0.5422								CR1010511 [CLASS=DP MUT=ALT PHEN="Ovarian cancer increased risk association with" GENE=KRAS]; 		73	130					KRAS (inh=n/a pLI=0.00)
chr12	25358663	25358664	TT	-	hom		QUAL=8471;DP=235;AF=0.99;MQM=56;TRIO=HOM,235,0.99,HOM,37,1.00,HET,53,0.49	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4186_*4187delAA:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*4065_*4066delAA:		rs57698689;rs796922820	0.5435	0.0000	0/0/0	0.4391										70	128					KRAS (inh=n/a pLI=0.00)
chr12	25358828	25358828	T	G	hom		QUAL=7935;DP=143;AF=1.00;MQM=60;TRIO=HOM,143,1.00,HOM,61,1.00,HET,74,0.54	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4022A>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3901A>C:		rs12587	0.5483	0.0000	0/0/0	0.5650										68	130					KRAS (inh=n/a pLI=0.00)
chr12	25358943	25358943	T	C	hom		QUAL=15667;DP=367;AF=0.99;MQM=59;TRIO=HOM,367,0.99,HOM,77,1.00,HET,102,0.46	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3907A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3786A>G:		rs8720	0.5485	0.0000	0/0/0	0.5578										68	128					KRAS (inh=n/a pLI=0.00)
chr12	25358969	25358969	T	G	hom		QUAL=12878;DP=297;AF=0.99;MQM=59;TRIO=HOM,297,0.99,HOM,63,1.00,HET,93,0.49	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3881A>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3760A>C:		rs1137196	0.4333	0.0000	0/0/0	0.4646										54	116					KRAS (inh=n/a pLI=0.00)
chr12	25359328	25359328	A	T	hom		QUAL=11447;DP=199;AF=0.99;MQM=59;TRIO=HOM,199,0.99,HOM,93,1.00,HET,153,0.42	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3522T>A:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3401T>A:		rs1137189	0.5481	0.0000	0/0/0	0.0770										68	130					KRAS (inh=n/a pLI=0.00)
chr12	25359352	25359352	G	A	hom		QUAL=11558;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HOM,76,0.99,HET,136,0.44	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3498C>T:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3377C>T:		rs1137188	0.5485	0.0000	0/0/0	0.5418										68	130					KRAS (inh=n/a pLI=0.00)
chr12	25359465	25359465	A	-	hom		QUAL=14928;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,105,1.00,HET,172,0.45	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3385delT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3264delT:		rs796285705	0.5485	0.0000	0/0/0	0.4990										69	130					KRAS (inh=n/a pLI=0.00)
chr12	25359841	25359841	T	C	hom		QUAL=6843;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,18,1.00,HET,38,0.55	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3009A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2888A>G:		rs13096	0.5256	0.0000	0/0/0	0.5579										67	130					KRAS (inh=n/a pLI=0.00)
chr12	25360138	25360138	T	C	hom		QUAL=31421;DP=309;AF=0.99;MQM=59;TRIO=HOM,309,0.99,HOM,263,1.00,HOM,405,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*2712A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2591A>G:	L2a	rs4963858	0.9886	0.0000	0/0/0	0.8760										263	1					KRAS (inh=n/a pLI=0.00)
chr12	25360449	25360449	-	A	het		QUAL=4164;DP=136;AF=0.71;MQM=59;TRIO=HET,136,0.71,HOM,38,0.84,HOM,41,0.83	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*2400dupT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2279dupT:	AluSz	rs397747594	0.8788	0.0000	0/0/0	0.6037										43	214					KRAS (inh=n/a pLI=0.00)
chr12	25361091	25361091	T	C	hom		QUAL=17642;DP=287;AF=1.00;MQM=59;TRIO=HOM,287,1.00,HOM,120,1.00,HOM,157,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*1759A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*1638A>G:		rs4597149	0.9974	0.0000	0/0/0	0.5453										264	0					KRAS (inh=n/a pLI=0.00)
chr12	25361101	25361101	-	A	het		QUAL=8155;DP=240;AF=0.78;MQM=59;TRIO=HET,240,0.78,HOM,92,0.91,HET,129,0.43	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*1748dupT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*1627dupT:		rs398116239	0.5711	0.0000	0/0/0	0.3700										33	174					KRAS (inh=n/a pLI=0.00)
chr12	25362217	25362217	A	G	hom		QUAL=14119;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,103,1.00,HET,149,0.48	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*633T>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*512T>C:		rs9266	0.5491	0.5240	2234/513/17	0.1501										178	317					KRAS (inh=n/a pLI=0.00)
chr12	25362465	25362465	G	A	hom		QUAL=19026;DP=324;AF=1.00;MQM=58;TRIO=HOM,324,1.00,HOM,114,1.00,HOM,163,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*385C>T:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*264C>T:		rs4285970	0.9972	0.0000	0/0/0	0.1502										314	0					KRAS (inh=n/a pLI=0.00)
chr12	25362552	25362552	A	C	hom		QUAL=14601;DP=266;AF=0.99;MQM=60;TRIO=HOM,266,0.99,HOM,109,1.00,HET,171,0.51	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*298T>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*177T>G:		rs712	0.5206	0.0000	0/0/0	0.5578										71	131					KRAS (inh=n/a pLI=0.00)
chr12	25368462	25368462	C	T	hom		QUAL=14340;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,93,1.00,HOM,146,1.00	KRAS	synonymous,intron	KRAS:NM_033360.3:synonymous:LOW:exon5/6:c.483G>A:p.Arg161Arg,KRAS:NM_004985.4:intron:MODIFIER:exon4/4:c.451-5617G>A:		rs4362222	0.9976	1.0000	60632/33359/5147	0.9349						190070 [KRAS (confirmed) Lung cancer,somatic|Bladder cancer,somatic|Pancreatic carcinoma,somatic|Gastric cancer,somatic|Leukemia,acute myeloid|Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|Breast cancer,somatic|Schimmelpenning-feuerstein-Mims syndrome,somatic mosaic|RAS-associated autoimmune leukoproliferative disorder];	RCV000150886.1 [benign]; RCV000039808.2 [benign]; RCV000149847.3 [benign]; 			1226	0					KRAS (inh=n/a pLI=0.00)
chr12	31226934	31226934	C	T	het	low_MQM	QUAL=52;DP=85;AF=0.25;MQM=44;TRIO=HET,85,0.25,WT,211,0.00,WT,258,0.02	DDX11	5'UTR,intron	DDX11:NM_004399.2:5'UTR:MODIFIER:exon1/26:c.-96C>T:,DDX11:NM_030653.3:5'UTR:MODIFIER:exon1/27:c.-96C>T:,DDX11:NM_152438.1:5'UTR:MODIFIER:exon1/27:c.-96C>T:,DDX11:NM_001257144.1:intron:MODIFIER:exon1/26:c.-5+31C>T:,DDX11:NM_001257145.1:intron:MODIFIER:exon1/26:c.-10+31C>T:		rs74087917	0.0000	0.0000	0/0/0	0.0007										0	76					DDX11 (inh=AR pLI=n/a)
chr12	31256995	31256995	G	A	hom		QUAL=12123;DP=181;AF=0.98;MQM=50;TRIO=HOM,181,0.98,HOM,142,1.00,HET,197,0.53	DDX11	3'UTR	DDX11:NM_001257144.1:3'UTR:MODIFIER:exon27/27:c.*28G>A:,DDX11:NM_001257145.1:3'UTR:MODIFIER:exon27/27:c.*225G>A:,DDX11:NM_004399.2:3'UTR:MODIFIER:exon26/26:c.*225G>A:,DDX11:NM_030653.3:3'UTR:MODIFIER:exon27/27:c.*225G>A:,DDX11:NM_152438.1:3'UTR:MODIFIER:exon27/27:c.*28G>A:		rs11545332	0.1546	0.1430	530/274/6	0.0768										8	75					DDX11 (inh=AR pLI=n/a)
chr12	32735236	32735236	C	T	het		QUAL=11852;DP=543;AF=0.44;MQM=60;TRIO=HET,543,0.44,WT,342,0.00,HET,455,0.50	FGD4	synonymous,5'UTR	FGD4:NM_001304480.1:synonymous:LOW:exon4/17:c.771C>T:p.Asp257Asp,FGD4:NM_001304481.1:synonymous:LOW:exon4/17:c.690C>T:p.Asp230Asp,FGD4:NM_139241.3:synonymous:LOW:exon4/17:c.435C>T:p.Asp145Asp,FGD4:NM_001304483.1:5'UTR:MODIFIER:exon4/17:c.-410C>T:,FGD4:NM_001304484.1:5'UTR:MODIFIER:exon4/18:c.-717C>T:		rs904582	0.4671	0.4110	10927/4889/2424	0.4017						611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H];	RCV000178387.1 [benign]; 			222	497					FGD4 (inh=n/a pLI=0.34)
chr12	32778581	32778581	T	C	het		QUAL=4518;DP=185;AF=0.49;MQM=60;TRIO=HET,185,0.49,WT,109,0.00,HET,173,0.50	FGD4	splice_region&intron	FGD4:NM_001304480.1:splice_region&intron:LOW:exon13/16:c.1972-7T>C:,FGD4:NM_001304481.1:splice_region&intron:LOW:exon13/16:c.1891-7T>C:,FGD4:NM_001304483.1:splice_region&intron:LOW:exon14/16:c.892-7T>C:,FGD4:NM_001304484.1:splice_region&intron:LOW:exon14/17:c.604-7T>C:,FGD4:NM_139241.3:splice_region&intron:LOW:exon13/16:c.1636-7T>C:		rs11052113	0.1402	0.1300	1264/523/258	0.1260						611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H];				20	277					FGD4 (inh=n/a pLI=0.34)
chr12	32794600	32794600	A	C	het		QUAL=6019;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,167,0.00,HET,185,0.48	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*1133A>C:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*1133A>C:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*1133A>C:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*1133A>C:		rs10844268	0.3616	0.0000	0/0/0	0.0540										31	103					FGD4 (inh=n/a pLI=0.34)
chr12	32794921	32794921	A	G	het		QUAL=6481;DP=295;AF=0.54;MQM=59;TRIO=HET,295,0.54,WT,118,0.00,HET,131,0.58	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*1454A>G:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*1454A>G:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*1454A>G:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*1454A>G:		rs7964947	0.3171	0.0000	0/0/0	0.0506										27	101					FGD4 (inh=n/a pLI=0.34)
chr12	32794959	32794959	T	G	het		QUAL=6215;DP=278;AF=0.50;MQM=59;TRIO=HET,278,0.50,WT,143,0.00,HET,153,0.56	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*1492T>G:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*1492T>G:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*1492T>G:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*1492T>G:		rs7980205	0.3618	0.0000	0/0/0	0.0540										31	103					FGD4 (inh=n/a pLI=0.34)
chr12	32795421	32795421	A	G	het		QUAL=2479;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,WT,16,0.00,HET,32,0.59	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*1954A>G:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*1954A>G:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*1954A>G:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*1954A>G:		rs1239829	0.7418	0.0000	0/0/0	0.0995										67	99					FGD4 (inh=n/a pLI=0.34)
chr12	32796604	32796604	T	-	het		QUAL=2414;DP=164;AF=0.54;MQM=59;TRIO=HET,164,0.54,WT,27,0.04,HET,29,0.62	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*3148delT:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*3148delT:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*3148delT:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*3148delT:		rs797002948	0.3351	0.0000	0/0/0	0.2159										27	105					FGD4 (inh=n/a pLI=0.34)
chr12	32797237	32797237	G	T	het		QUAL=4856;DP=237;AF=0.44;MQM=60;TRIO=HET,237,0.44,WT,135,0.00,HET,167,0.49	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*3770G>T:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*3770G>T:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*3770G>T:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*3770G>T:		rs11052123	0.4337	0.0000	0/0/0	0.4234										60	102					FGD4 (inh=n/a pLI=0.34)
chr12	32797822	32797822	-	A	het		QUAL=769;DP=195;AF=0.27;MQM=59;TRIO=HET,195,0.27,WT,79,0.04,HET,78,0.35	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*4369dupA:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*4369dupA:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*4369dupA:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*4369dupA:		rs35874340;rs397713417	0.2957	0.0000	0/0/0	0.0745										2	70					FGD4 (inh=n/a pLI=0.34)
chr12	32797905	32797905	A	G	het		QUAL=6330;DP=312;AF=0.50;MQM=60;TRIO=HET,312,0.50,WT,140,0.00,HET,156,0.51	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*4438A>G:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*4438A>G:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*4438A>G:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*4438A>G:		rs11052124	0.4966	0.0000	0/0/0	0.0757										61	101					FGD4 (inh=n/a pLI=0.34)
chr12	32798458	32798458	A	G	hom		QUAL=6497;DP=144;AF=0.99;MQM=59;TRIO=HOM,144,0.99,HOM,26,1.00,HOM,35,1.00	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*4991A>G:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*4991A>G:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*4991A>G:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*4991A>G:	AluSg	rs1239830	0.9902	0.0000	0/0/0	0.8762										201	0					FGD4 (inh=n/a pLI=0.34)
chr12	32798665	32798665	G	A	het		QUAL=3742;DP=158;AF=0.50;MQM=56;TRIO=HET,158,0.50,WT,114,0.02,HET,166,0.45	FGD4	3'UTR	FGD4:NM_001304480.1:3'UTR:MODIFIER:exon17/17:c.*5198G>A:,FGD4:NM_001304481.1:3'UTR:MODIFIER:exon17/17:c.*5198G>A:,FGD4:NM_001304484.1:3'UTR:MODIFIER:exon18/18:c.*5198G>A:,FGD4:NM_139241.3:3'UTR:MODIFIER:exon17/17:c.*5198G>A:	AluSg	rs1133509	0.4677	0.0000	0/0/0	0.4216										59	102					FGD4 (inh=n/a pLI=0.34)
chr12	32899495	32899495	C	T	het		QUAL=217;DP=27;AF=0.33;MQM=60;TRIO=HET,27,0.33,WT,11,0.00,HET,10,0.40	YARS2	3'UTR	YARS2:NM_001040436.2:3'UTR:MODIFIER:exon5/5:c.*643G>A:	AluSz6	rs11052214	0.1266	0.0000	0/0/0	0.1179										10	34					YARS2 (inh=n/a pLI=0.00)
chr12	32899929	32899929	C	G	het		QUAL=5695;DP=289;AF=0.48;MQM=60;TRIO=HET,289,0.48,WT,124,0.01,HET,182,0.48	YARS2	3'UTR	YARS2:NM_001040436.2:3'UTR:MODIFIER:exon5/5:c.*209G>C:		rs10844337	0.1438	0.0000	0/0/0	0.1297										10	56					YARS2 (inh=n/a pLI=0.00)
chr12	32908237	32908237	C	A	het	phylop_high;anno_pathogenic_clinvar	QUAL=3547;DP=229;AF=0.47;MQM=59;TRIO=HET,229,0.47,WT,105,0.00,HET,158,0.47	YARS2	missense	YARS2:NM_001040436.2:missense:MODERATE:exon1/5:c.572G>T:p.Gly191Val		rs11539445	0.1266	0.1260	1011/648/149	0.1197	4.2110	T	T	P	B	610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2];	RCV000088672.3 [pathogenic]; 	CM1312757 [CLASS=FP MUT=ALT PHEN="Reduced catalytic efficiency" GENE=YARS2]; 	COSM3753192	40	249					YARS2 (inh=n/a pLI=0.00)
chr12	32908518	32908518	G	A	het		QUAL=9548;DP=407;AF=0.56;MQM=59;TRIO=HET,407,0.56,WT,278,0.00,HET,379,0.48	YARS2	synonymous	YARS2:NM_001040436.2:synonymous:LOW:exon1/5:c.291C>T:p.Gly97Gly		rs11539444	0.1270	0.1260	1018/651/152	0.1244						610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2];	RCV000126351.1 [benign]; 		COSM3753193	40	248					YARS2 (inh=n/a pLI=0.00)
chr12	44182706	44182706	A	G	het		QUAL=3945;DP=180;AF=0.53;MQM=60;TRIO=HET,180,0.53,HET,106,0.54,WT,150,0.00	IRAK4	3'UTR	IRAK4:NM_001114182.2:3'UTR:MODIFIER:exon13/13:c.*2188A>G:,IRAK4:NM_001145256.1:3'UTR:MODIFIER:exon12/12:c.*2188A>G:,IRAK4:NM_001145257.1:3'UTR:MODIFIER:exon11/11:c.*2188A>G:,IRAK4:NM_001145258.1:3'UTR:MODIFIER:exon10/10:c.*2188A>G:,IRAK4:NM_016123.3:3'UTR:MODIFIER:exon12/12:c.*2188A>G:	MSTB-int	rs1141168	0.4225	0.0000	0/0/0	0.4654										55	81					IRAK4 (inh=n/a pLI=0.00)
chr12	48236386	48236386	T	A	het	low_MQM	QUAL=1275;DP=75;AF=0.45;MQM=49;TRIO=HET,75,0.45,HOM,19,1.00,WT,26,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*2143A>T:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*2143A>T:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*2143A>T:	AluSp	rs2853562	0.5433	0.0000	0/0/0	0.4743										46	73					VDR (inh=n/a pLI=0.39)
chr12	48236550	48236550	G	C	hom		QUAL=22719;DP=329;AF=0.99;MQM=59;TRIO=HOM,329,0.99,HOM,206,1.00,HOM,206,1.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*1979C>G:	AluSp	rs2544043	0.9782	0.0000	0/0/0	0.8690										142	22					VDR (inh=n/a pLI=0.39)
chr12	48236623	48236623	G	T	het		QUAL=14045;DP=237;AF=0.60;MQM=60;TRIO=HET,237,0.60,HOM,314,1.00,WT,306,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*1906C>A:	MIRc	rs9729	0.5026	0.0000	0/0/0	0.4969										49	77					VDR (inh=n/a pLI=0.39)
chr12	48237736	48237736	A	-	het		QUAL=8380;DP=216;AF=0.50;MQM=59;TRIO=HET,216,0.50,HOM,207,1.00,WT,287,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*793delT:		rs78783628	0.0000	0.0000	0/0/0	0.3669										61	119					VDR (inh=n/a pLI=0.39)
chr12	48238221	48238221	G	T	het		QUAL=6431;DP=209;AF=0.57;MQM=59;TRIO=HET,209,0.57,HOM,122,0.98,WT,130,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*308C>A:		rs739837	0.4942	0.0000	0/0/0	0.0848										61	120					VDR (inh=n/a pLI=0.39)
chr12	48238757	48238757	A	G	het		QUAL=14273;DP=254;AF=0.48;MQM=59;TRIO=HET,254,0.48,HOM,400,0.99,WT,547,0.00	VDR	synonymous	VDR:NM_001017536.1:synonymous:LOW:exon10/10:c.1206T>C:p.Ile402Ile,VDR:NM_000376.2:synonymous:LOW:exon10/10:c.1056T>C:p.Ile352Ile,VDR:NM_001017535.1:synonymous:LOW:exon11/11:c.1056T>C:p.Ile352Ile		rs731236	0.2766	0.3340	7505/5336/418	0.3310						601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];			COSM431157, COSM3753247	192	518					VDR (inh=n/a pLI=0.39)
chr12	48272895	48272895	A	G	hom	anno_high_impact;phylop_high;pred_pathogenic_2	QUAL=4369;DP=48;AF=1.00;MQM=60;TRIO=HOM,48,1.00,HOM,48,1.00,HOM,48,1.00	VDR	start_lost,missense	VDR:NM_000376.2:start_lost:HIGH:exon3/10:c.2T>C:p.Met1?,VDR:NM_001017535.1:start_lost:HIGH:exon4/11:c.2T>C:p.Met1?,VDR:NM_001017536.1:missense:MODERATE:exon3/10:c.152T>C:p.Met51Thr		rs2228570	0.6715	0.6370	25052/12547/3235	0.6232	4.2980	T	D,D,D,D,D,D,D	B,D	B,P	601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];		CM972826 [CLASS=DFP MUT=ALT PHEN="Higher bone mineral density association with" GENE=VDR]; 	COSM3753248	521	459	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			VDR (inh=n/a pLI=0.39)
chr12	48293716	48293716	G	T	het		QUAL=16795;DP=313;AF=0.50;MQM=60;TRIO=HET,313,0.50,WT,341,0.00,HOM,407,1.00	VDR	5'UTR,intron	VDR:NM_001017535.1:5'UTR:MODIFIER:exon2/11:c.-180C>A:,VDR:NM_001017536.1:intron:MODIFIER:exon1/9:c.67+4631C>A:,VDR:NM_000376.2:intron:MODIFIER:exon1/9:c.-84+5022C>A:		rs11168293	0.1661	0.0000	0/0/0	0.2512						601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];				17	56					VDR (inh=n/a pLI=0.39)
chr12	48375568	48375568	A	G	het		QUAL=20953;DP=232;AF=0.41;MQM=59;TRIO=HET,232,0.41,HOM,397,0.99,HET,525,0.50	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon36/54:c.2400T>C:p.Asn800Asn,COL2A1:NM_033150.2:synonymous:LOW:exon35/53:c.2193T>C:p.Asn731Asn		rs1635553	0.4828	0.3350	2790/1189/317	0.3003						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia|Spondyloepiphyseal dysplasia,Stanescu type];	RCV000079724.4 [benign]; 		COSM1606169, COSM1606168	217	562					COL2A1 (inh=n/a pLI=1.00)
chr12	48376291	48376291	G	A	het		QUAL=15820;DP=296;AF=0.47;MQM=59;TRIO=HET,296,0.47,HOM,266,1.00,HET,313,0.59	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon34/54:c.2295C>T:p.Gly765Gly,COL2A1:NM_033150.2:synonymous:LOW:exon33/53:c.2088C>T:p.Gly696Gly		rs2276454	0.4297	0.3930	9914/5059/631	0.3931						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia|Spondyloepiphyseal dysplasia,Stanescu type];				167	541					COL2A1 (inh=n/a pLI=1.00)
chr12	48391416	48391416	G	T	het		QUAL=7844;DP=195;AF=0.53;MQM=59;TRIO=HET,195,0.53,HOM,197,0.98,WT,249,0.00	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon7/54:c.504C>A:p.Gly168Gly,COL2A1:NM_033150.2:synonymous:LOW:exon6/53:c.297C>A:p.Gly99Gly	(GACCAGGGG)n	rs3737548	0.2192	0.2040	2642/1526/119	0.2022						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia|Spondyloepiphyseal dysplasia,Stanescu type];	RCV000179829.1 [benign]; 		COSM3753254, COSM3753255	31	329					COL2A1 (inh=n/a pLI=1.00)
chr12	48391657	48391657	T	A	het		QUAL=11112;DP=513;AF=0.52;MQM=60;TRIO=HET,513,0.52,HET,364,0.48,WT,481,0.00	COL2A1	missense	COL2A1:NM_001844.4:missense:MODERATE:exon6/54:c.426A>T:p.Glu142Asp,COL2A1:NM_033150.2:missense:MODERATE:exon5/53:c.219A>T:p.Glu73Asp		rs34392760	0.0180	0.0380	117/108/0	0.0381	0.5040	T	T,T,T	B,B	B,B	120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia|Spondyloepiphyseal dysplasia,Stanescu type];				1	104					COL2A1 (inh=n/a pLI=1.00)
chr12	49418435	49418435	A	C	het		QUAL=2479;DP=113;AF=0.50;MQM=60;TRIO=HET,113,0.50,HET,106,0.45,WT,144,0.00	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon50/54:c.15978T>G:p.Leu5326Leu		rs55776396	0.0174	0.0270	66/43/1	0.0261						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080152.5 [benign]; 			2	90					KMT2D (inh=AD pLI=1.00)
chr12	49424534	49424534	G	A	het		QUAL=1799;DP=87;AF=0.54;MQM=60;TRIO=HET,87,0.54,WT,53,0.00,HET,65,0.54	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon41/54:c.13689C>T:p.Pro4563Pro		rs11168830	0.1228	0.0930	1243/47/12	0.0878						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080132.5 [benign]; 		COSM3753293, COSM3753292	6	91					KMT2D (inh=AD pLI=1.00)
chr12	49426460	49426460	A	G	het	pred_pathogenic_1	QUAL=6875;DP=210;AF=0.41;MQM=59;TRIO=HET,210,0.41,HET,358,0.53,WT,454,0.00	KMT2D	missense	KMT2D:NM_003482.3:missense:MODERATE:exon39/54:c.12028T>C:p.Ser4010Pro		rs80132640	0.0172	0.0260	56/35/1	0.0256	1.4120	T	D	B	B	602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080117.6 [benign]; 			2	88					KMT2D (inh=AD pLI=1.00)
chr12	49427652	49427652	C	T	het		QUAL=13869;DP=308;AF=0.46;MQM=59;TRIO=HET,308,0.46,HET,388,0.49,HET,515,0.51	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon39/54:c.10836G>A:p.Gln3612Gln	(TGC)n	rs3782357	0.4435	0.3370	3953/1823/660	0.3110						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080105.5 [benign]; 		COSM431202, COSM431203	153	506					KMT2D (inh=AD pLI=1.00)
chr12	49434074	49434074	C	A	het		QUAL=649;DP=26;AF=0.46;MQM=59;TRIO=HET,26,0.46,HET,19,0.63,HET,24,0.46	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon31/54:c.7479G>T:p.Gly2493Gly		rs10747559	0.4355	0.4090	9996/5433/993	0.3929						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080211.5 [benign]; 		COSM3722550, COSM3722551	197	547					KMT2D (inh=AD pLI=1.00)
chr12	49442562	49442563	AG	-	het		QUAL=7161;DP=294;AF=0.49;MQM=59;TRIO=HET,294,0.49,HET,334,0.48,WT,437,0.00	KMT2D	splice_region&intron	KMT2D:NM_003482.3:splice_region&intron:LOW:exon12/53:c.4021-11_4021-10delCT:		rs55776244	0.0539	0.0380	138/37/78	0.0350						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080177.5 [benign]; 			2	94					KMT2D (inh=AD pLI=1.00)
chr12	49444545	49444545	G	A	het		QUAL=1097;DP=54;AF=0.48;MQM=59;TRIO=HET,54,0.48,HET,25,0.40,HET,25,0.52	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon11/54:c.2826C>T:p.Ile942Ile		rs2241726	0.4036	0.3770	8821/4499/894	0.3702						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080169.5 [benign]; 		COSM147497, COSM3753294	161	499					KMT2D (inh=AD pLI=1.00)
chr12	49448463	49448463	C	T	het		QUAL=2811;DP=130;AF=0.51;MQM=59;TRIO=HET,130,0.51,HET,101,0.50,WT,136,0.00	KMT2D	missense	KMT2D:NM_003482.3:missense:MODERATE:exon3/54:c.248G>A:p.Arg83Gln		rs55865069	0.0164	0.0260	53/34/1	0.0250	0.6130	T	T,T	B	B	602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080166.6 [benign]; 		COSM3773643, COSM3773644	2	85					KMT2D (inh=AD pLI=1.00)
chr12	51135275	51135275	T	C	hom		QUAL=47585;DP=460;AF=1.00;MQM=60;TRIO=HOM,460,1.00,HOM,465,1.00,HOM,546,1.00	DIP2B	synonymous	DIP2B:NM_173602.2:synonymous:LOW:exon37/38:c.4431T>C:p.Ile1477Ile		rs1866422	0.9599	0.9880	59362/33338/3978	0.9509						611379 [DIP2B (provisional) Mental retardation,FRA12A type];				1106	4					DIP2B (inh=n/a pLI=1.00)
chr12	51139279	51139279	A	G	hom		QUAL=10730;DP=181;AF=0.99;MQM=60;TRIO=HOM,181,0.99,HET,147,0.49,HET,210,0.57	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*657A>G:		rs4768914	0.2905	0.0000	0/0/0	0.3022										15	95					DIP2B (inh=n/a pLI=1.00)
chr12	51139692	51139692	T	G	hom		QUAL=12555;DP=310;AF=0.99;MQM=60;TRIO=HOM,310,0.99,HET,99,0.42,HET,133,0.45	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1070T>G:		rs35845404	0.2907	0.0000	0/0/0	0.3019										14	96					DIP2B (inh=n/a pLI=1.00)
chr12	51139803	51139803	C	A	hom		QUAL=9694;DP=195;AF=1.00;MQM=60;TRIO=HOM,195,1.00,HET,108,0.45,HET,171,0.43	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1181C>A:		rs3742063	0.2534	0.0000	0/0/0	0.2908										14	96					DIP2B (inh=n/a pLI=1.00)
chr12	51139892	51139892	C	T	hom		QUAL=12200;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HET,146,0.40,HET,214,0.43	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1270C>T:		rs3742064	0.2740	0.0000	0/0/0	0.2973										14	96					DIP2B (inh=n/a pLI=1.00)
chr12	51140410	51140410	C	G	hom		QUAL=28644;DP=389;AF=1.00;MQM=60;TRIO=HOM,389,1.00,HOM,225,1.00,HOM,271,1.00	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1788C>G:		rs7303202	0.8389	0.0000	0/0/0	0.8966										212	18					DIP2B (inh=n/a pLI=1.00)
chr12	51141883	51141883	A	G	hom		QUAL=29929;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,253,1.00,HOM,305,1.00	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*3261A>G:		rs4768915	0.7953	0.0000	0/0/0	0.1792										212	18					DIP2B (inh=n/a pLI=1.00)
chr12	53703021	53703021	G	A	hom		QUAL=9602;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HOM,71,1.00,HOM,98,1.00	AAAS	synonymous	AAAS:NM_015665.5:synonymous:LOW:exon9/16:c.855C>T:p.Phe285Phe,AAAS:NM_001173466.1:synonymous:LOW:exon8/15:c.756C>T:p.Phe252Phe		rs1546808	0.9153	0.9740	57989/33276/2750	0.9058						605378 [AAAS (confirmed) Achalasia-addisonianism-alacrimia syndrome];	RCV000116212.2 [likely benign]; 			1097	10					AAAS (inh=AR pLI=0.00)
chr12	56082025	56082025	G	C	het		QUAL=14845;DP=612;AF=0.52;MQM=60;TRIO=HET,612,0.52,HET,495,0.50,WT,656,0.00	ITGA7	synonymous	ITGA7:NM_001144996.1:synonymous:LOW:exon23/25:c.3030C>G:p.Ser1010Ser,ITGA7:NM_002206.2:synonymous:LOW:exon23/25:c.3018C>G:p.Ser1006Ser,ITGA7:NM_001144997.1:synonymous:LOW:exon23/25:c.2739C>G:p.Ser913Ser		rs17117883	0.0443	0.0420	134/77/17	0.0416						600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000117295.2 [likely benign]; 		COSM1128538, COSM1128539	8	130					ITGA7 (inh=AR pLI=0.00)
chr12	56089344	56089344	A	G	het		QUAL=2330;DP=107;AF=0.42;MQM=59;TRIO=HET,107,0.42,WT,129,0.00,HET,136,0.46	ITGA7	synonymous	ITGA7:NM_001144996.1:synonymous:LOW:exon14/25:c.1977T>C:p.Cys659Cys,ITGA7:NM_002206.2:synonymous:LOW:exon14/25:c.1965T>C:p.Cys655Cys,ITGA7:NM_001144997.1:synonymous:LOW:exon14/25:c.1686T>C:p.Cys562Cys		rs7971022	0.0098	0.0160	24/15/0	0.0166						600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000079980.7 [other]; 			1	46					ITGA7 (inh=AR pLI=0.00)
chr12	56089357	56089357	C	T	het		QUAL=7536;DP=166;AF=0.38;MQM=59;TRIO=HET,166,0.38,HET,149,0.54,HOM,151,1.00	ITGA7	missense	ITGA7:NM_001144996.1:missense:MODERATE:exon14/25:c.1964G>A:p.Arg655His,ITGA7:NM_002206.2:missense:MODERATE:exon14/25:c.1952G>A:p.Arg651His,ITGA7:NM_001144997.1:missense:MODERATE:exon14/25:c.1673G>A:p.Arg558His		rs1800974	0.5994	0.5850	22147/8870/590	0.5764	0.2040	T	T,T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000079979.5 [benign]; 	CM067685 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=ITGA7]; 	COSM4147273, COSM4147274, COSM4147272, COSM4147275	309	531					ITGA7 (inh=AR pLI=0.00)
chr12	56398454	56398454	G	C	hom		QUAL=23432;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HOM,210,1.00,HOM,283,1.00	SUOX	synonymous	SUOX:NM_000456.2:synonymous:LOW:exon6/6:c.1281G>C:p.Ser427Ser,SUOX:NM_001032386.1:synonymous:LOW:exon5/5:c.1281G>C:p.Ser427Ser,SUOX:NM_001032387.1:synonymous:LOW:exon4/4:c.1281G>C:p.Ser427Ser		rs773115	0.7522	0.8730	47850/27916/655	0.8421						606887 [SUOX (provisional) Sulfite oxidase deficiency];	RCV000118423.2 [likely benign]; 			930	169					SUOX (inh=AR pLI=0.00)
chr12	56473808	56473808	T	C	het		QUAL=1499;DP=35;AF=0.60;MQM=59;TRIO=HET,35,0.60,HET,37,0.59,HET,52,0.46	RPS26-ERBB3	intergenic_region	RPS26-ERBB3:RPS26-ERBB3:intergenic_region:MODIFIER::n.56473808T>C:		rs7297175	0.6508	0.0000	0/0/0	0.5476										66	69					RPS26-ERBB3 (inh=n/a pLI=n/a)
chr12	56477694	56477694	A	T	het		QUAL=12299;DP=205;AF=0.44;MQM=59;TRIO=HET,205,0.44,HET,356,0.48,HET,482,0.52	ERBB3	splice_region&intron	ERBB3:NM_001982.3:splice_region&intron:LOW:exon2/27:c.234+8A>T:,ERBB3:NM_001005915.1:splice_region&intron:LOW:exon2/2:c.234+8A>T:		rs2271194	0.5923	0.6170	24096/11601/525	0.6014						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];				462	527					ERBB3 (inh=n/a pLI=0.00)
chr12	56493822	56493822	A	C	het		QUAL=15969;DP=417;AF=0.49;MQM=59;TRIO=HET,417,0.49,HET,342,0.52,HET,442,0.51	ERBB3	splice_region&intron	ERBB3:NM_001982.3:splice_region&intron:LOW:exon25/27:c.3129+9A>C:		rs2292238	0.2951	0.3610	8237/5447/198	0.3603						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];			COSM3998886, COSM3998887	150	535					ERBB3 (inh=n/a pLI=0.00)
chr12	56494991	56494991	G	A	het		QUAL=7856;DP=193;AF=0.52;MQM=60;TRIO=HET,193,0.52,HET,198,0.51,HET,252,0.48	ERBB3	synonymous	ERBB3:NM_001982.3:synonymous:LOW:exon27/28:c.3348G>A:p.Arg1116Arg		rs2271189	0.2522	0.3410	7518/5186/93	0.3369						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];				146	522					ERBB3 (inh=n/a pLI=0.00)
chr12	65108160	65108160	G	C	het		QUAL=16111;DP=573;AF=0.49;MQM=60;TRIO=HET,573,0.49,HOM,284,0.99,WT,371,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*2361C>G:		rs1061743	0.6064	0.0000	0/0/0	0.6114										82	138					GNS (inh=n/a pLI=0.08)
chr12	65108586	65108586	G	C	het		QUAL=5333;DP=251;AF=0.46;MQM=60;TRIO=HET,251,0.46,WT,116,0.00,HET,166,0.50	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*1935C>G:			0.0000	0.0000	0/0/0	0.0000										0	1					GNS (inh=n/a pLI=0.08)
chr12	65109168	65109168	C	T	het		QUAL=5596;DP=203;AF=0.46;MQM=56;TRIO=HET,203,0.46,HOM,107,0.99,WT,129,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*1353G>A:	AluSx3	rs1269548	0.5939	0.0000	0/0/0	0.5368										104	137					GNS (inh=n/a pLI=0.08)
chr12	65110141	65110141	G	A	het		QUAL=11986;DP=483;AF=0.50;MQM=60;TRIO=HET,483,0.50,HOM,182,1.00,WT,306,0.01	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*380C>T:	(GT)n	rs674	0.7157	0.0000	0/0/0	0.6438										85	140					GNS (inh=n/a pLI=0.08)
chr12	65110252	65110252	G	A	het		QUAL=13124;DP=520;AF=0.48;MQM=60;TRIO=HET,520,0.48,HOM,206,1.00,WT,337,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*269C>T:		rs2279597	0.1953	0.0000	0/0/0	0.2582										25	147					GNS (inh=n/a pLI=0.08)
chr12	65146532	65146532	C	T	het		QUAL=7720;DP=352;AF=0.42;MQM=60;TRIO=HET,352,0.42,HOM,125,1.00,WT,175,0.00	GNS	synonymous	GNS:NM_002076.3:synonymous:LOW:exon2/14:c.198G>A:p.Pro66Pro		rs1147096	0.0000	0.6480	25120/11214/3804	0.6181						607664 [GNS (provisional) Mucopolysaccharidosis type IIID];	RCV000079972.4 [benign]; 			383	542					GNS (inh=n/a pLI=0.08)
chr12	66218507	66218507	-	TCTCTG	hom	low_DP	QUAL=3401;DP=1;AF=0.00;MQM=60;TRIO=HOM,1,0.00,HOM,42,0.19,WT,92,0.48	HMGA2,RPSAP52	5'UTR,intron	HMGA2:NM_001300919.1:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:NM_003484.1:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:NM_001300918.1:5'UTR:MODIFIER:exon1/5:c.-539_-538insGTCTCT:,HMGA2:NM_003483.4:5'UTR:MODIFIER:exon1/5:c.-539_-538insGTCTCT:,RPSAP52:NR_026825.2:intron:MODIFIER:exon1/1:n.132+2115_132+2116insCAGAGA:	(TC)n		0.0000	0.0000	0/0/0	0.0003										0	0					HMGA2 (inh=n/a pLI=0.73), RPSAP52 (inh=n/a pLI=n/a)
chr12	66358120	66358121	TT	-	het		QUAL=4137;DP=287;AF=0.50;MQM=59;TRIO=HET,287,0.50,HET,62,0.60,WT,117,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1048_*1049delTT:	(TC)n	rs10573247	0.3327	0.0000	0/0/0	0.2350										5	77					HMGA2 (inh=n/a pLI=0.73)
chr12	66358347	66358347	C	T	het		QUAL=6508;DP=188;AF=0.57;MQM=60;TRIO=HET,188,0.57,HOM,107,1.00,WT,174,0.01	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1275C>T:		rs1042725	0.5825	0.0000	0/0/0	0.0945								CR078543 [CLASS=DFP MUT=REF PHEN="Increased height association with" GENE=HMGA2]; 		67	113					HMGA2 (inh=n/a pLI=0.73)
chr12	66358571	66358571	C	A	het		QUAL=3224;DP=194;AF=0.52;MQM=60;TRIO=HET,194,0.52,HET,48,0.46,WT,47,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1499C>A:		rs1042729	0.0176	0.0000	0/0/0	0.0071										1	25					HMGA2 (inh=n/a pLI=0.73)
chr12	66359752	66359752	C	A	het		QUAL=9267;DP=397;AF=0.50;MQM=60;TRIO=HET,397,0.50,HOM,129,0.99,WT,188,0.01	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*2680C>A:		rs8756	0.6919	0.0000	0/0/0	0.6109										74	110					HMGA2 (inh=n/a pLI=0.73)
chr12	66360068	66360068	C	T	het		QUAL=8874;DP=367;AF=0.49;MQM=60;TRIO=HET,367,0.49,HET,328,0.50,WT,473,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*2996C>T:		rs11175982	0.3325	0.0000	0/0/0	0.2897										5	77					HMGA2 (inh=n/a pLI=0.73)
chr12	66741538	66741538	T	-	het		QUAL=4146;DP=203;AF=0.51;MQM=59;TRIO=HET,203,0.51,HET,63,0.62,HET,89,0.49	GRIP1	3'UTR	GRIP1:NM_021150.3:3'UTR:MODIFIER:exon24/24:c.*1261delA:,GRIP1:NM_001178074.1:3'UTR:MODIFIER:exon23/23:c.*1261delA:		rs397850337	0.4770	0.0000	0/0/0	0.2970										48	116					GRIP1 (inh=AR pLI=0.92)
chr12	66742183	66742183	A	G	het		QUAL=15616;DP=529;AF=0.49;MQM=60;TRIO=HET,529,0.49,HET,296,0.48,HET,378,0.50	GRIP1	3'UTR	GRIP1:NM_021150.3:3'UTR:MODIFIER:exon24/24:c.*616T>C:,GRIP1:NM_001178074.1:3'UTR:MODIFIER:exon23/23:c.*616T>C:		rs1168308	0.5038	0.0000	0/0/0	0.4863										47	117					GRIP1 (inh=AR pLI=0.92)
chr12	66786091	66786091	G	C	hom	phylop_high	QUAL=13465;DP=139;AF=1.00;MQM=60;TRIO=HOM,139,1.00,HOM,134,1.00,HOM,152,1.00	GRIP1	missense	GRIP1:NM_021150.3:missense:MODERATE:exon18/24:c.2305C>G:p.Gln769Glu,GRIP1:NM_001178074.1:missense:MODERATE:exon18/23:c.2305C>G:p.Gln769Glu		rs13277	0.8437	0.9490	55143/33228/1967	0.9296	7.3090	T	T,T,T,T,T,T	P,P,P,P	B,B,B,B	604597 [GRIP1 (provisional) Fraser syndrome];				1079	18					GRIP1 (inh=AR pLI=0.92)
chr12	66786171	66786171	A	C	het	anno_pathogenic_hgmd	QUAL=8180;DP=381;AF=0.53;MQM=59;TRIO=HET,381,0.53,WT,182,0.00,HET,219,0.53	GRIP1	missense	GRIP1:NM_021150.3:missense:MODERATE:exon18/24:c.2225T>G:p.Met742Arg,GRIP1:NM_001178074.1:missense:MODERATE:exon18/23:c.2225T>G:p.Met742Arg		rs144494437	0.0014	0.0018	2/1/0	0.0016	1.3260	T,T	.,T,T,T,T,T,T	.,B,B,B,B	.,B,B,B,B	604597 [GRIP1 (provisional) Fraser syndrome];	RCV000216399.1 [likely benign]; 	CM112031 [CLASS=DM MUT=ALT PHEN="Autism" GENE=GRIP1]; 		0	17	3	[3] Stephan Waldm?ller 13.08.2014 [n/a] comment imported from detected variant: Nur 1 Bericht mit Assoziation			GRIP1 (inh=AR pLI=0.92)
chr12	81102891	81102891	C	A	het		QUAL=14036;DP=379;AF=0.46;MQM=60;TRIO=HET,379,0.46,HET,308,0.47,HET,449,0.50	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*152C>A:		rs3120	0.1064	0.0000	0/0/0	0.0346										17	78					MYF6 (inh=n/a pLI=0.08)
chr12	81102921	81102921	T	C	het		QUAL=20318;DP=341;AF=0.45;MQM=59;TRIO=HET,341,0.45,HET,260,0.48,HOM,419,1.00	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*182T>C:		rs3121	0.4585	0.0000	0/0/0	0.3895										36	100					MYF6 (inh=n/a pLI=0.08)
chr12	81103085	81103085	A	G	het		QUAL=8522;DP=484;AF=0.48;MQM=60;TRIO=HET,484,0.48,HET,83,0.45,HET,132,0.47	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*346A>G:		rs1047183	0.1056	0.0000	0/0/0	0.0289										16	79					MYF6 (inh=n/a pLI=0.08)
chr12	81103144	81103144	A	G	het		QUAL=3987;DP=125;AF=0.50;MQM=60;TRIO=HET,125,0.50,HET,39,0.41,HOM,64,1.00	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*405A>G:		rs1047185	0.4585	0.0000	0/0/0	0.0770										35	100					MYF6 (inh=n/a pLI=0.08)
chr12	88483273	88483273	A	-	hom		QUAL=8604;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,67,1.00,HOM,71,1.00	CEP290	splice_region&intron	CEP290:NM_025114.3:splice_region&intron:LOW:exon30/53:c.3574-9delT:		rs398020484	0.8736	0.8860	6265/3194/382	0.5248						610142 [CEP290 (confirmed) Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Meckel syndrome 4|Bardet-Biedl syndrome 14];	RCV000082247.4 [benign]; RCV000196108.2 [benign]; RCV000196108.2 [benign]; RCV000196108.2 [benign]; 			1953	238					CEP290 (inh=AR pLI=0.00)
chr12	88505078	88505078	T	C	hom		QUAL=13777;DP=207;AF=1.00;MQM=60;TRIO=HOM,207,1.00,HOM,85,1.00,HOM,120,1.00	CEP290	synonymous	CEP290:NM_025114.3:synonymous:LOW:exon22/54:c.2268A>G:p.Ser756Ser		rs2468255	0.7646	0.8750	28347/16074/567	0.8494						610142 [CEP290 (confirmed) Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Meckel syndrome 4|Bardet-Biedl syndrome 14];	RCV000124245.1 [benign]; RCV000114186.2 [likely benign]; 			1911	323					CEP290 (inh=AR pLI=0.00)
chr12	102154900	102154900	A	G	het		QUAL=5242;DP=244;AF=0.50;MQM=60;TRIO=HET,244,0.50,WT,148,0.00,HET,167,0.50	GNPTAB	splice_region&intron	GNPTAB:NM_024312.4:splice_region&intron:LOW:exon15/20:c.3135+5T>C:		rs759935	0.6905	0.5980	22256/9352/2819	0.5890						607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta|Mucolipidosis II alpha/beta];	RCV000082191.4 [benign]; 			360	530					GNPTAB (inh=AR pLI=0.00)
chr12	102158763	102158763	T	C	het		QUAL=8992;DP=439;AF=0.47;MQM=60;TRIO=HET,439,0.47,WT,210,0.01,HET,302,0.46	GNPTAB	synonymous	GNPTAB:NM_024312.4:synonymous:LOW:exon13/21:c.1932A>G:p.Thr644Thr		rs10778148	0.6514	0.5880	21589/9378/2161	0.5811						607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta|Mucolipidosis II alpha/beta];	RCV000082189.4 [benign]; 		COSM1127589	353	530					GNPTAB (inh=AR pLI=0.00)
chr12	102789901	102789901	G	A	het		QUAL=7375;DP=350;AF=0.48;MQM=60;TRIO=HET,350,0.48,WT,143,0.00,HET,230,0.48	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*6418C>T:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*6384C>T:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*6384C>T:		rs6222	0.0202	0.0000	0/0/0	0.0029										0	7					IGF1 (inh=n/a pLI=0.47)
chr12	102790780	102790780	A	T	het		QUAL=1769;DP=102;AF=0.61;MQM=59;TRIO=HET,102,0.61,HET,11,0.55,HOM,4,1.00	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*5539T>A:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*5505T>A:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*5505T>A:	AluSx3	rs1140655	0.6190	0.0000	0/0/0	0.6076										114	67					IGF1 (inh=n/a pLI=0.47)
chr12	102791801	102791801	A	-	het		QUAL=2529;DP=148;AF=0.60;MQM=60;TRIO=HET,148,0.60,WT,21,0.00,HET,28,0.57	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*4518delT:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*4484delT:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*4484delT:		rs397844200	0.0204	0.0000	0/0/0	0.0173										0	8					IGF1 (inh=n/a pLI=0.47)
chr12	102791881	102791881	C	A	het		QUAL=161;DP=56;AF=0.16;MQM=50;TRIO=HET,56,0.16,WT,6,0.17,WT,17,0.18	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*4438G>T:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*4404G>T:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*4404G>T:	(A)n	rs201936984	0.0000	0.0000	0/0/0	0.0005										0	20					IGF1 (inh=n/a pLI=0.47)
chr12	102792897	102792897	G	A	hom		QUAL=3286;DP=112;AF=0.36;MQM=59;TRIO=HOM,112,0.36,WT,83,0.00,HOM,139,0.53	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*3422C>T:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*3388C>T:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*3388C>T:	(TG)n	rs5742705	0.0208	0.0000	0/0/0	0.0141										0	8					IGF1 (inh=n/a pLI=0.47)
chr12	102793569	102793569	C	T	het		QUAL=12575;DP=367;AF=0.50;MQM=60;TRIO=HET,367,0.50,WT,191,0.00,HOM,231,0.99	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*2750G>A:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*2716G>A:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*2716G>A:		rs6214	0.4269	0.0000	0/0/0	0.0829										39	123					IGF1 (inh=n/a pLI=0.47)
chr12	102793921	102793921	T	C	het		QUAL=2771;DP=158;AF=0.47;MQM=60;TRIO=HET,158,0.47,WT,29,0.00,HOM,52,0.54	IGF1	3'UTR	IGF1:NM_001111283.2:3'UTR:MODIFIER:exon5/5:c.*2398A>G:,IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*2364A>G:,IGF1:NM_000618.4:3'UTR:MODIFIER:exon4/4:c.*2364A>G:		rs5742704	0.0208	0.0000	0/0/0	0.0030										0	8					IGF1 (inh=n/a pLI=0.47)
chr12	103237468	103237468	G	C	hom		QUAL=2175;DP=46;AF=1.00;MQM=60;TRIO=HOM,46,1.00,HOM,8,1.00,HOM,14,1.00	PAH	synonymous	PAH:NM_000277.1:synonymous:LOW:exon11/13:c.1155C>G:p.Leu385Leu		rs772897	0.8403	0.8580	44804/24014/3307	0.8486						612349 [PAH (confirmed) Phenylketonuria|Hyperphenylalaninemia,non-PKU mild];	RCV000088769.1 [not provided]; RCV000153631.2 [benign]; 			781	300					PAH (inh=AR pLI=0.00)
chr12	103248924	103248924	C	T	hom		QUAL=22067;DP=160;AF=1.00;MQM=59;TRIO=HOM,160,1.00,HOM,216,1.00,HOM,331,1.00	PAH	synonymous	PAH:NM_000277.1:synonymous:LOW:exon6/13:c.696G>A:p.Gln232Gln		rs1126758	0.5465	0.5780	21720/11666/3117	0.5695						612349 [PAH (confirmed) Phenylketonuria|Hyperphenylalaninemia,non-PKU mild];	RCV000089040.1 [not provided]; RCV000153637.2 [benign]; 			368	527					PAH (inh=AR pLI=0.00)
chr12	103351826	103351826	T	C	het		QUAL=5207;DP=123;AF=0.48;MQM=60;TRIO=HET,123,0.48,HOM,119,1.00,WT,189,0.00	ASCL1	5'UTR	ASCL1:NM_004316.3:5'UTR:MODIFIER:exon1/2:c.-197T>C:		rs9782	0.3001	0.0000	0/0/0	0.2868										29	141					ASCL1 (inh=n/a pLI=0.36)
chr12	103353209	103353209	A	-	hom		QUAL=11469;DP=144;AF=0.99;MQM=59;TRIO=HOM,144,0.99,HOM,111,0.99,HOM,135,0.99	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*126delA:	(AAAAGA)n	rs398020887	0.9760	0.0000	0/0/0	0.7104										178	16					ASCL1 (inh=n/a pLI=0.36)
chr12	103353525	103353525	T	C	hom		QUAL=16460;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,145,1.00,HOM,218,1.00	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*433T>C:		rs1391682	0.9764	0.0000	0/0/0	0.8875										212	17					ASCL1 (inh=n/a pLI=0.36)
chr12	103353538	103353538	A	G	hom		QUAL=17302;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,153,1.00,HOM,214,1.00	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*446A>G:		rs2291854	0.8215	0.0000	0/0/0	0.8278										152	72					ASCL1 (inh=n/a pLI=0.36)
chr12	103354187	103354187	T	-	hom		QUAL=8773;DP=174;AF=0.98;MQM=59;TRIO=HOM,174,0.98,HOM,47,1.00,HOM,61,1.00	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*1103delT:		rs869208400	0.8494	0.0000	0/0/0	0.6386										176	50					ASCL1 (inh=n/a pLI=0.36)
chr12	106838340	106838340	T	C	het		QUAL=7998;DP=369;AF=0.48;MQM=59;TRIO=HET,369,0.48,HET,267,0.50,WT,299,0.00	POLR3B	synonymous	POLR3B:NM_018082.5:synonymous:LOW:exon19/28:c.2055T>C:p.Tyr685Tyr,POLR3B:NM_001160708.1:synonymous:LOW:exon19/28:c.1881T>C:p.Tyr627Tyr		rs10861607	0.3179	0.3140	7200/2541/16	0.3020						614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118025.2 [likely benign]; 		COSM1358426	204	1010					POLR3B (inh=AR pLI=0.00)
chr12	106848414	106848414	A	G	het	phylop_high;pred_pathogenic_1	QUAL=5181;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,WT,143,0.00,HET,167,0.41	POLR3B	missense	POLR3B:NM_018082.5:missense:MODERATE:exon20/28:c.2218A>G:p.Thr740Ala,POLR3B:NM_001160708.1:missense:MODERATE:exon20/28:c.2044A>G:p.Thr682Ala		rs17038460	0.0266	0.0470	160/134/0	0.0477	9.3000	T	D,D	P	B	614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118026.2 [likely benign]; 			23	353					POLR3B (inh=AR pLI=0.00)
chr12	106903321	106903321	T	C	het		QUAL=7302;DP=322;AF=0.51;MQM=60;TRIO=HET,322,0.51,HET,210,0.52,WT,279,0.00	POLR3B,LOC100287944	synonymous,intron	POLR3B:NM_018082.5:synonymous:LOW:exon28/28:c.3396T>C:p.Asn1132Asn,POLR3B:NM_001160708.1:synonymous:LOW:exon28/28:c.3222T>C:p.Asn1074Asn,LOC100287944:NR_040246.1:intron:MODIFIER:exon1/3:n.143-1733A>G:		rs13561	0.3249	0.3240	7398/2815/34	0.3218						614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118027.2 [likely benign]; 		COSM3752870	220	1060					POLR3B (inh=AR pLI=0.00), LOC100287944 (inh=n/a pLI=n/a)
chr12	106903674	106903674	A	G	het		QUAL=4366;DP=270;AF=0.48;MQM=60;TRIO=HET,270,0.48,HET,81,0.42,WT,140,0.00	POLR3B,LOC100287944	3'UTR,intron	POLR3B:NM_018082.5:3'UTR:MODIFIER:exon28/28:c.*347A>G:,POLR3B:NM_001160708.1:3'UTR:MODIFIER:exon28/28:c.*347A>G:,LOC100287944:NR_040246.1:intron:MODIFIER:exon1/3:n.143-2086T>C:		rs2288266	0.3249	0.0000	0/0/0	0.3362										15	88					POLR3B (inh=AR pLI=0.00), LOC100287944 (inh=n/a pLI=n/a)
chr12	109993255	109993255	T	A	hom	low_DP	QUAL=6208;DP=15;AF=0.27;MQM=60;TRIO=HOM,15,0.27,HOM,33,0.00,HOM,50,0.00	MMAB	3'UTR,non_coding_exon	MMAB:NM_052845.3:3'UTR:MODIFIER:exon9/9:c.*1578A>T:,MMAB:NR_038118.1:non_coding_exon:MODIFIER:exon10/10:n.2491A>T:	AluSx1		0.0000	0.0000	0/0/0	0.0001										0	0					MMAB (inh=n/a pLI=0.00)
chr12	109994454	109994463	CACACACACA	-	hom		QUAL=2864;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR,non_coding_exon	MMAB:NM_052845.3:3'UTR:MODIFIER:exon9/9:c.*370_*379delTGTGTGTGTG:,MMAB:NR_038118.1:non_coding_exon:MODIFIER:exon10/10:n.1283_1292delTGTGTGTGTG:	(CA)n	rs762567631	0.0000	0.0390	3/0/0	0.0033										3	40					MMAB (inh=n/a pLI=0.00)
chr12	109994455	109994455	A	T	hom		QUAL=2864;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR,non_coding_exon	MMAB:NM_052845.3:3'UTR:MODIFIER:exon9/9:c.*378T>A:,MMAB:NR_038118.1:non_coding_exon:MODIFIER:exon10/10:n.1291T>A:	(CA)n	rs66497319	0.0000	0.0340	1/0/0	0.0013										0	94					MMAB (inh=n/a pLI=0.00)
chr12	109994457	109994457	A	T	hom		QUAL=2864;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR,non_coding_exon	MMAB:NM_052845.3:3'UTR:MODIFIER:exon9/9:c.*376T>A:,MMAB:NR_038118.1:non_coding_exon:MODIFIER:exon10/10:n.1289T>A:	(CA)n	rs527861371	0.1494	0.0200	1/0/0	0.0057										0	82					MMAB (inh=n/a pLI=0.00)
chr12	110240838	110240838	T	G	het		QUAL=10306;DP=240;AF=0.53;MQM=60;TRIO=HET,240,0.53,HET,203,0.53,HET,341,0.48	TRPV4	synonymous	TRPV4:NM_021625.4:synonymous:LOW:exon4/16:c.670A>C:p.Arg224Arg,TRPV4:NM_001177431.1:synonymous:LOW:exon4/16:c.568A>C:p.Arg190Arg,TRPV4:NM_001177428.1:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg,TRPV4:NM_001177433.1:synonymous:LOW:exon3/13:c.670A>C:p.Arg224Arg,TRPV4:NM_147204.2:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg		rs3825394	0.7544	0.6330	25572/9130/2574	0.6123						605427 [TRPV4 (confirmed) Brachyolmia type 3|Spondylometaphyseal dysplasia,Kozlowski type|Metatropic dysplasia|Hereditary motor and sensory neuropathy,type IIc|Scapuloperoneal spinal muscular atrophy|Sodium serum level QTL 1|Parastremmatic dwarfism|SED,Maroteaux type|Spinal muscular atrophy,distal,congenital nonprogressive|Digital arthropathy-brachydactyly,familial];			COSM3752895	498	784					TRPV4 (inh=AD pLI=0.00)
chr12	110784907	110784907	-	ATCA	het		QUAL=3137;DP=189;AF=0.51;MQM=56;TRIO=HET,189,0.51,HET,96,0.49,WT,120,0.00	ATP2A2	3'UTR,intron	ATP2A2:NM_170665.3:3'UTR:MODIFIER:exon20/20:c.*633_*636dupATCA:,ATP2A2:NM_001681.3:intron:MODIFIER:exon20/20:c.2980+782_2980+785dupATCA:		rs112750891	0.1378	0.0000	0/0/0	0.0877						108740 [ATP2A2 (confirmed) Darier disease|Acrokeratosis verruciformis];				1	35					ATP2A2 (inh=AD pLI=1.00)
chr12	112944602	112944602	G	-	het		QUAL=4477;DP=230;AF=0.48;MQM=58;TRIO=HET,230,0.48,HET,157,0.46,WT,233,0.00	PTPN11	3'UTR	PTPN11:NM_002834.3:3'UTR:MODIFIER:exon16/16:c.*1006delG:	MLT1H	rs146940557	0.0351	0.0000	0/0/0	0.0622										3	30					PTPN11 (inh=AD pLI=1.00)
chr12	116397088	116397088	A	T	het		QUAL=565;DP=47;AF=0.53;MQM=59;TRIO=HET,47,0.53,WT,72,0.51,WT,4,0.00	MED13L	3'UTR	MED13L:NM_015335.4:3'UTR:MODIFIER:exon31/31:c.*1983T>A:	(TT)n	rs12423578	0.1745	0.0000	0/0/0	0.0351										11	58					MED13L (inh=AD pLI=1.00)
chr12	116398626	116398626	A	C	het		QUAL=14359;DP=397;AF=0.52;MQM=60;TRIO=HET,397,0.52,WT,238,0.00,HOM,279,1.00	MED13L	3'UTR	MED13L:NM_015335.4:3'UTR:MODIFIER:exon31/31:c.*445T>G:		rs66898998	0.1324	0.0000	0/0/0	0.2672										32	107					MED13L (inh=AD pLI=1.00)
chr12	116406910	116406910	G	A	het		QUAL=4903;DP=191;AF=0.49;MQM=59;TRIO=HET,191,0.49,HET,183,0.54,WT,188,0.00	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon27/30:c.6068-8C>T:		rs61936939	0.0046	0.0110	10/7/0	0.0103						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				2	25					MED13L (inh=AD pLI=1.00)
chr12	116408538	116408538	A	G	het		QUAL=5899;DP=271;AF=0.50;MQM=60;TRIO=HET,271,0.50,HET,190,0.47,WT,265,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon27/31:c.5928T>C:p.Thr1976Thr		rs2304460	0.1528	0.1690	1863/1117/43	0.1689	0.4130	T				608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM147620	45	312					MED13L (inh=AD pLI=1.00)
chr12	116429689	116429689	A	G	het		QUAL=8726;DP=307;AF=0.53;MQM=59;TRIO=HET,307,0.53,HET,387,0.48,WT,552,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon17/31:c.3070T>C:p.Leu1024Leu		rs1865787	0.1558	0.1720	1904/1165/30	0.1716						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				43	320					MED13L (inh=AD pLI=1.00)
chr12	116445448	116445448	G	A	het		QUAL=908;DP=49;AF=0.43;MQM=55;TRIO=HET,49,0.43,HET,35,0.14,HET,69,0.22	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon10/30:c.2013-7C>T:	(A)n	rs199749418	0.0000	0.0017	0/0/0	0.0014						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3746277	9	80	2	Prima Vista kein Anhalt f?r Splice-Defekt; 160704 In 151162_01 vermutlich Artefakt [2] ahwalds1 05.07.2016			MED13L (inh=AD pLI=1.00)
chr12	116445450	116445450	C	A	het		QUAL=908;DP=49;AF=0.43;MQM=55;TRIO=HET,49,0.43,HET,35,0.14,HET,69,0.22	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon10/30:c.2013-9G>T:	(A)n	rs200367922	0.0000	0.0053	0/0/0	0.0036						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3746278	22	202	2	Prima Vista kein Anhalt f?r Splice-Defekt; 160704 In 151162_01 vermutlich Artefakt [2] ahwalds1 05.07.2016			MED13L (inh=AD pLI=1.00)
chr12	116446445	116446445	C	T	het		QUAL=6597;DP=260;AF=0.49;MQM=60;TRIO=HET,260,0.49,HET,235,0.53,WT,323,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon10/31:c.1773G>A:p.Gln591Gln		rs3741768	0.1434	0.1630	1764/1083/21	0.1638						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3752943	42	308					MED13L (inh=AD pLI=1.00)
chr12	116457090	116457090	C	T	het		QUAL=7654;DP=352;AF=0.47;MQM=60;TRIO=HET,352,0.47,HET,249,0.52,WT,348,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon7/31:c.948G>A:p.Lys316Lys		rs61748072	0.0044	0.0110	11/8/0	0.0103						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				1	25					MED13L (inh=AD pLI=1.00)
chr12	119632307	119632307	A	G	het		QUAL=2876;DP=127;AF=0.57;MQM=60;TRIO=HET,127,0.57,WT,99,0.00,HET,97,0.46	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*644A>G:		rs11038	0.3802	0.0000	0/0/0	0.3057										17	98					HSPB8 (inh=n/a pLI=0.03)
chr12	119632347	119632347	G	A	het		QUAL=2513;DP=99;AF=0.61;MQM=60;TRIO=HET,99,0.61,WT,70,0.00,HET,74,0.50	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*684G>A:		rs1133026	0.1370	0.0000	0/0/0	0.1816										8	80					HSPB8 (inh=n/a pLI=0.03)
chr12	119632511	119632516	TAATAA	-	het		QUAL=1684;DP=49;AF=0.80;MQM=59;TRIO=HET,49,0.80,WT,3,0.00,HOM,36,0.97	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*866_*871delTAATAA:	(AAT)n	rs112223147;rs555638888	0.0000	0.0000	0/0/0	0.1252										47	51					HSPB8 (inh=n/a pLI=0.03)
chr12	120941215	120941215	T	C	het		QUAL=5130;DP=257;AF=0.51;MQM=59;TRIO=HET,257,0.51,HET,138,0.47,WT,219,0.00	COQ5	3'UTR	COQ5:NM_032314.3:3'UTR:MODIFIER:exon7/7:c.*372A>G:		rs7471	0.2646	0.0000	0/0/0	0.3220										22	93					COQ5 (inh=n/a pLI=0.00)
chr12	120966921	120966921	A	G	het		QUAL=4057;DP=282;AF=0.46;MQM=59;TRIO=HET,282,0.46,HET,95,0.58,WT,145,0.00	COQ5	synonymous	COQ5:NM_032314.3:synonymous:LOW:exon1/7:c.24T>C:p.Ala8Ala		rs3742052	0.2646	0.2980	5778/2926/49	0.2969									COSM3752963	97	402					COQ5 (inh=n/a pLI=0.00)
chr12	121432117	121432117	G	C	hom		QUAL=11738;DP=131;AF=0.98;MQM=59;TRIO=HOM,131,0.98,HET,276,0.54,HET,370,0.54	HNF1A	synonymous	HNF1A:NM_001306179.1:synonymous:LOW:exon4/10:c.864G>C:p.Gly288Gly,HNF1A:NM_000545.6:synonymous:LOW:exon4/10:c.864G>C:p.Gly288Gly		rs56348580	0.1811	0.2430	3183/2067/136	0.2354						142410 [HNF1A (confirmed) MODY,type III|Diabetes mellitus,noninsulin-dependent,2|Diabetes mellitus,insulin-dependent|Hepatic adenoma,somatic|Renal cell carcinoma|Diabetes mellitus,insulin-dependent,20];	RCV000117234.3 [benign]; 	CM067044 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=HNF1A]; 		117	471	2	[2] old entry - no details available			HNF1A (inh=n/a pLI=0.97)
chr12	121437382	121437382	A	G	hom	anno_pathogenic_clinvar	QUAL=13894;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,165,1.00,HOM,215,1.00	HNF1A	missense	HNF1A:NM_001306179.1:missense:MODERATE:exon9/10:c.1741A>G:p.Ser581Gly,HNF1A:NM_000545.6:missense:MODERATE:exon9/10:c.1720A>G:p.Ser574Gly	(CCAG)n	rs1169305	0.9852	0.9960	57820/31915/4361	0.9294	0.3180	T	T,T,T,T,T,T	B	B	142410 [HNF1A (confirmed) MODY,type III|Diabetes mellitus,noninsulin-dependent,2|Diabetes mellitus,insulin-dependent|Hepatic adenoma,somatic|Renal cell carcinoma|Diabetes mellitus,insulin-dependent,20];	RCV000016077.25 [pathogenic]; RCV000030490.2 [not provided]; RCV000121200.1 [not provided]; 	CM020516 [CLASS=DFP MUT=REF PHEN="Diabetes type 2 association with" GENE=HNF1A]; 		1173	3	2	[2] old entry - no details available			HNF1A (inh=n/a pLI=0.97)
chr12	121440263	121440263	G	A	hom	pred_pathogenic_1	QUAL=9074;DP=164;AF=0.99;MQM=59;TRIO=HOM,164,0.99,HET,144,0.51,HET,178,0.50	HNF1A,C12orf43	3'UTR,non_coding_exon	HNF1A:NM_001306179.1:3'UTR:MODIFIER:exon10/10:c.*1268G>A:,C12orf43:NM_001286191.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,HNF1A:NM_000545.6:3'UTR:MODIFIER:exon10/10:c.*1268G>A:,C12orf43:NM_001286192.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286195.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286196.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286197.1:3'UTR:MODIFIER:exon5/5:c.*1693C>T:,C12orf43:NM_001286198.1:3'UTR:MODIFIER:exon7/7:c.*1693C>T:,C12orf43:NM_022895.2:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NR_104409.1:non_coding_exon:MODIFIER:exon6/6:n.2523C>T:		rs41279096	0.1054	0.0670	48/8/1	0.0270	0.2980	T	D							13	125					HNF1A (inh=n/a pLI=0.97), C12orf43 (inh=n/a pLI=0.00)
chr12	122064774	122064779	CCGCCA	-	hom	low_DP	QUAL=622;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HOM,6,0.83,HOM,13,1.00	ORAI1	disruptive_inframe_deletion	ORAI1:NM_032790.3:disruptive_inframe_deletion:MODERATE:exon1/2:c.138_143delACCGCC:p.Pro47_Pro48del	(GCCACC)n	rs531278468	0.9998	0.9940	50849/27505/3399	0.8785						610277 [ORAI1 (provisional) Immunodeficiency 9|Myopathy,tubular aggregate,2];	RCV000173541.1 [benign]; 		COSM430547	1001	38					ORAI1 (inh=n/a pLI=0.00)
chr12	122295335	122295335	T	C	hom	phylop_high;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=21457;DP=184;AF=1.00;MQM=59;TRIO=HOM,184,1.00,HOM,204,1.00,HOM,292,1.00	HPD	missense,5'UTR	HPD:NM_002150.2:missense:MODERATE:exon4/14:c.97A>G:p.Thr33Ala,HPD:NM_001171993.1:5'UTR:MODIFIER:exon6/16:c.-21A>G:		rs1154510	0.8764	0.8500	44159/24898/4816	0.8345	3.8970	T	T,T			609695 [HPD (confirmed) Tyrosinemia,type III|Hawkinsinuria];	RCV000001643.2 [pathogenic]; 	CM003889 [CLASS=DM? MUT=REF PHEN="Hawkinsinuria" GENE=HPD]; 	COSM3736057	826	265	2	[2] old entry - no details available			HPD (inh=AR+AD pLI=0.01)
chr12	122756470	122756470	C	A	het		QUAL=4279;DP=231;AF=0.42;MQM=60;TRIO=HET,231,0.42,WT,93,0.00,HET,143,0.48	CLIP1	3'UTR	CLIP1:NM_001247997.1:3'UTR:MODIFIER:exon26/26:c.*952G>T:,CLIP1:NM_002956.2:3'UTR:MODIFIER:exon25/25:c.*952G>T:,CLIP1:NM_198240.1:3'UTR:MODIFIER:exon24/24:c.*952G>T:		rs112052364	0.0012	0.0000	0/0/0	0.0022										0	6					CLIP1 (inh=n/a pLI=0.97)
chr12	122812503	122812503	G	C	hom		QUAL=18678;DP=198;AF=0.99;MQM=59;TRIO=HOM,198,0.99,HET,250,0.48,HOM,313,0.99	CLIP1	missense	CLIP1:NM_001247997.1:missense:MODERATE:exon17/26:c.3240C>G:p.Asp1080Glu,CLIP1:NM_002956.2:missense:MODERATE:exon16/25:c.3207C>G:p.Asp1069Glu,CLIP1:NM_198240.1:missense:MODERATE:exon15/24:c.3102C>G:p.Asp1034Glu		rs1129167	0.4066	0.5620	20626/13576/125	0.5454	0.2800	T	T,T,T,T,T,T,T	B,B,B	B,B,B					351	446					CLIP1 (inh=n/a pLI=0.97)
chr12	122817580	122817580	A	G	het	phylop_high;pred_pathogenic_3	QUAL=4918;DP=231;AF=0.53;MQM=60;TRIO=HET,231,0.53,HET,132,0.51,WT,185,0.00	CLIP1	missense	CLIP1:NM_001247997.1:missense:MODERATE:exon15/26:c.2821T>C:p.Ser941Pro,CLIP1:NM_002956.2:missense:MODERATE:exon14/25:c.2788T>C:p.Ser930Pro,CLIP1:NM_198240.1:missense:MODERATE:exon13/24:c.2683T>C:p.Ser895Pro		rs17883517	0.0313	0.0620	311/284/4	0.0633	8.6630	T	D,D,D,D,D,D,D	D,D,D	D,D,D				COSM3752995, COSM3752996	3	144					CLIP1 (inh=n/a pLI=0.97)
chr12	122956772	122956772	G	T	hom		QUAL=3567;DP=81;AF=0.00;MQM=60;TRIO=HOM,81,0.00,HOM,23,0.13,HOM,35,0.09	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*1272C>A:	AluSp		0.0000	0.0000	0/0/0	0.0001										0	0					ZCCHC8 (inh=n/a pLI=0.78)
chr12	122956842	122956842	A	C	hom		QUAL=3797;DP=79;AF=1.00;MQM=52;TRIO=HOM,79,1.00,HET,38,0.55,HOM,52,1.00	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*1202T>G:	AluSp	rs11608711	0.5791	0.0000	0/0/0	0.4785										61	89					ZCCHC8 (inh=n/a pLI=0.78)
chr12	122957085	122957085	G	A	hom	low_DP	QUAL=238;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,1,1.00,HOM,1,1.00	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*959C>T:		rs7132830	0.5789	0.0000	0/0/0	0.5331										49	44					ZCCHC8 (inh=n/a pLI=0.78)
chr12	123718301	123718301	C	T	het		QUAL=9125;DP=215;AF=0.55;MQM=60;TRIO=HET,215,0.55,HOM,150,1.00,HET,169,0.53	C12orf65	5'UTR,intron	C12orf65:NM_001143905.2:5'UTR:MODIFIER:exon1/3:c.-169C>T:,C12orf65:NM_001194995.1:5'UTR:MODIFIER:exon1/3:c.-199C>T:,C12orf65:NM_152269.4:intron:MODIFIER:exon1/2:c.-29+223C>T:		rs1727332	0.5569	0.0000	0/0/0	0.6906										112	92					C12orf65 (inh=AR pLI=0.17)
chr12	123738494	123738494	C	T	het		QUAL=6428;DP=264;AF=0.56;MQM=60;TRIO=HET,264,0.56,WT,155,0.00,HET,217,0.53	C12orf65	synonymous	C12orf65:NM_001143905.2:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:NM_152269.4:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:NM_001194995.1:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile		rs2280424	0.0909	0.0560	410/57/10	0.0572						613541 [C12orf65 (provisional) Combined oxidative phosphorylation deficiency 7|Spastic paraplegia 55,autosomal recessive];			COSM3998691	4	157					C12orf65 (inh=AR pLI=0.17)
chr12	123741706	123741706	C	A	het		QUAL=2423;DP=139;AF=0.52;MQM=60;TRIO=HET,139,0.52,WT,70,0.00,HET,71,0.37	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*128C>A:		rs11554169	0.0935	0.0000	0/0/0	0.0125										0	35					C12orf65 (inh=AR pLI=0.17)
chr12	123741776	123741776	T	C	hom		QUAL=14250;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HOM,104,1.00,HOM,123,1.00	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*198T>C:	AluSx1	rs1969354	0.6514	0.0000	0/0/0	0.6764										135	80					C12orf65 (inh=AR pLI=0.17)
chr12	123742032	123742032	A	C	het		QUAL=4174;DP=194;AF=0.51;MQM=57;TRIO=HET,194,0.51,WT,71,0.03,HET,113,0.60	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*454A>C:	AluSx1	rs76029248	0.0933	0.0000	0/0/0	0.0519										1	25					C12orf65 (inh=AR pLI=0.17)
chr12	123742061	123742061	G	A	het		QUAL=6284;DP=220;AF=0.50;MQM=59;TRIO=HET,220,0.50,HOM,75,1.00,HET,127,0.38	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*483G>A:	AluSx1	rs1969355	0.5573	0.0000	0/0/0	0.6277										90	68					C12orf65 (inh=AR pLI=0.17)
chr12	123742093	123742093	T	G	hom		QUAL=14962;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HOM,83,1.00,HOM,140,1.00	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*515T>G:		rs1533703	0.6506	0.0000	0/0/0	0.6816										112	57					C12orf65 (inh=AR pLI=0.17)
chr12	123742271	123742274	AAAG	-	het		QUAL=2413;DP=125;AF=0.58;MQM=59;TRIO=HET,125,0.58,WT,23,0.00,HET,53,0.60	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:	L1ME3B	rs202152701	0.0933	0.0000	0/0/0	0.0399										0	21					C12orf65 (inh=AR pLI=0.17)
chr12	123742287	123742289	TAC	-	het		QUAL=2815;DP=135;AF=0.59;MQM=59;TRIO=HET,135,0.59,WT,28,0.00,HET,57,0.60	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:	L1ME3B	rs148010033	0.0933	0.0000	0/0/0	0.0417										0	21					C12orf65 (inh=AR pLI=0.17)
chr12	124105848	124105848	A	G	hom		QUAL=32887;DP=354;AF=1.00;MQM=60;TRIO=HOM,354,1.00,HOM,264,1.00,HOM,404,1.00	EIF2B1	3'UTR	EIF2B1:NM_001414.3:3'UTR:MODIFIER:exon9/9:c.*455T>C:		rs7137332	0.9972	0.0000	0/0/0	0.9100										228	2					EIF2B1 (inh=AR pLI=0.10)
chr12	124197099	124197099	C	T	het	low_DP	QUAL=288;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,HET,6,0.50,HET,19,0.58	ATP6V0A2	5'UTR	ATP6V0A2:NM_012463.3:5'UTR:MODIFIER:exon1/20:c.-14C>T:		rs1139320	0.2722	0.2820	3200/2075/284	0.2537							RCV000081542.4 [benign]; 			58	157					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124209332	124209332	T	C	het		QUAL=6780;DP=217;AF=0.53;MQM=60;TRIO=HET,217,0.53,HET,141,0.49,HET,159,0.48	ATP6V0A2	synonymous	ATP6V0A2:NM_012463.3:synonymous:LOW:exon4/20:c.426T>C:p.Asn142Asn		rs1139789	0.7510	0.6790	28565/12919/2481	0.6544						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081551.4 [benign]; 		COSM3753015	453	489					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124210782	124210782	T	C	het		QUAL=9892;DP=287;AF=0.47;MQM=60;TRIO=HET,287,0.47,HET,218,0.47,HET,262,0.53	ATP6V0A2	synonymous	ATP6V0A2:NM_012463.3:synonymous:LOW:exon5/20:c.471T>C:p.Ser157Ser		rs1399961	0.7498	0.6760	28301/12692/2473	0.6580						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081553.4 [benign]; 		COSM3753016	450	490					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124229429	124229429	T	C	het		QUAL=18224;DP=324;AF=0.52;MQM=59;TRIO=HET,324,0.52,HET,479,0.51,HET,591,0.49	ATP6V0A2	splice_region&synonymous	ATP6V0A2:NM_012463.3:splice_region&synonymous:LOW:exon13/20:c.1515T>C:p.Asn505Asn		rs7135542	0.7995	0.6930	29854/12976/3617	0.6753						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081547.4 [benign]; 		COSM1127520	454	493					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124243707	124243707	T	C	het		QUAL=8074;DP=260;AF=0.54;MQM=60;TRIO=HET,260,0.54,HET,147,0.40,HET,201,0.52	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*1128T>C:		rs10744162	0.6176	0.0000	0/0/0	0.5632										81	100					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124244272	124244272	C	G	het		QUAL=12643;DP=355;AF=0.48;MQM=60;TRIO=HET,355,0.48,HET,264,0.50,HET,347,0.52	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*1693C>G:		rs10846553	0.7915	0.0000	0/0/0	0.6323										88	105					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124246004	124246004	G	A	het		QUAL=16881;DP=461;AF=0.46;MQM=60;TRIO=HET,461,0.46,HET,363,0.53,HET,445,0.51	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*3425G>A:		rs2333834	0.6066	0.0000	0/0/0	0.5612										79	103					ATP6V0A2 (inh=AR pLI=0.00)
chr13	20761763	20761763	A	G	hom		QUAL=22115;DP=286;AF=1.00;MQM=59;TRIO=HOM,286,1.00,HOM,159,1.00,HOM,230,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1277T>C:		rs7988691	0.9972	0.0000	0/0/0	0.8762										230	0					GJB2 (inh=n/a pLI=0.00)
chr13	20761888	20761888	C	T	hom		QUAL=20406;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,157,1.00,HOM,207,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1152G>A:		rs7623	0.8934	0.0000	0/0/0	0.1462										209	21					GJB2 (inh=n/a pLI=0.00)
chr13	20761973	20761973	C	A	hom		QUAL=30430;DP=477;AF=1.00;MQM=59;TRIO=HOM,477,1.00,HOM,189,1.00,HOM,265,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1067G>T:		rs9237	0.8702	0.0000	0/0/0	0.0981										190	40					GJB2 (inh=n/a pLI=0.00)
chr13	20762956	20762956	A	G	hom		QUAL=35620;DP=468;AF=0.99;MQM=60;TRIO=HOM,468,0.99,HOM,279,1.00,HOM,359,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*84T>C:		rs3751385	0.6867	0.0000	0/0/0	0.1097							RCV000029940.1 [benign]; 			211	94					GJB2 (inh=n/a pLI=0.00)
chr13	20978006	20978006	A	G	hom		QUAL=33137;DP=385;AF=1.00;MQM=59;TRIO=HOM,385,1.00,HOM,294,1.00,HOM,372,1.00	CRYL1	3'UTR	CRYL1:NM_015974.2:3'UTR:MODIFIER:exon8/8:c.*262T>C:		rs7165	0.6903	0.0000	0/0/0	0.1222										124	93					CRYL1 (inh=n/a pLI=0.00)
chr13	21063524	21063524	A	G	het		QUAL=9586;DP=240;AF=0.50;MQM=60;TRIO=HET,240,0.50,WT,196,0.00,HOM,219,1.00	CRYL1	synonymous	CRYL1:NM_015974.2:synonymous:LOW:exon3/8:c.261T>C:p.Gly87Gly		rs14236	0.2704	0.2290	3587/1867/990	0.2232									COSM3753610	50	241					CRYL1 (inh=n/a pLI=0.00)
chr13	23824783	23824783	T	G	hom		QUAL=9039;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,91,1.00,HET,122,0.57	SGCG	synonymous	SGCG:NM_000231.2:synonymous:LOW:exon4/8:c.312T>G:p.Leu104Leu		rs1800351	0.5248	0.4270	11651/4678/2403	0.4236						608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000078404.6 [benign]; 		COSM3753619	162	493					SGCG (inh=n/a pLI=0.01)
chr13	23898509	23898509	T	C	het		QUAL=7196;DP=153;AF=0.53;MQM=60;TRIO=HET,153,0.53,WT,89,0.01,HOM,169,0.99	SGCG	splice_region&synonymous	SGCG:NM_000231.2:splice_region&synonymous:LOW:exon8/8:c.705T>C:p.Leu235Leu		rs1800353	0.6298	0.6740	28194/14968/836	0.6690						608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000078407.6 [benign]; 			527	494					SGCG (inh=n/a pLI=0.01)
chr13	23898664	23898664	A	G	hom	phylop_high	QUAL=13522;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HOM,94,1.00,HOM,166,1.00	SGCG	missense	SGCG:NM_000231.2:missense:MODERATE:exon8/8:c.860A>G:p.Asn287Ser		rs1800354	0.8778	0.8820	47373/25293/2853	0.8478	4.0170	T	T,T,T	B	B	608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000153942.4 [benign]; 	CM1414776 [CLASS=R MUT=REF PHEN="Muscular dystrophy limb girdle 2C" GENE=SGCG]; 	COSM4147635	851	275	2	[2] Ute Grasshoff 24.11.2015			SGCG (inh=n/a pLI=0.01)
chr13	23898934	23898934	G	A	het		QUAL=16094;DP=484;AF=0.51;MQM=60;TRIO=HET,484,0.51,HOM,299,0.99,WT,443,0.01	SGCG	3'UTR	SGCG:NM_000231.2:3'UTR:MODIFIER:exon8/8:c.*254G>A:		rs3751371	0.3502	0.0000	0/0/0	0.0653										54	99					SGCG (inh=n/a pLI=0.01)
chr13	23898975	23898975	T	C	het		QUAL=19551;DP=421;AF=0.50;MQM=60;TRIO=HET,421,0.50,WT,340,0.01,HOM,444,0.99	SGCG	3'UTR	SGCG:NM_000231.2:3'UTR:MODIFIER:exon8/8:c.*295T>C:		rs3829352	0.3480	0.0000	0/0/0	0.0717										45	92					SGCG (inh=n/a pLI=0.01)
chr13	23903220	23903224	TAAAG	-	het		QUAL=6118;DP=238;AF=0.53;MQM=59;TRIO=HET,238,0.53,WT,131,0.00,HET,221,0.57	SACS	3'UTR	SACS:NM_014363.5:3'UTR:MODIFIER:exon10/10:c.*1051_*1055delCTTTA:,SACS:NM_001278055.1:3'UTR:MODIFIER:exon8/8:c.*1051_*1055delCTTTA:		rs66920661	0.0345	0.0000	0/0/0	0.0761										5	36					SACS (inh=AR pLI=0.00)
chr13	23903791	23903791	A	G	het		QUAL=13471;DP=471;AF=0.49;MQM=60;TRIO=HET,471,0.49,WT,195,0.02,HOM,221,0.98	SACS	3'UTR	SACS:NM_014363.5:3'UTR:MODIFIER:exon10/10:c.*484T>C:,SACS:NM_001278055.1:3'UTR:MODIFIER:exon8/8:c.*484T>C:		rs4770433	0.3444	0.0000	0/0/0	0.0715						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];				53	108					SACS (inh=AR pLI=0.00)
chr13	23907677	23907677	C	T	hom		QUAL=25269;DP=361;AF=1.00;MQM=60;TRIO=HOM,361,1.00,HOM,176,1.00,HOM,222,1.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon10/10:c.10338G>A:p.Gln3446Gln,SACS:NM_001278055.1:synonymous:LOW:exon8/8:c.9897G>A:p.Gln3299Gln		rs2737701	0.9854	0.9960	60154/33342/4714	0.9318						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118229.2 [likely benign]; 			2723	6					SACS (inh=AR pLI=0.00)
chr13	23908034	23908034	A	G	het		QUAL=14080;DP=403;AF=0.52;MQM=60;TRIO=HET,403,0.52,WT,198,0.00,HOM,259,1.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon10/10:c.9981T>C:p.Ala3327Ala,SACS:NM_001278055.1:synonymous:LOW:exon8/8:c.9540T>C:p.Ala3180Ala		rs2737700	0.3387	0.4050	10250/6340/153	0.4055						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118235.2 [likely benign]; 		COSM3999043	484	1280					SACS (inh=AR pLI=0.00)
chr13	23929095	23929095	T	C	het		QUAL=9491;DP=327;AF=0.50;MQM=60;TRIO=HET,327,0.50,HOM,164,0.98,WT,249,0.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon8/10:c.1656A>G:p.Leu552Leu,SACS:NM_001278055.1:synonymous:LOW:exon6/8:c.1215A>G:p.Leu405Leu		rs1536365	0.0867	0.1140	873/525/2	0.1118	-0.2340	T				604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118231.2 [likely benign]; 		COSM3753620, COSM3753621	50	582					SACS (inh=AR pLI=0.00)
chr13	23930055	23930055	A	T	het	pred_pathogenic_1	QUAL=9434;DP=392;AF=0.45;MQM=60;TRIO=HET,392,0.45,HOM,155,0.99,WT,249,0.01	SACS	missense	SACS:NM_014363.5:missense:MODERATE:exon8/10:c.696T>A:p.Asn232Lys,SACS:NM_001278055.1:missense:MODERATE:exon6/8:c.255T>A:p.Asn85Lys		rs2031640	0.0865	0.1140	871/522/2	0.1120	0.5360	T,T	T,T,.	D,P,P,.	P,P,B,.	604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118233.2 [likely benign]; 		COSM3753622, COSM3753623	48	586					SACS (inh=AR pLI=0.00)
chr13	23949252	23949252	G	A	het	low_DP	QUAL=677;DP=15;AF=0.27;MQM=60;TRIO=HET,15,0.27,WT,33,0.00,HET,62,0.50	SACS	splice_region&intron	SACS:NM_014363.5:splice_region&intron:LOW:exon3/9:c.171+6C>T:,SACS:NM_001278055.1:splice_region&intron:LOW:exon2/7:c.-183+6C>T:		rs3751368	0.0895	0.0590	69/30/1	0.0384						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];				72	719					SACS (inh=AR pLI=0.00)
chr13	24007783	24007783	C	T	het		QUAL=3459;DP=142;AF=0.56;MQM=60;TRIO=HET,142,0.56,HET,133,0.52,WT,178,0.00	SACS	5'UTR	SACS:NM_014363.5:5'UTR:MODIFIER:exon1/10:c.-531G>A:		rs73154650	0.0300	0.0000	0/0/0	0.0326										0	14					SACS (inh=AR pLI=0.00)
chr13	25456631	25456631	-	T	het		QUAL=8249;DP=403;AF=0.43;MQM=59;TRIO=HET,403,0.43,WT,307,0.00,HET,351,0.48	CENPJ	3'UTR,non_coding_exon	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*683dupA:,CENPJ:NR_047594.1:non_coding_exon:MODIFIER:exon18/18:n.5012dupA:,CENPJ:NR_047595.1:non_coding_exon:MODIFIER:exon16/16:n.4810dupA:		rs397718122;rs58955593	0.3239	0.0000	0/0/0	0.2335										30	112					CENPJ (inh=AR pLI=0.00)
chr13	25457005	25457007	CTT	-	het		QUAL=5832;DP=319;AF=0.54;MQM=59;TRIO=HET,319,0.54,HET,171,0.54,WT,186,0.00	CENPJ	3'UTR,non_coding_exon	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*308_*310delAAG:,CENPJ:NR_047594.1:non_coding_exon:MODIFIER:exon18/18:n.4637_4639delAAG:,CENPJ:NR_047595.1:non_coding_exon:MODIFIER:exon16/16:n.4435_4437delAAG:		rs796638364	0.1587	0.0000	0/0/0	0.2145										27	83					CENPJ (inh=AR pLI=0.00)
chr13	25457207	25457207	T	C	hom		QUAL=18779;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,124,1.00,HOM,180,1.00	CENPJ	3'UTR,non_coding_exon	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*108A>G:,CENPJ:NR_047594.1:non_coding_exon:MODIFIER:exon18/18:n.4437A>G:,CENPJ:NR_047595.1:non_coding_exon:MODIFIER:exon16/16:n.4235A>G:		rs9318911	0.9667	0.0000	0/0/0	0.1755										229	1					CENPJ (inh=AR pLI=0.00)
chr13	25466774	25466774	T	C	hom		QUAL=7049;DP=88;AF=1.00;MQM=59;TRIO=HOM,88,1.00,HOM,88,1.00,HET,121,0.55	CENPJ	splice_region&intron	CENPJ:NM_018451.4:splice_region&intron:LOW:exon10/16:c.3216+7A>G:,CENPJ:NR_047594.1:splice_region&intron:LOW:exon10/17:n.3411+7A>G:,CENPJ:NR_047595.1:splice_region&intron:LOW:exon10/15:n.3411+7A>G:		rs9318917	0.7372	0.8040	39655/23064/2190	0.7804						609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive|Seckel syndrome 4];	RCV000145574.4 [benign]; 			708	342					CENPJ (inh=AR pLI=0.00)
chr13	25466955	25466955	T	C	het		QUAL=6907;DP=226;AF=0.48;MQM=60;TRIO=HET,226,0.48,HET,148,0.47,HET,190,0.56	CENPJ	synonymous,non_coding_exon	CENPJ:NM_018451.4:synonymous:LOW:exon10/17:c.3042A>G:p.Glu1014Glu,CENPJ:NR_047594.1:non_coding_exon:MODIFIER:exon10/18:n.3237A>G:,CENPJ:NR_047595.1:non_coding_exon:MODIFIER:exon10/16:n.3237A>G:		rs3742165	0.4840	0.5390	18371/9675/435	0.5357	0.1810	T				609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive|Seckel syndrome 4];	RCV000145573.2 [benign]; 		COSM4147658	299	552					CENPJ (inh=AR pLI=0.00)
chr13	32676114	32676114	A	G	het		QUAL=6562;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,HET,186,0.56,WT,252,0.01	FRY	synonymous	FRY:NM_023037.2:synonymous:LOW:exon3/61:c.285A>G:p.Thr95Thr		rs364995	0.5815	0.6050	22418/13360/1665	0.5960									COSM3753642, COSM3753641	412	521					FRY (inh=n/a pLI=1.00)
chr13	32758834	32758834	A	G	het		QUAL=5146;DP=201;AF=0.49;MQM=60;TRIO=HET,201,0.49,HOM,80,1.00,WT,111,0.01	FRY	splice_region&intron	FRY:NM_023037.2:splice_region&intron:LOW:exon25/60:c.3146+6A>G:		rs798971	0.8217	0.7880	37731/18675/2948	0.7637										625	402					FRY (inh=n/a pLI=1.00)
chr13	32776603	32776603	T	C	het		QUAL=5456;DP=242;AF=0.50;MQM=59;TRIO=HET,242,0.50,HET,181,0.51,WT,249,0.00	FRY	synonymous	FRY:NM_023037.2:synonymous:LOW:exon31/61:c.3957T>C:p.Leu1319Leu		rs2428249	0.3458	0.3850	9423/5682/866	0.3763									COSM3765691	148	505					FRY (inh=n/a pLI=1.00)
chr13	32811607	32811607	G	A	hom	phylop_high	QUAL=16321;DP=177;AF=0.99;MQM=60;TRIO=HOM,177,0.99,HOM,231,1.00,HET,302,0.52	FRY	missense	FRY:NM_023037.2:missense:MODERATE:exon44/61:c.5902G>A:p.Gly1968Ser		rs2806639	0.2159	0.2810	5441/3587/546	0.2744	1.8580	T	T,T	B	B					98	484					FRY (inh=n/a pLI=1.00)
chr13	32890572	32890572	G	A	het		QUAL=6867;DP=301;AF=0.52;MQM=60;TRIO=HET,301,0.52,HET,200,0.50,WT,239,0.00	BRCA2	5'UTR	BRCA2:NM_000059.3:5'UTR:MODIFIER:exon2/27:c.-26G>A:		rs1799943	0.2093	0.2430	3755/2063/51	0.2438							RCV000112977.3 [benign]; RCV000114981.1 [not provided]; RCV000112978.1 [benign]; RCV000112979.1 [benign]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2]; 		42	229					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32906729	32906729	A	C	het		QUAL=10264;DP=395;AF=0.51;MQM=60;TRIO=HET,395,0.51,HET,133,0.54,HET,193,0.51	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon10/27:c.1114A>C:p.Asn372His		rs144848	0.2494	0.2770	4939/2667/82	0.2666	0.7570	T	T,T,T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000112880.1 [not provided]; RCV000009916.7 [benign]; RCV000034427.1 [benign]; RCV000120303.4 [benign]; RCV000130720.2 [benign]; RCV000207052.1 [uncertain significance]; 	CM002750 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BRCA2]; 	COSM147663, COSM3753646	227	1096	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32911888	32911888	A	G	het		QUAL=6648;DP=349;AF=0.51;MQM=59;TRIO=HET,349,0.51,HET,118,0.56,WT,158,0.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2930	5391/3115/273	0.2927						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113169.1 [benign]; RCV000113170.4 [benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.3 [benign]; 			271	1216	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32913055	32913055	A	G	hom		QUAL=17062;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,115,1.00,HOM,123,1.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9930	59672/33182/4417	0.9551						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113321.1 [benign]; RCV000160224.1 [benign]; RCV000164515.1 [likely benign]; RCV000198429.1 [likely benign]; RCV000119245.2 [benign]; RCV000132170.2 [benign]; RCV000152875.5 [benign]; 			2799	11	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32915005	32915005	G	C	hom		QUAL=26943;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HOM,165,1.00,HOM,228,1.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677/33272/4398	0.9628						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113602.1 [not provided]; RCV000119246.2 [benign]; RCV000152878.5 [benign]; RCV000162377.1 [benign]; RCV000163332.1 [likely benign]; RCV000168590.2 [other]; RCV000173959.1 [uncertain significance]; RCV000195987.2 [likely benign]; 		COSM4147690, COSM4147689	2800	14	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929232	32929232	A	G	het		QUAL=10727;DP=475;AF=0.49;MQM=60;TRIO=HET,475,0.49,HET,387,0.45,WT,505,0.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2240	3228/1556/231	0.2239						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.3 [benign]; 			133	1008	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929387	32929387	T	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=25309;DP=291;AF=1.00;MQM=60;TRIO=HOM,291,1.00,HOM,219,1.00,HOM,281,1.00	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9940	59912/33304/4522	0.9638	2.3530	T	T,T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000045197.4 [benign]; RCV000113751.2 [benign]; RCV000168597.1 [benign]; RCV000203672.1 [benign]; RCV000120357.5 [benign]; RCV000207137.1 [uncertain significance]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 		2811	11	2	[2] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32973439	32973439	A	G	het		QUAL=5679;DP=295;AF=0.47;MQM=60;TRIO=HET,295,0.47,HET,154,0.46,WT,195,0.00	BRCA2	3'UTR	BRCA2:NM_000059.3:3'UTR:MODIFIER:exon27/27:c.*532A>G:		rs11571836	0.1975	0.0000	0/0/0	0.2279							RCV000191876.1 [benign]; 			13	108					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32973737	32973737	T	-	het		QUAL=2483;DP=210;AF=0.43;MQM=59;TRIO=HET,210,0.43,HET,45,0.42,WT,86,0.02	BRCA2	3'UTR	BRCA2:NM_000059.3:3'UTR:MODIFIER:exon27/27:c.*839delT:		rs139813105	0.2310	0.0000	0/0/0	0.1505										13	109					BRCA2 (inh=AR+AD pLI=0.00)
chr13	36877519	36877519	-	ATA	het		QUAL=4900;DP=309;AF=0.48;MQM=59;TRIO=HET,309,0.48,HET,90,0.50,WT,147,0.00	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*980_*982dupTAT:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:		rs200142976	0.0040	0.0000	0/0/0	0.0047										0	7					SPG20 (inh=AR pLI=0.00)
chr13	36877656	36877656	C	T	het		QUAL=1731;DP=116;AF=0.53;MQM=59;TRIO=HET,116,0.53,WT,22,0.00,HET,28,0.36	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*846G>A:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*846G>A:		rs1054152	0.1382	0.0000	0/0/0	0.0298										10	70					SPG20 (inh=AR pLI=0.00)
chr13	36877878	36877878	T	C	hom		QUAL=12135;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,100,1.00,HOM,102,1.00	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*624A>G:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*624A>G:		rs2148049	0.9890	0.0000	0/0/0	0.8522										230	0					SPG20 (inh=AR pLI=0.00)
chr13	36920849	36920849	-	C	het		QUAL=1899;DP=48;AF=0.54;MQM=60;TRIO=HET,48,0.54,WT,199,0.00,HET,235,0.45	SPG20,SPG20-AS1	5'UTR,intron	SPG20:NM_001142295.1:5'UTR:MODIFIER:exon1/9:c.-134dupG:,SPG20:NM_001142294.1:intron:MODIFIER:exon1/8:c.-2-10881dupG:,SPG20-AS1:NR_045180.1:intron:MODIFIER:exon1/5:n.77+212dupC:,SPG20-AS1:NR_045181.1:intron:MODIFIER:exon1/4:n.77+212dupC:		rs146524559	0.2800	0.0000	0/0/0	0.3243										39	96					SPG20 (inh=AR pLI=0.00), SPG20-AS1 (inh=n/a pLI=n/a)
chr13	36920890	36920890	G	C	hom		QUAL=12961;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,164,1.00,HOM,217,1.00	SPG20,SPG20-AS1	5'UTR,intron	SPG20:NM_001142295.1:5'UTR:MODIFIER:exon1/9:c.-174C>G:,SPG20:NM_001142294.1:intron:MODIFIER:exon1/8:c.-2-10921C>G:,SPG20-AS1:NR_045180.1:intron:MODIFIER:exon1/5:n.77+246G>C:,SPG20-AS1:NR_045181.1:intron:MODIFIER:exon1/4:n.77+246G>C:		rs4943362	1.0000	0.0000	0/0/0	0.8487										230	0					SPG20 (inh=AR pLI=0.00), SPG20-AS1 (inh=n/a pLI=n/a)
chr13	36944274	36944274	C	T	het	low_DP	QUAL=145;DP=13;AF=0.46;MQM=60;TRIO=HET,13,0.46,HOM,1,1.00,HOM,1,1.00	SPG20	5'UTR	SPG20:NM_001142294.1:5'UTR:MODIFIER:exon1/9:c.-51G>A:		rs4287440	0.7476	0.0000	0/0/0	0.7084										87	76					SPG20 (inh=AR pLI=0.00)
chr13	37401918	37401918	T	-	hom		QUAL=21338;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,186,0.99,HOM,264,1.00	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*33delT:		rs869145024	0.8011	0.8760	45811/27682/2680	0.8210										393	83					RFXAP (inh=n/a pLI=0.44)
chr13	37402440	37402440	T	C	hom		QUAL=19274;DP=297;AF=1.00;MQM=59;TRIO=HOM,297,1.00,HOM,123,1.00,HOM,156,1.00	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*550T>C:		rs9547679	0.7961	0.0000	0/0/0	0.1471										177	50					RFXAP (inh=n/a pLI=0.44)
chr13	37403143	37403143	G	A	het		QUAL=8686;DP=349;AF=0.48;MQM=59;TRIO=HET,349,0.48,WT,202,0.00,HET,313,0.51	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*1253G>A:		rs10976	0.1414	0.0000	0/0/0	0.0230										10	68					RFXAP (inh=n/a pLI=0.44)
chr13	39262057	39262057	G	A	hom		QUAL=15525;DP=93;AF=1.00;MQM=60;TRIO=HOM,93,1.00,HOM,181,1.00,HOM,231,1.00	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon1/24:c.576G>A:p.Glu192Glu		rs1868464	1.0000	1.0000	45999/24829/3896	0.9379						608945 [FREM2 (provisional) Fraser syndrome];			COSM4147704	1108	0					FREM2 (inh=AR pLI=0.00)
chr13	39263714	39263714	T	C	hom	phylop_high	QUAL=33208;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,325,1.00,HOM,416,1.00	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon1/24:c.2233T>C:p.Ser745Pro		rs2496423	1.0000	1.0000	60494/33299/5198	0.9453	3.1680	T	T	B	B	608945 [FREM2 (provisional) Fraser syndrome];	RCV000173610.1 [benign]; 			1105	1					FREM2 (inh=AR pLI=0.00)
chr13	39264690	39264690	T	C	het		QUAL=12315;DP=398;AF=0.47;MQM=59;TRIO=HET,398,0.47,HET,214,0.48,HET,282,0.57	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon1/24:c.3209T>C:p.Phe1070Ser		rs2496425	0.4812	0.3470	8569/2562/3014	0.3410	0.9280	T	T	B	B	608945 [FREM2 (provisional) Fraser syndrome];	RCV000173599.1 [benign]; 	CM065186 [CLASS=DP MUT=ALT PHEN="Colorectal cancer increased risk association with" GENE=FREM2]; 	COSM1366801	97	420					FREM2 (inh=AR pLI=0.00)
chr13	39343822	39343822	C	T	het	pred_pathogenic_3	QUAL=9392;DP=318;AF=0.48;MQM=60;TRIO=HET,318,0.48,HET,178,0.49,HET,297,0.47	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon4/24:c.5518C>T:p.Arg1840Trp		rs9603422	0.1418	0.1210	1023/437/259	0.1206	0.8450	T	D	D	D	608945 [FREM2 (provisional) Fraser syndrome];				29	233					FREM2 (inh=AR pLI=0.00)
chr13	39422624	39422624	C	T	het	phylop_high;pred_pathogenic_3	QUAL=3261;DP=136;AF=0.48;MQM=60;TRIO=HET,136,0.48,WT,126,0.00,HET,124,0.52	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon8/24:c.6196C>T:p.Arg2066Cys		rs9548505	0.1096	0.1220	1333/348/104	0.1201	4.8040	T	D	D,D	P,D	608945 [FREM2 (provisional) Fraser syndrome];			COSM3753678	21	205					FREM2 (inh=AR pLI=0.00)
chr13	39424253	39424253	C	G	het	phylop_high	QUAL=3222;DP=225;AF=0.45;MQM=60;TRIO=HET,225,0.45,WT,60,0.00,HET,66,0.47	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon9/24:c.6458C>G:p.Thr2153Ser		rs9548506	0.0919	0.1170	1225/338/35	0.1093	3.4960	T	T	B,B	B,B	608945 [FREM2 (provisional) Fraser syndrome];			COSM3753679	20	201					FREM2 (inh=AR pLI=0.00)
chr13	39424254	39424254	T	C	het		QUAL=3222;DP=225;AF=0.45;MQM=60;TRIO=HET,225,0.45,WT,60,0.00,HET,66,0.47	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon9/24:c.6459T>C:p.Thr2153Thr		rs9548507	0.0919	0.1170	1223/337/35	0.1093						608945 [FREM2 (provisional) Fraser syndrome];			COSM3753680	20	201					FREM2 (inh=AR pLI=0.00)
chr13	39430314	39430314	C	T	het	phylop_high	QUAL=15444;DP=264;AF=0.44;MQM=60;TRIO=HET,264,0.44,HET,191,0.57,HOM,292,1.00	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon12/24:c.6977C>T:p.Thr2326Ile		rs9548509	0.7720	0.7400	33703/16210/2911	0.7216	6.1370	T	T	B,B	B,B	608945 [FREM2 (provisional) Fraser syndrome];			COSM432379	549	461					FREM2 (inh=AR pLI=0.00)
chr13	39433606	39433606	A	G	het		QUAL=27482;DP=416;AF=0.53;MQM=60;TRIO=HET,416,0.53,WT,496,0.00,HOM,709,0.99	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon14/24:c.7398A>G:p.Thr2466Thr		rs9532292	0.4367	0.3730	9063/3345/1621	0.3672						608945 [FREM2 (provisional) Fraser syndrome];			COSM3753681	145	476					FREM2 (inh=AR pLI=0.00)
chr13	39455916	39455916	T	C	het		QUAL=10901;DP=472;AF=0.49;MQM=60;TRIO=HET,472,0.49,WT,191,0.01,HET,325,0.51	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*992T>C:		rs9532297	0.0845	0.0000	0/0/0	0.0189										4	41					FREM2 (inh=AR pLI=0.00)
chr13	39455965	39455965	C	T	het		QUAL=10593;DP=491;AF=0.45;MQM=60;TRIO=HET,491,0.45,WT,232,0.00,HET,349,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1041C>T:		rs9548521	0.0675	0.0000	0/0/0	0.0158										3	30					FREM2 (inh=AR pLI=0.00)
chr13	39456352	39456352	A	G	het		QUAL=9492;DP=408;AF=0.45;MQM=59;TRIO=HET,408,0.45,HET,165,0.52,HET,176,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1428A>G:		rs9548522	0.4339	0.0000	0/0/0	0.0848										50	123					FREM2 (inh=AR pLI=0.00)
chr13	39456391	39456391	G	A	het		QUAL=7839;DP=443;AF=0.47;MQM=60;TRIO=HET,443,0.47,WT,165,0.00,HET,177,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1467G>A:		rs9548523	0.0675	0.0000	0/0/0	0.0158										3	30					FREM2 (inh=AR pLI=0.00)
chr13	39457064	39457064	C	G	het		QUAL=18088;DP=627;AF=0.49;MQM=60;TRIO=HET,627,0.49,HET,298,0.50,HET,416,0.51	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*2140C>G:		rs7324632	0.4339	0.0000	0/0/0	0.4991										51	122					FREM2 (inh=AR pLI=0.00)
chr13	39459389	39459389	C	T	het		QUAL=6613;DP=194;AF=0.43;MQM=59;TRIO=HET,194,0.43,HET,96,0.46,HOM,100,1.00	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*4465C>T:		rs2027770	0.7474	0.0000	0/0/0	0.1419										97	110					FREM2 (inh=AR pLI=0.00)
chr13	39460259	39460259	A	G	het		QUAL=4047;DP=224;AF=0.47;MQM=60;TRIO=HET,224,0.47,WT,78,0.00,HET,93,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5335A>G:		rs9548524	0.0843	0.0000	0/0/0	0.1110										4	41					FREM2 (inh=AR pLI=0.00)
chr13	39460415	39460415	G	A	het		QUAL=13061;DP=353;AF=0.48;MQM=59;TRIO=HET,353,0.48,HET,133,0.56,HOM,201,1.00	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5491G>A:		rs2226913	0.7504	0.0000	0/0/0	0.7284										97	107					FREM2 (inh=AR pLI=0.00)
chr13	39460486	39460486	C	G	het		QUAL=8979;DP=276;AF=0.51;MQM=59;TRIO=HET,276,0.51,HET,148,0.53,HET,203,0.61	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5562C>G:	(ATAC)n	rs1945507	0.4341	0.0000	0/0/0	0.4322										51	120					FREM2 (inh=AR pLI=0.00)
chr13	39460540	39460540	T	-	het		QUAL=4247;DP=114;AF=0.45;MQM=59;TRIO=HET,114,0.45,HET,89,0.52,HOM,101,0.93	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5627delT:	AluSp	rs5802961	0.7486	0.0000	0/0/0	0.2855										62	99					FREM2 (inh=AR pLI=0.00)
chr13	39460657	39460657	C	T	het		QUAL=3444;DP=153;AF=0.50;MQM=59;TRIO=HET,153,0.50,HET,41,0.56,HET,61,0.54	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5733C>T:	AluSp	rs1945505	0.4343	0.0000	0/0/0	0.4515										39	93					FREM2 (inh=AR pLI=0.00)
chr13	41382711	41382711	A	T	het		QUAL=4536;DP=166;AF=0.54;MQM=55;TRIO=HET,166,0.54,WT,153,0.00,HET,185,0.48	SLC25A15,TPTE2P5	missense,intron	SLC25A15:NM_014252.3:missense:MODERATE:exon6/7:c.760A>T:p.Ile254Leu,TPTE2P5:NR_038258.1:intron:MODIFIER:exon7/7:n.623-7851T>A:,TPTE2P5:NR_038259.1:intron:MODIFIER:exon5/5:n.452-7851T>A:		rs17849654	0.3227	0.3700	8648/5828/193	0.3632	1.3490	T	T,T	B,B	B,B	603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome];	RCV000128071.2 [benign]; 		COSM3753692	394	966					SLC25A15 (inh=AR pLI=0.00), TPTE2P5 (inh=n/a pLI=n/a)
chr13	41384156	41384156	A	G	het		QUAL=6076;DP=241;AF=0.53;MQM=59;TRIO=HET,241,0.53,WT,165,0.01,HET,213,0.51	SLC25A15,TPTE2P5	3'UTR,intron	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*353A>G:,TPTE2P5:NR_038258.1:intron:MODIFIER:exon7/7:n.623-9296T>C:,TPTE2P5:NR_038259.1:intron:MODIFIER:exon5/5:n.452-9296T>C:		rs9549293	0.4237	0.0000	0/0/0	0.0723										56	132					SLC25A15 (inh=AR pLI=0.00), TPTE2P5 (inh=n/a pLI=n/a)
chr13	41384318	41384318	A	G	het		QUAL=1988;DP=122;AF=0.53;MQM=58;TRIO=HET,122,0.53,WT,23,0.00,HET,28,0.64	SLC25A15,TPTE2P5	3'UTR,intron	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*515A>G:,TPTE2P5:NR_038258.1:intron:MODIFIER:exon7/7:n.623-9458T>C:,TPTE2P5:NR_038259.1:intron:MODIFIER:exon5/5:n.452-9458T>C:	AluSz	rs7322603	0.4237	0.0000	0/0/0	0.3827										54	120					SLC25A15 (inh=AR pLI=0.00), TPTE2P5 (inh=n/a pLI=n/a)
chr13	41384382	41384382	C	T	het		QUAL=2071;DP=145;AF=0.50;MQM=51;TRIO=HET,145,0.50,WT,12,0.00,HET,28,0.54	SLC25A15,TPTE2P5	3'UTR,intron	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*579C>T:,TPTE2P5:NR_038258.1:intron:MODIFIER:exon7/7:n.623-9522G>A:,TPTE2P5:NR_038259.1:intron:MODIFIER:exon5/5:n.452-9522G>A:	AluSz	rs7321976	0.4237	0.0000	0/0/0	0.3824										48	108					SLC25A15 (inh=AR pLI=0.00), TPTE2P5 (inh=n/a pLI=n/a)
chr13	48517289	48517289	A	G	hom		QUAL=30309;DP=439;AF=1.00;MQM=60;TRIO=HOM,439,1.00,HOM,213,1.00,HOM,267,1.00	SUCLA2	3'UTR	SUCLA2:NM_003850.2:3'UTR:MODIFIER:exon11/11:c.*217T>C:		rs4941618	0.9419	0.0000	0/0/0	0.1460										195	32					SUCLA2 (inh=n/a pLI=0.03)
chr13	48547467	48547467	A	T	hom	phylop_high	QUAL=12839;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HET,124,0.48,HOM,140,1.00	SUCLA2	missense	SUCLA2:NM_003850.2:missense:MODERATE:exon5/11:c.595T>A:p.Ser199Thr		rs7320366	0.6835	0.7510	34944/22378/1754	0.7436	4.7410	T	T,T,T,T,T,T,T,T,T,T	B	B	603921 [SUCLA2 (confirmed) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)];	RCV000128327.2 [benign]; 			675	380					SUCLA2 (inh=n/a pLI=0.03)
chr13	48563008	48563008	G	A	hom		QUAL=17856;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HET,162,0.40,HOM,207,1.00	SUCLA2	splice_region&intron	SUCLA2:NM_003850.2:splice_region&intron:LOW:exon3/10:c.371+9C>T:		rs6561424	0.6835	0.7510	34812/22285/1738	0.7448						603921 [SUCLA2 (confirmed) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)];	RCV000177179.2 [benign]; 			669	363					SUCLA2 (inh=n/a pLI=0.03)
chr13	78470350	78470350	A	G	hom		QUAL=7356;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,38,1.00,HOM,36,1.00	EDNRB,EDNRB-AS1	3'UTR,intron	EDNRB:NM_001201397.1:3'UTR:MODIFIER:exon8/8:c.*1985T>C:,EDNRB:NM_001122659.2:3'UTR:MODIFIER:exon7/7:c.*1985T>C:,EDNRB:NM_003991.3:3'UTR:MODIFIER:exon7/7:c.*227T>C:,EDNRB:NM_000115.3:3'UTR:MODIFIER:exon8/8:c.*1985T>C:,EDNRB-AS1:NR_103853.1:intron:MODIFIER:exon6/6:n.1695-11477A>G:		rs4885491	0.9255	0.0000	0/0/0	0.1342										159	67					EDNRB (inh=n/a pLI=0.02), EDNRB-AS1 (inh=n/a pLI=n/a)
chr13	78470568	78470568	G	A	het		QUAL=3341;DP=213;AF=0.47;MQM=60;TRIO=HET,213,0.47,WT,64,0.03,HET,60,0.58	EDNRB,EDNRB-AS1	3'UTR,intron	EDNRB:NM_001201397.1:3'UTR:MODIFIER:exon8/8:c.*1767C>T:,EDNRB:NM_001122659.2:3'UTR:MODIFIER:exon7/7:c.*1767C>T:,EDNRB:NM_003991.3:3'UTR:MODIFIER:exon7/7:c.*9C>T:,EDNRB:NM_000115.3:3'UTR:MODIFIER:exon8/8:c.*1767C>T:,EDNRB-AS1:NR_103853.1:intron:MODIFIER:exon6/6:n.1695-11259G>A:		rs3027092	0.0146	0.0110	7/4/0	0.0104							RCV000217389.1 [benign]; 			0	26					EDNRB (inh=n/a pLI=0.02), EDNRB-AS1 (inh=n/a pLI=n/a)
chr13	78477674	78477674	A	G	hom		QUAL=24512;DP=334;AF=0.99;MQM=59;TRIO=HOM,334,0.99,HOM,183,1.00,HOM,226,1.00	EDNRB,EDNRB-AS1	synonymous,intron	EDNRB:NM_001201397.1:synonymous:LOW:exon3/8:c.822T>C:p.Ser274Ser,EDNRB:NM_001122659.2:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser,EDNRB:NM_003991.3:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser,EDNRB:NM_000115.3:synonymous:LOW:exon3/8:c.552T>C:p.Ser184Ser,EDNRB-AS1:NR_103853.1:intron:MODIFIER:exon6/6:n.1695-4153A>G:		rs5348	0.9838	0.9950	59991/33323/4723	0.9405						131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2|ABCD syndrome|Waardenburg syndrome,type 4A];	RCV000220746.1 [benign]; 			1107	0					EDNRB (inh=n/a pLI=0.02), EDNRB-AS1 (inh=n/a pLI=n/a)
chr13	78549635	78549635	C	T	het	low_DP	QUAL=139;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,7,0.00,HET,6,0.67	EDNRB	5'UTR	EDNRB:NM_000115.3:5'UTR:MODIFIER:exon1/8:c.-205G>A:	HERVE_a-int	rs12720104	0.0146	0.0000	0/0/0	0.0121										0	2					EDNRB (inh=n/a pLI=0.02)
chr13	100635377	100635377	C	T	het		QUAL=7505;DP=233;AF=0.46;MQM=59;TRIO=HET,233,0.46,WT,385,0.00,HET,462,0.44	ZIC2	synonymous	ZIC2:NM_007129.3:synonymous:LOW:exon1/3:c.1059C>T:p.His353His		rs1831992	0.0417	0.0790	549/492/3	0.0801						603073 [ZIC2 (provisional) Holoprosencephaly-5];	RCV000081471.4 [benign]; 			19	196					ZIC2 (inh=AD pLI=n/a)
chr13	100638392	100638392	G	A	hom		QUAL=27395;DP=553;AF=0.99;MQM=59;TRIO=HOM,553,0.99,HET,170,0.49,HOM,288,0.98	ZIC2	3'UTR	ZIC2:NM_007129.3:3'UTR:MODIFIER:exon3/3:c.*456G>A:		rs13542	0.3105	0.0000	0/0/0	0.2696										27	147					ZIC2 (inh=AD pLI=n/a)
chr13	102373563	102373563	A	T	hom		QUAL=25448;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,168,1.00,HOM,261,1.00	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1618T>A:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1618T>A:		rs15608	0.8325	0.0000	0/0/0	0.7843										138	104					FGF14 (inh=AD pLI=0.72)
chr13	102373569	102373569	C	A	het		QUAL=9563;DP=322;AF=0.45;MQM=60;TRIO=HET,322,0.45,HOM,178,0.99,WT,273,0.00	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1612G>T:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1612G>T:		rs1046197	0.3431	0.0000	0/0/0	0.3412										24	134					FGF14 (inh=AD pLI=0.72)
chr13	102373790	102373790	-	TTTA	hom		QUAL=24827;DP=406;AF=0.98;MQM=59;TRIO=HOM,406,0.98,HOM,159,0.99,HOM,201,0.99	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1387_*1390dupTAAA:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1387_*1390dupTAAA:		rs10626847;rs5806245	0.4169	0.0000	0/0/0	0.2646										43	138					FGF14 (inh=AD pLI=0.72)
chr13	102374208	102374208	-	T	hom		QUAL=3478;DP=117;AF=0.61;MQM=59;TRIO=HOM,117,0.61,HOM,80,0.69,HOM,101,0.64	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*972dupA:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*972dupA:		rs397768294;rs557319654	0.3570	0.0000	0/0/0	0.2348										4	167					FGF14 (inh=AD pLI=0.72)
chr13	103498198	103498198	A	G	het		QUAL=3289;DP=110;AF=0.44;MQM=59;TRIO=HET,110,0.44,HET,53,0.53,HOM,64,1.00	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:NM_000123.3:5'UTR:MODIFIER:exon1/15:c.-419A>G:,BIVM-ERCC5:NM_001204425.1:intron:MODIFIER:exon9/22:c.1450+6045A>G:		rs751402	0.6889	0.0000	0/0/0	0.1265								CR1510212 [CLASS=DFP MUT=REF PHEN="Oral squamous cell carcinoma increased risk" GENE=ERCC5]; 		138	77					ERCC5 (inh=AR pLI=0.00), BIVM-ERCC5 (inh=n/a pLI=n/a)
chr13	103498375	103498375	T	C	het		QUAL=15543;DP=268;AF=0.45;MQM=60;TRIO=HET,268,0.45,HET,254,0.46,HOM,317,0.99	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:NM_000123.3:5'UTR:MODIFIER:exon1/15:c.-242T>C:,BIVM-ERCC5:NM_001204425.1:intron:MODIFIER:exon9/22:c.1451-6093T>C:		rs2296147	0.2979	0.0000	0/0/0	0.0652										47	111					ERCC5 (inh=AR pLI=0.00), BIVM-ERCC5 (inh=n/a pLI=n/a)
chr13	103504517	103504517	T	C	het		QUAL=8021;DP=158;AF=0.51;MQM=60;TRIO=HET,158,0.51,HET,113,0.55,HOM,129,0.99	BIVM-ERCC5,ERCC5	synonymous	BIVM-ERCC5:NM_001204425.1:synonymous:LOW:exon10/23:c.1500T>C:p.His500His,ERCC5:NM_000123.3:synonymous:LOW:exon2/15:c.138T>C:p.His46His		rs1047768	0.4930	0.5290	18075/11535/2239	0.5227						133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome|Cerebrooculofacioskeletal syndrome 3];	RCV000116990.2 [likely benign]; 		COSM3753565	792	1211					BIVM-ERCC5 (inh=n/a pLI=n/a), ERCC5 (inh=AR pLI=0.00)
chr13	103527849	103527849	G	C	hom	phylop_high;pred_pathogenic_1	QUAL=17138;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,118,1.00,HOM,156,1.00	BIVM-ERCC5,ERCC5	missense	BIVM-ERCC5:NM_001204425.1:missense:MODERATE:exon23/23:c.4519G>C:p.Gly1507Arg,ERCC5:NM_000123.3:missense:MODERATE:exon15/15:c.3157G>C:p.Gly1053Arg		rs9514066	0.9982	0.9990	60603/33354/5133	0.9353	3.2550	T	T,D,D,T	P	P	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome|Cerebrooculofacioskeletal syndrome 3];	RCV000120845.1 [not provided]; 			2468	1					BIVM-ERCC5 (inh=n/a pLI=n/a), ERCC5 (inh=AR pLI=0.00)
chr13	103527930	103527930	G	C	hom	anno_pathogenic_clinvar	QUAL=16156;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HOM,108,1.00,HOM,130,1.00	BIVM-ERCC5,ERCC5	missense	BIVM-ERCC5:NM_001204425.1:missense:MODERATE:exon23/23:c.4600G>C:p.Gly1534Arg,ERCC5:NM_000123.3:missense:MODERATE:exon15/15:c.3238G>C:p.Gly1080Arg		rs9514067	0.9972	0.9990	60574/33341/5128	0.9354	-0.3730	T	T,T,T,T	B	B	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome|Cerebrooculofacioskeletal syndrome 3];	RCV000120846.1 [not provided]; RCV000190581.1 [likely pathogenic]; 			2465	2	1	[1] harmuth 11.02.2016; bei 1700 homo Beobachtungen in unser db ist es sicher der Wildtyp			BIVM-ERCC5 (inh=n/a pLI=n/a), ERCC5 (inh=AR pLI=0.00)
chr13	103528337	103528337	G	A	hom		QUAL=25215;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,186,0.99,HOM,259,1.00	BIVM-ERCC5,ERCC5	3'UTR	BIVM-ERCC5:NM_001204425.1:3'UTR:MODIFIER:exon23/23:c.*84G>A:,ERCC5:NM_000123.3:3'UTR:MODIFIER:exon15/15:c.*84G>A:		rs873601	0.5495	0.0000	0/0/0	0.1295										118	91					BIVM-ERCC5 (inh=n/a pLI=n/a), ERCC5 (inh=AR pLI=0.00)
chr13	110818598	110818598	T	G	het		QUAL=9472;DP=306;AF=0.50;MQM=60;TRIO=HET,306,0.50,HET,218,0.43,HET,259,0.49	COL4A1	missense	COL4A1:NM_001845.5:missense:MODERATE:exon45/52:c.4002A>C:p.Gln1334His		rs3742207	0.2883	0.3100	6036/3924/420	0.3093	0.4600	T	T,T,T	B	B	120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];	RCV000178573.1 [benign]; 	CM083606 [CLASS=DP MUT=ALT PHEN="Myocardial infarction protection association with" GENE=COL4A1]; 	COSM3736082, COSM3736081	132	488					COL4A1 (inh=AD pLI=1.00)
chr13	110819586	110819586	G	A	het		QUAL=8372;DP=160;AF=0.48;MQM=60;TRIO=HET,160,0.48,HET,219,0.54,HET,284,0.49	COL4A1	splice_region&intron	COL4A1:NM_001845.5:splice_region&intron:LOW:exon43/51:c.3877-9C>T:		rs589985	0.6554	0.6720	27659/14576/1577	0.6640						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				497	483					COL4A1 (inh=AD pLI=1.00)
chr13	110827574	110827574	T	A	hom		QUAL=15280;DP=184;AF=1.00;MQM=60;TRIO=HOM,184,1.00,HET,183,0.47,HOM,247,1.00	COL4A1	synonymous	COL4A1:NM_001845.5:synonymous:LOW:exon37/52:c.3189A>T:p.Arg1063Arg		rs874203	0.3179	0.3520	7525/4271/388	0.3451						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				139	459					COL4A1 (inh=AD pLI=1.00)
chr13	110827580	110827580	C	T	hom		QUAL=14700;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HET,189,0.47,HOM,256,1.00	COL4A1	synonymous	COL4A1:NM_001845.5:synonymous:LOW:exon37/52:c.3183G>A:p.Gly1061Gly		rs874204	0.3181	0.3520	7529/4277/386	0.3428						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				139	462					COL4A1 (inh=AD pLI=1.00)
chr13	110833702	110833702	C	T	hom		QUAL=10751;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HET,143,0.41,HOM,153,0.98	COL4A1	synonymous	COL4A1:NM_001845.5:synonymous:LOW:exon29/52:c.2130G>A:p.Pro710Pro		rs16975492	0.3071	0.3480	7309/4163/299	0.3391						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];			COSM4147573	136	466					COL4A1 (inh=AD pLI=1.00)
chr13	110839550	110839550	T	G	hom	phylop_high	QUAL=17149;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,172,1.00,HOM,233,1.00	COL4A1	missense	COL4A1:NM_001845.5:missense:MODERATE:exon25/52:c.1663A>C:p.Thr555Pro		rs536174	1.0000	1.0000	60706/33370/5203	0.9362	5.9870	T	T	B	B	120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				1106	1					COL4A1 (inh=AD pLI=1.00)
chr13	110857895	110857895	A	G	hom		QUAL=33307;DP=486;AF=1.00;MQM=59;TRIO=HOM,486,1.00,HOM,231,1.00,HOM,318,1.00	COL4A1	splice_region&intron	COL4A1:NM_001845.5:splice_region&intron:LOW:exon15/51:c.859-10T>C:,COL4A1:NM_001303110.1:splice_region&intron:LOW:exon15/24:c.859-10T>C:		rs677877	0.5964	0.6220	24081/13926/913	0.6189						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				471	504					COL4A1 (inh=AD pLI=1.00)
chr13	110859743	110859743	C	T	hom		QUAL=15099;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,101,1.00,HOM,162,1.00	COL4A1	splice_region&intron	COL4A1:NM_001845.5:splice_region&intron:LOW:exon13/51:c.780+7G>A:,COL4A1:NM_001303110.1:splice_region&intron:LOW:exon13/24:c.780+7G>A:		rs598893	0.5960	0.6210	24010/13898/910	0.6181						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];				471	503					COL4A1 (inh=AD pLI=1.00)
chr13	110866265	110866265	G	A	hom		QUAL=12910;DP=224;AF=0.99;MQM=59;TRIO=HOM,224,0.99,HET,195,0.50,HET,309,0.51	COL4A1	splice_region&intron	COL4A1:NM_001845.5:splice_region&intron:LOW:exon3/51:c.234+8C>T:,COL4A1:NM_001303110.1:splice_region&intron:LOW:exon3/24:c.234+8C>T:		rs9521650	0.1304	0.1430	1412/888/35	0.1440						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with or without ocular anomalies|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps|Hemorrhage,intracerebral,susceptibility to|Retinal arteries,tortuosity of];	RCV000177133.1 [benign]; 			38	265					COL4A1 (inh=AD pLI=1.00)
chr13	111077197	111077197	G	A	het		QUAL=14518;DP=256;AF=0.53;MQM=60;TRIO=HET,256,0.53,HET,242,0.53,HOM,260,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon5/48:c.297G>A:p.Thr99Thr		rs4238272	0.9427	0.9610	55860/30956/3576	0.9357						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1007	99					COL4A2 (inh=n/a pLI=0.00)
chr13	111098226	111098226	C	T	het		QUAL=2639;DP=136;AF=0.47;MQM=60;TRIO=HET,136,0.47,WT,75,0.00,HET,90,0.48	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon17/48:c.1008C>T:p.Pro336Pro		rs4103	0.4828	0.5130	16167/9407/779	0.5093						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM1365445	284	533					COL4A2 (inh=n/a pLI=0.00)
chr13	111111173	111111173	G	A	het		QUAL=16779;DP=368;AF=0.50;MQM=59;TRIO=HET,368,0.50,HOM,249,1.00,HET,317,0.51	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon22/48:c.1488G>A:p.Pro496Pro		rs7990214	0.4914	0.5280	17896/12114/1962	0.5239						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM3999021	416	524					COL4A2 (inh=n/a pLI=0.00)
chr13	111111235	111111235	G	A	het		QUAL=10915;DP=143;AF=0.46;MQM=59;TRIO=HET,143,0.46,HOM,210,1.00,HET,268,0.48	COL4A2	missense	COL4A2:NM_001846.2:missense:MODERATE:exon22/48:c.1550G>A:p.Arg517Lys		rs7990383	0.5092	0.5320	17979/11948/2311	0.5265	-1.2950	T	T,T	B	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM3931786	415	525					COL4A2 (inh=n/a pLI=0.00)
chr13	111117745	111117745	C	T	het		QUAL=4020;DP=136;AF=0.55;MQM=60;TRIO=HET,136,0.55,HOM,67,1.00,WT,92,0.02	COL4A2	splice_region&intron	COL4A2:NM_001846.2:splice_region&intron:LOW:exon24/47:c.1777-7C>T:		rs3803236	0.5140	0.5340	17734/11700/1981	0.5294						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				411	502					COL4A2 (inh=n/a pLI=0.00)
chr13	111121620	111121620	C	T	het		QUAL=2521;DP=195;AF=0.47;MQM=59;TRIO=HET,195,0.47,HET,99,0.31,WT,150,0.00	COL4A2	missense	COL4A2:NM_001846.2:missense:MODERATE:exon28/48:c.2152C>T:p.Pro718Ser		rs9583500	0.1909	0.1710	1736/1173/364	0.1663	1.2810	T	T,T	B	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				72	362					COL4A2 (inh=n/a pLI=0.00)
chr13	111130519	111130519	C	T	het		QUAL=2459;DP=79;AF=0.62;MQM=59;TRIO=HET,79,0.62,HOM,54,0.98,WT,68,0.00	COL4A2	splice_region&intron	COL4A2:NM_001846.2:splice_region&intron:LOW:exon30/47:c.2587+8C>T:		rs2281974	0.4691	0.3580	7042/2486/1156	0.3488						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				124	443					COL4A2 (inh=n/a pLI=0.00)
chr13	111154058	111154058	T	A	hom	low_DP	QUAL=657;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon41/48:c.3804T>A:p.Pro1268Pro		rs439831	0.9395	0.9840	58581/33264/3312	0.9360						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1039	2					COL4A2 (inh=n/a pLI=0.00)
chr13	111154061	111154061	T	C	hom	low_DP	QUAL=657;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon41/48:c.3807T>C:p.Gly1269Gly		rs409858	0.9395	0.9840	58579/33262/3310	0.9360						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1043	2					COL4A2 (inh=n/a pLI=0.00)
chr13	111155773	111155773	T	C	hom		QUAL=3656;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HOM,25,1.00,HOM,32,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:NM_001846.2:synonymous:LOW:exon43/48:c.4083T>C:p.Thr1361Thr,COL4A2-AS1:NR_046583.1:intron:MODIFIER:exon2/2:n.187-498A>G:		rs438758	0.9802	0.9880	41431/23365/3096	0.9105						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1103	4					COL4A2 (inh=n/a pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111156250	111156250	G	A	het	low_DP	QUAL=171;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HOM,1,1.00,WT,5,0.00	COL4A2,COL4A2-AS1	missense,intron	COL4A2:NM_001846.2:missense:MODERATE:exon44/48:c.4195G>A:p.Val1399Ile,COL4A2-AS1:NR_046583.1:intron:MODIFIER:exon2/2:n.187-975C>T:		rs45520539	0.0144	0.0310	77/64/0	0.0304	-0.5270	T	T,T	P	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1	91					COL4A2 (inh=n/a pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111156499	111156499	C	T	hom		QUAL=18090;DP=109;AF=1.00;MQM=60;TRIO=HOM,109,1.00,HOM,225,1.00,HOM,250,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:NM_001846.2:synonymous:LOW:exon45/48:c.4290C>T:p.Phe1430Phe,COL4A2-AS1:NR_046583.1:intron:MODIFIER:exon2/2:n.187-1224G>A:		rs4771683	0.9359	0.9830	58522/33267/3251	0.9409						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM4147578	1104	3					COL4A2 (inh=n/a pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111158874	111158874	A	G	hom		QUAL=21638;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HOM,197,1.00,HOM,290,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:NM_001846.2:synonymous:LOW:exon46/48:c.4515A>G:p.Pro1505Pro,COL4A2-AS1:NR_046583.1:intron:MODIFIER:exon2/2:n.186+1120T>C:		rs445348	0.7520	0.8290	40861/26131/2866	0.7979						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				939	160					COL4A2 (inh=n/a pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111160304	111160304	G	A	het		QUAL=8224;DP=261;AF=0.55;MQM=59;TRIO=HET,261,0.55,WT,366,0.00,HET,469,0.47	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:NM_001846.2:synonymous:LOW:exon47/48:c.4617G>A:p.Ala1539Ala,COL4A2-AS1:NR_046583.1:intron:MODIFIER:exon1/2:n.81+142C>T:		rs391859	0.1008	0.1000	775/314/37	0.0985						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				17	205					COL4A2 (inh=n/a pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111164614	111164614	T	C	het		QUAL=8708;DP=279;AF=0.58;MQM=59;TRIO=HET,279,0.58,WT,88,0.02,HOM,151,1.00	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*76T>C:		rs422733	0.4663	0.0000	0/0/0	0.1047										168	228					COL4A2 (inh=n/a pLI=0.00)
chr13	111164629	111164630	AA	-	het		QUAL=6058;DP=196;AF=0.52;MQM=59;TRIO=HET,196,0.52,WT,70,0.03,HOM,141,0.95	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*101_*102delAA:		rs397838577	0.4677	0.0000	0/0/0	0.3720										122	137					COL4A2 (inh=n/a pLI=0.00)
chr13	111164955	111164955	C	G	het		QUAL=11639;DP=188;AF=0.48;MQM=59;TRIO=HET,188,0.48,HOM,194,1.00,HET,270,0.54	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*417C>G:		rs10509	0.8868	0.0000	0/0/0	0.8961										191	33					COL4A2 (inh=n/a pLI=0.00)
chr13	111165079	111165079	C	T	het		QUAL=10656;DP=269;AF=0.45;MQM=60;TRIO=HET,269,0.45,HOM,242,0.99,WT,270,0.00	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*541C>T:		rs1049906	0.5054	0.0000	0/0/0	0.0824										43	103					COL4A2 (inh=n/a pLI=0.00)
chr13	111165265	111165265	G	C	het		QUAL=4711;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,HOM,91,0.99,WT,113,0.03	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*727G>C:		rs15457	0.5108	0.0000	0/0/0	0.0826										44	103					COL4A2 (inh=n/a pLI=0.00)
chr14	20757383	20757383	A	G	het		QUAL=2597;DP=148;AF=0.53;MQM=60;TRIO=HET,148,0.53,HET,52,0.62,WT,49,0.00	TTC5	3'UTR	TTC5:NM_138376.2:3'UTR:MODIFIER:exon10/10:c.*403T>C:	A-rich	rs74596138	0.1140	0.0000	0/0/0	0.0107										0	25					TTC5 (inh=n/a pLI=0.00)
chr14	20764585	20764585	A	C	het		QUAL=20752;DP=395;AF=0.52;MQM=60;TRIO=HET,395,0.52,HET,285,0.48,HOM,356,1.00	TTC5	synonymous	TTC5:NM_138376.2:synonymous:LOW:exon6/10:c.660T>G:p.Ala220Ala		rs1953552	0.4012	0.4580	13125/8312/359	0.4422	-0.0430	T							COSM1128303	160	349					TTC5 (inh=n/a pLI=0.00)
chr14	20770036	20770036	T	C	hom		QUAL=41162;DP=427;AF=1.00;MQM=59;TRIO=HOM,427,1.00,HOM,326,1.00,HOM,513,1.00	TTC5	missense	TTC5:NM_138376.2:missense:MODERATE:exon2/10:c.140A>G:p.Gln47Arg		rs3742945	0.7456	0.7370	33266/18133/2884	0.7285	-0.3360	T	T	B	B				COSM1179594	408	245					TTC5 (inh=n/a pLI=0.00)
chr14	20937588	20937588	G	A	het		QUAL=8993;DP=437;AF=0.54;MQM=59;TRIO=HET,437,0.54,HET,274,0.50,WT,416,0.00	PNP	5'UTR	PNP:NM_000270.3:5'UTR:MODIFIER:exon1/6:c.-96G>A:		rs17881206	0.0058	0.0000	0/0/0	0.0039										1	8					PNP (inh=AR pLI=0.07)
chr14	20942744	20942744	A	G	het		QUAL=13749;DP=259;AF=0.51;MQM=60;TRIO=HET,259,0.51,HOM,337,0.99,WT,418,0.00	PNP	splice_region&intron	PNP:NM_000270.3:splice_region&intron:LOW:exon3/5:c.285+10A>G:		rs1713420	0.2023	0.1940	2549/1492/528	0.1911						164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency];				44	326					PNP (inh=AR pLI=0.07)
chr14	20945355	20945355	C	T	het		QUAL=5281;DP=263;AF=0.48;MQM=60;TRIO=HET,263,0.48,HET,192,0.46,WT,221,0.00	PNP	3'UTR	PNP:NM_000270.3:3'UTR:MODIFIER:exon6/6:c.*595C>T:		rs17878900	0.0647	0.0000	0/0/0	0.0363										0	11					PNP (inh=AR pLI=0.07)
chr14	20945488	20945488	T	C	hom		QUAL=47450;DP=619;AF=1.00;MQM=59;TRIO=HOM,619,1.00,HOM,417,1.00,HOM,442,1.00	PNP	3'UTR	PNP:NM_000270.3:3'UTR:MODIFIER:exon6/6:c.*728T>C:		rs1760933	0.9774	0.0000	0/0/0	0.8747										137	13					PNP (inh=AR pLI=0.07)
chr14	23242828	23242828	T	C	hom		QUAL=12854;DP=178;AF=0.99;MQM=60;TRIO=HOM,178,0.99,HOM,112,0.99,HOM,125,1.00	SLC7A7	synonymous,non_coding_exon	SLC7A7:NM_001126105.2:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:NM_001126106.2:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:NR_040448.1:non_coding_exon:MODIFIER:exon10/10:n.2142A>G:		rs1061040	0.7855	0.8650	46223/26587/1361	0.8591						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128147.2 [benign]; 			903	197					SLC7A7 (inh=AR pLI=0.00)
chr14	23282110	23282110	A	G	het		QUAL=2667;DP=79;AF=0.42;MQM=59;TRIO=HET,79,0.42,HOM,73,1.00,WT,83,0.00	SLC7A7	splice_region&synonymous,splice_region&non_coding_exon	SLC7A7:NM_001126105.2:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile,SLC7A7:NR_040448.1:splice_region&non_coding_exon:LOW:exon2/10:n.1113T>C:,SLC7A7:NM_001126106.2:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile		rs8018462	0.5821	0.5560	19314/9431/1158	0.5492						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128149.2 [benign]; 			290	551					SLC7A7 (inh=AR pLI=0.00)
chr14	23282449	23282449	C	T	het		QUAL=7646;DP=281;AF=0.54;MQM=59;TRIO=HET,281,0.54,HOM,128,1.00,WT,142,0.01	SLC7A7	synonymous,non_coding_exon	SLC7A7:NM_001126105.2:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:NM_001126106.2:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:NR_040448.1:non_coding_exon:MODIFIER:exon2/10:n.774G>A:		rs1805059	0.6060	0.6060	22980/12266/1276	0.5866						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128148.2 [benign]; 		COSM3753883	382	553					SLC7A7 (inh=AR pLI=0.00)
chr14	23284572	23284572	A	G	het		QUAL=7856;DP=231;AF=0.42;MQM=59;TRIO=HET,231,0.42,HOM,175,0.99,WT,264,0.01	SLC7A7	5'UTR,non_coding_exon	SLC7A7:NM_001126105.2:5'UTR:MODIFIER:exon2/11:c.-86T>C:,SLC7A7:NM_001126106.2:5'UTR:MODIFIER:exon2/11:c.-86T>C:,SLC7A7:NR_040448.1:non_coding_exon:MODIFIER:exon1/10:n.530T>C:		rs2281677	0.5781	0.4770	1992/691/83	0.1633										208	339					SLC7A7 (inh=AR pLI=0.00)
chr14	23588642	23588642	G	A	het		QUAL=16509;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,HET,270,0.49,HOM,315,0.99	CEBPE	5'UTR	CEBPE:NM_001805.3:5'UTR:MODIFIER:exon1/2:c.-342C>T:		rs12434881	0.3231	0.0000	0/0/0	0.4011										31	72					CEBPE (inh=n/a pLI=0.00)
chr14	23588731	23588731	G	C	het		QUAL=15139;DP=198;AF=0.49;MQM=59;TRIO=HET,198,0.49,HET,247,0.46,HOM,327,0.99	CEBPE	5'UTR	CEBPE:NM_001805.3:5'UTR:MODIFIER:exon1/2:c.-431C>G:		rs2239635	0.6643	0.0000	0/0/0	0.6806										64	77					CEBPE (inh=n/a pLI=0.00)
chr14	23902753	23902753	G	A	het		QUAL=7033;DP=141;AF=0.45;MQM=59;TRIO=HET,141,0.45,WT,118,0.02,HOM,181,1.00	MYH7	synonymous	MYH7:NM_000257.3:synonymous:LOW:exon3/40:c.189C>T:p.Thr63Thr		rs2069540	0.5204	0.4880	14779/7595/2050	0.4827						160760 [MYH7 (confirmed) Cardiomyopathy,hypertrophic,1|Cardiomyopathy,dilated,1S|Myopathy,myosin storage,autosomal dominant|Liang distal myopathy|Scapuloperoneal syndrome,myopathic type|Left ventricular noncompaction 5|Myopathy,myosin storage,autosomal recessive];	RCV000154237.1 [benign]; RCV000035752.4 [benign]; 		COSM3753910	299	591					MYH7 (inh=AD pLI=0.00)
chr14	24718380	24718401	CTCCGGGAGCCCTGGACTCCCC	-	het		QUAL=11379;DP=153;AF=0.99;MQM=59;TRIO=HET,153,0.99,HOM,159,1.00,HOM,206,1.00	TGM1	3'UTR	TGM1:NM_000359.2:3'UTR:MODIFIER:exon15/15:c.*118_*139delGGGGAGTCCAGGGCTCCCGGAG:		rs531264904	0.9914	0.0000	0/0/0	0.8322										207	23					TGM1 (inh=n/a pLI=0.00)
chr14	24718515	24718515	G	A	hom		QUAL=25620;DP=294;AF=0.99;MQM=59;TRIO=HOM,294,0.99,HOM,343,1.00,HET,446,0.49	TGM1	3'UTR	TGM1:NM_000359.2:3'UTR:MODIFIER:exon15/15:c.*4C>T:		rs2229463	0.7163	0.7910	38491/24275/2501	0.7865										817	265					TGM1 (inh=n/a pLI=0.00)
chr14	29238048	29238048	C	-	het		QUAL=2766;DP=182;AF=0.46;MQM=59;TRIO=HET,182,0.46,WT,81,0.00,HET,113,0.48	FOXG1	3'UTR	FOXG1:NM_005249.4:3'UTR:MODIFIER:exon1/1:c.*100delC:		rs397788971	0.0737	0.0000	0/0/0	0.0590										0	26					FOXG1 (inh=AD pLI=n/a)
chr14	32047217	32047217	T	C	het		QUAL=8895;DP=360;AF=0.48;MQM=60;TRIO=HET,360,0.48,HET,360,0.48,WT,353,0.01	NUBPL	5'UTR,intron	NUBPL:NM_001201573.1:5'UTR:MODIFIER:exon1/9:c.-12T>C:,NUBPL:NM_025152.2:intron:MODIFIER:exon3/10:c.291+12963T>C:,NUBPL:NR_120408.1:intron:MODIFIER:exon3/9:n.346+12963T>C:	L2c	rs7142098	0.3041	0.3300	864/169/6	0.0890						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				65	262					NUBPL (inh=AR pLI=0.00)
chr14	32183848	32183848	C	T	het		QUAL=16210;DP=249;AF=0.51;MQM=59;TRIO=HET,249,1.00,HET,136,1.00,WT,166,1.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-198C>T:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41068C>T:,NUBPL:NR_120408.1:intron:MODIFIER:exon6/9:n.568+41068C>T:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41068C>T:	MSTB	rs11623835	0.2829	0.0000	0/0/0	0.2247						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				26	65					NUBPL (inh=AR pLI=0.00)
chr14	32183849	32183849	A	G	hom		QUAL=16210;DP=249;AF=0.51;MQM=59;TRIO=HOM,249,1.00,HOM,136,1.00,HOM,166,1.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-197A>G:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41069A>G:,NUBPL:NR_120408.1:intron:MODIFIER:exon6/9:n.568+41069A>G:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41069A>G:	MSTB	rs11156699	0.7063	0.0000	0/0/0	0.7132						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				140	9					NUBPL (inh=AR pLI=0.00)
chr14	32183970	32183970	A	T	het		QUAL=4632;DP=252;AF=0.50;MQM=59;TRIO=HET,252,0.50,HET,101,0.57,WT,105,0.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-76A>T:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41190A>T:,NUBPL:NR_120408.1:intron:MODIFIER:exon6/9:n.568+41190A>T:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41190A>T:	MLT1L	rs11624772	0.2829	0.0000	0/0/0	0.3368						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				26	65					NUBPL (inh=AR pLI=0.00)
chr14	35180389	35180389	T	A	het		QUAL=7032;DP=233;AF=0.52;MQM=59;TRIO=HET,233,0.52,HOM,78,1.00,HET,115,0.54	CFL2	3'UTR,non_coding_exon	CFL2:NM_021914.7:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:NM_001243645.1:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:NM_138638.4:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:NR_028130.1:non_coding_exon:MODIFIER:exon4/4:n.2323A>T:,CFL2:NR_028131.1:non_coding_exon:MODIFIER:exon4/4:n.2212A>T:		rs712301	0.3421	0.3880	972/410/20	0.1002										177	293					CFL2 (inh=n/a pLI=0.16)
chr14	35180678	35180678	T	-	het		QUAL=15673;DP=297;AF=0.55;MQM=59;TRIO=HET,297,0.55,HOM,222,1.00,HET,293,0.55	CFL2	3'UTR,non_coding_exon	CFL2:NM_021914.7:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:NM_001243645.1:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:NM_138638.4:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:NR_028130.1:non_coding_exon:MODIFIER:exon4/4:n.2034delA:,CFL2:NR_028131.1:non_coding_exon:MODIFIER:exon4/4:n.1923delA:		rs869039195	0.6595	0.7360	3602/1221/187	0.1785										402	218					CFL2 (inh=n/a pLI=0.16)
chr14	36986023	36986023	A	-	hom		QUAL=837;DP=102;AF=0.10;MQM=59;TRIO=HOM,102,0.10,HET,89,0.26,WT,132,0.10	NKX2-1	3'UTR	NKX2-1:NM_001079668.2:3'UTR:MODIFIER:exon3/3:c.*460delT:,NKX2-1:NM_003317.3:3'UTR:MODIFIER:exon2/2:c.*460delT:		rs5807883	0.0000	0.0000	0/0/0	0.0192										0	53					NKX2-1 (inh=AD pLI=0.08)
chr14	36986273	36986273	A	T	hom		QUAL=4795;DP=100;AF=0.94;MQM=60;TRIO=HOM,100,0.95,HET,30,0.97,HOM,39,1.00	NKX2-1	3'UTR	NKX2-1:NM_001079668.2:3'UTR:MODIFIER:exon3/3:c.*210T>A:,NKX2-1:NM_003317.3:3'UTR:MODIFIER:exon2/2:c.*210T>A:		rs10139625	0.6218	0.0000	0/0/0	0.2975										87	115					NKX2-1 (inh=AD pLI=0.08)
chr14	50087753	50087753	T	C	het		QUAL=8353;DP=50;AF=0.38;MQM=60;TRIO=HET,50,0.38,HET,130,0.43,HOM,234,0.99	MGAT2	5'UTR	MGAT2:NM_002408.3:5'UTR:MODIFIER:exon1/1:c.-234T>C:		rs7519	0.2953	0.3010	1352/444/4	0.1105										161	319					MGAT2 (inh=AR pLI=0.96)
chr14	50712569	50712569	A	G	hom		QUAL=15904;DP=221;AF=0.99;MQM=59;TRIO=HOM,221,0.99,HOM,197,1.00,HET,233,0.47	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*1207T>C:	AluSq2	rs7157035	0.8377	0.0000	0/0/0	0.8033						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				166	61					L2HGDH (inh=AR pLI=0.31)
chr14	50712797	50712797	T	C	hom		QUAL=8504;DP=153;AF=1.00;MQM=54;TRIO=HOM,153,1.00,HOM,74,1.00,HET,141,0.51	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*979A>G:	AluSq2	rs1964845	0.8902	0.0000	0/0/0	0.7934						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				156	45					L2HGDH (inh=AR pLI=0.31)
chr14	50712852	50712852	T	A	hom		QUAL=8940;DP=189;AF=0.87;MQM=57;TRIO=HOM,189,0.87,HOM,89,0.90,HET,166,0.36	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*924A>T:	AluSq2	rs6572652	0.8377	0.0000	0/0/0	0.6728						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				116	54					L2HGDH (inh=AR pLI=0.31)
chr14	50712980	50712980	A	G	het		QUAL=5125;DP=196;AF=0.49;MQM=59;TRIO=HET,196,0.49,HOM,88,1.00,WT,150,0.00	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*796T>C:	AluJb	rs74541550	0.2756	0.0000	0/0/0	0.0340						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				10	55					L2HGDH (inh=AR pLI=0.31)
chr14	50713679	50713679	T	G	hom		QUAL=10438;DP=185;AF=1.00;MQM=59;TRIO=HOM,185,1.00,HOM,62,1.00,HOM,78,1.00	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*97A>C:		rs7143186	0.9990	0.0000	0/0/0	0.2044						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				227	2					L2HGDH (inh=AR pLI=0.31)
chr14	50769717	50769717	G	A	hom		QUAL=21683;DP=381;AF=1.00;MQM=60;TRIO=HOM,381,1.00,HOM,201,1.00,HET,220,0.50	L2HGDH	synonymous	L2HGDH:NM_024884.2:synonymous:LOW:exon2/10:c.159C>T:p.Ile53Ile		rs2297995	0.5966	0.5700	19824/10678/1970	0.5608						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];	RCV000146249.1 [likely benign]; 		COSM4150800, COSM4150799	733	1080					L2HGDH (inh=AR pLI=0.31)
chr14	50778816	50778816	A	C	hom		QUAL=5287;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,84,1.00,HET,117,0.51	L2HGDH	missense	L2HGDH:NM_024884.2:missense:MODERATE:exon1/10:c.53T>G:p.Leu18Arg		rs2275591	0.5727	0.5550	16174/9166/1257	0.5346	-4.0100	T	T,T,T,T,T,T	B,B	B,B	609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];	RCV000146250.1 [likely benign]; 		COSM3753977, COSM433105	753	1100					L2HGDH (inh=AR pLI=0.31)
chr14	51054598	51054598	A	G	het		QUAL=7700;DP=213;AF=0.49;MQM=60;TRIO=HET,213,0.49,WT,229,0.00,HET,363,0.55	ATL1	synonymous	ATL1:NM_015915.4:synonymous:LOW:exon2/14:c.84A>G:p.Pro28Pro,ATL1:NM_001127713.1:synonymous:LOW:exon3/14:c.84A>G:p.Pro28Pro,ATL1:NM_181598.3:synonymous:LOW:exon2/13:c.84A>G:p.Pro28Pro		rs35014209	0.1641	0.1360	1425/664/552	0.1347						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000020724.1 [benign]; RCV000116421.3 [other]; 		COSM3753981	28	372					ATL1 (inh=AD pLI=0.99)
chr14	51057727	51057727	G	A	hom		QUAL=15292;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HET,213,0.43,HET,245,0.46	ATL1	synonymous	ATL1:NM_015915.4:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu,ATL1:NM_001127713.1:synonymous:LOW:exon4/14:c.351G>A:p.Glu117Glu,ATL1:NM_181598.3:synonymous:LOW:exon3/13:c.351G>A:p.Glu117Glu		rs1060197	0.8215	0.7630	35571/17438/4515	0.7550						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000020720.1 [benign]; RCV000116420.2 [likely benign]; 			800	639	1	[1] old entry - no details available	n/a (2xTP, 0xFP)		ATL1 (inh=AD pLI=0.99)
chr14	51062357	51062357	G	A	het		QUAL=5485;DP=205;AF=0.49;MQM=59;TRIO=HET,205,0.49,WT,165,0.00,HET,230,0.49	ATL1	splice_region&intron	ATL1:NM_015915.4:splice_region&intron:LOW:exon6/13:c.630+7G>A:,ATL1:NM_001127713.1:splice_region&intron:LOW:exon7/13:c.630+7G>A:,ATL1:NM_181598.3:splice_region&intron:LOW:exon6/12:c.630+7G>A:		rs3759588	0.1494	0.1330	1300/692/398	0.1319						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000123709.1 [benign]; 		COSM3999276	29	370					ATL1 (inh=AD pLI=0.99)
chr14	55308770	55308770	C	A	hom		QUAL=8146;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,48,1.00,HOM,59,1.00	GCH1	3'UTR	GCH1:NM_000161.2:3'UTR:MODIFIER:exon6/6:c.*1965G>T:,GCH1:NM_001024024.1:3'UTR:MODIFIER:exon7/7:c.*1019G>T:,GCH1:NM_001024070.1:3'UTR:MODIFIER:exon7/7:c.*1015G>T:,GCH1:NM_001024071.1:3'UTR:MODIFIER:exon6/6:c.*987G>T:		rs6572984	0.9900	0.0000	0/0/0	0.8749										255	0					GCH1 (inh=n/a pLI=0.94)
chr14	55369502	55369502	A	G	hom	low_DP	QUAL=1272;DP=9;AF=1.00;MQM=59;TRIO=HOM,9,1.00,HOM,14,1.00,HOM,21,1.00	GCH1	5'UTR	GCH1:NM_000161.2:5'UTR:MODIFIER:exon1/6:c.-121T>C:,GCH1:NM_001024024.1:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:NM_001024070.1:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:NM_001024071.1:5'UTR:MODIFIER:exon1/6:c.-121T>C:		rs1753589	0.9457	0.0000	0/0/0	0.1505										342	8					GCH1 (inh=n/a pLI=0.94)
chr14	57268443	57268443	C	T	het		QUAL=5031;DP=279;AF=0.43;MQM=59;TRIO=HET,279,0.43,HET,144,0.49,WT,193,0.00	OTX2	3'UTR,non_coding_exon	OTX2:NM_001270525.1:3'UTR:MODIFIER:exon3/3:c.*10G>A:,OTX2:NM_172337.2:3'UTR:MODIFIER:exon3/3:c.*10G>A:,OTX2:NM_001270523.1:3'UTR:MODIFIER:exon5/5:c.*10G>A:,OTX2:NM_001270524.1:3'UTR:MODIFIER:exon4/4:c.*10G>A:,OTX2:NM_021728.3:3'UTR:MODIFIER:exon5/5:c.*10G>A:,OTX2:NR_073036.1:non_coding_exon:MODIFIER:exon2/2:n.935G>A:,OTX2:NR_073034.1:non_coding_exon:MODIFIER:exon4/4:n.1012G>A:		rs171978	0.0315	0.0650	338/303/3	0.0658										17	169					OTX2 (inh=AD pLI=0.74)
chr14	64491695	64491695	T	C	hom		QUAL=28525;DP=395;AF=1.00;MQM=59;TRIO=HOM,395,1.00,HOM,231,1.00,HOM,253,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon40/116:c.5906T>C:p.Met1969Thr,SYNE2:NM_015180.4:missense:MODERATE:exon40/115:c.5906T>C:p.Met1969Thr,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-72587A>G:		rs4902264	0.6789	0.8120	40789/25249/878	0.8027	0.1190	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118541.1 [benign]; 			884	291					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64494278	64494278	C	T	hom		QUAL=16646;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,96,1.00,HOM,119,1.00	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon43/116:c.6481C>T:p.Leu2161Leu,SYNE2:NM_015180.4:synonymous:LOW:exon43/115:c.6481C>T:p.Leu2161Leu,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-75170G>A:		rs10151127	0.7520	0.8690	46325/27862/1488	0.8591						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118543.2 [benign]; 			965	234					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64496749	64496749	C	T	hom		QUAL=12599;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,85,1.00,HOM,97,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon44/116:c.6851C>T:p.Ala2284Val,SYNE2:NM_015180.4:missense:MODERATE:exon44/115:c.6851C>T:p.Ala2284Val,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-77641G>A:		rs4027402	0.6719	0.8120	40858/25441/856	0.8031	0.3380	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118544.1 [benign]; 			888	287					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64497930	64497930	G	A	hom		QUAL=33185;DP=485;AF=1.00;MQM=60;TRIO=HOM,485,1.00,HOM,230,1.00,HOM,308,0.99	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon45/116:c.7076G>A:p.Ser2359Asn,SYNE2:NM_015180.4:missense:MODERATE:exon45/115:c.7076G>A:p.Ser2359Asn,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-78822C>T:		rs4027404	0.7025	0.8210	41396/25465/1249	0.8113	0.9820	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118548.1 [benign]; 			897	288					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64498037	64498037	G	A	hom	phylop_high	QUAL=23671;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,190,1.00,HOM,274,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon45/116:c.7183G>A:p.Ala2395Thr,SYNE2:NM_015180.4:missense:MODERATE:exon45/115:c.7183G>A:p.Ala2395Thr,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-78929C>T:		rs4027405	0.8373	0.8920	48092/27760/2937	0.8825	1.8170	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118551.1 [benign]; 			980	228					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64519035	64519035	A	G	hom		QUAL=25977;DP=298;AF=0.99;MQM=60;TRIO=HOM,298,0.99,HOM,234,1.00,HOM,262,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon48/116:c.8404A>G:p.Ser2802Gly,SYNE2:NM_015180.4:missense:MODERATE:exon48/115:c.8404A>G:p.Ser2802Gly,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-99927T>C:		rs1890908	0.8618	0.9070	49811/28871/3670	0.8970	-1.6090	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118553.1 [benign]; 			1039	172					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64519455	64519455	A	G	hom		QUAL=31160;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HOM,231,1.00,HOM,315,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon48/116:c.8824A>G:p.Ile2942Val,SYNE2:NM_015180.4:missense:MODERATE:exon48/115:c.8824A>G:p.Ile2942Val,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-100347T>C:		rs3829767	0.6651	0.8020	39757/24554/758	0.7932	-0.8420	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118556.1 [benign]; 			886	299					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64522674	64522674	G	C	hom	phylop_high	QUAL=21764;DP=285;AF=1.00;MQM=59;TRIO=HOM,285,1.00,HOM,180,0.99,HOM,224,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon49/116:c.9757G>C:p.Asp3253His,SYNE2:NM_015180.4:missense:MODERATE:exon49/115:c.9757G>C:p.Asp3253His,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-103566C>G:		rs8010911	0.6813	0.8060	40017/24574/972	0.7970	2.7620	T	T,T,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118560.1 [benign]; 			875	294					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64522843	64522843	A	G	hom	pred_pathogenic_1	QUAL=40103;DP=430;AF=1.00;MQM=60;TRIO=HOM,430,1.00,HOM,367,1.00,HOM,451,1.00	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon49/116:c.9926A>G:p.His3309Arg,SYNE2:NM_015180.4:missense:MODERATE:exon49/115:c.9926A>G:p.His3309Arg,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.45-103735T>C:		rs8010699	0.6823	0.8070	40218/24698/987	0.7955	1.1020	T	D,D,T,T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118561.1 [benign]; 			879	303					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64565536	64565536	C	T	het		QUAL=8560;DP=377;AF=0.53;MQM=60;TRIO=HET,377,0.53,WT,247,0.00,HET,316,0.47	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon63/116:c.12378C>T:p.Ser4126Ser,SYNE2:NM_015180.4:synonymous:LOW:exon63/115:c.12378C>T:p.Ser4126Ser,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+137088G>A:		rs36007735	0.0024	0.0054	3/3/0	0.0053						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000179624.1 [benign]; 		COSM1240354	0	25					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64612845	64612845	C	T	het		QUAL=7498;DP=259;AF=0.56;MQM=60;TRIO=HET,259,0.56,WT,157,0.00,HET,240,0.58	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon84/116:c.15543C>T:p.Ile5181Ile,SYNE2:NM_015180.4:synonymous:LOW:exon84/115:c.15543C>T:p.Ile5181Ile,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+89779G>A:		rs11629287	0.4419	0.3680	8457/3585/1500	0.3661						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118519.1 [benign]; 		COSM1128227	138	521					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64612858	64612858	C	A	het		QUAL=8063;DP=264;AF=0.57;MQM=60;TRIO=HET,264,0.57,WT,177,0.01,HET,268,0.57	SYNE2,MIR548AZ	missense,intron	SYNE2:NM_182914.2:missense:MODERATE:exon84/116:c.15556C>A:p.Leu5186Met,SYNE2:NM_015180.4:missense:MODERATE:exon84/115:c.15556C>A:p.Leu5186Met,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+89766G>T:		rs10151658	0.6318	0.5020	16305/6360/3881	0.4952	-0.5950	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118520.1 [benign]; 		COSM1128226	267	574					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64637147	64637147	C	A	het		QUAL=7273;DP=202;AF=0.50;MQM=60;TRIO=HET,202,0.50,WT,286,0.00,HET,388,0.50	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon94/116:c.17202C>A:p.Leu5734Leu,SYNE2:NM_015180.4:synonymous:LOW:exon94/115:c.17202C>A:p.Leu5734Leu,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+65477G>T:		rs7161192	0.3658	0.3290	6653/3213/668	0.3293						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118525.1 [benign]; 			127	529					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64656855	64656855	T	C	het		QUAL=5887;DP=227;AF=0.51;MQM=60;TRIO=HET,227,0.51,WT,138,0.01,HET,210,0.50	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon99/116:c.17938T>C:p.Leu5980Leu,SYNE2:NM_015180.4:synonymous:LOW:exon99/115:c.17938T>C:p.Leu5980Leu,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+45769A>G:		rs2256191	0.4870	0.3940	10411/4412/2967	0.3887						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118528.1 [benign]; 		COSM3999320, COSM3999321	201	544					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64681193	64681193	C	T	het		QUAL=4326;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,WT,51,0.00,HOM,73,1.00	SYNE2,MIR548AZ	splice_region&intron,intron	SYNE2:NM_182914.2:splice_region&intron:LOW:exon106/115:c.19333+5C>T:,SYNE2:NM_015180.4:splice_region&intron:LOW:exon106/114:c.19333+5C>T:,SYNE2:NM_182913.2:splice_region&intron:LOW:exon1/10:c.235+5C>T:,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+21431G>A:		rs1152590	0.5833	0.4410	12006/4538/2895	0.4347						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118529.1 [benign]; 			214	505					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64686125	64686125	G	T	het		QUAL=5745;DP=115;AF=0.39;MQM=60;TRIO=HET,115,0.39,WT,110,0.00,HOM,156,1.00	SYNE2,MIR548AZ	synonymous,intron	SYNE2:NM_182914.2:synonymous:LOW:exon110/116:c.19857G>T:p.Leu6619Leu,SYNE2:NM_015180.4:synonymous:LOW:exon109/115:c.19788G>T:p.Leu6596Leu,SYNE2:NM_182913.2:synonymous:LOW:exon5/11:c.759G>T:p.Leu253Leu,SYNE2:NM_182910.2:synonymous:LOW:exon3/9:c.381G>T:p.Leu127Leu,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+16499C>A:		rs35648226	0.2097	0.2400	3759/2615/223	0.2398						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118530.1 [benign]; 			110	475					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64692630	64692630	G	C	het		QUAL=7140;DP=229;AF=0.46;MQM=60;TRIO=HET,229,0.46,WT,118,0.00,HOM,134,1.00	SYNE2,MIR548AZ	3'UTR,intron	SYNE2:NM_182914.2:3'UTR:MODIFIER:exon116/116:c.*386G>C:,SYNE2:NM_015180.4:3'UTR:MODIFIER:exon115/115:c.*386G>C:,SYNE2:NM_182913.2:3'UTR:MODIFIER:exon11/11:c.*386G>C:,SYNE2:NM_182910.2:3'UTR:MODIFIER:exon9/9:c.*386G>C:,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+9994C>G:		rs1152582	0.6895	0.0000	0/0/0	0.5974										77	108					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	64692825	64692825	G	A	het		QUAL=5936;DP=177;AF=0.41;MQM=60;TRIO=HET,177,0.41,WT,114,0.00,HOM,128,1.00	SYNE2,MIR548AZ	3'UTR,intron	SYNE2:NM_182914.2:3'UTR:MODIFIER:exon116/116:c.*581G>A:,SYNE2:NM_015180.4:3'UTR:MODIFIER:exon115/115:c.*581G>A:,SYNE2:NM_182913.2:3'UTR:MODIFIER:exon11/11:c.*581G>A:,SYNE2:NM_182910.2:3'UTR:MODIFIER:exon9/9:c.*581G>A:,MIR548AZ:NR_106755.1:intron:MODIFIER:exon2/2:n.44+9799C>T:		rs7229	0.6909	0.0000	0/0/0	0.1158										76	107					SYNE2 (inh=AD pLI=0.00), MIR548AZ (inh=n/a pLI=n/a)
chr14	66974474	66974474	T	C	het		QUAL=3493;DP=150;AF=0.48;MQM=59;TRIO=HET,150,0.48,WT,124,0.01,HET,164,0.48	GPHN	5'UTR	GPHN:NM_020806.4:5'UTR:MODIFIER:exon1/23:c.-772T>C:,GPHN:NM_001024218.1:5'UTR:MODIFIER:exon1/22:c.-772T>C:		rs928553	0.4507	0.2500	607/100/118	0.0705										21	151					GPHN (inh=n/a pLI=1.00)
chr14	67147816	67147816	T	C	het		QUAL=3322;DP=175;AF=0.49;MQM=60;TRIO=HET,175,0.49,WT,75,0.00,HET,87,0.49	GPHN	splice_region&intron	GPHN:NM_020806.4:splice_region&intron:LOW:exon1/22:c.65-9T>C:,GPHN:NM_001024218.1:splice_region&intron:LOW:exon1/21:c.65-9T>C:		rs3759753	0.4503	0.2640	6113/784/2292	0.2589						603930 [GPHN (confirmed) Molybdenum cofactor deficiency C];			COSM147798, COSM3999345	56	306					GPHN (inh=n/a pLI=1.00)
chr14	68213571	68213571	C	T	hom		QUAL=44420;DP=555;AF=1.00;MQM=60;TRIO=HOM,555,1.00,HOM,333,1.00,HOM,471,1.00	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1582G>A:		rs8017209	0.9501	0.0000	0/0/0	0.1542										225	5					ZFYVE26 (inh=AR pLI=0.00)
chr14	68213744	68213744	G	A	hom		QUAL=24824;DP=364;AF=1.00;MQM=59;TRIO=HOM,364,1.00,HOM,177,1.00,HOM,213,1.00	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1409C>T:		rs10288	0.9501	0.0000	0/0/0	0.1542										225	5					ZFYVE26 (inh=AR pLI=0.00)
chr14	68213792	68213792	A	G	hom		QUAL=28149;DP=369;AF=1.00;MQM=59;TRIO=HOM,369,1.00,HOM,223,0.99,HOM,291,0.99	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1361T>C:		rs1044126	0.3135	0.0000	0/0/0	0.0804										71	107					ZFYVE26 (inh=AR pLI=0.00)
chr14	68234539	68234539	T	C	hom		QUAL=35153;DP=312;AF=1.00;MQM=60;TRIO=HOM,312,1.00,HOM,304,1.00,HOM,476,1.00	ZFYVE26	missense	ZFYVE26:NM_015346.3:missense:MODERATE:exon31/42:c.5672A>G:p.Asn1891Ser		rs3742883	0.9032	0.9550	55500/32425/3741	0.9365	-0.3940	T	T,T,T	B	B	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118901.2 [likely benign]; 			1552	44					ZFYVE26 (inh=AR pLI=0.00)
chr14	68249499	68249499	C	T	hom	phylop_high	QUAL=11258;DP=238;AF=0.99;MQM=59;TRIO=HOM,238,0.99,HET,136,0.51,HET,159,0.54	ZFYVE26	missense&splice_region	ZFYVE26:NM_015346.3:missense&splice_region:MODERATE:exon21/42:c.4370G>A:p.Cys1457Tyr		rs2235967	0.1601	0.2630	5052/4072/40	0.2544	2.5290	T	T,T,T	B,B	B,B	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118900.2 [likely benign]; 		COSM3754058	216	680					ZFYVE26 (inh=AR pLI=0.00)
chr14	68257485	68257485	C	T	hom		QUAL=7472;DP=104;AF=0.99;MQM=60;TRIO=HOM,104,0.99,HET,154,0.54,HET,213,0.46	ZFYVE26	synonymous	ZFYVE26:NM_015346.3:synonymous:LOW:exon15/42:c.2559G>A:p.Leu853Leu		rs7143196	0.0747	0.1460	1669/1409/8	0.1471						612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118895.2 [likely benign]; 			66	493					ZFYVE26 (inh=AR pLI=0.00)
chr14	75476071	75476071	G	C	hom		QUAL=37658;DP=442;AF=0.99;MQM=59;TRIO=HOM,442,0.99,HET,431,0.50,HOM,571,0.99	EIF2B2	3'UTR	EIF2B2:NM_014239.3:3'UTR:MODIFIER:exon8/8:c.*180G>C:		rs4556	0.5176	0.0000	0/0/0	0.0970										63	129					EIF2B2 (inh=n/a pLI=0.00)
chr14	77741394	77741394	T	C	hom		QUAL=9414;DP=201;AF=1.00;MQM=59;TRIO=HOM,201,1.00,HET,71,0.46,HOM,81,0.98	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*2325A>G:		rs11547793	0.2913	0.0000	0/0/0	0.2835										19	87					POMT2 (inh=AR pLI=0.00)
chr14	77741977	77741977	C	T	hom		QUAL=20064;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HET,210,0.54,HOM,254,1.00	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*1742G>A:		rs12894594	0.8522	0.0000	0/0/0	0.7411										163	56					POMT2 (inh=AR pLI=0.00)
chr14	77742218	77742218	C	T	hom		QUAL=18940;DP=232;AF=0.98;MQM=60;TRIO=HOM,232,0.98,HET,245,0.51,HOM,280,1.00	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*1501G>A:		rs4141640	0.8558	0.0000	0/0/0	0.1282										163	58					POMT2 (inh=AR pLI=0.00)
chr14	77743644	77743644	G	A	hom		QUAL=10214;DP=141;AF=0.96;MQM=60;TRIO=HOM,141,0.96,HET,92,0.62,HOM,151,0.99	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*75C>T:		rs1055592	0.2686	0.0000	0/0/0	0.0506										19	81					POMT2 (inh=AR pLI=0.00)
chr14	77745193	77745193	A	C	hom		QUAL=23108;DP=126;AF=1.00;MQM=59;TRIO=HOM,126,1.00,HET,339,0.53,HOM,480,1.00	POMT2	synonymous	POMT2:NM_013382.5:synonymous:LOW:exon19/21:c.1911T>G:p.Leu637Leu		rs3209079	0.8470	0.8160	40497/22244/3618	0.7953	-0.7790	T				607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2];	RCV000118038.2 [benign]; RCV000153051.3 [benign]; 		COSM4148271	775	291					POMT2 (inh=AR pLI=0.00)
chr14	77751925	77751925	C	T	hom		QUAL=16953;DP=186;AF=1.00;MQM=60;TRIO=HOM,186,1.00,HET,194,0.52,HOM,257,1.00	POMT2	synonymous	POMT2:NM_013382.5:synonymous:LOW:exon13/21:c.1383G>A:p.Arg461Arg		rs2270419	0.8582	0.8210	41097/22217/3920	0.7728						607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2];	RCV000127577.2 [benign]; RCV000153056.3 [benign]; 		COSM4148272	776	292					POMT2 (inh=AR pLI=0.00)
chr14	77893276	77893276	G	A	het		QUAL=10822;DP=339;AF=0.45;MQM=60;TRIO=HET,339,0.45,HET,270,0.51,HET,341,0.39	VIPAS39	3'UTR	VIPAS39:NM_001193314.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_001193315.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_001193316.1:3'UTR:MODIFIER:exon19/19:c.*683C>T:,VIPAS39:NM_001193317.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_022067.3:3'UTR:MODIFIER:exon21/21:c.*683C>T:		rs4223	0.4896	0.0000	0/0/0	0.4777										58	108					VIPAS39 (inh=AR pLI=0.00)
chr14	77893431	77893431	A	G	hom		QUAL=28179;DP=346;AF=1.00;MQM=59;TRIO=HOM,346,1.00,HOM,245,1.00,HOM,267,1.00	VIPAS39	3'UTR	VIPAS39:NM_001193314.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_001193315.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_001193316.1:3'UTR:MODIFIER:exon19/19:c.*528T>C:,VIPAS39:NM_001193317.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_022067.3:3'UTR:MODIFIER:exon21/21:c.*528T>C:		rs8009177	0.9764	0.0000	0/0/0	0.8722										230	0					VIPAS39 (inh=AR pLI=0.00)
chr14	77923783	77923783	C	T	het		QUAL=12548;DP=376;AF=0.43;MQM=60;TRIO=HET,376,0.43,HET,332,0.52,HET,426,0.47	VIPAS39	5'UTR,intron	VIPAS39:NM_001193314.1:5'UTR:MODIFIER:exon1/20:c.-346G>A:,VIPAS39:NM_001193317.1:5'UTR:MODIFIER:exon1/20:c.-123G>A:,VIPAS39:NM_001193315.1:intron:MODIFIER:exon1/19:c.-1+55G>A:,VIPAS39:NM_001193316.1:intron:MODIFIER:exon1/18:c.-1+55G>A:,VIPAS39:NM_022067.3:intron:MODIFIER:exon1/20:c.-272+55G>A:		rs11845345	0.1396	0.1700	285/37/0	0.0463										29	156					VIPAS39 (inh=AR pLI=0.00)
chr14	77973953	77973953	-	CA	hom		QUAL=14258;DP=206;AF=0.97;MQM=58;TRIO=HOM,206,0.97,HOM,132,1.00,HOM,128,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4673_*4674insTG:	AluSz6	rs58831828	0.8512	0.0000	0/0/0	0.8270										182	42					SPTLC2 (inh=n/a pLI=0.82)
chr14	77973982	77973982	T	C	hom		QUAL=19233;DP=312;AF=1.00;MQM=59;TRIO=HOM,312,1.00,HOM,133,1.00,HOM,144,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4645A>G:		rs10132095	0.9451	0.0000	0/0/0	0.8985										225	3					SPTLC2 (inh=n/a pLI=0.82)
chr14	77974181	77974181	C	A	hom		QUAL=9626;DP=178;AF=0.99;MQM=59;TRIO=HOM,178,0.99,HOM,55,1.00,HOM,62,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4446G>T:		rs11159268	0.5962	0.0000	0/0/0	0.5989										87	112					SPTLC2 (inh=n/a pLI=0.82)
chr14	77974990	77974990	C	T	hom		QUAL=27089;DP=409;AF=0.99;MQM=60;TRIO=HOM,409,0.99,HOM,215,1.00,HOM,219,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3637G>A:		rs1063271	0.7690	0.0000	0/0/0	0.7442										150	73					SPTLC2 (inh=n/a pLI=0.82)
chr14	77975015	77975015	A	T	hom		QUAL=23646;DP=343;AF=1.00;MQM=60;TRIO=HOM,343,1.00,HOM,169,1.00,HOM,200,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3612T>A:		rs2364160	0.9475	0.0000	0/0/0	0.8645										230	0					SPTLC2 (inh=n/a pLI=0.82)
chr14	77975103	77975103	T	G	hom		QUAL=18932;DP=285;AF=1.00;MQM=60;TRIO=HOM,285,1.00,HOM,131,1.00,HOM,160,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3524A>C:		rs1063270	0.7762	0.0000	0/0/0	0.7446										149	74					SPTLC2 (inh=n/a pLI=0.82)
chr14	77976325	77976325	T	C	hom		QUAL=21897;DP=320;AF=1.00;MQM=60;TRIO=HOM,320,1.00,HOM,144,1.00,HOM,192,0.99	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*2302A>G:		rs11159269	0.7606	0.0000	0/0/0	0.7418										150	73					SPTLC2 (inh=n/a pLI=0.82)
chr14	78028803	78028803	A	G	hom		QUAL=12515;DP=167;AF=0.99;MQM=60;TRIO=HOM,167,0.99,HOM,91,1.00,HOM,123,1.00	SPTLC2	synonymous	SPTLC2:NM_004863.3:synonymous:LOW:exon6/12:c.786T>C:p.Asn262Asn		rs2364602	0.8375	0.9030	50110/29097/2098	0.8821	1.1100	T				605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC];				973	127					SPTLC2 (inh=n/a pLI=0.82)
chr14	81562998	81562998	T	C	het		QUAL=5322;DP=204;AF=0.50;MQM=60;TRIO=HET,204,0.50,HET,224,0.46,WT,284,0.00	TSHR	synonymous	TSHR:NM_000369.2:synonymous:LOW:exon7/10:c.561T>C:p.Asn187Asn,TSHR:NM_001018036.2:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn,TSHR:NM_001142626.2:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn		rs2075179	0.3001	0.1910	3097/654/1528	0.1875						603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];			COSM147826, COSM3754139	20	275					TSHR (inh=n/a pLI=0.00)
chr14	81574959	81574959	A	G	het		QUAL=11607;DP=400;AF=0.49;MQM=59;TRIO=HET,400,0.49,HET,292,0.41,HET,365,0.42	TSHR	synonymous,intron	TSHR:NM_001018036.2:synonymous:LOW:exon9/9:c.696A>G:p.Leu232Leu,TSHR:NM_001142626.2:synonymous:LOW:exon9/9:c.759A>G:p.Leu253Leu,TSHR:NM_000369.2:intron:MODIFIER:exon8/9:c.692+163A>G:		rs3783942	0.6112	0.6470	25939/14472/2079	0.6356						603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];				510	500					TSHR (inh=n/a pLI=0.00)
chr14	81575005	81575005	C	A	het		QUAL=16713;DP=600;AF=0.46;MQM=60;TRIO=HET,600,0.46,HET,383,0.41,HET,508,0.45	TSHR	missense,intron	TSHR:NM_001018036.2:missense:MODERATE:exon9/9:c.742C>A:p.Arg248Ser,TSHR:NM_001142626.2:missense:MODERATE:exon9/9:c.805C>A:p.Arg269Ser,TSHR:NM_000369.2:intron:MODIFIER:exon8/9:c.692+209C>A:		rs3783941	0.6102	0.6460	25847/14428/2044	0.6299	-0.9880	T	T,T	B,B	B,B	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];	RCV000122257.1 [not provided]; 			510	498					TSHR (inh=n/a pLI=0.00)
chr14	81610583	81610583	G	C	hom		QUAL=16098;DP=186;AF=0.99;MQM=60;TRIO=HOM,186,0.99,HOM,147,1.00,HOM,165,0.99	TSHR	missense	TSHR:NM_000369.2:missense:MODERATE:exon10/10:c.2181G>C:p.Glu727Asp		rs1991517	0.8968	0.9000	49233/27565/4600	0.8936	-0.1250	T	T,T,T	B	B	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];	RCV000122254.1 [not provided]; 	CM994612 [CLASS=DFP MUT=REF PHEN="Toxic multinodular goitre association with" GENE=TSHR]; 		910	132					TSHR (inh=n/a pLI=0.00)
chr14	81610942	81610942	C	T	het		QUAL=13161;DP=304;AF=0.51;MQM=59;TRIO=HET,304,0.51,HOM,159,1.00,HET,269,0.51	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*245C>T:		rs7144481	0.8433	0.0000	0/0/0	0.8596										177	50					TSHR (inh=n/a pLI=0.00)
chr14	81611849	81611849	T	A	het		QUAL=12124;DP=331;AF=0.54;MQM=59;TRIO=HET,331,0.54,HOM,135,1.00,HET,189,0.48	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1152T>A:		rs2288494	0.8472	0.0000	0/0/0	0.3084										177	50					TSHR (inh=n/a pLI=0.00)
chr14	81611850	81611850	-	T	het		QUAL=12124;DP=331;AF=0.54;MQM=59;TRIO=HET,331,0.54,HOM,135,1.00,HET,189,0.48	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1154dupT:		rs3214569	0.8476	0.0000	0/0/0	0.5683										177	50					TSHR (inh=n/a pLI=0.00)
chr14	81611919	81611919	G	C	het		QUAL=12577;DP=429;AF=0.54;MQM=59;TRIO=HET,429,0.54,HET,203,0.45,HET,256,0.52	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1222G>C:		rs2288495	0.2931	0.0000	0/0/0	0.4147										67	106					TSHR (inh=n/a pLI=0.00)
chr14	81612114	81612114	T	C	het		QUAL=9036;DP=241;AF=0.53;MQM=60;TRIO=HET,241,0.53,HET,178,0.50,HET,210,0.54	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1417T>C:		rs2288496	0.2935	0.0000	0/0/0	0.4150										67	105					TSHR (inh=n/a pLI=0.00)
chr14	88399623	88399623	T	C	hom		QUAL=19205;DP=265;AF=1.00;MQM=60;TRIO=HOM,265,1.00,HET,160,0.49,HOM,258,1.00	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*1453A>G:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*1453A>G:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*1453A>G:	L1ME2	rs405567	0.4479	0.0000	0/0/0	0.0744										55	108					GALC (inh=AR pLI=0.00)
chr14	88400087	88400087	C	T	hom		QUAL=27201;DP=512;AF=1.00;MQM=60;TRIO=HOM,512,1.00,HOM,144,1.00,HOM,179,1.00	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*989G>A:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*989G>A:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*989G>A:		rs370559	0.9409	0.0000	0/0/0	0.1455										359	3					GALC (inh=AR pLI=0.00)
chr14	88400353	88400353	C	T	hom		QUAL=36486;DP=571;AF=1.00;MQM=60;TRIO=HOM,571,1.00,HET,311,0.50,HOM,432,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*723G>A:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*723G>A:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*723G>A:		rs412915	0.4475	0.4000	1083/333/34	0.1101						606890 [GALC (confirmed) Krabbe disease];				476	1006					GALC (inh=AR pLI=0.00)
chr14	88400449	88400449	T	C	hom		QUAL=26941;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HOM,141,1.00,HOM,179,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*627A>G:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*627A>G:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*627A>G:		rs413750	0.9409	0.0000	0/0/0	0.1796						606890 [GALC (confirmed) Krabbe disease];				384	6					GALC (inh=AR pLI=0.00)
chr14	88400450	88400450	G	A	hom		QUAL=26941;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HET,141,1.00,HOM,179,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*626C>T:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*626C>T:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*626C>T:		rs432946	0.4475	0.0000	0/0/0	0.3097						606890 [GALC (confirmed) Krabbe disease];				94	175					GALC (inh=AR pLI=0.00)
chr14	88401213	88401213	T	C	hom	anno_pathogenic_hgmd	QUAL=28141;DP=326;AF=1.00;MQM=59;TRIO=HOM,326,1.00,HOM,243,1.00,HOM,312,1.00	GALC	missense	GALC:NM_000153.3:missense:MODERATE:exon17/17:c.1921A>G:p.Thr641Ala,GALC:NM_001201401.1:missense:MODERATE:exon16/16:c.1852A>G:p.Thr618Ala,GALC:NM_001201402.1:missense:MODERATE:exon17/17:c.1843A>G:p.Thr615Ala		rs421262	0.9407	0.9830	58239/33275/3619	0.9489	0.5190	T	T,T,T,T	B	B	606890 [GALC (confirmed) Krabbe disease];	RCV000078197.4 [benign]; 	CM950521 [CLASS=DM? MUT=REF PHEN="Krabbe disease" GENE=GALC]; 		2703	17	2	[2] old entry - no details available			GALC (inh=AR pLI=0.00)
chr14	88407734	88407734	G	C	hom		QUAL=8703;DP=185;AF=0.99;MQM=59;TRIO=HOM,185,0.99,HOM,57,1.00,HOM,82,1.00	GALC	splice_region&intron	GALC:NM_000153.3:splice_region&intron:LOW:exon15/16:c.1834+5C>G:,GALC:NM_001201401.1:splice_region&intron:LOW:exon14/15:c.1765+5C>G:,GALC:NM_001201402.1:splice_region&intron:LOW:exon15/16:c.1756+5C>G:		rs448805	0.9409	0.9830	57978/33136/3573	0.9009						606890 [GALC (confirmed) Krabbe disease];	RCV000078196.4 [benign]; 			2701	18					GALC (inh=AR pLI=0.00)
chr14	88407875	88407875	T	A	hom		QUAL=21043;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HOM,134,1.00,HOM,197,0.99	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon15/17:c.1698A>T:p.Val566Val,GALC:NM_001201401.1:synonymous:LOW:exon14/16:c.1629A>T:p.Val543Val,GALC:NM_001201402.1:synonymous:LOW:exon15/17:c.1620A>T:p.Val540Val		rs421466	0.9409	0.9830	58347/33328/3624	0.9247						606890 [GALC (confirmed) Krabbe disease];	RCV000078195.4 [benign]; 			2701	16					GALC (inh=AR pLI=0.00)
chr14	88407888	88407888	A	G	hom	phylop_high;pred_pathogenic_1	QUAL=16485;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HET,122,0.49,HOM,182,0.99	GALC	missense	GALC:NM_000153.3:missense:MODERATE:exon15/17:c.1685T>C:p.Ile562Thr,GALC:NM_001201401.1:missense:MODERATE:exon14/16:c.1616T>C:p.Ile539Thr,GALC:NM_001201402.1:missense:MODERATE:exon15/17:c.1607T>C:p.Ile536Thr		rs398607	0.4475	0.4400	12358/7521/1838	0.4319	9.2700	T	D,D,T,D,D	P,P,P,P	B,B,B,B	606890 [GALC (confirmed) Krabbe disease];	RCV000078194.4 [benign]; 	CM140252 [CLASS=DFP MUT=ALT PHEN="Krabbe disease late-onset" GENE=GALC]; 	COSM3754140	607	1299					GALC (inh=AR pLI=0.00)
chr14	88411947	88411947	T	C	hom		QUAL=9979;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,62,1.00,HOM,86,1.00	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon14/17:c.1620A>G:p.Thr540Thr,GALC:NM_001201401.1:synonymous:LOW:exon13/16:c.1551A>G:p.Thr517Thr,GALC:NM_001201402.1:synonymous:LOW:exon14/17:c.1542A>G:p.Thr514Thr		rs367327	0.9427	0.9830	58378/33309/3665	0.9156						606890 [GALC (confirmed) Krabbe disease];	RCV000153295.2 [benign]; 			2708	16					GALC (inh=AR pLI=0.00)
chr14	88414211	88414211	G	A	hom		QUAL=13369;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HET,221,0.51,HET,303,0.51	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon13/17:c.1350C>T:p.Ser450Ser,GALC:NM_001201401.1:synonymous:LOW:exon12/16:c.1281C>T:p.Ser427Ser,GALC:NM_001201402.1:synonymous:LOW:exon13/17:c.1272C>T:p.Ser424Ser		rs398076	0.3666	0.3720	8642/5333/905	0.3678						606890 [GALC (confirmed) Krabbe disease];	RCV000078191.4 [benign]; 		COSM3999388	418	1254					GALC (inh=AR pLI=0.00)
chr14	88417096	88417096	A	-	hom		QUAL=12020;DP=186;AF=0.95;MQM=59;TRIO=HOM,186,0.95,HOM,87,0.93,HOM,160,0.96	GALC	splice_region&intron	GALC:NM_000153.3:splice_region&intron:LOW:exon10/16:c.1162-4delT:,GALC:NM_001201401.1:splice_region&intron:LOW:exon9/15:c.1093-4delT:,GALC:NM_001201402.1:splice_region&intron:LOW:exon10/16:c.1084-4delT:		rs398099546	0.9483	0.9650	50900/28362/3134	0.8639						606890 [GALC (confirmed) Krabbe disease];	RCV000078190.4 [benign]; 			2426	256	2	[2] Peter Bauer 27.08.2014			GALC (inh=AR pLI=0.00)
chr14	89042180	89042180	T	G	hom		QUAL=12496;DP=187;AF=1.00;MQM=59;TRIO=HOM,187,1.00,HET,137,0.42,HOM,146,1.00	ZC3H14	splice_region&intron	ZC3H14:NM_024824.4:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_001160103.1:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_001160104.1:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_207660.3:splice_region&intron:LOW:exon7/13:c.1023-4T>G:,ZC3H14:NM_207661.2:splice_region&intron:LOW:exon7/14:c.921-4T>G:		rs1469602	0.4858	0.6180	24782/17739/560	0.6151							RCV000118883.2 [likely benign]; 		COSM3999396	541	445					ZC3H14 (inh=n/a pLI=1.00)
chr14	89078927	89078927	A	G	hom		QUAL=10975;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,65,1.00,HOM,73,1.00	ZC3H14	3'UTR	ZC3H14:NM_024824.4:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_001160103.1:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_001160104.1:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_207660.3:3'UTR:MODIFIER:exon14/14:c.*832A>G:,ZC3H14:NM_207661.2:3'UTR:MODIFIER:exon15/15:c.*832A>G:,ZC3H14:NM_207662.3:3'UTR:MODIFIER:exon7/7:c.*832A>G:		rs8008847	0.9103	0.0000	0/0/0	0.1773										223	7					ZC3H14 (inh=n/a pLI=1.00)
chr14	92347680	92347680	A	G	hom		QUAL=25913;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,304,1.00,HET,457,0.51	FBLN5	synonymous	FBLN5:NM_006329.3:synonymous:LOW:exon9/11:c.945T>C:p.Ile315Ile		rs2430347	0.7849	0.7610	35359/17889/3216	0.7554						604580 [FBLN5 (confirmed) Cutis laxa,autosomal recessive,type IA|Cutis laxa,autosomal dominant 2|Macular degeneration,age-related,3];	RCV000150685.1 [benign]; 			614	402					FBLN5 (inh=n/a pLI=1.00)
chr14	92413987	92413987	G	A	het		QUAL=6101;DP=277;AF=0.53;MQM=59;TRIO=HET,277,0.53,HET,99,0.56,HET,167,0.44	FBLN5	5'UTR	FBLN5:NM_006329.3:5'UTR:MODIFIER:exon1/11:c.-414C>T:		rs7149187	0.2508	0.0000	0/0/0	0.2816										30	90					FBLN5 (inh=n/a pLI=1.00)
chr14	92525145	92525145	A	G	het		QUAL=8556;DP=324;AF=0.50;MQM=59;TRIO=HET,324,0.50,HET,173,0.41,HET,228,0.45	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5519T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5519T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5519T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5655T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5655T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5655T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5655T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5519T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5519T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5519T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5655T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5519T>C:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.6588T>C:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.6423T>C:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.6642T>C:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.6477T>C:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.6733T>C:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.6577T>C:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.6728T>C:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.6103T>C:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.6586T>C:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.6565T>C:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.6277T>C:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.6575T>C:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.6597T>C:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.6223T>C:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.6589T>C:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.6421T>C:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.6435T>C:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.5893T>C:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.6090T>C:		rs1047795	0.3007	0.0000	0/0/0	0.2696										14	83					ATXN3 (inh=n/a pLI=0.18)
chr14	92525290	92525290	A	-	het		QUAL=103;DP=135;AF=0.21;MQM=59;TRIO=HET,135,0.21,HET,25,0.32,WT,30,0.20	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5374delT:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5374delT:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5374delT:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5510delT:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5510delT:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5510delT:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5510delT:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5374delT:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5374delT:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5374delT:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5510delT:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5374delT:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.6443delT:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.6278delT:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.6497delT:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.6332delT:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.6588delT:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.6432delT:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.6583delT:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5958delT:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.6441delT:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.6420delT:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.6132delT:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.6430delT:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.6452delT:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.6078delT:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.6444delT:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.6276delT:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.6290delT:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.5748delT:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.5945delT:		rs762458117	0.0000	0.0000	0/0/0	0.0018										0	38					ATXN3 (inh=n/a pLI=0.18)
chr14	92525471	92525471	C	T	hom		QUAL=10510;DP=117;AF=0.99;MQM=60;TRIO=HOM,117,0.99,HOM,89,1.00,HOM,117,1.00	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5193G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5193G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5193G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5329G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5329G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5329G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5329G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5193G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5193G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5193G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5329G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5193G>A:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.6262G>A:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.6097G>A:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.6316G>A:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.6151G>A:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.6407G>A:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.6251G>A:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.6402G>A:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5777G>A:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.6260G>A:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.6239G>A:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.5951G>A:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.6249G>A:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.6271G>A:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.5897G>A:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.6263G>A:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.6095G>A:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.6109G>A:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.5567G>A:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.5764G>A:		rs8022758	0.7508	0.0000	0/0/0	0.7487										126	90					ATXN3 (inh=n/a pLI=0.18)
chr14	92525613	92525613	C	T	het		QUAL=2733;DP=131;AF=0.41;MQM=59;TRIO=HET,131,0.41,HET,38,0.53,HET,55,0.58	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5051G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5051G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5051G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5187G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5187G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5187G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5187G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5051G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5051G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5051G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5187G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5051G>A:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.6120G>A:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.5955G>A:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.6174G>A:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.6009G>A:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.6265G>A:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.6109G>A:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.6260G>A:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5635G>A:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.6118G>A:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.6097G>A:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.5809G>A:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.6107G>A:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.6129G>A:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.5755G>A:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.6121G>A:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.5953G>A:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.5967G>A:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.5425G>A:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.5622G>A:		rs10151945	0.4706	0.0000	0/0/0	0.4054										32	105					ATXN3 (inh=n/a pLI=0.18)
chr14	92525998	92525998	-	A	het		QUAL=1923;DP=105;AF=0.49;MQM=59;TRIO=HET,105,0.49,HET,33,0.52,HET,40,0.55	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4665dupT:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4665dupT:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4665dupT:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4801dupT:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4801dupT:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4801dupT:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4801dupT:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4665dupT:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4665dupT:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4665dupT:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4801dupT:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4665dupT:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.5734dupT:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.5569dupT:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.5788dupT:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.5623dupT:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.5879dupT:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.5723dupT:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.5874dupT:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5249dupT:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.5732dupT:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.5711dupT:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.5423dupT:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.5721dupT:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.5743dupT:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.5369dupT:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.5735dupT:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.5567dupT:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.5581dupT:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.5039dupT:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.5236dupT:	AluSx1	rs398118522;rs552780970	0.3085	0.0000	0/0/0	0.1543										9	64					ATXN3 (inh=n/a pLI=0.18)
chr14	92526157	92526157	G	A	het		QUAL=2831;DP=174;AF=0.49;MQM=58;TRIO=HET,174,0.49,HET,42,0.50,HET,57,0.39	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4507C>T:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4507C>T:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4507C>T:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4643C>T:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4643C>T:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4643C>T:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4643C>T:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4507C>T:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4507C>T:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4507C>T:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4643C>T:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4507C>T:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.5576C>T:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.5411C>T:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.5630C>T:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.5465C>T:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.5721C>T:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.5565C>T:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.5716C>T:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5091C>T:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.5574C>T:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.5553C>T:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.5265C>T:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.5563C>T:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.5585C>T:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.5211C>T:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.5577C>T:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.5409C>T:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.5423C>T:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.4881C>T:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.5078C>T:	AluSx1	rs112733683	0.3143	0.0000	0/0/0	0.2008										11	59					ATXN3 (inh=n/a pLI=0.18)
chr14	92526240	92526240	A	C	het		QUAL=1459;DP=99;AF=0.42;MQM=59;TRIO=HET,99,0.42,HET,27,0.63,HET,34,0.32	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4424T>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4424T>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4424T>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4560T>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4560T>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4560T>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4560T>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4424T>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4424T>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4424T>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4560T>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4424T>G:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.5493T>G:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.5328T>G:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.5547T>G:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.5382T>G:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.5638T>G:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.5482T>G:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.5633T>G:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.5008T>G:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.5491T>G:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.5470T>G:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.5182T>G:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.5480T>G:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.5502T>G:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.5128T>G:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.5494T>G:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.5326T>G:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.5340T>G:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.4798T>G:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.4995T>G:		rs67089639	0.3007	0.0000	0/0/0	0.2327										9	63					ATXN3 (inh=n/a pLI=0.18)
chr14	92526429	92526429	T	G	het		QUAL=312;DP=29;AF=0.48;MQM=56;TRIO=HET,29,0.48,HOM,1,1.00,HET,2,0.50	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4235A>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4235A>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4235A>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4371A>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4371A>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4371A>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4371A>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4235A>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4235A>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4235A>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4371A>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4235A>C:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.5304A>C:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.5139A>C:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.5358A>C:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.5193A>C:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.5449A>C:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.5293A>C:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.5444A>C:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.4819A>C:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.5302A>C:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.5281A>C:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.4993A>C:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.5291A>C:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.5313A>C:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.4939A>C:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.5305A>C:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.5137A>C:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.5151A>C:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.4609A>C:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.4806A>C:	AluSq2	rs8009456	0.3143	0.0000	0/0/0	0.1955										8	20					ATXN3 (inh=n/a pLI=0.18)
chr14	92526630	92526630	A	G	het	low_DP	QUAL=33;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,1,0.00,HET,2,0.50	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4034T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4034T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4034T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4170T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4170T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4170T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4170T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4034T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4034T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4034T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4170T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4034T>C:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.5103T>C:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.4938T>C:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.5157T>C:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.4992T>C:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.5248T>C:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.5092T>C:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.5243T>C:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.4618T>C:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.5101T>C:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.5080T>C:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.4792T>C:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.5090T>C:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.5112T>C:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.4738T>C:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.5104T>C:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.4936T>C:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.4950T>C:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.4408T>C:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.4605T>C:	AluSz	rs8008405	0.3139	0.0000	0/0/0	0.2088										5	29					ATXN3 (inh=n/a pLI=0.18)
chr14	92527145	92527145	T	C	het		QUAL=4098;DP=147;AF=0.51;MQM=59;TRIO=HET,147,0.51,HET,61,0.56,HET,104,0.51	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3519A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3519A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3519A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3655A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3655A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3655A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3655A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3519A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3519A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3519A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3655A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3519A>G:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.4588A>G:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.4423A>G:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.4642A>G:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.4477A>G:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.4733A>G:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.4577A>G:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.4728A>G:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.4103A>G:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.4586A>G:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.4565A>G:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.4277A>G:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.4575A>G:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.4597A>G:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.4223A>G:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.4589A>G:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.4421A>G:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.4435A>G:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.3893A>G:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.4090A>G:	AluSg4	rs1134378	0.3149	0.0000	0/0/0	0.2316										14	83					ATXN3 (inh=n/a pLI=0.18)
chr14	92527164	92527164	T	C	het		QUAL=4438;DP=186;AF=0.51;MQM=59;TRIO=HET,186,0.51,HET,59,0.51,HET,100,0.52	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3500A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3500A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3500A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3636A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3636A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3636A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3636A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3500A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3500A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3500A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3636A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3500A>G:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.4569A>G:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.4404A>G:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.4623A>G:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.4458A>G:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.4714A>G:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.4558A>G:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.4709A>G:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.4084A>G:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.4567A>G:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.4546A>G:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.4258A>G:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.4556A>G:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.4578A>G:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.4204A>G:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.4570A>G:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.4402A>G:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.4416A>G:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.3874A>G:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.4071A>G:	AluSg4	rs1134377	0.3141	0.0000	0/0/0	0.2339										14	79					ATXN3 (inh=n/a pLI=0.18)
chr14	92527399	92527399	A	G	het		QUAL=7526;DP=312;AF=0.49;MQM=59;TRIO=HET,312,0.49,HET,86,0.48,HET,169,0.54	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3265T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3265T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3265T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3401T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3401T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3401T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3401T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3265T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3265T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3265T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3401T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3265T>C:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.4334T>C:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.4169T>C:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.4388T>C:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.4223T>C:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.4479T>C:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.4323T>C:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.4474T>C:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.3849T>C:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.4332T>C:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.4311T>C:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.4023T>C:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.4321T>C:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.4343T>C:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.3969T>C:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.4335T>C:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.4167T>C:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.4181T>C:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.3639T>C:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.3836T>C:		rs1055996	0.2406	0.0000	0/0/0	0.2498										14	79					ATXN3 (inh=n/a pLI=0.18)
chr14	92527977	92527977	T	C	het		QUAL=13012;DP=449;AF=0.50;MQM=60;TRIO=HET,449,0.50,HET,239,0.51,HET,261,0.55	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*2687A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*2687A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*2687A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*2823A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*2823A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*2823A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*2823A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*2687A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*2687A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*2687A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*2823A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*2687A>G:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.3756A>G:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.3591A>G:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.3810A>G:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.3645A>G:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.3901A>G:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.3745A>G:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.3896A>G:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.3271A>G:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.3754A>G:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.3733A>G:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.3445A>G:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.3743A>G:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.3765A>G:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.3391A>G:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.3757A>G:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.3589A>G:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.3603A>G:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.3061A>G:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.3258A>G:		rs11628764	0.1761	0.0000	0/0/0	0.2419										17	90					ATXN3 (inh=n/a pLI=0.18)
chr14	92528429	92528429	C	T	het		QUAL=5287;DP=175;AF=0.46;MQM=59;TRIO=HET,175,0.46,HET,98,0.54,HET,169,0.53	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*2235G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*2235G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*2235G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*2371G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*2371G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*2371G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*2371G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*2235G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*2235G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*2235G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*2371G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*2235G>A:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.3304G>A:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.3139G>A:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.3358G>A:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.3193G>A:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.3449G>A:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.3293G>A:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.3444G>A:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.2819G>A:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.3302G>A:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.3281G>A:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.2993G>A:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.3291G>A:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.3313G>A:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.2939G>A:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.3305G>A:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.3137G>A:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.3151G>A:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.2609G>A:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.2806G>A:	AluSx1	rs8019545	0.3165	0.0000	0/0/0	0.2389										14	78					ATXN3 (inh=n/a pLI=0.18)
chr14	92530282	92530282	C	A	het		QUAL=8597;DP=302;AF=0.54;MQM=59;TRIO=HET,302,0.54,HET,156,0.49,HET,154,0.51	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*382G>T:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*382G>T:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*382G>T:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*518G>T:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*518G>T:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*518G>T:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*518G>T:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*382G>T:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*382G>T:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*382G>T:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*518G>T:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*382G>T:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.1451G>T:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.1286G>T:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.1505G>T:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.1340G>T:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.1596G>T:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.1440G>T:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.1591G>T:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.966G>T:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.1449G>T:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.1428G>T:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.1140G>T:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.1438G>T:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.1460G>T:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.1086G>T:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.1452G>T:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.1284G>T:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.1298G>T:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.756G>T:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.953G>T:		rs910369	0.2877	0.0000	0/0/0	0.0453										14	83					ATXN3 (inh=n/a pLI=0.18)
chr14	92530513	92530513	C	T	het		QUAL=4455;DP=229;AF=0.46;MQM=60;TRIO=HET,229,0.46,HET,64,0.53,HET,69,0.55	ATXN3	3'UTR,non_coding_exon	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*151G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*151G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*151G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*287G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*287G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*287G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*287G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*151G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*151G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*151G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*287G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*151G>A:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon10/10:n.1220G>A:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon9/9:n.1055G>A:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon11/11:n.1274G>A:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon10/10:n.1109G>A:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon12/12:n.1365G>A:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon10/10:n.1209G>A:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon12/12:n.1360G>A:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon6/6:n.735G>A:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon10/10:n.1218G>A:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon10/10:n.1197G>A:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon7/7:n.909G>A:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon10/10:n.1207G>A:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon10/10:n.1229G>A:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon6/6:n.855G>A:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon10/10:n.1221G>A:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon9/9:n.1053G>A:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon9/9:n.1067G>A:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon4/4:n.525G>A:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon5/5:n.722G>A:		rs709930	0.2819	0.0000	0/0/0	0.0454										14	83					ATXN3 (inh=n/a pLI=0.18)
chr14	92537379	92537379	T	C	het	low_DP	QUAL=291;DP=8;AF=0.13;MQM=58;TRIO=HET,8,0.13,HET,35,0.29,HET,32,0.25	ATXN3	missense,synonymous,non_coding_exon	ATXN3:NM_001164774.1:missense:MODERATE:exon3/4:c.208A>G:p.Thr70Ala,ATXN3:NM_001164776.1:missense:MODERATE:exon4/5:c.253A>G:p.Thr85Ala,ATXN3:NM_001164777.1:missense:MODERATE:exon3/4:c.88A>G:p.Thr30Ala,ATXN3:NM_001164778.1:missense:MODERATE:exon6/7:c.406A>G:p.Thr136Ala,ATXN3:NM_001164782.1:missense:MODERATE:exon2/3:c.43A>G:p.Thr15Ala,ATXN3:NM_004993.5:synonymous:LOW:exon10/11:c.891A>G:p.Gln297Gln,ATXN3:NM_001127696.1:synonymous:LOW:exon9/10:c.846A>G:p.Gln282Gln,ATXN3:NM_001127697.2:synonymous:LOW:exon8/9:c.738A>G:p.Gln246Gln,ATXN3:NM_001164779.1:synonymous:LOW:exon6/7:c.528A>G:p.Gln176Gln,ATXN3:NM_001164780.1:synonymous:LOW:exon7/8:c.354A>G:p.Gln118Gln,ATXN3:NM_001164781.1:synonymous:LOW:exon8/9:c.681A>G:p.Gln227Gln,ATXN3:NM_030660.4:synonymous:LOW:exon9/10:c.726A>G:p.Gln242Gln,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon9/10:n.874A>G:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon8/9:n.709A>G:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon10/11:n.928A>G:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon9/10:n.763A>G:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon11/12:n.1019A>G:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon9/10:n.863A>G:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon11/12:n.1014A>G:,ATXN3:NR_028460.1:non_coding_exon:MODIFIER:exon5/6:n.389A>G:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon9/10:n.872A>G:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon9/10:n.851A>G:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon6/7:n.563A>G:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon9/10:n.861A>G:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon9/10:n.883A>G:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon5/6:n.509A>G:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon9/10:n.875A>G:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon8/9:n.707A>G:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon8/9:n.721A>G:,ATXN3:NR_028470.1:non_coding_exon:MODIFIER:exon3/4:n.179A>G:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon4/5:n.376A>G:	(CTG)n	rs12896583	0.0000	0.1690	136/60/40	0.0012						607047 [ATXN3 (confirmed) Machado-Joseph disease];	RCV000116484.2 [likely benign]; 		COSM3749284, COSM3749285, COSM433493	4	360					ATXN3 (inh=n/a pLI=0.18)
chr14	92548785	92548785	C	T	het	phylop_high	QUAL=9368;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,HET,227,0.58,HET,279,0.48	ATXN3	missense,intron,non_coding_exon	ATXN3:NM_004993.5:missense:MODERATE:exon8/11:c.634G>A:p.Val212Met,ATXN3:NM_001127696.1:missense:MODERATE:exon7/10:c.589G>A:p.Val197Met,ATXN3:NM_001127697.2:missense:MODERATE:exon6/9:c.481G>A:p.Val161Met,ATXN3:NM_001164779.1:missense:MODERATE:exon4/7:c.271G>A:p.Val91Met,ATXN3:NM_001164780.1:missense:MODERATE:exon5/8:c.97G>A:p.Val33Met,ATXN3:NM_001164781.1:missense:MODERATE:exon6/9:c.424G>A:p.Val142Met,ATXN3:NM_030660.4:missense:MODERATE:exon7/10:c.469G>A:p.Val157Met,ATXN3:NM_001164774.1:intron:MODIFIER:exon2/3:c.190-11388G>A:,ATXN3:NM_001164776.1:intron:MODIFIER:exon3/4:c.235-11388G>A:,ATXN3:NM_001164777.1:intron:MODIFIER:exon2/3:c.70-11388G>A:,ATXN3:NM_001164778.1:intron:MODIFIER:exon5/6:c.387+10811G>A:,ATXN3:NM_001164782.1:intron:MODIFIER:exon1/2:c.25-11388G>A:,ATXN3:NR_028460.1:intron:MODIFIER:exon4/5:n.370+10811G>A:,ATXN3:NR_028468.1:intron:MODIFIER:exon6/8:n.591+685G>A:,ATXN3:NR_028470.1:intron:MODIFIER:exon2/3:n.160+10811G>A:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon7/10:n.617G>A:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon6/9:n.452G>A:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon7/11:n.617G>A:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon6/10:n.452G>A:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon8/12:n.708G>A:,ATXN3:NR_028458.1:non_coding_exon:MODIFIER:exon7/10:n.594G>A:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon8/12:n.703G>A:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon7/10:n.615G>A:,ATXN3:NR_028462.1:non_coding_exon:MODIFIER:exon7/10:n.594G>A:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon3/7:n.252G>A:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon6/10:n.550G>A:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon6/10:n.572G>A:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon3/6:n.252G>A:,ATXN3:NR_028467.1:non_coding_exon:MODIFIER:exon7/10:n.618G>A:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon6/9:n.452G>A:,ATXN3:NR_031765.1:non_coding_exon:MODIFIER:exon2/5:n.119G>A:		rs1048755	0.3251	0.2710	4838/2011/615	0.2699	2.2370	T	T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T	B,B,B,B,B	B,B,B,B,B	607047 [ATXN3 (confirmed) Machado-Joseph disease];	RCV000116481.2 [likely benign]; 		COSM3754168, COSM3754167, COSM3754169	77	404					ATXN3 (inh=n/a pLI=0.18)
chr14	92549586	92549586	G	A	het		QUAL=6481;DP=307;AF=0.51;MQM=59;TRIO=HET,307,0.51,HET,103,0.48,HET,149,0.38	ATXN3	splice_region&intron,synonymous,5'UTR_premature_start_codon_gain,5'UTR,intron,non_coding_exon	ATXN3:NR_028458.1:splice_region&intron:LOW:exon5/9:n.459-7C>T:,ATXN3:NR_028462.1:splice_region&intron:LOW:exon5/9:n.459-7C>T:,ATXN3:NR_028467.1:splice_region&intron:LOW:exon5/9:n.483-7C>T:,ATXN3:NM_004993.5:synonymous:LOW:exon7/11:c.492C>T:p.Val164Val,ATXN3:NM_001127696.1:synonymous:LOW:exon6/10:c.447C>T:p.Val149Val,ATXN3:NM_001127697.2:synonymous:LOW:exon5/9:c.339C>T:p.Val113Val,ATXN3:NM_001164779.1:synonymous:LOW:exon3/7:c.129C>T:p.Val43Val,ATXN3:NM_001164781.1:synonymous:LOW:exon5/9:c.282C>T:p.Val94Val,ATXN3:NM_030660.4:synonymous:LOW:exon6/10:c.327C>T:p.Val109Val,ATXN3:NM_001164780.1:5'UTR_premature_start_codon_gain:LOW:exon4/8:c.-46C>T:,ATXN3:NM_001164780.1:5'UTR:MODIFIER:exon4/8:c.-46C>T:,ATXN3:NM_001164774.1:intron:MODIFIER:exon2/3:c.190-12189C>T:,ATXN3:NM_001164776.1:intron:MODIFIER:exon3/4:c.235-12189C>T:,ATXN3:NM_001164777.1:intron:MODIFIER:exon2/3:c.70-12189C>T:,ATXN3:NM_001164778.1:intron:MODIFIER:exon5/6:c.387+10010C>T:,ATXN3:NM_001164782.1:intron:MODIFIER:exon1/2:c.25-12189C>T:,ATXN3:NR_028460.1:intron:MODIFIER:exon4/5:n.370+10010C>T:,ATXN3:NR_028470.1:intron:MODIFIER:exon2/3:n.160+10010C>T:,ATXN3:NR_031765.1:intron:MODIFIER:exon1/4:n.94-776C>T:,ATXN3:NR_028453.1:non_coding_exon:MODIFIER:exon6/10:n.475C>T:,ATXN3:NR_028454.1:non_coding_exon:MODIFIER:exon5/9:n.310C>T:,ATXN3:NR_028455.1:non_coding_exon:MODIFIER:exon6/11:n.475C>T:,ATXN3:NR_028456.1:non_coding_exon:MODIFIER:exon5/10:n.310C>T:,ATXN3:NR_028457.1:non_coding_exon:MODIFIER:exon7/12:n.566C>T:,ATXN3:NR_028459.1:non_coding_exon:MODIFIER:exon7/12:n.561C>T:,ATXN3:NR_028461.1:non_coding_exon:MODIFIER:exon6/10:n.473C>T:,ATXN3:NR_028463.1:non_coding_exon:MODIFIER:exon2/7:n.110C>T:,ATXN3:NR_028464.1:non_coding_exon:MODIFIER:exon5/10:n.408C>T:,ATXN3:NR_028465.1:non_coding_exon:MODIFIER:exon5/10:n.430C>T:,ATXN3:NR_028466.1:non_coding_exon:MODIFIER:exon2/6:n.110C>T:,ATXN3:NR_028468.1:non_coding_exon:MODIFIER:exon6/9:n.475C>T:,ATXN3:NR_028469.1:non_coding_exon:MODIFIER:exon5/9:n.310C>T:		rs16999141	0.5667	0.5020	15770/7814/2396	0.4915						607047 [ATXN3 (confirmed) Machado-Joseph disease];	RCV000116480.2 [likely benign]; 		COSM147835	251	571					ATXN3 (inh=n/a pLI=0.18)
chr14	93673580	93673580	A	G	het		QUAL=2422;DP=87;AF=0.37;MQM=59;TRIO=HET,87,0.37,WT,148,0.00,HET,190,0.51	UBR7	5'UTR,non_coding_exon	UBR7:NM_175748.3:5'UTR:MODIFIER:exon1/11:c.-57A>G:,UBR7:NR_038150.1:non_coding_exon:MODIFIER:exon1/10:n.180A>G:		rs2255370	0.3622	0.2160	1351/321/145	0.1541										74	274					UBR7 (inh=n/a pLI=0.43)
chr14	93693422	93693422	C	T	het		QUAL=13827;DP=392;AF=0.49;MQM=59;TRIO=HET,392,0.49,HET,286,0.53,HET,385,0.50	UBR7	3'UTR,non_coding_exon	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*41C>T:,UBR7:NR_038150.1:non_coding_exon:MODIFIER:exon10/10:n.1421C>T:		rs2905	0.1945	0.2730	4801/3511/16	0.2705										103	398					UBR7 (inh=n/a pLI=0.43)
chr14	93693604	93693604	T	G	het		QUAL=15362;DP=366;AF=0.50;MQM=60;TRIO=HET,366,0.50,HET,370,0.45,HET,505,0.48	UBR7	3'UTR,non_coding_exon	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*223T>G:,UBR7:NR_038150.1:non_coding_exon:MODIFIER:exon10/10:n.1603T>G:		rs10144530	0.3878	0.3170	975/500/30	0.1405										167	317					UBR7 (inh=n/a pLI=0.43)
chr14	93693831	93693831	C	T	het		QUAL=12044;DP=358;AF=0.53;MQM=60;TRIO=HET,358,0.53,HET,221,0.52,HET,285,0.53	UBR7	3'UTR,non_coding_exon	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*450C>T:,UBR7:NR_038150.1:non_coding_exon:MODIFIER:exon10/10:n.1830C>T:		rs11621915	0.1939	0.1860	378/224/1	0.0689										74	292					UBR7 (inh=n/a pLI=0.43)
chr14	97321689	97321689	C	T	het		QUAL=8859;DP=190;AF=0.53;MQM=60;TRIO=HET,190,0.53,HET,192,0.56,HET,274,0.52	VRK1	synonymous	VRK1:NM_003384.2:synonymous:LOW:exon8/13:c.705C>T:p.Gly235Gly		rs2230532	0.4167	0.3890	10581/4415/157	0.3865	-0.6900	T				602168 [VRK1 (provisional) Pontocerebellar hypoplasia type 1A];	RCV000118848.2 [likely benign]; 			291	988					VRK1 (inh=AR pLI=0.04)
chr14	106321590	106321590	C	A	hom		QUAL=21838;DP=279;AF=1.00;MQM=59;TRIO=HOM,279,1.00,HOM,215,1.00,HOM,268,1.00	ELK2AP-MIR4507	intergenic_region	ELK2AP-MIR4507:ELK2AP-MIR4507:intergenic_region:MODIFIER::n.106321590C>A:		rs12365	0.9149	0.9700	53543/31053/2148	0.9343										852	15					ELK2AP-MIR4507 (inh=n/a pLI=n/a)
chr14	106321913	106321913	G	A	hom		QUAL=23027;DP=305;AF=0.99;MQM=59;TRIO=HOM,305,0.99,HOM,199,0.99,HOM,246,0.99	ELK2AP-MIR4507	intergenic_region	ELK2AP-MIR4507:ELK2AP-MIR4507:intergenic_region:MODIFIER::n.106321913G>A:		rs1136534	0.5631	0.5250	16813/8406/2257	0.5077										272	452					ELK2AP-MIR4507 (inh=n/a pLI=n/a)
chr15	23043896	23043896	G	A	hom		QUAL=22297;DP=379;AF=1.00;MQM=60;TRIO=HOM,379,1.00,HOM,123,1.00,HOM,169,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*4933C>T:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*4933C>T:		rs7181789	0.5557	0.0000	0/0/0	0.0965										59	122					NIPA1 (inh=n/a pLI=0.21)
chr15	23046770	23046770	-	AA	het		QUAL=10432;DP=383;AF=0.49;MQM=59;TRIO=HET,383,0.49,HOM,173,0.99,WT,233,0.01	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:		rs3057642	0.7214	0.0000	0/0/0	0.6452										125	86					NIPA1 (inh=n/a pLI=0.21)
chr15	23046848	23046848	T	C	hom		QUAL=30589;DP=472;AF=1.00;MQM=59;TRIO=HOM,472,1.00,HOM,199,1.00,HOM,238,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1981A>G:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1981A>G:		rs6606822	1.0000	0.0000	0/0/0	0.8794										230	0					NIPA1 (inh=n/a pLI=0.21)
chr15	23046855	23046855	G	T	hom		QUAL=27198;DP=398;AF=1.00;MQM=59;TRIO=HOM,398,1.00,HOM,185,1.00,HOM,228,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1974C>A:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1974C>A:		rs6606823	0.9639	0.0000	0/0/0	0.1469										196	34					NIPA1 (inh=n/a pLI=0.21)
chr15	23046902	23046902	T	C	het		QUAL=10778;DP=344;AF=0.50;MQM=59;TRIO=HET,344,0.50,HOM,186,1.00,WT,217,0.01	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1927A>G:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1927A>G:		rs17807140	0.2558	0.0000	0/0/0	0.0487										24	90					NIPA1 (inh=n/a pLI=0.21)
chr15	23046982	23046982	-	T	het		QUAL=9285;DP=275;AF=0.50;MQM=59;TRIO=HET,275,0.50,HOM,191,0.97,WT,194,0.02	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1846dupA:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1846dupA:		rs113532349	0.2722	0.0000	0/0/0	0.2688										24	90					NIPA1 (inh=n/a pLI=0.21)
chr15	23047857	23047857	G	A	het		QUAL=8939;DP=251;AF=0.50;MQM=59;TRIO=HET,251,0.50,HOM,178,0.99,WT,245,0.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*972C>T:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*972C>T:	Tigger3a	rs8025849	0.6879	0.0000	0/0/0	0.1235										122	86					NIPA1 (inh=n/a pLI=0.21)
chr15	23048542	23048542	A	G	het		QUAL=12873;DP=343;AF=0.52;MQM=60;TRIO=HET,343,0.52,HOM,250,1.00,WT,312,0.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*287T>C:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*287T>C:		rs3812924	0.1893	0.0000	0/0/0	0.0453										24	91					NIPA1 (inh=n/a pLI=0.21)
chr15	23052632	23052632	T	C	het		QUAL=6668;DP=193;AF=0.47;MQM=60;TRIO=HET,193,0.47,HOM,147,0.99,WT,224,0.00	NIPA1	synonymous	NIPA1:NM_144599.4:synonymous:LOW:exon4/5:c.441A>G:p.Thr147Thr,NIPA1:NM_001142275.1:synonymous:LOW:exon4/5:c.216A>G:p.Thr72Thr		rs11263683	0.7041	0.7360	33561/17397/1324	0.7290						608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant];	RCV000117820.2 [likely benign]; 		COSM3999473	844	628					NIPA1 (inh=n/a pLI=0.21)
chr15	23931507	23931507	G	A	hom		QUAL=7973;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HET,87,0.51,HET,126,0.47	NDN	synonymous	NDN:NM_002487.2:synonymous:LOW:exon1/1:c.858C>T:p.Asp286Asp		rs2192206	0.1895	0.2150	3136/1558/9	0.2155						602117 [NDN (confirmed) Prader-Willi syndrome];			COSM3754246	60	382					NDN (inh=n/a pLI=0.47)
chr15	25219512	25219512	T	C	hom		QUAL=35242;DP=308;AF=0.99;MQM=60;TRIO=HOM,308,0.99,HOM,343,1.00,HOM,440,1.00	SNRPN,SNURF	5'UTR,3'UTR	SNRPN:NM_003097.3:5'UTR:MODIFIER:exon4/10:c.-89T>C:,SNRPN:NM_022806.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:NM_022807.2:5'UTR:MODIFIER:exon7/13:c.-89T>C:,SNRPN:NM_022808.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:NM_022805.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNURF:NM_005678.3:3'UTR:MODIFIER:exon4/10:c.*100T>C:		rs705	0.5218	0.0000	0/0/0	0.0975										75	182					SNRPN (inh=AD pLI=0.85), SNURF (inh=n/a pLI=0.78)
chr15	32460419	32460419	C	T	het	low_DP;low_MQM	QUAL=326;DP=4;AF=0.50;MQM=26;TRIO=HET,4,0.50,HET,73,0.27,HET,117,0.24	CHRNA7	synonymous,non_coding_exon	CHRNA7:NM_001190455.2:synonymous:LOW:exon10/10:c.1356C>T:p.Gly452Gly,CHRNA7:NM_000746.5:synonymous:LOW:exon10/10:c.1269C>T:p.Gly423Gly,CHRNA7:NR_046324.1:non_coding_exon:MODIFIER:exon8/8:n.1191C>T:		rs1042724	0.0000	0.2020	119/82/9	0.1263						118511 [CHRNA7 (confirmed) Schizophrenia,neurophysiologic defect in];			COSM4148629, COSM4148628	27	533					CHRNA7 (inh=n/a pLI=n/a)
chr15	32461233	32461233	T	C	hom	low_MQM	QUAL=993;DP=25;AF=0.04;MQM=32;TRIO=HOM,25,0.04,WT,50,0.00,HOM,26,0.27	CHRNA7	3'UTR,non_coding_exon	CHRNA7:NM_001190455.2:3'UTR:MODIFIER:exon10/10:c.*574T>C:,CHRNA7:NM_000746.5:3'UTR:MODIFIER:exon10/10:c.*574T>C:,CHRNA7:NR_046324.1:non_coding_exon:MODIFIER:exon8/8:n.2005T>C:		rs67960669	0.0000	0.0000	0/0/0	0.0004										0	9					CHRNA7 (inh=n/a pLI=n/a)
chr15	34522679	34522679	C	T	hom		QUAL=11998;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,134,0.43,HOM,169,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*3403G>A:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*3403G>A:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*3403G>A:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:		rs4530104	0.5449	0.0000	0/0/0	0.1103										94	104					SLC12A6 (inh=AR pLI=0.98)
chr15	34522985	34522985	C	G	hom		QUAL=21793;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,199,1.00,HOM,208,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*3097G>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*3097G>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*3097G>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:		rs4238571	0.9671	0.0000	0/0/0	0.8691										229	1					SLC12A6 (inh=AR pLI=0.98)
chr15	34524590	34524590	A	G	hom		QUAL=15754;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,112,0.99,HOM,152,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1492T>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1492T>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1492T>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:	AluSz	rs6495640	0.9457	0.0000	0/0/0	0.8628										192	1					SLC12A6 (inh=AR pLI=0.98)
chr15	34524995	34524995	G	T	hom		QUAL=26473;DP=336;AF=1.00;MQM=59;TRIO=HOM,336,1.00,HET,274,0.50,HOM,377,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1087C>A:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1087C>A:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1087C>A:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:		rs4779660	0.7895	0.0000	0/0/0	0.1310										157	68					SLC12A6 (inh=AR pLI=0.98)
chr15	34525035	34525035	T	C	hom		QUAL=30096;DP=404;AF=0.99;MQM=59;TRIO=HOM,404,0.99,HET,295,0.51,HOM,395,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1047A>G:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1047A>G:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1047A>G:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:		rs4780233	0.5861	0.0000	0/0/0	0.1130										94	108					SLC12A6 (inh=AR pLI=0.98)
chr15	34525258	34525258	A	G	het		QUAL=5560;DP=341;AF=0.48;MQM=60;TRIO=HET,341,0.48,HET,95,0.52,WT,168,0.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*824T>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*824T>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*824T>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:		rs75307067	0.0421	0.0000	0/0/0	0.0099										0	36					SLC12A6 (inh=AR pLI=0.98)
chr15	34528948	34528948	G	A	hom		QUAL=29103;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HET,307,0.50,HOM,429,1.00	SLC12A6	synonymous	SLC12A6:NM_133647.1:synonymous:LOW:exon22/25:c.3003C>T:p.Leu1001Leu,SLC12A6:NM_005135.2:synonymous:LOW:exon22/25:c.2850C>T:p.Leu950Leu,SLC12A6:NM_001042497.1:synonymous:LOW:exon21/24:c.2958C>T:p.Leu986Leu,SLC12A6:NM_001042494.1:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu,SLC12A6:NM_001042496.1:synonymous:LOW:exon23/26:c.2976C>T:p.Leu992Leu,SLC12A6:NM_001042495.1:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu		rs4577050	0.5721	0.6510	26234/15441/995	0.6484						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];	RCV000147486.1 [benign]; 		COSM3754266, COSM3754264, COSM3754265	474	477					SLC12A6 (inh=AR pLI=0.98)
chr15	34551082	34551082	G	A	het		QUAL=9292;DP=381;AF=0.47;MQM=60;TRIO=HET,381,0.47,HET,348,0.50,WT,427,0.00	SLC12A6	synonymous	SLC12A6:NM_133647.1:synonymous:LOW:exon4/25:c.475C>T:p.Leu159Leu,SLC12A6:NM_005135.2:synonymous:LOW:exon4/25:c.322C>T:p.Leu108Leu,SLC12A6:NM_001042497.1:synonymous:LOW:exon3/24:c.430C>T:p.Leu144Leu,SLC12A6:NM_001042494.1:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu,SLC12A6:NM_001042496.1:synonymous:LOW:exon5/26:c.448C>T:p.Leu150Leu,SLC12A6:NM_001042495.1:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu		rs7164902	0.2768	0.2510	4022/1945/240	0.2486						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];	RCV000147488.1 [benign]; 		COSM3754270, COSM3754271, COSM3754272	100	383					SLC12A6 (inh=AR pLI=0.98)
chr15	34610964	34610964	G	C	het		QUAL=8053;DP=569;AF=0.46;MQM=59;TRIO=HET,569,0.46,HET,184,0.47,WT,240,0.00	SLC12A6	5'UTR,intron	SLC12A6:NM_005135.2:5'UTR:MODIFIER:exon1/25:c.-85C>G:,SLC12A6:NM_133647.1:intron:MODIFIER:exon1/24:c.271+17647C>G:,SLC12A6:NM_001042497.1:intron:MODIFIER:exon1/23:c.271+17647C>G:,SLC12A6:NM_001042494.1:intron:MODIFIER:exon2/25:c.94+17647C>G:,SLC12A6:NM_001042496.1:intron:MODIFIER:exon2/25:c.244+17647C>G:,SLC12A6:NM_001042495.1:intron:MODIFIER:exon2/25:c.94+17647C>G:		rs347867	0.4515	0.0000	0/0/0	0.0609						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];				36	123					SLC12A6 (inh=AR pLI=0.98)
chr15	34629024	34629024	C	T	het		QUAL=3904;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,85,0.55,WT,115,0.00	SLC12A6	5'UTR,intron	SLC12A6:NM_133647.1:5'UTR:MODIFIER:exon1/25:c.-143G>A:,SLC12A6:NM_001042497.1:5'UTR:MODIFIER:exon1/24:c.-143G>A:,SLC12A6:NM_001042494.1:intron:MODIFIER:exon1/25:c.-98-222G>A:,SLC12A6:NM_001042496.1:intron:MODIFIER:exon1/25:c.-14-156G>A:,SLC12A6:NM_001042495.1:intron:MODIFIER:exon1/25:c.-98-222G>A:		rs73374490	0.2107	0.0000	0/0/0	0.0398										5	57					SLC12A6 (inh=AR pLI=0.98)
chr15	40710723	40710723	G	A	hom		QUAL=28457;DP=517;AF=1.00;MQM=60;TRIO=HOM,517,1.00,HET,455,0.48,HET,556,0.47	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*261G>A:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*261G>A:		rs2075624	0.3578	0.0000	0/0/0	0.0549										22	101					IVD (inh=AR pLI=0.00)
chr15	40711270	40711270	C	G	hom		QUAL=9415;DP=147;AF=1.00;MQM=57;TRIO=HOM,147,1.00,HOM,102,0.99,HET,155,0.47	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*808C>G:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*808C>G:	AluSq2	rs2075625	0.5074	0.0000	0/0/0	0.4814										113	203					IVD (inh=AR pLI=0.00)
chr15	40711933	40711933	G	A	hom	low_MQM	QUAL=2268;DP=59;AF=0.98;MQM=48;TRIO=HOM,59,0.98,HOM,7,1.00,HOM,13,1.00	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1471G>A:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1471G>A:	AluSg7	rs4923865	0.5869	0.0000	0/0/0	0.5735										94	77					IVD (inh=AR pLI=0.00)
chr15	40712039	40712039	C	G	hom		QUAL=1268;DP=40;AF=1.00;MQM=55;TRIO=HOM,40,1.00,HOM,3,1.00,HET,3,0.33	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1577C>G:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1577C>G:	AluSg	rs11630850	0.5068	0.0000	0/0/0	0.4713										61	75					IVD (inh=AR pLI=0.00)
chr15	40712072	40712072	C	T	hom		QUAL=1142;DP=37;AF=0.97;MQM=52;TRIO=HOM,37,0.97,HOM,5,1.00,HET,4,0.75	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1610C>T:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1610C>T:	AluSg	rs11630878	0.5070	0.0000	0/0/0	0.4262										58	85					IVD (inh=AR pLI=0.00)
chr15	40712349	40712349	G	-	hom		QUAL=18434;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,178,0.99,HET,247,0.99	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1893delG:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1893delG:		rs398026948	0.5070	0.0000	0/0/0	0.4808										92	160					IVD (inh=AR pLI=0.00)
chr15	40712737	40712737	T	C	hom		QUAL=20211;DP=193;AF=0.99;MQM=60;TRIO=HOM,193,0.99,HOM,191,0.99,HOM,258,1.00	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*2275T>C:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*2275T>C:		rs11790	0.6112	0.0000	0/0/0	0.1122										270	286					IVD (inh=AR pLI=0.00)
chr15	40713306	40713306	T	C	hom		QUAL=22519;DP=356;AF=0.99;MQM=59;TRIO=HOM,356,0.99,HOM,205,0.99,HET,308,0.56	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*2844T>C:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*2844T>C:		rs7207	0.5072	0.0000	0/0/0	0.0936										71	133					IVD (inh=AR pLI=0.00)
chr15	40713491	40713491	A	-	hom		QUAL=13402;DP=218;AF=0.98;MQM=59;TRIO=HOM,218,0.98,HOM,160,0.99,HET,207,0.48	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*3036delA:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*3036delA:		rs869246493	0.5072	0.0000	0/0/0	0.4799										69	134					IVD (inh=AR pLI=0.00)
chr15	42704105	42704105	C	T	hom		QUAL=35856;DP=376;AF=0.99;MQM=59;TRIO=HOM,376,0.99,HOM,363,1.00,HOM,429,1.00	CAPN3	3'UTR	CAPN3:NM_000070.2:3'UTR:MODIFIER:exon24/24:c.*134C>T:,CAPN3:NM_024344.1:3'UTR:MODIFIER:exon23/23:c.*134C>T:,CAPN3:NM_173087.1:3'UTR:MODIFIER:exon21/21:c.*134C>T:,CAPN3:NM_173088.1:3'UTR:MODIFIER:exon13/13:c.*134C>T:,CAPN3:NM_173089.1:3'UTR:MODIFIER:exon9/9:c.*134C>T:,CAPN3:NM_173090.1:3'UTR:MODIFIER:exon10/10:c.*134C>T:		rs3098423	0.9912	0.0000	0/0/0	0.1807						114240 [CAPN3 (confirmed) Muscular dystrophy,limb-girdle,type 2A];				625	12					CAPN3 (inh=n/a pLI=0.00)
chr15	43212818	43212818	C	G	hom	low_DP	QUAL=888;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,5,1.00,HOM,23,1.00	TTBK2	5'UTR	TTBK2:NM_173500.3:5'UTR:MODIFIER:exon1/15:c.-250G>C:		rs12437637	0.5387	0.0000	0/0/0	0.0956										91	46					TTBK2 (inh=AD pLI=1.00)
chr15	43236612	43236612	C	T	hom		QUAL=18226;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HOM,119,1.00,HOM,174,1.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*915G>A:		rs7178567	0.8442	0.0000	0/0/0	0.1464										189	39					UBR1 (inh=AR pLI=0.32)
chr15	43237203	43237203	T	C	hom		QUAL=11867;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,67,1.00,HOM,86,1.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*324A>G:		rs3803341	0.7869	0.0000	0/0/0	0.1444										187	40					UBR1 (inh=AR pLI=0.32)
chr15	43237414	43237414	C	T	het		QUAL=9199;DP=390;AF=0.49;MQM=60;TRIO=HET,390,0.49,HET,297,0.53,WT,381,0.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*113G>A:		rs62020698	0.0347	0.0000	0/0/0	0.0129										2	39					UBR1 (inh=AR pLI=0.32)
chr15	44943757	44943757	A	G	het		QUAL=21575;DP=339;AF=0.53;MQM=59;TRIO=HET,339,0.53,HOM,374,1.00,HET,464,0.48	SPG11	missense	SPG11:NM_025137.3:missense:MODERATE:exon6/40:c.1388T>C:p.Phe463Ser,SPG11:NM_001160227.1:missense:MODERATE:exon6/38:c.1388T>C:p.Phe463Ser		rs3759871	0.4748	0.4660	13393/7070/1456	0.4628	1.2260	T	T,T,T	B,B,B,B	B,B,B,B	610844 [SPG11 (confirmed) Spastic paraplegia 11,autosomal recessive|Amyotrophic lateral sclerosis 5,juvenile];	RCV000034172.2 [benign]; RCV000118403.2 [likely benign]; 		COSM147894	333	750	1	[1] old entry - no details available			SPG11 (inh=AR pLI=0.00)
chr15	45385496	45385496	A	T	het		QUAL=9616;DP=337;AF=0.47;MQM=60;TRIO=HET,337,0.47,HOM,192,0.99,WT,305,0.00	DUOX2	3'UTR	DUOX2:NM_014080.4:3'UTR:MODIFIER:exon34/34:c.*852T>A:		rs4775744	0.2302	0.0000	0/0/0	0.0206										3	38					DUOX2 (inh=n/a pLI=0.00)
chr15	45392075	45392075	G	A	hom	phylop_high;pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=18718;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HET,313,0.51,HOM,359,1.00	DUOX2	missense	DUOX2:NM_014080.4:missense:MODERATE:exon25/34:c.3200C>T:p.Ser1067Leu		rs269868	0.7202	0.8640	47538/28550/377	0.8378	7.9340	T	D	B	B	606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];		CM085371 [CLASS=DM? MUT=REF PHEN="Hypothyroidism transient" GENE=DUOX2]; 	COSM4148787	922	166	2	[2] old entry - no details available			DUOX2 (inh=n/a pLI=0.00)
chr15	45400358	45400358	C	G	hom		QUAL=15127;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,126,1.00,HOM,219,1.00	DUOX2	synonymous	DUOX2:NM_014080.4:synonymous:LOW:exon13/34:c.1461G>C:p.Gly487Gly		rs269860	0.8614	0.9410	54417/31502/1980	0.9115						606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];			COSM4148789	1052	51					DUOX2 (inh=n/a pLI=0.00)
chr15	45404066	45404066	G	A	hom	low_DP;phylop_high	QUAL=1615;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HET,19,0.53,HOM,33,1.00	DUOX2	missense	DUOX2:NM_014080.4:missense:MODERATE:exon5/34:c.413C>T:p.Pro138Leu		rs2001616	0.7600	0.8600	45622/26862/943	0.8538	2.4090	T	T	B	B	606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];			COSM4148790	885	197					DUOX2 (inh=n/a pLI=0.00)
chr15	45408414	45408414	C	G	hom	phylop_high	QUAL=28364;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,301,1.00,HOM,398,1.00	DUOXA2	missense	DUOXA2:NM_207581.3:missense:MODERATE:exon3/6:c.298C>G:p.Arg100Gly		rs2576090	0.8584	0.9610	56765/33327/1497	0.9217	7.3630	T	T	B	B	612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				1097	6					DUOXA2 (inh=AR pLI=0.00)
chr15	45408710	45408710	A	G	hom		QUAL=11425;DP=106;AF=1.00;MQM=59;TRIO=HOM,106,1.00,HOM,122,1.00,HOM,151,1.00	DUOXA2	splice_region&intron	DUOXA2:NM_207581.3:splice_region&intron:LOW:exon3/5:c.341-4A>G:		rs2554459	0.9203	0.9810	58282/33236/3025	0.8969						612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				1099	8					DUOXA2 (inh=AR pLI=0.00)
chr15	45408933	45408933	T	C	hom		QUAL=10075;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HET,124,0.55,HOM,183,1.00	DUOXA2	splice_region&intron	DUOXA2:NM_207581.3:splice_region&intron:LOW:exon4/5:c.554+6T>C:		rs2576092	0.7642	0.8710	46739/27701/817	0.8572						612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				903	185					DUOXA2 (inh=AR pLI=0.00)
chr15	48580713	48580713	T	C	hom		QUAL=23445;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,151,1.00,HOM,238,1.00	SLC12A1	missense&splice_region	SLC12A1:NM_000338.2:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala,SLC12A1:NM_001184832.1:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala		rs1552311	0.9978	0.9980	13825/6167/1679	0.7480	1.0800	T	T,T	B,B	B,B	600839 [SLC12A1 (confirmed) Bartter syndrome,type 1];				1103	0					SLC12A1 (inh=n/a pLI=0.00)
chr15	48595192	48595192	G	T	hom		QUAL=19221;DP=330;AF=1.00;MQM=60;TRIO=HOM,330,1.00,HET,150,0.51,HOM,193,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*110G>T:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*110G>T:		rs8025278	0.7352	0.0000	0/0/0	0.1721										208	22					SLC12A1 (inh=n/a pLI=0.00)
chr15	48595366	48595366	A	G	hom		QUAL=18065;DP=278;AF=0.99;MQM=60;TRIO=HOM,278,0.99,HET,143,0.49,HOM,218,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*284A>G:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*284A>G:		rs12902028	0.6961	0.0000	0/0/0	0.1456										211	18					SLC12A1 (inh=n/a pLI=0.00)
chr15	48596166	48596166	A	T	hom		QUAL=13630;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,96,1.00,HOM,128,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*1084A>T:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*1084A>T:		rs12438818	0.8207	0.0000	0/0/0	0.1527										218	12					SLC12A1 (inh=n/a pLI=0.00)
chr15	48701029	48701029	C	T	hom		QUAL=26474;DP=399;AF=1.00;MQM=59;TRIO=HOM,399,1.00,HOM,183,0.99,HOM,221,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*2158G>A:		rs11070641	0.7823	0.0000	0/0/0	0.7994										140	75					FBN1 (inh=n/a pLI=1.00)
chr15	48701612	48701612	A	C	hom		QUAL=31868;DP=416;AF=1.00;MQM=60;TRIO=HOM,416,1.00,HOM,254,1.00,HOM,324,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*1575T>G:		rs4775760	0.6569	0.0000	0/0/0	0.7346										138	77					FBN1 (inh=n/a pLI=1.00)
chr15	48702457	48702457	C	A	hom		QUAL=37677;DP=408;AF=1.00;MQM=59;TRIO=HOM,408,1.00,HOM,323,1.00,HOM,408,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*730G>T:		rs13598	0.9193	0.0000	0/0/0	0.1412										183	45					FBN1 (inh=n/a pLI=1.00)
chr15	48702873	48702873	G	A	hom		QUAL=52448;DP=607;AF=1.00;MQM=59;TRIO=HOM,607,1.00,HOM,437,1.00,HOM,555,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*314C>T:		rs1042078	0.6000	0.0000	0/0/0	0.6823										117	94					FBN1 (inh=n/a pLI=1.00)
chr15	48807637	48807637	C	T	hom	phylop_high	QUAL=34238;DP=399;AF=0.99;MQM=59;TRIO=HOM,399,0.99,HOM,299,1.00,HOM,396,1.00	FBN1	missense	FBN1:NM_000138.4:missense:MODERATE:exon12/66:c.1415G>A:p.Cys472Tyr		rs4775765	1.0000	1.0000	60683/33360/5200	0.9362	5.9640	T	T	B	B	134797 [FBN1 (confirmed) Marfan syndrome|Ectopia lentis,familial|MASS syndrome|Weill-Marchesani syndrome 2,dominant|Aortic aneurysm,ascending,and dissection|Stiff skin syndrome|Acromicric dysplasia|Geleophysic dysplasia 2];	RCV000223162.1 [not provided]; 			1153	0					FBN1 (inh=n/a pLI=1.00)
chr15	48902965	48902965	G	A	het		QUAL=7462;DP=364;AF=0.45;MQM=60;TRIO=HET,364,0.45,WT,187,0.00,HET,238,0.51	FBN1	synonymous	FBN1:NM_000138.4:synonymous:LOW:exon4/66:c.306C>T:p.Cys102Cys		rs25388	0.0008	0.0041	2/2/0	0.0039						134797 [FBN1 (confirmed) Marfan syndrome|Ectopia lentis,familial|MASS syndrome|Weill-Marchesani syndrome 2,dominant|Aortic aneurysm,ascending,and dissection|Stiff skin syndrome|Acromicric dysplasia|Geleophysic dysplasia 2];	RCV000154417.2 [benign]; 			0	5					FBN1 (inh=n/a pLI=1.00)
chr15	49044538	49044538	C	G	hom		QUAL=11290;DP=183;AF=1.00;MQM=60;TRIO=HOM,183,1.00,HET,176,0.52,HET,215,0.58	CEP152	splice_region&intron	CEP152:NM_001194998.1:splice_region&intron:LOW:exon21/26:c.3466+8G>C:,CEP152:NM_014985.3:splice_region&intron:LOW:exon21/25:c.3466+8G>C:		rs2306187	0.3247	0.1990	3511/562/1308	0.1967						613529 [CEP152 (provisional) Microcephaly 9,primary,autosomal recessive|Seckel syndrome 5];	RCV000081686.6 [benign]; 			21	249					CEP152 (inh=AR pLI=0.00)
chr15	49103244	49103244	T	C	hom		QUAL=9220;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HET,133,0.50,HET,177,0.47	CEP152	5'UTR	CEP152:NM_001194998.1:5'UTR:MODIFIER:exon1/27:c.-94A>G:,CEP152:NM_014985.3:5'UTR:MODIFIER:exon1/26:c.-94A>G:		rs2304546	0.1971	0.0000	0/0/0	0.1476										0	23					CEP152 (inh=AR pLI=0.00)
chr15	51296015	51296015	G	A	het		QUAL=6371;DP=300;AF=0.47;MQM=60;TRIO=HET,300,0.47,WT,117,0.00,HET,184,0.50	AP4E1	3'UTR	AP4E1:NM_007347.4:3'UTR:MODIFIER:exon21/21:c.*1156G>A:,AP4E1:NM_001252127.1:3'UTR:MODIFIER:exon21/21:c.*1156G>A:		rs2619685	0.1566	0.0000	0/0/0	0.0270										4	65					AP4E1 (inh=AR pLI=0.98)
chr15	52601750	52601750	A	G	hom		QUAL=38808;DP=377;AF=1.00;MQM=59;TRIO=HOM,377,1.00,HOM,396,1.00,HOM,436,1.00	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*4143T>C:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*4143T>C:		rs2414136	0.9770	0.0000	0/0/0	0.1485										224	1					MYO5A (inh=AR pLI=0.99)
chr15	52603363	52603363	G	A	hom		QUAL=25234;DP=487;AF=0.99;MQM=59;TRIO=HOM,487,0.99,HET,347,0.48,HET,452,0.47	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*2530C>T:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*2530C>T:		rs7176482	0.3063	0.0000	0/0/0	0.0817										74	108					MYO5A (inh=AR pLI=0.99)
chr15	52604136	52604136	-	TTTGTCATT	hom		QUAL=11039;DP=229;AF=0.97;MQM=59;TRIO=HOM,229,0.97,HOM,41,1.00,HOM,62,0.98	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*1756_*1757insAATGACAAA:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*1756_*1757insAATGACAAA:		rs11282676	0.9766	0.0000	0/0/0	0.8231										220	10					MYO5A (inh=AR pLI=0.99)
chr15	52667552	52667552	G	A	hom		QUAL=30002;DP=395;AF=1.00;MQM=59;TRIO=HOM,395,1.00,HOM,237,1.00,HOM,285,1.00	MYO5A	synonymous	MYO5A:NM_000259.3:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile,MYO5A:NM_001142495.1:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile		rs2414145	0.8446	0.9510	55390/33103/1738	0.9188						160777 [MYO5A (confirmed) Griscelli syndrome,type 1];				1080	27					MYO5A (inh=AR pLI=0.99)
chr15	52689526	52689526	T	C	hom		QUAL=34585;DP=389;AF=0.99;MQM=59;TRIO=HOM,389,0.99,HOM,287,1.00,HOM,389,1.00	MYO5A	synonymous	MYO5A:NM_000259.3:synonymous:LOW:exon10/41:c.1191A>G:p.Thr397Thr,MYO5A:NM_001142495.1:synonymous:LOW:exon10/40:c.1191A>G:p.Thr397Thr		rs2924130	0.9617	0.9890	59189/33361/3794	0.9229						160777 [MYO5A (confirmed) Griscelli syndrome,type 1];				1109	1					MYO5A (inh=AR pLI=0.99)
chr15	52689631	52689631	T	G	hom		QUAL=22056;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,214,1.00,HOM,309,1.00	MYO5A	missense	MYO5A:NM_000259.3:missense:MODERATE:exon10/41:c.1086A>C:p.Glu362Asp,MYO5A:NM_001142495.1:missense:MODERATE:exon10/40:c.1086A>C:p.Glu362Asp		rs1724577	0.8868	0.9630	56334/33115/2483	0.9298	-0.1140	T	T,T,T,T,T	B,B	B,B	160777 [MYO5A (confirmed) Griscelli syndrome,type 1];			COSM4128296, COSM4128297	1086	21					MYO5A (inh=AR pLI=0.99)
chr15	55495545	55495545	T	C	het		QUAL=8724;DP=396;AF=0.49;MQM=59;TRIO=HET,396,0.49,WT,193,0.00,HET,247,0.50	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*2160A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:		rs62020099	0.0036	0.0000	0/0/0	0.0015										0	3					RAB27A (inh=AR pLI=0.00)
chr15	55495698	55495698	C	T	het	low_MQM	QUAL=2225;DP=143;AF=0.48;MQM=43;TRIO=HET,143,0.48,HET,70,0.47,WT,128,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*2007G>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:	AluY	rs6493769	0.2654	0.0000	0/0/0	0.1887										6	43					RAB27A (inh=AR pLI=0.00)
chr15	55495774	55495774	A	G	het		QUAL=1105;DP=84;AF=0.37;MQM=51;TRIO=HET,84,0.37,HET,53,0.43,WT,90,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1931T>C:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:	AluY	rs6493770	0.2652	0.0000	0/0/0	0.1014										6	43					RAB27A (inh=AR pLI=0.00)
chr15	55495779	55495779	A	T	het		QUAL=1168;DP=59;AF=0.42;MQM=54;TRIO=HET,59,0.42,HET,38,0.45,WT,72,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1926T>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:	AluY	rs8028801	0.2656	0.0000	0/0/0	0.0867										6	43					RAB27A (inh=AR pLI=0.00)
chr15	55495782	55495782	-	TTA	het		QUAL=1168;DP=59;AF=0.42;MQM=54;TRIO=HET,59,0.42,HET,38,0.45,WT,72,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1922_*1923insTAA:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:	AluY	rs555244731	0.0000	0.0000	0/0/0	0.0270										3	38					RAB27A (inh=AR pLI=0.00)
chr15	55495786	55495786	T	A	het		QUAL=1161;DP=89;AF=0.31;MQM=54;TRIO=HET,89,0.31,HET,61,0.34,WT,81,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1919A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:	AluY	rs867969605	0.0000	0.0000	0/0/0	0.0002										3	42					RAB27A (inh=AR pLI=0.00)
chr15	55495790	55495790	T	A	het		QUAL=1161;DP=89;AF=0.31;MQM=54;TRIO=HET,89,0.31,HET,61,0.34,WT,81,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1915A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:	AluY		0.0000	0.0000	0/0/0	0.0002										2	38					RAB27A (inh=AR pLI=0.00)
chr15	55495801	55495801	T	A	het		QUAL=1668;DP=95;AF=0.46;MQM=51;TRIO=HET,95,0.46,HET,60,0.55,WT,69,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1904A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:	AluY	rs28620827	0.0000	0.0000	0/0/0	0.0259										4	45					RAB27A (inh=AR pLI=0.00)
chr15	55495963	55495963	T	C	het		QUAL=5457;DP=288;AF=0.45;MQM=59;TRIO=HET,288,0.45,HET,174,0.49,WT,269,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1742A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:		rs1061824	0.2652	0.0000	0/0/0	0.0334										9	44					RAB27A (inh=AR pLI=0.00)
chr15	55496043	55496043	T	A	het		QUAL=3034;DP=138;AF=0.48;MQM=60;TRIO=HET,138,0.48,HET,122,0.47,WT,176,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1662A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:		rs1061823	0.2654	0.0000	0/0/0	0.0314										9	45					RAB27A (inh=AR pLI=0.00)
chr15	55496058	55496058	A	C	het		QUAL=2922;DP=141;AF=0.46;MQM=60;TRIO=HET,141,0.46,HET,112,0.47,WT,161,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1647T>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:		rs1061822	0.2654	0.0000	0/0/0	0.0332										10	44					RAB27A (inh=AR pLI=0.00)
chr15	55496111	55496111	T	C	het		QUAL=2898;DP=196;AF=0.41;MQM=60;TRIO=HET,196,0.41,HET,66,0.50,WT,91,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1594A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:		rs1061821	0.2652	0.0000	0/0/0	0.0327										7	45					RAB27A (inh=AR pLI=0.00)
chr15	55496278	55496278	C	T	het		QUAL=3459;DP=205;AF=0.53;MQM=59;TRIO=HET,205,0.53,HET,44,0.50,WT,60,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1427G>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:		rs1061875	0.2652	0.0000	0/0/0	0.0320										9	63					RAB27A (inh=AR pLI=0.00)
chr15	55496287	55496287	A	T	het		QUAL=3189;DP=186;AF=0.51;MQM=59;TRIO=HET,186,0.51,HET,46,0.50,WT,58,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1418T>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:		rs1061874	0.2654	0.0000	0/0/0	0.0322										9	63					RAB27A (inh=AR pLI=0.00)
chr15	55496756	55496756	T	C	het		QUAL=6441;DP=344;AF=0.47;MQM=60;TRIO=HET,344,0.47,HET,178,0.46,WT,247,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*949A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:		rs1061873	0.2650	0.0000	0/0/0	0.0334										9	63					RAB27A (inh=AR pLI=0.00)
chr15	55496769	55496769	G	T	het		QUAL=6403;DP=335;AF=0.46;MQM=60;TRIO=HET,335,0.46,HET,176,0.47,WT,265,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*936C>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:		rs1061870	0.2652	0.0000	0/0/0	0.0334										9	63					RAB27A (inh=AR pLI=0.00)
chr15	55496853	55496853	G	A	het		QUAL=4364;DP=264;AF=0.46;MQM=60;TRIO=HET,264,0.46,HET,112,0.47,WT,204,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*852C>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:		rs3179664	0.3267	0.0000	0/0/0	0.0365										10	63					RAB27A (inh=AR pLI=0.00)
chr15	55497691	55497691	G	A	het		QUAL=10480;DP=537;AF=0.47;MQM=60;TRIO=HET,537,0.47,HET,358,0.45,WT,399,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*14C>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:		rs1050931	0.2648	0.2010	3129/1157/1301	0.1965									COSN164951	28	152					RAB27A (inh=AR pLI=0.00)
chr15	65369395	65369395	C	T	hom	low_DP;phylop_high	QUAL=293;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HOM,11,1.00,WT,14,0.00	KBTBD13	missense	KBTBD13:NM_001101362.2:missense:MODERATE:exon1/1:c.242C>T:p.Ala81Val		rs2919358	0.5218	0.2830	814/220/49	0.1895	7.2510	T	T	P	P	613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117309.1 [benign]; 		COSM3749303	183	437					KBTBD13 (inh=n/a pLI=0.00)
chr15	65369531	65369531	G	T	het	low_DP	QUAL=472;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,17,1.00,WT,14,0.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.378G>T:p.Ala126Ala		rs2946642	0.5016	0.2990	763/201/35	0.1697						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117310.1 [benign]; 		COSM3754413	189	444					KBTBD13 (inh=n/a pLI=0.00)
chr15	65369951	65369951	A	G	hom		QUAL=3542;DP=21;AF=1.00;MQM=59;TRIO=HOM,21,1.00,HOM,43,1.00,HOM,54,1.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.798A>G:p.Glu266Glu		rs2919359	0.9038	0.8600	30318/15899/1992	0.7621						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117312.1 [benign]; 		COSM3749304	821	235					KBTBD13 (inh=n/a pLI=0.00)
chr15	65370353	65370353	T	C	hom		QUAL=16649;DP=113;AF=0.99;MQM=59;TRIO=HOM,113,0.99,HOM,183,1.00,HOM,257,1.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.1200T>C:p.Gly400Gly		rs2919360	0.9894	0.9950	55898/30708/3823	0.9146						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117308.1 [benign]; 		COSM3754414	1085	11					KBTBD13 (inh=n/a pLI=0.00)
chr15	65370652	65370652	T	C	het		QUAL=14467;DP=352;AF=0.51;MQM=59;TRIO=HET,352,0.51,WT,284,0.00,HOM,329,0.98	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*122T>C:		rs12901617	0.3908	0.0000	0/0/0	0.4272										36	77					KBTBD13 (inh=n/a pLI=0.00)
chr15	65370835	65370835	C	T	hom		QUAL=23617;DP=305;AF=1.00;MQM=59;TRIO=HOM,305,1.00,HOM,192,1.00,HOM,270,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*305C>T:		rs2946643	0.8894	0.0000	0/0/0	0.7833										121	23					KBTBD13 (inh=n/a pLI=0.00)
chr15	65371050	65371050	A	G	het		QUAL=14560;DP=420;AF=0.49;MQM=60;TRIO=HET,420,0.49,WT,157,0.00,HOM,281,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*520A>G:		rs12904843	0.3433	0.0000	0/0/0	0.3896										29	83					KBTBD13 (inh=n/a pLI=0.00)
chr15	65371427	65371427	A	G	het		QUAL=16453;DP=287;AF=0.51;MQM=60;TRIO=HET,287,0.51,WT,304,0.01,HOM,419,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*897A>G:		rs12905499	0.3832	0.0000	0/0/0	0.4069										31	81					KBTBD13 (inh=n/a pLI=0.00)
chr15	68499321	68499321	T	C	het		QUAL=1317;DP=39;AF=0.49;MQM=60;TRIO=HET,39,0.49,HOM,21,1.00,HET,28,0.39	CALML4-CLN6	intergenic_region	CALML4-CLN6:CALML4-CLN6:intergenic_region:MODIFIER::n.68499321T>C:		rs8028241	0.4842	0.0000	0/0/0	0.4951										66	115					CALML4-CLN6 (inh=n/a pLI=n/a)
chr15	68499661	68499661	G	A	het	low_DP	QUAL=353;DP=16;AF=0.50;MQM=60;TRIO=HET,16,0.50,HOM,7,1.00,WT,2,0.00	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*817C>T:		rs8142	0.4050	0.0000	0/0/0	0.0793										62	101					CLN6 (inh=AR pLI=0.38)
chr15	68500317	68500317	-	AC	het		QUAL=6602;DP=98;AF=0.51;MQM=59;TRIO=HET,98,0.51,WT,106,0.93,HET,157,0.52	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*159_*160dupGT:	(CA)n	rs138882836;rs201282122;rs765543395;rs780072735	0.3345	0.0000	0/0/0	0.2518										29	165					CLN6 (inh=AR pLI=0.38)
chr15	68500318	68500321	ACAC	-	het		QUAL=6602;DP=98;AF=0.32;MQM=59;TRIO=HET,98,0.32,HOM,106,0.00,HET,157,0.35	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*157_*160delGTGT:	(CA)n	rs141886537;rs748086627;rs780072735	0.0000	0.0000	0/0/0	0.2620										106	136					CLN6 (inh=AR pLI=0.38)
chr15	72635829	72635829	A	C	hom		QUAL=8020;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HOM,53,1.00,HOM,61,1.00	HEXA	3'UTR	HEXA:NM_001318825.1:3'UTR:MODIFIER:exon14/14:c.*589T>G:,HEXA:NM_000520.5:3'UTR:MODIFIER:exon14/14:c.*589T>G:		rs11629508	0.6933	0.0000	0/0/0	0.1426										200	30					HEXA (inh=AR pLI=0.00)
chr15	72635903	72635903	C	T	hom		QUAL=9523;DP=122;AF=0.99;MQM=60;TRIO=HOM,122,0.99,HOM,85,1.00,HOM,101,1.00	HEXA	3'UTR	HEXA:NM_001318825.1:3'UTR:MODIFIER:exon14/14:c.*515G>A:,HEXA:NM_000520.5:3'UTR:MODIFIER:exon14/14:c.*515G>A:		rs3087652	0.6929	0.0000	0/0/0	0.1428										200	30					HEXA (inh=AR pLI=0.00)
chr15	72637795	72637795	T	C	hom		QUAL=21227;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,205,1.00,HOM,216,1.00	HEXA	synonymous,non_coding_exon	HEXA:NM_001318825.1:synonymous:LOW:exon13/14:c.1551A>G:p.Glu517Glu,HEXA:NM_000520.5:synonymous:LOW:exon13/14:c.1518A>G:p.Glu506Glu,HEXA:NR_134869.1:non_coding_exon:MODIFIER:exon11/11:n.1762A>G:		rs4777502	0.8770	0.9640	57123/33251/1969	0.9432						606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];	RCV000079051.7 [other]; 			2790	32					HEXA (inh=AR pLI=0.00)
chr15	72638892	72638892	T	C	hom		QUAL=7793;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,58,1.00,HOM,93,1.00	HEXA	missense,intron	HEXA:NM_001318825.1:missense:MODERATE:exon11/14:c.1339A>G:p.Ile447Val,HEXA:NM_000520.5:missense:MODERATE:exon11/14:c.1306A>G:p.Ile436Val,HEXA:NR_134869.1:intron:MODIFIER:exon9/10:n.1575-226A>G:		rs1800431	0.8764	0.9640	57089/33227/1971	0.9339	-0.2020	T	T,T	B,B	B,B	606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];	RCV000079049.7 [other]; 			2788	33					HEXA (inh=AR pLI=0.00)
chr15	72668304	72668304	A	G	het	pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=4138;DP=126;AF=0.52;MQM=59;TRIO=HET,126,0.52,WT,183,0.01,HET,227,0.47	HEXA	missense,non_coding_exon	HEXA:NM_001318825.1:missense:MODERATE:exon1/14:c.10T>C:p.Ser4Pro,HEXA:NM_000520.5:missense:MODERATE:exon1/14:c.10T>C:p.Ser4Pro,HEXA:NR_134869.1:non_coding_exon:MODIFIER:exon1/11:n.511T>C:		rs146938346	0.0000	0.0001	0/0/0	0.0001	-0.1370	D	T	P,P	B,B	606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];		CM045965 [CLASS=DM? MUT=ALT PHEN="Beta-hexosaminidase pseudodeficiency" GENE=HEXA]; 		0	7					HEXA (inh=AR pLI=0.00)
chr15	72978552	72978552	C	T	het		QUAL=2373;DP=121;AF=0.31;MQM=60;TRIO=HET,121,0.31,HET,82,0.56,HET,81,0.43	BBS4	5'UTR,non_coding_exon	BBS4:NM_033028.4:5'UTR:MODIFIER:exon1/16:c.-17C>T:,BBS4:NM_001252678.1:5'UTR:MODIFIER:exon1/15:c.-486C>T:,BBS4:NR_045565.1:non_coding_exon:MODIFIER:exon1/17:n.33C>T:,BBS4:NR_045566.1:non_coding_exon:MODIFIER:exon1/16:n.33C>T:		rs56368716	0.0375	0.0410	94/83/0	0.0402							RCV000020935.2 [benign]; RCV000173544.1 [benign]; 			6	168					BBS4 (inh=AR pLI=0.00)
chr15	73002035	73002035	G	A	hom		QUAL=24132;DP=294;AF=1.00;MQM=59;TRIO=HOM,294,1.00,HOM,208,1.00,HOM,244,1.00	BBS4	splice_region&intron	BBS4:NM_033028.4:splice_region&intron:LOW:exon2/15:c.77-6G>A:,BBS4:NM_001252678.1:splice_region&intron:LOW:exon1/14:c.-445-6G>A:,BBS4:NR_045565.1:splice_region&intron:LOW:exon3/16:n.184-6G>A:,BBS4:NR_045566.1:splice_region&intron:LOW:exon2/15:n.439-6G>A:		rs8033604	0.9421	0.9830	58833/33340/3448	0.9549						600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];				1097	10					BBS4 (inh=AR pLI=0.00)
chr15	73023937	73023937	T	C	hom		QUAL=40926;DP=372;AF=1.00;MQM=60;TRIO=HOM,372,1.00,HOM,388,1.00,HOM,482,1.00	BBS4	synonymous,non_coding_exon	BBS4:NM_033028.4:synonymous:LOW:exon12/16:c.906T>C:p.Phe302Phe,BBS4:NM_001252678.1:synonymous:LOW:exon11/15:c.390T>C:p.Phe130Phe,BBS4:NR_045565.1:non_coding_exon:MODIFIER:exon13/17:n.1013T>C:,BBS4:NR_045566.1:non_coding_exon:MODIFIER:exon12/16:n.1268T>C:		rs12914333	0.9605	0.9870	59279/33354/3854	0.9501						600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];	RCV000152839.3 [benign]; 			1098	8					BBS4 (inh=AR pLI=0.00)
chr15	73027478	73027478	T	C	hom		QUAL=31562;DP=376;AF=1.00;MQM=59;TRIO=HOM,376,1.00,HET,345,0.53,HOM,430,1.00	BBS4	missense,non_coding_exon	BBS4:NM_033028.4:missense:MODERATE:exon13/16:c.1061T>C:p.Ile354Thr,BBS4:NM_001252678.1:missense:MODERATE:exon12/15:c.545T>C:p.Ile182Thr,BBS4:NR_045565.1:non_coding_exon:MODIFIER:exon14/17:n.1168T>C:,BBS4:NR_045566.1:non_coding_exon:MODIFIER:exon13/16:n.1423T>C:		rs2277598	0.4289	0.5730	21186/14353/508	0.5651	-0.2460	T	T,T,T,T	B,B,B,B	B,B,B,B	600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];	RCV000020938.2 [benign]; RCV000132688.1 [likely benign]; RCV000152842.3 [benign]; 	CM1010466 [CLASS=FP MUT=REF PHEN="Altered function" GENE=BBS4]; 	COSM3999597, COSM3999596	448	503					BBS4 (inh=AR pLI=0.00)
chr15	74472199	74472199	C	T	hom		QUAL=20115;DP=265;AF=0.99;MQM=59;TRIO=HOM,265,0.99,HOM,234,1.00,HET,330,0.51	STRA6	3'UTR	STRA6:NM_001199042.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_022369.3:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142618.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001199041.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142617.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142619.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001199040.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:		rs10910	0.5327	0.0000	0/0/0	0.6346										120	95					STRA6 (inh=AR pLI=0.00)
chr15	74476340	74476340	G	C	het		QUAL=5824;DP=70;AF=0.54;MQM=60;TRIO=HET,70,0.54,WT,134,0.00,HOM,174,0.99	STRA6	splice_region&intron	STRA6:NM_001199042.1:splice_region&intron:LOW:exon13/18:c.1284-10C>G:,STRA6:NM_022369.3:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001142618.1:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001199041.1:splice_region&intron:LOW:exon13/18:c.1212-10C>G:,STRA6:NM_001142617.1:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001142619.1:splice_region&intron:LOW:exon13/18:c.1140-10C>G:,STRA6:NM_001199040.1:splice_region&intron:LOW:exon13/18:c.1278-10C>G:		rs2277608	0.2081	0.1950	2696/770/44	0.1899						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];			COSM147951	36	299					STRA6 (inh=AR pLI=0.00)
chr15	74487024	74487024	A	G	het		QUAL=19397;DP=386;AF=0.50;MQM=60;TRIO=HET,386,0.50,WT,324,0.00,HOM,449,1.00	STRA6	3'UTR,intron	STRA6:NM_001142620.1:3'UTR:MODIFIER:exon6/6:c.*919T>C:,STRA6:NM_001199042.1:intron:MODIFIER:exon7/18:c.714+619T>C:,STRA6:NM_022369.3:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001142618.1:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001199041.1:intron:MODIFIER:exon7/18:c.642+619T>C:,STRA6:NM_001142617.1:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001142619.1:intron:MODIFIER:exon7/18:c.570+619T>C:,STRA6:NM_001199040.1:intron:MODIFIER:exon7/18:c.708+619T>C:	L2a	rs58138979	0.0531	0.0000	0/0/0	0.0928						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				5	36					STRA6 (inh=AR pLI=0.00)
chr15	74487036	74487036	T	A	het		QUAL=20211;DP=377;AF=0.51;MQM=59;TRIO=HET,377,0.51,WT,322,0.00,HOM,474,1.00	STRA6	3'UTR,intron	STRA6:NM_001142620.1:3'UTR:MODIFIER:exon6/6:c.*907A>T:,STRA6:NM_001199042.1:intron:MODIFIER:exon7/18:c.714+607A>T:,STRA6:NM_022369.3:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001142618.1:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001199041.1:intron:MODIFIER:exon7/18:c.642+607A>T:,STRA6:NM_001142617.1:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001142619.1:intron:MODIFIER:exon7/18:c.570+607A>T:,STRA6:NM_001199040.1:intron:MODIFIER:exon7/18:c.708+607A>T:	L2a	rs351224	0.4922	0.0000	0/0/0	0.4899						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				45	95					STRA6 (inh=AR pLI=0.00)
chr15	74495556	74495557	TG	-	het		QUAL=698;DP=52;AF=0.46;MQM=60;TRIO=HET,52,0.46,HOM,10,1.00,WT,11,0.00	STRA6	5'UTR,intron,non_coding_transcript	STRA6:NM_001142618.1:5'UTR:MODIFIER:exon1/19:c.-949_-228delCA:,STRA6:NM_001199041.1:intron:MODIFIER:exon1/18:c.31-934_31-933delCA:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.97-934_97-933delCA:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-15-934_-15-933delCA:,STRA6:NM_001142618.1:non_coding_transcript:MODIFIER:exon15/19:c.-949_-228delCA:		rs148745262;rs372268345	0.2927	0.0000	0/0/0	0.2738						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				25	104					STRA6 (inh=AR pLI=0.00)
chr15	74500105	74500105	G	A	het		QUAL=7501;DP=268;AF=0.49;MQM=59;TRIO=HET,268,0.49,HET,363,0.50,WT,426,0.00	STRA6	5'UTR_premature_start_codon_gain,5'UTR,intron	STRA6:NM_001199041.1:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-38C>T:,STRA6:NM_001199041.1:5'UTR:MODIFIER:exon1/19:c.-38C>T:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.96+1595C>T:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-16+1036C>T:		rs12915846	0.1999	0.1660	269/71/2	0.0586						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				18	104					STRA6 (inh=AR pLI=0.00)
chr15	74500238	74500238	C	T	het		QUAL=10287;DP=262;AF=0.50;MQM=59;TRIO=HET,262,0.50,HET,609,0.48,WT,686,0.00	STRA6	5'UTR,intron	STRA6:NM_001199041.1:5'UTR:MODIFIER:exon1/19:c.-171G>A:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.96+1462G>A:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-16+903G>A:		rs10152959	0.2260	0.0000	0/0/0	0.2443						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				11	75					STRA6 (inh=AR pLI=0.00)
chr15	74658315	74658315	-	A	hom	low_DP	QUAL=2609;DP=12;AF=0.83;MQM=60;TRIO=HOM,12,0.83,HOM,42,1.00,HOM,48,1.00	CYP11A1	5'UTR,intron	CYP11A1:NM_001099773.1:5'UTR:MODIFIER:exon1/9:c.-465dupT:,CYP11A1:NM_000781.2:intron:MODIFIER:exon1/8:c.269+1342dupT:		rs386383486;rs79534403	0.9998	0.0000	0/0/0	0.9136						118485 [CYP11A1 (confirmed) Adrenal insufficiency,congenital,with 46XY sex reversal,partial or complete];				221	2					CYP11A1 (inh=n/a pLI=0.00)
chr15	75185670	75185670	A	G	het		QUAL=6205;DP=104;AF=0.52;MQM=60;TRIO=HET,104,0.52,HOM,162,1.00,WT,189,0.00	MPI	splice_region&intron,intron	MPI:NM_002435.2:splice_region&intron:LOW:exon5/7:c.670+9A>G:,MPI:NM_001289155.1:splice_region&intron:LOW:exon5/6:c.670+9A>G:,MPI:NM_001289156.1:splice_region&intron:LOW:exon4/6:c.520+9A>G:,MPI:NM_001289157.1:intron:MODIFIER:exon4/6:c.487+527A>G:		rs7495739	0.3383	0.4360	12640/9238/543	0.4431						154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib];	RCV000080014.4 [benign]; 		COSM4128400	238	551					MPI (inh=n/a pLI=0.00)
chr15	75189930	75189930	A	G	het		QUAL=5925;DP=182;AF=0.47;MQM=60;TRIO=HET,182,0.47,HOM,124,0.99,WT,195,0.00	MPI	synonymous,3'UTR	MPI:NM_002435.2:synonymous:LOW:exon8/8:c.1131A>G:p.Val377Val,MPI:NM_001289156.1:synonymous:LOW:exon7/7:c.981A>G:p.Val327Val,MPI:NM_001289157.1:synonymous:LOW:exon7/7:c.948A>G:p.Val316Val,MPI:NM_001289155.1:3'UTR:MODIFIER:exon7/7:c.*58A>G:		rs1130741	0.3387	0.4370	12747/9315/548	0.4438						154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib];	RCV000080011.4 [benign]; 			239	551					MPI (inh=n/a pLI=0.00)
chr15	76508684	76508684	T	A	hom		QUAL=14989;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,107,1.00,HOM,137,1.00	ETFA	3'UTR	ETFA:NM_000126.3:3'UTR:MODIFIER:exon12/12:c.*216A>T:,ETFA:NM_001127716.1:3'UTR:MODIFIER:exon11/11:c.*216A>T:		rs1803550	0.9742	0.0000	0/0/0	0.9005										229	0					ETFA (inh=n/a pLI=0.01)
chr15	76673716	76673716	T	C	het		QUAL=6918;DP=189;AF=0.54;MQM=60;TRIO=HET,189,0.54,HOM,145,0.99,WT,186,0.00	SCAPER	splice_region&intron	SCAPER:NM_020843.2:splice_region&intron:LOW:exon27/30:c.3705+3A>G:,SCAPER:NM_001145923.1:splice_region&intron:LOW:exon28/31:c.2967+3A>G:		rs3765115	0.4157	0.3660	8160/3189/383	0.3609										100	287					SCAPER (inh=n/a pLI=0.04)
chr15	76726465	76726465	G	T	het		QUAL=5853;DP=228;AF=0.45;MQM=60;TRIO=HET,228,0.45,HOM,115,1.00,WT,202,0.00	SCAPER	missense	SCAPER:NM_020843.2:missense:MODERATE:exon25/31:c.3265C>A:p.Pro1089Thr,SCAPER:NM_001145923.1:missense:MODERATE:exon26/32:c.2527C>A:p.Pro843Thr		rs1607017	0.3560	0.3500	8098/3389/78	0.3452	0.6870	T	T,T,.	B,B	B,B					98	279					SCAPER (inh=n/a pLI=0.04)
chr15	77085740	77085740	C	A	hom		QUAL=14755;DP=104;AF=1.00;MQM=60;TRIO=HOM,104,1.00,HOM,175,1.00,HOM,196,1.00	SCAPER	splice_region&intron,intron	SCAPER:NM_001145923.1:splice_region&intron:LOW:exon7/31:c.-125-8G>T:,SCAPER:NM_020843.2:intron:MODIFIER:exon7/30:c.772+1881G>T:	MER21B	rs3102707	0.9673	0.0000	0/0/0	0.9065										150	0					SCAPER (inh=n/a pLI=0.04)
chr15	77087785	77087785	T	C	het		QUAL=2918;DP=109;AF=0.50;MQM=60;TRIO=HET,109,0.50,HOM,55,1.00,WT,66,0.00	SCAPER	splice_region&intron	SCAPER:NM_020843.2:splice_region&intron:LOW:exon6/30:c.612-4A>G:,SCAPER:NM_001145923.1:splice_region&intron:LOW:exon6/31:c.-286-4A>G:		rs11852395	0.3532	0.3340	7222/2797/110	0.3273										82	274					SCAPER (inh=n/a pLI=0.04)
chr15	77176158	77176158	T	C	het	anno_high_impact;phylop_high	QUAL=4564;DP=159;AF=0.39;MQM=60;TRIO=HET,159,0.39,HOM,96,0.99,WT,124,0.00	SCAPER	start_lost	SCAPER:NM_020843.2:start_lost:HIGH:exon1/31:c.1A>G:p.Met1?		rs3812908	0.4177	0.3120	4526/1605/337	0.3126	2.6450	T,T	T,.	P,.	P,.					89	284	1	[1] auto-classification 16.06.2016  			SCAPER (inh=n/a pLI=0.04)
chr15	77176200	77176200	A	T	het		QUAL=5090;DP=202;AF=0.40;MQM=60;TRIO=HET,202,0.40,HOM,100,0.98,WT,136,0.01	SCAPER	5'UTR	SCAPER:NM_020843.2:5'UTR:MODIFIER:exon1/31:c.-42T>A:		rs3812909	0.4169	0.2960	3539/1191/276	0.2983	0.4960	T								67	218					SCAPER (inh=n/a pLI=0.04)
chr15	85326955	85326955	G	A	het	phylop_high;pred_pathogenic_3	QUAL=5783;DP=229;AF=0.51;MQM=59;TRIO=HET,229,0.51,WT,191,0.00,HET,213,0.52	ZNF592	missense	ZNF592:NM_014630.2:missense:MODERATE:exon4/11:c.1049G>A:p.Arg350His		rs61737677	0.0138	0.0084	7/1/3	0.0086	4.6240	T	D	D	D					0	35					ZNF592 (inh=AR pLI=0.95)
chr15	85347114	85347114	T	C	hom		QUAL=23059;DP=261;AF=1.00;MQM=59;TRIO=HOM,261,1.00,HOM,190,1.00,HOM,284,1.00	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*1490T>C:		rs9806315	0.8670	0.0000	0/0/0	0.7334										138	81					ZNF592 (inh=AR pLI=0.95)
chr15	85347673	85347673	T	C	het		QUAL=5005;DP=192;AF=0.47;MQM=60;TRIO=HET,192,0.47,WT,175,0.00,HET,204,0.51	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2049T>C:		rs114257982	0.0280	0.0000	0/0/0	0.0141										0	3					ZNF592 (inh=AR pLI=0.95)
chr15	85348172	85348172	G	T	het		QUAL=9076;DP=370;AF=0.50;MQM=60;TRIO=HET,370,0.50,HET,286,0.55,WT,399,0.00	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2548G>T:	MIRb	rs1719	0.0585	0.0000	0/0/0	0.0517										2	27					ZNF592 (inh=AR pLI=0.95)
chr15	85348551	85348551	G	C	het		QUAL=5778;DP=268;AF=0.48;MQM=60;TRIO=HET,268,0.48,WT,106,0.00,HET,157,0.57	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2927G>C:		rs117658444	0.0142	0.0000	0/0/0	0.0099										0	3					ZNF592 (inh=AR pLI=0.95)
chr15	89835937	89835937	A	G	het		QUAL=7547;DP=289;AF=0.54;MQM=59;TRIO=HET,289,0.54,HET,255,0.51,WT,291,0.00	FANCI	missense	FANCI:NM_001113378.1:missense:MODERATE:exon21/38:c.2011A>G:p.Ile671Val,FANCI:NM_018193.2:missense:MODERATE:exon21/37:c.2011A>G:p.Ile671Val		rs139814895	0.0038	0.0039	3/0/0	0.0033	1.0600	T	T,T,T	B,B,B	B,B,B	611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	11					FANCI (inh=n/a pLI=0.00)
chr15	89837139	89837139	G	T	het		QUAL=3724;DP=218;AF=0.44;MQM=60;TRIO=HET,218,0.44,HET,117,0.42,WT,154,0.00	FANCI	synonymous	FANCI:NM_001113378.1:synonymous:LOW:exon23/38:c.2367G>T:p.Ala789Ala,FANCI:NM_018193.2:synonymous:LOW:exon23/37:c.2367G>T:p.Ala789Ala		rs11857960	0.0789	0.0280	301/2/291	0.0265						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				1	25					FANCI (inh=n/a pLI=0.00)
chr15	89838236	89838236	G	A	hom		QUAL=29395;DP=417;AF=1.00;MQM=60;TRIO=HOM,417,1.00,HOM,181,1.00,HOM,293,1.00	FANCI	synonymous,intron	FANCI:NM_001113378.1:synonymous:LOW:exon24/38:c.2547G>A:p.Lys849Lys,FANCI:NM_018193.2:intron:MODIFIER:exon23/36:c.2456+1008G>A:		rs7183618	0.9808	0.9580	11000/4586/1263	0.3080						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				1232	121					FANCI (inh=n/a pLI=0.00)
chr15	89838293	89838293	A	C	het		QUAL=5454;DP=266;AF=0.50;MQM=60;TRIO=HET,266,0.50,HET,154,0.51,WT,247,0.00	FANCI	missense,intron	FANCI:NM_001113378.1:missense:MODERATE:exon24/38:c.2604A>C:p.Glu868Asp,FANCI:NM_018193.2:intron:MODIFIER:exon23/36:c.2456+1065A>C:		rs118031800	0.0038	0.0041	2/0/0	0.0009	-0.0490	T	T	B	B	611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	11					FANCI (inh=n/a pLI=0.00)
chr15	89848645	89848645	-	T	het		QUAL=14030;DP=634;AF=0.53;MQM=59;TRIO=HET,634,0.53,HET,519,0.50,WT,668,0.00	FANCI	splice_region&intron	FANCI:NM_001113378.1:splice_region&intron:LOW:exon30/37:c.3255+6dupT:,FANCI:NM_018193.2:splice_region&intron:LOW:exon29/36:c.3075+6dupT:		rs200261324	0.0036	0.0039	3/0/0	0.0033						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	11					FANCI (inh=n/a pLI=0.00)
chr15	89858602	89858602	T	C	het		QUAL=11685;DP=204;AF=0.44;MQM=60;TRIO=HET,204,0.44,HOM,178,1.00,HET,298,0.55	FANCI	synonymous	FANCI:NM_001113378.1:synonymous:LOW:exon37/38:c.3906T>C:p.Gly1302Gly,FANCI:NM_018193.2:synonymous:LOW:exon36/37:c.3726T>C:p.Gly1242Gly		rs1138465	0.4123	0.4120	10413/5346/1018	0.4032						611360 [FANCI (provisional) Fanconi anemia,complementation group I];			COSM3754561, COSM3754560	226	625					FANCI (inh=n/a pLI=0.00)
chr15	89860350	89860350	A	C	het		QUAL=3570;DP=164;AF=0.53;MQM=60;TRIO=HET,164,0.53,HOM,21,1.00,HET,54,0.39	FANCI,POLG	3'UTR,intron	FANCI:NM_001113378.1:3'UTR:MODIFIER:exon38/38:c.*660A>C:,FANCI:NM_018193.2:3'UTR:MODIFIER:exon37/37:c.*660A>C:,POLG:NM_001126131.1:intron:MODIFIER:exon22/22:c.3643+257T>G:,POLG:NM_002693.2:intron:MODIFIER:exon22/22:c.3643+257T>G:		rs1061316	0.4459	0.0000	0/0/0	0.0785						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];				24	101					FANCI (inh=n/a pLI=0.00), POLG (inh=AR+AD pLI=0.00)
chr15	89867380	89867380	C	T	het		QUAL=4087;DP=258;AF=0.44;MQM=60;TRIO=HET,258,0.44,HET,158,0.44,WT,235,0.00	POLG	synonymous	POLG:NM_001126131.1:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala,POLG:NM_002693.2:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala		rs373550219	0.0000	0.0004	0/0/0	0.0003						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];	RCV000127516.1 [benign]; 			0	10					POLG (inh=AR+AD pLI=0.00)
chr15	89872249	89872249	C	T	het	anno_pathogenic_hgmd	QUAL=3930;DP=203;AF=0.47;MQM=59;TRIO=HET,203,0.47,HET,138,0.48,WT,162,0.00	POLG	synonymous	POLG:NM_001126131.1:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys,POLG:NM_002693.2:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys		rs61756401	0.0036	0.0039	3/0/0	0.0033						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];	RCV000118023.3 [other]; RCV000127554.6 [uncertain significance]; 	CM133443 [CLASS=DM? MUT=ALT PHEN="SANDO" GENE=POLG]; 		0	14	2	[2] Stephan Waldm?ller 13.08.2014			POLG (inh=AR+AD pLI=0.00)
chr15	90171306	90171306	A	G	het		QUAL=9630;DP=383;AF=0.50;MQM=59;TRIO=HET,383,0.50,WT,282,0.01,HET,369,0.49	KIF7	3'UTR	KIF7:NM_198525.2:3'UTR:MODIFIER:exon19/19:c.*344T>C:		rs1054435	0.4485	0.0000	0/0/0	0.3664										39	108					KIF7 (inh=AR pLI=0.00)
chr15	90172600	90172600	G	A	het		QUAL=1277;DP=60;AF=0.63;MQM=59;TRIO=HET,60,0.63,WT,33,0.00,HET,53,0.47	KIF7	splice_region&intron	KIF7:NM_198525.2:splice_region&intron:LOW:exon17/18:c.3517+6C>T:		rs74251725	0.2752	0.3000	5557/3286/56	0.2913						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117423.2 [likely benign]; 			155	471					KIF7 (inh=AR pLI=0.00)
chr15	90173734	90173734	-	AG	het		QUAL=6988;DP=118;AF=0.36;MQM=59;TRIO=HET,118,0.36,HOM,138,1.00,HET,188,0.51	KIF7	splice_region&intron	KIF7:NM_198525.2:splice_region&intron:LOW:exon15/18:c.3112-11_3112-10insCT:		rs35820949	0.4922	0.4500	3268/1570/505	0.3005						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];				313	517					KIF7 (inh=AR pLI=0.00)
chr15	90174789	90174789	C	T	het		QUAL=1125;DP=54;AF=0.33;MQM=60;TRIO=HET,54,0.33,HET,25,0.88,HET,47,0.28	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon15/19:c.3048G>A:p.Ser1016Ser		rs9672286	0.4511	0.4470	5814/3549/539	0.4280						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082817.7 [other]; 		COSM3932192, COSM3932193	305	519					KIF7 (inh=AR pLI=0.00)
chr15	90174824	90174824	C	T	het		QUAL=1375;DP=59;AF=0.44;MQM=60;TRIO=HET,59,0.44,HET,22,0.86,HET,50,0.34	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon15/19:c.3013G>A:p.Gly1005Arg		rs12900805	0.4393	0.4060	3876/2157/361	0.3791	1.1430	T	T	B,B	B,B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082815.7 [other]; 			306	522					KIF7 (inh=AR pLI=0.00)
chr15	90176073	90176073	C	A	het	low_DP	QUAL=710;DP=18;AF=0.11;MQM=60;TRIO=HET,18,0.11,HOM,17,1.00,HET,32,0.41	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon14/19:c.2873G>T:p.Ser958Ile		rs3803530	0.4383	0.5230	16267/10811/1038	0.4930	1.1000	T	T	P,B	B,B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082813.7 [other]; 			305	496					KIF7 (inh=AR pLI=0.00)
chr15	90176432	90176432	T	G	hom		QUAL=10444;DP=86;AF=1.00;MQM=60;TRIO=HOM,86,1.00,HOM,88,1.00,HOM,153,1.00	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon13/19:c.2658A>C:p.Ala886Ala		rs3803531	0.7945	0.8520	40722/25357/2898	0.8169						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117420.3 [other]; 		COSM147979	884	211					KIF7 (inh=AR pLI=0.00)
chr15	90191827	90191827	T	C	hom	low_DP	QUAL=709;DP=15;AF=1.00;MQM=60;TRIO=HOM,15,1.00,HOM,5,1.00,HOM,6,1.00	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon5/19:c.1102A>G:p.Thr368Ala	(CCGCTCG)n	rs8037349	0.8614	0.8790	5930/2140/604	0.2337	-0.4760	T	T	B	B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082811.7 [other]; 		COSM4128555	871	194					KIF7 (inh=AR pLI=0.00)
chr15	90195967	90195967	C	G	hom		QUAL=27263;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HOM,298,0.99,HOM,367,1.00	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon2/19:c.195G>C:p.Ala65Ala		rs8179066	0.8602	0.8600	8050/3473/1003	0.3219						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117415.6 [other]; 			884	206					KIF7 (inh=AR pLI=0.00)
chr15	90196008	90196008	C	T	het		QUAL=5839;DP=173;AF=0.54;MQM=59;TRIO=HET,173,0.54,WT,286,0.00,HET,348,0.45	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon2/19:c.154G>A:p.Asp52Asn		rs8179065	0.2424	0.2030	779/303/4	0.0862	0.7100	T	T	B	B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117413.3 [other]; 		COSM3754564	102	460					KIF7 (inh=AR pLI=0.00)
chr15	91312823	91312823	T	C	hom		QUAL=1935;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HET,10,0.30,HET,8,0.88	BLM	splice_region&intron	BLM:NM_000057.3:splice_region&intron:LOW:exon12/21:c.2555+7T>C:,BLM:NM_001287246.1:splice_region&intron:LOW:exon13/22:c.2555+7T>C:,BLM:NM_001287247.1:splice_region&intron:LOW:exon12/19:c.2555+7T>C:,BLM:NM_001287248.1:splice_region&intron:LOW:exon12/21:c.1430+7T>C:		rs3815003	0.3666	0.2860	5554/2506/1864	0.2830						604610 [BLM (confirmed) Bloom syndrome];	RCV000078057.7 [other]; 			208	910	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91337479	91337479	G	A	het		QUAL=3535;DP=150;AF=0.47;MQM=60;TRIO=HET,150,0.47,WT,111,0.00,HET,128,0.48	BLM	synonymous	BLM:NM_000057.3:synonymous:LOW:exon16/22:c.3102G>A:p.Thr1034Thr,BLM:NM_001287246.1:synonymous:LOW:exon17/23:c.3102G>A:p.Thr1034Thr,BLM:NM_001287247.1:synonymous:LOW:exon16/20:c.3102G>A:p.Thr1034Thr,BLM:NM_001287248.1:synonymous:LOW:exon16/22:c.1977G>A:p.Thr659Thr		rs2227933	0.1512	0.1610	1682/1159/184	0.1599						604610 [BLM (confirmed) Bloom syndrome];	RCV000078059.7 [other]; RCV000123848.2 [benign]; 			83	724	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91346923	91346923	C	A	het		QUAL=6620;DP=263;AF=0.52;MQM=60;TRIO=HET,263,0.52,WT,195,0.00,HET,246,0.50	BLM	synonymous,intron	BLM:NM_000057.3:synonymous:LOW:exon18/22:c.3531C>A:p.Ala1177Ala,BLM:NM_001287246.1:synonymous:LOW:exon19/23:c.3531C>A:p.Ala1177Ala,BLM:NM_001287248.1:synonymous:LOW:exon18/22:c.2406C>A:p.Ala802Ala,BLM:NM_001287247.1:intron:MODIFIER:exon17/19:c.3358+5356C>A:		rs2227934	0.1332	0.1550	1569/1157/68	0.1557						604610 [BLM (confirmed) Bloom syndrome];	RCV000078060.7 [other]; 			83	717	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91354505	91354505	C	T	het		QUAL=8301;DP=258;AF=0.49;MQM=59;TRIO=HET,258,0.49,WT,216,0.00,HET,341,0.56	BLM	synonymous	BLM:NM_000057.3:synonymous:LOW:exon21/22:c.3945C>T:p.Leu1315Leu,BLM:NM_001287246.1:synonymous:LOW:exon22/23:c.3945C>T:p.Leu1315Leu,BLM:NM_001287247.1:synonymous:LOW:exon19/20:c.3552C>T:p.Leu1184Leu,BLM:NM_001287248.1:synonymous:LOW:exon21/22:c.2820C>T:p.Leu940Leu		rs1063147	0.1328	0.1560	1589/1170/81	0.1556						604610 [BLM (confirmed) Bloom syndrome];	RCV000078061.7 [other]; 			86	722	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91354521	91354521	G	A	het		QUAL=11068;DP=281;AF=0.50;MQM=60;TRIO=HET,281,0.50,HOM,233,0.99,WT,354,0.00	BLM	missense	BLM:NM_000057.3:missense:MODERATE:exon21/22:c.3961G>A:p.Val1321Ile,BLM:NM_001287246.1:missense:MODERATE:exon22/23:c.3961G>A:p.Val1321Ile,BLM:NM_001287247.1:missense:MODERATE:exon19/20:c.3568G>A:p.Val1190Ile,BLM:NM_001287248.1:missense:MODERATE:exon21/22:c.2836G>A:p.Val946Ile		rs7167216	0.0671	0.0660	309/164/35	0.0647	-0.6680	T	T,T,T	B,B	B,B	604610 [BLM (confirmed) Bloom syndrome];	RCV000116501.3 [likely benign]; 			12	265	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91543761	91543761	C	T	het	phylop_high	QUAL=20759;DP=414;AF=0.48;MQM=60;TRIO=HET,414,0.48,HOM,312,1.00,HET,429,0.49	VPS33B	missense	VPS33B:NM_018668.4:missense:MODERATE:exon20/23:c.1540G>A:p.Gly514Ser,VPS33B:NM_001289148.1:missense:MODERATE:exon19/22:c.1459G>A:p.Gly487Ser,VPS33B:NM_001289149.1:missense:MODERATE:exon19/22:c.1267G>A:p.Gly423Ser		rs11073964	0.7678	0.5630	21914/5394/4150	0.5408	4.2670	T	T,T,T,T	B,B	B,B	608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1];			COSM3754589	243	534					VPS33B (inh=AR pLI=0.00)
chr15	91548601	91548601	G	A	het		QUAL=18207;DP=292;AF=0.51;MQM=59;TRIO=HET,292,0.51,HOM,298,1.00,HET,387,0.50	VPS33B	splice_region&intron	VPS33B:NM_018668.4:splice_region&intron:LOW:exon14/22:c.1105+9C>T:,VPS33B:NM_001289148.1:splice_region&intron:LOW:exon13/21:c.1024+9C>T:,VPS33B:NM_001289149.1:splice_region&intron:LOW:exon13/21:c.832+9C>T:		rs3826033	0.2081	0.1790	2808/595/2	0.1767						608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1];			COSM3999688	26	249					VPS33B (inh=AR pLI=0.00)
chr15	91565804	91565804	A	G	het		QUAL=13244;DP=455;AF=0.52;MQM=59;TRIO=HET,455,0.52,HOM,187,0.99,HET,206,0.49	VPS33B	5'UTR	VPS33B:NM_018668.4:5'UTR:MODIFIER:exon1/23:c.-325T>C:,VPS33B:NM_001289148.1:5'UTR:MODIFIER:exon1/22:c.-325T>C:,VPS33B:NM_001289149.1:5'UTR:MODIFIER:exon1/22:c.-536T>C:		rs11073967	0.7566	0.0000	0/0/0	0.4870										44	118					VPS33B (inh=AR pLI=0.00)
chr15	97347632	97347632	C	T	het		QUAL=7034;DP=234;AF=0.50;MQM=60;TRIO=HET,234,0.50,HOM,128,0.99,WT,300,0.00	SPATA8-LOC101927286	intergenic_region	SPATA8-LOC101927286:SPATA8-LOC101927286:intergenic_region:MODIFIER::n.97347632C>T:		rs12902162	0.2879	0.0000	0/0/0	0.3108										20	67					SPATA8-LOC101927286 (inh=n/a pLI=n/a)
chr15	101109677	101109677	C	A	hom		QUAL=9270;DP=149;AF=0.98;MQM=60;TRIO=HOM,149,0.98,HET,135,0.59,HET,181,0.53	LINS1	missense	LINS1:NM_001040616.2:missense:MODERATE:exon7/7:c.2040G>T:p.Arg680Ser		rs8451	0.3115	0.3850	9739/7089/359	0.3856	-0.3100	T	T	B	B				COSM147993	246	521					LINS1 (inh=n/a pLI=0.00)
chr15	101109794	101109794	C	G	hom		QUAL=8183;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HET,68,0.56,HET,92,0.55	LINS1	missense	LINS1:NM_001040616.2:missense:MODERATE:exon7/7:c.1923G>C:p.Glu641Asp		rs12157	0.3115	0.3850	9733/7085/359	0.3856	0.0660	T	T	B	B				COSM3999451	246	522					LINS1 (inh=n/a pLI=0.00)
chr15	101109818	101109818	G	A	hom		QUAL=8847;DP=204;AF=0.99;MQM=59;TRIO=HOM,204,0.99,HET,75,0.53,HET,90,0.53	LINS1	synonymous	LINS1:NM_001040616.2:synonymous:LOW:exon7/7:c.1899C>T:p.Asp633Asp		rs12460	0.4563	0.5050	15889/10248/746	0.5057									COSM4148339	371	508					LINS1 (inh=n/a pLI=0.00)
chr15	101109893	101109893	C	A	hom		QUAL=8560;DP=195;AF=0.99;MQM=60;TRIO=HOM,195,0.99,HET,118,0.50,HET,110,0.51	LINS1	synonymous	LINS1:NM_001040616.2:synonymous:LOW:exon7/7:c.1824G>T:p.Gly608Gly		rs6598356	0.3117	0.3850	9709/7071/356	0.3733									COSM3999452	242	526					LINS1 (inh=n/a pLI=0.00)
chr15	101110265	101110265	T	A	hom		QUAL=14328;DP=336;AF=1.00;MQM=60;TRIO=HOM,336,1.00,HET,114,0.50,HET,144,0.48	LINS1	synonymous	LINS1:NM_001040616.2:synonymous:LOW:exon7/7:c.1452A>T:p.Thr484Thr		rs2411836	0.3115	0.3810	9286/6832/342	0.3816									COSM147994	244	503					LINS1 (inh=n/a pLI=0.00)
chr15	101110302	101110302	C	G	hom		QUAL=17335;DP=429;AF=1.00;MQM=59;TRIO=HOM,429,1.00,HET,97,0.52,HET,139,0.53	LINS1	missense	LINS1:NM_001040616.2:missense:MODERATE:exon7/7:c.1415G>C:p.Ser472Thr		rs2411837	0.2548	0.3400	7753/5790/123	0.3407	-0.1740	T	T	B	B				COSM147995	191	471					LINS1 (inh=n/a pLI=0.00)
chr15	101113862	101113862	C	T	hom	phylop_high	QUAL=9828;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,62,1.00,HOM,67,1.00	LINS1	missense	LINS1:NM_001040616.2:missense:MODERATE:exon5/7:c.1216G>A:p.Val406Met		rs12719734	0.8952	0.9540	55343/32548/4654	0.9428	2.0920	T	T	B,B	B,B					1084	19					LINS1 (inh=n/a pLI=0.00)
chr15	101113950	101113950	A	G	hom		QUAL=12849;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HET,164,0.44,HET,207,0.51	LINS1	synonymous	LINS1:NM_001040616.2:synonymous:LOW:exon5/7:c.1128T>C:p.Ser376Ser		rs12592868	0.3275	0.3880	9876/7092/488	0.3898									COSM147996, COSM3999453	244	526					LINS1 (inh=n/a pLI=0.00)
chr15	101114418	101114418	G	A	hom		QUAL=5208;DP=140;AF=1.00;MQM=60;TRIO=HOM,140,1.00,HET,33,0.58,HET,37,0.54	LINS1	synonymous	LINS1:NM_001040616.2:synonymous:LOW:exon5/7:c.660C>T:p.Phe220Phe		rs8039437	0.3143	0.3840	9596/6970/340	0.3846									COSM3722370, COSM3722371	237	508					LINS1 (inh=n/a pLI=0.00)
chr15	101120963	101120963	T	C	hom		QUAL=29635;DP=568;AF=1.00;MQM=59;TRIO=HOM,568,1.00,HET,332,0.50,HET,461,0.51	LINS1	missense	LINS1:NM_001040616.2:missense:MODERATE:exon2/7:c.85A>G:p.Ile29Val		rs11247226	0.2985	0.3800	9489/6974/237	0.3817	-2.6700	T	T	B,B	B,B				COSM3936696, COSM3936697	242	512					LINS1 (inh=n/a pLI=0.00)
chr15	101142449	101142449	G	T	hom		QUAL=6482;DP=117;AF=0.97;MQM=59;TRIO=HOM,117,0.97,HET,131,0.42,HET,188,0.48	LINS1-ASB7	intergenic_region	LINS1-ASB7:LINS1-ASB7:intergenic_region:MODIFIER::n.101142449G>T:		rs7166822	0.3448	0.0000	0/0/0	0.4161										29	69					LINS1-ASB7 (inh=n/a pLI=n/a)
chr16	1250559	1250559	T	C	hom		QUAL=11079;DP=85;AF=0.98;MQM=59;TRIO=HOM,85,0.98,HET,338,0.46,HET,399,0.49	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon7/35:c.1107T>C:p.Ile369Ile,CACNA1H:NM_001005407.1:synonymous:LOW:exon7/34:c.1107T>C:p.Ile369Ile		rs8044363	0.3327	0.3760	9204/5909/1130	0.3693						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000152871.3 [benign]; 	CM071580 [CLASS=DP MUT=ALT PHEN="Epilepsy childhood absence association with" GENE=CACNA1H]; 	COSM3999710, COSM3999709, COSM3999711	165	476					CACNA1H (inh=n/a pLI=0.76)
chr16	1252259	1252259	A	G	hom	low_DP	QUAL=286;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HET,10,0.60,HET,9,0.56	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon9/35:c.1809A>G:p.Arg603Arg,CACNA1H:NM_001005407.1:synonymous:LOW:exon9/34:c.1809A>G:p.Arg603Arg		rs9934839	0.3966	0.3710	4284/2879/466	0.3406						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082063.4 [benign]; 	CM071579 [CLASS=DP MUT=REF PHEN="Epilepsy childhood absence association with" GENE=CACNA1H]; 	COSM3754631, COSM3754630, COSM3754629	210	463					CACNA1H (inh=n/a pLI=0.76)
chr16	1260481	1260481	T	C	het		QUAL=13561;DP=109;AF=0.50;MQM=59;TRIO=HET,109,0.50,HOM,273,1.00,HET,368,0.46	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon19/35:c.3957T>C:p.Asp1319Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon19/34:c.3957T>C:p.Asp1319Asp		rs8063574	0.9199	0.8590	44276/21587/4008	0.8151						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082071.4 [benign]; 		COSM4128659, COSM4128661, COSM4128660	751	322					CACNA1H (inh=n/a pLI=0.76)
chr16	1261219	1261219	A	G	het		QUAL=15495;DP=90;AF=0.38;MQM=59;TRIO=HET,90,0.38,HOM,300,0.99,HET,393,0.51	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4275A>G:p.Ser1425Ser,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4275A>G:p.Ser1425Ser		rs2753326	0.7097	0.6420	25385/11745/2618	0.6300						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765849, COSM3765850, COSM3765851	403	530					CACNA1H (inh=n/a pLI=0.76)
chr16	1261222	1261222	A	G	het		QUAL=15495;DP=90;AF=0.38;MQM=59;TRIO=HET,90,0.38,HOM,300,0.99,HET,393,0.51	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4278A>G:p.Ser1426Ser,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4278A>G:p.Ser1426Ser		rs2753325	0.7097	0.6420	25402/11754/2624	0.6335						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765854, COSM3765852, COSM3765853	403	530					CACNA1H (inh=n/a pLI=0.76)
chr16	1261282	1261282	T	C	het		QUAL=15583;DP=74;AF=0.50;MQM=59;TRIO=HET,74,0.50,HOM,316,1.00,HET,382,0.50	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4338T>C:p.Ile1446Ile,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4338T>C:p.Ile1446Ile		rs4984637	0.9177	0.8590	44695/21924/4005	0.8252						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765857, COSM3765855, COSM3765856	754	321					CACNA1H (inh=n/a pLI=0.76)
chr16	1268494	1268494	C	T	het		QUAL=20503;DP=194;AF=0.47;MQM=60;TRIO=HET,194,0.47,HOM,424,0.99,HET,512,0.47	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon33/35:c.5730C>T:p.Asp1910Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon32/34:c.5712C>T:p.Asp1904Asp		rs2745136	0.6991	0.5490	4475/2095/539	0.4512						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM434641, COSM434640, COSM3754639	398	533					CACNA1H (inh=n/a pLI=0.76)
chr16	1269029	1269029	T	C	het		QUAL=2003;DP=26;AF=0.38;MQM=60;TRIO=HET,26,0.38,HOM,47,0.98,HET,62,0.32	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon34/35:c.5947T>C:p.Leu1983Leu,CACNA1H:NM_001005407.1:synonymous:LOW:exon33/34:c.5929T>C:p.Leu1977Leu		rs2738893	0.6917	0.5270	3593/1506/397	0.2399						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];				393	530					CACNA1H (inh=n/a pLI=0.76)
chr16	1270162	1270162	G	A	het		QUAL=4330;DP=47;AF=0.45;MQM=60;TRIO=HET,47,0.45,HOM,86,1.00,HET,133,0.52	CACNA1H	missense	CACNA1H:NM_021098.2:missense:MODERATE:exon35/35:c.6230G>A:p.Arg2077His,CACNA1H:NM_001005407.1:missense:MODERATE:exon34/34:c.6212G>A:p.Arg2071His		rs1054645	0.7007	0.6280	20660/9821/1832	0.5942	-0.6630	T	T,T	B,B	B,B	607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082076.4 [benign]; 		COSM3754643, COSM434644, COSM434645	394	514					CACNA1H (inh=n/a pLI=0.76)
chr16	1270349	1270349	T	C	het		QUAL=2349;DP=59;AF=0.39;MQM=60;TRIO=HET,59,0.39,HOM,42,1.00,HET,52,0.54	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon35/35:c.6417T>C:p.Asp2139Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon34/34:c.6399T>C:p.Asp2133Asp		rs4247094	0.9139	0.8510	35348/17568/2683	0.7500						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082078.4 [benign]; 		COSM3749326, COSM3749327, COSM3749328	712	267					CACNA1H (inh=n/a pLI=0.76)
chr16	1271189	1271189	G	A	het		QUAL=10720;DP=128;AF=0.48;MQM=59;TRIO=HET,128,0.48,HOM,201,1.00,HET,260,0.53	CACNA1H	3'UTR	CACNA1H:NM_021098.2:3'UTR:MODIFIER:exon35/35:c.*195G>A:,CACNA1H:NM_001005407.1:3'UTR:MODIFIER:exon34/34:c.*195G>A:		rs2248457	0.6933	0.0000	0/0/0	0.6490										77	119					CACNA1H (inh=n/a pLI=0.76)
chr16	1495243	1495243	T	G	hom		QUAL=3454;DP=53;AF=1.00;MQM=60;TRIO=HOM,53,1.00,HET,37,0.57,HOM,44,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*1389A>C:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*1389A>C:		rs710900	0.9189	0.0000	0/0/0	0.8173										189	38					CLCN7 (inh=n/a pLI=0.98)
chr16	1495745	1495745	G	A	hom		QUAL=1892;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HET,15,0.67,HOM,40,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*887C>T:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*887C>T:		rs6600146	0.9066	0.0000	0/0/0	0.0984										162	59					CLCN7 (inh=n/a pLI=0.98)
chr16	1495746	1495746	G	A	hom		QUAL=1892;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HET,15,0.67,HOM,40,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*886C>T:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*886C>T:		rs1050834	0.9066	0.0000	0/0/0	0.5819										162	59					CLCN7 (inh=n/a pLI=0.98)
chr16	1503879	1503879	T	A	het		QUAL=8668;DP=226;AF=0.50;MQM=60;TRIO=HET,226,0.50,HET,189,0.56,HET,252,0.51	CLCN7	synonymous	CLCN7:NM_001287.5:synonymous:LOW:exon14/25:c.1170A>T:p.Ala390Ala,CLCN7:NM_001114331.2:synonymous:LOW:exon13/24:c.1098A>T:p.Ala366Ala		rs2235579	0.5559	0.5320	17293/8469/1355	0.5164						602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4|Osteopetrosis,autosomal dominant 2];			COSM3754669	283	571					CLCN7 (inh=n/a pLI=0.98)
chr16	2150466	2150466	T	A	het	low_MQM;pred_pathogenic_3;anno_pathogenic_hgmd	QUAL=4004;DP=161;AF=0.43;MQM=48;TRIO=HET,161,0.43,HET,266,0.44,WT,346,0.00	PKD1	missense	PKD1:NM_001009944.2:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe,PKD1:NM_000296.3:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe		rs139945204	0.0002	0.0011	2/2/0	0.0009	1.3330	T	D,D,D	D,D	P,D	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];		CM022663 [CLASS=DM MUT=ALT PHEN="Polycystic kidney disease 1" GENE=PKD1]; 	COSM3754779	0	2					PKD1 (inh=n/a pLI=1.00)
chr16	2160494	2160494	C	T	het		QUAL=4601;DP=250;AF=0.48;MQM=59;TRIO=HET,250,0.48,HET,120,0.61,WT,151,0.01	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr,PKD1:NM_000296.3:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr		rs79884128	0.0711	0.0750	424/194/0	0.0751						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM3754780	8	147					PKD1 (inh=n/a pLI=1.00)
chr16	2164808	2164808	C	T	het	low_DP;low_MQM	QUAL=3112;DP=10;AF=0.30;MQM=31;TRIO=HET,10,0.30,HOM,90,1.00,HET,153,0.40	PKD1	missense	PKD1:NM_001009944.2:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln,PKD1:NM_000296.3:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln		rs40433	0.9792	0.7900	4288/1221/255	0.1506	0.0910	T	T,T	B,B	B,B	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM4128808	577	72					PKD1 (inh=n/a pLI=1.00)
chr16	2167874	2167874	G	A	het	low_MQM	QUAL=5445;DP=78;AF=0.86;MQM=30;TRIO=HET,78,0.86,HOM,118,1.00,HET,122,0.56	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu,PKD1:NM_000296.3:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu		rs35842	0.9443	0.8440	1062/323/151	0.1336						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM4128810	355	281					PKD1 (inh=n/a pLI=1.00)
chr16	2167970	2167970	G	A	het	low_DP;low_MQM	QUAL=615;DP=19;AF=0.37;MQM=29;TRIO=HET,19,0.37,WT,89,0.00,HET,83,0.48	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala,PKD1:NM_000296.3:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala		rs11643513	0.0260	0.0140	7/3/0	0.0026						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];				3	59					PKD1 (inh=n/a pLI=1.00)
chr16	2331430	2331430	A	G	hom		QUAL=25801;DP=287;AF=0.99;MQM=59;TRIO=HOM,287,0.99,HOM,229,1.00,HOM,307,1.00	ABCA3	synonymous	ABCA3:NM_001089.2:synonymous:LOW:exon27/33:c.4116T>C:p.Ser1372Ser		rs149532	0.9010	0.9190	51391/27749/3132	0.8966						601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3];	RCV000150112.1 [benign]; 		COSM4128822	891	203					ABCA3 (inh=n/a pLI=0.00)
chr16	2348528	2348528	G	C	het		QUAL=2519;DP=121;AF=0.43;MQM=60;TRIO=HET,121,0.43,HET,139,0.42,WT,204,0.00	ABCA3	synonymous	ABCA3:NM_001089.2:synonymous:LOW:exon15/33:c.1755C>G:p.Pro585Pro		rs323043	0.0817	0.1430	1572/1299/28	0.1407						601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3];	RCV000155454.1 [benign]; 		COSM3754801	34	312					ABCA3 (inh=n/a pLI=0.00)
chr16	2551147	2551147	C	T	het		QUAL=4290;DP=179;AF=0.48;MQM=59;TRIO=HET,179,0.48,HET,195,0.48,WT,223,0.00	TBC1D24	3'UTR	TBC1D24:NM_001199107.1:3'UTR:MODIFIER:exon8/8:c.*188C>T:,TBC1D24:NM_020705.2:3'UTR:MODIFIER:exon7/7:c.*188C>T:		rs62040717	0.0284	0.0000	0/0/0	0.0575						613577 [TBC1D24 (provisional) Myoclonic epilepsy,infantile,familial|Epileptic encephalopathy,early infantile,16|DOOR syndrome|Deafness,autosomal recessive 86|Deafness,autosomal dominant 65];				2	44					TBC1D24 (inh=AR pLI=0.00)
chr16	3292398	3292398	A	G	het	low_MQM	QUAL=300;DP=20;AF=0.60;MQM=45;TRIO=HET,20,0.60,HOM,3,1.00,WT,4,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*743T>C:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1293T>C:	AluSx	rs170387	0.6943	0.0000	0/0/0	0.5033										38	53					MEFV (inh=n/a pLI=0.00)
chr16	3292666	3292666	T	C	het		QUAL=7979;DP=149;AF=0.42;MQM=55;TRIO=HET,149,0.42,HOM,222,1.00,WT,239,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*475A>G:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1025A>G:	AluSx	rs11466052	0.6514	0.0000	0/0/0	0.1267										54	104					MEFV (inh=n/a pLI=0.00)
chr16	3292667	3292667	G	C	het		QUAL=7979;DP=149;AF=0.42;MQM=55;TRIO=HET,149,0.42,HOM,222,1.00,WT,239,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*474C>G:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1024C>G:	AluSx	rs11466051	0.6512	0.0000	0/0/0	0.1267										54	104					MEFV (inh=n/a pLI=0.00)
chr16	3292673	3292675	AAA	-	hom		QUAL=3947;DP=86;AF=0.45;MQM=57;TRIO=HOM,86,0.45,HOM,179,0.75,WT,157,0.01	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*466_*468delTTT:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1016_*1018delTTT:	AluSx	rs796294754	0.6571	0.0000	0/0/0	0.3617										39	95					MEFV (inh=n/a pLI=0.00)
chr16	3292874	3292874	C	T	het		QUAL=15013;DP=229;AF=0.56;MQM=60;TRIO=HET,229,0.56,HOM,376,1.00,WT,432,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*267G>A:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*817G>A:		rs2741918	0.6462	0.0000	0/0/0	0.0998							RCV000209906.1 [likely benign]; 			54	116					MEFV (inh=n/a pLI=0.00)
chr16	3292896	3292896	C	T	het		QUAL=16212;DP=303;AF=0.55;MQM=60;TRIO=HET,303,0.55,HOM,374,1.00,WT,401,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*245G>A:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*795G>A:		rs2741919	0.6398	0.0000	0/0/0	0.0996							RCV000209870.1 [likely benign]; 			54	116					MEFV (inh=n/a pLI=0.00)
chr16	3293888	3293888	C	T	het		QUAL=16280;DP=300;AF=0.51;MQM=59;TRIO=HET,300,0.51,WT,327,0.00,HOM,384,1.00	MEFV	missense,synonymous	MEFV:NM_001198536.1:missense:MODERATE:exon8/9:c.1306G>A:p.Gly436Arg,MEFV:NM_000243.2:synonymous:LOW:exon9/10:c.1764G>A:p.Pro588Pro		rs1231122	0.3536	0.3940	9774/6909/594	0.3946	0.1690	T	T			608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000126738.1 [benign]; RCV000030177.2 [benign]; 		COSM3754866, COSM3754867	263	530					MEFV (inh=n/a pLI=0.00)
chr16	3293922	3293922	A	T	het	pred_pathogenic_1	QUAL=17940;DP=303;AF=0.54;MQM=60;TRIO=HET,303,0.54,WT,365,0.00,HOM,434,1.00	MEFV	missense,intron	MEFV:NM_001198536.1:missense:MODERATE:exon8/9:c.1272T>A:p.Asp424Glu,MEFV:NM_000243.2:intron:MODIFIER:exon8/9:c.1760-30T>A:		rs1231123	0.3113	0.3760	8787/6520/449	0.3610	-0.0680	T	D			608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];				230	492					MEFV (inh=n/a pLI=0.00)
chr16	3297073	3297073	A	G	het		QUAL=11631;DP=147;AF=0.47;MQM=60;TRIO=HET,147,0.47,HOM,323,1.00,WT,366,0.01	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1530T>C:p.Asp510Asp,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.897T>C:p.Asp299Asp		rs224206	0.6631	0.6100	23159/9953/2456	0.5952						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030175.1 [benign]; 			315	527					MEFV (inh=n/a pLI=0.00)
chr16	3297175	3297175	T	C	het		QUAL=13298;DP=280;AF=0.51;MQM=59;TRIO=HET,280,0.51,HOM,315,1.00,WT,376,0.01	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1428A>G:p.Gln476Gln,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.795A>G:p.Gln265Gln		rs224207	0.6506	0.6060	22800/9899/2177	0.5907						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];				313	527					MEFV (inh=n/a pLI=0.00)
chr16	3297181	3297181	C	T	het		QUAL=12085;DP=249;AF=0.50;MQM=59;TRIO=HET,249,0.50,HOM,303,1.00,WT,361,0.01	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1422G>A:p.Glu474Glu,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.789G>A:p.Glu263Glu		rs224208	0.6390	0.6030	22578/9895/2139	0.5876						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030172.1 [benign]; 			311	527					MEFV (inh=n/a pLI=0.00)
chr16	3299749	3299749	G	A	het		QUAL=2449;DP=86;AF=0.52;MQM=59;TRIO=HET,86,0.52,HOM,57,0.98,WT,59,0.00	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon3/10:c.942C>T:p.Arg314Arg,MEFV:NM_001198536.1:synonymous:LOW:exon2/9:c.309C>T:p.Arg103Arg		rs224213	0.6907	0.6250	24123/10133/2666	0.6148						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030188.1 [benign]; 		COSM3754869, COSM3754868	327	506					MEFV (inh=n/a pLI=0.00)
chr16	3304573	3304573	G	T	hom		QUAL=2511;DP=56;AF=0.98;MQM=59;TRIO=HOM,56,0.98,HOM,21,1.00,HET,35,0.57	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.495C>A:p.Ala165Ala,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1738C>A:		rs224223	0.3864	0.3900	6129/3819/562	0.3662						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030184.1 [benign]; 		COSM1128970	228	505					MEFV (inh=n/a pLI=0.00)
chr16	3304654	3304654	T	C	hom	low_DP	QUAL=937;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,10,1.00,HET,31,0.68	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.414A>G:p.Gly138Gly,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1657A>G:		rs224224	0.3866	0.4260	11379/6808/1066	0.4011						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030183.1 [benign]; RCV000126740.1 [benign]; 		COSM3754870	220	485					MEFV (inh=n/a pLI=0.00)
chr16	3304762	3304762	A	G	hom		QUAL=984;DP=25;AF=1.00;MQM=59;TRIO=HOM,25,1.00,HOM,3,1.00,HET,10,0.90	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.306T>C:p.Asp102Asp,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1549T>C:		rs224225	0.3894	0.4340	12231/7333/1175	0.4282						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030182.1 [benign]; 		COSM435205	225	489					MEFV (inh=n/a pLI=0.00)
chr16	3775717	3775717	C	T	hom		QUAL=17917;DP=271;AF=1.00;MQM=59;TRIO=HOM,271,1.00,HOM,117,1.00,HOM,162,1.00	CREBBP	3'UTR	CREBBP:NM_004380.2:3'UTR:MODIFIER:exon31/31:c.*2002G>A:,CREBBP:NM_001079846.1:3'UTR:MODIFIER:exon30/30:c.*2002G>A:		rs1635400	0.9808	0.0000	0/0/0	0.1551										227	3					CREBBP (inh=AD pLI=1.00)
chr16	3776414	3776426	CGCCCACCTCAGT	-	het		QUAL=10255;DP=92;AF=0.96;MQM=59;TRIO=HET,92,0.96,HET,188,0.96,HET,294,0.98	CREBBP	3'UTR	CREBBP:NM_004380.2:3'UTR:MODIFIER:exon31/31:c.*1293_*1305delACTGAGGTGGGCG:,CREBBP:NM_001079846.1:3'UTR:MODIFIER:exon30/30:c.*1293_*1305delACTGAGGTGGGCG:		rs113182995	0.9790	0.0000	0/0/0	0.5463										153	77					CREBBP (inh=AD pLI=1.00)
chr16	5132636	5132636	C	T	hom		QUAL=15311;DP=188;AF=0.99;MQM=57;TRIO=HOM,188,0.99,HET,348,0.54,HET,412,0.47	ALG1	synonymous	ALG1:NM_019109.4:synonymous:LOW:exon11/13:c.1149C>T:p.Phe383Phe		rs1047732	0.5198	0.5240	17005/8740/793	0.5047						605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik];	RCV000081982.4 [benign]; 		COSM3754927	218	367					ALG1 (inh=n/a pLI=0.00)
chr16	5135380	5135380	A	G	hom	low_MQM	QUAL=15810;DP=317;AF=0.99;MQM=47;TRIO=HOM,317,0.99,HET,193,0.58,HET,259,0.47	ALG1,EEF2KMT	3'UTR	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*498A>G:,EEF2KMT:NM_201400.3:3'UTR:MODIFIER:exon8/8:c.*253T>C:,EEF2KMT:NM_001289029.1:3'UTR:MODIFIER:exon6/6:c.*253T>C:,EEF2KMT:NM_201598.3:3'UTR:MODIFIER:exon7/7:c.*253T>C:		rs11554416	0.5595	0.0000	0/0/0	0.5243										27	104					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5135947	5135947	C	G	hom		QUAL=11357;DP=187;AF=0.99;MQM=56;TRIO=HOM,187,0.99,HET,168,0.56,HET,250,0.51	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1065C>G:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-214G>C:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-214G>C:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-214G>C:		rs4483845	0.5687	0.0000	0/0/0	0.5063										74	110					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5135979	5135979	T	C	hom		QUAL=20920;DP=235;AF=0.99;MQM=59;TRIO=HOM,235,0.99,HOM,173,0.99,HOM,260,1.00	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1097T>C:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-246A>G:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-246A>G:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-246A>G:		rs4238853	0.9852	0.0000	0/0/0	0.8444										230	0					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5136320	5136320	G	A	hom		QUAL=8497;DP=112;AF=1.00;MQM=54;TRIO=HOM,112,1.00,HOM,84,1.00,HOM,101,1.00	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1438G>A:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-587C>T:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-587C>T:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-587C>T:	AluSz	rs12922304	0.9599	0.0000	0/0/0	0.4693										179	0					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5136336	5136339	AAAA	-	hom		QUAL=3004;DP=81;AF=0.72;MQM=58;TRIO=HOM,81,0.72,HOM,55,0.67,HOM,68,0.50	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1468_*1471delAAAA:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-606_893-603delTTTT:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-606_710-603delTTTT:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-606_791-603delTTTT:	AluSz	rs556079793	0.7480	0.0000	0/0/0	0.4468										50	65					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5136900	5136900	C	A	hom		QUAL=18076;DP=162;AF=1.00;MQM=56;TRIO=HOM,162,1.00,HOM,163,1.00,HOM,253,1.00	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2018C>A:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1167G>T:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1167G>T:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1167G>T:	AluSg	rs4786595	0.9599	0.0000	0/0/0	0.6495										230	0					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5136901	5136901	C	G	hom		QUAL=18076;DP=162;AF=1.00;MQM=56;TRIO=HOM,162,1.00,HOM,163,1.00,HOM,253,1.00	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2019C>G:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1168G>C:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1168G>C:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1168G>C:	AluSg	rs4786596	0.9599	0.0000	0/0/0	0.6875										230	0					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5137069	5137069	C	G	hom		QUAL=15265;DP=262;AF=1.00;MQM=58;TRIO=HOM,262,1.00,HET,233,0.48,HET,279,0.51	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2187C>G:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1336G>C:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1336G>C:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1336G>C:		rs12928220	0.3704	0.0000	0/0/0	0.3970										46	108					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5137285	5137285	A	G	hom		QUAL=30180;DP=441;AF=1.00;MQM=59;TRIO=HOM,441,1.00,HOM,218,1.00,HOM,260,1.00	ALG1,EEF2KMT	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2403A>G:,EEF2KMT:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1552T>C:,EEF2KMT:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1552T>C:,EEF2KMT:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1552T>C:		rs4786597	0.9619	0.0000	0/0/0	0.8641										230	0					ALG1 (inh=n/a pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	8873456	8873456	T	C	het		QUAL=8502;DP=151;AF=0.49;MQM=60;TRIO=HET,151,0.49,HET,267,0.51,HET,324,0.44	ABAT	splice_region&intron	ABAT:NM_000663.4:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:NM_020686.5:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:NM_001127448.1:splice_region&intron:LOW:exon15/15:c.1381+9T>C:		rs1079348	0.3500	0.3020	5670/2655/1003	0.2969						137150 [ABAT (provisional) GABA-transaminase deficiency];				114	433					ABAT (inh=n/a pLI=0.37)
chr16	8875529	8875529	G	T	het		QUAL=1449;DP=104;AF=0.41;MQM=59;TRIO=HET,104,0.41,HET,27,0.48,HET,24,0.46	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*242G>T:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*242G>T:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*242G>T:		rs2270288	0.3738	0.0000	0/0/0	0.0731										58	97					ABAT (inh=n/a pLI=0.37)
chr16	8875545	8875545	G	C	het		QUAL=2021;DP=106;AF=0.56;MQM=60;TRIO=HET,106,0.56,HET,26,0.42,HET,17,0.65	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*258G>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*258G>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*258G>C:		rs737695	0.3239	0.0000	0/0/0	0.0555										23	93					ABAT (inh=n/a pLI=0.37)
chr16	8875763	8875763	T	C	het		QUAL=2513;DP=75;AF=0.60;MQM=59;TRIO=HET,75,0.60,HET,58,0.47,HET,77,0.40	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*476T>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*476T>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*476T>C:		rs1731071	0.3902	0.0000	0/0/0	0.3586										27	95					ABAT (inh=n/a pLI=0.37)
chr16	8875799	8875799	G	A	het		QUAL=3906;DP=112;AF=0.46;MQM=60;TRIO=HET,112,0.46,HET,76,0.51,HET,106,0.65	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*512G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*512G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*512G>A:		rs3743798	0.3712	0.0000	0/0/0	0.0728										58	97					ABAT (inh=n/a pLI=0.37)
chr16	8875858	8875858	A	C	het		QUAL=5088;DP=222;AF=0.44;MQM=60;TRIO=HET,222,0.44,HET,100,0.44,HET,149,0.42	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*571A>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*571A>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*571A>C:		rs1641031	0.3928	0.0000	0/0/0	0.3566										28	93					ABAT (inh=n/a pLI=0.37)
chr16	8875861	8875861	A	G	het		QUAL=5088;DP=222;AF=0.44;MQM=60;TRIO=HET,222,0.44,HET,100,0.44,HET,149,0.42	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*574A>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*574A>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*574A>G:		rs1641032	0.3932	0.0000	0/0/0	0.3568										28	93					ABAT (inh=n/a pLI=0.37)
chr16	8876202	8876202	C	G	het		QUAL=11629;DP=319;AF=0.54;MQM=59;TRIO=HET,319,0.54,HET,247,0.49,HET,341,0.45	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*915C>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*915C>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*915C>G:		rs3743801	0.3850	0.0000	0/0/0	0.0732										60	94					ABAT (inh=n/a pLI=0.37)
chr16	8876277	8876277	G	C	het		QUAL=12284;DP=302;AF=0.52;MQM=60;TRIO=HET,302,0.52,HET,298,0.47,HET,371,0.48	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*990G>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*990G>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*990G>C:		rs4985000	0.6064	0.0000	0/0/0	0.1086										110	91					ABAT (inh=n/a pLI=0.37)
chr16	8876418	8876418	G	A	het		QUAL=15828;DP=375;AF=0.50;MQM=59;TRIO=HET,375,0.50,HET,337,0.48,HET,463,0.53	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1131G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1131G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1131G>A:		rs7205816	0.5503	0.0000	0/0/0	0.0991										90	100					ABAT (inh=n/a pLI=0.37)
chr16	8876692	8876692	C	T	het		QUAL=15445;DP=462;AF=0.50;MQM=60;TRIO=HET,462,0.50,HET,301,0.51,HET,329,0.57	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1405C>T:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1405C>T:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1405C>T:		rs7201586	0.2788	0.0000	0/0/0	0.0462										12	85					ABAT (inh=n/a pLI=0.37)
chr16	8876880	8876880	T	A	het		QUAL=11397;DP=249;AF=0.47;MQM=60;TRIO=HET,249,0.47,HET,251,0.55,HET,337,0.51	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1593T>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1593T>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1593T>A:		rs1061842	0.3862	0.0000	0/0/0	0.0734										56	98					ABAT (inh=n/a pLI=0.37)
chr16	8877220	8877220	T	C	hom		QUAL=45031;DP=367;AF=1.00;MQM=60;TRIO=HOM,367,1.00,HOM,484,1.00,HOM,532,1.00	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1933T>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1933T>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1933T>C:	L2c	rs4985036	0.9081	0.0000	0/0/0	0.1714										176	18					ABAT (inh=n/a pLI=0.37)
chr16	8877401	8877401	G	A	het		QUAL=18966;DP=423;AF=0.52;MQM=60;TRIO=HET,423,0.52,HET,432,0.50,HET,516,0.52	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*2114G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*2114G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*2114G>A:		rs11648372	0.6068	0.0000	0/0/0	0.6388										108	86					ABAT (inh=n/a pLI=0.37)
chr16	8877854	8877854	C	G	het		QUAL=5980;DP=248;AF=0.45;MQM=59;TRIO=HET,248,0.45,HET,95,0.45,HET,141,0.53	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*2567C>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*2567C>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*2567C>G:		rs12597124	0.6054	0.0000	0/0/0	0.1086										110	91					ABAT (inh=n/a pLI=0.37)
chr16	8900241	8900241	G	A	het		QUAL=540;DP=33;AF=0.55;MQM=60;TRIO=HET,33,0.55,WT,7,0.00,HET,8,0.63	PMM2	synonymous	PMM2:NM_000303.2:synonymous:LOW:exon4/8:c.324G>A:p.Ala108Ala		rs62031146	0.0148	0.0180	40/22/0	0.0169						601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia];	RCV000117997.2 [other]; 			4	100					PMM2 (inh=AR pLI=0.00)
chr16	8941818	8941818	A	C	het		QUAL=2768;DP=129;AF=0.40;MQM=60;TRIO=HET,129,0.40,HET,144,0.45,WT,173,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*136A>C:		rs2075827	0.2590	0.0000	0/0/0	0.2313										13	83					PMM2 (inh=AR pLI=0.00)
chr16	8941857	8941857	G	A	het		QUAL=3552;DP=217;AF=0.42;MQM=59;TRIO=HET,217,0.42,HET,139,0.41,WT,164,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*175G>A:		rs2072688	0.2694	0.0000	0/0/0	0.0442										13	83					PMM2 (inh=AR pLI=0.00)
chr16	8941934	8941934	C	A	het		QUAL=3219;DP=85;AF=0.55;MQM=60;TRIO=HET,85,0.55,HET,70,0.61,HET,67,0.70	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*252C>A:		rs2075828	0.3962	0.0000	0/0/0	0.4493										56	107					PMM2 (inh=AR pLI=0.00)
chr16	8942473	8942473	G	C	hom		QUAL=18697;DP=293;AF=0.99;MQM=59;TRIO=HOM,293,0.99,HOM,129,1.00,HOM,173,0.99	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*791G>C:		rs2437722	0.9209	0.0000	0/0/0	0.8460										199	25					PMM2 (inh=AR pLI=0.00)
chr16	8942679	8942679	A	G	het		QUAL=4064;DP=157;AF=0.59;MQM=60;TRIO=HET,157,0.59,HET,112,0.54,WT,151,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*997A>G:		rs1056898	0.2905	0.0000	0/0/0	0.2679										13	83					PMM2 (inh=AR pLI=0.00)
chr16	9848471	9848471	T	G	hom		QUAL=10929;DP=200;AF=1.00;MQM=60;TRIO=HOM,200,1.00,HOM,70,1.00,HOM,59,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*8535A>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*8741A>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*8535A>C:		rs767749	0.7506	0.0000	0/0/0	0.1343										307	105					GRIN2A (inh=n/a pLI=1.00)
chr16	9850397	9850397	A	G	hom		QUAL=28034;DP=325;AF=0.99;MQM=59;TRIO=HOM,325,0.99,HOM,240,1.00,HOM,280,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6609T>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6815T>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6609T>C:		rs1420040	0.4233	0.0000	0/0/0	0.0736										84	211					GRIN2A (inh=n/a pLI=1.00)
chr16	9850857	9850857	G	C	hom		QUAL=36387;DP=441;AF=0.99;MQM=60;TRIO=HOM,441,0.99,HOM,298,1.00,HOM,372,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6149C>G:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6355C>G:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6149C>G:		rs9940680	0.4163	0.0000	0/0/0	0.0729										84	209					GRIN2A (inh=n/a pLI=1.00)
chr16	9850878	9850878	T	C	hom		QUAL=29746;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HOM,267,1.00,HOM,339,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6128A>G:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6334A>G:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6128A>G:		rs9933624	0.4173	0.0000	0/0/0	0.0732										86	210					GRIN2A (inh=n/a pLI=1.00)
chr16	9851122	9851122	C	T	hom		QUAL=24520;DP=414;AF=1.00;MQM=60;TRIO=HOM,414,1.00,HOM,156,0.98,HOM,184,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*5884G>A:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6090G>A:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*5884G>A:		rs8045712	0.3676	0.0000	0/0/0	0.0691										80	208					GRIN2A (inh=n/a pLI=1.00)
chr16	9851188	9851188	G	A	hom		QUAL=13168;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,71,1.00,HOM,96,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*5818C>T:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6024C>T:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*5818C>T:		rs8044472	0.7522	0.0000	0/0/0	0.1340										306	103					GRIN2A (inh=n/a pLI=1.00)
chr16	9854389	9854389	C	G	hom		QUAL=30624;DP=462;AF=0.99;MQM=59;TRIO=HOM,462,0.99,HOM,233,1.00,HOM,255,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*2617G>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*2823G>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*2617G>C:		rs62034910	0.3740	0.0000	0/0/0	0.0699										78	207					GRIN2A (inh=n/a pLI=1.00)
chr16	10995933	10995933	A	G	hom	phylop_high	QUAL=12974;DP=131;AF=0.99;MQM=60;TRIO=HOM,131,0.99,HOM,114,1.00,HOM,176,1.00	CIITA	missense,intron,non_coding_exon	CIITA:NM_001286402.1:missense:MODERATE:exon7/20:c.523A>G:p.Arg175Gly,CIITA:NM_000246.3:missense:MODERATE:exon7/20:c.520A>G:p.Arg174Gly,CIITA:NM_001286403.1:intron:MODIFIER:exon6/17:c.481+518A>G:,CIITA:NR_104444.1:non_coding_exon:MODIFIER:exon7/18:n.653A>G:		rs8046121	0.9872	0.9960	60198/33353/4741	0.9321	1.7160	T	T,T	B,B	B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM4128622	1105	2					CIITA (inh=n/a pLI=0.00)
chr16	11000848	11000848	G	C	het		QUAL=1857;DP=83;AF=0.59;MQM=60;TRIO=HET,83,0.59,WT,55,0.00,HET,46,0.50	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.1502G>C:p.Gly501Ala,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.1499G>C:p.Gly500Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1992G>C:,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1139+2179G>C:		rs4774	0.2590	0.2900	5522/2877/353	0.2882	0.7060	T	T,T	B,B,B	B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];		CM102885 [CLASS=DP MUT=ALT PHEN="Multiple sclerosis increased risk association with" GENE=CIITA]; 	COSM434601	101	433					CIITA (inh=n/a pLI=0.00)
chr16	11001691	11001691	C	T	het		QUAL=4716;DP=154;AF=0.54;MQM=59;TRIO=HET,154,0.54,WT,194,0.00,HET,246,0.48	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.2345C>T:p.Ser782Leu,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.2342C>T:p.Ser781Leu,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1149C>T:,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-2354C>T:		rs13330686	0.0397	0.0630	277/221/5	0.0613	-0.2870	T	T,T	B,B,B,B	B,B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				9	175					CIITA (inh=n/a pLI=0.00)
chr16	11001694	11001694	T	C	het		QUAL=4716;DP=154;AF=0.54;MQM=59;TRIO=HET,154,0.54,WT,194,0.00,HET,246,0.48	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.2348T>C:p.Val783Ala,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.2345T>C:p.Val782Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1146T>C:,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-2351T>C:		rs13336804	0.0399	0.0630	275/219/5	0.0616	0.4060	T	T,T	B,B,B,B	B,B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754601	9	174					CIITA (inh=n/a pLI=0.00)
chr16	11001743	11001743	G	A	het		QUAL=2525;DP=119;AF=0.45;MQM=59;TRIO=HET,119,0.45,HET,115,0.59,WT,141,0.00	CIITA	synonymous,intron	CIITA:NM_001286402.1:synonymous:LOW:exon11/20:c.2397G>A:p.Pro799Pro,CIITA:NM_000246.3:synonymous:LOW:exon11/20:c.2394G>A:p.Pro798Pro,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1097G>A:,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-2302G>A:		rs2229320	0.1893	0.2070	2804/1448/12	0.2018						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754602	53	380					CIITA (inh=n/a pLI=0.00)
chr16	11001914	11001914	G	A	het		QUAL=1853;DP=89;AF=0.51;MQM=59;TRIO=HET,89,0.51,WT,50,0.00,HET,61,0.52	CIITA	synonymous,intron	CIITA:NM_001286402.1:synonymous:LOW:exon11/20:c.2568G>A:p.Ala856Ala,CIITA:NM_000246.3:synonymous:LOW:exon11/20:c.2565G>A:p.Ala855Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-926G>A:,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-2131G>A:		rs2229321	0.0397	0.0630	290/232/5	0.0624						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754603	9	173					CIITA (inh=n/a pLI=0.00)
chr16	11002904	11002904	G	A	het		QUAL=16957;DP=139;AF=0.44;MQM=59;TRIO=HET,139,0.44,HOM,326,0.99,HET,451,0.49	CIITA	synonymous,intron	CIITA:NM_001286402.1:synonymous:LOW:exon12/20:c.2679G>A:p.Thr893Thr,CIITA:NM_000246.3:synonymous:LOW:exon12/20:c.2676G>A:p.Thr892Thr,CIITA:NM_001286403.1:synonymous:LOW:exon10/18:c.924G>A:p.Thr308Thr,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-1141G>A:		rs2228238	0.6631	0.6830	28826/16292/1325	0.6763						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				543	450					CIITA (inh=n/a pLI=0.00)
chr16	11002927	11002927	A	G	hom		QUAL=36313;DP=270;AF=1.00;MQM=59;TRIO=HOM,270,1.00,HOM,375,1.00,HOM,513,1.00	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon12/20:c.2702A>G:p.Gln901Arg,CIITA:NM_000246.3:missense:MODERATE:exon12/20:c.2699A>G:p.Gln900Arg,CIITA:NM_001286403.1:missense:MODERATE:exon10/18:c.947A>G:p.Gln316Arg,CIITA:NR_104444.1:intron:MODIFIER:exon10/17:n.1140-1118A>G:		rs7197779	0.9287	0.9790	58319/33286/3054	0.9252	0.8840	T	T,T	B,B	B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				1094	10					CIITA (inh=n/a pLI=0.00)
chr16	11016045	11016045	C	T	het		QUAL=5588;DP=233;AF=0.48;MQM=59;TRIO=HET,233,0.48,WT,181,0.00,HET,261,0.49	CIITA	synonymous,non_coding_exon	CIITA:NM_001286402.1:synonymous:LOW:exon17/20:c.3174C>T:p.Cys1058Cys,CIITA:NM_000246.3:synonymous:LOW:exon17/20:c.3171C>T:p.Cys1057Cys,CIITA:NM_001286403.1:synonymous:LOW:exon15/18:c.1419C>T:p.Cys473Cys,CIITA:NR_104444.1:non_coding_exon:MODIFIER:exon15/18:n.1494C>T:		rs2229322	0.1048	0.1010	674/369/22	0.1017						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754604, COSM148019	17	187					CIITA (inh=n/a pLI=0.00)
chr16	11018622	11018622	T	C	het		QUAL=5541;DP=222;AF=0.53;MQM=60;TRIO=HET,222,0.53,HET,205,0.49,WT,247,0.01	CIITA	3'UTR,non_coding_exon	CIITA:NM_001286402.1:3'UTR:MODIFIER:exon20/20:c.*910T>C:,CIITA:NM_000246.3:3'UTR:MODIFIER:exon20/20:c.*910T>C:,CIITA:NM_001286403.1:3'UTR:MODIFIER:exon18/18:c.*910T>C:,CIITA:NR_104444.1:non_coding_exon:MODIFIER:exon18/18:n.2626T>C:		rs1139564	0.6917	0.0000	0/0/0	0.7563										147	74					CIITA (inh=n/a pLI=0.00)
chr16	11642242	11642242	T	C	hom		QUAL=14602;DP=212;AF=1.00;MQM=60;TRIO=HOM,212,1.00,HOM,152,1.00,HET,192,0.52	LITAF	3'UTR,non_coding_exon	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*1251A>G:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*1251A>G:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*1376A>G:,LITAF:NR_024320.1:non_coding_exon:MODIFIER:exon4/4:n.1871A>G:		rs7102	0.4105	0.3640	916/193/16	0.0968										87	304					LITAF (inh=n/a pLI=0.31)
chr16	11642445	11642445	T	-	het		QUAL=2375;DP=287;AF=0.42;MQM=59;TRIO=HET,287,0.42,HET,122,0.49,WT,131,0.15	LITAF	3'UTR,non_coding_exon	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*1048delA:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*1048delA:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*1173delA:,LITAF:NR_024320.1:non_coding_exon:MODIFIER:exon4/4:n.1668delA:	(T)n	rs71778957	0.0000	0.3980	0/0/0	0.0149										5	262					LITAF (inh=n/a pLI=0.31)
chr16	11642910	11642910	-	A	hom		QUAL=11573;DP=211;AF=0.95;MQM=59;TRIO=HOM,211,0.95,HOM,136,0.99,HET,165,0.42	LITAF	3'UTR,non_coding_exon	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*582dupT:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*582dupT:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*707dupT:,LITAF:NR_024320.1:non_coding_exon:MODIFIER:exon4/4:n.1202dupT:		rs398119229;rs71406254	0.3732	0.2810	378/99/12	0.0657										44	320					LITAF (inh=n/a pLI=0.31)
chr16	11647492	11647492	T	C	het		QUAL=16068;DP=339;AF=0.43;MQM=60;TRIO=HET,339,0.43,WT,392,0.00,HOM,395,1.00	LITAF	missense,non_coding_exon	LITAF:NM_001136472.1:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:NM_004862.3:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:NM_001136473.1:missense:MODERATE:exon3/5:c.274A>G:p.Ile92Val,LITAF:NR_024320.1:non_coding_exon:MODIFIER:exon3/4:n.408A>G:		rs4280262	0.1026	0.1620	1860/1469/25	0.1623	0.2440	T	T,T,T	B,B	B,B	603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C];		CM1410967 [CLASS=DFP MUT=ALT PHEN="Charcot-Marie-Tooth disease 1a/Neuropathy with liability to pressure palsies earlier onset association with" GENE=LITAF]; 		58	326					LITAF (inh=n/a pLI=0.31)
chr16	14026007	14026007	G	A	hom		QUAL=26920;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HOM,242,1.00,HOM,284,1.00	ERCC4	splice_region&intron	ERCC4:NM_005236.2:splice_region&intron:LOW:exon5/10:c.974-7G>A:		rs254942	0.9465	0.9660	56802/32023/5142	0.9567						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];				2342	127					ERCC4 (inh=AR pLI=0.00)
chr16	14041958	14041958	T	C	het		QUAL=8506;DP=268;AF=0.49;MQM=59;TRIO=HET,268,0.49,WT,317,0.00,HET,387,0.50	ERCC4	synonymous	ERCC4:NM_005236.2:synonymous:LOW:exon11/11:c.2505T>C:p.Ser835Ser		rs1799801	0.2412	0.2720	4606/2859/175	0.2717						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];	RCV000116988.2 [likely benign]; 			251	983					ERCC4 (inh=AR pLI=0.00)
chr16	14042108	14042108	G	A	het		QUAL=13845;DP=577;AF=0.50;MQM=59;TRIO=HET,577,0.50,WT,407,0.00,HET,481,0.48	ERCC4	synonymous	ERCC4:NM_005236.2:synonymous:LOW:exon11/11:c.2655G>A:p.Thr885Thr		rs16963255	0.0046	0.0110	10/7/0	0.0104						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];				0	74					ERCC4 (inh=AR pLI=0.00)
chr16	14042688	14042688	G	T	het		QUAL=10690;DP=331;AF=0.47;MQM=60;TRIO=HET,331,0.47,WT,431,0.00,HET,535,0.46	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*484G>T:		rs3743538	0.3496	0.0000	0/0/0	0.3433										28	102					ERCC4 (inh=AR pLI=0.00)
chr16	14042930	14042930	G	C	het		QUAL=5307;DP=283;AF=0.47;MQM=60;TRIO=HET,283,0.47,WT,101,0.01,HET,137,0.47	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*726G>C:		rs2276464	0.2376	0.0000	0/0/0	0.2722										23	94					ERCC4 (inh=AR pLI=0.00)
chr16	14043014	14043014	G	A	het		QUAL=6709;DP=327;AF=0.50;MQM=59;TRIO=HET,327,0.50,WT,124,0.00,HET,189,0.49	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*810G>A:		rs2276465	0.2592	0.0000	0/0/0	0.3083										22	103					ERCC4 (inh=AR pLI=0.00)
chr16	14043175	14043175	C	G	het		QUAL=6077;DP=187;AF=0.49;MQM=60;TRIO=HET,187,0.49,WT,190,0.00,HET,269,0.51	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*971C>G:		rs2276466	0.2372	0.0000	0/0/0	0.2717										23	94					ERCC4 (inh=AR pLI=0.00)
chr16	14044717	14044717	C	A	het		QUAL=6305;DP=205;AF=0.57;MQM=59;TRIO=HET,205,0.57,WT,131,0.01,HET,220,0.51	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2513C>A:		rs11075223	0.2592	0.0000	0/0/0	0.3064										22	102					ERCC4 (inh=AR pLI=0.00)
chr16	14044776	14044776	C	-	het		QUAL=5372;DP=154;AF=0.53;MQM=59;TRIO=HET,154,0.53,WT,155,0.00,HET,230,0.53	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2577delC:		rs796908123	0.2596	0.0000	0/0/0	0.2316							RCV000192706.1 [likely benign]; 			22	103					ERCC4 (inh=AR pLI=0.00)
chr16	14044781	14044781	C	A	het		QUAL=5372;DP=154;AF=0.53;MQM=59;TRIO=HET,154,0.53,WT,155,0.00,HET,230,0.53	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2577C>A:		rs56012340	0.2133	0.0000	0/0/0	0.0831							RCV000194891.1 [likely benign]; 			17	93					ERCC4 (inh=AR pLI=0.00)
chr16	14045236	14045236	G	T	het		QUAL=4012;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,WT,85,0.00,HET,91,0.51	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3032G>T:		rs4781562	0.2574	0.0000	0/0/0	0.2648										17	90					ERCC4 (inh=AR pLI=0.00)
chr16	14045399	14045399	G	A	het		QUAL=8717;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,WT,233,0.00,HET,281,0.46	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3195G>A:		rs4781563	0.2139	0.0000	0/0/0	0.2521										17	93					ERCC4 (inh=AR pLI=0.00)
chr16	14046150	14046150	T	-	het		QUAL=6298;DP=378;AF=0.48;MQM=59;TRIO=HET,378,0.48,WT,68,0.00,HET,127,0.53	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3953delT:		rs397778750	0.2133	0.0000	0/0/0	0.2252										17	92					ERCC4 (inh=AR pLI=0.00)
chr16	20360101	20360101	G	A	hom		QUAL=6919;DP=73;AF=1.00;MQM=59;TRIO=HOM,73,1.00,HOM,75,1.00,HOM,84,1.00	UMOD	synonymous	UMOD:NM_001278614.1:synonymous:LOW:exon4/12:c.621C>T:p.Cys207Cys,UMOD:NM_001008389.2:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys,UMOD:NM_003361.3:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys		rs7193058	0.5439	0.5010	2858/1456/352	0.3382						191845 [UMOD (confirmed) Hyperuricemic nephropathy,familial juvenile 1|Medullary cystic kidney disease 2|Glomerulocystic kidney disease with hyperuricemia and isosthenuria];	RCV000080093.4 [benign]; 		COSM3749349, COSM3749348	562	420					UMOD (inh=n/a pLI=0.00)
chr16	23197545	23197545	C	G	het		QUAL=3883;DP=130;AF=0.49;MQM=60;TRIO=HET,130,0.49,WT,144,0.00,HET,194,0.52	SCNN1G	splice_region&intron	SCNN1G:NM_001039.3:splice_region&intron:LOW:exon1/12:c.-44-4C>G:		rs5731	0.1969	0.2350	3475/1719/66	0.2284										29	114					SCNN1G (inh=n/a pLI=0.37)
chr16	23197562	23197562	A	G	het		QUAL=3951;DP=111;AF=0.48;MQM=60;TRIO=HET,111,0.48,WT,180,0.00,HET,231,0.52	SCNN1G	5'UTR	SCNN1G:NM_001039.3:5'UTR:MODIFIER:exon2/13:c.-31A>G:		rs5732	0.1969	0.2360	3674/1818/71	0.2309										40	165					SCNN1G (inh=n/a pLI=0.37)
chr16	23200761	23200761	T	C	het		QUAL=8899;DP=380;AF=0.49;MQM=59;TRIO=HET,380,0.49,WT,264,0.00,HET,357,0.48	SCNN1G	synonymous	SCNN1G:NM_001039.3:synonymous:LOW:exon3/13:c.387T>C:p.Tyr129Tyr		rs5734	0.2390	0.3020	5980/3366/136	0.2963						600761 [SCNN1G (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 3];	RCV000151819.1 [benign]; 			122	449					SCNN1G (inh=n/a pLI=0.37)
chr16	23200848	23200848	T	C	het		QUAL=9807;DP=311;AF=0.48;MQM=60;TRIO=HET,311,0.48,WT,336,0.00,HET,479,0.51	SCNN1G	synonymous	SCNN1G:NM_001039.3:synonymous:LOW:exon3/13:c.474T>C:p.Ile158Ile		rs5735	0.2392	0.3020	5991/3371/136	0.2937						600761 [SCNN1G (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 3];	RCV000151820.1 [benign]; 		COSM4128821	122	448					SCNN1G (inh=n/a pLI=0.37)
chr16	23227362	23227362	A	G	het		QUAL=16593;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,HET,240,0.53,HOM,295,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*572A>G:		rs5728	0.3395	0.0000	0/0/0	0.0659										51	101					SCNN1G (inh=n/a pLI=0.37)
chr16	23227449	23227449	T	C	het		QUAL=12903;DP=318;AF=0.47;MQM=60;TRIO=HET,318,0.47,HET,186,0.47,HOM,219,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*659T>C:		rs9922851	0.3395	0.0000	0/0/0	0.0659										49	91					SCNN1G (inh=n/a pLI=0.37)
chr16	23227579	23227579	T	C	het		QUAL=21112;DP=436;AF=0.51;MQM=59;TRIO=HET,436,0.51,HET,294,0.39,HOM,431,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*789T>C:	MIR	rs9923016	0.3389	0.0000	0/0/0	0.0479										51	98					SCNN1G (inh=n/a pLI=0.37)
chr16	23360199	23360199	T	C	het		QUAL=6271;DP=311;AF=0.48;MQM=59;TRIO=HET,311,0.48,HET,270,0.44,WT,396,0.00	SCNN1B	synonymous	SCNN1B:NM_000336.2:synonymous:LOW:exon2/13:c.279T>C:p.Pro93Pro		rs238547	0.7885	0.6350	26254/10387/4313	0.6109						600760 [SCNN1B (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 1];	RCV000151814.2 [benign]; 			421	515					SCNN1B (inh=n/a pLI=0.00)
chr16	23399964	23399964	G	T	hom		QUAL=216;DP=28;AF=0.11;MQM=60;TRIO=HOM,28,0.11,HOM,6,0.00,HOM,15,0.00	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*277C>A:	Alu		0.0000	0.0000	0/0/0	0.0000										0	1					COG7 (inh=n/a pLI=0.00)
chr16	23400054	23400054	T	C	het		QUAL=6299;DP=227;AF=0.44;MQM=57;TRIO=HET,227,0.44,HET,166,0.48,HET,201,0.48	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*187A>G:	AluSg	rs250588	0.3610	0.0000	0/0/0	0.2286										13	77					COG7 (inh=n/a pLI=0.00)
chr16	23400194	23400194	G	A	het		QUAL=13345;DP=299;AF=0.54;MQM=59;TRIO=HET,299,0.54,HET,328,0.51,HET,439,0.49	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*47C>T:		rs250587	0.2436	0.2030	2715/1088/411	0.1887										6	67					COG7 (inh=n/a pLI=0.00)
chr16	23646191	23646191	T	C	het		QUAL=5941;DP=153;AF=0.52;MQM=60;TRIO=HET,153,0.52,WT,242,0.00,HET,272,0.53	PALB2	missense	PALB2:NM_024675.3:missense:MODERATE:exon4/13:c.1676A>G:p.Gln559Arg		rs152451	0.1508	0.1060	771/232/252	0.1046	0.4010	T	T	B	B	610355 [PALB2 (provisional) Fanconi anemia,complementation group N|Breast cancer,susceptibility to|Pancreatic cancer,susceptibility to,3];	RCV000114486.2 [other]; RCV000121747.2 [benign]; RCV000128962.2 [benign]; 	CM1312156 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=PALB2]; 		23	491	1	[1] Christopher Schroeder 27.04.2015			PALB2 (inh=AR+AD pLI=0.00)
chr16	28944396	28944396	C	G	hom		QUAL=10112;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HOM,90,1.00,HOM,134,0.99	CD19	missense	CD19:NM_001178098.1:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val,CD19:NM_001770.5:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val		rs2904880	0.8303	0.7290	33026/15765/4563	0.7190	0.0920	T	T,T,T	B,B	B,B	107265 [CD19 (provisional) Immunodeficiency,common variable,3];				599	418					CD19 (inh=n/a pLI=0.85)
chr16	28950051	28950051	G	A	het		QUAL=3273;DP=134;AF=0.41;MQM=60;TRIO=HET,134,0.41,HET,163,0.54,WT,181,0.00	CD19	missense	CD19:NM_001178098.1:missense:MODERATE:exon13/15:c.1544G>A:p.Arg515His,CD19:NM_001770.5:missense:MODERATE:exon13/15:c.1541G>A:p.Arg514His		rs34763945	0.0182	0.0400	130/97/3	0.0403	0.2880	T	T,T,T,T	B,B	B,B	107265 [CD19 (provisional) Immunodeficiency,common variable,3];				4	117					CD19 (inh=n/a pLI=0.85)
chr16	29825126	29825126	T	C	hom		QUAL=21222;DP=118;AF=1.00;MQM=59;TRIO=HOM,118,1.00,HOM,243,1.00,HOM,341,1.00	PRRT2	synonymous	PRRT2:NM_001256442.1:synonymous:LOW:exon2/3:c.751T>C:p.Leu251Leu,PRRT2:NM_001256443.1:synonymous:LOW:exon2/2:c.751T>C:p.Leu251Leu,PRRT2:NM_145239.2:synonymous:LOW:exon2/4:c.751T>C:p.Leu251Leu		rs11150573	0.9918	0.9980	59929/33124/4804	0.9333						614386 [PRRT2 (provisional) Episodic kinesigenic dyskinesia 1|Seizures,benign familial infantile,2|Convulsions,familial infantile,with paroxysmal choreoathetosis];	RCV000127623.2 [benign]; RCV000153784.2 [benign]; 			1993	2					PRRT2 (inh=AD pLI=0.30)
chr16	29826538	29826538	T	C	hom		QUAL=20237;DP=203;AF=1.00;MQM=59;TRIO=HOM,203,1.00,HOM,185,1.00,HOM,250,1.00	PRRT2	3'UTR	PRRT2:NM_001256442.1:3'UTR:MODIFIER:exon3/3:c.*579T>C:,PRRT2:NM_001256443.1:3'UTR:MODIFIER:exon2/2:c.*1263T>C:,PRRT2:NM_145239.2:3'UTR:MODIFIER:exon4/4:c.*579T>C:		rs10204	0.7816	0.0000	0/0/0	0.1321										173	51					PRRT2 (inh=AD pLI=0.30)
chr16	30194840	30194840	A	G	het		QUAL=4124;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HET,136,0.49,HET,162,0.38	CORO1A	5'UTR	CORO1A:NM_001193333.2:5'UTR:MODIFIER:exon1/12:c.-326A>G:,CORO1A:NM_007074.3:5'UTR:MODIFIER:exon1/11:c.-208A>G:		rs930392	0.7911	0.0000	0/0/0	0.5790										55	71					CORO1A (inh=n/a pLI=0.95)
chr16	30198151	30198151	A	G	het		QUAL=5983;DP=160;AF=0.58;MQM=59;TRIO=HET,160,0.58,HET,154,0.47,HET,181,0.43	CORO1A	synonymous	CORO1A:NM_001193333.2:synonymous:LOW:exon5/12:c.336A>G:p.Pro112Pro,CORO1A:NM_007074.3:synonymous:LOW:exon4/11:c.336A>G:p.Pro112Pro		rs1132812	0.7941	0.6510	26673/10035/4050	0.6416						605000 [CORO1A (provisional) Immunodeficiency 8];			COSM3721331	416	492					CORO1A (inh=n/a pLI=0.95)
chr16	31191482	31191482	A	G	hom		QUAL=21607;DP=243;AF=0.99;MQM=59;TRIO=HOM,243,0.99,HOM,200,1.00,HOM,282,1.00	FUS	5'UTR,non_coding_exon	FUS:NM_004960.3:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:NM_001170634.1:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:NM_001170937.1:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon1/14:n.52A>G:		rs929867	0.9391	0.9820	44807/25930/2605	0.9101										898	5					FUS (inh=AR+AD pLI=1.00)
chr16	31193942	31193942	C	A	het		QUAL=11576;DP=416;AF=0.54;MQM=60;TRIO=HET,416,0.54,WT,334,0.00,HET,438,0.53	FUS	synonymous,non_coding_exon	FUS:NM_004960.3:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:NM_001170634.1:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:NM_001170937.1:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon3/14:n.252C>A:		rs741810	0.2790	0.3220	7130/3180/26	0.3143						137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia|Tremor,hereditary essential,4];			COSM1377614, COSM3754865	132	594					FUS (inh=AR+AD pLI=1.00)
chr16	31195279	31195279	C	T	het		QUAL=3808;DP=239;AF=0.48;MQM=60;TRIO=HET,239,0.48,HET,111,0.53,WT,158,0.01	FUS	synonymous,non_coding_exon	FUS:NM_004960.3:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr,FUS:NM_001170634.1:synonymous:LOW:exon4/15:c.288C>T:p.Tyr96Tyr,FUS:NM_001170937.1:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon4/14:n.396C>T:		rs1052352	0.4738	0.5180	17189/10275/360	0.4883						137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia|Tremor,hereditary essential,4];				593	716					FUS (inh=AR+AD pLI=1.00)
chr16	31202800	31202800	G	A	het	anno_pathogenic_hgmd	QUAL=6944;DP=374;AF=0.48;MQM=59;TRIO=HET,374,0.48,WT,178,0.00,HET,218,0.44	FUS	3'UTR,non_coding_exon	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon14/14:n.1692G>A:		rs80301724	0.0044	0.0066	6/1/0	0.0063								CR121643 [CLASS=DM MUT=ALT PHEN="Amyotrophic lateral sclerosis" GENE=FUS]; 		2	24					FUS (inh=AR+AD pLI=1.00)
chr16	31203529	31203529	G	C	het		QUAL=7269;DP=381;AF=0.47;MQM=60;TRIO=HET,381,0.47,WT,185,0.00,HET,223,0.45	FUS	3'UTR,non_coding_exon	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*770G>C:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*770G>C:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*770G>C:,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon14/14:n.2421G>C:		rs4889537	0.2817	0.3380	1066/89/2	0.0831										55	232					FUS (inh=AR+AD pLI=1.00)
chr16	31204235	31204235	T	C	hom		QUAL=40393;DP=452;AF=1.00;MQM=60;TRIO=HOM,452,1.00,HOM,335,1.00,HOM,435,1.00	FUS	3'UTR,non_coding_exon	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*1476T>C:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*1476T>C:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*1476T>C:,FUS:NR_028388.2:non_coding_exon:MODIFIER:exon14/14:n.3127T>C:		rs11860134	0.9910	0.9970	5389/1374/89	0.2328										573	1					FUS (inh=AR+AD pLI=1.00)
chr16	56545175	56545175	T	C	het		QUAL=12550;DP=337;AF=0.46;MQM=60;TRIO=HET,337,0.46,HOM,264,1.00,WT,388,0.00	BBS2	missense	BBS2:NM_031885.3:missense:MODERATE:exon3/17:c.367A>G:p.Ile123Val		rs11373	0.2636	0.2090	2948/1009/273	0.2089	0.4020	T	T	B,B	B,B	606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2|Retinitis pigmentosa 74];		CM144738 [CLASS=DFP MUT=ALT PHEN="Bardet-Biedl syndrome" GENE=BBS2]; 		52	320					BBS2 (inh=AR pLI=0.00)
chr16	56548501	56548501	C	T	hom	phylop_high;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=19343;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,161,1.00,HOM,202,1.00	BBS2	missense	BBS2:NM_031885.3:missense:MODERATE:exon2/17:c.209G>A:p.Ser70Asn		rs4784677	0.9964	0.9940	59947/32858/5179	0.9713	5.0110	T	T			606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2|Retinitis pigmentosa 74];	RCV000004838.3 [pathogenic]; 	CM012900 [CLASS=DM MUT=REF PHEN="Bardet-Biedl syndrome" GENE=BBS2]; 		1081	24	2	[2] old entry - no details available [n/a] comment imported from detected variant: Wirkt falsch annotiert; 30.03.14, PB			BBS2 (inh=AR pLI=0.00)
chr16	56554016	56554016	A	G	hom		QUAL=8283;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HOM,65,1.00,HOM,119,1.00	BBS2-MT4	intergenic_region	BBS2-MT4:BBS2-MT4:intergenic_region:MODIFIER::n.56554016A>G:		rs12446354	0.9970	0.0000	0/0/0	0.8581										217	0					BBS2-MT4 (inh=n/a pLI=n/a)
chr16	57495026	57495026	T	C	hom		QUAL=25237;DP=280;AF=1.00;MQM=59;TRIO=HOM,280,1.00,HOM,229,1.00,HOM,298,1.00	COQ9	3'UTR	COQ9:NM_020312.3:3'UTR:MODIFIER:exon9/9:c.*490T>C:		rs223870	0.9926	0.0000	0/0/0	0.8911										445	32					COQ9 (inh=AR pLI=0.00)
chr16	66514962	66514962	C	T	het		QUAL=13035;DP=226;AF=0.49;MQM=59;TRIO=HET,226,0.49,HOM,335,0.99,WT,460,0.00	BEAN1	3'UTR,intron	BEAN1:NM_001178020.2:3'UTR:MODIFIER:exon5/5:c.*134C>T:,BEAN1:NM_001136106.4:3'UTR:MODIFIER:exon4/4:c.*134C>T:,BEAN1:NM_001197224.2:intron:MODIFIER:exon3/4:c.114-1819C>T:,BEAN1:NM_001197225.2:intron:MODIFIER:exon3/4:c.114-1823C>T:	(CA)n	rs3743709	0.1110	0.0000	0/0/0	0.0768						612051 [BEAN1 (provisional) Spinocerebellar ataxia 31];				5	35					BEAN1 (inh=n/a pLI=n/a)
chr16	66527192	66527192	G	A	het		QUAL=5772;DP=97;AF=0.51;MQM=59;TRIO=HET,97,0.51,HOM,160,0.99,WT,184,0.00	BEAN1	missense,3'UTR	BEAN1:NM_001197225.2:missense:MODERATE:exon5/5:c.475G>A:p.Gly159Arg,BEAN1:NM_001197224.2:3'UTR:MODIFIER:exon5/5:c.*224G>A:		rs58468753	0.1114	0.0410	27/6/5	0.0194						612051 [BEAN1 (provisional) Spinocerebellar ataxia 31];				8	121					BEAN1 (inh=n/a pLI=n/a)
chr16	66584002	66584002	T	C	het		QUAL=8403;DP=259;AF=0.54;MQM=60;TRIO=HET,259,0.54,HOM,112,0.97,HET,156,0.57	TK2	5'UTR,intron,non_coding_exon	TK2:NM_004614.4:5'UTR:MODIFIER:exon1/10:c.-38A>G:,TK2:NM_001172644.1:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:NM_001172645.1:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:NM_001271934.1:5'UTR:MODIFIER:exon1/11:c.-280A>G:,TK2:NM_001172643.1:intron:MODIFIER:exon1/9:c.31+154A>G:,TK2:NM_001271935.1:intron:MODIFIER:exon1/7:c.31+154A>G:,TK2:NR_073520.1:non_coding_exon:MODIFIER:exon1/9:n.314A>G:		rs3743716	0.3259	0.1950	2735/378/1059	0.1863	0.3800	T	T	B	B	188250 [TK2 (confirmed) Mitochondrial DNA depletion syndrome 2 (myopathic type)];	RCV000125522.1 [benign]; 		COSM435490	14	146					TK2 (inh=n/a pLI=0.00)
chr16	67311767	67311767	G	A	het		QUAL=6161;DP=278;AF=0.46;MQM=59;TRIO=HET,278,0.46,HET,306,0.45,WT,450,0.00	SLC9A5-PLEKHG4	intergenic_region	SLC9A5-PLEKHG4:SLC9A5-PLEKHG4:intergenic_region:MODIFIER::n.67311767G>A:		rs8050745	0.2410	0.0000	0/0/0	0.1124										6	102					SLC9A5-PLEKHG4 (inh=n/a pLI=n/a)
chr16	67313805	67313805	G	A	het		QUAL=3344;DP=187;AF=0.45;MQM=59;TRIO=HET,187,0.45,HET,102,0.54,WT,156,0.00	PLEKHG4	5'UTR	PLEKHG4:NM_001129727.2:5'UTR:MODIFIER:exon3/23:c.-143G>A:,PLEKHG4:NM_001129728.1:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:NM_001129729.2:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:NM_001129731.2:5'UTR:MODIFIER:exon1/20:c.-143G>A:		rs141261466	0.0062	0.0000	0/0/0	0.0116										0	14					PLEKHG4 (inh=AD pLI=0.00)
chr16	67316234	67316234	C	T	het	pred_pathogenic_1	QUAL=2675;DP=125;AF=0.54;MQM=59;TRIO=HET,125,0.54,HET,107,0.49,WT,102,0.01	PLEKHG4	missense	PLEKHG4:NM_001129727.2:missense:MODERATE:exon10/23:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129728.1:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129729.2:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129731.2:missense:MODERATE:exon7/20:c.992C>T:p.Thr331Ile		rs11860295	0.2440	0.1290	2240/217/1724	0.1237	0.0090	T	T,T,T,T	D,B	P,B		RCV000117985.2 [likely benign]; 			34	299					PLEKHG4 (inh=AD pLI=0.00)
chr16	67318242	67318242	A	G	het		QUAL=1432;DP=94;AF=0.45;MQM=60;TRIO=HET,94,0.45,HET,82,0.34,WT,124,0.00	PLEKHG4	missense	PLEKHG4:NM_001129727.2:missense:MODERATE:exon13/23:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129728.1:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129729.2:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129731.2:missense:MODERATE:exon10/20:c.1331A>G:p.Asp444Gly		rs8044843	0.2816	0.1630	2920/433/2029	0.1550	0.6240	T	T,T,T,T	B,B	B,B		RCV000117986.2 [likely benign]; 		COSM3765919	50	395					PLEKHG4 (inh=AD pLI=0.00)
chr16	67320223	67320223	G	A	het	low_DP;phylop_high;pred_pathogenic_1	QUAL=184;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HET,11,0.36,WT,24,0.00	PLEKHG4	missense	PLEKHG4:NM_001129727.2:missense:MODERATE:exon16/23:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129728.1:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129729.2:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129731.2:missense:MODERATE:exon13/20:c.2246G>A:p.Arg749His		rs3868142	0.2414	0.1290	2253/234/1716	0.1233	2.0690	T	D,D,D,D	B,B	B,B		RCV000117987.2 [likely benign]; 		COSM4129187	34	292					PLEKHG4 (inh=AD pLI=0.00)
chr16	67469733	67469733	C	A	het		QUAL=5923;DP=157;AF=0.53;MQM=59;TRIO=HET,157,0.53,HET,311,0.51,WT,353,0.00	HSD11B2	synonymous	HSD11B2:NM_000196.3:synonymous:LOW:exon2/5:c.468C>A:p.Thr156Thr		rs5479	0.0927	0.0590	357/76/202	0.0563						614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess];		CM057710 [CLASS=DP MUT=ALT PHEN="Hypertension association with" GENE=HSD11B2]; 	COSM4129203	15	103					HSD11B2 (inh=n/a pLI=0.24)
chr16	67469915	67469915	G	A	het		QUAL=7862;DP=368;AF=0.44;MQM=59;TRIO=HET,368,0.44,HET,341,0.49,WT,385,0.00	HSD11B2	synonymous	HSD11B2:NM_000196.3:synonymous:LOW:exon3/5:c.534G>A:p.Glu178Glu		rs45483293	0.0144	0.0310	87/74/0	0.0308						614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess];				7	88					HSD11B2 (inh=n/a pLI=0.24)
chr16	69373414	69373414	T	C	hom		QUAL=3355;DP=59;AF=0.98;MQM=60;TRIO=HOM,59,0.98,HET,48,0.52,HET,87,0.47	COG8	synonymous	COG8:NM_032382.4:synonymous:LOW:exon1/6:c.42A>G:p.Thr14Thr		rs11542583	0.2576	0.2830	5104/2940/519	0.2712						606979 [COG8 (confirmed) Congenital disorder of glycosylation,type IIh];	RCV000082299.4 [benign]; 		COSM4129245	106	428					COG8 (inh=n/a pLI=0.00)
chr16	70287177	70287177	A	G	hom		QUAL=21255;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,226,1.00,HOM,305,1.00	AARS	synonymous	AARS:NM_001605.2:synonymous:LOW:exon20/21:c.2715T>C:p.Val905Val		rs4081753	0.8812	0.8230	41311/20791/4840	0.8013						601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N|Epileptic encephalopathy,early infantile,29];			COSM435653	726	338					AARS (inh=AR+AD pLI=0.00)
chr16	70303580	70303580	G	A	het		QUAL=20552;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HET,313,0.55,HOM,456,0.99	AARS	synonymous	AARS:NM_001605.2:synonymous:LOW:exon7/21:c.903C>T:p.His301His		rs2070203	0.4253	0.4660	13572/8545/1128	0.4574						601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N|Epileptic encephalopathy,early infantile,29];		CM995271 [CLASS=FP MUT=ALT PHEN="Altered mRNA folding" GENE=AARS]; 		251	557					AARS (inh=AR+AD pLI=0.00)
chr16	74747267	74747267	G	C	het		QUAL=3730;DP=241;AF=0.46;MQM=59;TRIO=HET,241,0.46,WT,97,0.00,HET,102,0.53	FA2H	3'UTR	FA2H:NM_024306.4:3'UTR:MODIFIER:exon7/7:c.*821C>G:		rs573058036	0.0014	0.0000	0/0/0	0.0021										0	3					FA2H (inh=AR pLI=0.73)
chr16	74747451	74747451	C	G	het		QUAL=1405;DP=67;AF=0.52;MQM=59;TRIO=HET,67,0.52,HOM,18,1.00,WT,34,0.00	FA2H	3'UTR	FA2H:NM_024306.4:3'UTR:MODIFIER:exon7/7:c.*637G>C:		rs56033857	0.2378	0.0000	0/0/0	0.0506										29	102					FA2H (inh=AR pLI=0.73)
chr16	74750405	74750405	G	A	het		QUAL=18154;DP=162;AF=0.49;MQM=60;TRIO=HET,162,0.49,HOM,338,0.99,HET,425,0.53	FA2H	synonymous	FA2H:NM_024306.4:synonymous:LOW:exon6/7:c.879C>T:p.Pro293Pro		rs2301865	0.7252	0.7680	35691/21638/2641	0.7629						611026 [FA2H (provisional) Spastic paraplegia 35,autosomal recessive];	RCV000117012.1 [benign]; 			990	540					FA2H (inh=AR pLI=0.73)
chr16	81399026	81399026	C	T	het	phylop_high	QUAL=4104;DP=167;AF=0.49;MQM=60;TRIO=HET,167,0.49,WT,142,0.00,HET,178,0.46	GAN	missense	GAN:NM_022041.3:missense:MODERATE:exon9/11:c.1445C>T:p.Ala482Val		rs146576740	0.0008	0.0016	0/0/0	0.0016	1.8290	T	T	B	B	605379 [GAN (confirmed) Giant axonal neuropathy-1];				1	15	3	[3] Stephan Waldm?ller 13.08.2014			GAN (inh=AR pLI=0.04)
chr16	81411448	81411448	G	A	hom		QUAL=21087;DP=328;AF=0.99;MQM=60;TRIO=HOM,328,0.99,HOM,220,1.00,HET,298,0.45	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*247G>A:		rs2216769	0.6276	0.0000	0/0/0	0.1038										90	108					GAN (inh=AR pLI=0.04)
chr16	81411673	81411673	C	G	hom		QUAL=31887;DP=451;AF=1.00;MQM=59;TRIO=HOM,451,1.00,HOM,368,1.00,HET,431,0.44	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*472C>G:		rs1816122	0.6711	0.0000	0/0/0	0.1110										99	107					GAN (inh=AR pLI=0.04)
chr16	81411793	81411793	T	A	hom		QUAL=19915;DP=291;AF=0.99;MQM=60;TRIO=HOM,291,0.99,HOM,211,1.00,HET,264,0.45	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*592T>A:		rs1345895	0.6418	0.0000	0/0/0	0.1073										99	105					GAN (inh=AR pLI=0.04)
chr16	81412168	81412168	G	A	hom		QUAL=14455;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,87,1.00,HET,168,0.54	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*967G>A:		rs12920236	0.3055	0.0000	0/0/0	0.0701										69	104					GAN (inh=AR pLI=0.04)
chr16	83941726	83941726	C	T	het	anno_pathogenic_hgmd	QUAL=2568;DP=107;AF=0.43;MQM=60;TRIO=HET,107,0.43,HET,133,0.51,WT,174,0.00	MLYCD	splice_region&intron	MLYCD:NM_012213.2:splice_region&intron:LOW:exon2/4:c.642-5C>T:		rs2278037	0.0773	0.0640	320/84/54	0.0647						606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency];	RCV000081530.5 [benign]; 	CS016047 [CLASS=DM? MUT=ALT PHEN="Malonyl-CoA decarboxylase deficiency" GENE=MLYCD]; 		6	90	2	[2] old entry - no details available			MLYCD (inh=AR pLI=0.00)
chr16	83941821	83941821	G	A	het		QUAL=4937;DP=258;AF=0.47;MQM=59;TRIO=HET,258,0.47,HET,159,0.52,WT,213,0.00	MLYCD	synonymous	MLYCD:NM_012213.2:synonymous:LOW:exon3/5:c.732G>A:p.Ser244Ser		rs2278038	0.0481	0.0560	283/89/2	0.0568						606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency];	RCV000126785.2 [benign]; 		COSM3755130	6	89					MLYCD (inh=AR pLI=0.00)
chr16	83949506	83949506	T	C	het		QUAL=9360;DP=444;AF=0.51;MQM=60;TRIO=HET,444,0.51,HET,303,0.46,WT,349,0.00	MLYCD	3'UTR	MLYCD:NM_012213.2:3'UTR:MODIFIER:exon5/5:c.*412T>C:		rs1127382	0.1556	0.0000	0/0/0	0.1113										3	39					MLYCD (inh=AR pLI=0.00)
chr16	85945231	85945231	C	T	het		QUAL=5656;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,HET,237,0.55,WT,240,0.00	IRF8	synonymous	IRF8:NM_002163.2:synonymous:LOW:exon4/9:c.414C>T:p.Cys138Cys		rs8052064	0.0875	0.1230	980/614/84	0.1206						601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive];				19	235					IRF8 (inh=n/a pLI=0.93)
chr16	85955242	85955242	C	T	hom		QUAL=9855;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HET,159,0.52,HET,168,0.48	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*354C>T:		rs10514611	0.1905	0.0000	0/0/0	0.0361								CR127264 [CLASS=DFP MUT=ALT PHEN="Tuberculosis association with" GENE=IRF8]; 		17	71					IRF8 (inh=n/a pLI=0.93)
chr16	85955304	85955304	G	T	hom		QUAL=11969;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,79,1.00,HOM,78,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*416G>T:		rs1568391	0.6751	0.0000	0/0/0	0.0790										80	104					IRF8 (inh=n/a pLI=0.93)
chr16	85955671	85955671	C	T	hom		QUAL=31120;DP=374;AF=1.00;MQM=59;TRIO=HOM,374,1.00,HOM,270,1.00,HOM,305,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*783C>T:		rs1044873	0.3548	0.0000	0/0/0	0.0441										38	108					IRF8 (inh=n/a pLI=0.93)
chr16	85955730	85955730	A	-	hom		QUAL=30986;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,311,1.00,HOM,359,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*843delA:		rs397844297	0.7362	0.0000	0/0/0	0.4127										82	103					IRF8 (inh=n/a pLI=0.93)
chr16	85956044	85956044	A	T	hom		QUAL=4631;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HOM,16,1.00,HOM,16,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*1156A>T:		rs6638	0.6538	0.0000	0/0/0	0.0785										80	101					IRF8 (inh=n/a pLI=0.93)
chr16	88494947	88494947	T	C	hom		QUAL=11401;DP=72;AF=1.00;MQM=59;TRIO=HOM,72,1.00,HOM,113,1.00,HOM,190,0.99	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon1/2:c.1069T>C:p.Ser357Pro		rs11648572	0.9890	0.9730	7497/2594/595	0.2947	-0.4430	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];	RCV000173223.1 [benign]; 		COSM4129466	1025	58					ZNF469 (inh=n/a pLI=n/a)
chr16	88494976	88494976	A	C	hom		QUAL=12663;DP=108;AF=1.00;MQM=59;TRIO=HOM,108,1.00,HOM,122,1.00,HOM,185,1.00	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon1/2:c.1098A>C:p.Arg366Ser		rs11640794	0.8550	0.9010	6850/2497/245	0.2848	0.5620	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];	RCV000173224.1 [benign]; 			958	120					ZNF469 (inh=n/a pLI=n/a)
chr16	88495407	88495407	G	C	hom		QUAL=5351;DP=45;AF=1.00;MQM=59;TRIO=HOM,45,1.00,HOM,50,1.00,HOM,90,1.00	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon1/2:c.1529G>C:p.Gly510Ala		rs7199961	0.9916	0.9980	6667/2144/323	0.2560	0.1520	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755187	1085	3					ZNF469 (inh=n/a pLI=n/a)
chr16	88495654	88495654	A	G	hom		QUAL=6047;DP=51;AF=1.00;MQM=59;TRIO=HOM,51,1.00,HOM,61,1.00,HOM,100,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon1/2:c.1776A>G:p.Pro592Pro		rs12927001	0.8748	0.9060	6586/2406/265	0.2707						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM4129467	975	118					ZNF469 (inh=n/a pLI=n/a)
chr16	88496008	88496008	T	C	het		QUAL=2465;DP=30;AF=0.47;MQM=59;TRIO=HET,30,0.47,HET,32,0.31,HOM,70,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon1/2:c.2130T>C:p.Pro710Pro		rs12918876	0.6044	0.6440	3871/1356/50	0.1846						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM4129468	583	406					ZNF469 (inh=n/a pLI=n/a)
chr16	88497031	88497031	T	C	hom	low_DP	QUAL=1997;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,22,1.00,HOM,40,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon1/2:c.3153T>C:p.Ile1051Ile		rs9924504	1.0000	1.0000	5554/1442/164	0.2465						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];	RCV000173219.1 [benign]; 			1064	1					ZNF469 (inh=n/a pLI=n/a)
chr16	88497394	88497394	T	C	het		QUAL=1597;DP=57;AF=0.49;MQM=59;TRIO=HET,57,0.49,WT,76,0.00,HET,78,0.53	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.3432T>C:p.Arg1144Arg		rs111557381	0.0381	0.0430	25/5/4	0.0138						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755188	4	103					ZNF469 (inh=n/a pLI=n/a)
chr16	88497400	88497400	G	A	hom		QUAL=6012;DP=50;AF=0.96;MQM=59;TRIO=HOM,50,0.96,HOM,76,1.00,HOM,76,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.3438G>A:p.Pro1146Pro		rs9938800	0.9026	0.9430	6472/2108/248	0.2137						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755189	998	70					ZNF469 (inh=n/a pLI=n/a)
chr16	88497446	88497446	A	G	het		QUAL=4954;DP=65;AF=0.62;MQM=59;TRIO=HET,65,0.62,HOM,86,1.00,HET,105,0.52	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.3484A>G:p.Lys1162Glu		rs7197071	0.8189	0.8670	6438/2480/172	0.2691	-0.3040	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755190	914	166					ZNF469 (inh=n/a pLI=n/a)
chr16	88498221	88498221	C	T	hom	phylop_high	QUAL=13563;DP=125;AF=0.97;MQM=59;TRIO=HOM,125,0.97,HOM,147,1.00,HOM,182,0.99	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.4259C>T:p.Pro1420Leu		rs4782300	0.8442	0.8680	7440/3382/649	0.2616	2.7110	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755191	892	189					ZNF469 (inh=n/a pLI=n/a)
chr16	88498297	88498297	T	G	hom		QUAL=19052;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,239,1.00,HOM,251,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.4335T>G:p.Ser1445Ser		rs12445417	0.8464	0.9180	8616/3898/311	0.2852						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM4129472	1030	73					ZNF469 (inh=n/a pLI=n/a)
chr16	88499539	88499539	C	G	hom		QUAL=18190;DP=252;AF=1.00;MQM=59;TRIO=HOM,252,1.00,HOM,151,1.00,HOM,190,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.5577C>G:p.Thr1859Thr		rs9931465	0.7796	0.8500	7264/3417/329	0.2598						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM435898	897	189					ZNF469 (inh=n/a pLI=n/a)
chr16	88501034	88501034	G	C	het		QUAL=727;DP=47;AF=0.43;MQM=60;TRIO=HET,47,0.43,HET,17,0.53,HET,10,0.50	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.7072G>C:p.Gly2358Arg		rs12598474	0.2951	0.2340	896/513/69	0.1077	-1.1320	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM472205	139	479					ZNF469 (inh=n/a pLI=n/a)
chr16	88501971	88501971	T	A	het		QUAL=3792;DP=74;AF=0.46;MQM=60;TRIO=HET,74,0.46,HET,98,0.52,HET,131,0.52	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.8009T>A:p.Leu2670Gln		rs3812956	0.2943	0.2570	895/509/53	0.1063	-1.0570	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM3755192	136	484					ZNF469 (inh=n/a pLI=n/a)
chr16	88502482	88502482	C	T	het		QUAL=6290;DP=182;AF=0.61;MQM=59;TRIO=HET,182,0.61,HET,125,0.50,HET,160,0.54	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.8520C>T:p.Arg2840Arg		rs3812953	0.4700	0.4730	2564/900/138	0.1508						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];			COSM435901	259	546					ZNF469 (inh=n/a pLI=n/a)
chr16	88502505	88502505	A	G	hom	phylop_high	QUAL=11651;DP=118;AF=0.99;MQM=59;TRIO=HOM,118,0.99,HOM,114,1.00,HOM,146,1.00	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.8543A>G:p.His2848Arg		rs1983014	0.9962	0.9980	9014/3586/897	0.2909	4.7990	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];	RCV000175671.1 [benign]; 			1105	0					ZNF469 (inh=n/a pLI=n/a)
chr16	88504206	88504206	G	C	het		QUAL=2431;DP=55;AF=0.53;MQM=59;TRIO=HET,55,0.53,HET,215,0.39,WT,294,0.00	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.10244G>C:p.Gly3415Ala		rs140056980	0.0000	0.0012	0/0/0	0.0003	0.5390	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];				0	3					ZNF469 (inh=n/a pLI=n/a)
chr16	88504850	88504850	G	C	het	pred_pathogenic_1	QUAL=6778;DP=130;AF=0.50;MQM=59;TRIO=HET,130,0.50,HET,175,0.52,HET,230,0.51	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.10888G>C:p.Glu3630Gln		rs1105066	0.3910	0.3140	845/368/169	0.1117	-0.5190	T	D	P	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];				175	488					ZNF469 (inh=n/a pLI=n/a)
chr16	88504868	88504868	A	G	hom		QUAL=14955;DP=100;AF=0.99;MQM=59;TRIO=HOM,100,0.99,HOM,168,1.00,HOM,234,1.00	ZNF469	missense	ZNF469:NM_001127464.2:missense:MODERATE:exon2/2:c.10906A>G:p.Thr3636Ala		rs904783	0.9992	0.9990	7998/2965/661	0.2799	-1.3970	T	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];	RCV000175660.1 [benign]; 		COSM4129476	1109	0					ZNF469 (inh=n/a pLI=n/a)
chr16	88505635	88505635	A	G	het		QUAL=10113;DP=132;AF=0.48;MQM=59;TRIO=HET,132,0.48,HET,183,0.52,HOM,206,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.11673A>G:p.Pro3891Pro		rs4782301	0.7963	0.7550	5981/2403/638	0.2412						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];				690	352					ZNF469 (inh=n/a pLI=n/a)
chr16	88505734	88505734	C	T	hom		QUAL=21675;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HOM,207,1.00,HOM,255,1.00	ZNF469	synonymous	ZNF469:NM_001127464.2:synonymous:LOW:exon2/2:c.11772C>T:p.Ser3924Ser		rs4782362	0.9872	0.9950	9082/3711/856	0.2868						612078 [ZNF469 (confirmed) Brittle cornea syndrome 1];				1098	2					ZNF469 (inh=n/a pLI=n/a)
chr16	88505748	88505748	G	A	het		QUAL=3772;DP=176;AF=0.43;MQM=59;TRIO=HET,176,0.43,HET,194,0.43,WT,234,0.00	ZNF469	3'UTR	ZNF469:NM_001127464.2:3'UTR:MODIFIER:exon2/2:c.*8G>A:		rs45504291	0.2214	0.2010	418/209/37	0.0700										69	382					ZNF469 (inh=n/a pLI=n/a)
chr16	88506358	88506358	T	G	hom		QUAL=33589;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,350,1.00,HOM,423,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.2:3'UTR:MODIFIER:exon2/2:c.*618T>G:		rs3859020	0.9473	0.0000	0/0/0	0.8699										219	11					ZNF469 (inh=n/a pLI=n/a)
chr16	88506528	88506528	G	A	hom		QUAL=21422;DP=206;AF=0.98;MQM=59;TRIO=HOM,206,0.98,HOM,214,1.00,HOM,303,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.2:3'UTR:MODIFIER:exon2/2:c.*788G>A:		rs3894713	0.9862	0.0000	0/0/0	0.8741										230	0					ZNF469 (inh=n/a pLI=n/a)
chr16	88506600	88506600	T	-	het		QUAL=10381;DP=184;AF=0.48;MQM=59;TRIO=HET,184,0.48,HET,199,0.48,HOM,248,0.94	ZNF469	3'UTR	ZNF469:NM_001127464.2:3'UTR:MODIFIER:exon2/2:c.*870delT:		rs35684712	0.5501	0.0000	0/0/0	0.4404										86	109					ZNF469 (inh=n/a pLI=n/a)
chr16	88506741	88506741	A	G	hom		QUAL=12053;DP=120;AF=1.00;MQM=59;TRIO=HOM,120,1.00,HOM,135,0.99,HOM,130,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.2:3'UTR:MODIFIER:exon2/2:c.*1001A>G:		rs3848234	0.8409	0.0000	0/0/0	0.8364										164	61					ZNF469 (inh=n/a pLI=n/a)
chr16	88713236	88713236	A	G	hom	phylop_high;pred_pathogenic_2	QUAL=21552;DP=203;AF=1.00;MQM=59;TRIO=HOM,203,1.00,HET,328,0.47,HOM,396,1.00	CYBA	missense	CYBA:NM_000101.3:missense:MODERATE:exon4/6:c.214T>C:p.Tyr72His		rs4673	0.6643	0.6900	29452/14998/1554	0.6757	4.4150	T	T	D	D	608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];	RCV000002351.2 [benign]; 	CM983302 [CLASS=DFP MUT=REF PHEN="Coronary artery disease lower risk association" GENE=CYBA]; 	COSM3755197	455	492					CYBA (inh=n/a pLI=0.00)
chr16	88713501	88713501	A	G	hom		QUAL=5378;DP=97;AF=1.00;MQM=59;TRIO=HOM,97,1.00,HET,55,0.45,HOM,62,1.00	CYBA	splice_region&intron	CYBA:NM_000101.3:splice_region&intron:LOW:exon3/5:c.203+8T>C:		rs4782393	0.3660	0.4670	12972/8034/427	0.4564						608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];	RCV000176978.1 [benign]; 			253	495					CYBA (inh=n/a pLI=0.00)
chr16	88717386	88717386	T	C	hom		QUAL=1528;DP=21;AF=1.00;MQM=60;TRIO=HOM,21,1.00,HOM,12,1.00,HOM,21,1.00	CYBA	synonymous	CYBA:NM_000101.3:synonymous:LOW:exon1/6:c.36A>G:p.Glu12Glu		rs8053867	0.9956	0.9990	44806/25040/3395	0.9239						608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];			COSM4129484	1099	0					CYBA (inh=n/a pLI=0.00)
chr16	89238190	89238190	G	A	hom		QUAL=6483;DP=92;AF=0.99;MQM=59;TRIO=HOM,92,0.99,HOM,114,0.98,HET,94,0.59	CDH15	5'UTR	CDH15:NM_004933.2:5'UTR:MODIFIER:exon1/14:c.-50G>A:		rs12927793	0.2510	0.3260	1657/1248/11	0.2741										143	227					CDH15 (inh=n/a pLI=0.00)
chr16	89597221	89597221	A	G	het		QUAL=18013;DP=143;AF=0.48;MQM=59;TRIO=HET,143,0.48,HOM,367,1.00,HET,451,0.50	SPG7	splice_region&intron	SPG7:NM_003119.3:splice_region&intron:LOW:exon7/16:c.987+5A>G:,SPG7:NM_199367.2:splice_region&intron:LOW:exon7/9:c.987+5A>G:		rs4785691	0.5294	0.4730	14027/6950/910	0.4472						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				598	1168					SPG7 (inh=AR+AD pLI=0.00)
chr16	89603586	89603586	A	G	het		QUAL=6304;DP=147;AF=0.47;MQM=59;TRIO=HET,147,0.47,HOM,101,1.00,HET,140,0.44	SPG7	3'UTR,intron	SPG7:NM_199367.2:3'UTR:MODIFIER:exon10/10:c.*268A>G:,SPG7:NM_003119.3:intron:MODIFIER:exon9/16:c.1324+4542A>G:		rs382745	0.5387	0.0000	0/0/0	0.3659						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				53	119					SPG7 (inh=AR+AD pLI=0.00)
chr16	89603698	89603698	-	T	het		QUAL=2982;DP=132;AF=0.42;MQM=60;TRIO=HET,132,0.42,WT,84,0.00,HET,116,0.59	SPG7	3'UTR,intron	SPG7:NM_199367.2:3'UTR:MODIFIER:exon10/10:c.*380_*381insT:,SPG7:NM_003119.3:intron:MODIFIER:exon9/16:c.1324+4654_1324+4655insT:		rs3833827	0.4359	0.0000	0/0/0	0.4776						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				58	120					SPG7 (inh=AR+AD pLI=0.00)
chr16	89623746	89623746	G	T	het		QUAL=4168;DP=221;AF=0.46;MQM=60;TRIO=HET,221,0.46,WT,121,0.00,HET,141,0.48	SPG7	3'UTR	SPG7:NM_003119.3:3'UTR:MODIFIER:exon17/17:c.*245G>T:		rs780776019	0.0000	0.0000	0/0/0	0.0001										0	1					SPG7 (inh=AR+AD pLI=0.00)
chr16	89804336	89804336	T	-	het		QUAL=5699;DP=227;AF=0.49;MQM=59;TRIO=HET,227,0.49,WT,234,0.00,HET,298,0.46	FANCA,ZNF276	3'UTR,intron	FANCA:NM_000135.2:3'UTR:MODIFIER:exon43/43:c.*673delA:,FANCA:NM_001286167.1:3'UTR:MODIFIER:exon43/43:c.*770delA:,ZNF276:NM_001113525.1:intron:MODIFIER:exon10/10:c.1574+23delT:,ZNF276:NR_110128.1:intron:MODIFIER:exon10/10:n.1552+23delT:,ZNF276:NR_110122.1:intron:MODIFIER:exon10/10:n.1746+23delT:,ZNF276:NR_110126.1:intron:MODIFIER:exon10/10:n.1629+23delT:,ZNF276:NM_152287.3:intron:MODIFIER:exon10/10:c.1349+23delT:,ZNF276:NR_110129.1:intron:MODIFIER:exon10/10:n.1641+23delT:		rs869276460	0.0000	0.4850	16320/4399/2087	0.4356										90	190					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89804855	89804855	C	T	het		QUAL=9522;DP=319;AF=0.51;MQM=60;TRIO=HET,319,0.51,WT,332,0.00,HET,447,0.47	ZNF276,FANCA	3'UTR,non_coding_exon	ZNF276:NM_001113525.1:3'UTR:MODIFIER:exon11/11:c.*201C>T:,FANCA:NM_000135.2:3'UTR:MODIFIER:exon43/43:c.*154G>A:,ZNF276:NM_152287.3:3'UTR:MODIFIER:exon11/11:c.*201C>T:,FANCA:NM_001286167.1:3'UTR:MODIFIER:exon43/43:c.*251G>A:,ZNF276:NR_110128.1:non_coding_exon:MODIFIER:exon11/11:n.2024C>T:,ZNF276:NR_110122.1:non_coding_exon:MODIFIER:exon11/11:n.2218C>T:,ZNF276:NR_110126.1:non_coding_exon:MODIFIER:exon11/11:n.2101C>T:,ZNF276:NR_110129.1:non_coding_exon:MODIFIER:exon11/11:n.2113C>T:		rs1230	0.6977	0.0000	0/0/0	0.0804										25	69					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89836323	89836323	C	T	het		QUAL=6396;DP=219;AF=0.49;MQM=59;TRIO=HET,219,0.49,WT,203,0.00,HET,270,0.53	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:NM_001286167.1:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.4670	16070/3144/2387	0.4485	0.3050	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120927.1 [not provided]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	324	1112	2	[2] old entry - no details available			FANCA (inh=AR pLI=0.00)
chr16	89838078	89838078	A	G	het		QUAL=4280;DP=134;AF=0.48;MQM=59;TRIO=HET,134,0.48,WT,197,0.00,HET,251,0.47	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.4310	12977/3039/1411	0.4236						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				276	1103	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89849480	89849480	C	T	het		QUAL=7910;DP=244;AF=0.53;MQM=60;TRIO=HET,244,0.53,WT,273,0.00,HET,319,0.55	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4990	16447/5298/2452	0.4917	-0.0380	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		465	1245	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89865103	89865103	T	A	het		QUAL=10095;DP=416;AF=0.48;MQM=60;TRIO=HET,416,0.48,WT,318,0.00,HET,411,0.47	FANCA	3'UTR,intron	FANCA:NM_001018112.1:3'UTR:MODIFIER:exon11/11:c.*384A>T:,FANCA:NM_000135.2:intron:MODIFIER:exon10/42:c.893+471A>T:,FANCA:NM_001286167.1:intron:MODIFIER:exon10/42:c.893+471A>T:		rs11076626	0.6913	0.0000	0/0/0	0.4746						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				48	99					FANCA (inh=AR pLI=0.00)
chr16	89865242	89865242	T	C	het		QUAL=5611;DP=230;AF=0.51;MQM=60;TRIO=HET,230,0.51,WT,193,0.00,HET,249,0.49	FANCA	3'UTR,intron	FANCA:NM_001018112.1:3'UTR:MODIFIER:exon11/11:c.*245A>G:,FANCA:NM_000135.2:intron:MODIFIER:exon10/42:c.893+332A>G:,FANCA:NM_001286167.1:intron:MODIFIER:exon10/42:c.893+332A>G:		rs10852623	0.6871	0.0000	0/0/0	0.4734						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				48	99					FANCA (inh=AR pLI=0.00)
chr16	89866043	89866043	T	C	het		QUAL=8225;DP=305;AF=0.48;MQM=59;TRIO=HET,305,0.48,WT,244,0.00,HET,334,0.50	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.5170	18422/4824/2761	0.4992	0.4020	T	T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		437	1199	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr17	1247850	1247851	AG	-	het		QUAL=3405;DP=240;AF=0.46;MQM=59;TRIO=HET,240,0.46,HET,108,0.42,WT,132,0.00	YWHAE	3'UTR,non_coding_exon	YWHAE:NM_006761.4:3'UTR:MODIFIER:exon6/6:c.*890_*891delCT:,YWHAE:NR_024058.1:non_coding_exon:MODIFIER:exon7/7:n.1843_1844delCT:	(TTTAAG)n	rs147204530	0.0379	0.0000	0/0/0	0.0513										3	25					YWHAE (inh=n/a pLI=0.96)
chr17	1248466	1248466	C	T	het		QUAL=4907;DP=355;AF=0.44;MQM=60;TRIO=HET,355,0.44,HET,118,0.33,WT,160,0.00	YWHAE	3'UTR,non_coding_exon	YWHAE:NM_006761.4:3'UTR:MODIFIER:exon6/6:c.*275G>A:,YWHAE:NR_024058.1:non_coding_exon:MODIFIER:exon7/7:n.1228G>A:		rs7266	0.0379	0.0000	0/0/0	0.0089										3	25					YWHAE (inh=n/a pLI=0.96)
chr17	2586229	2586229	A	G	het		QUAL=25193;DP=581;AF=0.46;MQM=60;TRIO=HET,581,0.46,HET,323,0.47,HOM,418,1.00	PAFAH1B1	3'UTR	PAFAH1B1:NM_000430.3:3'UTR:MODIFIER:exon11/11:c.*1133A>G:		rs4790356	0.8367	0.0000	0/0/0	0.8885										194	36					PAFAH1B1 (inh=AR+AD pLI=1.00)
chr17	2588917	2588931	TTTTTTTTTTTTTTT	-	hom		QUAL=393;DP=20;AF=0.80;MQM=59;TRIO=HOM,20,0.80,HET,11,1.00,HOM,9,0.78	PAFAH1B1-CLUH	intergenic_region	PAFAH1B1-CLUH:PAFAH1B1-CLUH:intergenic_region:MODIFIER::n.2588917_2588931delTTTTTTTTTTTTTTT:	(T)n	rs200593896;rs749202525;rs780861755	0.9982	0.0000	0/0/0	0.4472										53	14					PAFAH1B1-CLUH (inh=n/a pLI=n/a)
chr17	3377396	3377396	C	G	hom		QUAL=12534;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HET,108,0.49,HOM,132,1.00	SPATA22-ASPA	intergenic_region	SPATA22-ASPA:SPATA22-ASPA:intergenic_region:MODIFIER::n.3377396C>G:		rs11078450	0.1945	0.0000	0/0/0	0.2096										56	93					SPATA22-ASPA (inh=n/a pLI=n/a)
chr17	3402521	3402521	C	A	hom		QUAL=12679;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HOM,88,1.00,HOM,108,1.00	ASPA	3'UTR	ASPA:NM_000049.2:3'UTR:MODIFIER:exon6/6:c.*139C>A:,ASPA:NM_001128085.1:3'UTR:MODIFIER:exon7/7:c.*139C>A:	L2d2	rs1552830	0.9992	0.0000	0/0/0	0.1419										229	0					ASPA (inh=n/a pLI=0.01)
chr17	3540042	3540042	G	A	het		QUAL=3120;DP=145;AF=0.50;MQM=59;TRIO=HET,145,0.50,HET,111,0.51,WT,121,0.00	CTNS	5'UTR,intron	CTNS:NM_004937.2:5'UTR:MODIFIER:exon1/12:c.-313G>A:,CTNS:NM_001031681.2:intron:MODIFIER:exon1/12:c.-230+40G>A:		rs17707869	0.1540	0.0000	0/0/0	0.1721										8	62					CTNS (inh=n/a pLI=0.03)
chr17	3559823	3559823	G	A	het		QUAL=5371;DP=196;AF=0.45;MQM=60;TRIO=HET,196,0.45,HET,303,0.47,WT,423,0.00	CTNS	synonymous	CTNS:NM_001031681.2:synonymous:LOW:exon8/13:c.504G>A:p.Thr168Thr,CTNS:NM_004937.2:synonymous:LOW:exon8/12:c.504G>A:p.Thr168Thr		rs1800528	0.1506	0.1790	2052/1095/9	0.1743						606272 [CTNS (confirmed) Cystinosis,nephropathic|Cystinosis,ocular nonnephropathic|Cystinosis,late-onset juvenile or adolescent nephropathic|Cystinosis,atypical nephropathic];				39	316					CTNS (inh=n/a pLI=0.03)
chr17	3561396	3561396	C	T	hom	phylop_high	QUAL=32296;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HOM,325,1.00,HOM,470,1.00	CTNS	missense	CTNS:NM_001031681.2:missense:MODERATE:exon10/13:c.779C>T:p.Thr260Ile,CTNS:NM_004937.2:missense:MODERATE:exon10/12:c.779C>T:p.Thr260Ile		rs161400	0.8183	0.9180	51792/30388/1763	0.9114	2.3950	T	T,T,T,T	B,B,B	B,B,B	606272 [CTNS (confirmed) Cystinosis,nephropathic|Cystinosis,ocular nonnephropathic|Cystinosis,late-onset juvenile or adolescent nephropathic|Cystinosis,atypical nephropathic];				972	122					CTNS (inh=n/a pLI=0.03)
chr17	3564068	3564068	G	A	het		QUAL=2368;DP=161;AF=0.46;MQM=59;TRIO=HET,161,0.46,HET,71,0.42,WT,87,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*40G>A:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*405G>A:		rs760273	0.1973	0.2100	2562/1313/86	0.2011										15	148					CTNS (inh=n/a pLI=0.03)
chr17	3564073	3564073	A	G	het		QUAL=2522;DP=166;AF=0.48;MQM=59;TRIO=HET,166,0.48,HET,71,0.39,WT,89,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*45A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*410A>G:		rs3826496	0.1977	0.2100	2543/1297/85	0.2010										15	149					CTNS (inh=n/a pLI=0.03)
chr17	3564084	3564084	T	C	het		QUAL=2312;DP=158;AF=0.49;MQM=59;TRIO=HET,158,0.49,HET,71,0.35,WT,96,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*56T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*421T>C:		rs760274	0.1973	0.0000	0/0/0	0.0373										15	148					CTNS (inh=n/a pLI=0.03)
chr17	3564218	3564218	T	C	het		QUAL=4072;DP=258;AF=0.40;MQM=60;TRIO=HET,258,0.40,HET,187,0.40,WT,276,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*190T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*555T>C:		rs1048646	0.1983	0.0000	0/0/0	0.2124										10	77					CTNS (inh=n/a pLI=0.03)
chr17	3564235	3564235	A	G	het		QUAL=5451;DP=325;AF=0.43;MQM=60;TRIO=HET,325,0.43,HET,209,0.43,WT,302,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*207A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*572A>G:		rs3826493	0.2053	0.0000	0/0/0	0.0365										10	77					CTNS (inh=n/a pLI=0.03)
chr17	3564290	3564290	T	C	het		QUAL=6664;DP=348;AF=0.45;MQM=59;TRIO=HET,348,0.45,HET,203,0.45,WT,294,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*262T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*627T>C:	L3	rs1048647	0.1983	0.0000	0/0/0	0.0361										10	75					CTNS (inh=n/a pLI=0.03)
chr17	3564294	3564294	T	C	het		QUAL=6664;DP=348;AF=0.45;MQM=59;TRIO=HET,348,0.45,HET,203,0.45,WT,294,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*266T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*631T>C:	L3	rs1048648	0.1981	0.0000	0/0/0	0.0361										10	76					CTNS (inh=n/a pLI=0.03)
chr17	3564378	3564378	C	T	het		QUAL=6133;DP=261;AF=0.49;MQM=59;TRIO=HET,261,0.49,HET,184,0.59,WT,245,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*350C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*715C>T:		rs1048649	0.1967	0.0000	0/0/0	0.2117										10	73					CTNS (inh=n/a pLI=0.03)
chr17	3564401	3564401	T	G	hom		QUAL=22530;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,176,1.00,HOM,260,1.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*373T>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*738T>G:		rs224562	0.9954	0.0000	0/0/0	0.1925										229	1					CTNS (inh=n/a pLI=0.03)
chr17	3564687	3564687	C	T	het		QUAL=4156;DP=174;AF=0.35;MQM=59;TRIO=HET,174,0.35,HET,298,0.44,WT,492,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*659C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1024C>T:		rs1048673	0.1947	0.0000	0/0/0	0.0593										12	76					CTNS (inh=n/a pLI=0.03)
chr17	3564688	3564688	A	G	het		QUAL=4156;DP=174;AF=0.35;MQM=59;TRIO=HET,174,0.35,HET,298,0.44,WT,492,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*660A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1025A>G:		rs1048674	0.1939	0.0000	0/0/0	0.0598										12	76					CTNS (inh=n/a pLI=0.03)
chr17	3564693	3564693	-	GTC	het		QUAL=2232;DP=158;AF=0.30;MQM=59;TRIO=HET,158,0.30,HET,261,0.39,WT,481,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*666_*668dupGTC:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1031_*1033dupGTC:		rs397831765	0.1923	0.0000	0/0/0	0.1196										11	74					CTNS (inh=n/a pLI=0.03)
chr17	3564716	3564716	T	G	het		QUAL=4836;DP=198;AF=0.44;MQM=59;TRIO=HET,198,0.44,HET,252,0.46,WT,417,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*688T>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1053T>G:		rs1048677	0.0000	0.0000	0/0/0	0.0070										12	76					CTNS (inh=n/a pLI=0.03)
chr17	3564779	3564779	C	T	het		QUAL=3635;DP=220;AF=0.40;MQM=59;TRIO=HET,220,0.40,HET,202,0.39,WT,343,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*751C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1116C>T:		rs1048682	0.1929	0.0000	0/0/0	0.0349										11	76					CTNS (inh=n/a pLI=0.03)
chr17	3564815	3564815	A	G	het		QUAL=3392;DP=233;AF=0.41;MQM=59;TRIO=HET,233,0.41,HET,158,0.35,WT,287,0.01	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*787A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1152A>G:		rs2235104	0.1871	0.0000	0/0/0	0.0348										12	75					CTNS (inh=n/a pLI=0.03)
chr17	3564837	3564838	CT	-	het		QUAL=3439;DP=287;AF=0.42;MQM=59;TRIO=HET,287,0.42,HET,140,0.36,WT,255,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*811_*812delCT:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1176_*1177delCT:		rs397857879	0.1931	0.0000	0/0/0	0.1885										12	75					CTNS (inh=n/a pLI=0.03)
chr17	3565103	3565103	A	G	het		QUAL=5089;DP=146;AF=0.46;MQM=59;TRIO=HET,146,0.46,HOM,109,1.00,WT,159,0.01	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1075A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1440A>G:		rs161398	0.7420	0.0000	0/0/0	0.6885										105	97					CTNS (inh=n/a pLI=0.03)
chr17	3565606	3565606	A	-	hom		QUAL=8480;DP=156;AF=0.76;MQM=58;TRIO=HOM,156,0.76,HOM,101,0.80,HOM,164,0.79	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1592delA:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1957delA:	AluSq2	rs869283071	0.4742	0.0000	0/0/0	0.4643										26	198					CTNS (inh=n/a pLI=0.03)
chr17	3565969	3565969	T	C	hom		QUAL=21427;DP=210;AF=0.99;MQM=59;TRIO=HOM,210,0.99,HOM,219,1.00,HOM,261,1.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1941T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2306T>C:		rs161397	0.6384	0.0000	0/0/0	0.7702										155	68					CTNS (inh=n/a pLI=0.03)
chr17	3566045	3566045	-	C	hom		QUAL=12318;DP=125;AF=0.98;MQM=59;TRIO=HOM,125,0.98,HOM,136,1.00,HOM,154,1.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*2018dupC:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2383dupC:		rs397702352	0.7676	0.0000	0/0/0	0.7613										165	60					CTNS (inh=n/a pLI=0.03)
chr17	3566232	3566232	C	T	het		QUAL=6203;DP=252;AF=0.55;MQM=59;TRIO=HET,252,0.55,HOM,113,1.00,WT,126,0.01	CTNS,TAX1BP3,P2RX5-TAX1BP3	3'UTR,non_coding_exon	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*2204C>T:,TAX1BP3:NM_014604.3:3'UTR:MODIFIER:exon4/4:c.*810G>A:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2569C>T:,TAX1BP3:NM_001204698.1:3'UTR:MODIFIER:exon3/3:c.*810G>A:,P2RX5-TAX1BP3:NR_037928.1:non_coding_exon:MODIFIER:exon15/15:n.6240G>A:		rs7093	0.3616	0.0000	0/0/0	0.0657										22	61					CTNS (inh=n/a pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00), P2RX5-TAX1BP3 (inh=n/a pLI=n/a)
chr17	4801125	4801125	C	G	het		QUAL=593;DP=26;AF=0.62;MQM=59;TRIO=HET,26,0.62,HET,28,0.61,WT,33,0.00	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*543C>G:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*906G>C:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*543C>G:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*543C>G:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*543C>G:		rs9914357	0.2153	0.0000	0/0/0	0.0171										0	22					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=n/a pLI=0.00)
chr17	4801273	4801273	-	CTC	hom		QUAL=2426;DP=30;AF=0.83;MQM=58;TRIO=HOM,30,0.83,HOM,23,0.96,HOM,43,1.00	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*755_*757dupGAG:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*693_*695dupTCC:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:		rs368356907;rs538982347	0.0000	0.0000	0/0/0	0.5897										88	54					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=n/a pLI=0.00)
chr17	4801286	4801286	C	T	hom		QUAL=2449;DP=33;AF=0.97;MQM=60;TRIO=HOM,33,0.97,HOM,28,0.82,HOM,44,0.93	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*704C>T:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*745G>A:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*704C>T:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*704C>T:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*704C>T:		rs1053751	0.7712	0.0000	0/0/0	0.2560										108	34					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=n/a pLI=0.00)
chr17	4801288	4801288	A	C	hom		QUAL=2449;DP=33;AF=0.97;MQM=58;TRIO=HOM,33,0.97,HOM,28,0.82,HET,44,0.93	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*706A>C:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*743T>G:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*706A>C:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*706A>C:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*706A>C:		rs1053754	0.3662	0.0000	0/0/0	0.0797										52	69					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=n/a pLI=0.00)
chr17	4802685	4802685	G	A	het		QUAL=2365;DP=110;AF=0.55;MQM=59;TRIO=HET,110,0.55,HET,58,0.71,WT,84,0.00	CHRNE	splice_region&intron	CHRNE:NM_000080.3:splice_region&intron:LOW:exon9/11:c.1033-6C>T:		rs2075763	0.1062	0.0510	86/14/1	0.0476						100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel|Myasthenic syndrome,congenital,4B,fast-channel|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency];	RCV000116734.2 [likely benign]; 			7	149					CHRNE (inh=n/a pLI=0.00)
chr17	7127718	7127718	T	C	het		QUAL=5916;DP=292;AF=0.49;MQM=59;TRIO=HET,292,0.49,HET,244,0.46,WT,273,0.00	ACADVL	splice_region&intron	ACADVL:NM_001270447.1:splice_region&intron:LOW:exon17/20:c.1674+6T>C:,ACADVL:NM_000018.3:splice_region&intron:LOW:exon16/19:c.1605+6T>C:,ACADVL:NM_001033859.2:splice_region&intron:LOW:exon15/18:c.1539+6T>C:,ACADVL:NM_001270448.1:splice_region&intron:LOW:exon15/18:c.1377+6T>C:		rs17671352	0.5198	0.5980	21852/13466/920	0.5818						609575 [ACADVL (confirmed) VLCAD deficiency];	RCV000077908.5 [benign]; RCV000169539.1 [benign]; 			513	464					ACADVL (inh=n/a pLI=0.00)
chr17	7360110	7360110	T	C	het		QUAL=9935;DP=355;AF=0.51;MQM=59;TRIO=HET,355,0.51,WT,266,0.00,HET,364,0.54	CHRNB1	3'UTR	CHRNB1:NM_000747.2:3'UTR:MODIFIER:exon11/11:c.*68T>C:		rs2302764	0.3057	0.0000	0/0/0	0.0483										7	75					CHRNB1 (inh=n/a pLI=0.00)
chr17	7490810	7490810	G	A	het	pred_pathogenic_1	QUAL=9223;DP=339;AF=0.50;MQM=59;TRIO=HET,339,0.50,HOM,175,1.00,WT,156,0.01	MPDU1	missense,non_coding_exon	MPDU1:NM_004870.3:missense:MODERATE:exon7/7:c.685G>A:p.Ala229Thr,MPDU1:NR_024603.1:non_coding_exon:MODIFIER:exon7/7:n.896G>A:		rs10852891	0.1562	0.1540	1582/983/164	0.1520	0.8700	T,T	T,D	P,.	B,.	604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If];	RCV000081188.4 [benign]; 		COSM3766188	26	265					MPDU1 (inh=n/a pLI=0.14)
chr17	7491177	7491177	G	T	hom		QUAL=36340;DP=370;AF=1.00;MQM=59;TRIO=HOM,370,1.00,HOM,306,1.00,HOM,447,1.00	MPDU1	3'UTR,non_coding_exon	MPDU1:NM_004870.3:3'UTR:MODIFIER:exon7/7:c.*308G>T:,MPDU1:NR_024603.1:non_coding_exon:MODIFIER:exon7/7:n.1263G>T:		rs4227	0.6819	0.6550	3712/912/51	0.2145						604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If];				377	232					MPDU1 (inh=n/a pLI=0.14)
chr17	7750177	7750177	-	ACC	hom	low_DP	QUAL=172;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,7,0.86,WT,6,1.00	KDM6B	disruptive_inframe_insertion	KDM6B:NM_001080424.1:disruptive_inframe_insertion:MODERATE:exon9/22:c.789_791dupACC:p.Pro264dup	(CCA)n	rs771743551;rs779500270	0.0000	0.0250	38/17/8	0.0213										10	24					KDM6B (inh=n/a pLI=1.00)
chr17	10297658	10297658	A	G	het		QUAL=12506;DP=454;AF=0.48;MQM=55;TRIO=HET,454,0.48,WT,521,0.00,HET,612,0.45	MYH8,MYHAS	missense,intron	MYH8:NM_002472.2:missense:MODERATE:exon35/40:c.5074T>C:p.Trp1692Arg,MYHAS:NR_125367.1:intron:MODIFIER:exon1/10:n.76+11134A>G:		rs8069834	0.4854	0.5090	17218/11431/2748	0.5024	0.9480	T	T,T	B	B	160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117692.1 [benign]; 		COSM3765969	399	484					MYH8 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10304500	10304500	C	T	het		QUAL=6565;DP=321;AF=0.46;MQM=60;TRIO=HET,321,0.46,WT,111,0.00,HET,167,0.62	MYH8,MYHAS	synonymous,intron	MYH8:NM_002472.2:synonymous:LOW:exon25/40:c.3117G>A:p.Gly1039Gly,MYHAS:NR_125367.1:intron:MODIFIER:exon1/10:n.77-4965C>T:		rs3744553	0.0505	0.0590	286/135/1	0.0559						160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117687.1 [benign]; 		COSM3999995	8	106					MYH8 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10318636	10318636	A	G	het		QUAL=28920;DP=590;AF=0.52;MQM=59;TRIO=HET,590,0.52,HOM,427,1.00,HET,519,0.48	MYH8,MYHAS	synonymous,intron	MYH8:NM_002472.2:synonymous:LOW:exon8/40:c.714T>C:p.Thr238Thr,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.167+9081A>G:		rs8068729	0.8624	0.9220	52039/29586/2290	0.8959						160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117694.1 [benign]; 			927	167					MYH8 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10324980	10324980	C	T	het		QUAL=7813;DP=260;AF=0.44;MQM=60;TRIO=HET,260,0.44,HOM,87,0.99,HET,150,0.53	MYH8,MYHAS	splice_region,5'UTR,intron	MYH8:NM_002472.2:splice_region:LOW:exon2/40:c.-31G>A:,MYH8:NM_002472.2:5'UTR:MODIFIER:exon2/40:c.-31G>A:,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.167+15425C>T:		rs2277648	0.4365	0.0000	0/0/0	0.4004										31	98					MYH8 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10427924	10427924	G	A	het	low_MQM	QUAL=17043;DP=391;AF=0.42;MQM=47;TRIO=HET,391,0.42,HET,493,0.47,HET,602,0.51	MYH2,MYHAS	synonymous,intron	MYH2:NM_001100112.1:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala,MYH2:NM_017534.5:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.168-42930G>A:		rs1042236	0.3189	0.2560	5940/882/52	0.2433						160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia];			COSM3765976	32	266					MYH2 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10448769	10448769	A	T	het		QUAL=13996;DP=278;AF=0.47;MQM=59;TRIO=HET,278,0.47,HOM,228,0.99,HET,304,0.50	MYH2,MYHAS	synonymous,intron	MYH2:NM_001100112.1:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro,MYH2:NM_017534.5:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.168-22085A>T:		rs11078850	0.5168	0.4810	15288/5671/517	0.4708						160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia];				208	517					MYH2 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10450816	10450816	T	C	het		QUAL=20351;DP=291;AF=0.46;MQM=59;TRIO=HET,291,0.46,HOM,356,1.00,HET,439,0.52	MYH2,MYHAS	synonymous,intron	MYH2:NM_001100112.1:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu,MYH2:NM_017534.5:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.168-20038T>C:		rs12600539	0.5435	0.4920	15912/5811/779	0.4796						160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia];			COSM3765977	222	512					MYH2 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10453015	10453015	T	C	het		QUAL=7036;DP=427;AF=0.42;MQM=60;TRIO=HET,427,0.42,HET,254,0.46,WT,346,0.00	MYH2,MYHAS	5'UTR_premature_start_codon_gain,5'UTR,intron	MYH2:NM_017534.5:5'UTR_premature_start_codon_gain:LOW:exon1/40:c.-126A>G:,MYH2:NM_017534.5:5'UTR:MODIFIER:exon1/40:c.-126A>G:,MYHAS:NR_125367.1:intron:MODIFIER:exon2/10:n.168-17839T>C:		rs74967762	0.0765	0.0000	0/0/0	0.0722										0	10					MYH2 (inh=n/a pLI=0.00), MYHAS (inh=n/a pLI=n/a)
chr17	10536018	10536018	G	A	het		QUAL=20145;DP=311;AF=0.49;MQM=60;TRIO=HET,311,0.49,WT,365,0.00,HOM,504,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon34/41:c.4731C>T:p.Ile1577Ile		rs2285479	0.4696	0.6090	24040/17495/504	0.5892						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117675.1 [benign]; 		COSM4000000	522	455					MYH3 (inh=AD pLI=0.00)
chr17	10541515	10541515	C	T	het		QUAL=23212;DP=270;AF=0.51;MQM=59;TRIO=HET,270,0.51,WT,478,0.01,HOM,651,1.00	MYH3	missense	MYH3:NM_002470.3:missense:MODERATE:exon27/41:c.3574G>A:p.Ala1192Thr		rs2285477	0.5865	0.6900	29937/20587/1707	0.6816	-0.4290	T	T	B	B	160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117670.1 [benign]; 		COSM4000001	612	406					MYH3 (inh=AD pLI=0.00)
chr17	10541741	10541741	A	G	het		QUAL=3334;DP=69;AF=0.43;MQM=59;TRIO=HET,69,0.43,HOM,106,0.98,WT,192,0.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon27/41:c.3348T>C:p.Ile1116Ile		rs201626	0.2610	0.1850	3362/355/79	0.1821						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117669.1 [benign]; 		COSM1749857	19	219					MYH3 (inh=AD pLI=0.00)
chr17	10542471	10542471	T	G	het		QUAL=9848;DP=274;AF=0.58;MQM=59;TRIO=HET,274,0.58,WT,142,0.01,HOM,171,0.99	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon25/41:c.3138A>C:p.Arg1046Arg		rs2285475	0.4665	0.6080	24022/17511/486	0.6077						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117668.1 [benign]; 		COSM4000003	523	454					MYH3 (inh=AD pLI=0.00)
chr17	10542765	10542765	A	G	het		QUAL=9317;DP=206;AF=0.52;MQM=60;TRIO=HET,206,0.52,WT,158,0.01,HOM,202,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon24/41:c.2952T>C:p.Ser984Ser		rs2285474	0.4665	0.6080	23991/17489/485	0.6075						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117665.1 [benign]; 		COSM4000004	524	454					MYH3 (inh=AD pLI=0.00)
chr17	10542886	10542886	T	C	het		QUAL=12561;DP=232;AF=0.48;MQM=59;TRIO=HET,232,0.48,WT,242,0.00,HOM,297,0.99	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon23/41:c.2916A>G:p.Thr972Thr		rs2285472	0.4663	0.6080	24022/17513/486	0.5778						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117664.1 [benign]; 		COSM4000005	523	456					MYH3 (inh=AD pLI=0.00)
chr17	10543463	10543463	T	C	het		QUAL=17678;DP=262;AF=0.50;MQM=59;TRIO=HET,262,0.50,WT,365,0.01,HOM,441,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon22/41:c.2532A>G:p.Ala844Ala		rs2285469	0.4665	0.6080	24025/17513/486	0.5967						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117662.1 [benign]; 		COSM4000006	524	454					MYH3 (inh=AD pLI=0.00)
chr17	10544416	10544416	G	T	het		QUAL=14953;DP=290;AF=0.48;MQM=60;TRIO=HET,290,0.48,WT,279,0.01,HOM,358,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon19/41:c.2151C>A:p.Gly717Gly		rs876657	0.0000	0.6080	23980/17489/479	0.5864						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];	RCV000117661.1 [benign]; 		COSM4000007	524	443					MYH3 (inh=AD pLI=0.00)
chr17	10544697	10544697	A	-	het		QUAL=11033;DP=243;AF=0.55;MQM=59;TRIO=HET,243,0.55,WT,201,0.01,HOM,267,0.98	MYH3	splice_region&intron	MYH3:NM_002470.3:splice_region&intron:LOW:exon17/40:c.1960-8delT:		rs3216884;rs397857823	0.4673	0.6100	23904/17389/472	0.5513						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B|Arthrogryposis,distal,type 8];				513	456					MYH3 (inh=AD pLI=0.00)
chr17	10583714	10583714	G	C	hom		QUAL=13159;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HET,175,0.51,HET,202,0.57	SCO1	3'UTR	SCO1:NM_004589.3:3'UTR:MODIFIER:exon6/6:c.*722C>G:		rs7512	0.4778	0.0000	0/0/0	0.0762										41	112					SCO1 (inh=n/a pLI=0.51)
chr17	10584116	10584116	C	T	hom		QUAL=15078;DP=148;AF=1.00;MQM=59;TRIO=HOM,148,1.00,HOM,155,1.00,HOM,220,1.00	SCO1	3'UTR	SCO1:NM_004589.3:3'UTR:MODIFIER:exon6/6:c.*320G>A:		rs2040570	1.0000	0.0000	0/0/0	0.1480										230	0					SCO1 (inh=n/a pLI=0.51)
chr17	13972811	13972811	G	A	hom	low_DP	QUAL=467;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,2,1.00,HOM,10,1.00	COX10	5'UTR	COX10:NM_001303.3:5'UTR:MODIFIER:exon1/7:c.-112G>A:		rs6502330	0.9956	0.0000	0/0/0	0.8663										185	6					COX10 (inh=n/a pLI=0.65)
chr17	13980058	13980058	A	T	het	phylop_high	QUAL=9024;DP=434;AF=0.46;MQM=60;TRIO=HET,434,0.46,WT,230,0.00,HET,295,0.53	COX10	missense	COX10:NM_001303.3:missense:MODERATE:exon3/7:c.184A>T:p.Thr62Ser		rs2230351	0.0615	0.0760	415/204/2	0.0748	6.0420	T,T	.,T	.,B	.,B	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124571.1 [benign]; 		COSM4000018	5	116					COX10 (inh=n/a pLI=0.65)
chr17	13980350	13980350	G	A	het	phylop_high	QUAL=19869;DP=406;AF=0.55;MQM=60;TRIO=HET,406,0.55,HOM,277,1.00,HET,385,0.50	COX10	missense	COX10:NM_001303.3:missense:MODERATE:exon3/7:c.476G>A:p.Arg159Gln		rs2072279	0.4639	0.4940	14893/8373/1058	0.4890	7.1630	T,T	T,T	B,B	B,B	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124574.1 [benign]; 			318	514					COX10 (inh=n/a pLI=0.65)
chr17	14095309	14095309	A	G	het		QUAL=6582;DP=185;AF=0.45;MQM=52;TRIO=HET,185,0.45,HOM,105,0.99,HET,156,0.48	COX10	synonymous	COX10:NM_001303.3:synonymous:LOW:exon6/7:c.699A>G:p.Pro233Pro		rs2230354	0.5483	0.5850	20957/11887/1153	0.5297						602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124560.2 [benign]; 		COSM3765989	383	532					COX10 (inh=n/a pLI=0.65)
chr17	14110669	14110670	TT	-	het		QUAL=1904;DP=181;AF=0.46;MQM=59;TRIO=HET,181,0.46,HET,116,0.51,WT,131,0.02	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*151_*152delTT:		rs200239586	0.2021	0.0000	0/0/0	0.1075										5	52					COX10 (inh=n/a pLI=0.65)
chr17	14110852	14110852	T	C	het		QUAL=5974;DP=218;AF=0.48;MQM=60;TRIO=HET,218,0.48,HET,275,0.48,WT,396,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*322T>C:		rs11078233	0.1991	0.0000	0/0/0	0.0307										6	57					COX10 (inh=n/a pLI=0.65)
chr17	14110901	14110901	A	G	het		QUAL=5242;DP=230;AF=0.46;MQM=60;TRIO=HET,230,0.46,HET,241,0.44,WT,342,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*371A>G:		rs11078234	0.2206	0.0000	0/0/0	0.1876										6	59					COX10 (inh=n/a pLI=0.65)
chr17	14111176	14111176	C	A	het		QUAL=6349;DP=257;AF=0.47;MQM=59;TRIO=HET,257,0.47,HET,261,0.53,WT,321,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*646C>A:		rs7214082	0.1995	0.0000	0/0/0	0.1725										6	59					COX10 (inh=n/a pLI=0.65)
chr17	14111287	14111287	T	C	het		QUAL=8350;DP=366;AF=0.49;MQM=60;TRIO=HET,366,0.49,HET,261,0.54,WT,309,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*757T>C:		rs1802618	0.2001	0.0000	0/0/0	0.0310										6	59					COX10 (inh=n/a pLI=0.65)
chr17	14111361	14111362	CT	-	het		QUAL=7158;DP=330;AF=0.50;MQM=59;TRIO=HET,330,0.50,HET,312,0.48,WT,375,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*833_*834delCT:		rs397763766	0.1999	0.0000	0/0/0	0.1580										6	59					COX10 (inh=n/a pLI=0.65)
chr17	14111606	14111606	T	C	het		QUAL=7928;DP=421;AF=0.50;MQM=59;TRIO=HET,421,0.50,HET,176,0.53,WT,208,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1076T>C:		rs1050216	0.2133	0.0000	0/0/0	0.1857										6	59					COX10 (inh=n/a pLI=0.65)
chr17	14111797	14111797	A	G	het		QUAL=6314;DP=322;AF=0.51;MQM=60;TRIO=HET,322,0.51,HET,139,0.50,WT,170,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1267A>G:		rs75844637	0.0086	0.0000	0/0/0	0.0024										0	7					COX10 (inh=n/a pLI=0.65)
chr17	14111915	14111915	C	T	het		QUAL=7095;DP=303;AF=0.48;MQM=60;TRIO=HET,303,0.48,WT,158,0.00,HET,224,0.54	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1385C>T:		rs1050223	0.2266	0.0000	0/0/0	0.0490										30	85					COX10 (inh=n/a pLI=0.65)
chr17	15133706	15133707	AG	-	hom		QUAL=10971;DP=260;AF=0.98;MQM=59;TRIO=HOM,260,0.98,HET,130,0.44,HET,170,0.52	PMP22	3'UTR,non_coding_exon	PMP22:NM_000304.3:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_153322.2:3'UTR:MODIFIER:exon4/4:c.*527_*528delCT:,PMP22:NM_001281455.1:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_153321.2:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_001281456.1:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NR_104017.1:non_coding_exon:MODIFIER:exon4/4:n.1136_1137delCT:,PMP22:NR_104018.1:non_coding_exon:MODIFIER:exon3/3:n.1036_1037delCT:		rs869161943	0.3193	0.0000	0/0/0	0.3481										35	118					PMP22 (inh=n/a pLI=0.83)
chr17	15134175	15134175	T	G	hom		QUAL=24063;DP=309;AF=1.00;MQM=60;TRIO=HOM,309,1.00,HOM,301,1.00,HET,387,0.45	PMP22	3'UTR,non_coding_exon	PMP22:NM_000304.3:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_153322.2:3'UTR:MODIFIER:exon4/4:c.*59A>C:,PMP22:NM_001281455.1:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_153321.2:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_001281456.1:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NR_104017.1:non_coding_exon:MODIFIER:exon4/4:n.668A>C:,PMP22:NR_104018.1:non_coding_exon:MODIFIER:exon3/3:n.568A>C:		rs13422	0.5954	0.5310	17161/8416/2590	0.5257										131	243					PMP22 (inh=n/a pLI=0.83)
chr17	15931693	15931693	G	A	het		QUAL=9885;DP=293;AF=0.51;MQM=60;TRIO=HET,293,0.51,HET,202,0.46,HET,249,0.52	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*857G>A:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*857G>A:		rs72821769	0.0327	0.0480	27/20/0	0.0139										5	120					TTC19 (inh=AR pLI=0.00)
chr17	15932071	15932071	-	TT	hom		QUAL=6737;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HOM,62,1.00,HET,75,0.49	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:		rs386385756;rs61349729	0.4944	0.4620	1380/555/31	0.1190										236	320					TTC19 (inh=AR pLI=0.00)
chr17	15932420	15932420	-	GAG	het		QUAL=1937;DP=88;AF=0.47;MQM=59;TRIO=HET,88,0.47,WT,47,0.00,HET,95,0.43	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1584_*1585insGAG:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1584_*1585insGAG:		rs758709551	0.0000	0.0110	3/3/0	0.0004										0	27					TTC19 (inh=AR pLI=0.00)
chr17	15932422	15932422	-	AGTAAAAA	het		QUAL=1716;DP=85;AF=0.44;MQM=59;TRIO=HET,85,0.44,WT,43,0.00,HET,91,0.41	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1586_*1587insAGTAAAAA:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1586_*1587insAGTAAAAA:		rs778157002	0.0000	0.0110	3/3/0	0.0004										0	26					TTC19 (inh=AR pLI=0.00)
chr17	15932627	15932627	T	C	hom		QUAL=9314;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,53,1.00,HET,84,0.45	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1791T>C:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1791T>C:		rs9890012	0.3674	0.4110	1112/483/8	0.1086										186	294					TTC19 (inh=AR pLI=0.00)
chr17	16842912	16842912	A	G	het		QUAL=874;DP=48;AF=0.40;MQM=59;TRIO=HET,48,0.40,HET,59,0.41,WT,66,0.00	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon5/5:c.831T>C:p.Ser277Ser		rs11078355	0.5952	0.4920	15663/5421/1951	0.4748						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];			COSM3766008	276	514					TNFRSF13B (inh=n/a pLI=0.00)
chr17	16852206	16852206	A	C	het		QUAL=6336;DP=242;AF=0.46;MQM=60;TRIO=HET,242,0.46,HET,284,0.48,WT,346,0.00	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon3/5:c.291T>G:p.Pro97Pro		rs35062843	0.0485	0.0420	165/56/3	0.0414						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];				2	90					TNFRSF13B (inh=n/a pLI=0.00)
chr17	16855878	16855878	C	T	hom		QUAL=18887;DP=173;AF=0.99;MQM=59;TRIO=HOM,173,0.99,HOM,190,0.99,HOM,266,0.99	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon2/5:c.81G>A:p.Thr27Thr		rs8072293	0.8996	0.8110	40369/18884/4689	0.7824						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];	RCV000030561.1 [benign]; 			629	386					TNFRSF13B (inh=n/a pLI=0.00)
chr17	17697094	17697096	CAG	-	hom		QUAL=2690;DP=47;AF=0.49;MQM=60;TRIO=HOM,47,0.49,HET,303,0.53,WT,362,0.10	RAI1	disruptive_inframe_deletion	RAI1:NM_030665.3:disruptive_inframe_deletion:MODERATE:exon3/6:c.870_872delGCA:p.Gln291del	(CAG)n	rs113303801;rs371983878;rs794727527;rs794727528	0.0000	0.1550	48/16/27	0.1382						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000177381.3,RCV000177381.3 [benign,benign]; 		COSM1479304	10	84	1	[1] Ute Grasshoff 04.07.2014			RAI1 (inh=AD pLI=1.00)
chr17	17698254	17698254	G	A	hom		QUAL=8161;DP=142;AF=0.99;MQM=59;TRIO=HOM,142,0.99,HOM,56,1.00,HOM,79,0.99	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.1992G>A:p.Pro664Pro		rs8067439	0.3998	0.5060	17240/12958/1675	0.5075						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082257.7 [other]; 		COSM3766017, COSM3766018	390	508					RAI1 (inh=AD pLI=1.00)
chr17	17700573	17700573	T	C	het		QUAL=2518;DP=185;AF=0.44;MQM=59;TRIO=HET,185,0.44,HET,56,0.63,WT,106,0.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.4311T>C:p.Pro1437Pro		rs4925112	0.0946	0.0640	505/128/339	0.0625						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082268.7 [other]; 			7	117					RAI1 (inh=AD pLI=1.00)
chr17	17700792	17700792	C	T	het		QUAL=2837;DP=86;AF=0.38;MQM=60;TRIO=HET,86,0.38,HET,176,0.55,WT,227,0.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.4530C>T:p.Pro1510Pro		rs35686634	0.0731	0.0580	340/125/178	0.0557						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082270.7 [other]; 			7	112					RAI1 (inh=AD pLI=1.00)
chr17	17707105	17707105	T	C	het		QUAL=13511;DP=195;AF=0.48;MQM=59;TRIO=HET,195,0.48,HET,212,0.58,HOM,251,1.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon4/6:c.5601T>C:p.Ile1867Ile		rs3818717	0.2406	0.4210	12779/10732/166	0.4193	-1.2000	T	T,T			607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082273.7 [other]; 		COSM3766019	305	529					RAI1 (inh=AD pLI=1.00)
chr17	17714717	17714717	G	A	hom		QUAL=1212;DP=40;AF=0.20;MQM=60;TRIO=HOM,40,0.20,HOM,11,0.18,HOM,7,0.00	RAI1,SREBF1	3'UTR	RAI1:NM_030665.3:3'UTR:MODIFIER:exon6/6:c.*1422G>A:,SREBF1:NM_001005291.2:3'UTR:MODIFIER:exon20/20:c.*1219C>T:,SREBF1:NM_004176.4:3'UTR:MODIFIER:exon19/19:c.*1219C>T:			0.0000	0.0000	0/0/0	0.0001										0	34					RAI1 (inh=AD pLI=1.00), SREBF1 (inh=n/a pLI=0.99)
chr17	19578873	19578873	A	T	hom		QUAL=18056;DP=331;AF=1.00;MQM=60;TRIO=HOM,331,1.00,HET,239,0.51,HET,308,0.47	ALDH3A2	splice_region,splice_region&synonymous,3'UTR	ALDH3A2:NM_001031806.1:splice_region:LOW:exon11/11:c.*44A>T:,ALDH3A2:NM_000382.2:splice_region&synonymous:LOW:exon10/10:c.1446A>T:p.Ala482Ala,ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*44A>T:		rs7216	0.6785	0.6150	24079/10338/1460	0.5986						609523 [ALDH3A2 (confirmed) Sjogren-Larsson syndrome];			COSM3766033	493	769					ALDH3A2 (inh=AR pLI=0.01)
chr17	19580494	19580494	A	G	hom		QUAL=23112;DP=528;AF=1.00;MQM=60;TRIO=HOM,528,1.00,HET,237,0.44,HET,288,0.43	ALDH3A2	3'UTR	ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*1665A>G:,ALDH3A2:NM_000382.2:3'UTR:MODIFIER:exon10/10:c.*1609A>G:		rs7215	0.6042	0.0000	0/0/0	0.1016										81	99					ALDH3A2 (inh=AR pLI=0.01)
chr17	19580761	19580762	AC	-	hom		QUAL=6063;DP=176;AF=0.98;MQM=59;TRIO=HOM,176,0.98,HET,58,0.50,HET,84,0.50	ALDH3A2	3'UTR	ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*1935_*1936delCA:,ALDH3A2:NM_000382.2:3'UTR:MODIFIER:exon10/10:c.*1879_*1880delCA:		rs4646805	0.3273	0.0000	0/0/0	0.2855										33	103					ALDH3A2 (inh=AR pLI=0.01)
chr17	26864302	26864302	G	C	het		QUAL=10785;DP=116;AF=0.60;MQM=59;TRIO=HET,116,0.60,HOM,191,1.00,HET,243,0.50	FOXN1	missense	FOXN1:NM_003593.2:missense:MODERATE:exon8/8:c.1795G>C:p.Ala599Pro		rs532648	0.3928	0.3220	6785/2847/1780	0.3164	0.5980	T	T	B	B	600838 [FOXN1 (provisional) T-cell immunodeficiency,congenital alopecia,and nail dystrophy];			COSM4000076	99	469					FOXN1 (inh=n/a pLI=0.97)
chr17	29483108	29483108	C	T	het		QUAL=4729;DP=242;AF=0.51;MQM=60;TRIO=HET,242,0.51,WT,191,0.00,HET,211,0.34	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon2/58:c.168C>T:p.Ser56Ser,NF1:NM_001128147.2:synonymous:LOW:exon2/15:c.168C>T:p.Ser56Ser,NF1:NM_000267.3:synonymous:LOW:exon2/57:c.168C>T:p.Ser56Ser		rs17881168	0.0046	0.0120	14/11/1	0.0129						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000163256.1 [benign]; RCV000205406.1 [benign]; RCV000215995.1 [benign]; 			2	89					NF1 (inh=AD pLI=1.00)
chr17	29508775	29508775	G	A	het		QUAL=6185;DP=330;AF=0.45;MQM=59;TRIO=HET,330,0.45,WT,146,0.00,HET,190,0.46	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon7/58:c.702G>A:p.Leu234Leu,NF1:NM_001128147.2:synonymous:LOW:exon7/15:c.702G>A:p.Leu234Leu,NF1:NM_000267.3:synonymous:LOW:exon7/57:c.702G>A:p.Leu234Leu		rs1801052	0.5118	0.6220	24613/16345/471	0.6200						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000162647.1 [benign]; RCV000218671.1 [benign]; 		COSM3755377, COSM3755378	1149	972					NF1 (inh=AD pLI=1.00)
chr17	29553485	29553485	G	A	het		QUAL=6887;DP=133;AF=0.53;MQM=59;TRIO=HET,133,0.53,HOM,113,1.00,HET,141,0.57	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.3820	9925/3078/2462	0.3658						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000162648.1 [benign]; RCV000219876.1 [benign]; 			215	973					NF1 (inh=AD pLI=1.00)
chr17	29559088	29559088	C	T	het		QUAL=71;DP=66;AF=0.21;MQM=51;TRIO=HET,66,0.21,WT,25,0.08,WT,45,0.04	NF1	splice_region&intron	NF1:NM_001042492.2:splice_region&intron:LOW:exon24/57:c.3198-3C>T:,NF1:NM_000267.3:splice_region&intron:LOW:exon24/56:c.3198-3C>T:		rs777759972	0.0000	0.0001	0/0/0	0.0001						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0	63	2	[2] Stefanie Beck-Woedl 29.03.2015			NF1 (inh=AD pLI=1.00)
chr17	29702031	29702032	TA	-	hom	low_DP	QUAL=149;DP=6;AF=0.83;MQM=60;TRIO=HOM,6,0.83,HOM,1,1.00,WT,45,0.04	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*873_*874delAT:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*873_*874delAT:	(TA)n	rs34207771;rs369548314	0.5551	0.0000	0/0/0	0.2688										21	61					NF1 (inh=AD pLI=1.00)
chr17	29703374	29703374	G	A	het		QUAL=12801;DP=278;AF=0.54;MQM=60;TRIO=HET,278,0.54,HOM,185,0.99,HET,207,0.56	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2201G>A:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2201G>A:		rs7406983	0.5306	0.0000	0/0/0	0.0684										25	95					NF1 (inh=AD pLI=1.00)
chr17	29703438	29703438	C	G	het		QUAL=10318;DP=332;AF=0.47;MQM=60;TRIO=HET,332,0.47,HOM,124,0.99,HET,135,0.58	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2265C>G:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2265C>G:		rs1800845	0.5587	0.0000	0/0/0	0.0699										25	96					NF1 (inh=AD pLI=1.00)
chr17	29704002	29704002	T	C	het		QUAL=10917;DP=424;AF=0.50;MQM=60;TRIO=HET,424,0.50,WT,340,0.01,HET,432,0.51	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2829T>C:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2829T>C:		rs1048317	0.6126	0.0000	0/0/0	0.1199										93	104					NF1 (inh=AD pLI=1.00)
chr17	33901918	33901921	TAAG	-	het		QUAL=1871;DP=136;AF=0.51;MQM=59;TRIO=HET,136,0.51,HET,32,0.56,WT,41,0.00	PEX12	3'UTR	PEX12:NM_000286.2:3'UTR:MODIFIER:exon3/3:c.*880_*883delCTTA:		rs35050283	0.4465	0.0000	0/0/0	0.4390										50	118					PEX12 (inh=n/a pLI=0.00)
chr17	33901965	33901965	C	G	het		QUAL=4812;DP=197;AF=0.54;MQM=60;TRIO=HET,197,0.54,HET,69,0.51,HET,91,0.46	PEX12	3'UTR	PEX12:NM_000286.2:3'UTR:MODIFIER:exon3/3:c.*836G>C:		rs10068	0.4010	0.0000	0/0/0	0.0649										32	113					PEX12 (inh=n/a pLI=0.00)
chr17	33905468	33905468	A	G	hom		QUAL=13338;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HOM,167,1.00,HET,233,0.49	PEX12	5'UTR	PEX12:NM_000286.2:5'UTR:MODIFIER:exon1/3:c.-428T>C:		rs321600	0.8774	0.0000	0/0/0	0.1393										146	75					PEX12 (inh=n/a pLI=0.00)
chr17	37822311	37822311	A	C	het		QUAL=9785;DP=201;AF=0.51;MQM=59;TRIO=HET,201,0.51,WT,230,0.00,HOM,238,1.00	TCAP	synonymous	TCAP:NM_003673.3:synonymous:LOW:exon2/2:c.453A>C:p.Ala151Ala		rs1053651	0.5497	0.6690	27830/17324/955	0.6617						604488 [TCAP (confirmed) Muscular dystrophy,limb-girdle,type 2G|Cardiomyopathy,hypertrophic,25];	RCV000154431.1 [benign]; RCV000037796.8 [benign]; 		COSM436493	618	494					TCAP (inh=n/a pLI=0.08)
chr17	38783971	38783972	TT	-	hom		QUAL=4530;DP=118;AF=0.99;MQM=59;TRIO=HOM,118,0.99,HOM,16,1.00,HOM,23,1.00	CCR7-SMARCE1	intergenic_region	CCR7-SMARCE1:CCR7-SMARCE1:intergenic_region:MODIFIER::n.38783971_38783972delTT:		rs59835738;rs869254366	0.0000	0.0000	0/0/0	0.2492										53	101					CCR7-SMARCE1 (inh=n/a pLI=n/a)
chr17	40465420	40465420	G	A	het		QUAL=203;DP=65;AF=0.43;MQM=51;TRIO=HET,65,0.43,WT,39,0.15,HET,52,0.25	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*2343C>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*2437C>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*2343C>T:	(A)n	rs200029754	0.0000	0.0000	0/0/0	0.0004										0	58					STAT3 (inh=n/a pLI=1.00)
chr17	40465422	40465422	C	A	het		QUAL=203;DP=65;AF=0.43;MQM=51;TRIO=HET,65,0.43,WT,39,0.15,HET,52,0.25	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*2341G>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*2435G>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*2341G>T:	(A)n		0.0000	0.0000	0/0/0	0.0006										0	37					STAT3 (inh=n/a pLI=1.00)
chr17	40466092	40466092	G	A	het		QUAL=9468;DP=175;AF=0.56;MQM=60;TRIO=HET,175,0.56,HET,137,0.63,HOM,165,1.00	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*1671C>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*1765C>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*1671C>T:		rs1053004	0.4499	0.0000	0/0/0	0.0988										90	115					STAT3 (inh=n/a pLI=1.00)
chr17	40466869	40466869	C	T	het		QUAL=353;DP=181;AF=0.30;MQM=56;TRIO=HET,181,0.30,HET,54,0.19,HET,70,0.17	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*894G>A:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*988G>A:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*894G>A:	AluSc8		0.0000	0.0000	0/0/0	0.0003										7	46					STAT3 (inh=n/a pLI=1.00)
chr17	40689455	40689455	T	C	hom		QUAL=21766;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,198,1.00,HOM,295,1.00	NAGLU	synonymous	NAGLU:NM_000263.3:synonymous:LOW:exon2/6:c.423T>C:p.Ser141Ser		rs659497	0.9976	0.9950	60052/32838/5192	0.9721						609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B)|Charcot-Marie-Tooth disease,axonal,type 2V];	RCV000078458.4 [benign]; 			1098	9					NAGLU (inh=AR+AD pLI=0.00)
chr17	40696233	40696233	C	G	hom	pred_pathogenic_1	QUAL=2856;DP=46;AF=0.98;MQM=59;TRIO=HOM,46,0.98,HOM,17,1.00,HOM,30,1.00	NAGLU	missense	NAGLU:NM_000263.3:missense:MODERATE:exon6/6:c.2209C>G:p.Arg737Gly		rs86312	0.8592	0.9050	49702/28044/2166	0.8676	0.8780	T	D,T	P	B	609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B)|Charcot-Marie-Tooth disease,axonal,type 2V];	RCV000078456.4 [benign]; RCV000078457.4 [benign]; 		COSM4130095	925	173					NAGLU (inh=AR+AD pLI=0.00)
chr17	42085150	42085150	T	C	hom	low_DP	QUAL=337;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,4,1.00,HOM,2,1.00	NAGS	splice_region&intron	NAGS:NM_153006.2:splice_region&intron:LOW:exon6/6:c.1451+9T>C:		rs228773	0.9603	0.9270	24550/11656/1857	0.7860						608300 [NAGS (confirmed) N-acetylglutamate synthase deficiency];				946	99					NAGS (inh=AR pLI=0.00)
chr17	42085972	42085972	C	T	hom		QUAL=15950;DP=286;AF=0.99;MQM=59;TRIO=HOM,286,0.99,HOM,146,1.00,HET,227,0.52	NAGS	3'UTR	NAGS:NM_153006.2:3'UTR:MODIFIER:exon7/7:c.*3C>T:		rs186636	0.4756	0.5660	20389/13970/861	0.5506										472	479					NAGS (inh=AR pLI=0.00)
chr17	42086180	42086180	C	T	hom		QUAL=32772;DP=365;AF=0.99;MQM=59;TRIO=HOM,365,0.99,HOM,282,1.00,HOM,386,1.00	NAGS	3'UTR	NAGS:NM_153006.2:3'UTR:MODIFIER:exon7/7:c.*211C>T:		rs640631	0.8948	0.0000	0/0/0	0.8553										209	21					NAGS (inh=AR pLI=0.00)
chr17	42148205	42148205	C	T	het		QUAL=1286;DP=56;AF=0.64;MQM=58;TRIO=HET,56,0.64,HOM,25,0.96,WT,39,0.00	G6PC3	5'UTR_premature_start_codon_gain,5'UTR,non_coding_exon	G6PC3:NM_138387.3:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-129C>T:,G6PC3:NM_138387.3:5'UTR:MODIFIER:exon1/6:c.-129C>T:,G6PC3:NR_028581.1:non_coding_exon:MODIFIER:exon1/7:n.108C>T:,G6PC3:NR_028582.1:non_coding_exon:MODIFIER:exon1/6:n.108C>T:		rs228758	0.3231	0.3700	1438/377/1	0.1066										184	317					G6PC3 (inh=n/a pLI=0.00)
chr17	42983193	42983193	A	G	het		QUAL=6361;DP=170;AF=0.52;MQM=59;TRIO=HET,170,0.52,HET,158,0.54,HET,177,0.46	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*1522T>C:		rs17027	0.2438	0.0000	0/0/0	0.2478										22	99					GFAP (inh=AD pLI=0.00)
chr17	42984085	42984085	C	T	het		QUAL=7716;DP=325;AF=0.50;MQM=59;TRIO=HET,325,0.50,WT,253,0.00,HET,325,0.50	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*630G>A:	FLAM_A	rs72828813	0.0036	0.0000	0/0/0	0.0085										0	4					GFAP (inh=AD pLI=0.00)
chr17	42984687	42984687	G	C	het		QUAL=3909;DP=119;AF=0.55;MQM=59;TRIO=HET,119,0.55,HET,68,0.50,HET,100,0.53	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*28C>G:		rs11558961	0.2438	0.2670	4378/2546/281	0.2599							RCV000056816.1 [not provided]; 			30	143					GFAP (inh=AD pLI=0.00)
chr17	42987523	42987523	G	A	het	phylop_high;pred_pathogenic_1	QUAL=9188;DP=223;AF=0.45;MQM=59;TRIO=HET,223,0.45,HET,228,0.47,HET,355,0.50	GFAP	missense,3'UTR,intron	GFAP:NM_001131019.2:missense:MODERATE:exon8/8:c.1277C>T:p.Thr426Met,GFAP:NM_001242376.1:3'UTR:MODIFIER:exon7/7:c.*314C>T:,GFAP:NM_002055.4:intron:MODIFIER:exon7/8:c.1171+460C>T:		rs9908084	0.1056	0.1370	1356/952/36	0.1265	1.9410	T	D	B	B	137780 [GFAP (confirmed) Alexander disease];			COSM3755582	86	709					GFAP (inh=AD pLI=0.00)
chr17	42987524	42987524	T	C	het		QUAL=9188;DP=223;AF=0.45;MQM=59;TRIO=HET,223,0.45,HET,228,0.47,HET,355,0.50	GFAP	missense,3'UTR,intron	GFAP:NM_001131019.2:missense:MODERATE:exon8/8:c.1276A>G:p.Thr426Ala,GFAP:NM_001242376.1:3'UTR:MODIFIER:exon7/7:c.*313A>G:,GFAP:NM_002055.4:intron:MODIFIER:exon7/8:c.1171+459A>G:		rs9916491	0.2436	0.2670	4424/2575/266	0.2521	0.7530	T	T	B	B	137780 [GFAP (confirmed) Alexander disease];			COSM4000176	224	967					GFAP (inh=AD pLI=0.00)
chr17	45196190	45196190	T	C	het		QUAL=8090;DP=277;AF=0.53;MQM=59;TRIO=HET,277,0.53,HET,132,0.57,HET,166,0.49	CDC27	3'UTR	CDC27:NM_001114091.2:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001256.4:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001293089.1:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001293091.1:3'UTR:MODIFIER:exon18/18:c.*2111A>G:		rs1713494	0.2808	0.0000	0/0/0	0.0616										35	104					CDC27 (inh=n/a pLI=0.49)
chr17	45214558	45214558	G	A	het	low_MQM;anno_high_impact;phylop_high	QUAL=72;DP=143;AF=0.16;MQM=37;TRIO=HET,143,0.16,WT,80,0.01,WT,122,0.07	CDC27	stop_gained	CDC27:NM_001114091.2:stop_gained:HIGH:exon14/19:c.1891C>T:p.Arg631*,CDC27:NM_001256.4:stop_gained:HIGH:exon14/19:c.1873C>T:p.Arg625*,CDC27:NM_001293089.1:stop_gained:HIGH:exon14/19:c.1870C>T:p.Arg624*,CDC27:NM_001293091.1:stop_gained:HIGH:exon13/18:c.1690C>T:p.Arg564*		rs77685276	0.0000	0.4950	0/0/0	0.0196	2.0410									0	433	2	[2] old entry - no details available			CDC27 (inh=n/a pLI=0.49)
chr17	45214682	45214682	A	G	het	low_MQM	QUAL=59;DP=169;AF=0.15;MQM=39;TRIO=HET,169,0.15,WT,81,0.01,WT,126,0.03	CDC27	synonymous	CDC27:NM_001114091.2:synonymous:LOW:exon14/19:c.1767T>C:p.His589His,CDC27:NM_001256.4:synonymous:LOW:exon14/19:c.1749T>C:p.His583His,CDC27:NM_001293089.1:synonymous:LOW:exon14/19:c.1746T>C:p.His582His,CDC27:NM_001293091.1:synonymous:LOW:exon13/18:c.1566T>C:p.His522His		rs62075622	0.0000	0.4860	0/0/0	0.0149									COSM4130203, COSM4130204	0	288					CDC27 (inh=n/a pLI=0.49)
chr17	45219669	45219669	G	A	het	low_MQM;phylop_high;pred_pathogenic_2	QUAL=87;DP=102;AF=0.25;MQM=26;TRIO=HET,102,0.25,WT,25,0.00,WT,34,0.00	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon11/19:c.1322C>T:p.Ser441Phe,CDC27:NM_001256.4:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe,CDC27:NM_001293089.1:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe,CDC27:NM_001293091.1:missense:MODERATE:exon10/18:c.1121C>T:p.Ser374Phe		rs11491191	0.0000	0.0350	0/0/0	0.0005	4.9730	T	D,D,D,D	D,D,D,D	P,P,P,P				COSM3932634, COSM3932635	0	136					CDC27 (inh=n/a pLI=0.49)
chr17	45234303	45234303	G	C	het	low_MQM;phylop_high;pred_pathogenic_1	QUAL=453;DP=131;AF=0.36;MQM=34;TRIO=HET,131,0.36,HET,41,0.22,HET,44,0.23	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.635C>G:p.Ala212Gly		rs200611688	0.0000	0.4380	0/0/0	0.0050	9.2600	T	D,D,D,D,D	B,P,P,B	B,B,B,B				COSM1178872, COSM1178871	0	342					CDC27 (inh=n/a pLI=0.49)
chr17	45234407	45234407	A	-	het	low_MQM;anno_high_impact	QUAL=1934;DP=223;AF=0.35;MQM=34;TRIO=HET,223,0.35,HET,81,0.28,HET,107,0.35	CDC27	frameshift	CDC27:NM_001114091.2:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs,CDC27:NM_001256.4:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs,CDC27:NM_001293089.1:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs,CDC27:NM_001293091.1:frameshift:HIGH:exon6/18:c.531delT:p.Val178fs		rs112848754	0.0000	0.4880	0/0/0	0.0132										1	485	1	[1] old entry - no details available			CDC27 (inh=n/a pLI=0.49)
chr17	45234417	45234417	A	G	het	low_MQM;phylop_high	QUAL=1728;DP=208;AF=0.28;MQM=34;TRIO=HET,208,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.521T>C:p.Ile174Thr		rs193061947	0.0000	0.4810	0/0/0	0.0003	8.7540	T	T,T,T,T,T	B,B,B,B	B,B,B,B				COSM4130263, COSM4130264	1	443					CDC27 (inh=n/a pLI=0.49)
chr17	45234420	45234420	T	G	het	low_MQM;phylop_high	QUAL=1728;DP=208;AF=0.28;MQM=34;TRIO=HET,208,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.518A>C:p.Tyr173Ser		rs78493795	0.0000	0.4830	0/0/0	0.0005	7.5220	T	T,T,T,T,T	B,B,B,B	B,B,B,B				COSM3734971, COSM3734972	1	438					CDC27 (inh=n/a pLI=0.49)
chr17	45234449	45234449	G	A	het	low_MQM	QUAL=451;DP=179;AF=0.13;MQM=35;TRIO=HET,179,0.13,HET,76,0.21,HET,105,0.30	CDC27	synonymous	CDC27:NM_001114091.2:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001256.4:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001293089.1:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001293091.1:synonymous:LOW:exon6/18:c.489C>T:p.Tyr163Tyr		rs112216339	0.0000	0.3670	0/0/0	0.0003									COSM1383886, COSM1383887	0	315					CDC27 (inh=n/a pLI=0.49)
chr17	45234707	45234707	T	A	het	low_MQM;pred_pathogenic_1	QUAL=682;DP=365;AF=0.20;MQM=36;TRIO=HET,365,0.20,WT,149,0.04,WT,149,0.02	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001256.4:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001293089.1:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001293091.1:missense:MODERATE:exon5/18:c.336A>T:p.Leu112Phe		rs75353677	0.0000	0.4540	0/0/0	0.0029	0.5090	T	D,D,D,D,D	P,B,P,B	B,B,P,B				COSM1737257, COSM1737258	0	294					CDC27 (inh=n/a pLI=0.49)
chr17	45234710	45234710	A	C	het	low_MQM	QUAL=682;DP=365;AF=0.20;MQM=36;TRIO=HET,365,0.20,WT,149,0.04,WT,149,0.02	CDC27	synonymous	CDC27:NM_001114091.2:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser,CDC27:NM_001256.4:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser,CDC27:NM_001293089.1:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser,CDC27:NM_001293091.1:synonymous:LOW:exon5/18:c.333T>G:p.Ser111Ser		rs78395997	0.0000	0.3330	0/0/0	0.0007									COSM4130284, COSM4130283	0	244					CDC27 (inh=n/a pLI=0.49)
chr17	45234713	45234713	T	C	het	low_MQM	QUAL=439;DP=360;AF=0.19;MQM=32;TRIO=HET,360,0.19,WT,143,0.02,WT,141,0.03	CDC27	synonymous	CDC27:NM_001114091.2:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr,CDC27:NM_001256.4:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr,CDC27:NM_001293089.1:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr,CDC27:NM_001293091.1:synonymous:LOW:exon5/18:c.330A>G:p.Thr110Thr		rs139751753	0.0000	0.0480	0/0/0	0.0376									COSM1130261, COSM1130260	0	38					CDC27 (inh=n/a pLI=0.49)
chr17	45234760	45234760	-	A	het		QUAL=823;DP=103;AF=0.32;MQM=59;TRIO=HET,103,0.32,HET,59,0.29,HET,67,0.61	CDC27	splice_region&intron	CDC27:NM_001114091.2:splice_region&intron:LOW:exon5/18:c.476-11dupT:,CDC27:NM_001256.4:splice_region&intron:LOW:exon5/18:c.476-11dupT:,CDC27:NM_001293089.1:splice_region&intron:LOW:exon5/18:c.476-11dupT:,CDC27:NM_001293091.1:splice_region&intron:LOW:exon4/17:c.293-11dupT:		rs11372544;rs577503859	0.2694	0.3760	560/341/43	0.0495										70	289					CDC27 (inh=n/a pLI=0.49)
chr17	45368337	45368337	A	C	het		QUAL=18417;DP=235;AF=0.51;MQM=60;TRIO=HET,235,0.51,HET,298,0.55,HOM,349,0.99	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon9/15:c.1143A>C:p.Val381Val		rs15908	0.4311	0.3900	9633/4589/970	0.3807						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];				180	537					ITGB3 (inh=n/a pLI=0.14)
chr17	45369777	45369777	A	G	het		QUAL=5610;DP=105;AF=0.51;MQM=59;TRIO=HET,105,0.51,WT,103,0.01,HOM,147,1.00	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon10/15:c.1533A>G:p.Glu511Glu		rs4642	0.2873	0.2860	5006/2824/359	0.2842						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];			COSM1383908, COSM1383909, COSM4000179	111	457					ITGB3 (inh=n/a pLI=0.14)
chr17	45369789	45369789	G	A	het		QUAL=4968;DP=115;AF=0.45;MQM=59;TRIO=HET,115,0.45,WT,91,0.01,HOM,132,1.00	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon10/15:c.1545G>A:p.Arg515Arg		rs4634	0.2873	0.2860	5006/2822/359	0.2841						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];			COSM4000180, COSM1383912, COSM1383913	111	458					ITGB3 (inh=n/a pLI=0.14)
chr17	45385012	45385012	C	T	het		QUAL=6444;DP=184;AF=0.53;MQM=60;TRIO=HET,184,0.53,HET,357,0.46,WT,377,0.00	ITGB3,THCAT158	splice_region&intron,intron	ITGB3:NM_000212.2:splice_region&intron:LOW:exon14/14:c.2301+9C>T:,THCAT158:NR_110880.1:intron:MODIFIER:exon2/2:n.363-3864G>A:,THCAT158:NR_110881.1:intron:MODIFIER:exon2/2:n.227-3864G>A:		rs3809863	0.3990	0.4340	11551/7186/1198	0.4288						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];				217	552					ITGB3 (inh=n/a pLI=0.14), THCAT158 (inh=n/a pLI=n/a)
chr17	45388586	45388586	T	A	het		QUAL=7951;DP=292;AF=0.44;MQM=60;TRIO=HET,292,0.44,HOM,174,1.00,WT,271,0.01	ITGB3,THCAT158	3'UTR,intron	ITGB3:NM_000212.2:3'UTR:MODIFIER:exon15/15:c.*1016T>A:,THCAT158:NR_110880.1:intron:MODIFIER:exon2/2:n.362+7252A>T:,THCAT158:NR_110881.1:intron:MODIFIER:exon2/2:n.226+7252A>T:		rs3809865	0.7234	0.0000	0/0/0	0.1193										129	87					ITGB3 (inh=n/a pLI=0.14), THCAT158 (inh=n/a pLI=n/a)
chr17	46020698	46020698	C	T	het		QUAL=6571;DP=261;AF=0.54;MQM=60;TRIO=HET,261,0.54,HET,233,0.49,WT,343,0.00	PNPO	synonymous	PNPO:NM_018129.3:synonymous:LOW:exon2/7:c.165C>T:p.Ser55Ser		rs11079804	0.1625	0.1820	2276/900/33	0.1789						603287 [PNPO (provisional) Pyridoxamine 5'-phosphate oxidase deficiency];	RCV000118001.2 [likely benign]; 		COSM1179771	28	324					PNPO (inh=n/a pLI=0.00)
chr17	46026031	46026031	G	C	het		QUAL=10136;DP=396;AF=0.47;MQM=59;TRIO=HET,396,0.47,HET,427,0.50,WT,579,0.00	PNPO	3'UTR	PNPO:NM_018129.3:3'UTR:MODIFIER:exon7/7:c.*1883G>C:	MER5A1	rs1986694	0.1132	0.0000	0/0/0	0.1094										0	45					PNPO (inh=n/a pLI=0.00)
chr17	46026156	46026156	A	G	het		QUAL=18611;DP=264;AF=0.48;MQM=59;TRIO=HET,264,0.48,HOM,316,1.00,HET,427,0.47	PNPO	3'UTR	PNPO:NM_018129.3:3'UTR:MODIFIER:exon7/7:c.*2008A>G:	Tigger19a	rs1986693	0.8079	0.0000	0/0/0	0.7384										153	69					PNPO (inh=n/a pLI=0.00)
chr17	48252804	48252804	T	C	hom	low_DP	QUAL=869;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,HOM,4,1.00,HOM,15,1.00	SGCA	3'UTR	SGCA:NM_000023.2:3'UTR:MODIFIER:exon9/10:c.*6T>C:,SGCA:NM_001135697.1:3'UTR:MODIFIER:exon7/8:c.*6T>C:		rs2696288	0.9219	0.9550	54006/29806/3068	0.9221							RCV000153940.3 [benign]; 			1010	71					SGCA (inh=n/a pLI=0.19)
chr17	48261852	48261852	A	G	het		QUAL=2922;DP=185;AF=0.06;MQM=58;TRIO=HET,185,0.06,HET,52,0.19,WT,71,0.00	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*1011T>C:	A-rich	rs1061970	0.0000	0.0000	0/0/0	0.0644										2	41					COL1A1 (inh=n/a pLI=1.00)
chr17	48262181	48262181	-	TGCT	het		QUAL=5040;DP=50;AF=0.50;MQM=59;TRIO=HET,50,0.50,WT,136,0.00,HOM,164,0.99	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*681_*682insAGCA:		rs112626388;rs35521741;rs3840870	0.5803	0.0000	0/0/0	0.5860										95	113					COL1A1 (inh=n/a pLI=1.00)
chr17	48262619	48262619	T	-	hom		QUAL=597;DP=31;AF=0.10;MQM=59;TRIO=HOM,31,0.10,HOM,6,0.00,HOM,20,0.10	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*244delA:	(T)n		0.0000	0.0000	0/0/0	0.0000										0	0					COL1A1 (inh=n/a pLI=1.00)
chr17	48262775	48262775	A	G	het		QUAL=4489;DP=85;AF=0.41;MQM=59;TRIO=HET,85,0.41,HOM,128,0.98,WT,171,0.00	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*88T>C:		rs1061237	0.3786	0.0000	0/0/0	0.0528										18	88					COL1A1 (inh=n/a pLI=1.00)
chr17	48265475	48265475	A	G	het		QUAL=3233;DP=73;AF=0.49;MQM=59;TRIO=HET,73,0.49,HET,204,0.51,WT,283,0.01	COL1A1	synonymous	COL1A1:NM_000088.3:synonymous:LOW:exon44/51:c.3243T>C:p.Val1081Val		rs1800217	0.0040	0.0060	7/4/0	0.0055						120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|Osteogenesis imperfecta,type II|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type IV|Ehlers-Danlos syndrome,classic|Ehlers-Danlos syndrome,type VIIA|Caffey disease|Bone mineral density variation QTL,osteoporosis];	RCV000178543.1 [benign]; 			0	23					COL1A1 (inh=n/a pLI=1.00)
chr17	48265495	48265495	T	C	hom		QUAL=14663;DP=67;AF=0.99;MQM=59;TRIO=HOM,67,0.99,HOM,175,1.00,HOM,246,1.00	COL1A1	missense	COL1A1:NM_000088.3:missense:MODERATE:exon44/51:c.3223A>G:p.Thr1075Ala		rs1800215	0.9788	0.9790	23381/11926/2154	0.8885	0.5710	T	T	B	B	120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|Osteogenesis imperfecta,type II|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type IV|Ehlers-Danlos syndrome,classic|Ehlers-Danlos syndrome,type VIIA|Caffey disease|Bone mineral density variation QTL,osteoporosis];			COSM4130378	1080	27					COL1A1 (inh=n/a pLI=1.00)
chr17	48268223	48268223	A	G	hom		QUAL=44290;DP=198;AF=1.00;MQM=59;TRIO=HOM,198,1.00,HOM,482,1.00,HOM,726,1.00	COL1A1	synonymous	COL1A1:NM_000088.3:synonymous:LOW:exon33/51:c.2298T>C:p.Thr766Thr		rs2734272	0.9998	1.0000	60645/33352/5192	0.9451						120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|Osteogenesis imperfecta,type II|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type IV|Ehlers-Danlos syndrome,classic|Ehlers-Danlos syndrome,type VIIA|Caffey disease|Bone mineral density variation QTL,osteoporosis];			COSM4130379	1106	1					COL1A1 (inh=n/a pLI=1.00)
chr17	48653354	48653354	C	A	het		QUAL=9926;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,HET,165,0.47,HOM,236,1.00	CACNA1G	synonymous,non_coding_exon	CACNA1G:NM_018896.4:synonymous:LOW:exon8/38:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256324.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256325.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256326.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256327.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256328.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256329.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256330.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256331.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256332.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256333.1:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256334.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256359.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256360.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256361.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198376.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198377.2:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198378.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198379.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198380.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198382.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198383.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198384.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198385.2:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198386.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198387.2:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198388.2:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198396.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NR_046054.1:non_coding_exon:MODIFIER:exon8/36:n.1983C>A:,CACNA1G:NR_046055.1:non_coding_exon:MODIFIER:exon8/35:n.1983C>A:,CACNA1G:NR_046056.1:non_coding_exon:MODIFIER:exon8/35:n.1983C>A:,CACNA1G:NR_046057.1:non_coding_exon:MODIFIER:exon8/35:n.1983C>A:,CACNA1G:NR_046058.1:non_coding_exon:MODIFIER:exon8/34:n.1983C>A:		rs12449998	0.5240	0.4290	3740/1310/44	0.3873									COSM436875, COSM436878, COSM436877, COSM436876	276	647					CACNA1G (inh=AD pLI=1.00)
chr17	48692881	48692881	C	T	het		QUAL=5304;DP=33;AF=0.48;MQM=59;TRIO=HET,33,0.48,HOM,191,0.99,WT,214,0.00	CACNA1G	splice_region&intron	CACNA1G:NM_018896.4:splice_region&intron:LOW:exon27/37:c.4911+8C>T:,CACNA1G:NM_001256324.1:splice_region&intron:LOW:exon26/35:c.4857+8C>T:,CACNA1G:NM_001256325.1:splice_region&intron:LOW:exon27/35:c.4932+8C>T:,CACNA1G:NM_001256326.1:splice_region&intron:LOW:exon26/35:c.4776+8C>T:,CACNA1G:NM_001256327.1:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:NM_001256328.1:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:NM_001256329.1:splice_region&intron:LOW:exon27/35:c.4809+8C>T:,CACNA1G:NM_001256330.1:splice_region&intron:LOW:exon26/34:c.4776+8C>T:,CACNA1G:NM_001256331.1:splice_region&intron:LOW:exon26/34:c.4755+8C>T:,CACNA1G:NM_001256332.1:splice_region&intron:LOW:exon26/34:c.4740+8C>T:,CACNA1G:NM_001256333.1:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:NM_001256334.1:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:NM_001256359.1:splice_region&intron:LOW:exon27/35:c.4830+8C>T:,CACNA1G:NM_001256360.1:splice_region&intron:LOW:exon26/34:c.4803+8C>T:,CACNA1G:NM_001256361.1:splice_region&intron:LOW:exon26/34:c.4797+8C>T:,CACNA1G:NM_198376.2:splice_region&intron:LOW:exon25/34:c.4809+8C>T:,CACNA1G:NM_198377.2:splice_region&intron:LOW:exon26/36:c.4878+8C>T:,CACNA1G:NM_198378.2:splice_region&intron:LOW:exon26/34:c.4878+8C>T:,CACNA1G:NM_198379.2:splice_region&intron:LOW:exon25/34:c.4809+8C>T:,CACNA1G:NM_198380.2:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:NM_198382.2:splice_region&intron:LOW:exon26/34:c.4842+8C>T:,CACNA1G:NM_198383.2:splice_region&intron:LOW:exon26/35:c.4842+8C>T:,CACNA1G:NM_198384.2:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:NM_198385.2:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:NM_198386.2:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:NM_198387.2:splice_region&intron:LOW:exon25/33:c.4809+8C>T:,CACNA1G:NM_198388.2:splice_region&intron:LOW:exon25/33:c.4788+8C>T:,CACNA1G:NM_198396.2:splice_region&intron:LOW:exon25/35:c.4809+8C>T:,CACNA1G:NR_046054.1:splice_region&intron:LOW:exon27/35:n.5303+8C>T:,CACNA1G:NR_046055.1:splice_region&intron:LOW:exon26/34:n.5270+8C>T:,CACNA1G:NR_046056.1:splice_region&intron:LOW:exon26/34:n.5249+8C>T:,CACNA1G:NR_046057.1:splice_region&intron:LOW:exon26/34:n.5234+8C>T:,CACNA1G:NR_046058.1:splice_region&intron:LOW:exon25/33:n.5180+8C>T:		rs8066527	0.2001	0.2790	4983/3686/296	0.2748										150	529					CACNA1G (inh=AD pLI=1.00)
chr17	48703752	48703752	T	C	het		QUAL=4626;DP=156;AF=0.58;MQM=59;TRIO=HET,156,0.58,HOM,73,1.00,WT,94,0.01	CACNA1G	synonymous,non_coding_exon	CACNA1G:NM_018896.4:synonymous:LOW:exon38/38:c.6774T>C:p.Pro2258Pro,CACNA1G:NM_001256324.1:synonymous:LOW:exon36/36:c.6585T>C:p.Pro2195Pro,CACNA1G:NM_001256325.1:synonymous:LOW:exon36/36:c.6516T>C:p.Pro2172Pro,CACNA1G:NM_001256326.1:synonymous:LOW:exon36/36:c.6504T>C:p.Pro2168Pro,CACNA1G:NM_001256327.1:synonymous:LOW:exon36/36:c.6474T>C:p.Pro2158Pro,CACNA1G:NM_001256328.1:synonymous:LOW:exon35/35:c.6420T>C:p.Pro2140Pro,CACNA1G:NM_001256329.1:synonymous:LOW:exon36/36:c.6393T>C:p.Pro2131Pro,CACNA1G:NM_001256330.1:synonymous:LOW:exon35/35:c.6360T>C:p.Pro2120Pro,CACNA1G:NM_001256331.1:synonymous:LOW:exon35/35:c.6339T>C:p.Pro2113Pro,CACNA1G:NM_001256332.1:synonymous:LOW:exon35/35:c.6324T>C:p.Pro2108Pro,CACNA1G:NM_001256333.1:synonymous:LOW:exon37/37:c.6258T>C:p.Pro2086Pro,CACNA1G:NM_001256334.1:synonymous:LOW:exon36/36:c.6225T>C:p.Pro2075Pro,CACNA1G:NM_001256359.1:synonymous:LOW:exon36/36:c.6414T>C:p.Pro2138Pro,CACNA1G:NM_001256360.1:synonymous:LOW:exon35/35:c.6387T>C:p.Pro2129Pro,CACNA1G:NM_001256361.1:synonymous:LOW:exon35/35:c.6381T>C:p.Pro2127Pro,CACNA1G:NM_198376.2:synonymous:LOW:exon35/35:c.6156T>C:p.Pro2052Pro,CACNA1G:NM_198377.2:synonymous:LOW:exon37/37:c.6741T>C:p.Pro2247Pro,CACNA1G:NM_198378.2:synonymous:LOW:exon35/35:c.6462T>C:p.Pro2154Pro,CACNA1G:NM_198379.2:synonymous:LOW:exon35/35:c.6537T>C:p.Pro2179Pro,CACNA1G:NM_198380.2:synonymous:LOW:exon36/36:c.6606T>C:p.Pro2202Pro,CACNA1G:NM_198382.2:synonymous:LOW:exon35/35:c.6426T>C:p.Pro2142Pro,CACNA1G:NM_198383.2:synonymous:LOW:exon36/36:c.6561T>C:p.Pro2187Pro,CACNA1G:NM_198384.2:synonymous:LOW:exon36/36:c.6495T>C:p.Pro2165Pro,CACNA1G:NM_198385.2:synonymous:LOW:exon37/37:c.6639T>C:p.Pro2213Pro,CACNA1G:NM_198386.2:synonymous:LOW:exon35/35:c.6441T>C:p.Pro2147Pro,CACNA1G:NM_198387.2:synonymous:LOW:exon34/34:c.6393T>C:p.Pro2131Pro,CACNA1G:NM_198388.2:synonymous:LOW:exon34/34:c.6372T>C:p.Pro2124Pro,CACNA1G:NM_198396.2:synonymous:LOW:exon36/36:c.6672T>C:p.Pro2224Pro,CACNA1G:NR_046054.1:non_coding_exon:MODIFIER:exon36/36:n.6838T>C:,CACNA1G:NR_046055.1:non_coding_exon:MODIFIER:exon35/35:n.6805T>C:,CACNA1G:NR_046056.1:non_coding_exon:MODIFIER:exon35/35:n.6784T>C:,CACNA1G:NR_046057.1:non_coding_exon:MODIFIER:exon35/35:n.6769T>C:,CACNA1G:NR_046058.1:non_coding_exon:MODIFIER:exon34/34:n.6715T>C:		rs739925	0.3672	0.3980	9847/6278/1230	0.3892									COSM4130401, COSM4130402, COSM4130403	266	619					CACNA1G (inh=AD pLI=1.00)
chr17	48703986	48703986	G	A	het		QUAL=1621;DP=61;AF=0.57;MQM=59;TRIO=HET,61,0.57,WT,61,0.00,HET,85,0.45	CACNA1G	synonymous,non_coding_exon	CACNA1G:NM_018896.4:synonymous:LOW:exon38/38:c.7008G>A:p.Pro2336Pro,CACNA1G:NM_001256324.1:synonymous:LOW:exon36/36:c.6819G>A:p.Pro2273Pro,CACNA1G:NM_001256325.1:synonymous:LOW:exon36/36:c.6750G>A:p.Pro2250Pro,CACNA1G:NM_001256326.1:synonymous:LOW:exon36/36:c.6738G>A:p.Pro2246Pro,CACNA1G:NM_001256327.1:synonymous:LOW:exon36/36:c.6708G>A:p.Pro2236Pro,CACNA1G:NM_001256328.1:synonymous:LOW:exon35/35:c.6654G>A:p.Pro2218Pro,CACNA1G:NM_001256329.1:synonymous:LOW:exon36/36:c.6627G>A:p.Pro2209Pro,CACNA1G:NM_001256330.1:synonymous:LOW:exon35/35:c.6594G>A:p.Pro2198Pro,CACNA1G:NM_001256331.1:synonymous:LOW:exon35/35:c.6573G>A:p.Pro2191Pro,CACNA1G:NM_001256332.1:synonymous:LOW:exon35/35:c.6558G>A:p.Pro2186Pro,CACNA1G:NM_001256333.1:synonymous:LOW:exon37/37:c.6492G>A:p.Pro2164Pro,CACNA1G:NM_001256334.1:synonymous:LOW:exon36/36:c.6459G>A:p.Pro2153Pro,CACNA1G:NM_001256359.1:synonymous:LOW:exon36/36:c.6648G>A:p.Pro2216Pro,CACNA1G:NM_001256360.1:synonymous:LOW:exon35/35:c.6621G>A:p.Pro2207Pro,CACNA1G:NM_001256361.1:synonymous:LOW:exon35/35:c.6615G>A:p.Pro2205Pro,CACNA1G:NM_198376.2:synonymous:LOW:exon35/35:c.6390G>A:p.Pro2130Pro,CACNA1G:NM_198377.2:synonymous:LOW:exon37/37:c.6975G>A:p.Pro2325Pro,CACNA1G:NM_198378.2:synonymous:LOW:exon35/35:c.6696G>A:p.Pro2232Pro,CACNA1G:NM_198379.2:synonymous:LOW:exon35/35:c.6771G>A:p.Pro2257Pro,CACNA1G:NM_198380.2:synonymous:LOW:exon36/36:c.6840G>A:p.Pro2280Pro,CACNA1G:NM_198382.2:synonymous:LOW:exon35/35:c.6660G>A:p.Pro2220Pro,CACNA1G:NM_198383.2:synonymous:LOW:exon36/36:c.6795G>A:p.Pro2265Pro,CACNA1G:NM_198384.2:synonymous:LOW:exon36/36:c.6729G>A:p.Pro2243Pro,CACNA1G:NM_198385.2:synonymous:LOW:exon37/37:c.6873G>A:p.Pro2291Pro,CACNA1G:NM_198386.2:synonymous:LOW:exon35/35:c.6675G>A:p.Pro2225Pro,CACNA1G:NM_198387.2:synonymous:LOW:exon34/34:c.6627G>A:p.Pro2209Pro,CACNA1G:NM_198388.2:synonymous:LOW:exon34/34:c.6606G>A:p.Pro2202Pro,CACNA1G:NM_198396.2:synonymous:LOW:exon36/36:c.6906G>A:p.Pro2302Pro,CACNA1G:NR_046054.1:non_coding_exon:MODIFIER:exon36/36:n.7072G>A:,CACNA1G:NR_046055.1:non_coding_exon:MODIFIER:exon35/35:n.7039G>A:,CACNA1G:NR_046056.1:non_coding_exon:MODIFIER:exon35/35:n.7018G>A:,CACNA1G:NR_046057.1:non_coding_exon:MODIFIER:exon35/35:n.7003G>A:,CACNA1G:NR_046058.1:non_coding_exon:MODIFIER:exon34/34:n.6949G>A:		rs9893223	0.1927	0.1150	1359/126/600	0.1095									COSM436909, COSM436907, COSM436908	8	168					CACNA1G (inh=AD pLI=1.00)
chr17	48704800	48704800	A	C	het		QUAL=1609;DP=64;AF=0.75;MQM=60;TRIO=HET,64,0.75,HOM,11,1.00,WT,7,0.00	CACNA1G	3'UTR,non_coding_exon	CACNA1G:NM_018896.4:3'UTR:MODIFIER:exon38/38:c.*688A>C:,CACNA1G:NM_001256324.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256325.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256326.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256327.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256328.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256329.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256330.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256331.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256332.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256333.1:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_001256334.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256359.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256360.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256361.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198376.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198377.2:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_198378.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198379.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198380.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198382.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198383.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198384.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198385.2:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_198386.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198387.2:3'UTR:MODIFIER:exon34/34:c.*688A>C:,CACNA1G:NM_198388.2:3'UTR:MODIFIER:exon34/34:c.*688A>C:,CACNA1G:NM_198396.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NR_046054.1:non_coding_exon:MODIFIER:exon36/36:n.7886A>C:,CACNA1G:NR_046055.1:non_coding_exon:MODIFIER:exon35/35:n.7853A>C:,CACNA1G:NR_046056.1:non_coding_exon:MODIFIER:exon35/35:n.7832A>C:,CACNA1G:NR_046057.1:non_coding_exon:MODIFIER:exon35/35:n.7817A>C:,CACNA1G:NR_046058.1:non_coding_exon:MODIFIER:exon34/34:n.7763A>C:	(TATA)n	rs34036927	0.1348	0.1490	3/1/0	0.0367										39	218					CACNA1G (inh=AD pLI=1.00)
chr17	56283089	56283089	C	-	hom		QUAL=15383;DP=342;AF=0.97;MQM=59;TRIO=HOM,342,0.97,HET,200,0.50,HET,238,0.54	MKS1	3'UTR	MKS1:NM_017777.3:3'UTR:MODIFIER:exon18/18:c.*351delG:,MKS1:NM_001165927.1:3'UTR:MODIFIER:exon18/18:c.*351delG:		rs35298266	0.0152	0.0190	7/4/0	0.0096										0	38					MKS1 (inh=AR pLI=0.00)
chr17	56290334	56290334	T	C	hom		QUAL=11582;DP=143;AF=0.99;MQM=60;TRIO=HOM,143,0.99,HOM,98,1.00,HOM,125,1.00	MKS1	splice_region&intron	MKS1:NM_017777.3:splice_region&intron:LOW:exon8/17:c.858+9A>G:,MKS1:NM_001165927.1:splice_region&intron:LOW:exon8/17:c.828+9A>G:		rs3826300	0.4808	0.4460	13147/6816/3120	0.4355						609883 [MKS1 (confirmed) Meckel syndrome 1|Bardet-Biedl syndrome 13];	RCV000114214.2 [likely benign]; 		COSM4000229, COSM4000228	217	532					MKS1 (inh=AR pLI=0.00)
chr17	57076104	57076104	T	A	het		QUAL=3794;DP=179;AF=0.46;MQM=60;TRIO=HET,179,0.46,HET,28,0.54,HOM,37,1.00	TRIM37	3'UTR,intron	TRIM37:NM_015294.3:3'UTR:MODIFIER:exon24/24:c.*634A>T:,TRIM37:NM_001005207.2:intron:MODIFIER:exon24/24:c.2891+638A>T:		rs28475409	0.3277	0.0000	0/0/0	0.3325						605073 [TRIM37 (confirmed) Mulibrey nanism];				35	105					TRIM37 (inh=n/a pLI=0.17)
chr17	57184162	57184162	A	C	het	low_DP	QUAL=1031;DP=15;AF=0.47;MQM=59;TRIO=HET,15,0.47,HET,17,0.35,HOM,29,0.97	TRIM37	5'UTR	TRIM37:NM_001005207.2:5'UTR:MODIFIER:exon1/25:c.-340T>G:,TRIM37:NM_015294.3:5'UTR:MODIFIER:exon1/24:c.-340T>G:		rs7503190	0.6118	0.0000	0/0/0	0.1008										77	88					TRIM37 (inh=n/a pLI=0.17)
chr17	62006129	62006129	-	G	het		QUAL=965;DP=62;AF=0.50;MQM=59;TRIO=HET,62,0.50,WT,34,0.00,HET,37,0.54	CD79B	3'UTR	CD79B:NM_001039933.1:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:NM_000626.2:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:NM_021602.2:3'UTR:MODIFIER:exon5/5:c.*456dupC:		rs554643850	0.0014	0.0000	0/0/0	0.0017										0	2					CD79B (inh=n/a pLI=0.95)
chr17	62006406	62006406	A	G	het		QUAL=1848;DP=101;AF=0.47;MQM=60;TRIO=HET,101,0.47,HET,65,0.46,WT,127,0.00	CD79B	3'UTR	CD79B:NM_001039933.1:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:NM_000626.2:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:NM_021602.2:3'UTR:MODIFIER:exon5/5:c.*180T>C:		rs147717759	0.0030	0.0000	0/0/0	0.0015										0	6					CD79B (inh=n/a pLI=0.95)
chr17	62018002	62018002	C	A	het		QUAL=5440;DP=199;AF=0.52;MQM=60;TRIO=HET,199,0.52,WT,212,0.00,HET,242,0.50	SCN4A	3'UTR	SCN4A:NM_000334.4:3'UTR:MODIFIER:exon24/24:c.*129G>T:		rs140026321	0.0016	0.0000	0/0/0	0.0033										0	2					SCN4A (inh=n/a pLI=0.01)
chr17	62028920	62028920	C	G	het		QUAL=4329;DP=194;AF=0.47;MQM=59;TRIO=HET,194,0.47,HET,170,0.52,WT,193,0.00	SCN4A	missense	SCN4A:NM_000334.4:missense:MODERATE:exon14/24:c.2717G>C:p.Ser906Thr		rs41280102	0.0050	0.0094	8/6/0	0.0095	0.5540	T	T	B	B	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2|Paramyotonia congenita|Myotonia congenita,atypical,acetazolamide-responsive|Myasthenic syndrome,congenital,16|Hypokalemic periodic paralysis,type 2];	RCV000020269.1 [benign]; RCV000078659.7 [other]; 	CM034679 [CLASS=FP MUT=ALT PHEN="Impaired slow inactivation" GENE=SCN4A]; 		0	31	2	[2] Stefanie Beck-Woedl 11.12.2014			SCN4A (inh=n/a pLI=0.01)
chr17	62041068	62041068	T	C	hom		QUAL=7750;DP=107;AF=1.00;MQM=60;TRIO=HOM,107,1.00,HOM,63,1.00,HOM,83,1.00	SCN4A	missense	SCN4A:NM_000334.4:missense:MODERATE:exon10/24:c.1570A>G:p.Ser524Gly		rs6504191	0.9443	0.9260	50207/26766/3789	0.8993	1.3430	T	T	B	B	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2|Paramyotonia congenita|Myotonia congenita,atypical,acetazolamide-responsive|Myasthenic syndrome,congenital,16|Hypokalemic periodic paralysis,type 2];	RCV000118264.4 [benign]; 		COSM4130494	943	156					SCN4A (inh=n/a pLI=0.01)
chr17	71197323	71197323	G	C	het	phylop_high	QUAL=8285;DP=382;AF=0.48;MQM=59;TRIO=HET,382,0.48,WT,289,0.00,HET,377,0.39	COG1	missense	COG1:NM_018714.2:missense:MODERATE:exon7/14:c.1357G>C:p.Glu453Gln		rs62621249	0.0503	0.0670	359/255/8	0.0671	4.1400	T	T,T	P,P,P	B,B,B	606973 [COG1 (confirmed) Congenital disorder of glycosylation,type IIg];	RCV000081961.4 [benign]; 		COSM3755789	16	185					COG1 (inh=n/a pLI=0.10)
chr17	72912265	72912265	C	G	hom		QUAL=9057;DP=94;AF=0.99;MQM=59;TRIO=HOM,94,0.99,HOM,132,1.00,HET,144,0.60	USH1G	3'UTR	USH1G:NM_173477.4:3'UTR:MODIFIER:exon3/3:c.*1903G>C:,USH1G:NM_001282489.2:3'UTR:MODIFIER:exon3/3:c.*1903G>C:		rs1568448	0.3540	0.0000	0/0/0	0.4056										42	104					USH1G (inh=n/a pLI=0.00)
chr17	72913797	72913797	T	-	hom		QUAL=16403;DP=145;AF=0.99;MQM=59;TRIO=HOM,145,0.99,HOM,185,1.00,HOM,250,1.00	USH1G	3'UTR	USH1G:NM_173477.4:3'UTR:MODIFIER:exon3/3:c.*371delA:,USH1G:NM_001282489.2:3'UTR:MODIFIER:exon3/3:c.*371delA:		rs869131676	1.0000	0.0000	0/0/0	0.9157										230	0					USH1G (inh=n/a pLI=0.00)
chr17	73269258	73269258	G	C	hom		QUAL=42827;DP=274;AF=1.00;MQM=59;TRIO=HOM,274,1.00,HOM,465,1.00,HOM,598,1.00	SLC25A19,LOC100287042	3'UTR,non_coding_exon	SLC25A19:NM_001126121.1:3'UTR:MODIFIER:exon8/8:c.*274C>G:,SLC25A19:NM_001126122.1:3'UTR:MODIFIER:exon7/7:c.*274C>G:,SLC25A19:NM_021734.4:3'UTR:MODIFIER:exon8/8:c.*274C>G:,LOC100287042:NR_036520.1:non_coding_exon:MODIFIER:exon1/1:n.1879G>C:		rs7198	0.5365	0.0000	0/0/0	0.6635										131	108					SLC25A19 (inh=n/a pLI=0.93), LOC100287042 (inh=n/a pLI=n/a)
chr17	73269530	73269530	A	G	hom		QUAL=34421;DP=301;AF=1.00;MQM=60;TRIO=HOM,301,1.00,HOM,319,1.00,HOM,441,1.00	SLC25A19,LOC100287042	3'UTR,non_coding_exon	SLC25A19:NM_001126121.1:3'UTR:MODIFIER:exon8/8:c.*2T>C:,SLC25A19:NM_001126122.1:3'UTR:MODIFIER:exon7/7:c.*2T>C:,SLC25A19:NM_021734.4:3'UTR:MODIFIER:exon8/8:c.*2T>C:,LOC100287042:NR_036520.1:non_coding_exon:MODIFIER:exon1/1:n.2151A>G:		rs1809352	0.9002	0.9280	51858/28159/3027	0.9060							RCV000118365.1 [benign]; 			943	153					SLC25A19 (inh=n/a pLI=0.93), LOC100287042 (inh=n/a pLI=n/a)
chr17	73269676	73269676	C	T	hom		QUAL=32496;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HOM,294,1.00,HOM,430,1.00	SLC25A19,LOC100287042	synonymous,non_coding_exon	SLC25A19:NM_001126121.1:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu,SLC25A19:NM_001126122.1:synonymous:LOW:exon7/7:c.819G>A:p.Leu273Leu,SLC25A19:NM_021734.4:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu,LOC100287042:NR_036520.1:non_coding_exon:MODIFIER:exon1/1:n.2297C>T:		rs4789164	0.5302	0.6520	27604/15403/119	0.6449						606521 [SLC25A19 (confirmed) Microcephaly,Amish type|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)];	RCV000118371.2 [likely benign]; 			449	498					SLC25A19 (inh=n/a pLI=0.93), LOC100287042 (inh=n/a pLI=n/a)
chr17	73279624	73279624	A	G	hom		QUAL=10216;DP=91;AF=1.00;MQM=60;TRIO=HOM,91,1.00,HOM,100,1.00,HOM,132,1.00	SLC25A19	synonymous	SLC25A19:NM_001126121.1:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr,SLC25A19:NM_001126122.1:synonymous:LOW:exon4/7:c.339T>C:p.Tyr113Tyr,SLC25A19:NM_021734.4:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr		rs7213318	0.8896	0.9610	55939/33017/3409	0.9403						606521 [SLC25A19 (confirmed) Microcephaly,Amish type|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)];	RCV000118368.2 [likely benign]; 		COSM4130610	1086	20					SLC25A19 (inh=n/a pLI=0.93)
chr17	73285461	73285461	A	C	hom		QUAL=7895;DP=90;AF=1.00;MQM=59;TRIO=HOM,90,1.00,HOM,75,1.00,HOM,100,1.00	SLC25A19	5'UTR	SLC25A19:NM_001126121.1:5'UTR:MODIFIER:exon1/8:c.-155T>G:,SLC25A19:NM_001126122.1:5'UTR:MODIFIER:exon1/7:c.-65T>G:,SLC25A19:NM_021734.4:5'UTR:MODIFIER:exon1/8:c.-139T>G:		rs2291033	0.8612	0.0000	0/0/0	0.8551										223	6					SLC25A19 (inh=n/a pLI=0.93)
chr17	73518203	73518203	G	C	hom	phylop_high;pred_pathogenic_2	QUAL=21643;DP=189;AF=1.00;MQM=59;TRIO=HOM,189,1.00,HOM,221,1.00,HOM,295,0.99	TSEN54	missense	TSEN54:NM_207346.2:missense:MODERATE:exon8/11:c.1041G>C:p.Lys347Asn		rs9911502	0.4447	0.5420	10356/6865/111	0.5181	3.6300	T	D	D	P	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5];	RCV000147767.4 [benign]; 		COSM437385	947	978					TSEN54 (inh=AR pLI=0.00)
chr17	73518284	73518284	G	C	hom		QUAL=15916;DP=112;AF=1.00;MQM=59;TRIO=HOM,112,1.00,HOM,186,1.00,HOM,229,1.00	TSEN54	synonymous	TSEN54:NM_207346.2:synonymous:LOW:exon8/11:c.1122G>C:p.Arg374Arg		rs6501820	0.8143	0.7800	8961/4099/1218	0.6336						608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5];	RCV000082834.5 [benign]; 			1811	371					TSEN54 (inh=AR pLI=0.00)
chr17	73519413	73519413	C	T	hom		QUAL=33493;DP=358;AF=0.99;MQM=59;TRIO=HOM,358,0.99,HOM,355,1.00,HOM,431,1.00	TSEN54	missense	TSEN54:NM_207346.2:missense:MODERATE:exon9/11:c.1310C>T:p.Ala437Val		rs8064529	0.5613	0.6240	24545/15568/1756	0.6146	0.3350	T	T	P	B	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5];	RCV000147771.1 [benign]; 			958	974					TSEN54 (inh=AR pLI=0.00)
chr17	73750859	73750859	C	G	hom		QUAL=22693;DP=189;AF=1.00;MQM=59;TRIO=HOM,189,1.00,HOM,398,1.00,HET,503,0.44	ITGB4	synonymous	ITGB4:NM_000213.3:synonymous:LOW:exon34/40:c.4521C>G:p.Pro1507Pro,ITGB4:NM_001005731.1:synonymous:LOW:exon33/39:c.4311C>G:p.Pro1437Pro,ITGB4:NM_001005619.1:synonymous:LOW:exon32/39:c.4311C>G:p.Pro1437Pro		rs8669	0.3772	0.4520	13004/8106/94	0.4429						147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia|Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa of hands and feet];			COSM3755857, COSM3755858	241	541					ITGB4 (inh=n/a pLI=0.00)
chr17	73753503	73753503	T	C	hom	phylop_high;pred_pathogenic_2	QUAL=31656;DP=162;AF=0.98;MQM=59;TRIO=HOM,162,0.98,HOM,398,0.99,HOM,467,1.00	ITGB4	missense	ITGB4:NM_000213.3:missense:MODERATE:exon40/40:c.5336T>C:p.Leu1779Pro,ITGB4:NM_001005731.1:missense:MODERATE:exon39/39:c.5126T>C:p.Leu1709Pro,ITGB4:NM_001005619.1:missense:MODERATE:exon39/39:c.5285T>C:p.Leu1762Pro		rs871443	0.5715	0.7130	32047/19478/324	0.7067	4.7950	T	T,T,T	D,D,D	D,P,P	147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia|Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa of hands and feet];			COSM3722197, COSM3722198	612	420					ITGB4 (inh=n/a pLI=0.00)
chr17	73753661	73753661	C	T	hom		QUAL=23988;DP=172;AF=0.98;MQM=59;TRIO=HOM,172,0.98,HOM,289,1.00,HOM,390,1.00	ITGB4	3'UTR	ITGB4:NM_000213.3:3'UTR:MODIFIER:exon40/40:c.*25C>T:,ITGB4:NM_001005731.1:3'UTR:MODIFIER:exon39/39:c.*25C>T:,ITGB4:NM_001005619.1:3'UTR:MODIFIER:exon39/39:c.*25C>T:		rs9367	0.6530	0.7360	33375/20646/1478	0.7104										134	86					ITGB4 (inh=n/a pLI=0.00)
chr17	73942196	73942196	C	G	het		QUAL=2292;DP=115;AF=0.48;MQM=60;TRIO=HET,115,0.48,HET,92,0.45,WT,117,0.00	ACOX1	3'UTR	ACOX1:NM_004035.6:3'UTR:MODIFIER:exon14/14:c.*633G>C:,ACOX1:NM_001185039.1:3'UTR:MODIFIER:exon14/14:c.*633G>C:,ACOX1:NM_007292.5:3'UTR:MODIFIER:exon14/14:c.*633G>C:		rs71382188	0.0266	0.0000	0/0/0	0.0480										0	31					ACOX1 (inh=AR pLI=0.09)
chr17	73949540	73949540	G	C	hom		QUAL=19540;DP=164;AF=0.98;MQM=60;TRIO=HOM,164,0.98,HOM,198,1.00,HOM,256,1.00	ACOX1	missense	ACOX1:NM_004035.6:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met,ACOX1:NM_001185039.1:missense:MODERATE:exon7/14:c.822C>G:p.Ile274Met,ACOX1:NM_007292.5:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met		rs1135640	0.5507	0.6420	26247/14634/252	0.6323	1.0860	T	T,T,T,T,T	B,B,B,B	B,B,B,B	609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency];			COSM3755874, COSM3755875	446	490					ACOX1 (inh=AR pLI=0.09)
chr17	75372339	75372339	C	T	het		QUAL=6849;DP=96;AF=0.59;MQM=59;TRIO=HET,96,0.59,HET,113,0.48,HOM,153,1.00	SEPT9	5'UTR,intron	SEPT9:NM_001113494.1:5'UTR:MODIFIER:exon1/11:c.-558C>T:,SEPT9:NM_001113491.1:intron:MODIFIER:exon2/11:c.77-25802C>T:,SEPT9:NM_001293695.1:intron:MODIFIER:exon1/10:c.20-25802C>T:,SEPT9:NM_001113492.1:intron:MODIFIER:exon2/11:c.-416-25802C>T:,SEPT9:NM_006640.4:intron:MODIFIER:exon1/10:c.23-25802C>T:,SEPT9:NM_001113493.1:intron:MODIFIER:exon1/10:c.55+2705C>T:		rs312826	0.6066	0.0000	0/0/0	0.5936						604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic];				87	102					SEPT9 (inh=n/a pLI=0.89)
chr17	75494705	75494705	A	G	hom		QUAL=3637;DP=27;AF=1.00;MQM=59;TRIO=HOM,27,1.00,HOM,39,1.00,HOM,54,1.00	SEPT9	missense	SEPT9:NM_001113491.1:missense:MODERATE:exon12/12:c.1726A>G:p.Met576Val,SEPT9:NM_001293695.1:missense:MODERATE:exon11/11:c.1669A>G:p.Met557Val,SEPT9:NM_001113492.1:missense:MODERATE:exon12/12:c.1234A>G:p.Met412Val,SEPT9:NM_006640.4:missense:MODERATE:exon11/11:c.1672A>G:p.Met558Val,SEPT9:NM_001113493.1:missense:MODERATE:exon11/11:c.1705A>G:p.Met569Val,SEPT9:NM_001113494.1:missense:MODERATE:exon11/11:c.1234A>G:p.Met412Val,SEPT9:NM_001293696.1:missense:MODERATE:exon10/10:c.1054A>G:p.Met352Val,SEPT9:NM_001113496.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001293697.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001293698.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001113495.1:missense:MODERATE:exon10/10:c.1390A>G:p.Met464Val		rs2627223	0.9066	0.9340	50761/28109/2740	0.8450	0.0380	T	T,T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic];			COSM4130688, COSM4130689, COSM4130691, COSM4130690, COSM4130692	982	119					SEPT9 (inh=n/a pLI=0.89)
chr17	75494787	75494787	-	C	hom	low_DP	QUAL=911;DP=6;AF=0.83;MQM=59;TRIO=HOM,6,0.83,HOM,11,0.91,HOM,26,0.96	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:		rs5822173	0.9363	0.8540	8612/3906/601	0.6319										458	98					SEPT9 (inh=n/a pLI=0.89)
chr17	75495840	75495840	T	C	hom		QUAL=8584;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HOM,90,1.00,HOM,126,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:		rs407525	0.9876	0.0000	0/0/0	0.8986										301	7					SEPT9 (inh=n/a pLI=0.89)
chr17	75496342	75496342	T	C	hom		QUAL=17249;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,183,1.00,HOM,222,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:		rs448767	0.9864	0.0000	0/0/0	0.1529										270	7					SEPT9 (inh=n/a pLI=0.89)
chr17	75496361	75496361	A	G	hom		QUAL=20859;DP=193;AF=0.99;MQM=60;TRIO=HOM,193,0.99,HOM,212,1.00,HOM,251,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:		rs2627222	0.9864	0.0000	0/0/0	0.1535										268	7					SEPT9 (inh=n/a pLI=0.89)
chr17	75496460	75496460	T	C	hom		QUAL=5556;DP=78;AF=0.99;MQM=59;TRIO=HOM,78,0.99,HET,142,0.49,HET,154,0.55	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:		rs445507	0.4321	0.0000	0/0/0	0.4311										68	119					SEPT9 (inh=n/a pLI=0.89)
chr17	76127431	76127431	G	C	hom		QUAL=10661;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HOM,102,0.98,HOM,153,1.00	TMC8,TMC6	5'UTR,intron	TMC8:NM_152468.4:5'UTR:MODIFIER:exon2/16:c.-239G>C:,TMC6:NM_007267.6:intron:MODIFIER:exon1/19:c.-75+991C>G:	MIRb	rs383603	0.6987	0.0000	0/0/0	0.6726										133	85					TMC8 (inh=n/a pLI=0.00), TMC6 (inh=n/a pLI=0.00)
chr17	76130575	76130575	A	T	hom		QUAL=10259;DP=84;AF=0.98;MQM=59;TRIO=HOM,84,0.98,HET,155,0.52,HOM,200,1.00	TMC8	missense	TMC8:NM_152468.4:missense:MODERATE:exon8/16:c.917A>T:p.Asn306Ile		rs7208422	0.5523	0.5140	16335/8279/2409	0.5070	1.3510	T	T	B,B	B,B	605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];		CM091876 [CLASS=DP MUT=ALT PHEN="Epidermodysplasia verruciformis susceptibility in HIV association" GENE=TMC8]; 		344	495					TMC8 (inh=n/a pLI=0.00)
chr17	76130947	76130947	G	T	het		QUAL=7515;DP=60;AF=0.58;MQM=59;TRIO=HET,60,0.58,HET,257,0.49,HET,283,0.52	TMC8	splice_region&intron	TMC8:NM_152468.4:splice_region&intron:LOW:exon8/15:c.988-4G>T:		rs62079073	0.0777	0.0780	413/265/32	0.0750						605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];				13	201					TMC8 (inh=n/a pLI=0.00)
chr17	76131070	76131070	G	A	het		QUAL=20535;DP=144;AF=0.50;MQM=59;TRIO=HET,144,0.50,HET,374,0.50,HOM,446,0.99	TMC8	synonymous	TMC8:NM_152468.4:synonymous:LOW:exon9/16:c.1107G>A:p.Glu369Glu		rs12452890	0.5403	0.5340	17787/9533/2491	0.5259						605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];				387	505					TMC8 (inh=n/a pLI=0.00)
chr17	76137198	76137198	T	G	hom		QUAL=3388;DP=47;AF=1.00;MQM=59;TRIO=HOM,47,1.00,HOM,32,1.00,HOM,36,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*5T>G:		rs369764	0.9986	0.9950	49659/27823/3664	0.9259										1030	10					TMC8 (inh=n/a pLI=0.00)
chr17	76137337	76137337	C	G	het		QUAL=4847;DP=95;AF=0.45;MQM=59;TRIO=HET,95,0.45,HET,62,0.53,HOM,89,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*144C>G:		rs454138	0.6569	0.0000	0/0/0	0.5989										107	99					TMC8 (inh=n/a pLI=0.00)
chr17	76137477	76137477	T	G	het		QUAL=1839;DP=86;AF=0.50;MQM=60;TRIO=HET,86,0.50,HET,22,0.50,HET,38,0.42	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*284T>G:		rs2871647	0.1296	0.0000	0/0/0	0.1188										6	58					TMC8 (inh=n/a pLI=0.00)
chr17	76138577	76138577	A	G	het		QUAL=14163;DP=234;AF=0.52;MQM=59;TRIO=HET,234,0.52,HET,214,0.51,HOM,276,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*1384A>G:		rs4789015	0.5795	0.0000	0/0/0	0.5494										89	105					TMC8 (inh=n/a pLI=0.00)
chr17	78075462	78075462	G	C	het		QUAL=1496;DP=95;AF=0.57;MQM=59;TRIO=HET,95,0.57,WT,21,0.00,HET,36,0.53	GAA	5'UTR,intron	GAA:NM_000152.4:5'UTR:MODIFIER:exon1/20:c.-260G>C:,GAA:NR_134848.1:intron:MODIFIER:exon1/1:n.100+38G>C:,GAA:NM_001079803.2:intron:MODIFIER:exon1/20:c.-113+38G>C:,GAA:NM_001079804.2:intron:MODIFIER:exon1/19:c.-33+38G>C:		rs2304849	0.1180	0.0000	0/0/0	0.1841										10	72					GAA (inh=AR pLI=0.00)
chr17	78078709	78078709	T	C	hom		QUAL=3656;DP=53;AF=0.98;MQM=59;TRIO=HOM,53,0.98,HOM,38,1.00,HET,58,0.62	GAA	synonymous	GAA:NM_000152.4:synonymous:LOW:exon2/20:c.324T>C:p.Cys108Cys,GAA:NM_001079803.2:synonymous:LOW:exon3/21:c.324T>C:p.Cys108Cys,GAA:NM_001079804.2:synonymous:LOW:exon2/20:c.324T>C:p.Cys108Cys		rs1800300	0.7145	0.7310	32095/18688/2459	0.7198						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078180.5 [benign]; 		COSM3755978	680	411					GAA (inh=AR pLI=0.00)
chr17	78079544	78079544	C	G	hom		QUAL=20803;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,270,1.00,HET,379,0.51	GAA	splice_region&intron	GAA:NM_000152.4:splice_region&intron:LOW:exon2/19:c.547-4C>G:,GAA:NM_001079803.2:splice_region&intron:LOW:exon3/20:c.547-4C>G:,GAA:NM_001079804.2:splice_region&intron:LOW:exon2/19:c.547-4C>G:		rs3816256	0.6028	0.6750	28330/18491/1489	0.6631						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078182.5 [benign]; 			659	419					GAA (inh=AR pLI=0.00)
chr17	78079597	78079597	A	G	hom		QUAL=15938;DP=167;AF=0.99;MQM=59;TRIO=HOM,167,0.99,HOM,245,1.00,HET,344,0.47	GAA	missense	GAA:NM_000152.4:missense:MODERATE:exon3/20:c.596A>G:p.His199Arg,GAA:NM_001079803.2:missense:MODERATE:exon4/21:c.596A>G:p.His199Arg,GAA:NM_001079804.2:missense:MODERATE:exon3/20:c.596A>G:p.His199Arg		rs1042393	0.6008	0.6740	28199/18465/1486	0.6691	-0.2170	T	T,T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078183.5 [benign]; 		COSM3755979	659	419					GAA (inh=AR pLI=0.00)
chr17	78079643	78079643	C	T	het		QUAL=8107;DP=138;AF=0.50;MQM=60;TRIO=HET,138,0.50,HOM,212,1.00,WT,286,0.00	GAA	synonymous	GAA:NM_000152.4:synonymous:LOW:exon3/20:c.642C>T:p.Ser214Ser,GAA:NM_001079803.2:synonymous:LOW:exon4/21:c.642C>T:p.Ser214Ser,GAA:NM_001079804.2:synonymous:LOW:exon3/20:c.642C>T:p.Ser214Ser		rs1800301	0.1060	0.1800	2343/1763/29	0.1761						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078184.5 [benign]; 		COSM3755980	86	359					GAA (inh=AR pLI=0.00)
chr17	78079669	78079669	G	A	hom		QUAL=10107;DP=121;AF=0.93;MQM=59;TRIO=HOM,121,0.93,HOM,184,0.99,HET,243,0.47	GAA	missense	GAA:NM_000152.4:missense:MODERATE:exon3/20:c.668G>A:p.Arg223His,GAA:NM_001079803.2:missense:MODERATE:exon4/21:c.668G>A:p.Arg223His,GAA:NM_001079804.2:missense:MODERATE:exon3/20:c.668G>A:p.Arg223His		rs1042395	0.6024	0.6750	28120/18333/1473	0.6642	-0.0440	T	T,T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078185.5 [benign]; RCV000169616.1 [likely benign]; 		COSM3721877	658	417					GAA (inh=AR pLI=0.00)
chr17	78081526	78081526	-	GCAGCGG	hom		QUAL=9090;DP=30;AF=0.87;MQM=59;TRIO=HOM,30,0.87,HOM,198,0.97,HET,238,0.54	GAA	splice_region&intron	GAA:NM_000152.4:splice_region&intron:LOW:exon4/19:c.858+7_858+8insAGCGGGC:,GAA:NM_001079803.2:splice_region&intron:LOW:exon5/20:c.858+7_858+8insAGCGGGC:,GAA:NM_001079804.2:splice_region&intron:LOW:exon4/19:c.858+7_858+8insAGCGGGC:		rs3071247;rs372331052	0.5929	0.6620	26638/17376/1313	0.0935						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078186.5 [benign]; 			440	589					GAA (inh=AR pLI=0.00)
chr17	78082504	78082504	G	A	hom		QUAL=11662;DP=131;AF=0.98;MQM=59;TRIO=HOM,131,0.98,HOM,161,1.00,HET,215,0.50	GAA	synonymous	GAA:NM_000152.4:synonymous:LOW:exon8/20:c.1203G>A:p.Gln401Gln,GAA:NM_001079803.2:synonymous:LOW:exon9/21:c.1203G>A:p.Gln401Gln,GAA:NM_001079804.2:synonymous:LOW:exon8/20:c.1203G>A:p.Gln401Gln		rs1800304	0.6028	0.6730	27460/17905/1391	0.6674						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078155.5 [benign]; 		COSM3755981	657	419					GAA (inh=AR pLI=0.00)
chr17	78084769	78084769	G	A	het		QUAL=5763;DP=203;AF=0.41;MQM=60;TRIO=HET,203,0.41,WT,282,0.00,HET,316,0.49	GAA	synonymous	GAA:NM_000152.4:synonymous:LOW:exon11/20:c.1581G>A:p.Arg527Arg,GAA:NM_001079803.2:synonymous:LOW:exon12/21:c.1581G>A:p.Arg527Arg,GAA:NM_001079804.2:synonymous:LOW:exon11/20:c.1581G>A:p.Arg527Arg		rs1042396	0.1595	0.2310	3584/2541/27	0.2303						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078160.5 [benign]; 		COSM148357	90	450					GAA (inh=AR pLI=0.00)
chr17	78091405	78091405	G	A	hom	low_DP	QUAL=1008;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HOM,15,1.00,HET,15,0.33	GAA	missense	GAA:NM_000152.4:missense:MODERATE:exon17/20:c.2338G>A:p.Val780Ile,GAA:NM_001079803.2:missense:MODERATE:exon18/21:c.2338G>A:p.Val780Ile,GAA:NM_001079804.2:missense:MODERATE:exon17/20:c.2338G>A:p.Val780Ile		rs1126690	0.7119	0.7280	32675/19277/2490	0.7210	-0.3890	T	T,T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078171.5 [benign]; 		COSM3755982	680	401					GAA (inh=AR pLI=0.00)
chr17	78092063	78092063	G	A	hom		QUAL=6629;DP=58;AF=0.97;MQM=59;TRIO=HOM,58,0.97,HOM,116,0.99,HET,139,0.51	GAA	synonymous	GAA:NM_000152.4:synonymous:LOW:exon18/20:c.2553G>A:p.Gly851Gly,GAA:NM_001079803.2:synonymous:LOW:exon19/21:c.2553G>A:p.Gly851Gly,GAA:NM_001079804.2:synonymous:LOW:exon18/20:c.2553G>A:p.Gly851Gly		rs1042397	0.5094	0.5770	20899/13839/1484	0.5703						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078176.5 [benign]; 		COSM3766205	521	481					GAA (inh=AR pLI=0.00)
chr17	78093549	78093549	G	T	hom		QUAL=882;DP=35;AF=0.94;MQM=60;TRIO=HOM,35,0.94,HET,9,0.33,HET,17,0.41	GAA	3'UTR	GAA:NM_000152.4:3'UTR:MODIFIER:exon20/20:c.*419G>T:,GAA:NM_001079803.2:3'UTR:MODIFIER:exon21/21:c.*419G>T:,GAA:NM_001079804.2:3'UTR:MODIFIER:exon20/20:c.*419G>T:		rs7567	0.1560	0.0000	0/0/0	0.2179										15	78					GAA (inh=AR pLI=0.00)
chr17	78183396	78183396	A	G	het		QUAL=33545;DP=274;AF=0.38;MQM=58;TRIO=HET,274,0.38,HET,814,0.47,HOM,851,0.98	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*855T>C:		rs1046832	0.4507	0.0000	0/0/0	0.2794										50	129					SGSH (inh=AR pLI=0.00)
chr17	78183403	78183403	G	C	het		QUAL=41641;DP=264;AF=0.40;MQM=58;TRIO=HET,264,0.40,HET,844,0.53,HOM,979,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*848C>G:		rs709677	0.6542	0.0000	0/0/0	0.3617										118	82					SGSH (inh=AR pLI=0.00)
chr17	78183411	78183411	T	C	het		QUAL=41950;DP=269;AF=0.42;MQM=58;TRIO=HET,269,0.42,HET,822,0.55,HOM,991,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*840A>G:		rs709678	0.6470	0.0000	0/0/0	0.4118										115	86					SGSH (inh=AR pLI=0.00)
chr17	78183936	78183936	G	A	het		QUAL=8167;DP=126;AF=0.43;MQM=60;TRIO=HET,126,0.43,HET,151,0.49,HOM,172,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*315C>T:		rs2071148	0.4483	0.0000	0/0/0	0.5359										83	96					SGSH (inh=AR pLI=0.00)
chr17	78184393	78184393	C	T	het		QUAL=4300;DP=160;AF=0.45;MQM=60;TRIO=HET,160,0.45,HET,229,0.50,WT,304,0.00	SGSH	missense	SGSH:NM_000199.3:missense:MODERATE:exon8/8:c.1367G>A:p.Arg456His		rs7503034	0.3458	0.3540	7750/3342/233	0.3465	-0.3080	T	T,T	B	B	605270 [SGSH (confirmed) Mucopolysaccharidisis type IIIA (Sanfilippo A)];	RCV000078352.4 [benign]; 		COSM3755983	140	444					SGSH (inh=AR pLI=0.00)
chr17	79478019	79478019	G	A	hom		QUAL=35479;DP=356;AF=0.98;MQM=59;TRIO=HOM,356,0.98,HOM,331,1.00,HOM,484,1.00	ACTG1	synonymous,non_coding_exon	ACTG1:NM_001199954.1:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr,ACTG1:NM_001614.3:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr,ACTG1:NR_037688.1:non_coding_exon:MODIFIER:exon5/7:n.1057C>T:		rs1139405	0.7562	0.7900	38122/22217/2075	0.7765						102560 [ACTG1 (confirmed) Deafness,autosomal dominant 20/26|Baraitser-Winter syndrome 2];	RCV000037126.5 [other]; 		COSM1387303	731	323					ACTG1 (inh=AD pLI=0.22)
chr17	79479808	79479808	C	T	hom	low_DP	QUAL=226;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HET,7,0.43,HOM,7,1.00	ACTG1	5'UTR,non_coding_exon	ACTG1:NM_001199954.1:5'UTR:MODIFIER:exon1/6:c.-174G>A:,ACTG1:NM_001614.3:5'UTR:MODIFIER:exon1/6:c.-55G>A:,ACTG1:NR_037688.1:non_coding_exon:MODIFIER:exon1/7:n.85G>A:		rs7503278	0.7344	0.7750	3217/820/35	0.1410										390	160					ACTG1 (inh=AD pLI=0.22)
chr17	79479843	79479843	C	G	hom	low_DP	QUAL=55;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,WT,4,0.00,HET,11,0.36	ACTG1	5'UTR,non_coding_exon	ACTG1:NM_001199954.1:5'UTR:MODIFIER:exon1/6:c.-209G>C:,ACTG1:NM_001614.3:5'UTR:MODIFIER:exon1/6:c.-90G>C:,ACTG1:NR_037688.1:non_coding_exon:MODIFIER:exon1/7:n.50G>C:		rs542961891	0.0034	0.0140	3/0/0	0.0003										1	10					ACTG1 (inh=AD pLI=0.22)
chr17	79891147	79891147	T	C	hom		QUAL=30092;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HOM,349,1.00,HOM,451,1.00	PYCR1	synonymous,intron	PYCR1:NM_001282281.1:synonymous:LOW:exon8/8:c.984A>G:p.Ser328Ser,PYCR1:NM_006907.3:synonymous:LOW:exon7/7:c.903A>G:p.Ser301Ser,PYCR1:NM_001282279.1:synonymous:LOW:exon7/7:c.810A>G:p.Ser270Ser,PYCR1:NM_001282280.1:synonymous:LOW:exon8/8:c.903A>G:p.Ser301Ser,PYCR1:NM_153824.2:intron:MODIFIER:exon7/7:c.867+36A>G:		rs61747618	0.9860	0.9950	59613/32948/4604	0.9363						179035 [PYCR1 (provisional) Cutis laxa,autosomal recessive,type IIB|Cutis laxa,autosomal recessive,type IIIB];			COSM4130834	1106	0					PYCR1 (inh=AR pLI=0.00)
chr17	80036877	80036877	A	G	het		QUAL=1584;DP=31;AF=0.45;MQM=59;TRIO=HET,31,0.45,HET,59,0.56,HET,79,0.41	FASN	3'UTR	FASN:NM_004104.4:3'UTR:MODIFIER:exon43/43:c.*142T>C:		rs11550611	0.5885	0.0000	0/0/0	0.5375										118	90					FASN (inh=n/a pLI=1.00)
chr17	80045086	80045086	G	C	het		QUAL=2064;DP=70;AF=0.49;MQM=59;TRIO=HET,70,0.49,HET,111,0.51,WT,126,0.00	FASN	synonymous	FASN:NM_004104.4:synonymous:LOW:exon21/43:c.3267C>G:p.Ala1089Ala		rs4485435	0.2230	0.1810	2331/851/383	0.1668									COSM4130849	49	341					FASN (inh=n/a pLI=1.00)
chr17	80051183	80051183	A	G	het		QUAL=5891;DP=158;AF=0.46;MQM=59;TRIO=HET,158,0.46,WT,154,0.01,HOM,136,0.99	FASN	synonymous	FASN:NM_004104.4:synonymous:LOW:exon5/43:c.567T>C:p.Asn189Asn		rs2228309	0.3918	0.4580	10895/7835/893	0.4004									COSM3756037	289	528					FASN (inh=n/a pLI=1.00)
chr17	80572628	80572628	A	G	het		QUAL=5105;DP=270;AF=0.44;MQM=59;TRIO=HET,270,0.44,WT,117,0.00,HET,162,0.52	WDR45B	3'UTR	WDR45B:NM_019613.3:3'UTR:MODIFIER:exon10/10:c.*1167T>C:		rs1059672	0.6310	0.0000	0/0/0	0.0862										78	109					WDR45B (inh=n/a pLI=0.64)
chr17	80573272	80573272	A	G	hom		QUAL=9647;DP=181;AF=1.00;MQM=58;TRIO=HOM,181,1.00,HET,140,0.46,HET,175,0.53	WDR45B	3'UTR	WDR45B:NM_019613.3:3'UTR:MODIFIER:exon10/10:c.*523T>C:		rs9271	0.8634	0.0000	0/0/0	0.1210										162	63					WDR45B (inh=n/a pLI=0.64)
chr17	80579609	80579609	T	C	het	phylop_high	QUAL=4538;DP=222;AF=0.49;MQM=60;TRIO=HET,222,0.49,WT,148,0.00,HET,180,0.47	WDR45B	missense	WDR45B:NM_019613.3:missense:MODERATE:exon6/10:c.494A>G:p.His165Arg		rs74895287	0.0132	0.0130	21/14/4	0.0129	7.5030	T	T,T	B	B				COSM3756047	4	47					WDR45B (inh=n/a pLI=0.64)
chr17	80585094	80585094	C	T	het		QUAL=5074;DP=196;AF=0.55;MQM=57;TRIO=HET,196,0.55,HET,202,0.48,WT,215,0.00	WDR45B	synonymous	WDR45B:NM_019613.3:synonymous:LOW:exon4/10:c.318G>A:p.Lys106Lys		rs2291393	0.2007	0.2310	3485/2039/65	0.2159									COSM3756048	79	394					WDR45B (inh=n/a pLI=0.64)
chr18	2917152	2917152	T	C	het		QUAL=7986;DP=339;AF=0.52;MQM=60;TRIO=HET,339,0.52,HET,243,0.49,WT,340,0.00	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*3139A>G:		rs1164	0.1420	0.0000	0/0/0	0.0300										12	71					LPIN2 (inh=n/a pLI=0.67)
chr18	2917357	2917357	G	A	het		QUAL=19697;DP=652;AF=0.52;MQM=60;TRIO=HET,652,0.52,HET,191,0.55,HOM,226,1.00	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*2934C>T:		rs7980	0.5455	0.0000	0/0/0	0.0995										84	110					LPIN2 (inh=n/a pLI=0.67)
chr18	2919343	2919343	-	T	hom		QUAL=15953;DP=375;AF=0.96;MQM=59;TRIO=HOM,375,0.96,HET,174,0.54,HET,222,0.54	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*947dupA:		rs3840906	0.3265	0.0000	0/0/0	0.3498										36	109					LPIN2 (inh=n/a pLI=0.67)
chr18	2919606	2919606	A	T	het		QUAL=11329;DP=292;AF=0.41;MQM=60;TRIO=HET,292,0.41,HOM,185,1.00,HET,260,0.51	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*685T>A:		rs607549	0.6913	0.0000	0/0/0	0.1169										125	86					LPIN2 (inh=n/a pLI=0.67)
chr18	3412167	3412167	C	T	hom		QUAL=1818;DP=49;AF=0.96;MQM=59;TRIO=HOM,49,0.96,HET,20,0.55,HOM,21,1.00	TGIF1	5'UTR	TGIF1:NM_174886.2:5'UTR:MODIFIER:exon1/4:c.-203C>T:		rs11571505	0.6166	0.0000	0/0/0	0.5401										69	113					TGIF1 (inh=n/a pLI=0.09)
chr18	3447725	3447725	C	T	het		QUAL=8899;DP=597;AF=0.43;MQM=60;TRIO=HET,597,0.43,HET,215,0.52,WT,295,0.00	TGIF1	5'UTR,intron	TGIF1:NM_173207.2:5'UTR:MODIFIER:exon1/3:c.-13C>T:,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-8627C>T:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-8627C>T:		rs238137	0.0837	0.0480	220/41/104	0.0477										0	42					TGIF1 (inh=n/a pLI=0.09)
chr18	3450455	3450455	C	A	het		QUAL=8859;DP=146;AF=0.47;MQM=59;TRIO=HET,146,0.47,HOM,246,0.99,WT,292,0.00	TGIF1	5'UTR,intron	TGIF1:NM_001278684.1:5'UTR:MODIFIER:exon2/4:c.-33C>A:,TGIF1:NM_173208.2:5'UTR:MODIFIER:exon2/4:c.-33C>A:,TGIF1:NM_003244.3:5'UTR:MODIFIER:exon1/3:c.-33C>A:,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-5897C>A:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-5897C>A:,TGIF1:NM_173207.2:intron:MODIFIER:exon1/2:c.58+2660C>A:,TGIF1:NM_001278682.1:intron:MODIFIER:exon1/2:c.25+801C>A:,TGIF1:NM_173209.2:intron:MODIFIER:exon1/2:c.-45+387C>A:		rs238132	0.2839	0.0980	668/96/430	0.0988						602630 [TGIF1 (confirmed) Holoprosencephaly-4];				27	130					TGIF1 (inh=n/a pLI=0.09)
chr18	3452223	3452223	T	-	het	anno_high_impact	QUAL=468;DP=22;AF=0.45;MQM=59;TRIO=HET,22,0.45,WT,33,0.00,HET,43,0.35	TGIF1	frameshift,intron	TGIF1:NM_170695.3:frameshift:HIGH:exon1/3:c.246delT:p.Pro83fs,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-4129delT:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-4129delT:,TGIF1:NM_173207.2:intron:MODIFIER:exon1/2:c.59-4129delT:,TGIF1:NM_001278682.1:intron:MODIFIER:exon1/2:c.25+2569delT:,TGIF1:NM_001278684.1:intron:MODIFIER:exon2/3:c.16+1720delT:,TGIF1:NM_173208.2:intron:MODIFIER:exon2/3:c.16+1720delT:,TGIF1:NM_173209.2:intron:MODIFIER:exon1/2:c.-45+2155delT:,TGIF1:NM_003244.3:intron:MODIFIER:exon1/2:c.16+1720delT:,TGIF1:NM_173210.2:intron:MODIFIER:exon1/2:c.-45+450delT:		rs11571510	0.2556	0.3240	6049/4473/371	0.2965						602630 [TGIF1 (confirmed) Holoprosencephaly-4];			COSM296436	110	267	1	[1] old entry - no details available			TGIF1 (inh=n/a pLI=0.09)
chr18	3457606	3457606	C	T	het	phylop_high;pred_pathogenic_1	QUAL=6456;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,237,0.54,WT,315,0.00	TGIF1	missense	TGIF1:NM_170695.3:missense:MODERATE:exon3/3:c.874C>T:p.Pro292Ser,TGIF1:NM_174886.2:missense:MODERATE:exon4/4:c.427C>T:p.Pro143Ser,TGIF1:NM_001278686.1:missense:MODERATE:exon4/4:c.427C>T:p.Pro143Ser,TGIF1:NM_173207.2:missense:MODERATE:exon3/3:c.529C>T:p.Pro177Ser,TGIF1:NM_001278682.1:missense:MODERATE:exon3/3:c.496C>T:p.Pro166Ser,TGIF1:NM_001278684.1:missense:MODERATE:exon4/4:c.487C>T:p.Pro163Ser,TGIF1:NM_173208.2:missense:MODERATE:exon4/4:c.487C>T:p.Pro163Ser,TGIF1:NM_173209.2:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:NM_003244.3:missense:MODERATE:exon3/3:c.487C>T:p.Pro163Ser,TGIF1:NM_173210.2:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:NM_173211.1:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser		rs4468717	0.0313	0.0600	302/211/0	0.0582	3.6330	T	D,T,T,D,T,T,T,T,T,T,T,T,T	P,P,P	B,B,B	602630 [TGIF1 (confirmed) Holoprosencephaly-4];		CM1411534 [CLASS=DP MUT=ALT PHEN="Myopia high-grade association with" GENE=TGIF1]; 		10	172					TGIF1 (inh=n/a pLI=0.09)
chr18	6943264	6943264	G	A	hom		QUAL=28838;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,275,1.00,HOM,337,1.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon62/63:c.8982C>T:p.Asp2994Asp		rs2016639	0.2861	0.3310	7376/3447/31	0.3242						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];			COSM148377	110	445					LAMA1 (inh=n/a pLI=0.00)
chr18	6980523	6980523	T	C	hom		QUAL=19935;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,258,1.00,HET,292,0.51	LAMA1	missense	LAMA1:NM_005559.3:missense:MODERATE:exon42/63:c.6004A>G:p.Lys2002Glu		rs607230	0.6937	0.7270	32332/17088/1629	0.7198	1.4670	T	T	B	B	150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];				587	430					LAMA1 (inh=n/a pLI=0.00)
chr18	6985631	6985631	C	T	hom		QUAL=26754;DP=389;AF=0.99;MQM=60;TRIO=HOM,389,0.99,HOM,310,0.99,HET,367,0.47	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon38/63:c.5391G>A:p.Leu1797Leu		rs617206	0.5521	0.5150	16844/6495/1378	0.5003						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];			COSM3756200	194	545					LAMA1 (inh=n/a pLI=0.00)
chr18	7008591	7008591	T	C	het	pred_pathogenic_1	QUAL=6657;DP=310;AF=0.54;MQM=60;TRIO=HET,310,0.54,HET,172,0.45,WT,242,0.00	LAMA1	missense	LAMA1:NM_005559.3:missense:MODERATE:exon28/63:c.4018A>G:p.Met1340Val		rs662471	0.1871	0.2380	3959/2876/287	0.2343	-0.0350	T	D	P	B	150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];				93	435					LAMA1 (inh=n/a pLI=0.00)
chr18	7012123	7012123	A	G	het		QUAL=9426;DP=238;AF=0.46;MQM=60;TRIO=HET,238,0.46,HOM,219,1.00,WT,341,0.01	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon24/63:c.3378T>C:p.Gly1126Gly		rs9946794	0.4201	0.3770	9575/4683/3020	0.3682						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];			COSM438362	158	527					LAMA1 (inh=n/a pLI=0.00)
chr18	7017322	7017322	A	G	het		QUAL=18258;DP=440;AF=0.48;MQM=59;TRIO=HET,440,0.48,HOM,397,1.00,WT,564,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon20/63:c.2763T>C:p.Cys921Cys		rs539713	0.5475	0.5190	17510/9437/3769	0.5090						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];			COSM4131076	366	529					LAMA1 (inh=n/a pLI=0.00)
chr18	7023371	7023371	A	G	het		QUAL=1440;DP=54;AF=0.48;MQM=60;TRIO=HET,54,0.48,HET,53,0.64,WT,60,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon19/63:c.2493T>C:p.Cys831Cys		rs684634	0.4373	0.3800	9955/4884/3110	0.3756						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];			COSM1179774	152	504					LAMA1 (inh=n/a pLI=0.00)
chr18	7033037	7033037	G	A	het		QUAL=8169;DP=284;AF=0.50;MQM=59;TRIO=HET,284,0.50,HOM,157,0.97,WT,225,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon15/63:c.2109C>T:p.Ala703Ala		rs621993	0.4066	0.3840	9166/5102/2046	0.3770						150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome];				169	530					LAMA1 (inh=n/a pLI=0.00)
chr18	9117867	9117867	T	C	hom		QUAL=11262;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,42,1.00,HOM,54,1.00	NDUFV2	missense	NDUFV2:NM_021074.4:missense:MODERATE:exon2/8:c.86T>C:p.Val29Ala		rs906807	0.7790	0.8000	39013/22176/2993	0.7909	1.5370	T	T,T	B	B	600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency];	RCV000009621.2 [uncertain significance]; RCV000117718.3 [other]; 	CM983407 [CLASS=DP MUT=REF PHEN="Parkinson disease susceptibility to association" GENE=NDUFV2]; 	COSM3773839	745	331					NDUFV2 (inh=AR pLI=0.01)
chr18	9119489	9119489	A	T	het		QUAL=8746;DP=402;AF=0.50;MQM=55;TRIO=HET,402,0.50,HET,247,0.51,WT,299,0.00	NDUFV2	synonymous	NDUFV2:NM_021074.4:synonymous:LOW:exon4/8:c.201A>T:p.Val67Val		rs41274300	0.0751	0.0840	542/368/110	0.0845						600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency];	RCV000117717.2 [likely benign]; 		COSM4131120	14	226					NDUFV2 (inh=AR pLI=0.01)
chr18	9134344	9134344	T	C	het		QUAL=2987;DP=117;AF=0.55;MQM=60;TRIO=HET,117,0.55,HET,118,0.51,WT,143,0.00	NDUFV2-AS1	intron	NDUFV2-AS1:NR_110771.1:intron:MODIFIER:exon1/3:n.358-836A>G:,NDUFV2-AS1:NR_110772.1:intron:MODIFIER:exon1/2:n.358-836A>G:		rs62088771	0.0034	0.0000	0/0/0	0.0016										0	8					NDUFV2-AS1 (inh=n/a pLI=n/a)
chr18	12348285	12348285	T	C	hom		QUAL=15844;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HET,184,0.46,HOM,213,1.00	AFG3L2	synonymous	AFG3L2:NM_006796.2:synonymous:LOW:exon13/17:c.1650A>G:p.Glu550Glu		rs11553521	0.7099	0.7490	34444/20351/3067	0.7403						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000116249.3 [other]; 		COSM148398	1692	931					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	12351342	12351342	C	T	hom		QUAL=16470;DP=202;AF=0.99;MQM=59;TRIO=HOM,202,0.99,HET,194,0.53,HOM,252,1.00	AFG3L2	synonymous	AFG3L2:NM_006796.2:synonymous:LOW:exon11/17:c.1389G>A:p.Leu463Leu		rs11080572	0.6232	0.7200	32215/20238/1251	0.7140						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000116248.4 [other]; 		COSM148399	1679	933					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	12359920	12359920	G	A	hom		QUAL=14167;DP=179;AF=1.00;MQM=59;TRIO=HOM,179,1.00,HET,146,0.52,HOM,202,1.00	AFG3L2	splice_region&intron	AFG3L2:NM_006796.2:splice_region&intron:LOW:exon7/16:c.752+6C>T:		rs8097342	0.6196	0.7180	31953/20115/1248	0.7050						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000179927.2 [benign]; 		COSM148400	1654	916					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	21119777	21119777	G	A	hom		QUAL=14838;DP=201;AF=1.00;MQM=59;TRIO=HOM,201,1.00,HET,207,0.48,HOM,209,1.00	NPC1	splice_region&synonymous	NPC1:NM_000271.4:splice_region&synonymous:LOW:exon18/25:c.2793C>T:p.Asn931Asn		rs1140458	0.4840	0.4890	15043/7063/759	0.4859						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020228.2 [benign]; RCV000078475.7 [other]; 		COSM437978	486	1109					NPC1 (inh=AR pLI=0.00)
chr18	21120444	21120444	T	C	hom	phylop_high	QUAL=28222;DP=561;AF=1.00;MQM=59;TRIO=HOM,561,1.00,HET,198,0.54,HOM,223,0.99	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon17/25:c.2572A>G:p.Ile858Val		rs1805082	0.4858	0.4900	15014/7024/758	0.4897	4.9470	T	T,T,T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020227.2 [benign]; RCV000078474.7 [other]; 			489	1110	1	[1] old entry - no details available			NPC1 (inh=AR pLI=0.00)
chr18	21123537	21123537	A	-	hom		QUAL=845;DP=60;AF=0.42;MQM=59;TRIO=HOM,60,0.42,HET,64,0.42,WT,49,0.22	NPC1	splice_region&intron	NPC1:NM_000271.4:splice_region&intron:LOW:exon13/24:c.2131-4delT:	(A)n	rs533551695;rs560653962;rs796757567	0.5022	0.4310	165/73/30	0.3868						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				134	1583	2	[2] Stephan Waldm?ller 13.11.2014			NPC1 (inh=AR pLI=0.00)
chr18	21124917	21124917	G	C	het	low_DP;low_MQM	QUAL=870;DP=4;AF=0.00;MQM=49;TRIO=HET,4,0.00,WT,83,0.00,HET,73,0.34	NPC1	splice_region&intron	NPC1:NM_000271.4:splice_region&intron:LOW:exon12/24:c.1947+7C>G:		rs56394541	0.0000	0.0001	0/0/0	0.0001						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				20	95	2	[2] Stefanie Beck-Woedl 20.03.2015			NPC1 (inh=AR pLI=0.00)
chr18	21124918	21124918	G	C	het	low_DP;low_MQM	QUAL=870;DP=4;AF=0.00;MQM=49;TRIO=HET,4,0.00,WT,83,0.00,HET,73,0.34	NPC1	splice_region&intron	NPC1:NM_000271.4:splice_region&intron:LOW:exon12/24:c.1947+6C>G:		rs745432812	0.0000	0.0001	0/0/0	0.0001						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				0	57					NPC1 (inh=AR pLI=0.00)
chr18	21124945	21124945	C	G	hom	phylop_high	QUAL=5168;DP=51;AF=0.98;MQM=59;TRIO=HOM,51,0.98,HET,110,0.24,HOM,113,1.00	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon12/25:c.1926G>C:p.Met642Ile		rs1788799	0.8317	0.7180	32007/13600/4398	0.6903	3.3010	T	T,T,T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020225.2 [benign]; RCV000078467.7 [other]; 			987	1015					NPC1 (inh=AR pLI=0.00)
chr18	21134786	21134786	G	A	het	phylop_high	QUAL=7443;DP=217;AF=0.48;MQM=60;TRIO=HET,217,0.48,WT,247,0.00,HET,361,0.52	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon9/25:c.1489C>T:p.His497Tyr		rs770838112	0.0000	0.0001	0/0/0	0.0001	6.4200	T	T,T,T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				0	1	3	[3] Stephan Waldm?ller 13.08.2014			NPC1 (inh=AR pLI=0.00)
chr18	21140432	21140432	T	C	hom		QUAL=2361;DP=42;AF=0.98;MQM=59;TRIO=HOM,42,0.98,HET,31,0.42,HOM,29,1.00	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon6/25:c.644A>G:p.His215Arg		rs1805081	0.2187	0.3270	7279/5277/37	0.3285	0.5890	T	T,T	B	B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000078484.7 [other]; RCV000158944.1 [benign]; 			301	1027					NPC1 (inh=AR pLI=0.00)
chr18	21413869	21413869	T	C	het		QUAL=19977;DP=347;AF=0.48;MQM=59;TRIO=HET,347,0.48,HET,326,0.52,HOM,370,0.99	LAMA3	synonymous	LAMA3:NM_198129.2:synonymous:LOW:exon24/75:c.2901T>C:p.Ala967Ala,LAMA3:NM_001127717.2:synonymous:LOW:exon24/74:c.2901T>C:p.Ala967Ala		rs9962023	0.6244	0.6620	27016/16761/1443	0.6569						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM4130939	548	472					LAMA3 (inh=n/a pLI=0.00)
chr18	21437931	21437931	G	C	het		QUAL=25123;DP=355;AF=0.52;MQM=60;TRIO=HET,355,0.52,HET,392,0.53,HOM,525,0.99	LAMA3	synonymous	LAMA3:NM_198129.2:synonymous:LOW:exon33/75:c.4260G>C:p.Gly1420Gly,LAMA3:NM_001127717.2:synonymous:LOW:exon33/74:c.4260G>C:p.Gly1420Gly		rs867449	0.3437	0.4960	16492/12782/336	0.4860						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				384	524					LAMA3 (inh=n/a pLI=0.00)
chr18	21441717	21441717	C	T	het		QUAL=10335;DP=134;AF=0.53;MQM=60;TRIO=HET,134,0.53,HET,141,0.50,HOM,222,1.00	LAMA3	synonymous	LAMA3:NM_198129.2:synonymous:LOW:exon35/75:c.4530C>T:p.Pro1510Pro,LAMA3:NM_001127717.2:synonymous:LOW:exon35/74:c.4530C>T:p.Pro1510Pro		rs12965685	0.3407	0.4930	16084/12519/296	0.4880						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				385	525					LAMA3 (inh=n/a pLI=0.00)
chr18	21481233	21481233	C	G	het		QUAL=4344;DP=246;AF=0.52;MQM=60;TRIO=HET,246,0.52,HET,96,0.46,WT,138,0.00	LAMA3	synonymous	LAMA3:NM_198129.2:synonymous:LOW:exon48/75:c.6147C>G:p.Ala2049Ala,LAMA3:NM_001127717.2:synonymous:LOW:exon47/74:c.5979C>G:p.Ala1993Ala,LAMA3:NM_000227.4:synonymous:LOW:exon11/38:c.1320C>G:p.Ala440Ala,LAMA3:NM_001127718.2:synonymous:LOW:exon10/37:c.1152C>G:p.Ala384Ala		rs1154226	0.1683	0.2340	3696/2434/17	0.2339						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM1179775, COSM1179776	65	426					LAMA3 (inh=n/a pLI=0.00)
chr18	21511034	21511034	C	A	het		QUAL=5183;DP=215;AF=0.55;MQM=60;TRIO=HET,215,0.55,HET,132,0.61,WT,197,0.00	LAMA3	missense	LAMA3:NM_198129.2:missense:MODERATE:exon65/75:c.8445C>A:p.Asn2815Lys,LAMA3:NM_001127717.2:missense:MODERATE:exon64/74:c.8277C>A:p.Asn2759Lys,LAMA3:NM_000227.4:missense:MODERATE:exon28/38:c.3618C>A:p.Asn1206Lys,LAMA3:NM_001127718.2:missense:MODERATE:exon27/37:c.3450C>A:p.Asn1150Lys		rs1154232	0.1567	0.1890	2374/1348/18	0.1874	-0.0070	T	T,T,T	B,B,B,B	B,B,B,B	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				45	356					LAMA3 (inh=n/a pLI=0.00)
chr18	21511089	21511089	A	G	hom		QUAL=22691;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,177,1.00,HOM,249,1.00	LAMA3	missense	LAMA3:NM_198129.2:missense:MODERATE:exon65/75:c.8500A>G:p.Ser2834Gly,LAMA3:NM_001127717.2:missense:MODERATE:exon64/74:c.8332A>G:p.Ser2778Gly,LAMA3:NM_000227.4:missense:MODERATE:exon28/38:c.3673A>G:p.Ser1225Gly,LAMA3:NM_001127718.2:missense:MODERATE:exon27/37:c.3505A>G:p.Ser1169Gly		rs1154233	1.0000	1.0000	60703/33370/5202	0.9419	-1.2560	T	T,T,T	B,B,B,B	B,B,B,B	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				1123	0					LAMA3 (inh=n/a pLI=0.00)
chr18	21511172	21511172	G	C	hom		QUAL=17370;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HOM,154,1.00,HOM,201,1.00	LAMA3	splice_region&intron	LAMA3:NM_198129.2:splice_region&intron:LOW:exon65/74:c.8576+7G>C:,LAMA3:NM_001127717.2:splice_region&intron:LOW:exon64/73:c.8408+7G>C:,LAMA3:NM_000227.4:splice_region&intron:LOW:exon28/37:c.3749+7G>C:,LAMA3:NM_001127718.2:splice_region&intron:LOW:exon27/36:c.3581+7G>C:		rs1258107	0.9489	0.9730	57551/32496/4160	0.9305						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				1076	44					LAMA3 (inh=n/a pLI=0.00)
chr18	21513768	21513768	C	T	het		QUAL=2822;DP=135;AF=0.46;MQM=60;TRIO=HET,135,0.46,HET,89,0.55,WT,105,0.04	LAMA3	synonymous	LAMA3:NM_198129.2:synonymous:LOW:exon67/75:c.8731C>T:p.Leu2911Leu,LAMA3:NM_001127717.2:synonymous:LOW:exon66/74:c.8563C>T:p.Leu2855Leu,LAMA3:NM_000227.4:synonymous:LOW:exon30/38:c.3904C>T:p.Leu1302Leu,LAMA3:NM_001127718.2:synonymous:LOW:exon29/37:c.3736C>T:p.Leu1246Leu		rs1131521	0.1484	0.1860	2331/1334/11	0.1850						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM3756099, COSM3756100	45	354					LAMA3 (inh=n/a pLI=0.00)
chr18	21529722	21529722	G	A	het		QUAL=10922;DP=225;AF=0.52;MQM=60;TRIO=HET,225,0.52,HET,178,0.49,HOM,190,1.00	LAMA3	splice_region&intron	LAMA3:NM_198129.2:splice_region&intron:LOW:exon70/74:c.9352-7G>A:,LAMA3:NM_001127717.2:splice_region&intron:LOW:exon69/73:c.9184-7G>A:,LAMA3:NM_000227.4:splice_region&intron:LOW:exon33/37:c.4525-7G>A:,LAMA3:NM_001127718.2:splice_region&intron:LOW:exon32/36:c.4357-7G>A:		rs2241643	0.3590	0.5370	19668/15371/360	0.5302						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				446	498					LAMA3 (inh=n/a pLI=0.00)
chr18	21534701	21534701	C	A	het		QUAL=17672;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,HET,258,0.46,HOM,346,1.00	LAMA3	3'UTR	LAMA3:NM_198129.2:3'UTR:MODIFIER:exon75/75:c.*89C>A:,LAMA3:NM_001127717.2:3'UTR:MODIFIER:exon74/74:c.*89C>A:,LAMA3:NM_000227.4:3'UTR:MODIFIER:exon38/38:c.*89C>A:,LAMA3:NM_001127718.2:3'UTR:MODIFIER:exon37/37:c.*89C>A:		rs1051149	0.3596	0.0000	0/0/0	0.0830										88	110					LAMA3 (inh=n/a pLI=0.00)
chr18	21534703	21534703	C	T	het		QUAL=17672;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,HET,258,0.46,HOM,346,1.00	LAMA3	3'UTR	LAMA3:NM_198129.2:3'UTR:MODIFIER:exon75/75:c.*91C>T:,LAMA3:NM_001127717.2:3'UTR:MODIFIER:exon74/74:c.*91C>T:,LAMA3:NM_000227.4:3'UTR:MODIFIER:exon38/38:c.*91C>T:,LAMA3:NM_001127718.2:3'UTR:MODIFIER:exon37/37:c.*91C>T:		rs1051150	0.3596	0.0000	0/0/0	0.0830										88	110					LAMA3 (inh=n/a pLI=0.00)
chr18	31320229	31320229	A	G	het		QUAL=11713;DP=370;AF=0.49;MQM=60;TRIO=HET,370,0.49,HET,224,0.45,HET,265,0.55	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon11/12:c.2861A>G:p.Asn954Ser		rs2282632	0.7033	0.5950	22038/8392/2969	0.5850	0.4050	T	T	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				166	353					ASXL3 (inh=n/a pLI=1.00)
chr18	31323848	31323848	A	G	het	pred_pathogenic_1	QUAL=9221;DP=383;AF=0.46;MQM=60;TRIO=HET,383,0.46,WT,303,0.00,HET,421,0.44	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon12/12:c.4036A>G:p.Ile1346Val		rs61995734	0.0246	0.0160	39/10/24	0.0160	0.4170	T	D	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				0	15					ASXL3 (inh=n/a pLI=1.00)
chr18	31324934	31324934	A	G	het		QUAL=15392;DP=356;AF=0.52;MQM=59;TRIO=HET,356,0.52,HET,350,0.45,HET,506,0.50	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon12/12:c.5122A>G:p.Met1708Val		rs7232237	0.6791	0.5860	21888/8534/2669	0.5773	-1.4340	T	T	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				165	355					ASXL3 (inh=n/a pLI=1.00)
chr18	31327296	31327296	A	C	het		QUAL=7616;DP=415;AF=0.50;MQM=60;TRIO=HET,415,0.50,WT,176,0.01,HET,221,0.52	ASXL3	3'UTR	ASXL3:NM_030632.1:3'UTR:MODIFIER:exon12/12:c.*737A>C:		rs7243541	0.2169	0.0000	0/0/0	0.1578										2	52					ASXL3 (inh=n/a pLI=1.00)
chr18	33713287	33713287	T	A	het		QUAL=12045;DP=383;AF=0.46;MQM=60;TRIO=HET,383,0.46,HET,272,0.48,HET,315,0.48	ELP2	splice_region&intron	ELP2:NM_001242875.1:splice_region&intron:LOW:exon2/22:c.217+8T>A:,ELP2:NM_001242879.1:splice_region&intron:LOW:exon2/18:c.217+8T>A:,ELP2:NR_040110.1:splice_region&intron:LOW:exon2/21:n.277+8T>A:,ELP2:NM_001242876.1:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:NM_001242877.1:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:NM_001242878.1:splice_region&intron:LOW:exon2/19:c.217+8T>A:,ELP2:NM_018255.2:splice_region&intron:LOW:exon2/21:c.217+8T>A:		rs1785905	0.3205	0.3420	7387/4583/754	0.3392										156	516					ELP2 (inh=n/a pLI=0.00)
chr18	33718326	33718326	A	C	het		QUAL=7291;DP=266;AF=0.42;MQM=60;TRIO=HET,266,0.42,HET,171,0.55,HET,150,0.49	ELP2	missense,non_coding_exon	ELP2:NM_001242875.1:missense:MODERATE:exon4/23:c.382A>C:p.Thr128Pro,ELP2:NM_001242879.1:missense:MODERATE:exon4/19:c.382A>C:p.Thr128Pro,ELP2:NM_001242876.1:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:NM_001242877.1:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:NM_001242878.1:missense:MODERATE:exon4/20:c.382A>C:p.Thr128Pro,ELP2:NM_018255.2:missense:MODERATE:exon4/22:c.382A>C:p.Thr128Pro,ELP2:NR_040110.1:non_coding_exon:MODIFIER:exon4/22:n.442A>C:		rs1785934	0.3205	0.3420	7445/4635/756	0.3395	0.6540	T	T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B					155	520					ELP2 (inh=n/a pLI=0.00)
chr18	33719434	33719434	C	T	het		QUAL=6371;DP=155;AF=0.52;MQM=60;TRIO=HET,155,0.52,HET,133,0.48,HET,216,0.51	ELP2	synonymous,intron	ELP2:NM_001242875.1:synonymous:LOW:exon6/23:c.576C>T:p.Ala192Ala,ELP2:NM_001242876.1:synonymous:LOW:exon5/21:c.498C>T:p.Ala166Ala,ELP2:NM_001242879.1:intron:MODIFIER:exon4/18:c.445+1045C>T:,ELP2:NR_040110.1:intron:MODIFIER:exon5/21:n.583+599C>T:,ELP2:NM_001242877.1:intron:MODIFIER:exon4/20:c.445+1045C>T:,ELP2:NM_001242878.1:intron:MODIFIER:exon4/19:c.445+1045C>T:,ELP2:NM_018255.2:intron:MODIFIER:exon5/21:c.523+599C>T:		rs1785932	0.2452	0.2080	348/189/3	0.0725										131	460					ELP2 (inh=n/a pLI=0.00)
chr18	33725931	33725931	G	A	het		QUAL=9142;DP=325;AF=0.49;MQM=59;TRIO=HET,325,0.49,HET,177,0.44,HET,251,0.46	ELP2	missense,non_coding_exon	ELP2:NM_001242875.1:missense:MODERATE:exon11/23:c.1108G>A:p.Val370Met,ELP2:NM_001242879.1:missense:MODERATE:exon7/19:c.703G>A:p.Val235Met,ELP2:NM_001242876.1:missense:MODERATE:exon10/21:c.1030G>A:p.Val344Met,ELP2:NM_001242877.1:missense:MODERATE:exon9/21:c.835G>A:p.Val279Met,ELP2:NM_001242878.1:missense:MODERATE:exon9/20:c.835G>A:p.Val279Met,ELP2:NM_018255.2:missense:MODERATE:exon10/22:c.913G>A:p.Val305Met,ELP2:NR_040110.1:non_coding_exon:MODIFIER:exon10/22:n.973G>A:		rs1785928	0.3217	0.3430	7458/4632/762	0.3302	0.2480	T	T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B				COSM1388588	155	522					ELP2 (inh=n/a pLI=0.00)
chr18	33750046	33750046	C	T	het		QUAL=5337;DP=121;AF=0.50;MQM=60;TRIO=HET,121,0.50,HET,120,0.57,HET,159,0.57	ELP2	synonymous,non_coding_exon	ELP2:NM_001242875.1:synonymous:LOW:exon21/23:c.2292C>T:p.Cys764Cys,ELP2:NM_001242879.1:synonymous:LOW:exon17/19:c.1887C>T:p.Cys629Cys,ELP2:NM_001242876.1:synonymous:LOW:exon19/21:c.2082C>T:p.Cys694Cys,ELP2:NM_001242877.1:synonymous:LOW:exon19/21:c.2019C>T:p.Cys673Cys,ELP2:NM_001242878.1:synonymous:LOW:exon18/20:c.1887C>T:p.Cys629Cys,ELP2:NM_018255.2:synonymous:LOW:exon20/22:c.2097C>T:p.Cys699Cys,ELP2:NR_040110.1:non_coding_exon:MODIFIER:exon20/22:n.2105C>T:		rs8299	0.3237	0.3510	7827/4961/762	0.3481									COSM1388592	167	530					ELP2 (inh=n/a pLI=0.00)
chr18	42260911	42260911	G	T	het		QUAL=2047;DP=110;AF=0.43;MQM=59;TRIO=HET,110,0.43,HET,71,0.54,WT,109,0.00	SETBP1	5'UTR_premature_start_codon_gain,5'UTR,intron	SETBP1:NM_015559.2:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-248G>T:,SETBP1:NM_015559.2:5'UTR:MODIFIER:exon1/6:c.-248G>T:,SETBP1:NM_001130110.1:intron:MODIFIER:exon1/3:c.-173+551G>T:		rs563748893	0.0018	0.0000	0/0/0	0.0069									COSN148355	0	9					SETBP1 (inh=AD pLI=1.00)
chr18	42456653	42456653	G	A	hom	pred_pathogenic_1	QUAL=7046;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HET,91,0.47,HET,134,0.52	SETBP1	missense,intron	SETBP1:NM_001130110.1:missense:MODERATE:exon4/4:c.664G>A:p.Ala222Thr,SETBP1:NM_015559.2:intron:MODIFIER:exon3/5:c.540+7405G>A:		rs663651	0.4930	0.4840	2819/1389/305	0.1671	-0.9690	T	D	B	B	611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome|Mental retardation,autosomal dominant 29];	RCV000147471.1 [likely benign]; 			328	537					SETBP1 (inh=AD pLI=1.00)
chr18	42456670	42456670	-	TCTT	hom	anno_high_impact	QUAL=6204;DP=145;AF=0.96;MQM=59;TRIO=HOM,145,0.96,HET,80,0.46,HET,119,0.49	SETBP1	frameshift,intron	SETBP1:NM_001130110.1:frameshift:HIGH:exon4/4:c.681_682insTCTT:p.Thr228fs,SETBP1:NM_015559.2:intron:MODIFIER:exon3/5:c.540+7422_540+7423insTCTT:		rs3085861	0.4938	0.4820	2765/1366/302	0.0840						611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome|Mental retardation,autosomal dominant 29];			COSM1480329	327	535	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			SETBP1 (inh=AD pLI=1.00)
chr18	42529996	42529996	G	C	het	pred_pathogenic_1	QUAL=5410;DP=191;AF=0.50;MQM=60;TRIO=HET,191,0.50,HET,251,0.49,WT,328,0.01	SETBP1	missense	SETBP1:NM_015559.2:missense:MODERATE:exon4/6:c.691G>C:p.Val231Leu		rs11082414	0.1567	0.1930	2511/1430/123	0.1880	-0.1230	T	D	B	B	611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome|Mental retardation,autosomal dominant 29];	RCV000147472.1 [benign]; 			61	308					SETBP1 (inh=AD pLI=1.00)
chr18	42533130	42533130	A	G	hom		QUAL=18632;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HOM,126,1.00,HOM,177,0.99	SETBP1	synonymous	SETBP1:NM_015559.2:synonymous:LOW:exon4/6:c.3825A>G:p.Ser1275Ser		rs8096662	0.9069	0.8770	46900/24556/4935	0.8514						611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome|Mental retardation,autosomal dominant 29];	RCV000147461.1 [uncertain significance]; RCV000147462.1 [benign]; RCV000147463.1 [uncertain significance]; 			830	227					SETBP1 (inh=AD pLI=1.00)
chr18	42646635	42646635	T	-	het		QUAL=519;DP=115;AF=0.56;MQM=59;TRIO=HET,115,0.56,WT,24,0.21,HOM,21,0.67	SETBP1	3'UTR	SETBP1:NM_015559.2:3'UTR:MODIFIER:exon6/6:c.*2987delT:		rs34125334	0.3756	0.0000	0/0/0	0.1125										3	151					SETBP1 (inh=AD pLI=1.00)
chr18	46987023	46987023	C	G	het		QUAL=2411;DP=59;AF=0.51;MQM=59;TRIO=HET,59,0.51,HET,138,0.53,WT,165,0.01	DYM	5'UTR	DYM:NM_017653.3:5'UTR:MODIFIER:exon1/17:c.-309G>C:		rs28364579	0.1194	0.0000	0/0/0	0.1197										2	33					DYM (inh=n/a pLI=0.00)
chr18	52889712	52889712	-	A	het		QUAL=420;DP=108;AF=0.31;MQM=59;TRIO=HET,108,0.31,WT,26,0.04,HET,25,0.16	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5553dupT:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5553dupT:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*5553dupT:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5553dupT:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5553dupT:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*5553dupT:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5553dupT:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5553dupT:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5553dupT:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5553dupT:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5553dupT:		rs71670792	0.2208	0.0000	0/0/0	0.1693										1	110					TCF4 (inh=AD pLI=1.00)
chr18	52889967	52889967	T	C	het		QUAL=8118;DP=280;AF=0.50;MQM=60;TRIO=HET,280,0.50,WT,89,0.00,HOM,135,0.99	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5299A>G:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5299A>G:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*5299A>G:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5299A>G:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5299A>G:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*5299A>G:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5299A>G:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5299A>G:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5299A>G:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5299A>G:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5299A>G:		rs1261085	0.3974	0.0000	0/0/0	0.0642										42	116					TCF4 (inh=AD pLI=1.00)
chr18	52890160	52890160	A	G	het		QUAL=6287;DP=280;AF=0.47;MQM=60;TRIO=HET,280,0.47,WT,100,0.00,HOM,96,1.00	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5106T>C:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5106T>C:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*5106T>C:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5106T>C:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5106T>C:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*5106T>C:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5106T>C:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5106T>C:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5106T>C:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5106T>C:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5106T>C:		rs1261084	0.4437	0.0000	0/0/0	0.0720										51	111					TCF4 (inh=AD pLI=1.00)
chr18	52890913	52890914	TT	-	het		QUAL=2294;DP=164;AF=0.43;MQM=59;TRIO=HET,164,0.43,WT,25,0.00,HOM,70,0.80	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*4352_*4353delAA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*4352_*4353delAA:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*4352_*4353delAA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*4352_*4353delAA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*4352_*4353delAA:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*4352_*4353delAA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*4352_*4353delAA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*4352_*4353delAA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:		rs773076214	0.5080	0.0000	0/0/0	0.2628										40	80					TCF4 (inh=AD pLI=1.00)
chr18	52890946	52890946	-	TC	het		QUAL=3981;DP=202;AF=0.47;MQM=59;TRIO=HET,202,0.47,WT,33,0.00,HOM,73,0.99	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*4319_*4320insGA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*4319_*4320insGA:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*4319_*4320insGA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*4319_*4320insGA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*4319_*4320insGA:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*4319_*4320insGA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*4319_*4320insGA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*4319_*4320insGA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:		rs373174214;rs61382440	0.4145	0.0000	0/0/0	0.3797										20	104					TCF4 (inh=AD pLI=1.00)
chr18	52891284	52891284	T	-	het		QUAL=1817;DP=125;AF=0.53;MQM=60;TRIO=HET,125,0.53,WT,19,0.00,HET,43,0.56	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*3982delA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*3982delA:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*3982delA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*3982delA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*3982delA:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*3982delA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*3982delA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*3982delA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*3982delA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*3982delA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*3982delA:	(T)n	rs35555522	0.2376	0.0000	0/0/0	0.1621										8	100					TCF4 (inh=AD pLI=1.00)
chr18	52893255	52893255	-	A	het		QUAL=3220;DP=268;AF=0.47;MQM=59;TRIO=HET,268,0.47,WT,63,0.00,HET,58,0.40	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*2010dupT:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*2010dupT:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*2010dupT:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*2010dupT:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*2010dupT:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*2010dupT:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*2010dupT:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*2010dupT:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*2010dupT:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*2010dupT:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*2010dupT:		rs374574975;rs550740474	0.2240	0.0000	0/0/0	0.1603										18	93					TCF4 (inh=AD pLI=1.00)
chr18	52893505	52893505	T	-	het		QUAL=9984;DP=384;AF=0.47;MQM=59;TRIO=HET,384,0.47,WT,147,0.01,HOM,206,0.97	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*1761delA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*1761delA:,TCF4:NM_001306208.1:3'UTR:MODIFIER:exon16/16:c.*1761delA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*1761delA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*1761delA:,TCF4:NM_001306207.1:3'UTR:MODIFIER:exon19/19:c.*1761delA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*1761delA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*1761delA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*1761delA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*1761delA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*1761delA:		rs71674214	0.3460	0.0000	0/0/0	0.2427										31	112					TCF4 (inh=AD pLI=1.00)
chr18	52895531	52895531	T	C	het		QUAL=6755;DP=241;AF=0.50;MQM=60;TRIO=HET,241,0.50,WT,89,0.00,HOM,116,1.00	TCF4	synonymous	TCF4:NM_001243226.2:synonymous:LOW:exon20/21:c.2247A>G:p.Ser749Ser,TCF4:NM_001243236.1:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:NM_001243234.1:synonymous:LOW:exon12/13:c.1461A>G:p.Ser487Ser,TCF4:NM_001243235.1:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:NM_001243232.1:synonymous:LOW:exon15/16:c.1728A>G:p.Ser576Ser,TCF4:NM_001306208.1:synonymous:LOW:exon15/16:c.1716A>G:p.Ser572Ser,TCF4:NM_001243233.1:synonymous:LOW:exon15/16:c.1539A>G:p.Ser513Ser,TCF4:NM_001243231.1:synonymous:LOW:exon17/18:c.1803A>G:p.Ser601Ser,TCF4:NM_001306207.1:synonymous:LOW:exon18/19:c.1857A>G:p.Ser619Ser,TCF4:NM_001083962.1:synonymous:LOW:exon19/20:c.1941A>G:p.Ser647Ser,TCF4:NM_001243230.1:synonymous:LOW:exon18/19:c.1920A>G:p.Ser640Ser,TCF4:NM_003199.2:synonymous:LOW:exon19/20:c.1929A>G:p.Ser643Ser,TCF4:NM_001243227.1:synonymous:LOW:exon18/19:c.1869A>G:p.Ser623Ser,TCF4:NM_001243228.1:synonymous:LOW:exon19/20:c.1959A>G:p.Ser653Ser		rs8766	0.3425	0.3710	8710/5314/549	0.3700						602272 [TCF4 (confirmed) Pitt-Hopkins syndrome|Corneal dystrophy,Fuchs endothelial,3];	RCV000079460.6 [benign]; 			154	529					TCF4 (inh=AD pLI=1.00)
chr18	53070914	53070914	G	A	het	phylop_high;pred_pathogenic_1	QUAL=20870;DP=521;AF=0.52;MQM=60;TRIO=HET,521,0.52,WT,308,0.00,HOM,416,1.00	TCF4	missense,intron	TCF4:NM_001243232.1:missense:MODERATE:exon1/16:c.32C>T:p.Ala11Val,TCF4:NM_001306208.1:missense:MODERATE:exon1/16:c.32C>T:p.Ala11Val,TCF4:NM_001243226.2:intron:MODIFIER:exon6/20:c.611-165C>T:,TCF4:NM_001243233.1:intron:MODIFIER:exon1/15:c.-86-165C>T:,TCF4:NM_001243231.1:intron:MODIFIER:exon3/17:c.179-165C>T:,TCF4:NM_001306207.1:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:NM_001083962.1:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:NM_001243230.1:intron:MODIFIER:exon4/18:c.299-165C>T:,TCF4:NM_003199.2:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:NM_001243227.1:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:NM_001243228.1:intron:MODIFIER:exon5/19:c.305-165C>T:		rs17522826	0.1923	0.1520	695/261/8	0.1434	2.9740	T	D	B	B	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome|Corneal dystrophy,Fuchs endothelial,3];	RCV000147721.1 [likely benign]; 			44	325					TCF4 (inh=AD pLI=1.00)
chr18	53303101	53303101	C	G	hom		QUAL=14562;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,106,1.00,HOM,164,1.00	TCF4	missense	TCF4:NM_001243226.2:missense:MODERATE:exon1/21:c.28G>C:p.Ala10Pro		rs611326	0.9968	0.9990	23663/11825/1809	0.8732	1.4190	T	T	B	B	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome|Corneal dystrophy,Fuchs endothelial,3];				980	0	2	[2] Stefanie Beck-Woedl 30.07.2015			TCF4 (inh=AD pLI=1.00)
chr18	53303150	53303150	T	C	het		QUAL=3390;DP=124;AF=0.55;MQM=60;TRIO=HET,124,0.55,WT,91,0.00,HET,129,0.52	TCF4	5'UTR_premature_start_codon_gain,5'UTR	TCF4:NM_001243226.2:5'UTR_premature_start_codon_gain:LOW:exon1/21:c.-22A>G:,TCF4:NM_001243226.2:5'UTR:MODIFIER:exon1/21:c.-22A>G:	OldhAT1	rs77891683	0.0048	0.0093	4/4/0	0.0100										0	3					TCF4 (inh=AD pLI=1.00)
chr18	55313705	55313705	T	-	het		QUAL=1262;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,19,0.00,HET,40,0.30	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*2015delA:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+4427delT:		rs35833803	0.1753	0.0000	0/0/0	0.1320										3	48					ATP8B1 (inh=n/a pLI=0.00), LOC100505549 (inh=n/a pLI=n/a)
chr18	55314211	55314211	T	C	het		QUAL=2550;DP=143;AF=0.50;MQM=60;TRIO=HET,143,0.50,WT,34,0.00,HET,60,0.48	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*1509A>G:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+4927T>C:		rs1968274	0.3085	0.0000	0/0/0	0.0463										15	77					ATP8B1 (inh=n/a pLI=0.00), LOC100505549 (inh=n/a pLI=n/a)
chr18	55314820	55314820	C	A	het		QUAL=6789;DP=310;AF=0.52;MQM=60;TRIO=HET,310,0.52,WT,167,0.00,HET,216,0.41	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*900G>T:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+5536C>A:		rs4940950	0.4661	0.0000	0/0/0	0.0831										60	110					ATP8B1 (inh=n/a pLI=0.00), LOC100505549 (inh=n/a pLI=n/a)
chr18	55317676	55317676	C	T	hom	phylop_high	QUAL=32297;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HOM,298,1.00,HOM,377,1.00	ATP8B1,LOC100505549	missense,intron	ATP8B1:NM_005603.4:missense:MODERATE:exon27/28:c.3454G>A:p.Ala1152Thr,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+8392C>T:		rs222581	0.9998	1.0000	60671/33368/5171	0.9360	2.0100	T	T,T	B	B	602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1106	0					ATP8B1 (inh=n/a pLI=0.00), LOC100505549 (inh=n/a pLI=n/a)
chr18	55362532	55362532	T	G	hom		QUAL=16478;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HOM,94,1.00,HOM,148,1.00	ATP8B1	synonymous	ATP8B1:NM_005603.4:synonymous:LOW:exon10/28:c.811A>C:p.Arg271Arg		rs319443	0.9926	0.9970	60322/33323/4892	0.9429						602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1106	1					ATP8B1 (inh=n/a pLI=0.00)
chr18	55364852	55364852	A	G	hom		QUAL=32554;DP=443;AF=1.00;MQM=59;TRIO=HOM,443,1.00,HOM,253,1.00,HOM,338,1.00	ATP8B1	splice_region&synonymous	ATP8B1:NM_005603.4:splice_region&synonymous:LOW:exon8/28:c.696T>C:p.Asp232Asp		rs319438	0.9946	0.9980	60416/33333/4978	0.9303						602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1105	2					ATP8B1 (inh=n/a pLI=0.00)
chr18	77473127	77473127	C	T	hom		QUAL=11794;DP=188;AF=1.00;MQM=59;TRIO=HOM,188,1.00,HET,192,0.53,HET,232,0.54	CTDP1	missense	CTDP1:NM_004715.4:missense:MODERATE:exon7/13:c.1019C>T:p.Thr340Met,CTDP1:NM_001318511.1:missense:MODERATE:exon7/12:c.1019C>T:p.Thr340Met,CTDP1:NM_048368.3:missense:MODERATE:exon7/12:c.1019C>T:p.Thr340Met,CTDP1:NM_001202504.1:missense:MODERATE:exon7/13:c.662C>T:p.Thr221Met		rs2279103	0.0827	0.1360	1387/1090/9	0.1375	0.0990	T	T,T	B,B,B	B,B,B	604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy];				15	266					CTDP1 (inh=AR pLI=0.92)
chr18	77513721	77513721	T	C	hom		QUAL=37390;DP=267;AF=0.99;MQM=59;TRIO=HOM,267,0.99,HOM,397,1.00,HOM,549,1.00	CTDP1	synonymous,3'UTR	CTDP1:NM_004715.4:synonymous:LOW:exon13/13:c.2817T>C:p.Asp939Asp,CTDP1:NM_001202504.1:synonymous:LOW:exon13/13:c.2460T>C:p.Asp820Asp,CTDP1:NM_001318511.1:3'UTR:MODIFIER:exon12/12:c.*46T>C:,CTDP1:NM_048368.3:3'UTR:MODIFIER:exon12/12:c.*50T>C:		rs626169	0.8952	0.9660	56942/32743/2566	0.9433						604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy];	RCV000116845.2 [likely benign]; 		COSM4131107	1080	25					CTDP1 (inh=AR pLI=0.92)
chr18	77513841	77513841	G	A	hom		QUAL=15305;DP=276;AF=0.99;MQM=59;TRIO=HOM,276,0.99,HET,252,0.48,HET,343,0.47	CTDP1	3'UTR	CTDP1:NM_004715.4:3'UTR:MODIFIER:exon13/13:c.*51G>A:,CTDP1:NM_001318511.1:3'UTR:MODIFIER:exon12/12:c.*166G>A:,CTDP1:NM_048368.3:3'UTR:MODIFIER:exon12/12:c.*170G>A:,CTDP1:NM_001202504.1:3'UTR:MODIFIER:exon13/13:c.*51G>A:		rs76088733	0.1306	0.1780	1814/1267/30	0.1678										3	74					CTDP1 (inh=AR pLI=0.92)
chr19	863356	863356	C	T	het		QUAL=10057;DP=318;AF=0.52;MQM=59;TRIO=HET,318,0.52,HET,449,0.53,WT,568,0.00	CFD	3'UTR	CFD:NM_001317335.1:3'UTR:MODIFIER:exon5/5:c.*118C>T:,CFD:NM_001928.3:3'UTR:MODIFIER:exon5/5:c.*118C>T:	AluJr	rs10506	0.2754	0.0000	0/0/0	0.1599										6	57					CFD (inh=n/a pLI=0.02)
chr19	1388538	1388538	C	T	het		QUAL=3508;DP=69;AF=0.57;MQM=59;TRIO=HET,69,0.57,HOM,52,1.00,HET,72,0.56	NDUFS7	missense	NDUFS7:NM_024407.4:missense:MODERATE:exon3/8:c.68C>T:p.Pro23Leu		rs1142530	0.4557	0.5430	17944/11720/688	0.5139	0.8850	T	T,T,T,T,T,T,T	B,B,B	B,B,B	601825 [NDUFS7 (provisional) Leigh syndrome];	RCV000117716.2 [likely benign]; 		COSM4131259	423	503					NDUFS7 (inh=AR pLI=0.75)
chr19	1398750	1398750	C	T	het		QUAL=8871;DP=308;AF=0.48;MQM=59;TRIO=HET,308,0.48,WT,350,0.00,HET,408,0.52	GAMT	synonymous,intron	GAMT:NM_138924.2:synonymous:LOW:exon5/5:c.735G>A:p.Ala245Ala,GAMT:NM_000156.5:intron:MODIFIER:exon5/5:c.570+165G>A:		rs74253480	0.0114	0.0037	2/1/0	0.0037						601240 [GAMT (provisional) Cerebral creatine deficiency syndrome 2];	RCV000125193.2 [benign]; 			0	20					GAMT (inh=AR pLI=0.00)
chr19	3631036	3631036	A	G	hom		QUAL=25253;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,211,1.00,HOM,293,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*2129T>C:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*2129T>C:		rs4807493	0.8508	0.0000	0/0/0	0.7485										162	61					PIP5K1C (inh=n/a pLI=0.86)
chr19	3631569	3631569	C	G	hom		QUAL=1069;DP=33;AF=0.91;MQM=59;TRIO=HOM,33,0.91,HET,5,0.80,HOM,5,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*1596G>C:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*1596G>C:		rs4807494	0.8452	0.0000	0/0/0	0.8136										147	61					PIP5K1C (inh=n/a pLI=0.86)
chr19	3631694	3631694	G	A	hom		QUAL=2851;DP=66;AF=0.98;MQM=59;TRIO=HOM,66,0.98,HET,29,0.72,HOM,26,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*1471C>T:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*1471C>T:		rs4806946	0.3980	0.0000	0/0/0	0.4688										96	98					PIP5K1C (inh=n/a pLI=0.86)
chr19	3653525	3653525	C	T	het		QUAL=28340;DP=177;AF=0.45;MQM=59;TRIO=HET,177,0.45,HET,487,0.55,HOM,642,1.00	PIP5K1C	synonymous	PIP5K1C:NM_001300849.1:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:NM_001195733.1:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:NM_012398.2:synonymous:LOW:exon7/18:c.684G>A:p.Ser228Ser		rs2074957	0.5429	0.5600	19550/10423/1113	0.5569						606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3];			COSM4131725	370	530					PIP5K1C (inh=n/a pLI=0.86)
chr19	4090422	4090422	G	T	het		QUAL=4652;DP=119;AF=0.52;MQM=59;TRIO=HET,119,0.52,HET,278,0.52,WT,363,0.00	MAP2K2	3'UTR	MAP2K2:NM_030662.3:3'UTR:MODIFIER:exon11/11:c.*174C>A:		rs6630	0.1717	0.0000	0/0/0	0.0960										1	31					MAP2K2 (inh=AD pLI=0.86)
chr19	4101062	4101062	G	T	het		QUAL=3999;DP=104;AF=0.51;MQM=53;TRIO=HET,104,0.51,HOM,94,1.00,WT,147,0.01	MAP2K2	synonymous	MAP2K2:NM_030662.3:synonymous:LOW:exon6/11:c.660C>A:p.Ile220Ile		rs11539507	0.4333	0.4400	8097/4588/241	0.4267						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039490.2 [benign]; RCV000149846.1,RCV000039490.2 [benign,benign]; RCV000149846.1 [benign]; 		COSM439538, COSM1481088	251	566					MAP2K2 (inh=AD pLI=0.86)
chr19	4102449	4102449	G	A	het		QUAL=6916;DP=138;AF=0.48;MQM=59;TRIO=HET,138,0.48,WT,322,0.00,HET,435,0.49	MAP2K2	splice_region&synonymous	MAP2K2:NM_030662.3:splice_region&synonymous:LOW:exon4/11:c.453C>T:p.Asp151Asp		rs17851657	0.1112	0.1550	1446/1006/11	0.1491						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039484.2 [benign]; RCV000149845.3 [benign]; 		COSM4131862, COSM1129849	42	376					MAP2K2 (inh=AD pLI=0.86)
chr19	4117528	4117528	G	A	het		QUAL=4190;DP=181;AF=0.47;MQM=57;TRIO=HET,181,0.47,HET,176,0.51,WT,236,0.00	MAP2K2	synonymous	MAP2K2:NM_030662.3:synonymous:LOW:exon2/11:c.192C>T:p.Val64Val		rs8157	0.0583	0.0620	294/157/25	0.0588						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039473.2 [benign]; 			2	139					MAP2K2 (inh=AD pLI=0.86)
chr19	5891299	5891299	C	T	het		QUAL=935;DP=41;AF=0.49;MQM=59;TRIO=HET,41,0.49,WT,21,0.00,HOM,22,0.95	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*1629G>A:	AluSx1	rs1674158	0.4750	0.0000	0/0/0	0.4335										26	68					NDUFA11 (inh=n/a pLI=0.54)
chr19	5891746	5891746	G	C	hom		QUAL=15158;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HET,229,0.46,HOM,268,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*1182C>G:	L2b	rs1678866	0.6272	0.0000	0/0/0	0.6737										62	67					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892267	5892267	G	T	het		QUAL=2609;DP=119;AF=0.52;MQM=59;TRIO=HET,119,0.52,HET,104,0.49,WT,170,0.01	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*661C>A:		rs74500071	0.0980	0.0000	0/0/0	0.1302										3	28					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892317	5892317	C	T	hom		QUAL=8557;DP=79;AF=0.97;MQM=60;TRIO=HOM,79,0.97,HET,86,0.51,HOM,173,0.99	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*611G>A:		rs1626918	0.6410	0.0000	0/0/0	0.1196										56	73					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892382	5892382	C	T	hom		QUAL=7545;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HET,65,0.46,HOM,151,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*546G>A:		rs1678867	0.7272	0.0000	0/0/0	0.7148										99	109					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892433	5892433	C	T	het		QUAL=4248;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,WT,51,0.02,HOM,114,0.99	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*495G>A:		rs1627779	0.4742	0.0000	0/0/0	0.0883										60	183					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892486	5892486	C	T	hom		QUAL=7001;DP=80;AF=1.00;MQM=59;TRIO=HOM,80,1.00,HET,68,0.57,HOM,119,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*442G>A:		rs1628564	0.5839	0.0000	0/0/0	0.1100										116	197					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892568	5892568	G	T	hom		QUAL=8458;DP=121;AF=0.98;MQM=59;TRIO=HOM,121,0.98,HET,85,0.54,HOM,116,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*360C>A:		rs1629368	0.5759	0.0000	0/0/0	0.1100										113	199					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892585	5892585	G	A	het		QUAL=2268;DP=128;AF=0.41;MQM=59;TRIO=HET,128,0.41,HET,84,0.55,WT,126,0.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*343C>T:		rs60236148	0.0891	0.0000	0/0/0	0.0193										15	77					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892743	5892743	C	T	het		QUAL=6632;DP=112;AF=0.46;MQM=59;TRIO=HET,112,0.46,WT,124,0.01,HOM,182,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*185G>A:		rs10432306	0.4127	0.0000	0/0/0	0.0842										59	179					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892770	5892770	C	T	hom		QUAL=12453;DP=107;AF=1.00;MQM=59;TRIO=HOM,107,1.00,HET,143,0.48,HOM,234,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*158G>A:		rs1631032	0.5859	0.0000	0/0/0	0.1110										113	200					NDUFA11 (inh=n/a pLI=0.54)
chr19	5892954	5892954	T	C	het	pred_pathogenic_1	QUAL=12720;DP=174;AF=0.44;MQM=60;TRIO=HET,174,0.44,WT,272,0.00,HOM,352,0.99	NDUFA11	missense	NDUFA11:NM_001193375.1:missense:MODERATE:exon4/4:c.661A>G:p.Thr221Ala	MIR	rs1678868	0.4770	0.3540	417/145/19	0.1227	-0.0270	T	D	B	B	612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency];				173	450					NDUFA11 (inh=n/a pLI=0.54)
chr19	5903807	5903807	G	T	hom		QUAL=26139;DP=194;AF=0.97;MQM=59;TRIO=HOM,194,0.97,HET,375,0.53,HOM,560,1.00	NDUFA11	5'UTR,non_coding_exon	NDUFA11:NM_001193375.1:5'UTR:MODIFIER:exon1/4:c.-88C>A:,NDUFA11:NM_175614.4:5'UTR:MODIFIER:exon1/4:c.-88C>A:,NDUFA11:NR_034166.2:non_coding_exon:MODIFIER:exon1/5:n.218C>A:		rs8108064	0.6815	0.6380	4379/1717/478	0.2050										313	336					NDUFA11 (inh=n/a pLI=0.54)
chr19	5903936	5903936	T	C	hom		QUAL=14537;DP=79;AF=0.99;MQM=59;TRIO=HOM,79,0.99,HET,204,0.55,HOM,312,1.00	NDUFA11	5'UTR,non_coding_exon	NDUFA11:NM_001193375.1:5'UTR:MODIFIER:exon1/4:c.-217A>G:,NDUFA11:NM_175614.4:5'UTR:MODIFIER:exon1/4:c.-217A>G:,NDUFA11:NR_034166.2:non_coding_exon:MODIFIER:exon1/5:n.89A>G:		rs1056987	0.7266	0.6740	3262/674/101	0.1990										314	269					NDUFA11 (inh=n/a pLI=0.54)
chr19	6677989	6677989	G	A	het		QUAL=22178;DP=302;AF=0.49;MQM=59;TRIO=HET,302,0.49,HOM,390,1.00,HET,461,0.52	C3	synonymous	C3:NM_000064.3:synonymous:LOW:exon41/41:c.4896C>T:p.Pro1632Pro		rs17030	0.5329	0.5240	16781/8886/1266	0.5175						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];			COSM3766459	324	505					C3 (inh=n/a pLI=1.00)
chr19	6679511	6679511	C	T	het		QUAL=19508;DP=352;AF=0.53;MQM=59;TRIO=HET,352,0.53,HOM,319,1.00,HET,381,0.52	C3	splice_region&intron	C3:NM_000064.3:splice_region&intron:LOW:exon36/40:c.4457-4G>A:		rs2277984	0.5244	0.5210	16622/8906/1034	0.5104						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				323	507					C3 (inh=n/a pLI=1.00)
chr19	6696597	6696597	G	A	hom		QUAL=37916;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HOM,472,1.00,HOM,524,1.00	C3	splice_region&intron	C3:NM_000064.3:splice_region&intron:LOW:exon22/40:c.2863+7C>T:		rs2287845	0.7324	0.6660	27443/12486/2543	0.6191						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				468	488					C3 (inh=n/a pLI=1.00)
chr19	6697406	6697406	A	G	hom		QUAL=14949;DP=208;AF=0.99;MQM=59;TRIO=HOM,208,0.99,HOM,140,1.00,HOM,138,1.00	C3	synonymous	C3:NM_000064.3:synonymous:LOW:exon21/41:c.2745T>C:p.Ala915Ala		rs423490	0.8149	0.7890	37958/19091/2952	0.7804						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				667	369					C3 (inh=n/a pLI=1.00)
chr19	6702157	6702157	C	G	hom		QUAL=22860;DP=239;AF=0.98;MQM=59;TRIO=HOM,239,0.98,HOM,205,1.00,HOM,270,1.00	C3	synonymous	C3:NM_000064.3:synonymous:LOW:exon19/41:c.2421G>C:p.Val807Val		rs428453	0.7324	0.6660	27406/12467/2524	0.6610						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];			COSM3757394	468	488					C3 (inh=n/a pLI=1.00)
chr19	6702598	6702598	G	A	hom		QUAL=20082;DP=187;AF=0.99;MQM=60;TRIO=HOM,187,0.99,HOM,193,1.00,HOM,265,1.00	C3	splice_region&intron	C3:NM_000064.3:splice_region&intron:LOW:exon17/40:c.2246-8C>T:		rs406514	0.8149	0.7890	37935/19094/2939	0.7717						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				665	369					C3 (inh=n/a pLI=1.00)
chr19	7112265	7112265	G	A	het		QUAL=201;DP=26;AF=0.38;MQM=60;TRIO=HET,26,0.38,WT,3,0.00,HOM,1,1.00	ZNF557-INSR	intergenic_region	ZNF557-INSR:ZNF557-INSR:intergenic_region:MODIFIER::n.7112265G>A:		rs12150997	0.3019	0.0000	0/0/0	0.2208										10	57					ZNF557-INSR (inh=n/a pLI=n/a)
chr19	7112593	7112593	G	A	het		QUAL=9762;DP=316;AF=0.50;MQM=59;TRIO=HET,316,0.50,WT,138,0.00,HOM,190,0.99	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*4474C>T:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*4474C>T:		rs1052371	0.3075	0.0000	0/0/0	0.2234										12	82					INSR (inh=AR+AD pLI=0.19)
chr19	7112645	7112645	C	A	het		QUAL=6610;DP=240;AF=0.48;MQM=60;TRIO=HET,240,0.48,WT,181,0.00,HET,265,0.54	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*4422G>T:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*4422G>T:		rs12642	0.1248	0.0000	0/0/0	0.1363										8	75					INSR (inh=AR+AD pLI=0.19)
chr19	7114213	7114213	C	A	het		QUAL=7488;DP=338;AF=0.41;MQM=60;TRIO=HET,338,0.41,WT,265,0.00,HET,347,0.48	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*2854G>T:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*2854G>T:		rs1864193	0.1282	0.0000	0/0/0	0.1379										8	73					INSR (inh=AR+AD pLI=0.19)
chr19	7114288	7114288	C	T	het		QUAL=19256;DP=375;AF=0.48;MQM=60;TRIO=HET,375,0.48,HOM,311,0.99,HET,416,0.50	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*2779G>A:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*2779G>A:		rs3745551	0.7177	0.0000	0/0/0	0.6713										90	101					INSR (inh=AR+AD pLI=0.19)
chr19	7114920	7114920	-	T	het		QUAL=2038;DP=90;AF=0.44;MQM=59;TRIO=HET,90,0.44,HOM,28,1.00,HET,43,0.44	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*2146dupA:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*2146dupA:		rs57473640;rs71915849	0.0000	0.0000	0/0/0	0.3140										34	162					INSR (inh=AR+AD pLI=0.19)
chr19	7115057	7115057	C	T	het		QUAL=862;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,WT,14,0.00,HET,15,0.47	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*2010G>A:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*2010G>A:		rs55972112	0.1250	0.0000	0/0/0	0.1350										8	69					INSR (inh=AR+AD pLI=0.19)
chr19	7115651	7115651	T	-	het		QUAL=18968;DP=342;AF=0.46;MQM=59;TRIO=HET,342,0.46,WT,328,0.00,HOM,504,1.00	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*1416delA:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*1416delA:		rs3833238	0.3325	0.0000	0/0/0	0.2221										20	88					INSR (inh=AR+AD pLI=0.19)
chr19	7116136	7116136	-	T	hom		QUAL=1352;DP=115;AF=0.46;MQM=59;TRIO=HOM,115,0.46,HOM,27,0.59,HOM,30,0.50	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*930dupA:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*930dupA:	(T)n	rs34045095;rs397813616	0.8291	0.0000	0/0/0	0.5179										2	152					INSR (inh=AR+AD pLI=0.19)
chr19	7116283	7116283	G	C	het		QUAL=6231;DP=243;AF=0.51;MQM=60;TRIO=HET,243,0.51,WT,186,0.00,HET,246,0.48	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*784C>G:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*784C>G:		rs1051651	0.2959	0.0000	0/0/0	0.2089										20	75					INSR (inh=AR+AD pLI=0.19)
chr19	7116963	7116963	T	C	het		QUAL=6681;DP=173;AF=0.45;MQM=60;TRIO=HET,173,0.45,HET,98,0.46,HOM,113,1.00	INSR	3'UTR	INSR:NM_000208.3:3'UTR:MODIFIER:exon22/22:c.*104A>G:,INSR:NM_001079817.2:3'UTR:MODIFIER:exon21/21:c.*104A>G:		rs1051690	0.8774	0.0000	0/0/0	0.1541								CR082021 [CLASS=DFP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=INSR]; 		162	63					INSR (inh=AR+AD pLI=0.19)
chr19	7125297	7125297	G	A	het		QUAL=3431;DP=95;AF=0.48;MQM=59;TRIO=HET,95,0.48,WT,149,0.02,HET,222,0.46	INSR	synonymous	INSR:NM_000208.3:synonymous:LOW:exon17/22:c.3255C>T:p.His1085His,INSR:NM_001079817.2:synonymous:LOW:exon16/21:c.3219C>T:p.His1073His		rs1799817	0.2925	0.2270	3491/1057/268	0.2215						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];	RCV000175129.1 [benign]; 	CM092295 [CLASS=DP MUT=ALT PHEN="Polycystic ovary syndrome in lean women association with" GENE=INSR]; 	COSM4001047, COSM4001048	66	380					INSR (inh=AR+AD pLI=0.19)
chr19	7141775	7141775	G	A	het		QUAL=1531;DP=50;AF=0.48;MQM=60;TRIO=HET,50,0.48,WT,36,0.00,HOM,32,1.00	INSR	synonymous	INSR:NM_000208.3:synonymous:LOW:exon13/22:c.2595C>T:p.Asn865Asn,INSR:NM_001079817.2:synonymous:LOW:exon12/21:c.2559C>T:p.Asn853Asn		rs2229431	0.0869	0.0610	307/80/134	0.0609						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];				4	116					INSR (inh=AR+AD pLI=0.19)
chr19	7166376	7166376	C	T	het		QUAL=2869;DP=160;AF=0.49;MQM=60;TRIO=HET,160,0.49,HET,94,0.48,WT,119,0.00	INSR	synonymous	INSR:NM_000208.3:synonymous:LOW:exon8/22:c.1650G>A:p.Ala550Ala,INSR:NM_001079817.2:synonymous:LOW:exon8/21:c.1650G>A:p.Ala550Ala		rs2059806	0.2448	0.2550	3909/2174/194	0.2487						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];	RCV000180111.1 [benign]; 	CM004252 [CLASS=DP MUT=ALT PHEN="Reduced diastolic blood pressure association with" GENE=INSR]; 	COSM148469, COSM4132751	75	402					INSR (inh=AR+AD pLI=0.19)
chr19	7593589	7593589	C	T	het		QUAL=24726;DP=182;AF=0.50;MQM=59;TRIO=HET,182,0.50,HOM,498,0.99,HET,630,0.50	MCOLN1	splice_region&synonymous	MCOLN1:NM_020533.2:splice_region&synonymous:LOW:exon8/14:c.984C>T:p.Asn328Asn		rs612862	0.2556	0.2870	5504/3980/301	0.2835						605248 [MCOLN1 (confirmed) Mucolipidosis IV];			COSM4132764	153	499					MCOLN1 (inh=AR pLI=0.04)
chr19	7703605	7703605	C	T	het		QUAL=543;DP=36;AF=0.42;MQM=60;TRIO=HET,36,0.42,HET,19,0.58,WT,19,0.00	STXBP2	splice_region&intron	STXBP2:NM_001272034.1:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:NM_001127396.2:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:NM_006949.3:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:NR_073560.1:splice_region&intron:LOW:exon1/18:n.87-7C>T:		rs8104339	0.4824	0.4040	10443/4768/1346	0.4058						601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];				178	494					STXBP2 (inh=n/a pLI=0.00)
chr19	7711221	7711221	T	C	het		QUAL=3411;DP=95;AF=0.48;MQM=59;TRIO=HET,95,0.48,HET,194,0.50,WT,326,0.00	STXBP2	synonymous,non_coding_exon	STXBP2:NM_001272034.1:synonymous:LOW:exon16/19:c.1476T>C:p.Asp492Asp,STXBP2:NM_001127396.2:synonymous:LOW:exon16/19:c.1434T>C:p.Asp478Asp,STXBP2:NM_006949.3:synonymous:LOW:exon16/19:c.1443T>C:p.Asp481Asp,STXBP2:NR_073560.1:non_coding_exon:MODIFIER:exon16/19:n.1467T>C:		rs10001	0.5042	0.4030	8932/3784/1061	0.3943						601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];			COSM1178455	170	501					STXBP2 (inh=n/a pLI=0.00)
chr19	7712277	7712277	A	G	het	low_DP	QUAL=201;DP=12;AF=0.42;MQM=60;TRIO=HET,12,0.42,HET,17,0.41,WT,26,0.00	STXBP2	missense,non_coding_exon	STXBP2:NM_001272034.1:missense:MODERATE:exon18/19:c.1609A>G:p.Ile537Val,STXBP2:NM_001127396.2:missense:MODERATE:exon18/19:c.1567A>G:p.Ile523Val,STXBP2:NM_006949.3:missense:MODERATE:exon18/19:c.1576A>G:p.Ile526Val,STXBP2:NR_073560.1:non_coding_exon:MODIFIER:exon18/19:n.1600A>G:		rs6791	0.7061	0.6320	24381/12303/2856	0.6314	-0.1760	T	T,T,T,T	B,B,B,B	B,B,B,B	601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];			COSM440643	412	502					STXBP2 (inh=n/a pLI=0.00)
chr19	8376431	8376431	G	A	het		QUAL=8811;DP=318;AF=0.47;MQM=60;TRIO=HET,318,0.47,HET,459,0.45,WT,579,0.00	NDUFA7	synonymous	NDUFA7:NM_005001.3:synonymous:LOW:exon4/4:c.300C>T:p.Pro100Pro		rs561	0.1382	0.1740	2182/1197/10	0.1735										30	298					NDUFA7 (inh=n/a pLI=0.00)
chr19	10265312	10265312	T	C	hom		QUAL=16586;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,161,1.00,HOM,168,1.00	DNMT1	synonymous	DNMT1:NM_001130823.2:synonymous:LOW:exon21/41:c.1782A>G:p.Thr594Thr,DNMT1:NM_001318730.1:synonymous:LOW:exon20/40:c.1734A>G:p.Thr578Thr,DNMT1:NM_001318731.1:synonymous:LOW:exon21/41:c.1419A>G:p.Thr473Thr,DNMT1:NM_001379.3:synonymous:LOW:exon20/40:c.1734A>G:p.Thr578Thr		rs721186	0.9958	0.9910	59584/32465/5165	0.9416						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				1080	25					DNMT1 (inh=n/a pLI=1.00)
chr19	10267077	10267077	T	C	het		QUAL=7805;DP=225;AF=0.47;MQM=59;TRIO=HET,225,0.47,HET,186,0.54,HET,229,0.48	DNMT1	synonymous	DNMT1:NM_001130823.2:synonymous:LOW:exon18/41:c.1389A>G:p.Pro463Pro,DNMT1:NM_001318730.1:synonymous:LOW:exon17/40:c.1341A>G:p.Pro447Pro,DNMT1:NM_001318731.1:synonymous:LOW:exon18/41:c.1026A>G:p.Pro342Pro,DNMT1:NM_001379.3:synonymous:LOW:exon17/40:c.1341A>G:p.Pro447Pro		rs2228611	0.5339	0.5180	16554/8241/1413	0.5129						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				291	520					DNMT1 (inh=n/a pLI=1.00)
chr19	10270747	10270747	A	-	het		QUAL=7924;DP=270;AF=0.53;MQM=59;TRIO=HET,270,0.53,HET,181,0.52,HET,249,0.49	DNMT1	splice_region&intron	DNMT1:NM_001130823.2:splice_region&intron:LOW:exon14/40:c.1044-8delT:,DNMT1:NM_001318730.1:splice_region&intron:LOW:exon13/39:c.996-8delT:,DNMT1:NM_001318731.1:splice_region&intron:LOW:exon14/40:c.681-8delT:,DNMT1:NM_001379.3:splice_region&intron:LOW:exon13/39:c.996-8delT:		rs3079962;rs397859148;rs59599980;rs796846833	0.5795	0.6290	23788/14795/2955	0.5306						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				471	491					DNMT1 (inh=n/a pLI=1.00)
chr19	10939792	10939792	T	C	het		QUAL=3918;DP=163;AF=0.53;MQM=59;TRIO=HET,163,0.53,WT,149,0.00,HET,179,0.46	DNM2	synonymous	DNM2:NM_001005360.2:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_001005361.2:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_001005362.2:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala,DNM2:NM_001190716.1:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_004945.3:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala		rs2229920	0.3383	0.3090	6082/2703/408	0.3090						602378 [DNM2 (confirmed) Charcot-Marie-Tooth disease,dominant intermediate B|Myopathy,centronuclear|Charcot-Marie-Tooth disease,axonal,type 2M|Lethal congenital contracture syndrome 5];	RCV000145914.2 [other]; 		COSM3766266, COSM3766265, COSM3766264	104	474					DNM2 (inh=n/a pLI=1.00)
chr19	11105608	11105608	T	C	het		QUAL=7091;DP=207;AF=0.48;MQM=60;TRIO=HET,207,0.48,WT,293,0.01,HET,377,0.49	SMARCA4	synonymous	SMARCA4:NM_001128849.1:synonymous:LOW:exon9/36:c.1524T>C:p.His508His,SMARCA4:NM_001128844.1:synonymous:LOW:exon10/36:c.1524T>C:p.His508His,SMARCA4:NM_003072.3:synonymous:LOW:exon9/35:c.1524T>C:p.His508His,SMARCA4:NM_001128845.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128846.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128847.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128848.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His		rs7935	0.3115	0.3330	6930/3973/490	0.3275						603254 [SMARCA4 (provisional) Rhabdoid tumor predisposition syndrome 2|Mental retardation,autosomal dominant 16];	RCV000114302.1 [benign]; 		COSM4131184, COSM4131185	246	913					SMARCA4 (inh=AD pLI=1.00)
chr19	12772090	12772090	C	T	het		QUAL=8883;DP=221;AF=0.47;MQM=60;TRIO=HET,221,0.47,HET,485,0.51,WT,577,0.00	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln,MAN2B1:NM_001173498.1:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln		rs1133330	0.2484	0.3100	6628/4984/557	0.3093	-0.0410	T	T,T,T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079070.7 [other]; 		COSM1582962	177	528					MAN2B1 (inh=AR pLI=0.00)
chr19	12772165	12772165	G	A	het	phylop_high	QUAL=8580;DP=240;AF=0.38;MQM=60;TRIO=HET,240,0.38,HET,540,0.48,WT,661,0.00	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile,MAN2B1:NM_001173498.1:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile		rs1054487	0.3279	0.3400	8097/5345/1594	0.3382	1.9380	T	T,T,T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079081.7 [other]; 		COSM1178457	195	522					MAN2B1 (inh=AR pLI=0.00)
chr19	12774208	12774208	G	C	het		QUAL=9143;DP=333;AF=0.47;MQM=59;TRIO=HET,333,0.47,WT,345,0.01,HET,433,0.47	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val,MAN2B1:NM_001173498.1:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val		rs1054486	0.2394	0.2570	4512/2834/779	0.2516	-0.4280	T	T,T,T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079080.7 [other]; 			98	437					MAN2B1 (inh=AR pLI=0.00)
chr19	13227354	13227354	G	A	het		QUAL=3910;DP=177;AF=0.53;MQM=60;TRIO=HET,177,0.53,WT,113,0.00,HET,158,0.49	TRMT1	5'UTR_premature_start_codon_gain,5'UTR,intron	TRMT1:NM_001142554.1:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-141C>T:,TRMT1:NM_017722.3:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-141C>T:,TRMT1:NM_001142554.1:5'UTR:MODIFIER:exon1/15:c.-141C>T:,TRMT1:NM_017722.3:5'UTR:MODIFIER:exon1/16:c.-141C>T:,TRMT1:NM_001136035.2:intron:MODIFIER:exon1/16:c.-32-109C>T:		rs2302159	0.0980	0.0000	0/0/0	0.0793										1	49					TRMT1 (inh=n/a pLI=0.00)
chr19	13317491	13317493	TTA	-	hom		QUAL=7687;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,64,0.97,HET,85,0.59	CACNA1A	3'UTR	CACNA1A:NM_023035.2:3'UTR:MODIFIER:exon47/47:c.*634_*636delTAA:,CACNA1A:NM_000068.3:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:,CACNA1A:NM_001127221.1:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:,CACNA1A:NM_001127222.1:3'UTR:MODIFIER:exon47/47:c.*634_*636delTAA:,CACNA1A:NM_001174080.1:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:	(ATT)n	rs143342886;rs869287699	0.5569	0.0000	0/0/0	0.1065										161	302					CACNA1A (inh=AD pLI=1.00)
chr19	13317759	13317770	TTTTTTTTTTTT	-	hom	low_DP	QUAL=246;DP=17;AF=0.18;MQM=60;TRIO=HOM,17,0.18,WT,9,0.00,HOM,5,0.00	CACNA1A	3'UTR	CACNA1A:NM_023035.2:3'UTR:MODIFIER:exon47/47:c.*357_*368delAAAAAAAAAAAA:,CACNA1A:NM_000068.3:3'UTR:MODIFIER:exon47/47:c.*1090_*1101delAAAAAAAAAAAA:,CACNA1A:NM_001127221.1:3'UTR:MODIFIER:exon47/47:c.*1090_*1101delAAAAAAAAAAAA:,CACNA1A:NM_001127222.1:3'UTR:MODIFIER:exon47/47:c.*357_*368delAAAAAAAAAAAA:,CACNA1A:NM_001174080.1:3'UTR:MODIFIER:exon47/47:c.*1090_*1101delAAAAAAAAAAAA:	(T)n		0.0000	0.0000	0/0/0	0.0000										0	0					CACNA1A (inh=AD pLI=1.00)
chr19	13317980	13317980	G	T	hom		QUAL=3501;DP=41;AF=0.93;MQM=59;TRIO=HOM,41,0.93,HOM,52,1.00,HET,67,0.52	CACNA1A	3'UTR	CACNA1A:NM_023035.2:3'UTR:MODIFIER:exon47/47:c.*147C>A:,CACNA1A:NM_000068.3:3'UTR:MODIFIER:exon47/47:c.*880C>A:,CACNA1A:NM_001127221.1:3'UTR:MODIFIER:exon47/47:c.*880C>A:,CACNA1A:NM_001127222.1:3'UTR:MODIFIER:exon47/47:c.*147C>A:,CACNA1A:NM_001174080.1:3'UTR:MODIFIER:exon47/47:c.*880C>A:		rs7254351	0.5080	0.0000	0/0/0	0.4214										91	173					CACNA1A (inh=AD pLI=1.00)
chr19	13445208	13445208	C	T	het		QUAL=3163;DP=139;AF=0.42;MQM=60;TRIO=HET,139,0.42,HET,140,0.51,WT,138,0.00	CACNA1A	synonymous	CACNA1A:NM_023035.2:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_000068.3:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001127221.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001127222.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001174080.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu		rs2248069	0.6412	0.6850	28664/15595/1344	0.6738						601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1|Episodic ataxia,type 2|Spinocerebellar ataxia 6|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia];	RCV000079475.7 [other]; 			1026	930	1	[1] Julia Bickmann 23.09.2014	n/a (2xTP, 0xFP)		CACNA1A (inh=AD pLI=1.00)
chr19	14038791	14038791	C	T	hom	phylop_high;pred_pathogenic_2	QUAL=11525;DP=211;AF=0.99;MQM=59;TRIO=HOM,211,0.99,HET,212,0.50,HET,242,0.50	CC2D1A	missense	CC2D1A:NM_017721.4:missense:MODERATE:exon23/29:c.2402C>T:p.Thr801Met		rs2305777	0.1250	0.2090	3013/2348/12	0.2082	3.9450	T	T,T	P,D,D	B,D,D	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3];	RCV000116591.2 [likely benign]; 		COSM4000530	83	385					CC2D1A (inh=AR pLI=0.00)
chr19	14040896	14040896	G	A	het		QUAL=2244;DP=84;AF=0.58;MQM=59;TRIO=HET,84,0.58,HET,99,0.52,WT,139,0.00	CC2D1A	missense	CC2D1A:NM_017721.4:missense:MODERATE:exon27/29:c.2716G>A:p.Ala906Thr		rs11669628	0.1332	0.1320	1154/558/11	0.1276	-2.5760	T	T,T	B,B,B	B,B,B	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3];	RCV000116594.2 [likely benign]; 		COSM1750675	23	261					CC2D1A (inh=AR pLI=0.00)
chr19	15270583	15270583	G	A	hom		QUAL=23983;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,269,1.00,HET,377,0.51	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*890C>T:		rs1044123	0.6238	0.0000	0/0/0	0.6973										110	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270665	15270665	C	T	hom		QUAL=22329;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,270,1.00,HET,382,0.51	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*808G>A:		rs1044116	0.6238	0.0000	0/0/0	0.6973										110	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270805	15270805	C	A	hom		QUAL=8812;DP=134;AF=1.00;MQM=59;TRIO=HOM,134,1.00,HOM,100,0.99,HET,143,0.51	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*668G>T:		rs1044055	0.6234	0.0000	0/0/0	0.1186										110	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270910	15270910	A	G	hom		QUAL=5077;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HET,57,0.44,HET,68,0.54	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*563T>C:		rs77669983	0.0110	0.0000	0/0/0	0.0318										0	26					NOTCH3 (inh=AD pLI=0.21)
chr19	15271135	15271135	T	G	hom		QUAL=4660;DP=67;AF=1.00;MQM=59;TRIO=HOM,67,1.00,HOM,36,1.00,HOM,54,1.00	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*338A>C:	(TAAAAA)n	rs7247906	0.8708	0.0000	0/0/0	0.8430										142	45					NOTCH3 (inh=AD pLI=0.21)
chr19	15271771	15271771	G	A	hom		QUAL=3362;DP=25;AF=1.00;MQM=59;TRIO=HOM,25,1.00,HOM,62,1.00,HET,74,0.50	NOTCH3	missense	NOTCH3:NM_000435.2:missense:MODERATE:exon33/33:c.6668C>T:p.Ala2223Val		rs1044009	0.6294	0.6940	19791/12817/819	0.6543	1.1220	T	T	B	B	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];			COSM3756389, COSM3756390	638	407					NOTCH3 (inh=AD pLI=0.21)
chr19	15273381	15273381	A	G	hom		QUAL=23110;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,231,1.00,HOM,312,1.00	NOTCH3	splice_region&intron	NOTCH3:NM_000435.2:splice_region&intron:LOW:exon31/32:c.5816-8T>C:		rs4809030	0.8690	0.8730	46287/26814/4941	0.8661						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];				898	221					NOTCH3 (inh=AD pLI=0.21)
chr19	15278057	15278057	A	G	hom		QUAL=9842;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,83,1.00,HOM,111,1.00	NOTCH3	splice_region&intron	NOTCH3:NM_000435.2:splice_region&intron:LOW:exon29/32:c.5362+3T>C:		rs1548555	0.8700	0.8740	46647/26964/4975	0.8678						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];				898	222					NOTCH3 (inh=AD pLI=0.21)
chr19	15285052	15285052	T	C	hom		QUAL=22803;DP=181;AF=1.00;MQM=59;TRIO=HOM,181,1.00,HOM,219,1.00,HOM,348,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon25/33:c.4563A>G:p.Pro1521Pro		rs1044006	0.8718	0.8630	34152/19607/3360	0.8146						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];			COSM438775, COSM1480700	897	219					NOTCH3 (inh=AD pLI=0.21)
chr19	15292437	15292437	T	C	hom		QUAL=8496;DP=66;AF=1.00;MQM=59;TRIO=HOM,66,1.00,HOM,87,1.00,HOM,128,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon17/33:c.2742A>G:p.Pro914Pro		rs1043997	0.7390	0.7340	6280/2876/430	0.4975						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];			COSM4131310, COSM4131309	803	300					NOTCH3 (inh=AD pLI=0.21)
chr19	15295134	15295134	G	A	hom		QUAL=13277;DP=125;AF=0.98;MQM=60;TRIO=HOM,125,0.98,HOM,212,1.00,HET,277,0.49	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon16/33:c.2538C>T:p.Cys846Cys		rs1043996	0.5200	0.6420	26200/17147/378	0.6382						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];			COSM4131311, COSM4131312	526	486					NOTCH3 (inh=AD pLI=0.21)
chr19	15299051	15299051	G	A	het	phylop_high;pred_pathogenic_3	QUAL=2578;DP=127;AF=0.55;MQM=59;TRIO=HET,127,0.55,HET,88,0.48,WT,85,0.00	NOTCH3	missense	NOTCH3:NM_000435.2:missense:MODERATE:exon9/33:c.1487C>T:p.Pro496Leu		rs11670799	0.0036	0.0100	16/16/0	0.0101	4.5180	D	D,D	P,D	P,P	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];				1	46					NOTCH3 (inh=AD pLI=0.21)
chr19	15300136	15300136	A	G	het		QUAL=5245;DP=200;AF=0.50;MQM=59;TRIO=HET,200,0.50,HET,261,0.44,WT,292,0.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon7/33:c.1140T>C:p.Pro380Pro		rs61749020	0.0152	0.0260	62/54/2	0.0249						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];			COSM3773842, COSM3773843	2	102					NOTCH3 (inh=AD pLI=0.21)
chr19	15302844	15302844	T	C	hom		QUAL=37951;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HOM,462,1.00,HOM,555,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon4/33:c.606A>G:p.Ala202Ala		rs1043994	0.8558	0.8580	44532/25552/4278	0.8278						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2|Lateral meningocele syndrome];				851	267					NOTCH3 (inh=AD pLI=0.21)
chr19	17935585	17935586	AA	-	het		QUAL=4025;DP=97;AF=0.61;MQM=59;TRIO=HET,97,0.61,HET,62,1.00,WT,124,0.42	INSL3-JAK3	intergenic_region	INSL3-JAK3:INSL3-JAK3:intergenic_region:MODIFIER::n.17935585_17935586delAA:		rs796392933	0.3197	0.0000	0/0/0	0.2350										10	64					INSL3-JAK3 (inh=n/a pLI=n/a)
chr19	17935626	17935626	T	C	het		QUAL=6482;DP=188;AF=0.49;MQM=59;TRIO=HET,188,0.49,HOM,80,1.00,HET,154,0.44	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*1926A>G:	L2c	rs11888	0.3980	0.0000	0/0/0	0.3754										25	72					JAK3 (inh=n/a pLI=1.00)
chr19	17936259	17936259	G	A	het		QUAL=3670;DP=146;AF=0.47;MQM=60;TRIO=HET,146,0.47,HOM,64,1.00,WT,64,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*1293C>T:		rs73014967	0.1591	0.0000	0/0/0	0.1875										15	86					JAK3 (inh=n/a pLI=1.00)
chr19	17936898	17936898	T	A	het	low_DP	QUAL=87;DP=18;AF=0.33;MQM=59;TRIO=HET,18,0.33,HET,4,0.25,WT,12,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*654A>T:		rs71332114	0.2077	0.0000	0/0/0	0.0441										5	20					JAK3 (inh=n/a pLI=1.00)
chr19	17937104	17937104	G	T	het		QUAL=478;DP=31;AF=0.65;MQM=50;TRIO=HET,31,0.65,HET,4,0.75,WT,7,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*448C>A:	AluSz	rs3212802	0.2194	0.0000	0/0/0	0.1661										3	26					JAK3 (inh=n/a pLI=1.00)
chr19	17937429	17937429	A	G	het		QUAL=5338;DP=112;AF=0.57;MQM=60;TRIO=HET,112,0.57,HOM,122,1.00,WT,177,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*123T>C:		rs3008	0.5401	0.0000	0/0/0	0.0956										39	87					JAK3 (inh=n/a pLI=1.00)
chr19	17945696	17945696	C	T	het	pred_pathogenic_1;anno_pathogenic_hgmd	QUAL=3841;DP=237;AF=0.52;MQM=60;TRIO=HET,237,0.52,HET,102,0.37,WT,150,0.00	JAK3	missense	JAK3:NM_000215.3:missense:MODERATE:exon16/24:c.2164G>A:p.Val722Ile		rs3213409	0.0036	0.0086	11/9/0	0.0085	1.5240	T	D,D,D	B,B	B,B	600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type];	RCV000121262.1 [not provided]; 	CM000172 [CLASS=DM? MUT=ALT PHEN="Immunodeficiency severe combined" GENE=JAK3]; 	COSM34213	0	37					JAK3 (inh=n/a pLI=1.00)
chr19	18001686	18001686	G	A	het		QUAL=4007;DP=120;AF=0.57;MQM=60;TRIO=HET,120,0.57,WT,174,0.01,HET,231,0.48	SLC5A5	splice_region&intron	SLC5A5:NM_000453.2:splice_region&intron:LOW:exon13/14:c.1652-9G>A:		rs4808708	0.1246	0.1790	2297/1742/64	0.1762						601843 [SLC5A5 (provisional) Thyroid dyshormonogenesis 1];				59	398					SLC5A5 (inh=AR pLI=0.74)
chr19	18004912	18004912	T	C	het		QUAL=3270;DP=203;AF=0.38;MQM=59;TRIO=HET,203,0.38,WT,116,0.01,HET,154,0.42	SLC5A5	3'UTR	SLC5A5:NM_000453.2:3'UTR:MODIFIER:exon15/15:c.*226T>C:		rs12327843	0.1520	0.0000	0/0/0	0.1910										7	80					SLC5A5 (inh=AR pLI=0.74)
chr19	18180413	18180413	C	G	het		QUAL=10016;DP=108;AF=0.56;MQM=60;TRIO=HET,108,0.56,HET,320,0.48,HET,399,0.50	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon11/18:c.1252G>C:p.Gly418Arg,IL12RB1:NM_001290023.1:missense:MODERATE:exon10/17:c.1132G>C:p.Gly378Arg,IL12RB1:NM_005535.2:missense:MODERATE:exon10/17:c.1132G>C:p.Gly378Arg		rs401502	0.2516	0.2840	5086/3432/190	0.2828	-1.8560	T	T	B,B	B,B	601604 [IL12RB1 (provisional) Immunodeficiency 30];		CM030471 [CLASS=DP MUT=ALT PHEN="Tuberculosis susceptibility to association with" GENE=IL12RB1]; 		120	468					IL12RB1 (inh=n/a pLI=0.00)
chr19	18180451	18180451	A	G	het		QUAL=12484;DP=189;AF=0.52;MQM=59;TRIO=HET,189,0.52,HET,367,0.46,HET,474,0.51	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon11/18:c.1214T>C:p.Met405Thr,IL12RB1:NM_001290023.1:missense:MODERATE:exon10/17:c.1094T>C:p.Met365Thr,IL12RB1:NM_005535.2:missense:MODERATE:exon10/17:c.1094T>C:p.Met365Thr		rs375947	0.2686	0.2890	5295/3473/331	0.2881	-0.9480	T	T	B,B	B,B	601604 [IL12RB1 (provisional) Immunodeficiency 30];		CM030470 [CLASS=DP MUT=ALT PHEN="Tuberculosis susceptibility to association with" GENE=IL12RB1]; 	COSM4000563, COSM4000562	120	469					IL12RB1 (inh=n/a pLI=0.00)
chr19	18181569	18181569	A	G	het		QUAL=5324;DP=120;AF=0.46;MQM=59;TRIO=HET,120,0.46,HET,168,0.47,HET,194,0.46	IL12RB1	3'UTR,intron	IL12RB1:NM_153701.2:3'UTR:MODIFIER:exon10/10:c.*450T>C:,IL12RB1:NM_001290024.1:intron:MODIFIER:exon10/17:c.1142-1046T>C:,IL12RB1:NM_001290023.1:intron:MODIFIER:exon9/16:c.1022-1046T>C:,IL12RB1:NM_005535.2:intron:MODIFIER:exon9/16:c.1022-1046T>C:	AluJr	rs845380	0.6585	0.0000	0/0/0	0.6312						601604 [IL12RB1 (provisional) Immunodeficiency 30];				81	62					IL12RB1 (inh=n/a pLI=0.00)
chr19	18186575	18186575	G	A	het		QUAL=6615;DP=148;AF=0.43;MQM=60;TRIO=HET,148,0.43,HET,192,0.47,HET,227,0.49	IL12RB1	synonymous	IL12RB1:NM_001290024.1:synonymous:LOW:exon8/18:c.804C>T:p.Pro268Pro,IL12RB1:NM_001290023.1:synonymous:LOW:exon7/17:c.684C>T:p.Pro228Pro,IL12RB1:NM_005535.2:synonymous:LOW:exon7/17:c.684C>T:p.Pro228Pro,IL12RB1:NM_153701.2:synonymous:LOW:exon7/10:c.684C>T:p.Pro228Pro		rs17852635	0.2298	0.2770	4994/3457/68	0.2784						601604 [IL12RB1 (provisional) Immunodeficiency 30];			COSM4000566, COSM4000564, COSM4000565	120	467					IL12RB1 (inh=n/a pLI=0.00)
chr19	18186618	18186618	T	C	het	anno_pathogenic_hgmd	QUAL=7824;DP=144;AF=0.55;MQM=59;TRIO=HET,144,0.55,HET,218,0.46,HET,261,0.50	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon8/18:c.761A>G:p.Gln254Arg,IL12RB1:NM_001290023.1:missense:MODERATE:exon7/17:c.641A>G:p.Gln214Arg,IL12RB1:NM_005535.2:missense:MODERATE:exon7/17:c.641A>G:p.Gln214Arg,IL12RB1:NM_153701.2:missense:MODERATE:exon7/10:c.641A>G:p.Gln214Arg		rs11575934	0.2294	0.2760	4992/3459/64	0.2732	-0.2090	T	T,.	B,B,B	B,B,B	601604 [IL12RB1 (provisional) Immunodeficiency 30];		CM984025 [CLASS=DM? MUT=ALT PHEN="Mycobacterial infection" GENE=IL12RB1]; 	COSM4131454, COSM4131452, COSM4131453	120	466	2	[2] old entry - no details available			IL12RB1 (inh=n/a pLI=0.00)
chr19	18191664	18191664	C	G	het		QUAL=5030;DP=131;AF=0.50;MQM=59;TRIO=HET,131,0.50,HET,159,0.38,HET,194,0.54	IL12RB1	synonymous	IL12RB1:NM_001290024.1:synonymous:LOW:exon5/18:c.507G>C:p.Val169Val,IL12RB1:NM_001290023.1:synonymous:LOW:exon4/17:c.387G>C:p.Val129Val,IL12RB1:NM_005535.2:synonymous:LOW:exon4/17:c.387G>C:p.Val129Val,IL12RB1:NM_153701.2:synonymous:LOW:exon4/10:c.387G>C:p.Val129Val		rs11086087	0.1300	0.1180	998/494/11	0.1186						601604 [IL12RB1 (provisional) Immunodeficiency 30];			COSM4000567, COSM4000569, COSM4000568	23	225					IL12RB1 (inh=n/a pLI=0.00)
chr19	33882222	33882222	G	A	het		QUAL=900;DP=34;AF=0.59;MQM=60;TRIO=HET,34,0.59,HET,52,0.40,WT,79,0.00	PEPD	synonymous	PEPD:NM_000285.3:synonymous:LOW:exon13/15:c.1131C>T:p.His377His,PEPD:NM_001166056.1:synonymous:LOW:exon11/13:c.1008C>T:p.His336His,PEPD:NM_001166057.1:synonymous:LOW:exon11/13:c.939C>T:p.His313His		rs17569	0.0984	0.1290	1115/692/3	0.1307						613230 [PEPD (confirmed) Prolidase deficiency];				17	285					PEPD (inh=AR pLI=0.01)
chr19	33953912	33953912	A	G	het		QUAL=8399;DP=301;AF=0.48;MQM=60;TRIO=HET,301,0.48,HET,313,0.53,WT,436,0.00	PEPD	synonymous,intron	PEPD:NM_000285.3:synonymous:LOW:exon9/15:c.660T>C:p.Tyr220Tyr,PEPD:NM_001166057.1:synonymous:LOW:exon7/13:c.468T>C:p.Tyr156Tyr,PEPD:NM_001166056.1:intron:MODIFIER:exon7/12:c.548+15040T>C:		rs3745969	0.0298	0.0380	159/51/1	0.0375						613230 [PEPD (confirmed) Prolidase deficiency];				3	53					PEPD (inh=AR pLI=0.01)
chr19	34872382	34872382	G	A	het		QUAL=9051;DP=241;AF=0.49;MQM=60;TRIO=HET,241,0.49,WT,451,0.00,HET,560,0.44	GPI	synonymous	GPI:NM_001289789.1:synonymous:LOW:exon10/19:c.879G>A:p.Lys293Lys,GPI:NM_001184722.1:synonymous:LOW:exon9/18:c.795G>A:p.Lys265Lys,GPI:NM_000175.3:synonymous:LOW:exon9/18:c.762G>A:p.Lys254Lys,GPI:NM_001289790.1:synonymous:LOW:exon8/17:c.678G>A:p.Lys226Lys		rs1864139	0.1200	0.0810	700/126/261	0.0746						172400 [GPI (confirmed) Hemolytic anemia,nonspherocytic,due to glucose phosphate isomerase deficiency];				8	156					GPI (inh=AR pLI=0.00)
chr19	34891482	34891482	C	G	het		QUAL=32356;DP=459;AF=0.48;MQM=60;TRIO=HET,459,0.48,HOM,548,1.00,HET,717,0.48	GPI	3'UTR	GPI:NM_001289789.1:3'UTR:MODIFIER:exon19/19:c.*541C>G:,GPI:NM_001184722.1:3'UTR:MODIFIER:exon18/18:c.*541C>G:,GPI:NM_000175.3:3'UTR:MODIFIER:exon18/18:c.*541C>G:,GPI:NM_001289790.1:3'UTR:MODIFIER:exon17/17:c.*541C>G:		rs4619515	0.8826	0.7990	11/6/3	0.1603										131	17					GPI (inh=AR pLI=0.00)
chr19	35524824	35524824	T	C	het	pred_pathogenic_1	QUAL=7370;DP=176;AF=0.47;MQM=60;TRIO=HET,176,0.47,WT,267,0.00,HET,397,0.52	SCN1B	missense,intron	SCN1B:NM_199037.3:missense:MODERATE:exon3/3:c.629T>C:p.Leu210Pro,SCN1B:NM_001037.4:intron:MODIFIER:exon3/5:c.448+181T>C:		rs55742440	0.3776	0.3270	3359/1869/617	0.2947	0.0050	T	D	B	B	600235 [SCN1B (confirmed) Epilepsy,generalized,with febrile seizures plus,type 1|Brugada syndrome 5|Cardiac conduction defect,nonspecific|Atrial fibrillation,familial,13];	RCV000127905.4 [benign]; 		COSM4131651	206	515					SCN1B (inh=n/a pLI=0.21)
chr19	36139172	36139172	G	A	hom		QUAL=6853;DP=64;AF=0.98;MQM=59;TRIO=HOM,64,0.98,HET,178,0.49,HET,251,0.47	COX6B1	5'UTR	COX6B1:NM_001863.4:5'UTR:MODIFIER:exon1/4:c.-145G>A:		rs10420252	0.1148	0.0000	0/0/0	0.1049										3	43					COX6B1 (inh=n/a pLI=0.08)
chr19	36316710	36316710	T	C	hom		QUAL=14464;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,147,1.00,HET,196,0.47	NPHS1	3'UTR	NPHS1:NM_004646.3:3'UTR:MODIFIER:exon29/29:c.*706A>G:		rs80296922	0.0162	0.0000	0/0/0	0.0267										1	21					NPHS1 (inh=n/a pLI=0.00)
chr19	36317556	36317556	C	A	hom		QUAL=18795;DP=240;AF=0.98;MQM=60;TRIO=HOM,240,0.98,HOM,266,1.00,HET,275,0.48	NPHS1	splice_region&intron	NPHS1:NM_004646.3:splice_region&intron:LOW:exon28/28:c.3595-9G>T:		rs77309273	0.0198	0.0410	148/96/1	0.0397						602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];				3	83					NPHS1 (inh=n/a pLI=0.00)
chr19	36322270	36322270	C	T	hom		QUAL=42098;DP=291;AF=0.97;MQM=59;TRIO=HOM,291,0.97,HOM,469,1.00,HOM,611,1.00	NPHS1	synonymous	NPHS1:NM_004646.3:synonymous:LOW:exon26/29:c.3315G>A:p.Ser1105Ser		rs2071327	0.3676	0.3920	10277/5006/51	0.3812						602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];				141	472					NPHS1 (inh=n/a pLI=0.00)
chr19	36342212	36342212	C	T	het	phylop_high;pred_pathogenic_2	QUAL=8700;DP=296;AF=0.48;MQM=60;TRIO=HET,296,0.48,HOM,170,0.99,WT,268,0.01	NPHS1	missense	NPHS1:NM_004646.3:missense:MODERATE:exon3/29:c.349G>A:p.Glu117Lys		rs3814995	0.2919	0.3110	6569/2984/40	0.3109	2.5550	T	T,T	D	D	602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];			COSM3756680	92	432					NPHS1 (inh=n/a pLI=0.00)
chr19	36487146	36487146	A	G	het		QUAL=3772;DP=171;AF=0.51;MQM=60;TRIO=HET,171,0.51,WT,106,0.00,HET,132,0.46	SDHAF1	3'UTR	SDHAF1:NM_001042631.2:3'UTR:MODIFIER:exon1/1:c.*622A>G:		rs7925	0.0948	0.0000	0/0/0	0.1207										15	45					SDHAF1 (inh=n/a pLI=0.11)
chr19	36583651	36583651	G	A	het		QUAL=8944;DP=267;AF=0.49;MQM=59;TRIO=HET,267,0.49,WT,294,0.00,HET,429,0.50	WDR62	synonymous	WDR62:NM_001083961.1:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu,WDR62:NM_173636.4:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu		rs61494900	0.1228	0.1060	880/422/273	0.1051						613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147931.1 [benign]; 			35	247					WDR62 (inh=AR pLI=0.00)
chr19	36590329	36590329	T	C	hom		QUAL=11753;DP=109;AF=1.00;MQM=59;TRIO=HOM,109,1.00,HET,184,0.48,HOM,216,0.99	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser,WDR62:NM_173636.4:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser		rs2285745	0.6542	0.6400	24832/13944/2641	0.6157	0.7020	T	T,T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147938.1 [benign]; 		COSM4131728	485	481					WDR62 (inh=AR pLI=0.00)
chr19	36594063	36594063	C	T	het		QUAL=6694;DP=217;AF=0.54;MQM=59;TRIO=HET,217,0.54,WT,201,0.00,HET,307,0.49	WDR62	synonymous	WDR62:NM_001083961.1:synonymous:LOW:exon29/32:c.3468C>T:p.Leu1156Leu,WDR62:NM_173636.4:synonymous:LOW:exon29/32:c.3453C>T:p.Leu1151Leu		rs17851502	0.1212	0.1060	860/422/257	0.1044						613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147957.1 [benign]; 			35	247					WDR62 (inh=AR pLI=0.00)
chr19	36594659	36594659	A	T	hom		QUAL=15292;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HET,285,0.53,HET,347,0.55	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon30/32:c.3929A>T:p.Gln1310Leu,WDR62:NM_173636.4:missense:MODERATE:exon30/32:c.3914A>T:p.Gln1305Leu		rs2074435	0.7296	0.6530	26222/12268/3229	0.6479	0.5110	T	T,T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000079454.5 [benign]; 		COSM3756682	452	493					WDR62 (inh=AR pLI=0.00)
chr19	36595436	36595436	A	C	hom		QUAL=2150;DP=33;AF=0.97;MQM=59;TRIO=HOM,33,0.97,HOM,25,1.00,HET,46,0.50	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon31/32:c.4170A>C:p.Leu1390Phe,WDR62:NM_173636.4:missense:MODERATE:exon31/32:c.4155A>C:p.Leu1385Phe		rs1008328	0.7163	0.7420	33744/19823/2495	0.7322	0.3220	T	T,T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147972.4 [benign]; 		COSM1129883	654	390					WDR62 (inh=AR pLI=0.00)
chr19	38935280	38935280	A	G	het		QUAL=5140;DP=143;AF=0.52;MQM=59;TRIO=HET,143,0.52,WT,170,0.01,HET,238,0.52	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon7/106:c.594A>G:p.Leu198Leu,RYR1:NM_001042723.1:synonymous:LOW:exon7/105:c.594A>G:p.Leu198Leu		rs2229139	0.5433	0.6030	22424/13822/1384	0.5922						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079154.7 [other]; RCV000119644.1 [not provided]; 			467	513					RYR1 (inh=n/a pLI=0.00)
chr19	38939408	38939408	T	C	het		QUAL=10388;DP=233;AF=0.44;MQM=59;TRIO=HET,233,0.44,HET,191,0.40,HOM,201,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon11/106:c.1077T>C:p.Ala359Ala,RYR1:NM_001042723.1:synonymous:LOW:exon11/105:c.1077T>C:p.Ala359Ala		rs10406027	0.9040	0.8840	47713/26148/4496	0.8600						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079119.6 [benign]; RCV000119418.1 [not provided]; 		COSM4131781	882	233					RYR1 (inh=n/a pLI=0.00)
chr19	38946182	38946182	G	A	het		QUAL=22412;DP=281;AF=0.47;MQM=59;TRIO=HET,281,0.47,HET,346,0.53,HOM,484,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon15/106:c.1668G>A:p.Ser556Ser,RYR1:NM_001042723.1:synonymous:LOW:exon15/105:c.1668G>A:p.Ser556Ser		rs2288888	0.5713	0.6360	25034/15457/1561	0.6226						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079135.6 [benign]; RCV000119582.1 [not provided]; 			515	501					RYR1 (inh=n/a pLI=0.00)
chr19	38949904	38949904	C	T	het		QUAL=10920;DP=218;AF=0.56;MQM=59;TRIO=HET,218,0.56,HET,145,0.48,HOM,194,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon19/106:c.2286C>T:p.Pro762Pro,RYR1:NM_001042723.1:synonymous:LOW:exon19/105:c.2286C>T:p.Pro762Pro		rs3745847	0.5541	0.6210	23949/14881/1456	0.6179						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079136.6 [benign]; RCV000119595.1 [not provided]; 		COSM4131782	498	502					RYR1 (inh=n/a pLI=0.00)
chr19	38959680	38959680	C	T	hom		QUAL=29070;DP=199;AF=0.99;MQM=60;TRIO=HOM,199,0.99,HET,451,0.50,HOM,528,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon26/106:c.3456C>T:p.Ile1152Ile,RYR1:NM_001042723.1:synonymous:LOW:exon26/105:c.3456C>T:p.Ile1152Ile		rs11083462	0.4493	0.3950	9943/4353/1022	0.3855						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079140.6 [benign]; RCV000119611.1 [not provided]; 		COSM148605	171	485					RYR1 (inh=n/a pLI=0.00)
chr19	38965952	38965952	T	C	het		QUAL=2738;DP=111;AF=0.43;MQM=60;TRIO=HET,111,0.43,HET,137,0.52,WT,175,0.00	RYR1	splice_region&intron	RYR1:NM_000540.2:splice_region&intron:LOW:exon28/105:c.4161-6T>C:,RYR1:NM_001042723.1:splice_region&intron:LOW:exon28/104:c.4161-6T>C:		rs55845760	0.2171	0.1190	860/188/418	0.1177						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079145.5 [benign]; 			28	224					RYR1 (inh=n/a pLI=0.00)
chr19	38981284	38981284	A	G	het		QUAL=12334;DP=284;AF=0.56;MQM=60;TRIO=HET,284,0.56,HOM,251,1.00,WT,251,0.01	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon37/106:c.6039A>G:p.Lys2013Lys,RYR1:NM_001042723.1:synonymous:LOW:exon37/105:c.6039A>G:p.Lys2013Lys		rs2228068	0.0751	0.0920	695/321/6	0.0894						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079155.6 [benign]; RCV000119646.1 [not provided]; 		COSM4131783	22	187					RYR1 (inh=n/a pLI=0.00)
chr19	38983180	38983180	G	T	het	pred_pathogenic_1	QUAL=7646;DP=206;AF=0.42;MQM=59;TRIO=HET,206,0.42,HOM,190,0.99,WT,231,0.00	RYR1	missense	RYR1:NM_000540.2:missense:MODERATE:exon38/106:c.6178G>T:p.Gly2060Cys,RYR1:NM_001042723.1:missense:MODERATE:exon38/105:c.6178G>T:p.Gly2060Cys		rs35364374	0.0549	0.0690	447/176/1	0.0670	0.6150	T	T,T,T	D,P	P,B	180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000056058.1 [benign]; RCV000079156.6 [benign]; RCV000119647.1 [not provided]; RCV000209979.1 [benign]; 			13	137					RYR1 (inh=n/a pLI=0.00)
chr19	38991516	38991516	G	A	het		QUAL=9443;DP=230;AF=0.54;MQM=59;TRIO=HET,230,0.54,WT,310,0.00,HET,458,0.54	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon47/106:c.7500G>A:p.Ala2500Ala,RYR1:NM_001042723.1:synonymous:LOW:exon47/105:c.7500G>A:p.Ala2500Ala		rs2228072	0.1508	0.1140	937/252/66	0.1115						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079165.6 [benign]; RCV000119716.1 [not provided]; 			8	205					RYR1 (inh=n/a pLI=0.00)
chr19	38991543	38991543	G	A	het		QUAL=10854;DP=297;AF=0.51;MQM=59;TRIO=HET,297,0.51,WT,342,0.00,HET,509,0.53	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon47/106:c.7527G>A:p.Val2509Val,RYR1:NM_001042723.1:synonymous:LOW:exon47/105:c.7527G>A:p.Val2509Val		rs2071088	0.1360	0.1110	913/253/41	0.1087						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079166.6 [benign]; RCV000119720.1 [not provided]; 			8	204					RYR1 (inh=n/a pLI=0.00)
chr19	38993372	38993372	A	G	het	low_DP	QUAL=707;DP=13;AF=0.23;MQM=60;TRIO=HET,13,0.23,WT,22,0.00,HOM,26,1.00	RYR1	splice_region&intron	RYR1:NM_000540.2:splice_region&intron:LOW:exon48/105:c.7835+5A>G:,RYR1:NM_001042723.1:splice_region&intron:LOW:exon48/104:c.7835+5A>G:		rs1469695	0.4219	0.3280	6386/2083/965	0.3043						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079170.6 [benign]; RCV000119729.1 [not provided]; 			86	448					RYR1 (inh=n/a pLI=0.00)
chr19	38993547	38993547	C	T	het		QUAL=4909;DP=164;AF=0.51;MQM=59;TRIO=HET,164,0.51,WT,78,0.00,HOM,107,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon49/106:c.7863C>T:p.His2621His,RYR1:NM_001042723.1:synonymous:LOW:exon49/105:c.7863C>T:p.His2621His		rs2229142	0.2378	0.1810	2233/752/190	0.1721						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079172.6 [benign]; RCV000119732.1 [not provided]; 		COSM148609	29	320					RYR1 (inh=n/a pLI=0.00)
chr19	38994910	38994910	G	A	het		QUAL=9306;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,WT,163,0.01,HOM,195,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon50/106:c.7977G>A:p.Thr2659Thr,RYR1:NM_001042723.1:synonymous:LOW:exon50/105:c.7977G>A:p.Thr2659Thr		rs2229144	0.4123	0.3250	6847/2252/1130	0.3167						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079174.6 [benign]; RCV000119736.1 [not provided]; 		COSM148610	83	463					RYR1 (inh=n/a pLI=0.00)
chr19	38995438	38995438	T	C	het		QUAL=9122;DP=173;AF=0.51;MQM=59;TRIO=HET,173,0.51,WT,184,0.01,HOM,224,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon51/106:c.8118T>C:p.Ile2706Ile,RYR1:NM_001042723.1:synonymous:LOW:exon51/105:c.8118T>C:p.Ile2706Ile		rs2960340	0.4151	0.3260	6973/2271/1133	0.3133						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079175.6 [benign]; RCV000119738.1 [not provided]; 		COSM148611	83	463					RYR1 (inh=n/a pLI=0.00)
chr19	38995510	38995510	T	C	het		QUAL=13993;DP=319;AF=0.49;MQM=59;TRIO=HET,319,0.49,WT,277,0.01,HOM,317,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon51/106:c.8190T>C:p.Asp2730Asp,RYR1:NM_001042723.1:synonymous:LOW:exon51/105:c.8190T>C:p.Asp2730Asp		rs2915951	0.4171	0.3290	7072/2345/1136	0.3216						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079176.6 [benign]; RCV000119741.1 [not provided]; 		COSM148612	85	467					RYR1 (inh=n/a pLI=0.00)
chr19	38995975	38995975	G	A	het		QUAL=4727;DP=153;AF=0.47;MQM=60;TRIO=HET,153,0.47,WT,76,0.00,HOM,93,0.99	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon53/106:c.8337G>A:p.Glu2779Glu,RYR1:NM_001042723.1:synonymous:LOW:exon53/105:c.8337G>A:p.Glu2779Glu		rs2915952	0.4060	0.3200	6270/2046/892	0.3125						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079177.6 [benign]; RCV000119745.1 [not provided]; 		COSM148613	83	461					RYR1 (inh=n/a pLI=0.00)
chr19	38996990	38996990	T	C	het		QUAL=13469;DP=249;AF=0.53;MQM=59;TRIO=HET,249,0.53,WT,268,0.01,HOM,330,0.99	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon55/106:c.8589T>C:p.Ser2863Ser,RYR1:NM_001042723.1:synonymous:LOW:exon55/105:c.8589T>C:p.Ser2863Ser		rs2229146	0.4081	0.3260	6923/2338/1002	0.3139						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079178.6 [benign]; RCV000119753.1 [not provided]; 		COSM148614	84	466					RYR1 (inh=n/a pLI=0.00)
chr19	39002725	39002725	A	G	het		QUAL=3647;DP=101;AF=0.48;MQM=60;TRIO=HET,101,0.48,WT,110,0.00,HOM,89,0.98	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon62/106:c.9186A>G:p.Pro3062Pro,RYR1:NM_001042723.1:synonymous:LOW:exon62/105:c.9186A>G:p.Pro3062Pro		rs2071089	0.4069	0.3250	6688/2227/977	0.3142						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079184.6 [benign]; RCV000119767.1 [not provided]; 		COSM3756756	83	463					RYR1 (inh=n/a pLI=0.00)
chr19	39010053	39010053	C	T	het	low_DP	QUAL=216;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,WT,7,0.00,HET,8,0.88	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon67/106:c.10218C>T:p.Tyr3406Tyr,RYR1:NM_001042723.1:synonymous:LOW:exon67/105:c.10218C>T:p.Tyr3406Tyr		rs41274330	0.1022	0.0720	516/56/1	0.0688						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079116.6 [benign]; RCV000119405.1 [not provided]; 			4	124					RYR1 (inh=n/a pLI=0.00)
chr19	40900865	40900865	C	T	hom		QUAL=12699;DP=116;AF=0.97;MQM=59;TRIO=HOM,116,0.97,HOM,125,0.99,HOM,181,0.99	PRX	missense,3'UTR	PRX:NM_181882.2:missense:MODERATE:exon7/7:c.3394G>A:p.Gly1132Arg,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*3599G>A:		rs268674	0.9655	0.9470	54288/29495/5083	0.9253	-0.1040	T	T,T	B	B	605725 [PRX (provisional) Dejerine-Sottas disease|Charcot-Marie-Tooth disease,type 4F];	RCV000118080.2 [likely benign]; 		COSM3756794	942	157					PRX (inh=n/a pLI=0.00)
chr19	40901604	40901604	A	G	het		QUAL=8452;DP=195;AF=0.54;MQM=59;TRIO=HET,195,0.54,HOM,203,0.99,WT,288,0.00	PRX	synonymous,3'UTR	PRX:NM_181882.2:synonymous:LOW:exon7/7:c.2655T>C:p.Pro885Pro,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*2860T>C:		rs268672	0.5319	0.5070	16573/8832/3336	0.5004						605725 [PRX (provisional) Dejerine-Sottas disease|Charcot-Marie-Tooth disease,type 4F];	RCV000118076.2 [likely benign]; 		COSM4131847	283	533					PRX (inh=n/a pLI=0.00)
chr19	40901614	40901614	A	G	het	phylop_high	QUAL=8298;DP=210;AF=0.53;MQM=59;TRIO=HET,210,0.53,HOM,202,0.99,WT,272,0.01	PRX	missense,3'UTR	PRX:NM_181882.2:missense:MODERATE:exon7/7:c.2645T>C:p.Val882Ala,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*2850T>C:		rs268671	0.5319	0.5070	16557/8815/3340	0.4859	2.6800	T	T,T	B	B	605725 [PRX (provisional) Dejerine-Sottas disease|Charcot-Marie-Tooth disease,type 4F];	RCV000118075.2 [likely benign]; 		COSM4000733	282	534					PRX (inh=n/a pLI=0.00)
chr19	41892269	41892269	C	T	hom		QUAL=5873;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HOM,64,1.00,HOM,71,1.00	TMEM91-EXOSC5	intergenic_region	TMEM91-EXOSC5:TMEM91-EXOSC5:intergenic_region:MODIFIER::n.41892269C>T:	L2b	rs3826713	0.5044	0.0000	0/0/0	0.5499						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];				74	106					TMEM91-EXOSC5 (inh=n/a pLI=n/a)
chr19	41903220	41903220	G	A	hom		QUAL=29155;DP=249;AF=0.99;MQM=60;TRIO=HOM,249,0.99,HOM,293,1.00,HOM,400,1.00	EXOSC5	missense	EXOSC5:NM_020158.3:missense:MODERATE:exon1/6:c.14C>T:p.Thr5Met		rs10853751	0.6144	0.5950	22014/11928/3534	0.5876	-0.0950	T	T	B	B	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];				270	313					EXOSC5 (inh=n/a pLI=0.00)
chr19	41903699	41903699	T	G	het		QUAL=754;DP=67;AF=0.36;MQM=60;TRIO=HET,67,0.36,HET,26,0.46,WT,40,0.00	BCKDHA	5'UTR	BCKDHA:NM_000709.3:5'UTR:MODIFIER:exon1/9:c.-34T>G:,BCKDHA:NM_001164783.1:5'UTR:MODIFIER:exon1/9:c.-34T>G:		rs45500792	0.0825	0.1150	899/589/1	0.1127						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079215.4 [benign]; 			0	58					BCKDHA (inh=AR pLI=0.00)
chr19	41916549	41916549	C	A	het		QUAL=2294;DP=67;AF=0.58;MQM=59;TRIO=HET,67,0.58,HET,140,0.45,WT,178,0.01	BCKDHA	missense	BCKDHA:NM_000709.3:missense:MODERATE:exon2/9:c.116C>A:p.Pro39His,BCKDHA:NM_001164783.1:missense:MODERATE:exon2/9:c.116C>A:p.Pro39His		rs11549936	0.0553	0.0980	711/538/1	0.0943	-1.4150	T	T,T,T,T	B,B,B	B,B,B	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079222.8 [other]; 		COSM4131898	21	264					BCKDHA (inh=AR pLI=0.00)
chr19	41928652	41928652	C	T	hom		QUAL=16688;DP=129;AF=0.98;MQM=59;TRIO=HOM,129,0.98,HOM,186,0.99,HOM,247,1.00	BCKDHA	synonymous	BCKDHA:NM_000709.3:synonymous:LOW:exon7/9:c.972C>T:p.Phe324Phe,BCKDHA:NM_001164783.1:synonymous:LOW:exon7/9:c.969C>T:p.Phe323Phe		rs284652	0.6164	0.5990	22181/12060/3531	0.5894						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079266.7 [other]; 		COSM3933055	418	504					BCKDHA (inh=AR pLI=0.00)
chr19	41930396	41930396	A	G	hom		QUAL=4690;DP=74;AF=0.96;MQM=59;TRIO=HOM,74,0.96,HOM,43,1.00,HOM,52,1.00	BCKDHA	synonymous	BCKDHA:NM_000709.3:synonymous:LOW:exon9/9:c.1221A>G:p.Leu407Leu,BCKDHA:NM_001164783.1:synonymous:LOW:exon9/9:c.1218A>G:p.Leu406Leu		rs4674	0.6170	0.6000	22302/12132/3540	0.5924						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079224.7 [other]; 			421	504					BCKDHA (inh=AR pLI=0.00)
chr19	45854919	45854919	T	G	hom		QUAL=20147;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HET,334,0.44,HOM,412,1.00	ERCC2	missense	ERCC2:NM_000400.3:missense:MODERATE:exon23/23:c.2251A>C:p.Lys751Gln		rs13181	0.2366	0.3300	7354/5029/253	0.3182	1.1980	T	T,T,T,T	B,B	B,B	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy 1,photosensitive|Cerebrooculofacioskeletal syndrome 2];	RCV000120777.1 [not provided]; 	CM004814 [CLASS=DFP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=ERCC2]; 	COSM4132125	539	1551					ERCC2 (inh=AR pLI=0.00)
chr19	45855524	45855524	G	A	hom		QUAL=7015;DP=136;AF=1.00;MQM=60;TRIO=HOM,136,1.00,HET,45,0.56,HOM,77,1.00	ERCC2	synonymous	ERCC2:NM_000400.3:synonymous:LOW:exon22/23:c.2133C>T:p.Asp711Asp		rs1052555	0.1823	0.2850	5793/4062/58	0.2780						126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy 1,photosensitive|Cerebrooculofacioskeletal syndrome 2];		CM052870 [CLASS=DP MUT=ALT PHEN="Reduced risk oligodendroglioma development association" GENE=ERCC2]; 	COSM3756953	460	1479					ERCC2 (inh=AR pLI=0.00)
chr19	45867259	45867259	C	T	hom	phylop_high	QUAL=5146;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HET,70,0.46,HOM,99,1.00	ERCC2	missense	ERCC2:NM_000400.3:missense:MODERATE:exon10/23:c.934G>A:p.Asp312Asn,ERCC2:NM_001130867.1:missense:MODERATE:exon9/12:c.862G>A:p.Asp288Asn		rs1799793	0.1945	0.2130	1102/479/9	0.1892	7.1920	T	T,T,T,T,T	B,P,B	B,B,B	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy 1,photosensitive|Cerebrooculofacioskeletal syndrome 2];	RCV000120789.1 [not provided]; 	CM015299 [CLASS=DFP MUT=ALT PHEN="Increased response to UV association with" GENE=ERCC2]; 	COSM3749518, COSM3749519	524	1527					ERCC2 (inh=AR pLI=0.00)
chr19	45868309	45868309	T	G	hom		QUAL=23228;DP=138;AF=1.00;MQM=59;TRIO=HOM,138,1.00,HET,364,0.49,HOM,475,1.00	ERCC2	synonymous	ERCC2:NM_000400.3:synonymous:LOW:exon6/23:c.468A>C:p.Arg156Arg,ERCC2:NM_001130867.1:synonymous:LOW:exon5/12:c.396A>C:p.Arg132Arg		rs238406	0.6362	0.5880	21339/10481/3987	0.5765						126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy 1,photosensitive|Cerebrooculofacioskeletal syndrome 2];		CM057545 [CLASS=DP MUT=REF PHEN="Lung adenocarcinoma increased risk association with" GENE=ERCC2]; 		1120	1653					ERCC2 (inh=AR pLI=0.00)
chr19	45910672	45910672	A	G	hom		QUAL=9194;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,56,1.00,HET,95,0.47	ERCC1,CD3EAP	3'UTR,intron	ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*2261T>C:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*2261T>C:,CD3EAP:NM_001297590.1:intron:MODIFIER:exon2/2:c.170+179A>G:,CD3EAP:NM_012099.1:intron:MODIFIER:exon2/2:c.164+179A>G:	MER41D	rs1046282	0.3249	0.0000	0/0/0	0.2845										19	80					ERCC1 (inh=AR pLI=0.00), CD3EAP (inh=n/a pLI=0.00)
chr19	45911320	45911320	A	-	hom		QUAL=21151;DP=212;AF=0.95;MQM=59;TRIO=HOM,212,0.95,HOM,328,0.98,HET,447,0.56	ERCC1,CD3EAP	3'UTR,intron	ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*1613delT:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*1613delT:,CD3EAP:NM_001297590.1:intron:MODIFIER:exon2/2:c.171-62delA:,CD3EAP:NM_012099.1:intron:MODIFIER:exon2/2:c.165-62delA:	AluSx1	rs11314106	0.0000	0.0000	0/0/0	0.0284										40	138					ERCC1 (inh=AR pLI=0.00), CD3EAP (inh=n/a pLI=0.00)
chr19	45912490	45912492	AAG	-	hom		QUAL=13792;DP=178;AF=0.98;MQM=59;TRIO=HOM,178,0.98,HOM,212,0.97,HET,233,0.55	CD3EAP,ERCC1	disruptive_inframe_deletion,3'UTR	CD3EAP:NM_001297590.1:disruptive_inframe_deletion:MODERATE:exon3/3:c.1287_1289delGAA:p.Lys430del,CD3EAP:NM_012099.1:disruptive_inframe_deletion:MODERATE:exon3/3:c.1281_1283delGAA:p.Lys428del,ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*441_*443delCTT:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*441_*443delCTT:	(AAG)n	rs35729377;rs374686338	0.0000	0.2160	1707/1238/29	0.1949									COSM1481223	60	334					CD3EAP (inh=n/a pLI=0.00), ERCC1 (inh=AR pLI=0.00)
chr19	45912736	45912736	C	A	hom		QUAL=11258;DP=133;AF=1.00;MQM=59;TRIO=HOM,133,1.00,HOM,170,0.99,HET,180,0.48	CD3EAP,ERCC1	missense,3'UTR	CD3EAP:NM_001297590.1:missense:MODERATE:exon3/3:c.1516C>A:p.Gln506Lys,CD3EAP:NM_012099.1:missense:MODERATE:exon3/3:c.1510C>A:p.Gln504Lys,ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*197G>T:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*197G>T:	(AGC)n	rs3212986	0.2951	0.2710	4297/1703/385	0.2625	-1.3970	T	T	B,B	B,B		RCV000211219.1 [drug response]; RCV000211315.1 [drug response]; RCV000211398.1 [drug response]; 	CM005461 [CLASS=DP MUT=REF PHEN="Glioma adult-onset association with" GENE=CD3EAP]; 		78	369					CD3EAP (inh=n/a pLI=0.00), ERCC1 (inh=AR pLI=0.00)
chr19	45923653	45923653	A	G	hom		QUAL=22904;DP=179;AF=0.99;MQM=60;TRIO=HOM,179,0.99,HOM,357,0.99,HET,456,0.52	ERCC1	synonymous	ERCC1:NM_202001.2:synonymous:LOW:exon3/8:c.354T>C:p.Asn118Asn,ERCC1:NM_001166049.1:synonymous:LOW:exon4/9:c.354T>C:p.Asn118Asn,ERCC1:NM_001983.3:synonymous:LOW:exon4/10:c.354T>C:p.Asn118Asn		rs11615	0.6689	0.5000	16939/4659/4049	0.4918						126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4];	RCV000211176.1 [drug response]; RCV000211179.1 [drug response]; RCV000211295.1 [drug response]; RCV000211304.1 [drug response]; RCV000211427.1 [drug response]; 			246	569					ERCC1 (inh=AR pLI=0.00)
chr19	45998346	45998346	C	A	hom		QUAL=13652;DP=244;AF=0.99;MQM=59;TRIO=HOM,244,0.99,HET,208,0.45,HET,330,0.45	RTN2	splice_region&intron	RTN2:NM_005619.4:splice_region&intron:LOW:exon2/10:c.79+7G>T:,RTN2:NM_206900.2:splice_region&intron:LOW:exon2/9:c.79+7G>T:		rs2298887	0.1494	0.1570	1716/873/163	0.1519						603183 [RTN2 (provisional) Spastic paraplegia 12,autosomal dominant];				53	464					RTN2 (inh=AD pLI=0.64)
chr19	46031606	46031606	T	C	hom		QUAL=25304;DP=282;AF=1.00;MQM=59;TRIO=HOM,282,1.00,HOM,257,1.00,HOM,278,1.00	OPA3	3'UTR	OPA3:NM_001017989.2:3'UTR:MODIFIER:exon2/2:c.*708A>G:		rs7259834	0.9888	0.0000	0/0/0	0.8909										221	9					OPA3 (inh=AR pLI=0.00)
chr19	46049982	46049982	A	G	hom		QUAL=853;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,7,1.00,HOM,1,1.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*6790T>C:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-17268T>C:	AluSz	rs10422253	0.7754	0.0000	0/0/0	0.7131						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				125	48					OPA3 (inh=AR pLI=0.00)
chr19	46050760	46050760	T	C	het		QUAL=17543;DP=384;AF=0.52;MQM=59;TRIO=HET,384,0.52,HET,395,0.54,HET,484,0.51	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*6012A>G:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-18046A>G:	L2b	rs11083772	0.6380	0.0000	0/0/0	0.6388						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				72	70					OPA3 (inh=AR pLI=0.00)
chr19	46051915	46051915	T	A	het		QUAL=2467;DP=135;AF=0.44;MQM=59;TRIO=HET,135,0.44,HOM,46,0.96,WT,60,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4857A>T:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19201A>T:	(T)n	rs4803833	0.7610	0.0000	0/0/0	0.3638						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				55	105					OPA3 (inh=AR pLI=0.00)
chr19	46051920	46051922	TTT	-	het		QUAL=1189;DP=101;AF=0.44;MQM=59;TRIO=HET,101,0.44,HOM,33,0.88,WT,37,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4850_*4852delAAA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19208_143-19206delAAA:	(T)n	rs761676585	0.7610	0.0000	0/0/0	0.4274						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				70	82					OPA3 (inh=AR pLI=0.00)
chr19	46052454	46052454	A	G	het		QUAL=18559;DP=392;AF=0.56;MQM=60;TRIO=HET,392,0.56,HOM,389,1.00,WT,530,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4318T>C:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19740T>C:		rs4802261	0.7584	0.0000	0/0/0	0.7016						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				89	110					OPA3 (inh=AR pLI=0.00)
chr19	46052621	46052625	CAGGG	-	het		QUAL=11254;DP=178;AF=0.53;MQM=59;TRIO=HET,178,0.53,HOM,335,0.99,WT,403,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4147_*4151delCCCTG:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19911_143-19907delCCCTG:		rs774875450	0.7584	0.0000	0/0/0	0.6262						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				89	110					OPA3 (inh=AR pLI=0.00)
chr19	46052898	46052898	C	T	het		QUAL=4822;DP=191;AF=0.52;MQM=55;TRIO=HET,191,0.52,HET,187,0.48,WT,213,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3874G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20184G>A:	AluSz6	rs62109650	0.1546	0.0000	0/0/0	0.2137						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				14	72					OPA3 (inh=AR pLI=0.00)
chr19	46053385	46053385	C	T	het		QUAL=1792;DP=96;AF=0.50;MQM=59;TRIO=HET,96,0.50,HOM,18,1.00,WT,21,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3387G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20671G>A:	AluSx1	rs3760844	0.7602	0.0000	0/0/0	0.6370						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				89	102					OPA3 (inh=AR pLI=0.00)
chr19	46053655	46053655	-	GCT	het		QUAL=10780;DP=277;AF=0.43;MQM=59;TRIO=HET,277,0.43,HOM,268,1.00,WT,336,0.01	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3114_*3116dupAGC:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20944_143-20942dupAGC:		rs10650481;rs542311224	0.7574	0.0000	0/0/0	0.4477						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				89	110					OPA3 (inh=AR pLI=0.00)
chr19	46054822	46054822	C	T	het		QUAL=16321;DP=477;AF=0.46;MQM=59;TRIO=HET,477,0.46,HOM,374,0.99,WT,424,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*1950G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-22108G>A:	MLT1B	rs4404183	0.7568	0.0000	0/0/0	0.6967						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				78	75					OPA3 (inh=AR pLI=0.00)
chr19	46055477	46055477	-	T	het		QUAL=1647;DP=179;AF=0.44;MQM=60;TRIO=HET,179,0.44,HET,46,0.33,WT,74,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*1294dupA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-22764dupA:		rs74313320	0.3183	0.0000	0/0/0	0.3478						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				32	104					OPA3 (inh=AR pLI=0.00)
chr19	46055786	46055786	T	-	hom		QUAL=1174;DP=53;AF=0.57;MQM=59;TRIO=HOM,53,0.57,HOM,52,0.77,WT,52,0.31	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*986delA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-23072delA:	AluSg4	rs377547137	0.6052	0.0000	0/0/0	0.1758						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				4	123					OPA3 (inh=AR pLI=0.00)
chr19	46056620	46056620	C	T	het		QUAL=13551;DP=228;AF=0.49;MQM=59;TRIO=HET,228,0.49,HOM,356,1.00,WT,380,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*152G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-23906G>A:		rs3826861	0.7107	0.0000	0/0/0	0.6736						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				90	109					OPA3 (inh=AR pLI=0.00)
chr19	46057081	46057081	A	G	het		QUAL=5140;DP=135;AF=0.52;MQM=60;TRIO=HET,135,0.52,HOM,113,1.00,WT,162,0.00	OPA3	synonymous,intron	OPA3:NM_025136.3:synonymous:LOW:exon2/2:c.231T>C:p.Ala77Ala,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-24367T>C:		rs3826860	0.7670	0.7020	29591/13637/2757	0.6871						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];	RCV000020908.1 [benign]; RCV000082252.7 [other]; RCV000132683.1 [likely benign]; 		COSM439792	1119	1250	1	[1] old entry - no details available			OPA3 (inh=AR pLI=0.00)
chr19	47258674	47258674	C	T	het	low_DP	QUAL=158;DP=18;AF=0.50;MQM=60;TRIO=HET,18,0.50,WT,8,0.00,HET,9,0.33	FKRP	5'UTR	FKRP:NM_001039885.2:5'UTR:MODIFIER:exon4/4:c.-34C>T:,FKRP:NM_024301.4:5'UTR:MODIFIER:exon4/4:c.-34C>T:		rs3201779	0.1038	0.1750	1810/1393/16	0.1663							RCV000082170.5 [benign]; 			13	66					FKRP (inh=AR pLI=0.00)
chr19	50411012	50411012	C	T	het		QUAL=4872;DP=185;AF=0.57;MQM=53;TRIO=HET,185,0.57,WT,128,0.00,HET,170,0.54	NUP62,IL4I1	3'UTR,intron	NUP62:NM_001193357.1:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_012346.4:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_153718.3:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_153719.3:3'UTR:MODIFIER:exon3/3:c.*484G>A:,NUP62:NM_016553.4:3'UTR:MODIFIER:exon3/3:c.*484G>A:,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-3434G>A:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-3434G>A:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-3434G>A:,IL4I1:NR_047577.1:intron:MODIFIER:exon2/10:n.337-3434G>A:	AluSz	rs1127729	0.0677	0.0000	0/0/0	0.0858										7	54					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	50411742	50411742	A	G	het		QUAL=29880;DP=294;AF=0.51;MQM=59;TRIO=HET,294,0.51,HET,483,0.51,HOM,640,1.00	NUP62,IL4I1	synonymous,intron	NUP62:NM_001193357.1:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_012346.4:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_153718.3:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_153719.3:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,NUP62:NM_016553.4:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-4164T>C:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-4164T>C:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-4164T>C:,IL4I1:NR_047577.1:intron:MODIFIER:exon2/10:n.337-4164T>C:		rs892028	0.9740	0.9440	54164/28535/5072	0.9210						605815 [NUP62 (confirmed) Striatonigral degeneration,infantile];	RCV000117863.2 [likely benign]; 			979	120					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	50412417	50412417	G	A	het		QUAL=5682;DP=64;AF=0.47;MQM=60;TRIO=HET,64,0.47,WT,147,0.00,HOM,167,1.00	NUP62,IL4I1	synonymous,intron	NUP62:NM_001193357.1:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_012346.4:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_153718.3:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_153719.3:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,NUP62:NM_016553.4:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-4839C>T:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-4839C>T:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-4839C>T:,IL4I1:NR_047577.1:intron:MODIFIER:exon2/10:n.337-4839C>T:		rs999583	0.8604	0.7920	38333/18884/4313	0.7831						605815 [NUP62 (confirmed) Striatonigral degeneration,infantile];	RCV000117865.2 [likely benign]; 		COSM3757052	680	345					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	51850290	51850290	G	A	het	phylop_high;pred_pathogenic_2	QUAL=5301;DP=80;AF=0.59;MQM=60;TRIO=HET,80,0.59,HOM,90,1.00,HET,133,0.47	ETFB	missense	ETFB:NM_001014763.1:missense:MODERATE:exon4/5:c.734C>T:p.Thr245Met,ETFB:NM_001985.2:missense:MODERATE:exon5/6:c.461C>T:p.Thr154Met		rs1130426	0.4197	0.4890	15226/10649/1277	0.4881	3.6820	T	D,D	D,D	P,P	130410 [ETFB (confirmed) Glutaric acidemia IIB];	RCV000079961.4 [benign]; 		COSM3721676, COSM3721677	490	713					ETFB (inh=AR pLI=0.00)
chr19	54385820	54385820	C	T	hom		QUAL=5629;DP=43;AF=1.00;MQM=59;TRIO=HOM,43,1.00,HOM,64,1.00,HOM,89,1.00	PRKCG	synonymous	PRKCG:NM_001316329.1:synonymous:LOW:exon1/19:c.72C>T:p.Ala24Ala,PRKCG:NM_002739.4:synonymous:LOW:exon1/18:c.72C>T:p.Ala24Ala		rs2547362	0.8964	0.9460	54518/30486/2768	0.9210						176980 [PRKCG (confirmed) Spinocerebellar ataxia 14];	RCV000118063.2 [likely benign]; 			1976	129	2	[2] Julia Bickmann 18.09.2014	n/a (2xTP, 0xFP)		PRKCG (inh=AD pLI=1.00)
chr19	54394965	54394965	T	C	het		QUAL=9523;DP=175;AF=0.50;MQM=60;TRIO=HET,175,0.50,HET,253,0.45,HET,359,0.50	PRKCG	synonymous	PRKCG:NM_001316329.1:synonymous:LOW:exon6/19:c.567T>C:p.Asn189Asn,PRKCG:NM_002739.4:synonymous:LOW:exon6/18:c.567T>C:p.Asn189Asn		rs3745406	0.3295	0.3980	9824/5601/233	0.3927						176980 [PRKCG (confirmed) Spinocerebellar ataxia 14];	RCV000118062.2 [likely benign]; 		COSM148736	389	1073	2	[2] Julia Bickmann 18.09.2014	n/a (1xTP, 0xFP)		PRKCG (inh=AD pLI=1.00)
chr19	54695163	54695163	T	C	het	low_DP	QUAL=185;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,2,0.00,HOM,7,1.00	TSEN34	5'UTR,intron	TSEN34:NM_001077446.3:5'UTR:MODIFIER:exon1/4:c.-53T>C:,TSEN34:NM_001282333.1:intron:MODIFIER:exon1/5:c.6-49T>C:,TSEN34:NM_024075.4:intron:MODIFIER:exon1/4:c.-4-49T>C:,TSEN34:NM_001282332.1:intron:MODIFIER:exon1/4:c.-4-49T>C:		rs593073	0.7418	0.6050	4870/1825/381	0.3350										163	71					TSEN34 (inh=n/a pLI=0.40)
chr19	54697079	54697079	C	T	het		QUAL=17624;DP=179;AF=0.50;MQM=60;TRIO=HET,179,0.50,HET,268,0.56,HOM,360,1.00	TSEN34	synonymous	TSEN34:NM_001282333.1:synonymous:LOW:exon5/6:c.804C>T:p.Pro268Pro,TSEN34:NM_024075.4:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:NM_001282332.1:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:NM_001077446.3:synonymous:LOW:exon4/4:c.795C>T:p.Pro265Pro		rs7595	0.7482	0.7720	36753/22253/3502	0.7517						608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C];	RCV000147766.1 [benign]; 			1411	736					TSEN34 (inh=n/a pLI=0.40)
chr19	54697602	54697602	G	A	het		QUAL=4750;DP=128;AF=0.61;MQM=59;TRIO=HET,128,0.61,HET,40,0.68,HOM,62,1.00	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*76G>A:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*385G>A:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*385G>A:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*385G>A:	MIRb	rs36622	0.7482	0.0000	0/0/0	0.7088										280	136					TSEN34 (inh=n/a pLI=0.40)
chr19	54697714	54697714	C	T	het		QUAL=6082;DP=184;AF=0.51;MQM=60;TRIO=HET,184,0.51,HET,65,0.62,HOM,77,1.00	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*188C>T:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*497C>T:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*497C>T:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*497C>T:	MIRb	rs36621	0.7488	0.0000	0/0/0	0.7528										266	124					TSEN34 (inh=n/a pLI=0.40)
chr19	54698196	54698198	GGA	-	het		QUAL=9669;DP=296;AF=0.58;MQM=60;TRIO=HET,296,0.58,HET,115,0.52,HOM,165,1.00	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*671_*673delGAG:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*980_*982delGAG:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*980_*982delGAG:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*980_*982delGAG:		rs146122151	0.0000	0.0000	0/0/0	0.3139										73	132					TSEN34 (inh=n/a pLI=0.40)
chr19	55644325	55644325	A	C	hom	low_DP	QUAL=250;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,1,1.00,WT,165,1.00	TNNT1	synonymous	TNNT1:NM_003283.5:synonymous:LOW:exon14/14:c.795T>G:p.Arg265Arg,TNNT1:NM_001126132.2:synonymous:LOW:exon14/14:c.747T>G:p.Arg249Arg,TNNT1:NM_001126133.2:synonymous:LOW:exon13/13:c.714T>G:p.Arg238Arg,TNNT1:NM_001291774.1:synonymous:LOW:exon14/14:c.714T>G:p.Arg238Arg		rs890868	0.9804	0.9870	48080/27722/4166	0.9379						191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type];	RCV000024552.1 [not provided]; RCV000154008.3 [benign]; 			999	1					TNNT1 (inh=n/a pLI=0.00)
chr19	55658387	55658387	T	C	het	phylop_high;pred_pathogenic_1	QUAL=900;DP=20;AF=0.55;MQM=59;TRIO=HET,20,0.55,WT,54,0.00,HET,64,0.45	TNNT1	missense&splice_region	TNNT1:NM_003283.5:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:NM_001126132.2:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:NM_001126133.2:missense&splice_region:MODERATE:exon3/13:c.35A>G:p.Glu12Gly,TNNT1:NM_001291774.1:missense&splice_region:MODERATE:exon4/14:c.35A>G:p.Glu12Gly		rs112562759	0.0359	0.0700	348/282/1	0.0681	2.0130	T	D,T,D,D	B,B,B,B	B,B,B,B	191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type];	RCV000024560.1 [not provided]; RCV000080082.6 [benign]; 			17	163					TNNT1 (inh=n/a pLI=0.00)
chr19	55660537	55660537	T	C	hom		QUAL=17327;DP=142;AF=1.00;MQM=59;TRIO=HOM,142,1.00,HOM,178,1.00,HOM,234,1.00	TNNT1	5'UTR	TNNT1:NM_003283.5:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:NM_001126132.2:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:NM_001126133.2:5'UTR:MODIFIER:exon1/13:c.-20A>G:,TNNT1:NM_001291774.1:5'UTR:MODIFIER:exon1/14:c.-115A>G:		rs9636153	0.8101	0.7850	3817/1005/70	0.2328	-0.9490	T	T				RCV000024550.1 [not provided]; 			479	137					TNNT1 (inh=n/a pLI=0.00)
chr20	3214819	3214819	T	G	het		QUAL=8624;DP=189;AF=0.45;MQM=60;TRIO=HET,189,0.45,WT,405,0.00,HET,523,0.50	SLC4A11	synonymous,non_coding_exon	SLC4A11:NM_001174090.1:synonymous:LOW:exon5/20:c.562A>C:p.Arg188Arg,SLC4A11:NM_032034.3:synonymous:LOW:exon4/19:c.481A>C:p.Arg161Arg,SLC4A11:NM_001174089.1:synonymous:LOW:exon5/20:c.433A>C:p.Arg145Arg,SLC4A11:NR_135000.1:non_coding_exon:MODIFIER:exon5/20:n.601A>C:		rs3827075	0.4798	0.4360	12113/5554/2180	0.4320						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];				161	531					SLC4A11 (inh=n/a pLI=0.00)
chr20	3215548	3215548	C	A	het		QUAL=7604;DP=350;AF=0.47;MQM=59;TRIO=HET,350,0.47,WT,235,0.00,HET,338,0.57	SLC4A11	splice_region&intron	SLC4A11:NM_001174090.1:splice_region&intron:LOW:exon2/19:c.218-8G>T:,SLC4A11:NM_032034.3:splice_region&intron:LOW:exon1/18:c.137-8G>T:,SLC4A11:NR_135000.1:splice_region&intron:LOW:exon2/19:n.257-8G>T:,SLC4A11:NM_001174089.1:splice_region&intron:LOW:exon2/19:c.89-8G>T:		rs3803957	0.2724	0.2990	5646/2851/232	0.2930						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];			COSM4001879, COSM4001880	76	445					SLC4A11 (inh=n/a pLI=0.00)
chr20	3218355	3218355	C	G	het		QUAL=5535;DP=147;AF=0.51;MQM=59;TRIO=HET,147,0.51,WT,207,0.00,HET,305,0.49	SLC4A11	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC4A11:NM_032034.3:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-30G>C:,SLC4A11:NM_032034.3:5'UTR:MODIFIER:exon1/19:c.-30G>C:,SLC4A11:NM_001174090.1:intron:MODIFIER:exon1/19:c.173-121G>C:,SLC4A11:NR_135000.1:intron:MODIFIER:exon1/19:n.212-121G>C:,SLC4A11:NM_001174089.1:intron:MODIFIER:exon1/19:c.44-121G>C:		rs3827076	0.4503	0.4110	10717/4934/1649	0.4017						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];				31	100					SLC4A11 (inh=n/a pLI=0.00)
chr20	3218634	3218634	G	C	het		QUAL=3772;DP=116;AF=0.51;MQM=59;TRIO=HET,116,0.51,WT,107,0.00,HET,187,0.50	SLC4A11	missense,intron	SLC4A11:NM_001174090.1:missense:MODERATE:exon1/20:c.77C>G:p.Pro26Arg,SLC4A11:NR_135000.1:intron:MODIFIER:exon1/19:n.212-400C>G:,SLC4A11:NM_001174089.1:intron:MODIFIER:exon1/19:c.44-400C>G:		rs3810562	0.6416	0.4960	2540/825/282	0.1850	-0.8580	T	T	B	B	610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];			COSM330384	310	481					SLC4A11 (inh=n/a pLI=0.00)
chr20	3870124	3870124	G	C	hom	low_DP	QUAL=454;DP=2;AF=1.00;MQM=59;TRIO=HOM,2,1.00,HOM,11,1.00,HOM,4,1.00	PANK2	missense,intron	PANK2:NM_153638.2:missense:MODERATE:exon1/7:c.377G>C:p.Gly126Ala,PANK2:NM_024960.4:intron:MODIFIER:exon1/6:c.-246+573G>C:		rs3737084	0.8792	0.8370	10763/6307/798	0.6936	1.0190	T	T	B	B	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1|HARP syndrome];	RCV000082679.4 [benign]; 		COSM4134538	1262	340					PANK2 (inh=AR pLI=0.01)
chr20	3891347	3891347	T	G	het	pred_pathogenic_1	QUAL=8779;DP=358;AF=0.45;MQM=60;TRIO=HET,358,0.45,WT,257,0.00,HET,341,0.49	PANK2	missense	PANK2:NM_153638.2:missense:MODERATE:exon3/7:c.1105T>G:p.Ser369Ala,PANK2:NM_024960.4:missense:MODERATE:exon3/7:c.232T>G:p.Ser78Ala,PANK2:NM_153640.2:missense:MODERATE:exon3/7:c.232T>G:p.Ser78Ala			0.0000	0.0000	0/0/0	0.0000	0.9130	D	T,T,T	B	B	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1|HARP syndrome];				0	1	3	[3] Stephan Waldm?ller 13.08.2014			PANK2 (inh=AR pLI=0.01)
chr20	10618574	10618574	T	C	het		QUAL=6102;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,96,1.00,WT,117,0.01	JAG1	3'UTR	JAG1:NM_000214.2:3'UTR:MODIFIER:exon26/26:c.*1572A>G:		rs8708	0.4742	0.0000	0/0/0	0.0867										76	107					JAG1 (inh=AD pLI=1.00)
chr20	10620386	10620386	A	G	het		QUAL=7947;DP=264;AF=0.50;MQM=60;TRIO=HET,264,0.50,HOM,141,1.00,WT,182,0.01	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon26/26:c.3417T>C:p.Tyr1139Tyr		rs1051419	0.7127	0.6590	27182/13748/4203	0.6490						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000150844.2 [benign]; RCV000125430.2 [benign]; 		COSM149140, COSM3758426	514	519					JAG1 (inh=AD pLI=1.00)
chr20	10633237	10633237	G	A	het	anno_pathogenic_clinvar	QUAL=3252;DP=88;AF=0.64;MQM=59;TRIO=HET,88,0.64,HOM,65,0.98,WT,91,0.00	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon6/26:c.765C>T:p.Tyr255Tyr		rs1131695	0.4233	0.4530	12652/7312/620	0.4460						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000150845.2 [benign]; RCV000132569.1 [likely benign]; RCV000199026.1 [benign]; RCV000214085.1 [pathogenic]; 		COSM3758428, COSM3758427	325	559	1	hohe Frequenz, keine splice site Ver?nderung[1] swoedl 28.06.2016			JAG1 (inh=AD pLI=1.00)
chr20	10653469	10653469	C	T	het		QUAL=6558;DP=247;AF=0.56;MQM=59;TRIO=HET,247,0.56,HET,343,0.46,WT,475,0.00	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon2/26:c.267G>A:p.Gly89Gly		rs1051415	0.0653	0.0930	658/447/8	0.0929						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000035331.3 [benign]; 			14	169					JAG1 (inh=AD pLI=1.00)
chr20	10654563	10654563	A	C	het		QUAL=3157;DP=96;AF=0.43;MQM=59;TRIO=HET,96,0.43,HET,94,0.43,HET,122,0.50	JAG1	5'UTR	JAG1:NM_000214.2:5'UTR:MODIFIER:exon1/26:c.-385T>G:		rs1051412	0.5545	0.0000	0/0/0	0.4532										66	105					JAG1 (inh=AD pLI=1.00)
chr20	13798449	13798470	ACAGTCATCAGTTTATTGTTAA	-	hom		QUAL=8851;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HET,117,0.59,HET,124,0.57	NDUFAF5	3'UTR,non_coding_exon	NDUFAF5:NM_024120.4:3'UTR:MODIFIER:exon11/11:c.*593_*614delACAGTCATCAGTTTATTGTTAA:,NDUFAF5:NM_001039375.2:3'UTR:MODIFIER:exon10/10:c.*593_*614delACAGTCATCAGTTTATTGTTAA:,NDUFAF5:NR_029377.1:non_coding_exon:MODIFIER:exon12/12:n.1772_1793delACAGTCATCAGTTTATTGTTAA:		rs35624053	0.2426	0.2720	632/254/5	0.0466										40	104					NDUFAF5 (inh=AR pLI=0.00)
chr20	13798776	13798776	T	C	hom		QUAL=24056;DP=229;AF=1.00;MQM=59;TRIO=HOM,229,1.00,HOM,256,1.00,HOM,269,1.00	NDUFAF5	3'UTR,non_coding_exon	NDUFAF5:NM_024120.4:3'UTR:MODIFIER:exon11/11:c.*920T>C:,NDUFAF5:NM_001039375.2:3'UTR:MODIFIER:exon10/10:c.*920T>C:,NDUFAF5:NR_029377.1:non_coding_exon:MODIFIER:exon12/12:n.2099T>C:		rs2423752	0.8872	0.8560	4016/1283/93	0.2350										207	24					NDUFAF5 (inh=AR pLI=0.00)
chr20	25281027	25281027	C	T	het		QUAL=4550;DP=142;AF=0.51;MQM=60;TRIO=HET,142,0.51,WT,178,0.00,HET,246,0.48	ABHD12	3'UTR,intron	ABHD12:NM_001042472.2:3'UTR:MODIFIER:exon13/13:c.*454G>A:,ABHD12:NM_015600.4:intron:MODIFIER:exon12/12:c.1157+1828G>A:		rs41309917	0.0194	0.0000	0/0/0	0.0045						613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract];				0	15					ABHD12 (inh=AR pLI=0.00)
chr20	25288632	25288632	G	A	hom		QUAL=10403;DP=164;AF=0.98;MQM=59;TRIO=HOM,164,0.98,HOM,124,1.00,HET,155,0.43	ABHD12	synonymous	ABHD12:NM_015600.4:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg,ABHD12:NM_001042472.2:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg		rs6107027	0.3361	0.4690	14984/9197/355	0.4603						613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract];	RCV000116215.2 [likely benign]; 		COSM4134339, COSM4134340	787	1309					ABHD12 (inh=AR pLI=0.00)
chr20	31022959	31022959	T	C	hom		QUAL=35809;DP=389;AF=1.00;MQM=59;TRIO=HOM,389,1.00,HOM,300,1.00,HOM,402,1.00	ASXL1	missense	ASXL1:NM_015338.5:missense:MODERATE:exon12/12:c.2444T>C:p.Leu815Pro		rs6058694	1.0000	1.0000	60464/33254/5131	0.9362	-0.1360	T	T,T,T,T,T	B,B	B,B	612990 [ASXL1 (provisional) Bohring-Opitz syndrome|Myelodysplastic syndrome,somatic];	RCV000120112.1 [not provided]; 			1133	0					ASXL1 (inh=AD pLI=0.00)
chr20	31024274	31024274	T	C	hom		QUAL=14470;DP=317;AF=0.99;MQM=59;TRIO=HOM,317,0.99,HOM,84,0.99,HET,123,0.50	ASXL1	synonymous	ASXL1:NM_015338.5:synonymous:LOW:exon12/12:c.3759T>C:p.Ser1253Ser		rs4911231	0.4058	0.4180	11590/5178/192	0.4130						612990 [ASXL1 (provisional) Bohring-Opitz syndrome|Myelodysplastic syndrome,somatic];			COSM4134436, COSM4134435	160	513					ASXL1 (inh=AD pLI=0.00)
chr20	31025163	31025163	A	G	hom		QUAL=36544;DP=394;AF=1.00;MQM=60;TRIO=HOM,394,1.00,HOM,499,0.99,HET,534,0.54	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*22A>G:		rs2295764	0.4000	0.4060	11069/4730/184	0.4009										67	225					ASXL1 (inh=AD pLI=0.00)
chr20	31025231	31025231	T	C	hom		QUAL=30497;DP=356;AF=0.99;MQM=60;TRIO=HOM,356,0.99,HOM,391,0.99,HET,441,0.56	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*90T>C:		rs2295763	0.3998	0.0000	0/0/0	0.0793										28	107					ASXL1 (inh=AD pLI=0.00)
chr20	31025535	31025535	A	G	hom		QUAL=22744;DP=368;AF=1.00;MQM=59;TRIO=HOM,368,1.00,HOM,232,1.00,HET,274,0.53	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*394A>G:		rs2295762	0.4289	0.0000	0/0/0	0.4125										28	107					ASXL1 (inh=AD pLI=0.00)
chr20	31386347	31386347	T	C	hom		QUAL=6729;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,42,1.00,HET,72,0.46	DNMT3B	synonymous	DNMT3B:NM_006892.3:synonymous:LOW:exon15/23:c.1572T>C:p.Cys524Cys,DNMT3B:NM_001207055.1:synonymous:LOW:exon13/19:c.1386T>C:p.Cys462Cys,DNMT3B:NM_001207056.1:synonymous:LOW:exon12/18:c.1284T>C:p.Cys428Cys,DNMT3B:NM_175848.1:synonymous:LOW:exon14/22:c.1512T>C:p.Cys504Cys,DNMT3B:NM_175849.1:synonymous:LOW:exon14/20:c.1512T>C:p.Cys504Cys,DNMT3B:NM_175850.2:synonymous:LOW:exon14/22:c.1548T>C:p.Cys516Cys		rs6058891	0.7558	0.5790	22601/6622/3879	0.5595						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];			COSM4134441, COSM4134442	245	531					DNMT3B (inh=AR pLI=1.00)
chr20	31386449	31386449	T	C	hom		QUAL=1172;DP=26;AF=1.00;MQM=59;TRIO=HOM,26,1.00,HOM,11,1.00,HET,20,0.45	DNMT3B	splice_region&synonymous	DNMT3B:NM_006892.3:splice_region&synonymous:LOW:exon15/23:c.1674T>C:p.Tyr558Tyr,DNMT3B:NM_001207055.1:splice_region&synonymous:LOW:exon13/19:c.1488T>C:p.Tyr496Tyr,DNMT3B:NM_001207056.1:splice_region&synonymous:LOW:exon12/18:c.1386T>C:p.Tyr462Tyr,DNMT3B:NM_175848.1:splice_region&synonymous:LOW:exon14/22:c.1614T>C:p.Tyr538Tyr,DNMT3B:NM_175849.1:splice_region&synonymous:LOW:exon14/20:c.1614T>C:p.Tyr538Tyr,DNMT3B:NM_175850.2:splice_region&synonymous:LOW:exon14/22:c.1650T>C:p.Tyr550Tyr		rs2424922	0.7558	0.5770	22012/6451/3616	0.5545						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];			COSM4134443, COSM4134444	239	531					DNMT3B (inh=AR pLI=1.00)
chr20	31387954	31387954	C	G	hom		QUAL=18395;DP=173;AF=0.99;MQM=59;TRIO=HOM,173,0.99,HOM,274,1.00,HET,352,0.51	DNMT3B	splice_region&intron	DNMT3B:NM_006892.3:splice_region&intron:LOW:exon16/22:c.1760-5C>G:,DNMT3B:NM_001207055.1:splice_region&intron:LOW:exon14/18:c.1574-5C>G:,DNMT3B:NM_001207056.1:splice_region&intron:LOW:exon13/17:c.1472-5C>G:,DNMT3B:NM_175848.1:splice_region&intron:LOW:exon15/21:c.1700-5C>G:,DNMT3B:NM_175849.1:splice_region&intron:LOW:exon15/19:c.1700-5C>G:,DNMT3B:NM_175850.2:splice_region&intron:LOW:exon15/21:c.1736-5C>G:		rs1997797	0.7141	0.5660	21416/6619/2755	0.5434						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];				234	539					DNMT3B (inh=AR pLI=1.00)
chr20	31388636	31388636	T	C	hom		QUAL=18738;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HOM,252,1.00,HET,348,0.50	DNMT3B	splice_region&intron	DNMT3B:NM_006892.3:splice_region&intron:LOW:exon17/22:c.1906-5T>C:,DNMT3B:NM_001207055.1:splice_region&intron:LOW:exon15/18:c.1720-5T>C:,DNMT3B:NM_001207056.1:splice_region&intron:LOW:exon14/17:c.1618-5T>C:,DNMT3B:NM_175848.1:splice_region&intron:LOW:exon16/21:c.1846-5T>C:,DNMT3B:NM_175849.1:splice_region&intron:LOW:exon16/19:c.1846-5T>C:,DNMT3B:NM_175850.2:splice_region&intron:LOW:exon16/21:c.1882-5T>C:	(CTCTCT)n	rs2424928	0.7426	0.5740	22080/6633/3366	0.5429						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];				245	531					DNMT3B (inh=AR pLI=1.00)
chr20	31396536	31396536	A	G	hom		QUAL=25677;DP=524;AF=1.00;MQM=59;TRIO=HOM,524,1.00,HOM,201,1.00,HET,242,0.47	DNMT3B	3'UTR	DNMT3B:NM_006892.3:3'UTR:MODIFIER:exon23/23:c.*827A>G:,DNMT3B:NM_001207055.1:3'UTR:MODIFIER:exon19/19:c.*827A>G:,DNMT3B:NM_001207056.1:3'UTR:MODIFIER:exon18/18:c.*827A>G:,DNMT3B:NM_175848.1:3'UTR:MODIFIER:exon22/22:c.*827A>G:,DNMT3B:NM_175849.1:3'UTR:MODIFIER:exon20/20:c.*827A>G:,DNMT3B:NM_175850.2:3'UTR:MODIFIER:exon22/22:c.*827A>G:		rs2424932	0.8047	0.0000	0/0/0	0.1191										87	105					DNMT3B (inh=AR pLI=1.00)
chr20	31397020	31397020	T	-	hom		QUAL=9076;DP=197;AF=1.00;MQM=53;TRIO=HOM,197,1.00,HOM,75,1.00,HET,84,0.49	DNMT3B	3'UTR	DNMT3B:NM_006892.3:3'UTR:MODIFIER:exon23/23:c.*1318delT:,DNMT3B:NM_001207055.1:3'UTR:MODIFIER:exon19/19:c.*1318delT:,DNMT3B:NM_001207056.1:3'UTR:MODIFIER:exon18/18:c.*1318delT:,DNMT3B:NM_175848.1:3'UTR:MODIFIER:exon22/22:c.*1318delT:,DNMT3B:NM_175849.1:3'UTR:MODIFIER:exon20/20:c.*1318delT:,DNMT3B:NM_175850.2:3'UTR:MODIFIER:exon22/22:c.*1318delT:		rs398088406	0.7093	0.0000	0/0/0	0.4773										47	110					DNMT3B (inh=AR pLI=1.00)
chr20	43034693	43034693	C	T	het		QUAL=1853;DP=90;AF=0.47;MQM=60;TRIO=HET,90,0.47,WT,89,0.00,HET,107,0.49	HNF4A	splice_region&intron	HNF4A:NM_000457.4:splice_region&intron:LOW:exon1/9:c.116-5C>T:,HNF4A:NM_001030004.2:splice_region&intron:LOW:exon1/7:c.50-5C>T:,HNF4A:NM_001287184.1:splice_region&intron:LOW:exon2/8:c.41-5C>T:,HNF4A:NM_001030003.2:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:NM_001287182.1:splice_region&intron:LOW:exon2/10:c.41-5C>T:,HNF4A:NM_001287183.1:splice_region&intron:LOW:exon2/10:c.41-5C>T:,HNF4A:NM_175914.4:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:NM_178850.2:splice_region&intron:LOW:exon1/7:c.116-5C>T:,HNF4A:NM_001258355.1:splice_region&intron:LOW:exon2/10:c.95-5C>T:,HNF4A:NM_178849.2:splice_region&intron:LOW:exon1/9:c.116-5C>T:		rs745975	0.1687	0.2000	2690/1802/55	0.1967						600281 [HNF4A (confirmed) MODY,type I|Diabetes mellitus,noninsulin-dependent|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young];	RCV000117237.2 [likely benign]; 	CS004500 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=HNF4A]; 		54	324					HNF4A (inh=n/a pLI=0.92)
chr20	43034783	43034783	C	T	het		QUAL=4710;DP=195;AF=0.51;MQM=59;TRIO=HET,195,0.51,WT,170,0.00,HET,206,0.49	HNF4A	synonymous	HNF4A:NM_000457.4:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala,HNF4A:NM_001030004.2:synonymous:LOW:exon2/8:c.135C>T:p.Ala45Ala,HNF4A:NM_001287184.1:synonymous:LOW:exon3/9:c.126C>T:p.Ala42Ala,HNF4A:NM_001030003.2:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:NM_001287182.1:synonymous:LOW:exon3/11:c.126C>T:p.Ala42Ala,HNF4A:NM_001287183.1:synonymous:LOW:exon3/11:c.126C>T:p.Ala42Ala,HNF4A:NM_175914.4:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:NM_178850.2:synonymous:LOW:exon2/8:c.201C>T:p.Ala67Ala,HNF4A:NM_001258355.1:synonymous:LOW:exon3/11:c.180C>T:p.Ala60Ala,HNF4A:NM_178849.2:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala		rs736823	0.0146	0.0330	115/101/2	0.0342						600281 [HNF4A (confirmed) MODY,type I|Diabetes mellitus,noninsulin-dependent|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young];	RCV000117236.2 [benign]; 			4	47					HNF4A (inh=n/a pLI=0.92)
chr20	43059211	43059211	A	C	het		QUAL=24190;DP=447;AF=0.49;MQM=59;TRIO=HET,447,0.49,HOM,360,1.00,HET,487,0.52	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*906A>C:	L2d2	rs3212210	0.5713	0.0000	0/0/0	0.5503										111	99					HNF4A (inh=n/a pLI=0.92)
chr20	43059238	43059256	GAGGAAGAATGGTGTGGGA	-	het		QUAL=11965;DP=290;AF=0.59;MQM=59;TRIO=HET,290,0.59,HOM,332,0.99,WT,391,0.00	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:	L2d2	rs72137187	0.1881	0.0000	0/0/0	0.1283										8	64					HNF4A (inh=n/a pLI=0.92)
chr20	43059596	43059603	TCCTCCCT	-	het		QUAL=5107;DP=170;AF=0.49;MQM=59;TRIO=HET,170,0.49,WT,218,0.00,HET,327,0.54	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:	MIRb:MIR	rs868132750	0.0517	0.0000	0/0/0	0.0639										0	27					HNF4A (inh=n/a pLI=0.92)
chr20	43264927	43264927	C	T	hom		QUAL=16063;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,125,1.00,HOM,149,1.00	ADA	splice_region&synonymous	ADA:NM_000022.2:splice_region&synonymous:LOW:exon2/12:c.36G>A:p.Val12Val		rs394105	0.9822	0.9950	53996/30140/4118	0.9400						608958 [ADA (confirmed) Severe combined immunodeficiency due to ADA deficiency|Adenosine deaminase deficiency,partial];	RCV000029300.1 [benign]; 			1104	2					ADA (inh=n/a pLI=0.00)
chr20	44519643	44519643	G	A	het		QUAL=4131;DP=55;AF=0.49;MQM=60;TRIO=HET,55,0.49,HET,69,0.41,HOM,97,1.00	NEURL2,CTSA	5'UTR,non_coding_exon	NEURL2:NM_080749.3:5'UTR:MODIFIER:exon1/2:c.-13C>T:,CTSA:NM_000308.3:5'UTR:MODIFIER:exon1/15:c.-322G>A:,NEURL2:NM_001278535.1:5'UTR:MODIFIER:exon1/2:c.-13C>T:,CTSA:NM_001127695.2:5'UTR:MODIFIER:exon1/15:c.-422G>A:,CTSA:NM_001167594.2:5'UTR:MODIFIER:exon1/14:c.-322G>A:,CTSA:NR_133656.1:non_coding_exon:MODIFIER:exon1/15:n.861G>A:		rs2868362	0.3842	0.4040	2477/1828/34	0.3506										112	200					NEURL2 (inh=n/a pLI=0.00), CTSA (inh=AR pLI=0.00)
chr20	44520238	44520240	CTG	-	hom	anno_pathogenic_hgmd	QUAL=2584;DP=22;AF=0.50;MQM=60;TRIO=HOM,22,0.50,HET,69,0.55,HOM,63,0.98	CTSA	disruptive_inframe_deletion,non_coding_exon	CTSA:NM_000308.3:disruptive_inframe_deletion:MODERATE:exon2/15:c.108_110delGCT:p.Leu37del,CTSA:NM_001127695.2:disruptive_inframe_deletion:MODERATE:exon2/15:c.54_56delGCT:p.Leu19del,CTSA:NM_001167594.2:disruptive_inframe_deletion:MODERATE:exon2/14:c.108_110delGCT:p.Leu37del,CTSA:NR_133656.1:non_coding_exon:MODIFIER:exon2/15:n.1290_1292delGCT:	(CTG)n	rs3080212;rs397784956	0.6494	0.6100	19878/10192/1647	0.5456						613111 [CTSA (confirmed) Galactosialidosis];	RCV000175578.1 [benign]; 	CD1413773 [CLASS=DM? MUT=ALT PHEN="Galactosialidosis" GENE=CTSA]; 	COSM443915	450	471	2	[2] Ute Grasshoff 28.10.2015			CTSA (inh=AR pLI=0.00)
chr20	44523547	44523547	G	A	het		QUAL=24393;DP=217;AF=0.49;MQM=59;TRIO=HET,217,0.49,HET,449,0.49,HOM,508,1.00	CTSA	splice_region&intron	CTSA:NM_000308.3:splice_region&intron:LOW:exon10/14:c.1002+7G>A:,CTSA:NM_001127695.2:splice_region&intron:LOW:exon10/14:c.948+7G>A:,CTSA:NM_001167594.2:splice_region&intron:LOW:exon9/13:c.951+7G>A:,CTSA:NR_133656.1:splice_region&intron:LOW:exon10/14:n.2191+7G>A:		rs2075961	0.6783	0.6600	26737/13039/2302	0.6485						613111 [CTSA (confirmed) Galactosialidosis];				454	512					CTSA (inh=AR pLI=0.00)
chr20	44523782	44523782	C	T	het		QUAL=13927;DP=91;AF=0.46;MQM=60;TRIO=HET,91,0.46,HET,266,0.50,HOM,318,1.00	CTSA	splice_region&intron	CTSA:NM_000308.3:splice_region&intron:LOW:exon11/14:c.1142+10C>T:,CTSA:NM_001127695.2:splice_region&intron:LOW:exon11/14:c.1088+10C>T:,CTSA:NM_001167594.2:splice_region&intron:LOW:exon10/13:c.1091+10C>T:,CTSA:NR_133656.1:splice_region&intron:LOW:exon11/14:n.2331+10C>T:		rs4608591	0.6799	0.6600	26736/13016/2338	0.6537						613111 [CTSA (confirmed) Galactosialidosis];				455	510					CTSA (inh=AR pLI=0.00)
chr20	44746982	44746982	T	C	hom		QUAL=3938;DP=62;AF=1.00;MQM=60;TRIO=HOM,62,1.00,HOM,27,1.00,HOM,38,1.00	CD40	5'UTR,non_coding_exon	CD40:NM_001250.5:5'UTR:MODIFIER:exon1/9:c.-1T>C:,CD40:NM_001302753.1:5'UTR:MODIFIER:exon1/9:c.-1T>C:,CD40:NM_152854.3:5'UTR:MODIFIER:exon1/8:c.-1T>C:,CD40:NR_126502.1:non_coding_exon:MODIFIER:exon1/7:n.90T>C:		rs1883832	0.7712	0.7520	34693/18125/4613	0.7452								CR052074 [CLASS=DFP MUT=REF PHEN="Graves' disease association with" GENE=CD40]; 		588	438					CD40 (inh=n/a pLI=0.66)
chr20	47626847	47626847	T	C	het		QUAL=10589;DP=310;AF=0.48;MQM=59;TRIO=HET,310,0.48,HET,225,0.48,HET,332,0.48	ARFGEF2	synonymous	ARFGEF2:NM_006420.2:synonymous:LOW:exon27/39:c.3663T>C:p.Gly1221Gly		rs2295580	0.3542	0.3190	6571/3519/1513	0.3165						605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly];	RCV000116402.3 [other]; 		COSM1412311	120	478					ARFGEF2 (inh=AR pLI=1.00)
chr20	47651492	47651492	G	A	het		QUAL=13041;DP=359;AF=0.50;MQM=59;TRIO=HET,359,0.50,HET,286,0.51,HET,340,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*1756G>A:		rs6019602	0.3462	0.0000	0/0/0	0.0518										15	98					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652254	47652254	A	G	het		QUAL=6619;DP=171;AF=0.43;MQM=60;TRIO=HET,171,0.43,HET,128,0.59,HET,199,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2518A>G:		rs707533	0.3462	0.0000	0/0/0	0.0519										15	98					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652338	47652338	A	G	het		QUAL=5564;DP=233;AF=0.41;MQM=60;TRIO=HET,233,0.41,HET,87,0.56,HET,126,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2602A>G:		rs707534	0.3462	0.0000	0/0/0	0.0517										15	98					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652530	47652530	-	A	het		QUAL=248;DP=98;AF=0.38;MQM=59;TRIO=HET,98,0.38,HET,42,0.24,HET,48,0.29	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2806dupA:		rs397957165	0.3411	0.0000	0/0/0	0.1853										0	92					ARFGEF2 (inh=AR pLI=1.00)
chr20	49551780	49551780	-	A	het		QUAL=1620;DP=159;AF=0.40;MQM=59;TRIO=HET,159,0.40,WT,45,0.02,HET,63,0.52	DPM1,ADNP-AS1	splice_region&intron,intron	DPM1:NM_001317034.1:splice_region&intron:LOW:exon9/9:c.784-8dupT:,DPM1:NM_001317035.1:splice_region&intron:LOW:exon9/9:c.760-8dupT:,DPM1:NM_001317036.1:splice_region&intron:LOW:exon7/7:c.610-8dupT:,DPM1:NM_003859.2:splice_region&intron:LOW:exon8/8:c.679-8dupT:,DPM1:NR_133648.1:splice_region&intron:LOW:exon8/8:n.742-8dupT:,ADNP-AS1:NR_110007.1:intron:MODIFIER:exon3/3:n.250+1428dupA:,ADNP-AS1:NR_110008.1:intron:MODIFIER:exon2/2:n.149+3806dupA:,ADNP-AS1:NR_110009.1:intron:MODIFIER:exon2/2:n.146+3806dupA:		rs11483542;rs397978438;rs560680352	0.3059	0.3250	2658/1234/630	0.2769						603503 [DPM1 (provisional) Congenital disorder of glycosylation,type Ie];				48	482					DPM1 (inh=n/a pLI=0.54), ADNP-AS1 (inh=n/a pLI=n/a)
chr20	57019491	57019492	AT	-	het		QUAL=6982;DP=347;AF=0.44;MQM=59;TRIO=HET,347,0.44,WT,232,0.00,HET,332,0.45	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*200_*201delAT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*270_*271delAT:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1088_1089delAT:		rs571412501	0.0300	0.0210	9/0/0	0.0010										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019495	57019495	A	T	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*204A>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*274A>T:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1092A>T:			0.0000	0.0000	0/0/0	0.0001										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019496	57019496	T	G	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*205T>G:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*275T>G:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1093T>G:			0.0000	0.0000	0/0/0	0.0001										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019497	57019497	-	GGGG	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*207_*208insGGGG:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*277_*278insGGGG:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1095_1096insGGGG:		rs777453383	0.0000	0.0000	0/0/0	0.0001										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019499	57019499	T	A	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*208T>A:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*278T>A:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1096T>A:		rs577029630	0.0300	0.0000	0/0/0	0.0010										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019502	57019502	-	AT	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*211_*212insAT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*281_*282insAT:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1099_1100insAT:			0.0000	0.0000	0/0/0	0.0000										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019504	57019504	G	A	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*213G>A:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*283G>A:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1101G>A:		rs202245892	0.0000	0.0000	0/0/0	0.0001										4	69					VAPB (inh=AD pLI=0.74)
chr20	57019505	57019505	-	AAG	het		QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*214_*215insAAG:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*284_*285insAAG:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.1102_1103insAAG:			0.0000	0.0000	0/0/0	0.0000										4	69					VAPB (inh=AD pLI=0.74)
chr20	57020741	57020758	TGTGTGTGTGTGTGTGTG	-	het		QUAL=3312;DP=271;AF=0.63;MQM=59;TRIO=HET,271,0.63,HET,143,0.59,WT,173,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*1469_*1486delGTGTGTGTGTGTGTGTGT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*1539_*1556delGTGTGTGTGTGTGTGTGT:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.2357_2374delGTGTGTGTGTGTGTGTGT:	(TG)n	rs138225455	0.0000	0.2220	137/51/10	0.0211										70	109					VAPB (inh=AD pLI=0.74)
chr20	57022713	57022720	TGTGTGCA	-	hom		QUAL=12275;DP=143;AF=0.97;MQM=59;TRIO=HOM,143,0.97,HOM,164,0.99,HOM,158,0.99	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*3444_*3451delCATGTGTG:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*3514_*3521delCATGTGTG:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.4332_4339delCATGTGTG:	(TGTGTGCA)n	rs201983028	0.9091	0.8720	4487/1101/76	0.1964										468	83					VAPB (inh=AD pLI=0.74)
chr20	57023343	57023343	C	T	het		QUAL=7841;DP=425;AF=0.47;MQM=60;TRIO=HET,425,0.47,HET,263,0.43,WT,345,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4052C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4122C>T:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.4940C>T:		rs76295834	0.0210	0.0210	5/2/0	0.0102										2	66					VAPB (inh=AD pLI=0.74)
chr20	57023737	57023737	G	A	het		QUAL=5562;DP=312;AF=0.49;MQM=60;TRIO=HET,312,0.49,HET,116,0.53,WT,164,0.01	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4446G>A:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4516G>A:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.5334G>A:		rs79623348	0.0270	0.0230	6/2/0	0.0107										2	66					VAPB (inh=AD pLI=0.74)
chr20	57024159	57024159	C	T	het		QUAL=3314;DP=170;AF=0.59;MQM=59;TRIO=HET,170,0.59,HET,75,0.44,WT,119,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4868C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4938C>T:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.5756C>T:		rs74748993	0.0212	0.0220	5/2/0	0.0102										2	66					VAPB (inh=AD pLI=0.74)
chr20	57024541	57024541	T	C	het		QUAL=4802;DP=319;AF=0.42;MQM=60;TRIO=HET,319,0.42,HET,154,0.41,WT,171,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*5250T>C:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*5320T>C:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.6138T>C:		rs6015274	0.4832	0.4040	1026/252/26	0.1124										122	287					VAPB (inh=AD pLI=0.74)
chr20	57024589	57024589	C	T	het		QUAL=6082;DP=368;AF=0.45;MQM=60;TRIO=HET,368,0.45,HET,171,0.42,WT,220,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*5298C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*5368C>T:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.6186C>T:		rs6015275	0.2091	0.2210	375/69/3	0.0564										31	214					VAPB (inh=AD pLI=0.74)
chr20	57025407	57025410	TCTG	-	het		QUAL=9433;DP=420;AF=0.55;MQM=59;TRIO=HET,420,0.55,HET,320,0.53,WT,416,0.00	VAPB	3'UTR,non_coding_exon	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*6121_*6124delCTGT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*6191_*6194delCTGT:,VAPB:NR_036633.1:non_coding_exon:MODIFIER:exon4/4:n.7009_7012delCTGT:		rs143261907	0.0214	0.0200	5/2/0	0.0100										2	66					VAPB (inh=AD pLI=0.74)
chr20	57415110	57415110	A	G	hom		QUAL=15038;DP=131;AF=0.99;MQM=59;TRIO=HOM,131,0.99,HOM,240,1.00,HET,294,0.51	GNAS,GNAS-AS1	5'UTR,intron	GNAS:NM_016592.3:5'UTR:MODIFIER:exon1/13:c.-52A>G:,GNAS-AS1:NR_002785.2:intron:MODIFIER:exon4/4:n.819+1882T>C:		rs1800900	0.5976	0.0000	0/0/0	0.1298										92	99					GNAS (inh=AD pLI=1.00), GNAS-AS1 (inh=AD pLI=n/a)
chr20	57478807	57478807	C	T	het		QUAL=32990;DP=596;AF=0.48;MQM=60;TRIO=HET,596,0.48,WT,577,0.00,HOM,796,1.00	GNAS	synonymous,3'UTR	GNAS:NM_080425.3:synonymous:LOW:exon5/13:c.2322C>T:p.Ile774Ile,GNAS:NM_001309861.1:synonymous:LOW:exon5/13:c.216C>T:p.Ile72Ile,GNAS:NM_001309840.1:synonymous:LOW:exon5/13:c.216C>T:p.Ile72Ile,GNAS:NM_000516.5:synonymous:LOW:exon5/13:c.393C>T:p.Ile131Ile,GNAS:NM_001077488.3:synonymous:LOW:exon5/13:c.396C>T:p.Ile132Ile,GNAS:NM_001077489.3:synonymous:LOW:exon4/12:c.348C>T:p.Ile116Ile,GNAS:NM_080426.3:synonymous:LOW:exon4/12:c.351C>T:p.Ile117Ile,GNAS:NM_016592.3:3'UTR:MODIFIER:exon5/13:c.*299C>T:,GNAS:NM_001077490.2:3'UTR:MODIFIER:exon5/13:c.*254C>T:		rs7121	0.6444	0.5470	18875/8501/2997	0.5393	-0.3130	T				139320 [GNAS (confirmed) Pseudohypoparathyroidism Ia|McCune-Albright syndrome,somatic,mosaic 174800|Pseudohypoparathyroidism Ic|Osseous heteroplasia,progressive|Pseudohypoparathyroidism Ib|  Acromegaly,somatic|Pseudopseudohypoparathyroidism|ACTH-independent macronodular adrenal hyperplasia];	RCV000178784.1 [benign]; 	CM023931 [CLASS=DP MUT=REF PHEN="Essential hypertension association with" GENE=GNAS]; 	COSM3758661, COSM3758662	346	532					GNAS (inh=AD pLI=1.00)
chr20	57899654	57899654	C	-	het		QUAL=2597;DP=152;AF=0.61;MQM=59;TRIO=HET,152,0.61,HET,93,0.56,WT,106,0.09	EDN3	3'UTR	EDN3:NM_207034.2:3'UTR:MODIFIER:exon5/5:c.*149delC:,EDN3:NM_001302455.1:3'UTR:MODIFIER:exon5/5:c.*273delC:,EDN3:NM_001302456.1:3'UTR:MODIFIER:exon4/4:c.*241delC:,EDN3:NM_207032.2:3'UTR:MODIFIER:exon5/5:c.*241delC:,EDN3:NM_207033.2:3'UTR:MODIFIER:exon4/4:c.*149delC:		rs754876648	0.0000	0.0000	0/0/0	0.1017										9	84					EDN3 (inh=n/a pLI=0.07)
chr20	61974862	61974862	C	T	het		QUAL=8475;DP=152;AF=0.51;MQM=59;TRIO=HET,152,0.51,WT,393,0.00,HET,523,0.51	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3228G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3228G>A:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5368G>A:		rs45601435	0.0262	0.0440	33/18/0	0.0089										3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61974929	61974929	-	AT	het		QUAL=6694;DP=215;AF=0.47;MQM=59;TRIO=HET,215,0.47,WT,305,0.00,HET,399,0.48	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3160_*3161insAT:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3160_*3161insAT:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5300_5301insAT:	MER74A	rs79237427	0.1134	0.1390	228/33/1	0.0296										10	139					CHRNA4 (inh=AD pLI=0.02)
chr20	61974986	61974986	C	A	het		QUAL=4399;DP=111;AF=0.48;MQM=59;TRIO=HET,111,0.48,WT,202,0.00,HET,272,0.51	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3104G>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3104G>T:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5244G>T:	MER74A	rs45543134	0.0789	0.1060	150/31/0	0.0248										10	127					CHRNA4 (inh=AD pLI=0.02)
chr20	61974991	61974991	-	G	het		QUAL=4203;DP=104;AF=0.51;MQM=59;TRIO=HET,104,0.51,WT,194,0.00,HET,257,0.51	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3098dupC:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3098dupC:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5238dupC:	MER74A	rs148816386	0.0292	0.0430	32/16/0	0.0092										3	72					CHRNA4 (inh=AD pLI=0.02)
chr20	61975084	61975084	A	G	het		QUAL=2452;DP=90;AF=0.51;MQM=59;TRIO=HET,90,0.51,WT,84,0.00,HET,121,0.54	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3006T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3006T>C:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5146T>C:	MER74A	rs45620536	0.0835	0.1050	143/31/0	0.0247										13	120					CHRNA4 (inh=AD pLI=0.02)
chr20	61975091	61975091	A	G	het		QUAL=2082;DP=84;AF=0.46;MQM=59;TRIO=HET,84,0.46,WT,82,0.00,HET,108,0.52	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2999T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2999T>C:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.5139T>C:	MER74A	rs45600338	0.0771	0.1050	140/32/0	0.0242										13	118					CHRNA4 (inh=AD pLI=0.02)
chr20	61975378	61975378	A	G	het		QUAL=4978;DP=200;AF=0.47;MQM=59;TRIO=HET,200,0.47,WT,186,0.00,HET,251,0.48	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2712T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2712T>C:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4852T>C:	L1ME3	rs6090378	0.0677	0.0780	78/18/0	0.0143										4	72					CHRNA4 (inh=AD pLI=0.02)
chr20	61975624	61975624	G	C	het		QUAL=7365;DP=261;AF=0.46;MQM=60;TRIO=HET,261,0.46,WT,325,0.00,HET,334,0.50	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2466C>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2466C>G:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4606C>G:	L1ME3	rs45494793	0.0296	0.0420	34/18/0	0.0093										3	77					CHRNA4 (inh=AD pLI=0.02)
chr20	61975829	61975829	-	T	het		QUAL=1818;DP=131;AF=0.44;MQM=59;TRIO=HET,131,0.44,WT,134,0.04,HET,145,0.41	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2260dupA:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2260dupA:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4400dupA:		rs11480478;rs568329035	0.2746	0.1740	39/8/0	0.0277										13	224					CHRNA4 (inh=AD pLI=0.02)
chr20	61975846	61975846	-	A	het		QUAL=1249;DP=144;AF=0.40;MQM=59;TRIO=HET,144,0.40,WT,116,0.03,HET,122,0.38	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2243dupT:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2243dupT:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4383dupT:		rs551959449	0.2885	0.3260	2/0/0	0.0175										12	270					CHRNA4 (inh=AD pLI=0.02)
chr20	61976028	61976028	G	A	het		QUAL=4541;DP=115;AF=0.49;MQM=59;TRIO=HET,115,0.49,WT,168,0.00,HET,210,0.53	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2062C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2062C>T:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4202C>T:		rs45536037	0.0296	0.0440	34/18/0	0.0091										3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61976032	61976032	A	G	het		QUAL=4541;DP=115;AF=0.49;MQM=59;TRIO=HET,115,0.49,WT,168,0.00,HET,210,0.53	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2058T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2058T>C:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.4198T>C:		rs45523232	0.0296	0.0440	34/18/0	0.0092										3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61976530	61976530	C	T	het		QUAL=2407;DP=76;AF=0.42;MQM=60;TRIO=HET,76,0.42,WT,78,0.00,HET,129,0.52	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1560G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1560G>A:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.3700G>A:		rs45476096	0.0262	0.0420	27/17/0	0.0087										3	77					CHRNA4 (inh=AD pLI=0.02)
chr20	61976920	61976920	T	C	het		QUAL=1199;DP=80;AF=0.48;MQM=60;TRIO=HET,80,0.48,WT,53,0.00,HET,48,0.42	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1170A>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1170A>G:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.3310A>G:		rs41283006	0.0487	0.0700	60/10/0	0.0126										3	78					CHRNA4 (inh=AD pLI=0.02)
chr20	61977015	61977015	C	T	het		QUAL=327;DP=35;AF=0.46;MQM=59;TRIO=HET,35,0.46,WT,17,0.00,HET,14,0.29	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1075G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1075G>A:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.3215G>A:		rs41283008	0.0302	0.0450	34/18/0	0.0092										2	80					CHRNA4 (inh=AD pLI=0.02)
chr20	61977049	61977049	G	C	het		QUAL=335;DP=44;AF=0.39;MQM=59;TRIO=HET,44,0.39,WT,15,0.00,HET,13,0.23	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1041C>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1041C>G:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.3181C>G:		rs41283010	0.0302	0.0450	34/18/0	0.0093										3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61977335	61977335	A	G	het		QUAL=550;DP=42;AF=0.43;MQM=59;TRIO=HET,42,0.43,WT,22,0.00,HET,29,0.34	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*755T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*755T>C:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.2895T>C:		rs45624232	0.0751	0.1140	147/34/0	0.0244										10	137					CHRNA4 (inh=AD pLI=0.02)
chr20	61977373	61977373	G	A	het		QUAL=562;DP=38;AF=0.45;MQM=59;TRIO=HET,38,0.45,WT,32,0.00,HET,35,0.34	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*717C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*717C>T:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.2857C>T:		rs45556643	0.0304	0.0480	34/18/0	0.0089										3	78					CHRNA4 (inh=AD pLI=0.02)
chr20	61977556	61977556	G	A	het		QUAL=9544;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,282,0.47,HET,310,0.55	CHRNA4	3'UTR,non_coding_exon	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*534C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*534C>T:,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon6/6:n.2674C>T:		rs2236196	0.6142	0.5910	2122/541/16	0.1777								CR077876 [CLASS=DFP MUT=REF PHEN="Nicotine dependence association with" GENE=CHRNA4]; 		327	267					CHRNA4 (inh=AD pLI=0.02)
chr20	61981104	61981104	C	T	het		QUAL=3933;DP=49;AF=0.39;MQM=60;TRIO=HET,49,0.39,HET,163,0.46,HET,226,0.50	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1659G>A:p.Ala553Ala,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.1131G>A:p.Ala377Ala,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.1915G>A:		rs1044397	0.3518	0.4710	14137/9170/80	0.4603						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079314.7 [other]; 		COSM3758737	198	334					CHRNA4 (inh=AD pLI=0.02)
chr20	61981134	61981134	G	A	het		QUAL=6113;DP=103;AF=0.47;MQM=60;TRIO=HET,103,0.47,HET,189,0.51,HET,258,0.49	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1629C>T:p.Ser543Ser,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.1101C>T:p.Ser367Ser,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.1885C>T:		rs1044396	0.3235	0.4590	13598/9089/75	0.4511						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079313.7 [other]; 		COSM3758738	194	329					CHRNA4 (inh=AD pLI=0.02)
chr20	61981536	61981536	A	G	hom		QUAL=14911;DP=110;AF=1.00;MQM=59;TRIO=HOM,110,1.00,HET,214,0.56,HOM,286,1.00	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1227T>C:p.Cys409Cys,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.699T>C:p.Cys233Cys,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.1483T>C:		rs2229960	0.8708	0.9260	40678/23296/1633	0.8704						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079311.7 [other]; 		COSM4134782	956	121					CHRNA4 (inh=AD pLI=0.02)
chr20	61981554	61981554	C	A	hom		QUAL=14161;DP=105;AF=0.97;MQM=59;TRIO=HOM,105,0.97,HET,231,0.53,HOM,299,1.00	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1209G>T:p.Pro403Pro,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.681G>T:p.Pro227Pro,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.1465G>T:		rs2229959	0.7338	0.8210	35239/21198/881	0.7850						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079310.7 [other]; 		COSM4134783	784	270					CHRNA4 (inh=AD pLI=0.02)
chr20	61982085	61982085	A	G	hom		QUAL=68729;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HET,1118,0.50,HOM,1336,1.00	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.678T>C:p.Cys226Cys,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.150T>C:p.Cys50Cys,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.934T>C:		rs1044394	0.8636	0.9200	51602/28961/2215	0.8980						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000116723.2 [likely benign]; 			953	146					CHRNA4 (inh=AD pLI=0.02)
chr20	61982124	61982124	A	G	hom		QUAL=61752;DP=469;AF=0.99;MQM=59;TRIO=HOM,469,0.99,HET,987,0.50,HOM,1172,1.00	CHRNA4	synonymous,non_coding_exon	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.639T>C:p.Asp213Asp,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.111T>C:p.Asp37Asp,CHRNA4:NR_046317.1:non_coding_exon:MODIFIER:exon5/6:n.895T>C:		rs1044393	0.7572	0.8350	42869/25323/1471	0.8109						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000116722.2 [likely benign]; 			789	286					CHRNA4 (inh=AD pLI=0.02)
chr20	62037879	62037879	A	C	het	low_QUAL	QUAL=21;DP=29;AF=0.52;MQM=59;TRIO=HET,29,0.52,WT,20,0.10,HET,48,0.21	KCNQ2	3'UTR	KCNQ2:NM_172107.2:3'UTR:MODIFIER:exon17/17:c.*118T>G:,KCNQ2:NM_004518.4:3'UTR:MODIFIER:exon15/15:c.*118T>G:,KCNQ2:NM_172106.1:3'UTR:MODIFIER:exon16/16:c.*118T>G:,KCNQ2:NM_172108.3:3'UTR:MODIFIER:exon16/16:c.*118T>G:			0.0000	0.0000	0/0/0	0.0002										0	6					KCNQ2 (inh=AD pLI=1.00)
chr20	62038277	62038277	T	G	het	phylop_high	QUAL=1090;DP=50;AF=0.52;MQM=60;TRIO=HET,50,0.52,HET,61,0.43,WT,105,0.00	KCNQ2	missense	KCNQ2:NM_172107.2:missense:MODERATE:exon17/17:c.2339A>C:p.Asn780Thr,KCNQ2:NM_004518.4:missense:MODERATE:exon15/15:c.2255A>C:p.Asn752Thr,KCNQ2:NM_172106.1:missense:MODERATE:exon16/16:c.2285A>C:p.Asn762Thr,KCNQ2:NM_172108.3:missense:MODERATE:exon16/16:c.2246A>C:p.Asn749Thr		rs1801475	0.5905	0.6040	19837/12061/1048	0.5794	1.8720	T	T,T,T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	602235 [KCNQ2 (confirmed) Seizures,benign neonatal,1|Myokymia|Epileptic encephalopathy,early infantile,7];	RCV000020987.1 [benign]; RCV000082686.7 [benign]; 		COSM3758740, COSM3758739, COSM3758741	451	497					KCNQ2 (inh=AD pLI=1.00)
chr20	62565646	62565646	G	A	het		QUAL=2701;DP=128;AF=0.53;MQM=59;TRIO=HET,128,0.53,WT,68,0.00,HET,100,0.52	DNAJC5	3'UTR	DNAJC5:NM_025219.2:3'UTR:MODIFIER:exon5/5:c.*2725G>A:		rs11554628	0.0310	0.0000	0/0/0	0.0120										0	25					DNAJC5 (inh=n/a pLI=0.86)
chr21	34787312	34787312	A	G	het		QUAL=5157;DP=230;AF=0.54;MQM=59;TRIO=HET,230,0.54,HET,188,0.44,WT,314,0.00	IFNGR2	missense	IFNGR2:NM_005534.3:missense:MODERATE:exon2/7:c.191A>G:p.Gln64Arg		rs9808753	0.2720	0.1960	2951/574/275	0.1943	0.1630	T	T,T	B,B	B,B	147569 [IFNGR2 (confirmed) Immunodeficiency 28,mycobacteriosis];		CM1111763 [CLASS=DP MUT=REF PHEN="Non-Hodgkin lymphoma increased risk association with" GENE=IFNGR2]; 	COSM3758854	28	255					IFNGR2 (inh=n/a pLI=0.88)
chr21	34809693	34809693	C	T	het		QUAL=5611;DP=99;AF=0.52;MQM=59;TRIO=HET,99,0.52,HOM,88,1.00,HET,102,0.59	IFNGR2,TMEM50B	3'UTR,intron	IFNGR2:NM_005534.3:3'UTR:MODIFIER:exon7/7:c.*424C>T:,TMEM50B:NR_040016.1:intron:MODIFIER:exon8/8:n.2810+1828G>A:		rs1059293	0.6807	0.0000	0/0/0	0.0963										50	109					IFNGR2 (inh=n/a pLI=0.88), TMEM50B (inh=n/a pLI=0.30)
chr21	38123320	38123320	-	A	het		QUAL=2184;DP=219;AF=0.37;MQM=59;TRIO=HET,219,0.37,WT,74,0.03,HET,92,0.37	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*3226dupT:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*3226dupT:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*3226dupT:		rs762985167	0.0000	0.0000	0/0/0	0.0142										0	34					HLCS (inh=AR pLI=0.49)
chr21	38123404	38123404	-	AT	het		QUAL=4099;DP=275;AF=0.41;MQM=59;TRIO=HET,275,0.41,WT,80,0.00,HET,112,0.42	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:		rs3031056;rs5843777	0.3524	0.0000	0/0/0	0.3626										47	105					HLCS (inh=AR pLI=0.49)
chr21	38123925	38123925	C	T	het		QUAL=11779;DP=371;AF=0.56;MQM=59;TRIO=HET,371,0.56,WT,357,0.00,HET,452,0.53	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*2622G>A:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*2622G>A:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*2622G>A:		rs14407	0.4465	0.0000	0/0/0	0.0757										51	103					HLCS (inh=AR pLI=0.49)
chr21	38308774	38308774	C	T	het	pred_pathogenic_1	QUAL=8708;DP=320;AF=0.50;MQM=60;TRIO=HET,320,0.50,HET,380,0.51,WT,446,0.00	HLCS	missense	HLCS:NM_000411.6:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His,HLCS:NM_001242784.1:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His,HLCS:NM_001242785.1:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His		rs61732501	0.0070	0.0097	10/8/0	0.0094	-2.1740	D	T,T	B,B	B,B	609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];	RCV000125363.2 [benign]; 			0	18					HLCS (inh=AR pLI=0.49)
chr21	38320006	38320006	C	G	het		QUAL=15822;DP=586;AF=0.48;MQM=60;TRIO=HET,586,0.48,HET,284,0.53,HET,336,0.53	HLCS	5'UTR,intron	HLCS:NM_001242784.1:5'UTR:MODIFIER:exon3/12:c.-485G>C:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-1552G>C:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-1552G>C:		rs13047776	0.4940	0.0000	0/0/0	0.3797						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				49	70					HLCS (inh=AR pLI=0.49)
chr21	38320007	38320007	T	G	het		QUAL=15822;DP=586;AF=0.48;MQM=60;TRIO=HET,586,0.48,HET,284,0.53,HET,336,0.53	HLCS	5'UTR,intron	HLCS:NM_001242784.1:5'UTR:MODIFIER:exon3/12:c.-486A>C:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-1553A>C:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-1553A>C:		rs13048613	0.4948	0.0000	0/0/0	0.3780						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				49	70					HLCS (inh=AR pLI=0.49)
chr21	38320591	38320591	G	A	hom		QUAL=876;DP=26;AF=0.31;MQM=58;TRIO=HOM,26,0.31,HOM,9,0.22,HOM,3,0.00	HLCS	splice_region&intron,intron	HLCS:NM_001242784.1:splice_region&intron:LOW:exon2/11:c.-1066-4C>T:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-2137C>T:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-2137C>T:	AluSg		0.0000	0.0000	0/0/0	0.0001						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				0	4					HLCS (inh=AR pLI=0.49)
chr21	38353268	38353268	-	TCCG	het	low_DP	QUAL=363;DP=9;AF=0.56;MQM=59;TRIO=HET,9,0.56,HET,37,0.49,WT,53,0.00	HLCS	intron	HLCS:NM_000411.6:intron:MODIFIER:exon1/11:c.-393+9186_-393+9189dupCGGA:		rs35269254;rs71328533	0.3405	0.0000	0/0/0	0.3532										15	53					HLCS (inh=AR pLI=0.49)
chr21	38782911	38782911	T	C	het		QUAL=6622;DP=278;AF=0.53;MQM=59;TRIO=HET,278,0.53,WT,223,0.00,HET,228,0.53	DYRK1A	5'UTR	DYRK1A:NM_101395.2:5'UTR:MODIFIER:exon2/13:c.-138T>C:	FRAM	rs9981736	0.5543	0.0000	0/0/0	0.4639										34	80					DYRK1A (inh=AD pLI=1.00)
chr21	38791581	38791581	A	C	het		QUAL=14186;DP=662;AF=0.49;MQM=60;TRIO=HET,662,0.49,WT,328,0.00,HET,412,0.54	DYRK1A	5'UTR,intron	DYRK1A:NM_130436.2:5'UTR:MODIFIER:exon1/11:c.-1096A>C:,DYRK1A:NM_101395.2:intron:MODIFIER:exon2/12:c.-76-1020A>C:		rs2835726	0.5000	0.0000	0/0/0	0.0758										55	112					DYRK1A (inh=AD pLI=1.00)
chr21	38792131	38792131	T	C	het		QUAL=4963;DP=241;AF=0.48;MQM=60;TRIO=HET,241,0.48,WT,102,0.00,HET,137,0.56	DYRK1A	5'UTR,intron	DYRK1A:NM_130436.2:5'UTR:MODIFIER:exon1/11:c.-546T>C:,DYRK1A:NM_101395.2:intron:MODIFIER:exon2/12:c.-76-470T>C:		rs13049514	0.0996	0.0000	0/0/0	0.0206										4	64					DYRK1A (inh=AD pLI=1.00)
chr21	44473425	44473425	G	A	hom		QUAL=21708;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HET,271,0.48,HOM,299,1.00	CBS	3'UTR	CBS:NM_000071.2:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:NM_001178008.1:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:NM_001178009.1:3'UTR:MODIFIER:exon18/18:c.*351C>T:	L1MB5	rs706209	0.3654	0.0000	0/0/0	0.0709										55	92					CBS (inh=AR pLI=0.01)
chr21	44473446	44473446	A	G	hom		QUAL=22057;DP=302;AF=1.00;MQM=59;TRIO=HOM,302,1.00,HET,244,0.47,HOM,283,1.00	CBS	3'UTR	CBS:NM_000071.2:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:NM_001178008.1:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:NM_001178009.1:3'UTR:MODIFIER:exon18/18:c.*330T>C:	L1MB5	rs706208	0.3662	0.0000	0/0/0	0.0710										52	96					CBS (inh=AR pLI=0.01)
chr21	44480616	44480616	G	A	hom		QUAL=12928;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HET,186,0.51,HOM,248,1.00	CBS	synonymous	CBS:NM_000071.2:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:NM_001178008.1:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:NM_001178009.1:synonymous:LOW:exon12/18:c.1080C>T:p.Ala360Ala		rs1801181	0.2955	0.3310	7601/4195/25	0.3295	-2.6190	T				613381 [CBS (confirmed) Homocystinuria,B6-responsive and nonresponsive types|Thrombosis,hyperhomocysteinemic];	RCV000078107.6 [benign]; 		COSM3758919, COSM3758920	171	491					CBS (inh=AR pLI=0.01)
chr21	45193728	45193728	G	C	het		QUAL=5827;DP=241;AF=0.52;MQM=60;TRIO=HET,241,0.52,HET,199,0.54,WT,281,0.00	CSTB	3'UTR	CSTB:NM_000100.3:3'UTR:MODIFIER:exon3/3:c.*355C>G:	MIR	rs143062585	0.0070	0.0000	0/0/0	0.0065										0	5					CSTB (inh=n/a pLI=0.00)
chr21	45709568	45709568	C	T	het		QUAL=3784;DP=115;AF=0.43;MQM=60;TRIO=HET,115,0.43,WT,150,0.00,HET,208,0.56	AIRE	synonymous	AIRE:NM_000383.3:synonymous:LOW:exon6/14:c.681C>T:p.Gly227Gly		rs1055311	0.1176	0.2200	3552/2538/16	0.2184						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116302.2 [likely benign]; 		COSM3758929	65	393					AIRE (inh=n/a pLI=0.00)
chr21	45712290	45712290	G	A	het	anno_pathogenic_hgmd	QUAL=1572;DP=98;AF=0.48;MQM=59;TRIO=HET,98,0.48,HET,106,0.39,WT,144,0.00	AIRE	splice_region&intron	AIRE:NM_000383.3:splice_region&intron:LOW:exon9/13:c.1095+6G>A:		rs1800525	0.1496	0.0780	166/43/15	0.0603						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116292.2 [likely benign]; 	CS1412655 [CLASS=DM? MUT=ALT PHEN="Autoimmune polyglandular syndrome type 2" GENE=AIRE]; 		22	221					AIRE (inh=n/a pLI=0.00)
chr21	45712977	45712977	T	C	het		QUAL=1990;DP=32;AF=0.38;MQM=60;TRIO=HET,32,0.38,HOM,36,0.97,HET,84,0.44	AIRE	synonymous	AIRE:NM_000383.3:synonymous:LOW:exon10/14:c.1197T>C:p.Ala399Ala		rs1800521	0.3562	0.3470	6924/3950/1081	0.3372						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116299.2 [likely benign]; 		COSM1483985, COSM444569	152	513					AIRE (inh=n/a pLI=0.00)
chr21	45714294	45714294	C	T	het	low_DP;pred_pathogenic_3;anno_pathogenic_hgmd	QUAL=332;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HET,13,0.69,WT,12,0.00	AIRE	missense	AIRE:NM_000383.3:missense:MODERATE:exon12/14:c.1411C>T:p.Arg471Cys		rs74203920	0.0044	0.0085	7/5/0	0.0081	0.0570	D	D,D,D,D	D,D	P,P	607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116295.2 [likely benign]; 	CM109490 [CLASS=DM? MUT=ALT PHEN="Hypoparathyroidism without APECED" GENE=AIRE]; 		0	21					AIRE (inh=n/a pLI=0.00)
chr21	46311813	46311813	A	G	het		QUAL=10702;DP=113;AF=0.55;MQM=59;TRIO=HET,113,0.55,WT,222,0.00,HOM,298,1.00	ITGB2	synonymous	ITGB2:NM_000211.4:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val,ITGB2:NM_001303238.1:synonymous:LOW:exon11/16:c.1116T>C:p.Val372Val,ITGB2:NM_001127491.2:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val		rs235326	0.7630	0.6880	29127/14797/4422	0.6819						600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];			COSM3766671	508	499					ITGB2 (inh=n/a pLI=0.00)
chr21	46314907	46314907	T	A	hom	pred_pathogenic_1	QUAL=27322;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,303,1.00,HOM,332,1.00	ITGB2	missense	ITGB2:NM_000211.4:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His,ITGB2:NM_001303238.1:missense:MODERATE:exon9/16:c.855A>T:p.Gln285His,ITGB2:NM_001127491.2:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His		rs235330	1.0000	1.0000	60689/33355/5203	0.9520	-0.9340	T	D,D,T,D,D,D,T	B,P	B,P	600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];	RCV000087107.1 [not provided]; 		COSM4135040	1107	0					ITGB2 (inh=n/a pLI=0.00)
chr21	46320313	46320313	C	T	het		QUAL=2594;DP=64;AF=0.44;MQM=59;TRIO=HET,64,0.44,HET,75,0.52,HET,90,0.52	ITGB2	synonymous	ITGB2:NM_000211.4:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly,ITGB2:NM_001303238.1:synonymous:LOW:exon7/16:c.612G>A:p.Gly204Gly,ITGB2:NM_001127491.2:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly		rs2230528	0.2230	0.2420	3830/1944/132	0.2373						600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];	RCV000087125.1 [not provided]; 			73	420					ITGB2 (inh=n/a pLI=0.00)
chr21	46348700	46348700	T	G	hom		QUAL=12753;DP=132;AF=1.00;MQM=60;TRIO=HOM,132,1.00,HOM,135,1.00,HOM,139,1.00	ITGB2,ITGB2-AS1	5'UTR,non_coding_exon	ITGB2:NM_001127491.2:5'UTR:MODIFIER:exon1/16:c.-135A>C:,ITGB2-AS1:NR_038311.1:non_coding_exon:MODIFIER:exon5/5:n.1500T>G:,ITGB2-AS1:NR_038312.1:non_coding_exon:MODIFIER:exon4/4:n.1457T>G:,ITGB2-AS1:NR_038313.1:non_coding_exon:MODIFIER:exon5/5:n.1476T>G:,ITGB2-AS1:NR_038314.1:non_coding_exon:MODIFIER:exon4/4:n.1405T>G:,ITGB2-AS1:NR_038315.1:non_coding_exon:MODIFIER:exon4/4:n.1401T>G:,ITGB2-AS1:NR_038316.1:non_coding_exon:MODIFIER:exon3/3:n.1362T>G:		rs9982872	0.9884	0.0000	0/0/0	0.8964										227	3					ITGB2 (inh=n/a pLI=0.00), ITGB2-AS1 (inh=n/a pLI=n/a)
chr21	46875564	46875564	T	C	het		QUAL=16418;DP=215;AF=0.48;MQM=59;TRIO=HET,215,0.48,HOM,287,1.00,HET,387,0.47	COL18A1	synonymous,intron	COL18A1:NM_130444.2:synonymous:LOW:exon1/42:c.120T>C:p.His40His,COL18A1:NM_030582.3:synonymous:LOW:exon1/42:c.120T>C:p.His40His,COL18A1:NM_130445.3:intron:MODIFIER:exon2/42:c.107-12592T>C:		rs914230	0.9884	0.9700	56851/30556/4837	0.9454						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];				1031	72					COL18A1 (inh=AR pLI=0.00)
chr21	46876083	46876083	A	G	het		QUAL=3841;DP=69;AF=0.61;MQM=59;TRIO=HET,69,0.61,HET,110,0.52,HET,135,0.44	COL18A1	synonymous,intron	COL18A1:NM_130444.2:synonymous:LOW:exon1/42:c.639A>G:p.Pro213Pro,COL18A1:NM_030582.3:synonymous:LOW:exon1/42:c.639A>G:p.Pro213Pro,COL18A1:NM_130445.3:intron:MODIFIER:exon2/42:c.107-12073A>G:		rs2236451	0.3756	0.3340	6980/3629/1394	0.3262						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM4004829, COSM4004828	133	433					COL18A1 (inh=AR pLI=0.00)
chr21	46908355	46908355	T	C	het		QUAL=6050;DP=233;AF=0.50;MQM=59;TRIO=HET,233,0.50,HET,241,0.51,WT,295,0.00	COL18A1	synonymous	COL18A1:NM_130444.2:synonymous:LOW:exon17/42:c.3165T>C:p.Leu1055Leu,COL18A1:NM_130445.3:synonymous:LOW:exon18/43:c.1920T>C:p.Leu640Leu,COL18A1:NM_030582.3:synonymous:LOW:exon17/42:c.2460T>C:p.Leu820Leu		rs11702425	0.3199	0.3050	5764/3096/691	0.2972						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM3758950, COSM3758951	100	444					COL18A1 (inh=AR pLI=0.00)
chr21	46924426	46924434	GGCCCCCCA	-	hom	low_DP	QUAL=782;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HOM,13,1.00,HOM,14,1.00	COL18A1	disruptive_inframe_deletion	COL18A1:NM_130444.2:disruptive_inframe_deletion:MODERATE:exon34/42:c.4074_4082delCCCAGGCCC:p.Pro1359_Pro1361del,COL18A1:NM_130445.3:disruptive_inframe_deletion:MODERATE:exon35/43:c.2829_2837delCCCAGGCCC:p.Pro944_Pro946del,COL18A1:NM_030582.3:disruptive_inframe_deletion:MODERATE:exon34/42:c.3369_3377delCCCAGGCCC:p.Pro1124_Pro1126del		rs149296338;rs78227997	0.0000	0.9650	29713/15968/1807	0.0525						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM1031439	906	111	2	[2] old entry - no details available			COL18A1 (inh=AR pLI=0.00)
chr21	46927489	46927489	A	G	het		QUAL=2314;DP=124;AF=0.39;MQM=60;TRIO=HET,124,0.39,HET,150,0.39,WT,226,0.00	COL18A1	synonymous	COL18A1:NM_130444.2:synonymous:LOW:exon38/42:c.4467A>G:p.Thr1489Thr,COL18A1:NM_130445.3:synonymous:LOW:exon39/43:c.3222A>G:p.Thr1074Thr,COL18A1:NM_030582.3:synonymous:LOW:exon38/42:c.3762A>G:p.Thr1254Thr		rs12483761	0.1184	0.1210	882/503/85	0.1181						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];				16	247					COL18A1 (inh=AR pLI=0.00)
chr21	46931109	46931109	G	A	het	phylop_high;pred_pathogenic_3;anno_pathogenic_clinvar	QUAL=2039;DP=80;AF=0.51;MQM=60;TRIO=HET,80,0.51,HET,94,0.46,WT,145,0.00	COL18A1	missense	COL18A1:NM_130444.2:missense:MODERATE:exon41/42:c.5014G>A:p.Asp1672Asn,COL18A1:NM_130445.3:missense:MODERATE:exon42/43:c.3769G>A:p.Asp1257Asn,COL18A1:NM_030582.3:missense:MODERATE:exon41/42:c.4309G>A:p.Asp1437Asn		rs12483377	0.0443	0.0590	186/157/4	0.0576	5.7980	T	T,T,T,T,D,T	D,D,D,D	D,D,D,D	120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];	RCV000018655.28 [pathogenic]; 		COSM1579620	6	181	2	[2] old entry - no details available			COL18A1 (inh=AR pLI=0.00)
chr21	46932618	46932618	G	C	het		QUAL=4605;DP=203;AF=0.49;MQM=59;TRIO=HET,203,0.49,HET,165,0.50,WT,177,0.00	COL18A1	3'UTR	COL18A1:NM_130444.2:3'UTR:MODIFIER:exon42/42:c.*306G>C:,COL18A1:NM_130445.3:3'UTR:MODIFIER:exon43/43:c.*306G>C:,COL18A1:NM_030582.3:3'UTR:MODIFIER:exon42/42:c.*306G>C:		rs17004785	0.1036	0.0000	0/0/0	0.1051										2	47					COL18A1 (inh=AR pLI=0.00)
chr21	47410931	47410931	T	C	hom		QUAL=6012;DP=121;AF=0.99;MQM=60;TRIO=HOM,121,0.99,HET,90,0.47,HET,136,0.45	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon15/35:c.1095T>C:p.Gly365Gly		rs1980982	0.5449	0.5310	17619/10012/2922	0.5227						120220 [COL6A1 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1];	RCV000079742.5 [benign]; 		COSM3758956	335	544					COL6A1 (inh=AD pLI=1.00)
chr21	47423389	47423389	G	A	hom		QUAL=6589;DP=89;AF=0.96;MQM=59;TRIO=HOM,89,0.96,HET,154,0.54,HET,184,0.55	COL6A1	missense	COL6A1:NM_001848.2:missense:MODERATE:exon35/35:c.2549G>A:p.Arg850His		rs1053312	0.2702	0.2830	4969/2844/771	0.2789	-0.0010	T	T	B	B	120220 [COL6A1 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1];	RCV000079798.5 [benign]; 		COSM3758957	113	466					COL6A1 (inh=AD pLI=1.00)
chr21	47423507	47423507	G	A	hom		QUAL=3249;DP=43;AF=0.95;MQM=59;TRIO=HOM,43,0.95,HET,79,0.53,HET,93,0.55	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon35/35:c.2667G>A:p.Ala889Ala		rs1053315;rs71336107	0.2682	0.2830	5021/2870/764	0.2765						120220 [COL6A1 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1];	RCV000079801.7 [other]; 		COSM329269	112	461					COL6A1 (inh=AD pLI=1.00)
chr21	47423636	47423636	C	T	hom		QUAL=2636;DP=75;AF=0.96;MQM=59;TRIO=HOM,75,0.96,HET,45,0.47,HET,27,0.37	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon35/35:c.2796C>T:p.Ser932Ser		rs1053320	0.2642	0.2680	4530/2543/809	0.2639						120220 [COL6A1 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1];	RCV000079807.5 [benign]; 		COSM444608	98	434					COL6A1 (inh=AD pLI=1.00)
chr21	47424187	47424187	A	G	hom		QUAL=8431;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,87,0.99,HET,127,0.44	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*260A>G:		rs1053331	0.8704	0.0000	0/0/0	0.8401										241	65					COL6A1 (inh=AD pLI=1.00)
chr21	47424275	47424287	CTCCTGCCCTGCC	-	het		QUAL=3219;DP=56;AF=0.95;MQM=59;TRIO=HET,56,0.95,HET,92,0.57,HET,140,0.46	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*357_*369delTGCCCTCCTGCCC:	(GCCCT)n	rs752193493	0.0469	0.0000	0/0/0	0.0758										4	43					COL6A1 (inh=AD pLI=1.00)
chr21	47424346	47424346	A	G	hom		QUAL=11974;DP=98;AF=0.99;MQM=59;TRIO=HOM,98,0.99,HOM,178,1.00,HET,277,0.53	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*419A>G:		rs9254	0.8820	0.0000	0/0/0	0.8740										285	82					COL6A1 (inh=AD pLI=1.00)
chr21	47538960	47538960	G	A	hom		QUAL=24132;DP=209;AF=1.00;MQM=59;TRIO=HOM,209,1.00,HOM,243,1.00,HOM,315,1.00	COL6A2	missense	COL6A2:NM_001849.3:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:NM_058174.2:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:NM_058175.2:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn		rs2839110	0.7053	0.7720	36591/21934/1479	0.7586	0.3610	T	T,T,T,T,T	B,B,B	B,B,B	120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079842.5 [benign]; 		COSM3758958, COSM3758960, COSM3758959	716	343					COL6A2 (inh=n/a pLI=0.00)
chr21	47542861	47542861	A	G	hom		QUAL=20931;DP=139;AF=0.99;MQM=59;TRIO=HOM,139,0.99,HOM,234,1.00,HOM,315,1.00	COL6A2	splice_region&intron	COL6A2:NM_001849.3:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:NM_058174.2:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:NM_058175.2:splice_region&intron:LOW:exon21/27:c.1671+10A>G:		rs915786	0.8474	0.8120	40202/21592/4615	0.7715						120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079853.7 [other]; 			718	340					COL6A2 (inh=n/a pLI=0.00)
chr21	47545768	47545768	G	A	hom	phylop_high;pred_pathogenic_3	QUAL=24899;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,243,1.00,HOM,361,1.00	COL6A2	missense	COL6A2:NM_001849.3:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:NM_058174.2:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:NM_058175.2:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His		rs1042917	0.3940	0.4770	14691/8634/318	0.4742	4.7640	T	T,D,T,T,D,T	D,D,D	D,P,P	120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079868.5 [benign]; 		COSM3758963, COSM3758961, COSM3758962	252	544					COL6A2 (inh=n/a pLI=0.00)
chr21	47545823	47545823	G	A	hom		QUAL=28429;DP=235;AF=0.92;MQM=59;TRIO=HOM,235,0.92,HOM,311,0.98,HOM,441,0.99	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala		rs13052956	0.3942	0.4750	14468/8494/320	0.4716						120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079869.5 [benign]; 		COSM3758965, COSM3758964, COSM3758966	252	543					COL6A2 (inh=n/a pLI=0.00)
chr21	47545826	47545826	C	T	hom		QUAL=28429;DP=235;AF=0.92;MQM=59;TRIO=HOM,235,0.92,HOM,311,0.98,HOM,441,0.99	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly		rs13046639	0.3940	0.4750	14471/8495/317	0.4650						120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079870.5 [benign]; 		COSM3758968, COSM3758969, COSM3758967	252	543					COL6A2 (inh=n/a pLI=0.00)
chr21	47545913	47545913	G	A	het		QUAL=12986;DP=175;AF=0.47;MQM=59;TRIO=HET,175,0.47,HET,408,0.48,HET,546,0.50	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val		rs2839114	0.3221	0.3740	9378/4800/96	0.3712						120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];	RCV000079875.5 [benign]; 		COSM3758972, COSM3758971, COSM3758970	140	490					COL6A2 (inh=n/a pLI=0.00)
chr21	47549629	47549629	T	A	hom		QUAL=19716;DP=217;AF=0.99;MQM=59;TRIO=HOM,217,0.99,HOM,193,0.99,HOM,254,1.00	COL6A2	3'UTR,intron	COL6A2:NM_058174.2:3'UTR:MODIFIER:exon28/28:c.*224T>A:,COL6A2:NM_058175.2:3'UTR:MODIFIER:exon28/28:c.*787T>A:,COL6A2:NM_001849.3:intron:MODIFIER:exon27/27:c.2462-2239T>A:	MLT1C2	rs1044598	0.3868	0.0000	0/0/0	0.4675						120240 [COL6A2 (confirmed) Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Myosclerosis,congenital];				38	121					COL6A2 (inh=n/a pLI=0.00)
chr21	47744038	47744038	G	-	hom		QUAL=6744;DP=33;AF=1.00;MQM=59;TRIO=HOM,33,1.00,HOM,102,1.00,HOM,108,1.00	PCNT	5'UTR	PCNT:NM_006031.5:5'UTR:MODIFIER:exon1/47:c.-100delG:		rs397802954	0.7672	0.0000	0/0/0	0.4779										207	92					PCNT (inh=AR pLI=0.00)
chr21	47766650	47766650	G	A	hom		QUAL=8877;DP=82;AF=0.99;MQM=59;TRIO=HOM,82,0.99,HOM,173,1.00,HET,164,0.42	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon4/46:c.721-7G>A:,PCNT:NM_001315529.1:splice_region&intron:LOW:exon4/46:c.367-7G>A:		rs2839217	0.2999	0.3200	4846/3264/144	0.3115						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147195.1 [benign]; 			186	514					PCNT (inh=AR pLI=0.00)
chr21	47773103	47773103	C	A	hom		QUAL=25357;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,353,1.00,HET,478,0.54	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon10/47:c.1542C>A:p.Ser514Ser,PCNT:NM_001315529.1:synonymous:LOW:exon10/47:c.1188C>A:p.Ser396Ser		rs2249057	0.2895	0.3190	6428/3931/272	0.3172						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147090.1 [benign]; 		COSM1130514	140	517					PCNT (inh=AR pLI=0.00)
chr21	47777063	47777063	G	A	hom	phylop_high	QUAL=20878;DP=197;AF=1.00;MQM=60;TRIO=HOM,197,1.00,HOM,191,0.99,HOM,273,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon13/47:c.2111G>A:p.Gly704Glu,PCNT:NM_001315529.1:missense:MODERATE:exon13/47:c.1757G>A:p.Gly586Glu		rs2839223	0.8486	0.8560	44630/25532/4423	0.8488	3.8370	T	T,T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147093.1 [benign]; 		COSM4135102	800	283					PCNT (inh=AR pLI=0.00)
chr21	47783796	47783796	T	C	hom		QUAL=10135;DP=135;AF=0.99;MQM=60;TRIO=HOM,135,0.99,HOM,91,1.00,HOM,117,0.99	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon14/47:c.2556T>C:p.Ala852Ala,PCNT:NM_001315529.1:synonymous:LOW:exon14/47:c.2202T>C:p.Ala734Ala		rs8131546	0.8470	0.8540	43091/24499/4074	0.8342						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147097.1 [benign]; 		COSM444637	792	280					PCNT (inh=AR pLI=0.00)
chr21	47786494	47786494	C	T	hom		QUAL=2503;DP=57;AF=1.00;MQM=59;TRIO=HOM,57,1.00,HOM,10,1.00,HOM,20,1.00	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon14/46:c.2610-5C>T:,PCNT:NM_001315529.1:splice_region&intron:LOW:exon14/46:c.2256-5C>T:		rs2839226	0.6577	0.7480	34455/21052/1003	0.7359						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147099.1 [benign]; 			667	382					PCNT (inh=AR pLI=0.00)
chr21	47786817	47786817	C	G	hom		QUAL=32471;DP=158;AF=0.99;MQM=60;TRIO=HOM,158,0.99,HOM,361,1.00,HOM,507,1.00	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon15/47:c.2928C>G:p.Leu976Leu,PCNT:NM_001315529.1:synonymous:LOW:exon15/47:c.2574C>G:p.Leu858Leu		rs2839228	0.8389	0.8530	44245/25455/4136	0.8456						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147104.1 [benign]; 		COSM1414625	798	288					PCNT (inh=AR pLI=0.00)
chr21	47787002	47787002	T	C	hom		QUAL=22537;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,251,0.99,HOM,383,0.99	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon15/47:c.3113T>C:p.Val1038Ala,PCNT:NM_001315529.1:missense:MODERATE:exon15/47:c.2759T>C:p.Val920Ala		rs6518289	0.8377	0.8520	43999/25340/4085	0.8314	-0.9870	T	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147106.1 [benign]; 			798	288					PCNT (inh=AR pLI=0.00)
chr21	47811272	47811272	C	T	hom		QUAL=5639;DP=61;AF=0.98;MQM=59;TRIO=HOM,61,0.98,HOM,98,1.00,HET,114,0.49	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon21/47:c.4197C>T:p.Asp1399Asp,PCNT:NM_001315529.1:synonymous:LOW:exon21/47:c.3843C>T:p.Asp1281Asp		rs3737438	0.3015	0.2590	1224/677/52	0.2170						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147122.1 [benign]; 		COSM444639	186	515					PCNT (inh=AR pLI=0.00)
chr21	47832836	47832836	A	G	het	phylop_high;pred_pathogenic_2	QUAL=5968;DP=158;AF=0.47;MQM=59;TRIO=HET,158,0.47,WT,286,0.00,HET,361,0.45	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon29/47:c.6080A>G:p.Gln2027Arg,PCNT:NM_001315529.1:missense:MODERATE:exon29/47:c.5726A>G:p.Gln1909Arg		rs147189224	0.0008	0.0019	0/0/0	0.0019	4.5150	T	T	D,D	D,D	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000192953.1 [uncertain significance]; 			0	4	3	[3] Stephan Waldm?ller 13.08.2014			PCNT (inh=AR pLI=0.00)
chr21	47836653	47836653	C	T	het		QUAL=2792;DP=100;AF=0.46;MQM=59;TRIO=HET,100,0.46,HET,61,0.62,HET,74,0.47	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon30/47:c.6821C>T:p.Pro2274Leu,PCNT:NM_001315529.1:missense:MODERATE:exon30/47:c.6467C>T:p.Pro2156Leu		rs2070425	0.2496	0.2690	4341/2592/126	0.2635	0.0390	T	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147179.1 [benign]; 		COSM3759001	103	450					PCNT (inh=AR pLI=0.00)
chr21	47850484	47850484	G	C	hom		QUAL=21158;DP=159;AF=0.99;MQM=59;TRIO=HOM,159,0.99,HOM,225,1.00,HOM,311,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon37/47:c.7977G>C:p.Gln2659His,PCNT:NM_001315529.1:missense:MODERATE:exon37/47:c.7623G>C:p.Gln2541His		rs2070426	0.4882	0.4520	5215/3037/211	0.4282	-3.2770	T	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147219.2 [benign]; 		COSM3759003	406	514					PCNT (inh=AR pLI=0.00)
chr21	47851753	47851753	A	G	hom		QUAL=19184;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HOM,174,0.98,HOM,216,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon38/47:c.8375A>G:p.Gln2792Arg,PCNT:NM_001315529.1:missense:MODERATE:exon38/47:c.8021A>G:p.Gln2674Arg		rs2073376	0.6699	0.6390	25038/14058/3257	0.6326	0.2460	T	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147222.4 [benign]; 		COSM4135105	510	479					PCNT (inh=AR pLI=0.00)
chr21	47852085	47852085	G	A	het	phylop_high	QUAL=5734;DP=281;AF=0.41;MQM=59;TRIO=HET,281,0.41,HET,264,0.50,WT,357,0.00	PCNT	missense,intron	PCNT:NM_006031.5:missense:MODERATE:exon38/47:c.8707G>A:p.Ala2903Thr,PCNT:NM_001315529.1:intron:MODIFIER:exon38/46:c.8160+193G>A:		rs35147998	0.0385	0.0610	286/228/0	0.0603	3.8120	T	T	B	B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147227.1 [likely benign]; RCV000147228.1 [benign]; 			3	169					PCNT (inh=AR pLI=0.00)
chr21	47860764	47860764	T	C	het		QUAL=2903;DP=132;AF=0.61;MQM=60;TRIO=HET,132,0.61,HET,33,0.91,WT,73,0.00	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon42/46:c.9394-4T>C:,PCNT:NM_001315529.1:splice_region&intron:LOW:exon42/46:c.8803-4T>C:		rs2839260	0.1058	0.1260	1151/905/102	0.1261						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147245.1 [benign]; 			31	307					PCNT (inh=AR pLI=0.00)
chr21	47863757	47863757	A	C	het		QUAL=1975;DP=93;AF=0.44;MQM=59;TRIO=HET,93,0.44,WT,67,0.00,HET,98,0.46	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon45/47:c.9735A>C:p.Arg3245Ser,PCNT:NM_001315529.1:missense:MODERATE:exon45/47:c.9144A>C:p.Arg3048Ser		rs2073380	0.2063	0.2280	3506/1775/23	0.2260	-0.0160	T	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147250.1 [benign]; 		COSM1751704	62	414					PCNT (inh=AR pLI=0.00)
chr22	17565888	17565888	C	A	hom		QUAL=5776;DP=30;AF=1.00;MQM=60;TRIO=HOM,30,1.00,HET,106,0.58,HOM,111,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-94C>A:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-94C>A:		rs13053694	0.3195	0.0000	0/0/0	0.0870										93	147					IL17RA (inh=n/a pLI=0.12)
chr22	17565932	17565932	T	C	hom		QUAL=5607;DP=24;AF=1.00;MQM=60;TRIO=HOM,24,1.00,HOM,82,1.00,HOM,85,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-50T>C:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-50T>C:		rs917864	0.7750	0.2510	11/8/1	0.1496										335	129					IL17RA (inh=n/a pLI=0.12)
chr22	17565974	17565974	G	C	hom	low_DP	QUAL=3124;DP=9;AF=1.00;MQM=59;TRIO=HOM,9,1.00,HOM,47,1.00,HOM,54,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-8G>C:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-8G>C:		rs917865	0.7748	0.4880	85/11/4	0.1888										733	281					IL17RA (inh=n/a pLI=0.12)
chr22	17591089	17591089	G	A	het		QUAL=12189;DP=249;AF=0.44;MQM=59;TRIO=HET,249,0.44,HOM,236,1.00,HET,268,0.44	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*379G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*379G>A:	L2c	rs2895332	0.7310	0.0000	0/0/0	0.6933										84	69					IL17RA (inh=n/a pLI=0.12)
chr22	17591144	17591144	C	T	het		QUAL=6614;DP=187;AF=0.51;MQM=58;TRIO=HET,187,0.51,HOM,149,1.00,WT,166,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*434C>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*434C>T:	AluSz	rs3179921	0.5397	0.0000	0/0/0	0.5250										56	75					IL17RA (inh=n/a pLI=0.12)
chr22	17591697	17591697	G	A	het		QUAL=5070;DP=146;AF=0.45;MQM=59;TRIO=HET,146,0.45,HOM,111,0.99,WT,149,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*987G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*987G>A:	AluJo	rs882644	0.5555	0.0000	0/0/0	0.5295										47	79					IL17RA (inh=n/a pLI=0.12)
chr22	17591973	17591973	G	T	het		QUAL=3470;DP=45;AF=0.69;MQM=59;TRIO=HET,45,0.69,HOM,66,0.95,HET,82,0.71	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*1263G>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*1263G>T:	L2c	rs887795	0.0000	0.0000	0/0/0	0.4753										87	56					IL17RA (inh=n/a pLI=0.12)
chr22	17593048	17593049	AT	-	het		QUAL=10433;DP=423;AF=0.52;MQM=59;TRIO=HET,423,0.52,HET,433,0.52,WT,582,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*2338_*2339delAT:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*2338_*2339delAT:		rs57380532	0.1152	0.0000	0/0/0	0.0949										2	31					IL17RA (inh=n/a pLI=0.12)
chr22	17593685	17593685	G	A	het		QUAL=15314;DP=338;AF=0.54;MQM=60;TRIO=HET,338,0.54,HOM,221,1.00,HET,293,0.46	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*2975G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*2975G>A:		rs887796	0.8367	0.0000	0/0/0	0.1404										101	41					IL17RA (inh=n/a pLI=0.12)
chr22	17593891	17593891	T	G	het		QUAL=4872;DP=369;AF=0.31;MQM=59;TRIO=HET,369,0.31,HET,192,0.66,WT,172,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*3181T>G:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*3181T>G:	(T)n	rs73876645	0.0000	0.0000	0/0/0	0.0323										0	7					IL17RA (inh=n/a pLI=0.12)
chr22	17594623	17594623	C	T	het		QUAL=6390;DP=233;AF=0.54;MQM=59;TRIO=HET,233,0.54,HET,232,0.54,WT,352,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*3913C>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*3913C>T:		rs11702918	0.1134	0.0000	0/0/0	0.0158										2	31					IL17RA (inh=n/a pLI=0.12)
chr22	17594755	17594755	G	A	het		QUAL=5496;DP=226;AF=0.45;MQM=59;TRIO=HET,226,0.45,HET,272,0.46,WT,362,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4045G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4045G>A:	MIR	rs11703539	0.0984	0.0000	0/0/0	0.0151										1	30					IL17RA (inh=n/a pLI=0.12)
chr22	17594886	17594886	T	C	het		QUAL=16638;DP=420;AF=0.53;MQM=60;TRIO=HET,420,0.53,HOM,341,0.99,WT,454,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4176T>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4176T>C:		rs738035	0.4874	0.0000	0/0/0	0.5276										45	81					IL17RA (inh=n/a pLI=0.12)
chr22	17594915	17594915	G	A	het		QUAL=18854;DP=433;AF=0.56;MQM=60;TRIO=HET,433,0.56,HOM,374,1.00,WT,471,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4205G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4205G>A:		rs738034	0.4864	0.0000	0/0/0	0.5259										45	81					IL17RA (inh=n/a pLI=0.12)
chr22	17595070	17595070	T	G	het		QUAL=16981;DP=472;AF=0.48;MQM=59;TRIO=HET,472,0.48,HOM,348,1.00,WT,380,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4360T>G:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4360T>G:		rs5992628	0.4860	0.0000	0/0/0	0.5267										45	81					IL17RA (inh=n/a pLI=0.12)
chr22	17596178	17596178	T	C	het		QUAL=14101;DP=425;AF=0.52;MQM=60;TRIO=HET,425,0.52,HOM,162,1.00,HET,221,0.50	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*5468T>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*5468T>C:	MIRc	rs4819962	0.6186	0.0000	0/0/0	0.1125										75	62					IL17RA (inh=n/a pLI=0.12)
chr22	17596388	17596388	G	C	het		QUAL=11335;DP=320;AF=0.55;MQM=60;TRIO=HET,320,0.55,HOM,132,1.00,HET,153,0.58	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*5678G>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*5678G>C:		rs1654	0.8369	0.0000	0/0/0	0.8257										101	42					IL17RA (inh=n/a pLI=0.12)
chr22	18570974	18570974	C	T	het		QUAL=6537;DP=255;AF=0.48;MQM=59;TRIO=HET,255,0.48,WT,212,0.00,HET,286,0.50	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*133C>T:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*133C>T:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*133C>T:		rs200243782	0.0010	0.0012	0/0/0	0.0012										0	6					PEX26 (inh=n/a pLI=0.44)
chr22	18571008	18571008	G	A	hom	pred_pathogenic_1	QUAL=22698;DP=292;AF=0.99;MQM=59;TRIO=HOM,292,0.99,HET,248,0.47,HOM,343,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*167G>A:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*167G>A:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*167G>A:		rs464385	0.4227	0.5000	5812/3358/143	0.4018	-0.0230	T	D							187	216					PEX26 (inh=n/a pLI=0.44)
chr22	18571670	18571670	A	G	hom		QUAL=33052;DP=302;AF=1.00;MQM=59;TRIO=HOM,302,1.00,HOM,321,1.00,HOM,397,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*829A>G:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*829A>G:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*829A>G:		rs362057	0.9958	0.0000	0/0/0	0.1826										226	4					PEX26 (inh=n/a pLI=0.44)
chr22	18571828	18571828	T	C	hom		QUAL=33097;DP=395;AF=0.99;MQM=59;TRIO=HOM,395,0.99,HOM,287,1.00,HOM,379,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*987T>C:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*987T>C:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*987T>C:		rs361807	0.8734	0.0000	0/0/0	0.8826										182	43					PEX26 (inh=n/a pLI=0.44)
chr22	18572106	18572106	T	A	hom		QUAL=13214;DP=204;AF=0.98;MQM=59;TRIO=HOM,204,0.98,HET,171,0.50,HOM,166,0.99	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1265T>A:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1265T>A:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1265T>A:		rs456551	0.4231	0.0000	0/0/0	0.0615										92	103					PEX26 (inh=n/a pLI=0.44)
chr22	18572371	18572371	-	TTGG	hom		QUAL=29834;DP=264;AF=0.93;MQM=59;TRIO=HOM,264,0.93,HOM,333,0.99,HOM,419,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1532_*1535dupTGGT:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1532_*1535dupTGGT:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1532_*1535dupTGGT:		rs361782;rs397708785	0.8680	0.0000	0/0/0	0.8058										118	29					PEX26 (inh=n/a pLI=0.44)
chr22	18572499	18572499	-	CTCA	hom		QUAL=14678;DP=169;AF=0.97;MQM=54;TRIO=HOM,169,0.97,HOM,181,0.98,HOM,216,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1661_*1662insACTC:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1661_*1662insACTC:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1661_*1662insACTC:	AluYf1	rs10629935;rs361571;rs772261665	0.9952	0.0000	0/0/0	0.8529										148	2					PEX26 (inh=n/a pLI=0.44)
chr22	18572892	18572892	A	G	hom		QUAL=10531;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,71,1.00,HOM,83,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*2051A>G:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*2051A>G:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*2051A>G:		rs361946	0.8734	0.0000	0/0/0	0.1510										119	28					PEX26 (inh=n/a pLI=0.44)
chr22	18573122	18573122	T	C	hom		QUAL=23816;DP=264;AF=1.00;MQM=59;TRIO=HOM,264,1.00,HOM,193,1.00,HOM,284,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*2281T>C:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*2281T>C:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*2281T>C:	L2b	rs362209	0.9960	0.0000	0/0/0	0.1545										148	2					PEX26 (inh=n/a pLI=0.44)
chr22	21213380	21213380	C	T	hom		QUAL=14514;DP=166;AF=0.99;MQM=59;TRIO=HOM,166,0.99,HOM,130,1.00,HOM,217,0.99	SNAP29	5'UTR_premature_start_codon_gain,5'UTR	SNAP29:NM_004782.3:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-19C>T:,SNAP29:NM_004782.3:5'UTR:MODIFIER:exon1/5:c.-19C>T:		rs1061063	0.4639	0.5080	12802/7587/536	0.4767										120	239					SNAP29 (inh=n/a pLI=0.15)
chr22	21213416	21213416	A	G	hom		QUAL=21139;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HOM,206,0.99,HOM,303,0.99	SNAP29	synonymous	SNAP29:NM_004782.3:synonymous:LOW:exon1/5:c.18A>G:p.Lys6Lys		rs1061064	0.4036	0.5020	14180/8596/164	0.4765						604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome];			COSM444738	293	530					SNAP29 (inh=n/a pLI=0.15)
chr22	21242600	21242603	CACA	-	hom		QUAL=2069;DP=94;AF=0.55;MQM=59;TRIO=HOM,94,0.55,HOM,89,0.44,WT,118,0.36	SNAP29	3'UTR	SNAP29:NM_004782.3:3'UTR:MODIFIER:exon5/5:c.*517_*520delACAC:	(CA)n	rs575240461;rs760058624	0.0000	0.0000	0/0/0	0.1234										2	9					SNAP29 (inh=n/a pLI=0.15)
chr22	21244940	21244940	A	G	hom	low_DP;low_MQM	QUAL=330;DP=10;AF=1.00;MQM=47;TRIO=HOM,10,1.00,HOM,1,1.00,HET,4,0.75	SNAP29	3'UTR	SNAP29:NM_004782.3:3'UTR:MODIFIER:exon5/5:c.*2816A>G:	AluYk3	rs165739	0.8321	0.0000	0/0/0	0.7231										101	23					SNAP29 (inh=n/a pLI=0.15)
chr22	23915370	23915370	G	A	het		QUAL=2069;DP=101;AF=0.48;MQM=59;TRIO=HET,101,0.48,HET,73,0.56,WT,83,0.01	IGLL1	3'UTR	IGLL1:NM_020070.3:3'UTR:MODIFIER:exon3/3:c.*83C>T:,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*354C>T:		rs8141940	0.1204	0.0000	0/0/0	0.0106										1	27					IGLL1 (inh=n/a pLI=0.02)
chr22	23915610	23915610	A	T	het	phylop_high;pred_pathogenic_1	QUAL=4835;DP=193;AF=0.42;MQM=55;TRIO=HET,193,0.42,HET,245,0.53,WT,300,0.00	IGLL1	missense,3'UTR	IGLL1:NM_020070.3:missense:MODERATE:exon3/3:c.485T>A:p.Met162Lys,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*114T>A:		rs111903752	0.0383	0.0310	65/41/11	0.0286	2.2680	T	D,D	B	B	146770 [IGLL1 (confirmed) Agammaglobulinemia 2];			COSM228749	2	59					IGLL1 (inh=n/a pLI=0.02)
chr22	23915652	23915652	G	A	het		QUAL=5837;DP=238;AF=0.45;MQM=56;TRIO=HET,238,0.45,WT,223,0.00,HET,256,0.52	IGLL1	missense,3'UTR	IGLL1:NM_020070.3:missense:MODERATE:exon3/3:c.443C>T:p.Thr148Ile,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*72C>T:		rs73157031	0.1388	0.1500	1679/537/8	0.1442	0.2820	T	T,T	B	B	146770 [IGLL1 (confirmed) Agammaglobulinemia 2];			COSM149263	25	214					IGLL1 (inh=n/a pLI=0.02)
chr22	24891292	24891292	C	G	hom		QUAL=11035;DP=96;AF=1.00;MQM=59;TRIO=HOM,96,1.00,HOM,180,1.00,HET,217,0.56	UPB1	5'UTR	UPB1:NM_016327.2:5'UTR:MODIFIER:exon1/10:c.-80C>G:		rs2070474	0.5327	0.0000	0/0/0	0.1059							RCV000086537.1 [not provided]; 			78	120					UPB1 (inh=AR pLI=0.00)
chr22	31003138	31003138	A	G	hom		QUAL=6543;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,61,1.00,HOM,92,0.99	TCN2	5'UTR	TCN2:NM_000355.3:5'UTR:MODIFIER:exon1/9:c.-181A>G:,TCN2:NM_001184726.1:5'UTR:MODIFIER:exon1/9:c.-181A>G:		rs2240433	0.5545	0.0000	0/0/0	0.4920										45	77					TCN2 (inh=AR pLI=0.02)
chr22	31011610	31011610	G	C	hom		QUAL=15750;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HET,310,0.50,HET,359,0.51	TCN2	missense	TCN2:NM_000355.3:missense:MODERATE:exon6/9:c.776G>C:p.Arg259Pro,TCN2:NM_001184726.1:missense:MODERATE:exon6/9:c.695G>C:p.Arg232Pro		rs1801198	0.5797	0.5670	20120/10854/3008	0.5604	0.1460	T	T,T,T	B,B,B	B,B,B	613441 [TCN2 (confirmed) Transcobalamin II deficiency];	RCV000000117.2 [benign]; 	CM022466 [CLASS=DFP MUT=REF PHEN="Decreased holo TCII levels association with" GENE=TCN2]; 	COSM4002151	356	538					TCN2 (inh=AR pLI=0.02)
chr22	31022635	31022635	C	T	hom		QUAL=15920;DP=256;AF=0.99;MQM=59;TRIO=HOM,256,0.99,HET,225,0.59,HET,337,0.53	TCN2	3'UTR	TCN2:NM_000355.3:3'UTR:MODIFIER:exon9/9:c.*127C>T:,TCN2:NM_001184726.1:3'UTR:MODIFIER:exon9/9:c.*127C>T:		rs12160073	0.0675	0.0000	0/0/0	0.0261										5	60					TCN2 (inh=AR pLI=0.02)
chr22	33669492	33669492	G	C	het		QUAL=8345;DP=398;AF=0.50;MQM=59;TRIO=HET,398,0.50,HET,235,0.50,WT,322,0.00	LARGE	3'UTR	LARGE:NM_004737.4:3'UTR:MODIFIER:exon16/16:c.*921C>G:,LARGE:NM_133642.3:3'UTR:MODIFIER:exon15/15:c.*921C>G:		rs16992034	0.0543	0.0000	0/0/0	0.0093										1	22					LARGE (inh=AR pLI=0.96)
chr22	33670584	33670584	G	A	het		QUAL=4251;DP=172;AF=0.49;MQM=60;TRIO=HET,172,0.49,HET,160,0.51,WT,176,0.00	LARGE	synonymous	LARGE:NM_004737.4:synonymous:LOW:exon16/16:c.2100C>T:p.Asn700Asn,LARGE:NM_133642.3:synonymous:LOW:exon15/15:c.2100C>T:p.Asn700Asn		rs17722172	0.0210	0.0470	178/163/0	0.0472						603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6];	RCV000081178.7 [other]; 			7	119					LARGE (inh=AR pLI=0.96)
chr22	34022284	34022284	G	A	het		QUAL=15377;DP=340;AF=0.49;MQM=60;TRIO=HET,340,0.49,HET,366,0.53,HET,489,0.49	LARGE	synonymous	LARGE:NM_004737.4:synonymous:LOW:exon5/16:c.435C>T:p.Ala145Ala,LARGE:NM_133642.3:synonymous:LOW:exon4/15:c.435C>T:p.Ala145Ala		rs86487	0.4129	0.4770	14434/7968/126	0.4745						603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6];	RCV000081181.6 [other]; 		COSM4156187	292	549					LARGE (inh=AR pLI=0.96)
chr22	37271882	37271882	T	C	hom	pred_pathogenic_1	QUAL=15839;DP=114;AF=1.00;MQM=59;TRIO=HOM,114,1.00,HOM,184,0.99,HOM,229,1.00	NCF4	missense,intron	NCF4:NM_013416.3:missense:MODERATE:exon8/9:c.815T>C:p.Leu272Pro,NCF4:NM_000631.4:intron:MODIFIER:exon8/9:c.758+57T>C:		rs2075939	0.8281	0.8340	42411/23351/4665	0.8159	0.2940	T	D	B	B	601488 [NCF4 (provisional) Granulomatous disease,chronic,autosomal recessive,cytochrome b-positive,type III];			COSM4156206	777	292					NCF4 (inh=n/a pLI=0.00)
chr22	38369027	38369027	C	T	het		QUAL=8649;DP=173;AF=0.48;MQM=60;TRIO=HET,173,0.48,HOM,149,0.99,HET,192,0.44	SOX10,POLR2F	3'UTR,intron	SOX10:NM_006941.3:3'UTR:MODIFIER:exon4/4:c.*475G>A:,POLR2F:NM_001301130.1:intron:MODIFIER:exon4/5:c.293+5850C>T:,POLR2F:NM_001301131.1:intron:MODIFIER:exon4/4:c.293+5850C>T:		rs139883	0.6084	0.0000	0/0/0	0.1069										107	124					SOX10 (inh=AD pLI=0.91), POLR2F (inh=n/a pLI=0.65)
chr22	38369976	38369976	A	G	het		QUAL=3406;DP=95;AF=0.55;MQM=60;TRIO=HET,95,0.55,HOM,46,1.00,HET,72,0.44	SOX10,POLR2F	synonymous,intron	SOX10:NM_006941.3:synonymous:LOW:exon4/4:c.927T>C:p.His309His,POLR2F:NM_001301130.1:intron:MODIFIER:exon4/5:c.293+6799A>G:,POLR2F:NM_001301131.1:intron:MODIFIER:exon4/4:c.293+6799A>G:		rs139884	0.7133	0.6530	26127/13186/3510	0.6486						602229 [SOX10 (confirmed) Waardenburg syndrome,type 4C|Waardenburg syndrome,type 2E,with or without neurologic involvement|PCWH syndrome];	RCV000218215.1 [benign]; 		COSM4156245	639	761					SOX10 (inh=AD pLI=0.91), POLR2F (inh=n/a pLI=0.65)
chr22	41323897	41323897	G	A	het	low_MQM	QUAL=524;DP=84;AF=0.14;MQM=37;TRIO=HET,84,0.54,WT,19,0.47,WT,19,0.68	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*1458G>A:	AluYm1		0.0000	0.0000	0/0/0	0.0008										0	83					XPNPEP3 (inh=n/a pLI=0.00)
chr22	41324205	41324205	C	T	hom		QUAL=1471;DP=34;AF=0.41;MQM=56;TRIO=HOM,34,0.41,HOM,21,0.14,HOM,28,0.11	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*1766C>T:	AluSx3	rs371229000	0.0000	0.0000	0/0/0	0.0002										0	23					XPNPEP3 (inh=n/a pLI=0.00)
chr22	41325068	41325068	G	A	hom		QUAL=16964;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,227,1.00,HET,268,0.46	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*2629G>A:		rs2899341	0.5946	0.0000	0/0/0	0.0952										41	68					XPNPEP3 (inh=n/a pLI=0.00)
chr22	41325196	41325196	C	T	hom		QUAL=2365;DP=93;AF=0.20;MQM=54;TRIO=HOM,93,0.20,HOM,37,0.22,HOM,58,0.31	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*2757C>T:	AluSx3	rs201927557	0.0000	0.0000	0/0/0	0.0004										0	30					XPNPEP3 (inh=n/a pLI=0.00)
chr22	42454354	42454354	G	A	hom		QUAL=19175;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HET,291,0.49,HET,346,0.53	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1929C>T:	L1MC5a	rs5758566	0.6476	0.0000	0/0/0	0.1161										105	100					NAGA (inh=AR pLI=0.00)
chr22	42454494	42454494	A	-	hom		QUAL=21013;DP=308;AF=0.92;MQM=59;TRIO=HOM,308,0.92,HOM,205,0.96,HOM,215,0.95	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1789delT:		rs796216027	0.8966	0.0000	0/0/0	0.3680										198	29					NAGA (inh=AR pLI=0.00)
chr22	42454950	42454950	A	G	het		QUAL=11053;DP=450;AF=0.47;MQM=60;TRIO=HET,450,0.47,HET,381,0.52,WT,449,0.00	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1333T>C:		rs1063392	0.4595	0.0000	0/0/0	0.0869										55	114					NAGA (inh=AR pLI=0.00)
chr22	42455248	42455248	C	T	het		QUAL=10862;DP=368;AF=0.45;MQM=60;TRIO=HET,368,0.45,WT,344,0.00,HET,470,0.53	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1035G>A:		rs62238588	0.0306	0.0000	0/0/0	0.0107										0	27					NAGA (inh=AR pLI=0.00)
chr22	42458827	42458827	G	C	het	low_DP	QUAL=53;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,7,0.00,HET,4,0.25	NAGA	splice_region&intron	NAGA:NM_000262.2:splice_region&intron:LOW:exon7/8:c.957+4C>G:		rs55715427	0.0298	0.0580	280/249/0	0.0585						104170 [NAGA (confirmed) Schindler disease,type I|Kanzaki disease|Schindler disease,type III];				5	129					NAGA (inh=AR pLI=0.00)
chr22	42463814	42463814	C	T	hom		QUAL=13517;DP=186;AF=0.99;MQM=59;TRIO=HOM,186,0.99,HET,278,0.47,HET,384,0.51	NAGA	synonymous	NAGA:NM_000262.2:synonymous:LOW:exon3/9:c.279G>A:p.Pro93Pro		rs133369	0.6769	0.6730	27836/14900/1773	0.6700						104170 [NAGA (confirmed) Schindler disease,type I|Kanzaki disease|Schindler disease,type III];	RCV000177025.1 [benign]; 		COSM3759227	474	498					NAGA (inh=AR pLI=0.00)
chr22	42466509	42466509	C	G	hom		QUAL=18767;DP=324;AF=0.99;MQM=59;TRIO=HOM,324,0.99,HET,294,0.48,HET,377,0.52	NAGA	5'UTR	NAGA:NM_000262.2:5'UTR:MODIFIER:exon1/9:c.-208G>C:		rs133375	0.6424	0.0000	0/0/0	0.1156										105	100					NAGA (inh=AR pLI=0.00)
chr22	42522550	42522550	G	A	het	low_QUAL;low_DP;low_MQM	QUAL=17;DP=7;AF=0.43;MQM=42;TRIO=HET,7,0.43,WT,1,0.00,WT,1,0.00	CYP2D6,LOC101929829	3'UTR,non_coding_exon	CYP2D6:NM_000106.5:3'UTR:MODIFIER:exon9/9:c.*26C>T:,CYP2D6:NM_001025161.2:3'UTR:MODIFIER:exon8/8:c.*26C>T:,LOC101929829:NR_111920.1:non_coding_exon:MODIFIER:exon9/9:n.1609C>T:		rs201759814	0.0000	0.0230	0/0/0	0.0011										2	26					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42523003	42523003	A	G	hom	low_DP;low_MQM	QUAL=286;DP=9;AF=1.00;MQM=31;TRIO=HOM,9,1.00,WT,110,0.01,HET,157,0.21	CYP2D6,LOC101929829	splice_region&intron	CYP2D6:NM_000106.5:splice_region&intron:LOW:exon7/8:c.1174-9T>C:,LOC101929829:NR_111920.1:splice_region&intron:LOW:exon7/8:n.1263-9T>C:,CYP2D6:NM_001025161.2:splice_region&intron:LOW:exon6/7:c.1021-9T>C:		rs4987144	0.0000	0.1260	1097/562/98	0.0958						124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];				477	327					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42523528	42523528	C	T	het	phylop_high;pred_pathogenic_3	QUAL=2573;DP=175;AF=0.30;MQM=52;TRIO=HET,175,0.30,WT,137,0.00,HET,465,0.23	CYP2D6,LOC101929829	missense,non_coding_exon	CYP2D6:NM_000106.5:missense:MODERATE:exon7/9:c.1094G>A:p.Arg365His,CYP2D6:NM_001025161.2:missense:MODERATE:exon6/8:c.941G>A:p.Arg314His,LOC101929829:NR_111920.1:non_coding_exon:MODIFIER:exon7/9:n.1183G>A:		rs1058172	0.0000	0.1200	10/6/0	0.0989	7.6100	T	D,D,D,D,D	D,D,D	D,D,D	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM445068, COSM445067	0	191					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42523636	42523636	C	A	het	low_MQM;pred_pathogenic_1	QUAL=371;DP=116;AF=0.33;MQM=40;TRIO=HET,116,0.33,WT,105,0.04,WT,330,0.07	CYP2D6,LOC101929829	missense&splice_region,splice_region&non_coding_exon	CYP2D6:NM_000106.5:missense&splice_region:MODERATE:exon7/9:c.986G>T:p.Arg329Leu,CYP2D6:NM_001025161.2:missense&splice_region:MODERATE:exon6/8:c.833G>T:p.Arg278Leu,LOC101929829:NR_111920.1:splice_region&non_coding_exon:LOW:exon7/9:n.1075G>T:		rs3915951	0.0000	0.0740	1/1/0	0.0010	0.4480	T	D,D,D,D,D	B,B,B	B,B,B	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM304740, COSM225813	0	70					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42523943	42523943	A	G	hom		QUAL=14082;DP=187;AF=0.99;MQM=56;TRIO=HOM,187,0.99,WT,245,0.02,HET,671,0.50	CYP2D6,LOC101929829	missense,non_coding_exon	CYP2D6:NM_000106.5:missense:MODERATE:exon6/9:c.886T>C:p.Cys296Arg,CYP2D6:NM_001025161.2:missense:MODERATE:exon5/8:c.733T>C:p.Cys245Arg,LOC101929829:NR_111920.1:non_coding_exon:MODIFIER:exon6/9:n.975T>C:		rs16947	0.6408	0.6560	27465/14944/1310	0.6417	-1.2000	T	T,T,T,T,T	B,B	B,B	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018391.27 [drug response]; 	CM930187 [CLASS=DFP MUT=REF PHEN="Parkinson disease association with" GENE=CYP2D6]; 	COSM1130423, COSM1130422	484	484					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42524795	42524795	A	G	het		QUAL=1101;DP=110;AF=0.22;MQM=55;TRIO=HET,110,0.22,HET,327,0.21,WT,270,0.00	CYP2D6,LOC101929829	synonymous,non_coding_exon	CYP2D6:NM_000106.5:synonymous:LOW:exon4/9:c.657T>C:p.Phe219Phe,CYP2D6:NM_001025161.2:synonymous:LOW:exon3/8:c.504T>C:p.Phe168Phe,LOC101929829:NR_111920.1:non_coding_exon:MODIFIER:exon4/9:n.746T>C:		rs28371713	0.0000	0.2860	35/17/7	0.0098						124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM1632628, COSM1632629	2	664					CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42524947	42524947	C	T	hom	low_MQM;anno_high_impact;phylop_high	QUAL=4903;DP=68;AF=0.93;MQM=48;TRIO=HOM,68,0.93,WT,145,0.00,HET,303,0.47	CYP2D6,LOC101929829	splice_acceptor	CYP2D6:NM_000106.5:splice_acceptor:HIGH:exon3/8:c.506-1G>A:,LOC101929829:NR_111920.1:splice_acceptor:HIGH:exon3/8:n.596-2G>A:,CYP2D6:NM_001025161.2:splice_acceptor:HIGH:exon2/7:c.353-1G>A:		rs3892097	0.0931	0.1100	530/393/37	0.1080	5.1840					124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018385.23 [drug response]; RCV000211167.1 [drug response]; RCV000211174.1 [drug response]; RCV000211232.1 [drug response]; RCV000211292.1 [drug response]; RCV000211293.1 [drug response]; RCV000211307.1 [drug response]; RCV000211390.1 [drug response]; RCV000211415.1 [drug response]; RCV000211422.1 [drug response]; 	CS900241 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		42	279	1	[1] auto-classification 16.06.2016  [2] Peter Bauer 05.08.2014			CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	42526694	42526694	G	A	hom	phylop_high;pred_pathogenic_3	QUAL=2290;DP=39;AF=0.95;MQM=59;TRIO=HOM,39,0.95,WT,44,0.00,HET,109,0.54	CYP2D6,LOC101929829	missense,non_coding_exon	CYP2D6:NM_000106.5:missense:MODERATE:exon1/9:c.100C>T:p.Pro34Ser,CYP2D6:NM_001025161.2:missense:MODERATE:exon1/8:c.100C>T:p.Pro34Ser,LOC101929829:NR_111920.1:non_coding_exon:MODIFIER:exon1/9:n.190C>T:		rs1065852	0.2380	0.2040	3570/1648/121	0.1838	7.1060	T	D,D,D,D	D,P	D,P	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018389.23 [drug response]; 	CM900081 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		57	308	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			CYP2D6 (inh=n/a pLI=0.00), LOC101929829 (inh=n/a pLI=n/a)
chr22	43014714	43014714	A	-	het		QUAL=61;DP=74;AF=0.26;MQM=58;TRIO=HET,74,0.26,WT,23,0.09,WT,30,0.27	CYB5R3	3'UTR	CYB5R3:NM_001171660.1:3'UTR:MODIFIER:exon9/9:c.*1065delT:,CYB5R3:NM_001129819.2:3'UTR:MODIFIER:exon9/9:c.*1065delT:,CYB5R3:NM_001171661.1:3'UTR:MODIFIER:exon10/10:c.*1065delT:,CYB5R3:NM_007326.4:3'UTR:MODIFIER:exon9/9:c.*1065delT:,CYB5R3:NM_000398.6:3'UTR:MODIFIER:exon9/9:c.*1065delT:	AluSg4	rs36011098;rs796931131	0.0000	0.0000	0/0/0	0.0113										1	64					CYB5R3 (inh=AR pLI=0.21)
chr22	43032742	43032742	C	T	het		QUAL=5138;DP=151;AF=0.50;MQM=60;TRIO=HET,151,0.50,HET,317,0.49,WT,419,0.00	CYB5R3	synonymous	CYB5R3:NM_001171660.1:synonymous:LOW:exon2/9:c.231G>A:p.Pro77Pro,CYB5R3:NM_001129819.2:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:NM_001171661.1:synonymous:LOW:exon3/10:c.63G>A:p.Pro21Pro,CYB5R3:NM_007326.4:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:NM_000398.6:synonymous:LOW:exon2/9:c.132G>A:p.Pro44Pro		rs5996200	0.0737	0.1130	889/725/59	0.1112						613213 [CYB5R3 (confirmed) Methemoglobinemia,type I|Methemoglobinemia,type II];				33	297					CYB5R3 (inh=AR pLI=0.21)
chr22	46239934	46239934	C	T	het		QUAL=8567;DP=408;AF=0.52;MQM=60;TRIO=HET,408,0.52,HET,242,0.43,WT,333,0.00	ATXN10	3'UTR	ATXN10:NM_013236.3:3'UTR:MODIFIER:exon12/12:c.*383C>T:,ATXN10:NM_001167621.1:3'UTR:MODIFIER:exon11/11:c.*383C>T:		rs9614791	0.0200	0.0000	0/0/0	0.0074										2	29					ATXN10 (inh=n/a pLI=0.75)
chr22	50297591	50297591	G	A	het		QUAL=5676;DP=205;AF=0.44;MQM=59;TRIO=HET,205,0.44,HET,299,0.51,WT,428,0.00	ALG12	synonymous	ALG12:NM_024105.3:synonymous:LOW:exon10/10:c.1362C>T:p.Val454Val		rs12163163	0.0012	0.0010	1/0/0	0.0009	0.0060	T				607144 [ALG12 (confirmed) Congenital disorder of glycosylation,type Ig];				0	2					ALG12 (inh=n/a pLI=0.01)
chr22	50498030	50498030	-	C	het		QUAL=2977;DP=166;AF=0.46;MQM=59;TRIO=HET,166,0.46,HET,173,0.46,WT,175,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1981dupG:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1981dupG:		rs145385166	0.1322	0.0000	0/0/0	0.1364										1	58					MLC1 (inh=AR pLI=0.00)
chr22	50498176	50498176	C	T	het		QUAL=4789;DP=151;AF=0.46;MQM=60;TRIO=HET,151,0.46,HET,132,0.58,HET,138,0.45	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1836G>A:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1836G>A:		rs11703598	0.0563	0.0000	0/0/0	0.0157										5	54					MLC1 (inh=AR pLI=0.00)
chr22	50498389	50498389	C	A	het		QUAL=4808;DP=156;AF=0.49;MQM=59;TRIO=HET,156,0.49,HET,89,0.49,HET,123,0.59	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1623G>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1623G>T:		rs35730155	0.1510	0.0000	0/0/0	0.0247										5	56					MLC1 (inh=AR pLI=0.00)
chr22	50499021	50499021	A	C	het		QUAL=7318;DP=195;AF=0.52;MQM=59;TRIO=HET,195,0.52,HET,445,0.47,WT,565,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*991T>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*991T>G:		rs11704648	0.1304	0.0000	0/0/0	0.0239										5	55					MLC1 (inh=AR pLI=0.00)
chr22	50499075	50499075	G	A	het		QUAL=5237;DP=221;AF=0.48;MQM=59;TRIO=HET,221,0.48,HET,338,0.42,WT,457,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*937C>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*937C>T:		rs41283491	0.1306	0.0000	0/0/0	0.1392										5	55					MLC1 (inh=AR pLI=0.00)
chr22	50499239	50499239	C	T	het		QUAL=741;DP=90;AF=0.46;MQM=54;TRIO=HET,90,0.46,WT,92,0.00,WT,168,0.02	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*773G>A:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*773G>A:		rs4838880	0.1793	0.0000	0/0/0	0.1414										5	58					MLC1 (inh=AR pLI=0.00)
chr22	50499634	50499634	-	GACCCCC	het		QUAL=2902;DP=196;AF=0.42;MQM=59;TRIO=HET,196,0.42,HET,183,0.43,WT,286,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:		rs368794754	0.1304	0.0000	0/0/0	0.1256										4	54					MLC1 (inh=AR pLI=0.00)
chr22	50499964	50499964	T	C	het		QUAL=8616;DP=178;AF=0.46;MQM=60;TRIO=HET,178,0.46,HET,266,0.45,HET,327,0.45	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*48A>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*48A>G:		rs137919	0.2829	0.2970	5755/2771/78	0.2915										27	92					MLC1 (inh=AR pLI=0.00)
chr22	50499967	50499967	T	C	het		QUAL=10516;DP=166;AF=0.55;MQM=60;TRIO=HET,166,0.55,HET,258,0.55,HET,327,0.54	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*45A>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*45A>G:		rs2072873	0.1504	0.1460	1336/617/181	0.1419										5	56					MLC1 (inh=AR pLI=0.00)
chr22	50502491	50502491	T	C	het		QUAL=1472;DP=72;AF=0.50;MQM=59;TRIO=HET,72,0.50,HET,90,0.42,WT,122,0.00	MLC1	missense	MLC1:NM_015166.3:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser,MLC1:NM_139202.2:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser		rs11568188	0.1312	0.0820	670/280/17	0.0800	0.6210	T	T,T,T,T,T,T	B,B,B	B,B,B	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000020711.2 [benign]; RCV000117622.2 [likely benign]; 		COSM1416980	38	382					MLC1 (inh=AR pLI=0.00)
chr22	50502526	50502526	A	G	het		QUAL=2707;DP=133;AF=0.47;MQM=59;TRIO=HET,133,0.47,HET,132,0.47,WT,174,0.00	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser,MLC1:NM_139202.2:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser		rs11568187	0.1312	0.1280	1030/499/31	0.1233						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117629.2 [likely benign]; 		COSM3722537	37	369					MLC1 (inh=AR pLI=0.00)
chr22	50502544	50502544	G	A	het		QUAL=3549;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,HET,153,0.46,WT,180,0.01	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys,MLC1:NM_139202.2:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys		rs11568186	0.1312	0.1280	1027/493/29	0.1249						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117628.2 [likely benign]; 			33	360					MLC1 (inh=AR pLI=0.00)
chr22	50502636	50502636	G	A	het		QUAL=1725;DP=58;AF=0.26;MQM=59;TRIO=HET,58,0.26,HET,136,0.51,WT,191,0.01	MLC1	splice_region&intron	MLC1:NM_015166.3:splice_region&intron:LOW:exon10/11:c.895-9C>T:,MLC1:NM_139202.2:splice_region&intron:LOW:exon10/11:c.895-9C>T:		rs11568185	0.1316	0.1080	584/234/18	0.1074						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117627.2 [likely benign]; 			39	470					MLC1 (inh=AR pLI=0.00)
chr22	50515270	50515270	T	C	het		QUAL=8752;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,407,0.53,WT,443,0.00	MLC1	splice_region&synonymous	MLC1:NM_015166.3:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser,MLC1:NM_139202.2:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser		rs6010164	0.1306	0.1270	1096/468/66	0.1259						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117626.2 [likely benign]; 		COSM4002217	38	428					MLC1 (inh=AR pLI=0.00)
chr22	50515273	50515273	G	A	het		QUAL=8752;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,407,0.53,WT,443,0.00	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr,MLC1:NM_139202.2:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr		rs6010165	0.1306	0.1270	1096/468/66	0.1258						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117625.2 [likely benign]; 		COSM4002218	38	428					MLC1 (inh=AR pLI=0.00)
chr22	50515843	50515843	C	A	het	phylop_high;pred_pathogenic_1	QUAL=2287;DP=99;AF=0.43;MQM=60;TRIO=HET,99,0.43,HET,111,0.50,WT,153,0.00	MLC1	missense	MLC1:NM_015166.3:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe,MLC1:NM_139202.2:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe		rs6010260	0.1216	0.1230	1025/444/27	0.1226	2.1120	T	D,D,D,D,D,D,D	B,B,B,B	B,B,B,B	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000020714.2 [benign]; RCV000117624.2 [likely benign]; 			37	428					MLC1 (inh=AR pLI=0.00)
chr22	50524250	50524250	-	C	hom		QUAL=12325;DP=133;AF=0.91;MQM=59;TRIO=HOM,133,0.91,HOM,130,0.98,HOM,187,0.98	MLC1	5'UTR	MLC1:NM_015166.3:5'UTR:MODIFIER:exon1/12:c.-527dupG:		rs137931	0.6719	0.0000	0/0/0	0.6744										122	98					MLC1 (inh=AR pLI=0.00)
chr22	50524285	50524285	C	T	het		QUAL=3720;DP=162;AF=0.48;MQM=59;TRIO=HET,162,0.48,HET,89,0.37,HET,142,0.44	MLC1	5'UTR	MLC1:NM_015166.3:5'UTR:MODIFIER:exon1/12:c.-561G>A:		rs4838883	0.1494	0.0000	0/0/0	0.1540										6	59					MLC1 (inh=AR pLI=0.00)
chr22	50962208	50962208	T	G	het		QUAL=2899;DP=145;AF=0.48;MQM=60;TRIO=HET,145,0.48,WT,86,0.00,HET,80,0.54	SCO2,NCAPH2	synonymous,3'UTR	SCO2:NM_001169109.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_001169111.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_005138.2:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_001169110.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,NCAPH2:NM_001185011.1:3'UTR:MODIFIER:exon20/20:c.*404T>G:,NCAPH2:NM_152299.3:3'UTR:MODIFIER:exon20/20:c.*404T>G:		rs12148	0.6556	0.6380	24848/12588/2265	0.6312						604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1|Myopia 6];	RCV000128016.1 [benign]; 			441	543					SCO2 (inh=n/a pLI=0.00), NCAPH2 (inh=n/a pLI=0.65)
chr22	50962782	50962782	C	G	het		QUAL=1851;DP=96;AF=0.45;MQM=60;TRIO=HET,96,0.45,WT,45,0.02,HET,75,0.49	SCO2,NCAPH2	missense,3'UTR	SCO2:NM_001169109.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_001169111.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_005138.2:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_001169110.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,NCAPH2:NM_001185011.1:3'UTR:MODIFIER:exon20/20:c.*978C>G:,NCAPH2:NM_152299.3:3'UTR:MODIFIER:exon20/20:c.*978C>G:		rs140523	0.6516	0.6330	23621/11904/1889	0.6245	-3.5700	T	T,T,T,T,T,T	B	B	604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1|Myopia 6];	RCV000128012.1 [benign]; 		COSM445183, COSM1484348	443	536					SCO2 (inh=n/a pLI=0.00), NCAPH2 (inh=n/a pLI=0.65)
chr22	50963965	50963965	C	G	het		QUAL=1567;DP=53;AF=0.57;MQM=60;TRIO=HET,53,0.57,WT,51,0.00,HET,78,0.54	SCO2	5'UTR,intron	SCO2:NM_001169111.1:5'UTR:MODIFIER:exon1/2:c.-108G>C:,SCO2:NM_005138.2:5'UTR:MODIFIER:exon1/2:c.-78G>C:,SCO2:NM_001169109.1:intron:MODIFIER:exon1/1:c.-14+710G>C:,SCO2:NM_001169110.1:intron:MODIFIER:exon1/1:c.-14+465G>C:		rs131806	0.5339	0.0000	0/0/0	0.5079										73	108					SCO2 (inh=n/a pLI=0.00)
chr22	50964862	50964862	G	A	hom	low_DP	QUAL=47;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,WT,8,0.00,WT,3,0.00	TYMP,SCO2	synonymous,5'UTR	TYMP:NM_001257989.1:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001113755.2:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001113756.2:synonymous:LOW:exon7/9:c.972C>T:p.Ala324Ala,TYMP:NM_001257988.1:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001953.4:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,SCO2:NM_001169109.1:5'UTR:MODIFIER:exon1/2:c.-201C>T:		rs131804	0.5329	0.5260	3624/1538/63	0.3645						131222 [TYMP (confirmed) Mitochondrial DNA depletion syndrome 1 (MNGIE type)];	RCV000118808.4 [other]; 			308	473					TYMP (inh=n/a pLI=0.00), SCO2 (inh=n/a pLI=0.00)
chr22	51062051	51062051	G	T	het		QUAL=3136;DP=170;AF=0.45;MQM=58;TRIO=HET,170,0.45,WT,52,0.00,HOM,53,1.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*1522C>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*1522C>A:	AluSx	rs6009939	0.3321	0.0000	0/0/0	0.2131										4	48					ARSA (inh=AR pLI=0.00)
chr22	51062222	51062222	G	C	het	low_DP	QUAL=119;DP=14;AF=0.50;MQM=51;TRIO=HET,14,0.50,WT,1,0.00,WT,53,1.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*1351C>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*1351C>G:	AluSx	rs131717	0.4762	0.0000	0/0/0	0.4178										47	40					ARSA (inh=AR pLI=0.00)
chr22	51062654	51062654	T	C	hom		QUAL=5566;DP=79;AF=0.99;MQM=55;TRIO=HOM,79,0.99,HET,57,0.53,HOM,88,1.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*919A>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*919A>G:	AluSp	rs5770805	0.8349	0.0000	0/0/0	0.6361										85	58					ARSA (inh=AR pLI=0.00)
chr22	51062718	51062718	C	T	het		QUAL=2003;DP=89;AF=0.48;MQM=50;TRIO=HET,89,0.48,HET,105,0.48,WT,144,0.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*855G>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*855G>A:	AluSp	rs7288050	0.3490	0.0000	0/0/0	0.2005										30	79					ARSA (inh=AR pLI=0.00)
chr22	51062832	51062832	G	A	het		QUAL=8738;DP=305;AF=0.49;MQM=59;TRIO=HET,305,0.49,WT,268,0.00,HET,386,0.50	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*741C>T:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*741C>T:	L2	rs8142033	0.1773	0.0000	0/0/0	0.1096										0	31					ARSA (inh=AR pLI=0.00)
chr22	51062891	51062891	C	G	het		QUAL=4813;DP=177;AF=0.55;MQM=60;TRIO=HET,177,0.55,HET,227,0.42,WT,336,0.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*682G>C:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*682G>C:		rs7288338	0.3510	0.0000	0/0/0	0.3790										33	77					ARSA (inh=AR pLI=0.00)
chr22	51062938	51062938	C	T	het		QUAL=8993;DP=131;AF=0.46;MQM=59;TRIO=HET,131,0.46,WT,198,0.00,HOM,252,0.98	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*635G>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*635G>A:		rs5770953	0.3588	0.0000	0/0/0	0.2397										4	48					ARSA (inh=AR pLI=0.00)
chr22	51063477	51063477	T	C	het	anno_pathogenic_clinvar	QUAL=11488;DP=210;AF=0.49;MQM=59;TRIO=HET,210,0.49,WT,582,0.00,HET,740,0.49	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*96A>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*96A>G:		rs6151429	0.0499	0.0000	0/0/0	0.0092							RCV000003190.2 [pathogenic]; RCV000020309.1 [pathogenic]; RCV000180167.1 [not provided]; 	CR890137 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency association" GENE=ARSA]; 		1	47	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chr22	51064039	51064039	G	C	het	anno_pathogenic_clinvar	QUAL=9971;DP=201;AF=0.56;MQM=59;TRIO=HET,201,0.56,HET,206,0.67,HET,290,0.45	ARSA	missense	ARSA:NM_000487.5:missense:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser,ARSA:NM_001085425.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085426.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085427.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085428.2:missense:MODERATE:exon7/8:c.920C>G:p.Thr307Ser		rs743616	0.4056	0.4830	14735/9758/824	0.4707	0.1030	T	T,T,T,T,T,T,T	B	B	607574 [ARSA (confirmed) Metachromatic leukodystrophy];	RCV000020311.1 [pathogenic]; RCV000078937.4 [benign]; 	CM910052 [CLASS=DP MUT=ALT PHEN="Phenotype modifier association with" GENE=ARSA]; 		587	1136	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chr22	51064416	51064416	T	C	het	phylop_high;anno_pathogenic_clinvar	QUAL=6149;DP=166;AF=0.49;MQM=59;TRIO=HET,166,0.49,WT,283,0.00,HET,303,0.54	ARSA	missense	ARSA:NM_000487.5:missense:MODERATE:exon6/8:c.1055A>G:p.Asn352Ser,ARSA:NM_001085425.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085426.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085427.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085428.2:missense:MODERATE:exon6/8:c.797A>G:p.Asn266Ser		rs2071421	0.2248	0.1320	839/252/316	0.1258	1.7670	T	T,T,T,T,T,T,T	B	B	607574 [ARSA (confirmed) Metachromatic leukodystrophy];	RCV000003191.2 [benign]; RCV000020310.1 [pathogenic]; RCV000078931.4 [not provided]; 	CM890013 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency association" GENE=ARSA]; 	COSM4004968	40	559	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chrX	2856155	2856155	C	T	hom	phylop_high	QUAL=5926;DP=75;AF=1.00;MQM=59;TRIO=HOM,75,1.00,HOM,69,0.99,HOM,58,1.00	ARSE	missense	ARSE:NM_001282628.1:missense:MODERATE:exon10/12:c.1345G>A:p.Gly449Ser,ARSE:NM_000047.2:missense:MODERATE:exon9/11:c.1270G>A:p.Gly424Ser,ARSE:NM_001282631.1:missense:MODERATE:exon8/10:c.1135G>A:p.Gly379Ser		rs35143646	0.5746	0.6640	11756/6675/93	0.6127	6.3350	T	T,T,T	P,P,P	P,B,P	300180 [ARSE (confirmed) Chondrodysplasia punctata,X-linked recessive];	RCV000145026.1 [benign]; 			738	197					ARSE (inh=XLR pLI=0.12)
chrX	5808861	5808861	G	A	hom		QUAL=12150;DP=196;AF=0.99;MQM=60;TRIO=HOM,196,0.99,HET,150,0.55,HOM,113,1.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*1997C>T:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*1997C>T:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*1997C>T:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*1997C>T:		rs1882260	0.7083	0.0000	0/0/0	0.4939										234	44					NLGN4X (inh=n/a pLI=0.93)
chrX	5810090	5810090	A	G	hom		QUAL=3648;DP=98;AF=0.98;MQM=60;TRIO=HOM,98,0.98,HET,58,0.47,WT,27,0.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*768T>C:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*768T>C:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*768T>C:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*768T>C:	(TA)n	rs3810685	0.3687	0.0000	0/0/0	0.2203										129	64					NLGN4X (inh=n/a pLI=0.93)
chrX	5810574	5810574	C	T	hom		QUAL=9755;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,252,0.46,WT,176,0.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*284G>A:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*284G>A:		rs3810686	0.3674	0.0000	0/0/0	0.0476										130	60					NLGN4X (inh=n/a pLI=0.93)
chrX	10588431	10588431	C	A	hom		QUAL=13531;DP=281;AF=0.97;MQM=59;TRIO=HOM,281,0.97,HET,441,0.51,WT,236,0.00	MID1	5'UTR,intron	MID1:NM_000381.3:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:NM_033289.1:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:NM_001098624.2:intron:MODIFIER:exon1/9:c.-56-52788G>T:,MID1:NM_033290.3:intron:MODIFIER:exon1/9:c.-56-52788G>T:		rs147326498	0.0037	0.0000	0/0/0	0.0095										5	1					MID1 (inh=n/a pLI=0.50)
chrX	12725042	12725042	C	T	hom	low_QUAL;low_DP	QUAL=20;DP=11;AF=0.45;MQM=57;TRIO=HOM,11,0.45,WT,16,0.13,WT,13,0.15	FRMPD4	splice_region&intron	FRMPD4:NM_014728.3:splice_region&intron:LOW:exon12/16:c.1287+8C>T:	(T)n	rs201309783	0.0000	0.0720	0/0/0	0.0529										0	196					FRMPD4 (inh=n/a pLI=1.00)
chrX	12739294	12739294	A	G	hom		QUAL=8278;DP=167;AF=0.99;MQM=59;TRIO=HOM,167,0.99,HET,284,0.45,WT,188,0.01	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*642A>G:		rs3827468	0.2662	0.0000	0/0/0	0.0338										177	133					FRMPD4 (inh=n/a pLI=1.00)
chrX	12739359	12739359	G	C	hom		QUAL=7871;DP=146;AF=0.99;MQM=59;TRIO=HOM,146,0.99,HET,314,0.45,WT,184,0.00	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*707G>C:		rs5979716	0.0885	0.0000	0/0/0	0.0057										20	17					FRMPD4 (inh=n/a pLI=1.00)
chrX	12740371	12740371	A	G	hom		QUAL=6742;DP=118;AF=0.99;MQM=60;TRIO=HOM,118,0.99,HOM,93,1.00,WT,55,0.00	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*1719A>G:	GA-rich	rs5978572	0.5089	0.0000	0/0/0	0.0455										98	53					FRMPD4 (inh=n/a pLI=1.00)
chrX	12741502	12741502	T	G	hom		QUAL=13505;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HOM,249,1.00,WT,184,0.01	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*2850T>G:		rs5979717	0.6310	0.0000	0/0/0	0.0701										100	33					FRMPD4 (inh=n/a pLI=1.00)
chrX	13752895	13752895	G	T	hom		QUAL=3278;DP=93;AF=1.00;MQM=59;TRIO=HOM,93,1.00,HET,82,0.40,WT,57,0.02	OFD1	5'UTR	OFD1:NM_003611.2:5'UTR:MODIFIER:exon1/23:c.-296G>T:		rs2285635	0.3767	0.0000	0/0/0	0.0370							RCV000034056.2 [benign]; 			62	42					OFD1 (inh=XLR+XLD pLI=0.98)
chrX	14868806	14868806	A	G	hom	low_DP	QUAL=75;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HET,2,0.50,WT,1,0.00	FANCB	splice_region&intron	FANCB:NM_001018113.1:splice_region&intron:LOW:exon6/9:c.1327-10T>C:,FANCB:NM_152633.2:splice_region&intron:LOW:exon5/8:c.1327-10T>C:		rs2905223	0.4336	0.5140	6784/4686/666	0.4555						300515 [FANCB (confirmed) Fanconi anemia,complementation group B];	RCV000079364.4 [benign]; 			634	291					FANCB (inh=n/a pLI=0.99)
chrX	14887147	14887147	C	G	hom		QUAL=8719;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HET,236,0.47,WT,164,0.00	FANCB	5'UTR,intron	FANCB:NM_001018113.1:5'UTR:MODIFIER:exon2/10:c.-173G>C:,FANCB:NM_152633.2:intron:MODIFIER:exon1/8:c.-70-3445G>C:		rs2188383	0.5256	0.0000	0/0/0	0.3993										172	48					FANCB (inh=n/a pLI=0.99)
chrX	15337614	15337614	T	C	hom		QUAL=2299;DP=63;AF=1.00;MQM=60;TRIO=HOM,63,1.00,HET,40,0.40,WT,32,0.00	PIGA	3'UTR,non_coding_exon	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*2014A>G:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*2014A>G:,PIGA:NR_033835.1:non_coding_exon:MODIFIER:exon6/6:n.3211A>G:,PIGA:NR_033836.1:non_coding_exon:MODIFIER:exon6/6:n.2927A>G:		rs3434	0.3608	0.0000	0/0/0	0.2642										111	49					PIGA (inh=n/a pLI=0.92)
chrX	15337849	15337849	-	A	hom		QUAL=5572;DP=92;AF=0.97;MQM=60;TRIO=HOM,92,0.97,HOM,86,1.00,WT,57,0.00	PIGA	3'UTR,non_coding_exon	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1778dupT:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1778dupT:,PIGA:NR_033835.1:non_coding_exon:MODIFIER:exon6/6:n.2975dupT:,PIGA:NR_033836.1:non_coding_exon:MODIFIER:exon6/6:n.2691dupT:		rs397950456;rs776526231	0.5783	0.0000	0/0/0	0.3293										139	51					PIGA (inh=n/a pLI=0.92)
chrX	15337882	15337882	A	T	hom		QUAL=5005;DP=124;AF=1.00;MQM=59;TRIO=HOM,124,1.00,HET,81,0.48,WT,54,0.00	PIGA	3'UTR,non_coding_exon	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1746T>A:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1746T>A:,PIGA:NR_033835.1:non_coding_exon:MODIFIER:exon6/6:n.2943T>A:,PIGA:NR_033836.1:non_coding_exon:MODIFIER:exon6/6:n.2659T>A:		rs3087965	0.3793	0.0000	0/0/0	0.0457										114	46					PIGA (inh=n/a pLI=0.92)
chrX	15338002	15338002	A	G	hom		QUAL=4585;DP=111;AF=0.99;MQM=59;TRIO=HOM,111,0.99,HET,81,0.44,WT,61,0.00	PIGA	3'UTR,non_coding_exon	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1626T>C:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1626T>C:,PIGA:NR_033835.1:non_coding_exon:MODIFIER:exon6/6:n.2823T>C:,PIGA:NR_033836.1:non_coding_exon:MODIFIER:exon6/6:n.2539T>C:		rs3661	0.4146	0.0000	0/0/0	0.0470										115	46					PIGA (inh=n/a pLI=0.92)
chrX	15844899	15844899	A	-	hom		QUAL=666;DP=48;AF=0.58;MQM=59;TRIO=HOM,48,0.58,HOM,26,0.50,WT,7,0.00	AP1S2	3'UTR	AP1S2:NM_001272071.1:3'UTR:MODIFIER:exon6/6:c.*549delT:,AP1S2:NM_003916.4:3'UTR:MODIFIER:exon5/5:c.*549delT:		rs201939651	0.0000	0.0000	0/0/0	0.0126										7	88					AP1S2 (inh=n/a pLI=0.79)
chrX	17753436	17753436	A	T	hom		QUAL=18798;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,225,1.00,HOM,167,1.00	NHS	3'UTR	NHS:NM_001291867.1:3'UTR:MODIFIER:exon9/9:c.*2852A>T:,NHS:NM_198270.3:3'UTR:MODIFIER:exon8/8:c.*2852A>T:,NHS:NM_001136024.3:3'UTR:MODIFIER:exon9/9:c.*2852A>T:,NHS:NM_001291868.1:3'UTR:MODIFIER:exon8/8:c.*2852A>T:		rs5909331	1.0000	0.0000	0/0/0	0.1205										335	0					NHS (inh=XLD pLI=1.00)
chrX	21392713	21392715	GCA	-	hom	low_DP	QUAL=3726;DP=4;AF=0.25;MQM=59;TRIO=HOM,4,0.25,HET,192,0.53,HOM,124,0.94	CNKSR2	5'UTR	CNKSR2:NM_014927.3:5'UTR:MODIFIER:exon1/22:c.-268_-266delAGC:,CNKSR2:NM_001168648.1:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:,CNKSR2:NM_001168649.1:5'UTR:MODIFIER:exon1/20:c.-268_-266delAGC:,CNKSR2:NM_001168647.1:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:	(GCA)n	rs3217648	0.0000	0.0000	0/0/0	0.0542										13	8					CNKSR2 (inh=XLR+XLD pLI=1.00)
chrX	21672413	21672413	C	A	het		QUAL=948;DP=104;AF=0.55;MQM=51;TRIO=HET,104,0.55,HET,27,0.37,HET,23,0.17	CNKSR2	3'UTR	CNKSR2:NM_014927.3:3'UTR:MODIFIER:exon22/22:c.*1774C>A:,CNKSR2:NM_001168647.1:3'UTR:MODIFIER:exon21/21:c.*1774C>A:	(A)n	rs202179371	0.0000	0.0000	0/0/0	0.0022									COSN200730	2	122					CNKSR2 (inh=XLR+XLD pLI=1.00)
chrX	21861434	21861434	A	G	hom		QUAL=11502;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HET,250,0.50,HOM,167,1.00	MBTPS2	splice_region&synonymous	MBTPS2:NM_015884.3:splice_region&synonymous:LOW:exon2/11:c.222A>G:p.Gln74Gln		rs3213451	0.4577	0.4150	5335/2120/750	0.3857						300294 [MBTPS2 (provisional) IFAP syndrome with or without BRESHECK syndrome|Keratosis follicularis spinulosa decalvans,X-linked|Olmsted syndrome,X-linked];	RCV000081783.4 [benign]; 		COSM3759449, COSM3759448	386	230					MBTPS2 (inh=XLR pLI=0.94)
chrX	21901903	21901903	G	A	hom		QUAL=13902;DP=162;AF=0.99;MQM=59;TRIO=HOM,162,0.99,HET,251,0.53,HOM,166,0.99	MBTPS2	3'UTR	MBTPS2:NM_015884.3:3'UTR:MODIFIER:exon11/11:c.*1130G>A:		rs5951476	0.4281	0.0000	0/0/0	0.0513										115	54					MBTPS2 (inh=XLR pLI=0.94)
chrX	23412685	23412685	T	C	hom		QUAL=8760;DP=119;AF=1.00;MQM=59;TRIO=HOM,119,1.00,HET,121,0.53,HOM,103,1.00	PTCHD1	3'UTR	PTCHD1:NM_173495.2:3'UTR:MODIFIER:exon3/3:c.*383T>C:		rs5926307	0.5513	0.0000	0/0/0	0.0586										95	54					PTCHD1 (inh=XLR pLI=0.95)
chrX	23412936	23412936	T	C	hom		QUAL=17721;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HET,310,0.56,HOM,201,0.98	PTCHD1	3'UTR	PTCHD1:NM_173495.2:3'UTR:MODIFIER:exon3/3:c.*634T>C:		rs1317583	0.6302	0.0000	0/0/0	0.0623										97	54					PTCHD1 (inh=XLR pLI=0.95)
chrX	24073761	24073761	C	T	hom		QUAL=14974;DP=181;AF=0.99;MQM=59;TRIO=HOM,181,0.99,HOM,207,1.00,HOM,126,1.00	EIF2S3	synonymous	EIF2S3:NM_001415.3:synonymous:LOW:exon2/12:c.99C>T:p.His33His		rs36018672	0.3632	0.5470	9349/6732/120	0.5130	0.0700						RCV000116975.2 [likely benign]; 		COSM3759453, COSM3759454	466	147					EIF2S3 (inh=n/a pLI=0.92)
chrX	24095043	24095043	C	T	hom		QUAL=4759;DP=112;AF=0.79;MQM=57;TRIO=HOM,112,0.79,HOM,56,0.91,HOM,36,0.75	EIF2S3	3'UTR	EIF2S3:NM_001415.3:3'UTR:MODIFIER:exon12/12:c.*141C>T:	(T)n	rs5949273	0.3650	0.0000	0/0/0	0.0953										128	115					EIF2S3 (inh=n/a pLI=0.92)
chrX	25022104	25022104	T	-	hom		QUAL=405;DP=45;AF=0.58;MQM=59;TRIO=HOM,45,0.58,HOM,72,0.43,WT,51,0.22	ARX	3'UTR	ARX:NM_139058.2:3'UTR:MODIFIER:exon5/5:c.*683delA:	(T)n	rs67950419	0.4731	0.0000	0/0/0	0.2470										4	109					ARX (inh=XLR pLI=0.75)
chrX	28807442	28807442	G	A	hom		QUAL=7681;DP=86;AF=0.99;MQM=60;TRIO=HOM,86,0.99,HOM,85,1.00,HOM,67,1.00	IL1RAPL1	5'UTR	IL1RAPL1:NM_014271.3:5'UTR:MODIFIER:exon2/11:c.-19G>A:		rs6526806	0.7351	0.5830	10243/3559/2751	0.5379										361	106					IL1RAPL1 (inh=XLR pLI=1.00)
chrX	30686141	30686141	G	A	hom		QUAL=5724;DP=131;AF=0.98;MQM=57;TRIO=HOM,131,0.98,HET,113,0.52,WT,94,0.00	GK	synonymous	GK:NM_001205019.1:synonymous:LOW:exon3/21:c.165G>A:p.Gln55Gln,GK:NM_000167.5:synonymous:LOW:exon3/19:c.165G>A:p.Gln55Gln,GK:NM_001128127.2:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln,GK:NM_203391.3:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln		rs34795481	0.0313	0.0520	91/78/1	0.0502						300474 [GK (confirmed) Glycerol kinase deficiency];				57	55					GK (inh=n/a pLI=0.90)
chrX	30747199	30747199	C	T	hom	low_MQM	QUAL=5585;DP=148;AF=0.99;MQM=37;TRIO=HOM,148,0.99,HET,161,0.44,WT,107,0.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*340C>T:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*340C>T:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*340C>T:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*340C>T:		rs3931219	0.0318	0.0000	0/0/0	0.0201										17	14					GK (inh=n/a pLI=0.90)
chrX	30749081	30749081	T	C	hom		QUAL=23152;DP=232;AF=1.00;MQM=60;TRIO=HOM,232,1.00,HOM,287,1.00,HOM,187,1.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*2222T>C:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*2222T>C:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*2222T>C:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*2222T>C:		rs2170611	0.8011	0.0000	0/0/0	0.5399										107	21					GK (inh=n/a pLI=0.90)
chrX	30749142	30749142	T	G	hom		QUAL=21663;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,303,1.00,HOM,184,1.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*2283T>G:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*2283T>G:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*2283T>G:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*2283T>G:		rs5927599	0.7581	0.0000	0/0/0	0.5332										107	21					GK (inh=n/a pLI=0.90)
chrX	31138589	31138589	T	C	hom		QUAL=9228;DP=153;AF=0.99;MQM=60;TRIO=HOM,153,0.99,HET,114,0.58,HOM,75,1.00	DMD	3'UTR	DMD:NM_004006.2:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_004015.2:3'UTR:MODIFIER:exon18/18:c.*1447A>G:,DMD:NM_004016.2:3'UTR:MODIFIER:exon17/17:c.*1361A>G:,DMD:NM_004017.2:3'UTR:MODIFIER:exon17/17:c.*1447A>G:,DMD:NM_004018.2:3'UTR:MODIFIER:exon16/16:c.*1361A>G:,DMD:NM_004014.2:3'UTR:MODIFIER:exon25/25:c.*1447A>G:,DMD:NM_004013.2:3'UTR:MODIFIER:exon36/36:c.*1447A>G:,DMD:NM_004020.3:3'UTR:MODIFIER:exon32/32:c.*1447A>G:,DMD:NM_004021.2:3'UTR:MODIFIER:exon35/35:c.*1361A>G:,DMD:NM_004022.2:3'UTR:MODIFIER:exon34/34:c.*1361A>G:,DMD:NM_004023.2:3'UTR:MODIFIER:exon31/31:c.*1361A>G:,DMD:NM_004011.3:3'UTR:MODIFIER:exon51/51:c.*1447A>G:,DMD:NM_004012.3:3'UTR:MODIFIER:exon51/51:c.*1447A>G:,DMD:NM_004010.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_004009.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_000109.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:		rs3361	0.3542	0.0000	0/0/0	0.0317										53	48					DMD (inh=XLR pLI=1.00)
chrX	31496350	31496350	C	T	hom	anno_pathogenic_hgmd	QUAL=9207;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,96,1.00,HOM,77,1.00	DMD	missense	DMD:NM_004006.2:missense:MODERATE:exon59/79:c.8810G>A:p.Arg2937Gln,DMD:NM_004014.2:missense:MODERATE:exon5/25:c.623G>A:p.Arg208Gln,DMD:NM_004013.2:missense:MODERATE:exon16/36:c.1430G>A:p.Arg477Gln,DMD:NM_004020.3:missense:MODERATE:exon16/32:c.1430G>A:p.Arg477Gln,DMD:NM_004021.2:missense:MODERATE:exon16/35:c.1430G>A:p.Arg477Gln,DMD:NM_004022.2:missense:MODERATE:exon16/34:c.1430G>A:p.Arg477Gln,DMD:NM_004023.2:missense:MODERATE:exon16/31:c.1430G>A:p.Arg477Gln,DMD:NM_004011.3:missense:MODERATE:exon31/51:c.4787G>A:p.Arg1596Gln,DMD:NM_004012.3:missense:MODERATE:exon31/51:c.4778G>A:p.Arg1593Gln,DMD:NM_004010.3:missense:MODERATE:exon59/79:c.8441G>A:p.Arg2814Gln,DMD:NM_004009.3:missense:MODERATE:exon59/79:c.8798G>A:p.Arg2933Gln,DMD:NM_000109.3:missense:MODERATE:exon59/79:c.8786G>A:p.Arg2929Gln		rs1800280	0.8819	0.8980	22571/13029/3238	0.8399	0.8710	T	T,T,T,T,T,T,T,T,T,T,T,T,T	B,B,B,B,B,B,B,B,B	B,B,B,B,B,B,B,B,B	300377 [DMD (confirmed) Duchenne muscular dystrophy|Becker muscular dystrophy|Cardiomyopathy,dilated,3B];	RCV000124712.2 [benign]; RCV000206630.1 [benign]; RCV000152765.4 [benign]; 	CM135605 [CLASS=DM? MUT=REF PHEN="Muscular dystrophy Duchenne" GENE=DMD]; 		1267	42	2	[2] old entry - no details available			DMD (inh=XLR pLI=1.00)
chrX	31697636	31697636	A	G	hom		QUAL=9151;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,172,0.49,HOM,131,0.99	DMD	synonymous	DMD:NM_004006.2:synonymous:LOW:exon53/79:c.7728T>C:p.Asn2576Asn,DMD:NM_004013.2:synonymous:LOW:exon10/36:c.348T>C:p.Asn116Asn,DMD:NM_004020.3:synonymous:LOW:exon10/32:c.348T>C:p.Asn116Asn,DMD:NM_004021.2:synonymous:LOW:exon10/35:c.348T>C:p.Asn116Asn,DMD:NM_004022.2:synonymous:LOW:exon10/34:c.348T>C:p.Asn116Asn,DMD:NM_004023.2:synonymous:LOW:exon10/31:c.348T>C:p.Asn116Asn,DMD:NM_004011.3:synonymous:LOW:exon25/51:c.3705T>C:p.Asn1235Asn,DMD:NM_004012.3:synonymous:LOW:exon25/51:c.3696T>C:p.Asn1232Asn,DMD:NM_004010.3:synonymous:LOW:exon53/79:c.7359T>C:p.Asn2453Asn,DMD:NM_004009.3:synonymous:LOW:exon53/79:c.7716T>C:p.Asn2572Asn,DMD:NM_000109.3:synonymous:LOW:exon53/79:c.7704T>C:p.Asn2568Asn		rs1801188	0.1812	0.1720	915/514/34	0.1636	1.0650					300377 [DMD (confirmed) Duchenne muscular dystrophy|Becker muscular dystrophy|Cardiomyopathy,dilated,3B];	RCV000080769.6 [benign]; 		COSM3759470, COSM3759467, COSM3759469, COSM3759468, COSM3759471	203	153					DMD (inh=XLR pLI=1.00)
chrX	31893307	31893307	T	G	hom	anno_high_impact;phylop_high;pred_pathogenic_2	QUAL=3434;DP=64;AF=0.98;MQM=60;TRIO=HOM,64,0.98,HET,118,0.50,WT,68,0.00	DMD	splice_donor	DMD:NM_004006.2:splice_donor:HIGH:exon48/78:c.7095+1A>C:,DMD:NM_004013.2:splice_donor:HIGH:exon5/35:c.-286+1A>C:,DMD:NM_004020.3:splice_donor:HIGH:exon5/31:c.-286+1A>C:,DMD:NM_004021.2:splice_donor:HIGH:exon5/34:c.-286+1A>C:,DMD:NM_004022.2:splice_donor:HIGH:exon5/33:c.-286+1A>C:,DMD:NM_004023.2:splice_donor:HIGH:exon5/30:c.-286+1A>C:,DMD:NM_004011.3:splice_donor:HIGH:exon20/50:c.3072+1A>C:,DMD:NM_004012.3:splice_donor:HIGH:exon20/50:c.3063+1A>C:,DMD:NM_004010.3:splice_donor:HIGH:exon48/78:c.6726+1A>C:,DMD:NM_004009.3:splice_donor:HIGH:exon48/78:c.7083+1A>C:,DMD:NM_000109.3:splice_donor:HIGH:exon48/78:c.7071+1A>C:		rs1800275	0.1833	0.2200	1898/640/111	0.2051	2.4550	T,.	T,T,T,T,T,T,T,T,.	D,D,D,D,D,.	D,D,D,D,D,.	300377 [DMD (confirmed) Duchenne muscular dystrophy|Becker muscular dystrophy|Cardiomyopathy,dilated,3B];	RCV000124703.2 [benign]; RCV000204283.1 [benign]; RCV000152810.3 [benign]; 		COSM3759475, COSM3759474, COSM3759473, COSM3759472	197	162	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			DMD (inh=XLR pLI=1.00)
chrX	38547308	38547308	C	A	hom		QUAL=17599;DP=220;AF=0.99;MQM=60;TRIO=HOM,220,0.99,HOM,410,0.99,WT,297,0.00	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*123C>A:		rs15765	0.7115	0.0000	0/0/0	0.0739										196	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	38547862	38547862	G	A	hom		QUAL=13506;DP=176;AF=0.99;MQM=60;TRIO=HOM,176,0.99,HOM,246,1.00,WT,168,0.01	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*677G>A:		rs10333	0.7229	0.0000	0/0/0	0.4601										196	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	38548083	38548083	G	A	hom		QUAL=6009;DP=130;AF=0.97;MQM=60;TRIO=HOM,130,0.97,HOM,58,1.00,WT,48,0.00	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*898G>A:		rs3269	0.7200	0.0000	0/0/0	0.4593										196	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	39911629	39911629	C	T	hom		QUAL=8966;DP=212;AF=0.98;MQM=60;TRIO=HOM,212,0.98,HET,199,0.50,WT,138,0.00	BCOR	synonymous	BCOR:NM_001123385.1:synonymous:LOW:exon15/15:c.5001G>A:p.Ser1667Ser,BCOR:NM_017745.5:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:NM_001123383.1:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:NM_001123384.1:synonymous:LOW:exon14/14:c.4845G>A:p.Ser1615Ser		rs375878497	0.0000	0.0001	0/0/0	0.0001	-1.5110	T				300485 [BCOR (confirmed) Microphthalmia,syndromic 2];				0	1					BCOR (inh=XLD pLI=1.00)
chrX	39933339	39933339	A	G	hom		QUAL=15685;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,237,1.00,HOM,145,0.98	BCOR	synonymous	BCOR:NM_001123385.1:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_017745.5:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_001123383.1:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_001123384.1:synonymous:LOW:exon4/14:c.1260T>C:p.Asp420Asp		rs5917933	0.9030	0.8890	22091/11549/2805	0.8251						300485 [BCOR (confirmed) Microphthalmia,syndromic 2];	RCV000081809.7 [other]; 		COSM4156839, COSM4156840	1081	115					BCOR (inh=XLD pLI=1.00)
chrX	43571197	43571197	A	C	hom		QUAL=7055;DP=143;AF=0.99;MQM=60;TRIO=HOM,143,0.99,HET,205,0.50,WT,150,0.00	MAOA	synonymous,5'UTR	MAOA:NM_000240.3:synonymous:LOW:exon4/15:c.385A>C:p.Arg129Arg,MAOA:NM_001270458.1:5'UTR:MODIFIER:exon5/16:c.-15A>C:		rs1800464	0.1571	0.0740	843/21/816	0.0690						309850 [MAOA (confirmed) Brunner syndrome];	RCV000117593.3 [other]; 			57	65					MAOA (inh=n/a pLI=0.99)
chrX	43591036	43591036	G	T	hom		QUAL=20763;DP=194;AF=0.99;MQM=60;TRIO=HOM,194,0.99,HOM,291,1.00,HOM,169,0.99	MAOA	synonymous	MAOA:NM_000240.3:synonymous:LOW:exon8/15:c.891G>T:p.Arg297Arg,MAOA:NM_001270458.1:synonymous:LOW:exon9/16:c.492G>T:p.Arg164Arg		rs6323	0.6249	0.6460	12444/7177/2388	0.6045						309850 [MAOA (confirmed) Brunner syndrome];	RCV000078415.7 [other]; 	CM073190 [CLASS=DP MUT=REF PHEN="Bipolar disorder association with" GENE=MAOA]; 	COSM4156846	906	215					MAOA (inh=n/a pLI=0.99)
chrX	43603391	43603391	T	C	hom		QUAL=27885;DP=320;AF=1.00;MQM=59;TRIO=HOM,320,1.00,HOM,293,1.00,HOM,229,1.00	MAOA	synonymous	MAOA:NM_000240.3:synonymous:LOW:exon14/15:c.1410T>C:p.Asp470Asp,MAOA:NM_001270458.1:synonymous:LOW:exon15/16:c.1011T>C:p.Asp337Asp		rs1137070	0.5518	0.6190	10989/7170/1286	0.5797						309850 [MAOA (confirmed) Brunner syndrome];	RCV000078414.7 [other]; 			896	218					MAOA (inh=n/a pLI=0.99)
chrX	43604841	43604841	A	G	hom		QUAL=6805;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HOM,41,1.00,HOM,34,1.00	MAOA	3'UTR	MAOA:NM_000240.3:3'UTR:MODIFIER:exon15/15:c.*1081A>G:,MAOA:NM_001270458.1:3'UTR:MODIFIER:exon16/16:c.*1081A>G:		rs3027407	0.5510	0.0000	0/0/0	0.0766										334	79					MAOA (inh=n/a pLI=0.99)
chrX	43605100	43605100	A	-	hom		QUAL=4913;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HET,61,0.46,WT,50,0.00	MAOA	3'UTR	MAOA:NM_000240.3:3'UTR:MODIFIER:exon15/15:c.*1341delA:,MAOA:NM_001270458.1:3'UTR:MODIFIER:exon16/16:c.*1341delA:			0.0000	0.0000	0/0/0	0.0000										0	1					MAOA (inh=n/a pLI=0.99)
chrX	43818002	43818002	C	A	hom		QUAL=17680;DP=403;AF=0.99;MQM=60;TRIO=HOM,403,0.99,HET,388,0.50,WT,210,0.00	NDP	5'UTR	NDP:NM_000266.3:5'UTR:MODIFIER:exon2/3:c.-111G>T:		rs45501198	0.0132	0.0000	0/0/0	0.0021										8	9					NDP (inh=n/a pLI=0.64)
chrX	44938563	44938563	G	A	hom	phylop_high	QUAL=4296;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HET,139,0.41,WT,93,0.00	KDM6A	synonymous,non_coding_exon	KDM6A:NM_001291415.1:synonymous:LOW:exon21/30:c.3267G>A:p.Gln1089Gln,KDM6A:NM_001291416.1:synonymous:LOW:exon20/29:c.3132G>A:p.Gln1044Gln,KDM6A:NM_001291417.1:synonymous:LOW:exon19/28:c.2976G>A:p.Gln992Gln,KDM6A:NM_001291418.1:synonymous:LOW:exon18/27:c.2874G>A:p.Gln958Gln,KDM6A:NM_001291421.1:synonymous:LOW:exon18/27:c.2223G>A:p.Gln741Gln,KDM6A:NM_021140.3:synonymous:LOW:exon20/29:c.3111G>A:p.Gln1037Gln,KDM6A:NR_111960.1:non_coding_exon:MODIFIER:exon19/28:n.3407G>A:		rs20539	0.2217	0.2350	2158/492/8	0.2140	1.8190	T				300128 [KDM6A (provisional) Kabuki syndrome 2];	RCV000146125.5 [benign]; 		COSM1179848	224	140					KDM6A (inh=XLD pLI=1.00)
chrX	47061018	47061018	C	G	hom		QUAL=16955;DP=87;AF=1.00;MQM=60;TRIO=HOM,87,1.00,HOM,279,1.00,HOM,175,1.00	UBA1	splice_region&intron	UBA1:NM_003334.3:splice_region&intron:LOW:exon8/25:c.811+9C>G:,UBA1:NM_153280.2:splice_region&intron:LOW:exon8/25:c.811+9C>G:		rs4239964	0.9711	0.9780	26029/14170/3253	0.9158						314370 [UBA1 (confirmed) Spinal muscular atrophy,X-linked 2,infantile];				1187	12					UBA1 (inh=n/a pLI=1.00)
chrX	47466361	47466361	A	G	hom		QUAL=21026;DP=176;AF=0.99;MQM=60;TRIO=HOM,176,0.99,HOM,311,1.00,HOM,180,1.00	SYN1	synonymous	SYN1:NM_006950.3:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn,SYN1:NM_133499.2:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn		rs1142636	0.3687	0.3710	4055/2291/610	0.3447						313440 [SYN1 (confirmed) Epilepsy,X-linked,with variable learning disabilities and behavior disorders];	RCV000082513.7 [other]; 			384	193					SYN1 (inh=n/a pLI=0.88)
chrX	48759204	48759204	C	T	hom		QUAL=9350;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HOM,256,0.99,WT,162,0.01	PQBP1	splice_region&intron	PQBP1:NM_001032381.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001032382.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001032383.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_144495.2:splice_region&intron:LOW:exon3/5:c.180-3C>T:,PQBP1:NM_001167989.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001167990.1:splice_region&intron:LOW:exon3/6:c.156-3C>T:,PQBP1:NM_001032384.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_005710.2:splice_region&intron:LOW:exon2/5:c.180-3C>T:,PQBP1:NM_001167992.1:splice_region&intron:LOW:exon2/5:c.180-3C>T:		rs741932	0.6254	0.6120	10022/5244/980	0.5647						300463 [PQBP1 (confirmed) Renpenning syndrome];	RCV000081326.7 [other]; 			683	210					PQBP1 (inh=n/a pLI=0.59)
chrX	49646968	49646968	G	A	het		QUAL=164;DP=27;AF=0.41;MQM=57;TRIO=HET,27,0.41,HET,4,0.25,WT,2,0.00	USP27X	3'UTR	USP27X:NM_001145073.2:3'UTR:MODIFIER:exon1/1:c.*741G>A:	(A)n	rs199555442	0.0000	0.0000	0/0/0	0.0022										0	61					USP27X (inh=n/a pLI=0.59)
chrX	50334695	50334698	TTTC	-	hom	low_DP;low_MQM	QUAL=255;DP=12;AF=0.75;MQM=46;TRIO=HOM,12,0.75,HOM,1,1.00,WT,2,0.00	SHROOM4	3'UTR,non_coding_exon	SHROOM4:NM_020717.3:3'UTR:MODIFIER:exon9/9:c.*4997_*5000delGAAA:,SHROOM4:NR_027121.1:non_coding_exon:MODIFIER:exon10/10:n.5952_5955delGAAA:	(TTTC)n	rs782605261	0.0000	0.1450	37/21/1	0.0127										116	60					SHROOM4 (inh=n/a pLI=1.00)
chrX	53220836	53220836	G	T	hom		QUAL=18788;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,238,1.00,HOM,157,1.00	KDM5C	3'UTR	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*1313C>A:,KDM5C:NM_001146702.1:3'UTR:MODIFIER:exon24/24:c.*1090C>A:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*1313C>A:		rs1886889	0.8072	0.0000	0/0/0	0.6428										319	6					KDM5C (inh=XLR pLI=1.00)
chrX	53221259	53221259	-	G	hom		QUAL=4903;DP=73;AF=0.99;MQM=59;TRIO=HOM,73,0.99,HOM,71,1.00,HOM,23,1.00	KDM5C	3'UTR	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*889dupC:,KDM5C:NM_001146702.1:3'UTR:MODIFIER:exon24/24:c.*666dupC:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*889dupC:	MIRb	rs66463350;rs75167298	0.7650	0.0000	0/0/0	0.6296										238	5					KDM5C (inh=XLR pLI=1.00)
chrX	53222043	53222043	-	C	het	low_DP	QUAL=121;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,6,0.33,HET,4,0.75	KDM5C	3'UTR,intron	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:NM_001146702.1:intron:MODIFIER:exon23/23:c.4047-25dupG:		rs146836963;rs150558161	0.7759	0.8860	6720/4012/257	0.6426						314690 [KDM5C (confirmed) Mental retardation,X-linked,syndromic,Claes-Jensen type];				579	21					KDM5C (inh=XLR pLI=1.00)
chrX	53449568	53449568	G	A	hom		QUAL=15947;DP=186;AF=0.98;MQM=60;TRIO=HOM,186,0.98,HOM,233,1.00,HOM,140,1.00	SMC1A	5'UTR_premature_start_codon_gain,5'UTR	SMC1A:NM_006306.3:5'UTR_premature_start_codon_gain:LOW:exon1/25:c.-19C>T:,SMC1A:NM_001281463.1:5'UTR_premature_start_codon_gain:LOW:exon1/26:c.-231C>T:,SMC1A:NM_006306.3:5'UTR:MODIFIER:exon1/25:c.-19C>T:,SMC1A:NM_001281463.1:5'UTR:MODIFIER:exon1/26:c.-231C>T:		rs1264011	0.3984	0.5150	7564/4983/34	0.4778							RCV000081383.4 [benign]; 			344	103					SMC1A (inh=n/a pLI=1.00)
chrX	53559668	53559668	C	A	hom		QUAL=9849;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HOM,195,1.00,WT,109,0.00	HUWE1	3'UTR	HUWE1:NM_031407.6:3'UTR:MODIFIER:exon84/84:c.*602G>T:		rs12836234	0.0570	0.0000	0/0/0	0.0846										14	18					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53563589	53563589	A	G	hom		QUAL=19956;DP=160;AF=0.99;MQM=59;TRIO=HOM,160,0.99,HOM,316,1.00,HOM,170,1.00	HUWE1	synonymous	HUWE1:NM_031407.6:synonymous:LOW:exon79/84:c.12177T>C:p.Gly4059Gly		rs426298	0.9950	0.9980	26877/14624/3158	0.9080	-0.3880	T				300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type];	RCV000082281.7 [other]; 			1308	0	1	[1] Peter Bauer 07.08.2014			HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53641647	53641647	T	C	hom		QUAL=4778;DP=66;AF=1.00;MQM=60;TRIO=HOM,66,1.00,HOM,91,0.98,WT,70,0.01	HUWE1	synonymous	HUWE1:NM_031407.6:synonymous:LOW:exon23/84:c.2109A>G:p.Ser703Ser		rs6638360	0.3897	0.4900	6721/4208/32	0.4559						300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type];	RCV000117252.2 [likely benign]; 			588	221					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53713601	53713601	C	T	het		QUAL=39;DP=52;AF=0.25;MQM=60;TRIO=HET,52,0.25,WT,129,0.00,WT,81,0.00	HUWE1	5'UTR	HUWE1:NM_031407.6:5'UTR:MODIFIER:exon1/84:c.-330G>A:		rs5978184	0.1881	0.0000	0/0/0	0.1159										10	42					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53713640	53713640	G	C	hom		QUAL=8807;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,131,1.00,HOM,83,1.00	HUWE1	5'UTR	HUWE1:NM_031407.6:5'UTR:MODIFIER:exon1/84:c.-369C>G:		rs2333864	1.0000	0.0000	0/0/0	0.4018										212	1					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	66944120	66944120	A	-	hom		QUAL=2053;DP=48;AF=0.96;MQM=60;TRIO=HOM,48,0.96,HET,76,0.57,HET,69,0.17	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*447delA:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*447delA:	A-rich	rs11351755	0.6805	0.0000	0/0/0	0.4152										206	37					AR (inh=n/a pLI=0.99)
chrX	66945740	66945740	T	C	hom		QUAL=23221;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,342,1.00,HOM,194,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*2057T>C:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*2057T>C:		rs5919413	0.8593	0.0000	0/0/0	0.1140										150	0					AR (inh=n/a pLI=0.99)
chrX	66946851	66946851	T	C	hom		QUAL=15014;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HOM,189,1.00,HOM,110,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*3168T>C:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*3168T>C:		rs1931537	0.8593	0.0000	0/0/0	0.1368										150	0					AR (inh=n/a pLI=0.99)
chrX	66948019	66948019	-	T	hom		QUAL=5168;DP=137;AF=0.91;MQM=59;TRIO=HOM,137,0.91,HOM,39,0.90,HOM,23,0.96	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*4345dupT:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*4345dupT:		rs397737842;rs5902611	0.8416	0.0000	0/0/0	0.5158										100	49					AR (inh=n/a pLI=0.99)
chrX	66949722	66949722	C	T	hom		QUAL=10081;DP=136;AF=0.99;MQM=60;TRIO=HOM,136,0.99,HOM,119,1.00,HOM,75,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6039C>T:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6039C>T:		rs7440	0.8585	0.0000	0/0/0	0.1133										150	0					AR (inh=n/a pLI=0.99)
chrX	66950023	66950025	AAG	-	hom		QUAL=3735;DP=32;AF=1.00;MQM=60;TRIO=HOM,32,1.00,HOM,58,0.98,HOM,32,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6344_*6346delAGA:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6344_*6346delAGA:	A-rich	rs140258587	0.0000	0.0000	0/0/0	0.4732										149	0					AR (inh=n/a pLI=0.99)
chrX	66950105	66950105	C	T	hom		QUAL=9656;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HOM,113,1.00,HOM,60,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6422C>T:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6422C>T:		rs2362520	0.8583	0.0000	0/0/0	0.1140										150	0					AR (inh=n/a pLI=0.99)
chrX	67263222	67263222	G	A	hom	low_DP;low_MQM	QUAL=336;DP=6;AF=1.00;MQM=47;TRIO=HOM,6,1.00,HOM,3,1.00,HOM,4,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3792C>T:	L1HS	rs7883184	0.1195	0.0000	0/0/0	0.0514										57	51					OPHN1 (inh=XLR pLI=1.00)
chrX	67263229	67263229	A	G	het	low_DP	QUAL=133;DP=6;AF=0.50;MQM=51;TRIO=HET,6,0.50,HOM,2,1.00,HOM,2,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3785T>C:		rs184510922	0.1788	0.0000	0/0/0	0.0401										9	53					OPHN1 (inh=XLR pLI=1.00)
chrX	67263293	67263293	A	G	hom	low_DP	QUAL=1023;DP=16;AF=1.00;MQM=60;TRIO=HOM,16,1.00,HOM,11,1.00,HOM,5,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3721T>C:	Arthur2	rs7888212	0.5189	0.0000	0/0/0	0.2618										89	42					OPHN1 (inh=XLR pLI=1.00)
chrX	67263844	67263844	C	T	hom		QUAL=15569;DP=196;AF=1.00;MQM=60;TRIO=HOM,196,1.00,HOM,165,0.99,HOM,122,0.98	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3170G>A:		rs492933	0.5094	0.0000	0/0/0	0.2671										93	46					OPHN1 (inh=XLR pLI=1.00)
chrX	67265417	67265417	G	T	hom		QUAL=11604;DP=105;AF=1.00;MQM=60;TRIO=HOM,105,1.00,HOM,149,1.00,HOM,108,0.98	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*1597C>A:		rs2254886	0.4297	0.0000	0/0/0	0.2490										91	47					OPHN1 (inh=XLR pLI=1.00)
chrX	67265915	67265915	-	T	hom		QUAL=5146;DP=79;AF=0.99;MQM=60;TRIO=HOM,79,0.99,HOM,47,1.00,HOM,37,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*1098dupA:	Charlie4z	rs397698299	0.1823	0.0000	0/0/0	0.1498										61	41					OPHN1 (inh=XLR pLI=1.00)
chrX	69080840	69080840	G	A	hom		QUAL=13353;DP=145;AF=1.00;MQM=60;TRIO=HOM,145,1.00,HOM,169,1.00,HOM,102,1.00	EDA	3'UTR,intron	EDA:NM_001005610.3:3'UTR:MODIFIER:exon2/2:c.*141G>A:,EDA:NM_001005613.3:3'UTR:MODIFIER:exon3/3:c.*186G>A:,EDA:NM_001399.4:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:NM_001005609.1:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:NM_001005612.2:intron:MODIFIER:exon1/7:c.397-96037G>A:	L1MEd	rs1203003	1.0000	0.0000	0/0/0	0.1227						300451 [EDA (confirmed) Ectodermal dysplasia 1,hypohidrotic,X-linked|Tooth agenesis,selective,X-linked 1];				559	0					EDA (inh=n/a pLI=0.92)
chrX	69258515	69258515	T	G	hom		QUAL=11138;DP=183;AF=1.00;MQM=60;TRIO=HOM,183,1.00,HET,144,0.51,HOM,91,1.00	EDA	3'UTR	EDA:NM_001399.4:3'UTR:MODIFIER:exon8/8:c.*3056T>G:,EDA:NM_001005609.1:3'UTR:MODIFIER:exon8/8:c.*3056T>G:,EDA:NM_001005612.2:3'UTR:MODIFIER:exon8/8:c.*3056T>G:		rs3795170	0.3939	0.0000	0/0/0	0.2767										104	49					EDA (inh=n/a pLI=0.92)
chrX	69626739	69626739	C	T	hom		QUAL=5022;DP=102;AF=1.00;MQM=59;TRIO=HOM,102,1.00,HET,150,0.48,WT,102,0.00	KIF4A	splice_region&intron	KIF4A:NM_012310.4:splice_region&intron:LOW:exon27/30:c.3073-4C>T:		rs10482161	0.0601	0.0680	180/118/52	0.0638						300521 [KIF4A (provisional) Mental retardation,X-linked 100];				32	56					KIF4A (inh=n/a pLI=1.00)
chrX	69640700	69640700	C	T	hom		QUAL=8407;DP=192;AF=0.99;MQM=60;TRIO=HOM,192,0.99,HET,172,0.49,WT,118,0.00	KIF4A	3'UTR	KIF4A:NM_012310.4:3'UTR:MODIFIER:exon31/31:c.*585C>T:		rs1063088	0.0257	0.0000	0/0/0	0.0446										19	20					KIF4A (inh=n/a pLI=1.00)
chrX	69724731	69724731	G	T	hom		QUAL=12644;DP=265;AF=0.98;MQM=59;TRIO=HOM,265,0.98,HET,363,0.50,WT,253,0.01	DLG3	3'UTR	DLG3:NM_021120.3:3'UTR:MODIFIER:exon19/19:c.*2612G>T:,DLG3:NM_020730.2:3'UTR:MODIFIER:exon14/14:c.*2612G>T:,DLG3:NM_001166278.1:3'UTR:MODIFIER:exon12/12:c.*2612G>T:		rs3828017	0.5592	0.0000	0/0/0	0.3416										123	58					DLG3 (inh=XLR pLI=1.00)
chrX	70390007	70390007	-	CACA	hom		QUAL=494;DP=33;AF=0.55;MQM=58;TRIO=HOM,33,0.55,HET,93,0.34,WT,58,0.00	NLGN3	3'UTR	NLGN3:NM_181303.1:3'UTR:MODIFIER:exon8/8:c.*78_*81dupACAC:,NLGN3:NM_001166660.1:3'UTR:MODIFIER:exon6/6:c.*78_*81dupACAC:,NLGN3:NM_018977.3:3'UTR:MODIFIER:exon7/7:c.*78_*81dupACAC:		rs112095862;rs35156036	0.0000	0.0000	0/0/0	0.0013										0	6					NLGN3 (inh=n/a pLI=0.90)
chrX	70469182	70469182	G	A	hom		QUAL=18021;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,217,1.00,HOM,164,1.00	ZMYM3,BCYRN1	3'UTR,intron	ZMYM3:NM_001171163.1:3'UTR:MODIFIER:exon7/7:c.*111C>T:,BCYRN1:NR_001568.1:intron:MODIFIER:exon3/3:n.173-39129C>T:,ZMYM3:NM_005096.3:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:NM_201599.2:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:NM_001171162.1:intron:MODIFIER:exon7/24:c.1470+129C>T:	L1ME3Cz	rs2341539	0.9992	0.0000	0/0/0	0.6958										344	1					ZMYM3 (inh=n/a pLI=1.00), BCYRN1 (inh=n/a pLI=n/a)
chrX	73956893	73956893	T	G	het		QUAL=428;DP=83;AF=0.57;MQM=60;TRIO=HET,83,0.57,WT,49,0.00,WT,31,0.00	KIAA2022	3'UTR	KIAA2022:NM_001008537.2:3'UTR:MODIFIER:exon4/4:c.*2347A>C:		rs199521894	0.0000	0.0000	0/0/0	0.0002										0	145					KIAA2022 (inh=XLR pLI=0.95)
chrX	73958629	73958629	G	A	hom		QUAL=9364;DP=115;AF=1.00;MQM=59;TRIO=HOM,115,1.00,HOM,105,1.00,HOM,62,1.00	KIAA2022	3'UTR	KIAA2022:NM_001008537.2:3'UTR:MODIFIER:exon4/4:c.*611C>T:		rs2209549	0.4095	0.0000	0/0/0	0.0836										263	33					KIAA2022 (inh=XLR pLI=0.95)
chrX	74589117	74589117	C	T	hom		QUAL=16413;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HOM,205,1.00,HOM,130,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*3696G>A:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*3696G>A:		rs7052314	0.4199	0.0000	0/0/0	0.4704										164	38					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74589151	74589154	TGTG	-	hom		QUAL=10249;DP=113;AF=0.74;MQM=59;TRIO=HOM,113,0.74,HOM,203,0.85,WT,125,0.94	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*3659_*3662delCACA:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*3659_*3662delCACA:	(TG)n	rs752312995	0.0000	0.0000	0/0/0	0.1817										77	64					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590136	74590136	G	C	hom		QUAL=13807;DP=124;AF=1.00;MQM=60;TRIO=HOM,124,1.00,HOM,180,1.00,HOM,115,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2677C>G:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2677C>G:		rs1998494	0.8127	0.0000	0/0/0	0.6448										214	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590180	74590180	G	A	hom		QUAL=13482;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,150,1.00,HOM,81,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2633C>T:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2633C>T:		rs1998493	0.8127	0.0000	0/0/0	0.6405										214	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590258	74590258	G	T	hom		QUAL=13889;DP=195;AF=0.99;MQM=60;TRIO=HOM,195,0.99,HOM,167,1.00,HOM,83,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2555C>A:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2555C>A:		rs1998492	0.8130	0.0000	0/0/0	0.6443										214	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590359	74590368	TTTTTTTTTT	-	hom		QUAL=3089;DP=63;AF=0.56;MQM=58;TRIO=HOM,63,0.56,HOM,77,0.65,HOM,40,0.75	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2445_*2454delAAAAAAAAAA:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2445_*2454delAAAAAAAAAA:	AluSp	rs367924484;rs747471622;rs775337620	0.9065	0.0000	0/0/0	0.3612										76	70					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74591706	74591706	T	C	hom		QUAL=11075;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HOM,114,1.00,HOM,68,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*1107A>G:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*1107A>G:		rs2146770	0.9253	0.0000	0/0/0	0.6823										228	0					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74743194	74743194	C	G	hom		QUAL=6533;DP=71;AF=1.00;MQM=60;TRIO=HOM,71,1.00,HOM,99,1.00,HOM,43,1.00	ZDHHC15	5'UTR	ZDHHC15:NM_144969.2:5'UTR:MODIFIER:exon1/12:c.-335G>C:,ZDHHC15:NM_001146256.1:5'UTR:MODIFIER:exon1/11:c.-335G>C:,ZDHHC15:NM_001146257.1:5'UTR:MODIFIER:exon1/3:c.-335G>C:		rs11796028	0.3846	0.0000	0/0/0	0.4576										161	39					ZDHHC15 (inh=n/a pLI=0.90)
chrX	76762375	76762375	C	T	het		QUAL=84;DP=53;AF=0.25;MQM=53;TRIO=HET,53,0.25,WT,14,0.00,WT,8,0.00	ATRX	3'UTR	ATRX:NM_000489.4:3'UTR:MODIFIER:exon35/35:c.*1454G>A:,ATRX:NM_138270.3:3'UTR:MODIFIER:exon34/34:c.*1454G>A:	(T)n	rs782665097	0.3462	0.0000	0/0/0	0.0502										0	151					ATRX (inh=XLR pLI=1.00)
chrX	77298857	77298857	G	A	hom	phylop_high	QUAL=15672;DP=104;AF=1.00;MQM=60;TRIO=HOM,104,1.00,HOM,237,1.00,HOM,131,1.00	ATP7A	missense,non_coding_exon	ATP7A:NM_000052.6:missense:MODERATE:exon21/23:c.4048G>A:p.Glu1350Lys,ATP7A:NM_001282224.1:missense:MODERATE:exon20/22:c.3814G>A:p.Glu1272Lys,ATP7A:NR_104109.1:non_coding_exon:MODIFIER:exon8/10:n.1258G>A:		rs4826245	1.0000	1.0000	27055/14628/3310	0.9028	7.0780	T	T,T,T	B	B	300011 [ATP7A (confirmed) Menkes disease|Occipital horn syndrome|Spinal muscular atrophy,distal,X-linked 3];	RCV000078036.5 [benign]; 			1293	0					ATP7A (inh=XLR pLI=1.00)
chrX	79925246	79925246	A	G	hom		QUAL=2458;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HOM,15,1.00,HOM,14,1.00	BRWD3	3'UTR	BRWD3:NM_153252.4:3'UTR:MODIFIER:exon41/41:c.*6862T>C:		rs2063579	0.5211	0.0000	0/0/0	0.4593										89	32					BRWD3 (inh=XLR pLI=1.00)
chrX	79931832	79931835	GTGT	-	hom		QUAL=16579;DP=128;AF=0.98;MQM=59;TRIO=HOM,128,0.98,HOM,257,0.98,HOM,176,1.00	BRWD3	3'UTR	BRWD3:NM_153252.4:3'UTR:MODIFIER:exon41/41:c.*273_*276delACAC:	(GT)n	rs35220611;rs397895620	0.5136	0.0000	0/0/0	0.4064										209	50					BRWD3 (inh=XLR pLI=1.00)
chrX	79943569	79943569	T	C	hom		QUAL=14390;DP=116;AF=0.99;MQM=60;TRIO=HOM,116,0.99,HOM,208,1.00,HOM,115,1.00	BRWD3	missense&splice_region	BRWD3:NM_153252.4:missense&splice_region:MODERATE:exon34/41:c.3863A>G:p.Lys1288Arg		rs3122407	0.9897	0.9970	26864/14624/3144	0.8998	0.1700	T	T	B	B	300553 [BRWD3 (provisional) Mental retardation,X-linked 93];				1305	2					BRWD3 (inh=XLR pLI=1.00)
chrX	80065236	80065237	AG	-	hom	low_DP	QUAL=1686;DP=7;AF=0.71;MQM=59;TRIO=HOM,7,0.71,HOM,36,0.94,HOM,33,0.97	BRWD3-HMGN5	intergenic_region	BRWD3-HMGN5:BRWD3-HMGN5:intergenic_region:MODIFIER::n.80065236_80065237delAG:	GA-rich	rs199953219;rs762475206	0.8167	0.0000	0/0/0	0.3676										252	8					BRWD3-HMGN5 (inh=n/a pLI=n/a)
chrX	99550883	99550883	G	A	hom		QUAL=873;DP=26;AF=0.96;MQM=60;TRIO=HOM,26,0.96,HET,15,0.53,WT,12,0.00	PCDH19	3'UTR	PCDH19:NM_001184880.1:3'UTR:MODIFIER:exon6/6:c.*392C>T:,PCDH19:NM_001105243.1:3'UTR:MODIFIER:exon5/5:c.*392C>T:,PCDH19:NM_020766.2:3'UTR:MODIFIER:exon5/5:c.*392C>T:		rs1335268	0.2299	0.0000	0/0/0	0.0377										79	44					PCDH19 (inh=AR+AD pLI=0.98)
chrX	99661969	99661969	G	A	hom		QUAL=9210;DP=127;AF=0.99;MQM=59;TRIO=HOM,127,0.99,HET,448,0.50,WT,280,0.00	PCDH19	synonymous	PCDH19:NM_001184880.1:synonymous:LOW:exon1/6:c.1627C>T:p.Leu543Leu,PCDH19:NM_001105243.1:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu,PCDH19:NM_020766.2:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu		rs1953337	0.0861	0.2040	1550/1211/14	0.1932						300460 [PCDH19 (confirmed) Epileptic encephalopathy,early infantile,9];	RCV000079603.5 [benign]; 		COSM3759554	215	155					PCDH19 (inh=AR+AD pLI=0.98)
chrX	99926122	99926122	G	A	hom		QUAL=31706;DP=271;AF=1.00;MQM=60;TRIO=HOM,271,1.00,HOM,415,1.00,HOM,291,1.00	SRPX2	3'UTR	SRPX2:NM_014467.2:3'UTR:MODIFIER:exon11/11:c.*138G>A:		rs5967163	0.9656	0.0000	0/0/0	0.1175										335	0					SRPX2 (inh=n/a pLI=0.96)
chrX	100532621	100532621	T	C	hom	phylop_high	QUAL=6398;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HET,91,0.44,WT,70,0.00	TAF7L	missense	TAF7L:NM_024885.3:missense:MODERATE:exon9/13:c.922A>G:p.Ser308Gly,TAF7L:NM_001168474.1:missense:MODERATE:exon9/13:c.664A>G:p.Ser222Gly		rs35899692	0.1804	0.1440	733/263/194	0.1313	2.3940	T	T,T,T,T	B,B	B,B				COSM3759316	126	126					TAF7L (inh=n/a pLI=0.84)
chrX	100547933	100547933	A	G	hom		QUAL=28125;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,424,1.00,HOM,259,1.00	TAF7L	missense	TAF7L:NM_024885.3:missense:MODERATE:exon1/13:c.101T>C:p.Leu34Pro		rs5951328	0.9950	0.9900	26499/14215/3284	0.8939	-1.2920	T	T	B	B					1190	10					TAF7L (inh=n/a pLI=0.84)
chrX	103046527	103046527	G	-	hom		QUAL=17487;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HOM,191,1.00,HOM,133,1.00	PLP1	3'UTR	PLP1:NM_000533.4:3'UTR:MODIFIER:exon7/7:c.*1005delG:,PLP1:NM_001128834.2:3'UTR:MODIFIER:exon8/8:c.*1005delG:,PLP1:NM_199478.2:3'UTR:MODIFIER:exon7/7:c.*1005delG:,PLP1:NM_001305004.1:3'UTR:MODIFIER:exon7/7:c.*1005delG:		rs796941012	1.0000	0.0000	0/0/0	0.6272										335	0					PLP1 (inh=n/a pLI=0.90)
chrX	110540014	110540014	G	A	hom		QUAL=1481;DP=36;AF=0.08;MQM=59;TRIO=HOM,36,0.08,HOM,33,0.12,HOM,21,0.00	DCX	3'UTR	DCX:NM_000555.3:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:NM_178151.2:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:NM_001195553.1:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:NM_178152.2:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:NM_178153.2:3'UTR:MODIFIER:exon7/7:c.*4901C>T:			0.0000	0.0000	0/0/0	0.0000										0	6					DCX (inh=XLR+XLD pLI=0.86)
chrX	119560599	119560599	T	C	hom		QUAL=9284;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HET,111,0.49,HOM,80,1.00	LAMP2	3'UTR	LAMP2:NM_001122606.1:3'UTR:MODIFIER:exon9/9:c.*1740A>G:,LAMP2:NM_002294.2:3'UTR:MODIFIER:exon9/9:c.*4579A>G:		rs42885	0.7097	0.0000	0/0/0	0.4471										160	55					LAMP2 (inh=XLD pLI=0.95)
chrX	119561929	119561929	A	G	hom		QUAL=6634;DP=135;AF=1.00;MQM=60;TRIO=HOM,135,1.00,HET,160,0.53,WT,82,0.00	LAMP2	3'UTR	LAMP2:NM_001122606.1:3'UTR:MODIFIER:exon9/9:c.*410T>C:,LAMP2:NM_002294.2:3'UTR:MODIFIER:exon9/9:c.*3249T>C:		rs41300908	0.0032	0.0000	0/0/0	0.0018										2	3					LAMP2 (inh=XLD pLI=0.95)
chrX	119571157	119571157	-	AT	hom		QUAL=1946;DP=64;AF=0.89;MQM=59;TRIO=HOM,64,0.89,HET,34,0.41,WT,26,0.00	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1850_*1851dupAT:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:	(TA)n	rs755523524;rs765735586	0.3033	0.0000	0/0/0	0.1275						309060 [LAMP2 (confirmed) Danon disease];				15	50					LAMP2 (inh=XLD pLI=0.95)
chrX	119571268	119571268	A	-	hom		QUAL=1185;DP=52;AF=0.67;MQM=59;TRIO=HOM,52,0.67,HOM,24,0.42,WT,20,0.10	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1741delT:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4317delT:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4317delT:	A-rich	rs10565432	0.0000	0.0000	0/0/0	0.0176						309060 [LAMP2 (confirmed) Danon disease];				4	66					LAMP2 (inh=XLD pLI=0.95)
chrX	119571541	119571541	T	C	hom		QUAL=8117;DP=94;AF=1.00;MQM=60;TRIO=HOM,94,1.00,HOM,84,1.00,HOM,67,1.00	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1468A>G:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4044A>G:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4044A>G:		rs42889	0.7889	0.0000	0/0/0	0.0809						309060 [LAMP2 (confirmed) Danon disease];				168	52					LAMP2 (inh=XLD pLI=0.95)
chrX	119572548	119572553	CACACA	-	hom		QUAL=2592;DP=41;AF=0.80;MQM=59;TRIO=HOM,41,0.80,HET,74,0.89,WT,19,0.74	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*456_*461delTGTGTG:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+3032_1093+3037delTGTGTG:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+3032_1093+3037delTGTGTG:	(CA)n	rs767342235	0.0000	0.0000	0/0/0	0.0333						309060 [LAMP2 (confirmed) Danon disease];				14	9					LAMP2 (inh=XLD pLI=0.95)
chrX	119590533	119590533	T	A	hom		QUAL=3226;DP=53;AF=1.00;MQM=60;TRIO=HOM,53,1.00,HET,37,0.49,HOM,36,1.00	LAMP2	synonymous	LAMP2:NM_001122606.1:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:NM_002294.2:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:NM_013995.2:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val		rs12097	0.3809	0.3970	4103/2443/431	0.3689						309060 [LAMP2 (confirmed) Danon disease];	RCV000037405.7 [benign]; 		COSM4156558, COSM4156557, COSM4156559	479	236					LAMP2 (inh=XLD pLI=0.95)
chrX	122318386	122318386	-	G	hom		QUAL=7216;DP=67;AF=0.99;MQM=59;TRIO=HOM,67,0.99,HOM,96,1.00,HOM,78,1.00	GRIA3	5'UTR	GRIA3:NM_000828.4:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:,GRIA3:NM_001256743.1:5'UTR:MODIFIER:exon1/4:c.-2_-1insG:,GRIA3:NM_007325.4:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:		rs58044961	1.0000	1.0000	27060/14630/3313	0.9018										1293	0					GRIA3 (inh=XLR pLI=1.00)
chrX	122336600	122336600	-	G	hom	anno_high_impact	QUAL=17088;DP=94;AF=0.93;MQM=59;TRIO=HOM,94,0.93,HOM,332,0.98,HOM,192,0.98	GRIA3	frameshift,intron	GRIA3:NM_001256743.1:frameshift:HIGH:exon3/4:c.384dupG:p.Pro129fs,GRIA3:NM_000828.4:intron:MODIFIER:exon2/15:c.268+16761dupG:,GRIA3:NM_007325.4:intron:MODIFIER:exon2/15:c.268+16761dupG:		rs11452643	0.9995	1.0000	3156/1449/286	0.2340						305915 [GRIA3 (confirmed) Mental retardation,X-linked 94];				1068	98	1	[1] auto-classification 16.06.2016  [2] old entry - no details available		n/a (14.10.13, UG)	GRIA3 (inh=XLR pLI=1.00)
chrX	122622934	122622937	ACAC	-	hom		QUAL=2886;DP=86;AF=0.85;MQM=59;TRIO=HOM,86,0.85,HOM,33,0.94,WT,18,0.78	GRIA3	3'UTR	GRIA3:NM_000828.4:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:,GRIA3:NM_007325.4:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:	(AC)n	rs201935330	0.0000	0.0000	0/0/0	0.0416										13	13					GRIA3 (inh=XLR pLI=1.00)
chrX	123034511	123034511	A	C	hom	phylop_high;pred_pathogenic_1	QUAL=10416;DP=76;AF=0.99;MQM=60;TRIO=HOM,76,0.99,HOM,145,1.00,HOM,103,0.99	XIAP	missense,non_coding_exon	XIAP:NM_001167.3:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro,XIAP:NM_001204401.1:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon5/6:n.518A>C:		rs5956583	0.3036	0.3300	3387/1917/724	0.3084	2.0790	T	D,D,D	B	B	300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2];		CM097066 [CLASS=DFP MUT=REF PHEN="Periodic fever idiopathic association with" GENE=XIAP]; 	COSM3759346	333	211					XIAP (inh=n/a pLI=0.98)
chrX	123044718	123044718	A	-	het	low_QUAL	QUAL=9;DP=37;AF=0.30;MQM=51;TRIO=HET,37,0.30,WT,12,0.25,HET,12,0.25	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*3702delA:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*3702delA:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.4446delA:	AluY	rs762891006	0.0000	0.1190	0/0/0	0.0001										0	89					XIAP (inh=n/a pLI=0.98)
chrX	123045327	123045327	-	A	hom	low_DP	QUAL=303;DP=7;AF=0.71;MQM=57;TRIO=HOM,7,0.71,HOM,9,0.89,HET,3,0.67	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*4309dupA:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*4309dupA:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.5053dupA:	AluSp	rs34868593;rs397713705;rs748304435	0.3038	0.1570	7/1/0	0.0385										24	200					XIAP (inh=n/a pLI=0.98)
chrX	123045641	123045641	C	T	hom		QUAL=8498;DP=94;AF=0.99;MQM=59;TRIO=HOM,94,0.99,HOM,93,1.00,HOM,76,1.00	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*4610C>T:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*4610C>T:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.5354C>T:		rs9856	0.5844	0.5460	488/185/19	0.1102										281	106					XIAP (inh=n/a pLI=0.98)
chrX	123046272	123046272	A	T	hom		QUAL=10487;DP=169;AF=1.00;MQM=59;TRIO=HOM,169,1.00,HOM,105,0.99,HOM,57,0.96	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5241A>T:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5241A>T:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.5985A>T:	MER2	rs5958343	0.5846	0.5510	487/184/19	0.1099										287	107					XIAP (inh=n/a pLI=0.98)
chrX	123046537	123046537	T	-	hom		QUAL=2729;DP=93;AF=0.73;MQM=59;TRIO=HOM,93,0.73,HOM,40,0.70,HOM,25,0.76	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5519delT:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5519delT:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.6263delT:	AluSz	rs374013599	0.2490	0.3050	4/4/0	0.0281										38	228					XIAP (inh=n/a pLI=0.98)
chrX	123046923	123046923	T	G	hom		QUAL=5354;DP=53;AF=1.00;MQM=59;TRIO=HOM,53,1.00,HOM,74,1.00,HOM,47,1.00	XIAP	3'UTR,non_coding_exon	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5892T>G:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5892T>G:,XIAP:NR_037916.1:non_coding_exon:MODIFIER:exon6/6:n.6636T>G:	AluSx	rs6648556	0.6212	0.5520	480/173/24	0.1100										276	109					XIAP (inh=n/a pLI=0.98)
chrX	123506104	123506104	T	A	hom		QUAL=6225;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HOM,87,1.00,WT,57,0.00	SH2D1A	3'UTR	SH2D1A:NM_002351.4:3'UTR:MODIFIER:exon4/4:c.*863T>A:,SH2D1A:NM_001114937.2:3'UTR:MODIFIER:exon4/4:c.*863T>A:		rs7876065	0.8140	0.0000	0/0/0	0.1043										269	30					SH2D1A (inh=n/a pLI=0.08)
chrX	128938958	128938958	T	C	hom		QUAL=15207;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,156,1.00,HOM,106,1.00	ZDHHC9	3'UTR	ZDHHC9:NM_001008222.2:3'UTR:MODIFIER:exon10/10:c.*1388A>G:,ZDHHC9:NM_016032.3:3'UTR:MODIFIER:exon11/11:c.*1388A>G:		rs1053486	0.6196	0.0000	0/0/0	0.1025										314	10					ZDHHC9 (inh=n/a pLI=0.89)
chrX	129283520	129283520	A	G	hom		QUAL=16470;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HOM,204,1.00,HOM,134,0.99	AIFM1	synonymous,non_coding_exon	AIFM1:NM_004208.3:synonymous:LOW:exon3/16:c.273T>C:p.Asp91Asp,AIFM1:NM_001130847.3:synonymous:LOW:exon3/17:c.273T>C:p.Asp91Asp,AIFM1:NM_145812.2:synonymous:LOW:exon3/16:c.261T>C:p.Asp87Asp,AIFM1:NR_132647.1:non_coding_exon:MODIFIER:exon2/16:n.361T>C:		rs1139851	0.4911	0.4310	5607/2478/1687	0.4003						300169 [AIFM1 (confirmed) Combined oxidative phosphorylation deficiency 6|Cowchock syndrome];			COSM1465605, COSM1465604	443	230					AIFM1 (inh=XLR pLI=0.98)
chrX	132838306	132838306	A	-	het		QUAL=139;DP=71;AF=0.30;MQM=59;TRIO=HET,71,0.30,WT,71,0.18,HET,67,0.15	GPC3	splice_region&intron,intron	GPC3:NM_001164617.1:splice_region&intron:LOW:exon3/8:c.1033-5delT:,GPC3:NM_001164618.1:intron:MODIFIER:exon3/7:c.985-4250delT:,GPC3:NM_001164619.1:intron:MODIFIER:exon2/6:c.871-4250delT:,GPC3:NM_004484.3:intron:MODIFIER:exon3/7:c.1033-4250delT:		rs374169314	0.0000	0.0830	0/0/0	0.0321						300037 [GPC3 (confirmed) Simpson-Golabi-Behmel syndrome,type 1|Wilms tumor,somatic];			COSM1625536	2	220					GPC3 (inh=XLR pLI=0.99)
chrX	135251679	135251679	-	A	hom		QUAL=4123;DP=104;AF=0.88;MQM=59;TRIO=HOM,104,0.88,HOM,56,0.95,WT,39,0.00	FHL1	5'UTR,intron	FHL1:NM_001159704.1:5'UTR:MODIFIER:exon1/6:c.-478dupA:,FHL1:NM_001159702.2:intron:MODIFIER:exon1/7:c.-100-378dupA:,FHL1:NR_027621.1:intron:MODIFIER:exon1/6:n.312-378dupA:,FHL1:NM_001159703.1:intron:MODIFIER:exon1/5:c.-100-378dupA:,FHL1:NM_001449.4:intron:MODIFIER:exon1/6:c.-100-378dupA:,FHL1:NM_001159700.1:intron:MODIFIER:exon1/6:c.-100-378dupA:		rs397710404;rs760593394	0.0000	0.0000	0/0/0	0.3150										167	125					FHL1 (inh=n/a pLI=0.92)
chrX	135292022	135292022	C	T	hom		QUAL=11269;DP=96;AF=0.99;MQM=59;TRIO=HOM,96,0.99,HOM,140,1.00,HOM,133,1.00	FHL1	splice_region&intron	FHL1:NM_001159702.2:splice_region&intron:LOW:exon7/7:c.889-8C>T:,FHL1:NR_027621.1:splice_region&intron:LOW:exon6/6:n.1100-8C>T:,FHL1:NM_001159703.1:splice_region&intron:LOW:exon5/5:c.502-8C>T:,FHL1:NM_001449.4:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159700.1:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159704.1:splice_region&intron:LOW:exon5/5:c.689-8C>T:,FHL1:NM_001167819.1:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159701.1:splice_region&intron:LOW:exon5/5:c.776-8C>T:,FHL1:NM_001159699.1:splice_region&intron:LOW:exon5/5:c.737-8C>T:	(TTTCT)n	rs2076705	0.5197	0.4900	6087/3308/376	0.4202						300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant|Myopathy,X-linked,with postural muscle atrophy|Myopathy,reducing body,X-linked,severe early-onset|Myopathy,reducing body,X-linked,childhood-onset|Emery-Dreifuss muscular dystrophy 6,X-linked];	RCV000179824.1 [benign]; 			491	240					FHL1 (inh=n/a pLI=0.92)
chrX	135292164	135292164	G	A	hom	phylop_high;pred_pathogenic_1	QUAL=8223;DP=187;AF=0.99;MQM=59;TRIO=HOM,187,0.99,HET,205,0.45,WT,149,0.00	FHL1	missense,3'UTR,non_coding_exon	FHL1:NM_001449.4:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159700.1:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159704.1:missense:MODERATE:exon6/6:c.823G>A:p.Asp275Asn,FHL1:NM_001167819.1:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159701.1:missense:MODERATE:exon6/6:c.910G>A:p.Asp304Asn,FHL1:NM_001159699.1:missense:MODERATE:exon6/6:c.871G>A:p.Asp291Asn,FHL1:NM_001159702.2:3'UTR:MODIFIER:exon8/8:c.*51G>A:,FHL1:NM_001159703.1:3'UTR:MODIFIER:exon6/6:c.*51G>A:,FHL1:NR_027621.1:non_coding_exon:MODIFIER:exon7/7:n.1234G>A:		rs151315725	0.0048	0.0110	10/10/0	0.0105	6.2260	T	D,D,D,D,D,D,D,D,D	P,B	B,B	300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant|Myopathy,X-linked,with postural muscle atrophy|Myopathy,reducing body,X-linked,severe early-onset|Myopathy,reducing body,X-linked,childhood-onset|Emery-Dreifuss muscular dystrophy 6,X-linked];				10	11					FHL1 (inh=n/a pLI=0.92)
chrX	135293082	135293082	G	A	hom		QUAL=18935;DP=226;AF=0.99;MQM=60;TRIO=HOM,226,0.99,HOM,214,1.00,HOM,141,1.00	FHL1	3'UTR,non_coding_exon	FHL1:NM_001159702.2:3'UTR:MODIFIER:exon8/8:c.*969G>A:,FHL1:NM_001159703.1:3'UTR:MODIFIER:exon6/6:c.*969G>A:,FHL1:NM_001449.4:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159700.1:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159704.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:NM_001167819.1:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159701.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:NM_001159699.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:NR_027621.1:non_coding_exon:MODIFIER:exon7/7:n.2152G>A:		rs9018	0.5068	0.4380	353/142/6	0.0967										303	121					FHL1 (inh=n/a pLI=0.92)
chrX	135742076	135742076	G	C	het		QUAL=396;DP=50;AF=0.48;MQM=52;TRIO=HET,50,0.48,WT,28,0.00,WT,20,0.00	CD40LG	3'UTR	CD40LG:NM_000074.2:3'UTR:MODIFIER:exon5/5:c.*502G>C:			0.0000	0.0000	0/0/0	0.0000										0	4					CD40LG (inh=n/a pLI=0.86)
chrX	135742096	135742096	G	C	hom	low_DP	QUAL=362;DP=19;AF=0.68;MQM=52;TRIO=HOM,19,0.68,HOM,10,0.10,HOM,6,0.50	CD40LG	3'UTR	CD40LG:NM_000074.2:3'UTR:MODIFIER:exon5/5:c.*522G>C:	(C)n	rs867476242	0.0000	0.0000	0/0/0	0.0002										0	16					CD40LG (inh=n/a pLI=0.86)
chrX	135742258	135742258	C	T	hom		QUAL=2129;DP=61;AF=1.00;MQM=58;TRIO=HOM,61,1.00,HET,44,0.45,WT,35,0.00	CD40LG	3'UTR	CD40LG:NM_000074.2:3'UTR:MODIFIER:exon5/5:c.*684C>T:	(TC)n	rs779484195	0.0029	0.0000	0/0/0	0.0030										0	2					CD40LG (inh=n/a pLI=0.86)
chrX	147031538	147031538	C	T	hom		QUAL=4529;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HOM,40,1.00,HOM,30,1.00	FMR1	3'UTR,non_coding_exon	FMR1:NM_002024.5:3'UTR:MODIFIER:exon17/17:c.*1174C>T:,FMR1:NM_001185075.1:3'UTR:MODIFIER:exon16/16:c.*1188C>T:,FMR1:NM_001185076.1:3'UTR:MODIFIER:exon16/16:c.*1174C>T:,FMR1:NM_001185081.1:3'UTR:MODIFIER:exon15/15:c.*1188C>T:,FMR1:NM_001185082.1:3'UTR:MODIFIER:exon16/16:c.*1174C>T:,FMR1:NR_033699.1:non_coding_exon:MODIFIER:exon16/16:n.3106C>T:,FMR1:NR_033700.1:non_coding_exon:MODIFIER:exon15/15:n.3043C>T:		rs25704	0.4956	0.2610	228/49/73	0.0628								CR114249 [CLASS=DP MUT=ALT PHEN="Epithelial ovarian cancer increased risk association" GENE=FMR1]; 		159	90					FMR1 (inh=XLD pLI=0.13)
chrX	148055144	148055144	A	G	hom		QUAL=15818;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,256,1.00,HOM,160,1.00	AFF2	splice_region&intron	AFF2:NM_002025.3:splice_region&intron:LOW:exon16/20:c.3404+7A>G:,AFF2:NM_001169122.1:splice_region&intron:LOW:exon15/19:c.3299+7A>G:,AFF2:NM_001169123.1:splice_region&intron:LOW:exon16/20:c.3374+7A>G:,AFF2:NM_001169124.1:splice_region&intron:LOW:exon15/19:c.3299+7A>G:,AFF2:NM_001169125.1:splice_region&intron:LOW:exon15/19:c.3287+7A>G:,AFF2:NM_001170628.1:splice_region&intron:LOW:exon13/17:c.2327+7A>G:		rs5980615	0.9542	0.9840	25940/14606/2279	0.8886						300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type];	RCV000079971.8 [other]; 			1279	3					AFF2 (inh=XLR pLI=1.00)
chrX	148079639	148079639	A	C	hom		QUAL=12505;DP=141;AF=0.99;MQM=60;TRIO=HOM,141,0.99,HOM,139,1.00,HOM,98,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*6777A>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*6777A>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*6777A>C:		rs16994920	0.8760	0.0000	0/0/0	0.1080										305	13					AFF2 (inh=XLR pLI=1.00)
chrX	148079740	148079740	A	C	hom		QUAL=18890;DP=161;AF=1.00;MQM=60;TRIO=HOM,161,1.00,HOM,265,1.00,HOM,160,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*6878A>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*6878A>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*6878A>C:		rs58901446	0.8707	0.0000	0/0/0	0.6319										307	12					AFF2 (inh=XLR pLI=1.00)
chrX	148079877	148079877	T	C	hom		QUAL=18325;DP=163;AF=0.99;MQM=60;TRIO=HOM,163,0.99,HOM,238,1.00,HOM,164,0.99	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*7015T>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*7015T>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*7015T>C:		rs16994922	0.8302	0.0000	0/0/0	0.6235										308	12					AFF2 (inh=XLR pLI=1.00)
chrX	148081140	148081140	A	G	hom		QUAL=21607;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,319,1.00,HOM,215,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*8278A>G:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*8278A>G:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*8278A>G:	(GT)n	rs184050542	0.9966	0.0000	0/0/0	0.6029										325	1					AFF2 (inh=XLR pLI=1.00)
chrX	148081451	148081451	A	G	hom		QUAL=13091;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HOM,139,1.00,HOM,77,0.99	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*8589A>G:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*8589A>G:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*8589A>G:		rs141776682	1.0000	0.0000	0/0/0	0.1189										334	0					AFF2 (inh=XLR pLI=1.00)
chrX	149826503	149826503	G	A	hom		QUAL=3747;DP=64;AF=1.00;MQM=60;TRIO=HOM,64,1.00,HOM,57,1.00,WT,35,0.00	MTM1	splice_region&intron	MTM1:NM_000252.2:splice_region&intron:LOW:exon11/14:c.1260+3G>A:		rs222410	0.6570	0.5600	8850/3658/2570	0.5198						300415 [MTM1 (confirmed) Myotubular myopathy,X-linked];	RCV000078428.7 [other]; 			587	218					MTM1 (inh=n/a pLI=1.00)
chrX	153008675	153008675	G	A	het	low_MQM	QUAL=369;DP=98;AF=0.39;MQM=34;TRIO=HET,98,0.39,WT,362,0.00,WT,208,0.00	ABCD1	splice_region&synonymous	ABCD1:NM_000033.3:splice_region&synonymous:LOW:exon9/10:c.1866G>A:p.Arg622Arg		rs201197921	0.0000	0.0000	0/0/0	0.0002						300371 [ABCD1 (confirmed) Adrenoleukodystrophy|Adrenomyeloneuropathy,adult];			COSM1636441	0	174					ABCD1 (inh=XLR pLI=0.98)
chrX	153008984	153008984	G	A	het	low_MQM;phylop_high;pred_pathogenic_4	QUAL=380;DP=77;AF=0.43;MQM=32;TRIO=HET,77,0.43,WT,288,0.00,WT,180,0.00	ABCD1	missense	ABCD1:NM_000033.3:missense:MODERATE:exon10/10:c.2033G>A:p.Gly678Asp		rs75125350	0.0000	0.0002	0/0/0	0.0005	9.4050	D	D	D	D	300371 [ABCD1 (confirmed) Adrenoleukodystrophy|Adrenomyeloneuropathy,adult];				0	139					ABCD1 (inh=XLR pLI=0.98)
chrX	153009017	153009017	G	A	het	low_MQM;phylop_high;pred_pathogenic_4	QUAL=179;DP=76;AF=0.34;MQM=31;TRIO=HET,76,0.34,WT,260,0.00,WT,168,0.00	ABCD1	missense	ABCD1:NM_000033.3:missense:MODERATE:exon10/10:c.2066G>A:p.Arg689His		rs781952886	0.0000	0.0001	0/0/0	0.0001	7.5710	D	D	D	D	300371 [ABCD1 (confirmed) Adrenoleukodystrophy|Adrenomyeloneuropathy,adult];				0	145					ABCD1 (inh=XLR pLI=0.98)
chrX	153009140	153009140	C	T	het	low_MQM;pred_pathogenic_1	QUAL=42;DP=49;AF=0.27;MQM=39;TRIO=HET,49,0.27,WT,78,0.00,WT,62,0.00	ABCD1	missense	ABCD1:NM_000033.3:missense:MODERATE:exon10/10:c.2189C>T:p.Pro730Leu		rs375489051	0.0000	0.0001	0/0/0	0.0001	-0.2740	D	T	B	B	300371 [ABCD1 (confirmed) Adrenoleukodystrophy|Adrenomyeloneuropathy,adult];				0	58					ABCD1 (inh=XLR pLI=0.98)
chrX	153009289	153009289	C	A	het		QUAL=88;DP=45;AF=0.24;MQM=51;TRIO=HET,45,0.24,WT,39,0.00,WT,31,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*100C>A:		rs182735515	0.0000	0.0000	0/0/0	0.0001										0	86					ABCD1 (inh=XLR pLI=0.98)
chrX	153009303	153009303	A	G	het	low_MQM	QUAL=56;DP=42;AF=0.21;MQM=47;TRIO=HET,42,0.21,WT,43,0.00,WT,38,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*114A>G:			0.0000	0.0000	0/0/0	0.0000										0	84					ABCD1 (inh=XLR pLI=0.98)
chrX	153009304	153009304	A	G	het	low_MQM	QUAL=56;DP=42;AF=0.21;MQM=47;TRIO=HET,42,0.21,WT,43,0.00,WT,38,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*115A>G:			0.0000	0.0000	0/0/0	0.0000										0	80					ABCD1 (inh=XLR pLI=0.98)
chrX	153009314	153009314	C	A	het	low_QUAL;low_MQM	QUAL=14;DP=56;AF=0.21;MQM=43;TRIO=HET,56,0.21,WT,51,0.00,WT,39,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*125C>A:			0.0000	0.0000	0/0/0	0.0000										0	123					ABCD1 (inh=XLR pLI=0.98)
chrX	153009342	153009342	C	T	het	low_MQM	QUAL=102;DP=73;AF=0.29;MQM=38;TRIO=HET,73,0.29,WT,58,0.00,WT,48,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*153C>T:			0.0000	0.0000	0/0/0	0.0000										0	151					ABCD1 (inh=XLR pLI=0.98)
chrX	153009350	153009350	G	A	het	low_MQM	QUAL=186;DP=67;AF=0.28;MQM=38;TRIO=HET,67,0.28,WT,64,0.00,WT,54,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*161G>A:			0.0000	0.0000	0/0/0	0.0000										1	160					ABCD1 (inh=XLR pLI=0.98)
chrX	153009352	153009352	A	G	het	low_MQM	QUAL=186;DP=67;AF=0.28;MQM=38;TRIO=HET,67,0.28,WT,64,0.00,WT,54,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*163A>G:		rs191015436	0.0000	0.0000	0/0/0	0.0001										1	157					ABCD1 (inh=XLR pLI=0.98)
chrX	153009364	153009364	G	A	het	low_MQM	QUAL=375;DP=86;AF=0.36;MQM=36;TRIO=HET,86,0.36,WT,64,0.00,WT,53,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*175G>A:			0.0000	0.0000	0/0/0	0.0001										1	163					ABCD1 (inh=XLR pLI=0.98)
chrX	153009385	153009385	C	G	het	low_MQM	QUAL=155;DP=63;AF=0.35;MQM=31;TRIO=HET,63,0.35,WT,73,0.00,WT,55,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*196C>G:		rs367591611	0.0000	0.0000	0/0/0	0.0001										0	76					ABCD1 (inh=XLR pLI=0.98)
chrX	153009386	153009386	G	T	het	low_MQM	QUAL=155;DP=63;AF=0.35;MQM=31;TRIO=HET,63,0.35,WT,73,0.00,WT,55,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*197G>T:		rs371380320	0.0000	0.0000	0/0/0	0.0001										0	73					ABCD1 (inh=XLR pLI=0.98)
chrX	153009448	153009448	A	G	het	low_MQM	QUAL=362;DP=54;AF=0.43;MQM=36;TRIO=HET,54,0.43,WT,76,0.00,WT,54,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*259A>G:		rs374092960	0.0000	0.0000	0/0/0	0.0013										0	222					ABCD1 (inh=XLR pLI=0.98)
chrX	153009488	153009488	C	T	het	low_MQM	QUAL=86;DP=68;AF=0.25;MQM=34;TRIO=HET,68,0.25,WT,77,0.00,WT,55,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*299C>T:		rs201959080	0.0000	0.0000	0/0/0	0.0004										0	130					ABCD1 (inh=XLR pLI=0.98)
chrX	153009665	153009665	A	G	het	low_MQM	QUAL=464;DP=131;AF=0.32;MQM=36;TRIO=HET,131,0.32,WT,165,0.01,WT,91,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*476A>G:		rs372234126	0.0000	0.0000	0/0/0	0.0066										0	239					ABCD1 (inh=XLR pLI=0.98)
chrX	153009670	153009670	G	T	het	low_MQM	QUAL=1145;DP=154;AF=0.46;MQM=38;TRIO=HET,154,0.46,WT,161,0.01,WT,91,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*481G>T:		rs199942817	0.0000	0.0000	0/0/0	0.0067										0	243					ABCD1 (inh=XLR pLI=0.98)
chrX	153009719	153009719	G	A	het	low_MQM	QUAL=2164;DP=164;AF=0.69;MQM=40;TRIO=HET,164,0.69,WT,163,0.00,WT,93,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*530G>A:		rs67211405	0.0000	0.0000	0/0/0	0.0122										0	274					ABCD1 (inh=XLR pLI=0.98)
chrX	153009769	153009769	C	G	het	low_MQM	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*580C>G:			0.0000	0.0000	0/0/0	0.0000										0	10					ABCD1 (inh=XLR pLI=0.98)
chrX	153009770	153009770	A	G	het	low_MQM	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*581A>G:			0.0000	0.0000	0/0/0	0.0000										0	9					ABCD1 (inh=XLR pLI=0.98)
chrX	153009774	153009774	G	A	het	low_MQM	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*585G>A:			0.0000	0.0000	0/0/0	0.0001										0	9					ABCD1 (inh=XLR pLI=0.98)
chrX	153009808	153009808	A	T	het	low_MQM	QUAL=56;DP=127;AF=0.21;MQM=38;TRIO=HET,127,0.21,WT,229,0.03,HET,154,0.12	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*619A>T:			0.0000	0.0000	0/0/0	0.0002										0	50					ABCD1 (inh=XLR pLI=0.98)
chrX	153009810	153009810	C	G	het	low_MQM	QUAL=56;DP=127;AF=0.21;MQM=38;TRIO=HET,127,0.21,WT,229,0.03,HET,154,0.12	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*621C>G:			0.0000	0.0000	0/0/0	0.0002										0	46					ABCD1 (inh=XLR pLI=0.98)
chrX	153009818	153009818	A	G	het	low_MQM	QUAL=276;DP=138;AF=0.25;MQM=36;TRIO=HET,138,0.25,WT,248,0.06,HET,169,0.15	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*629A>G:			0.0000	0.0000	0/0/0	0.0003										0	84					ABCD1 (inh=XLR pLI=0.98)
chrX	153009838	153009838	C	A	het	low_MQM	QUAL=667;DP=165;AF=0.27;MQM=35;TRIO=HET,165,0.27,WT,259,0.08,HET,183,0.21	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*649C>A:		rs372449563	0.0000	0.0000	0/0/0	0.0026										0	120					ABCD1 (inh=XLR pLI=0.98)
chrX	153009876	153009876	G	C	het	low_MQM	QUAL=960;DP=104;AF=0.30;MQM=34;TRIO=HET,104,0.30,WT,247,0.09,HET,186,0.26	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*687G>C:		rs377207559	0.0000	0.0000	0/0/0	0.0036										0	215					ABCD1 (inh=XLR pLI=0.98)
chrX	153009912	153009912	G	C	het	low_MQM	QUAL=443;DP=40;AF=0.25;MQM=35;TRIO=HET,40,0.25,WT,217,0.10,HET,171,0.28	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*723G>C:		rs369704281	0.0000	0.0000	0/0/0	0.0027										0	236					ABCD1 (inh=XLR pLI=0.98)
chrX	153009914	153009914	G	T	het	low_MQM	QUAL=443;DP=40;AF=0.25;MQM=35;TRIO=HET,40,0.25,WT,217,0.10,HET,171,0.28	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*725G>T:		rs202120253	0.0000	0.0000	0/0/0	0.0025										0	216					ABCD1 (inh=XLR pLI=0.98)
chrX	153010019	153010019	A	G	het	low_MQM	QUAL=764;DP=37;AF=0.05;MQM=39;TRIO=HET,37,0.05,HET,130,0.17,HET,122,0.39	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*830A>G:			0.0000	0.0000	0/0/0	0.0002										1	142					ABCD1 (inh=XLR pLI=0.98)
chrX	153010020	153010020	G	T	het	low_MQM	QUAL=764;DP=37;AF=0.05;MQM=39;TRIO=HET,37,0.05,HET,130,0.17,HET,122,0.39	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*831G>T:			0.0000	0.0000	0/0/0	0.0002										1	138					ABCD1 (inh=XLR pLI=0.98)
chrX	153010059	153010059	G	T	het	low_MQM	QUAL=3041;DP=104;AF=0.63;MQM=37;TRIO=HET,104,0.63,HET,122,0.30,HET,136,0.52	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*870G>T:		rs72616452	0.0000	0.0000	0/0/0	0.0041										0	334					ABCD1 (inh=XLR pLI=0.98)
chrX	153010090	153010090	G	A	het	low_MQM	QUAL=2848;DP=117;AF=0.61;MQM=38;TRIO=HET,117,0.61,HET,138,0.28,HET,144,0.53	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*901G>A:		rs75637470	0.0000	0.0000	0/0/0	0.0051										0	335					ABCD1 (inh=XLR pLI=0.98)
chrX	153010092	153010092	G	A	het	low_MQM	QUAL=2848;DP=117;AF=0.61;MQM=38;TRIO=HET,117,0.61,HET,138,0.28,HET,144,0.53	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*903G>A:		rs78155328	0.0000	0.0000	0/0/0	0.0044										0	335					ABCD1 (inh=XLR pLI=0.98)
chrX	153010137	153010137	C	T	het	low_MQM	QUAL=889;DP=91;AF=0.16;MQM=38;TRIO=HET,91,0.16,HET,161,0.17,HET,126,0.40	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*948C>T:		rs112109783	0.0000	0.0000	0/0/0	0.0022										0	304					ABCD1 (inh=XLR pLI=0.98)
chrX	153127735	153127735	G	A	hom		QUAL=1988;DP=32;AF=1.00;MQM=60;TRIO=HOM,32,1.00,HET,133,0.44,WT,96,0.00	L1CAM	3'UTR	L1CAM:NM_000425.4:3'UTR:MODIFIER:exon28/28:c.*383C>T:,L1CAM:NM_001143963.2:3'UTR:MODIFIER:exon26/26:c.*383C>T:,L1CAM:NM_024003.3:3'UTR:MODIFIER:exon27/27:c.*383C>T:,L1CAM:NM_001278116.1:3'UTR:MODIFIER:exon29/29:c.*383C>T:		rs41311708	0.0207	0.0000	0/0/0	0.0048										11	11					L1CAM (inh=XLR pLI=1.00)
chrX	153170980	153170980	T	G	hom		QUAL=2223;DP=38;AF=0.97;MQM=59;TRIO=HOM,38,0.97,HOM,25,1.00,HOM,18,1.00	AVPR2	splice_region&intron,intron	AVPR2:NM_000054.4:splice_region&intron:LOW:exon1/2:c.26-6T>G:,AVPR2:NM_001146151.1:splice_region&intron:LOW:exon1/1:c.26-6T>G:,AVPR2:NR_027419.1:intron:MODIFIER:exon2/3:n.559+356T>G:		rs56689668	0.9992	0.9980	14332/7851/1445	0.8146						300538 [AVPR2 (confirmed) Diabetes insipidus,nephrogenic|Nephrogenic syndrome of inappropriate antidiuresis];				1171	1					AVPR2 (inh=XLR pLI=0.12)
chrX	153215839	153215839	G	A	hom		QUAL=4672;DP=31;AF=0.97;MQM=59;TRIO=HOM,31,0.97,HOM,77,1.00,HOM,59,1.00	HCFC1	synonymous	HCFC1:NM_005334.2:synonymous:LOW:exon24/26:c.5859C>T:p.Cys1953Cys		rs3027875	0.1913	0.4320	6497/5802/27	0.4102	-0.6000	T				300019 [HCFC1 (confirmed) Mental retardation,X-linked 3 (methylmalonic acidemia and homocysteinemia,cblX type )];	RCV000081294.7 [other]; 		COSM457075, COSM457076	410	146					HCFC1 (inh=n/a pLI=1.00)
chrX	153287325	153287325	T	G	het		QUAL=44;DP=39;AF=0.36;MQM=58;TRIO=HET,39,0.36,HET,3,0.33,WT,7,0.00	MECP2	3'UTR	MECP2:NM_004992.3:3'UTR:MODIFIER:exon4/4:c.*8493A>C:		rs868980743	0.0000	0.0000	0/0/0	0.0001										0	22					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153292180	153292180	T	C	hom		QUAL=16671;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,223,1.00,HOM,131,1.00	MECP2	3'UTR	MECP2:NM_004992.3:3'UTR:MODIFIER:exon4/4:c.*3638A>G:		rs2734647	0.6262	0.0000	0/0/0	0.5229										257	30					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153294542	153294542	T	C	hom		QUAL=16172;DP=133;AF=0.99;MQM=60;TRIO=HOM,133,0.99,HOM,241,1.00,HOM,154,1.00	MECP2	3'UTR	MECP2:NM_004992.3:3'UTR:MODIFIER:exon4/4:c.*1276A>G:		rs2853337	0.9936	0.0000	0/0/0	0.1183										335	0					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153629155	153629155	A	G	hom	low_MQM	QUAL=12907;DP=185;AF=0.99;MQM=44;TRIO=HOM,185,0.99,HOM,156,1.00,HOM,93,1.00	RPL10	missense,3'UTR	RPL10:NM_001256577.2:missense:MODERATE:exon6/6:c.442A>G:p.Ile148Val,RPL10:NM_001256580.2:missense:MODERATE:exon6/6:c.497A>G:p.Asn166Ser,RPL10:NM_001303625.1:missense:MODERATE:exon7/7:c.605A>G:p.Asn202Ser,RPL10:NM_006013.4:missense:MODERATE:exon7/7:c.605A>G:p.Asn202Ser,RPL10:NM_001303624.1:missense:MODERATE:exon6/6:c.605A>G:p.Asn202Ser,RPL10:NM_001303626.1:3'UTR:MODIFIER:exon6/6:c.*156A>G:		rs868992861	0.6689	0.8150	17974/11413/162	0.6914	1.2780	T,T	T,T,T,T,T	B,B	B,B	312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5];	RCV000081344.7 [other]; 			1072	134					RPL10 (inh=n/a pLI=0.90)
chrX	153630255	153630255	G	C	hom		QUAL=21658;DP=193;AF=1.00;MQM=59;TRIO=HOM,193,1.00,HOM,301,1.00,HOM,178,1.00	RPL10,DNASE1L1	3'UTR	RPL10:NM_001256577.2:3'UTR:MODIFIER:exon6/6:c.*891G>C:,DNASE1L1:NM_001009932.2:3'UTR:MODIFIER:exon10/10:c.*793C>G:,RPL10:NM_001256580.2:3'UTR:MODIFIER:exon6/6:c.*1060G>C:,RPL10:NM_001303625.1:3'UTR:MODIFIER:exon7/7:c.*1060G>C:,RPL10:NM_006013.4:3'UTR:MODIFIER:exon7/7:c.*1060G>C:,RPL10:NM_001303624.1:3'UTR:MODIFIER:exon6/6:c.*1060G>C:,RPL10:NM_001303626.1:3'UTR:MODIFIER:exon6/6:c.*1256G>C:,DNASE1L1:NM_001303620.1:3'UTR:MODIFIER:exon8/8:c.*793C>G:,DNASE1L1:NM_006730.3:3'UTR:MODIFIER:exon8/8:c.*793C>G:,DNASE1L1:NM_001009933.2:3'UTR:MODIFIER:exon9/9:c.*793C>G:,DNASE1L1:NM_001009934.2:3'UTR:MODIFIER:exon8/8:c.*793C>G:		rs12877	0.6678	0.0000	0/0/0	0.0967						312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5];				245	20					RPL10 (inh=n/a pLI=0.90), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153630293	153630293	C	T	hom		QUAL=20341;DP=188;AF=1.00;MQM=59;TRIO=HOM,188,1.00,HOM,305,1.00,HOM,161,1.00	RPL10,DNASE1L1	3'UTR	RPL10:NM_001256577.2:3'UTR:MODIFIER:exon6/6:c.*929C>T:,DNASE1L1:NM_001009932.2:3'UTR:MODIFIER:exon10/10:c.*755G>A:,RPL10:NM_001256580.2:3'UTR:MODIFIER:exon6/6:c.*1098C>T:,RPL10:NM_001303625.1:3'UTR:MODIFIER:exon7/7:c.*1098C>T:,RPL10:NM_006013.4:3'UTR:MODIFIER:exon7/7:c.*1098C>T:,RPL10:NM_001303624.1:3'UTR:MODIFIER:exon6/6:c.*1098C>T:,RPL10:NM_001303626.1:3'UTR:MODIFIER:exon6/6:c.*1294C>T:,DNASE1L1:NM_001303620.1:3'UTR:MODIFIER:exon8/8:c.*755G>A:,DNASE1L1:NM_006730.3:3'UTR:MODIFIER:exon8/8:c.*755G>A:,DNASE1L1:NM_001009933.2:3'UTR:MODIFIER:exon9/9:c.*755G>A:,DNASE1L1:NM_001009934.2:3'UTR:MODIFIER:exon8/8:c.*755G>A:		rs12559	0.6681	0.0000	0/0/0	0.5667						312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5];				248	18					RPL10 (inh=n/a pLI=0.90), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153640061	153640061	T	-	hom	low_DP	QUAL=477;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,10,1.00,HOM,6,1.00	TAZ,DNASE1L1	5'UTR,intron,non_coding_exon	TAZ:NM_001303465.1:5'UTR:MODIFIER:exon1/10:c.-120delT:,TAZ:NM_000116.4:5'UTR:MODIFIER:exon1/11:c.-120delT:,TAZ:NM_181311.3:5'UTR:MODIFIER:exon1/10:c.-120delT:,TAZ:NM_181312.3:5'UTR:MODIFIER:exon1/10:c.-120delT:,TAZ:NM_181313.3:5'UTR:MODIFIER:exon1/9:c.-120delT:,DNASE1L1:NM_001009932.2:intron:MODIFIER:exon1/9:c.-431+167delA:,DNASE1L1:NM_001009933.2:intron:MODIFIER:exon1/8:c.-173+167delA:,DNASE1L1:NM_001009934.2:intron:MODIFIER:exon1/7:c.-88+167delA:,TAZ:NR_024048.2:non_coding_exon:MODIFIER:exon1/10:n.208delT:		rs11388353	0.7473	0.7610	1111/550/10	0.1659										527	36					TAZ (inh=n/a pLI=0.97), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153649813	153649813	G	C	hom		QUAL=8103;DP=73;AF=1.00;MQM=60;TRIO=HOM,73,1.00,HOM,109,1.00,HOM,80,1.00	TAZ	3'UTR,non_coding_exon	TAZ:NM_001303465.1:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:NM_000116.4:3'UTR:MODIFIER:exon11/11:c.*470G>C:,TAZ:NM_181311.3:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:NM_181312.3:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:NM_181313.3:3'UTR:MODIFIER:exon9/9:c.*470G>C:,TAZ:NR_024048.2:non_coding_exon:MODIFIER:exon10/10:n.1692G>C:		rs743547	0.0000	0.8530	1678/879/168	0.1637										662	46					TAZ (inh=n/a pLI=0.97)
chrX	153994596	153994596	G	T	hom		QUAL=17951;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,228,1.00,HOM,140,1.00	DKC1	synonymous,non_coding_exon	DKC1:NM_001363.4:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr,DKC1:NM_001142463.2:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr,DKC1:NM_001288747.1:synonymous:LOW:exon5/14:c.369G>T:p.Thr123Thr,DKC1:NR_110021.1:non_coding_exon:MODIFIER:exon4/14:n.1070G>T:,DKC1:NR_110022.1:non_coding_exon:MODIFIER:exon5/14:n.593G>T:,DKC1:NR_110023.1:non_coding_exon:MODIFIER:exon5/15:n.593G>T:		rs2728532	0.9926	0.9980	26889/14628/3152	0.8994	-3.5150	T				300126 [DKC1 (confirmed) Dyskeratosis congenita,X-linked];	RCV000153151.2 [benign]; 			1294	1					DKC1 (inh=n/a pLI=1.00)
chrX	154064200	154064200	C	T	hom		QUAL=11091;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,105,1.00,HOM,59,1.00	F8	3'UTR	F8:NM_000132.3:3'UTR:MODIFIER:exon26/26:c.*1672G>A:,F8:NM_019863.2:3'UTR:MODIFIER:exon5/5:c.*1672G>A:	LTR37B	rs1050705	0.5560	0.0000	0/0/0	0.0793										182	42					F8 (inh=n/a pLI=1.00)
chrX	154064580	154064580	T	C	hom		QUAL=10757;DP=114;AF=1.00;MQM=60;TRIO=HOM,114,1.00,HOM,124,0.99,HOM,91,1.00	F8	3'UTR	F8:NM_000132.3:3'UTR:MODIFIER:exon26/26:c.*1292A>G:,F8:NM_019863.2:3'UTR:MODIFIER:exon5/5:c.*1292A>G:		rs1396947	0.9926	0.0000	0/0/0	0.1187										335	0					F8 (inh=n/a pLI=1.00)
chrX	154488153	154488153	C	T	hom		QUAL=7494;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HET,101,0.52,WT,78,0.00	RAB39B	3'UTR	RAB39B:NM_171998.3:3'UTR:MODIFIER:exon2/2:c.*1935G>A:		rs782447828	0.0005	0.0000	0/0/0	0.0007										0	1					RAB39B (inh=XLR pLI=0.72)
chrM	72	72	T	C	hom		QUAL=223975;DP=3729;AF=0.99;MQM=56;TRIO=HOM,3729,0.99,HOM,3682,0.99,WT,4469,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0042										4	1					 (inh=n/a pLI=n/a)
chrM	73	73	G	A	hom		QUAL=223975;DP=3729;AF=0.99;MQM=56;TRIO=HOM,3729,0.99,HOM,3682,0.99,WT,4469,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0375										135	3					 (inh=n/a pLI=n/a)
chrM	150	150	T	C	hom		QUAL=247541;DP=4309;AF=1.00;MQM=59;TRIO=HOM,4309,1.00,HOM,3401,1.00,WT,4228,0.01		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.1187										322	1					 (inh=n/a pLI=n/a)
chrM	195	195	C	T	hom		QUAL=197074;DP=3718;AF=1.00;MQM=59;TRIO=HOM,3718,1.00,HOM,2443,1.00,WT,3389,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.1306										280	3					 (inh=n/a pLI=n/a)
chrM	302	302	-	C	hom		QUAL=53400;DP=1241;AF=0.55;MQM=59;TRIO=HOM,1241,0.55,HOM,421,0.48,WT,1558,0.97		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0478										6	28					 (inh=n/a pLI=n/a)
chrM	410	410	A	T	hom		QUAL=185578;DP=2981;AF=1.00;MQM=59;TRIO=HOM,2981,1.00,HOM,1061,1.00,HOM,1742,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										360	0					 (inh=n/a pLI=n/a)
chrM	2354	2354	C	T	hom		QUAL=335592;DP=4651;AF=1.00;MQM=59;TRIO=HOM,4651,1.00,HOM,2591,1.00,HOM,2981,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										346	1					 (inh=n/a pLI=n/a)
chrM	2485	2485	C	T	hom	low_MQM	QUAL=154072;DP=3124;AF=0.98;MQM=48;TRIO=HOM,3124,0.98,HOM,1231,0.81,HOM,1424,0.80		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										355	0					 (inh=n/a pLI=n/a)
chrM	4581	4581	G	A	hom	low_MQM	QUAL=125655;DP=2767;AF=0.99;MQM=31;TRIO=HOM,2767,0.99,HOM,2178,0.99,WT,2525,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0001										4	1					 (inh=n/a pLI=n/a)
chrM	5581	5581	C	T	hom	low_MQM	QUAL=240110;DP=2981;AF=1.00;MQM=42;TRIO=HOM,2981,1.00,HOM,2436,1.00,HOM,2724,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										317	0					 (inh=n/a pLI=n/a)
chrM	8702	8702	G	A	hom		QUAL=251669;DP=3249;AF=1.00;MQM=54;TRIO=HOM,3249,1.00,HOM,2200,1.00,HOM,2606,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										334	1					 (inh=n/a pLI=n/a)
chrM	9378	9378	G	A	hom	low_MQM	QUAL=364207;DP=3121;AF=1.00;MQM=46;TRIO=HOM,3121,1.00,HOM,4107,1.00,HOM,4868,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										355	0					 (inh=n/a pLI=n/a)
chrM	9541	9541	C	T	hom		QUAL=334445;DP=4709;AF=1.00;MQM=59;TRIO=HOM,4709,1.00,HOM,2727,1.00,HOM,3323,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										337	1					 (inh=n/a pLI=n/a)
chrM	10399	10399	G	A	hom		QUAL=256807;DP=4722;AF=1.00;MQM=59;TRIO=HOM,4722,1.00,HOM,3109,1.00,WT,3742,0.01		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										262	7					 (inh=n/a pLI=n/a)
chrM	10820	10820	G	A	hom		QUAL=376983;DP=5083;AF=1.00;MQM=57;TRIO=HOM,5083,1.00,HOM,3065,1.00,HOM,3661,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										356	0					 (inh=n/a pLI=n/a)
chrM	10874	10874	C	T	hom		QUAL=408222;DP=6084;AF=1.00;MQM=59;TRIO=HOM,6084,1.00,HOM,3073,1.00,HOM,3592,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										335	1					 (inh=n/a pLI=n/a)
chrM	11018	11018	C	T	hom		QUAL=354220;DP=5384;AF=1.00;MQM=53;TRIO=HOM,5384,1.00,HOM,2917,1.00,HOM,3324,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										358	1					 (inh=n/a pLI=n/a)
chrM	11720	11720	A	G	hom		QUAL=493351;DP=6255;AF=0.99;MQM=50;TRIO=HOM,6255,1.00,HOM,4020,1.00,WT,5281,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										141	2					 (inh=n/a pLI=n/a)
chrM	11723	11723	C	T	hom		QUAL=493351;DP=6255;AF=0.99;MQM=57;TRIO=HOM,6255,1.00,HOM,4020,1.00,HOM,5281,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										354	1					 (inh=n/a pLI=n/a)
chrM	12706	12706	T	C	hom		QUAL=448216;DP=5243;AF=0.98;MQM=59;TRIO=HOM,5243,0.98,HOM,4046,0.97,HOM,4672,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										289	10					 (inh=n/a pLI=n/a)
chrM	12851	12851	G	A	hom		QUAL=527427;DP=7307;AF=1.00;MQM=58;TRIO=HOM,7307,1.00,HOM,4410,1.00,HOM,4917,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										361	0					 (inh=n/a pLI=n/a)
chrM	14213	14213	C	T	hom		QUAL=295508;DP=3978;AF=1.00;MQM=54;TRIO=HOM,3978,1.00,HOM,2557,1.00,HOM,2795,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										356	0					 (inh=n/a pLI=n/a)
chrM	14371	14371	A	G	hom		QUAL=191957;DP=3971;AF=0.99;MQM=59;TRIO=HOM,3971,0.99,HOM,2191,0.99,WT,2363,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										1	0					 (inh=n/a pLI=n/a)
chrM	14581	14581	G	A	hom		QUAL=214544;DP=4472;AF=1.00;MQM=56;TRIO=HOM,4472,1.00,HOM,1001,1.00,HOM,1162,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										352	0					 (inh=n/a pLI=n/a)
chrM	14767	14767	T	C	hom		QUAL=172191;DP=3288;AF=1.00;MQM=59;TRIO=HOM,3288,1.00,HOM,2101,0.99,WT,2306,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0002										136	8					 (inh=n/a pLI=n/a)
chrM	14906	14906	A	G	hom		QUAL=355254;DP=4816;AF=1.00;MQM=57;TRIO=HOM,4816,1.00,HOM,3018,1.00,HOM,3292,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										319	4					 (inh=n/a pLI=n/a)
chrM	15302	15302	A	G	hom		QUAL=362721;DP=4208;AF=1.00;MQM=59;TRIO=HOM,4208,1.00,HOM,3470,1.00,HOM,3642,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										334	2					 (inh=n/a pLI=n/a)
chrM	15905	15905	C	T	hom		QUAL=301509;DP=6015;AF=0.99;MQM=59;TRIO=HOM,6015,0.99,HOM,3324,0.99,WT,3781,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0001										5	0					 (inh=n/a pLI=n/a)
chrM	15933	15933	C	T	hom		QUAL=475498;DP=7182;AF=1.00;MQM=59;TRIO=HOM,7182,1.00,HOM,3357,1.00,HOM,3800,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										348	1					 (inh=n/a pLI=n/a)
chrM	16173	16173	C	T	hom		QUAL=422227;DP=5597;AF=1.00;MQM=59;TRIO=HOM,5597,1.00,HOM,4019,1.00,HOM,3961,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0002										356	4					 (inh=n/a pLI=n/a)
chrM	16184	16184	C	-	het		QUAL=317912;DP=4846;AF=0.80;MQM=59;TRIO=HET,4846,0.99,HOM,3749,1.00,HOM,3684,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0022										242	76					 (inh=n/a pLI=n/a)
chrM	16184	16184	C	A	het		QUAL=317912;DP=4846;AF=0.80;MQM=59;TRIO=HET,4846,0.99,WT,3749,1.00,WT,3684,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										2	77					 (inh=n/a pLI=n/a)
chrM	16185	16185	C	A	het		QUAL=317912;DP=4846;AF=0.80;MQM=59;TRIO=HET,4846,0.99,HOM,3749,1.00,HOM,3684,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										242	74					 (inh=n/a pLI=n/a)
chrM	16191	16191	C	T	hom		QUAL=368515;DP=5434;AF=0.92;MQM=59;TRIO=HOM,5434,0.92,HOM,4024,0.96,HOM,4077,0.96		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										165	125					 (inh=n/a pLI=n/a)
chrM	16225	16225	T	C	hom		QUAL=504513;DP=6630;AF=1.00;MQM=59;TRIO=HOM,6630,1.00,HOM,4441,1.00,HOM,4656,1.00		intergenic_region	::intergenic_region:MODIFIER:::	(TCAACT)n		0.0000	0.0000	0/0/0	0.0000										306	5					 (inh=n/a pLI=n/a)
chrM	16300	16300	T	C	hom		QUAL=332532;DP=6126;AF=0.99;MQM=59;TRIO=HOM,6126,0.99,HOM,4225,0.99,WT,4799,0.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0001										10	2					 (inh=n/a pLI=n/a)
chrM	16322	16322	T	C	hom		QUAL=483793;DP=5641;AF=1.00;MQM=59;TRIO=HOM,5641,1.00,HOM,4399,1.00,HOM,4877,1.00		intergenic_region	::intergenic_region:MODIFIER:::			0.0000	0.0000	0/0/0	0.0000										357	0					 (inh=n/a pLI=n/a)
